PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Flanagan, SE; Xie, WJ; Caswell, R; Damhuis, A; Vianey-Saban, C; Akcay, T; Darendeliler, F; Bas, F; Guven, A; Siklar, Z; Ocal, G; Berberoglu, M; Murphy, N; O'Sullivan, M; Green, A; Clayton, PE; Banerjee, I; Clayton, PT; Hussain, K; Weedon, MN; Ellard, S				Flanagan, Sarah E.; Xie, Weijia; Caswell, Richard; Damhuis, Annet; Vianey-Saban, Christine; Akcay, Teoman; Darendeliler, Feyza; Bas, Firdevs; Guven, Alya; Siklar, Zeynep; Ocal, Gonul; Berberoglu, Merih; Murphy, Nuala; O'Sullivan, Maureen; Green, Andrew; Clayton, Peter E.; Banerjee, Indraneel; Clayton, Peter T.; Hussain, Khalid; Weedon, Michael N.; Ellard, Sian			Next-Generation Sequencing Reveals Deep Intronic Cryptic ABCC8 and HADH Splicing Founder Mutations Causing Hyperinsulinism by Pseudoexon Activation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							3-HYDROXYACYL-COA DEHYDROGENASE; BETA-THALASSEMIA; GENE; HYPOGLYCEMIA; DEFICIENCY; MECHANISM; DELETION; DEFECTS	Next-generation sequencing (NGS) enables analysis of the human genome on a scale previously unachievable by Sanger sequencing. Exome sequencing of the coding regions and conserved splice sites has been very successful in the identification of disease-causing mutations, and targeting of these regions has extended clinical diagnostic testing from analysis of fewer than ten genes per phenotype to more than 100. Noncoding mutations have been less extensively studied despite evidence from mRNA analysis for the existence of deep intronic mutations in >20 genes. We investigated individuals with hyperinsulinaemic hypoglycaemia and biochemical or genetic evidence to suggest noncoding mutations by using NGS to analyze the entire genomic regions of ABCC8 (117 kb) and HADH (94 kb) from overlapping similar to 10 kb PCR amplicons. Two deep intronic mutations, c.1333-1013A>G in ABCC8 and c.636+471G>T HADH, were identified. Both are predicted to create a cryptic splice donor site and an out-of-frame pseudoexon. Sequence analysis of mRNA from affected individuals' fibroblasts or lymphoblastoid cells confirmed mutant transcripts with pseudoexon inclusion and premature termination codons. Testing of additional individuals showed that these are founder mutations in the Irish and Turkish populations, accounting for 14% of focal hyperinsulinism cases and 32% of subjects with HADH mutations in our cohort. The identification of deep intronic mutations has previously focused on the detection of aberrant mRNA transcripts in a subset of disorders for which RNA is readily obtained from the target tissue or ectopically expressed at sufficient levels. Our approach of using NGS to analyze the entire genomic DNA sequence is applicable to any disease.	[Flanagan, Sarah E.; Xie, Weijia; Caswell, Richard; Weedon, Michael N.; Ellard, Sian] Univ Exeter, Sch Med, Inst Biomed & Clin Sci, Exeter EX2 5DW, Devon, England; [Damhuis, Annet; Ellard, Sian] Royal Devon & Exeter Natl Hlth Serv Fdn Trust, Dept Mol Genet, Exeter EX2 5AD, Devon, England; [Vianey-Saban, Christine] Ctr Hosp Univ, Ctr Biol & Pathol Est, Serv Malad Hereditaires Metab & Depistage Neonata, F-69677 Lyon, France; [Akcay, Teoman] Sisli Etfal Educ & Res Hosp, Dept Pediat Endocrinol, TR-34377 Istanbul, Turkey; [Darendeliler, Feyza; Bas, Firdevs] Istanbul Univ, Istanbul Fac Med, Pediat Endocrinol Unit, TR-34394 Istanbul, Turkey; [Guven, Alya] Goztepe Educ & Res Hosp, Dept Pediat Endocrinol, TR-34730 Istanbul, Turkey; [Siklar, Zeynep; Ocal, Gonul; Berberoglu, Merih] Ankara Univ, Sch Med, Dept Pediat Endocrinol, TR-06100 Ankara, Turkey; [Murphy, Nuala] Childrens Univ Hosp, Dept Endocrinol, Dublin 12, Ireland; [Green, Andrew] Our Ladys Childrens Hosp, Natl Ctr Med Genet, Dublin 12, Ireland; [O'Sullivan, Maureen] Univ Dublin Trinity Coll, Dublin 12, Ireland; [Green, Andrew] Univ Coll Dublin, Sch Med & Med Sci, Dublin 12, Ireland; [Clayton, Peter E.; Banerjee, Indraneel] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester M13 9WL, Lancs, England; [Banerjee, Indraneel] Royal Manchester Childrens Hosp, Dept Paediat Endocrinol, Manchester M13 9WL, Lancs, England; [Clayton, Peter E.] UCL, Great Ormond St Hosp Children NHS Trust, Inst Child Hlth, Clin & Mol Genet Unit, London WC1N 1EH, England; [Hussain, Khalid] Great Ormond St Hosp Sick Children, London Ctr Paediat Endocrinol & Metab, London WC1N 1EH, England	University of Exeter; CHU Lyon; Istanbul Sisli Hamidiye Etfal Training & Research Hospital; Istanbul University; Istanbul Goztepe Training and Research Hospital; Ankara University; Childrens University Hospital - Temple Street; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin; University College Dublin; University of Manchester; Royal Manchester Children's Hospital; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Ellard, S (corresponding author), Univ Exeter, Sch Med, Inst Biomed & Clin Sci, Exeter EX2 5DW, Devon, England.	sian.ellard@nhs.net	siklar, zeynep/AAN-3819-2020; GÜVEN, PROF.DR.AYLA/I-8448-2019; Bas, Firdevs/AAF-6511-2020; Darendeliler, Feyza/AAH-1013-2020; Green, Andrew/AAJ-7592-2020	siklar, zeynep/0000-0003-0921-2694; GÜVEN, PROF.DR.AYLA/0000-0002-2026-1326; Bas, Firdevs/0000-0001-9689-4464; Caswell, Richard/0000-0003-0713-4602; Ellard, Sian/0000-0002-7620-5526; Clayton, Peter/0000-0003-1225-4537; Green, Andrew/0000-0002-1077-7417; Weedon, Michael/0000-0002-6174-6135; Clayton, Peter/0000-0001-7592-4302; O'Sullivan, Maureen/0000-0001-5838-1609; berberoglu, merih/0000-0003-3102-0242; Flanagan, Sarah/0000-0002-8670-6340	Medical Research Council; Great Ormond Street Hospital Children's Charity; Diabetes UK; Diabetes UK [11/0004193] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1254] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Great Ormond Street Hospital Children's Charity; Diabetes UK(Diabetes UK); Diabetes UK(Diabetes UK); Great Ormond Street Hospital Childrens Charity	Bayarchimeg Mashbat provided technical assistance, and Hana Lango Allen provided bioinformatic support. We are grateful to Lorna Harries, Jonathan Locke, and Alice Holley for their assistance with the RNA studies. We also thank Konrad Paszkiewicz and colleagues at the University of Exeter Sequencing Service. The research leading to these results was funded by the Medical Research Council and Diabetes UK. Professor Peter T. Clayton is funded by Great Ormond Street Hospital Children's Charity.	Banerjee I, 2011, EUR J ENDOCRINOL, V164, P733, DOI 10.1530/EJE-10-1136; CHENG TC, 1984, P NATL ACAD SCI-BIOL, V81, P2821, DOI 10.1073/pnas.81.9.2821; Damaj L, 2008, J CLIN ENDOCR METAB, V93, P4941, DOI 10.1210/jc.2008-0673; deLonlay P, 1997, J CLIN INVEST, V100, P802, DOI 10.1172/JCI119594; DOBKIN C, 1983, P NATL ACAD SCI-BIOL, V80, P1184, DOI 10.1073/pnas.80.5.1184; Flanagan SE, 2012, PEDIATR DIABETES, V13, P285, DOI 10.1111/j.1399-5448.2011.00821.x; Flanagan SE, 2011, J CLIN ENDOCR METAB, V96, pE498, DOI 10.1210/jc.2010-1906; Heslegrave AJ, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-25; HIGHSMITH WE, 1994, NEW ENGL J MED, V331, P974, DOI 10.1056/NEJM199410133311503; Kapoor RR, 2009, J CLIN ENDOCR METAB, V94, P2221, DOI 10.1210/jc.2009-0423; Li CH, 2010, J BIOL CHEM, V285, P31806, DOI 10.1074/jbc.M110.123638; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mancini C, 2012, NEUROGENETICS, V13, P205, DOI 10.1007/s10048-012-0331-z; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nakamura K, 2012, HUM MUTAT, V33, P198, DOI 10.1002/humu.21632; Spier I, 2012, HUM MUTAT, V33, P1045, DOI 10.1002/humu.22082; TREISMAN R, 1983, NATURE, V302, P591, DOI 10.1038/302591a0; Tuffery-Giraud S, 2003, HUM MUTAT, V21, P608, DOI 10.1002/humu.10214	18	59	59	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 10	2013	92	1					131	136		10.1016/j.ajhg.2012.11.017	http://dx.doi.org/10.1016/j.ajhg.2012.11.017			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	073RA	23273570	Green Published, hybrid			2022-12-18	WOS:000313759000014
J	Froyen, G; Belet, S; Martinez, F; Santos-Reboucas, CB; Declercq, M; Verbeeck, J; Donckers, L; Berland, S; Mayo, S; Rosello, M; Pimentel, MMG; Fintelman-Rodrigues, N; Hovland, R; dos Santos, SR; Raymond, FL; Bose, T; Corbett, MA; Sheffield, L; van Ravenswaaij-Arts, CMA; Dijkhuizen, T; Coutton, C; Satre, V; Siu, V; Marynen, P				Froyen, Guy; Belet, Stefanie; Martinez, Francisco; Santos-Reboucas, Cintia Barros; Declercq, Matthias; Verbeeck, Jelle; Donckers, Lene; Berland, Siren; Mayo, Sonia; Rosello, Monica; Goncalves Pimentel, Marcia Mattos; Fintelman-Rodrigues, Natalia; Hovland, Randi; dos Santos, Suely Rodrigues; Raymond, F. Lucy; Bose, Tulika; Corbett, Mark A.; Sheffield, Leslie; van Ravenswaaij-Arts, Conny M. A.; Dijkhuizen, Trijnie; Coutton, Charles; Satre, Veronique; Siu, Victoria; Marynen, Peter			Copy-Number Gains of HUWE1 Due to Replication- and Recombination-Based Rearrangements	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							UBIQUITIN LIGASE HUWE1; LINKED MENTAL-RETARDATION; INTELLECTUAL DISABILITY; HUMAN GENOME; CHROMOSOMAL REARRANGEMENTS; MAMMALIAN-CELLS; MECP2 GENE; DUPLICATION; ARCHITECTURE; DISEASE	We previously reported on nonrecurrent overlapping duplications at Xp11.22 in individuals with nonsyndromic intellectual disability (ID) harboring HSD17B10, HUWE1, and the microRNAs miR-98 and let-7f-2 in the smallest region of overlap. Here, we describe six additional individuals with nonsyndromic ID and overlapping microduplications that segregate in the families. High-resolution mapping of the 12 copy-number gains reduced the minimal duplicated region to the HUWE1 locus only. Consequently, increased mRNA levels were detected for HUWE1, but not HSD17B10. Marker and SNP analysis, together with identification of two de novo events, suggested a paternally derived intrachromosomal duplication event. In four independent families, we report on a polymorphic 70 kb recurrent copy-number gain, which harbors part of HUWE1 (exon 28 to 3' untranslated region), including miR-98 and let-7f-2. Our findings thus demonstrate that HUWE1 is the only remaining dosage-sensitive gene associated with the ID phenotype. Junction and in silico analysis of breakpoint regions demonstrated simple microhomology-mediated rearrangements suggestive of replication-based duplication events. Intriguingly, in a single family, the duplication was generated through nonallelic homologous recombination (NAHR) with the use of HUWE1-flanking imperfect low-copy repeats, which drive this infrequent NAHR event. The recurrent partial HUWE1 copy-number gain was also generated through NAHR, but here, the homologous sequences used were identified as TcMAR-Tigger DNA elements, a template that has not yet been reported for NAHR. In summary, we showed that an increased dosage of HUWE1 causes nonsyndromic ID and demonstrated that the Xp11.22 region is prone to recombination- and replication-based rearrangements.	[Froyen, Guy; Belet, Stefanie; Declercq, Matthias; Verbeeck, Jelle; Donckers, Lene] Katholieke Univ Leuven VIB, Human Genome Lab, Ctr Biol Dis, B-3000 Louvain, Belgium; [Froyen, Guy; Belet, Stefanie; Declercq, Matthias; Verbeeck, Jelle; Donckers, Lene; Marynen, Peter] Katholieke Univ Leuven, Ctr Human Genet, Human Genome Lab, B-3000 Louvain, Belgium; [Martinez, Francisco; Mayo, Sonia; Rosello, Monica] Hosp Univ La Fe, Genet Unit, Valencia 46009, Spain; [Santos-Reboucas, Cintia Barros; Goncalves Pimentel, Marcia Mattos; Fintelman-Rodrigues, Natalia] Univ Estado Rio De Janeiro, Dept Genet, BR-20550013 Rio De Janeiro, Brazil; [Berland, Siren] St Olavs Hosp, Dept Clin Genet, N-7018 Trondheim, Norway; [Berland, Siren; Hovland, Randi] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [dos Santos, Suely Rodrigues] Univ Fed Rio de Janeiro, Gaffree & Guinle Univ Hosp, BR-20550013 Rio De Janeiro, Brazil; [Raymond, F. Lucy] Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Bose, Tulika; Corbett, Mark A.; Sheffield, Leslie] Womens & Childrens Hosp, Adelaide, SA 5006, Australia; [van Ravenswaaij-Arts, Conny M. A.; Dijkhuizen, Trijnie] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Coutton, Charles; Satre, Veronique] CHU Grenoble, Hop Couple Enfant, Dept Genet & Procreat, Lab Genet Chromosom, F-38700 Grenoble, France; [Coutton, Charles; Satre, Veronique] CNRS, Lab AGIM, Equipe Genet Infertilite & Therapeut, FRE3405, F-38706 Grenoble, France; [Coutton, Charles; Satre, Veronique] Univ Grenoble 1, F-38706 Grenoble, France; [Siu, Victoria] Univ Western Ontario, Dept Pediat, London, ON N6C 2V5, Canada	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; Hospital Universitari i Politecnic La Fe; Universidade do Estado do Rio de Janeiro; Norwegian University of Science & Technology (NTNU); University of Bergen; Haukeland University Hospital; Universidade Federal do Rio de Janeiro; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Womens & Childrens Hospital Australia; University of Groningen; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Western University (University of Western Ontario)	Froyen, G (corresponding author), Katholieke Univ Leuven VIB, Human Genome Lab, Ctr Biol Dis, B-3000 Louvain, Belgium.	guy.froyen@cme.vib-kuleuven.be; guy.froyen@cme.vib-kuleuven.be	Corbett, Mark/A-8063-2010; Rosello, Monica/B-2319-2009; Mayo, Sonia/A-4931-2010; Martinez, Francisco/A-2543-2009; COUTTON, Charles/G-2859-2014; Santos-Rebouças, Cíntia Barros/C-2230-2018; SATRE, Veronique/G-2864-2014	Corbett, Mark/0000-0001-9298-3072; Rosello, Monica/0000-0001-9234-2953; Mayo, Sonia/0000-0002-5465-7783; Martinez, Francisco/0000-0002-0589-2584; Santos-Rebouças, Cíntia Barros/0000-0003-4729-2373; Berland, Siren/0000-0002-8048-6682; Pimentel, Marcia/0000-0002-8872-7073; SATRE, Veronique/0000-0001-7852-8591; Coutton, Charles/0000-0002-8873-8098	Fondo de Investigaciones Sanitarias (Spanish Ministry of Health)/FEDER (Fondo Europeo de Desarrollo Regional) [PI080648]; CNPq (National Council for Scientific and Technological Development) [565705/2008-3]; FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro) in Brazil [E-26/110.765/2010, E-26/103.215/2011]; Women's and Children's Hospital Foundation in Australia; ITS Fundacion La Fe-Bancaja fellowship (Spain)	Fondo de Investigaciones Sanitarias (Spanish Ministry of Health)/FEDER (Fondo Europeo de Desarrollo Regional); CNPq (National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro) in Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Women's and Children's Hospital Foundation in Australia; ITS Fundacion La Fe-Bancaja fellowship (Spain)	We thank the families for their willingness to participate in this study. The microarray analyses were performed by the VIB Nucleomics Core. This study is supported by grants from the Fondo de Investigaciones Sanitarias (Spanish Ministry of Health)/FEDER (Fondo Europeo de Desarrollo Regional) (PI080648), from the CNPq (National Council for Scientific and Technological Development) (565705/2008-3) and FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro) (E-26/110.765/2010 and E-26/103.215/2011) in Brazil, and from the Women's and Children's Hospital Foundation in Australia. S.M. is supported by an ITS Fundacion La Fe-Bancaja fellowship (Spain).	Abeysinghe SS, 2003, HUM MUTAT, V22, P229, DOI 10.1002/humu.10254; Albano F, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-120; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Arlt MF, 2009, AM J HUM GENET, V84, P339, DOI 10.1016/j.ajhg.2009.01.024; Bacolla A, 2004, P NATL ACAD SCI USA, V101, P14162, DOI 10.1073/pnas.0405974101; Bauters M, 2008, GENOME RES, V18, P847, DOI 10.1101/gr.075903.107; Bonnet C, 2006, J HUM GENET, V51, P815, DOI 10.1007/s10038-006-0023-3; Carvalho CMB, 2009, HUM MOL GENET, V18, P2188, DOI 10.1093/hmg/ddp151; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; D'Arca D, 2010, P NATL ACAD SCI USA, V107, P5875, DOI 10.1073/pnas.0912874107; del Gaudio D, 2006, GENET MED, V8, P784, DOI 10.1097/01.gim.0000250502.28516.3c; Froyen G, 2008, AM J HUM GENET, V82, P432, DOI 10.1016/j.ajhg.2007.11.002; Gajecka M, 2008, GENOME RES, V18, P1733, DOI 10.1101/gr.077453.108; Gecz J, 2009, TRENDS GENET, V25, P308, DOI 10.1016/j.tig.2009.05.002; Giorda R, 2009, AM J HUM GENET, V85, P394, DOI 10.1016/j.ajhg.2009.08.001; Hannes F, 2010, EUR J MED GENET, V53, P136, DOI 10.1016/j.ejmg.2010.02.004; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Kasai M, 1997, J BIOL CHEM, V272, P11402; Kurahashi H, 2006, DNA REPAIR, V5, P1136, DOI 10.1016/j.dnarep.2006.05.035; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Lee JA, 2006, HUM MOL GENET, V15, P2250, DOI 10.1093/hmg/ddl150; Legesse-Miller A, 2009, J BIOL CHEM, V284, P6605, DOI 10.1074/jbc.C900002200; Lenski C, 2007, AM J HUM GENET, V80, P372, DOI 10.1086/511527; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Liu Y, 2011, FEBS LETT, V585, P1963, DOI 10.1016/j.febslet.2011.05.029; Lovett ST, 2004, MOL MICROBIOL, V52, P1243, DOI 10.1111/j.1365-2958.2004.04076.x; Madrigal I, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-443; Medrano S, 2005, BIOCHEM BIOPH RES CO, V331, P828, DOI 10.1016/j.bbrc.2005.03.194; Meins M, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.023804; Ofman R, 2003, AM J HUM GENET, V72, P1300, DOI 10.1086/375116; Ropers HH, 2008, CURR OPIN GENET DEV, V18, P241, DOI 10.1016/j.gde.2008.07.008; RUBNITZ J, 1984, MOL CELL BIOL, V4, P2253, DOI 10.1128/MCB.4.11.2253; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; Simmons AD, 2012, METHODS MOL BIOL, V838, P1, DOI 10.1007/978-1-61779-507-7_1; Smit AFA, 1996, P NATL ACAD SCI USA, V93, P1443, DOI 10.1073/pnas.93.4.1443; Stallings RL, 2007, CANCER GENET CYTOGEN, V176, P28, DOI 10.1016/j.cancergencyto.2007.02.014; Stankiewicz P, 2003, AM J HUM GENET, V72, P1101, DOI 10.1086/374385; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; Vandewalle J, 2009, AM J HUM GENET, V85, P809, DOI 10.1016/j.ajhg.2009.10.019; WALDMAN AS, 1988, MOL CELL BIOL, V8, P5350, DOI 10.1128/MCB.8.12.5350; Wang S, 2011, GENES IMMUN, V12, P149, DOI 10.1038/gene.2010.53; Wendler A, 2011, ONCOL REP, V25, P273, DOI 10.3892/or_00001071; Whibley AC, 2010, AM J HUM GENET, V87, P173, DOI 10.1016/j.ajhg.2010.06.017; Wu YL, 2010, FEBS J, V277, P3470, DOI 10.1111/j.1742-4658.2010.07760.x; Zhao JH, 2010, CELL MOL LIFE SCI, V67, P43, DOI 10.1007/s00018-009-0131-2; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727; Zhao X, 2009, DEV CELL, V17, P210, DOI 10.1016/j.devcel.2009.07.009; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	48	59	60	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG 10	2012	91	2					252	264		10.1016/j.ajhg.2012.06.010	http://dx.doi.org/10.1016/j.ajhg.2012.06.010			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	990CN	22840365	Green Published, Bronze			2022-12-18	WOS:000307608700004
J	Basel-Vanagaite, L; Zevit, N; Zahav, AH; Guo, L; Parathath, S; Pasmanik-Chor, M; McIntyre, AD; Wang, J; Albin-Kaplanski, A; Hartman, C; Marom, D; Zeharia, A; Badir, A; Shoerman, O; Simon, AJ; Rechavi, G; Shohat, M; Hegele, RA; Fisher, EA; Shamir, R				Basel-Vanagaite, Lina; Zevit, Noam; Zahav, Adi Har; Guo, Liang; Parathath, Saj; Pasmanik-Chor, Metsada; McIntyre, Adam D.; Wang, Jian; Albin-Kaplanski, Adi; Hartman, Corina; Marom, Daphna; Zeharia, Avraham; Badir, Abir; Shoerman, Oded; Simon, Amos J.; Rechavi, Gideon; Shohat, Mordechai; Hegele, Robert A.; Fisher, Edward A.; Shamir, Raanan			Transient Infantile Hypertriglyceridemia, Fatty Liver, and Hepatic Fibrosis Caused by Mutated GPD1, Encoding Glycerol-3-Phosphate Dehydrogenase 1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GLYCEROL 3-PHOSPHATE; RISK-FACTORS; FOLLOW-UP; EXPRESSION; CHILDREN; OBESITY; HYPERLIPIDEMIA; METHYLGLYOXAL; TRIGLYCERIDES; ASSOCIATION	The molecular basis for primary hereditary hypertriglyceridemia has been identified in fewer than 5% of cases. Investigation of monogenic dyslipidemias has the potential to expose key metabolic pathways. We describe a hitherto unreported disease in ten individuals manifesting as moderate to severe transient childhood hypertriglyceridemia and fatty liver followed by hepatic fibrosis and the identification of the mutated gene responsible for this condition. We performed SNP array-based homozygosity mapping and found a single large continuous segment of homozygosity on chromosomal region 12q13.12. The candidate region contained 35 genes that are listed in Online Mendelian Inheritance in Man (OMIM) and 27 other genes. We performed candidate gene sequencing and screened both clinically affected individuals (children and adults with hypertriglyceridemia) and also a healthy cohort for mutations in GPD1, which encodes glycerol-3-phosphate dehydrogenase 1. Mutation analysis revealed a homozygous splicing mutation, c.361-1G>C, which resulted in an aberrantly spliced mRNA in the ten affected individuals. This mutation is predicted to result in a truncated protein lacking essential conserved residues, including a functional site responsible for initial substrate recognition. Functional consequences of the mutation were evaluated by measuring intracellular concentrations of cholesterol and triglyceride as well as triglyceride secretion in HepG2 (hepatocellular carcinoma) human cells lines overexpressing normal and mutant GPD1 cDNA. Overexpression of mutant GPD1 in HepG2 cells, in comparison to overexpression of wild-type GPD1, resulted in increased secretion of triglycerides (p = 0.01). This finding supports the pathogenicity of the identified mutation.	[Basel-Vanagaite, Lina] Schneider Childrens Med Ctr Israel, Dept Pediat Genet, IL-49202 Petah Tiqwa, Israel; [Basel-Vanagaite, Lina; Zevit, Noam; Zahav, Adi Har; Hartman, Corina; Marom, Daphna; Zeharia, Avraham; Shoerman, Oded; Rechavi, Gideon; Shohat, Mordechai; Shamir, Raanan] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Basel-Vanagaite, Lina; Shohat, Mordechai] Beilinson Med Ctr, Rabin Med Ctr, Raphael Recanati Genet Inst, IL-49100 Petah Tiqwa, Israel; [Zevit, Noam; Hartman, Corina; Shamir, Raanan] Schneider Childrens Med Ctr Israel, Inst Gastroenterol Nutr & Liver Dis, IL-49202 Petah Tiqwa, Israel; [Guo, Liang; Parathath, Saj; Fisher, Edward A.] NYU, Sch Med, Dept Med, New York, NY 10016 USA; [Guo, Liang; Parathath, Saj; Fisher, Edward A.] NYU, Sch Med, Leon H Charney Div Cardiol, New York, NY 10016 USA; [Guo, Liang; Parathath, Saj; Fisher, Edward A.] NYU, Sch Med, Marc & Ruti Bell Vasc Biol & Dis Program, New York, NY 10016 USA; [Pasmanik-Chor, Metsada] Tel Aviv Univ, George S Wise Fac Life Sci, Bioinformat Unit, IL-69978 Tel Aviv, Israel; [McIntyre, Adam D.; Wang, Jian; Hegele, Robert A.] Univ Western Ontario, Robarts Res Inst, London, ON N6A 5K8, Canada; [McIntyre, Adam D.; Wang, Jian; Hegele, Robert A.] Univ Western Ontario, Schulich Sch Med & Dent, London, ON N6A 5K8, Canada; [Albin-Kaplanski, Adi] Beilinson Med Ctr, Rabin Med Ctr, Tissue Typing Lab, IL-49100 Petah Tiqwa, Israel; [Marom, Daphna] Schneider Childrens Med Ctr Israel, Dept Pediat A, IL-49202 Petah Tiqwa, Israel; [Zeharia, Avraham] Schneider Childrens Med Ctr Israel, Day Clin, IL-49202 Petah Tiqwa, Israel; [Badir, Abir] Clalit Hlth Serv, IL-48810 Kfar Kasem, Israel; [Shoerman, Oded] Schneider Childrens Med Ctr Israel, Dept Pediat B, IL-49202 Petah Tiqwa, Israel; [Simon, Amos J.; Rechavi, Gideon] Chaim Sheba Med Ctr, Sheba Canc Res Ctr, IL-52621 Tel Hashomer, Israel; [Basel-Vanagaite, Lina; Shohat, Mordechai] Tel Aviv Univ, Rabin Med Ctr, Sch Med, Felsenstein Med Res Ctr, IL-49100 Petah Tiqwa, Israel	Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; New York University; New York University; New York University; Tel Aviv University; Western University (University of Western Ontario); Western University (University of Western Ontario); Rabin Medical Center; Clalit Health Services; Chaim Sheba Medical Center; Rabin Medical Center; Tel Aviv University	Basel-Vanagaite, L (corresponding author), Schneider Childrens Med Ctr Israel, Dept Pediat Genet, 14 Kaplan St, IL-49202 Petah Tiqwa, Israel.	basel@post.tau.ac.il; nzevit@gmail.com	Zevit, Noam/AAB-1129-2019; Hegele, Robert/G-3301-2011; Fisher, Edward/ABE-7469-2020; Hegele, Robert/AAF-6482-2020; Parathath, Saj/ABE-2183-2021	Hegele, Robert/0000-0003-2861-5325; Guo, Liang/0000-0003-1633-1544; Parathath, Sajesh/0000-0003-3431-297X; Basel-Vanagaite, Vanagaite, Lina/0000-0002-9076-8157; Fisher, Edward/0000-0001-9802-143X; Zevit, Noam/0000-0003-1970-9143	Canadian Institutes for Health Research [MOP-13430, MOP-79523, CTP-79853]; Heart and Stroke Foundation of Ontario [NA-6059, T-6018, PRG-4854]; Genome Canada through the Ontario Genomics Institute; National Institute of Health [HL58541]; Adler Chair in Pediatric Cardiology, Tel Aviv University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058541] Funding Source: NIH RePORTER	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Genome Canada through the Ontario Genomics Institute(Genome Canada); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Adler Chair in Pediatric Cardiology, Tel Aviv University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Gabrielle J. Halpern for her help with editing the manuscript, Hava Fleischaker for her help with the multiple tests these families underwent, and the families for their participation. R.A.H. is supported by operating grants from the Canadian Institutes for Health Research (MOP-13430, MOP-79523, CTP-79853), the Heart and Stroke Foundation of Ontario (NA-6059, T-6018, PRG-4854), and Genome Canada through the Ontario Genomics Institute. L.G., SP., and E.A.F. were supported by National Institute of Health grant HL58541. This study was supported by the Adler Chair in Pediatric Cardiology, Tel Aviv University.	ALBERTYN J, 1994, MOL CELL BIOL, V14, P4135, DOI 10.1128/MCB.14.6.4135; Assmann G, 1998, EUR HEART J, V19, pA2; Athyros VG, 2002, J CLIN GASTROENTEROL, V34, P472, DOI 10.1097/00004836-200204000-00020; Bastian F, 2008, LECT N BIOINFORMAT, V5109, P124, DOI 10.1007/978-3-540-69828-9_12; Bishop JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013919; Boyd GS, 2005, PEDIATRICS, V116, P442, DOI 10.1542/peds.2004-1877; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; Chaplen FWR, 1998, P NATL ACAD SCI USA, V95, P5533, DOI 10.1073/pnas.95.10.5533; Cohen H., 2007, PEDIAT ENDOCRINOLOGY, P279; CRIQUI MH, 1993, NEW ENGL J MED, V328, P1220, DOI 10.1056/NEJM199304293281702; Cullen P, 2000, AM J CARDIOL, V86, P943, DOI 10.1016/S0002-9149(00)01127-9; DECLERCQ PE, 1982, BIOCHEM J, V204, P247, DOI 10.1042/bj2040247; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gao YZ, 2011, MOL BIOL REP, V38, P1875, DOI 10.1007/s11033-010-0305-x; Garces C, 2005, OBES RES, V13, P959, DOI 10.1038/oby.2005.111; Hegele RA, 2009, NAT REV GENET, V10, P109, DOI 10.1038/nrg2481; Ho C, 2007, NEPHROLOGY, V12, P348, DOI 10.1111/j.1440-1797.2007.00809.x; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; Hopkins PN, 2005, J AM COLL CARDIOL, V45, P1003, DOI 10.1016/j.jacc.2004.11.062; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jacobs MJ, 2005, DIABETES RES CLIN PR, V70, P263, DOI 10.1016/j.diabres.2005.03.032; JAMDAR SC, 1978, J LIPID RES, V19, P763; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Lai Shih-Wei, 2001, Yale Journal of Biology and Medicine, V74, P205; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Lee WS, 2007, HEPATOLOGY, V45, P1555, DOI 10.1002/hep.21710; MENAYA J, 1995, BBA-GENE STRUCT EXPR, V1262, P91, DOI 10.1016/0167-4781(95)00069-S; Merkel M, 2002, J LIPID RES, V43, P1997, DOI 10.1194/jlr.R200015-JLR200; Ou XJ, 2006, J MOL BIOL, V357, P858, DOI 10.1016/j.jmb.2005.12.074; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; PROCHAZKA M, 1989, J BIOL CHEM, V264, P4679; Reid A.E., 2010, SLEISENGER FORDTRANS, P1401; Reinehr T, 2005, NUTR METAB CARDIOVAS, V15, P181, DOI 10.1016/j.numecd.2004.06.003; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; Sherry N, 2005, J PEDIATR ENDOCR MET, V18, P1063; Swierczynski J, 2003, MOL CELL BIOCHEM, V254, P55, DOI 10.1023/A:1027332523114; Tonstad S, 1996, ARTERIOSCL THROM VAS, V16, P984, DOI 10.1161/01.ATV.16.8.984; Waterman IJ, 2002, J LIPID RES, V43, P1555, DOI 10.1194/jlr.M200051-JLR200; Yuan G, 2007, CAN MED ASSOC J, V176, P1113, DOI 10.1503/cmaj.060963	40	59	62	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 13	2012	90	1					49	60		10.1016/j.ajhg.2011.11.028	http://dx.doi.org/10.1016/j.ajhg.2011.11.028			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	880LR	22226083	Green Published, Bronze			2022-12-18	WOS:000299409100004
J	Tzeng, JY; Zhang, DW; Pongpanich, M; Smith, C; McCarthy, MI; Sale, MM; Worrall, BB; Hsu, FC; Thomas, DC; Sullivan, PF				Tzeng, Jung-Ying; Zhang, Daowen; Pongpanich, Monnat; Smith, Chris; McCarthy, Mark I.; Sale, Michele M.; Worrall, Bradford B.; Hsu, Fang-Chi; Thomas, Duncan C.; Sullivan, Patrick F.			Studying Gene and Gene-Environment Effects of Uncommon and Common Variants on Continuous Traits: A Marker-Set Approach Using Gene-Trait Similarity Regression	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							31 BP VNTR; TESTING ASSOCIATION; GENOMIC SIMILARITY; WIDE ASSOCIATION; MULTIPLE GENES; COMPLEX TRAITS; LINKAGE PHASE; CBS GENE; HOMOCYSTEINE; POWERFUL	Genomic association analyses of complex traits demand statistical tools that are capable of detecting small effects of common and rare variants and modeling complex interaction effects and yet are computationally feasible. In this work, we introduce a similarity-based regression method for assessing the main genetic and interaction effects of a group of markers on quantitative traits. The method uses genetic similarity to aggregate information from multiple polymorphic sites and integrates adaptive weights that depend on allele frequencies to accomodate common and uncommon variants. Collapsing information at the similarity level instead of the genotype level avoids canceling signals that have the opposite etiological effects and is applicable to any class of genetic variants without the need for dichotomizing the allele types. To assess gene-trait associations, we regress trait similarities for pairs of unrelated individuals on their genetic similarities and assess association by using a score test whose limiting distribution is derived in this work. The proposed regression framework allows for covariates, has the capacity to model both main and interaction effects, can be applied to a mixture of different polymorphism types, and is computationally efficient. These features make it an ideal tool for evaluating associations between phenotype and marker sets defined by linkage disequilibrium (LD) blocks, genes, or pathways in whole-genome analysis.	[Tzeng, Jung-Ying; Zhang, Daowen] N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; [Tzeng, Jung-Ying; Pongpanich, Monnat; Smith, Chris] N Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC 27695 USA; [McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Sale, Michele M.] Univ Virginia, Ctr Publ Hlth Genom, Dept Med & Biochem, Charlottesville, VA 22908 USA; [Sale, Michele M.] Univ Virginia, Ctr Publ Hlth Genom, Dept Mol Genet, Charlottesville, VA 22908 USA; [Worrall, Bradford B.] Univ Virginia, Ctr Publ Hlth Genom, Dept Publ Hlth Sci, Charlottesville, VA 22908 USA; [Worrall, Bradford B.] Univ Virginia, Ctr Publ Hlth Genom, Dept Neurol, Charlottesville, VA 22908 USA; [Hsu, Fang-Chi] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC 27157 USA; [Thomas, Duncan C.] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of Oxford; Wellcome Centre for Human Genetics; University of Virginia; University of Virginia; University of Virginia; University of Virginia; Wake Forest University; University of Southern California; University of North Carolina; University of North Carolina Chapel Hill	Tzeng, JY (corresponding author), N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA.	jung-ying_tzeng@ncsu.edu	; McCarthy, Mark/M-3763-2015	Tzeng, Jung-Ying/0000-0002-5505-1775; McCarthy, Mark/0000-0002-4393-0510; Pongpanich, Monnat/0000-0003-3228-3351	National Institutes of Health [R01 MH074027, P01 CA142538, R37 AI031789-20, R01 CA85848, U01 HG005160]; Wake Forest University General Clinical Research Center [M01 RR07122]; NATIONAL CANCER INSTITUTE [P01CA142538, R01CA085848] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR007122] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG005160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI031789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074027, R01MH084022] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wake Forest University General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank all the study subjects who participated in the VISP study. They also thank the two anonymous reviewers for their constructive comments and Alison Motsinger-Reif, Dmitri Zaykin, and Arnab Maity for their helpful discussions. This work was supported by National Institutes of Health grants R01 MH074027 (J.Y.T., D.Z., M.P., C.S., D.C.T., and P.F.S.), P01 CA142538 (J.Y.T.), R37 AI031789-20 (D.Z.), R01 CA85848 (D.Z.), and U01 HG005160 (M.M.S. and B.B.W.) and the Wake Forest University General Clinical Research Center M01 RR07122 (M.M.S. and F.C.H.).	[Anonymous], 1932, STAT METHODS RES WOR; Ballard DH, 2010, GENET EPIDEMIOL, V34, P201, DOI 10.1002/gepi.20448; Beckmann L, 2005, HUM HERED, V59, P67, DOI 10.1159/000085221; Chapman J, 2008, GENET EPIDEMIOL, V32, P560, DOI 10.1002/gepi.20330; Chatterjee N, 2006, AM J HUM GENET, V79, P1002, DOI 10.1086/509704; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; De la Cruz O, 2010, GENET EPIDEMIOL, V34, P222, DOI 10.1002/gepi.20452; Dempfle A, 2008, EUR J HUM GENET, V16, P1164, DOI 10.1038/ejhg.2008.106; Dempfle Astrid, 2007, BMC Proc, V1 Suppl 1, pS73; Fridley BL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012693; Gauderman WJ, 2007, GENET EPIDEMIOL, V31, P383, DOI 10.1002/gepi.20219; Goeman JJ, 2006, J ROY STAT SOC B, V68, P477, DOI 10.1111/j.1467-9868.2006.00551.x; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; HARVILLE DA, 1977, J AM STAT ASSOC, V72, P320, DOI 10.2307/2286796; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; HSU FC, 2011, NEUROLOGY IN PRESS; IMHOF JP, 1961, BIOMETRIKA, V48, P419, DOI 10.2307/2332763; Kraft P, 2007, HUM HERED, V63, P111, DOI 10.1159/000099183; Kwee LC, 2008, AM J HUM GENET, V82, P386, DOI 10.1016/j.ajhg.2007.10.010; Lake SL, 2003, HUM HERED, V55, P56, DOI 10.1159/000071811; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li MY, 2009, BIOINFORMATICS, V25, P497, DOI 10.1093/bioinformatics/btn641; Lievers KJA, 2006, EUR J HUM GENET, V14, P1125, DOI 10.1038/sj.ejhg.5201677; Lievers KJA, 2001, EUR J HUM GENET, V9, P583, DOI 10.1038/sj.ejhg.5200679; Lindstrom S, 2009, HUM HERED, V68, P171, DOI 10.1159/000224637; Luan YH, 2008, BIOSTATISTICS, V9, P100, DOI 10.1093/biostatistics/kxm015; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Moskvina V, 2008, GENET EPIDEMIOL, V32, P567, DOI 10.1002/gepi.20331; Mukhopadhyay I, 2010, GENET EPIDEMIOL, V34, P213, DOI 10.1002/gepi.20451; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; PEARSON ES, 1959, BIOMETRIKA, V46, P364, DOI 10.2307/2333533; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Qian DJ, 2001, GENET EPIDEMIOL, V21, pS582, DOI 10.1002/gepi.2001.21.s1.s582; Schaid DJ, 2010, HUM HERED, V70, P109, DOI 10.1159/000312641; Schaid DJ, 2010, HUM HERED, V70, P132, DOI 10.1159/000312643; Schaid DJ, 2005, AM J HUM GENET, V76, P780, DOI 10.1086/429838; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; SMITH PG, 1984, INT J EPIDEMIOL, V13, P356, DOI 10.1093/ije/13.3.356; Thomas D, 2010, ANNU REV PUBL HEALTH, V31, P21, DOI 10.1146/annurev.publhealth.012809.103619; Thomas D, 2010, NAT REV GENET, V11, P259, DOI 10.1038/nrg2764; Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565; Tsai MY, 1999, MOL GENET METAB, V67, P352, DOI 10.1006/mgme.1999.2874; Tzeng JY, 2007, AM J HUM GENET, V81, P927, DOI 10.1086/521558; Tzeng JY, 2009, BIOMETRICS, V65, P822, DOI 10.1111/j.1541-0420.2008.01176.x; Tzeng JY, 2003, J AM STAT ASSOC, V98, P236, DOI 10.1198/016214503388619256; Tzeng JY, 2003, AM J HUM GENET, V72, P891, DOI 10.1086/373881; Wang K, 2008, GENET EPIDEMIOL, V32, P108, DOI 10.1002/gepi.20266; Wang T, 2007, AM J HUM GENET, V80, P353, DOI 10.1086/511312; Wei Z, 2008, ANN HUM GENET, V72, P821, DOI 10.1111/j.1469-1809.2008.00473.x; Wessel J, 2006, AM J HUM GENET, V79, P792, DOI 10.1086/508346; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Zhang DW, 2003, BIOSTATISTICS, V4, P57, DOI 10.1093/biostatistics/4.1.57; Zhao JY, 2005, AM J HUM GENET, V77, P27, DOI 10.1086/431243	54	59	60	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 12	2011	89	2					277	288		10.1016/j.ajhg.2011.07.007	http://dx.doi.org/10.1016/j.ajhg.2011.07.007			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	810TA	21835306	Green Published, Bronze			2022-12-18	WOS:000294148800007
J	Feinstein, M; Markus, B; Noyman, I; Shalev, H; Flusser, H; Shelef, I; Liani-Leibson, K; Shorer, Z; Cohen, I; Khateeb, S; Sivan, S; Birk, OS				Feinstein, Miora; Markus, Barak; Noyman, Iris; Shalev, Hannah; Flusser, Hagit; Shelef, Ilan; Liani-Leibson, Keren; Shorer, Zamir; Cohen, Idan; Khateeb, Shareef; Sivan, Sara; Birk, Ohad S.			Pelizaeus-Merzbacher-like Disease Caused by AIMP1/p43 Homozygous Mutation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTERACTING MULTIFUNCTIONAL PROTEIN; GENE; PHOSPHORYLATION; IDENTIFICATION; COMPUTERS; DISORDER; PATHWAY; TYPE-2	Pelizaeus-Merzbacher disease is an X-linked hypomyelinating leukodystrophy caused by PLP1 mutations. A similar autosomal-recessive phenotype, Pelizaeus-Merzbacher-like disease (PMLD), has been shown to be caused by homozygous mutations in GJC2 or HSPD1. We report a consanguineous Israeli Bedouin kindred with clinical and radiological findings compatible with PMLD in which linkage to PLP1, GJC2, and HSPD1 was excluded. Through genome-wide homozygosity mapping and mutation analysis, we demonstrated in all affected individuals a homozygous frameshift mutation that fully abrogates the main active domain of AIMP1, encoding ARS-interacting multifunctional protein 1. The mutation fully segregates with the disease-associated phenotype and was not found in 250 Bedouin controls. Our findings are in line with the previously demonstrated inability of mutant mice lacking the AIMP1/p43 ortholog to maintain axon integrity in the central and peripheral neural system.	[Feinstein, Miora; Markus, Barak; Liani-Leibson, Keren; Cohen, Idan; Khateeb, Shareef; Sivan, Sara; Birk, Ohad S.] Natl Inst Biotechnol Negev, Morris Kahn Lab Human Genet, IL-84101 Beer Sheva, Israel; [Noyman, Iris; Shalev, Hannah; Flusser, Hagit; Shorer, Zamir] Ben Gurion Univ Negev, Div Pediat, IL-84101 Beer Sheva, Israel; [Shelef, Ilan] Ben Gurion Univ Negev, Diagnost Imaging Inst, IL-84101 Beer Sheva, Israel; [Birk, Ohad S.] Ben Gurion Univ Negev, Soroka Med Ctr, Genet Inst, IL-84101 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University; Soroka Medical Center	Birk, OS (corresponding author), Natl Inst Biotechnol Negev, Morris Kahn Lab Human Genet, IL-84101 Beer Sheva, Israel.	obirk@bgu.ac.il	Cohen, Idan/ACB-5528-2022	shelef, ilan/0000-0002-8398-6455; Cohen, Idan/0000-0002-5524-2344; Birk, Ohad/0000-0003-1430-1296	Israel Science Foundation; Morasha Legacy Heritage Fund; Morris Kahn Family Foundation	Israel Science Foundation(Israel Science Foundation); Morasha Legacy Heritage Fund; Morris Kahn Family Foundation	The authors deeply thank the Israel Science Foundation, the Morasha Legacy Heritage Fund, and the Morris Kahn Family Foundation for making this study possible.	Abe A, 2009, J HUM GENET, V54, P94, DOI 10.1038/jhg.2008.13; Agamy O, 2010, AM J HUM GENET, V87, P538, DOI 10.1016/j.ajhg.2010.09.007; [Anonymous], ONLINE MENDELIAN INH; Birnbaum RY, 2006, NAT GENET, V38, P749, DOI 10.1038/ng1813; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Budde BS, 2008, NAT GENET, V40, P1113, DOI 10.1038/ng.204; Fabrizi GM, 2007, BRAIN, V130, P394, DOI 10.1093/brain/awl284; Gefen A, 2010, HUM MUTAT, V31, P229, DOI 10.1002/humu.21171; Georgiou DM, 2002, NEUROGENETICS, V4, P93, DOI 10.1007/s10048-002-0138-4; Han JM, 2006, BIOCHEM BIOPH RES CO, V342, P113, DOI 10.1016/j.bbrc.2006.01.117; KAO J, 1994, J BIOL CHEM, V269, P25106; Khateeb S, 2006, AM J HUM GENET, V79, P942, DOI 10.1086/508572; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Lee SW, 2008, EXPERT OPIN DRUG DIS, V3, P945, DOI 10.1517/17460441.3.8.945; Magen D, 2008, AM J HUM GENET, V83, P30, DOI 10.1016/j.ajhg.2008.05.016; *MARSHF, MARSHF MAPS; Mersiyanova IV, 2000, AM J HUM GENET, V67, P37, DOI 10.1086/302962; Narkis G, 2007, AM J HUM GENET, V81, P530, DOI 10.1086/520771; Narkis G, 2007, AM J HUM GENET, V81, P589, DOI 10.1086/520770; *NEW ENGL BIOL, NEW ENGL BIOL NEBCUT; NIXON RA, 1991, TRENDS NEUROSCI, V14, P501, DOI 10.1016/0166-2236(91)90062-Y; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Petzold A, 2005, J NEUROL SCI, V233, P183, DOI 10.1016/j.jns.2005.03.015; Salviati L, 2007, NEUROGENETICS, V8, P57, DOI 10.1007/s10048-006-0065-x; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Silberstein M, 2006, AM J HUM GENET, V78, P922, DOI 10.1086/504158; Uhlenberg B, 2004, AM J HUM GENET, V75, P251, DOI 10.1086/422763; van der Knaap MS, 1999, RADIOLOGY, V213, P121, DOI 10.1148/radiology.213.1.r99se01121; Zhu XD, 2009, P NATL ACAD SCI USA, V106, P15944, DOI 10.1073/pnas.0901872106; SYNDROME GENE S2G; CHROMAS; SUPERLINK ONLINE VER; PRIMER3 V 0 4 0 PICK	34	59	63	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 10	2010	87	6					820	828		10.1016/j.ajhg.2010.10.016	http://dx.doi.org/10.1016/j.ajhg.2010.10.016			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	698AT	21092922	Bronze, Green Published			2022-12-18	WOS:000285564600008
J	Wang, H; Li, ZH; Wang, JZ; Sun, K; Cui, QQ; Song, L; Zou, YB; Wang, XJ; Liu, XA; Hui, RT; Fan, YX				Wang, Hu; Li, Zhaohui; Wang, Jizheng; Sun, Kai; Cui, Qiqiong; Song, Lei; Zou, Yubao; Wang, Xiaojian; Liu, Xuan; Hui, Rutai; Fan, Yuxin			Mutations in NEXN, a Z-Disc Gene, Are Associated with Hypertrophic Cardiomyopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DILATED CARDIOMYOPATHY; PROTEIN GENE; SUDDEN-DEATH; DISEASE; NEXILIN; STRESS; SERVER; HEART	Hypertrophic cardiomyopathy (HCM), the most common inherited cardiac disorder, is characterized by increased ventricular wall thickness that cannot be explained by underlying conditions, cadiomyocyte hypertrophy and disarray and increased myocardial fibrosis In as many as 50% of HCM cases, the genetic cause remains unknown suggesting that more genes may be involved Nexilin, encoded by NEXN, is a cardiac Z disc protein recently identified as a crucial protein that functions to protect cardiac Z discs from forces generated within the sarcomere We screened NEXN in 121 unrelated HCM patients who did not carry any mutation in eight genes commonly mutated in myofilament disease Two missense mutations, c 391C>G (p Q131E) and c 835C>T (p R279C), were identified in exons 5 and 8 of NEXN, respectively in two probands Each of the two mutations segregated with the HCM phenotype in the family and was absent in 384 control chromosomes In silico analysts revealed that both of the mutations affect highly conserved amino acid residues, which are predicted to be functionally deleterious Cellular transfection studies showed that the two mutations resulted in local accumulations of nexilin and that the expressed fragment of actin binding domain containing p Q131E completely lost the ability to bind F actin in C2C12 cells Coimmunoprecipitation assay indicated that the p Q131E mutation decreased the binding of full length NEXN to cc actin and abolished the interaction between the fragment of actin binding domain and alpha actin Therefore, the mutations in NEXN that we describe here may further expand the knowledge of Z disc genes in the pathogenesis of HCM	[Wang, Hu; Wang, Jizheng; Sun, Kai; Song, Lei; Zou, Yubao; Wang, Xiaojian; Liu, Xuan; Hui, Rutai] FuWai Hosp, Sino German Lab Mol Med, Beijing 100037, Peoples R China; [Wang, Hu; Wang, Jizheng; Sun, Kai; Cui, Qiqiong; Song, Lei; Zou, Yubao; Wang, Xiaojian; Liu, Xuan; Hui, Rutai] Chinese Acad Med Sci, Cardiovasc Inst, Peking Union Med Coll, Beijing 100037, Peoples R China; [Wang, Hu; Li, Zhaohui; Fan, Yuxin] Texas Childrens Hosp, Baylor Coll Med, Cardiol Sect, Dept Pediat, Houston, TX 77030 USA; [Cui, Qiqiong] FuWai Hosp, Dept Echocardiog, Beijing 100037, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Baylor College of Medicine; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS	Hui, RT (corresponding author), FuWai Hosp, Sino German Lab Mol Med, Beijing 100037, Peoples R China.		Sun, Kai/GQG-9680-2022		National Natural Science Foundation of China [30971234]; Abby Glaser Children's Heart Fund; Ministry of Science and Technology of China [2007DFC30340]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Abby Glaser Children's Heart Fund; Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants from the National Natural Science Foundation of China (30971234 to H W), the Abby Glaser Children's Heart Fund (Y F), and the Ministry of Science and Technology of China (2007DFC30340 to R H) We thank the patients and family members for participating in this study We are grateful to B Lee Ligon for critical reading of the manuscript	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahmad F, 2005, ANNU REV GENOM HUM G, V6, P185, DOI 10.1146/annurev.genom.6.080604.162132; Arimura T, 2009, J AM COLL CARDIOL, V54, P334, DOI 10.1016/j.jacc.2008.12.082; Bos JM, 2010, J AM COLL CARDIOL, V55, P1136, DOI 10.1016/j.jacc.2009.12.016; Bos JM, 2009, J AM COLL CARDIOL, V54, P201, DOI 10.1016/j.jacc.2009.02.075; Charron P, 2006, EXPERT REV MOL DIAGN, V6, P65, DOI 10.1586/14737159.6.1.65; Chien KR, 2002, CELL, V110, P153, DOI 10.1016/S0092-8674(02)00834-6; Chiu C, 2010, J AM COLL CARDIOL, V55, P1127, DOI 10.1016/j.jacc.2009.11.016; Elliott P, 2004, LANCET, V363, P1881, DOI 10.1016/S0140-6736(04)16358-7; Elliott PM, 2006, HEART, V92, P785, DOI 10.1136/hrt.2005.068577; Elliott PM, 2000, J AM COLL CARDIOL, V36, P2212, DOI 10.1016/S0735-1097(00)01003-2; Frank D, 2006, J MOL MED, V84, P446, DOI 10.1007/s00109-005-0033-1; Frey N, 2004, NAT MED, V10, P1336, DOI 10.1038/nm1132; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Geier C, 2003, CIRCULATION, V107, P1390, DOI 10.1161/01.CIR.0000056522.82563.5F; Haghighi K, 2006, P NATL ACAD SCI USA, V103, P1388, DOI 10.1073/pnas.0510519103; Hassel D, 2009, NAT MED, V15, P1281, DOI 10.1038/nm.2037; Hayashi T, 2004, J AM COLL CARDIOL, V44, P2192, DOI 10.1016/j.jacc.2004.08.058; Ho CY, 2006, CIRCULATION, V113, pE396, DOI 10.1161/CIRCULATIONAHA.105.579268; Hoshijima M, 2006, AM J PHYSIOL-HEART C, V290, pH1313, DOI 10.1152/ajpheart.00816.2005; Knoll R, 2002, CELL, V111, P943, DOI 10.1016/S0092-8674(02)01226-6; Landstrom AP, 2007, J MOL CELL CARDIOL, V42, P1026, DOI 10.1016/j.yjmcc.2007.04.006; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ohtsuka T, 1998, J CELL BIOL, V143, P1227, DOI 10.1083/jcb.143.5.1227; Osio A, 2007, CIRC RES, V100, P766, DOI 10.1161/01.RES.0000263008.66799.aa; Pyle WG, 2004, CIRC RES, V94, P296, DOI 10.1161/01.RES.0000116143.74830.A9; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110	31	59	73	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 12	2010	87	5					687	693		10.1016/j.ajhg.2010.10.002	http://dx.doi.org/10.1016/j.ajhg.2010.10.002			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	686AE	20970104	Bronze, Green Published			2022-12-18	WOS:000284668400015
J	Langmann, T; Di Gioia, SA; Rau, I; Stohr, H; Maksimovic, NS; Corbo, JC; Renner, AB; Zrenner, E; Kumaramanickavel, G; Karlstetter, M; Arsenijevic, Y; Weber, BHF; Gal, A; Rivolta, C				Langmann, Thomas; Di Gioia, Silvio Alessandro; Rau, Isabella; Stoehr, Heidi; Maksimovic, Nela S.; Corbo, Joseph C.; Renner, Agnes B.; Zrenner, Eberhart; Kumaramanickavel, Govindasamy; Karlstetter, Marcus; Arsenijevic, Yvan; Weber, Bernhard H. F.; Gal, Andreas; Rivolta, Carlo			Nonsense Mutations in FAM161A Cause RP28-Associated Recessive Retinitis Pigmentosa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE; IDENTIFICATION; LOCUS	Retinitis pigmentosa (RP) is a degenerative disease of the retina leading to progressive loss of vision and, in many instances, to legal blindness at the end stage. The RP28 locus was assigned in 1999 to the short arm of chromosome 2 by homozygosity mapping in a large Indian family segregating autosomal-recessive RP (arRP). Following a combined approach of chromatin immunoprecipitation and parallel sequencing of genomic DNA, we identified a gene, FAM161A, which was shown to carry a homozygous nonsense mutation (p.Arg229X) in patients from the original RP28 pedigree. Another homozygous FAM161A stop mutation (p.Arg437X) was detected in three subjects from a cohort of 118 apparently unrelated German RP patients. Age at disease onset in these patients was in the second to third decade, with severe visual handicap in the fifth decade and legal blindness in the sixth to seventh decades. FAM161A is a phylogenetically conserved gene, expressed in the retina at relatively high levels and encoding a putative 76 kDa protein of unknown function. In the mouse retina, Fam161a mRNA is developmentally regulated and controlled by the transcription factor Crx, as demonstrated by chromatin immunoprecipitation and organotypic reporter assays on explanted retinas. Fam161a protein localizes to photoreceptor cells during development, and in adult animals it is present in the inner segment as well as the outer plexiform layer of the retina, the synaptic interface between photoreceptors and their efferent neurons. Taken together, our data indicate that null mutations in FAM161A are responsible for the RP28-associated arRP.	[Rau, Isabella; Maksimovic, Nela S.; Gal, Andreas] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, D-20246 Hamburg, Germany; [Langmann, Thomas; Stoehr, Heidi; Karlstetter, Marcus; Weber, Bernhard H. F.] Univ Regensburg, Inst Human Genet, D-93053 Regensburg, Germany; [Di Gioia, Silvio Alessandro; Rivolta, Carlo] Univ Lausanne, Dept Med Sci, CH-1005 Lausanne, Switzerland; [Corbo, Joseph C.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Renner, Agnes B.] Univ Med Ctr Regensburg, Dept Ophthalmol, D-93053 Regensburg, Germany; [Zrenner, Eberhart] Univ Tubingen, Inst Ophthalm Res, Ctr Ophthalmol, D-72076 Tubingen, Germany; [Kumaramanickavel, Govindasamy] Sankara Nethralaya, Dept Genet & Mol Biol, Madras 600006, Tamil Nadu, India; [Arsenijevic, Yvan] Univ Lausanne, Jules Gonin Eye Hosp, Unit Gene Therapy & Stem Cell Biol, CH-1004 Lausanne, Switzerland; [Maksimovic, Nela S.] Univ Belgrade, Sch Med, Inst Human Genet, Belgrade 11000, Serbia	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Regensburg; University of Lausanne; Washington University (WUSTL); University of Regensburg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Lausanne; University of Belgrade	Gal, A (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, D-20246 Hamburg, Germany.	gal@uke.de; carlo.rivolta@unil.ch	KUMARAMANICKAVEL, GOVINDASAMY/AAN-9203-2021	KUMARAMANICKAVEL, GOVINDASAMY/0000-0001-8516-8301; Weber, Bernhard H.F./0000-0002-8808-7723; Rivolta, Carlo/0000-0002-0733-9950; Di Gioia, Silvio Alessandro/0000-0002-7235-5682; Arsenijevic, Yvan/0000-0001-6960-1291; Corbo, Joseph/0000-0002-9323-7140	Swiss National Science Foundation [320030-121929]; Gebert Ruf Foundation; German Research Foundation [FOR1075]; Pro Retina; DAAD; NATIONAL EYE INSTITUTE [R01EY018826] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Gebert Ruf Foundation; German Research Foundation(German Research Foundation (DFG)); Pro Retina; DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Swiss National Science Foundation (grant no. 320030-121929, to C.R.), the Gebert Ruf Foundation (Rare Diseases - New Technologies grant, to C.R.), the German Research Foundation (FOR1075 with grants to B.H.F.W., H.S., and T.L.), and Pro Retina (to B.H.F.W., T.L., and H.S.). N.M. received financial support from the DAAD aimed to promote the cooperation between the Universities of Hamburg and Belgrade. The authors would also like to thank Anne Maillard-Menoud for technical support, as well as scientists at Genotypic Technology Pvt. Ltd., Bangalore, India, and at Fastens SA, Plan-les-Ouates, Switzerland.	Bowne SJ, 2006, INVEST OPHTH VIS SCI, V47, P3754, DOI 10.1167/iovs.06-0207; CORBO JC, 2010, GENOME RES IN PRESS; Frio TR, 2009, MOL VIS, V15, P2627; Gu SM, 1999, J MED GENET, V36, P705; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Koenekoop RK, 2009, OPHTHALMIC GENET, V30, P152, DOI 10.1080/13816810902788974; Kumar A, 2004, MOL VIS, V10, P399; Neidhardt J, 2007, HUM MUTAT, V28, P797, DOI 10.1002/humu.20521; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Rohrer B, 2005, INVEST OPHTH VIS SCI, V46, P3876, DOI 10.1167/iovs.05-0533; van Wijk E, 2004, AM J HUM GENET, V74, P738, DOI 10.1086/383096	12	59	62	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 10	2010	87	3					376	381		10.1016/j.ajhg.2010.07.018	http://dx.doi.org/10.1016/j.ajhg.2010.07.018			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651JH	20705278	Green Published, Bronze			2022-12-18	WOS:000281923500007
J	Guernsey, DL; Jiang, HY; Evans, SC; Ferguson, M; Matsuoka, M; Nightingale, M; Rideout, AL; Provost, S; Bedard, K; Orr, A; Dube, MP; Ludman, M; Samuels, ME				Guernsey, Duane L.; Jiang, Haiyan; Evans, Susan C.; Ferguson, Meghan; Matsuoka, Makoto; Nightingale, Mathew; Rideout, Andrea L.; Provost, Sylvie; Bedard, Karen; Orr, Andrew; Dube, Marie-Pierre; Ludman, Mark; Samuels, Mark E.			Mutation in Pyrroline-5-Carboxylate Reductase 1 Gene in Families with Cutis Laxa Type 2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WRINKLY SKIN SYNDROME; STATURE TYPE-II; GERODERMIA OSTEODYSPLASTICA; MOYAMOYA-DISEASE; REDUCED ORNITHINE; MISSENSE MUTATION; PROLINE; FIBULIN-5; HYPERAMMONEMIA; GLYCOSYLATION	Autosomal-recessive cutis laxa type 2 (ARCL2) is a multisystem disorder characterized by the appearance of premature aging, wrinkled and lax skin, joint laxity, and a general developmental delay. Cutis laxa includes a family of clinically overlapping conditions with confusing nomenclature, generally requiring molecular analyses for definitive diagnosis. Six genes are currently known to mutate to yield one of these related conditions. We ascertained a cohort of typical ARCL2 patients from a subpopulation isolate within eastern Canada. Homozygosity mapping with high-density SNP genotyping excluded all six known genes, and instead identified a single homozygous region near the telomere of chromosome 17, shared identically by state by all genotyped affected individuals from the families. A putative pathogenic variant was identified by direct DNA sequencing of genes within the region. The single nucleotide change leads to a missense mutation adjacent to a splice junction in the gene encoding pyrroline-5-carboxylate reductase 1 (PYCR1). Bioinformatic analysis predicted a pathogenic effect of the variant on splice donor site function. Skipping of the associated exon was confirmed in RNA from blood lymphocytes of affected homozygotes and heterozygous mutation carriers. Exon skipping leads to deletion of the reductase functional domain-coding region and an obligatory downstream frameshift. PYCR1 plays a critical role in proline biosynthesis. Pathogenicity of the genetic variant in PYCR1 is likely, given that a similar clinical phenotype has been documented for mutation carriers of another proline biosynthetic enzyme, pyrroline-5-carboxylate synthase. Our results support a significant role for proline in normal development.	[Samuels, Mark E.] Univ Montreal, Ctr Rech Ste Justine, Montreal, PQ H3T 1C5, Canada; [Guernsey, Duane L.; Jiang, Haiyan; Evans, Susan C.; Matsuoka, Makoto; Nightingale, Mathew; Bedard, Karen] Dalhousie Univ, Dept Pathol, Halifax, NS B3H 1X5, Canada; [Orr, Andrew] Dalhousie Univ, Dept Ophthalmol & Visual Sci, Halifax, NS B3H 1X5, Canada; [Ferguson, Meghan; Rideout, Andrea L.] IWK Hlth Ctr, Maritime Med Genet Serv, Halifax, NS B3K 6R8, Canada; [Ludman, Mark] IWK Hlth Ctr, Div Med Genet, Dept Pediat, Halifax, NS B3K 6R8, Canada; [Ludman, Mark] Dalhousie Univ, Halifax, NS B3K 6R8, Canada; [Provost, Sylvie; Dube, Marie-Pierre] Univ Montreal, Inst Cardiol, Montreal, PQ H3T 1C5, Canada	Universite de Montreal; Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University; Universite de Montreal; Institut de Cardiologie de Montreal	Samuels, ME (corresponding author), Univ Montreal, Ctr Rech Ste Justine, Montreal, PQ H3T 1C5, Canada.	mark.e.samuels@umontreal.ca	Dubé, Marie-Pierre/B-9364-2008	Dubé, Marie-Pierre/0000-0001-8442-4393; Nightingale, Mat/0000-0003-1465-7911; Bedard, Karen/0000-0001-5864-5344; Orr, Andrew/0000-0002-9388-9034; Ludman, Mark/0000-0002-9658-6784	Genome Canada; Genome Atlantic; Nova Scotia Health Research Foundation; Nova Scotia Research and Innovation Trust; Dalhousie Faculty of Medicine; IWK Health Centre Foundation; Capital Health Research Fund	Genome Canada(Genome Canada); Genome Atlantic; Nova Scotia Health Research Foundation; Nova Scotia Research and Innovation Trust; Dalhousie Faculty of Medicine; IWK Health Centre Foundation; Capital Health Research Fund	We are grateful to the family members who generously contributed their time and materials for this research. The following agencies provided funding for this project: Genome Canada, Genome Atlantic, Nova Scotia Health Research Foundation, Nova Scotia Research and Innovation Trust, Dalhousie Faculty of Medicine, IWK Health Centre Foundation, and Capital Health Research Fund.	Al-Gazali LI, 2001, AM J MED GENET, V101, P213, DOI 10.1002/ajmg.1352; ALBINA JE, 1993, J SURG RES, V55, P97, DOI 10.1006/jsre.1993.1114; Barbul A, 2008, J NUTR, V138, p2021S, DOI 10.1093/jn/138.10.2021S; Baumgartner MR, 2000, HUM MOL GENET, V9, P2853, DOI 10.1093/hmg/9.19.2853; Baumgartner MR, 2005, EUR J PEDIATR, V164, P31, DOI 10.1007/s00431-004-1545-3; Bicknell LS, 2008, EUR J HUM GENET, V16, P1176, DOI 10.1038/ejhg.2008.91; Burke GM, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.1.FOCUS08310; Claus S, 2008, J INVEST DERMATOL, V128, P1442, DOI 10.1038/sj.jid.5701211; Dasouki M, 2007, AM J MED GENET A, V143A, P2635, DOI 10.1002/ajmg.a.31980; De Schepper S, 2003, EUR J DERMATOL, V13, P529; Ernst T, 2002, AM J PATHOL, V160, P2169, DOI 10.1016/S0002-9440(10)61165-0; Galasso C, 2008, PEDIATR NEUROL, V38, P435, DOI 10.1016/j.pediatrneurol.2008.02.011; Graul-Neumann LM, 2008, AM J MED GENET A, V146A, P977, DOI 10.1002/ajmg.a.32242; Gupta N, 2006, PEDIATR DERMATOL, V23, P225, DOI 10.1111/j.1525-1470.2006.00222.x; Hennies HC, 2008, NAT GENET, V40, P1410, DOI 10.1038/ng.252; Hu CAA, 2008, AMINO ACIDS, V35, P655, DOI 10.1007/s00726-008-0107-9; Hucthagowder V, 2006, AM J HUM GENET, V78, P1075, DOI 10.1086/504304; IMAIZUMI K, 1994, CLIN GENET, V45, P40; Jariwala U, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-39; Kannu P, 2004, AM J MED GENET A, V128A, P98, DOI 10.1002/ajmg.a.30086; Kornak U, 2008, NAT GENET, V40, P32, DOI 10.1038/ng.2007.45; LISKER R, 1979, AM J MED GENET, V3, P389, DOI 10.1002/ajmg.1320030410; Loeys B, 2002, HUM MOL GENET, V11, P2113, DOI 10.1093/hmg/11.18.2113; Markova D, 2003, AM J HUM GENET, V72, P998, DOI 10.1086/373940; MENSING H, 1984, HAUTARZT, V35, P506; Mineharu Y, 2008, NEUROLOGY, V70, P2357, DOI 10.1212/01.wnl.0000291012.49986.f9; Mitsubuchi H, 2008, J NUTR, V138, p2016S, DOI 10.1093/jn/138.10.2016S; Morava E, 2008, EUR J HUM GENET, V16, P28, DOI 10.1038/sj.ejhg.5201947; Morava E, 2005, EUR J HUM GENET, V13, P414, DOI 10.1038/sj.ejhg.5201361; Nanda A, 2008, PEDIATR DERMATOL, V25, P66, DOI 10.1111/j.1525-1470.2007.00586.x; Nishimura G, 2003, AM J MED GENET A, V117A, P299, DOI 10.1002/ajmg.a.10230; Rajab A, 2008, AM J MED GENET A, V146A, P965, DOI 10.1002/ajmg.a.32143; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174; Rodriguez-Revenga L, 2004, ARCH DERMATOL, V140, P1135, DOI 10.1001/archderm.140.9.1135; Scherrer DZ, 2008, AM J MED GENET A, V146A, P2740, DOI 10.1002/ajmg.a.32345; Shao HB, 2008, CR BIOL, V331, P433, DOI 10.1016/j.crvi.2008.03.011; Shao HB, 2008, INT J BIOL SCI, V4, P8; Steiner CE, 2005, GENET MOL BIOL, V28, P181, DOI 10.1590/S1415-47572005000200001; Takagi H, 2008, APPL MICROBIOL BIOT, V81, P211, DOI 10.1007/s00253-008-1698-5; Tassabehji M, 1998, HUM MOL GENET, V7, P1021, DOI 10.1093/hmg/7.6.1021; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Webber N, 2008, PEDIATR DERMATOL, V25, P401, DOI 10.1111/j.1525-1470.2008.00698.x; Wopereis S, 2005, BBA-MOL BASIS DIS, V1741, P156, DOI 10.1016/j.bbadis.2004.11.009; Yamauchi T, 2000, STROKE, V31, P930, DOI 10.1161/01.STR.31.4.930; Young ID, 2004, AM J MED GENET A, V127A, P218, DOI 10.1002/ajmg.a.20647; Zhang MC, 1999, J BIOL CHEM, V274, P981, DOI 10.1074/jbc.274.2.981	46	59	63	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 10	2009	85	1					120	129		10.1016/j.ajhg.2009.06.008	http://dx.doi.org/10.1016/j.ajhg.2009.06.008			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	470RO	19576563	Green Published, Bronze			2022-12-18	WOS:000267997600014
J	Melquist, S; Craig, DW; Huentelman, MJ; Crook, R; Pearson, JV; Baker, M; Zismann, VL; Gass, J; Adamson, J; Szelinger, S; Corneveaux, J; Cannon, A; Coon, KD; Lincoln, S; Adler, C; Tuite, P; Calne, DB; Bigio, EH; Uitti, RJ; Wszolek, ZK; Golbe, LI; Caselli, RJ; Graff-Radford, N; Litvan, I; Farrer, MJ; Dickson, DW; Hutton, M; Stephan, DA				Melquist, Stacey; Craig, David W.; Huentelman, Matthew J.; Crook, Richard; Pearson, John V.; Baker, Matt; Zismann, Victoria L.; Gass, Jennifer; Adamson, Jennifer; Szelinger, Szabolcs; Corneveaux, Jason; Cannon, Ashley; Coon, Keith D.; Lincoln, Sarah; Adler, Charles; Tuite, Paul; Calne, Donald B.; Bigio, Eileen H.; Uitti, Ryan J.; Wszolek, Zbigniew K.; Golbe, Lawrence I.; Caselli, Richard J.; Graff-Radford, Neill; Litvan, Irene; Farrer, Matthew J.; Dickson, Dennis W.; Hutton, Mike; Stephan, Dietrich A.			Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphisms	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LYSOSOMAL ACID-PHOSPHATASE; NINDS NEUROPATHOLOGIC CRITERIA; TAU-GENE; XERODERMA-PIGMENTOSUM; PARKINSON-DISEASE; NEUROFIBRILLARY TANGLES; DELN296 MUTATION; UBIQUITIN LIGASE; ASSOCIATION; HAPLOTYPE	To date, only the H1 MAPT haplotype has been consistently associated with risk of developing the neurodegenerative disease progressive supranuclear palsy (PSP). We hypothesized that additional genetic loci may be involved in conferring risk of PSP that could be identified through a pooling-based genomewide association study of 1500,000 SNPs. Candidate SNPs with large differences in allelic frequency were identified by ranking all SNPs by their probe-intensity difference between cohorts. The MAPT H1 haplotype was strongly detected by this methodology, as was a second major locus on chromosome 11p12-p11 that showed evidence of association at allelic (P < .001), genotypic (P < .001), and haplotypic (P < .001) levels and was narrowed to a single haplotype block containing the DNA damage-binding protein 2 (DDB2) and lysosomal acid phosphatase 2 (ACP2) genes. Since DNA damage and lysosomal dysfunction have been implicated in aging and neurodegenerative processes, both genes are viable candidates for conferring risk of disease.	Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA; Mayo Clin, Coll Med, Dept Neurol, Jacksonville, FL 32224 USA; TGen, Neurogenom Div, Phoenix, AZ USA; Mayo Clin, Dept Neurol, Scottsdale, AZ USA; Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA; Univ British Columbia, Pacific Pk Res Ctr, Vancouver, BC V5Z 1M9, Canada; Northwestern Feinberg Sch Med, Dept Neuropathy, Chicago, IL USA; Univ Med & Dent New Jersey, Dept Neurol, Robert Wood Johson Med Sch, Newark, NJ 07103 USA; Univ Louisville, Dept Neurol, Louisville, KY 40292 USA	Mayo Clinic; Mayo Clinic; Translational Genomics Research Institute; Mayo Clinic; Mayo Clinic Phoenix; University of Minnesota System; University of Minnesota Twin Cities; University of British Columbia; Northwestern University; Feinberg School of Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Louisville	Hutton, M (corresponding author), Mayo Clin, Coll Med, Dept Neurosci, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	hutton.michael@mayo.edu	Pearson, John V/F-2249-2011; Wszolek, Zbigniew K./AAB-1431-2019; Pearson, John/AAT-4211-2020; Craig, David Wesley/K-6961-2019; Litvan, Irene/X-9319-2018; Tuite, Paul/P-3164-2014	Pearson, John V/0000-0003-0904-4598; Craig, David Wesley/0000-0003-2040-1955; Litvan, Irene/0000-0002-3485-3445; Farrer, Matthew/0000-0003-1159-5321; Tuite, Paul/0000-0003-1413-7924; Dickson, Dennis W/0000-0001-7189-7917	NIA NIH HHS [P01 AG017216, F32 AG024030, P01 AG 17216] Funding Source: Medline; NINDS NIH HHS [U24 NS043571, 1U24NS043571] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS043571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017216] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AUER IA, 1995, ACTA NEUROPATHOL, V90, P547; Baker M, 1999, HUM MOL GENET, V8, P711, DOI 10.1093/hmg/8.4.711; Bansal A, 2002, P NATL ACAD SCI USA, V99, P16871, DOI 10.1073/pnas.262671399; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Caffrey TM, 2006, HUM MOL GENET, V15, P3529, DOI 10.1093/hmg/ddl429; Caselli RJ, 2002, J AM GERIATR SOC, V50, P49, DOI 10.1046/j.1532-5415.2002.50007.x; Caselli RJ, 2001, J NEUROL SCI, V189, P93, DOI 10.1016/S0022-510X(01)00577-9; Clarimon J, 2006, AM J HUM GENET, V78, P1082, DOI 10.1086/504727; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; Conrad C, 1997, ANN NEUROL, V41, P277, DOI 10.1002/ana.410410222; Craig DW, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-138; Cruts M, 2005, HUM MOL GENET, V14, P1753, DOI 10.1093/hmg/ddi182; Evans W, 2004, NEUROSCI LETT, V369, P183, DOI 10.1016/j.neulet.2004.05.119; Farrer MJ, 2006, AM J HUM GENET, V78, P1084, DOI 10.1086/504728; Fung HC, 2006, LANCET NEUROL, V5, P911, DOI 10.1016/S1474-4422(06)70578-6; Goris A, 2006, AM J HUM GENET, V78, P1088, DOI 10.1086/504726; HAUW JJ, 1994, NEUROLOGY, V44, P2015, DOI 10.1212/WNL.44.11.2015; Higgins JJ, 2000, NEUROLOGY, V55, P1364, DOI 10.1212/WNL.55.9.1364; Inoki T, 2004, BIOCHEM BIOPH RES CO, V314, P1036, DOI 10.1016/j.bbrc.2004.01.003; Ishizawa K, 2001, J NEUROPATH EXP NEUR, V60, P647, DOI 10.1093/jnen/60.6.647; Josephs KA, 2003, MOVEMENT DISORD, V18, P1018, DOI 10.1002/mds.10488; Kapetanaki MG, 2006, P NATL ACAD SCI USA, V103, P2588, DOI 10.1073/pnas.0511160103; Kwok JBJ, 2004, ANN NEUROL, V55, P329, DOI 10.1002/ana.10826; Li YH, 2006, AM J HUM GENET, V78, P1090, DOI 10.1086/504725; Litvan I, 1996, J NEUROPATH EXP NEUR, V55, P97, DOI 10.1097/00005072-199601000-00010; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Litvan I, 1996, NEUROLOGY, V46, P922, DOI 10.1212/WNL.46.4.922; Litvan Irene, 2004, Curr Neurol Neurosci Rep, V4, P296, DOI 10.1007/s11910-004-0055-z; LOVE S, 1995, BRAIN, V118, P119, DOI 10.1093/brain/118.1.119; Lovmar L, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-35; Mannan AU, 2004, NEUROGENETICS, V5, P229, DOI 10.1007/s10048-004-0197-9; Maraganore DM, 2005, AM J HUM GENET, V77, P685, DOI 10.1086/496902; Meaburn E, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj027; Morris HR, 1999, J NEUROL NEUROSUR PS, V66, P665, DOI 10.1136/jnnp.66.5.665; MYERS AJ, 2006, MAPT H1C RISK HAPLOT; Myers RH, 2006, AM J HUM GENET, V78, P1081; Oliva R, 2004, ANN NEUROL, V55, P448, DOI 10.1002/ana.20025; Oliva R, 1998, ARCH NEUROL-CHICAGO, V55, P1122, DOI 10.1001/archneur.55.8.1122; OMAR R, 1993, ARCH PATHOL LAB MED, V117, P166; Pastor P, 2001, ANN NEUROL, V49, P263, DOI 10.1002/1531-8249(20010201)49:2<263::AID-ANA50>3.0.CO;2-K; Pearson JV, 2007, AM J HUM GENET, V80, P126, DOI 10.1086/510686; Pittman AM, 2005, J MED GENET, V42, P837, DOI 10.1136/jmg.2005.031377; Pittman AM, 2004, HUM MOL GENET, V13, P1267, DOI 10.1093/hmg/ddh138; POHLMANN R, 1988, EMBO J, V7, P2343, DOI 10.1002/j.1460-2075.1988.tb03078.x; Qin ZH, 2003, HUM MOL GENET, V12, P3231, DOI 10.1093/hmg/ddg346; Rademakers R, 2005, HUM MOL GENET, V14, P3281, DOI 10.1093/hmg/ddi361; ROBBINS JH, 1993, EUR NEUROL, V33, P188, DOI 10.1159/000116932; Rojo A, 1999, BRAIN, V122, P1233, DOI 10.1093/brain/122.7.1233; Ros R, 2005, ARCH NEUROL-CHICAGO, V62, P1444, DOI 10.1001/archneur.62.9.1444; Ros R, 2005, ANN NEUROL, V57, P634, DOI 10.1002/ana.20449; Rossi G, 2004, ANN NEUROL, V55, P448, DOI 10.1002/ana.20006; Saftig P, 1997, J BIOL CHEM, V272, P18628, DOI 10.1074/jbc.272.30.18628; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Spillantini MG, 2000, BRAIN, V123, P857, DOI 10.1093/brain/123.5.857; Stanford PM, 2000, BRAIN, V123, P880, DOI 10.1093/brain/123.5.880; STEELE JC, 1964, ARCH NEUROL-CHICAGO, V10, P333, DOI 10.1001/archneur.1964.00460160003001; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; SUZUKI K, 1995, ACTA NEUROPATHOL, V89, P227; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Wszolek ZK, 2001, BRAIN, V124, P1666, DOI 10.1093/brain/124.8.1666	61	59	60	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2007	80	4					769	778		10.1086/513320	http://dx.doi.org/10.1086/513320			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	153VV	17357082	Green Published, Bronze			2022-12-18	WOS:000245465200017
J	Han, Y; Gu, S; Oota, H; Osier, MV; Pakstis, AJ; Speed, WC; Kidd, JR; Kidd, KK				Han, Yi; Gu, Sheng; Oota, Hiroki; Osier, Michael V.; Pakstis, Andrew J.; Speed, William C.; Kidd, Judith R.; Kidd, Kenneth K.			Evidence of positive selection on a class I ADH locus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALDEHYDE DEHYDROGENASE GENOTYPES; AMERICAN-INDIAN POPULATION; ALCOHOL-METABOLISM GENES; LINKAGE DISEQUILIBRIUM; ADH2-ASTERISK-2 ALLELE; RISK; POLYMORPHISM; DEPENDENCE; MEN; GENOME	The alcohol dehydrogenase (ADH) family of enzymes catalyzes the reversible oxidation of alcohol to acetaldehyde. Seven ADH genes exist in a segment of similar to 370 kb on 4q21. Products of the three class I ADH genes that share 95% sequence identity are believed to play the major role in the first step of ethanol metabolism. Because the common belief that selection has operated at the ADH1B*47His allele in East Asian populations lacks direct biological or statistical evidence, we used genomic data to test the hypothesis. Data consisted of 54 single-nucleotide polymorphisms ( SNPs) across the ADH clusters in a global sampling of 42 populations. Both the F-st statistic and the long-range haplotype (LRH) test provided positive evidence of selection in several East Asian populations. The ADH1B Arg47His functional polymorphism has the highest F-st of the 54 SNPs in the ADH cluster, and it is significantly above the mean F-st of 382 presumably neutral sites tested on the same 42 population samples. The LRH test that uses cores including that site and extending on both sides also gives significant evidence of positive selection in some East Asian populations for a specific haplotype carrying the ADH1B*47His allele. Interestingly, this haplotype is present at a high frequency in only some East Asian populations, whereas the specific allele also exists in other East Asian populations and in the Near East and Europe but does not show evidence of selection with use of the LRH test. Although the ADH1B*47His allele conveys a well-confirmed protection against alcoholism, that modern phenotypic manifestation does not easily translate into a positive selective force, and the nature of that selective force, in the past and/or currently, remains speculative.	Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA	Yale University	Kidd, KK (corresponding author), Yale Univ, Sch Med, Dept Genet, 333 Cedar St,SHM 1-353, New Haven, CT 06510 USA.	kenneth.kidd@yale.edu			NIAAA NIH HHS [AA09379, R01 AA009379] Funding Source: Medline; NIGMS NIH HHS [P01 GM057672, GM57672] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM057672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA009379] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		AGARWAL DP, 1992, PHARMACOGENETICS, V2, P48, DOI 10.1097/00008571-199204000-00002; ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; Borras E, 2000, HEPATOLOGY, V31, P984, DOI 10.1053/he.2000.5978; Chen CC, 1999, AM J HUM GENET, V65, P795, DOI 10.1086/302540; Chen WJ, 1996, BRIT J PSYCHIAT, V168, P762, DOI 10.1192/bjp.168.6.762; Chen XN, 1999, GENOME RES, V9, P492; Cichoz-Lach H, 2006, ALCOHOL ALCOHOLISM, V41, P14, DOI 10.1093/alcalc/agh225; Endo T, 1996, MOL BIOL EVOL, V13, P685, DOI 10.1093/oxfordjournals.molbev.a025629; GOLDMAN D, 1990, WORLD REV NUTR DIET, V63, P143; Gu S, 2005, BIOINFORMATICS, V21, P3938, DOI 10.1093/bioinformatics/bti649; Han Y, 2005, ALCOHOL CLIN EXP RES, V29, P2091, DOI 10.1097/01.alc.0000191769.92667.04; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; HIGUCHI S, 1994, LANCET, V343, P741, DOI 10.1016/S0140-6736(94)91629-2; Higuchi S, 1994, Alcohol Alcohol Suppl, V2, P29; HIGUCHI S, 1995, AM J PSYCHIAT, V152, P1219; Hu XS, 2005, J THEOR BIOL, V235, P207, DOI 10.1016/j.jtbi.2005.01.004; Kidd KK, 2004, J HERED, V95, P406, DOI 10.1093/jhered/esh060; Kim JJ, 2005, HUM GENET, V117, P511, DOI 10.1007/s00439-005-1334-8; Konishi T, 2003, EXP MOL PATHOL, V74, P183, DOI 10.1016/S0014-4800(03)00006-6; Long JC, 1998, AM J MED GENET, V81, P216, DOI 10.1002/(SICI)1096-8628(19980508)81:3<216::AID-AJMG2>3.0.CO;2-U; Mulligan CJ, 2003, HUM GENET, V113, P325, DOI 10.1007/s00439-003-0971-z; MURAMATSU T, 1995, HUM GENET, V96, P151, DOI 10.1007/BF00207371; Neumark YD, 1998, J STUD ALCOHOL, V59, P133, DOI 10.15288/jsa.1998.59.133; Norman PJ, 2004, IMMUNOGENETICS, V56, P225, DOI 10.1007/s00251-004-0674-1; Oota H, 2004, ANN HUM GENET, V68, P93, DOI 10.1046/j.1529-8817.2003.00060.x; Osier M, 1999, AM J HUM GENET, V64, P1147, DOI 10.1086/302317; Osier MV, 2002, ALCOHOL CLIN EXP RES, V26, P1759, DOI 10.1097/01.ALC.0000042013.13899.75; Osier MV, 2002, AM J HUM GENET, V71, P84, DOI 10.1086/341290; Ramchandani VA, 2001, PATHOL BIOL, V49, P676, DOI 10.1016/S0369-8114(01)00232-2; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Reich T, 1998, AM J MED GENET, V81, P207, DOI 10.1002/(SICI)1096-8628(19980508)81:3<207::AID-AJMG1>3.3.CO;2-X; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Saccone NL, 2000, AM J MED GENET, V96, P632, DOI 10.1002/1096-8628(20001009)96:5<632::AID-AJMG8>3.0.CO;2-#; Sakai Y, 2000, J HUM GENET, V45, P127, DOI 10.1007/s100380050198; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Shen YC, 1997, ALCOHOL CLIN EXP RES, V21, P1272, DOI 10.1111/j.1530-0277.1997.tb04448.x; THOMASSON HR, 1994, ALCOHOL CLIN EXP RES, V18, P640, DOI 10.1111/j.1530-0277.1994.tb00923.x; THOMASSON HR, 1991, AM J HUM GENET, V48, P677; Tiemersma EW, 2003, CANCER EPIDEM BIOMAR, V12, P419; Tishkoff SA, 2004, NAT GENET, V36, pS21, DOI 10.1038/ng1438; Uhl GR, 2004, NEUROPHARMACOLOGY, V47, P140, DOI 10.1016/j.neuropharm.2004.07.029; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Walsh EC, 2006, HUM GENET, V119, P92, DOI 10.1007/s00439-005-0090-0; Whitfield JB, 1998, ALCOHOL CLIN EXP RES, V22, P1463; YOSHIDA A, 1991, PROG NUCLEIC ACID RE, V40, P255; Yu FL, 2005, PLOS GENET, V1, P404, DOI 10.1371/journal.pgen.0010041	47	59	60	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2007	80	3					441	456		10.1086/512485	http://dx.doi.org/10.1086/512485			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	139AB	17273965	Green Published, Bronze			2022-12-18	WOS:000244403300005
J	Fan, XL; Zhang, HW; Zhang, SQ; Bagshaw, RD; Tropak, MB; Callahan, JW; Mahuran, DJ				Fan, Xiaolian; Zhang, Huiwen; Zhang, Sunqu; Bagshaw, Richard D.; Tropak, Michael B.; Callahan, John W.; Mahuran, Don J.			Identification of the gene encoding the enzyme deficient in mucopolysaccharidosis IIIC (Sanfilippo disease type C)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GLUCOSAMINIDE N-ACETYLTRANSFERASE; HEXOSAMINIDASE; FIBROBLASTS; LYSOSOMES; ISOZYMES; PROTEIN	Mucopolysaccharidosis IIIC ( MPS IIIC), or Sanfilippo C, represents the only MPS disorder in which the responsible gene has not been identified; however, the gene has been localized to the pericentromeric region of chromosome 8. In an ongoing proteomics study of mouse lysosomal membrane proteins, we identified an unknown protein whose human homolog, TMEM76, was encoded by a gene that maps to 8p11.1. A full-length mouse expressed sequence tag was expressed in human MPS IIIC fibroblasts, and its protein product localized to the lysosome and corrected the enzymatic defect. The mouse sequence was used to identify the full-length human homolog (HGSNAT), which encodes a protein with no homology to other proteins of known function but is highly conserved among plants and bacteria. Mutational analyses of two MPS IIIC cell lines identified a splice-junction mutation that accounted for three mutant alleles, and a single base-pair insertion accounted for the fourth.	Hosp Sick Children, Res Inst, Metab Program, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; Univ Toronto, Dept Biochem, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Mahuran, DJ (corresponding author), Hosp Sick Children, Res Inst, Metab Program, 555 Univ Ave,Room 9146A, Toronto, ON M5G 1X8, Canada.	hex@sickkids.ca	zhang, hui/GXH-6098-2022; Bagshaw, Rick/B-7739-2009	Bagshaw, Rick/0000-0001-5013-4291				Ausseil K, 2006, MOL GENET METAB, V87, P22, DOI 10.1016/j.ymgme.2005.09.021; Bagshaw RD, 2005, MOL CELL PROTEOMICS, V4, P133, DOI 10.1074/mcp.M400128-MCP200; Bagshaw RD, 2006, BIOCHEM BIOPH RES CO, V344, P1186, DOI 10.1016/j.bbrc.2006.03.221; BAME KJ, 1986, SCIENCE, V233, P1087, DOI 10.1126/science.3090688; BROWN CA, 1993, AM J HUM GENET, V53, P497; CARLSSON Sr, 1990, J BIOL CHEM, V265, P20488; Heck AJR, 2004, EXPERT REV PROTEOMIC, V1, P317, DOI 10.1586/14789450.1.3.317; Hou YM, 2001, BIOCHEMISTRY-US, V40, P2201, DOI 10.1021/bi002018s; KLEIN U, 1978, P NATL ACAD SCI USA, V75, P5185, DOI 10.1073/pnas.75.10.5185; KRAWCZAK M, 1992, HUM GENET, V90, P41; KRESSE H, 1978, EUR J BIOCHEM, V92, P333, DOI 10.1111/j.1432-1033.1978.tb12752.x; MEIKLE PJ, 1995, BIOCHEM J, V308, P327, DOI 10.1042/bj3080327; MUHLRAD D, 1994, NATURE, V370, P578, DOI 10.1038/370578a0; Neufeld EF., 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; TOMMASINI R, 1985, CAN J BIOCHEM CELL B, V63, P219, DOI 10.1139/o85-031; VOZNYI YV, 1993, J INHERIT METAB DIS, V16, P465, DOI 10.1007/BF00710299	16	59	62	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2006	79	4					738	744		10.1086/508068	http://dx.doi.org/10.1086/508068			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	089BV	16960811	Green Published, Bronze			2022-12-18	WOS:000240855900016
J	Yang, S; Lee, YJ; Kim, JM; Park, S; Peris, J; Laipis, P; Park, YS; Chung, JH; Oh, SP				Yang, S; Lee, YJ; Kim, JM; Park, S; Peris, J; Laipis, P; Park, YS; Chung, JH; Oh, SP			A murine model for human sepiapterin-reductase deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GROWTH-FACTOR-I; TETRAHYDROBIOPTERIN BIOSYNTHESIS; TYROSINE-HYDROXYLASE; POINT MUTATION; GENE CAUSE; IGF-I; MICE; HYPERPHENYLALANINEMIA; PHENYLALANINE; DEHYDRATASE	Tetrahydrobiopterin ( BH4) is an essential cofactor for several enzymes, including all three forms of nitric oxide synthases, the three aromatic hydroxylases, and glyceryl-ether mono-oxygenase. A proper level of BH4 is, therefore, necessary for the metabolism of phenylalanine and the production of nitric oxide, catecholamines, and serotonin. BH4 deficiency has been shown to be closely associated with diverse neurological psychiatric disorders. Sepiapterin reductase ( SPR) is an enzyme that catalyzes the final step of BH4 biosynthesis. Whereas the number of cases of neuropsychological disorders resulting from deficiencies of other catalytic enzymes involved in BH4 biosynthesis and metabolism has been increasing, only a handful of cases of SPR deficiency have been reported, and the role of SPR in BH4 biosynthesis in vivo has been poorly understood. Here, we report that mice deficient in the Spr gene ( Spr(-/-)) display disturbed pterin profiles and greatly diminished levels of dopamine, norepinephrine, and serotonin, indicating that SPR is essential for homeostasis of BH4 and for the normal functions of BH4-dependent enzymes. The Spr(-/-) mice exhibit phenylketonuria, dwarfism, and impaired body movement. Oral supplementation of BH4 and neurotransmitter precursors completely rescued dwarfism and phenylalanine metabolism. The biochemical and behavioral characteristics of Spr(-/-) mice share striking similarities with the symptoms observed in SPR-deficient patients. This Spr mutant strain of mice will be an invaluable resource to elucidate many important issues regarding SPR and BH4 deficiencies.	Univ Florida, Dept Physiol & Funct Genom, Coll Med, Gainesville, FL 32610 USA; Univ Florida, Dept Biochem & Mol Biol, Coll Med, 1600 Gainesville, FL 32610 USA; Univ Florida, Coll Pharm, Dept Pharmacodynam, Gainesville, FL 32610 USA; Inje Univ, Sch Biotechnol & Biomed Sci, Kimhae, South Korea; Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; Chungnam Natl Univ, Sch Med, Dept Pathol, Taejon, South Korea	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Inje University; Korea Advanced Institute of Science & Technology (KAIST); Chungnam National University	Oh, SP (corresponding author), Univ Florida, Dept Physiol & Funct Genom, Coll Med, 1600 SW Archer Rd,Room D533d, Gainesville, FL 32610 USA.	ohp@phys.med.ufl.edu	Park, Young Shik/E-7317-2017; Park, Young Shik/S-1978-2019	Park, Young Shik/0000-0002-8808-4530; Lee, Young Jae/0000-0002-3841-1994; Park, Sean/0000-0003-3814-853X; KIM, JIN MAN/0000-0003-0905-9730	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064024] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL64024, R01 HL064024] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Agar J, 2003, AMYOTROPH LATERAL SC, V4, P232, DOI 10.1080/14660820310011278; BLAU N, 1992, PEDIATR RES, V32, P726, DOI 10.1203/00006450-199212000-00021; Blau N, 1996, J INHERIT METAB DIS, V19, P8, DOI 10.1007/BF01799342; Blau N, 2001, MOL GENET METAB, V74, P172, DOI 10.1006/mgme.2001.3213; Blau N, 1999, J INHERIT METAB DIS, V22, P216, DOI 10.1023/A:1005584627797; Blau N., 2001, METABOLIC MOL BASIS, P1725; Bonafe L, 2001, AM J HUM GENET, V69, P269, DOI 10.1086/321970; Brambilla F, 1997, BIOL PSYCHIAT, V42, P889, DOI 10.1016/S0006-3223(96)00549-5; BREIER BH, 1991, J ENDOCRINOL, V128, P347, DOI 10.1677/joe.0.1280347; Diaz-Torga G, 2002, ENDOCRINOLOGY, V143, P1270, DOI 10.1210/en.143.4.1270; Elzaouk L, 2003, J BIOL CHEM, V278, P28303, DOI 10.1074/jbc.M303986200; Elzaouk L., 2002, CHEM BIOL PTERIDINES, P277; Fiege B, 2005, MOL GENET METAB, V86, pS91, DOI 10.1016/j.ymgme.2005.09.014; Fiege B, 2004, MOL GENET METAB, V81, P45, DOI 10.1016/j.ymgme.2003.09.014; Fitzpatrick PF, 1999, ANNU REV BIOCHEM, V68, P355, DOI 10.1146/annurev.biochem.68.1.355; Huttenlocher PR, 2000, EUR J PEDIATR, V159, pS102, DOI 10.1007/PL00014371; Karamohamed S, 2003, NEUROLOGY, V61, P1557, DOI 10.1212/01.WNL.0000095966.99430.F4; Khoo JP, 2005, CIRCULATION, V111, P2126, DOI 10.1161/01.CIR.0000162470.26840.89; Kuhn DM, 2003, MOL PHARMACOL, V64, P946, DOI 10.1124/mol.64.4.946; Lee SW, 1999, BBA-GENE STRUCT EXPR, V1445, P165, DOI 10.1016/S0167-4781(99)00030-5; LEVINE RA, 1990, J NEUROCHEM, V54, P1218, DOI 10.1111/j.1471-4159.1990.tb01951.x; Liu JL, 1998, MOL ENDOCRINOL, V12, P1452, DOI 10.1210/me.12.9.1452; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; LUDECKE B, 1995, HUM GENET, V95, P123; Ludecke B, 1996, HUM MOL GENET, V5, P1023, DOI 10.1093/hmg/5.7.1023; MCCAMAN MW, 1962, J LAB CLIN MED, V59, P885; MILSTIEN S, 1989, BIOCHEM BIOPH RES CO, V165, P845, DOI 10.1016/S0006-291X(89)80043-9; Mungrue IN, 2003, ACTA PHYSIOL SCAND, V179, P123, DOI 10.1046/j.1365-201X.2003.01182.x; Nandi M, 2005, CIRCULATION, V111, P2086, DOI 10.1161/01.CIR.0000163268.32638.F4; Neville BGR, 2005, BRAIN, V128, P2291, DOI 10.1093/brain/awh603; OTA A, 1995, BBA-GENE STRUCT EXPR, V1260, P320, DOI 10.1016/0167-4781(94)00225-R; PARK YS, 1991, BIOCHEM BIOPH RES CO, V175, P738, DOI 10.1016/0006-291X(91)91628-P; PELLE R, 1993, NUCLEIC ACIDS RES, V21, P2783, DOI 10.1093/nar/21.11.2783; POWELLBRAXTON L, 1993, GENE DEV, V7, P2609, DOI 10.1101/gad.7.12b.2609; SCRIVER CR, 2001, METABOLIC MOL BASES, V2, P1667; SHEDLOVSKY A, 1993, GENETICS, V134, P1205; Spaapen LJM, 2003, MOL GENET METAB, V78, P93, DOI 10.1016/S1096-7192(02)00229-9; Steinberger D, 2004, NEUROGENETICS, V5, P187, DOI 10.1007/s10048-004-0182-3; Sumi-Ichinose C, 2001, J BIOL CHEM, V276, P41150, DOI 10.1074/jbc.M102237200; Szczypka MS, 2001, NEURON, V30, P819, DOI 10.1016/S0896-6273(01)00319-1; Terpstra AHM, 2001, J NUTR, V131, P2067, DOI 10.1093/jn/131.7.2067; Thony B, 1997, HUM MUTAT, V10, P11; Thony B, 2000, BIOCHEM J, V347, P1, DOI 10.1042/0264-6021:3470001; Thony B, 1998, HUM GENET, V103, P162, DOI 10.1007/s004390050800; Thony B, 1998, AM J HUM GENET, V62, P1302, DOI 10.1086/301887; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Zorzi G, 2002, MOL GENET METAB, V75, P174, DOI 10.1006/mgme.2001.3273	47	59	60	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2006	78	4					575	587		10.1086/501372	http://dx.doi.org/10.1086/501372			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032EE	16532389	Bronze, Green Published			2022-12-18	WOS:000236755900005
J	Jaeken, J; Martens, K; Francois, I; Eyskens, F; Lecointre, C; Derua, R; Meulemans, S; Slootstra, JW; Waelkens, E; de Zegher, F; Creemers, JWM; Matthijs, G				Jaeken, J; Martens, K; Francois, I; Eyskens, F; Lecointre, C; Derua, R; Meulemans, S; Slootstra, JW; Waelkens, E; de Zegher, F; Creemers, JWM; Matthijs, G			Deletion of PREPL, a gene encoding a putative serine oligopeptidase, in patients with hypotonia-cystinuria syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HOST-CELL INVASION; PROLYL OLIGOPEPTIDASE; PROCESSING ENZYME; ACTIVE-SITE; ENDOPEPTIDASE; SUBSTRATE; MUTATIONS; HYDROLASE; IDENTIFICATION; DEPRESSION	In 11 patients with a recessive congenital disorder, which we refer to as "the hypotonia-cystinuria syndrome," microdeletion of part of the SLC3A1 and PREPL genes on chromosome 2p21 was found. Patients present with generalized hypotonia at birth, nephrolithiasis, growth hormone deficiency, minor facial dysmorphism, and failure to thrive, followed by hyperphagia and rapid weight gain in late childhood. Since loss-of-function mutations in SLC3A1 are known to cause isolated cystinuria type I, and since the expression of the flanking genes, C2orf34 and PPM1B, was normal, the extended phenotype can be attributed to the deletion of PREPL. PREPL is localized in the cytosol and shows homology with prolyl endopeptidase and oligopeptidase B. Substitution of the predicted catalytic residues (Ser470, Asp556, and His601) by alanines resulted in loss of reactivity with a serine hydrolase-specific probe. In sharp contrast to prolyl oligopeptidase and oligopeptidase B, which require both aminoterminal and carboxyterminal sequences for activity, PREPL activity appears to depend only on the carboxyterminal domain. Taken together, these results suggest that PREPL is a novel oligopeptidase, with unique structural and functional characteristics, involved in hypotonia-cystinuria syndrome.	Katholieke Univ Leuven VIB, Lab Mol Cell Biol, Dept Human Genet, Gasthuisberg ON 6, B-3000 Louvain, Belgium; Katholieke Univ Leuven Hosp, Dept Paediat, Louvain, Belgium; Flanders Interuniv Inst Biotechnol, Louvain, Belgium; Katholieke Univ Leuven, Lab Mol Diag, Dept Human Genet, Louvain, Belgium; Katholieke Univ Leuven, Dept Biochem, Louvain, Belgium; Univ Antwerp, Dept Paediat, B-2020 Antwerp, Belgium; Univ Rouen, Dept Paediat, Rouen, France; PEPSCAN Syst, Lelystad, Netherlands	Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; University of Antwerp; Universite de Rouen Normandie	Creemers, JWM (corresponding author), Katholieke Univ Leuven VIB, Lab Mol Cell Biol, Dept Human Genet, Gasthuisberg ON 6, Box 602,Herestr 49, B-3000 Louvain, Belgium.	John.Creemers@med.kuleuven.be	Eyskens, Francois J M/P-3968-2018; Eyskens, Francois/AAW-9963-2021	Eyskens, Francois J M/0000-0003-3981-0142; Matthijs, Gert/0000-0001-6710-1912				BERGER A, 1970, PHILOS T R SOC B, V257, P249, DOI 10.1098/rstb.1970.0024; Bisceglia L, 1996, HUM GENET, V98, P447, DOI 10.1007/s004390050237; Buiting K, 1998, AM J HUM GENET, V63, P170, DOI 10.1086/301935; Burleigh BA, 1997, J CELL BIOL, V136, P609, DOI 10.1083/jcb.136.3.609; Caler EV, 1998, EMBO J, V17, P4975, DOI 10.1093/emboj/17.17.4975; Caler EV, 2000, INFECT IMMUN, V68, P6602, DOI 10.1128/IAI.68.12.6602-6610.2000; CALONGE MT, 1994, NAT GENET, V6, P420, DOI 10.1038/ng0494-420; Clara R, 1966, Bull Acad R Med Belg, V6, P577; Creemers JWM, 2000, J BIOL CHEM, V275, P38842, DOI 10.1074/jbc.M006758200; Creemers JWM, 1996, J BIOL CHEM, V271, P25284, DOI 10.1074/jbc.271.41.25284; Drucker DJ, 2001, ENDOCRINOLOGY, V142, P521, DOI 10.1210/en.142.2.521; Font-Llitjos M, 2005, J MED GENET, V42, P58, DOI 10.1136/jmg.2004.022244; Fulop V, 2000, EMBO REP, V1, P277, DOI 10.1093/embo-reports/kvd048; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; Gerczei T, 2000, J MOL GRAPH MODEL, V18, P7, DOI 10.1016/S1093-3263(99)00042-X; Goodyer P, 2000, EXP NEPHROL, V8, P123; Jackson RS, 2003, J CLIN INVEST, V112, P1550, DOI 10.1172/JCI18784; Juhasz T, 2005, J MOL BIOL, V346, P907, DOI 10.1016/j.jmb.2004.12.014; Kikuno R, 2004, NUCLEIC ACIDS RES, V32, pD502, DOI 10.1093/nar/gkh035; Leung D, 2003, NAT BIOTECHNOL, V21, P687, DOI 10.1038/nbt826; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; MAES M, 1994, BIOL PSYCHIAT, V35, P545, DOI 10.1016/0006-3223(94)90101-5; MAES M, 1995, PSYCHIAT RES, V58, P217, DOI 10.1016/0165-1781(95)02698-V; Morty RE, 2002, J BACTERIOL, V184, P3329, DOI 10.1128/JB.184.12.3329-3337.2002; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Parvari R, 2005, GENOMICS, V86, P195, DOI 10.1016/j.ygeno.2005.04.001; Parvari R, 2001, AM J HUM GENET, V69, P869, DOI 10.1086/323624; Polgar L, 2002, CELL MOL LIFE SCI, V59, P349, DOI 10.1007/s00018-002-8427-5; Purroy J, 2000, HUM MUTAT, V15, P373, DOI 10.1002/(SICI)1098-1004(200004)15:4<373::AID-HUMU10>3.3.CO;2-F; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P19; Roebroek AJM, 2004, J BIOL CHEM, V279, P53442, DOI 10.1074/jbc.M407152200; Saadi I, 1998, KIDNEY INT, V54, P48, DOI 10.1046/j.1523-1755.1998.00956.x; SCALONI A, 1992, J LAB CLIN MED, V120, P546; Schuth F, 2002, ADV ENG MATER, V4, P269, DOI 10.1002/1527-2648(20020503)4:5<269::AID-ADEM269>3.0.CO;2-7; Szeltner Z, 2000, PROTEIN SCI, V9, P353; Turk BE, 2004, METHODS, V32, P398, DOI 10.1016/j.ymeth.2003.10.003; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; Vilsboll T, 2001, DIABETES, V50, P609, DOI 10.2337/diabetes.50.3.609; Williams RSB, 1999, EMBO J, V18, P2734, DOI 10.1093/emboj/18.10.2734; Williams RSB, 2002, NATURE, V417, P292, DOI 10.1038/417292a; YOSHIMOTO T, 1979, BIOCHIM BIOPHYS ACTA, V569, P184, DOI 10.1016/0005-2744(79)90053-6; Zaffanello M, 2003, PEDIATR NEPHROL, V18, P846, DOI 10.1007/s00467-003-1189-y	43	59	63	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2006	78	1					38	51		10.1086/498852	http://dx.doi.org/10.1086/498852			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	993CN	16385448	Bronze, Green Published			2022-12-18	WOS:000233930400005
J	Pimm, J; McQuillin, A; Thirumalai, S; Lawrence, J; Quested, D; Bass, N; Lamb, G; Moorey, H; Datta, SR; Kalsi, G; Badacsonyi, A; Kelly, K; Morgan, J; Punukollu, B; Curtis, D; Gurling, H				Pimm, J; McQuillin, A; Thirumalai, S; Lawrence, J; Quested, D; Bass, N; Lamb, G; Moorey, H; Datta, SR; Kalsi, G; Badacsonyi, A; Kelly, K; Morgan, J; Punukollu, B; Curtis, D; Gurling, H			The Epsin 4 gene on chromosome 5q, which encodes the clathrin-associated protein enthoprotin, is involved in the genetic susceptibility to schizophrenia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; FAMILIES; LOCUS; SUPPORT; TESTS; 5Q	Chromosome 5q33 is a region that has previously shown good evidence of linkage to schizophrenia, with four LOD scores >3.00 in independent linkage studies. We studied 450 unrelated white English, Irish, Welsh, and Scottish research subjects with schizophrenia and 450 ancestrally matched supernormal controls. Four adjacent markers at the 5' end of the Epsin 4 gene showed significant evidence of linkage disequilibrium with schizophrenia. These included two microsatellite markers, D5S1403 (P = .01) and AAAT11 (P = .009), and two single-nucleotide-polymorphism markers within the Epsin 4 gene, rs10046055 (P = .007) and rs254664 (P = .01). A series of different two- and three-marker haplotypes were also significantly associated with schizophrenia, as confirmed with a permutation test (HapA, P = .004; HapB, P = .0005; HapC, P = .007; and HapD, P = .01). The Epsin 4 gene encodes the clathrin-associated protein enthoprotin, which has a role in transport and stability of neurotransmitter vesicles at the synapses and within neurons. A genetically determined abnormality in the structure, function, or expression of enthoprotin is likely to be responsible for genetic susceptibility to a subtype of schizophrenia on chromosome 5q33.3.	UCL, Sch Med, Mol Psychiat Lab, Dept Mental Hlth Sci,Windeyer Inst Med Sci, London W1T 4JF, England; St Pancras Hosp, Camden & Islington Mental Hlth & Social Care Trus, London, England; Hammersmith & Fulham Mental Hlth Unit, W London Mental Hlth Trust, London, England; St Bernards Hosp, London, England; Univ London & E Lond, Queen Mary Coll, London, England; Royal London Hosp, City Mental Hlth Trust, London E1 1BB, England; W Berkshire Natl Hlth Serv NHS Trust, Reading, Berks, England; Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England; Gloucestershire Partnership NHS Trust, Gloucester, England	University of London; University College London; UCL Medical School; University of London; Queen Mary University London; Barts Health NHS Trust; Royal London Hospital; University of Oxford; Gloucestershire Hospitals NHS Foundation Trust	Gurling, H (corresponding author), UCL, Sch Med, Mol Psychiat Lab, Dept Mental Hlth Sci,Windeyer Inst Med Sci, 46 Cleveland St, London W1T 4JF, England.	rejuhxg@ucl.ac.uk	Curtis, David/HGB-3921-2022; McQuillin, Andrew/C-1623-2008; Gurling, Hugh M/A-5029-2010	Curtis, David/0000-0002-4089-9183; McQuillin, Andrew/0000-0003-1567-2240; 				Curtis D, 2002, ANN HUM GENET, V66, P235, DOI 10.1017/S0003480002001094; Devlin B, 2002, MOL PSYCHIATR, V7, P689, DOI 10.1038/sj.mp.4001056; Gurling HMD, 2001, AM J HUM GENET, V68, P661, DOI 10.1086/318788; Kalsi G, 1999, ANN HUM GENET, V63, P235, DOI 10.1046/j.1469-1809.1999.6330235.x; Koshiba Seizo, 2002, Journal of Structural and Functional Genomics, V2, P1, DOI 10.1023/A:1011397007366; Levinson DF, 1999, AM J HUM GENET, V65, pA259; Paunio T, 2001, HUM MOL GENET, V10, P3037, DOI 10.1093/hmg/10.26.3037; Schwab SG, 1997, MOL PSYCHIATR, V2, P156, DOI 10.1038/sj.mp.4000263; SHAM PC, 1995, ANN HUM GENET, V59, P97, DOI 10.1111/j.1469-1809.1995.tb01608.x; SHERRINGTON R, 1988, NATURE, V336, P164, DOI 10.1038/336164a0; SPITZER REJ, 1977, SCHEDULE AFFECTIVE D; STRAUSS AL, 1997, EUR J ULTRASOUND, V5, P31; Wasiak S, 2002, J CELL BIOL, V158, P855, DOI 10.1083/jcb.200205078; Zhao JH, 2002, BIOINFORMATICS, V18, P1694, DOI 10.1093/bioinformatics/18.12.1694; Zhao JH, 2000, HUM HERED, V50, P133, DOI 10.1159/000022901	15	59	61	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2005	76	5					902	907		10.1086/430095	http://dx.doi.org/10.1086/430095			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	914BB	15793701	Green Published, Bronze			2022-12-18	WOS:000228198300018
J	Ikeda, Y; Dalton, JC; Moseley, ML; Gardner, KL; Bird, TD; Ashizawa, T; Seltzer, WK; Pandolfo, M; Milunsky, A; Potter, NT; Shoji, M; Vincent, JB; Day, JW; Ranum, LPW				Ikeda, Y; Dalton, JC; Moseley, ML; Gardner, KL; Bird, TD; Ashizawa, T; Seltzer, WK; Pandolfo, M; Milunsky, A; Potter, NT; Shoji, M; Vincent, JB; Day, JW; Ranum, LPW			Spinocerebellar ataxia type 8: Molecular genetic comparisons and haplotype analysis of 37 families with ataxia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRINUCLEOTIDE-REPEAT; SCA8 LOCUS; MYOTONIC-DYSTROPHY; EXPANDED REPEATS; BINDING PROTEIN; EXPANSION; BIOMEDICINE; TRANSCRIPT; (CTG)(N); CARRIERS	We reported elsewhere that an untranslated CTG expansion causes the dominantly inherited neurodegenerative disorder spinocerebellar ataxia type 8 (SCA8). SCA8 shows a complex inheritance pattern with extremes of incomplete penetrance, in which often only one or two affected individuals are found in a given family. SCA8 expansions have also been found in control chromosomes, indicating that separate genetic or environmental factors increase disease penetrance among SCA8-expansion-carrying patients with ataxia. We describe the molecular genetic features and disease penetrance of 37 different families with SCA8 ataxia from the United States, Canada, Japan, and Mexico. Haplotype analysis using 17 STR markers spanning an similar to1-Mb region was performed on the families with ataxia, on a group of expansion carriers in the general population, and on psychiatric patients, to clarify the genetic basis of the reduced penetrance and to investigate whether CTG expansions among different populations share a common ancestral background. Two major ancestrally related haplotypes (A and A') were found among white families with ataxia, normal controls, and patients with major psychosis, indicating a common ancestral origin of both pathogenic and nonpathogenic SCA8 expansions among whites. Two additional and distinct haplotypes were found among a group of Japanese families with ataxia (haplotype B) and a Mexican family with ataxia ( haplotype C). Our finding that SCA8 expansions on three independently arising haplotypes are found among patients with ataxia and cosegregate with ataxia when multiple family members are affected further supports the direct role of the CTG expansion in disease pathogenesis.	Univ Minnesota, Inst Human Genet, MMC 206, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA; Univ Pittsburgh, Sch Med, Vet Adm Hosp Dept Neurol, Pittsburgh, PA USA; Univ Washington, Sch Med, Dept Neurol, Seattle, WA USA; Univ Texas, Med Branch, Dept Neurol, Galveston, TX 77550 USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Vet Affairs Med Ctr, Houston, TX 77030 USA; Athena Diagnost, Worcester, MA USA; Free Univ Brussels, Erasme Hosp, Dept Neurol, B-1050 Brussels, Belgium; Boston Univ, Sch Med, Ctr Human Genet, Boston, MA 02118 USA; Univ Tennessee, Med Ctr, Dept Med Genet, Knoxville, TN USA; Okayama Univ, Grad Sch Med & Dent, Dept Neurol, Div Neurosci, Okayama 7008530, Japan; Ctr Addict & Mental Hlth, Neurogenet Sect, Toronto, ON, Canada	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Medical Branch Galveston; Baylor College of Medicine; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Universite Libre de Bruxelles; Vrije Universiteit Brussel; Boston University; University of Tennessee System; University of Tennessee Health Science Center; Okayama University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	Ranum, LPW (corresponding author), Univ Minnesota, Inst Human Genet, MMC 206, 420 Delaware St SE, Minneapolis, MN 55455 USA.	ranum001@umn.edu	Pandolfo, Massimo/B-2853-2010	Shoji, Mikio/0000-0003-1027-1712; Day, John/0000-0002-0086-9529; Milunsky, Aubrey/0000-0003-2114-4823	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040389] Funding Source: NIH RePORTER; NINDS NIH HHS [NS40389, R01 NS040389, R37 NS040389] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Benzow KA, 2002, MAMM GENOME, V13, P134, DOI 10.1007/s0033501-2105-2; Brusco A, 2002, J NEUROL, V249, P923, DOI 10.1007/s00415-002-0760-y; Cellini E, 2002, ARCH NEUROL-CHICAGO, V59, P1952, DOI 10.1001/archneur.59.12.1952; Day JW, 2003, AM J HUM GENET, V73, P548; Day JW, 2000, NEUROLOGY, V55, P649, DOI 10.1212/WNL.55.5.649; Hagerman RJ, 2001, NEUROLOGY, V57, P127, DOI 10.1212/WNL.57.1.127; Holmes SE, 1999, NAT GENET, V23, P391, DOI 10.1038/70493; Holmes SE, 2001, BRAIN RES BULL, V56, P397, DOI 10.1016/S0361-9230(01)00596-2; Ikeda Y, 2000, NEUROLOGY, V54, P950, DOI 10.1212/WNL.54.4.950; Izumi Y, 2003, AM J HUM GENET, V72, P704, DOI 10.1086/367775; Jacquemont S, 2003, AM J HUM GENET, V72, P869, DOI 10.1086/374321; Jin P, 2000, HUM MOL GENET, V9, P901, DOI 10.1093/hmg/9.6.901; Juvonen V, 2000, ANN NEUROL, V48, P354, DOI 10.1002/1531-8249(200009)48:3<354::AID-ANA10>3.0.CO;2-A; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Koob MD, 1999, NAT GENET, V21, P379, DOI 10.1038/7710; Koob MD, 1998, NAT GENET, V18, P72, DOI 10.1038/ng0198-72; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Matsuura T, 2000, NAT GENET, V26, P191, DOI 10.1038/79911; Moseley ML, 2000, HUM MOL GENET, V9, P2125, DOI 10.1093/hmg/9.14.2125; Moseley ML, 2000, NAT GENET, V24, P215, DOI 10.1038/73415; Mosemiller AK, 2003, CYTOGENET GENOME RES, V100, P175, DOI 10.1159/000072852; Nemes JP, 2000, HUM MOL GENET, V9, P1543, DOI 10.1093/hmg/9.10.1543; Nemes JP, 2000, HUM MOL GENET, V9, P2777; Orr HT, 2001, GENE DEV, V15, P925, DOI 10.1101/gad.888401; Ott J., 1991, ANAL HUMAN GENETIC L; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Ranum LPW, 2002, CURR OPIN GENET DEV, V12, P266, DOI 10.1016/S0959-437X(02)00297-6; Schols L, 2003, ANN NEUROL, V54, P110, DOI 10.1002/ana.10608; Silveira I, 2000, AM J HUM GENET, V66, P830, DOI 10.1086/302827; Sobrido MJ, 2001, NEUROLOGY, V57, P1310, DOI 10.1212/WNL.57.7.1310; Stevanin G, 2000, NAT GENET, V24, P213, DOI 10.1038/73408; Tapscott SJ, 2000, SCIENCE, V289, P1701, DOI 10.1126/science.289.5485.1701; Tapscott SJ, 2001, SCIENCE, V293, P816, DOI 10.1126/science.1063517; Topisirovic I, 2002, CLIN GENET, V62, P321, DOI 10.1034/j.1399-0004.2002.620412.x; Vincent JB, 2000, AM J MED GENET, V96, P873, DOI 10.1002/1096-8628(20001204)96:6<873::AID-AJMG37>3.0.CO;2-9; Vincent JB, 2000, AM J HUM GENET, V66, P819, DOI 10.1086/302803; Warren ST, 1996, SCIENCE, V271, P1374, DOI 10.1126/science.271.5254.1374; WEEKS DE, 1995, AM J HUM GENET, V56, P1506; Worth PF, 2000, NAT GENET, V24, P214, DOI 10.1038/73411; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	42	59	61	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2004	75	1					3	16		10.1086/422014	http://dx.doi.org/10.1086/422014			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	829FG	15152344	Bronze, Green Published			2022-12-18	WOS:000222031300002
J	Bucheton, B; Abel, L; El-Safi, S; Kheir, MM; Pavek, S; Lemainque, A; Dessein, AJ				Bucheton, B; Abel, L; El-Safi, S; Kheir, MM; Pavek, S; Lemainque, A; Dessein, AJ			A major susceptibility locus on chromosome 22q12 plays a critical role in the control of Kala-azar	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ATBARA-RIVER AREA; VISCERAL-LEISHMANIASIS; EASTERN SUDAN; CUTANEOUS LEISHMANIASIS; NATURAL-RESISTANCE; LINKAGE ANALYSIS; COMPLEX TRAITS; IL-2 RECEPTOR; INFECTION; MICE	Kala-azar (KA) is a life-threatening protozoal disease caused by Leishmania parasites (L. donovani, L. chagasi, and L. infantum). The disease, which is also called "visceral leishmaniasis," is prevalent in Africa, South America, Asia, and the Mediterranean basin. Epidemics occur periodically, killing a large number of infected individuals. Factors determining whether a patient remains asymptomatic or develops KA are still largely unknown. In a previous study that was performed during an outbreak of KA in a village on the Ethiopian-Sudanese border, we showed that KA was more frequent in certain families and ethnic groups, thereby suggesting that host genetic factors play an important role in the development of the disease. Here, we report the results of a genomewide linkage study performed on 63 Sudanese families selected from the most affected ethnic group and including 169 children with KA. Significant linkage (LOD score 3.50 [P=3x10(-5)] in all patients; LOD score 3.90 [P=10(-5)] in patients who were affected early in the outbreak) was obtained with markers on chromosome 22q12. These results are the first evidence of a major genetic effect on the development of human KA. They may lead to identification of genes critical in the pathogenesis of this disease and to new therapeutic interventions against this parasite, which is developing resistance to available drugs.	Fac Med La Timone, INSERM, U399, F-13385 Marseille 05, France; Fac Med Necker Enfants Malad, INSERM, U550, Paris, France; Univ Khartoum, Fac Med, Dept Microbiol & Parasitol, Khartoum, Sudan; Ctr Natl Genotypage, Evry, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Khartoum; CEA; UDICE-French Research Universities; Universite Paris Saclay	Dessein, AJ (corresponding author), Fac Med La Timone, INSERM, U399, 27 Blvd Jean Moulin, F-13385 Marseille 05, France.	alain.dessein@medecine.univ-mrs.fr	Abel, Laurent/H-8888-2017; Alain, Dessein/A-3142-2009	Abel, Laurent/0000-0001-7016-6493; 				Abel L, 1998, AM J HUM GENET, V63, P638, DOI 10.1086/301958; Abel L, 1998, GENET EPIDEMIOL, V15, P371, DOI 10.1002/(SICI)1098-2272(1998)15:4<371::AID-GEPI4>3.0.CO;2-5; BADARO R, 1986, J INFECT DIS, V154, P639, DOI 10.1093/infdis/154.4.639; BADARO R, 1986, J INFECT DIS, V154, P1003, DOI 10.1093/infdis/154.6.1003; BARBIER D, 1987, TISSUE ANTIGENS, V30, P63, DOI 10.1111/j.1399-0039.1987.tb01598.x; BARRALNETTO M, 1991, J IMMUNOL, V147, P281; Beebe AM, 1997, IMMUNITY, V6, P551, DOI 10.1016/S1074-7613(00)80343-X; BLACKWELL J, 1980, NATURE, V283, P72, DOI 10.1038/283072a0; BLACKWELL JM, 1983, J TROP MED HYG, V86, P17; Blackwell JM, 2003, IMMUNOL LETT, V85, P197, DOI 10.1016/S0165-2478(02)00231-6; Blackwell JM, 1996, PARASITOLOGY, V112, pS67, DOI 10.1017/S0031182000076678; BRADLEY DJ, 1979, CLIN EXP IMMUNOL, V37, P7; Bucheton B, 2003, GENES IMMUN, V4, P104, DOI 10.1038/sj.gene.6363927; Bucheton B, 2002, MICROBES INFECT, V4, P1449, DOI 10.1016/S1286-4579(02)00027-8; BUCHETON B, IN PRESS T R SOC TRO; CABELLO PH, 1995, AM J TROP MED HYG, V52, P364, DOI 10.4269/ajtmh.1995.52.364; CABRERA M, 1995, J EXP MED, V182, P1259, DOI 10.1084/jem.182.5.1259; CARVALHO EM, 1981, INFECT IMMUN, V33, P498, DOI 10.1128/IAI.33.2.498-500.1981; CARVALHO EM, 1985, J CLIN INVEST, V76, P2066, DOI 10.1172/JCI112209; Demant P, 1996, SCIENCE, V274, P1392, DOI 10.1126/science.274.5291.1392; Desjeux P, 1996, CLIN DERMATOL, V14, P417, DOI 10.1016/0738-081X(96)00057-0; Desjeux P, 2001, T ROY SOC TROP MED H, V95, P239, DOI 10.1016/S0035-9203(01)90223-8; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; El-Safi SH, 2002, MICROBES INFECT, V4, P1439, DOI 10.1016/S1286-4579(02)00026-6; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; Ibrahim ME, 1999, AM J TROP MED HYG, V61, P941, DOI 10.4269/ajtmh.1999.61.941; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lambert M, 2002, ANN TROP MED PARASIT, V96, P631, DOI 10.1179/000349802125001474; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LARA ML, 1991, HUM IMMUNOL, V30, P129, DOI 10.1016/0198-8859(91)90081-J; LIU J, 1995, AM J HUM GENET, V56, P845; Majumder S, 1996, J IMMUNOL, V156, P3866; Marquet S, 1996, NAT GENET, V14, P181, DOI 10.1038/ng1096-181; Mira MT, 2003, NAT GENET, V33, P412, DOI 10.1038/ng1096; Pearson RD, 1996, CLIN INFECT DIS, V22, P1, DOI 10.1093/clinids/22.1.1; PETZLERLER ML, 1991, HUM IMMUNOL, V32, P254, DOI 10.1016/0198-8859(91)90088-Q; Pratlong F, 2001, PARASITOLOGY, V122, P599, DOI 10.1017/S0031182001007867; RISCH N, 1990, AM J HUM GENET, V46, P229; ROBERTS M, 1993, EUR J IMMUNOGENET, V20, P349, DOI 10.1111/j.1744-313X.1993.tb00154.x; Seaman J, 1996, INT J EPIDEMIOL, V25, P862, DOI 10.1093/ije/25.4.862; Siddiqui MR, 2001, NAT GENET, V27, P439, DOI 10.1038/86958; SOUTHGATE BA, 1967, J TROP MED HYG, V70, P29; VIDAL S, 1995, J EXP MED, V182, P655, DOI 10.1084/jem.182.3.655; ZIJLSTRA EE, 1994, AM J TROP MED HYG, V51, P826, DOI 10.4269/ajtmh.1994.51.826	44	59	63	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2003	73	5					1052	1060		10.1086/379084	http://dx.doi.org/10.1086/379084			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	742AR	14557985	Green Published, Bronze			2022-12-18	WOS:000186493400007
J	Majewski, J				Majewski, J			Dependence of mutational asymmetry on gene-expression levels in the human genome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NORMAL HUMAN TISSUES; SUBSTITUTION PATTERNS; STRAND; RATES; DNA; TRANSCRIPTION; PSEUDOGENES; EVOLUTION; BIASES; USAGE	A great deal of effort has been devoted to measuring the rates of different types of nucleotide substitutions. Mutation rates are known to depend on factors such as methylation status and nearest-neighbor nucleotide effects. However, until recently, in eukaryotes, the rates have not been considered to be strand specific. In a recent analysis of mammalian lineages, Green et al. ( 2003) uncovered an asymmetry in the frequencies of substitutions on the coding and noncoding strands of genes and showed that this resulted in a nucleotide-content asymmetry within most genes. The authors argue that this bias may be caused by the mammalian transcription-coupled repair in germ cells, but they did not demonstrate an association with germ-cell gene expression. In this work, I analyze nucleotide contents in genes with known expression patterns and levels and provide evidence that the observed asymmetry in mutation rates is, in fact, caused by transcription. The results also imply that germline transcription may occur in a large percentage, 71%-91%, of all human genes.	Rockefeller Univ, Lab Stat Genet, New York, NY 10021 USA	Rockefeller University	Majewski, J (corresponding author), Rockefeller Univ, Lab Stat Genet, Box 192,1230 York Ave, New York, NY 10021 USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K01HG000008] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG000008, HG00008] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Beletskii A, 1996, P NATL ACAD SCI USA, V93, P13919, DOI 10.1073/pnas.93.24.13919; BULMER M, 1986, MOL BIOL EVOL, V3, P322; BULMER M, 1991, J MOL EVOL, V33, P305, DOI 10.1007/BF02102861; CHARGAFF E, 1951, FED PROC, V10, P654; CHELLY J, 1989, P NATL ACAD SCI USA, V86, P2617, DOI 10.1073/pnas.86.8.2617; Duret L, 2002, CURR OPIN GENET DEV, V12, P640, DOI 10.1016/S0959-437X(02)00353-2; Frank AC, 1999, GENE, V238, P65, DOI 10.1016/S0378-1119(99)00297-8; GOJOBORI T, 1982, J MOL EVOL, V18, P360, DOI 10.1007/BF01733904; Green P, 2003, NAT GENET, V33, P514, DOI 10.1038/ng1103; Haverty PM, 2002, NUCLEIC ACIDS RES, V30, P214, DOI 10.1093/nar/30.1.214; HESS ST, 1994, J MOL BIOL, V236, P1022, DOI 10.1016/0022-2836(94)90009-4; Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001; Kano-Sueoka T, 1999, GENE, V238, P59, DOI 10.1016/S0378-1119(99)00296-6; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Krawczak M, 1998, AM J HUM GENET, V63, P474, DOI 10.1086/301965; LEADON SA, 1991, MUTAT RES, V255, P67, DOI 10.1016/0921-8777(91)90019-L; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Majewski J, 2002, GENOME RES, V12, P1827, DOI 10.1101/gr.606402; Stanton JL, 2001, MOL HUM REPROD, V7, P521, DOI 10.1093/molehr/7.6.521; SUEOKA N, 1995, J MOL EVOL, V40, P318, DOI 10.1007/BF00163236; TANAKA M, 1994, GENOMICS, V22, P327, DOI 10.1006/geno.1994.1391; WU CI, 1987, NATURE, V327, P169, DOI 10.1038/327169a0	22	59	64	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2003	73	3					688	692		10.1086/378134	http://dx.doi.org/10.1086/378134			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	718FG	12881777	Green Published, Bronze			2022-12-18	WOS:000185134000024
J	Ijlst, L; Loupatty, FJ; Ruiter, JPN; Duran, M; Lehnert, W; Wanders, RJA				Ijlst, L; Loupatty, FJ; Ruiter, JPN; Duran, M; Lehnert, W; Wanders, RJA			3-methylglutaconic aciduria type I is caused by mutations in AUH	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ENOYL-COA HYDRATASE; DEFICIENCY; PROTEIN	3-Methylglutaconic aciduria type I is an autosomal recessive disorder clinically characterized by various symptoms ranging from delayed speech development to severe neurological handicap. This disorder is caused by a deficiency of 3-methylglutaconyl-CoA hydratase, one of the key enzymes of leucine degradation. This results in elevated urinary levels of 3-methylglutaconic acid, 3-methylglutaric acid, and 3-hydroxyisovaleric acid. By heterologous expression in Escherichia coli, we show that 3-methylglutaconyl-CoA hydratase is encoded by the AUH gene, whose product had been reported elsewhere as an AU-specific RNA-binding protein. Mutation analysis of AUH in two patients revealed a nonsense mutation (R197X) and a splice-site mutation (IVS8-1G-->A), demonstrating that mutations in AUH cause 3-methylglutaconic aciduria type I.	Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Clin Chem, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands; Univ Freiburg, Childrens Hosp, Freiburg, Germany	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Freiburg	Wanders, RJA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pediat, Lab Genet Metab Dis F0 224, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.							DURAN M, 1982, J PEDIATR-US, V101, P551, DOI 10.1016/S0022-3476(82)80698-7; Ensenauer R, 2000, J INHERIT METAB DIS, V23, P341, DOI 10.1023/A:1005670911799; GIBSON KM, 1992, J INHERIT METAB DIS, V15, P363, DOI 10.1007/BF02435977; Gibson KM, 1998, J INHERIT METAB DIS, V21, P631, DOI 10.1023/A:1005476315892; HILZ H, 1958, BIOCHEM Z, V329, P476; Kurimoto K, 2001, STRUCTURE, V9, P1253, DOI 10.1016/S0969-2126(01)00686-4; NAKAGAWA J, 1995, P NATL ACAD SCI USA, V92, P2051, DOI 10.1073/pnas.92.6.2051; NARISAWA K, 1989, CLIN CHIM ACTA, V184, P57, DOI 10.1016/0009-8981(89)90256-8; NARISAWA K, 1986, J CLIN INVEST, V77, P1148, DOI 10.1172/JCI112415; Shoji Y, 1999, J INHERIT METAB DIS, V22, P1, DOI 10.1023/A:1005421111554; WANDERS RJA, 1992, BIOCHEM BIOPH RES CO, V188, P1139, DOI 10.1016/0006-291X(92)91350-Y	11	59	62	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2002	71	6					1463	1466		10.1086/344712	http://dx.doi.org/10.1086/344712			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621KD	12434311	Green Published, Bronze			2022-12-18	WOS:000179586800021
J	Hegele, RA				Hegele, RA			Monogenic dyslipidemias: Window on determinants of plasma lipoprotein metabolism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							FAMILIAL COMBINED HYPERLIPIDEMIA; CORONARY-HEART-DISEASE; TRANSFER-PROTEIN GENE; TRIGLYCERIDE-TRANSFER-PROTEIN; COMPLEX SEGREGATION ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISMS; COA-CHOLESTEROL ACYLTRANSFERASE; FACTOR-1-ALPHA G319S VARIANT; CASSETTE TRANSPORTER 1; LEMLI-OPITZ-SYNDROME		John P Robarts Res Inst, Blackburn Cardiovasc Genet Lab, London, ON N6A 5K8, Canada	Western University (University of Western Ontario)	Hegele, RA (corresponding author), John P Robarts Res Inst, Blackburn Cardiovasc Genet Lab, 406-100 Perth Dr, London, ON N6A 5K8, Canada.	robert.hegele@rri.on.ca	Hegele, Robert/G-3301-2011; Hegele, Robert/AAF-6482-2020	Hegele, Robert/0000-0003-2861-5325				Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Aitman TJ, 1997, ARTERIOSCL THROM VAS, V17, P748, DOI 10.1161/01.ATV.17.4.748; Almasy L, 1999, AM J HUM GENET, V64, P1686, DOI 10.1086/302425; ANDERSON RA, 1994, P NATL ACAD SCI USA, V91, P2718, DOI 10.1073/pnas.91.7.2718; Anderson RA, 1998, J BIOL CHEM, V273, P26747, DOI 10.1074/jbc.273.41.26747; Aouizerat BE, 1999, AM J HUM GENET, V65, P397, DOI 10.1086/302490; Austin MA, 1999, AM J CARDIOL, V83, p13F; Austin MA, 2000, CIRCULATION, V101, P2777, DOI 10.1161/01.CIR.101.24.2777; BASSEN FA, 1950, BLOOD, V5, P381, DOI 10.1182/blood.V5.4.381.381; Benlian P, 1996, NEW ENGL J MED, V335, P848, DOI 10.1056/NEJM199609193351203; BERG K, 1992, MONOGRAPHS HUMAN GEN, V14, P189; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; BOERWINKLE E, 1992, J CLIN INVEST, V90, P52, DOI 10.1172/JCI115855; Bouchard L, 2001, PEDIATR RES, V49, P326, DOI 10.1203/00006450-200103000-00005; BRECKENRIDGE WC, 1978, NEW ENGL J MED, V298, P1265, DOI 10.1056/NEJM197806082982301; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; Buhman KK, 2000, NAT MED, V6, P1341, DOI 10.1038/82153; CABEZAS MC, 1993, ARTERIOSCLER THROMB, V13, P804, DOI 10.1161/01.ATV.13.6.804; CALI JJ, 1991, J BIOL CHEM, V266, P7779; Cao H, 2000, HUM MOL GENET, V9, P109, DOI 10.1093/hmg/9.1.109; Cases S, 1998, J BIOL CHEM, V273, P26755, DOI 10.1074/jbc.273.41.26755; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Castellani LW, 1998, NAT GENET, V18, P374, DOI 10.1038/ng0498-374; CHANG CCY, 1993, J BIOL CHEM, V268, P20747; Chang TY, 2001, CURR OPIN LIPIDOL, V12, P289, DOI 10.1097/00041433-200106000-00008; CIANFLONE K, 1995, INT J OBESITY, V19, pS34; Ciccarese M, 2000, AM J HUM GENET, V66, P453, DOI 10.1086/302753; Clee SM, 2000, J CLIN INVEST, V106, P1263, DOI 10.1172/JCI10727; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cohen JC, 1999, CURR OPIN LIPIDOL, V10, P259, DOI 10.1097/00041433-199906000-00008; COHEN JC, 1993, J CLIN INVEST, V91, P1630, DOI 10.1172/JCI116370; Coon H, 2000, ARTERIOSCL THROM VAS, V20, P2275, DOI 10.1161/01.ATV.20.10.2275; CORTNER JA, 1991, J INHERIT METAB DIS, V14, P915, DOI 10.1007/BF01800473; Costet P, 2000, J BIOL CHEM, V275, P28240; COX DW, 1978, NEW ENGL J MED, V299, P1421, DOI 10.1056/NEJM197812282992601; CULLEN P, 1994, ARTERIOSCLER THROMB, V14, P1233, DOI 10.1161/01.ATV.14.8.1233; DallingaThie GM, 1996, J LIPID RES, V37, P136; DallingaThie GM, 1997, J CLIN INVEST, V99, P953, DOI 10.1172/JCI119260; DAMMERMAN M, 1995, CIRCULATION, V91, P505, DOI 10.1161/01.CIR.91.2.505; Danesh J, 2000, CIRCULATION, V102, P1082, DOI 10.1161/01.CIR.102.10.1082; Dannoura AH, 1999, ARTERIOSCL THROM VAS, V19, P2494, DOI 10.1161/01.ATV.19.10.2494; del Castillo-Olivares A, 2000, NUCLEIC ACIDS RES, V28, P3587; Dietschy JM, 2001, CURR OPIN LIPIDOL, V12, P105, DOI 10.1097/00041433-200104000-00003; Duggirala R, 2000, AM J HUM GENET, V66, P1237, DOI 10.1086/302849; EMI M, 1991, ARTERIOSCLER THROMB, V11, P1349, DOI 10.1161/01.ATV.11.5.1349; FRANCIS GA, 1995, J CLIN INVEST, V96, P78, DOI 10.1172/JCI118082; FREDRICK.DS, 1967, NEW ENGL J MED, V276, P273, DOI 10.1056/NEJM196702022760507; FREDRICKSON D, 1961, ANN INTERN MED, V55, P1016, DOI 10.7326/0003-4819-55-6-1016; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; GENEST JJ, 1992, CIRCULATION, V85, P2025, DOI 10.1161/01.CIR.85.6.2025; Geurts JMW, 2000, HUM MOL GENET, V9, P2067, DOI 10.1093/hmg/9.14.2067; Glatz JFC, 2001, CURR OPIN LIPIDOL, V12, P267, DOI 10.1097/00041433-200106000-00005; Glomset J A, 1980, Adv Intern Med, V25, P91; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Goldstein JL, 2001, SCIENCE, V292, P1310, DOI 10.1126/science.1061815; Haddad L, 1999, J LIPID RES, V40, P1113; Havel RJ, 2000, CURR OPIN LIPIDOL, V11, P615, DOI 10.1097/00041433-200012000-00008; Hegele RA, 2000, ARTERIOSCL THROM VAS, V20, P217, DOI 10.1161/01.ATV.20.1.217; Hegele RA, 1999, J CLIN ENDOCR METAB, V84, P1077, DOI 10.1210/jc.84.3.1077; Hegele RA, 2000, GENOME RES, V10, P652, DOI 10.1101/gr.10.5.652; HEGELE RA, 1993, ARTERIOSCLER THROMB, V13, P720, DOI 10.1161/01.ATV.13.5.720; Hegele RA, 1997, ARTERIOSCL THROM VAS, V17, P1701, DOI 10.1161/01.ATV.17.9.1701; Hegele RA, 2001, J HUM GENET, V46, P423, DOI 10.1007/s100380170061; Hegele RA, 2001, J HUM GENET, V46, P320, DOI 10.1007/s100380170066; Hegele RA, 1999, CLIN CHEM, V45, P1579; Hegele RA, 2001, CIRCULATION, V103, P2225; HERBERT PN, 1978, NEW ENGL J MED, V299, P519, DOI 10.1056/NEJM197809072991005; HOBBS HH, 1989, J CLIN INVEST, V84, P656, DOI 10.1172/JCI114212; HODGES P, 1992, TRENDS BIOCHEM SCI, V17, P77, DOI 10.1016/0968-0004(92)90506-5; Hunt SC, 2000, ARTERIOSCL THROM VAS, V20, P1089, DOI 10.1161/01.ATV.20.4.1089; Imperatore G, 2000, ARTERIOSCL THROM VAS, V20, P2651, DOI 10.1161/01.ATV.20.12.2651; INAZU A, 1990, NEW ENGL J MED, V323, P1234, DOI 10.1056/NEJM199011013231803; ISELIUS L, 1981, HUM HERED, V31, P222, DOI 10.1159/000153212; JAUHIAINEN M, 1991, ATHEROSCLEROSIS, V89, P59, DOI 10.1016/0021-9150(91)90007-P; Jaye M, 1999, NAT GENET, V21, P424, DOI 10.1038/7766; Jiang XC, 1999, J CLIN INVEST, V103, P907, DOI 10.1172/JCI5578; Jiao XD, 2000, AM J HUM GENET, V67, P1309; Jones P J, 1999, Curr Atheroscler Rep, V1, P230, DOI 10.1007/s11883-999-0037-3; Keller AM, 2000, J EUKARYOT MICROBIOL, V47, P1, DOI 10.1111/j.1550-7408.2000.tb00001.x; Kelley RI, 1998, AM J HUM GENET, V63, P322, DOI 10.1086/301987; KISSEBAH AH, 1981, METABOLISM, V30, P856, DOI 10.1016/0026-0495(81)90064-0; Klos KL, 2001, ARTERIOSCL THROM VAS, V21, P971, DOI 10.1161/01.ATV.21.6.971; Knoblauch H, 2000, AM J HUM GENET, V66, P157, DOI 10.1086/302704; Kort EN, 2000, AM J HUM GENET, V66, P1845, DOI 10.1086/302945; Kuivenhoven JA, 1997, J LIPID RES, V38, P191; Langmann T, 1999, BIOCHEM BIOPH RES CO, V257, P29, DOI 10.1006/bbrc.1999.0406; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; Lee MH, 2001, CURR OPIN LIPIDOL, V12, P141, DOI 10.1097/00041433-200104000-00007; Lee MH, 2001, NAT GENET, V27, P79, DOI 10.1038/83799; LEROY A, 1993, J BIOL CHEM, V268, P4798; Lu KM, 2001, AM J HUM GENET, V69, P278, DOI 10.1086/321294; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Mahley RW, 1999, J LIPID RES, V40, P1933; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Marcovina S M, 1999, Curr Cardiol Rep, V1, P105, DOI 10.1007/s11886-999-0067-z; Meiner VL, 1996, P NATL ACAD SCI USA, V93, P14041, DOI 10.1073/pnas.93.24.14041; MOLL PP, 1989, AM J HUM GENET, V44, P124; Morrisett J D, 2000, Curr Atheroscler Rep, V2, P243, DOI 10.1007/s11883-000-0026-z; MULLER DPR, 1985, J INHERIT METAB DIS, V8, P88, DOI 10.1007/BF01800666; MYANT NB, 1993, ATHEROSCLEROSIS, V104, P1, DOI 10.1016/0021-9150(93)90171-P; NARCISI TME, 1995, AM J HUM GENET, V57, P1298; Near SE, 2001, J HUM GENET, V46, P490, DOI 10.1007/s100380170051; Nicholson AC, 2000, ANN NY ACAD SCI, V902, P128; NIKKILA EA, 1973, LANCET, V1, P954; Nowaczyk MJM, 2001, AM J MED GENET, V102, P383, DOI 10.1002/ajmg.1441; Oelkers P, 1998, J BIOL CHEM, V273, P26765, DOI 10.1074/jbc.273.41.26765; Oelkers P, 1997, J CLIN INVEST, V99, P1880, DOI 10.1172/JCI119355; OPITZ JM, 1994, AM J MED GENET, V50, P339, DOI 10.1002/ajmg.1320500407; Pajukanta P, 1997, ARTERIOSCL THROM VAS, V17, P841, DOI 10.1161/01.ATV.17.5.841; Pajukanta P, 1999, AM J HUM GENET, V64, P1453, DOI 10.1086/302365; Pajukanta P, 1998, NAT GENET, V18, P369, DOI 10.1038/ng0498-369; Parisi M J, 1998, Cell Res, V8, P15; Patel SB, 1998, J CLIN INVEST, V102, P1041, DOI 10.1172/JCI3963; PEDERSEN TR, 1994, LANCET, V344, P1383; Pei WD, 2000, CLIN GENET, V57, P29, DOI 10.1034/j.1399-0004.2000.570105.x; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Pocovi M, 1998, LANCET, V351, P1919, DOI 10.1016/S0140-6736(97)09490-7; RADER DJ, 1993, JAMA-J AM MED ASSOC, V270, P865, DOI 10.1001/jama.270.7.865; Rainwater DL, 1999, ARTERIOSCL THROM VAS, V19, P777, DOI 10.1161/01.ATV.19.3.777; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; REYNISDOTTIR S, 1995, J CLIN INVEST, V95, P2161, DOI 10.1172/JCI117905; RHOADS GG, 1986, JAMA-J AM MED ASSOC, V256, P2540, DOI 10.1001/jama.256.18.2540; RHOADS GG, 1976, NEW ENGL J MED, V294, P293, DOI 10.1056/NEJM197602052940601; ROSE HG, 1973, AM J MED, V54, P148, DOI 10.1016/0002-9343(73)90218-0; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; RUSSELL DW, 1992, BIOCHEMISTRY-US, V31, P4737, DOI 10.1021/bi00135a001; Russell DW, 1999, CELL, V97, P539, DOI 10.1016/S0092-8674(00)80763-1; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Sakai J, 2001, CURR OPIN LIPIDOL, V12, P261, DOI 10.1097/00041433-200106000-00004; Santamarina-Fojo S, 1998, ENDOCRIN METAB CLIN, V27, P551, DOI 10.1016/S0889-8529(05)70025-6; SCANU AM, 1990, J CLIN INVEST, V85, P1709, DOI 10.1172/JCI114625; Scanu AM, 2001, FRONT BIOSCI-LANDMRK, V6, pD546, DOI 10.2741/Scanu; SCHAEFER EJ, 1980, ANN INTERN MED, V93, P261, DOI 10.7326/0003-4819-93-2-261; Schmitz G, 2000, CURR OPIN LIPIDOL, V11, P493, DOI 10.1097/00041433-200010000-00007; SCHONFELD G, 1995, CAN J CARDIOL, V11, pG86; SERFATYLACROSNIERE C, 1994, ATHEROSCLEROSIS, V107, P85, DOI 10.1016/0021-9150(94)90144-9; Setchell KDR, 1998, J CLIN INVEST, V102, P1690, DOI 10.1172/JCI2962; Shachter NS, 2001, CURR OPIN LIPIDOL, V12, P297, DOI 10.1097/00041433-200106000-00009; Shearman AM, 2000, HUM MOL GENET, V9, P1315, DOI 10.1093/hmg/9.9.1315; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Sijbrands EJG, 2001, BMJ-BRIT MED J, V322, P1019, DOI 10.1136/bmj.322.7293.1019; Smith JD, 2000, ANN MED, V32, P118, DOI 10.3109/07853890009011761; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; SNIDERMAN AD, 1988, CAN J CARDIOL, V4, pA24; SORRENTINO MJ, 1992, AM J MED, V93, P658, DOI 10.1016/0002-9343(92)90199-L; Stamler J, 2000, JAMA-J AM MED ASSOC, V284, P311, DOI 10.1001/jama.284.3.311; Stieger B, 1998, CURR OPIN CELL BIOL, V10, P462, DOI 10.1016/S0955-0674(98)80059-8; Superko HR, 1996, CIRCULATION, V94, P2351, DOI 10.1161/01.CIR.94.10.2351; Tacken PJ, 2001, CURR OPIN LIPIDOL, V12, P275, DOI 10.1097/00041433-200106000-00006; Tall AR, 2000, J CLIN INVEST, V106, P1205, DOI 10.1172/JCI11538; Tall AR, 2000, ARTERIOSCL THROM VAS, V20, P1185, DOI 10.1161/01.ATV.20.5.1185; Talmud P J, 2001, Curr Atheroscler Rep, V3, P191, DOI 10.1007/s11883-001-0061-4; Talmud PJ, 2001, CURR OPIN LIPIDOL, V12, P405, DOI 10.1097/00041433-200108000-00006; THOROGOOD M, 1991, BRIT MED J, V303, P893; TREEM WR, 1991, PEDIATRICS, V87, P328; Vakkilainen J, 1998, EUR J CLIN INVEST, V28, P24; Van Berkel TJC, 2000, ANN NY ACAD SCI, V902, P113; Vance DE, 2000, BBA-MOL CELL BIOL L, V1529, P1, DOI 10.1016/S1388-1981(00)00133-5; VIANA MB, 1990, J MED GENET, V27, P499, DOI 10.1136/jmg.27.8.499; WALDEN CC, 1994, ANN INTERN MED, V120, P1026, DOI 10.7326/0003-4819-120-12-199406150-00009; Wan YJY, 2000, MOL CELL BIOL, V20, P4436, DOI 10.1128/MCB.20.12.4436-4444.2000; Wang J, 2001, Hum Mutat, V18, P359; Wassif CA, 1998, AM J HUM GENET, V63, P55, DOI 10.1086/301936; Waterham HR, 1998, AM J HUM GENET, V63, P329, DOI 10.1086/301982; WETTERAU JR, 1992, SCIENCE, V258, P999; WETTERAU JR, 1991, BIOCHEMISTRY-US, V30, P4406, DOI 10.1021/bi00232a006; Wijsman EM, 1998, ARTERIOSCL THROM VAS, V18, P215, DOI 10.1161/01.ATV.18.2.215; WILLIAMS RR, 1986, JAMA-J AM MED ASSOC, V255, P219, DOI 10.1001/jama.255.2.219; WILLIAMS RR, 1993, AM J CARDIOL, V72, P171, DOI 10.1016/0002-9149(93)90155-6; WILLIAMS WR, 1982, HUM HERED, V32, P24, DOI 10.1159/000153254; WOJCIECHOWSKI AP, 1991, NATURE, V349, P161, DOI 10.1038/349161a0; Wu JS, 1999, J LIPID RES, V40, P955; Yang WS, 1996, J LIPID RES, V37, P2627; Yarnell JWG, 2001, ARTERIOSCL THROM VAS, V21, P1340, DOI 10.1161/hq0801.093505; Yuan B, 2000, AM J HUM GENET, V66, P1699, DOI 10.1086/302904; Zhong SB, 1996, J CLIN INVEST, V97, P2917, DOI 10.1172/JCI118751; Zuliani G, 1999, ARTERIOSCL THROM VAS, V19, P802, DOI 10.1161/01.ATV.19.3.802; ZULIANI G, 1995, EUR J CLIN INVEST, V25, P322, DOI 10.1111/j.1365-2362.1995.tb01709.x	185	59	62	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2001	69	6					1161	1177		10.1086/324647	http://dx.doi.org/10.1086/324647			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	491AY	11704922	Green Published, Bronze			2022-12-18	WOS:000172086900001
J	Jamieson, CR; Fryns, JP; Jacobs, J; Matthijs, G; Abramowicz, MJ				Jamieson, CR; Fryns, JP; Jacobs, J; Matthijs, G; Abramowicz, MJ			Primary autosomal recessive microcephaly: MCPH5 maps to 1q25-q32	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRAITS	Primary microcephaly is thought to result from genetic defects of the developmental program that generates large brain hemispheres in humans. Autosomal recessive inheritance is likely in most familial cases, and four loci were recently mapped by homozygosity. We report homozygosity mapping of a new locus, MCPH5, with a maximum multipoint LOD score of 3.51 at marker D1S1723, in a family of Turkish origin. The minimal critical region spans 11.4 cM between markers D1S384 and D1S2655, at 1q25-q32, and encompasses the cytogenetic breakpoints of chromosomal aberrations previously reported in unrelated patients with microcephaly.	Free Univ Brussels, Hop Erasme, Dept Genet, Med Genet Lab, B-1070 Brussels, Belgium; Free Univ Brussels, Hop Erasme, MPI Molenstede, B-1070 Brussels, Belgium; Free Univ Brussels, Hop Erasme, Serv Genet Med, B-1070 Brussels, Belgium; Katholieke Univ Leuven, Centrum Menselijke Erfelijkheid, Louvain, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Vrije Universiteit Brussel; KU Leuven	Abramowicz, MJ (corresponding author), Free Univ Brussels, Hop Erasme, Dept Genet, Med Genet Lab, 808 Route Lennik, B-1070 Brussels, Belgium.	marcabra@ulb.ac.be	Abramowicz, Marc/AAX-6419-2020	Matthijs, Gert/0000-0001-6710-1912; Abramowicz, Marc/0000-0003-0623-8768				BOURROUILLOU G, 1978, CR SOC BIOL, V172, P359; Brewer C, 1998, AM J HUM GENET, V63, P1153, DOI 10.1086/302041; COWIE V, 1960, J MENT DEFIC RES, V4, P42; Jackson AP, 1998, AM J HUM GENET, V63, P541, DOI 10.1086/301966; Jamieson CR, 1999, AM J HUM GENET, V65, P1465, DOI 10.1086/302640; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Moynihan L, 2000, AM J HUM GENET, V66, P724, DOI 10.1086/302777; PEREZCASTILLO A, 1984, HUM GENET, V67, P230, DOI 10.1007/BF00273009; Roberts E, 1999, EUR J HUM GENET, V7, P815, DOI 10.1038/sj.ejhg.5200385; Ross JJ, 1977, HDB CLIN NEUROLOGY, V30, P507; Vaccarino FM, 1999, NAT NEUROSCI, V2, P246, DOI 10.1038/6350; VANDENBOSCH J, 1958, ANN HUM GENET, V23, P91	13	59	60	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2000	67	6					1575	1577		10.1086/316909	http://dx.doi.org/10.1086/316909			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	378WE	11067780	Bronze, Green Published			2022-12-18	WOS:000165607600022
J	Ghaedi, K; Honsho, M; Shimozawa, N; Suzuki, Y; Kondo, N; Fujiki, Y				Ghaedi, K; Honsho, M; Shimozawa, N; Suzuki, Y; Kondo, N; Fujiki, Y			PEX3 is the causal gene responsible for peroxisome membrane assembly-defective Zellweger syndrome of complementation group G	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OVARY CELL MUTANTS; FUNCTIONAL COMPLEMENTATION; MUTATION ANALYSIS; CDNA CLONING; BIOGENESIS; DISORDERS; IDENTIFICATION; PROTEIN; GHOSTS; HUMANS	Peroxisome biogenesis disorders (PBDs) such as Zellweger syndrome (ZS) and neonatal adrenoleukodystrophy are autosomal recessive diseases caused by defects in peroxisome assembly, for which 13 genotypes have been identified. Expression of the human peroxin Pex3p cDNA encoding a 373-amino-acid peroxisomal membrane protein morphologically and biochemically restored peroxisome biogenesis, including peroxisomal membrane assembly, in fibroblasts from PBDG-02, a patient with complementation group G (CG-G) ZS. Patient PBDG-02 carried a homozygous, inactivating mutation-a 97-bp deletion of nucleotide residues at positions 342-1038-resulting in a 32-amino-acid truncation and in a frameshift inducing both a S-amino-acid substitution and a termination codon. Genomic PCR analysis revealed mutation of T --> G at eight bases upstream of the splicing site at the boundary of intron 10 and exon 11 of PEX3 gene, giving rise to a deletion of all of exon 11. When assessed by expression in a pex3 mutant of Chinese hamster ovary cells and the patient's fibroblasts, PBDG-02-derived PEX3 cDNA was found to be defective in peroxisome-restoring activity. These results provide evidence that PEX3 is a novel, pathogenic gene responsible for CG-G PBDs.	Kyushu Univ, Fac Sci, Dept Biol, Higashi Ku, Fukuoka 8128581, Japan; Japan Sci & Technol Corp, CREST, Tokyo, Japan; Gifu Univ, Sch Med, Dept Pediat, Gifu 500, Japan	Kyushu University; Japan Science & Technology Agency (JST); Gifu University	Fujiki, Y (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.		Ghaedi, Kamran/X-9824-2018	Ghaedi, Kamran/0000-0002-9790-5644; Shimozawa, Nobuyuki/0000-0003-3040-5458; Honsho, Masanori/0000-0001-6165-4516				BRAVERMAN N, 1995, HUM MOL GENET, V4, P1791, DOI 10.1093/hmg/4.suppl_1.1791; Fujiki Y, 2000, FEBS LETT, V476, P42, DOI 10.1016/S0014-5793(00)01667-7; Ghaedi K, 2000, MOL BIOL CELL, V11, P2085, DOI 10.1091/mbc.11.6.2085; Ghaedi K, 1999, EXP CELL RES, V248, P489, DOI 10.1006/excr.1999.4413; Honsho M, 1998, AM J HUM GENET, V63, P1622, DOI 10.1086/302161; Kinoshita N, 1998, J BIOL CHEM, V273, P24122, DOI 10.1074/jbc.273.37.24122; Lazarow P. B., 1995, METABOLIC MOL BASES, P2287; Matsuzono Y, 1999, P NATL ACAD SCI USA, V96, P2116, DOI 10.1073/pnas.96.5.2116; Muntau AC, 2000, BIOCHEM BIOPH RES CO, V268, P704, DOI 10.1006/bbrc.2000.2193; Otera H, 2000, J BIOL CHEM, V275, P21703, DOI 10.1074/jbc.M000720200; POULOS A, 1995, J PEDIATR-US, V127, P596, DOI 10.1016/S0022-3476(95)70121-4; Sacksteder KA, 2000, J CELL BIOL, V148, P931, DOI 10.1083/jcb.148.5.931; SANTOS MJ, 1992, J CELL PHYSIOL, V151, P103, DOI 10.1002/jcp.1041510115; Shimizu N, 1999, J BIOL CHEM, V274, P12593, DOI 10.1074/jbc.274.18.12593; SHIMOZAWA N, 1992, J CLIN INVEST, V90, P1864, DOI 10.1172/JCI116063; Shimozawa N, 1998, AM J HUM GENET, V63, P1898, DOI 10.1086/302142; Soukupova M, 1999, EUR J CELL BIOL, V78, P357, DOI 10.1016/S0171-9335(99)80078-8; South ST, 1999, J CELL BIOL, V144, P255, DOI 10.1083/jcb.144.2.255; Subramani S, 1997, NAT GENET, V15, P331, DOI 10.1038/ng0497-331; Tamura S, 1998, P NATL ACAD SCI USA, V95, P4350, DOI 10.1073/pnas.95.8.4350; Toyama R, 1999, HUM MOL GENET, V8, P1673, DOI 10.1093/hmg/8.9.1673; TSUKAMOTO T, 1990, J CELL BIOL, V110, P651, DOI 10.1083/jcb.110.3.651; VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105; WENDLAND M, 1993, J CLIN INVEST, V92, P2462, DOI 10.1172/JCI116854	24	59	61	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4					976	981		10.1086/303086	http://dx.doi.org/10.1086/303086			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	360DL	10968777	Bronze, Green Published			2022-12-18	WOS:000089651100019
J	Ross, JL; Roeltgen, D; Kushner, H; Wei, FL; Zinn, AR				Ross, JL; Roeltgen, D; Kushner, H; Wei, FL; Zinn, AR			The Burner syndrome-associated neurocognitive phenotype maps to distal Xp	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ULLRICH-TURNER-SYNDROME; PSEUDOAUTOSOMAL GENE; NEURODEVELOPMENTAL CHANGES; DISCRIMINANT-ANALYSIS; SHORT ARM; CHROMOSOME; DELETIONS; GIRLS; LOCUS; HAPLOINSUFFICIENCY	Turner syndrome (TS) is associated with a characteristic neurocognitive profile that includes impaired visuospatial/perceptual abilities. We used a molecular approach to identify a critical region of the X chromosome for neurocognitive aspects of TS. Partial deletions of Xp in 34 females were mapped by FISH or by loss of heterozygosity of polymorphic markers. Discriminant function analysis optimally identified the TS-associated neurocognitive phenotype. Only subjects missing similar to 10 Mb of distal Xp manifested the specified neurocognitive profile. The phenotype was seen with either paternally or maternally inherited deletions and with either complete or incomplete skewing of X inactivation. Fine mapping of informative deletions implicated a critical region of <2 Mb within the pseudoautosomal region (PAR1). We conclude that haploinsufficiency of PAR1 gene(s) is the basis for susceptibility to the TS neurocognitive phenotype.	Thomas Jefferson Univ, Dept Pediat, Philadelphia, PA 19107 USA; Biomed Comp Res Inst, Philadelphia, PA USA; Penn State Univ, Coll Med, Dept Neurol, Hershey, PA USA; Univ Texas, SW Med Sch, Dallas, TX 75230 USA	Jefferson University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Ross, JL (corresponding author), Thomas Jefferson Univ, Dept Pediat, 1025 Walnut St, Philadelphia, PA 19107 USA.			Ross, Judith/0000-0002-8613-2498; Zinn, Andrew/0000-0002-4935-3291	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035554, R01NS032531] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS35554, NS32531, R01 NS032531, R01 NS035554] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLANSON JE, 1993, AM J MED GENET, V47, P748, DOI 10.1002/ajmg.1320470530; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; BALLABIO A, 1989, P NATL ACAD SCI USA, V86, P10001, DOI 10.1073/pnas.86.24.10001; Belin V, 1998, NAT GENET, V19, P67, DOI 10.1038/ng0198-67; BENDER B, 1984, PEDIATRICS, V73, P175; COLLINGE J, 1991, BRIT J PSYCHIAT, V158, P624, DOI 10.1192/bjp.158.5.624; CONTE FA, 1975, J CLIN ENDOCR METAB, V40, P670, DOI 10.1210/jcem-40-4-670; CROW TJ, 1988, BRIT J PSYCHIAT, V153, P675, DOI 10.1192/bjp.153.5.675; DOWNEY J, 1991, J LEARN DISABIL, V24, P32, DOI 10.1177/002221949102400107; Epstein C J, 1993, Prog Clin Biol Res, V384, P1; EPSTEIN CJ, 1988, TURNER SYNDROME, P13; Frangiskakis JM, 1996, CELL, V86, P59, DOI 10.1016/S0092-8674(00)80077-X; GEERKENS C, 1994, AM J MED GENET, V50, P105, DOI 10.1002/ajmg.1320500202; Gianfrancesco F, 1998, HUM MOL GENET, V7, P407, DOI 10.1093/hmg/7.3.407; GILBERT J, 1995, CURRENT PROTOCOLS HU, V2; HIER DB, 1980, J MENT DEFIC RES, V24, P17; James RS, 1998, HUM GENET, V102, P507, DOI 10.1007/s004390050733; JONES KL, 1997, SMITHS RECOGNIZABLE, P442; Joseph M, 1996, J MED GENET, V33, P906, DOI 10.1136/jmg.33.11.906; Kaiser C, 1996, AM J MED GENET, V62, P113, DOI 10.1002/(SICI)1096-8628(19960315)62:2<113::AID-AJMG3>3.0.CO;2-X; KITAMURA T, 1991, CELL, V66, P1165, DOI 10.1016/0092-8674(91)90039-2; Kosho T, 1999, J CLIN ENDOCR METAB, V84, P4613, DOI 10.1210/jc.84.12.4613; Leser U, 1999, NUCLEIC ACIDS RES, V27, P123, DOI 10.1093/nar/27.1.123; MCCAULEY E, 1987, CHILD DEV, V58, P464, DOI 10.2307/1130523; Mervis CB, 1999, AM J HUM GENET, V65, P1222, DOI 10.1086/302633; MONEY J, 1973, CORTEX, V9, P313; NETLEY C, 1982, CORTEX, V18, P377, DOI 10.1016/S0010-9452(82)80036-1; PENNINGTON BF, 1985, CORTEX, V21, P391, DOI 10.1016/S0010-9452(85)80004-6; Rao E, 1997, NAT GENET, V16, P54, DOI 10.1038/ng0597-54; REISS AL, 1995, ANN NEUROL, V38, P731, DOI 10.1002/ana.410380507; Ried K, 1998, HUM MOL GENET, V7, P1771, DOI 10.1093/hmg/7.11.1771; Romans SM, 1998, AM J MED GENET, V79, P140, DOI 10.1002/(SICI)1096-8628(19980901)79:2<140::AID-AJMG10>3.0.CO;2-J; Ross JL, 2000, NEUROLOGY, V54, P164, DOI 10.1212/WNL.54.1.164; ROSS JL, 1995, AM J MED GENET, V58, P74, DOI 10.1002/ajmg.1320580115; Ross JL, 1998, J CLIN ENDOCR METAB, V83, P3198, DOI 10.1210/jc.83.9.3198; Ross JL, 1997, AM J MED GENET, V72, P275, DOI 10.1002/(SICI)1096-8628(19971031)72:3<275::AID-AJMG4>3.0.CO;2-Q; ROVET JF, 1991, SEX CHROMOSOME ABNOR, P39; SCHAEFER L, 1993, NAT GENET, V4, P272, DOI 10.1038/ng0793-272; SCHIEBEL K, 1993, NAT GENET, V3, P82, DOI 10.1038/ng0193-82; Shears DJ, 1998, NAT GENET, V19, P70, DOI 10.1038/ng0198-70; Skuse DH, 1997, NATURE, V387, P705, DOI 10.1038/42706; SWILLEN A, 1993, GENET COUNSEL, V4, P7; Thomas NS, 1999, HUM GENET, V104, P43, DOI 10.1007/s004390050908; VANDYKE DL, 1991, J PEDIATR-US, V118, P415, DOI 10.1016/S0022-3476(05)82159-6; WABER DP, 1979, DEV MED CHILD NEUROL, V21, P58; YI HF, 1993, HUM MOL GENET, V2, P127, DOI 10.1093/hmg/2.2.127; Zinn AR, 1998, AM J HUM GENET, V63, P1757, DOI 10.1086/302152; ZINN AR, 1993, TRENDS GENET, V9, P90, DOI 10.1016/0168-9525(93)90230-F	48	59	60	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2000	67	3					672	681		10.1086/303039	http://dx.doi.org/10.1086/303039			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	348TJ	10931762	Bronze, Green Published			2022-12-18	WOS:000089002300014
J	Siegmund, KD; Langholz, B; Kraft, P; Thomas, DC				Siegmund, KD; Langholz, B; Kraft, P; Thomas, DC			Testing linkage disequilibrium in sibships	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASSOCIATION	We describe the use of multivariate regression for testing allelic association in the presence of linkage, using marker genotype data from sibships. The test is valid, provided that the correct mean structure is modeled but does not require the correlation structure within families to be specified. The test can be implemented using standard statistical software such as the SAS programming language. In a simulation study, we evaluated this new test in comparison with one from a standard, matched-case-control analysis. First, we noted that the genetic effect needed to be quite extreme before residual familial correlation due to linkage led to false inference using the standard, matched-pair analysis. Second, we showed that under examples of extreme residual familial correlation, the new test had the correct test size. Third, we found that the test was more powerful than the sibship disequilibrium test of Horvath and Laird. Finally, we concluded that although the standard analysis may lead to correct inference for practical purposes, the new test is valid, even under extreme residual familial correlation and with no cost in power at the causal locus.	Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA	University of Southern California	Siegmund, KD (corresponding author), Univ So Calif, Dept Prevent Med, 1540 Alcazar St,Suite 220, Los Angeles, CA 90089 USA.				NCI NIH HHS [CA52862, R01 CA042949, R01 CA052862, CA42949] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA052862, R01CA042949] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Curtis D, 1997, ANN HUM GENET, V61, P319, DOI 10.1017/S000348009700626X; Horvath S, 1998, AM J HUM GENET, V63, P1886, DOI 10.1086/302137; Schaid DJ, 1998, AM J HUM GENET, V63, P1492, DOI 10.1086/302094; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; Therneau TM, 1997, STAT MED, V16, P2029, DOI 10.1002/(SICI)1097-0258(19970930)16:18<2029::AID-SIM637>3.0.CO;2-H	5	59	59	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2000	67	1					244	248		10.1086/302973	http://dx.doi.org/10.1086/302973			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	347JY	10831398	Bronze, Green Published			2022-12-18	WOS:000088926900028
J	Goring, HHH; Terwilliger, JD				Goring, HHH; Terwilliger, JD			Linkage analysis in the presence of errors II: Marker-locus genotyping errors modeled with hypercomplex recombination fractions	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							STRATEGIES; INTERFERENCE; HUMANS; MAP	It is well known that genotyping errors lead to loss of power in gene-mapping studies and underestimation of the strength of correlations between trait- and marker-locus genotypes. In two-point linkage analysis, these errors can be absorbed in an inflated recombination-fraction estimate, leaving the test statistic quite robust. In multipoint analysis, however, genotyping errors can easily result in false exclusion of the true location of a disease-predisposing gene. In a companion article, we described a "complex-valued" extension of the recombination fraction to accommodate errors in the assignment of trait-locus genotypes, leading to a multipoint LOD score with the same robustness to errors in trait-locus genotypes that is seen with the conventional two-point LOD score. Here, a further extension of this model to "hypercomplex-valued" recombination fractions (hereafter referred to as "hypercomplex recombination fractions") is presented, to handle random and systematic sources of marker-locus genotyping errors. This leads to a multipoint method (either "model-based" or "model-free") with the same robustness to marker-locus genotyping errors that is seen with conventional two-point analysis but with the advantage that multiple marker loci can be used jointly to increase meiotic informativeness. The cost of this increased robustness is a decrease in fine-scale resolution of the estimated map location of the trait locus, in comparison with traditional multipoint analysis. This probability model further leads to algorithms for the estimation of the lower bounds for the error rates for genomewide and locus-specific genotyping, based on the null-hypothesis distribution of the LOD-score statistic in the presence of such errors. It is argued that those genome scans in which the LOD score is 0 for >50% of the genome are likely to be characterized by high rates of genotyping errors in general.	Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; Columbia Univ, Dept Psychiat, New York, NY 10032 USA; Columbia Univ, Columbia Genome Ctr, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute	Goring, HHH (corresponding author), Columbia Univ, Dept Genet & Dev, 1150 St Nicholas Ave,Unit 109,Room 548, New York, NY 10032 USA.	jdt3@columbia.edu			NHGRI NIH HHS [HG00008, R01 HG000008] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000008, K01HG000008] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BRZUSTOWICZ LM, 1993, AM J HUM GENET, V53, P1137; BUETOW KH, 1991, AM J HUM GENET, V49, P985; De La Chapelle A, 1998, P NATL ACAD SCI USA, V95, P12416, DOI 10.1073/pnas.95.21.12416; Ehm MG, 1996, AM J HUM GENET, V58, P225; Goldstein DR, 1997, HUM HERED, V47, P86, DOI 10.1159/000154396; Goring HHH, 1997, AM J HUM GENET, V61, pA277; Goring HHH, 2000, AM J HUM GENET, V66, P1095, DOI 10.1086/302797; GORING HHH, 2000, IN PRESS AM J HUM GE; Haldane JBS, 1919, J GENET, V8, P299; Holmans P, 1997, AM J HUM GENET, V60, P657; Jaynes Edwin T., 1996, PROBABILITY THEORY L; Krause E. F., 1975, TAXICAB GEOMETRY ADV; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1983, AM J HUM GENET, V35, P241; LINCOLN SE, 1992, GENOMICS, V14, P604, DOI 10.1016/S0888-7543(05)80158-2; Lindqvist AKB, 1996, GENOME RES, V6, P1170, DOI 10.1101/gr.6.12.1170; MORTON NE, 1988, ANN HUM GENET, V52, P309, DOI 10.1111/j.1469-1809.1988.tb01110.x; MORTON NE, 1989, ANN HUM GENET, V53, P263, DOI 10.1111/j.1469-1809.1989.tb01793.x; NORDHEIM EV, 1984, BIOMETRICS, V40, P785, DOI 10.2307/2530922; OTT J, 1977, CLIN GENET, V12, P119; OTT J, 1992, AM J HUM GENET, V51, P283; PAGE RCL, 1995, DIABETIC MED, V12, P209, DOI 10.1111/j.1464-5491.1995.tb00460.x; SHIELDS DC, 1991, P NATL ACAD SCI USA, V88, P6501, DOI 10.1073/pnas.88.15.6501; Smith HF, 1937, ANN EUGENIC, V8, P94, DOI 10.1111/j.1469-1809.1937.tb02163.x; TAI J J, 1989, Proceedings of the National Science Council Republic of China Part B Life Sciences, V13, P38; Terwilliger J., 1994, HDB HUMAN GENETIC LI; Terwilliger JD, 1997, AM J HUM GENET, V61, P430, DOI 10.1086/514855; Terwilliger JD, 2000, HUM BIOL, V72, P63; Terwilliger JD, 1990, AM J HUM GENET S, V47, pA201; TERWILLIGER JD, IN PRESS GENETIC DIS; Walley P., 1991, STAT REASONING IMPRE; [No title captured]	33	59	60	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2000	66	3					1107	1118		10.1086/302798	http://dx.doi.org/10.1086/302798			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QM	10712221	Green Published, Bronze			2022-12-18	WOS:000088373200029
J	Melkoniemi, M; Brunner, HG; Manouvrier, S; Hennekam, R; Superti-Furga, A; Kaariainen, H; Pauli, RM; van Essen, T; Warman, ML; Bonaventure, J; Miny, P; Ala-Kokko, L				Melkoniemi, M; Brunner, HG; Manouvrier, S; Hennekam, R; Superti-Furga, A; Kaariainen, H; Pauli, RM; van Essen, T; Warman, ML; Bonaventure, J; Miny, P; Ala-Kokko, L			Autosomal recessive disorder otospondylomegaepiphyseal dysplasia is associated with loss-of-function mutations in the COL11A2 gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SENSITIVE GEL-ELECTROPHORESIS; MARSHALL-SYNDROME; STICKLER-SYNDROME; FIBRILLAR COLLAGENS; BONE DYSPLASIA; COL2A1 GENE; XI COLLAGEN; DEAFNESS; CHONDRODYSPLASIAS; ORGANIZATION	Otospondylomegaepiphyseal dysplasia (OSMED) is an autosomal recessive skeletal dysplasia accompanied by severe hearing loss. The phenotype overlaps that of the autosomal dominant disorders-Stickler and Marshall syndromes-but can be distinguished by disproportionately short limbs, severe hearing loss, and lack of ocular involvement. In one family with OSMED, a homozygous Gly-->Arg substitution has been described in COL11A2, which codes for the alpha 2 chain of type XI collagen. We report seven further families with OSMED. All affected individuals had a remarkably similar phenotype: profound sensorineural hearing loss, skeletal dysplasia with limb shortening and large epiphyses, cleft palate, an extremely aat face, hypoplasia of the mandible, a short nose with anteverted nares, and a nat nasal bridge. We screened affected individuals for mutations in COL11A2 and found different mutations in each family. Individuals from four families, including three with consanguineous parents, were homozygous for mutations. Individuals from three other families, in whom parents were non-consanguineous, were compound heterozygous. Of the 10 identified mutations, 9 are predicted to cause premature termination of translation, and 1 is predicted to cause an in-frame deletion, We conclude that the OSMED phenotype is highly homogenous and results from homozygosity or compound heterozygosity for COL11A2, mutations, most of which are predicted to cause complete absence of alpha 2(XI) chains.	Univ Oulu, Dept Med Biochem, FIN-90220 Oulu, Finland; Univ Oulu, Bioctr, Collagen Res Unit, Oulu, Finland; Univ Nijmegen Hosp, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Ctr Hosp Reg Lille, Serv Pediat, Lille, France; Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Human Genet, NL-1105 AZ Amsterdam, Netherlands; Univ Zurich, Childrens Hosp, Div Metab & Mol Dis, Zurich, Switzerland; Family Federat Finland, Dept Med Genet, Helsinki, Finland; Univ Wisconsin, Clin Genet Ctr, Madison, WI USA; Univ Groningen, Dept Med Genet, Groningen, Netherlands; Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; Hop Necker Enfants Malad, INSERM, U393, Paris, France; Univ Basel, Childrens Hosp, Div Med Genet, Basel, Switzerland	University of Oulu; University of Oulu; Radboud University Nijmegen; Universite de Lille - ISITE; CHU Lille; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University Children's Hospital Zurich; University of Zurich; Family Federation of Finland; University of Wisconsin System; University of Wisconsin Madison; University of Groningen; Case Western Reserve University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Basel	Ala-Kokko, L (corresponding author), Univ Oulu, Dept Med Biochem, Kajaanintie 52A, FIN-90220 Oulu, Finland.		superti-furga, andrea/E-9162-2015; Brunner, Han/C-9928-2013	superti-furga, andrea/0000-0002-3543-7531; 	NIAMS NIH HHS [AR-43827] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043827] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALAKOKKO L, 1990, P NATL ACAD SCI USA, V87, P6565, DOI 10.1073/pnas.87.17.6565; ALAKOKKO L, 1995, BIOCHEM J, V308, P923, DOI 10.1042/bj3080923; Annunen S, 1999, AM J HUM GENET, V65, P974, DOI 10.1086/302585; BREWTON RG, 1994, EXTRACELLULAR MATRIX, P129; Cremer MA, 1998, J MOL MED, V76, P275, DOI 10.1007/s001090050217; Eyre D, 1987, STRUCTURE FUNCTION C, P261; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; GIEDION A, 1982, HELV PAEDIATR ACTA, V37, P361; Griffith AJ, 1998, AM J HUM GENET, V62, P816, DOI 10.1086/301789; Horton WA, 1996, ENDOCRIN METAB CLIN, V25, P683, DOI 10.1016/S0889-8529(05)70347-9; INSLEY J, 1974, BRIT J RADIOL, V47, P244, DOI 10.1259/0007-1285-47-557-244; JOHNSTON KM, 1987, P GREENWOOD CTR, V6, P155; KAARIAINEN H, 1993, AM J MED GENET, V46, P223, DOI 10.1002/ajmg.1320460224; Korkko J, 1998, P NATL ACAD SCI USA, V95, P1681, DOI 10.1073/pnas.95.4.1681; Kuivaniemi H, 1997, HUM MUTAT, V9, P300, DOI 10.1002/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9; LI SW, 1995, GENE DEV, V9, P2821, DOI 10.1101/gad.9.22.2821; LI Y, 1995, CELL, V80, P423, DOI 10.1016/0092-8674(95)90492-1; LINSENMAYER TF, 1993, J CELL BIOL, V121, P1181, DOI 10.1083/jcb.121.5.1181; MAYNE R, 1993, J BIOL CHEM, V268, P9381; MINY P, 1985, AM J MED GENET, V21, P317, DOI 10.1002/ajmg.1320210214; Pihlajamaa T, 1998, AM J MED GENET, V80, P115, DOI 10.1002/(SICI)1096-8628(19981102)80:2<115::AID-AJMG5>3.0.CO;2-O; Richards AJ, 1996, HUM MOL GENET, V5, P1339, DOI 10.1093/hmg/5.9.1339; SALINAS CD, 1986, 7 INT C HUM GEN BERL; Sirko-Osadsa D, 1998, J PEDIATR-US, V132, P368, DOI 10.1016/S0022-3476(98)70466-4; Spranger J, 1998, PEDIATR RADIOL, V28, P745, DOI 10.1007/s002470050459; SPRANGER J, 1994, EUR J PEDIATR, V153, P56, DOI 10.1007/BF01959208; vanSteensel MAM, 1997, AM J MED GENET, V70, P315; VIKKULA M, 1995, CELL, V80, P431, DOI 10.1016/0092-8674(95)90493-X; VUORISTO MM, 1995, J BIOL CHEM, V270, P22873, DOI 10.1074/jbc.270.39.22873; Williams CJ, 1996, AM J MED GENET, V63, P461, DOI 10.1002/(SICI)1096-8628(19960614)63:3<461::AID-AJMG9>3.0.CO;2-U	30	59	60	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					368	377		10.1086/302750	http://dx.doi.org/10.1086/302750			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	10677296	Green Published, Bronze			2022-12-18	WOS:000088373100003
J	Floeth, M; Bruckner-Tuderman, L				Floeth, M; Bruckner-Tuderman, L			Digenic junctional epidermolysis bullosa: Mutations in COL17A1 and LAMB3 genes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PEMPHIGOID ANTIGEN BPAG2; RETINITIS-PIGMENTOSA; EXTRACELLULAR DOMAIN; COLLAGEN; LAMININ-5; PERIPHERIN/RDS; INHERITANCE; DELETION; DOMINANT; FAMILY	Junctional epidermolysis bullosa (JEB), a genetically heterogeneous group of blistering skin diseases, can be caused by mutations in the genes encoding laminin 5 or collagen XVII, which are components of the hemidesmosome-anchoring filament complex in the skin. Here, a family with severe nonlethal JEB and with mutations in genes for both proteins was identified. The index patient was compound heterozygous for the COL17A1 mutations L855X and R1226X and was heterozygous for the LAMB3 mutation R635X. As a consequence, two functionally related proteins were affected. Absence of collagen XVII and attenuated laminin 5 expression resulted in rudimentary hemidesmosome structure and separation of the epidermis from the basement membrane, with severe skin blistering as the clinical manifestation. In contrast, single heterozygotes carrying either (1) one or the other of the COL17A1 null alleles or (2) a double heterozygote for a COL17A1 and a LAMB3 null allele did not have a pathological skin phenotype. These observations indicate that the known allelic heterogeneity in JEB is further complicated by interactions between unlinked mutations. They also demonstrate that identification of one mutation in one gene is not sufficient for determination of the genetic basis of JEB in a given family.	Univ Munster, Dept Dermatol, D-48149 Munster, Germany	University of Munster	Bruckner-Tuderman, L (corresponding author), Univ Munster, Dept Dermatol, Von Esmarch Str 56, D-48149 Munster, Germany.	tuderma@uni-muenster.de						ABERDAM D, 1994, CELL ADHES COMMUN, V2, P115, DOI 10.3109/15419069409004431; Aumailley M, 1999, MATRIX BIOL, V18, P19, DOI 10.1016/S0945-053X(98)00004-3; Balciuniene J, 1998, AM J HUM GENET, V63, P786, DOI 10.1086/302012; BRUCKNERTUDERMA.L, IN PRESS EXTRACELLUL; BRUCKNERTUDERMAN L, 1995, J CELL BIOL, V131, P551, DOI 10.1083/jcb.131.2.551; Chavanas S, 1997, J INVEST DERMATOL, V109, P74, DOI 10.1111/1523-1747.ep12276614; Darling TN, 1999, J CLIN INVEST, V103, P1371, DOI 10.1172/JCI4338; Dryja TP, 1997, INVEST OPHTH VIS SCI, V38, P1972; Floeth M, 1998, J INVEST DERMATOL, V111, P528, DOI 10.1046/j.1523-1747.1998.00325.x; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; Gatalica B, 1997, AM J HUM GENET, V60, P352; GEDDEDAHL T, 1996, PRINCIPLES PRACTICE, V1, P1225; GeorgesLabouesse E, 1996, NAT GENET, V13, P370, DOI 10.1038/ng0796-370; Goldberg AFX, 1996, P NATL ACAD SCI USA, V93, P13726, DOI 10.1073/pnas.93.24.13726; Heinonen S, 1999, J CELL SCI, V112, P3641; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; HINTNER H, 1981, J INVEST DERMATOL, V76, P113, DOI 10.1111/1523-1747.ep12525447; Jonkman MF, 1997, CELL, V88, P543, DOI 10.1016/S0092-8674(00)81894-2; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; Kivirikko S, 1996, HUM MOL GENET, V5, P231, DOI 10.1093/hmg/5.2.231; Kuster JE, 1997, MAMM GENOME, V8, P673, DOI 10.1007/s003359900535; Masunaga T, 1997, J INVEST DERMATOL, V109, P200, DOI 10.1111/1523-1747.ep12319337; McGrath JA, 1996, J INVEST DERMATOL, V106, P771, DOI 10.1111/1523-1747.ep12345821; McGrath JA, 1996, AM J PATHOL, V148, P1787; MCGRATH JA, 1995, NAT GENET, V11, P83, DOI 10.1038/ng0995-83; McGrath JA, 1996, J INVEST DERMATOL, V106, P1156; McMilian JR, 1998, J INVEST DERMATOL, V110, P132, DOI 10.1046/j.1523-1747.1998.00102.x; Morell R, 1997, HUM MOL GENET, V6, P659, DOI 10.1093/hmg/6.5.659; Nievers MG, 1999, MATRIX BIOL, V18, P5, DOI 10.1016/S0945-053X(98)00003-1; Pulkkinen L, 1997, J INVEST DERMATOL, V109, P232, DOI 10.1111/1523-1747.ep12319752; Pulkkinen L, 1999, MATRIX BIOL, V18, P29, DOI 10.1016/S0945-053X(98)00005-5; Reddy D, 1998, J INVEST DERMATOL, V110, P593; Rousselle P, 1997, J CELL BIOL, V138, P719, DOI 10.1083/jcb.138.3.719; Schacke H, 1998, J BIOL CHEM, V273, P25937, DOI 10.1074/jbc.273.40.25937; Schumann H, 1997, AM J HUM GENET, V60, P1344, DOI 10.1086/515463; vanderNeut R, 1996, NAT GENET, V13, P366, DOI 10.1038/ng0796-366	36	59	60	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1999	65	6					1530	1537		10.1086/302672	http://dx.doi.org/10.1086/302672			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	266CF	10577906	Green Published, Bronze			2022-12-18	WOS:000084282500007
J	Kalaydjieva, L; Perez-Lezaun, A; Angelicheva, D; Onengut, S; Dye, D; Bosshard, NU; Jordanova, A; Savov, A; Yanakiev, P; Kremensky, I; Radeva, B; Hallmayer, J; Markov, A; Nedkova, V; Tournev, I; Aneva, L; Gitzelmann, R				Kalaydjieva, L; Perez-Lezaun, A; Angelicheva, D; Onengut, S; Dye, D; Bosshard, NU; Jordanova, A; Savov, A; Yanakiev, P; Kremensky, I; Radeva, B; Hallmayer, J; Markov, A; Nedkova, V; Tournev, I; Aneva, L; Gitzelmann, R			A founder mutation in the GK1 gene is responsible for galactokinase deficiency in Roma (Gypsies)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CATARACTS; FAMILIES	Galactokinase deficiency is an inborn error in the first step of galactose metabolism. Its major clinical manifestation is the development of cataracts in the first weeks of life. It has also been suggested that carriers of the deficiency are predisposed to presenile cataracts developing at age 20-50 years. Newborn screening data suggest that the gene frequency is very low worldwide but is higher among the Roma in Europe. Since the cloning of the galactokinase gene (GK1) in 1995, only two disease-causing mutations, both confined to single families, have been identified. Here we present the results of a study of six affected Romani families from Bulgaria, where index patients with galactokinase deficiency have been detected by the mass screening. Genetic linkage mapping placed the disease locus on 17q, and haplotype analysis revealed a small conserved region of homozygosity. Using radiation hybrid mapping, we have shown that GK1 is located in this region. The founder Romani mutation identified in this study is a single nucleotide substitution in GK1 resulting in the replacement of the conserved proline residue at amino acid position 28 with threonine (P28T). The P28T carrier rate in this endogamous population is similar to 5%, suggesting that the mutation may be an important cause of early childhood blindness in countries with a sizeable Roma minority.	Edith Cowan Univ, Ctr Human Genet, Perth, WA 6027, Australia; Univ Western Australia, Graylands Hosp, Ctr Clin Res Neuropsychiat, Perth, WA 6009, Australia; Univ Zurich, Childrens Hosp, Div Metab & Mol Dis, Zurich, Switzerland; Med Univ, Sofia, Bulgaria; Univ Munster, Inst Med Biochem, D-4400 Munster, Germany; Sch Med, Dept Pediat, Pleven, Bulgaria; Reg Hosp, Dept Clin Chem, Blagoevgrad, Bulgaria	Edith Cowan University; University of Western Australia; University Children's Hospital Zurich; University of Zurich; Medical University Sofia; University of Munster; Medical University Pleven	Kalaydjieva, L (corresponding author), Edith Cowan Univ, Ctr Human Genet, Joondalup Campus, Perth, WA 6027, Australia.		Jordanova, Albena/H-8323-2015; Dye, Danielle/B-8143-2013	Jordanova, Albena/0000-0002-3833-3754; Dye, Danielle/0000-0002-3564-6579				Angelicheva D, 1999, EUR J HUM GENET, V7, P560, DOI 10.1038/sj.ejhg.5200319; Bergsma DJ, 1996, GENOME RES, V6, P980, DOI 10.1101/gr.6.10.980; Bolgiani M P, 1984, Pediatr Med Chir, V6, P333; Cotton RGH, 1998, HUM MUTAT, V12, P1, DOI 10.1002/(SICI)1098-1004(1998)12:1<1::AID-HUMU1>3.0.CO;2-M; CUATRECA.P, 1965, J BIOL CHEM, V240, P2382; DEBOUCK C, 1985, NUCLEIC ACIDS RES, V13, P1841, DOI 10.1093/nar/13.6.1841; GITZELMANN R, 1965, LANCET, V2, P670; GITZELMANN R, 1987, CC/LIFE SCI, P14; GITZELMANN R, 1967, PEDIATR RES, V1, P14, DOI 10.1203/00006450-196701000-00002; GITZELMANN R, 1980, INHERITED DISORDERS, P61; KALAYDJIEVA L, 1992, J MED GENET, V29, P656, DOI 10.1136/jmg.29.9.656; Kalaydjieva L, 1996, NAT GENET, V14, P214, DOI 10.1038/ng1096-214; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Levy H.L., 1980, INHERITED DISORDERS, P133, DOI [10.1007/978-94-009-9215-3_8, DOI 10.1007/978-94-009-9215-3_8]; MATHAI CK, 1967, ENZYMOLOGIA, V33, P224; MAYES JS, 1968, BIOCHEM GENET, V2, P219, DOI 10.1007/BF01474761; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; SHINBUEHRING YS, 1977, PEDIATR RES, V11, P1045, DOI 10.1203/00006450-197710000-00004; SITZMANN FC, 1973, KLIN PADIATR, V185, P444; STAMBOLIAN D, 1986, INVEST OPHTH VIS SCI, V27, P429; STAMBOLIAN D, 1995, NAT GENET, V10, P307, DOI 10.1038/ng0795-307; THALHAMMER O, 1968, PEDIATRICS, V42, P441	25	59	62	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1999	65	5					1299	1307		10.1086/302611	http://dx.doi.org/10.1086/302611			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252YZ	10521295	Bronze, Green Published			2022-12-18	WOS:000083531000011
J	Tanaka, F; Reeves, MF; Ito, Y; Matsumoto, M; Li, M; Miwa, S; Inukai, A; Yamamoto, M; Doyu, M; Yoshida, M; Hashizume, Y; Terao, S; Mitsuma, T; Sobue, G				Tanaka, F; Reeves, MF; Ito, Y; Matsumoto, M; Li, M; Miwa, S; Inukai, A; Yamamoto, M; Doyu, M; Yoshida, M; Hashizume, Y; Terao, S; Mitsuma, T; Sobue, G			Tissue-specific somatic mosaicism in spinal and bulbar muscular atrophy is dependent on CAG-repeat length and androgen receptor-gene expression level	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; SPINOCEREBELLAR ATAXIA TYPE-1; MACHADO-JOSEPH-DISEASE; RECESSIVE BULBOSPINAL NEURONOPATHY; TRINUCLEOTIDE REPEAT; TRANSGENIC MICE; INSTABILITY; BRAIN; INCLUSIONS; EXPANSION	The factors influencing the tissue-specific pattern of somatic mosaicism in GAG-repeat diseases have not yet been fully resolved. We performed a detailed analysis of the degree of somatic mosaicism in various tissues from 20 patients with spinal and bulbar muscular atrophy (SBMA), including 4 who were deceased. The most outstanding feature was the prominent somatic mosaicism observed in the cardiac and skeletal muscles, composed predominantly of postmitotic cells, and in the skin, prostate, and testis. The CNS tissues, liver, and spleen showed the least mosaicism. The tissue distribution of somatic mosaicism in patients with SBMA was markedly different from that in patients with Huntington disease (HD) and from that in patients with dentatorubral-pallidoluysian atrophy (DRPLA). The degree of somatic mosaicism correlated with the GAG-repeat number but not with age at examination. Furthermore, tissues with a higher mosaicism level corresponded well to those with a higher expression Level of androgen receptor protein. The tissue-specific pattern of somatic mosaicism related not only to cell composition with different cell turnover rates but to repeat size and gene expression levels, and postnatal cell division is unlikely to be a major cause of somatic mosaicism probably because of the relative stability of CAG repeat in SBMA.	Nagoya Univ, Sch Med, Dept Neurol, Showa Ku, Nagoya, Aichi 4668550, Japan; Aichi Med Univ, Dept Internal Med 4, Inst Med Sci Aging, Aichi, Japan; Aichi Med Univ, Dept Internal Med 4, Div Neurol, Aichi, Japan	Nagoya University; Aichi Medical University; Aichi Medical University	Sobue, G (corresponding author), Nagoya Univ, Sch Med, Dept Neurol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	sobueg@tsuru.med.nagoya-u.ac.jp		Reeves, Matthew/0000-0001-7749-7447				CAMPION DR, 1984, INT REV CYTOL, V87, P225, DOI 10.1016/S0074-7696(08)62444-4; CHONG SS, 1995, NAT GENET, V10, P344, DOI 10.1038/ng0795-344; Hashida H, 1997, ANN NEUROL, V41, P505, DOI 10.1002/ana.410410414; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; La Spada AR, 1998, HUM MOL GENET, V7, P959, DOI 10.1093/hmg/7.6.959; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Li I, 1998, AM J PATHOL, V153, P695, DOI 10.1016/S0002-9440(10)65612-X; Li M, 1998, ANN NEUROL, V44, P249, DOI 10.1002/ana.410440216; LI M, 1995, MUSCLE NERVE, V18, P301, DOI 10.1002/mus.880180306; LITT M, 1989, AM J HUM GENET, V44, P397; LopesCendes I, 1996, ANN NEUROL, V40, P199, DOI 10.1002/ana.410400211; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Maciel P, 1997, AM J HUM GENET, V60, P993; Mangiarini L, 1997, NAT GENET, V15, P197, DOI 10.1038/ng0297-197; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; NAGAFUCHI S, 1994, NAT GENET, V8, P177, DOI 10.1038/ng1094-177; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; SOBUE G, 1989, BRAIN, V112, P209, DOI 10.1093/brain/112.1.209; STRONG TV, 1993, NAT GENET, V5, P259, DOI 10.1038/ng1193-259; Takano H, 1996, AM J HUM GENET, V58, P1212; Tanaka F, 1996, J NEUROL SCI, V135, P43, DOI 10.1016/0022-510X(95)00249-2; Tanaka F, 1996, HUM MOL GENET, V5, P1253, DOI 10.1093/hmg/5.9.1253; TELENIUS H, 1994, NAT GENET, V6, P409, DOI 10.1038/ng0494-409; UENO S, 1995, HUM MOL GENET, V4, P663, DOI 10.1093/hmg/4.4.663	25	59	61	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1999	65	4					966	973		10.1086/302578	http://dx.doi.org/10.1086/302578			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	241XW	10486315	Green Published, Bronze			2022-12-18	WOS:000082910000005
J	Gronberg, H; Smith, J; Emanuelsson, M; Jonsson, BA; Bergh, A; Carpten, J; Isaacs, W; Xu, JF; Meyers, D; Trent, J; Damber, JE				Gronberg, H; Smith, J; Emanuelsson, M; Jonsson, BA; Bergh, A; Carpten, J; Isaacs, W; Xu, JF; Meyers, D; Trent, J; Damber, JE			In Swedish families with hereditary prostate cancer, linkage to the HPC1 locus on chromosome 1q24-25 is restricted to families with early-onset prostate cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUSCEPTIBILITY LOCUS; OVARIAN-CANCER; SWEDEN; GENE; RISK; 1Q; INHERITANCE; MUTATIONS; SUPPORT; HISTORY	Prostate cancer clusters in some families, and an estimated 5%-10% of all cases are estimated to result from inheritance of prostate cancer-susceptibility genes. We previously reported evidence of linkage to the 1q24-25 region (HPC1) in 91 North American and Swedish families each with multiple cases of prostate cancer (Smith et al. 1996). In the present report we analyze 40 (12 original and 28 newly identified) Swedish families with hereditary prostate cancer (HPC) that, on the basis of 40 markers spanning a 25-cM interval within 1q24-25, have evidence of linkage. In the complete set of families, a maximum two-point LOD score of 1.10 was observed at D1S413 (at a recombination fraction [theta] of .1), with a maximum NPL (nonparametric linkage) Z score of 1.64 at D1S202 (P = .05). The evidence of linkage to this region originated almost exclusively from the subset of 12 early-onset (age <65 years) families, which yielded a maximum LOD score of 2.38 at D1S413 (theta = 0) and an NPL Z score of 1.95 at D1S422 (P = .03). Estimates from heterogeneity tests suggest that, within Sweden, as many as 50% of early-onset families had evidence of linkage to the HPC1 region. These results are consistent with the hypothesis of linkage to HPC1 in a subset of families with prostate cancer, particularly those with an early age at diagnosis.	Umea Univ, Dept Oncol, S-90185 Umea, Sweden; Umea Univ, Dept Pathol, S-90185 Umea, Sweden; Umea Univ, Dept Urol & Androl, S-90185 Umea, Sweden; Natl Human Genome Res Inst, Prostate Canc Invest Grp, NIH, Bethesda, MD USA; Johns Hopkins Med Inst, Dept Urol, Baltimore, MD 21205 USA; Univ Maryland, Ctr Genet Asthma & Complex Dis, Baltimore, MD 21201 USA	Umea University; Umea University; Umea University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Johns Hopkins University; Johns Hopkins Medicine; University System of Maryland; University of Maryland Baltimore	Gronberg, H (corresponding author), Umea Univ, Dept Oncol, S-90185 Umea, Sweden.		Smith, Jeff/C-3484-2012	Smith, Jeffrey/0000-0001-8424-910X				Berthon P, 1998, AM J HUM GENET, V62, P1416, DOI 10.1086/301879; CARTER BS, 1992, P NATL ACAD SCI USA, V89, P3367, DOI 10.1073/pnas.89.8.3367; CARTER HB, 1992, JAMA-J AM MED ASSOC, V267, P2215, DOI 10.1001/jama.267.16.2215; Cooney KA, 1997, J NATL CANCER I, V89, P955, DOI 10.1093/jnci/89.13.955; EASTON DF, 1993, AM J HUM GENET, V52, P678; Eeles RA, 1998, AM J HUM GENET, V62, P653, DOI 10.1086/301745; Gronberg H, 1997, CANCER RES, V57, P4707; Gronberg H, 1997, AM J EPIDEMIOL, V146, P552, DOI 10.1093/oxfordjournals.aje.a009313; Gronberg H, 1996, CANCER, V77, P138, DOI 10.1002/(SICI)1097-0142(19960101)77:1<138::AID-CNCR23>3.0.CO;2-5; Hsieh CL, 1997, J NATL CANCER I, V89, P1893, DOI 10.1093/jnci/89.24.1893; Johannsson O, 1996, AM J HUM GENET, V58, P441; McIndoe RA, 1997, AM J HUM GENET, V61, P347, DOI 10.1086/514853; MONROE KR, 1995, NAT MED, V1, P827, DOI 10.1038/nm0895-827; NAROD SA, 1995, NAT MED, V1, P99, DOI 10.1038/nm0295-99; OTT J, 1985, ANAL HUMAN GENETIC L, P200; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; SPITZ MR, 1991, J UROLOGY, V146, P1305, DOI 10.1016/S0022-5347(17)38074-6; STEINBERG GD, 1990, PROSTATE, V17, P337, DOI 10.1002/pros.2990170409; Wijnen J, 1997, AM J HUM GENET, V61, P329, DOI 10.1086/514847; Xu JF, 1998, NAT GENET, V20, P175, DOI 10.1038/2477	20	59	61	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1999	65	1					134	140		10.1086/302447	http://dx.doi.org/10.1086/302447			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	212NZ	10364525	Green Published, Bronze			2022-12-18	WOS:000081224300017
J	Richter, A; Rioux, JD; Bouchard, JP; Mercier, J; Mathieu, J; Ge, B; Poirier, J; Julien, D; Gyapay, G; Weissenbach, J; Hudson, TJ; Melancon, SB; Morgan, K				Richter, A; Rioux, JD; Bouchard, JP; Mercier, J; Mathieu, J; Ge, B; Poirier, J; Julien, D; Gyapay, G; Weissenbach, J; Hudson, TJ; Melancon, SB; Morgan, K			Location score and haplotype analyses of the locus for autosomal recessive spastic ataxia of Charlevoix-Saguenay, in chromosome region 13q11	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; HUMAN GENOME; PEDIGREE ANALYSIS; YAC CONTIG; MAP; RECOMBINATION; COMPUTATIONS; PROGRAMS	Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is a clinically homogeneous form of early-onset familial spastic ataxia with prominent myelinated retinal nerve fibers. More than 300 patients have been identified, and most of their families originated in the Charlevoix-Saguenay region of northeastern Quebec, where the carrier prevalence has been estimated to be 1/22. Consistent with the hypothesis of a founder effect, we observed excess shared homozygosity at 13q11, among patients in a genomewide scan of 12 families. Analysis of 19 pedigrees demonstrated very tight linkage between the ARSACS locus and an intragenic polymorphism of the gamma-sarcoglycan (SGCG) gene, but genomic DNA sequence analysis of all eight exons of SCCG revealed no disease-causing mutation. On the basis of haplotypes composed of seven marker loci that spanned 11.1 cM, the most likely position of the ARSACS locus was 0.42 cM distal to the SCCG polymorphism. Two groups of ARSACS-associated haplotypes were identified: a large group that carries a common SGCG allele and a small group that carries a rare SGCG allele. The haplotype groups do not appear to be closely related. Therefore, although chromosomes within each haplotype group may harbor a single ARSACS mutation identical by descent, the two mutations could have independent origins.	Univ Montreal, Hop St Justine, Ctr Rech, Serv Genet Med, Montreal, PQ H3T 1C5, Canada; Montreal Gen Hosp, Res Inst, Montreal, PQ H3G 1A4, Canada; McGill Univ, Dept Human Genet, Montreal, PQ, Canada; McGill Univ, Dept Med, Montreal, PQ, Canada; MIT, Whitehead Inst Biomed Res, Cambridge, MA USA; Hop Enfants Jesus, Serv Neurol, Quebec City, PQ, Canada; Hop Chicoutimi, Serv Neurol, Chicoutimi, PQ, Canada; CNRS, Genethon, URA 1922, Evry, France	Universite de Montreal; McGill University; McGill University; McGill University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Laval University; Centre National de la Recherche Scientifique (CNRS)	Richter, A (corresponding author), Univ Montreal, Hop St Justine, Ctr Rech, Serv Genet Med, 3175 Chemin Cote St Catherine, Montreal, PQ H3T 1C5, Canada.	richtera@ere.umontreal.ca; ken@population.generics.mcgill.ca	Rioux, John D/A-9599-2015	Rioux, John D/0000-0001-7560-8326				BOUCHARD G, 1988, EUR J POPUL, V4, P39, DOI 10.1007/BF01797106; BOUCHARD G, 1991, HIST UN GENOME POPUL; BOUCHARD JP, 1978, CAN J NEUROL SCI, V5, P61, DOI 10.1017/S0317167100024793; Bouchard JP, 1998, NEUROMUSCULAR DISORD, V8, P474, DOI 10.1016/S0960-8966(98)00055-8; BOUCHARD JP, 1979, CAN J NEUROL SCI, V6, P185, DOI 10.1017/S0317167100119614; Bouchard JP., 1991, HDB CLIN NEUROLOGY H, V60, P451; Brinkmann B, 1998, AM J HUM GENET, V62, P1408, DOI 10.1086/301869; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Cayanis E, 1998, GENOMICS, V47, P26, DOI 10.1006/geno.1997.5087; Charbonneau H., 1987, HIST ATLAS CANADA, V1; CHUMAKOV IM, 1995, NATURE, V377, P175; CLERGETDARPOUX F, 1982, ANN HUM GENET, V46, P363, DOI 10.1111/j.1469-1809.1982.tb01587.x; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DEBRAEKELEER M, 1993, GENET EPIDEMIOL, V10, P17, DOI 10.1002/gepi.1370100103; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DUBOVSKY J, 1995, HUM MOL GENET, V4, P449, DOI 10.1093/hmg/4.3.449; Gauvreau D, 1991, HIST DUN GENOME, P145; GUILFORD P, 1995, GENOMICS, V29, P163, DOI 10.1006/geno.1995.1227; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HARDING AE, 1993, ADV NEUROL, V61, P1; HAWKINS TL, 1994, NUCLEIC ACIDS RES, V22, P4543, DOI 10.1093/nar/22.21.4543; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; Jette R., 1991, HIST GENOME POPULATI, P75; KNOPPERS BM, 1991, CAN MED ASSOC J, V144, P128; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; Lange K., 1997, MATH STAT METHODS GE; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1985, AM J HUM GENET, V37, P482; McNally EM, 1996, AM J HUM GENET, V59, P1040; RICHTER A, 1993, ADV NEUROL, V61, P97; Richter A., 1996, American Journal of Human Genetics, V59, pA379; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Schaffer AA, 1996, HUM HERED, V46, P226, DOI 10.1159/000154358; SHAW SH, 1995, GENOMICS, V27, P502, DOI 10.1006/geno.1995.1083; Sobel E, 1996, AM J HUM GENET, V58, P1323; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Terwilliger J., 1994, HDB HUMAN GENETIC LI; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WEEKS DE, 1995, AM J HUM GENET, V56, P1506	40	59	61	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1999	64	3					768	775		10.1086/302274	http://dx.doi.org/10.1086/302274			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	177HN	10053011	Bronze, Green Published			2022-12-18	WOS:000079204700014
J	Orstavik, KH; Orstavik, RE; Naumova, AK; D'Adamo, P; Gedeon, A; Bolhuis, PA; Barth, PG; Toniolo, D				Orstavik, KH; Orstavik, RE; Naumova, AK; D'Adamo, P; Gedeon, A; Bolhuis, PA; Barth, PG; Toniolo, D			X chromosome inactivation in carriers of Barth syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKED CARDIOSKELETAL MYOPATHY; LARGE FAMILY; GENE; LOCALIZATION; NEUTROPENIA; PHENOTYPE; MUTATIONS; PATTERNS; FEMALES; LINKAGE	Earth syndrome (BTHS) is a rare X-linked recessive disorder characterized by cardiac and skeletal myopathy, neutropenia, and short stature. A gene for BTHS, G4.5, was recently cloned and encodes several novel proteins, named "tafazzins." Unique mutations have been found. No correlation between the location or type of mutation and the phenotype of BTHS has been found. Female carriers of BTHS seem to be healthy, This could be due to a selection against cells that have the mutant allele on the active X chromosome. We therefore analyzed X chromosome inactivation in 16 obligate carriers of BTHS, from six families, using PCR in the androgen-receptor locus. An extremely skewed X-inactivation pattern (greater than or equal to 95:5), not found in 148 female controls, was found in six carriers. The skewed pattern in two carriers from one family was confirmed in DNA from cultured fibroblasts. Five carriers from two families had a skewed pattern (80:20-<95:5), a pattern that was found in only 11 of 148 female controls. Of the 11 carriers with a skewed pattern, the parental origin of the inactive X chromosome was maternal in all seven cases for which this could be determined. In two families, carriers with an extremely skewed pattern and carriers with a random pattern were found. The skewed X inactivation in 11 of 16 carriers is probably the result of a selection against cells with the mutated gene on the active X chromosome. Since BTHS also shows great clinical variation within families, additional factors are likely to influence the expression of the phenotype. Such factors may also influence the selection mechanism in carriers.	Ulleval Univ Hosp, Dept Med Genet, N-0315 Oslo, Norway; Temple Univ, Fels Inst Canc Res, Philadelphia, PA 19122 USA; CNR, Ist Genet Biochim & Evoluzionist, I-27100 Pavia, Italy; Womens & Childrens Hosp, Dept Cytogenet & Mol Genet, N Adelaide, SA, Australia; Univ Amsterdam, Dept Neurol, Amsterdam, Netherlands; Univ Amsterdam, Dept Pediat, Amsterdam, Netherlands	University of Oslo; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Consiglio Nazionale delle Ricerche (CNR); University of Amsterdam; University of Amsterdam	Orstavik, KH (corresponding author), Ulleval Univ Hosp, Dept Med Genet, Box 1036, N-0315 Oslo, Norway.		Toniolo, Daniela/AAE-2969-2019; Gedeon, Agi/G-7890-2011; D'Adamo, Patrizia/AAN-3919-2020	Toniolo, Daniela/0000-0001-9545-6032; D'Adamo, Patrizia/0000-0002-0312-5541; Naumova, Anna K./0000-0001-8481-5765	Telethon [E.0297] Funding Source: Medline	Telethon(Fondazione Telethon)		Abkowitz JL, 1998, P NATL ACAD SCI USA, V95, P3862, DOI 10.1073/pnas.95.7.3862; ADES LC, 1993, AM J MED GENET, V45, P327, DOI 10.1002/ajmg.1320450309; ALLEN RC, 1994, AM J HUM GENET, V54, P25; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; Barth PG, 1996, J INHERIT METAB DIS, V19, P157, DOI 10.1007/BF01799418; Belmont JW, 1996, AM J HUM GENET, V58, P1101; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; Bleyl SB, 1997, AM J HUM GENET, V61, P868, DOI 10.1086/514879; BOLHUIS PA, 1991, AM J HUM GENET, V48, P481; Busque L, 1996, BLOOD, V88, P59; CHRISTODOULOU J, 1994, AM J MED GENET, V50, P255, DOI 10.1002/ajmg.1320500309; DAdamo P, 1997, AM J HUM GENET, V61, P862, DOI 10.1086/514886; FEARON ER, 1988, BLOOD, V72, P1735; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Gale RE, 1997, BRIT J HAEMATOL, V98, P512, DOI 10.1046/j.1365-2141.1997.2573078.x; GIBBONS RJ, 1992, AM J HUM GENET, V51, P1136; Hoffman E. P., 1995, American Journal of Human Genetics, V57, pA49; Johnston J, 1997, AM J HUM GENET, V61, P1053, DOI 10.1086/301604; LINDENBAUM RH, 1973, BRIT HEART J, V35, P38; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; MIGEON BR, 1993, AM J HUM GENET, V52, P431; Naumova AK, 1996, AM J HUM GENET, V58, P1111; Neuwald AF, 1997, CURR BIOL, V7, pR465; Orstavik KH, 1996, AM J MED GENET, V64, P31, DOI 10.1002/(SICI)1096-8628(19960712)64:1<31::AID-AJMG4>3.0.CO;2-U; ORSTAVIK KH, 1993, J MED GENET, V30, P269, DOI 10.1136/jmg.30.4.269; Orstavik KH, 1996, J MED GENET, V33, P700, DOI 10.1136/jmg.33.8.700; PEGORARO E, 1994, AM J HUM GENET, V54, P989; Plenge RM, 1997, NAT GENET, V17, P353, DOI 10.1038/ng1197-353; Puck JM, 1998, NEW ENGL J MED, V338, P325, DOI 10.1056/NEJM199801293380611	30	59	59	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1998	63	5					1457	1463		10.1086/302095	http://dx.doi.org/10.1086/302095			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	138QZ	9792874	Green Published, Bronze			2022-12-18	WOS:000076985200023
J	Ahmad, W; Irvine, AD; Lam, H; Buckley, C; Bingham, EA; Panteleyev, AA; Ahmad, M; McGrath, JA; Christiano, AM				Ahmad, W; Irvine, AD; Lam, H; Buckley, C; Bingham, EA; Panteleyev, AA; Ahmad, M; McGrath, JA; Christiano, AM			A missense mutation in the zinc-finger domain of the human hairless gene underlies congenital atrichia in a family of Irish travellers	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PAPULAR LESIONS; DNA-BINDING; STEM-CELLS	Congenital atrichia is a rare, recessively inherited form of hair loss affecting both males and females and is characterized by a complete absence of hair follicles. Recently, a mutation in the human hairless gene was implicated in the pathogenesis of congenital atrichia. The human hairless gene encodes a putative single zinc-finger transcription-factor protein with restricted expression in brain and skin, which is believed to regulate catagen remodeling in the hair cycle. In this study, we report the identification of a missense mutation in the zinc-finger domain of the hairless gene in a large inbred family of Irish Travellers with congenital atrichia. The mutated arginine residue is conserved among human, mouse, and rat, suggesting that it is of significant importance to the function of the zinc-finger domain.	Columbia Univ Coll Phys & Surg, Dept Dermatol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; Royal Victoria Hosp, Dept Dermatol, Belfast BT12 6BA, Antrim, North Ireland; Waterford Res Hosp, Waterford, Ireland; Quaid I Azam Univ, Dept Biol Sci, Islamabad, Pakistan; St Thomas Hosp, St Johns Inst Dermatol, London, England	Columbia University; Columbia University; Quaid I Azam University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Christiano, AM (corresponding author), Columbia Univ Coll Phys & Surg, Dept Dermatol, 630 W 168th St, New York, NY 10032 USA.		Irvine, Alan D/A-3982-2008; Ahmad, Wasim/GSD-8904-2022; Ahmad, Wasim/E-9713-2015; McGrath, John/N-3529-2019; Panteleyev, Andrey A/R-9151-2016; McGrath, John/D-6824-2012	Irvine, Alan D/0000-0002-9048-2044; Panteleyev, Andrey A/0000-0002-8733-9183; McGrath, John/0000-0002-3708-9964	NIAMS NIH HHS [P30-AR44535] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR044535] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AHMAD M, 1993, AM J MED GENET, V46, P369, DOI 10.1002/ajmg.1320460405; Ahmad W, 1998, SCIENCE, V279, P720, DOI 10.1126/science.279.5351.720; AHMAD W, IN PRESS MOL BASIS R; AHMAD W, IN PRESS MOL BASIS N; CACHONGONZALEZ MB, 1994, P NATL ACAD SCI USA, V91, P7717, DOI 10.1073/pnas.91.16.7717; CANTU JM, 1980, CLIN GENET, V17, P209; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; DAMSTE J, 1954, DERMATOLOGICA, V108, P114; del Castillo V, 1974, Int J Dermatol, V13, P261; FLYNN MP, 1989, ARCH DIS CHILD, V64, P1699, DOI 10.1136/adc.64.12.1699; Fredrich HC, 1950, DERMATOL WOCHENSCHR, V121, P408; GMELCH G, 1977, J GYPSY LORE SOC, V1, P159; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; HOLLENBERG SM, 1987, CELL, V49, P39, DOI 10.1016/0092-8674(87)90753-7; JOHNSTON M, 1987, P NATL ACAD SCI USA, V84, P2401, DOI 10.1073/pnas.84.8.2401; KANZLER MH, 1986, ARCH DERMATOL, V122, P565, DOI 10.1001/archderm.122.5.565; LANDES E, 1956, Hautarzt, V7, P413; LOWENTHAL LJA, 1961, DERMATOLOGICA, V122, P85; MISCIALI C, 1992, DERMATOLOGY, V185, P284, DOI 10.1159/000247470; Nothen MM, 1998, AM J HUM GENET, V62, P386, DOI 10.1086/301717; Panteleyev AA, 1998, J INVEST DERMATOL, V110, P902, DOI 10.1046/j.1523-1747.1998.00219.x; PANTELEYEV AA, IN PRESS MOL BASIS R; PANTELEYEV AA, IN PRESS MOL FUNCTIO; ROCHAT A, 1994, CELL, V76, P1063, DOI 10.1016/0092-8674(94)90383-2; ROOK A, 1991, DIS HAIR SCALP, P187; Sambrook J, 1989, MOL CLONING LAB MANU; SUNDBERG JP, 1989, MONOGRAPHS PATHOLOGY, P192; Thompson CC, 1996, J NEUROSCI, V16, P7832; Thompson CC, 1997, P NATL ACAD SCI USA, V94, P8527, DOI 10.1073/pnas.94.16.8527	29	59	63	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1998	63	4					984	991		10.1086/302069	http://dx.doi.org/10.1086/302069			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	131LP	9758627	Bronze, Green Published			2022-12-18	WOS:000076577800010
J	McDermott, MF; Ogunkolade, BW; McDermott, EM; Jones, LC; Wan, Y; Quane, KA; McCarthy, J; Phelan, M; Molloy, MG; Powell, RJ; Amos, CI; Hitman, GA				McDermott, MF; Ogunkolade, BW; McDermott, EM; Jones, LC; Wan, Y; Quane, KA; McCarthy, J; Phelan, M; Molloy, MG; Powell, RJ; Amos, CI; Hitman, GA			Linkage of familial hibernian fever to chromosome 12p13	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MEDITERRANEAN FEVER; GENE; MAP; AMYLOIDOSIS; JEWS	Autosomal dominant periodic fevers are characterized by intermittent febrile attacks of unknown etiology and by recurrent abdominal pains. The biochemical and molecular bases of all autosomal dominant periodic fevers are unknown, and only familial Hibernian fever (FHF) has been described as a distinct clinical entity. FHF has been reported in three families-the original Irish-Scottish family and two Irish families with similar clinical features. We have undertaken a genomewide search in these families and report significant multipoint LOD scores between the disease and markers on chromosome 12p13. Cumulative multipoint linkage analyses indicate that an FHF gene is likely to be located in an 8-cM interval between D12S77 and D12S356, with a maximum LOD score (Z(max)) of 3.79. The two-point Z(max) was 3.11, for D12S77. There was no evidence of genetic heterogeneity in these three families; it is proposed that these markers should be tested in other families, of different background, that have autosomal dominant periodic fever, as a prelude to identification of the FHF-susceptibility gene.	St Bartholomews & Royal London Hosp, Sch Med & Dent, Med Unit, London, England; Univ Nottingham Hosp, Queens Med Ctr, Clin Immunol Unit, Nottingham NG7 2UH, England; Univ Texas, MD Anderson Cancer Ctr, Dept Epidemiol, Houston, TX 77030 USA; Natl Univ Ireland Univ Coll Cork, Dept Med, Cork, Ireland; Natl Univ Ireland Univ Coll Cork, Dept Rheumatol, Cork, Ireland	Barts Health NHS Trust; Royal London Hospital; University of London; Queen Mary University London; University of Nottingham; University of Texas System; UTMD Anderson Cancer Center; University College Cork; University College Cork	McDermott, MF (corresponding author), London Hosp, Roy Hosp NHS Trust, Med Unit, London E1 1BB, England.	M.F.McDermott@mds.qmw.ac.uk	McDermott, Michael Francis/GZM-5330-2022; McDermott, Michael/S-8490-2019	McDermott, Michael/0000-0002-1015-0745	NIAMS NIH HHS [AR44422] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044422] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AKSENTIJEVICH I, 1993, AM J HUM GENET, V53, P644; Aksentijevich I, 1997, CELL, V90, P797; BERGMAN F, 1968, AM J MED, V45, P601, DOI 10.1016/0002-9343(68)90174-5; Bernot A, 1997, NAT GENET, V17, P25; BOURONCLE BA, 1957, AM J MED, V23, P502, DOI 10.1016/0002-9343(57)90330-3; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; FEDERSPIEL B, 1987, SCHWEIZ MED WSCHR, V117, P173; GERTZ MA, 1987, MAYO CLIN PROC, V62, P1095, DOI 10.1016/S0025-6196(12)62502-6; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HAWLE H, 1989, DEUT MED WOCHENSCHR, V114, P665, DOI 10.1055/s-2008-1066652; KARENKO L, 1992, J INTERN MED, V232, P365, DOI 10.1111/j.1365-2796.1992.tb00600.x; KASTNER DL, 1997, ARTHRITIS ALLIED CON, P1279; KRAUTER K, 1995, NATURE, V377, P321; Kucherlapati R., 1997, Cytogenetics and Cell Genetics, V78, P82; LATHROP GM, 1985, AM J HUM GENET, V37, P482; Mache CJ, 1996, EUR J PEDIATR, V155, P787; McDermott EM, 1997, MAYO CLIN PROC, V72, P806, DOI 10.4065/72.9.806; McDermott EM, 1996, LANCET, V348, P554, DOI 10.1016/S0140-6736(05)64720-4; MCDERMOTT MF, J MED GENET, V35, P432; MEYERHOFF J, 1980, MEDICINE, V59, P66, DOI 10.1097/00005792-198001000-00004; Mulley J, 1997, AM J HUM GENET, V61, pA287; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; PRAS E, 1992, NEW ENGL J MED, V326, P1509, DOI 10.1056/NEJM199206043262301; Quane K. A., 1997, British Journal of Rheumatology, V36, P142; REICH CB, 1970, ARCH INTERN MED, V125, P337, DOI 10.1001/archinte.125.2.337; SHOHAT M, 1992, AM J HUM GENET, V51, P1349; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; VANDERMEER JW, 1984, LANCET, V2, P1087; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WILLIAMSON LM, 1982, Q J MED, V51, P469; Zweers E J, 1993, Ned Tijdschr Geneeskd, V137, P1570	32	59	60	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1998	62	6					1446	1451		10.1086/301886	http://dx.doi.org/10.1086/301886			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZU224	9585614	Green Published, Bronze			2022-12-18	WOS:000074174700021
J	de Bernabe, DBV; Granadino, B; Chiarelli, I; Porfirio, B; Mayatepek, E; Aquaron, R; Moore, MM; Festen, JJM; Sanmarti, R; Penalva, MA; de Cordoba, SR				de Bernabe, DBV; Granadino, B; Chiarelli, I; Porfirio, B; Mayatepek, E; Aquaron, R; Moore, MM; Festen, JJM; Sanmarti, R; Penalva, MA; de Cordoba, SR			Mutation and polymorphism analysis of the human homogentisate 1,2-dioxygenase gene in alkaptonuria patients	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								Alkaptonuria (AKU), a rare hereditary disorder of phenylalanine and tyrosine catabolism, was the first disease to be interpreted as an inborn error of metabolism. AKU patients are deficient for homogentisate 1,2 dioxygenase (HGO); this deficiency causes homogentisic aciduria, ochronosis, and arthritis. We cloned the human HGO gene and characterized two loss-of-function mutations, P230S and V300G, in the HGO gene in AKU patients. Here we report haplotype and mutational analysis of the HGO gene in 23 novel AKU chromosomes. We identified 12 novel mutations: 8 (E42A, W97G, D153G, S189I, I216T, R225H, F227S, and M368V) missense mutations that result in amino acid substitutions at positions conserved in HGO in different species, 1 (F10fs) frameshift mutation, 2 intronic mutations (IVS9-56G-->A, IVS9-17G-->A), and 1 splice-site mutation (IVS5 + 1G-->T). We also report characterization of five polymorphic sites in HGO and describe the haplotypic associations of alleles at these sites in normal and AKU chromosomes. One of these sites, HGO-3, is a variable dinucleotide repeat; IVS2+35T/A, IVS5+25T/C, and IVS6+46C/A are intronic sites at which single nucleotide substitutions (dimorphisms) have been detected; and c407T/A is a relatively frequent nucleotide substitution in the coding sequence, exon 4, resulting in an amino acid change (H80Q). These data provide insight into the origin and evolution of the various AKU alleles.	CSIC, Ctr Invest Biol, Dept Immunol, Madrid 28006, Spain; CSIC, Ctr Invest Biol, Dept Mol Microbiol, Madrid 28006, Spain; Fdn Jimenez Diaz, Unidad Patol Mol, E-28040 Madrid, Spain; Univ Florence, Dipartimento Fisiopatol Clin, Unita Genet Umana, Firenze, Italy; Univ Heidelberg, Childrens Hosp, Div Metab Dis, D-6900 Heidelberg, Germany; Ctr Hosp Reg & Univ Marseille, Hop Enfants La Timone, Biol Lab, Marseille, France; Bristol Royal Hosp Sick Children, Inst Child Hlth, Clin Genet Serv, Bristol, Avon, England; Med Spectrum Twente, Afdeling Reumatol, Enschede, Netherlands; Hosp Clin & Prov Barcelona, Serv Reumatol, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Florence; Ruprecht Karls University Heidelberg; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Bristol Royal Hospital For Children; University of Bristol; Medical Spectrum Twente; University of Barcelona; Hospital Clinic de Barcelona	de Cordoba, SR (corresponding author), CSIC, Ctr Invest Biol, Dept Immunol, Velazquez 144, Madrid 28006, Spain.		de Cordoba, Santiago Rodriguez/K-6727-2014; Sanmarti, Raimon/M-4434-2017; goenechea, begoña granadino/Y-4694-2019; Penalva, Miguel A/G-2295-2015; Porfirio, Berardino/I-1988-2012	de Cordoba, Santiago Rodriguez/0000-0001-6401-1874; Sanmarti, Raimon/0000-0002-8864-3806; Penalva, Miguel A/0000-0002-3102-2806; Porfirio, Berardino/0000-0003-4646-2502; granadino, begona/0000-0002-0144-8638				FERNANDEZCANON JM, 1995, J BIOL CHEM, V270, P21199, DOI 10.1074/jbc.270.36.21199; FernandezCanon JM, 1996, NAT GENET, V14, P19, DOI 10.1038/ng0996-19; Garrod AE, 1908, LANCET, V2, P73; Garrod AE, 1902, LANCET, V2, P1616; Gehrig A, 1997, CYTOGENET CELL GENET, V76, P14, DOI 10.1159/000134501; Granadino B, 1997, GENOMICS, V43, P115, DOI 10.1006/geno.1997.4805; KNOX WE, 1955, J BIOL CHEM, V216, P479; La Du BN, 1995, METABOLIC MOL BASES, P1371; LADU BN, 1958, J BIOL CHEM, V230, P251; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; RAMOSOLIVEIRA JE, 1971, HIST ESPANA, V2; RAMOSOLIVEIRA JE, 1971, HIST ESPANA, V1; Schmidt SR, 1997, MAMM GENOME, V8, P168, DOI 10.1007/s003359900383; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123	14	59	61	0	4	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1998	62	4					776	784		10.1086/301805	http://dx.doi.org/10.1086/301805			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZM197	9529363	Green Published, Bronze			2022-12-18	WOS:000073514400007
J	Labuda, D; Zietkiewicz, E; Labuda, M				Labuda, D; Zietkiewicz, E; Labuda, M			The genetic clock and the age of the founder effect in growing populations: A lesson from French Canadians and Ashkenazim	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							RECURRENT BRCA1; MUTATIONS; FAMILIES; JEWS		UNIV MONTREAL,HOP ST JUSTINE,DEPT PEDIAT,CTR RECH,CTR CANCEROL CHARLES BRUNEAU,MONTREAL,PQ H3T 1C5,CANADA; HOP NOTRE DAME DE BON SECOURS,CTR RECH,MONTREAL,PQ,CANADA	Universite de Montreal; Universite de Montreal			Zietkiewicz, Ewa/ABP-3539-2022	Zietkiewicz, Ewa/0000-0003-2437-5088				BARNAVI E, 1992, HIST ATLAS JEWISH PE; Beinart Haim, 1992, ATLAS MEDIEVAL JEWIS; BLUMENFELD A, 1993, NAT GENET, V4, P160, DOI 10.1038/ng0693-160; BOUCHARD G, 1990, HIST GENOME; DAVIES N, 1984, GODS PLAYGROUND HIST; DEBRAEKELEER M, 1991, HUM HERED, V41, P141, DOI 10.1159/000153992; DIAMOND JM, 1987, NATURE, V329, P105, DOI 10.1038/329105a0; GAUVREAU D, 1990, HIST GENOME, P145; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; Jennings HS, 1917, GENETICS, V2, P97; KAPLAN NL, 1995, AM J HUM GENET, V56, P18; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Labuda M, 1996, AM J HUM GENET, V59, P633; Luria SE, 1943, GENETICS, V28, P491; MOTULSKY AG, 1995, NAT GENET, V9, P99, DOI 10.1038/ng0295-99; Neuhausen SL, 1996, AM J HUM GENET, V58, P271; RISCH N, 1995, NAT GENET, V11, P14, DOI 10.1038/ng0995-14; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; ROBBINS RB, 1917, GENETICS, V3, P375; ROBERTS DF, 1968, NATURE, V220, P1084, DOI 10.1038/2201084a0; Thompson EA, 1997, AM J HUM GENET, V60, P197; Tonin P, 1996, NAT MED, V2, P1179, DOI 10.1038/nm1196-1179; ZOOSSMANNDISKIN A, 1995, NAT GENET, V11, P13, DOI 10.1038/ng0995-13; ZUCKERKANDL EMILE, 1965, P97	24	59	60	1	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1997	61	3					768	771		10.1016/S0002-9297(07)64341-9	http://dx.doi.org/10.1016/S0002-9297(07)64341-9			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XY523	9326343	Bronze, Green Published			2022-12-18	WOS:A1997XY52300035
J	MullerMyhsok, B; Stelma, FF; GuisseSow, F; Muntau, B; Thye, T; Burchard, GD; Gryseels, B; Horstmann, RD				MullerMyhsok, B; Stelma, FF; GuisseSow, F; Muntau, B; Thye, T; Burchard, GD; Gryseels, B; Horstmann, RD			Further evidence suggesting the presence of a locus, on human chromosome 5q31-q33, influencing the intensity of infection with Schistosoma mansoni	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							LINKAGE ANALYSIS; SEGREGATION; RESISTANCE		LEIDEN UNIV,DEPT PARASITOL,LEIDEN,NETHERLANDS; INST TROP MED PRINCE LEOPOLD,B-2000 ANTWERP,BELGIUM	Leiden University; Leiden University - Excl LUMC; Institute of Tropical Medicine (ITM)	MullerMyhsok, B (corresponding author), BERNHARD NOCHT INST TROP MED,DEPT MOL GENET,BERNHARD NOCHT STR 74,D-20359 HAMBURG,GERMANY.							ABEL L, 1991, AM J HUM GENET, V48, P959; *CHLC, 1994, SCIENCE, V265, P2049; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; COMMENGES D, 1994, GENET EPIDEMIOL, V11, P201, DOI 10.1002/gepi.1370110209; COMMENGES D, 1994, GENET EPIDEMIOL, V11, P189, DOI 10.1002/gepi.1370110208; Commenges D, 1996, GENET EPIDEMIOL, V13, P559, DOI 10.1002/(SICI)1098-2272(1996)13:6<559::AID-GEPI3>3.3.CO;2-E; DESSEIN AJ, 1988, J IMMUNOL, V140, P2727; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1986, GENET EPIDEMIOL, V3, P39, DOI 10.1002/gepi.1370030105; Marquet S, 1996, NAT GENET, V14, P181, DOI 10.1038/ng1096-181; Morton N.E., 1983, METHODS GENETIC EPID; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SCHAFFER AA, IN PRESS HUM HERED; STELMA FF, 1993, AM J TROP MED HYG, V49, P701, DOI 10.4269/ajtmh.1993.49.701	17	59	62	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1997	61	2					452	454		10.1016/S0002-9297(07)64073-7	http://dx.doi.org/10.1016/S0002-9297(07)64073-7			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XX701	9311752	Green Published			2022-12-18	WOS:A1997XX70100025
J	FalikZaccai, TC; Shachak, E; Yalon, M; Lis, Z; Borochowitz, Z; Macpherson, JN; Nelson, DL; Eichler, EE				FalikZaccai, TC; Shachak, E; Yalon, M; Lis, Z; Borochowitz, Z; Macpherson, JN; Nelson, DL; Eichler, EE			Predisposition to the fragile X syndrome in Jews of Tunisian descent is due to the absence of AGG interruptions on a rare Mediterranean haplotype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CGG REPEAT; JAPANESE POPULATION; FOUNDER CHROMOSOMES; MENTAL-RETARDATION; NORMAL ALLELES; MUTATION; INSTABILITY; LOCUS; SITE; GENE	We have studied the ethnic distribution of the fragile X syndrome in Israel and have found that 36/136 (26.5%) of apparently unrelated pedigrees were of Tunisian Jewish descent, The Tunisian Jews, however, constitute only 2%-3% of the general Israeli population, identifying the first ethnic group significantly (P < .001) predisposed to the development of this disease, Associated with this increase in disease prevalence, we have found an unusually high incidence of FMR1 CGG repeats devoid of AGG interruptions among the normal Tunisian Jewish population (30/150, or 20.0%), Furthermore, the proportion of these alleles beyond the FMR1 CGG repeat instability threshold (>35 repeats) (8/150, or 5.3%) was significantly greater (P < .04) than that proportion found among non-Tunisian Jewish controls in Israel (1/136), Haplotype analysis has indicated that these large uninterrupted CGG repeat alleles are present on a previously unreported (DXS548-FRAXAC1-FRAXAC2) haplotype that accounts for all observed cases of disease among Tunisian Jewish X chromosomes, The high prevalence of disease among Tunisian Jews, we suggest, is due to a founder effect of this rare haplotype, which is completely devoid of AGG interruptions in the Jewish population of Tunisia.	BNAI ZION MED CTR,SIMON WINTER INST HUMAN GENET,HAIFA,ISRAEL; KUPAT CHOLIM KLALIT,BEER SHEVA,ISRAEL; SALISBURY DIST HOSP,WESSEX REG GENET LAB,SALISBURY,WILTS,ENGLAND; BAYLOR COLL MED,CTR HUMAN GENOME,DEPT MOL & HUMAN GENET,HOUSTON,TX 77030	Bnai Zion Medical Center; Salisbury District Hospital; Baylor College of Medicine					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM052982] Funding Source: NIH RePORTER; NICHD NIH HHS [HD29256] Funding Source: Medline; NIGMS NIH HHS [GM52982] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aoi T, 1989, Keio J Med, V38, P36; ARINAMI T, 1993, HUM GENET, V92, P431, DOI 10.1007/BF00216445; ARINAMI T, 1986, HUM GENET, V73, P309, DOI 10.1007/BF00279092; BUNDEY S, 1985, J MED GENET, V22, P258, DOI 10.1136/jmg.22.4.258; BUYLE S, 1993, HUM GENET, V92, P269, DOI 10.1007/BF00244471; CHAKRAVARTI A, 1992, NAT GENET, V1, P237, DOI 10.1038/ng0792-237; Eichler EE, 1996, HUM MOL GENET, V5, P319, DOI 10.1093/hmg/5.3.319; EICHLER EE, 1995, HUM MOL GENET, V4, P2199, DOI 10.1093/hmg/4.12.2199; EICHLER EE, 1994, NAT GENET, V8, P88, DOI 10.1038/ng0994-88; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; HAATAJA R, 1994, HUM GENET, V94, P479; HIRST MC, 1993, J MED GENET, V30, P647, DOI 10.1136/jmg.30.8.647; HIRST MC, 1994, HUM MOL GENET, V3, P1553, DOI 10.1093/hmg/3.9.1553; JACOBS PA, 1993, J MED GENET, V30, P454, DOI 10.1136/jmg.30.6.454; JACOBS PA, 1986, AM J MED GENET, V23, P611, DOI 10.1002/ajmg.1320230155; KUNST CB, 1994, CELL, V77, P853, DOI 10.1016/0092-8674(94)90134-1; LI SY, 1988, HUM GENET, V79, P292; LUCOTTE G, 1993, HUM BIOL, V65, P835; MACPHERSON JN, 1994, HUM MOL GENET, V3, P399, DOI 10.1093/hmg/3.3.399; Malmgren Helena, 1994, European Journal of Human Genetics, V2, P103; MORTON NE, 1992, P NATL ACAD SCI USA, V89, P4215, DOI 10.1073/pnas.89.9.4215; MOULLEC J, 1954, SEM HOP PARIS, V30, P361; Mourant AE, 1978, BLOOD GROUPS DIS; Murray A, 1996, HUM MOL GENET, V5, P727, DOI 10.1093/hmg/5.6.727; Oudet C., 1993, European Journal of Human Genetics, V1, P181; OUDET C, 1993, AM J HUM GENET, V52, P297; RANQUE J, 1964, Bibl Haematol, V19, P210; RHOADS FA, 1984, AM J MED GENET, V17, P209, DOI 10.1002/ajmg.1320170113; RICHARDS RI, 1992, NAT GENET, V1, P257, DOI 10.1038/ng0792-257; RICHARDS RJ, 1994, AM J MED GENET, V51, P412, DOI 10.1002/ajmg.1320510422; ROUSSEAU F, 1995, AM J HUM GENET, V57, P1006; SNOW K, 1994, HUM MOL GENET, V3, P1543, DOI 10.1093/hmg/3.9.1543; TIKOCHINSKI Y, 1991, AM J HUM GENET, V48, P129; TURNER G, 1980, J PEDIATR-US, V96, P837, DOI 10.1016/S0022-3476(80)80552-X; VENTER PA, 1984, HUM GENET, V67, P107, DOI 10.1007/BF00270567; WEBB TP, 1986, J MED GENET, V23, P396, DOI 10.1136/jmg.23.5.396; WEBB TP, 1986, AM J MED GENET, V23, P573, DOI 10.1002/ajmg.1320230151; ZHONG N, 1993, NAT GENET, V5, P248, DOI 10.1038/ng1193-248; ZHONG N, 1995, AM J HUM GENET, V57, P351; ZHONG N, 1994, AM J MED GENET, V5, P405; ZLOTOGORA J, 1995, EUR J HUM GENET, V3, P147	41	59	60	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1997	60	1					103	112						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA818	8981953				2022-12-18	WOS:A1997WA81800016
J	Mears, AJ; Mirzayans, F; Gould, DB; Pearce, WG; Walter, MA				Mears, AJ; Mirzayans, F; Gould, DB; Pearce, WG; Walter, MA			Autosomal dominant iridogoniodysgenesis anomaly maps to 6p25	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RIEGER SYNDROME; HUMAN LINKAGE; GLAUCOMA; DELETION; REGION; GENE; CLONING	Autosomal dominant iridogoniodysgenesis anomaly (IGDA) is characterized by iris hypoplasia and goniodysgenesis with frequent juvenile glaucoma. IGDA is the result of aberrant migration or terminal induction of the neural crest cells involved in the formation of the anterior chamber of the eye. After eliminating candidate regions for other ocular disorders, a genome-wide scan for IGDA was performed using linkage analysis. Approximately 95% of the genome was excluded with >300 microsatellite markers before significant linkage was demonstrated between IGDA and chromosome 6 markers in two families. From haplotype analysis and identification of recombinants, the IGDA locus is mapped to an 8.3-cM interval distal to D6S477, at 6p25. Our linkage results are consistent with the ocular findings in rare cases of individuals with chromosomal anomalies involving deletions of 6p. This suggests that there is a major gene involved in eye anterior segment development at 6p25.	UNIV ALBERTA,HERITAGE MED RES CTR 671,DEPT OPHTHALMOL,OCULAR GENET LAB,EDMONTON,AB T6G 2S2,CANADA	University of Alberta								AXENFELD T, 1920, BER DTSCH OPHTHALMOL, V42, P381; BERG F, 1932, ACTA OPHTHALMOL, V10, P68; DAVIES AF, 1995, HUM MOL GENET, V4, P121; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; HEON E, 1995, HUM MOL GENET, V4, P1425; JERNDAL T, 1983, AM J HUM GENET, V35, P645; JERNDAL T, 1972, AM J OPHTHALMOL, V74, P28, DOI 10.1016/0002-9394(72)91121-X; KAISERKUPFER MI, 1989, AM J OPHTHALMOL, V107, P671, DOI 10.1016/0002-9394(89)90266-3; Larsson C, 1995, GENOMICS, V30, P464, DOI 10.1006/geno.1995.1266; LEGIUS E, 1994, J MED GENET, V31, P340, DOI 10.1136/jmg.31.4.340; Mann I., 1964, DEV HUMAN EYE; MIRZAYANS F, 1995, AM J HUM GENET, V57, P539; MORTON NE, 1956, AM J HUM GENET, V8, P80; MURRAY JC, 1992, NAT GENET, V2, P46, DOI 10.1038/ng0992-46; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; NICHOLS BE, 1993, COMPUT APPL BIOSCI, V9, P757; NIELSEN F, 1984, J MED GENET, V21, P218, DOI 10.1136/jmg.21.3.218; Ozanics V, 1982, OCULAR ANATOMY EMBRY, P11; PALMER CG, 1991, AM J MED GENET, V39, P155, DOI 10.1002/ajmg.1320390208; PEARCE WG, 1983, CAN J OPHTHALMOL, V18, P7; PIERROU S, 1994, EMBO J, V13, P5002, DOI 10.1002/j.1460-2075.1994.tb06827.x; PLAJA A, 1994, ANN GENET-PARIS, V37, P196; Rieger H., 1934, Z AUGENHEILKD, V84, P98; ROSSANO R, 1934, B SOC OPHTAL     JAN, P3; SHEFFIELD VC, 1993, NAT GENET, V4, P47, DOI 10.1038/ng0593-47; SHIELDS MB, 1985, SURV OPHTHALMOL, V29, P387, DOI 10.1016/0039-6257(85)90205-X; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI, P13; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; WALTE MA, IN PRESS OPHTHALMOL; WEATHERI.JR, 1969, BRIT J OPHTHALMOL, V53, P433, DOI 10.1136/bjo.53.7.433; WYATT HT, 1983, CAN J OPHTHALMOL, V18, P11; ZURCHER VL, 1990, AM J MED GENET, V35, P261, DOI 10.1002/ajmg.1320350223	32	59	65	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1996	59	6					1321	1327						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV315	8940278				2022-12-18	WOS:A1996VV31500019
J	Varilo, T; Savukoski, M; Norio, R; Santavuori, P; Peltonen, L; Jarvela, I				Varilo, T; Savukoski, M; Norio, R; Santavuori, P; Peltonen, L; Jarvela, I			The age of human mutation: Genealogical and linkage disequilibrium analysis of the CLN5 mutation in the Finnish population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							JANSKY-BIELSCHOWSKY DISEASE; SPECTRUM; FINLAND; VARIANT; LOCUS	Variant late infantile neuronal ceroid lipofuscinosis (vLINCL) is an autosomal recessive progressive encephalopathy of childhood enriched in the western part of Finland, with a local incidence of 1/1,500. We recently assigned the locus for vLINCL, CLN5, to 13q21.1-q32. In the present study, the haplotype analysis of Finnish CLN5 chromosomes provides evidence that one single mutation causes vLINCL in the Finnish population. Eight microsatellite markers closely linked to the CLN5 gene on chromosome 13q were analyzed, to study identity by descent by shared haplotype analysis. One single haplotype formed by flanking markers D13S160 and D13S162 in strong linkage disequilibrium (P <.0001) was present in 81% of disease-bearing chromosomes. Allele 4 at the marker locus D13S162 was detected in 94% of disease-bearing chromosomes. To evaluate the age of the CLN5 mutation by virtue of its restricted geographical distribution, church records were used to identify the common ancestors for 18 vLINCL families diagnosed in Finland. The pedigrees of the VLINCL ancestors merged on many occasions, which also supports a single founder mutation that obviously happened 20-30 generations ago (i.e., similar to 500 years ago) in this isolated population. Linkage disequilibrium was detected with seven markers covering an extended genetic distance of 11 cM, which further supports the young age of the CLN5 mutation. When the results of genealogical and linkage disequilibrium studies were combined, the CLN5 gene was predicted to lie similar to 200-400 kb (total range 30-1,360 kb) from the closest marker D13S162.	FAMILY FEDERAT FINLAND VAESTOLIITTO,DEPT MED GENET,HELSINKI,FINLAND; UNIV HELSINKI,DEPT CHILD NEUROL,HELSINKI,FINLAND	Family Federation of Finland; University of Helsinki	Varilo, T (corresponding author), NATL PUBL HLTH INST,DEPT HUMAN MOLEC GENET,MANNERHEIMINTIE 166,SF-00300 HELSINKI,FINLAND.		Jarvela, Irma E/L-5836-2013	Jarvela, Irma E/0000-0002-1770-6187; Varilo, Teppo/0000-0002-5839-8854				AKSENTIJEVICH I, 1993, AM J HUM GENET, V53, P644; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HELLSTEN E, 1993, GENOMICS, V16, P720, DOI 10.1006/geno.1993.1253; HIRVASNIEMI A, 1994, J MED GENET, V31, P177, DOI 10.1136/jmg.31.3.177; HOGLUND P, 1995, AM J HUM GENET, V57, P95; IKONEN E, 1991, P NATL ACAD SCI USA, V88, P11222, DOI 10.1073/pnas.88.24.11222; JARVELA I, 1991, GENOMICS, V10, P333, DOI 10.1016/0888-7543(91)90316-7; JORDE LB, 1995, AM J HUM GENET, V56, P11; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; LEHTINEN E, 1963, LAPUAN HIST, V1; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; NIKALI K, 1995, AM J HUM GENET, V56, P1088; NIKALI K, 1994, PEDIATR RES, V36, P607, DOI 10.1203/00006450-199411000-00012; NORIO R, 1973, ANN CLIN RES, V5, P109; Norio R., 1981, BIOCULTURAL ASPECTS, P359; RINTATASSI Q, 1980, KURIKAN HIST, V1; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; RUISMAKI L, 1989, KAUHAJOEN HIST; SANTAVUORI P, 1991, NEUROPEDIATRICS, V22, P92, DOI 10.1055/s-2008-1071423; SANTAVUORI P, 1982, NEUROPEDIATRICS, V13, P135, DOI 10.1055/s-2008-1059612; SARVELA J, 1986, ILMAJOEN PITAJA; SAVUKOSKI M, 1994, AM J HUM GENET, V55, P695; STLOUIS M, 1994, HUM MOL GENET, V3, P69, DOI 10.1093/hmg/3.1.69; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; VESA J, 1995, NATURE, V376, P584, DOI 10.1038/376584a0; WILLIAMS R, 1994, GENOMICS, V20, P289, DOI 10.1006/geno.1994.1168; YOUANQ J, 1994, AM J HUM GENET, V54, P252	28	59	60	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1996	58	3					506	512						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TV564	8644710				2022-12-18	WOS:A1996TV56400009
J	Lupski, JR; Roth, JR; Weinstock, GM				Lupski, JR; Roth, JR; Weinstock, GM			Chromosomal duplications in bacteria, fruit flies, and humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							TOOTH DISEASE TYPE-1A; TANDEM GENETIC DUPLICATIONS; UNEQUAL CROSSING-OVER; DROSOPHILA-MELANOGASTER; SALMONELLA-TYPHIMURIUM; ESCHERICHIA-COLI; POINT MUTATION; HIGH-FREQUENCY; MOLECULAR-GENETICS; DNA DUPLICATION		BAYLOR COLL MED, DEPT PEDIAT, HOUSTON, TX 77030 USA; UNIV TEXAS, HLTH SCI CTR, SCH MED, DEPT BIOCHEM & MOLEC BIOL, HOUSTON, TX USA; UNIV UTAH, DEPT BIOL, SALT LAKE CITY, UT 84112 USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Utah System of Higher Education; University of Utah	Lupski, JR (corresponding author), BAYLOR COLL MED, DEPT MOLEC & HUMAN GENET, ROOM 609E, 1 BAYLOR PLAZA, HOUSTON, TX 77030 USA.		Weinstock, George M/C-6314-2013	Weinstock, George M/0000-0002-2997-4592				ANDERSON P, 1981, P NATL ACAD SCI-BIOL, V78, P3113, DOI 10.1073/pnas.78.5.3113; ANDERSON RP, 1979, COLD SPRING HARB SYM, V43, P1083, DOI 10.1101/SQB.1979.043.01.120; ANDERSON RP, 1977, ANNU REV MICROBIOL, V31, P473, DOI 10.1146/annurev.mi.31.100177.002353; ANDERSON RP, 1978, J MOL BIOL, V119, P147, DOI 10.1016/0022-2836(78)90274-7; ANDERSON RP, 1976, J MOL BIOL, V105, P201, DOI 10.1016/0022-2836(76)90107-8; BAGLIONI C, 1962, P NATL ACAD SCI USA, V48, P1880, DOI 10.1073/pnas.48.11.1880; BALLABIO A, 1990, GENOMICS, V8, P263, DOI 10.1016/0888-7543(90)90281-X; Bridges CB, 1936, SCIENCE, V83, P210, DOI 10.1126/science.83.2148.210; CAMPBELL A, 1965, VIROLOGY, V27, P329, DOI 10.1016/0042-6822(65)90112-1; CAMPBELL A, 1963, VIROLOGY, V20, P344, DOI 10.1016/0042-6822(63)90124-7; CHANCE PF, 1994, HUM MOL GENET, V3, P223, DOI 10.1093/hmg/3.2.223; CHANCE PF, 1992, NEUROLOGY, V42, P2295, DOI 10.1212/WNL.42.12.2295; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; CHUMLEY FG, 1980, GENETICS, V94, P1; DAVIS PS, 1987, P NATL ACAD SCI USA, V84, P174, DOI 10.1073/pnas.84.1.174; Epstein C.J, 1986, CONSEQUENCES CHROMOS; GELBART WM, 1979, GENETICS, V92, P849; GOLDBERG ML, 1983, P NATL ACAD SCI-BIOL, V80, P5017, DOI 10.1073/pnas.80.16.5017; GOOSSENS M, 1980, P NATL ACAD SCI-BIOL, V77, P518, DOI 10.1073/pnas.77.1.518; GREEN MM, 1961, GENETICS, V46, P1555; GREEN MM, 1959, GENETICS, V44, P1243; HAACK KR, IN PRESS GENETICS; HEATH JD, 1991, BIOCHIMIE, V73, P343, DOI 10.1016/0300-9084(91)90099-M; HEATH JD, 1992, THESIS U TEXAS HLTH; HERTZ JM, 1994, CLIN GENET, V46, P291; HIGASHIJIMA SI, 1992, GENE DEV, V6, P50, DOI 10.1101/gad.6.1.50; HILL CW, 1973, MOL GEN GENET, V127, P197, DOI 10.1007/BF00333760; HILL CW, 1977, J MOL BIOL, V116, P407, DOI 10.1016/0022-2836(77)90077-8; HOOGENDIJK JE, 1992, LANCET, V339, P1081, DOI 10.1016/0140-6736(92)90668-S; HORIUCHI T, 1963, GENETICS, V48, P151; JUDD BH, 1961, GENETICS, V46, P1687; JUDD BH, 1961, P NATL ACAD SCI USA, V47, P545, DOI 10.1073/pnas.47.4.545; KOJIMA T, 1991, P NATL ACAD SCI USA, V88, P4343, DOI 10.1073/pnas.88.10.4343; KOJIMA T, 1993, GENETICA, V88, P85, DOI 10.1007/BF02424465; LAKICH D, 1993, NAT GENET, V5, P236, DOI 10.1038/ng1193-236; LEDBETTER DH, 1995, METABOLIC MOL BASES, P811; Li W-H., 1991, FUNDAMENTALS MOL EVO; LIFTON RP, 1992, NATURE, V355, P262, DOI 10.1038/355262a0; LIN RJ, 1984, J MOL BIOL, V177, P1, DOI 10.1016/0022-2836(84)90054-8; LORENZETTI D, 1995, AM J HUM GENET, V56, P91; LUPSKI JR, 1993, JAMA-J AM MED ASSOC, V270, P2326, DOI 10.1001/jama.270.19.2326; LUPSKI JR, 1993, AM J MED GENET, V45, P92, DOI 10.1002/ajmg.1320450122; LUPSKI JR, 1992, NAT GENET, V1, P29, DOI 10.1038/ng0492-29; LUPSKI JR, 1992, CLIN RES, V40, P645; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; MATISE TC, 1994, AM J HUM GENET, V54, P1110; MATSUNAMI N, 1992, NAT GENET, V1, P176, DOI 10.1038/ng0692-176; MELKI J, 1994, SCIENCE, V264, P1474, DOI 10.1126/science.7910982; NATHANS J, 1994, CELL, V78, P357, DOI 10.1016/0092-8674(94)90414-6; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; NICHOLSON GA, 1994, NAT GENET, V6, P263, DOI 10.1038/ng0394-263; Ohno S., 1970, EVOLUTION GENE DUPLI; PALAU F, 1993, HUM MOL GENET, V2, P2031, DOI 10.1093/hmg/2.12.2031; PATEL PI, 1994, TRENDS GENET, V10, P128, DOI 10.1016/0168-9525(94)90214-3; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; PETES TD, 1988, ANNU REV GENET, V22, P147, DOI 10.1146/annurev.ge.22.120188.001051; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; Roa B B, 1993, Prog Clin Biol Res, V384, P187; ROA BB, 1994, ADV HUM GENET, V22, P117; ROA BB, 1993, NAT GENET, V5, P189, DOI 10.1038/ng1093-189; ROA BB, 1993, NEW ENGL J MED, V329, P96, DOI 10.1056/NEJM199307083290205; ROA BB, 1993, NAT GENET, V5, P269, DOI 10.1038/ng1193-269; ROA BB, IN PRESS HUM GENET; ROSSITER JP, 1994, HUM MOL GENET, V3, P1035, DOI 10.1093/hmg/3.7.1035; ROTH JR, IN PRESS ESCHERICHIA; SCHMICKEL RD, 1986, J PEDIATR-US, V109, P231, DOI 10.1016/S0022-3476(86)80377-8; SONTI RV, 1989, GENETICS, V123, P19; Sturtevant AH, 1925, GENETICS, V10, P117; Sutton E, 1943, GENETICS, V28, P97; Tice SC, 1914, BIOL BULL-US, V26, P221, DOI 10.2307/1536196; TIMMERMAN V, 1992, NAT GENET, V1, P171, DOI 10.1038/ng0692-171; TSUBOTA SI, 1989, GENETICS, V122, P881; TSUBOTA SI, 1991, GENET RES, V57, P105, DOI 10.1017/S0016672300029165; VALENTIJN LJ, 1992, NAT GENET, V2, P288, DOI 10.1038/ng1292-288; VALENTIJN LJ, 1992, NAT GENET, V1, P166, DOI 10.1038/ng0692-166; VALENTIJN LJ, 1993, HUM MOL GENET, V2, P2143, DOI 10.1093/hmg/2.12.2143; WEINSTOCK GM, 1994, ASM NEWS, V60, P73; WISE CA, 1993, AM J HUM GENET, V53, P853	79	59	59	2	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1996	58	1					21	27						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TL697	8554058				2022-12-18	WOS:A1996TL69700005
J	HIRSCHHORN, R; YANG, DRX; ISRANI, A; HUIE, ML; OWNBY, DR				HIRSCHHORN, R; YANG, DRX; ISRANI, A; HUIE, ML; OWNBY, DR			SOMATIC MOSAICISM FOR A NEWLY IDENTIFIED SPLICE-SITE MUTATION IN A PATIENT WITH ADENOSINE DEAMINASE-DEFICIENT IMMUNODEFICIENCY AND SPONTANEOUS CLINICAL RECOVERY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ADA-SCID PATIENTS; POINT MUTATION; MISSENSE MUTATIONS; GENE; DELETION; EXPRESSION; SEQUENCE; PROTEIN; ENZYME; REGION	Absent or severely reduced adenosine deaminase (ADA) activity produces inherited immunodeficiency of varying severity, with defects of both cellular and humoral immunity. We report somatic mosaicism as the basis for a delayed presentation and unusual course of a currently healthy young adult receiving no therapy. He was diagnosed at age 2 1/2 years because of life-threatening pneumonia, recurrent infections, failure of normal growth, and lymphopenia, but he retained significant cellular immune function. A fibroblast cell line and a B cell line, established at diagnosis, lacked ADA activity and were heteroallelic for a splice-donor-site mutation in IVS 1 (+1GT-->CT) and a missense mutation (Arg101Gln). All clones (17/17) isolated from the B cell mRNA carried the missense mutation, indicating that the allele with the splice-site mutation produced unstable mRNA. In striking contrast, a B cell line established at age 16 years expressed 50% of normal ADA; 50% of ADA mRNA had normal sequence, and 50% had the missense mutation. Genomic DNA contained the missense mutation but not the splice-site mutation. All three cell lines were identical for multiple polymorphic markers and the presence of a Y chromosome. In vivo somatic mosaicism was demonstrated in genomic DNA from peripheral blood cells obtained at 16 years of age, in that less than half the DNA carried the splice-site mutation (P<.002, vs. original B cell line). Consistent with mosaicism, erythrocyte content of the toxic metabolite deoxyATP was only minimally elevated. Somatic mosaicism could have arisen either by somatic mutation or by reversion at the site of mutation. Selection in vivo for ADA normal hematopoietic cells may have played a role in the return to normal health, in the absence of therapy.	HENRY FORD HOSP, DEPT MED, DIV ALLERGY, DETROIT, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital	HIRSCHHORN, R (corresponding author), NYU, MED CTR, DEPT MED, DIV MED GENET, 550 1ST AVE, NEW YORK, NY 10016 USA.				NIAID NIH HHS [R37 AI 10343-23] Funding Source: Medline; NIDDK NIH HHS [DK07421-12] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI010343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T35DK007421] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AKESON AL, 1987, P NATL ACAD SCI USA, V84, P5947, DOI 10.1073/pnas.84.16.5947; AKESON AL, 1988, J BIOL CHEM, V263, P16291; ARREDONDOVEGA FX, 1990, J CLIN INVEST, V86, P444, DOI 10.1172/JCI114730; BARTON R, 1979, J IMMUNOL, V122, P216; BERKVENS TM, 1990, GENOMICS, V7, P486, DOI 10.1016/0888-7543(90)90190-6; BONTHRON DT, 1985, J CLIN INVEST, V76, P894, DOI 10.1172/JCI112050; COHEN A, 1978, P NATL ACAD SCI USA, V75, P472, DOI 10.1073/pnas.75.1.472; COLEMAN MS, 1978, J BIOL CHEM, V253, P1619; DADDONA PE, 1980, J BIOL CHEM, V255, P5681; DADDONA PE, 1984, J BIOL CHEM, V259, P2101; DADDONA PE, 1981, BIOCHIM BIOPHYS ACTA, V658, P280, DOI 10.1016/0005-2744(81)90298-9; HALL JG, 1988, AM J HUM GENET, V43, P355; HERSHFIELD MS, 1993, PEDIATR RES, V33, pS42; HIRSCHHORN R, 1994, ANN HUM GENET, V58, P1, DOI 10.1111/j.1469-1809.1994.tb00720.x; HIRSCHHORN R, 1992, J IMMUNOL, V149, P3107; HIRSCHHORN R, 1990, P NATL ACAD SCI USA, V87, P6171, DOI 10.1073/pnas.87.16.6171; HIRSCHHORN R, 1993, HUM MUTAT, V2, P320, DOI 10.1002/humu.1380020415; HIRSCHHORN R, 1991, AM J HUM GENET, V49, P878; HIRSCHHORN R, 1993, PEDIATR RES, V33, pS35; HIRSCHHORN R, 1981, J CLIN INVEST, V68, P1387, DOI 10.1172/JCI110389; Hirschhorn R., 1992, Human Mutation, V1, P166, DOI 10.1002/humu.1380010214; HIRSCHHORN R, 1979, J CLIN INVEST, V64, P1130, DOI 10.1172/JCI109552; Hirschhorn R, 1980, Isozymes Curr Top Biol Med Res, V4, P131; HIRSCHHORN R, 1982, PEDIATR RES, V16, P362, DOI 10.1203/00006450-198205000-00009; HIRSCHHORN R, 1992, AM J MED GENET, V42, P201, DOI 10.1002/ajmg.1320420213; HIRSCHHORN R, 1989, J CLIN INVEST, V83, P497, DOI 10.1172/JCI113909; HIRSCHHORN R, 1993, CELL IMMUNOL, V152, P383, DOI 10.1006/cimm.1993.1299; HIRSCHHORN R, 1993, IMMUNODEFICIENCIES, P177; HOPKINSON DA, 1969, ANN HUM GENET, V32, P361, DOI 10.1111/j.1469-1809.1969.tb00087.x; KAWAMOTO H, 1993, J CELL BIOCHEM, V51, P322, DOI 10.1002/jcb.240510311; KEITH TP, 1990, P NATL ACAD SCI USA, V87, P5754, DOI 10.1073/pnas.87.15.5754; KIDD KK, 1989, CYTOGENET CELL GENET, V51, P622, DOI 10.1159/000132810; KREDICH NM, 1989, METABOLIC BASIS INHE, P1045; KURLANDSKY LE, 1993, PEDIATR ASTHMA ALLER, V7, P51, DOI 10.1089/pai.1993.7.51; LEVINSON B, 1990, AM J HUM GENET, V46, P53; MADDALENA A, 1988, NEW ENGL J MED, V319, P999, DOI 10.1056/NEJM198810133191507; MARKERT ML, 1988, J CLIN INVEST, V81, P1323, DOI 10.1172/JCI113458; MARKERT ML, 1989, AM J HUM GENET, V45, P354; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P5222, DOI 10.1093/nar/16.11.5222; POLMAR SH, 1976, NEW ENGL J MED, V295, P1337, DOI 10.1056/NEJM197612092952402; RATECH H, 1981, ENZYME, V26, P74, DOI 10.1159/000459153; SCHWINDINGER WF, 1992, P NATL ACAD SCI USA, V89, P5152, DOI 10.1073/pnas.89.11.5152; SHOVLIN CL, 1993, LANCET, V341, P1471, DOI 10.1016/0140-6736(93)90910-9; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; TAYLOR SAM, 1991, P NATL ACAD SCI USA, V88, P39, DOI 10.1073/pnas.88.1.39; TUNG R, 1976, J CLIN INVEST, V57, P756, DOI 10.1172/JCI108334; TZALL S, 1989, AM J HUM GENET, V44, P864; UBERTI J, 1978, CLIN IMMUNOL IMMUNOP, V10, P446, DOI 10.1016/0090-1229(78)90157-5; UBERTI J, 1983, J IMMUNOL, V130, P2866; VALERIO D, 1986, EMBO J, V5, P113, DOI 10.1002/j.1460-2075.1986.tb04184.x; VALERIO D, 1984, GENE, V31, P147, DOI 10.1016/0378-1119(84)90205-1; VOIT T, 1992, EUR J PEDIATR, V151, P112, DOI 10.1007/BF01958954; WALLIS GA, 1990, AM J HUM GENET, V46, P1034; WIGINTON DA, 1984, NUCLEIC ACIDS RES, V12, P2439, DOI 10.1093/nar/12.5.2439; WIGINTON DA, 1986, BIOCHEMISTRY-US, V25, P8234, DOI 10.1021/bi00373a017; WOLF JR, 1976, J RETICULOENDOTHEL S, V20, P1694; YANG DRX, 1994, CLIN IMMUNOL IMMUNOP, V70, P171, DOI 10.1006/clin.1994.1026	57	59	61	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1994	55	1					59	68						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NW461	8023852				2022-12-18	WOS:A1994NW46100009
J	PANGALOS, C; AVRAMOPOULOS, D; BLOUIN, JL; RAOUL, O; DEBLOIS, MC; PRIEUR, M; SCHINZEL, AA; GIKA, M; ABAZIS, D; ANTONARAKIS, SE				PANGALOS, C; AVRAMOPOULOS, D; BLOUIN, JL; RAOUL, O; DEBLOIS, MC; PRIEUR, M; SCHINZEL, AA; GIKA, M; ABAZIS, D; ANTONARAKIS, SE			UNDERSTANDING THE MECHANISM(S) OF MOSAIC TRISOMY-21 BY USING DNA POLYMORPHISM ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PARENTAL ORIGIN; DOWN-SYNDROME; NONDISJUNCTION; CHROMOSOME-21; AMPLIFICATION; MARKERS	In order to investigate the mechanism(s) underlying mosaicism for trisomy 21, we genotyped 17 families with mosaic trisomy 21 probands, using 28 PCR-detectable DNA polymorphic markers that map in the pericentromeric region and Long arm of chromosome 21. The percentage of cells with trisomy 21 in the probands' blood lymphocytes was 6%-34%. There were two classes of autoradiographic results: In class I, a ''third allele'' of lower intensity was detected in the proband's DNA for at least two chromosome 21 markers. The interpretation of this result was that the proband had inherited three chromosomes 21 after meiotic nondisjunction (NDA) (trisomy 21 zygote) and subsequently lost one because of mitotic (somatic) error, the lost chromosome 21 being that with the lowest-intensity polymorphic allele. The parental origin and the meiotic stage of NDJ could also be determined. In class II, a ''third allele'' was never detected. In these cases, the mosaicism probably occurred either by a postzygotic, mitotic error in a normal zygote that followed a normal meiosis (class IIA mechanism); by premeiotic, mitotic NDJ yielding an aneusomic zygote after meiosis, and subsequent mitotic loss (class IIB mechanism); or by a meiosis II error with lack of crossover in the preceding meiosis I, followed by mitotic loss after fertilization (class IIC mechanism). Among class II mechanisms, the most likely is mechanism IIA, while IIC is the least likely. There were 10 cases of class I and 7 cases of class II results. Within class I, there were nine cases with maternal meiotic errors (six meiosis I and three meiosis II errors, on the basis of pericentromeric markers) and one with paternal meiosis I error. The postzygotic loss of chromosome 21 was determined in eight maternal class I cases, and it was maternally derived in five cases and paternally derived in three; this suggests that the postzygotic loss of chromosome 21 is probably random. The mean maternal age in meiotic class I errors was 31.4 years and in mitotic class II errors was 27.4 years, as expected.	JOHNS HOPKINS UNIV, SCH MED, CTR MED GENET, BALTIMORE, MD 21205 USA; UNIV PATRAS, SCH MED, BIOL LAB, Patras, GREECE; DIAGNOST GENET CTR, ATHENS, GREECE; HOSP NECKER ENFANTS MALAD, CYTOGENET LAB, PARIS, FRANCE; UNIV ZURICH, SCH MED, INST MED GENET, ZURICH, SWITZERLAND; UNIV GENEVA, SCH MED, DIV MED GENET, CH-1211 GENEVA, SWITZERLAND	Johns Hopkins University; University of Patras; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Zurich; University of Geneva			Antonarakis, Stylianos E/N-8866-2014; Avramopoulos, Dimitrios/J-4392-2012	Antonarakis, Stylianos E/0000-0001-8907-5823; 	NICHD NIH HHS [HD24605] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD024605] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANTONARAKIS SE, 1993, TRENDS GENET, V9, P142, DOI 10.1016/0168-9525(93)90210-9; ANTONARAKIS SE, 1993, AM J HUM GENET, V52, P1145; ANTONARAKIS SE, 1993, NAT GENET, V3, P146, DOI 10.1038/ng0293-146; ANTONARAKIS SE, 1991, NEW ENGL J MED, V324, P872, DOI 10.1056/NEJM199103283241302; ANTONARAKIS SE, 1992, AM J HUM GENET, V50, P544; AVRAMOPOULOS D, 1993, 4 CHROM 21 WORKSH, P3; BLOUIN JL, 1993, AM J HUM GENET, V53, P1074; BRICARELLI FD, 1990, AM J MED GENET, P129; CREAUGOLDBERG N, 1987, HUM GENET, V76, P396, DOI 10.1007/BF00272452; Epstein C. J., 1989, METABOLIC BASIS INHE, P291; HOOK EB, 1982, DOWN SYNDROME ADV BI, P11; JUBERG RC, 1990, AM J MED GENET, V37, P15, DOI 10.1002/ajmg.1320370105; LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P1721; MAGENIS RE, 1981, TRISOMY 21 RES PERSP, P77; MCINNIS MG, 1993, GENOMICS, V16, P562, DOI 10.1006/geno.1993.1231; MIKKELSEN M, 1977, HEREDITAS, V86, P45; NIIKAWA N, 1984, AM J HUM GENET, V36, P123; PANGALOS CG, 1992, AM J HUM GENET, V51, P1015; PETERSEN MB, 1992, AM J HUM GENET, V51, P516; PETERSEN MB, 1991, AM J HUM GENET, V48, P65; RICHARDS BW, 1974, J MENT DEFIC RES, V18, P199; RICHARDS BW, 1969, J MENT DEFIC RES, V13, P66; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SHERMAN SL, 1991, AM J HUM GENET, V49, P608; TAYLOR AI, 1968, NATURE, V219, P1028, DOI 10.1038/2191028a0; TAYLOR AI, 1970, NATURE, V227, P163, DOI 10.1038/227163a0; TURPIN R, 1962, CR HEBD ACAD SCI, V255, P3088; WEBER JL, 1989, AM J HUM GENET, V44, P388	28	59	62	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1994	54	3					473	481						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ158	8116616				2022-12-18	WOS:A1994MZ15800010
J	SPIELMAN, RS; MCGINNIS, RE; EWENS, WJ				SPIELMAN, RS; MCGINNIS, RE; EWENS, WJ			THE TRANSMISSION/DISEQUILIBRIUM TEST DETECTS COSEGREGATION AND LINKAGE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									UNIV PENN,DEPT BIOL,PHILADELPHIA,PA 19104	University of Pennsylvania	SPIELMAN, RS (corresponding author), UNIV PENN,SCH MED,DEPT GENET,PHILADELPHIA,PA 19104, USA.			McGinnis, Ralph/0000-0003-4540-9857				HODGE SE, 1993, AM J HUM GENET, V53, P367; Ott J., 1991, ANAL HUMAN GENETIC L; PARSIAN A, 1991, ARCH GEN PSYCHIAT, V48, P655; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506	4	59	62	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1994	54	3					559	560						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ158	8116627				2022-12-18	WOS:A1994MZ15800022
J	SCHINZEL, AA; BASARAN, S; BERNASCONI, F; KARAMAN, B; YUKSELAPAK, M; ROBINSON, WP				SCHINZEL, AA; BASARAN, S; BERNASCONI, F; KARAMAN, B; YUKSELAPAK, M; ROBINSON, WP			MATERNAL UNIPARENTAL DISOMY-22 HAS NO IMPACT ON THE PHENOTYPE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NORMAL DAUGHTER; TRANSLOCATION; TRANSMISSION; MOTHER	A 25-year-old normal healthy male was karyotyped because five of his wife's pregnancies terminated in spontaneous abortions at 6-14 wk of gestation. Cytogenetic investigation disclosed a de novo balanced Robertsonian t(22q;22q) translocation. Molecular studies revealed maternal only inheritance for chromosome 22 markers. Reduction to homozygosity for all informative markers indicates that the rearranged chromosome is an isochromosome derived from one of the maternal chromosomes 22. Except for the possibility of homozygosity for recessive mutations, maternal uniparental disomy 22 does not seem to have an adverse impact on the phenotype, apart from causing reproductive failure. It can be concluded that no maternally imprinted genes with major effect map to chromosome 22.	ISTANBUL UNIV,PRENATAL DIAGNOSIS & RES CTR,ISTANBUL,TURKEY; ISTANBUL UNIV,INST CHILD HLTH,ISTANBUL,TURKEY	Istanbul University; Istanbul University	SCHINZEL, AA (corresponding author), UNIV ZURICH,INST MED GENET,RAMISTR 74,CH-8001 ZURICH,SWITZERLAND.		Basaran, Seher/AAC-5463-2020; Karaman, Birsen/AAB-5941-2020; Robinson, Wendy/AAB-6420-2020; Robinson, Wendy P/I-9590-2014	Karaman, Birsen/0000-0001-8640-0176; Robinson, Wendy/0000-0002-2010-6174; Robinson, Wendy P/0000-0002-2010-6174				ANTONARAKIS SE, 1993, AM J HUM GENET, V52, P1145; BLOUIN JL, 1993, AM J HUM GENET, V53, P1074; FREEMAN SB, 1993, AM J MED GENET, V45, P625, DOI 10.1002/ajmg.1320450522; Henry I., 1993, European Journal of Human Genetics, V1, P19; KIRKELS VGHJ, 1980, CLIN GENET, V18, P456; PALMER CG, 1980, CLIN GENET, V17, P418; PENTAO L, 1992, AM J HUM GENET, V50, P690; ROBINSON WP, IN PRESS AM J HUM GE, V54; SCHINZEL A, 1993, GENOME PRIORITY REPO, V1, P658; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	10	59	60	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1994	54	1					21	24						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MQ700	8279466				2022-12-18	WOS:A1994MQ70000004
J	SCHWARTZ, LS; TARLETON, J; POPOVICH, B; SELTZER, WK; HOFFMAN, EP				SCHWARTZ, LS; TARLETON, J; POPOVICH, B; SELTZER, WK; HOFFMAN, EP			FLUORESCENT MULTIPLEX LINKAGE ANALYSIS AND CARRIER DETECTION FOR DUCHENNE BECKER MUSCULAR-DYSTROPHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMERASE CHAIN-REACTION; PRENATAL-DIAGNOSIS; GENE DELETIONS; POLYMORPHISMS; DNA; REPEAT; REGION; LOCUS; CDNA	We have developed a fast and accurate PCR-based linkage and carrier detection protocol for families of Duchenne muscular dystrophy (DMD)/Becker muscular dystrophy (BMD) patients with or without detectable deletions of the dystrophin gene, using fluorescent PCR products analyzed on an automated sequencer. When a deletion is found in the affected male DMD/BMD patient by standard multiplex PCR, fluorescently labeled primers specific for the deleted and nondeleted exon(s) are used to amplify the DNA of at-risk female relatives by using multiplex PCR at low cycle number (20 cycles). The products are then quantitatively analyzed on an automatic sequencer to determine whether they are heterozygous for the deletion and thus are carriers. As a confirmation of the deletion data, and in cases in which a deletion is not found in the proband, fluorescent multiplex PCR linkage is done by using four previously described polymorphic dinucleotide sequences. The four (CA)n repeats are located throughout the dystrophin gene, making the analysis highly informative and accurate. We present the successful application of this protocol in families who proved refractory to more traditional analyses.	UNIV PITTSBURGH,SCH MED,DEPT MOLEC GENET & BIOCHEM,BIOMED SCI TOWER W1211,PITTSBURGH,PA 15261; UNIV PITTSBURGH,SCH MED,DEPT HUMAN GENET,PITTSBURGH,PA 15261; UNIV PITTSBURGH,SCH MED,DEPT PEDIAT,PITTSBURGH,PA 15261; SELF MEM HOSP,DEPT MED GENET,GREENWOOD,SC; GREENWOOD GENET CTR,GREENWOOD,SC 29646; CHILDRENS HOSP & HLTH CTR,DEPT MOLEC GENET,SAN DIEGO,CA; UNIV COLORADO,HLTH SCI CTR,SCH MED,DEPT PEDIAT,DENVER,CO 80262	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Greenwood Genetic Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver				Hoffman, Eric/0000-0001-6470-5139; Schwartz, Lisa/0000-0003-4981-4948	NINDS NIH HHS [NS#28043] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABBS S, 1991, J MED GENET, V28, P304, DOI 10.1136/jmg.28.5.304; BAKKER E, 1985, LANCET, V1, P655; BEGGS AH, 1990, HUM GENET, V86, P45; BEGGS AH, 1990, NUCLEIC ACIDS RES, V18, P1931, DOI 10.1093/nar/18.7.1931; Chamberlain J.S., 1990, PCR PROTOCOLS GUIDE, P272; CLEMENS PR, 1991, AM J HUM GENET, V49, P951; FEENER CA, 1991, AM J HUM GENET, V48, P621; GRUEMER HD, 1985, AM J CLIN PATHOL, V84, P655, DOI 10.1093/ajcp/84.5.655; HIGUCHI R, 1989, AMPLIFICATIONS FORUM; HODGSON S, 1989, J MED GENET, V26, P682, DOI 10.1136/jmg.26.11.682; HODGSON SV, 1989, BRIT MED BULL, V45, P719, DOI 10.1093/oxfordjournals.bmb.a072354; HOFFMAN EP, 1989, NEURON, V2, P1019, DOI 10.1016/0896-6273(89)90226-2; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOFFMAN EP, 1991, MOL ASPECTS MED, V12, P175, DOI 10.1016/0098-2997(91)90001-3; HOFFMAN EP, IN PRESS MOL CELL BI; HU XY, 1990, AM J HUM GENET, V46, P682; KAN YW, 1977, NEW ENGL J MED, V297, P1081, DOI 10.1056/NEJM197711172972002; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; OUDET C, 1990, HUM GENET, V84, P283; WEBER JL, 1989, AM J HUM GENET, V44, P388; 1989, USER B DNA SEQUENCER, P7	22	59	76	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1992	51	4					721	729						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JQ667	1415217				2022-12-18	WOS:A1992JQ66700004
J	LONGO, N; LANGLEY, SD; GRIFFIN, LD; ELSAS, LJ				LONGO, N; LANGLEY, SD; GRIFFIN, LD; ELSAS, LJ			REDUCED MESSENGER-RNA AND A NONSENSE MUTATION IN THE INSULIN-RECEPTOR GENE PRODUCE HERITABLE SEVERE INSULIN RESISTANCE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMERASE CHAIN-REACTION; PROMOTER REGION; KINASE-ACTIVITY; FIBROBLASTS; LEPRECHAUNISM; PATIENT; AUTOPHOSPHORYLATION; BINDING; DEFECTS; EXPRESSION	Leprechaunism is an autosomal recessive syndrome of severe insulin resistance and is characterized by intra-uterine growth restriction, acanthosis nigricans, hirsutism, and loss of glucose homeostasis. Here we report a new female patient of Hispanic and Afro-American descent whose fibroblasts and lymphoblasts had markedly impaired insulin binding (less than 10% of that in controls). Insulin binding to lymphoblasts established from both unrelated parents was partially impaired. Insulin-like growth factor-I (IGF-I) and epidermal growth factor (EGF) binding to the patient's fibroblasts were within the normal range. Insulin stimulation of receptor autophosphorylation and kinase activity was markedly reduced in the patient's fibroblasts. The patient's fibroblasts had both a reduced number of immunoreactive insulin receptor (6% of those in controls) and concomitantly reduced amounts of insulin-receptor mRNA, suggesting that both mutations inherited by the patient reduced insulin-receptor mRNA. Sequencing of the insulin-receptor gene and cDNA indicated that the patient was heterozygous for a paternally derived mutation at bp 1333, converting Arg372 to a STOP codon. This nonsense mutation was observed in the insulin-receptor gene, but not in cDNA, indicating reduced amounts of mRNA for the allele containing this mutation. The coding sequence of the maternally inherited insulin-receptor allele was normal. Both the marked reduction in insulin-receptor mRNA in the compound heterozygous fibroblasts of the proband and the partially reduced insulin binding in maternal cells suggest that the maternally derived mutation is located in an insulin-receptor gene sequence that controls cellular mRNA content.			LONGO, N (corresponding author), EMORY UNIV,DEPT PEDIAT,DIV SHOWA KU,2040 RIDGEWOOD DR,ATLANTA,GA 30322, USA.				NIDDK NIH HHS [R01-DK 40362] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040362] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ACCILI D, 1991, J BIOL CHEM, V266, P434; ARAKI E, 1991, J BIOL CHEM, V266, P3944; ARAKI E, 1987, J BIOL CHEM, V262, P16186; ATWEH GF, 1988, J CLIN INVEST, V82, P557, DOI 10.1172/JCI113632; BARRERASALDANA H, 1985, EMBO J, V4, P3839, DOI 10.1002/j.1460-2075.1985.tb04156.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; ELSAS LJ, 1985, AM J HUM GENET, V37, P73; ELSAS LJ, 1989, YALE J BIOL MED, V62, P533; ELSAS LJ, 1985, CONGENITAL METABOLIC, P301; ENDO F, 1987, AM J HUM GENET, V41, P402; FOJO SS, 1988, J BIOL CHEM, V263, P17913; GAVIN JR, 1973, J BIOL CHEM, V248, P2202; IMANO E, 1991, DIABETES, V40, P547; KADOWAKI T, 1990, P NATL ACAD SCI USA, V87, P658, DOI 10.1073/pnas.87.2.658; KADOWAKI T, 1990, J CLIN INVEST, V86, P254, DOI 10.1172/JCI114693; LONGO N, 1990, BIOCHEM BIOPH RES CO, V167, P1229, DOI 10.1016/0006-291X(90)90655-7; LONGO N, 1989, METABOLISM, V38, P690, DOI 10.1016/0026-0495(89)90109-1; MAASSEN JA, 1988, DIABETOLOGIA, V31, P612, DOI 10.1007/BF00264769; MAMULA PW, 1988, DIABETES, V37, P1241, DOI 10.2337/diabetes.37.9.1241; MCKEON C, 1991, BIOCHEM BIOPH RES CO, V174, P721, DOI 10.1016/0006-291X(91)91477-T; MCKEON C, 1990, MOL ENDOCRINOL, V4, P647, DOI 10.1210/mend-4-4-647; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MULLERWIELAND D, 1989, DIABETES, V38, P31, DOI 10.2337/diabetes.38.1.31; MYEROWITZ R, 1988, J BIOL CHEM, V263, P18587; NORTON KI, 1990, DYSMORPHOL CLIN GENE, V4, P57; OJAMAA K, 1988, MOL ENDOCRINOL, V2, P242, DOI 10.1210/mend-2-3-242; PEZZINO V, 1989, AM J PHYSIOL, V257, pE451, DOI 10.1152/ajpendo.1989.257.3.E451; REDDY SS, 1989, J CLIN INVEST, V84, P1569, DOI 10.1172/JCI114334; REDDY SSK, 1988, J CLIN INVEST, V82, P1359, DOI 10.1172/JCI113739; SAMBROOK J, 1989, MOL CLONING LABORATO, pCH7; SEINO S, 1989, P NATL ACAD SCI USA, V86, P114, DOI 10.1073/pnas.86.1.114; SEINO S, 1990, DIABETES, V39, P123, DOI 10.2337/diabetes.39.1.123; TEWARI DS, 1989, J BIOL CHEM, V264, P16238; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; URLAUB G, 1989, MOL CELL BIOL, V9, P2868, DOI 10.1128/MCB.9.7.2868; VANOBBERGHENSCHILLING EE, 1981, J CLIN INVEST, V68, P1356, DOI 10.1172/JCI110383; WANG CS, 1975, ANAL BIOCHEM, V63, P414, DOI 10.1016/0003-2697(75)90363-2	38	59	59	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1992	50	5					998	1007						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HR473	1315125				2022-12-18	WOS:A1992HR47300013
J	WERTZ, DC; JANES, SR; ROSENFIELD, JM; ERBE, RW				WERTZ, DC; JANES, SR; ROSENFIELD, JM; ERBE, RW			ATTITUDES TOWARD THE PRENATAL-DIAGNOSIS OF CYSTIC-FIBROSIS - FACTORS IN DECISION-MAKING AMONG AFFECTED FAMILIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMORPHIC DNA MARKER; LOCUS; GENE; IDENTIFICATION; CHOICES	The objective of this study was to explore psychosocial factors underlying decisions about use of prenatal diagnosis for cystic fibrosis (CF), among parents of affected children. Anonymous survey questionnaires, supplemented by voluntary interviews, were used at 12 CF centers in six New England states, for a consecutive sample of families of minor children visiting CF centers during a 4-mo period. In all, 227 (71%) of 318 families responded. We hypothesized that attitudes toward utilization would be affected by (a) intentions to have children, (b) knowledge, (c) perception of risk, (d) the health of the child with CF, (e) expectations about the child's future, (f) attitudes toward abortion, (g) insurance, (h) genetic counseling, and (i) sociodemographic factors (including attendance at religious services). Of the 227 couples who responded, 69% were surgically sterile, over 45 years of age, widowed, or divorced, and 31% were at risk. Of 70 at-risk couples, 44% intended to have more children; of these, 77% had had or were considering CF prenatal diagnosis. Most families knew CF could be diagnosed prenatally; 20% would terminate for CF. Among intended prenatal diagnosis users, 44% would carry a fetus with CF to term, 28% would abort, and 28% were undecided. Stepwise logistic regression showed three variables significantly related to intentions to use prenatal diagnosis: (1) respondent's willingness to abort for CF (P < .02, odds ratio 3.36), (2) respondent's siblings' approval of abortion for CF (P < .03, odds ratio 2.99), and (3) respondent listed no accomplishments for the child with CF (P < .09, odds ratio 3.01). The majority of affected families reject selective abortion for CF; many will curtail childbearing rather than use prenatal diagnosis.	CHILDRENS HOSP,DEPT GYNECOL & OBSTET,BUFFALO,NY 14222; CHILDRENS HOSP,DIV GENET,BUFFALO,NY 14222; BETH ISRAEL HOSP,DIV GENET,BROOKLINE,MA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	WERTZ, DC (corresponding author), SHRIVER CTR MENTAL RETARDAT,SOCIAL SCI ETH & LAW,200 TRAPELO RD,WALTHAM,MA 02254, USA.				PHS HHS [MCJ-251003] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AMOS JA, 1990, CLIN INVEST MED, V13, P1; BEAUDET AL, 1989, AM J HUM GENET, V44, P319; Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; COLTEN HR, 1990, NEW ENGL J MED, V322, P328, DOI 10.1056/NEJM199002013220510; DENAYER L, 1990, CLIN GENET, V37, P198; DENNING CR, 1984, CYSTIC FIBROSIS, P461; ESTIVILL X, 1987, NATURE, V326, P840, DOI 10.1038/326840a0; FADEN RR, 1987, AM J PUBLIC HEALTH, V77, P288, DOI 10.2105/AJPH.77.3.288; KABACK M, 1984, CYSTIC FIBROSIS HORI, P15; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KNOWLTON RG, 1985, NATURE, V318, P380, DOI 10.1038/318380a0; KYLE D, 1988, BRIT J OBSTET GYNAEC, V95, P560, DOI 10.1111/j.1471-0528.1988.tb09483.x; LEMNA WK, 1990, NEW ENGL J MED, V322, P291, DOI 10.1056/NEJM199002013220503; MILLER CH, 1987, AM J MED GENET, V26, P591, DOI 10.1002/ajmg.1320260313; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1058; SCHOENFELD M, 1984, AM J MED GENET, V18, P423, DOI 10.1002/ajmg.1320180311; Swerts A, 1987, Birth Defects Orig Artic Ser, V23, P61; TSUI LC, 1985, SCIENCE, V230, P1054, DOI 10.1126/science.2997931; WAINWRIGHT BJ, 1985, NATURE, V318, P384, DOI 10.1038/318384a0; WERTZ DC, 1991, AM J PUBLIC HEALTH, V81, P992, DOI 10.2105/AJPH.81.8.992; WERTZ DC, 1992, ISSUES REPRODUCTIVE, P143; WHITE R, 1985, NATURE, V318, P382, DOI 10.1038/318382a0; 1990, NATIONAL REGISTRY CY; 1989, STATISITCAL ABSTRACT	25	59	59	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1992	50	5					1077	1085						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	HR473	1570837				2022-12-18	WOS:A1992HR47300024
J	OUDET, C; HEILIG, R; HANAUER, A; MANDEL, JL				OUDET, C; HEILIG, R; HANAUER, A; MANDEL, JL			NONRADIOACTIVE ASSAY FOR NEW MICROSATELLITE POLYMORPHISMS AT THE 5' END OF THE DYSTROPHIN GENE, AND ESTIMATION OF INTRAGENIC RECOMBINATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; POLYMERASE CHAIN-REACTION; DNA AMPLIFICATION; LINKAGE ANALYSIS; MARKER LOCI; DMD GENE; DELETION; REGION; BECKER; PROMOTER	Indirect tracking of mutation by DNA polymorphisms is still essential for carrier and prenatal diagnosis of Duchenne/Becker muscular dystrophy, at least in the families where no deletion can be detected. Because of the relatively high level of intragenic recombination, informative and easily testable markers at both ends of the gene are necessary for efficient and accurate diagnosis. We report the characterization of two polymorphic microsatellite sequences (TG repeats) at the 5' end of the dystrophin gene, within 40 kb of the muscle-specific promoter. The most useful one (5' DYS MSA) has 10 alleles with a 57% heterozygosity and can be tested on small polyacrylamide gels in a nonradioactive PCR-based assay. Despite its large number of alleles, this microsatellite shows strong linkage disequilibrium with a two-allele polymorphism reported by Roberts et al., an indication of the stability of this type of sequences. We have used the new microsatellites at the 5' end, along with one we reported previously for the 3' end, to type the families in the CEPH (Centre d'Etude du Polymorphisme Humain) panel. While the number of informative families has increased by a factor of about two with respect to the study of Abbs et al., the estimates of the recombination fractions are in good agreement with this previous report, suggesting a 11% recombination across the gene (3% between the 5' end and the pERT87 region, 8% between pERT87 and the 3' end), which is about fivefold more than expected. However, these estimates still have wide confidence limits.	FAC MED STRASBOURG,FAC CHIM BIOL,CNRS,GENET MOLEC EUCARYOTES LAB,INSERM,F-67085 STRASBOURG,FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg								ABBS S, 1990, GENOMICS, V7, P602, DOI 10.1016/0888-7543(90)90205-9; BEGGS AH, 1990, HUM GENET, V86, P45; BEGGS AH, 1990, NUCLEIC ACIDS RES, V18, P1931, DOI 10.1093/nar/18.7.1931; CHAMBERLAIN JS, 1988, NUCLEIC ACIDS RES, V16, P11141, DOI 10.1093/nar/16.23.11141; CHAMBERLAIN JS, 1989, UCLA S MOL CELL BIOL, V93, P951; CHEN JD, 1989, GENOMICS, V4, P105, DOI 10.1016/0888-7543(89)90322-4; FEENER CA, 1991, AM J HUM GENET, V48, P621; FORREST S M, 1988, Genomics, V2, P109, DOI 10.1016/0888-7543(88)90091-2; FREUND AM, 1989, P NATL ACAD SCI USA, V86, P7465, DOI 10.1073/pnas.86.19.7465; FUJITA R, 1990, P NATL ACAD SCI USA, V87, P1796, DOI 10.1073/pnas.87.5.1796; GILLARD EF, 1989, AM J HUM GENET, V45, P507; GRIMM T, 1989, AM J HUM GENET, V45, P368; HEILIG R, 1987, NUCLEIC ACIDS RES, V15, P9129, DOI 10.1093/nar/15.22.9129; HUNG T, 1990, NUCLEIC ACIDS RES, V18, P4953, DOI 10.1093/nar/18.16.4953; KIDD KK, 1989, CYTOGENET CELL GENET, V51, P622, DOI 10.1159/000132810; KLAMUT HJ, 1990, MOL CELL BIOL, V10, P193, DOI 10.1128/MCB.10.1.193; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; KUNKEL LM, 1986, NATURE, V322, P73, DOI 10.1038/322073a0; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LINDLOF M, 1989, AM J HUM GENET, V44, P496; LITT M, 1989, AM J HUM GENET, V44, P397; OUDET C, 1990, HUM GENET, V84, P283; ROBERTS RG, 1990, NUCLEIC ACIDS RES, V18, P1315, DOI 10.1093/nar/18.5.1315-a; ROBERTS RG, 1989, NUCLEIC ACIDS RES, V17, P5961, DOI 10.1093/nar/17.15.5961; ROBERTS RG, 1989, NUCLEIC ACIDS RES, V17, P811, DOI 10.1093/nar/17.2.811; SPEER A, 1989, NUCLEIC ACIDS RES, V17, P4892, DOI 10.1093/nar/17.12.4892; THOMPSON MW, 1986, J MED GENET, V23, P548, DOI 10.1136/jmg.23.6.548; WAPENAAR M C, 1988, Genomics, V2, P101, DOI 10.1016/0888-7543(88)90090-0; WEBER JL, 1989, AM J HUM GENET, V44, P388	30	59	59	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1991	49	2					311	319						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GA866	1867193				2022-12-18	WOS:A1991GA86600007
J	FORREST, SM; DAHL, HH; HOWELLS, DW; DIANZANI, I; COTTON, RGH				FORREST, SM; DAHL, HH; HOWELLS, DW; DIANZANI, I; COTTON, RGH			MUTATION DETECTION IN PHENYLKETONURIA BY USING CHEMICAL CLEAVAGE OF MISMATCH - IMPORTANCE OF USING PROBES FROM BOTH NORMAL AND PATIENT SAMPLES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE BASE SUBSTITUTIONS; PCR-AMPLIFIED DNA; CHAIN-REACTION; GENOMIC DNA; HYDROXYLASE; DEFICIENCY; CYTOSINE; SEQUENCE; THYMINE; LINKAGE	mRNA from a postmortem liver sample of a patient with classical phenylketonuria was examined using the chemical cleavage of mismatch (CCM) method to search for mutations in phenylalanine hydroxylase. Initial screening identified a heterozygous alteration in exon 2 which changed the encoded amino acid from phenylalanine (TTC) to leucine (TTG) at codon 39 and a polymorphism at codon 430 where the change from CTG to CTC did not alter the encoded leucine. Use of the CCM technique also revealed that the control refer nce clone differed from the published sequence by having a substitution of isoleucine (ATT) for methionine (ATG) at codon 276 and CAA rather than CAG as the codon for glutamine 232. By using the mRNA from the patient instead of the control as the source for the radiolabeled probe for the CCM technique, a second previously undetected alteration was identified in exon 10 where the change from TCA to CCA at codon 349 altered the amino acid from serine to arginine. Judicious choice of probes gives the CCM method the potential to detect close to 100% of single base mutations.	IST CLIN PEDIAT,TURIN,ITALY		FORREST, SM (corresponding author), ROYAL CHILDRENS HOSP,MURDOCH INST,OLIVE MILLER PROT LAB,FLEMINGTON RD,PARKVILLE,VIC 3052,AUSTRALIA.			Howells, David/0000-0002-2512-7724				ABADIE V, 1989, GENOMICS, V5, P936, DOI 10.1016/0888-7543(89)90137-7; BACHMANN B, 1990, NUCLEIC ACIDS RES, V18, P1309, DOI 10.1093/nar/18.5.1309; CHOO KH, 1979, BIOCHEM J, V181, P285, DOI 10.1042/bj1810285; COTTON RGH, 1989, NUCLEIC ACIDS RES, V17, P4223, DOI 10.1093/nar/17.11.4223; COTTON RGH, 1988, P NATL ACAD SCI USA, V85, P4397, DOI 10.1073/pnas.85.12.4397; COTTON RGH, 1989, BIOCHEM J, V263, P1; COTTON RGH, IN PRESS ADV GENOME; DAHL HHM, 1989, ANAL BIOCHEM, V183, P263, DOI 10.1016/0003-2697(89)90477-6; DAHL HHM, 1990, AM J HUM GENET, V47, P286; DIANZANI I, 1991, AM J HUM GENET, V48, P631; DIANZANI I, 1991, AM J HUM GENET, V48, P423; DILELLA AG, 1987, NATURE, V327, P333, DOI 10.1038/327333a0; DILELLA AG, 1986, NATURE, V322, P799, DOI 10.1038/322799a0; Fisher S.G., 1983, P NATL ACAD SCI USA, V80, P1579; GRENETT HE, 1987, P NATL ACAD SCI USA, V84, P5530, DOI 10.1073/pnas.84.16.5530; GROMPE M, 1989, P NATL ACAD SCI USA, V86, P5888, DOI 10.1073/pnas.86.15.5888; HOWELLS DW, 1990, AM J HUM GENET, V47, P279; KWOK SC, 1985, BIOCHEMISTRY-US, V54, P556; LUI CP, 1970, P NATL ACAD SCI USA, V76, P4503; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MONTANDON AJ, 1989, NUCLEIC ACIDS RES, V17, P3347, DOI 10.1093/nar/17.9.3347; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; MYERS RM, 1985, NATURE, V313, P495, DOI 10.1038/313495a0; MYERS RM, 1985, SCIENCE, V230, P1242, DOI 10.1126/science.4071043; OKANO Y, 1990, AM J HUM GENET, V46, P18; PILZ RB, 1990, J BIOL CHEM, V265, P8880; REISS J, 1990, NUCLEIC ACIDS RES, V18, P973, DOI 10.1093/nar/18.4.973; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; SPEER A, 1986, CLIN GENET, V29, P491; SVENSSON E, 1989, 27TH SOC STUD INB ER; WANG T, 1990, AM J HUM GENET, V47, pA241	32	59	60	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1991	49	1					175	183						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FW511	2063869				2022-12-18	WOS:A1991FW51100020
J	DAVIDSON, BL; TARLE, SA; VANANTWERP, M; GIBBS, DA; WATTS, RWE; KELLEY, WN; PALELLA, TD				DAVIDSON, BL; TARLE, SA; VANANTWERP, M; GIBBS, DA; WATTS, RWE; KELLEY, WN; PALELLA, TD			IDENTIFICATION OF 17 INDEPENDENT MUTATIONS RESPONSIBLE FOR HUMAN HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE (HPRT) DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LESCH-NYHAN SYNDROME; AMINO-ACID SEQUENCE; CARRIER STATE; DIAGNOSIS; FAMILY; GENE; CDNA	Complete hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency causes the Lesch-Nyhan syndrome, an X-linked, purine metabolism disorder manifested by hyperuricemia, hyperuricaciduria, and neurologic dysfunction. Partial HPRT deficiency causes hyperuricemia and gout. One requirement for understanding the molecular basis of HPRT deficiency is the determination of which amino acids in this salvage enzyme are necessary for structural or catalytic competence. In this study we have used the PCR coupled with direct sequencing to determine the nucleotide and subsequent amino acid changes in 22 subjects representing 17 unrelated kindreds from the United Kingdom. These mutations were confirmed by using either RNase mapping or Southern analyses. In addition, experiments were done to determine enzyme activity and electrophoretic mobility, and predictive paradigms were used to study the impact of these amino acid substitutions on secondary structure.	UNIV MICHIGAN,CTR MULTIPURPOSE ARTHRITIS,ANN ARBOR,MI 48109; MRC,CLIN RES CTR,DIV INHERITED METAB DIS,HARROW HA1 3UJ,MIDDX,ENGLAND; UNIV PENN,SCH MED,PHILADELPHIA,PA 19104	University of Michigan System; University of Michigan; Medical Research Council Clinical Trials Unit; University of Pennsylvania	DAVIDSON, BL (corresponding author), UNIV MICHIGAN,DEPT INTERNAL MED,RACKHAM ARTHRITIS RES UNIT,1150 W MED CTR DR,ANN ARBOR,MI 48109, USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR020557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019045] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR20557] Funding Source: Medline; NIDDK NIH HHS [R01 DK19045] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ausubel FM, 1989, CURRENT PROTOCOLS MO, V1-3; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; DAVIDSON BL, 1989, J CLIN INVEST, V84, P342, DOI 10.1172/JCI114160; DAVIDSON BL, 1989, J BIOL CHEM, V264, P520; GIBBS DA, 1986, J INHERIT METAB DIS, V9, P45, DOI 10.1007/BF01813902; GIBBS RA, 1989, P NATL ACAD SCI USA, V86, P1919, DOI 10.1073/pnas.86.6.1919; GIBBS RA, 1987, SCIENCE, V236, P303, DOI 10.1126/science.3563511; GIBBS RA, 1990, GENOMICS, V7, P234; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HERSHEY HV, 1986, GENE, V43, P287, DOI 10.1016/0378-1119(86)90218-0; HOLDEN JA, 1978, J BIOL CHEM, V253, P4459; KELLEY WN, 1967, P NATL ACAD SCI USA, V57, P1735, DOI 10.1073/pnas.57.6.1735; LESCH M, 1964, AM J MED, V36, P561, DOI 10.1016/0002-9343(64)90104-4; Maniatis T., 1982, MOL CLONING; MCKERAN RO, 1975, Q J MED, V44, P189; PAGE T, 1981, J INHERIT METAB DIS, V4, P203, DOI 10.1007/BF02263652; PATEL PI, 1984, SOMAT CELL MOLEC GEN, V10, P483, DOI 10.1007/BF01534853; SEEGMILLER JE, 1967, SCIENCE, V155, P1682, DOI 10.1126/science.155.3770.1682; WATTS RWE, 1982, Q J MED, V51, P43; WILSON JM, 1982, J CLIN INVEST, V69, P706, DOI 10.1172/JCI110499; WILSON JM, 1983, J CLIN INVEST, V72, P767, DOI 10.1172/JCI111047; WOLF H, 1988, COMPUT APPL BIOSCI, V4, P187	22	59	62	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1991	48	5					951	958						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK897	2018042				2022-12-18	WOS:A1991FK89700014
J	VASAN, NS; KUIVANIEMI, H; VOGEL, BE; MINOR, RR; WOOTTON, JAM; TROMP, G; WEKSBERG, R; PROCKOP, DJ				VASAN, NS; KUIVANIEMI, H; VOGEL, BE; MINOR, RR; WOOTTON, JAM; TROMP, G; WEKSBERG, R; PROCKOP, DJ			A MUTATION IN THE PRO-ALPHA-2(I) GENE (COL1A2) FOR TYPE-I PROCOLLAGEN IN EHLERS-DANLOS SYNDROME TYPE-VII - EVIDENCE SUGGESTING THAT SKIPPING OF EXON-6 IN RNA SPLICING MAY BE A COMMON CAUSE OF THE PHENOTYPE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRO-ALPHA-2(I) COLLAGEN GENE; LENGTH CDNA CLONE; OSTEOGENESIS IMPERFECTA; CULTURED FIBROBLASTS; CONNECTIVE-TISSUE; NUCLEIC-ACIDS; N-PROPEPTIDE; AMINO-ACIDS; CHAIN; PATIENT	Fibroblasts from a proband with Ehlers-Danlos syndrome type VII synthesized approximately equal amounts of normal and shortened pro-alpha-2(I) chains of type I procollagen. Nuclease S1 probe protection experiments with mRNA demonstrated that the pro-alpha-2(I) chains were shortened because of a deletion of most or all of the 54 nucleotides in exon 6, the exon that contains codons for the cleavage site for procollagen N-proteinase. Sequencing of genomic clones revealed a single-base mutation that converted the first nucleotide of intron 6 from G to A. Therefore, the mutation was a change, in the -GT- consensus splice site, that produced efficient exon skipping. Allele-specific oligonucleotide hybridization demonstrated that the proband's mother, father, and brother did not have the mutation. Therefore, the mutation was a sporadic one. Analysis of potential 5' splice sites in the 5' end of intron 6 indicated that none had favorable values by the two commonly employed techniques for evaluating such sites. The proband is the fourth reported proband with Ehlers-Danlos syndrome VII with a single-base mutation that causes skipping of exon 6 in the splicing of RNA from either the COL1A1 gene or COL1A2 gene. No other mutations in the two type I procollagen genes have been found in the syndrome. Therefore, such mutations may be a common cause of the phenotype. The primers developed should be useful in screening for the same or similar mutations causing the disease.	THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,JEFFERSON INST MOLEC MED,DEPT BIOCHEM & MOLEC BIOL,PHILADELPHIA,PA 19107; CORNELL UNIV,NEW YORK STATE COLL VET MED,DEPT PATHOL,ITHACA,NY 14853; HOSP SICK CHILDREN,TORONTO M5G 1X8,ONTARIO,CANADA	Jefferson University; Cornell University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)			Kuivaniemi, Helena/Q-8178-2019; Tromp, Gerard/B-2677-2017	Kuivaniemi, Helena/0000-0001-5753-8766; Tromp, Gerard/0000-0002-7761-0806	NIAMS NIH HHS [AR-38188] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR038188] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BATEMAN JF, 1990, BIOCHEM J, V267, P573, DOI 10.1042/bj2670573; BEIGHTON P, 1988, AM J MED GENET, V29, P581, DOI 10.1002/ajmg.1320290316; BEIGHTON P, 1970, EHLERSDANLOS SYNDROM; BORRESEN AL, 1985, MED GENETICS PAST PR, P37; BYERS PH, 1983, CLIN MED, P1; CHU ML, 1984, NATURE, V310, P337, DOI 10.1038/310337a0; COLE WG, 1986, J BIOL CHEM, V261, P5496; COTTON RGH, 1989, BIOCHEM J, V263, P1; COUNTS DF, 1980, J INVEST DERMATOL, V74, P96, DOI 10.1111/1523-1747.ep12519991; DALESSIO M, 1988, GENE, V67, P105, DOI 10.1016/0378-1119(88)90013-3; DEWET W, 1987, J BIOL CHEM, V262, P16032; DICKSON LA, 1985, NUCLEIC ACIDS RES, V13, P3427, DOI 10.1093/nar/13.10.3427; FJOLSTAD M, 1974, J PATHOL, V112, P183, DOI 10.1002/path.1711120309; FREIER SM, 1986, P NATL ACAD SCI USA, V83, P9373, DOI 10.1073/pnas.83.24.9373; GANGULY A, 1990, NUCLEIC ACIDS RES, V18, P3933, DOI 10.1093/nar/18.13.3933; GIBBS RA, 1989, P NATL ACAD SCI USA, V86, P1919, DOI 10.1073/pnas.86.6.1919; GRANDCHAMP B, 1989, P NATL ACAD SCI USA, V86, P661, DOI 10.1073/pnas.86.2.661; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HEGREBERG GA, 1970, ARCH PATHOL, V90, P159; HIGUCHI M, 1990, GENOMICS, V6, P65, DOI 10.1016/0888-7543(90)90448-4; HOJIMA Y, 1989, J BIOL CHEM, V264, P11336; HULMES DJS, 1989, J MOL BIOL, V210, P337, DOI 10.1016/0022-2836(89)90335-5; JACOB M, 1989, NUCLEIC ACIDS RES, V17, P2159, DOI 10.1093/nar/17.6.2159; KONTUSAARI S, 1990, AM J HUM GENET, V47, P112; KUIVANIEMI H, 1988, J BIOL CHEM, V263, P11407; KUIVANIEMI H, 1988, BIOCHEM J, V252, P633, DOI 10.1042/bj2520633; KUIVANIEMI H, 1990, J BIOL CHEM, V265, P12067; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANG KM, 1987, MOL CELL BIOL, V7, P3428, DOI 10.1128/MCB.7.10.3428; LENAERS A, 1971, EUR J BIOCHEM, V23, P533, DOI 10.1111/j.1432-1033.1971.tb01651.x; LICHTENSTEIN JR, 1973, SCIENCE, V182, P298, DOI 10.1126/science.182.4109.298; Maniatis T., 1982, MOL CLONING; McKusick V.A., 1983, MENDELIAN INHERITANC; MCKUSICK VA, 1972, HERITABLE DISORDERS, P292; MEINKOTH J, 1984, ANAL BIOCHEM, V138, P267, DOI 10.1016/0003-2697(84)90808-X; MINOR RR, 1986, J BIOL CHEM, V261, P6; MINOR RR, 1987, CONNECTIVE TISSUE DI, P293; MITCHELL PJ, 1986, MOL CELL BIOL, V6, P1926, DOI 10.1128/MCB.6.6.1926; MYERS JC, 1983, J BIOL CHEM, V258, P128; OHARA PJ, 1970, LAB INVEST, V23, P307; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHAMBAN A, 1989, TXB PEDIATRIC DERMAT, P117; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; STEINMANN B, 1980, J BIOL CHEM, V255, P8887; STUDENCKI AB, 1984, DNA-J MOLEC CELL BIO, V3, P7, DOI 10.1089/dna.1.1984.3.7; TROMP G, 1988, BIOCHEM J, V253, P919, DOI 10.1042/bj2530919; TSIPOURAS P, 1983, J CLIN INVEST, V72, P1262, DOI 10.1172/JCI111082; UITTO J, 1987, MODELS DERMATOLOGY, V3, P148; WEIL D, 1990, J BIOL CHEM, V265, P16007; WEIL D, 1989, J BIOL CHEM, V264, P16804; WEIL D, 1989, EMBO J, V8, P1705, DOI 10.1002/j.1460-2075.1989.tb03562.x; WEIL D, 1988, J BIOL CHEM, V263, P8561; WIRTZ MK, 1990, J BIOL CHEM, V265, P6312; WIRTZ MK, 1987, J BIOL CHEM, V262, P16376	55	59	60	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1991	48	2					305	317						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EV744	1990839				2022-12-18	WOS:A1991EV74400015
J	LERNMARK, A; DUCAT, L; EISENBARTH, G; OTT, J; PERMUTT, MA; RUBENSTEIN, P; SPIELMAN, R				LERNMARK, A; DUCAT, L; EISENBARTH, G; OTT, J; PERMUTT, MA; RUBENSTEIN, P; SPIELMAN, R			FAMILY CELL-LINES AVAILABLE FOR RESEARCH	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									UNIV PENN,SCH MED,NATL DIABET RES INTERCHANGE,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT HUMAN GENET,PHILADELPHIA,PA 19104; JOSLIN DIABET FDN INC,BOSTON,MA 02215; COLUMBIA UNIV,NEW YORK STATE PSYCHIAT INST,DEPT GENET,NEW YORK,NY 10027; NEW YORK BLOOD CTR,NEW YORK,NY 10021; WASHINGTON UNIV,SCH MED,DEPT MED,ST LOUIS,MO 63110	University of Pennsylvania; University of Pennsylvania; Harvard University; Joslin Diabetes Center, Inc.; Columbia University; New York State Psychiatry Institute; New York Blood Center; Washington University (WUSTL)	LERNMARK, A (corresponding author), UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195, USA.		Lernmark, Åke/F-8140-2015	Lernmark, Åke/0000-0003-1735-0499					0	59	59	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1990	47	6					1028	1030						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EK400	2239968				2022-12-18	WOS:A1990EK40000024
J	WERTZ, DC; FLETCHER, JC; MULVIHILL, JJ				WERTZ, DC; FLETCHER, JC; MULVIHILL, JJ			MEDICAL GENETICISTS CONFRONT ETHICAL DILEMMAS - CROSS-CULTURAL COMPARISONS AMONG 18 NATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV VIRGINIA,MED CTR,SCH MED,DEPT INTERNAL MED,CHARLOTTESVILLE,VA 22901; NCI,CLIN EPIDEMIOL BRANCH,CLIN GENET SECT,BETHESDA,MD 20205	University of Virginia; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	WERTZ, DC (corresponding author), BOSTON UNIV,SCH PUBL HLTH,HLTH SERV SECT,80 E CONCORD ST,BOSTON,MA 02118, USA.							BERG K, 1983, RES ETHICS, P261; BERG K, 1989, ETHICS HUMAN GENETIC, pR6; CRAWFURD MD, 1983, BR MED B, V39, P310; CZEIZEL A, 1987, RIGHT BE BORN HLTH E; FLETCHER JC, 1985, CLIN GENET, V27, P199; FRASER FC, 1977, GENETIC COUNSELING, P109; PFEIFFER RA, 1982, J GENET HUM, V30, P447; SCHROEDER TM, 1982, MONATSSCHR KINDERH, V130, P71; SORENSON JR, 1976, GENETICS LAW, P467; WERTZ D.C., 1989, HEALING TECHNOLOGY F, P221; WERTZ DC, 1988, AM J MED GENET, V29, P815, DOI 10.1002/ajmg.1320290411; WERTZ DC, 1988, AM J HUM GENET, V42, P592; WERTZ DC, 1989, PRENATAL DIAG, V9, P145, DOI 10.1002/pd.1970090302; WERTZ DC, 1989, PUBLIC HEALTH REP, V104, P35; Wertz DC, 1989, ETHICS HUMAN GENETIC; 1989, DHHS PHS891232 PUB; 1983, SCREENING COUNSELING	17	59	60	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1990	46	6					1200	1213						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	DF202	2339711				2022-12-18	WOS:A1990DF20200022
J	NOGUEIRA, CP; MCGUIRE, MC; GRAESER, C; BARTELS, CF; ARPAGAUS, M; VANDERSPEK, AFL; LIGHTSTONE, H; LOCKRIDGE, O; LADU, BN				NOGUEIRA, CP; MCGUIRE, MC; GRAESER, C; BARTELS, CF; ARPAGAUS, M; VANDERSPEK, AFL; LIGHTSTONE, H; LOCKRIDGE, O; LADU, BN			IDENTIFICATION OF A FRAMESHIFT MUTATION RESPONSIBLE FOR THE SILENT PHENOTYPE OF HUMAN SERUM-CHOLINESTERASE, GLY-117 (GGT-]GGAG)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MICHIGAN,SCH MED,DEPT ANESTHESIOL,ANN ARBOR,MI 48109; METROPOLITAN HOSP,DEPT ANESTHESIOL,PHILADELPHIA,PA	University of Michigan System; University of Michigan	NOGUEIRA, CP (corresponding author), UNIV MICHIGAN,SCH MED,DEPT PHARMACOL,M6322 MED SCI BLDG,ANN ARBOR,MI 48109, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM027028] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM27028] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGARWAL DP, 1976, HUM GENET, V32, P85, DOI 10.1007/BF00569981; ARNASON A, 1975, CLIN GENET, V7, P405; ARPAGAUS M, 1990, BIOCHEMISTRY-US, V29, P124, DOI 10.1021/bi00453a015; BATEMAN JF, 1989, J BIOL CHEM, V264, P10960; CHAN V, 1988, BLOOD, V72, P1420; DAS PK, 1973, HUM HERED, V23, P88, DOI 10.1159/000152559; ENDO H, 1989, AM J HUM GENET, V44, P358; EVANS RT, 1974, J MED GENET, V11, P117, DOI 10.1136/jmg.11.2.117; FARABAUGH PJ, 1978, J MOL BIOL, V126, P847, DOI 10.1016/0022-2836(78)90023-2; GOEDDE H. W., 1965, BIOCHIM BIOPHYS ACTA, V107, P391, DOI 10.1016/0304-4165(65)90149-2; GOEDDE HW, 1968, ANN NY ACAD SCI, V151, P540, DOI 10.1111/j.1749-6632.1968.tb11913.x; GOEDDE HW, 1979, HUM GENET S, V1, P45; GUTSCHE BB, 1967, NATURE, V215, P322, DOI 10.1038/215322b0; HARRIS H, 1961, NATURE, V191, P496, DOI 10.1038/191496a0; HARRIS H., 1960, ACTA GENET ET STATIST MED, V10, P1; HART SM, 1962, BRIT J ANAESTH, V34, P207, DOI 10.1093/bja/34.3.207; HODGKIN WE, 1965, J CLIN INVEST, V44, P486, DOI 10.1172/JCI105162; KALOW W, 1955, CAN J BIOCHEM PHYS, V33, P568; KALOW W, 1957, CAN J BIOCHEM PHYS, V35, P1305; KALOW W, 1957, CAN J BIOCHEM PHYS, V35, P339, DOI 10.1139/o57-041; KAZAZIAN HH, 1988, BLOOD, V72, P1107; KUNKEL TA, 1986, J BIOL CHEM, V261, P3581; LAURELL CB, 1966, ANAL BIOCHEM, V15, P45, DOI 10.1016/0003-2697(66)90246-6; LEHMANN H, 1956, LANCET, V2, P124; LIDDELL J, 1962, NATURE, V193, P561, DOI 10.1038/193561a0; LOCKRIDGE O, 1978, J BIOL CHEM, V253, P361; LUBIN AH, 1973, BIOCHEM MED METAB B, V8, P160, DOI 10.1016/0006-2944(73)90019-7; MANIATIS T, 1982, MOL CLONING LABORATO, P122; MCGUIRE MC, 1989, P NATL ACAD SCI USA, V86, P953, DOI 10.1073/pnas.86.3.953; MCTIERNAN C, 1987, P NATL ACAD SCI USA, V84, P6682, DOI 10.1073/pnas.84.19.6682; MIURA O, 1989, J CLIN INVEST, V83, P1598, DOI 10.1172/JCI114057; NUKIWA T, 1987, J BIOL CHEM, V262, P11999; OKADA Y, 1972, NATURE, V236, P338, DOI 10.1038/236338a0; PIHLAJANIEMI T, 1984, J BIOL CHEM, V259, P2941; PRODY CA, 1989, P NATL ACAD SCI USA, V86, P690, DOI 10.1073/pnas.86.2.690; RAO PR, 1979, HUM GENET, V52, P139; RUBINSTEIN H M, 1970, Journal of Clinical Investigation, V49, P479, DOI 10.1172/JCI106257; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCOTT EM, 1970, BIOCHEM BIOPH RES CO, V38, P902, DOI 10.1016/0006-291X(70)90806-5; SCOTT EM, 1973, ANN HUM GENET, V37, P139, DOI 10.1111/j.1469-1809.1973.tb01821.x; SCOTT EM, 1976, AM J HUM GENET, V28, P253; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; SIMPSON NE, 1968, ANN NY ACAD SCI, V151, P699; SIMPSON NE, 1964, AM J HUM GENET, V16, P180; STERN J, 1962, J MENT DEFIC RES, V6, P13; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014	47	59	59	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1990	46	5					934	942						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DD896	2339692				2022-12-18	WOS:A1990DD89600011
J	HANAUER, A; CHERY, M; FUJITA, R; DRIESEL, AJ; GILGENKRANTZ, S; MANDEL, JL				HANAUER, A; CHERY, M; FUJITA, R; DRIESEL, AJ; GILGENKRANTZ, S; MANDEL, JL			THE FRIEDREICH ATAXIA GENE IS ASSIGNED TO CHROMOSOME-9Q13-Q21 BY MAPPING OF TIGHTLY LINKED MARKERS AND SHOWS LINKAGE DISEQUILIBRIUM WITH D9S15	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									FAC MED STRASBOURG,INST CHIM BIOL,CNRS,GENET MOLEC EUCARYOTES LAB,INSERM,U184,11 RUE HUMANN,F-67085 STRASBOURG,FRANCE; CTR TRANSFUS SANGUINE,VANDOEUVRE NANCY,FRANCE; DECHEMA INST,FRANKFURT,GERMANY	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg				Fujita, Ricardo/0000-0002-9617-5109				BARBEAU A, 1984, CAN J NEUROL SCI, V11, P646, DOI 10.1017/S0317167100035228; CAMPANELLA G, 1980, CAN J NEUROL SCI, V7, P351, DOI 10.1017/S0317167100022873; CARLSON M, 1987, NUCLEIC ACIDS RES, V15, P10614, DOI 10.1093/nar/15.24.10614-a; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; CHAMBERLAIN S, 1989, AM J HUM GENET, V44, P518; CHAMBERLAIN S, 1988, NATURE, V334, P248, DOI 10.1038/334248a0; ESTIVILL X, 1987, NATURE, V326, P840, DOI 10.1038/326840a0; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FUJITA R, 1989, GENOMICS, V4, P110, DOI 10.1016/0888-7543(89)90323-6; GEOFFROY G, 1976, Canadian Journal of Neurological Sciences, V3, P279; HARPER ME, 1983, NATURE, V304, P169, DOI 10.1038/304169a0; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LATHROP GM, 1988, GENOMICS, V3, P361; MATTEI MG, 1985, HUM GENET, V69, P268, DOI 10.1007/BF00293038; OBERLE I, 1986, HUM GENET, V72, P43, DOI 10.1007/BF00278816; ORZECHOWSKI HDD, 1987, NUCLEIC ACIDS RES, V15, P610; PERRY P, 1974, NATURE, V251, P156, DOI 10.1038/251156a0; SKRE H, 1975, CLIN GENET, V7, P287; WINTER RM, 1981, CLIN GENET, V20, P419; YUNIS JJ, 1976, SCIENCE, V191, P1268, DOI 10.1126/science.1257746	20	59	60	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1990	46	1					133	137						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ043	2294745				2022-12-18	WOS:A1990CJ04300017
J	GUEGUEN, R; VISVIKIS, S; STEINMETZ, J; SIEST, G; BOERWINKLE, E				GUEGUEN, R; VISVIKIS, S; STEINMETZ, J; SIEST, G; BOERWINKLE, E			AN ANALYSIS OF GENOTYPE EFFECTS AND THEIR INTERACTIONS BY USING THE APOLIPOPROTEIN-E POLYMORPHISM AND LONGITUDINAL DATA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TEXAS, HLTH SCI CTR, CTR DEMOG & POPULAT GENET, POB 20334, HOUSTON, TX 77225 USA; CTR PREVENT MED, VANDOEUVRE LES NANCY, FRANCE	University of Texas System; University of Texas Health Science Center Houston			Visvikis-Siest, Sophie/H-2324-2014	Visvikis-Siest, Sophie/0000-0001-8104-8425; SIEST, Gerard/0000-0002-3001-760X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL040613] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-40613] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALLAIN CC, 1974, CLIN CHEM, V20, P470; ANGEL A, 1978, CAN MED ASSOC J, V119, P1401; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BOERWINKLE E, 1987, ANN HUM GENET, V51, P211, DOI 10.1111/j.1469-1809.1987.tb00874.x; BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x; BOERWINKLE E, 1988, AM J HUM GENET, V42, P104; BOERWINKLE E, 1989, P NATL ACAD SCI USA, V86, P212, DOI 10.1073/pnas.86.1.212; BOERWINKLE E, 1987, AM J MED GENET, V27, P567, DOI 10.1002/ajmg.1320270310; BOUTHILLIER D, 1983, J LIPID RES, V24, P1060; BURSTEIN M, 1959, Ann Biol Clin (Paris), V17, P23; CLARKE WR, 1978, CIRCULATION, V58, P626, DOI 10.1161/01.CIR.58.4.626; COOPER DN, 1988, HUM GENET, V78, P299, DOI 10.1007/BF00291724; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; EAVES L J, 1984, Genetic Epidemiology, V1, P215, DOI 10.1002/gepi.1370010302; ENOS WF, 1955, JAMA-J AM MED ASSOC, V158, P912, DOI 10.1001/jama.1955.02960110018005; ETO M, 1986, TOHOKU J EXP MED, V148, P25, DOI 10.1620/tjem.148.25; Fisher R., 1930, GENETICAL THEORY NAT; Fleiss JL, 1981, STAT METHODS RATES P; FUMERON F, 1988, CLIN GENET, V34, P258; GIANTURCO SH, 1983, J BIOL CHEM, V258, P4526; GREGG RE, 1986, J CLIN INVEST, V78, P815, DOI 10.1172/JCI112645; HANIS CL, 1983, AM J HUM GENET, V35, P1196; HOWARD BV, 1987, AM HEART J, V113, P522, DOI 10.1016/0002-8703(87)90625-9; HUI DY, 1984, J BIOL CHEM, V259, P860; ISELIUS L, 1988, QUANTITATIVE GENETIC, P341; JUDSON JJ, 1971, J AMER MED ASSOC, V216, P1185; KESANIEMI YA, 1983, ARTERIOSCLEROSIS, V3, P170, DOI 10.1161/01.ATV.3.2.170; KREISBERG RA, 1983, ANN INTERN MED, V99, P713, DOI 10.7326/0003-4819-99-5-713; MAHLEY RW, 1983, KLIN WOCHENSCHR, V61, P225, DOI 10.1007/BF01496128; MARTIN NG, 1987, AM J HUM GENET, V40, P267; MAUSNER JS, 1974, EPIDEMIOLOGY; NETER J, 1985, APPLIED LINEAR STATI; NIKKILA EA, 1971, SCAND J CLIN LAB INV, V27, P97, DOI 10.3109/00365517109080194; ORR JD, 1981, J CHRON DIS, V34, P545, DOI 10.1016/0021-9681(81)90017-5; SCHNEIDER WJ, 1981, J CLIN INVEST, V68, P1075, DOI 10.1172/JCI110330; SING CF, 1985, AM J HUM GENET, V37, P268; SOKAL RR, 1978, J CLIN CHEM CLIN BIO, V16, P613; TANNER JM, 1978, FETUS MAN PHYSICAL G; TEMPLETON AR, 1987, GENET RES, V49, P69, DOI 10.1017/S0016672300026756; TRINDER P, 1969, J CLIN PATHOL, V22, P246, DOI 10.1136/jcp.22.2.246-b; UTERMANN G, 1977, NATURE, V269, P604, DOI 10.1038/269604a0; Utermann G, 1985, DIABETES OBESITY HYP, P1; VISVIKIS SJ, UNPUB APOLIPOPROTEIN	43	59	60	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1989	45	5					793	802						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AZ049	2816943				2022-12-18	WOS:A1989AZ04900016
J	BURRI, BJ; SWEETMAN, L; NYHAN, WL				BURRI, BJ; SWEETMAN, L; NYHAN, WL			HETEROGENEITY OF HOLOCARBOXYLASE SYNTHETASE IN PATIENTS WITH BIOTIN-RESPONSIVE MULTIPLE CARBOXYLASE DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											BURRI, BJ (corresponding author), UNIV CALIF SAN DIEGO,DEPT PEDIAT,LA JOLLA,CA 92093, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD004608] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000827] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-00827] Funding Source: Medline; NICHD NIH HHS [HD04608] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BARTLETT K, 1980, CLIN CHIM ACTA, V100, P183, DOI 10.1016/0009-8981(80)90081-9; BARTLETT K, 1976, LANCET, V2, P804; BAUMGARTNER R, 1981, PEDIATR RES, V15, P1189; BAUMGARTNER R, 1982, ADV TREATMENT INBORN, P310; BURRI BJ, 1981, J CLIN INVEST, V68, P1491, DOI 10.1172/JCI110402; COWAN MJ, 1979, LANCET, V2, P115; GAUDRY M, 1983, LANCET, V2, P397; GHNEIM HK, 1982, LANCET, V1, P1187; GOMPERTZ D, 1971, LANCET, V2, P22; MUNNICH A, 1981, EUR J PEDIATR, V137, P203; PACKMAN S, 1981, J PEDIATR-US, V99, P418, DOI 10.1016/S0022-3476(81)80333-2; PACKMAN S, 1981, J PEDIATR-US, V99, P421, DOI 10.1016/S0022-3476(81)80334-4; PACKMAN S, 1984, AM J HUM GENET, V36, P80; PACKMAN S, 1982, LANCET, V1, P1435; ROTH K, 1976, J PEDIATR-US, V88, P229, DOI 10.1016/S0022-3476(76)80987-0; ROTH KS, 1982, PEDIATR RES, V16, P126, DOI 10.1203/00006450-198202000-00010; ROTH KS, 1980, J PEDIATR-US, V96, P845, DOI 10.1016/S0022-3476(80)80554-3; SAUNDERS M, 1979, J CLIN INVEST, V64, P1695, DOI 10.1172/JCI109632; SAUNDERS ME, 1982, AM J HUM GENET, V34, P590; SHERWOOD WG, 1982, J PEDIATR-US, V101, P546, DOI 10.1016/S0022-3476(82)80697-5; SWEETMAN L, 1977, PEDIATR RES, V11, P1144, DOI 10.1203/00006450-197711000-00006; SWEETMAN L, 1982, J INHERIT METAB DIS, V5, P49, DOI 10.1007/BF01799754; SWEETMAN L, 1981, J INHERIT METAB DIS, V4, P53, DOI 10.1007/BF02263587; THOENE J, 1983, LANCET, V2, P398; THOENE J, 1981, NEW ENGL J MED, V304, P817, DOI 10.1056/NEJM198104023041404; WEYLER W, 1977, CLIN CHIM ACTA, V76, P321, DOI 10.1016/0009-8981(77)90158-9; WILKINSON G, 1961, BIOCHEM J, V80, P324, DOI 10.1042/bj0800324; WOLF B, 1983, CLIN CHIM ACTA, V131, P273, DOI 10.1016/0009-8981(83)90096-7; WOLF B, 1983, NEW ENGL J MED, V308, P161; WOLF B, 1981, PEDIATRICS, V68, P113; WRIGHT LD, 1954, P SOC EXP BIOL MED, V86, P335	31	59	59	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	2					326	337						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AGY59	3920902				2022-12-18	WOS:A1985AGY5900007
J	ORTIGOZAFERADO, J; RICHTER, RJ; HORNUNG, SK; MOTULSKY, AG; FURLONG, CE				ORTIGOZAFERADO, J; RICHTER, RJ; HORNUNG, SK; MOTULSKY, AG; FURLONG, CE			PARAOXON HYDROLYSIS IN HUMAN-SERUM MEDIATED BY A GENETICALLY VARIABLE ARYLESTERASE AND ALBUMIN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT GENET,SEATTLE,WA 98195; UNIV WASHINGTON,CTR INHERITED DIS,SEATTLE,WA 98195	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM015253] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-15253] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOMAN H, 1976, CLIN GENET, V9, P513; CARROCIAMPI G, 1981, CAN J PHYSIOL PHARM, V59, P904, DOI 10.1139/y81-138; CASIDA JE, 1959, BIOCHIM BIOPHYS ACTA, V36, P411, DOI 10.1016/0006-3002(59)90184-2; DIRKS BM, 1951, CEREAL CHEM, V28, P483; ECKERSON HW, 1983, AM J HUM GENET, V35, P214; ECKERSON HW, 1981, FED PROC, V40, P724; EIBERG H, 1981, ANN HUM GENET, V45, P323, DOI 10.1111/j.1469-1809.1981.tb00345.x; ERDOES EG, 1961, NATURE, V190, P716, DOI 10.1038/190716a0; GELDMACHER V, 1969, ARCH TOXICOL BERL, V25, P223; GELDMACHER V, 1973, HUMANGENETIK, V19, P353; GELDMACHER V, 1979, HUM GENET, V50, P313; Geldmacher-von Mallinck, 1973, Humangenetik, V17, P331; HARRIS H, 1962, NATURE, V196, P1296, DOI 10.1038/1961296a0; KAPLAN A, 1967, CLIN CHEM, V11, P937; KITCHEN BJ, 1973, BIOCHEM J, V135, P93, DOI 10.1042/bj1350093; KRISCH K, 1968, Z KLIN CHEM KLIN BIO, V6, P41; MEANS GE, 1982, ADV CHEM SER, V198, P325; MULLER RF, 1983, AM J HUM GENET, V35, P393; PLAYFER JR, 1976, J MED GENET, V13, P337, DOI 10.1136/jmg.13.5.337; Taylor Ronald P, 1977, ALBUMIN STRUCTURE FU, P183; TOVE SB, 1962, BIOCHIM BIOPHYS ACTA, V57, P230, DOI 10.1016/0006-3002(62)91115-0; ZECH R, 1974, COMP BIOCHEM PHYSIOL, V48, P427, DOI 10.1016/0305-0491(74)90277-6	22	59	60	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	2					295	305						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SM324	6324579				2022-12-18	WOS:A1984SM32400004
J	YOSHIDA, A; WANG, G; DAVE, V				YOSHIDA, A; WANG, G; DAVE, V			DETERMINATION OF GENOTYPES OF HUMAN ALDEHYDE DEHYDROGENASE ALDH2 LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											YOSHIDA, A (corresponding author), CITY HOPE RES INST, DEPT BIOCHEM GENET, DUARTE, CA 91010 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL029515, R37HL029515] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-29515] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		CROW KE, 1974, BIOCHIM BIOPHYS ACTA, V350, P121, DOI 10.1016/0005-2744(74)90209-5; ECKFELDT J, 1976, J BIOL CHEM, V251, P236; ECKFELDT JH, 1976, ARCH BIOCHEM BIOPHYS, V175, P717, DOI 10.1016/0003-9861(76)90564-6; GOEDDE HW, 1980, ENZYME, V25, P281, DOI 10.1159/000459265; GOEDDE HW, 1979, HUM GENET, V51, P331; GREENFIELD NJ, 1977, BIOCHIM BIOPHYS ACTA, V483, P35, DOI 10.1016/0005-2744(77)90005-5; HARADA S, 1980, AM J HUM GENET, V32, P8; IKAWA M, 1983, J BIOL CHEM, V258, P6282; IMPRAIM C, 1982, AM J HUM GENET, V34, P837; KITABATAKE N, 1981, J BIOCHEM, V89, P1223; LAURELL CB, 1965, ANAL BIOCHEM, V10, P358, DOI 10.1016/0003-2697(65)90278-2; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MIZOI Y, 1979, PHARMACOL BIOCHEM BE, V10, P303, DOI 10.1016/0091-3057(79)90105-9; STAMATOYANNOPOULOS G, 1975, AM J HUM GENET, V27, P789; Stowell A, 1980, Adv Exp Med Biol, V132, P635; TENG YS, 1981, BIOCHEM GENET, V19, P107, DOI 10.1007/BF00486141; WASSERMAN E, 1961, J IMMUNOL, V87, P290; YOSHIDA A, 1982, JPN J HUM GENET, V27, P55, DOI 10.1007/BF01993894; YOSHIDA A, 1983, ISOZYMES-CURR T BIOL, V8, P245	19	59	60	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1983	35	6					1107	1116						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RU705	6650498				2022-12-18	WOS:A1983RU70500006
J	RAO, DC; KEATS, BJB; MORTON, NE; YEE, S; LEW, R				RAO, DC; KEATS, BJB; MORTON, NE; YEE, S; LEW, R			VARIABILITY OF HUMAN LINKAGE DATA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											RAO, DC (corresponding author), UNIV HAWAII,POPULAT GENET LAB,HONOLULU,HI 96822, USA.							BRANDTZAEG MERTON B, 1958, Acta Genet Stat Med, V8, P114; CHAUTARD.EA, 1974, ANN HUM GENET, V38, P191, DOI 10.1111/j.1469-1809.1974.tb01950.x; EDWARDS JH, 1974, HUMAN GENE MAPPING, P187; ELSTON RC, 1975, ANN HUM GENET, V38, P341, DOI 10.1111/j.1469-1809.1975.tb00619.x; Falk C T, 1975, Ser Haematol, V8, P153; FERGUSONSMITH MA, 1975, HUMAN GENE MAPPING, V2, P130; GEDDEDAHL T, 1975, ANN HUM GENET, V39, P43; Haldane JBS, 1940, BIOMETRIKA, V31, P346, DOI 10.1093/biomet/31.3-4.346; KEATS BJB, 1977, HUM GENET, V39, P157, DOI 10.1007/BF00287007; KEATS BJB, 1978, HUMAN GENE MAPPING, V4; KOMPF J, 1975, HUMANGENETIK, V28, P249, DOI 10.1007/BF00278552; MAYR WR, 1974, HUMANGENETIK, V24, P129; MCKUSICK VA, 1977, SCIENCE, V196, P390, DOI 10.1126/science.850784; MCKUSICK VA, 1975, HUMAN GENE MAPPING, V2, P26; METAXAS MN, 1959, VOX SANG, V4, P298; MOHR J, 1966, ACTA GENET STAT MED, V16, P1; MORTON NE, 1977, HUM HERED, V27, P38, DOI 10.1159/000152850; MORTON NE, 1964, COLD SPRING HARB SYM, V29, P69, DOI 10.1101/SQB.1964.029.01.012; MORTON NE, 1956, AM J HUM GENET, V8, P80; MORTON NE, 1955, AM J HUM GENET, V7, P277; OTT J, 1974, AM J HUM GENET, V26, P588; RAO DC, 1977, HUM HERED, V27, P99, DOI 10.1159/000152856; RENWICK JH, 1969, BRIT MED BULL, V25, P65, DOI 10.1093/oxfordjournals.bmb.a070673; SMITH CAB, 1957, ANN HUM GENET, V21, P254, DOI 10.1111/j.1469-1809.1972.tb00287.x; SMITH CAB, 1959, AM J HUM GENET, V11, P289; VANCONG N, 1971, ANN GENET, V14, P121; Wald A., 1947, SEQUENTIAL ANAL; WEITKAMP LR, 1974, HUMAN GENE MAPPING, P179; 1972, STANDARDIZATION HUMA	29	59	59	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1978	30	5					516	529						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GA288	736040				2022-12-18	WOS:A1978GA28800005
J	BACH, G; ZIEGLER, M; KOHN, G; COHEN, MM				BACH, G; ZIEGLER, M; KOHN, G; COHEN, MM			MUCOPOLYSACCHARIDE ACCUMULATION IN CULTURED SKIN FIBROBLASTS DERIVED FROM PATIENTS WITH MUCOLIPIDOSIS-IV	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HADASSAH UNIV,SCH MED,DEPT HUMAN GENET,JERUSALEM,ISRAEL	Hebrew University of Jerusalem; Hadassah University Medical Center								BACH G, 1975, BIOCHEM BIOPH RES CO, V66, P1483, DOI 10.1016/0006-291X(75)90526-4; BACH G, 1971, BIOCHIM BIOPHYS ACTA, V252, P453, DOI 10.1016/0304-4165(71)90148-6; BERMAN ER, 1974, J PEDIATR-US, V84, P519, DOI 10.1016/S0022-3476(74)80671-2; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; DODGSON KS, 1961, BIOCHEM J, V78, P312, DOI 10.1042/bj0780312; Elson LA, 1933, BIOCHEM J, V27, P1824, DOI 10.1042/bj0271824; ENDO M, 1975, ANAL BIOCHEM, V65, P537, DOI 10.1016/0003-2697(75)90539-4; FRANTANTONI JC, 1968, P NATL ACAD SCI USA, V60, P699; GATT R, 1966, ANAL BIOCHEM, V15, P167, DOI 10.1016/0003-2697(66)90262-4; HIEBER U, 1975, DISORDERS CONNECTIVE, P307; KELLY TE, 1975, JOHNS HOPKINS MED J, V137, P156; KOHN G, 1977, J PEDIATR-US, V90, P62, DOI 10.1016/S0022-3476(77)80765-8; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MERIN S, 1975, INVEST OPHTH VISUAL, V14, P437; NEUFELD EF, 1975, ANNU REV BIOCHEM, V44, P357, DOI 10.1146/annurev.bi.44.070175.002041; NEWELL FW, 1975, AM J OPHTHALMOL, V80, P440, DOI 10.1016/0002-9394(75)90532-2; OHYA T, 1970, BIOCHIM BIOPHYS ACTA, V198, P607, DOI 10.1016/0005-2744(70)90139-7; SPRANGER JW, 1970, HUMANGENETIK, V9, P113, DOI 10.1007/BF00278928; TELLEZNAGEL I, 1976, ARCH NEUROL-CHICAGO, V33, P828, DOI 10.1001/archneur.1976.00500120032005	19	59	59	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1977	29	6					610	618						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EC270	145180				2022-12-18	WOS:A1977EC27000009
J	RATTAZZI, MC; MARKS, JS; DAVIDSON, RG				RATTAZZI, MC; MARKS, JS; DAVIDSON, RG			ELECTROPHORESIS OF ARYLSULFATASE FROM NORMAL INDIVIDUALS AND PATIENTS WITH METACHROMATIC LEUKODYSTROPHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									SUNY, DEPT PEDIAT, DIV HUMAN GENET, BUFFALO, NY 14222 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; SUNY Maritime College								AUSTIN J, 1965, ARCH NEUROL-CHICAGO, V13, P593, DOI 10.1001/archneur.1965.00470060029003; BAUM H, 1959, CLIN CHIM ACTA, V4, P453, DOI 10.1016/0009-8981(59)90119-6; BRADY RO, 1970, BIOCHIM BIOPHYS ACTA, V210, P193, DOI 10.1016/0005-2760(70)90079-2; DODGSON KS, 1956, BIOCHEM J, V62, P500, DOI 10.1042/bj0620500; HARINATH BC, 1971, J NEUROCHEM, V18, P237, DOI 10.1111/j.1471-4159.1971.tb00562.x; HARINATH BC, 1971, J NEUROCHEM, V18, P245, DOI 10.1111/j.1471-4159.1971.tb00563.x; JATZKEWITZ M, 1969, J NEUROCHEM, V16, P19; MEHL E, 1968, BIOCHIM BIOPHYS ACTA, V151, P619, DOI 10.1016/0005-2744(68)90008-9; MEHL E, 1965, BIOCHEM BIOPH RES CO, V19, P407, DOI 10.1016/0006-291X(65)90137-3; MILSOM DW, 1968, BIOCHEM J, V109, pP40; MURPHY JV, 1971, LIPID STORAGE DISEAS; OBRIEN JS, 1965, SCIENCE, V150, P1613, DOI 10.1126/science.150.3703.1613; PEIFFER J, 1970, HDB CLINICAL NEUROLO, V10; PERCY AK, 1968, SCIENCE, V161, P594, DOI 10.1126/science.161.3841.594; PERCY AK, 1971, NEW ENGL J MED, V285, P785, DOI 10.1056/NEJM197109302851407; PORTER MT, 1971, BIOCHEM BIOPH RES CO, V44, P660, DOI 10.1016/S0006-291X(71)80134-1; RINDERKN.H, 1970, CLIN CHIM ACTA, V29, P481, DOI 10.1016/0009-8981(70)90019-7; ROY AB, 1958, BIOCHEM J, V68, P519, DOI 10.1042/bj0680519; SHERMAN WR, 1967, BIOCHEM J, V102, P905, DOI 10.1042/bj1020905; STUMPF D, 1971, ARCH NEUROL-CHICAGO, V24, P117, DOI 10.1001/archneur.1971.00480320045004; STUMPF DA, 1971, LIPID STORAGE DISEAS; SUZUKI Y, 1971, SCIENCE, V171, P73, DOI 10.1126/science.171.3966.73; VIALA R, 1955, CAN J BIOCHEM PHYS, V33, P839	23	59	59	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1973	25	3					310	316						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	P9182	4704863				2022-12-18	WOS:A1973P918200011
J	FREIREMAIA, N				FREIREMAIA, N			A NEWLY RECOGNIZED GENETIC SYNDROME OF TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, AND OTHER ABNORMALITIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		AZEVEDO E, 1969, AM J HUM GENET, V21, P1; CHAUTARD EA, IN PRESS; FREIREMAIA N, 1957, AM J HUM GENET, V9, P284; FREIREMAIA N, IN PRESS; FREIREMAIA N, 1969, 1 C CLIN DEL BIRTH D; FREIREMAIA N, 1969, CIENC CULT S PAULO, V21, P280; MEHL NM, IN PRESS; YASUDA N, 1966, THESIS U HAWAII	8	59	59	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1970	22	4					370	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	H0227	5432287				2022-12-18	WOS:A1970H022700002
J	VOS, GH; STEINBERG, AG; KIRK, RL				VOS, GH; STEINBERG, AG; KIRK, RL			DISTRIBUTION OF GAMMA GLOBULIN TYPES GM(A), GM(B), GM(X), AND GM-LIKE IN SOUTH AND SOUTHEAST ASIA AND AUSTRALIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		KIRK RL, 1961, ACTA GENET STAT MED, V11, P97; KIRK RL, 1962, AMER J PHYS ANTHROP; ROPARTZ C, 1961, REV FR ETUD CLIN BIO, V6, P813; ROPARTZ C, 1962, NOUV REV FR HEMATOL, V2, P86; ROPARTZ C, 1962, GM INV CHEZ IRANIENS; ROPARTZ C, 1962, GM INV FACTORS; ROPARTZ C, 1962, ESTIMATION TAUX METI; STEINBERG A, 1961, AM J HUM GENET, V13, P205; STEINBERG A, 1961, AM J HUM GENET, V13, P355; STEINBERG AG, 1962, MEDICAL GENETICS, V2; VOS GH, 1961, NATURE, V189, P321, DOI 10.1038/189321a0	11	59	59	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1963	15	1					44	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2969A	13997934				2022-12-18	WOS:A19632969A00014
J	Kraja, AT; Liu, CY; Fetterman, JL; Graff, M; Have, CT; Gu, C; Yanek, LR; Feitosa, MF; Arking, DE; Chasman, DI; Young, K; Ligthart, S; Hill, WD; Weiss, S; Luan, JA; Giulianini, F; Li-Gao, RF; Hartwig, FP; Lin, SJ; Wang, LH; Richardson, TG; Yao, J; Fernandez, EP; Ghanbari, M; Wojczynski, MK; Lee, WJ; Argos, M; Armasu, SM; Barve, RA; Ryan, KA; An, P; Baranski, TJ; Bielinski, SJ; Bowden, DW; Broeckel, U; Christensen, K; Chu, AY; Corley, J; Cox, SR; Uitterlinden, AG; Rivadeneira, F; Cropp, CD; Daw, EW; van Heemst, D; de las Fuentes, L; Gao, H; Tzoulaki, I; Ahluwalia, TS; de Mutsert, R; Emery, LS; Erzurumluoglu, AM; Perry, JA; Fu, M; Forouhi, NG; Gu, ZL; Hai, Y; Harris, SE; Hemani, G; Hunt, SC; Irvin, MR; Jonsson, AE; Justice, AE; Kernson, ND; Larson, NB; Lin, KH; Love-Gregory, LD; Mathias, RA; Lee, JH; Nauck, M; Noordam, R; Ong, KK; Pankow, J; Patki, A; Pattie, A; Petersmann, A; Qi, QB; Ribel-Madsen, R; Rohde, R; Sandow, K; Schnurr, TM; Sofer, T; Starr, JM; Taylor, AM; Teumer, A; Timpson, NJ; de Haan, HG; Wang, YJ; Weeke, PE; Williams, C; Wu, HS; Yang, W; Zeng, DL; Witte, DR; Weir, BS; Wareham, NJ; Vestergaard, H; Turner, ST; Torp-Pedersen, C; Stergiakouli, E; Sheu, WHH; Rosendaal, FR; Ikram, MA; Franco, OH; Ridker, PM; Perls, TT; Pedersen, O; Nohr, EA; Newman, AB; Linneberg, A; Langenberg, C; Kilpelainen, TO; Kardia, SLR; Jorgensen, ME; Jorgensen, T; Sorensen, TIA; Homuth, G; Hansen, T; Goodarzi, MO; Deary, IJ; Christensen, C; Chen, YDI; Chakravarti, A; Brandslund, I; Bonnelykke, K; Taylor, KD; Wilson, JG; Rodriguez, S; Davies, G; Horta, BL; Thyagarajan, B; Rao, DC; Grarup, N; Davila-Roman, VG; Hudson, G; Guo, XQ; Arnett, DK; Hayward, C; Vaidya, D; Mook-Kanamori, DO; Tiwari, HK; Levy, D; Loos, RJF; Dehghan, A; Elliott, P; Malik, AN; Scott, RA; Becker, DM; de Andrade, M; Province, MA; Meigs, JB; Rotter, JI; North, KE				Kraja, Aldi T.; Liu, Chunyu; Fetterman, Jessica L.; Graff, Mariaelisa; Have, Christian Theil; Gu, Charles; Yanek, Lisa R.; Feitosa, Mary F.; Arking, Dan E.; Chasman, Daniel, I; Young, Kristin; Ligthart, Symen; Hill, W. David; Weiss, Stefan; Luan, Jian'an; Giulianini, Franco; Li-Gao, Ruifang; Hartwig, Fernando P.; Lin, Shiow J.; Wang, Lihua; Richardson, Tom G.; Yao, Jie; Fernandez, Eliana P.; Ghanbari, Mohsen; Wojczynski, Mary K.; Lee, Wen-Jane; Argos, Maria; Armasu, Sebastian M.; Barve, Ruteja A.; Ryan, Kathleen A.; An, Ping; Baranski, Thomas J.; Bielinski, Suzette J.; Bowden, Donald W.; Broeckel, Ulrich; Christensen, Kaare; Chu, Audrey Y.; Corley, Janie; Cox, Simon R.; Uitterlinden, Andre G.; Rivadeneira, Fernando; Cropp, Cheryl D.; Daw, E. Warwick; van Heemst, Diana; de las Fuentes, Lisa; Gao, He; Tzoulaki, Ioanna; Ahluwalia, Tarunveer S.; de Mutsert, Renee; Emery, Leslie S.; Erzurumluoglu, A. Mesut; Perry, James A.; Fu, Mao; Forouhi, Nita G.; Gu, Zhenglong; Hai, Yang; Harris, Sarah E.; Hemani, Gibran; Hunt, Steven C.; Irvin, Marguerite R.; Jonsson, Anna E.; Justice, Anne E.; Kernson, Nicola D.; Larson, Nicholas B.; Lin, Keng-Hung; Love-Gregory, Latisha D.; Mathias, Rasika A.; Lee, Joseph H.; Nauck, Matthias; Noordam, Raymond; Ong, Ken K.; Pankow, James; Patki, Amit; Pattie, Alison; Petersmann, Astrid; Qi, Qibin; Ribel-Madsen, Rasmus; Rohde, Rebecca; Sandow, Kevin; Schnurr, Theresia M.; Sofer, Tamar; Starr, John M.; Taylor, Adele M.; Teumer, Alexander; Timpson, Nicholas J.; de Haan, Hugoline G.; Wang, Yujie; Weeke, Peter E.; Williams, Christine; Wu, Hongsheng; Yang, Wei; Zeng, Donglin; Witte, Daniel R.; Weir, Bruce S.; Wareham, Nicholas J.; Vestergaard, Henrik; Turner, Stephen T.; Torp-Pedersen, Christian; Stergiakouli, Evie; Sheu, Wayne Huey-Hemg; Rosendaal, Frits R.; Ikram, M. Arfan; Franco, Oscar H.; Ridker, Paul M.; Perls, Thomas T.; Pedersen, Oluf; Nohr, Ellen A.; Newman, Anne B.; Linneberg, Allan; Langenberg, Claudia; Kilpelainen, Tuomas O.; Kardia, Sharon L. R.; Jorgensen, Marit E.; Jorgensen, Torben; Sorensen, Thorkild I. A.; Homuth, Georg; Hansen, Torben; Goodarzi, Mark O.; Deary, Ian J.; Christensen, Cramer; Chen, Yii-Der Ida; Chakravarti, Aravinda; Brandslund, Ivan; Bonnelykke, Klaus; Taylor, Kent D.; Wilson, James G.; Rodriguez, Santiago; Davies, Gail; Horta, Bernardo L.; Thyagarajan, Bharat; Rao, D. C.; Grarup, Niels; Davila-Roman, Victor G.; Hudson, Gavin; Guo, Xiuqing; Arnett, Donna K.; Hayward, Caroline; Vaidya, Dhananjay; Mook-Kanamori, Dennis O.; Tiwari, Hemant K.; Levy, Daniel; Loos, Ruth J. F.; Dehghan, Abbas; Elliott, Paul; Malik, Afshan N.; Scott, Robert A.; Becker, Diane M.; de Andrade, Mariza; Province, Michael A.; Meigs, James B.; Rotter, Jerome, I; North, Kari E.			Associations of Mitochondrial and Nuclear Mitochondrial Variants and Genes with Seven Metabolic Traits	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; DNA COPY NUMBER; SUSCEPTIBILITY LOCI; ATHEROSCLEROSIS RISK; INDIVIDUALS REVEAL; PERIPHERAL-BLOOD; COMMON VARIANTS; GLYCEMIC TRAITS; ADIPOSE-TISSUE	Mitochondria (MT), the major site of cellular energy production, are under dual genetic control by 37 mitochondrial DNA (mtDNA) genes and numerous nuclear genes (MT-nDNA). In the CHARGEmtDNA+ Consortium, we studied genetic associations of mtDNA and MT-nDNA associations with body mass index (BMI), waist-hip-ratio (WHR), glucose, insulin, HOMA-B, HOMA-IR, and HbA1c. This 45-cohort collaboration comprised 70,775 (insulin) to 170,202 (BMI) pan-ancestry individuals. Validation and imputation of mtDNA variants was followed by single-variant and gene-based association testing. We report two significant common variants, one in MT-ATP6 associated (p <= 5E-04) with WHR and one in the D-loop with glucose. Five rare variants in MT-ATP6, MT-ND5, and MT-ND6 associated with BMI, WHR, or insulin. Gene-based meta-analysis identified MT-ND3 associated with BMI (p <= 1E-03). We considered 2,282 MT-nDNA candidate gene associations compiled from online summary results for our traits (20 unique studies with 31 dataset consortia's genome-wide associations [GWASs]). Of these, 109 genes associated (p <= 1E-06) with at least 1 of our 7 traits. We assessed regulatory features of variants in the 109 genes, cis- and trans-gene expression regulation, and performed enrichment and protein-protein interactions analyses. Of the identified mtDNA and MT-nDNA genes, 79 associated with adipose measures, 49 with glucose/insulin, 13 with risk for type 2 diabetes, and 18 with cardiovascular disease, indicating for pleiotropic effects with health implications. Additionally, 21 genes related to cholesterol, suggesting additional important roles for the genes identified. Our results suggest that mtDNA and MT-nDNA genes and variants reported make important contributions to glucose and insulin metabolism, adipocyte regulation, diabetes, and cardiovascular disease.	[Kraja, Aldi T.; Feitosa, Mary F.; Lin, Shiow J.; Wang, Lihua; Wojczynski, Mary K.; An, Ping; Daw, E. Warwick; Williams, Christine; Province, Michael A.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, Dept Genet,Div Stat Genom, St Louis, MO 63110 USA; [Liu, Chunyu] Boston Univ, Dept Biostat, Sch Publ Hlth, Boston, MA 02118 USA; [Fetterman, Jessica L.] Boston Univ, Sch Med, Evans Dept Med, Boston, MA 02118 USA; [Fetterman, Jessica L.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Graff, Mariaelisa; Young, Kristin; Justice, Anne E.; Rohde, Rebecca; Wang, Yujie; North, Kari E.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27516 USA; [Have, Christian Theil; Jonsson, Anna E.; Ribel-Madsen, Rasmus; Schnurr, Theresia M.; Vestergaard, Henrik; Pedersen, Oluf; Kilpelainen, Tuomas O.; Hansen, Torben; Grarup, Niels] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nord Fdn Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark; [Gu, Charles; Rao, D. C.] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Yanek, Lisa R.; Mathias, Rasika A.; Vaidya, Dhananjay; Becker, Diane M.] Johns Hopkins Univ, Sch Med, Dept Med, Div Gen Internal Med,GeneSTAR Res Program, Baltimore, MD 21287 USA; [Arking, Dan E.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Chasman, Daniel, I; Giulianini, Franco; Chu, Audrey Y.; Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, 75 Francis St, Boston, MA 02115 USA; [Chasman, Daniel, I; Ridker, Paul M.] Harvard Med Sch, Boston, MA 02115 USA; [Ligthart, Symen; Fernandez, Eliana P.; Ghanbari, Mohsen; Ikram, M. Arfan; Franco, Oscar H.] Erasmus Univ, Dept Epidemiol, Med Ctr, NL-3015 CE Rotterdam, Netherlands; [Hill, W. David; Corley, Janie; Cox, Simon R.; Pattie, Alison; Starr, John M.; Taylor, Adele M.; Deary, Ian J.; Davies, Gail] Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Weiss, Stefan; Homuth, Georg] Univ Med, Interfac Inst Genet & Funct Genom, D-17475 Greifswald, Germany; [Weiss, Stefan; Homuth, Georg] Ernst Moritz Arndt Univ Greifswald, D-17475 Greifswald, Germany; [Luan, Jian'an; Forouhi, Nita G.; Kernson, Nicola D.; Ong, Ken K.; Wareham, Nicholas J.; Langenberg, Claudia; Scott, Robert A.] Univ Cambridge, MRC Epidemiol Unit, Sch Clin Med, Cambridge CB2 0QQ, England; [Li-Gao, Ruifang; de Mutsert, Renee; de Haan, Hugoline G.; Rosendaal, Frits R.; Mook-Kanamori, Dennis O.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2333 ZA Leiden, Netherlands; [Hartwig, Fernando P.; Horta, Bernardo L.] Univ Fed Pelotas, Postgrad Program Epidemiol, BR-96020220 Pelotas, Brazil; [Hartwig, Fernando P.; Richardson, Tom G.; Hemani, Gibran; Timpson, Nicholas J.; Stergiakouli, Evie; Rodriguez, Santiago] Univ Bristol, MRC Integrat Epidemiol Unit IEU, Populat Hlth Sci, Bristol BS8 2BN, Avon, England; [Yao, Jie; Hai, Yang; Sandow, Kevin; Chen, Yii-Der Ida; Taylor, Kent D.; Guo, Xiuqing; Rotter, Jerome, I] Harbor UCLA Med Ctr, Inst Translat Genom & Populat Sci, LABioMed, Torrance, CA 90502 USA; [Yao, Jie; Hai, Yang; Sandow, Kevin; Chen, Yii-Der Ida; Taylor, Kent D.; Guo, Xiuqing; Rotter, Jerome, I] Harbor UCLA Med Ctr, Dept Pediat, Torrance, CA 90502 USA; [Lee, Wen-Jane] Taichung Vet Gen Hosp, Dept Med Res, Taichung 407, Taiwan; [Lee, Wen-Jane] Tunghai Univ, Dept Social Work, Taichung 407, Taiwan; [Argos, Maria] Univ Illinois, Dept Epidemiol & Biostat, Chicago, IL 60612 USA; [Armasu, Sebastian M.; de Andrade, Mariza] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [Barve, Ruteja A.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Ryan, Kathleen A.; Perry, James A.; Fu, Mao] Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Ryan, Kathleen A.; Perry, James A.; Fu, Mao] Univ Maryland, Sch Med, Program Personalized & Genom Med, Baltimore, MD 21201 USA; [Baranski, Thomas J.] Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA; [Bielinski, Suzette J.; Larson, Nicholas B.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Bowden, Donald W.] Wake Forest Sch Med, Ctr Diabet Res, Cincinnati, OH 45206 USA; [Broeckel, Ulrich] Med Coll Wisconsin, Human & Mol Genet Ctr, Milwaukee, WI 53226 USA; [Christensen, Kaare] Univ Southern Denmark, Danish Aging Res Ctr, DK-5000 Odense, Denmark; [Uitterlinden, Andre G.; Rivadeneira, Fernando] Erasmus MC, Dept Internal Med, NL-3000 CA Rotterdam, Netherlands; [Cropp, Cheryl D.] Samford Univ, McWhorter Sch Pharm, Birmingham, AL USA; [Cropp, Cheryl D.] Translat Genom Res Inst TGen, Phoenix, AZ USA; [van Heemst, Diana; Noordam, Raymond] Leiden Univ, Med Ctr, Sect Gerontol & Geriatr, Dept Internal Med, NL-2333 ZA Leiden, Netherlands; [de las Fuentes, Lisa; Davila-Roman, Victor G.] Washington Univ, Sch Med, Dept Med, Cardiovasc Div, St Louis, MO 63110 USA; [Gao, He; Tzoulaki, Ioanna; Dehghan, Abbas; Elliott, Paul] Imperial Coll London, Sch Publ Hlth, MRC PHE Ctr Environm & Hlth, Dept Biostat & Epidemiol, London W2 1PG, England; [Tzoulaki, Ioanna] Univ Ioannina, Dept Hyg & Epidemiol, Ioannina 45110, Greece; [Ahluwalia, Tarunveer S.; Vestergaard, Henrik; Jorgensen, Marit E.] Steno Diabet Ctr Copenhagen, DK-2820 Copenhagen, Denmark; [Emery, Leslie S.; Sofer, Tamar; Weir, Bruce S.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Erzurumluoglu, A. Mesut] Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England; [Gu, Zhenglong] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Harris, Sarah E.] Univ Edinburgh, Med Genet Sect, Ctr Genom & Expt Med, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh EH4 2XU, Midlothian, Scotland; [Hunt, Steven C.] Univ Utah, Dept Internal Med, Salt Lake City, UT 84132 USA; [Hunt, Steven C.] Weill Cornell Med, Dept Genet Med, POB 24144, Doha, Qatar; [Irvin, Marguerite R.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; [Justice, Anne E.] Geisinger Hlth, Biomed & Translat Informat, Danville, PA 17822 USA; [Lin, Keng-Hung] Taichung Vet Gen Hosp, Dept Ophthalmol, Taichung 407, Taiwan; [Love-Gregory, Latisha D.] Washington Univ, Sch Med, Dept Pathol & Immunol, Genom & Pathol Serv, St Louis, MO 63110 USA; [Mathias, Rasika A.] Johns Hopkins Univ, Sch Med, Dept Med, GeneSTAR Res Program,Div Allergy, Baltimore, MD 21287 USA; [Mathias, Rasika A.] Johns Hopkins Univ, Sch Med, Dept Med, GeneSTAR Res Program,Div Clin Immunol, Baltimore, MD 21287 USA; [Lee, Joseph H.] Columbia Univ, Med Ctr, Taub Inst Res Alzheimer Dis & Aging Brain, New York, NY 10032 USA; [Nauck, Matthias; Petersmann, Astrid] Univ Med Greifswald, Inst Clin Chem & Lab Med, D-17475 Greifswald, Germany; [Pankow, James] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA; [Patki, Amit; Tiwari, Hemant K.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Biostat, Birmingham, AL 35294 USA; [Qi, Qibin] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA; [Ribel-Madsen, Rasmus] Copenhagen Univ Hosp, Dept Endocrinol Diabet & Metab, Rigshosp, DK-2100 Copenhagen, Denmark; [Ribel-Madsen, Rasmus] Danish Diabet Acad, DK-5000 Odense, Denmark; [Sofer, Tamar; Meigs, James B.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Starr, John M.] Univ Edinburgh, Alzheimer Scotland Dementia Res Ctr, Edinburgh EH8 9JZ, Midlothian, Scotland; [Teumer, Alexander] Univ Med Greifswald, Inst Community Med, D-17475 Greifswald, Germany; [Weeke, Peter E.] Univ Copenhagen, Rigshosp, Heart Ctr, Dept Cardiol, DK-2100 Copenhagen, Denmark; [Wu, Hongsheng] Wentworth Inst Technol, Comp Sci & Networking, Boston, MA 02115 USA; [Yang, Wei] Washington Univ, Sch Med, Genome Technol Access Ctr, St Louis, MO 63110 USA; [Zeng, Donglin] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA; [Witte, Daniel R.] Odense Univ Hosp, Danish Diabet Acad, Aarhus Univ, Sect Epidemiol,Dept Publ Hlth, DK-5000 Odense, Denmark; [Turner, Stephen T.] Mayo Clin, Dept Cardiovasc Dis, Div Nephrol & Hypertens, Rochester, MN 55902 USA; [Torp-Pedersen, Christian] Aalborg Univ Hosp, Dept Hlth Sci & Technol, DK-9220 Aalborg, Denmark; [Sheu, Wayne Huey-Hemg] Taichung Vet Gen Hosp, Dept Internal Med, Div Endocrinol & Metab, Taichung 407, Taiwan; [Sheu, Wayne Huey-Hemg] Natl Chung Hsing Univ, Inst Med Technol, Taichung 402, Taiwan; [Sheu, Wayne Huey-Hemg] Natl Def Med Ctr, Sch Med, Taipei 114, Taiwan; [Sheu, Wayne Huey-Hemg] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Franco, Oscar H.] Univ Bern, ISPM, CH-3012 Bern, Switzerland; [Perls, Thomas T.] Boston Univ, Sch Med, Geriatr Sect, Dept Med, Boston, MA 02118 USA; [Perls, Thomas T.] Boston Med Ctr, Boston, MA 02118 USA; [Nohr, Ellen A.] Univ Southern Denmark, Dept Clin Res, Res Unit Gynecol & Obstet, DK-5000 Odense, Denmark; [Newman, Anne B.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Linneberg, Allan] Rigshosp, Dept Clin Expt Res, DK-2200 Copenhagen, Denmark; [Linneberg, Allan] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, DK-2200 Copenhagen, Denmark; [Linneberg, Allan] Bispebjerg & Frederiksberg Hosp, Ctr Clin Res & Prevent, DK-2000 Copenhagen, The Capital Reg, Denmark; [Kardia, Sharon L. R.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Jorgensen, Torben] Glostrup Cty Hosp, Res Ctr Prevent & Hlth, DK-2600 Glostrup, Denmark; [Jorgensen, Torben] Univ Copenhagen, Fac Hlth Sci, Dept Publ Hlth, DK-1014 Copenhagen, Denmark; [Jorgensen, Torben] Aalborg Univ, Fac Med, DK-9100 Aalborg, Denmark; [Sorensen, Thorkild I. A.] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Genet, DK-2200 Copenhagen N, Denmark; [Sorensen, Thorkild I. A.] Univ Copenhagen, Fac Hlth & Med Sci, Sect Epidemiol, Dept Publ Hlth, DK-2200 Copenhagen N, Denmark; [Goodarzi, Mark O.] Cedars Sinai Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Los Angeles, CA 90048 USA; [Christensen, Cramer] Vejle Lillebaelt Hosp, Sect Endocrinol, Dept Internal Med, DK-7100 Vejle, Denmark; [Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, Ctr Complex Dis Genom, Baltimore, MD 21205 USA; [Brandslund, Ivan] Vejle Hosp, Dept Clin Biochem, DK-7100 Vejle, Denmark; [Brandslund, Ivan] Univ Southern Denmark, Inst Reg Hlth Res, DK-5000 Odense C, Denmark; [Bonnelykke, Klaus] Copenhagen Univ Hosp, Copenhagen Prospect Studies Asthma Childhood, DK-2820 Gentofte, Denmark; [Bonnelykke, Klaus] Copenhagen Univ Hosp, Copenhagen Prospect Studies Asthma Childhood, DK-2820 Naestved, Denmark; [Bonnelykke, Klaus] Univ Copenhagen, Hlth Sci, DK-2200 Copenhagen, Denmark; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA; [Thyagarajan, Bharat] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Hudson, Gavin] Newcastle Univ, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Arnett, Donna K.] Univ Kentucky, Coll Publ Hlth, Lexington, KY 40508 USA; [Hayward, Caroline] Univ Edinburgh, Inst Genet & Mol Med, Western Gen Hosp, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Mook-Kanamori, Dennis O.] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, NL-2333 ZA Leiden, Netherlands; [Levy, Daniel] Framingham Heart Dis Epidemiol Study, Framingham, MA USA; [Levy, Daniel] NHLBI, Populat Sci Branch, NIH, Bethesda, MD 20892 USA; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Genet Obes & Related Traits Program, New York, NY 10029 USA; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA; [Malik, Afshan N.] Kings Coll London, Dept Diabet, Sch Life Course, Fac Life Sci & Med, London SE1 1NN, England; [Meigs, James B.] Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA; [Meigs, James B.] Brd Inst, Program Med & Populat Genet, Boston, MA 02142 USA	Washington University (WUSTL); Boston University; Boston University; Boston University; University of North Carolina; University of North Carolina Chapel Hill; University of Copenhagen; Washington University (WUSTL); Johns Hopkins University; Johns Hopkins University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Erasmus University Rotterdam; Erasmus MC; University of Edinburgh; Ernst Moritz Arndt Universitat Greifswald; University of Cambridge; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Universidade Federal de Pelotas; University of Bristol; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Taichung Veterans General Hospital; Tunghai University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Mayo Clinic; Washington University (WUSTL); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Washington University (WUSTL); Mayo Clinic; Medical College of Wisconsin; University of Southern Denmark; Erasmus University Rotterdam; Erasmus MC; Samford University; Translational Genomics Research Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Washington University (WUSTL); Imperial College London; University of Ioannina; Steno Diabetes Center; University of Washington; University of Washington Seattle; University of Leicester; Cornell University; University of Edinburgh; Utah System of Higher Education; University of Utah; Qatar Foundation (QF); Weill Cornell Medical College Qatar; University of Alabama System; University of Alabama Birmingham; Taichung Veterans General Hospital; Washington University (WUSTL); Johns Hopkins University; Johns Hopkins University; Columbia University; Greifswald Medical School; University of Minnesota System; University of Minnesota Twin Cities; University of Alabama System; University of Alabama Birmingham; Yeshiva University; Albert Einstein College of Medicine; Rigshospitalet; University of Copenhagen; Harvard University; Harvard Medical School; University of Edinburgh; Greifswald Medical School; Rigshospitalet; University of Copenhagen; Washington University (WUSTL); University of North Carolina; University of North Carolina Chapel Hill; Aarhus University; University of Southern Denmark; Odense University Hospital; Mayo Clinic; Aalborg University; Aalborg University Hospital; Taichung Veterans General Hospital; National Chung Hsing University; National Defense Medical Center; National Yang Ming Chiao Tung University; University of Bern; Boston University; Boston Medical Center; University of Southern Denmark; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Michigan System; University of Michigan; University of Copenhagen; University of Copenhagen; Aalborg University; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; Cedars Sinai Medical Center; Johns Hopkins University; University of Southern Denmark; Lillebaelt Hospital; University of Southern Denmark; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Mississippi; University of Mississippi Medical Center; University of Minnesota System; University of Minnesota Twin Cities; Newcastle University - UK; University of Kentucky; University of Edinburgh; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of London; King's College London; Harvard University; Massachusetts General Hospital	Kraja, AT (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, Dept Genet,Div Stat Genom, St Louis, MO 63110 USA.; North, KE (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27516 USA.	aldikraja@wustl.edu; kari_north@unc.edu	Erzurumluoglu, A Mesut/E-4445-2018; Teumer, Alexander/S-7438-2019; Turner, Stephen/GXM-4654-2022; Li-Gao, Ruifang/B-7172-2018; Franco, Óscar H/ABE-2305-2020; Dina, Christian R/D-3535-2015; Lee, Joseph H/D-2441-2012; Yang, Wei/H-4749-2019; Rivadeneira, Fernando/O-5385-2015; Kilpeläinen, Tuomas/F-8569-2012; Feitosa, Mary F/K-8044-2012; Pedersen, Oluf/AAG-8015-2020; Cox, Simon R./HDN-8568-2022; Ghanbari, Mohsen/AAH-1340-2020; Tzoulaki, Ioanna/ABE-6269-2020; Meigs, James/P-3927-2019; Levy, Daniel/ABB-2752-2021; Ligthart, Symen/AAF-7185-2020; Langenberg, Claudia/ABG-9067-2021; Loos, Ruth J F/Q-2862-2016; Levy, Daniel/ABF-6873-2021; Dehghan, Abbas/ABE-7377-2020; Goodarzi, Mark/AAH-7106-2021; Ahluwalia, Tarunveer Singh/C-5549-2009; Grarup, Niels/K-2807-2015; Hartwig, Fernando/AAG-5578-2020; Schnurr, Theresia M./AAY-9287-2020; Rotter, Jerome/AAY-6598-2021; Loos, Ruth/GON-5877-2022; Horta, Bernardo/A-7604-2008; Ikram, M. Arfan/AAM-5225-2021; Weir, Bruce S/A-2894-2013; Christensen, Kaare/C-2360-2009; Witte, Daniel/AAF-9535-2019; Timpson, Nicholas John/O-7548-2015; Pedersen, Oluf/Z-1731-2019; Bielinski, Suzette/A-2238-2009; Gu, C. Charles/A-7934-2010	Erzurumluoglu, A Mesut/0000-0003-1322-8138; Teumer, Alexander/0000-0002-8309-094X; Li-Gao, Ruifang/0000-0003-0650-1351; Franco, Óscar H/0000-0002-4606-4929; Dina, Christian R/0000-0002-7722-7348; Lee, Joseph H/0000-0002-2000-4821; Rivadeneira, Fernando/0000-0001-9435-9441; Kilpeläinen, Tuomas/0000-0002-8349-3028; Feitosa, Mary F/0000-0002-0933-2410; Cox, Simon R./0000-0003-4036-3642; Ghanbari, Mohsen/0000-0002-9476-7143; Tzoulaki, Ioanna/0000-0002-4275-9328; Meigs, James/0000-0002-2439-2657; Langenberg, Claudia/0000-0002-5017-7344; Loos, Ruth J F/0000-0002-8532-5087; Levy, Daniel/0000-0003-1843-8724; Goodarzi, Mark/0000-0001-6364-5103; Ahluwalia, Tarunveer Singh/0000-0002-7464-3354; Grarup, Niels/0000-0001-5526-1070; Schnurr, Theresia M./0000-0002-6573-4959; Horta, Bernardo/0000-0001-9843-412X; Christensen, Kaare/0000-0002-5429-5292; Witte, Daniel/0000-0002-0769-2922; Timpson, Nicholas John/0000-0002-7141-9189; Pedersen, Oluf/0000-0002-3321-3972; Stergiakouli, Evangelia/0000-0003-3586-0927; Kerrison, Nicola/0000-0002-1471-953X; Malik, Afshan/0000-0001-7207-1666; de Haan, Hugoline/0000-0003-1126-4776; Rodriguez, Santiago/0000-0001-6551-932X; Jonsson, Anna/0000-0003-1252-8673; Fetterman, Jessica/0000-0002-9286-7538; Justice, Anne/0000-0002-8903-8712; Elliott, Paul/0000-0002-7511-5684; Sofer, Tamar/0000-0001-8520-8860; Brandslund, Ivan/0000-0002-4203-5442; Emery, Leslie/0000-0002-9070-9886; Vestergaard, Henrik/0000-0003-3090-269X; Hemani, Gibran/0000-0003-0920-1055; Ikram, Mohammad Arfan/0000-0003-0372-8585; Yang, Wei/0000-0001-8162-033X; Richardson, Tom/0000-0002-7918-2040; Bielinski, Suzette/0000-0002-2905-5430; Cropp, Cheryl/0000-0001-7662-9567; Gu, C. Charles/0000-0002-8527-8145; Forouhi, Nita/0000-0002-5041-248X; Weiss, Stefan/0000-0002-3553-4315; Hansen, Torben/0000-0001-8748-3831; Bonnelykke, Klaus/0000-0003-2003-1018; de las Fuentes, Lisa/0000-0002-4689-325X; Pankow, James/0000-0001-7076-483X; Hudson, Gavin/0000-0001-7210-2733; Jorgensen, Torben/0000-0001-9453-2830; Noordam, Raymond/0000-0001-7801-809X; Jorgensen, Marit Eika/0000-0001-8356-5565; Linneberg, Allan/0000-0002-0994-0184	National Institutes of Health, National Heart, Lung, and Blood Institute (NHLBI) [5K99HL130580-02, 5R00HL130580-04]; Wellcome Trust Centre for Mitochondrial Research [G906919]; NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057194] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL131573, K99HL130580, K01HL143142, R00HL130580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK078616, P30DK056336, K24DK080140, P30DK056341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075091, U54GM115428] Funding Source: NIH RePORTER; BBSRC [BB/F019394/1] Funding Source: UKRI; MRC [MC_UU_12015/2, MR/R023484/1, MR/S003886/1, MR/L01632X/1, MC_UU_12015/1, MR/K002767/1, MC_UU_00007/10, MR/L01341X/1, MC_UU_12015/5] Funding Source: UKRI	National Institutes of Health, National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Wellcome Trust Centre for Mitochondrial Research(Wellcome Trust); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	A.E. Justice is supported by a K99/R00 from the National Institutes of Health, National Heart, Lung, and Blood Institute (NHLBI) (5K99HL130580-02 and 5R00HL130580-04). G. Hudson has received funding support by Wellcome Trust Centre for Mitochondrial Research, Grant Code G906919. J.I.R., X.G., Y.-D.I.C., K.D.T., Y.H., K.S., and J.Y. have received NIH support for research related to mitochondria. A.T.K., C. Liu, J.L.F., M. Graff, C.T.H., C.G., L.R.Y., M.F.F., D.E.A., D.I.C., K.Y., W.D.H., S.J.L., L.W., T.J.B., L.D.L.-G., T.I.A.S., G. Hudson, D.L., A.N.M., D.M.B., M.A.P., J.B.M., J.I.R., and K.E.N. were the writing group for this paper. M.A.P. and K.E.N. are from the CHARGE ADIPOSITY working group; J.I.R. and J.B.M. are from the CHARGE DIABETES working group.	Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Altshuler-Keylin S, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aai9248; Ashar FN, 2017, JAMA CARDIOL, V2, P1247, DOI 10.1001/jamacardio.2017.3683; Ashar FN, 2015, J MOL MED, V93, P177, DOI 10.1007/s00109-014-1233-3; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Bambace C, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-5; Beasley TM, 2009, BEHAV GENET, V39, P580, DOI 10.1007/s10519-009-9281-0; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Bernhard F, 2013, DIABETOLOGIA, V56, P311, DOI 10.1007/s00125-012-2773-0; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Brown DA, 2017, NAT REV CARDIOL, V14, P238, DOI 10.1038/nrcardio.2016.203; Buzaglo-Azriel L, 2016, CELL REP, V14, P1602, DOI 10.1016/j.celrep.2016.01.046; Byerly MS, 2014, J BIOL CHEM, V289, P4055, DOI 10.1074/jbc.M113.506956; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Castellana S, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005628; Chanda P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068585; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen H, 2013, GENET EPIDEMIOL, V37, P196, DOI 10.1002/gepi.21703; Chow J, 2017, NAT REV ENDOCRINOL, V13, P92, DOI 10.1038/nrendo.2016.151; Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426; Cunningham AD, 2017, CELL REP, V18, P2592, DOI 10.1016/j.celrep.2017.02.048; De Pauw A, 2009, AM J PATHOL, V175, P927, DOI 10.2353/ajpath.2009.081155; Delaneau O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4934; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; DORNER G, 1975, ENDOKRINOLOGIE, V66, P225; DUKES ID, 1994, J BIOL CHEM, V269, P10979; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; El-Hattab AW, 2014, MITOCHONDRION, V18, P63, DOI 10.1016/j.mito.2014.07.008; Eppinga RN, 2016, NAT GENET, V48, P1557, DOI 10.1038/ng.3708; ERNSTER L, 1981, J CELL BIOL, V91, pS227, DOI 10.1083/jcb.91.3.227s; Esteras N, 2017, REDOX BIOL, V12, P410, DOI 10.1016/j.redox.2017.03.008; Febbo PG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-461; Fetterman JL, 2018, MITOCHONDRION, V40, P51, DOI 10.1016/j.mito.2017.10.001; Fimia GM, 2013, ONCOGENE, V32, P3311, DOI 10.1038/onc.2012.455; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Fish J, 2004, SCIENCE, V306, P2098, DOI 10.1126/science.1102077; Francis Joshua W, 2016, Small GTPases, V7, P188; Frazier A. E., 2017, J BIOL CHEM JBC R, V117; Go MJ, 2013, J HUM GENET, V58, P362, DOI 10.1038/jhg.2013.14; Graff M, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006528; Guo H, 2017, SCIENCE, V358, P936, DOI 10.1126/science.aao4815; Guo YR, 2013, HUM MOL GENET, V22, P184, DOI 10.1093/hmg/dds396; Haag-Liautard C, 2008, PLOS BIOL, V6, P1706, DOI 10.1371/journal.pbio.0060204; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Heinonen S, 2015, DIABETES, V64, P3135, DOI 10.2337/db14-1937; Heymann Anthony D, 2012, Diabetes Care, V35, pe58, DOI 10.2337/dc11-2527; Hinds DA, 2016, HUM MOL GENET, V25, P1867, DOI 10.1093/hmg/ddw037; Hinney A, 2014, AM J MED GENET B, V165, P283, DOI 10.1002/ajmg.b.32234; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang HL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002177; Ilegems E, 2010, J NEUROSCI, V30, P13774, DOI 10.1523/JNEUROSCI.0091-10.2010; Jelinek D, 2013, GENE, V527, P65, DOI 10.1016/j.gene.2013.05.080; Justice AE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14977; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kraja AT, 2014, MOL GENET METAB, V112, P317, DOI 10.1016/j.ymgme.2014.04.007; Kristiansson K, 2012, CIRC-CARDIOVASC GENE, V5, P242, DOI 10.1161/CIRCGENETICS.111.961482; Lai YK, 2017, ANN HEMATOL, V96, P839, DOI 10.1007/s00277-017-2945-6; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; Lee HS, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/6873197; Lee S, 2014, AM J HUM GENET, V95, P5, DOI 10.1016/j.ajhg.2014.06.009; Li MLJ, 2013, NUCLEIC ACIDS RES, V41, pW150, DOI 10.1093/nar/gkt456; Li Q, 2011, CANCER LETT, V308, P203, DOI 10.1016/j.canlet.2011.05.005; LIN RS, 1994, INT J EPIDEMIOL, V23, P886, DOI 10.1093/ije/23.5.886; Liu CY, 2013, GENET EPIDEMIOL, V37, P239, DOI 10.1002/gepi.21706; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Lu HF, 2010, DIABETES, V59, P448, DOI 10.2337/db09-0129; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MACDONALD MJ, 1990, ARCH BIOCHEM BIOPHYS, V279, P104, DOI 10.1016/0003-9861(90)90468-E; Malik AN, 2015, DIABETES RES CLIN PR, V110, P257, DOI 10.1016/j.diabres.2015.10.006; Malik AN, 2013, MITOCHONDRION, V13, P481, DOI 10.1016/j.mito.2012.10.011; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; McDermott-Roe C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170458; Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Middelberg RPS, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-123; Monda KL, 2013, NAT GENET, V45, P690, DOI 10.1038/ng.2608; Montgomery MK, 2015, ENDOCR CONNECT, V4, DOI 10.1530/EC-14-0092; Mozaffarian D, 2015, AM J CLIN NUTR, V101, P398, DOI 10.3945/ajcn.114.094557; Nakamoto RK, 2008, ARCH BIOCHEM BIOPHYS, V476, P43, DOI 10.1016/j.abb.2008.05.004; Neiman M, 2009, P ROY SOC B-BIOL SCI, V276, P1201, DOI 10.1098/rspb.2008.1758; Nelson CP, 2017, NAT GENET, V49, P1385, DOI 10.1038/ng.3913; Ng MCY, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006719; Nobrega-Pereira S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10894; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pattin KA, 2009, EXPERT REV PROTEOMIC, V6, P647, DOI 10.1586/EPR.09.86; Pott J, 2017, ATHEROSCLEROSIS, V259, P32, DOI 10.1016/j.atherosclerosis.2017.02.018; Prasai Kanchanjunga, 2017, Pathophysiology, V24, P107, DOI 10.1016/j.pathophys.2017.03.001; Prokopenko I, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004235; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Randall JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003500; Ridler Charlotte, 2016, Nat Rev Endocrinol, V12, P497, DOI 10.1038/nrendo.2016.108; Sabater-Lleal M, 2013, CIRCULATION, V128, P1310, DOI 10.1161/CIRCULATIONAHA.113.002251; Saha A, 2017, GENOME RES, V27, P1843, DOI 10.1101/gr.216721.116; Samuels DC, 2006, AM J HUM GENET, V78, P713, DOI 10.1086/502682; Sane AT, 2017, ARTERIOSCL THROM VAS, V37, P2243, DOI 10.1161/ATVBAHA.117.310121; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Schaefer AM, 2013, MOL CELL ENDOCRINOL, V379, P2, DOI 10.1016/j.mce.2013.06.004; Schleinitz D, 2014, INT J OBESITY, V38, P120, DOI 10.1038/ijo.2013.56; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Semenkovich CF, 2017, DIABETES, V66, P1735, DOI 10.2337/db17-0093; Sepe M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022800; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Smith AC, 2016, NUCLEIC ACIDS RES, V44, pD1258, DOI 10.1093/nar/gkv1001; Soranzo N, 2010, DIABETES, V59, P3229, DOI 10.2337/db10-0502; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Spracklen CN, 2017, HUM MOL GENET, V26, P1770, DOI 10.1093/hmg/ddx062; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Szendroedi J, 2012, NAT REV ENDOCRINOL, V8, P92, DOI 10.1038/nrendo.2011.138; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Taniguchi K, 2018, BIOCHEM BIOPH RES CO, V496, P218, DOI 10.1016/j.bbrc.2018.01.029; THOMAS F, 1994, DIABETES, V43, P63, DOI 10.2337/diabetes.43.1.63; Tin A, 2016, J AM SOC NEPHROL, V27, P2467, DOI 10.1681/ASN.2015060661; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; van der Harst P, 2016, J AM COLL CARDIOL, V68, P1435, DOI 10.1016/j.jacc.2016.07.729; van der Wijst MGP, 2015, TRENDS GENET, V31, P353, DOI 10.1016/j.tig.2015.03.009; Vernochet C, 2014, FASEB J, V28, P4408, DOI 10.1096/fj.14-253971; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Walford GA, 2016, DIABETES, V65, P3200, DOI 10.2337/db16-0199; Wang HN, 2014, APMIS, V122, P443, DOI 10.1111/apm.12166; Wang L, 2016, GENET EPIDEMIOL, V40, P502, DOI 10.1002/gepi.21985; Wang ZM, 2010, AM J CLIN NUTR, V92, P1369, DOI 10.3945/ajcn.2010.29885; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Warren HR, 2017, NAT GENET, V49, P403, DOI 10.1038/ng.3768; West AP, 2017, NAT REV IMMUNOL, V17, P363, DOI 10.1038/nri.2017.21; Wheeler E, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002383; Wiklund P, 2016, SCI REP-UK, V6, DOI 10.1038/srep24540; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Winkler TW, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005378; Winkler TW, 2014, NAT PROTOC, V9, P1192, DOI 10.1038/nprot.2014.071; Wos M, 2016, ARCH BIOCHEM BIOPHYS, V593, P50, DOI 10.1016/j.abb.2016.02.012; Yang J, 2012, NATURE, V490, P267, DOI 10.1038/nature11401; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Yasuno K, 2010, NAT GENET, V42, P420, DOI 10.1038/ng.563; Yeo A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182115; Yuasa K, 2011, CELL SIGNAL, V23, P1179, DOI 10.1016/j.cellsig.2011.03.005; Zhang YY, 2017, EUR HEART J, V38, P3443, DOI 10.1093/eurheartj/ehx354; Zhao W, 2017, NAT GENET, V49, P1450, DOI 10.1038/ng.3943	142	58	59	2	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 3	2019	104	1					112	138		10.1016/j.ajhg.2018.12.001	http://dx.doi.org/10.1016/j.ajhg.2018.12.001			27	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HG2EH	30595373	Green Published, hybrid, Green Submitted			2022-12-18	WOS:000454775500012
J	Eicher, JD; Chami, N; Kacprowski, T; Nomura, A; Chen, MH; Yanek, LR; Tajuddin, SM; Schick, UM; Slater, AJ; Pankratz, N; Polfus, L; Schurmann, C; Giri, A; Brody, JA; Lange, LA; Manichaikul, A; Hill, WD; Pazoki, R; Elliot, P; Evangelou, E; Tzoulaki, I; Gao, H; Vergnaud, AC; Mathias, RA; Becker, DM; Becker, LC; Burt, A; Crosslin, DR; Lyytikainen, LP; Nikus, K; Hernesniemi, J; Kahonen, M; Raitoharju, E; Mononen, N; Raitakari, OT; Lehtimaki, T; Cushman, M; Zakai, NA; Nickerson, DA; Raffield, LM; Quarells, R; Willer, CJ; Peloso, GM; Abecasis, GR; Liu, DJJ; Deloukas, P; Samani, NJ; Schunkert, H; Erdmann, J; Fornage, M; Richard, M; Tardif, JC; Rioux, JD; Dube, MP; de Denus, S; Lu, YC; Bottinger, EP; Loos, RJF; Smith, AV; Harris, TB; Launer, LJ; Gudnason, V; Edwards, DRV; Torstenson, ES; Liu, YM; Tracy, RP; Rotter, JI; Rich, SS; Highland, HM; Boerwinkle, E; Li, J; Lange, E; Wilson, JG; Mihailov, E; Magi, R; Hirschhorn, J; Metspalu, A; Esko, T; Vacchi-Suzzi, C; Nalls, MA; Zonderman, AB; Evans, MK; Engstrom, G; Orho-Melander, M; Melander, O; O'Donoghue, ML; Waterworth, DM; Wallentin, L; White, HD; Floyd, JS; Bartz, TM; Rice, KM; Psaty, BM; Starr, JM; Liewald, DCM; Hayward, C; Deary, IJ; Greinacher, A; Volker, U; Thiele, T; Volzke, H; van Rooij, FJA; Uitterlinden, AG; Franco, OH; Dehghan, A; Edwards, TL; Ganesh, SK; Kathiresan, S; Faraday, N; Auer, PL; Reiner, AP; Lettre, G; Johnson, AD				Eicher, John D.; Chami, Nathalie; Kacprowski, Tim; Nomura, Akihiro; Chen, Ming-Huei; Yanek, Lisa R.; Tajuddin, Salman M.; Schick, Ursula M.; Slater, Andrew J.; Pankratz, Nathan; Polfus, Linda; Schurmann, Claudia; Giri, Ayush; Brody, Jennifer A.; Lange, Leslie A.; Manichaikul, Ani; Hill, W. David; Pazoki, Raha; Elliot, Paul; Evangelou, Evangelos; Tzoulaki, Ioanna; Gao, He; Vergnaud, Anne-Claire; Mathias, Rasika A.; Becker, Diane M.; Becker, Lewis C.; Burt, Amber; Crosslin, David R.; Lyytikainen, Leo-Pekka; Nikus, Kjell; Hernesniemi, Jussi; Kahonen, Mika; Raitoharju, Emma; Mononen, Nina; Raitakari, Olli T.; Lehtimaki, Terho; Cushman, Mary; Zakai, Neil A.; Nickerson, Deborah A.; Raffield, Laura M.; Quarells, Rakale; Willer, Cristen J.; Peloso, Gina M.; Abecasis, Goncalo R.; Liu, Dajiang J.; Deloukas, Panos; Samani, Nilesh J.; Schunkert, Heribert; Erdmann, Jeanette; Fornage, Myriam; Richard, Melissa; Tardif, Jean-Claude; Rioux, John D.; Dube, Marie-Pierre; de Denus, Simon; Lu, Yingchang; Bottinger, Erwin P.; Loos, Ruth J. F.; Smith, Albert Vernon; Harris, Tamara B.; Launer, Lenore J.; Gudnason, Vilmundur; Edwards, Digna R. Velez; Torstenson, Eric S.; Liu, Yongmei; Tracy, Russell P.; Rotter, Jerome I.; Rich, Stephen S.; Highland, Heather M.; Boerwinkle, Eric; Li, Jin; Lange, Ethan; Wilson, James G.; Mihailov, Evelin; Magi, Reedik; Hirschhorn, Joel; Metspalu, Andres; Esko, Tonu; Vacchi-Suzzi, Caterina; Nalls, Mike A.; Zonderman, Alan B.; Evans, Michele K.; Engstrom, Gunnar; Orho-Melander, Marju; Melander, Olle; O'Donoghue, Michelle L.; Waterworth, Dawn M.; Wallentin, Lars; White, Harvey D.; Floyd, James S.; Bartz, Traci M.; Rice, Kenneth M.; Psaty, Bruce M.; Starr, J. M.; Liewald, David C. M.; Hayward, Caroline; Deary, Ian J.; Greinacher, Andreas; Volker, Uwe; Thiele, Thomas; Volzke, Henry; van Rooij, Frank J. A.; Uitterlinden, Andre G.; Franco, Oscar H.; Dehghan, Abbas; Edwards, Todd L.; Ganesh, Santhi K.; Kathiresan, Sekar; Faraday, Nauder; Auer, Paul L.; Reiner, Alex P.; Lettre, Guillaume; Johnson, Andrew D.		Global Lipids Genetics Consortium; CARDIoGRAM Exome Consortium; Myocardial Infarction Genetics	Platelet-Related Variants Identified by Exomechip Meta-analysis in 157,293 Individuals	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BLOOD-CELL TRAITS; PIAS-LIKE PROTEIN; SEQUENCE VARIANTS; LOCI; VOLUME; COUNT; GENE; AGGREGATION; EXPRESSION	Platelet production, maintenance, and clearance are tightly controlled processes indicative of platelets' important roles in hemostasis and thrombosis. Platelets are common targets for primary and secondary prevention of several conditions. They are monitored clinically by complete blood counts, specifically with measurements of platelet count (PLT) and mean platelet volume (MPV). Identifying genetic effects on PLT and MPV can provide mechanistic insights into platelet biology and their role in disease. Therefore, we formed the Blood Cell Consortium (BCX) to perform a large-scale meta-analysis of Exomechip association results for PLT and MPV in 157,293 and 57,617 individuals, respectively. Using the low-frequency/rare coding variant-enriched Exomechip genotyping array, we sought to identify genetic variants associated with PLT and MPV. In addition to confirming 47 known PLT and 20 known MPV associations, we identified 32 PLT and 18 MPV associations not previously observed in the literature across the allele frequency spectrum, including rare large effect (FCER1A), low-frequency (IQGAP2, MAP1A, LY75), and common(ZMIZ2, SMG6, PEAR1, ARFGAP3/PACSIN2) variants. Several variants associated with PLT/MPV(PEAR1, MRVI1, PTGES3) were also associated with platelet reactivity. In concurrent BCX analyses, there was overlap of platelet-associated variants with red (MAP1A, TMPRSS6, ZMIZ2) and white (PEAR1, ZMIZ2, LY75) blood cell traits, suggesting common regulatory pathways with shared genetic architecture among these hematopoietic lineages. Our large-scale Exomechip analyses identified previously undocumented associations with platelet traits and further indicate that several complex quantitative hematological, lipid, and cardiovascular traits share genetic factors.	[Eicher, John D.; Chen, Ming-Huei; Johnson, Andrew D.] NHLBI, Populat Sci Branch, Framingham Heart Study, Framingham, MA 01702 USA; [Chami, Nathalie; Tardif, Jean-Claude; Rioux, John D.; Dube, Marie-Pierre; Lettre, Guillaume] Univ Montreal, Dept Med, Montreal, PQ H3T 1J4, Canada; [Chami, Nathalie; Tardif, Jean-Claude; Rioux, John D.; Dube, Marie-Pierre; de Denus, Simon; Lettre, Guillaume] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Kacprowski, Tim; Volker, Uwe] Univ Med Greifswald, Interfac Inst Genet & Funct Genom, Dept Funct Genom, D-17475 Greifswald, Germany; [Kacprowski, Tim; Volker, Uwe] Ernst Mortiz Arndt Univ Greifswald, D-17475 Greifswald, Germany; [Kacprowski, Tim; Volker, Uwe; Volzke, Henry] DZHK German Ctr Cardiovasc Res, Partner Site Greifswald, Greifswald, Germany; [Nomura, Akihiro; Peloso, Gina M.; Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Nomura, Akihiro; Peloso, Gina M.; Hirschhorn, Joel; Esko, Tonu; Kathiresan, Sekar] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Nomura, Akihiro; Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Nomura, Akihiro; Kathiresan, Sekar] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Nomura, Akihiro] Kanazawa Univ, Div Cardiovasc Med, Grad Sch Med Sci, Kanazawa, Ishikawa 9200942, Japan; [Yanek, Lisa R.; Mathias, Rasika A.; Becker, Diane M.; Becker, Lewis C.] Johns Hopkins Univ, Div Gen Internal Med, Dept Med, Sch Med, Baltimore, MD 21205 USA; [Tajuddin, Salman M.; Zonderman, Alan B.; Evans, Michele K.] NIA, Lab Epidemiol & Populat Sci, NIH, Baltimore, MD 21224 USA; [Schick, Ursula M.; Schurmann, Claudia; Lu, Yingchang; Bottinger, Erwin P.; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Schick, Ursula M.; Schurmann, Claudia] Icahn Sch Med Mt Sinai, Genet Obes & Related Metab Traits Program, New York, NY 10029 USA; [Slater, Andrew J.] GlaxoSmithKline, Genet, Target Sci, Res Triangle Pk, NC 27709 USA; [Slater, Andrew J.] OmicSoft Corp, Cary, NC 27513 USA; [Pankratz, Nathan] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55454 USA; [Polfus, Linda; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Ctr Human Genet, Houston, TX 77030 USA; [Giri, Ayush; Torstenson, Eric S.; Edwards, Todd L.] Vanderbilt Univ, Inst Med & Publ Hlth, Div Epidemiol, Nashville, TN 37235 USA; [Brody, Jennifer A.; Floyd, James S.] Univ Washington, Dept Med, Seattle, WA 98101 USA; [Lange, Leslie A.; Raffield, Laura M.; Lange, Ethan] Univ N Carolina, Dept Genet, Chapel Hill, NC 27514 USA; [Manichaikul, Ani; Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Gen, Charlottesville, VA 22908 USA; [Hill, W. David; Starr, J. M.; Liewald, David C. M.; Deary, Ian J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Hill, W. David; Liewald, David C. M.; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Pazoki, Raha; van Rooij, Frank J. A.; Uitterlinden, Andre G.; Franco, Oscar H.; Dehghan, Abbas] Erasmus MC, Dept Epidemiol, NL-3000 Rotterdam, Netherlands; [Elliot, Paul; Evangelou, Evangelos; Tzoulaki, Ioanna; Gao, He; Vergnaud, Anne-Claire] Univ London Imperial Coll Sci Technol & Med, MRC PHE Ctr Environm & Hlth, Dept Epidemiol & Biostat, Sch Publ Hlth, London W2 1PG, England; [Evangelou, Evangelos; Tzoulaki, Ioanna] Univ Ioannina, Dept Hyg & Epidemiol, Sch Med, Ioannina 45110, Greece; [Mathias, Rasika A.] Johns Hopkins Univ, Sch Med, Dept Med, Div Allergy, Baltimore, MD 21205 USA; [Mathias, Rasika A.] Johns Hopkins Univ, Sch Med, Dept Med, Div Immunol, Baltimore, MD 21205 USA; [Becker, Lewis C.] Johns Hopkins Univ, Div Cardiol, Dept Med, Sch Med, Baltimore, MD 21205 USA; [Burt, Amber] Univ Washington, Div Med Genet, Dept Med, Seattle, WA 98195 USA; [Crosslin, David R.] Univ Washington, Dept Biomed Informat & Med Educ, Seattle, WA 98105 USA; [Lyytikainen, Leo-Pekka; Hernesniemi, Jussi; Raitoharju, Emma; Mononen, Nina; Lehtimaki, Terho] Fimlab Labs, Dept Clin Chem, Tampere 33520, Finland; [Lyytikainen, Leo-Pekka; Hernesniemi, Jussi; Raitoharju, Emma; Mononen, Nina; Lehtimaki, Terho] Univ Tampere, Dept Clin Chem, Sch Med, Tampere 33514, Finland; [Nikus, Kjell; Hernesniemi, Jussi] Tampere Univ Hosp, Dept Cardiol, Ctr Heart, Tampere 33521, Finland; [Nikus, Kjell] Univ Tampere, Sch Med, Tampere 33514, Finland; [Kahonen, Mika] Tampere Univ Hosp, Dept Clin Physiol, Tampere 33521, Finland; [Kahonen, Mika] Univ Tampere, Dept Clin Physiol, Tampere 33514, Finland; [Raitakari, Olli T.] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, Turku 20521, Finland; [Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, FIN-20520 Turku, Finland; [Cushman, Mary; Zakai, Neil A.] Univ Vermont, Coll Med, Dept Med, Burlington, VT 05405 USA; [Cushman, Mary; Zakai, Neil A.] Univ Vermont, Coll Med, Dept Pathol, Burlington, VT 05405 USA; [Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98105 USA; [Quarells, Rakale] Morehouse Sch Med, Social Epidemiol Res Ctr, Cardiovasc Res Inst, Atlanta, GA 30310 USA; [Willer, Cristen J.] Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48108 USA; [Willer, Cristen J.] Univ Michigan, Dept Computat Med & Bioinformat, Dept Human Genet, Ann Arbor, MI 48108 USA; [Willer, Cristen J.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48108 USA; [Peloso, Gina M.] Boston Univ, Dept Biostat, Sch Publ Hlth, Boston, MA 02118 USA; [Abecasis, Goncalo R.] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48108 USA; [Liu, Dajiang J.] Penn State Univ Hosp, Dept Publ Hlth Sci, Coll Med, Hershey, PA 17033 USA; [Deloukas, Panos] Queen Mary Univ London, William Harvey Res Inst, London E1 4NS, England; [Deloukas, Panos] King Abdulaziz Univ, Princess Al Jawhara Al Brahim Ctr Excellence Res, Jeddah 21589, Saudi Arabia; [Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester LE1 7RH, Leics, England; [Samani, Nilesh J.] Glenfield Hosp, NIHR Leicester Cardiovasc Biomed Res Unit, Leicester LE3 9QP, Leics, England; [Schunkert, Heribert] DZHK German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, D-80333 Munich, Germany; [Schunkert, Heribert] Tech Univ Munich, Deutsch Herzzentrum Munchen, D-80333 Munich, Germany; [Erdmann, Jeanette] Univ Lubeck, Inst Integrat & Expt Genom, D-23562 Lubeck, Germany; [Erdmann, Jeanette] DZHK German Res Ctr Cardiovasc Res, Partner Site Hamburg Lubeck Kiel, D-23562 Lubeck, Germany; [Fornage, Myriam; Richard, Melissa] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, Houston, TX 77030 USA; [de Denus, Simon] Univ Montreal, Fac Pharm, Montreal H3T 1J4, PQ, Canada; [Smith, Albert Vernon; Gudnason, Vilmundur] Icelandic Heart Assoc, IS-201 Kopavogur, Iceland; [Smith, Albert Vernon; Gudnason, Vilmundur] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; [Harris, Tamara B.; Launer, Lenore J.] NIA, Lab Epidemiol Demog & Biometry, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Edwards, Digna R. Velez] Vanderbilt Univ, Vanderbilt Epidemiol Ctr, Dept Obstet & Gynecol, Inst Med & Publ Hlth,Vanderbilt Genet Inst, Nashville, TN 37203 USA; [Liu, Yongmei] Wake Forest Sch Med, Div Publ Hlth Sci, Ctr Human Genet, Winston Salem, NC 27157 USA; [Tracy, Russell P.] Univ Vermont, Coll Med, Dept Pathol & Lab Med, Colchester, VT 05446 USA; [Tracy, Russell P.] Univ Vermont, Coll Med, Dept Biochem, Colchester, VT 05446 USA; [Rotter, Jerome I.] Los Angeles Biomed Res Inst, Inst Translat Genom & Populat Sci, Torrance, CA 90502 USA; [Rotter, Jerome I.] Harbor UCLA Med Ctr, Dept Pediat, Torrance, CA 90502 USA; [Highland, Heather M.] Univ Texas Hlth Sci Ctr Houston, Univ Texas Grad Sch Biomed Sci Houston, Univ Texas Sch Publ Hlth, Houston, TX 77030 USA; [Highland, Heather M.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27514 USA; [Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Li, Jin] Stanford Univ, Sch Med, Dept Med, Div Cardiovasc Med, Palo Alto, CA 94305 USA; [Lange, Ethan] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27514 USA; [Wilson, James G.] Univ Mississippi, Dept Physiol & Biophys, Med Ctr, Jackson, MS 39216 USA; [Mihailov, Evelin; Magi, Reedik; Metspalu, Andres; Esko, Tonu] Univ Tartu, Estonian Genome Ctr, EE-51010 Tartu, Estonia; [Hirschhorn, Joel] Boston Childrens Hosp, Dept Endocrinol, Boston, MA 02115 USA; [Vacchi-Suzzi, Caterina] SUNY Stony Brook, Dept Family Populat & Prevent Med, Stony Brook, NY 11794 USA; [Nalls, Mike A.] NIA, Neurogenet Lab, NIH, Bethesda, MD 21224 USA; [Engstrom, Gunnar; Orho-Melander, Marju; Melander, Olle] Lund Univ, Dept Clin Sci Malmo, S-22100 Malmo, Sweden; [Engstrom, Gunnar; Orho-Melander, Marju; Melander, Olle] Skane Univ Hosp, S-22241 Malmo, Sweden; [O'Donoghue, Michelle L.] Brigham & Womens Hosp, TIMI Study Grp, Div Cardiovasc, Boston, MA 02115 USA; [Waterworth, Dawn M.] GlaxoSmithKline, Target Sci, Genet, King Of Prussia, PA 19406 USA; [Wallentin, Lars] Uppsala Univ, Dept Med Sci, Cardiol, S-75185 Uppsala, Sweden; [Wallentin, Lars] Uppsala Univ, Dept Med Sci, Uppsala Clin Res Ctr, S-75185 Uppsala, Sweden; [White, Harvey D.] Auckland City Hosp, Green Lane Cardiovasc Serv, Auckland 1142, New Zealand; [White, Harvey D.] Univ Auckland, Auckland 1142, New Zealand; [Bartz, Traci M.; Rice, Kenneth M.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98101 USA; [Psaty, Bruce M.] Grp Hlth Res Inst, Grp Hlth Cooperat, Seattle, WA 98101 USA; [Starr, J. M.] Alzheimer Scotland Res Ctr, Edinburgh EH8 9JZ, Midlothian, Scotland; [Hayward, Caroline] Univ Edinburgh, MRC Human Genet Unit, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Greinacher, Andreas; Thiele, Thomas] Univ Med Greifswald, Inst Immunol & Transfus Med, D-17475 Greifswald, Germany; [Volzke, Henry] Univ Med Greifswald, Inst Community Med, D-13347 Greifswald, Germany; [Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, NL-3000 Rotterdam, Netherlands; [Uitterlinden, Andre G.] Netherlands Consortium Hlth Ageing, NL-3015 Rotterdam, Netherlands; [Ganesh, Santhi K.] Univ Michigan, Dept Internal & Human Genet, Ann Arbor, MI 48108 USA; [Faraday, Nauder] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Auer, Paul L.] Univ Wisconsin, Zilber Sch Publ Hlth, Milwaukee, WI 53205 USA; [Reiner, Alex P.] Univ Washington, Dept Epidemiol, Seattle, WA 98105 USA; [Eicher, John D.; Chami, Nathalie; Kacprowski, Tim; Nomura, Akihiro; Faraday, Nauder; Auer, Paul L.; Reiner, Alex P.; Lettre, Guillaume; Johnson, Andrew D.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Universite de Montreal; Universite de Montreal; Greifswald Medical School; German Centre for Cardiovascular Research; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Kanazawa University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; GlaxoSmithKline; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Vanderbilt University; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of Virginia; University of Edinburgh; University of Edinburgh; Erasmus University Rotterdam; Erasmus MC; Imperial College London; University of Ioannina; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Tampere University; Tampere University; Tampere University Hospital; Tampere University; Tampere University; Tampere University Hospital; Tampere University; University of Turku; University of Turku; University of Vermont; University of Vermont; University of Washington; University of Washington Seattle; Morehouse School of Medicine; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Boston University; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of London; Queen Mary University London; King Abdulaziz University; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; German Centre for Cardiovascular Research; Munich Heart Alliance; German Heart Centre Munich; Technical University of Munich; University of Lubeck; German Centre for Cardiovascular Research; University of Texas System; University of Texas Health Science Center Houston; Universite de Montreal; Icelandic Heart Association; University of Iceland; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Vanderbilt University; Wake Forest University; University of Vermont; University of Vermont; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of North Carolina; University of North Carolina Chapel Hill; Baylor College of Medicine; Stanford University; University of North Carolina; University of North Carolina Chapel Hill; University of Mississippi; University of Mississippi Medical Center; University of Tartu; Harvard University; Boston Children's Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Lund University; Lund University; Skane University Hospital; Harvard University; Brigham & Women's Hospital; GlaxoSmithKline; Uppsala University; Uppsala University; Auckland City Hospital; University of Auckland; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; University of Edinburgh; Greifswald Medical School; Greifswald Medical School; Erasmus University Rotterdam; Erasmus MC; University of Michigan System; University of Michigan; Johns Hopkins University; University of Wisconsin System; University of Wisconsin Milwaukee; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Johnson, AD (corresponding author), NHLBI, Populat Sci Branch, Framingham Heart Study, Framingham, MA 01702 USA.; Johnson, AD (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA.	johnsonad2@nhlbi.nih.gov	Nomura, Akihiro/ABE-2871-2020; Kacprowski, Tim/K-8650-2013; Loos, Ruth/GON-5877-2022; Evangelou, Evangelos/C-3033-2013; Cushman, Mary/K-1157-2019; Dubé, Marie-Pierre/B-9364-2008; Rioux, John D/A-9599-2015; Erdmann, Jeanette/A-4417-2009; Dehghan, Abbas/ABE-7377-2020; Loos, Ruth J F/Q-2862-2016; Raitakari, Olli/AAQ-7389-2021; Gudnason, Vilmundur/AAE-7126-2019; Auer, Paul/AAC-5060-2019; Franco, Óscar H/ABE-2305-2020; Kacprowski, Tim/N-9692-2019; Johnson, Andrew D/G-6520-2013; Schurmann, Claudia/L-1204-2016; Evans, Michele Kim/AAE-4776-2019; Deloukas, Panos/B-2922-2013; Lehtimäki, Terho/AAD-1094-2022; Hernesniemi, Jussi/ABH-1842-2021; Tzoulaki, Ioanna/ABE-6269-2020; Rotter, Jerome/AAY-6598-2021; Deary, Ian J/C-6297-2009; Mägi, Reedik/AAJ-9679-2021; Floyd, James/G-7563-2015; Erdmann, Jeanette/P-7513-2014; Nikus, Kjell/K-7813-2019; Smith, Albert Vernon/K-5150-2015; Dehghan, Abbas/B-9896-2008	Nomura, Akihiro/0000-0001-6647-8240; Kacprowski, Tim/0000-0002-5393-2413; Evangelou, Evangelos/0000-0002-5488-2999; Cushman, Mary/0000-0002-7871-6143; Dubé, Marie-Pierre/0000-0001-8442-4393; Rioux, John D/0000-0001-7560-8326; Loos, Ruth J F/0000-0002-8532-5087; Gudnason, Vilmundur/0000-0001-5696-0084; Franco, Óscar H/0000-0002-4606-4929; Kacprowski, Tim/0000-0002-5393-2413; Johnson, Andrew D/0000-0001-6369-5178; Schurmann, Claudia/0000-0003-4158-9192; Deloukas, Panos/0000-0001-9251-070X; Lehtimäki, Terho/0000-0002-2555-4427; Hernesniemi, Jussi/0000-0002-8111-6421; Tzoulaki, Ioanna/0000-0002-4275-9328; Deary, Ian J/0000-0002-1733-263X; Erdmann, Jeanette/0000-0002-4486-6231; Gueranger, Anne-Claire/0000-0003-0728-9313; Rich, Stephen/0000-0003-3872-7793; Liu, Dajiang/0000-0001-6553-858X; Smith, Albert Vernon/0000-0003-1942-5845; Slater, Andrew/0000-0002-2467-0231; Nikus, Kjell/0000-0002-9345-9851; Volker, Uwe/0000-0002-5689-3448; Pazoki, Raha/0000-0002-5142-2348; Melander, Olle/0000-0002-2581-484X; Magi, Reedik/0000-0002-2964-6011; Evans, Michele/0000-0002-8546-2831; Chami, Nathalie/0000-0002-8547-6424; Chen, Ming-Huei/0000-0003-3551-8726; Pankratz, Nathan/0000-0001-5958-693X; Dehghan, Abbas/0000-0001-6403-016X; Zonderman, Alan B/0000-0002-6523-4778; Manichaikul, Ani/0000-0002-5998-795X; Raffield, Laura/0000-0002-7892-193X; Kahonen, Mika/0000-0002-4510-7341; Raitoharju, Emma/0000-0002-7023-8706; Tajuddin, Salman M./0000-0002-7919-8528	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095160, N01HC025195, N01HC095159] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD074711] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124, UL1TR000445] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086694, R01HL105756, R21HL121429, R01HL087698, U01HL107446, R01HL122684, R01HL120393, RC2HL102419, R01HL059367, R01HL127564, ZIAHL006170, U01HL072518, R01HL112064, R01HL087641, T32HL007055] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402, U01HG004603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000519] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018522] Funding Source: NIH RePORTER; British Heart Foundation [RG/14/5/30893] Funding Source: researchfish; Medical Research Council [MC_PC_U127561128, MR/L01341X/1, MR/K026992/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10136] Funding Source: researchfish; MRC [MR/L01341X/1, MC_PC_U127561128] Funding Source: UKRI	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2013, NAT GENET, DOI DOI 10.1038/NG.2797; [Anonymous], 2016, NEW ENGL J MED, V374, P1898; Auer PL, 2014, NAT GENET, V46, P629, DOI 10.1038/ng.2962; Auer PL, 2012, AM J HUM GENET, V91, P794, DOI 10.1016/j.ajhg.2012.08.031; Begonja AJ, 2015, BLOOD, V126, P80, DOI 10.1182/blood-2014-07-587600; Bertin A, 2007, MAMM GENOME, V18, P361, DOI 10.1007/s00335-007-9022-8; Bochenek G, 2013, HUM MOL GENET, V22, P4516, DOI 10.1093/hmg/ddt299; Butler M, 2007, IMMUNOLOGY, V120, P362, DOI 10.1111/j.1365-2567.2006.02512.x; Cao LX, 2015, P NATL ACAD SCI USA, V112, P7237, DOI 10.1073/pnas.1505924112; Catani L, 2011, EXP HEMATOL, V39, P486, DOI 10.1016/j.exphem.2010.12.011; Chami N, 2016, AM J HUM GENET, V99, P8, DOI 10.1016/j.ajhg.2016.05.007; Chu SG, 2010, J THROMB HAEMOST, V8, P148, DOI 10.1111/j.1538-7836.2009.03584.x; Cook JPD, 1997, BIOCHEMISTRY-US, V36, P15579, DOI 10.1021/bi9713005; Daly ME, 2011, HAEMATOL-HEMATOL J, V96, P10, DOI 10.3324/haematol.2010.035287; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Eicher JD, 2016, PLATELETS, V27, P230, DOI 10.3109/09537104.2015.1083543; Eicher JD, 2016, J THROMB THROMBOLYS, V41, P343, DOI 10.1007/s11239-015-1290-7; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Ganesh SK, 2013, HUM MOL GENET, V22, P1663, DOI 10.1093/hmg/dds555; Garman SC, 1999, ANNU REV IMMUNOL, V17, P973, DOI 10.1146/annurev.immunol.17.1.973; Gieger C, 2011, NATURE, V480, P201, DOI 10.1038/nature10659; Gomes AL, 2010, BLOOD, V115, P3886, DOI 10.1182/blood-2009-08-240580; Granada M, 2012, J ALLERGY CLIN IMMUN, V129, P840, DOI 10.1016/j.jaci.2011.09.029; Grove ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068095; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Guerrero JA, 2011, HAEMATOL-HEMATOL J, V96, P1335, DOI 10.3324/haematol.2011.042077; Hennekens CH, 1997, CIRCULATION, V96, P2751, DOI 10.1161/01.CIR.96.8.2751; Johnson AD, 2011, J THROMB HAEMOST, V9, P246, DOI 10.1111/j.1538-7836.2011.04359.x; Johnson AD, 2010, NAT GENET, V42, P608, DOI 10.1038/ng.604; KARPATKIN S, 1978, BLOOD, V51, P307; Kartberg F, 2010, J BIOL CHEM, V285, P36709, DOI 10.1074/jbc.M110.180380; Kauskot A, 2013, BLOOD, V121, P5208, DOI 10.1182/blood-2012-10-462887; Kim YK, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/914965; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604; Lewis JP, 2013, CIRC-CARDIOVASC GENE, V6, P184, DOI 10.1161/CIRCGENETICS.111.964627; Li J, 2013, HUM MOL GENET, V22, P1457, DOI 10.1093/hmg/dds534; Li TL, 2015, EMBO J, V34, P1630, DOI 10.15252/embj.201489947; Liu DJJ, 2014, NAT GENET, V46, P200, DOI 10.1038/ng.2852; Liu Y, 2015, J NEUROSCI, V35, P4587, DOI 10.1523/JNEUROSCI.2757-14.2015; Mackay GA, 2002, J IMMUNOL, V168, P1787, DOI 10.4049/jimmunol.168.4.1787; Moreno-Ayala R, 2015, DEV BIOL, V403, P89, DOI 10.1016/j.ydbio.2015.04.013; Murphy AJ, 2013, NAT MED, V19, P586, DOI 10.1038/nm.3150; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Nurnberg ST, 2012, BLOOD, V120, P4859, DOI 10.1182/blood-2012-01-401893; Nurden AT, 2011, SEMIN THROMB HEMOST, V37, P698, DOI 10.1055/s-0031-1291380; Obinata D, 2012, INT J CANCER, V130, P2240, DOI 10.1002/ijc.26224; Oh Ji Hee, 2014, Genomics & Informatics, V12, P225, DOI 10.5808/GI.2014.12.4.225; Olsson M, 2005, BLOOD, V105, P3577, DOI 10.1182/blood-2004-08-2980; Page C, 2014, CLIN EXP ALLERGY, V44, P901, DOI 10.1111/cea.12322; Panova-Noeva M, 2016, BLOOD, V127, P251, DOI 10.1182/blood-2015-07-660308; Peng Y, 2010, J BIOL CHEM, V285, P11465, DOI 10.1074/jbc.M109.079327; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Qayyum R, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0217-9; Qayyum R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002491; Reiner AP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002108; Sandomenico A, 2009, MOL IMMUNOL, V46, P3300, DOI 10.1016/j.molimm.2009.07.025; Schick UM, 2016, AM J HUM GENET, V98, P229, DOI 10.1016/j.ajhg.2015.12.003; Schmidt VA, 2003, BLOOD, V101, P3021, DOI 10.1182/blood-2002-09-2807; Shameer K, 2014, HUM GENET, V133, P95, DOI 10.1007/s00439-013-1355-7; Sloan A, 2015, ANN EPIDEMIOL, V25, P492, DOI 10.1016/j.annepidem.2015.01.010; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Soranzo N, 2009, BLOOD, V113, P3831, DOI 10.1182/blood-2008-10-184234; Stone James C, 2011, Genes Cancer, V2, P320, DOI 10.1177/1947601911408082; Su YH, 2006, HAEMATOLOGICA, V91, P1392; Sutcliffe P, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17420; Tajuddin SM, 2016, AM J HUM GENET, V99, P22, DOI 10.1016/j.ajhg.2016.05.003; van der Loo B, 1999, ARTERIOSCL THROM VAS, V19, P672, DOI 10.1161/01.ATV.19.3.672; Wang ZY, 2014, AM J HEMATOL, V89, P320, DOI 10.1002/ajh.23619; Weimer C, 2008, J CELL BIOL, V183, P725, DOI 10.1083/jcb.200806140; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Winkler TW, 2014, NAT PROTOC, V9, P1192, DOI 10.1038/nprot.2014.071; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Yamao T, 2002, J BIOL CHEM, V277, P39833, DOI 10.1074/jbc.M203287200; Yang Jian, 2011, Am J Hum Genet, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zhang XL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-532	77	58	58	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 7	2016	99	1					40	55		10.1016/j.ajhg.2016.05.005	http://dx.doi.org/10.1016/j.ajhg.2016.05.005			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT6TI	27346686	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000381616600004
J	Moltke, I; Fumagalli, M; Korneliussen, TS; Crawford, JE; Bjerregaard, P; Jorgensen, ME; Grarup, N; Gullov, HC; Linneberg, A; Pedersen, O; Hansen, T; Nielsen, R; Albrechtsen, A				Moltke, Ida; Fumagalli, Matteo; Korneliussen, Thorfinn S.; Crawford, Jacob E.; Bjerregaard, Peter; Jorgensen, Marit E.; Grarup, Niels; Gullov, Hans Christian; Linneberg, Allan; Pedersen, Oluf; Hansen, Torben; Nielsen, Rasmus; Albrechtsen, Anders			Uncovering the Genetic History of the Present-Day Greenlandic Population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ADMIXTURE; INUIT; ANCESTRY; MODEL	Because of past limitations in samples and genotyping technologies, important questions about the history of the present-day Greenlandic population remain unanswered. In an effort to answer these questions and in general investigate the genetic history of the Greenlandic population, we analyzed similar to 200,000 SNPs from more than 10% of the adult Greenlandic population (n = 4,674). We found that recent gene flow from Europe has had a substantial impact on the population: more than 80% of the Greenlanders have some European ancestry (on average similar to 25% of their genome). However, we also found that the amount of recent European gene flow varies across Greenland and is far smaller in the more historically isolated areas in the north and east and in the small villages in the south. Furthermore, we found that there is substantial population structure in the Inuit genetic component of the Greenlanders and that individuals from the east, west, and north can be distinguished from each other. Moreover, the genetic differences in the Inuit ancestry are consistent with a single colonization wave of the island from north to west to south to east. Although it has been speculated that there has been historical admixture between the Norse Vikings who lived in Greenland for a limited period similar to 600-1,000 years ago and the Inuit, we found no evidence supporting this hypothesis. Similarly, we found no evidence supporting a previously hypothesized admixture event between the Inuit in East Greenland and the Dorset people, who lived in Greenland before the Inuit.	[Moltke, Ida; Albrechtsen, Anders] Univ Copenhagen, Dept Biol, Bioinformat Ctr, DK-2200 Copenhagen, Denmark; [Moltke, Ida] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Fumagalli, Matteo; Crawford, Jacob E.; Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Fumagalli, Matteo] UCL, UCL Genet Inst, Dept Genet Evolut & Environm, London WC1E 6BT, England; [Korneliussen, Thorfinn S.] Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum Denmark, DK-1350 Copenhagen, Denmark; [Bjerregaard, Peter; Jorgensen, Marit E.] Univ Southern Denmark, Natl Inst Publ Hlth, DK-1353 Copenhagen, Denmark; [Jorgensen, Marit E.] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Grarup, Niels; Pedersen, Oluf; Hansen, Torben] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Genet, Fac Hlth & Med Sci, DK-2100 Copenhagen, Denmark; [Gullov, Hans Christian] Natl Museum Denmark, Arctic Ctr Ethnog Collect, DK-1220 Copenhagen, Denmark; [Linneberg, Allan] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, DK-2600 Glostrup, Denmark; [Linneberg, Allan] Glostrup Univ Hosp, Dept Clin Expt Res, DK-2600 Glostrup, Denmark; [Linneberg, Allan] Univ Copenhagen, Dept Clin Med, Fac Hlth & Med Sci, DK-2200 Copenhagen, Denmark; [Hansen, Torben] Univ Southern Denmark, Fac Hlth Sci, DK-5000 Odense, Denmark; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA	University of Copenhagen; University of Chicago; University of California System; University of California Berkeley; University of London; University College London; University of Copenhagen; University of Southern Denmark; Steno Diabetes Center; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Southern Denmark; University of California System; University of California Berkeley	Nielsen, R (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	rasmus_nielsen@berkeley.edu; albrecht@binf.ku.dk	Albrechtsen, Anders/K-4281-2013; Korneliussen, Thorfinn Sand/F-6421-2014; Korneliussen, Thorfinn Sand/ABB-7656-2021; Bjerregaard, Peter/ABD-8894-2020; Moltke, Ida/C-6158-2011; Pedersen, Oluf/AAG-8015-2020; Pedersen, Oluf/Z-1731-2019; Grarup, Niels/K-2807-2015; Fumagalli, Matteo/H-6448-2019; Nielsen, Rasmus/D-4405-2009	Albrechtsen, Anders/0000-0001-7306-031X; Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Bjerregaard, Peter/0000-0001-7153-8447; Moltke, Ida/0000-0001-7052-8554; Pedersen, Oluf/0000-0002-3321-3972; Grarup, Niels/0000-0001-5526-1070; Fumagalli, Matteo/0000-0002-4084-2953; Crawford, Jacob/0000-0002-6745-9145; Jorgensen, Marit Eika/0000-0001-8356-5565; Hansen, Torben/0000-0001-8748-3831; Linneberg, Allan/0000-0002-0994-0184; Nielsen, Rasmus/0000-0003-0513-6591	Danish Council for Independent Research (DFF-YDUN); Villum Foundation; Steno Diabetes Center; NIH [R01-HG003229]; Human Frontiers in Science Program Organization [LT00320/2104]; Novo Nordisk Foundation Center for Basic Metabolic Research, an independent research center at the University of Copenhagen; Novo Nordisk Foundation; Karen Elise Jensen's Foundation; NunaFonden; Danish Council for Independent Research; Medical Research Council of Greenland; Commission for Scientific Research in Greenland; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER; Villum Fonden [00007171] Funding Source: researchfish	Danish Council for Independent Research (DFF-YDUN); Villum Foundation(Villum Fonden); Steno Diabetes Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers in Science Program Organization(Human Frontier Science Program); Novo Nordisk Foundation Center for Basic Metabolic Research, an independent research center at the University of Copenhagen; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Karen Elise Jensen's Foundation; NunaFonden; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Medical Research Council of Greenland; Commission for Scientific Research in Greenland; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Villum Fonden(Villum Fonden)	We would first and foremost like to thank all the Greenlandic participants. Furthermore, we would like to thank the funding agencies and research centers whose funding made this study possible: the Danish Council for Independent Research (DFF-YDUN), the Villum Foundation, the Steno Diabetes Center, the NIH (R01-HG003229), the Human Frontiers in Science Program Organization (LT00320/2104), and the Novo Nordisk Foundation Center for Basic Metabolic Research, which is an independent research center at the University of Copenhagen and is partially funded by an unrestricted donation from the Novo Nordisk Foundation (www.metabol.ku.dk). The Inuit Health in Transition Study, from which a subset of the data used in this study originates, was supported by Karen Elise Jensen's Foundation, NunaFonden, the Danish Council for Independent Research, the Medical Research Council of Greenland, and the Commission for Scientific Research in Greenland.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Appelt M, 2009, NO WORLD AD 900 1400, P300; Bjerregaard P., 2003, INT J CIRCUMPOL HEAL, V62, P3, DOI [10.3402/ijch.v62i0.18212, DOI 10.3402/IJCH.V62I0.18212]; Bosch E, 2003, HUM GENET, V112, P353, DOI 10.1007/s00439-003-0913-9; Busing FMTA, 1999, STAT COMPUT, V9, P3, DOI 10.1023/A:1008800423698; Delaneau O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4934; Falush D, 2003, GENETICS, V164, P1567; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gravel S, 2012, GENETICS, V191, P607, DOI 10.1534/genetics.112.139808; Gullov H. C., 2004, GRONLANDS FORHISTORI; GullOv H. C., 1997, MIDDLE AGES COLONIAL; Gullov H. C., 2008, J N ATLANTIC, V1, P16, DOI DOI 10.3721/070425; GULLOV HC, 2000, IDENTITIES CULTURAL, P43; Helgason A, 2006, AM J PHYS ANTHROPOL, V130, P123, DOI 10.1002/ajpa.20313; Jorgensen ME, 2013, DIABETES CARE, V36, P2988, DOI 10.2337/dc12-2703; Jorgensen ME, 2003, INT J OBESITY, V27, P1507, DOI 10.1038/sj.ijo.0802434; Kleivan Inge, 1984, HDB N AM INDIANS, V5, P549; Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4; Liang M., 2014, UNDERSTANDING ADMIXT; Liang M, 2014, GENETICS, V197, P953, DOI 10.1534/genetics.114.162362; Lynnerup Niels., 1998, GREENLAND NORSE BIOL; Maples BK, 2013, AM J HUM GENET, V93, P278, DOI 10.1016/j.ajhg.2013.06.020; McGhee R., 1996, ANCIENT PEOPLE ARCTI; Moltke I, 2014, NATURE, V512, P190, DOI 10.1038/nature13425; Moltke I, 2014, BIOINFORMATICS, V30, P1027, DOI 10.1093/bioinformatics/btt652; Nielsen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037558; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Petersen R., 1984, HDB N AM INDIANS, V5, P622; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Pool JE, 2009, GENETICS, V181, P711, DOI 10.1534/genetics.108.098095; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000505; Raghavan M, 2014, SCIENCE, V345, P1020, DOI 10.1126/science.1255832; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Sorensen M, 2012, ARCTIC ANTHROPOL, V49, P88, DOI 10.1353/arc.2012.0016; Verdu P, 2011, GENETICS, V189, P1413, DOI 10.1534/genetics.111.132787; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	43	58	58	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 8	2015	96	1					54	69		10.1016/j.ajhg.2014.11.012	http://dx.doi.org/10.1016/j.ajhg.2014.11.012			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AY6YE	25557782	Green Published, hybrid			2022-12-18	WOS:000347707800004
J	Kapoor, A; Sekar, RB; Hansen, NF; Fox-Talbot, K; Morley, M; Pihur, V; Chatterjee, S; Brandimarto, J; Moravec, CS; Pulit, SL; Pfeufer, A; Mullikin, J; Ross, M; Green, ED; Bentley, D; Newton-Cheh, C; Boerwinkle, E; Tomaselli, GF; Cappola, TP; Arking, DE; Halushka, MK; Chakravarti, A				Kapoor, Ashish; Sekar, Rajesh B.; Hansen, Nancy F.; Fox-Talbot, Karen; Morley, Michael; Pihur, Vasyl; Chatterjee, Sumantra; Brandimarto, Jeffrey; Moravec, Christine S.; Pulit, Sara L.; Pfeufer, Arne; Mullikin, Jim; Ross, Mark; Green, Eric D.; Bentley, David; Newton-Cheh, Christopher; Boerwinkle, Eric; Tomaselli, Gordon F.; Cappola, Thomas P.; Arking, Dan E.; Halushka, Marc K.; Chakravarti, Aravinda		QT Interval-Int GWAS Consortium	An Enhancer Polymorphism at the Cardiomyocyte Intercalated Disc Protein NOS1AP Locus Is a Major Regulator of the QT Interval	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NITRIC-OXIDE SYNTHASE; SUDDEN CARDIAC DEATH; SIMPLE SEQUENCE REPEATS; HUMAN GENOME; COMMON VARIANTS; GENETIC-VARIATION; HUMAN-CELLS; REPOLARIZATION; CHROMATIN; DURATION	QT interval variation is assumed to arise from variation in repolarization as evidenced from rare Na- and K-channel mutations in Mendelian QT prolongation syndromes. However, in the general population, common noncoding variants at a chromosome 1q locus are the most common genetic regulators of QT interval variation. In this study, we use multiple human genetic, molecular genetic, and cellular assays to identify a functional variant underlying trait association: a noncoding polymorphism (rs7539120) that maps within an enhancer of NOS1AP and affects cardiac function by increasing NOS1AP transcript expression. We further localized NOS1AP to cardiomyocyte intercalated discs (IDs) and demonstrate that overexpression of NOS1AP in cardiomyocytes leads to altered cellular electrophysiology. We advance the hypothesis that NOS1AP affects cardiac electrical conductance and coupling and thereby regulates the QT interval through propagation defects. As further evidence of an important role for propagation variation affecting QT interval in humans, we show that common polymorphisms mapping near a specific set of 170 genes encoding ID proteins are significantly enriched for association with the QT interval, as compared to genome-wide markers. These results suggest that focused studies of proteins within the cardiomyocyte ID are likely to provide insights into QT prolongation and its associated disorders.	[Kapoor, Ashish; Pihur, Vasyl; Chatterjee, Sumantra; Arking, Dan E.; Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Sekar, Rajesh B.; Tomaselli, Gordon F.] Johns Hopkins Univ, Sch Med, Div Cardiol, Baltimore, MD 21205 USA; [Fox-Talbot, Karen; Halushka, Marc K.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Hansen, Nancy F.; Mullikin, Jim; Green, Eric D.] NHGRI, NIH, Bethesda, MD 20892 USA; [Morley, Michael; Brandimarto, Jeffrey; Cappola, Thomas P.] Univ Penn, Perelman Sch Med, Penn Cardiovasc Inst, Philadelphia, PA 19104 USA; [Moravec, Christine S.] Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA; [Pulit, Sara L.] Univ Med Ctr Utrecht, NL-3584 CX Utrecht, Netherlands; [Pfeufer, Arne] Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, D-85764 Neuherberg, Germany; [Pfeufer, Arne] Isar Med Zentrum, D-80331 Munich, Germany; [Ross, Mark; Bentley, David] Illumina United Kingdom, Saffron Walden CB10 1XL, Essex, England; [Newton-Cheh, Christopher] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Ctr Human Genet Res, Boston, MA 02114 USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Div Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Pennsylvania; Pennsylvania Medicine; Cleveland Clinic Foundation; Utrecht University; Utrecht University Medical Center; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Illumina; Harvard University; Massachusetts General Hospital; University of Texas System; University of Texas Health Science Center Houston	Chakravarti, A (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.	aravinda@jhmi.edu	Pfeufer, Arne/B-6634-2013	Halushka, Marc/0000-0002-7112-7389; Pulit, Sara/0000-0002-2502-3669; Morley, Michael/0000-0002-0958-7376; Kapoor, Ashish/0000-0003-3977-6140	NIH [RO1HL086694, RO1HL105993]; Donald W. Reynolds Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086694, R01HL105993] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200330, ZIBHG000196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104469] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Donald W. Reynolds Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to William C. Claycomb (Louisiana State University, New Orleans) for providing HL1 cells, Norman Barker (Johns Hopkins University, Baltimore) for help with imaging, and Akhilesh Pandey and Andrew S. McCallion (Johns Hopkins University, Baltimore) for critical discussions. We also thank Ashley O'Connor and Maria X. Sosa (Johns Hopkins University, Baltimore) for technical assistance, Paula Kokko-Gonzales, Louise Fraser, Niall Gormley, and Terena James (Illumina) for sequencing, and Ankit Rakha (Johns Hopkins University Baltimore), Keira Cheetham, and Lisa Murray (Illumina) for computational support. This work was supported by NIH grants RO1HL086694 and RO1HL105993 and funds from the Donald W. Reynolds Foundation. A.C. is on the Scientific Advisory Board of Biogen Idec and this potential competing interest is managed by the policies of the Johns Hopkins University, School of Medicine. M.R. and D.B. are employees of Illumina, Inc., a public company that develops and markets systems for genetic analysis.	Aarnoudse AJLHJ, 2007, CIRCULATION, V116, P10, DOI 10.1161/CIRCULATIONAHA.106.676783; Ahituv N, 2007, PLOS BIOL, V5, P1906, DOI 10.1371/journal.pbio.0050234; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; ARANY Z, 1994, CELL, V77, P799, DOI 10.1016/0092-8674(94)90127-9; Arking DE, 2006, NAT GENET, V38, P644, DOI 10.1038/ng1790; Arking DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004333; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boyle AP, 2008, BIOINFORMATICS, V24, P2537, DOI 10.1093/bioinformatics/btn480; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Chang KC, 2008, P NATL ACAD SCI USA, V105, P4477, DOI 10.1073/pnas.0709118105; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Crotti L, 2009, CIRCULATION, V120, P1657, DOI 10.1161/CIRCULATIONAHA.109.879643; Dekker JM, 2004, J AM COLL CARDIOL, V43, P565, DOI 10.1016/j.jacc.2003.09.040; Drake JA, 2006, NAT GENET, V38, P223, DOI 10.1038/ng1710; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Eijgelsheim M, 2009, HUM MOL GENET, V18, P4213, DOI 10.1093/hmg/ddp356; Emison ES, 2010, AM J HUM GENET, V87, P60, DOI 10.1016/j.ajhg.2010.06.007; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; Estigoy Colleen B, 2009, Biophys Rev, V1, P43, DOI 10.1007/s12551-008-0007-y; Fisher S, 2006, SCIENCE, V312, P276, DOI 10.1126/science.1124070; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Hedley PL, 2009, HUM MUTAT, V30, P1486, DOI 10.1002/humu.21106; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; Hong JW, 2008, SCIENCE, V321, P1314, DOI 10.1126/science.1160631; Jaffrey SR, 1998, NEURON, V20, P115, DOI 10.1016/S0896-6273(00)80439-0; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kao WHL, 2009, CIRCULATION, V119, P940, DOI 10.1161/CIRCULATIONAHA.108.791723; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kashi Y, 1997, TRENDS GENET, V13, P74, DOI 10.1016/S0168-9525(97)01008-1; Kashi Y, 2006, TRENDS GENET, V22, P253, DOI 10.1016/j.tig.2006.03.005; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lim ZY, 2006, CIRCULATION, V114, P2113, DOI 10.1161/CIRCULATIONAHA.105.598631; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; May D, 2012, NAT GENET, V44, P89, DOI 10.1038/ng.1006; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Milan DJ, 2009, CIRCULATION, V120, P553, DOI 10.1161/CIRCULATIONAHA.108.821082; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Newton-Cheh C, 2005, HEART RHYTHM, V2, P277, DOI 10.1016/j.hrthm.2004.11.009; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Pfeufer A, 2005, CIRC RES, V96, P693, DOI 10.1161/01.RES.0000161077.53751.e6; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Post W, 2007, HUM HERED, V64, P214, DOI 10.1159/000103630; Priori SG, 2004, ANN NY ACAD SCI, V1015, P96, DOI 10.1196/annals.1302.008; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Rozen S, 2000, Methods Mol Biol, V132, P365; Santos AM, 2012, NAT CHEM BIOL, V8, P102, DOI 10.1038/nchembio.717; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Sekar RB, 2007, AM J PHYSIOL-HEART C, V293, pH2757, DOI 10.1152/ajpheart.00477.2007; Sotoodehnia N, 2010, NAT GENET, V42, P1068, DOI 10.1038/ng.716; Teer JK, 2010, GENOME RES, V20, P1420, DOI 10.1101/gr.106716.110; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tomas M, 2010, J AM COLL CARDIOL, V55, P2745, DOI 10.1016/j.jacc.2009.12.065; Tsai IC, 2007, DEV CELL, V12, P335, DOI 10.1016/j.devcel.2007.02.009; Tung L, 2006, J ELECTROCARDIOL, V39, pS2, DOI 10.1016/j.jelectrocard.2006.04.010; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	67	58	60	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 5	2014	94	6					854	869		10.1016/j.ajhg.2014.05.001	http://dx.doi.org/10.1016/j.ajhg.2014.05.001			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AJ0HK	24857694	Green Published, Bronze			2022-12-18	WOS:000337331200006
J	Humbert, C; Silbermann, F; Morar, B; Parisot, M; Zarhrate, M; Masson, C; Tores, F; Blanchet, P; Perez, MJ; Petrov, Y; Van Kien, PK; Roume, J; Leroy, B; Gribouval, O; Kalaydjieva, L; Heidet, L; Salomon, R; Antignac, C; Benmerah, A; Saunier, S; Jeanpierre, C				Humbert, Camille; Silbermann, Flora; Morar, Bharti; Parisot, Melanie; Zarhrate, Mohammed; Masson, Cecile; Tores, Frederic; Blanchet, Patricia; Perez, Marie-Jose; Petrov, Yuliya; Van Kien, Philippe Khau; Roume, Joelle; Leroy, Brigitte; Gribouval, Olivier; Kalaydjieva, Luba; Heidet, Laurence; Salomon, Remi; Antignac, Corinne; Benmerah, Alexandre; Saunier, Sophie; Jeanpierre, Cecile			Integrin Alpha 8 Recessive Mutations Are Responsible for Bilateral Renal Agenesis in Humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							URINARY-TRACT CAKUT; CONGENITAL-ANOMALIES; KIDNEY DEVELOPMENT; FRASER-SYNDROME; RET; ALPHA-8-BETA-1; MORPHOGENESIS; NEPHRONECTIN; COHORT	Renal hypodysplasia (RHD) is a heterogeneous condition encompassing a spectrum of kidney development defects including renal agenesis, hypoplasia, and (cystic) dysplasia. Heterozygous mutations of several genes have been identified as genetic causes of RHD with various severity. However, these genes and mutations are not associated with bilateral renal agenesis, except for RET mutations, which could be involved in a few cases. The pathophysiological mechanisms leading to total absence of kidney development thus remain largely elusive. By using a whole-exome sequencing approach in families with several fetuses with bilateral renal agenesis, we identified recessive mutations in the integrin alpha 8-encoding gene ITGA8 in two families. Itga8 homozygous knockout in mice is known to result in absence of kidney development. We provide evidence of a damaging effect of the human ITGA8 mutations. These results demonstrate that mutations of ITGA8 are a genetic cause of bilateral renal agenesis and that, at least in some cases, bilateral renal agenesis is an autosomal-recessive disease.	[Humbert, Camille; Silbermann, Flora; Parisot, Melanie; Gribouval, Olivier; Salomon, Remi; Antignac, Corinne; Benmerah, Alexandre; Saunier, Sophie; Jeanpierre, Cecile] Hop Necker Enfants Malad, Inst Natl Sante & Rech Med U983, F-75015 Paris, France; [Humbert, Camille; Silbermann, Flora; Gribouval, Olivier; Salomon, Remi; Antignac, Corinne; Benmerah, Alexandre; Saunier, Sophie; Jeanpierre, Cecile] Univ Paris 05, Sorbonne Paris Cite, Inst Imagine, F-75015 Paris, France; [Morar, Bharti; Kalaydjieva, Luba] Univ Western Australia, Harry Perkins Inst Med Res, Med Res Ctr, Perth, WA 6009, Australia; [Parisot, Melanie; Zarhrate, Mohammed] Hop Necker Enfants Malad, Inst Imagine, Plateforme Genom, F-75015 Paris, France; [Masson, Cecile; Tores, Frederic] Univ Paris 05, Sorbonne Paris Cite, Inst Imagine, Plateforme Bioinformat, F-75015 Paris, France; [Blanchet, Patricia; Perez, Marie-Jose] Hop Arnaud de Villeneuve, Dept Med Genet, F-34090 Montpellier, France; CHU Nimes Hop Caremeau, Unite Genet Med & Cytogenet, Ctr Reference Anomalies Dev & Syndromes Malformat, F-30029 Nimes, France; [Roume, Joelle] CHI Poissy St Germain en Laye, Unite Genet Med, Serv Cytogenet & Biol Reprod, F-78300 Poissy, France; [Leroy, Brigitte] CHI Poissy St Germain en Laye, Serv Anatom & Cytol Pathol, F-78300 Poissy, France; [Heidet, Laurence; Salomon, Remi] Hop Necker Enfants Malad, AP HP, Ctr Reference MARHEA, Serv Nephrol Pediat, F-75015 Paris, France; [Antignac, Corinne] Hop Necker Enfants Malad, AP HP, Serv Genet, F-75015 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Harry Perkins Institute of Medical Research; University of Western Australia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; Hospital Chi of Poissy Saint Germain; Hospital Chi of Poissy Saint Germain; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Jeanpierre, C (corresponding author), Hop Necker Enfants Malad, Inst Natl Sante & Rech Med U983, F-75015 Paris, France.	cecile.jeanpierre@inserm.fr	ANTIGNAC, Corinne/H-8945-2017; Saunier, Sophie/G-6044-2015; Gribouval, Olivier/A-7689-2015; Jeanpierre, cecile/H-3770-2017; benmerah, alexandre/H-3742-2017; Morar, Bharti/O-8697-2014	ANTIGNAC, Corinne/0000-0002-9934-4940; Saunier, Sophie/0000-0002-1069-0047; Gribouval, Olivier/0000-0003-0238-8224; Jeanpierre, cecile/0000-0002-3463-5907; benmerah, alexandre/0000-0003-0188-8016; Morar, Bharti/0000-0003-3897-1403; legendre, flora/0000-0002-4149-1913; Heidet, Laurence/0000-0002-1362-5515; KHAU VAN KIEN, Philippe/0000-0001-7754-969X	European Union [305608]; GIS-Maladies Rares [AAE11010KSA]; Programme Hospitalier de la Recherche Clinique Assistance Publique [AOM07129]; EUrenOmics	European Union(European Commission); GIS-Maladies Rares; Programme Hospitalier de la Recherche Clinique Assistance Publique; EUrenOmics	We thank Yuya Sato for providing us with the ITGA8 cDNA construct and William Baron for his help for FACS analysis. We also thank Christine Bole-Feysot and Patrick Nitschke for their effective support in exome sequencing and bioinformatic analyses. We are grateful to the families for their participation. We also thank the fetopathologists of the SOFFOET for providing us with fetal tissue samples. The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP712007-2013) under grant agreement no. 305608 (EURenOmics), GIS-Maladies Rares (AAE11010KSA), and the Programme Hospitalier de la Recherche Clinique Assistance Publique (AOM07129). C.H. was funded by EUrenOmics.	Alazami AM, 2009, AM J HUM GENET, V85, P414, DOI 10.1016/j.ajhg.2009.08.010; Albuisson Juliette, 2005, Hum Mutat, V25, P98, DOI 10.1002/humu.9298; Barak H, 2012, DEV CELL, V22, P1191, DOI 10.1016/j.devcel.2012.04.018; Cain JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007313; Gresham D, 2001, AM J HUM GENET, V69, P1314, DOI 10.1086/324681; Heidet L, 2010, CLIN J AM SOC NEPHRO, V5, P1079, DOI 10.2215/CJN.06810909; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jeanpierre C, 2011, J MED GENET, V48, P497, DOI 10.1136/jmg.2010.088526; Krug P, 2011, HUM MUTAT, V32, P183, DOI 10.1002/humu.21402; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Y, 2010, AM J HUM GENET, V86, P696, DOI 10.1016/j.ajhg.2010.03.004; Linton JM, 2007, DEVELOPMENT, V134, P2501, DOI 10.1242/dev.005033; Madariaga L, 2013, CLIN J AM SOC NEPHRO, V8, P1179, DOI 10.2215/CJN.10221012; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miller EM, 2012, AM J MED GENET A, V158A, P533, DOI 10.1002/ajmg.a.34426; Muller U, 1997, CELL, V88, P603, DOI 10.1016/S0092-8674(00)81903-0; Orten DJ, 2008, HUM MUTAT, V29, P537, DOI 10.1002/humu.20691; Pitera JE, 2008, HUM MOL GENET, V17, P3953, DOI 10.1093/hmg/ddn297; Prato AP, 2009, MEDICINE, V88, P83, DOI 10.1097/MD.0b013e31819cf5da; Renkema KY, 2011, NEPHROL DIAL TRANSPL, V26, P3843, DOI 10.1093/ndt/gfr655; Sanna-Cherchi S, 2009, KIDNEY INT, V76, P528, DOI 10.1038/ki.2009.220; Sato Y, 2009, J BIOL CHEM, V284, P14524, DOI 10.1074/jbc.M900200200; SCHNAPP LM, 1995, J BIOL CHEM, V270, P23196, DOI 10.1074/jbc.270.39.23196; Skinner MA, 2008, AM J HUM GENET, V82, P344, DOI 10.1016/j.ajhg.2007.10.008; Ulinski T, 2006, J AM SOC NEPHROL, V17, P497, DOI 10.1681/ASN.2005101040; Van Esch H, 2000, NATURE, V406, P419, DOI 10.1038/35019088; van Haelst MM, 2008, AM J MED GENET A, V146A, P2252, DOI 10.1002/ajmg.a.32440; Weber S, 2006, J AM SOC NEPHROL, V17, P2864, DOI 10.1681/ASN.2006030277; Yosypiv IV., 2012, INT J NEPHROL, V202, P1, DOI DOI 10.1155/2012/909083; Zhang X, 2009, DEVELOPMENT, V136, P3357, DOI 10.1242/dev.036269	30	58	63	1	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 6	2014	94	2					288	294		10.1016/j.ajhg.2013.12.017	http://dx.doi.org/10.1016/j.ajhg.2013.12.017			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AA9NF	24439109	Bronze, Green Published			2022-12-18	WOS:000331419500012
J	Al-Sayed, MD; Al-Zaidan, H; Albakheet, A; Hakami, H; Kenana, R; Al-Yafee, Y; Al-Dosary, M; Qari, A; Al-Sheddi, T; Al-Muheiza, M; Al-Qubbaj, W; Lakmache, Y; Al-Hindi, H; Ghaziuddin, M; Colak, D; Kaya, N				Al-Sayed, Moeenaldeen D.; Al-Zaidan, Hamad; Albakheet, AlBandary; Hakami, Hana; Kenana, Rosan; Al-Yafee, Yusra; Al-Dosary, Mazhor; Qari, Alya; Al-Sheddi, Tarfa; Al-Muheiza, Muhammed; Al-Qubbaj, Wafa; Lakmache, Yamina; Al-Hindi, Hindi; Ghaziuddin, Muhammad; Colak, Dilek; Kaya, Namik			Mutations in NALCN Cause an Autosomal-Recessive Syndrome with Severe Hypotonia, Speech Impairment, and Cognitive Delay	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VOLTAGE-GATED SODIUM; ION-CHANNEL; SCHIZOPHRENIA; DATABASE	Sodium leak channel, nonselective (NALCN) is a voltage-independent and cation-nonselective channel that is mainly responsible for the leaky sodium transport across neuronal membranes and controls neuronal excitability. Although NALCN variants have been conflictingly reported to be in linkage disequilibrium with schizophrenia and bipolar disorder, to Our knowledge, no mutations have been reported to date for any inherited disorders. Using linkage, SNP-based homozygosity mapping, targeted sequencing, and confirmatory exome sequencing, we identified two mutations, one missense and one nonsense, in NALCN in two unrelated families. The mutations cause an autosomal-recessive syndrome characterized by subtle facial dysmorphism, variable degrees of hypotonia, speech impairment, chronic constipation, and intellectual disability. Furthermore, one of the families pursued preimplantation genetic diagnosis on the basis of the results from this study, and the mother recently delivered healthy twins, a boy and a girl, with no symptoms of hypotonia, which was present in all the affected children at birth. Hence, the two families we describe here represent instances of loss of function in human NALCN.	[Al-Sayed, Moeenaldeen D.; Al-Zaidan, Hamad; Kenana, Rosan; Al-Yafee, Yusra; Qari, Alya] King Faisal Specialist Hosp & Res Ctr, Dept Med Genet, Riyadh 11211, Saudi Arabia; [Albakheet, AlBandary; Hakami, Hana; Kenana, Rosan; Al-Yafee, Yusra; Al-Dosary, Mazhor; Al-Sheddi, Tarfa; Kaya, Namik] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Colak, Dilek] King Faisal Specialist Hosp & Res Ctr, Dept Biostat Epidemiol & Sci Comp, Riyadh 11211, Saudi Arabia; [Al-Muheiza, Muhammed] King Faisal Specialist Hosp & Res Ctr, Dept Neurosci, Riyadh 11211, Saudi Arabia; [Al-Qubbaj, Wafa; Al-Hindi, Hindi; Kaya, Namik] King Faisal Specialist Hosp & Res Ctr, Dept Pathol & Lab Med, Riyadh 11211, Saudi Arabia; [Lakmache, Yamina; Ghaziuddin, Muhammad] King Faisal Specialist Hosp & Res Ctr, Dept Mental Hlth, Riyadh 11211, Saudi Arabia	King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center	Kaya, N (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia.	nkaya@kfshrc.edu.sa	, WaNgtJ/AAR-7045-2020	Al-Hindi, Hindi/0000-0002-7800-5229; Colak, Dilek/0000-0001-6485-8768	King Faisal Specialist Hospital and Research Centre	King Faisal Specialist Hospital and Research Centre	The authors thank the families for their participation in this study. This work was supported by King Faisal Specialist Hospital and Research Centre seed research grants, and the authors are grateful for the financial support. We thank Fowzan S. Alkuraya, Yufei Shi, and Bedri Karakas for helpful discussions. We are grateful to our hospital's purchasing department for facilitating all ordering and receiving inquiries, including reagents, assays, and chemicals, as well as members of our core facilities (Genotyping/Microarray and Sequencing) for their continuous technical support.	Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Huang C, 2012, GENE, V498, P308, DOI 10.1016/j.gene.2012.01.083; Kim BJ, 2012, CELL PHYSIOL BIOCHEM, V29, P501, DOI 10.1159/000338504; Lee JH, 1999, FEBS LETT, V445, P231, DOI 10.1016/S0014-5793(99)00082-4; Lu BX, 2007, CELL, V129, P371, DOI 10.1016/j.cell.2007.02.041; Lu BX, 2010, NEURON, V68, P488, DOI 10.1016/j.neuron.2010.09.014; Lu BX, 2009, NATURE, V457, P741, DOI 10.1038/nature07579; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Siva Nayanah, 2008, Nat Biotechnol, V26, P256, DOI 10.1038/nbt0308-256b; Souza RP, 2011, PSYCHIAT RES, V185, P450, DOI 10.1016/j.psychres.2010.07.009; Stenson PD, 2008, J MED GENET, V45, P124, DOI 10.1136/jmg.2007.055210; Swayne LA, 2010, ISLETS, V2, P54, DOI 10.4161/isl.2.1.10522; Swayne LA, 2009, EMBO REP, V10, P873, DOI 10.1038/embor.2009.125; Teo C, 2012, PHARMACOGENET GENOM, V22, P807, DOI 10.1097/FPC.0b013e3283586c04; Wang KS, 2010, SCHIZOPHR RES, V124, P192, DOI 10.1016/j.schres.2010.09.002; Xia JF, 2012, HUM MUTAT, V33, pE2341, DOI 10.1002/humu.22096; Yu FH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-207	19	58	60	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 3	2013	93	4					721	726		10.1016/j.ajhg.2013.08.001	http://dx.doi.org/10.1016/j.ajhg.2013.08.001			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	243GT	24075186	Green Published, Bronze			2022-12-18	WOS:000326305600013
J	Jones, BL; Raga, TO; Liebert, A; Zmarz, P; Bekele, E; Danielsen, ET; Olsen, AK; Bradman, N; Troelsen, JT; Swallow, DM				Jones, Bryony L.; Raga, Tamiru O.; Liebert, Anke; Zmarz, Pawel; Bekele, Endashaw; Danielsen, E. Thomas; Olsen, Anders Krueger; Bradman, Neil; Troelsen, Jesper T.; Swallow, Dallas M.			Diversity of Lactase Persistence Alleles in Ethiopia: Signature of a Soft Selective Sweep	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MOLECULAR POPULATION-GENETICS; RECENT POSITIVE SELECTION; POLYMORPHISM; ADAPTATION; AFRICA; EVOLUTION; UPSTREAM; EUROPE; GENOME; DNA	The persistent expression of lactase into adulthood in humans is a recent genetic adaptation that allows the consumption of milk from other mammals after weaning. In Europe, a single allele (-13910*T, rs4988235) in an upstream region that acts as an enhancer to the expression of the lactase gene LCT is responsible for lactase persistence and appears to have been under strong directional selection in the last 5,000 years, evidenced by the widespread occurrence of this allele on an extended haplotype. In Africa and the Middle East, the situation is more complicated and at least three other alleles (-13907*G, rs41525747; -13915*G, rs41380347; -14010*C, rs145946881) in the same LCT enhancer region can cause continued lactase expression. Here we examine the LCT enhancer sequence in a large lactose-tolerance-tested Ethiopian cohort of more than 350 individuals. We show that a further SNP, -14009T>G (ss 820486563), is significantly associated with lactose-digester status, and in vitro functional tests confirm that the 14009*G allele also increases expression of an LCT promoter construct. The derived alleles in the LCT enhancer region are spread through several ethnic groups, and we report a greater genetic diversity in lactose digesters than in nondigesters. By examining flanking markers to control for the effects of mutation and demography, we further describe, from empirical evidence, the signature of a soft selective sweep.	[Jones, Bryony L.; Liebert, Anke; Zmarz, Pawel; Bradman, Neil; Swallow, Dallas M.] UCL, Res Dept Genet Evolut & Environm, London WC1E 6BT, England; [Raga, Tamiru O.; Bekele, Endashaw] Univ Addis Ababa, Dept Biol, Addis Ababa, Ethiopia; [Danielsen, E. Thomas; Olsen, Anders Krueger; Troelsen, Jesper T.] Roskilde Univ, Dept Sci Syst & Models, DK-4000 Roskilde, Denmark; [Bradman, Neil] Henry Stewart Grp, London WC1A 2HN, England	University of London; University College London; Addis Ababa University; Roskilde University	Swallow, DM (corresponding author), UCL, Res Dept Genet Evolut & Environm, Darwin Bldg, London WC1E 6BT, England.	d.swallow@ucl.ac.uk	Troelsen, Jesper Thorvald T/B-6264-2013; Danielsen, E. Thomas/W-8740-2019	Troelsen, Jesper Thorvald T/0000-0002-4177-3267; Zmarz, Pawel/0000-0001-5035-9423; Liebert, Anke/0000-0002-5849-6147; Danielsen, E. Thomas/0000-0002-5139-5466; Jones, Bryony/0000-0003-0428-9078	MRC UK (MRC DTA studentship); European Union [215362-2]; Annals of Human Genetics; Melford Charitable Trust	MRC UK (MRC DTA studentship); European Union(European Commission); Annals of Human Genetics; Melford Charitable Trust	This work was funded by the MRC UK (MRC DTA studentship for B.L.J.), the European Union (Marie Curie ITN FP7 Framework Programme grant, LeCHE, Grant ref 215362-2 to A.L.), the Annals of Human Genetics (B.L.J. and A.L.), and Melford Charitable Trust (studentship for T.O.R.). N.B. is the settlor and senior trustee of Melford Charitable Trust. Neither N.B. nor the charitable trust has any intellectual property or other rights with respect to the results of the study. We thank Mad Wyn Burley and Ranji Araseretnam for technical help, Mirna Kovacevic and Ripudaman Bains for their help with data handling, and Ed Hollox for helpful discussion.	Anagnostou P, 2009, AM J HUM BIOL, V21, P217, DOI 10.1002/ajhb.20851; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Coelho M, 2005, HUM GENET, V117, P329, DOI 10.1007/s00439-005-1322-z; Enattah NS, 2008, AM J HUM GENET, V82, P57, DOI 10.1016/j.ajhg.2007.09.012; Freeman B, 2003, BEHAV GENET, V33, P67, DOI 10.1023/A:1021055617738; Harvey CB, 1998, ANN HUM GENET, V62, P215, DOI 10.1046/j.1469-1809.1998.6230215.x; Hermisson J, 2005, GENETICS, V169, P2335, DOI 10.1534/genetics.104.036947; Hollox EJ, 2001, AM J HUM GENET, V68, P160, DOI 10.1086/316924; Ingram CJE, 2007, HUM GENET, V120, P779, DOI 10.1007/s00439-006-0291-1; Ingram CJE, 2009, J MOL EVOL, V69, P579, DOI 10.1007/s00239-009-9301-y; Ingram CJE, 2009, HUM GENET, V124, P579, DOI 10.1007/s00439-008-0593-6; Itan Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000491; Jensen TGK, 2011, HUM GENET, V130, P483, DOI 10.1007/s00439-011-0966-0; Jones Bryony L, 2011, Hugo J, V5, P13, DOI 10.1007/s11568-011-9155-4; Mulcare CA, 2004, AM J HUM GENET, V74, P1102, DOI 10.1086/421050; Olds LC, 2011, HUM GENET, V129, P111, DOI 10.1007/s00439-010-0898-0; Pennings PS, 2006, PLOS GENET, V2, P1998, DOI 10.1371/journal.pgen.0020186; Pennings PS, 2006, MOL BIOL EVOL, V23, P1076, DOI 10.1093/molbev/msj117; Poulter M, 2003, ANN HUM GENET, V67, P298, DOI 10.1046/j.1469-1809.2003.00048.x; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sibley Eric, 2011, Trans Am Clin Climatol Assoc, V122, P155; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Thomas MG, 2002, AM J HUM GENET, V70, P1411, DOI 10.1086/340609; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Troelsen JT, 2003, GASTROENTEROLOGY, V125, P1686, DOI 10.1053/j.gastro.2003.09.031; Wang Z, 2006, DNA CELL BIOL, V25, P215, DOI 10.1089/dna.2006.25.215	28	58	59	2	50	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 5	2013	93	3					538	544		10.1016/j.ajhg.2013.07.008	http://dx.doi.org/10.1016/j.ajhg.2013.07.008			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	297QB	23993196	Green Published, hybrid			2022-12-18	WOS:000330268900013
J	Schraders, M; Ruiz-Palmero, L; Kalay, E; Oostrik, J; del Castillo, FJ; Sezgin, O; Beynon, AJ; Strom, TM; Pennings, RJE; Seco, CZ; Oonk, AMM; Kunst, HPM; Dominguez-Ruiz, M; Garcia-Arumi, AM; del Campo, M; Villamar, M; Hoefsloot, LH; Moreno, F; Admiraal, RJC; del Castillo, I; Kremer, H				Schraders, Margit; Ruiz-Palmero, Laura; Kalay, Ersan; Oostrik, Jaap; del Castillo, Francisco J.; Sezgin, Orhan; Beynon, Andy J.; Strom, Tim M.; Pennings, Ronald J. E.; Seco, Celia Zazo; Oonk, Anne M. M.; Kunst, Henricus P. M.; Dominguez-Ruiz, Maria; Garcia-Arumi, Ana M.; del Campo, Miguel; Villamar, Manuela; Hoefsloot, Lies H.; Moreno, Felipe; Admiraal, Ronald J. C.; del Castillo, Ignacio; Kremer, Hannie			Mutations of the Gene Encoding Otogelin Are a Cause of Autosomal-Recessive Nonsyndromic Moderate Hearing Impairment	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TECTORIAL MEMBRANE; ALPHA-TECTORIN; INNER-EAR; ACELLULAR MEMBRANES; DEAFNESS DFNB18; TECTA; MOUSE; DFNA13/COL11A2; PHENOTYPE; FAMILY	Already 40 genes have been identified for autosomal-recessive nonsyndromic hearing impairment (arNSHI); however, many more genes are still to be identified. In a Dutch family segregating arNSHI, homozygosity mapping revealed a 2.4 Mb homozygous region on chromosome 11 in p15.1-15.2, which partially overlapped with the previously described DFNB18 locus. However, no putative pathogenic variants were found in USH1C, the gene mutated in DFNB18 hearing impairment. The homozygous region contained 12 additional annotated genes including OTOG, the gene encoding otogelin, a component of the tectorial membrane. It is thought that otogelin contributes to the stability and strength of this membrane through interaction or stabilization of its constituent fibers. The murine orthologous gene was already known to cause hearing loss when defective. Analysis of OTOG in the Dutch family revealed a homozygous 1 bp deletion, c.5508delC, which leads to a shift in the reading frame and a premature stop codon, p.Ala1838ProfsX31. Further screening of 60 unrelated probands from Spanish arNSHI families detected compound heterozygous OTOG mutations in one family, c.6347C>T (p.Pro2116Leu) and c. 6559C>T (p.Arg2187X). The missense mutation p.Pro2116Leu affects a highly conserved residue in the fourth von Willebrand factor type D domain of otogelin. The subjects with OTOG mutations have a moderate hearing impairment, which can be associated with vestibular dysfunction. The flat to shallow "U" or slightly downsloping shaped audiograms closely resembled audiograms of individuals with recessive mutations in the gene encoding a-tectorin, another component of the tectorial membrane. This distinctive phenotype may represent a clue to orientate the molecular diagnosis.	[Schraders, Margit; Oostrik, Jaap; Beynon, Andy J.; Pennings, Ronald J. E.; Seco, Celia Zazo; Oonk, Anne M. M.; Kunst, Henricus P. M.; Admiraal, Ronald J. C.; Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, NL-6500 HB Nijmegen, Netherlands; [Schraders, Margit; Oostrik, Jaap; Seco, Celia Zazo; Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Schraders, Margit; Oostrik, Jaap; Beynon, Andy J.; Pennings, Ronald J. E.; Seco, Celia Zazo; Oonk, Anne M. M.; Kunst, Henricus P. M.; Admiraal, Ronald J. C.; Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands; [Hoefsloot, Lies H.; Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Ruiz-Palmero, Laura; del Castillo, Francisco J.; Dominguez-Ruiz, Maria; Villamar, Manuela; Moreno, Felipe; del Castillo, Ignacio] Hosp Univ Ramon y Cajal, IRYCIS, Unidad Genet Mol, Madrid 28034, Spain; [Ruiz-Palmero, Laura; del Castillo, Francisco J.; Dominguez-Ruiz, Maria; Villamar, Manuela; Moreno, Felipe; del Castillo, Ignacio] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid 28034, Spain; [Kalay, Ersan] Karadeniz Tech Univ, Fac Med, Dept Med Biol, TR-61080 Trabzon, Turkey; [Sezgin, Orhan] Karadeniz Tech Univ, Inst Hlth Sci, Dept Med Biol, TR-61080 Trabzon, Turkey; [Strom, Tim M.] German Res Ctr Envirom Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Garcia-Arumi, Ana M.] Hosp Univ Vall dHebron, Serv ORL, Barcelona 08035, Spain; [del Campo, Miguel] Hosp Univ Vall dHebron, Unidad Genet Clin, Programa Med Mol & Genet, Barcelona 08035, Spain	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Hospital Universitario Ramon y Cajal; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Karadeniz Technical University; Karadeniz Technical University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron	Kremer, H (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, NL-6500 HB Nijmegen, Netherlands.	h.kremer@gen.umcn.nl	Admiraal, R.J.C./L-4171-2015; del Castillo, Ignacio/B-4314-2013; Kremer, Hannie/F-5126-2010; Beynon, Andy/D-3476-2009; Kalay, Ersan/AAL-2906-2021; Schraders, Margit/A-1607-2016; Oostrik, Jaap/A-1703-2016; Seco, Celia Zazo/AAB-7636-2020; del Castillo, Francisco J./A-6467-2013; Beynon, Andy/L-4198-2015; Dominguez-Ruiz, Maria/GQY-7939-2022; Oonk, Anne/G-3935-2016; Kunst, Henricus P.M./J-6456-2012; Villamar, Manuela/AAD-3842-2020; Pennings, Ronald JE/J-6651-2012	del Castillo, Ignacio/0000-0003-1188-3665; Kremer, Hannie/0000-0002-0841-8693; Beynon, Andy/0000-0002-3191-6113; Kalay, Ersan/0000-0002-1467-2268; Seco, Celia Zazo/0000-0003-3506-7611; del Castillo, Francisco J./0000-0003-0467-4320; Beynon, Andy/0000-0002-3191-6113; Dominguez-Ruiz, Maria/0000-0002-7583-0370; Kunst, Henricus P.M./0000-0003-1162-6394; Villamar, Manuela/0000-0002-5115-4937; Pennings, Ronald JE/0000-0001-5517-9683	Heinsius Houbolt Foundation; INTERREG IV A-program Germany-the Netherlands; Oticon Foundation [09-3742]; ZonMW [40-00812-98-09047, 90700388]; Netherlands Genomics Initiative [40-41009-98-9073]; Fondo de Investigaciones Sanitarias [PI 08/0818, PI 11/00612]; Fundacion Ramon Areces; Spanish Ministerio de Ciencia e Innovacion [SAF2008-03216]; Karadeniz Technical University Research Fund [2006.114.001.1]; Instituto de Salud Carlos III	Heinsius Houbolt Foundation; INTERREG IV A-program Germany-the Netherlands; Oticon Foundation; ZonMW(Netherlands Organization for Health Research and Development); Netherlands Genomics Initiative; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Fundacion Ramon Areces; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Karadeniz Technical University Research Fund; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	We are grateful to the families for their participation in this study. This work was financially supported by grants from the Heinsius Houbolt Foundation (to H.K.), the INTERREG IV A-program Germany-the Netherlands, The Oticon Foundation (09-3742, to H.K.), ZonMW (40-00812-98-09047, to H.K. and 90700388 to R.J.E.P.), Netherlands Genomics Initiative (40-41009-98-9073, to M.S.), Fondo de Investigaciones Sanitarias (PI 08/0818 and PI 11/00612, to I.d.C.), Fundacion Ramon Areces (to I.d.C.), and Spanish Ministerio de Ciencia e Innovacion (SAF2008-03216, to F.M.) and Karadeniz Technical University Research Fund (2006.114.001.1 to E.K.). L.R.-P. was a recipient of a predoctoral fellowship from Instituto de Salud Carlos III.	Ahmed ZM, 2002, HUM GENET, V110, P527, DOI 10.1007/s00439-002-0732-4; Alloisio N, 1999, EUR J HUM GENET, V7, P255, DOI 10.1038/sj.ejhg.5200273; Moreno-Pelayo MA, 2008, JARO-J ASSOC RES OTO, V9, P202, DOI 10.1007/s10162-008-0116-0; Balciuniene J, 1999, HUM GENET, V105, P211, DOI 10.1007/s004390051091; Brown SDM, 2008, NAT REV GENET, V9, P277, DOI 10.1038/nrg2309; Charizopoulou N, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1200; Chen W, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.032615; Cohen-Salmon M, 1997, P NATL ACAD SCI USA, V94, P14450, DOI 10.1073/pnas.94.26.14450; De Leenheer EMR, 2004, ANN OTO RHINOL LARYN, V113, P922, DOI 10.1177/000348940411301112; De Leenheer EMR, 2002, ADV OTO-RHINO-LARYNG, V61, P85; Dror AA, 2010, NEURON, V68, P293, DOI 10.1016/j.neuron.2010.10.011; El-Amraoui A, 2001, HEARING RES, V158, P151, DOI 10.1016/S0378-5955(01)00312-4; Francey LJ, 2012, AM J MED GENET A, V158A, P298, DOI 10.1002/ajmg.a.34391; Goodyear RJ, 2003, J NEUROSCI, V23, P9208; Govaerts PJ, 1998, AM J OTOL, V19, P718; Grillet N, 2009, AM J HUM GENET, V85, P328, DOI 10.1016/j.ajhg.2009.07.017; Gueta R, 2011, BIOPHYS J, V100, P2530, DOI 10.1016/j.bpj.2011.04.024; Hildebrand MS, 2011, HUM MUTAT, V32, P825, DOI 10.1002/humu.21512; Jain PK, 1998, GENOMICS, V50, P290, DOI 10.1006/geno.1998.5320; Legan PK, 2000, NEURON, V28, P273, DOI 10.1016/S0896-6273(00)00102-1; Legan PK, 2005, NAT NEUROSCI, V8, P1035, DOI 10.1038/nn1496; Lenz DR, 2011, HEARING RES, V281, P3, DOI 10.1016/j.heares.2011.05.021; Li Y, 2010, AM J HUM GENET, V86, P479, DOI 10.1016/j.ajhg.2010.02.003; Lukashkin AN, 2004, J NEUROPHYSIOL, V91, P163, DOI 10.1152/jn.00680.2003; Mustapha M, 1999, HUM MOL GENET, V8, P409, DOI 10.1093/hmg/8.3.409; Naz S, 2003, J MED GENET, V40, P360, DOI 10.1136/jmg.40.5.360; Ouyang XM, 2002, HUM GENET, V111, P26, DOI 10.1007/s00439-002-0736-0; Plantinga RF, 2006, JARO-J ASSOC RES OTO, V7, P173, DOI 10.1007/s10162-006-0033-z; Richardson GP, 2008, CURR OPIN OTOLARYNGO, V16, P458, DOI 10.1097/MOO.0b013e32830e20c4; Russell IJ, 2007, NAT NEUROSCI, V10, P215, DOI 10.1038/nn1828; Schraders M, 2010, AM J HUM GENET, V86, P604, DOI 10.1016/j.ajhg.2010.02.015; Schraders M, 2010, AM J HUM GENET, V86, P138, DOI 10.1016/j.ajhg.2009.12.017; Simmler MC, 2000, MAMM GENOME, V11, P961, DOI 10.1007/s003350010197; Simmler MC, 2000, NAT GENET, V24, P139, DOI 10.1038/72793; Verpy E, 2011, J COMP NEUROL, V519, P194, DOI 10.1002/cne.22509; Zheng J, 2011, P NATL ACAD SCI USA, V108, P4218, DOI 10.1073/pnas.1005842108	36	58	62	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV 2	2012	91	5					883	889		10.1016/j.ajhg.2012.09.012	http://dx.doi.org/10.1016/j.ajhg.2012.09.012			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	036FI	23122587	Green Published, Bronze			2022-12-18	WOS:000311011400010
J	Parry, DA; Brookes, SJ; Logan, CV; Poulter, JA; El-Sayed, W; Al-Bahlani, S; Al Harasi, S; Sayed, J; Raif, EM; Shore, RC; Dashash, M; Barron, M; Morgan, JE; Carr, IM; Taylor, GR; Johnson, CA; Aldred, MJ; Dixon, MJ; Wright, JT; Kirkham, J; Inglehearn, CF; Mighell, AJ				Parry, David A.; Brookes, Steven J.; Logan, Clare V.; Poulter, James A.; El-Sayed, Walid; Al-Bahlani, Suhaila; Al Harasi, Sharifa; Sayed, Jihad; Raif, El Mostafa; Shore, Roger C.; Dashash, Mayssoon; Barron, Martin; Morgan, Joanne E.; Carr, Ian M.; Taylor, Graham R.; Johnson, Colin A.; Aldred, Michael J.; Dixon, Michael J.; Wright, J. Tim; Kirkham, Jennifer; Inglehearn, Chris F.; Mighell, Alan J.			Mutations in C4orf26, Encoding a Peptide with In Vitro Hydroxyapatite Crystal Nucleation and Growth Activity, Cause Amelogenesis Imperfecta	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONE-ROD DYSTROPHY; PREDICTION; FRAMEWORK; SEQUENCE; PROTEIN	Autozygosity mapping and clonal sequencing of an Omani family identified mutations in the uncharacterized gene, C4orf26, as a cause of recessive hypomineralized amelogenesis imperfecta (AI), a disease in which the formation of tooth enamel fails. Screening of a panel of 57 autosomal-recessive AI-affected families identified eight further families with loss-of-function mutations in C4orf26. C4orf26 encodes a putative extracellular matrix acidic phosphoprotein expressed in the enamel organ. A mineral nucleation assay showed that the protein's phosphorylated C terminus has the capacity to promote nucleation of hydroxyapatite, suggesting a possible function in enamel mineralization during amelogenesis.	[Parry, David A.; Logan, Clare V.; Poulter, James A.; El-Sayed, Walid; Morgan, Joanne E.; Carr, Ian M.; Taylor, Graham R.; Johnson, Colin A.; Inglehearn, Chris F.; Mighell, Alan J.] Univ Leeds, Leeds Inst Mol Med, St Jamess Univ Hosp, Leeds LS9 7TF, W Yorkshire, England; [Brookes, Steven J.; El-Sayed, Walid; Sayed, Jihad; Raif, El Mostafa; Shore, Roger C.; Kirkham, Jennifer; Mighell, Alan J.] Univ Leeds, Leeds Dent Inst, Leeds LS2 9LU, W Yorkshire, England; [El-Sayed, Walid] Suez Canal Univ, Sch Dent, Ismailia, Egypt; [Al-Bahlani, Suhaila] Al Nanda Hosp, Muscat 111, Oman; [Al Harasi, Sharifa] Mil Dent Ctr, Seeb 121, Oman; [Dashash, Mayssoon] Damascus Univ, Dept Paediat Dent, Damascus, Syria; [Barron, Martin; Dixon, Michael J.] Univ Manchester, Fac Med & Human Sci, Manchester Acad Hlth Sci Ctr Michael Smith Bldg, Manchester M13 9PT, Lancs, England; [Barron, Martin; Dixon, Michael J.] Univ Manchester, Fac Life Sci, Manchester Acad Hlth Sci Ctr Michael Smith Bldg, Manchester M13 9PT, Lancs, England; [Aldred, Michael J.] Dorevitch Pathol, Heidelberg, Vic 3084, Australia; [Wright, J. Tim] Univ N Carolina, Sch Dent, Dept Pediat Dent, Chapel Hill, NC 27599 USA	Saint James's University Hospital; University of Leeds; University of Leeds; Egyptian Knowledge Bank (EKB); Suez Canal University; University of Manchester; University of Manchester; University of North Carolina; University of North Carolina Chapel Hill	Mighell, AJ (corresponding author), Univ Leeds, Leeds Inst Mol Med, St Jamess Univ Hosp, Leeds LS9 7TF, W Yorkshire, England.	a.j.mighell@leeds.ac.uk	Wright, John Timothy/AAX-5755-2020; Dashash, Mayssoon/AFQ-7952-2022; Poulter, James A/A-8190-2013; Inglehearn, Chris/GYD-9783-2022; Barron, Martin/E-9649-2015	Dashash, Mayssoon/0000-0002-9877-3217; Poulter, James A/0000-0003-2048-5693; Barron, Martin/0000-0002-2047-3513; Logan, Clare/0000-0003-4323-1602; Parry, David/0000-0003-0376-7736; Raif, El Mostafa/0000-0003-2556-6994; Al Harrasi, Sharifa/0000-0002-3010-4367; BROOKES, STEVEN/0000-0002-9097-7311; El-Sayed, walid/0000-0002-6647-516X; Johnson, Colin/0000-0002-2979-8234	Wellcome Trust; Sir Jules Thorn Award for Biomedical Research; The Sir Jules Thorn Charitable Trust [09JTA] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Sir Jules Thorn Award for Biomedical Research; The Sir Jules Thorn Charitable Trust	The authors thank the families for participating in this study. This work was supported by grants from The Wellcome Trust (to A.J.M., J.K., M.D., M.B., C.I., and S.B.) and the Sir Jules Thorn Award for Biomedical Research (to C.A.J, G.R.T., and C.I.).	Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; BACKMAN B, 1986, COMMUNITY DENT ORAL, V14, P43, DOI 10.1111/j.1600-0528.1986.tb01493.x; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; BOSKEY AL, 1990, BONE MINER, V11, P55, DOI 10.1016/0169-6009(90)90015-8; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; Carr IM, 2006, HUM MUTAT, V27, P1041, DOI 10.1002/humu.20383; Coffield KD, 2005, J AM DENT ASSOC, V136, P620, DOI 10.14219/jada.archive.2005.0233; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; El-Sayed W, 2009, AM J HUM GENET, V85, P699, DOI 10.1016/j.ajhg.2009.09.014; Gajjeraman S, 2007, J BIOL CHEM, V282, P1193, DOI 10.1074/jbc.M604732200; Gross SS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r269; Hart PS, 2004, J MED GENET, V41, P545, DOI 10.1136/jmg.2003.017657; HUNTER GK, 1993, P NATL ACAD SCI USA, V90, P8562, DOI 10.1073/pnas.90.18.8562; Kim JW, 2006, EUR J ORAL SCI, V114, P3, DOI 10.1111/j.1600-0722.2006.00278.x; Kim JW, 2008, AM J HUM GENET, V82, P489, DOI 10.1016/j.ajhg.2007.09.020; Kim JW, 2005, J MED GENET, V42, P271, DOI 10.1136/jmg.2004.024505; Kirkham J, 2007, J DENT RES, V86, P426, DOI 10.1177/154405910708600507; LAGERSTROM M, 1991, GENOMICS, V10, P971, DOI 10.1016/0888-7543(91)90187-J; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mory A, 2012, AM J HUM GENET, V90, P708, DOI 10.1016/j.ajhg.2012.03.005; O'Sullivan J, 2011, AM J HUM GENET, V88, P616, DOI 10.1016/j.ajhg.2011.04.005; Parry DA, 2009, AM J HUM GENET, V84, P266, DOI 10.1016/j.ajhg.2009.01.009; Polok B, 2009, AM J HUM GENET, V84, P259, DOI 10.1016/j.ajhg.2009.01.006; Rajpar MH, 2001, HUM MOL GENET, V10, P1673, DOI 10.1093/hmg/10.16.1673; Schossig A, 2012, AM J HUM GENET, V90, P701, DOI 10.1016/j.ajhg.2012.02.012; Strehle EM, 2007, GENET COUNSEL, V18, P189; Witkop CJ, 1976, ORAL FACIAL GENETICS, P151; Wright JT, 2011, CELLS TISSUES ORGANS, V194, P279, DOI 10.1159/000324339; WRIGHT JT, 1985, J ORAL PATHOL MED, V14, P366, DOI 10.1111/j.1600-0714.1985.tb00507.x	31	58	62	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 7	2012	91	3					565	571		10.1016/j.ajhg.2012.07.020	http://dx.doi.org/10.1016/j.ajhg.2012.07.020			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	004LL	22901946	hybrid, Green Published			2022-12-18	WOS:000308683100018
J	Rieder, MJ; Green, GE; Park, SS; Stamper, BD; Gordon, CT; Johnson, JM; Cunniff, CM; Smith, JD; Emery, SB; Lyonnet, S; Amiel, J; Holder, M; Heggie, AA; Bamshad, MJ; Nickerson, DA; Cox, TC; Hing, AV; Horst, JA; Cunningham, ML				Rieder, Mark J.; Green, Glenn E.; Park, Sarah S.; Stamper, Brendan D.; Gordon, Christopher T.; Johnson, Jason M.; Cunniff, Christopher M.; Smith, Joshua D.; Emery, Sarah B.; Lyonnet, Stanislas; Amiel, Jeanne; Holder, Muriel; Heggie, Andrew A.; Bamshad, Michael J.; Nickerson, Deborah A.; Cox, Timothy C.; Hing, Anne V.; Horst, Jeremy A.; Cunningham, Michael L.			A Human Homeotic Transformation Resulting from Mutations in PLCB4 and GNAI3 Causes Auriculocondylar Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUESTION MARK EARS; CONDYLAR SYNDROME; PHOSPHOLIPASE-C; MICE; ENDOTHELIN-1; ZEBRAFISH; JAW; MORPHOGENESIS; PROTEINS; EXPRESSION	Auriculocondylar syndrome (ACS) is a rare, autosomal-dominant craniofacial malformation syndrome characterized by variable micrognathia, temporomandibular joint ankylosis, cleft palate, and a characteristic "question-mark" ear malformation. Careful phenotypic characterization of severely affected probands in our cohort suggested the presence of a mandibular patterning defect resulting in a maxillary phenotype (i.e., homeotic transformation). We used exome sequencing of five probands and identified two novel (exclusive to the patient and/or family studied) missense mutations in PLCB4 and a shared mutation in GNAI3 in two unrelated probands. In confirmatory studies, three additional novel PLCB4 mutations were found in multigenerational ACS pedigrees. All mutations were confirmed by Sanger sequencing, were not present in more than 10,000 control chromosomes, and resulted in amino-acid substitutions located in highly conserved protein domains. Additionally, protein-structure modeling demonstrated that all ACS substitutions disrupt the catalytic sites of PLCB4 and GNAI3. We suggest that PLCB4 and GNAI3 are core signaling molecules of the endothelin-1-distal-less homeobox 5 and 6 (EDN1-DLX5/DLX6) pathway. Functional studies demonstrated a significant reduction in downstream DLX5 and DLX6 expression in ACS cases in assays using cultured osteoblasts from probands and controls. These results support the role of the previously implicated EDN1-DLX5/6 pathway in regulating mandibular specification in other species, which, when disrupted, results in a maxillary phenotype. This work defines the molecular basis of ACS as a homeotic transformation (mandible to maxilla) in humans.	[Rieder, Mark J.; Smith, Joshua D.; Bamshad, Michael J.; Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Green, Glenn E.; Emery, Sarah B.] Univ Michigan, Dept Otolaryngol Head & Neck Surg, Ann Arbor, MI 48109 USA; [Park, Sarah S.; Stamper, Brendan D.; Cox, Timothy C.; Hing, Anne V.; Cunningham, Michael L.] Seattle Childrens Res Inst, Ctr Tissue & Cell Sci, Seattle, WA 98101 USA; [Gordon, Christopher T.; Lyonnet, Stanislas; Amiel, Jeanne] Hop Necker Enfants Malad, INSERM, U781, F-75743 Paris, France; [Gordon, Christopher T.; Lyonnet, Stanislas; Amiel, Jeanne] Univ Paris Descartes Sorbonne Paris Cite, Inst Imagine, F-75743 Paris, France; [Johnson, Jason M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiol,Div Neuroradiol, Boston, MA 02114 USA; [Cunniff, Christopher M.] Univ Arizona, Dept Pediat, Tucson, AZ 85724 USA; [Lyonnet, Stanislas; Amiel, Jeanne] Hop Necker Enfants Malad, AP HP, Dept Genet, F-75743 Paris, France; [Holder, Muriel] CHRU, Hop Jeanne de Flandre, Serv Genet Clin, F-59037 Lille, France; [Heggie, Andrew A.] Royal Childrens Hosp, Dept Plast & Maxillofacial Surg, Melbourne, Vic 3052, Australia; [Bamshad, Michael J.; Cox, Timothy C.; Hing, Anne V.; Cunningham, Michael L.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Cox, Timothy C.; Hing, Anne V.; Cunningham, Michael L.] Seattle Childrens Res Inst, Craniofacial Ctr, Seattle, WA 98105 USA; [Cox, Timothy C.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia; [Horst, Jeremy A.] UCSF, Dept Orofacial Sci, Div Pediat Dent, San Francisco, CA 94143 USA	University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; Seattle Children's Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Arizona; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; Royal Children's Hospital Melbourne; University of Washington; University of Washington Seattle; Seattle Children's Hospital; Monash University; University of California System; University of California San Francisco	Rieder, MJ (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	acs_rieder_cunningham@uw.edu	Gordon, Chris/F-1267-2017; amiel, jeanne/AGX-1124-2022; Lyonnet, Stanislas/H-5483-2017; amiel, jeanne/H-3501-2017	Gordon, Chris/0000-0002-9300-8399; Lyonnet, Stanislas/0000-0001-5426-9417; amiel, jeanne/0000-0001-5973-4728; johnson, jason/0000-0001-7724-5784	NIH-NHGRI Next Generation Mendelian Genetics [HG005608]; Jean Renny Endowment for Craniofacial Medicine; Laurel Foundation Center for Craniofacial Research; NIH-NIDCD [P30-DC05188]; E-Rare CRANIRARE; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102926, RC2HL103010, UC2HL102923, RC2HL102923, RC2HL102924, UC2HL102926, UC2HL102925, UC2HL102924, UC2HL103010, RC2HL102925] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005188] Funding Source: NIH RePORTER	NIH-NHGRI Next Generation Mendelian Genetics; Jean Renny Endowment for Craniofacial Medicine; Laurel Foundation Center for Craniofacial Research; NIH-NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); E-Rare CRANIRARE; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by grants from the NIH-NHGRI Next Generation Mendelian Genetics (HG005608, M.J.R., D.A.N., M.J.B.), the Jean Renny Endowment for Craniofacial Medicine, the Laurel Foundation Center for Craniofacial Research (M.L.C.), NIH-NIDCD (P30-DC05188, G.E.G.), and the E-Rare CRANIRARE project (S.L.).	Barron F, 2011, DEVELOPMENT, V138, P2249, DOI 10.1242/dev.056929; Beverdam A, 2002, GENESIS, V34, P221, DOI 10.1002/gene.10156; Clouthier DE, 2010, AM J MED GENET A, V152A, P2962, DOI 10.1002/ajmg.a.33568; Clouthier DE, 1998, DEVELOPMENT, V125, P813; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Cooper GM, 2010, NAT METHODS, V7, P250, DOI 10.1038/nmeth0410-250; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Depew MJ, 2002, SCIENCE, V298, P381, DOI 10.1126/science.1075703; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Erlich MS, 2000, AM J MED GENET, V95, P269, DOI 10.1002/1096-8628(20001127)95:3<269::AID-AJMG14>3.0.CO;2-P; Gerkes EH, 2008, EUR J MED GENET, V51, P264, DOI 10.1016/j.ejmg.2008.01.002; Guion-Almeida ML, 1999, AM J MED GENET, V86, P130, DOI 10.1002/(SICI)1096-8628(19990910)86:2<130::AID-AJMG8>3.0.CO;2-O; Guion-Almeida ML, 2002, AM J MED GENET, V112, P209, DOI 10.1002/ajmg.10631; Ivey K, 2003, DEV BIOL, V255, P230, DOI 10.1016/S0012-1606(02)00097-0; Jampol M, 1998, AM J MED GENET, V75, P449, DOI 10.1002/(SICI)1096-8628(19980217)75:5<449::AID-AJMG1>3.0.CO;2-I; Jiang HP, 1996, P NATL ACAD SCI USA, V93, P14598, DOI 10.1073/pnas.93.25.14598; Kano M, 1998, P NATL ACAD SCI USA, V95, P15724, DOI 10.1073/pnas.95.26.15724; Kimmel CB, 2003, DEVELOPMENT, V130, P1339, DOI 10.1242/dev.00338; Kimple AJ, 2009, J BIOL CHEM, V284, P19402, DOI 10.1074/jbc.M109.024711; Kokitsu-Nakata NM, 2012, AM J MED GENET A, V158A, P59, DOI 10.1002/ajmg.a.34337; KURIHARA Y, 1994, NATURE, V368, P703, DOI 10.1038/368703a0; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LI WH, 1984, J MOL EVOL, V21, P58, DOI 10.1007/BF02100628; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Masotti C, 2008, EUR J HUM GENET, V16, P145, DOI 10.1038/sj.ejhg.5201955; Miller CT, 2000, DEVELOPMENT, V127, P3815; Nagano K, 1999, J BIOL CHEM, V274, P2872, DOI 10.1074/jbc.274.5.2872; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ngan Shing-Chung, 2008, V413, P243; Ozeki H, 2004, MECH DEVELOP, V121, P387, DOI 10.1016/j.mod.2004.02.002; Ozturk S, 2005, J CRANIOFAC SURG, V16, P489, DOI 10.1097/01.SCS.0000147655.94656.0D; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Priolo M, 2000, CLIN DYSMORPHOL, V9, P277, DOI 10.1097/00019605-200009040-00009; Reisoli E, 2010, DEVELOPMENT, V137, P2927, DOI 10.1242/dev.041079; Ruest LB, 2004, DEVELOPMENT, V131, P4413, DOI 10.1242/dev.01291; Scrima A, 2008, EMBO J, V27, P1145, DOI 10.1038/emboj.2008.30; Shkalim V, 2008, AM J MED GENET A, V146A, P2280, DOI 10.1002/ajmg.a.32452; Soundararajan M, 2008, P NATL ACAD SCI USA, V105, P6457, DOI 10.1073/pnas.0801508105; Storm AL, 2005, AM J MED GENET A, V138A, P141, DOI 10.1002/ajmg.a.30883; UUSPAA V, 1978, SCAND J PLAST RECONS, V12, P165, DOI 10.3109/02844317809012989; Vieux-Rochas M, 2010, GENESIS, V48, P362, DOI 10.1002/dvg.20625; Walker MB, 2006, DEV BIOL, V295, P194, DOI 10.1016/j.ydbio.2006.03.028; Walker MB, 2007, DEV BIOL, V304, P194, DOI 10.1016/j.ydbio.2006.12.027; Yanagisawa H, 1998, DEVELOPMENT, V125, P825	45	58	62	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 4	2012	90	5					907	914		10.1016/j.ajhg.2012.04.002	http://dx.doi.org/10.1016/j.ajhg.2012.04.002			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	940QG	22560091	Green Published, Bronze			2022-12-18	WOS:000303907500016
J	Rafiq, MA; Kuss, AW; Puettmann, L; Noor, A; Ramiah, A; Ali, G; Hu, H; Kerio, NA; Xiang, Y; Garshasbi, M; Khan, MA; Ishak, GE; Weksberg, R; Ullmann, R; Tzschach, A; Kahrizi, K; Mahmood, K; Naeem, F; Ayub, M; Moremen, KW; Vincent, JB; Ropers, HH; Ansar, M; Najmabadi, H				Rafiq, Muhammad Arshad; Kuss, Andreas W.; Puettmann, Lucia; Noor, Abdul; Ramiah, Annapoorani; Ali, Ghazanfar; Hu, Hao; Kerio, Nadir Ali; Xiang, Yong; Garshasbi, Masoud; Khan, Muzammil Ahmad; Ishak, Gisele E.; Weksberg, Rosanna; Ullmann, Reinhard; Tzschach, Andreas; Kahrizi, Kimia; Mahmood, Khalid; Naeem, Farooq; Ayub, Muhammad; Moremen, Kelley W.; Vincent, John B.; Ropers, Hans Hilger; Ansar, Muhammad; Najmabadi, Hossein			Mutations in the Alpha 1,2-Mannosidase Gene, MAN1B1, Cause Autosomal-Recessive Intellectual Disability	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RETICULUM QUALITY-CONTROL; MENTAL-RETARDATION; EXPRESSION; BIOSYNTHESIS; MANNOSIDASE; PREVALENCE; CLONING	We have used genome-wide genotyping to identify an overlapping homozygosity-by-descent locus on chromosome 9q34.3 (MRT15) in four consanguineous families affected by nonsyndromic autosomal-recessive intellectual disability (NS-ARID) and one in which the patients show additional clinical features. Four of the families are from Pakistan, and one is from Iran. Using a combination of next-generation sequencing and Sanger sequencing, we have identified mutations in the gene MAN1B1, encoding a mannosyl oligosaccharide, alpha 1,2-mannosidase. In one Pakistani family, MR43, a homozygous nonsense mutation (RefSeq number NM_016219.3: c.1418G>A [p.Trp473*]), segregated with intellectual disability and additional dysmorphic features. We also identified the missense mutation c. 1189G>A (p.Glu397Lys; RefSeq number NM_016219.3), which segregates with NS-ARID in three families who come from the same village and probably have shared inheritance. In the Iranian family, the missense mutation c.1000C>T (p.Arg334Cys; RefSeq number NM_016219.3) also segregates with NS-ARID. Both missense mutations are at amino acid residues that are conserved across the animal kingdom, and they either reduce k(cat) by similar to 1300-fold or disrupt stable protein expression in mammalian cells. MAN1B1 is one of the few NS-ARID genes with an elevated mutation frequency in patients with NS-ARID from different populations.	[Rafiq, Muhammad Arshad; Noor, Abdul; Khan, Muzammil Ahmad; Vincent, John B.] Ctr Addict & Mental Hlth, Neurogenet Sect, Mol Neuropsychiat & Dev Lab, Toronto, ON M5T 1R8, Canada; [Kuss, Andreas W.; Puettmann, Lucia; Hu, Hao; Garshasbi, Masoud; Ullmann, Reinhard; Tzschach, Andreas; Ropers, Hans Hilger] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Ramiah, Annapoorani; Xiang, Yong; Moremen, Kelley W.; Ansar, Muhammad] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Ali, Ghazanfar; Kerio, Nadir Ali; Khan, Muzammil Ahmad] Quaid I Azam Univ, Dept Biochem, Islamabad, Pakistan; [Ali, Ghazanfar] King Saud Univ, Ctr Excellence Biotechnol Res, Riyadh 11451, Saudi Arabia; [Ishak, Gisele E.] Univ Washington, Seattle Childrens Hosp, Dept Radiol, Seattle, WA 98105 USA; [Weksberg, Rosanna] Hosp Sick Children, Program Genet & Genom Biol, Toronto, ON M5G 1L7, Canada; [Kahrizi, Kimia; Najmabadi, Hossein] Univ Social Welf & Rehabil Sci, Genet Res Ctr, Tehran 1985713834, Iran; [Mahmood, Khalid] Arrahma Hosp Mental Hlth, Multan 60000, Pakistan; [Naeem, Farooq] Lahore Inst Res & Dev, Lahore 54000, Pakistan; [Ayub, Muhammad] Tees Esk & Wear Valleys Natl Hlth Serv Fdn Trust, Durham DL2 2TS, England; [Ayub, Muhammad] Univ Durham, Sch Hlth & Med, Durham TS17 6BH, England; [Vincent, John B.] Univ Toronto, Dept Psychiat, Toronto, ON M5T 1R8, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Max Planck Society; University System of Georgia; University of Georgia; Quaid I Azam University; King Saud University; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Durham University; University of Toronto	Vincent, JB (corresponding author), Ctr Addict & Mental Hlth, Neurogenet Sect, Mol Neuropsychiat & Dev Lab, Toronto, ON M5T 1R8, Canada.	john_vincent@camh.net	Ansar, Muhammad/H-5967-2011; Noor, Abdul/J-2345-2016; Moremen, Kelley/AAD-4661-2019; Khan, Muzammil Ahmad/AAJ-5704-2020; Ali, Ghazanfar/L-9277-2019; Ali, Ghazanfar/J-9971-2012; Naeem, Farooq/M-2310-2019; Tzschach, Andreas/I-2648-2019; Kahrizi, Kimia/D-7989-2017; Najmabadi, Hossein/P-8182-2017	Ansar, Muhammad/0000-0001-5891-7063; Khan, Muzammil Ahmad/0000-0001-8591-0377; Ali, Ghazanfar/0000-0002-6172-9503; Naeem, Farooq/0000-0003-4760-4840; Tzschach, Andreas/0000-0002-6840-965X; Garshasbi, Masoud/0000-0002-5508-7903; Najmabadi, Hossein/0000-0002-6084-7778; Kuss, Andreas/0000-0002-9401-4627	Pakistan Higher Education Commission [NRPU-1118]; Canadian Institutes of Health Research [MOP-102758]; German Federal Ministry of Education and Research [MRNET 01GS08161-2]; Max Planck Innovation Fund; Iranian National Science Foundation; U.S. National Institutes of Health [GM047533, DK075322]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047533] Funding Source: NIH RePORTER	Pakistan Higher Education Commission(Higher Education Commission of Pakistan); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Max Planck Innovation Fund; Iranian National Science Foundation(Iran National Science Foundation (INSF)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We wish to thank all the members of this family for their willing participation and cooperation with this study and Ines Mueller for technical assistance. J.B.V. is a National Alliance for Research on Schizophrenia and Depression Independent Investigator. This research was supported by grants from the Pakistan Higher Education Commission (NRPU-1118), the Canadian Institutes of Health Research (#MOP-102758), the German Federal Ministry of Education and Research (MRNET 01GS08161-2), the Max Planck Innovation Fund, the Iranian National Science Foundation, and the U.S. National Institutes of Health (GM047533 and DK075322). H.N., H.H.R., K.K., and A.T. are members of the GENCODYS consortium.	[Anonymous], GENEREVIEWS; Backliwal G, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn423; Bedilu R, 2002, MOL GENET METAB, V77, P282, DOI 10.1016/S1096-7192(02)00172-5; Gonzalez DS, 1999, J BIOL CHEM, V274, P21375, DOI 10.1074/jbc.274.30.21375; Karaveg K, 2005, J BIOL CHEM, V280, P16197, DOI 10.1074/jbc.M500119200; Karaveg K, 2005, J BIOL CHEM, V280, P29837, DOI 10.1074/jbc.M505130200; Kaufman L, 2010, J NEURODEV DISORD, V2, P182, DOI 10.1007/s11689-010-9055-2; Kuss AW, 2011, HUM GENET, V129, P141, DOI 10.1007/s00439-010-0907-3; Leonard H, 2002, MENT RETARD DEV D R, V8, P117, DOI 10.1002/mrdd.10031; Malm Dag, 1995, Tidsskrift for den Norske Laegeforening, V115, P594; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Rafiq MA, 2010, CLIN GENET, V78, P478, DOI 10.1111/j.1399-0004.2010.01405.x; Roeleveld N, 1997, DEV MED CHILD NEUROL, V39, P125, DOI 10.1111/j.1469-8749.1997.tb07395.x; Ropers HH, 2005, NAT REV GENET, V6, P46, DOI 10.1038/nrg1501; Tremblay LO, 1999, GLYCOBIOLOGY, V9, P1073, DOI 10.1093/glycob/9.10.1073; Vandersall-Nairn AS, 1998, GLYCOBIOLOGY, V8, P1183, DOI 10.1093/glycob/8.12.1183; CLUSTAL 2 1 MULTIPLE	17	58	59	2	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL 15	2011	89	1					176	182		10.1016/j.ajhg.2011.06.006	http://dx.doi.org/10.1016/j.ajhg.2011.06.006			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	796HF	21763484	Bronze, Green Published			2022-12-18	WOS:000293041700017
J	Vissers, LELM; Lausch, E; Unger, S; Campos-Xavier, AB; Gilissen, C; Rossi, A; Del Rosario, M; Venselaar, H; Knoll, U; Nampoothiri, S; Nair, M; Spranger, J; Brunner, HG; Bonafe, L; Veltman, JA; Zabel, B; Superti-Furga, A				Vissers, Lisenka E. L. M.; Lausch, Ekkehart; Unger, Sheila; Campos-Xavier, Ana Belinda; Gilissen, Christian; Rossi, Antonio; Del Rosario, Marisol; Venselaar, Hanka; Knoll, Ute; Nampoothiri, Sheela; Nair, Mohandas; Spranger, Juergen; Brunner, Han G.; Bonafe, Luisa; Veltman, Joris A.; Zabel, Bernhard; Superti-Furga, Andrea			Chondrodysplasia and Abnormal Joint Development Associated with Mutations in IMPAD1, Encoding the Golgi-Resident Nucleotide Phosphatase, gPAPP	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EHLERS-DANLOS-SYNDROME; OF-FUNCTION MUTATIONS; DESBUQUOIS DYSPLASIA; LARSEN-SYNDROME; GENE; DISLOCATIONS; DEFICIENCY; VARIANT	We used whole-exome sequencing to study three individuals with a distinct condition characterized by short stature, chondrodysplasia with brachydactyly, congenital joint dislocations, cleft palate, and facial dysmorphism. Affected individuals carried homozygous missense mutations in IMPAD1, the gene coding for gPAPP, a Golgi-resident nucleotide phosphatase that hydrolyzes phosphoadenosine phosphate (PAP), the byproduct of sulfotransferase reactions, to AMP. The mutations affected residues in or adjacent to the phosphatase active site and are predicted to impair enzyme activity. A fourth unrelated patient was subsequently found to be homozygous for a premature termination codon in IMPAD1. Impad1 inactivation in mice has previously been shown to produce chondrodysplasia with abnormal joint formation and impaired proteoglycan sulfation. The human chondrodysplasia associated with gPAPP deficiency joins a growing number of skeletoarticular conditions associated with defective synthesis of sulfated proteoglycans, highlighting the importance of proteoglycans in the development of skeletal elements and joints.	[Lausch, Ekkehart; Unger, Sheila; Spranger, Juergen; Zabel, Bernhard; Superti-Furga, Andrea] Univ Hosp Freiburg, Div Pediat Genet, Ctr Pediat & Adolescent Med, D-79106 Freiburg, Germany; [Vissers, Lisenka E. L. M.; Gilissen, Christian; Del Rosario, Marisol; Brunner, Han G.; Veltman, Joris A.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Vissers, Lisenka E. L. M.; Gilissen, Christian; Del Rosario, Marisol; Brunner, Han G.; Veltman, Joris A.] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Disorders, NL-6500 HB Nijmegen, Netherlands; [Unger, Sheila] Univ Lausanne, CHU Vaudois, Dept Med Genet, CH-1011 Lausanne, Switzerland; [Campos-Xavier, Ana Belinda; Bonafe, Luisa; Superti-Furga, Andrea] Univ Lausanne, CHU Vaudois, Dept Pediat, CH-1011 Lausanne, Switzerland; [Rossi, Antonio] Univ Pavia, Dept Biochem, I-27100 Pavia, Italy; [Venselaar, Hanka] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Ctr Mol & Biomol Informat, NL-6500 HB Nijmegen, Netherlands; [Knoll, Ute] Ctr Prenatal Diag, D-10719 Berlin, Germany; [Nampoothiri, Sheela] Amrita Inst Med Sci & Res Ctr, Cochin, Kerala, India; [Nair, Mohandas] Coll Med, Dept Pediat, Calicut, Kerala, India	University of Freiburg; Radboud University Nijmegen; Radboud University Nijmegen; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Pavia; Radboud University Nijmegen; Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Kochi	Superti-Furga, A (corresponding author), Univ Hosp Freiburg, Div Pediat Genet, Ctr Pediat & Adolescent Med, D-79106 Freiburg, Germany.	asuperti@unil.ch	Nampoothiri, Sheela/AAQ-4854-2021; Vissers, Lisenka ELM/A-2598-2015; Brunner, Han/C-9928-2013; Rossi, Antonio/E-9935-2012; Venselaar, Hanka/D-2009-2016; superti-furga, andrea/E-9162-2015; Veltman, Joris A/F-5128-2010; unger, sheila/E-9177-2015; Gilissen, Christian/E-5246-2012	Nampoothiri, Sheela/0000-0002-9575-0722; Vissers, Lisenka ELM/0000-0001-6470-5497; Venselaar, Hanka/0000-0001-9824-6559; superti-furga, andrea/0000-0002-3543-7531; Veltman, Joris A/0000-0002-3218-8250; Gilissen, Christian/0000-0003-1693-9699; Unger, Sheila/0000-0002-9539-8941; Campos-Xavier, Belinda/0000-0002-6271-0724	Swiss National Science Foundation [FN 310030-132940/BONAFE Luisa]; Fonds de Recherche du Departement Medico-Chirurgical de Pediatrie, CHUV, Lausanne; German Bundesministerium fur Bildung und Forschung; Deutsche Forschungsgemeinschaft [La 1381/1-3]; Netherlands Organization for Health Research and Development (ZonMW) [917-66-363, 911-08-025, 916-86-016]; Leenaards Foundation, Lausanne, Switzerland	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fonds de Recherche du Departement Medico-Chirurgical de Pediatrie, CHUV, Lausanne; German Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); Leenaards Foundation, Lausanne, Switzerland	The excellent technical work of Mme Carole Chiesa-Buzzi is gratefully acknowledged. This work has been supported by the Swiss National Science Foundation (grant no. FN 310030-132940/BONAFE Luisa, for which approval of the Institutional Ethics Committee has been obtained); by the Fonds de Recherche du Departement Medico-Chirurgical de Pediatrie, CHUV, Lausanne; by the German Bundesministerium fur Bildung und Forschung (SKELNET project), by the Deutsche Forschungsgemeinschaft (La 1381/1-3), and the Netherlands Organization for Health Research and Development (ZonMW grants 917-66-363 and 911-08-025 to J.A.V., and 916-86-016 to L.E.L.M.V.). A.S.-F. is supported by the Leenaards Foundation, Lausanne, Switzerland.	Bicknell LS, 2007, J MED GENET, V44, P89, DOI 10.1136/jmg.2006.043687; CHAKRABARTTY A, 1994, PROTEIN SCI, V3, P843; Dundar M, 2009, AM J HUM GENET, V85, P873, DOI 10.1016/j.ajhg.2009.11.010; Faivre L, 2004, AM J MED GENET A, V128A, P29, DOI 10.1002/ajmg.a.30042; Faivre L, 2004, AM J MED GENET A, V124A, P48, DOI 10.1002/ajmg.a.20440; Faiyaz-Ul-Haque M, 2004, AM J MED GENET A, V128A, P39, DOI 10.1002/ajmg.a.30005; Frederick JP, 2008, P NATL ACAD SCI USA, V105, P11605, DOI 10.1073/pnas.0801182105; Furuichi T, 2011, J MED GENET, V48, P32, DOI 10.1136/jmg.2010.080226; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; Gotte M, 2005, BIOCHEM GENET, V43, P65, DOI 10.1007/s10528-005-1068-2; Hermanns P, 2008, AM J HUM GENET, V82, P1368, DOI 10.1016/j.ajhg.2008.05.006; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Huber C, 2009, AM J HUM GENET, V85, P706, DOI 10.1016/j.ajhg.2009.10.001; Jennes I, 2009, HUM MUTAT, V30, P1620, DOI 10.1002/humu.21123; Kim OH, 2010, AM J MED GENET A, V152A, P875, DOI 10.1002/ajmg.a.33347; Krakow D, 2004, NAT GENET, V36, P405, DOI 10.1038/ng1319; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Li Y, 2010, AM J HUM GENET, V87, P757, DOI 10.1016/j.ajhg.2010.10.003; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Miyake N, 2010, HUM MUTAT, V31, P966, DOI 10.1002/humu.21300; Rossi A, 2001, HUM MUTAT, V17, P159, DOI 10.1002/humu.1; Sohaskey ML, 2008, DEVELOPMENT, V135, P2215, DOI 10.1242/dev.019950; Superti-Furga A., 2001, METABOLIC MOL BASES, P5189; Thiele H, 2004, P NATL ACAD SCI USA, V101, P10155, DOI 10.1073/pnas.0400334101; Tian J, 2010, AM J HUM GENET, V87, P768, DOI 10.1016/j.ajhg.2010.11.005; Ul Haque MF, 1998, NAT GENET, V20, P157, DOI 10.1038/2458; Unger S, 2010, AM J MED GENET A, V152A, P2543, DOI 10.1002/ajmg.a.33641; Venselaar H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-548; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Warman M.L., 2011, AM J MED GENET	31	58	63	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 13	2011	88	5					608	615		10.1016/j.ajhg.2011.04.002	http://dx.doi.org/10.1016/j.ajhg.2011.04.002			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	767CE	21549340	Green Published, Bronze			2022-12-18	WOS:000290832100008
J	Banka, S; Blom, HJ; Walter, J; Aziz, M; Urquhart, J; Clouthier, CM; Rice, GI; de Brouwer, APM; Hilton, E; Vassallo, G; Will, A; Smith, DEC; Smulders, YM; Wevers, RA; Steinfeld, R; Heales, S; Crow, YJ; Pelletier, JN; Jones, S; Newman, WG				Banka, Siddharth; Blom, Henk J.; Walter, John; Aziz, Majid; Urquhart, Jill; Clouthier, Christopher M.; Rice, Gillian I.; de Brouwer, Arjan P. M.; Hilton, Emma; Vassallo, Grace; Will, Andrew; Smith, Desiree E. C.; Smulders, Yvo M.; Wevers, Ron A.; Steinfeld, Robert; Heales, Simon; Crow, Yanick J.; Pelletier, Joelle N.; Jones, Simon; Newman, William G.			Identification and Characterization of an Inborn Error of Metabolism Caused by Dihydrofolate Reductase Deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FOLATE METABOLISM; DIHYDROPTERIDINE REDUCTASE; ACQUIRED-RESISTANCE; METHOTREXATE; TETRAHYDROBIOPTERIN; RISK; BIOSYNTHESIS; FAMILIES; LEUKEMIA; GENES	Dihydrofolate reductase (DHFR) is a critical enzyme in folate metabolism and an important target of antineoplastic, antimicrobial, and antiinflammatory drugs. We describe three individuals from two families with a recessive inborn error of metabolism, characterized by megaloblastic anemia and/or pancytopenia, severe cerebral folate deficiency, and cerebral tetrahydrobiopterin deficiency due to a germline missense mutation in DHFR, resulting in profound enzyme deficiency. We show that cerebral folate levels, anemia, and pancytopenia of DHFR deficiency can be corrected by treatment with folinic acid. The characterization of this disorder provides evidence for the link between DHFR and metabolism of cerebral tetrahydrobiopterin, which is required for the formation of dopamine, serotonin, and norepinephrine and for the hydroxylation of aromatic amino acids. Moreover, this relationship provides insight into the role of folates in neurological conditions, including depression, Alzheimer disease, and Parkinson disease.	[Banka, Siddharth; Walter, John; Urquhart, Jill; Rice, Gillian I.; Hilton, Emma; Crow, Yanick J.; Jones, Simon; Newman, William G.] Univ Manchester, MAHSC, St Marys Hosp, Manchester M13 9WL, Lancs, England; [Blom, Henk J.; Smith, Desiree E. C.] Vrije Univ Amsterdam, Metab Unit, Dept Clin Chem, Inst Cardiovasc Res,Med Ctr Amsterdam, NL-1081 HV Amsterdam, Netherlands; [Aziz, Majid; Vassallo, Grace] Cent Manchester Univ Hosp NHS Fdn Trust, MAHSC, St Marys Hosp, Manchester M13 9WL, Lancs, England; [Clouthier, Christopher M.; Pelletier, Joelle N.] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada; [Clouthier, Christopher M.; Pelletier, Joelle N.] Univ Montreal, Dept Chim, Montreal, PQ H3C 3J7, Canada; [de Brouwer, Arjan P. M.] Radboud Univ Nijmegen, Dept Human Genet, Inst Genet & Metab Dis, Med Ctr, NL-6525 GA Nijmegen, Netherlands; [Will, Andrew] Cent Manchester Fdn NHS Trust, MAHSC, St Marys Hosp, Manchester M13 9WL, Lancs, England; [Smulders, Yvo M.] Vrije Univ Amsterdam, Dept Internal Med, Inst Cardiovasc Res, Med Ctr Amsterdam, NL-1081 HV Amsterdam, Netherlands; [Wevers, Ron A.] Radboud Univ Nijmegen, Lab Genet Endocrine & Metab Dis, Dept Lab Med, Med Ctr, NL-6525 GA Nijmegen, Netherlands; [Steinfeld, Robert] Univ Gottingen, Dept Pediat, D-37075 Gottingen, Germany; [Heales, Simon] Great Ormond St Hosp Sick Children, Neurometab Unit, Natl Hosp, Clin & Mol Genet Unit,UCL Inst Child Hlth & Enzym, London WC1N 3JH, England; [Heales, Simon] Great Ormond St Hosp Sick Children, Metab Unit, London WC1N 3JH, England	University of Manchester; Vrije Universiteit Amsterdam; University of Manchester; Universite de Montreal; Universite de Montreal; Radboud University Nijmegen; University of Manchester; Vrije Universiteit Amsterdam; Radboud University Nijmegen; University of Gottingen; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Jones, S (corresponding author), Univ Manchester, MAHSC, St Marys Hosp, Manchester M13 9WL, Lancs, England.	simon.jones@cmft.nhs.uk; william.newman@manchester.ac.uk	Rice, Gillian I/G-3128-2015; Crow, Yanick J/N-6120-2014; Urquhart, Jill/G-2282-2015; Smulders, YM/AAG-7506-2021; Wevers, Ron A./H-8116-2014; de Brouwer, Arjan PM/P-5949-2015	Rice, Gillian I/0000-0002-4223-0571; Crow, Yanick J/0000-0001-7211-7564; Urquhart, Jill/0000-0002-5788-5511; Wevers, Ron A./0000-0003-2278-9746; Hilton, Emma/0000-0002-3750-577X; Steinfeld, Robert/0000-0003-0956-6601; Banka, Siddharth/0000-0002-8527-2210; Newman, William/0000-0002-6382-4678; Blom, Henk/0000-0001-5202-9241; Smith, Desiree/0000-0003-2053-3392	NIHR Manchester Biomedical Research Centre; Natural Sciences and Engineering Research Council of Canada	NIHR Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	We thank the families for their help with the study. The support of the NIHR Manchester Biomedical Research Centre and Natural Sciences and Engineering Research Council of Canada is acknowledged. We are also thankful for the expert help of William Fergusson during cell culture.	Antoniades C, 2006, CIRCULATION, V114, P1193, DOI 10.1161/CIRCULATIONAHA.106.612325; Bawle EV, 1998, TERATOLOGY, V57, P51, DOI 10.1002/(SICI)1096-9926(199802)57:2<51::AID-TERA2>3.0.CO;2-9; Bjarnason GA, 2001, AM J PATHOL, V158, P1793, DOI 10.1016/S0002-9440(10)64135-1; BOTTIGLIERI T, 1992, PSYCHOL MED, V22, P871, DOI 10.1017/S0033291700038447; Carr IM, 2006, HUM MUTAT, V27, P1041, DOI 10.1002/humu.20383; Crabtree MJ, 2009, J BIOL CHEM, V284, P28128, DOI 10.1074/jbc.M109.041483; Daly SB, 2010, AM J HUM GENET, V86, P963, DOI 10.1016/j.ajhg.2010.05.006; Djukic A, 2007, PEDIATR NEUROL, V37, P387, DOI 10.1016/j.pediatrneurol.2007.09.001; ERBE RW, 1975, NEW ENGL J MED, V293, P753, DOI 10.1056/NEJM197510092931506; GOKER E, 1995, BLOOD, V86, P677, DOI 10.1182/blood.V86.2.677.bloodjournal862677; Gorlick R, 1996, NEW ENGL J MED, V335, P1041, DOI 10.1056/NEJM199610033351408; Gregory JF, 2002, ANNU REV NUTR, V22, P199, DOI 10.1146/annurev.nutr.22.120701.083554; HOFFBRAND AV, 1984, NEW ENGL J MED, V310, P789; HYLAND K, 1993, PEDIATR RES, V34, P10, DOI 10.1203/00006450-199307000-00003; Johnson WG, 2005, AM J CLIN NUTR, V81, P664; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; NICHOL CA, 1983, P NATL ACAD SCI-BIOL, V80, P1546, DOI 10.1073/pnas.80.6.1546; Padmanabhan S, 2009, MUTAT RES-GEN TOX EN, V673, P43, DOI 10.1016/j.mrgentox.2008.11.011; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; POLLOCK RJ, 1978, J NEUROCHEM, V31, P115, DOI 10.1111/j.1471-4159.1978.tb12439.x; Ponzone A, 2004, MED RES REV, V24, P127, DOI 10.1002/med.10055; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Ramaekers VT, 2005, NEW ENGL J MED, V352, P1985, DOI 10.1056/NEJMoa043160; ROSENBLATT DS, 2001, METABOLIC MOL BASIS, P3903; Smith DEC, 2006, CLIN CHEM LAB MED, V44, P450, DOI 10.1515/CCLM.2006.085; Stanger O, 2009, EXPERT REV NEUROTHER, V9, P1393, DOI 10.1586/ERN.09.75; Steinfeld R, 2009, AM J HUM GENET, V85, P354, DOI 10.1016/j.ajhg.2009.08.005; TAURO GP, 1976, NEW ENGL J MED, V294, P466, DOI 10.1056/NEJM197602262940903; Thony B, 2000, BIOCHEM J, V347, P1, DOI 10.1042/0264-6021:3470001; TRIMBLE JJ, 1988, SCIENCE, V239, P1145, DOI 10.1126/science.2830673; van der Linden IJM, 2006, P NUTR SOC, V65, P204, DOI 10.1079/PNS2006495; van Ede AE, 2002, RHEUMATOLOGY, V41, P658, DOI 10.1093/rheumatology/41.6.658; Xu XR, 2007, AM J CLIN NUTR, V85, P1098, DOI 10.1093/ajcn/85.4.1098	33	58	61	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 11	2011	88	2					216	225		10.1016/j.ajhg.2011.01.004	http://dx.doi.org/10.1016/j.ajhg.2011.01.004			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	725YZ	21310276	Bronze, Green Published			2022-12-18	WOS:000287684100010
J	Crosby, AH; Patel, H; Chioza, BA; Proukakis, C; Gurtz, K; Patton, MA; Sharifi, R; Harlalka, G; Simpson, MA; Dick, K; Reed, JA; Al-Memar, A; Chrzanowska-Lightowlers, ZMA; Cross, HE; Lightowlers, RN				Crosby, Andrew H.; Patel, Heema; Chioza, Barry A.; Proukakis, Christos; Gurtz, Kay; Patton, Michael A.; Sharifi, Reza; Harlalka, Gaurav; Simpson, Michael A.; Dick, Katherine; Reed, Johanna A.; Al-Memar, Ali; Chrzanowska-Lightowlers, Zofia M. A.; Cross, Harold E.; Lightowlers, Robert N.			Defective Mitochondrial mRNA Maturation Is Associated with Spastic Ataxia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLY(A) POLYMERASE; PARAPLEGIA; MUTATIONS	In human mitochondria, polyadenylation of mRNA undertaken by the nuclear encoded mitochondrial poly(A) RNA polymerase, is essential for maintaining mitochondrial gene expression Our molecular investigation of an autosomal recessive spastic ataxia with optic atrophy, present among the Old Order Amish, identified a mutation of MTPAP associated with the disease phenotype When subjected to poly(A) tail length assays mitochondrial mRNAs from affected individuals were shown to have severely truncated poly(A) tails Although defective mitochondrial DNA maintenance underlies a well described group of clinical disorders, our findings reveal a defect of mitochondrial mRNA maturation associated with human disease and imply that this disease mechanism should be considered in other complex neurodegenerative disorders	[Crosby, Andrew H.; Patel, Heema; Chioza, Barry A.; Proukakis, Christos; Patton, Michael A.; Sharifi, Reza; Harlalka, Gaurav; Simpson, Michael A.; Dick, Katherine; Reed, Johanna A.] St Georges Univ London, Ctr Med Genet, London SW17 0RE, England; [Proukakis, Christos] UCL, Dept Clin Neurosci, Inst Neurol, London NW3 2PT, England; [Gurtz, Kay] Windows Hope Genet Study, Geauga Cty, OH 44687 USA; [Al-Memar, Ali] St George Hosp, Dept Neurol, London SW17 0RE, England; [Chrzanowska-Lightowlers, Zofia M. A.; Lightowlers, Robert N.] Newcastle Univ, Sch Med, Mitochondrial Res Grp, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Cross, Harold E.] Univ Arizona, Sch Med, Dept Ophthalmol, Tucson, AZ 85711 USA	St Georges University London; University of London; University College London; St Georges University London; Newcastle University - UK; University of Arizona	Crosby, AH (corresponding author), St Georges Univ London, Ctr Med Genet, Cranmer Terrace, London SW17 0RE, England.		Proukakis, Christos/G-4548-2013; Chioza, Barry/C-1586-2008; Crosby, Andrew H/E-2218-2015; proukakis, christos/ABE-3447-2020; Simpson, Michael/F-4737-2011	Chioza, Barry/0000-0002-3546-1726; Crosby, Andrew H/0000-0003-3667-9054; proukakis, christos/0000-0001-6423-6539; Simpson, Michael/0000-0002-8539-8753; Chrzanowska-Lightowlers, Zofia/0000-0002-0045-3152	Birth Defects Foundation (UK)/Newlife Foundation for Disabled Children; BBSRC [BB/F011520/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F011520/1] Funding Source: researchfish; Medical Research Council [G0700718B] Funding Source: researchfish	Birth Defects Foundation (UK)/Newlife Foundation for Disabled Children; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Birth Defects Foundation (UK)/Newlife Foundation for Disabled Children We would like to thank the Amish families for participating in this study Sequencing was done in the Medical Biomics (St George s, University of London) R N L and ZM A C I would like to thank The Wellcome Trust (074454/Z/04/Z) and the Biotechnology and Biological Sciences Research Council (BB/F011520/1) for continuing support	Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Di Bella D, 2010, NAT GENET, V42, P313, DOI 10.1038/ng.544; Mariotti C, 2008, CEREBELLUM, V7, P184, DOI 10.1007/s12311-008-0053-9; Nagaike T, 2005, J BIOL CHEM, V280, P19721, DOI 10.1074/jbc.M500804200; OJALA D, 1981, J MOL BIOL, V150, P303, DOI 10.1016/0022-2836(81)90454-X; Patel H, 2002, NAT GENET, V31, P347, DOI 10.1038/ng937; Rahman S, 2009, J NEUROL NEUROSUR PS, V80, P943, DOI 10.1136/jnnp.2008.158279; Simpson MA, 2004, NAT GENET, V36, P1225, DOI 10.1038/ng1460; Simpson MA, 2003, AM J HUM GENET, V73, P1147, DOI 10.1086/379522; Slomovic S, 2008, RNA, V14, P310, DOI 10.1261/rna.697308; Sobel E, 2001, HUM HERED, V52, P121, DOI 10.1159/000053366; Sobel E, 1996, AM J HUM GENET, V58, P1323; Stemmler TL, 2010, J BIOL CHEM, V285, P26737, DOI 10.1074/jbc.R110.118679; Temperley RJ, 2003, HUM MOL GENET, V12, P2341, DOI 10.1093/hmg/ddg238; Tomecki R, 2004, NUCLEIC ACIDS RES, V32, P6001, DOI 10.1093/nar/gkh923; Wilkinson PA, 2004, BRAIN, V127, P973, DOI 10.1093/brain/awh125; Wydro M, 2010, NUCLEIC ACIDS RES, V38, P3732, DOI 10.1093/nar/gkq068	17	58	59	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV 12	2010	87	5					655	660		10.1016/j.ajhg.2010.09.013	http://dx.doi.org/10.1016/j.ajhg.2010.09.013			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	686AE	20970105	Green Published, Bronze			2022-12-18	WOS:000284668400010
J	Au, AC; Hernandez, PA; Lieber, E; Nadroo, AM; Shen, YM; Kelley, KA; Gelb, BD; Diaz, GA				Au, Audrey C.; Hernandez, Paolo A.; Lieber, Ernest; Nadroo, Ali M.; Shen, Yu-Ming; Kelley, Kevin A.; Gelb, Bruce D.; Diaz, George A.			Protein Tyrosine Phosphatase PTPN14 Is a Regulator of Lymphatic Function and Choanal Development in Humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LYMPHEDEMA-DISTICHIASIS SYNDROME; HEREDITARY LYMPHEDEMA; TRANSCRIPTION FACTOR; TRANSGENIC MICE; NOONAN-SYNDROME; MUTATIONS; DISEASE; KINASE; GENE; LYMPHANGIOGENESIS	The lymphatic vasculature is essential for the recirculation of extracellular fluid, fat absorption, and immune function and as a route of tumor metastasis. The dissection of molecular mechanisms underlying lymphangiogenesis has been accelerated by the identification of tissue-specific lymphatic endothelial markers and the study of congenital lymphedema syndromes. We report the results of genetic analyses of a kindred inheriting a unique autosomal-recessive lymphedema-choanal atresia syndrome. These studies establish linkage of the trait to chromosome 1q32-q41 and identify a loss-of-function mutation in PTPN14, which encodes a nonreceptor tyrosine phosphatase. The causal role of PTPN14 deficiency was confirmed by the generation of a murine Ptpn14 gene trap model that manifested lymphatic hyperplasia with lymphedema. Biochemical studies revealed a potential interaction between PTPN14 and the vascular endothelial growth factor receptor 3 (VEGFR3), a receptor tyrosine kinase essential for lymphangiogenesis. These results suggest a unique and conserved role for PTPN14 in the regulation of lymphatic development in mammals and a nonconserved role in choanal development in humans.	[Au, Audrey C.; Hernandez, Paolo A.; Shen, Yu-Ming; Gelb, Bruce D.; Diaz, George A.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Gelb, Bruce D.; Diaz, George A.] Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; [Kelley, Kevin A.] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Lieber, Ernest] Lincoln Hosp, Dept Pediat, Bronx, NY 10451 USA; [Lieber, Ernest] Mental Hlth Ctr, Bronx, NY 10451 USA; [Nadroo, Ali M.] New York Methodist Hosp, Dept Pediat, Brooklyn, NY 11215 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; NewYork-Presbyterian Brooklyn Methodist Hospital; NewYork-Presbyterian Hospital	Diaz, GA (corresponding author), Mt Sinai Sch Med, Dept Genet & Genom Sci, 1 Gustave L Levy Pl, New York, NY 10029 USA.	george.diaz@mssm.edu	Diaz, George/AAF-6199-2021					Alders M, 2009, NAT GENET, V41, P1272, DOI 10.1038/ng.484; Blumenthal GM, 2008, EUR J HUM GENET, V16, P1289, DOI 10.1038/ejhg.2008.162; BOLLINGER A, 1983, LYMPHOLOGY, V16, P27; Brice G, 2005, J MED GENET, V42, P98, DOI 10.1136/jmg.2004.024802; Cardone L, 2004, MOL CELL BIOL, V24, P4613, DOI 10.1128/MCB.24.11.4613-4626.2004; Carlucci A, 2008, J BIOL CHEM, V283, P10919, DOI 10.1074/jbc.M707248200; Cueni Leah N., 2008, Lymphatic Research and Biology, V6, P109, DOI 10.1089/lrb.2008.1008; Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837; Fang JM, 2000, AM J HUM GENET, V67, P1382, DOI 10.1086/316915; Ferrell RE, 1998, HUM MOL GENET, V7, P2073, DOI 10.1093/hmg/7.13.2073; Funakoshi-Tago M, 2008, MOL CELL BIOL, V28, P1792, DOI 10.1128/MCB.01447-07; GELB BD, 1995, NAT GENET, V10, P235, DOI 10.1038/ng0695-235; Gelb BD, 2006, HUM MOL GENET, V15, pR220, DOI 10.1093/hmg/ddl197; HAREL G, 1991, ANN OTO RHINOL LARYN, V100, P661; Ichise T, 2010, DEVELOPMENT, V137, P1003, DOI 10.1242/dev.043489; Irrthum A, 2000, AM J HUM GENET, V67, P295, DOI 10.1086/303019; Irrthum A, 2003, AM J HUM GENET, V72, P1470, DOI 10.1086/375614; Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423; Karkkainen MJ, 2001, P NATL ACAD SCI USA, V98, P12677, DOI 10.1073/pnas.221449198; Karkkainen MJ, 2000, NAT GENET, V25, P153, DOI 10.1038/75997; Karpanen T, 2008, ANNU REV PATHOL-MECH, V3, P367, DOI 10.1146/annurev.pathol.3.121806.151515; Kriederman BM, 2003, HUM MOL GENET, V12, P1179, DOI 10.1093/hmg/ddg123; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kukk E, 1996, DEVELOPMENT, V122, P3829; MOLLER NPH, 1994, P NATL ACAD SCI USA, V91, P7477, DOI 10.1073/pnas.91.16.7477; Ogata M, 1999, J BIOL CHEM, V274, P12905, DOI 10.1074/jbc.274.18.12905; Ogata M, 1999, J BIOL CHEM, V274, P20717, DOI 10.1074/jbc.274.29.20717; Oishi K, 2009, HUM MOL GENET, V18, P193, DOI 10.1093/hmg/ddn336; Petrova TV, 2004, NAT MED, V10, P974, DOI 10.1038/nm1094; QAZI QH, 1982, AM J MED GENET, V13, P413, DOI 10.1002/ajmg.1320130409; Radhakrishnan K, 2008, ANN NY ACAD SCI, V1131, P203, DOI 10.1196/annals.1413.022; Rozen S, 2000, Methods Mol Biol, V132, P365; SAWADA M, 1994, BIOCHEM BIOPH RES CO, V203, P479, DOI 10.1006/bbrc.1994.2207; SMITH AL, 1995, BIOCHEM BIOPH RES CO, V209, P959, DOI 10.1006/bbrc.1995.1591; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; Veikkola T, 2001, EMBO J, V20, P1223, DOI 10.1093/emboj/20.6.1223; Voss AK, 1998, DEV DYNAM, V212, P171, DOI 10.1002/(SICI)1097-0177(199806)212:2<171::AID-AJA3>3.0.CO;2-E; Voss AK, 1998, DEV DYNAM, V212, P258; Wadham C, 2003, MOL BIOL CELL, V14, P2520, DOI 10.1091/mbc.E02-09-0577; Wadham C, 2000, J CELL SCI, V113, P3117; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505	47	58	62	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 10	2010	87	3					436	444		10.1016/j.ajhg.2010.08.008	http://dx.doi.org/10.1016/j.ajhg.2010.08.008			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651JH	20826270	Bronze, Green Published			2022-12-18	WOS:000281923500015
J	Pang, JF; Zhang, S; Yang, P; Hawkins-Lee, B; Zhong, JX; Zhang, YS; Ochoa, B; Agundez, JAG; Voelckel, MA; Gu, WK; Xiong, WC; Mei, L; She, JX; Wang, CY				Pang, Junfeng; Zhang, Shu; Yang, Ping; Hawkins-Lee, Bobbilynn; Zhong, Jixin; Zhang, Yushan; Ochoa, Bernardo; Agundez, Jose A. G.; Voelckel, Marie-Antoinette; Gu, Weikuan; Xiong, Wen-Cheng; Mei, Lin; She, Jin-Xiong; Wang, Cong-Yi			Loss-of-Function Mutations in HPSE2 Cause the Autosomal Recessive Urofacial Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OCHOA SYNDROME GENE; OVERACTIVE BLADDER; MOLECULAR-CLONING; FAMILY; HOMOGENEITY; REGION	Previously, we localized the defective gene for the urofacial syndrome (UFS) to a region on chromosome 10q24 by homozygosity flapping. We now report evidence that Heparanse 2 (HPSE2) is the culprit gene for the syndrome. Mutations with a loss of function in the Heparanase 2 (HPSE2) gene were identified in all UFS patients originating from Colombia, the United States, and France. HPSE2 encodes a 592 aa protein that contains a domain showing sequence homology to the glycosyl hydrolase motif in the heparanase (HPSE) gene, but its exact biological function has not yet been characterized, Complete loss of HPSE2 function in UPS patients suggests that HPSE2 may be important for the synergic action of muscles implicated in facial expression and urine voiding.	[Pang, Junfeng; Yang, Ping; Hawkins-Lee, Bobbilynn; Zhong, Jixin; Zhang, Yushan; She, Jin-Xiong; Wang, Cong-Yi] Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA; [Zhang, Shu; Yang, Ping; Zhong, Jixin] Huazhong Univ Sci & Technol, Ctr Biomed Res, Tongji Hosp, Tongji Med Coll, Wuhan 430030, Peoples R China; [Ochoa, Bernardo] Univ Antioquia, Dept Pediat Surg, Univ Hosp San Vincente de Paul, Medellin 90827, Colombia; [Agundez, Jose A. G.] Univ Extremadura, Sch Med, Dept Pharmacol, Badajoz 06006, Spain; [Voelckel, Marie-Antoinette] Hosp Enfants Timone, Dept Med Genet, F-13001 Marseille, France; [Gu, Weikuan] Univ Tennessee, Hlth Sci Ctr, Dept Orthopaed Surg Campbell Clin & Pathol, Memphis, TN 38104 USA; [Xiong, Wen-Cheng; Mei, Lin] Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA; [Xiong, Wen-Cheng; Mei, Lin] Med Coll Georgia, Dept Neurol, Augusta, GA 30912 USA; [Wang, Cong-Yi] Med Coll Georgia, Dept Pathol, Augusta, GA 30912 USA	University System of Georgia; Augusta University; Huazhong University of Science & Technology; Universidad de Antioquia; Universidad de Extremadura; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of Tennessee System; University of Tennessee Health Science Center; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	She, JX (corresponding author), Med Coll Georgia, Ctr Biotechnol & Genom Med, 1120 15th St,CA4098, Augusta, GA 30912 USA.	jshe@mcg.edu; cwang@mcg.edu	Pang, Junfeng/C-7783-2011; Mei, Lin/G-8755-2012; Zhong, Jixin/A-3077-2012; Agúndez, José A. G./A-5503-2008; Zhong, Jixin/ABE-3768-2020; Zhong, Jixin/G-5355-2012; Pang, Junfeng/I-9148-2014	Agúndez, José A. G./0000-0001-6895-9160; Pang, Junfeng/0000-0002-9982-8013; Zhong, Jixin/0000-0002-3534-7480; Wang, Cong-Yi/0000-0001-7914-168X; Zhong, Jixin/0000-0003-2196-678X	National Institutes of Health [DK074957, DK53266]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053266, R21DK074957] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to the affected subjects and their family members for participating in this study. We are also grateful to Leszek Ignatowicz for his great suggestion for manuscript preparation and Yan Jiao for her advice in high-throughput mutation screening. This work was supported by grants from the National Institutes of Health (DK074957 to C.-Y.W. and DK53266 to J.-X.S.).	Austin P F, 2000, Pediatr Rev, V21, P336, DOI 10.1542/pir.21-10-336; Aydogdu O, 2010, EUR J PEDIATR, V169, P431, DOI 10.1007/s00431-009-1042-9; BAUER SB, 1980, UROL CLIN N AM, V7, P321; Chauve X, 2000, AM J MED GENET, V95, P10, DOI 10.1002/1096-8628(20001106)95:1<10::AID-AJMG3>3.0.CO;2-Z; Feldman AS, 2006, CURR OPIN PEDIATR, V18, P139, DOI 10.1097/01.mop.0000193289.64151.49; Garcia-Minaur S, 2001, CLIN DYSMORPHOL, V10, P165, DOI 10.1097/00019605-200107000-00002; Guo DH, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-15; McKenzie E, 2000, BIOCHEM BIOPH RES CO, V276, P1170, DOI 10.1006/bbrc.2000.3586; Nicanor Francisco A., 2005, Int. braz j urol., V31, P477, DOI 10.1590/S1677-55382005000500012; Nowara Adam, 2007, Ginekol Pol, V78, P484; OCHOA B, 1992, J UROLOGY, V148, P580, DOI 10.1016/S0022-5347(17)36659-4; OCHOA B, 1987, AM J MED GENET, V27, P661, DOI 10.1002/ajmg.1320270320; Ochoa B, 2004, PEDIATR NEPHROL, V19, P6, DOI 10.1007/s00467-003-1291-1; Schulman SL, 2004, UROL CLIN N AM, V31, P481, DOI 10.1016/j.ucl.2004.04.019; Stewart WF, 2002, WORLD J UROL, V20, P327, DOI 10.1007/s00345-002-0301-4; Tyagi S, 2006, UROL CLIN N AM, V33, P433, DOI 10.1016/j.ucl.2006.06.002; Wang CY, 1999, GENOMICS, V60, P12, DOI 10.1006/geno.1999.5908; Wang CY, 1999, AM J MED GENET, V84, P454, DOI 10.1002/(SICI)1096-8628(19990611)84:5<454::AID-AJMG9>3.3.CO;2-4; Wang CY, 1997, AM J HUM GENET, V60, P1461, DOI 10.1086/515469; Wang CY, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-7; Wang CY, 2003, AM J MED GENET A, V119A, P9, DOI 10.1002/ajmg.a.20042; Wang CY, 2003, GENE, V306, P37, DOI 10.1016/S0378-1119(02)01210-6	22	58	61	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 11	2010	86	6					957	962		10.1016/j.ajhg.2010.04.016	http://dx.doi.org/10.1016/j.ajhg.2010.04.016			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	613AT	20560209	Green Published, Bronze			2022-12-18	WOS:000278948900013
J	Vandewalle, J; Van Esch, H; Govaerts, K; Verbeeck, J; Zweier, C; Madrigal, I; Mila, M; Pijkels, E; Fernandez, I; Kohlhase, J; Spaich, C; Rauch, A; Fryns, JP; Marynen, P; Froyen, G				Vandewalle, Joke; Van Esch, Hilde; Govaerts, Karen; Verbeeck, Jelle; Zweier, Christiane; Madrigal, Irene; Mila, Montserrat; Pijkels, Elly; Fernandez, Isabel; Kohlhase, Juergen; Spaich, Christiane; Rauch, Anita; Fryns, Jean-Pierre; Marynen, Peter; Froyen, Guy			Dosage-Dependent Severity of the Phenotype in Patients with Mental Retardation Due to a Recurrent Copy-Number Gain at Xq28 Mediated by an Unusual Recombination	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ARRAY-CGH; DUPLICATION; ARCHITECTURE; MECP2; REARRANGEMENTS; MUTATIONS; MECHANISM; IDENTIFICATION; DISORDERS; SUGGEST	We report on the identification of a 0.3 Mb inherited recurrent but variable copy-number gain at Xq28 in affected males of four unrelated families with X-linked mental retardation (MR). All aberrations segregate with the disease in the families, and the carrier mothers show nonrandom X chromosome inactivation. Tiling Xq28-region-specific oligo array revealed that all aberrations start at the beginning of the low copy repeat LCR-K1, at position 153.20 Mb, and end just distal to LCR-L2, at 153.54 Mb. The copy-number gain always includes 18 annotated genes, of which RPL10, ATP6AP1 and GDI1 are highly expressed in brain. From these, GDI1 is the most likely candidate gene. Its copy number correlates with the severity of clinical features, because it is duplicated in one family with nonsyndromic moderate MR, is triplicated in males from two families with mild MR and additional features, and is present in five copies in a fourth family with a severe syndromic form of MR. Moreover, expression analysis revealed copy-number-dependent increased mRNA levels in affected patients compared to control individuals. Interestingly, analysis of the breakpoint regions suggests a recombination mechanism that involves two adjacent but different sets of low copy repeats. Taken together, our data strongly suggest that an increased expression of GDI1 results in impaired cognition in a dosage-dependent manner. Moreover, these data also imply that a copy-number gain of all individual gene present in the larger genomic aberration that leads to the severe MECP2 duplication syndrome can of itself result in a clinical phenotype as well.	[Vandewalle, Joke; Govaerts, Karen; Verbeeck, Jelle; Marynen, Peter; Froyen, Guy] VIB, Human Genome Lab, Dept Mol & Dev Genet, B-3000 Louvain, Belgium; [Vandewalle, Joke; Govaerts, Karen; Verbeeck, Jelle; Marynen, Peter; Froyen, Guy] Katholieke Univ Leuven, Human Genome Lab, Ctr Human Genet, Univ Hosp Leuven, B-3000 Louvain, Belgium; [Zweier, Christiane; Rauch, Anita] Univ Erlangen Nurnberg, Inst Human Genet, Univ Hosp Erlangen, D-91054 Erlangen, Germany; [Madrigal, Irene; Mila, Montserrat] Hosp Clin Barcelona, Biochem & Mol Genet Dept, Inst Invest Biomed August Pi & Sunyer, E-08036 Barcelona, Spain; [Madrigal, Irene; Mila, Montserrat] CIBERER, Barcelona 08036, Spain; [Fernandez, Isabel] Univ Valladolid, Inst Biol & Genet Mol, Valladolid 47003, Spain; [Kohlhase, Juergen] Ctr Human Genet, D-79106 Freiburg, Germany; [Spaich, Christiane] Olga Hosp, Inst Clin Genet, D-70176 Stuttgart, Germany	Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; University of Erlangen Nuremberg; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; General Hospital of N. Ionia Agia Olga; Klinikum Stuttgart	Froyen, G (corresponding author), VIB, Human Genome Lab, Dept Mol & Dev Genet, B-3000 Louvain, Belgium.	guy.froyen@med.kuleuven.be	Zweier, Christiane/F-2202-2015; Van+Esch, Hilde/AAU-5688-2020; Madrigal, Irene/ACZ-4774-2022; Rauch, Anita/C-5568-2014	Zweier, Christiane/0000-0001-8002-2020; Rauch, Anita/0000-0003-2930-3163; Madrigal, Irene/0000-0002-7229-1199; Van Esch, Hilde/0000-0002-9604-5726; Mila, Montserrat/0000-0002-7906-0916	Fundacion Ramon Areces [V-2006-FRARECES-0]; CIBERER (the CIBER de Enfermedades Raras is an initiative of the ISCIII)	Fundacion Ramon Areces; CIBERER (the CIBER de Enfermedades Raras is an initiative of the ISCIII)	We are grateful to the patients and their families for their cooperation. We thank Detlef Bohm for performing the array-CGH experiments at the Center for Human Genetics in Freiburg (Germany), Stefanie Belet (VIB, K.U.Leuven, Belgium) for technical assistance with qPCR, and Richard Redon (The Welcome Trust Sanger Institute, Hinxton, UK) for suggesting the inversion polymorphism hypothesis. J.V. is supported by the IWT (Instituut voor aanmoediging van Innovatie door Technologie en Wetenschap), Flanders, Belgium. H.V.E. is a clinical investigator of the Fund for Scientific Research-Flanders, Belgium (FWO-Vlaanderen). This work was supported by Fundacion Ramon Areces (V-2006-FRARECES-0) and CIBERER (the CIBER de Enfermedades Raras is an initiative of the ISCIII).	ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Aradhya S, 2001, HUM MOL GENET, V10, P2557, DOI 10.1093/hmg/10.22.2557; BALLABIO A, 1989, P NATL ACAD SCI USA, V86, P10001, DOI 10.1073/pnas.86.24.10001; Barrett MT, 2004, P NATL ACAD SCI USA, V101, P17765, DOI 10.1073/pnas.0407979101; Bauters M, 2005, EUR J MED GENET, V48, P263, DOI 10.1016/j.ejmg.2005.04.008; Bauters M, 2008, GENOME RES, V18, P847, DOI 10.1101/gr.075903.107; Carvalho CMB, 2009, HUM MOL GENET, V18, P2188, DOI 10.1093/hmg/ddp151; Clayton-Smith J, 2009, EUR J HUM GENET, V17, P434, DOI 10.1038/ejhg.2008.192; D'Adamo P, 1998, NAT GENET, V19, P134, DOI 10.1038/487; del Gaudio D, 2006, GENET MED, V8, P784, DOI 10.1097/01.gim.0000250502.28516.3c; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Froyen G, 2008, AM J HUM GENET, V82, P432, DOI 10.1016/j.ajhg.2007.11.002; Froyen G, 2007, HUM MUTAT, V28, P1034, DOI 10.1002/humu.20564; Giorda R, 2007, HUM MUTAT, V28, P459, DOI 10.1002/humu.20465; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Jehee FS, 2005, AM J MED GENET A, V139A, P221, DOI 10.1002/ajmg.a.30991; Klauck SM, 2006, MOL PSYCHIATR, V11, P1073, DOI 10.1038/sj.mp.4001883; Koolen DA, 2006, NAT GENET, V38, P999, DOI 10.1038/ng1853; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Madrigal I, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-443; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Robertson SP, 2005, CURR OPIN GENET DEV, V15, P301, DOI 10.1016/j.gde.2005.04.001; Ross OA, 2008, ANN NEUROL, V63, P743, DOI 10.1002/ana.21380; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; Shaw-Smith C, 2006, NAT GENET, V38, P1032, DOI 10.1038/ng1858; Smahi A, 2000, NATURE, V405, P466; Small K, 1997, NAT GENET, V16, P96, DOI 10.1038/ng0597-96; Unger S, 2008, NAT GENET, V40, P287, DOI 10.1038/ng.86; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; Visser R, 2005, AM J HUM GENET, V76, P52, DOI 10.1086/426950; Willenbrock H, 2005, BIOINFORMATICS, V21, P4084, DOI 10.1093/bioinformatics/bti677; Wolf NI, 2005, BRAIN, V128, P743, DOI 10.1093/brain/awh409; Woodward KJ, 2005, AM J HUM GENET, V77, P966, DOI 10.1086/498048	35	58	58	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 11	2009	85	6					809	822		10.1016/j.ajhg.2009.10.019	http://dx.doi.org/10.1016/j.ajhg.2009.10.019			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	533BN	20004760	Green Published, Bronze			2022-12-18	WOS:000272797100005
J	Ayub, M; Basit, S; Jelani, M; Rehman, FU; Iqbal, M; Yasinzai, M; Ahmad, W				Ayub, Muhammad; Basit, Sulman; Jelani, Musharraf; Rehman, Fazal Ur; Iqbal, Muhammad; Yasinzai, Masoom; Ahmad, Wasim			A Homozygous Nonsense Mutation in the Human Desmocollin-3 (DSC3) Gene Underlies Hereditary Hypotrichosis and Recurrent Skin Vesicles	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WOOLLY HAIR; CARDIOMYOPATHY; DESMOSOMES; DELETION; DEFECTS	Desmosomes are the major players in epidermis and cardiac muscles and contribute to intercellular binding and maintenance of tissue integrity. Two important constituents of desmosomes are transmembrane cadherins named desmogleins and desmocollins. The critical role of these desmosomal proteins in epithelial integrity has been illustrated by their disruption in mouse models and human diseases. In the present study, we have investigated a large family from Afghanistan in which four individuals are affected with hereditary hypotrichosis and the appearance of recurrent skin vesicle formation. All four affected individuals showed sparse and fragile hair on scalp, as well as absent eyebrows and eyelashes. Vesicles filled with thin, watery fluid were observed on the affected individuals' scalps and on most of the skin covering their bodies. A scalp-skin biopsy of an affected individual showed mild hair-follicle plugging. Candidate-gene-based homozygosity linkage mapping assigned the disease locus to 8.30 cM (8.51 Mbp) on chromosome 18q12.1. A maximum multipoint LOD score of 3.30 (0 = 0.00) was obtained at marker D18S877. Sequence analysis of four desmoglein and three desmocollin genes, contained within the linkage interval, revealed a homozygous nonsense mutation (c.2129T>G [p.Leu710X]) in exon-14 of the desmocollin-3 (DSC3) gene.	[Ayub, Muhammad; Basit, Sulman; Jelani, Musharraf; Rehman, Fazal Ur; Ahmad, Wasim] Quaid I Azam Univ, Dept Biochem, Fac Biol Sci, Islamabad, Pakistan; [Ayub, Muhammad; Yasinzai, Masoom] Univ Baluchistan, Inst Biochem, Quetta, Pakistan; [Iqbal, Muhammad] Bolan Med Coll, Dept Dermatol, Baluchistan, Pakistan	Quaid I Azam University; University of Balochistan	Ahmad, W (corresponding author), Quaid I Azam Univ, Dept Biochem, Fac Biol Sci, Islamabad, Pakistan.	wahmad@qau.edu.pk	Basit, Sulman/AAY-9763-2021; Basit, Sulman/Q-7939-2018; Ahmad, Wasim/E-9713-2015; Jelani, Musharraf/D-4041-2013; Yasinzai, Masoom/I-6771-2015; Jelani, Musharraf/GPT-2377-2022; Basit, Sulman/B-2947-2013; Basit, Sulman/F-6395-2015; Ahmad, Wasim/GSD-8904-2022	Basit, Sulman/0000-0003-4294-6825; Basit, Sulman/0000-0003-4294-6825; Jelani, Musharraf/0000-0002-3421-0079; Jelani, Musharraf/0000-0002-3421-0079; Yasinzai, Masoom/0000-0003-3875-5858	Higher Education Commission (HEC), Islamabad, Pakistan	Higher Education Commission (HEC), Islamabad, Pakistan(Higher Education Commission of Pakistan)	We are grateful to the patients and their family members for their participation in the present research work. This work was funded by the Higher Education Commission (HEC), Islamabad, Pakistan.	Azeem Z, 2008, HUM GENET, V123, P515, DOI 10.1007/s00439-008-0507-7; Chen JL, 2008, J CELL SCI, V121, P2844, DOI 10.1242/jcs.031518; Chidgey M, 2001, J CELL BIOL, V155, P821, DOI 10.1083/jcb.200105009; Chidgey MAJ, 1997, DEV DYNAM, V210, P315, DOI 10.1002/(SICI)1097-0177(199711)210:3<315::AID-AJA11>3.0.CO;2-9; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Garrod D, 2008, BBA-BIOMEMBRANES, V1778, P572, DOI 10.1016/j.bbamem.2007.07.014; Green KJ, 2000, NAT REV MOL CELL BIO, V1, P208, DOI 10.1038/35043032; Gudbjartsson DF, 2005, NAT GENET, V37, P1015, DOI 10.1038/ng1005-1015; Kljuic A, 2003, CELL, V113, P249, DOI 10.1016/S0092-8674(03)00273-3; Koch PJ, 1998, J CELL SCI, V111, P2529; Koch PJ, 1997, J CELL BIOL, V137, P1091, DOI 10.1083/jcb.137.5.1091; Kong X, 2004, AM J HUM GENET, V75, P1143, DOI 10.1086/426405; Maquat LE, 1996, AM J HUM GENET, V59, P279; McGrath JA, 1997, NAT GENET, V17, P240, DOI 10.1038/ng1097-240; McKoy G, 2000, LANCET, V355, P2119, DOI 10.1016/S0140-6736(00)02379-5; McMillan JR, 2001, J DERMATOL, V28, P291, DOI 10.1111/j.1346-8138.2001.tb00136.x; MULLER R, 2009, CLIN EXP DE IN PRESS; Norgett EE, 2000, HUM MOL GENET, V9, P2761, DOI 10.1093/hmg/9.18.2761; NUBER UA, 1996, EUR J CELL BIOL, V106, P677; Rafiq MA, 2004, J INVEST DERMATOL, V123, P247, DOI 10.1111/j.0022-202X.2004.22715.x; Sobel E, 1996, AM J HUM GENET, V58, P1323; STAPPENBECK TS, 1994, J BIOL CHEM, V269, P29351; THEIS DG, 1993, INT J DEV BIOL, V37, P101; Wali A, 2007, CLIN GENET, V72, P23, DOI 10.1111/j.1399-0004.2007.00818.x; Whittock NV, 2003, J INVEST DERMATOL, V120, P523, DOI 10.1046/j.1523-1747.2003.12113.x	25	58	60	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 9	2009	85	4					515	520		10.1016/j.ajhg.2009.08.015	http://dx.doi.org/10.1016/j.ajhg.2009.08.015			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	507FA	19765682	Green Published, Bronze			2022-12-18	WOS:000270836000008
J	Kulkarni, A; Wilson, DM				Kulkarni, Avanti; Wilson, David M., III			The involvement of DNA-damage and -repair defects in neurological dysfunction	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							DOUBLE-STRAND-BREAK; NUCLEOTIDE-EXCISION-REPAIR; AMYOTROPHIC-LATERAL-SCLEROSIS; RNA-POLYMERASE-II; TRANSCRIPTION-COUPLED REPAIR; HISTIDINE TRIAD SUPERFAMILY; HUMAN POLYNUCLEOTIDE KINASE; ATAXIA-OCULOMOTOR APRAXIA; FACIO-SKELETAL SYNDROME; OCULAR MOTOR APRAXIA	A genetic link between defects in DNA repair and neurological abnormalities has been well established through studies of inherited disorders such as ataxia telangiectasia and xeroderma pigmentosum. In this review, we present a comprehensive summary of the major types of DNA damage, the molecular pathways that function in their repair, and the connection between defective DNA-repair responses and specific neurological disease. Particular attention is given to describing the nature of the repair defect and its relationship to the manifestation of the associated neurological dysfunction. Finally, the review touches upon the role of oxidative stress, a leading precursor to DNA damage, in the development of certain neurodegenerative pathologies, such as Alzheimer's and Parkinson's.	[Kulkarni, Avanti; Wilson, David M., III] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Wilson, DM (corresponding author), NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA.	wilsonda@grc.nia.nih.gov	Wilson, David M/AAK-5409-2021	Wilson, David M/0000-0002-8945-0395	NATIONAL INSTITUTE ON AGING [ZIAAG000751, Z01AG000751] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Adams KE, 2006, ONCOGENE, V25, P3894, DOI 10.1038/sj.onc.1209426; Ahel I, 2006, NATURE, V443, P713, DOI 10.1038/nature05164; Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; AICARDI J, 1988, ANN NEUROL, V24, P497, DOI 10.1002/ana.410240404; ALBIN RL, 1990, ANN NEUROL, V27, P357, DOI 10.1002/ana.410270403; Atamna H, 2000, P NATL ACAD SCI USA, V97, P686, DOI 10.1073/pnas.97.2.686; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; BARBARELLA G, 1991, NUCLEOS NUCLEOT, V10, P1759, DOI 10.1080/15257779108043060; Barnes DE, 1993, CURR OPIN CELL BIOL, V5, P424, DOI 10.1016/0955-0674(93)90007-D; Bartels CL, 2007, BIOCHEM BIOPH RES CO, V356, P219, DOI 10.1016/j.bbrc.2007.02.125; BARZILAY G, 1995, BIOESSAYS, V17, P713, DOI 10.1002/bies.950170808; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8; BENNETT CB, 1993, P NATL ACAD SCI USA, V90, P5613, DOI 10.1073/pnas.90.12.5613; Berneburg M, 2000, CANCER RES, V60, P431; Berneburg M, 2000, EMBO J, V19, P1157, DOI 10.1093/emboj/19.5.1157; BESSHO T, 1993, P NATL ACAD SCI USA, V90, P8901, DOI 10.1073/pnas.90.19.8901; BESSHO T, 1993, J BIOL CHEM, V268, P19416; Bi XL, 2004, CURR BIOL, V14, P1348, DOI 10.1016/j.cub.2004.06.063; Blair IP, 2000, NEUROGENETICS, V3, P1; BODER E, 1958, PEDIATRICS, V21, P526; Bohr VA, 2005, DNA REPAIR, V4, P293, DOI 10.1016/j.dnarep.2004.09.010; Bomont P, 2000, EUR J HUM GENET, V8, P986, DOI 10.1038/sj.ejhg.5200586; Botta E, 1998, AM J HUM GENET, V63, P1036, DOI 10.1086/302063; Brenner C, 1999, J CELL PHYSIOL, V181, P179, DOI 10.1002/(SICI)1097-4652(199911)181:2<179::AID-JCP1>3.0.CO;2-8; Brooks PJ, 2007, NEUROSCIENCE, V145, P1407, DOI 10.1016/j.neuroscience.2006.10.025; Broughton BC, 2002, P NATL ACAD SCI USA, V99, P815, DOI 10.1073/pnas.022473899; Browne SE, 1999, BRAIN PATHOL, V9, P147; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Buermeyer AB, 1999, ANNU REV GENET, V33, P533, DOI 10.1146/annurev.genet.33.1.533; Buscemi G, 2001, MOL CELL BIOL, V21, P5214, DOI 10.1128/MCB.21.15.5214-5222.2001; Butterfield DA, 2001, CURR MED CHEM, V8, P815, DOI 10.2174/0929867013373048; Cadet J, 2004, J ENVIRON PATHOL TOX, V23, P33, DOI 10.1615/JEnvPathToxOncol.v23.i1.30; Cadet J, 2003, MUTAT RES-FUND MOL M, V531, P5, DOI 10.1016/j.mrfmmm.2003.09.001; Cai HB, 2005, J NEUROSCI, V25, P7567, DOI 10.1523/JNEUROSCI.1645-05.2005; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; Calderon J, 2003, ECOTOX ENVIRON SAFE, V56, P93, DOI 10.1016/S0147-6513(03)00053-8; Campalans A, 2005, DNA REPAIR, V4, P826, DOI 10.1016/j.dnarep.2005.04.014; Cappelli E, 1997, J BIOL CHEM, V272, P23970, DOI 10.1074/jbc.272.38.23970; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Cavadini P, 2002, HUM MOL GENET, V11, P217, DOI 10.1093/hmg/11.3.217; Cavalieri EL, 1997, P NATL ACAD SCI USA, V94, P10937, DOI 10.1073/pnas.94.20.10937; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chappell C, 2002, EMBO J, V21, P2827, DOI 10.1093/emboj/21.11.2827; CHAUDHARY AK, 1994, SCIENCE, V265, P1580, DOI 10.1126/science.8079172; Chen YZ, 2006, NEUROBIOL DIS, V23, P97, DOI 10.1016/j.nbd.2006.02.007; Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054; Chung FL, 1996, CARCINOGENESIS, V17, P2105, DOI 10.1093/carcin/17.10.2105; Citterio E, 2000, MOL CELL BIOL, V20, P7643, DOI 10.1128/MCB.20.20.7643-7653.2000; Cleaver JE, 1999, HUM MUTAT, V14, P9, DOI 10.1002/(SICI)1098-1004(1999)14:1<9::AID-HUMU2>3.3.CO;2-Y; Cleaver JE, 2002, FRONT BIOSCI-LANDMRK, V7, pD1024, DOI 10.2741/cleaver; Clements PM, 2004, DNA REPAIR, V3, P1493, DOI 10.1016/j.dnarep.2004.06.017; Cohen SM, 2001, PROG NUCLEIC ACID RE, V67, P93, DOI 10.1016/S0079-6603(01)67026-0; Coin F, 2006, MOL CELL, V21, P215, DOI 10.1016/j.molcel.2005.10.024; Coin F, 1998, NAT GENET, V20, P184, DOI 10.1038/2491; Coin F, 1999, EMBO J, V18, P1357, DOI 10.1093/emboj/18.5.1357; Coin F, 2007, MOL CELL, V26, P245, DOI 10.1016/j.molcel.2007.03.009; Constantinou A, 2001, CELL, V104, P259, DOI 10.1016/S0092-8674(01)00210-0; Constantinou A, 2000, EMBO REP, V1, P80, DOI 10.1093/embo-reports/kvd004; Cordeiro-Stone M, 1999, J MOL BIOL, V289, P1207, DOI 10.1006/jmbi.1999.2847; CROY RG, 1978, P NATL ACAD SCI USA, V75, P1745, DOI 10.1073/pnas.75.4.1745; Cuadrado M, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-7; CULLINANE C, 1994, BIOCHEMISTRY-US, V33, P4632, DOI 10.1021/bi00181a025; D'Errico M, 2007, ONCOGENE, V26, P4336, DOI 10.1038/sj.onc.1210232; Date H, 2001, NAT GENET, V29, P184, DOI 10.1038/ng1001-184; Davies DR, 2002, STRUCTURE, V10, P237, DOI 10.1016/S0969-2126(02)00707-4; De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; de Laat WL, 1998, J BIOL CHEM, V273, P7835, DOI 10.1074/jbc.273.14.7835; de Sanctis C, 1932, RIV SPER FRENIATR ME, V56, P269; de Waard H, 2003, DNA REPAIR, V2, P13, DOI 10.1016/S1568-7864(02)00188-X; Delia D, 2004, HUM MOL GENET, V13, P2155, DOI 10.1093/hmg/ddh221; Desai-Mehta A, 2001, MOL CELL BIOL, V21, P2184, DOI 10.1128/MCB.21.6.2184-2191.2001; DESANTIS LP, 2006, EMBO J, V25, P1915; Dianov GL, 1999, J BIOL CHEM, V274, P13741, DOI 10.1074/jbc.274.20.13741; Dizdaroglu M, 2002, FREE RADICAL BIO MED, V32, P1102, DOI 10.1016/S0891-5849(02)00826-2; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; EDWARDS MJ, 1980, NATURE, V287, P745, DOI 10.1038/287745a0; El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314; El-Khamisy SF, 2007, DNA REPAIR, V6, P1485, DOI 10.1016/j.dnarep.2007.04.015; El-Khamisy SF, 2006, MUTAGENESIS, V21, P219, DOI 10.1093/mutage/gel024; Emmert S, 2002, J INVEST DERMATOL, V118, P972, DOI 10.1046/j.1523-1747.2002.01782.x; EPSTEIN SS, 1968, NATURE, V219, P385, DOI 10.1038/219385a0; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Faivre L, 2002, AM J MED GENET, V112, P379, DOI 10.1002/ajmg.10677; Fan JS, 2004, NUCLEIC ACIDS RES, V32, P2193, DOI 10.1093/nar/gkh556; FISHMANLOBELL J, 1992, SCIENCE, V258, P480, DOI 10.1126/science.1411547; Fortini P, 1998, BIOCHEMISTRY-US, V37, P3575, DOI 10.1021/bi972999h; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; FRIEDBERG E, 1995, W DNA REPAIRDNA REPA; Frosina G, 1996, J BIOL CHEM, V271, P9573, DOI 10.1074/jbc.271.16.9573; Fujimoto M, 2005, J INVEST DERMATOL, V125, P86, DOI 10.1111/j.0022-202X.2005.23745.x; Geldmacher David S, 2007, Prim Care Companion J Clin Psychiatry, V9, P113; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Giglia-Mari G, 2004, NAT GENET, V36, P714, DOI 10.1038/ng1387; Girard PM, 2004, HUM MOL GENET, V13, P2369, DOI 10.1093/hmg/ddh274; Goodship J, 2000, AM J HUM GENET, V67, P498, DOI 10.1086/303023; Grawunder U, 1997, NATURE, V388, P492, DOI 10.1038/41358; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Groisman R, 2006, GENE DEV, V20, P1429, DOI 10.1101/gad.378206; Gu LY, 1998, NUCLEIC ACIDS RES, V26, P1173, DOI 10.1093/nar/26.5.1173; Gueven N, 2007, NEUROSCIENCE, V145, P1418, DOI 10.1016/j.neuroscience.2006.12.010; Gueven N, 2004, HUM MOL GENET, V13, P1081, DOI 10.1093/hmg/ddh122; Hanakahi LA, 2000, CELL, V102, P721, DOI 10.1016/S0092-8674(00)00061-1; Hanakahi LA, 2002, EMBO J, V21, P2038, DOI 10.1093/emboj/21.8.2038; Hannun YA, 1997, BLOOD, V89, P1845, DOI 10.1182/blood.V89.6.1845; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; Hashimoto M, 2003, NEUROMOL MED, V4, P21, DOI 10.1385/NMM:4:1-2:21; Helleday T, 2003, MUTAT RES-FUND MOL M, V532, P103, DOI 10.1016/j.mrfmmm.2003.08.013; HENNING KA, 1995, CELL, V82, P555, DOI 10.1016/0092-8674(95)90028-4; HINMURA K, 1997, MUTAT RES, V385, P75; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; IMPELLIZZERI KJ, 1991, J BACTERIOL, V173, P6807, DOI 10.1128/jb.173.21.6807-6810.1991; Interthal H, 2005, EMBO J, V24, P2224, DOI 10.1038/sj.emboj.7600694; Interthal H, 2001, P NATL ACAD SCI USA, V98, P12009, DOI 10.1073/pnas.211429198; Itin PH, 2001, J AM ACAD DERMATOL, V44, P891, DOI 10.1067/mjd.2001.114294; Ito S, 2007, MOL CELL, V26, P231, DOI 10.1016/j.molcel.2007.03.013; Jackson AL, 2001, MUTAT RES-FUND MOL M, V477, P7, DOI 10.1016/S0027-5107(01)00091-4; Jaspers NGJ, 2007, AM J HUM GENET, V80, P457, DOI 10.1086/512486; Jeggo PA, 1997, MUTAT RES-DNA REPAIR, V384, P1, DOI 10.1016/S0921-8777(97)00009-8; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Joenje H, 2001, NAT REV GENET, V2, P446, DOI 10.1038/35076590; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; Kamiuchi S, 2002, P NATL ACAD SCI USA, V99, P201, DOI 10.1073/pnas.012473199; Kanekura K, 2004, J BIOL CHEM, V279, P19247, DOI 10.1074/jbc.M313236200; KANG H, 1995, CARCINOGENESIS, V16, P1277, DOI 10.1093/carcin/16.6.1277; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Katyal S, 2007, EMBO J, V26, P4720, DOI 10.1038/sj.emboj.7601869; Khan SG, 1998, J INVEST DERMATOL, V111, P791, DOI 10.1046/j.1523-1747.1998.00391.x; KHANNA KK, 1995, ONCOGENE, V11, P609; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Kijas AW, 2006, J BIOL CHEM, V281, P13939, DOI 10.1074/jbc.M507946200; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; Klungland A, 1999, MOL CELL, V3, P33, DOI 10.1016/S1097-2765(00)80172-0; Kobayashi J, 2002, CURR BIOL, V12, P1846, DOI 10.1016/S0960-9822(02)01259-9; Koutnikova H, 1997, NAT GENET, V16, P345, DOI 10.1038/ng0897-345; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; KRAEMER KH, 1984, CARCINOGENESIS, V5, P511, DOI 10.1093/carcin/5.4.511; KRAEMER KH, 1987, ARCH DERMATOL, V123, P241, DOI 10.1001/archderm.123.2.241; Krokan HE, 1997, BIOCHEM J, V325, P1; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; Laine JP, 2006, TRENDS GENET, V22, P430, DOI 10.1016/j.tig.2006.06.006; Lamerdin JE, 1996, GENOMICS, V34, P399, DOI 10.1006/geno.1996.0303; Larsen A K, 1999, Pathol Oncol Res, V5, P171, DOI 10.1053/paor.1999.0209; LAVIN MF, 1988, MUTAT RES, V193, P193, DOI 10.1016/0167-8817(88)90030-2; Lederer Carsten W., 2007, Biotechnology Journal, V2, P608, DOI 10.1002/biot.200600247; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; LEHMANN AR, 1988, CANCER RES, V48, P6090; Liehr JG, 2000, ENDOCR REV, V21, P40, DOI 10.1210/er.21.1.40; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Liu LF, 2000, ANN NY ACAD SCI, V922, P1; Liu YL, 2007, J BIOL CHEM, V282, P1973, DOI 10.1074/jbc.M609066200; Liu YL, 2004, SCIENCE, V303, P243, DOI 10.1126/science.1093037; LU X, 1993, CELL, V75, P765, DOI 10.1016/0092-8674(93)90496-D; Luo H, 2004, MOL CELL BIOL, V24, P8356, DOI 10.1128/MCB.24.19.8356-8365.2004; Mahajan KN, 2002, MOL CELL BIOL, V22, P5194, DOI 10.1128/MCB.22.14.5194-5202.2002; Mallery DL, 1998, AM J HUM GENET, V62, P77, DOI 10.1086/301686; MARIONNET C, 1995, J MOL BIOL, V252, P550, DOI 10.1006/jmbi.1995.0519; Maser RS, 2001, NAT GENET, V27, P417, DOI 10.1038/86920; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; MATSUNAGA T, 1995, J BIOL CHEM, V270, P20862, DOI 10.1074/jbc.270.35.20862; Matsuura S, 1997, AM J HUM GENET, V60, P1487, DOI 10.1086/515461; McIlwraith MJ, 2005, MOL CELL, V20, P783, DOI 10.1016/j.molcel.2005.10.001; Meira LB, 2000, AM J HUM GENET, V66, P1221, DOI 10.1086/302867; Mellon I, 2005, MUTAT RES-FUND MOL M, V577, P155, DOI 10.1016/j.mrfmmm.2005.03.016; Mistry N, 2003, LAB INVEST, V83, P241, DOI 10.1097/01.LAB.0000053915.88556.ED; Miyata M, 1996, NAT GENET, V14, P55, DOI 10.1038/ng0996-55; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; Montine TJ, 1996, J NEUROPATH EXP NEUR, V55, P202, DOI 10.1097/00005072-199602000-00009; Moreira MC, 2004, NAT GENET, V36, P225, DOI 10.1038/ng1303; Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189; Moreira MD, 2001, AM J HUM GENET, V68, P501, DOI 10.1086/318191; Morrison PJ, 2003, EUR J PAEDIATR NEURO, V7, P217, DOI 10.1016/S1090-3798(03)00105-3; Moser J, 2007, MOL CELL, V27, P311, DOI 10.1016/j.molcel.2007.06.014; Mosesso P, 2005, CELL MOL LIFE SCI, V62, P485, DOI 10.1007/s00018-004-4441-0; Mudher A, 2002, TRENDS NEUROSCI, V25, P22, DOI 10.1016/S0166-2236(00)02031-2; MYRIANTHOPOULOS NC, 1964, BRAIN, V87, P589, DOI 10.1093/brain/87.4.589; NAGASAWA H, 1983, MUTAT RES, V109, P297, DOI 10.1016/0027-5107(83)90054-4; Nakamura J, 1999, CANCER RES, V59, P2522; Nakatsu Y, 2000, J BIOL CHEM, V275, P34931, DOI 10.1074/jbc.M004936200; Nemeth AH, 2000, AM J HUM GENET, V67, P1320, DOI 10.1016/S0002-9297(07)62962-0; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Nishiwaki Y, 2004, J INVEST DERMATOL, V122, P526, DOI 10.1046/j.0022-202X.2004.22226.x; Nouspikel T, 2007, NEUROSCIENCE, V145, P1213, DOI 10.1016/j.neuroscience.2006.07.006; Nouspikel T, 2003, BIOESSAYS, V25, P168, DOI 10.1002/bies.10227; NUZZO F, 1989, DNA DAMAGE REPAIR, P61; O'Connor JM, 2001, BIOCHEM SOC T, V29, P354, DOI 10.1042/BST0290354; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; O'Driscoll M, 2001, MOL CELL, V8, P1175, DOI 10.1016/S1097-2765(01)00408-7; O'Driscoll M, 1999, CARCINOGENESIS, V20, P1855, DOI 10.1093/carcin/20.9.1855; ODONOVAN A, 1994, NATURE, V371, P432, DOI 10.1038/371432a0; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; Oh KS, 2006, HUM MUTAT, V27, P1092, DOI 10.1002/humu.20392; Olson E, 2007, MOL CELL BIOL, V27, P6053, DOI 10.1128/MCB.00532-07; PAINTER RB, 1980, P NATL ACAD SCI-BIOL, V77, P7315, DOI 10.1073/pnas.77.12.7315; PARK CH, 1995, J BIOL CHEM, V270, P4896, DOI 10.1074/jbc.270.9.4896; Park SY, 2002, CANCER RES, V62, P459; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Pastwa E, 2003, ACTA BIOCHIM POL, V50, P891; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paulson HL, 2007, SEMIN NEUROL, V27, P133, DOI 10.1055/s-2007-971172; Peto J, 2001, NATURE, V411, P390, DOI 10.1038/35077256; Plo I, 2003, DNA REPAIR, V2, P1087, DOI 10.1016/S1568-7864(03)00116-2; Podlutsky AJ, 2001, EMBO J, V20, P1477, DOI 10.1093/emboj/20.6.1477; Pourquier P, 1997, J BIOL CHEM, V272, P7792, DOI 10.1074/jbc.272.12.7792; Prasad R, 1996, J BIOL CHEM, V271, P16000, DOI 10.1074/jbc.271.27.16000; Rapin I, 2000, NEUROLOGY, V55, P1442, DOI 10.1212/WNL.55.10.1442; Rass U, 2007, J BIOL CHEM, V282, P9469, DOI 10.1074/jbc.M611489200; Raymond AC, 2005, J BIOL CHEM, V280, P22029, DOI 10.1074/jbc.M502148200; Reardon JT, 1997, P NATL ACAD SCI USA, V94, P9463, DOI 10.1073/pnas.94.17.9463; Rebeck GW, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-15; ROBBINS JH, 1991, BRAIN, V114, P1335, DOI 10.1093/brain/114.3.1335; ROBBINS JH, 1988, JAMA-J AM MED ASSOC, V260, P384; Roberts MJ, 2003, MUTAT RES-FUND MOL M, V522, P45, DOI 10.1016/S0027-5107(02)00232-4; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rossignol M, 1997, EMBO J, V16, P1628, DOI 10.1093/emboj/16.7.1628; RYDBERG B, 1982, EMBO J, V1, P211, DOI 10.1002/j.1460-2075.1982.tb01149.x; Saijo M, 2007, MOL CELL BIOL, V27, P2538, DOI 10.1128/MCB.01288-06; SANCHEZRAMOS JR, 1994, NEURODEGENERATION, V3, P197; Sano Y, 2004, ANN NEUROL, V55, P241, DOI 10.1002/ana.10808; Sarker AH, 2005, MOL CELL, V20, P187, DOI 10.1016/j.molcel.2005.09.022; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Schols L, 2004, LANCET NEUROL, V3, P291, DOI 10.1016/S1474-4422(04)00737-9; SCOTT D, 1982, INT J RADIAT BIOL, V42, P679, DOI 10.1080/09553008214551661; Sedgwick B, 2007, DNA REPAIR, V6, P429, DOI 10.1016/j.dnarep.2006.10.005; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; Shen ZZ, 2000, BIOCHEMISTRY-US, V39, P5474, DOI 10.1021/bi992809y; Shoichet SA, 2002, HUM MOL GENET, V11, P815, DOI 10.1093/hmg/11.7.815; Sijbers AM, 1996, NUCLEIC ACIDS RES, V24, P3370, DOI 10.1093/nar/24.17.3370; Sijbers AM, 1996, CELL, V86, P811, DOI 10.1016/S0092-8674(00)80155-5; SINGHAL RK, 1993, J BIOL CHEM, V268, P15906; Slupphaug G, 2003, MUTAT RES-FUND MOL M, V531, P231, DOI 10.1016/j.mrfmmm.2003.06.002; Smith MA, 2000, BBA-MOL BASIS DIS, V1502, P139, DOI 10.1016/S0925-4439(00)00040-5; SOFFER D, 1979, ANN NEUROL, V6, P340, DOI 10.1002/ana.410060407; States JC, 1998, HUM MUTAT, V12, P103, DOI 10.1002/(SICI)1098-1004(1998)12:2<103::AID-HUMU5>3.0.CO;2-6; STEFANINI M, 1993, AM J HUM GENET, V53, P817; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stracker TH, 2007, NATURE, V447, P218, DOI 10.1038/nature05740; Sunesen M, 2002, ONCOGENE, V21, P3571, DOI 10.1038/sj.onc.1205443; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; SUNG P, 1993, NATURE, V365, P852, DOI 10.1038/365852a0; Suraweera A, 2007, J CELL BIOL, V177, P969, DOI 10.1083/jcb.200701042; SUTHERLAND, 2002, J RADIAT RES, V149, P52; Sutherland BM, 2000, BIOCHEMISTRY-US, V39, P8026, DOI 10.1021/bi9927989; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Szyfter K, 1996, CARCINOGENESIS, V17, P501, DOI 10.1093/carcin/17.3.501; Takahashi T, 2007, NUCLEIC ACIDS RES, V35, P3797, DOI 10.1093/nar/gkm158; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; TANAKA K, 1981, SOMAT CELL GENET, V7, P445, DOI 10.1007/BF01542989; Taroni F, 2004, NAT REV NEUROSCI, V5, P641, DOI 10.1038/nrn1474; TEBBS, 1999, DEV BIOL, V208, pS13; Thoma BS, 2005, NUCLEIC ACIDS RES, V33, P2993, DOI 10.1093/nar/gki610; THOMPSON LH, 1987, SOMAT CELL MOLEC GEN, V13, P539, DOI 10.1007/BF01534495; Tian M, 2004, MOL CELL BIOL, V24, P1200, DOI 10.1128/MCB.24.3.1200-1205.2004; Tomkinson AE, 1998, MUTAT RES-DNA REPAIR, V407, P1, DOI 10.1016/S0921-8777(97)00050-5; Tovalin H, 2006, OCCUP ENVIRON MED, V63, P230, DOI 10.1136/oem.2005.019802; Trichopoulos D., 1994, MED EXERC NUTR HLTH, V3, P206; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; TUDEK B, 1992, NUCLEIC ACIDS RES, V20, P3079, DOI 10.1093/nar/20.12.3079; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Vaca CE, 1998, CHEM-BIOL INTERACT, V108, P197, DOI 10.1016/S0009-2797(97)00107-5; Van Dyck E, 1999, NATURE, V401, P403, DOI 10.1038/43947; van Hoffen A, 2003, TOXICOLOGY, V193, P79, DOI 10.1016/j.tox.2003.06.001; vanGool AJ, 1997, EMBO J, V16, P4155, DOI 10.1093/emboj/16.14.4155; VANHOFFEN A, 1993, NUCLEIC ACIDS RES, V21, P5890, DOI 10.1093/nar/21.25.5890; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; VENEMA J, 1990, P NATL ACAD SCI USA, V87, P4707, DOI 10.1073/pnas.87.12.4707; Vidal AE, 2001, EMBO J, V20, P6530, DOI 10.1093/emboj/20.22.6530; Vitorino M, 2007, J MOL BIOL, V368, P473, DOI 10.1016/j.jmb.2007.02.020; WAGNER JR, 1992, P NATL ACAD SCI USA, V89, P3380, DOI 10.1073/pnas.89.8.3380; Walker FO, 2007, SEMIN NEUROL, V27, P143, DOI 10.1055/s-2007-971176; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wallace SS, 1998, RADIAT RES, V150, pS60, DOI 10.2307/3579809; Wang Y, 2000, GENE DEV, V14, P927; WEEDA G, 1990, CELL, V62, P777, DOI 10.1016/0092-8674(90)90122-U; WEEMAES CMR, 1981, ACTA PAEDIATR SCAND, V70, P557, DOI 10.1111/j.1651-2227.1981.tb05740.x; Weissman L, 2007, NEUROSCIENCE, V145, P1318, DOI 10.1016/j.neuroscience.2006.08.061; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Wilson DM, 2003, FRONT BIOSCI-LANDMRK, V8, pD963, DOI 10.2741/1109; Wong HK, 2007, NUCLEIC ACIDS RES, V35, P4103, DOI 10.1093/nar/gkm404; Wood RD, 1997, CARCINOGENESIS, V18, P605, DOI 10.1093/carcin/18.4.605; Yang Y, 2001, J NEUROSCI, V21, P2661, DOI 10.1523/JNEUROSCI.21-08-02661.2001; Ye N, 1998, J MOL BIOL, V284, P269, DOI 10.1006/jmbi.1998.2138; Yi P, 1998, CHEM RES TOXICOL, V11, P1032, DOI 10.1021/tx9800497; Yokoi M, 2000, J BIOL CHEM, V275, P9870, DOI 10.1074/jbc.275.13.9870; Yoritaka A, 1996, P NATL ACAD SCI USA, V93, P2696, DOI 10.1073/pnas.93.7.2696; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; ZAMPETTIBOSSELER F, 1981, INT J RADIAT BIOL, V39, P547, DOI 10.1080/09553008114550651; Zhao S, 2000, NATURE, V405, P473, DOI 10.1038/35013083	291	58	58	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2008	82	3					539	566		10.1016/j.ajhg.2008.01.009	http://dx.doi.org/10.1016/j.ajhg.2008.01.009			28	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	275JN	18319069	Green Published, Bronze			2022-12-18	WOS:000254067800001
J	Thiel, CT; Mortier, G; Kaitila, I; Reis, A; Rauch, A				Thiel, Christian T.; Mortier, Geert; Kaitila, Ilkka; Reis, Andre; Rauch, Anita			Type and level of RMRP functional impairment predicts phenotype in the cartilage hair hypoplasia-anauxetic dysplasia spectrum	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MRP RIBONUCLEOPROTEIN COMPLEX; EXTREME SHORT STATURE; RNA-POLYMERASE-III; JAPANESE PATIENTS; MUTATIONS; COMPONENT; GENE; ENDORIBONUCLEASE; SEGREGATION; DWARFISM	Mutations in the RMRP gene lead to a wide spectrum of autosomal recessive skeletal dysplasias, ranging from the milder phenotypes metaphyseal dysplasia without hypotrichosis and cartilage hair hypoplasia (CHH) to the severe anauxetic dysplasia (AD). This clinical spectrum includes different degrees of short stature, hair hypoplasia, defective erythrogenesis, and immunodeficiency. The RMRP gene encodes the untranslated RNA component of the mitochondrial RNA-processing ribonuclease, RNase MRP. We recently demonstrated that mutations may affect both messenger RNA (mRNA) and ribosomal RNA (rRNA) cleavage and thus cell-cycle regulation and protein synthesis. To investigate the genotype-phenotype correlation, we analyzed the position and the functional effect of 13 mutations in patients with variable features of the CHH-AD spectrum. Those at the end of the spectrum include a novel patient with anauxetic dysplasia who was compound heterozygous for the null mutation g.254_263delCTCAGCGCGG and the mutation g.195C -> T, which was previously described in patients with milder phenotypes. Mapping of nucleotide conservation to the two-dimensional structure of the RMRP gene revealed that disease-causing mutations either affect evolutionarily conserved nucleotides or are likely to alter secondary structure through mispairing in stem regions. In vitro testing of RNase MRP multiprotein-specific mRNA and rRNA cleavage of different mutations revealed a strong correlation between the decrease in rRNA cleavage in ribosomal assembly and the degree of bone dysplasia, whereas reduced mRNA cleavage, and thus cell-cycle impairment, predicts the presence of hair hypoplasia, immunodeficiency, and hematological abnormalities and thus increased cancer risk.	Univ Erlangen Nurnberg, Univ Hosp Erlangen, Inst Human Genet, D-91054 Erlangen, Germany; State Univ Ghent Hosp, Dept Med Genet, B-9000 Ghent, Belgium; Univ Helsinki, Clin Genet Res, Helsinki, Finland	University of Erlangen Nuremberg; Ghent University; Ghent University Hospital; University of Helsinki	Thiel, CT (corresponding author), Univ Erlangen Nurnberg, Univ Hosp Erlangen, Inst Human Genet, Schwabachanlage 10, D-91054 Erlangen, Germany.	Christian.Thiel@humgenet.uni-erlangen.de	Rauch, Anita/C-5568-2014; Thiel, Christian T/H-8964-2012; Mortier, Geert/D-2542-2012; Reis, André/D-2309-2009	Rauch, Anita/0000-0003-2930-3163; Thiel, Christian T/0000-0003-3817-7277; Mortier, Geert/0000-0001-9871-4578; Reis, André/0000-0002-6301-6363				Bonafe L, 2005, PLOS GENET, V1, P444, DOI 10.1371/journal.pgen.0010047; Bonafe L, 2002, CLIN GENET, V61, P146, DOI 10.1034/j.1399-0004.2002.610210.x; Cai T, 1999, MOL CELL BIOL, V19, P7857; Cai T, 2002, GENETICS, V161, P1029; GUNNERY S, 1995, MOL CELL BIOL, V15, P3597; Hermanns P, 2005, HUM MOL GENET, V14, P3723, DOI 10.1093/hmg/ddi403; Hermanns P, 2006, AM J MED GENET A, V140A, P2121, DOI 10.1002/ajmg.a.31331; Hirose Y, 2006, J HUM GENET, V51, P706, DOI 10.1007/s10038-006-0015-3; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; Kuijpers TW, 2003, J MED GENET, V40, P761, DOI 10.1136/jmg.40.10.761; Lam ACF, 2006, PRENATAL DIAG, V26, P1018, DOI 10.1002/pd.1547; Martin AN, 2007, CELL RES, V17, P219, DOI 10.1038/sj.cr.7310120; MCKUSICK VA, 1965, B JOHNS HOPKINS HOSP, V116, P285; Menger H, 1996, AM J MED GENET, V63, P80, DOI 10.1002/(SICI)1096-8628(19960503)63:1<80::AID-AJMG16>3.0.CO;2-Q; Munoz-Robles J, 2006, IMMUNOBIOLOGY, V211, P753, DOI 10.1016/j.imbio.2006.05.001; Nakashima E, 2003, AM J MED GENET A, V123A, P253, DOI 10.1002/ajmg.a.20281; Pluk H, 1999, RNA, V5, P512, DOI 10.1017/S1355838299982079; Ridanpaa M, 2002, EUR J HUM GENET, V10, P439, DOI 10.1038/sj.ejhg.5200824; Ridanpaa M, 2001, CELL, V104, P195, DOI 10.1016/S0092-8674(01)00205-7; Sarafan-Vasseur N, 2002, ONCOGENE, V21, P2051, DOI 10.1038/sj.onc.1205257; Schmitt ME, 1999, J MOL BIOL, V292, P827, DOI 10.1006/jmbi.1999.3116; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; Thiel CT, 2005, AM J HUM GENET, V77, P795, DOI 10.1086/497708; Welting TJM, 2004, NUCLEIC ACIDS RES, V32, P2138, DOI 10.1093/nar/gkh539	24	58	59	0	8	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2007	81	3					519	529		10.1086/521034	http://dx.doi.org/10.1086/521034			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205PX	17701897	Green Published, Bronze			2022-12-18	WOS:000249128200008
J	Liquori, CL; Berg, MJ; Squitieri, F; Leedom, TP; Ptacek, L; Johnson, EW; Marchuk, DA				Liquori, Christina L.; Berg, Michel J.; Squitieri, Ferdinando; Leedom, Tracey P.; Ptacek, Louis; Johnson, Eric W.; Marchuk, Douglas A.			Deletions in CCM2 are a common cause of cerebral cavernous malformations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MUTATIONS; ANGIOMAS; PROTEIN; KRIT1; MAPS; EXON	Cerebral cavernous malformations (CCMs) are vascular abnormalities of the brain that can result in a variety of neurological disabilities, including hemorrhagic stroke and seizures. Mutations in the gene KRIT1 are responsible for CCM1, mutations in the gene MGC4607 are responsible for CCM2, and mutations in the gene PDCD10 are responsible for CCM3. DNA sequence analysis of the known CCM genes in a cohort of 63 CCM-affected families showed that a high proportion (40%) of these lacked any identifiable mutation. We used multiplex ligation-dependent probe analysis to screen 25 CCM1, -2, and -3 mutation-negative probands for potential deletions or duplications within all three CCM genes. We identified a total of 15 deletions: 1 in the CCM1 gene, 0 in the CCM3 gene, and 14 in the CCM2 gene. In our cohort, mutation screening that included sequence and deletion analyses gave disease-gene frequencies of 40% for CCM1, 38% for CCM2, 6% for CCM3, and 16% with no mutation detected. These data indicate that the prevalence of CCM2 is much higher than previously predicted, nearly equal to CCM1, and that large genomic deletions in the CCM2 gene represent a major component of this disease. A common 77.6-kb deletion spanning CCM2 exons 2-10 was identified, which is present in 13% of our entire CCM cohort. Eight probands exhibit an apparently identical recombination event in the CCM2 gene, involving an AluSx in intron 1 and an AluSg distal to exon 10. Haplotype analysis revealed that this CCM2 deletion occurred independently at least twice in our families. We hypothesize that these deletions occur in a hypermutable region because of surrounding repetitive sequence elements that may catalyze the formation of intragenic deletions.	Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; Univ Rochester, Med Ctr, Dept Neurol, Strong Epilepsy Ctr, Rochester, NY 14642 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Neurol, San Francisco, CA 94143 USA; IRCCS Neuromed, Neurogenet Unit, Pozzilli, IS, Italy; Prevent Genet, Mol Diagnost & Biobanking, Marshfield, WI USA	Duke University; University of Rochester; Howard Hughes Medical Institute; University of California System; University of California San Francisco; IRCCS Neuromed	Marchuk, DA (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Box 3175, Durham, NC 27710 USA.	march004@mc.duke.edu	Squitieri, Ferdinando/N-1852-2019	Squitieri, Ferdinando/0000-0002-7397-1727; Marchuk, Douglas/0000-0002-3110-6671	NINDS NIH HHS [R01 NS043543, NS43543, 1 F32 NS51082] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043543] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bergametti F, 2005, AM J HUM GENET, V76, P42, DOI 10.1086/426952; Craig HD, 1998, HUM MOL GENET, V7, P1851, DOI 10.1093/hmg/7.12.1851; Denier C, 2004, AM J HUM GENET, V74, P326, DOI 10.1086/381718; DUBOVSKY J, 1995, HUM MOL GENET, V4, P453, DOI 10.1093/hmg/4.3.453; GILNAGEL A, 1995, EPILEPSY RES, V21, P27, DOI 10.1016/0920-1211(95)00005-U; GUNEL M, 1995, P NATL ACAD SCI USA, V92, P6620, DOI 10.1073/pnas.92.14.6620; Hearle NCM, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.036830; Laberge S, 1999, EUR J HUM GENET, V7, P499, DOI 10.1038/sj.ejhg.5200324; Lai KKS, 2006, CLIN BIOCHEM, V39, P367, DOI 10.1016/j.clinbiochem.2005.11.019; Liquori Christina L, 2006, Hum Mutat, V27, P118, DOI 10.1002/humu.9389; Liquori CL, 2003, AM J HUM GENET, V73, P1459, DOI 10.1086/380314; MARCHUK DA, 1995, GENOMICS, V28, P311, DOI 10.1006/geno.1995.1147; RIGAMONTI D, 1988, NEW ENGL J MED, V319, P343, DOI 10.1056/NEJM198808113190605; Sahoo T, 2001, GENOMICS, V71, P123, DOI 10.1006/geno.2000.6426; Sahoo T, 1999, HUM MOL GENET, V8, P2325, DOI 10.1093/hmg/8.12.2325; Squitieri F, 2000, NEUROL SCI, V21, P129, DOI 10.1007/s100720070087; TOMLINSON FH, 1994, NEUROSURGERY, V34, P792, DOI 10.1227/00006123-199405000-00002; Verlaan DJ, 2004, ANN NEUROL, V55, P757, DOI 10.1002/ana.20112; Verlaan DJ, 2005, NEUROLOGY, V65, P1982, DOI 10.1212/01.wnl.0000188903.75144.49; Verlaan DJ, 2002, NEUROLOGY, V58, P853, DOI 10.1212/WNL.58.6.853; Wimmer K, 2006, GENE CHROMOSOME CANC, V45, P265, DOI 10.1002/gcc.20289; ZABRAMSKI JM, 1994, J NEUROSURG, V80, P422, DOI 10.3171/jns.1994.80.3.0422; Zabramski JM, 1999, NEUROSURG CLIN N AM, V10, P395, DOI 10.1016/S1042-3680(18)30174-8	23	58	60	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2007	80	1					69	75		10.1086/510439	http://dx.doi.org/10.1086/510439			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	120RG	17160895	Green Published, Bronze			2022-12-18	WOS:000243102500007
J	Kranz, C; Denecke, J; Lehle, L; Sohlbach, K; Jeske, S; Meinhardt, F; Rossi, R; Gudowius, S; Marquardt, T				Kranz, C; Denecke, J; Lehle, L; Sohlbach, K; Jeske, S; Meinhardt, F; Rossi, R; Gudowius, S; Marquardt, T			Congenital disorder of glycosylation type Ik (CDG-Ik): A defect of mannosyltransferase I	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							YEAST MUTANTS DEFICIENT; CLONING	This study describes the discovery of a new inherited disorder of glycosylation named "CDG-Ik." CDG-Ik ( congenital disorder of glycoslyation type Ik) is based on a defect of human mannosyltransferase I ( MT-I [MIM 605907]), an enzyme necessary for the elongation of dolichol-linked chitobiose during N-glycan biosynthesis. Mutations in semiconserved regions in the corresponding gene, HMT-1 ( yeast homologue, Alg1), in two patients caused drastically reduced enzyme activity, leading to a severe disease with death in early infancy. One patient had a homozygous point mutation (c.773C-->T, S258L), whereas the other patient was compound heterozygous for the mutations c. 773C-->T and c. 1025A-->C (E342P). Glycosylation and growth of Alg1-deficient PRY56 yeast cells, showing a temperature-sensitive phenotype, could be restored by the human wild-type allele, whereas only slight restoration was observed after transformation with the patients' alleles.	Klin & Poliklin Kinderheilkunde, D-48149 Munster, Germany; Inst Mol Mikrobiol & Biotechnol, Munster, Germany; Lehrstuhl Zellbiol & Pflanzenphysiol, Regensburg, Germany; Klinikum Neukolln, Kinderklin, Berlin, Germany; Univ Kinderklin, Dusseldorf, Germany	University of Munster; VIivantes Klinikum Neukolln; University of Hamburg; University Medical Center Hamburg-Eppendorf	Marquardt, T (corresponding author), Klin & Poliklin Kinderheilkunde, Albert Schweitzer Str 22, D-48149 Munster, Germany.	marquat@uni-muenster.de						COUTO JR, 1984, J BIOL CHEM, V259, P378; Cueva R, 1998, YEAST, V14, P773, DOI 10.1002/(SICI)1097-0061(19980615)14:8<773::AID-YEA284>3.3.CO;2-J; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; HUFFAKER TC, 1982, J BIOL CHEM, V257, P3203; HUFFAKER TC, 1983, P NATL ACAD SCI-BIOL, V80, P7466, DOI 10.1073/pnas.80.24.7466; Janik A, 2003, BBA-GEN SUBJECTS, V1621, P22, DOI 10.1016/S0304-4165(03)00026-6; KNAUER R, 1994, FEBS LETT, V344, P83, DOI 10.1016/0014-5793(94)00356-4; Kranz C, 2001, J CLIN INVEST, V108, P1613, DOI 10.1172/JCI200113635; Luhn K, 2001, BLOOD, V97, P330, DOI 10.1182/blood.V97.1.330; Marquardt T, 1999, BLOOD, V94, P3976, DOI 10.1182/blood.V94.12.3976.424k06_3976_3985; Matthijs G, 1998, AM J HUM GENET, V62, P542, DOI 10.1086/301763; Niehues R, 1998, J CLIN INVEST, V101, P1414, DOI 10.1172/JCI2350; SHARMA CB, 1982, EUR J BIOCHEM, V126, P319; Takahashi T, 2000, GLYCOBIOLOGY, V10, P321, DOI 10.1093/glycob/10.3.321; Thiel C, 2003, J BIOL CHEM, V278, P22498, DOI 10.1074/jbc.M302850200; Thiel C, 2002, BIOCHEM J, V367, P195, DOI 10.1042/BJ20020794; VanSchaftingen E, 1995, FEBS LETT, V377, P318, DOI 10.1016/0014-5793(95)01357-1	17	58	62	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2004	74	3					545	551		10.1086/382493	http://dx.doi.org/10.1086/382493			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	801TP	14973782	Bronze, Green Published			2022-12-18	WOS:000220118500020
J	Schwarz, M; Thiel, C; Lubbehusen, J; Dorland, B; de Koning, T; von Figura, K; Lehle, L; Korner, C				Schwarz, M; Thiel, C; Lubbehusen, J; Dorland, B; de Koning, T; von Figura, K; Lehle, L; Korner, C			Deficiency of GDP-Man : GlcNAc(2)-PP-dolichol mannosyltransferase causes congenital disorder of glycosylation type Ik	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OLIGOSACCHARYLTRANSFERASE COMPLEX; GLYCOPROTEIN	The molecular nature of a severe multisystemic disorder with a recurrent nonimmune hydrops fetalis was identified as deficiency of GDP-Man: GlcNAc(2)-PP-dolichol mannosyltransferase, the human orthologue of the yeast ALG1 gene (MIM 605907). The disease belongs to the group of congenital disorders of glycosylation (CDG) and is designated as subtype CDG-Ik. In patient-derived serum, the total amount of the glycoprotein transferrin was reduced. Moreover, a partial loss of N-glycan chains was observed, a characteristic feature of CDG type I forms. Metabolic labeling with [6-H-3] glucosamine revealed an accumulation of GlcNAc(2)-PP-dolichol and GlcNAc(1)-PP-dolichol in skin fibroblasts of the patient. Incubation of fibroblast extracts with [C-14] GlcNAc(2)-PP-dolichol and GDP-mannose indicated a severely reduced activity of the beta1,4- mannosyltransferase, elongating GlcNAc(2)-PP-dol-ichol to Man1 GlcNAc(2)-PP-dolichol at the cytosolic side of the endoplasmic reticulum. Genetic analysis of the patient's hALG1 gene identified a homozygous mutation leading to the exchange of a serine residue to leucine at position 258 in the hALG1 protein. The disease-causing nature of the hALG1 mutation for the glycosylation defect was verified by a retroviral complementation approach in patient-derived primary fibroblasts and was confirmed by the expression of wild-type and mutant hALG1 in the Saccharomyces cerevisiae alg1-1 strain.	Univ Gottingen, D-37073 Gottingen, Germany; Univ Regensburg, Lehrstuhl Zellbiol & Pflanzenphysiol, D-8400 Regensburg, Germany; UMC Utrecht, Dept Metab & Endocrine Dis, Utrecht, Netherlands; UMC Utrecht, Dept Pediat Metab Dis, Utrecht, Netherlands	University of Gottingen; University of Regensburg; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Korner, C (corresponding author), Univ Gottingen, Heinrich Duker Weg 12, D-37073 Gottingen, Germany.	ckoerne@gwdg.de	De Koning, Tom J/AAE-1323-2020	De Koning, Tom J/0000-0001-5609-1309; Thiel, Christian/0000-0001-6419-8747				Aebi M, 1999, Glycoconj J, V16, P669; de Koning TJ, 1998, J INHERIT METAB DIS, V21, P681, DOI 10.1023/A:1005496920435; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; HUFFAKER TC, 1982, J BIOL CHEM, V257, P3203; Jaeken J, 2003, J INHERIT METAB DIS, V26, P99, DOI 10.1023/A:1024431131208; KNAUER R, 1994, FEBS LETT, V344, P83, DOI 10.1016/0014-5793(94)00356-4; Knauer R, 1999, J BIOL CHEM, V274, P17249, DOI 10.1074/jbc.274.24.17249; Korner C, 1998, GLYCOBIOLOGY, V8, P165, DOI 10.1093/glycob/8.2.165; MANIATIS NT, 1989, MOL CLONING LAB MANU; Niehues R, 1998, J CLIN INVEST, V101, P1414, DOI 10.1172/JCI2350; SHARMA CB, 1982, EUR J BIOCHEM, V126, P319; SNIDER MD, 1984, CELL, V36, P753, DOI 10.1016/0092-8674(84)90355-6; Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R; Takahashi T, 2000, GLYCOBIOLOGY, V10, P321, DOI 10.1093/glycob/10.3.321; Thiel C, 2003, J BIOL CHEM, V278, P22498, DOI 10.1074/jbc.M302850200; Thiel C, 2002, BIOCHEM J, V367, P195, DOI 10.1042/BJ20020794; Trombetta ES, 2003, GLYCOBIOLOGY, V13, p77R, DOI 10.1093/glycob/cwg075; Wu XH, 2003, HUM MUTAT, V22, P144, DOI 10.1002/humu.10239	19	58	61	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2004	74	3					472	481		10.1086/382492	http://dx.doi.org/10.1086/382492			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	801TP	14973778	Bronze, Green Published			2022-12-18	WOS:000220118500014
J	King, RA; Willaert, RK; Schmidt, RM; Pietsch, J; Savage, S; Brott, MJ; Fryer, JP; Summers, CG; Oetting, WS				King, RA; Willaert, RK; Schmidt, RM; Pietsch, J; Savage, S; Brott, MJ; Fryer, JP; Summers, CG; Oetting, WS			MC1R mutations modify the classic phenotype of oculocutaneous albinism type 2 (OCA2)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HERMANSKY-PUDLAK-SYNDROME; HUMAN MELANOCORTIN-1 RECEPTOR; P-GENE; RED HAIR; HUMAN PIGMENTATION; MSH RECEPTOR; TYROSINASE GENE; PRADER-WILLI; IDENTIFICATION; MELANOMA	The heterogeneous group of disorders known as oculocutaneous albinism (OCA) shares cutaneous and ocular hypopigmentation associated with common developmental abnormalities of the eye. Mutations of at least 11 loci produce this phenotype. The majority of affected individuals develop some cutaneous melanin; this is predominantly seen as yellow/blond hair, whereas fewer have brown hair. The OCA phenotype is dependent on the constitutional pigmentation background of the family, with more OCA pigmentation found in families with darker constitutional pigmentation, which indicates that other genes may modify the OCA phenotype. Sequence variation in the melanocortin-1 receptor (MC1R) gene is associated with red hair in the normal population, but red hair is unusual in OCA. We identified eight probands with OCA who had red hair at birth. Mutations in the P gene were responsible for classic phenotype of oculocutaneous albinism type 2 (OCA2) in all eight, and mutations in the MC1R gene were responsible for the red ( rather than yellow/blond) hair in the six of eight who continued to have red hair after birth. This is the first demonstration of a gene modifying the OCA phenotype in humans.	Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Ophthalmol, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	King, RA (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, MMC 485,420 Delaware St SE, Minneapolis, MN 55455 USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044649] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR44649] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Akey JM, 2001, HUM GENET, V108, P516, DOI 10.1007/s004390100524; Anikster Y, 2001, NAT GENET, V28, P376, DOI 10.1038/ng576; Box NF, 2001, AM J HUM GENET, V69, P765, DOI 10.1086/323412; Box NF, 2001, J INVEST DERMATOL, V116, P224, DOI 10.1046/j.1523-1747.2001.01224.x; Box NF, 1997, HUM MOL GENET, V6, P1891, DOI 10.1093/hmg/6.11.1891; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Donatien P, 2002, INVEST OPHTH VIS SCI, V43, P1198; Flanagan N, 2000, HUM MOL GENET, V9, P2531, DOI 10.1093/hmg/9.17.2531; Frandberg PA, 1998, BIOCHEM BIOPH RES CO, V245, P490, DOI 10.1006/bbrc.1998.8459; GARDNER JM, 1992, SCIENCE, V257, P1121, DOI 10.1126/science.257.5073.1121; Grant S, 2001, VISUAL NEUROSCI, V18, P245, DOI 10.1017/S095252380118209X; Grimes EA, 2001, FORENSIC SCI INT, V122, P124, DOI 10.1016/S0379-0738(01)00480-7; Harding RM, 2000, AM J HUM GENET, V66, P1351, DOI 10.1086/302863; Healy E, 2001, HUM MOL GENET, V10, P2397, DOI 10.1093/hmg/10.21.2397; Hearing VJ, 2000, PIGM CELL RES, V13, P23, DOI 10.1034/j.1600-0749.13.s8.7.x; Huizing M, 2001, AM J HUM GENET, V69, P1022, DOI 10.1086/324168; Ilia M, 1996, DEV BRAIN RES, V95, P176; Introne W, 1999, MOL GENET METAB, V68, P283, DOI 10.1006/mgme.1999.2927; Kennedy C, 2001, J INVEST DERMATOL, V117, P294, DOI 10.1046/j.0022-202x.2001.01421.x; Kerr R, 2000, HUM MUTAT, V15, P166, DOI 10.1002/(SICI)1098-1004(200002)15:2<166::AID-HUMU5>3.0.CO;2-Z; KING RA, 2001, METABOLIC MOL BASES, P5587; Koppula SV, 1997, HUM MUTAT, V9, P30, DOI 10.1002/(SICI)1098-1004(1997)9:1<30::AID-HUMU5>3.3.CO;2-5; KROMBERG JGR, 1990, OPHTHALMIC PAED GEN, V11, P229, DOI 10.3109/13816819009020984; LEE ST, 1994, NEW ENGL J MED, V330, P529, DOI 10.1056/NEJM199402243300803; LEE ST, 1995, GENOMICS, V26, P354, DOI 10.1016/0888-7543(95)80220-G; LEE ST, 1994, HUM MOL GENET, V3, P2047; Manga P, 1997, AM J HUM GENET, V61, P1095, DOI 10.1086/301603; MOUNTJOY KG, 1992, SCIENCE, V257, P1248, DOI 10.1126/science.1325670; Newton JM, 2001, AM J HUM GENET, V69, P981, DOI 10.1086/324340; Newton JM, 2000, MAMM GENOME, V11, P24, DOI 10.1007/s003350010005; Oetting W S, 1998, Hum Mutat, V12, P434, DOI 10.1002/(SICI)1098-1004(1998)12:6<434::AID-HUMU15>3.0.CO;2-A; Oetting WS, 1999, HUM MUTAT, V13, P99, DOI 10.1002/(SICI)1098-1004(1999)13:2<99::AID-HUMU2>3.0.CO;2-C; OETTING WS, 1994, ELECTROPHORESIS, V15, P159, DOI 10.1002/elps.1150150127; Orlow SJ, 1999, EXP EYE RES, V68, P147, DOI 10.1006/exer.1998.0599; Palmer JS, 2000, AM J HUM GENET, V66, P176, DOI 10.1086/302711; Passmore LA, 1999, HUM GENET, V105, P200; Prota G., 1992, MELANINS MELANOGENES; Puri N, 2000, J INVEST DERMATOL, V115, P607, DOI 10.1046/j.1523-1747.2000.00108.x; RAYMOND SM, 1995, CURR BIOL, V5, P1286, DOI 10.1016/S0960-9822(95)00255-7; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; ROSEMBLAT S, 1994, P NATL ACAD SCI USA, V91, P12071, DOI 10.1073/pnas.91.25.12071; Schaffer JV, 2001, ARCH DERMATOL, V137, P1477; Schioth HB, 1999, BIOCHEM BIOPH RES CO, V260, P488, DOI 10.1006/bbrc.1999.0935; Schraermeyer U, 1999, PIGM CELL RES, V12, P219, DOI 10.1111/j.1600-0749.1999.tb00755.x; SCHRAERMEYER U, 1990, PIGM CELL RES, V3, P279, DOI 10.1111/j.1600-0749.1990.tb00299.x; Shotelersuk V, 1998, MOL GENET METAB, V65, P85, DOI 10.1006/mgme.1998.2729; SILVERS WK (ED), 1979, COAT COLORS MICE MOD; Smith AG, 2001, GENE, V281, P81, DOI 10.1016/S0378-1119(01)00791-0; Spritz RA, 1997, HUM MUTAT, V10, P175, DOI 10.1002/(SICI)1098-1004(1997)10:2<175::AID-HUMU12>3.0.CO;2-X; Sturm RA, 2002, MELANOMA RES, V12, P405, DOI 10.1097/00008390-200209000-00001; Sturm RA, 2001, GENE, V277, P49, DOI 10.1016/S0378-1119(01)00694-1; Summers C G, 1996, Trans Am Ophthalmol Soc, V94, P1095; Summers CG, 1996, AM J OPHTHALMOL, V121, P724, DOI 10.1016/S0002-9394(14)70647-6; SUMMERS CG, 1991, AM J MED GENET, V40, P327, DOI 10.1002/ajmg.1320400316; SUMMERS CG, 1988, OPHTHALMOLOGY, V95, P545; Suzuki T, 2002, NAT GENET, V30, P321, DOI 10.1038/ng835; Toyofuku K, 2001, FASEB J, V15, P2149, DOI 10.1096/fj.01-0216com; Valverde P, 1996, HUM MOL GENET, V5, P1663, DOI 10.1093/hmg/5.10.1663; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; Zhang Q, 2003, NAT GENET, V33, P145, DOI 10.1038/ng1087	60	58	59	1	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2003	73	3					638	645		10.1086/377569	http://dx.doi.org/10.1086/377569			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	718FG	12876664	Green Published, Bronze			2022-12-18	WOS:000185134000016
J	Ruddy, DM; Parton, MJ; Al-Chalabi, A; Lewis, CM; Vance, C; Smith, BN; Leigh, PN; Powell, JF; Siddique, T; Meyjes, EP; Baas, F; De Jong, V; Shaw, CE				Ruddy, DM; Parton, MJ; Al-Chalabi, A; Lewis, CM; Vance, C; Smith, BN; Leigh, PN; Powell, JF; Siddique, T; Meyjes, EP; Baas, F; De Jong, V; Shaw, CE			Two families with familial amyotrophic lateral sclerosis are linked to a novel locus on chromosome 16q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRONTOTEMPORAL DEMENTIA; LINKAGE ANALYSIS; SOD1 MUTATION; GENE; FORM; POPULATION; PROTEIN; TAU	Amyotrophic lateral sclerosis (ALS) is a fatal adult-onset disease in which motor neurons in the brain and spinal cord degenerate by largely unknown mechanisms. ALS is familial (FALS) in 10% of cases, and the inheritance is usually dominant, with variable penetrance. Mutations in copper/zinc super oxide dismutase (SOD1) are found in 20% of familial and 3% of sporadic ALS cases. Five families with ALS and frontotemporal dementia (ALS-FTD) are linked to 9q21, whereas one family with pure ALS is linked to 18q21. We identified two large European families with ALS without SOD1 mutations or linkage to known FALS loci and conducted a genomewide linkage screen using 400 microsatellite markers. In both families, two-point LOD scores 11 and a haplotype segregating with disease were demonstrated only across regions of chromosome 16. Subsequent fine mapping in family 1 gave a maximum two-point LOD score of 3.62 at D16S3137 and a three-point LOD score of 3.85 for markers D16S415 and D16S3137. Haplotype analysis revealed no recombination >similar to30 cM, ( flanking markers at D16S3075 and D16S3112). The maximum two-point LOD score for family 2 was 1.84 at D16S415, and the three-point LOD score was 2.10 for markers D16S419 and D16S415. Definite recombination occurred in several individuals, which narrowed the shared haplotype in affected individuals to a 10.1-cM region ( flanking markers: D16S3396 and D16S3112). The region shared by both families on chromosome 16q12 corresponds to similar to 4.5 Mb on the Marshfield map. Bioinformatic analysis of the region has identified 18 known genes and 70 predicted genes in this region, and sequencing of candidate genes has now begun.	Inst Psychiat, Dept Neurol, London SE5 9RS, England; Inst Psychiat, Dept Neurosci, London SE5 9RS, England; Guys Kings & St Thomas Sch Med, Dept Med & Mol Genet, London, England; Guys Kings & St Thomas Sch Med, Dept Neurol, London, England; Northwestern Univ, Dept Neurol, Chicago, IL 60611 USA; Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Mol Biol, NL-1105 AZ Amsterdam, Netherlands	University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; King's College London; Northwestern University; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Shaw, CE (corresponding author), Inst Psychiat, Dept Neurol, PO 41,De Crespigny Pk, London SE5 9RS, England.		Powell, John F/G-4412-2011; Lewis, Cathryn M/A-5225-2010; Al-Chalabi, Ammar/E-5361-2010; Smith, Bradley/H-6107-2013; Leigh, Peter/AAD-5638-2019; Vance, Caroline/C-3047-2012; Vance, Caroline/Q-2633-2019; Siddique, Teepu/AAT-8166-2021; Lewis, Cathryn/M-8766-2019; Baas, Frank/F-9574-2010	Powell, John F/0000-0001-6124-439X; Lewis, Cathryn M/0000-0002-8249-8476; Al-Chalabi, Ammar/0000-0002-4924-7712; Vance, Caroline/0000-0001-5780-6951; Vance, Caroline/0000-0001-5780-6951; Lewis, Cathryn/0000-0002-8249-8476; Baas, Frank/0000-0003-3912-5428; Siddique, Teepu/0000-0001-7293-9146	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Chance PF, 1998, AM J HUM GENET, V62, P633, DOI 10.1086/301769; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; Hand CK, 2002, AM J HUM GENET, V70, P251, DOI 10.1086/337945; HAVERKAMP LJ, 1995, BRAIN, V118, P707, DOI 10.1093/brain/118.3.707; Hentati A, 1998, NEUROGENETICS, V2, P55, DOI 10.1007/s100480050052; HENTATI A, 1994, NAT GENET, V7, P425, DOI 10.1038/ng0794-425; Hosler BA, 2000, JAMA-J AM MED ASSOC, V284, P1664, DOI 10.1001/jama.284.13.1664; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Kondo K, 1995, MOTOR NEURON DIS BIO, P19; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Rizzu P, 1999, AM J HUM GENET, V64, P414, DOI 10.1086/302256; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rouleau GA, 1996, ANN NEUROL, V39, P128, DOI 10.1002/ana.410390119; Shaw C E, 2001, Curr Neurol Neurosci Rep, V1, P69, DOI 10.1007/s11910-001-0078-7; Shaw CE, 1998, ANN NEUROL, V43, P390, DOI 10.1002/ana.410430319; Shaw CE, 1997, NEUROLOGY, V49, P1612, DOI 10.1212/WNL.49.6.1612; SIDDIQUE T, 1991, NEW ENGL J MED, V324, P1381, DOI 10.1056/NEJM199105163242001; WEEKS DE, 1995, AM J HUM GENET, V56, P1506; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160	22	58	61	0	8	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2003	73	2					390	396		10.1086/377157	http://dx.doi.org/10.1086/377157			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	702KW	12840784	Green Published, Bronze			2022-12-18	WOS:000184223900015
J	Gianfrancesco, F; Esposito, T; Ombra, MN; Forabosco, P; Maninchedda, G; Fattorini, M; Casula, S; Vaccargiu, S; Casu, G; Cardia, F; Deiana, I; Melis, P; Falchi, M; Pirastu, M				Gianfrancesco, F; Esposito, T; Ombra, MN; Forabosco, P; Maninchedda, G; Fattorini, M; Casula, S; Vaccargiu, S; Casu, G; Cardia, F; Deiana, I; Melis, P; Falchi, M; Pirastu, M			Identification of a novel gene and a common variant associated with uric acid nephrolithiasis in a sardinian genetic isolate	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PREDICTING COILED COILS; MAPPING COMPLEX TRAITS; SECONDARY-STRUCTURE; MEMBRANE-PROTEINS; GLOBULAR PROTEINS; URATE OXIDASE; POPULATIONS; FAMILIES; LOCUS	Uric acid nephrolithiasis (UAN) is a common disease with an established genetic component that presents a complex mode of inheritance. While studying an ancient founder population in Talana, a village in Sardinia, we recently identified a susceptibility locus of similar to2.5 cM for UAN on 10q21-q22 in a relatively small sample that was carefully selected through genealogical information. To refine the critical region and to identify the susceptibility gene, we extended our analysis to severely affected subjects from the same village. We confirm the involvement of this region in UAN through identical-by-descent sharing and autozygosity mapping, and we refine the critical region to an interval of similar to67 kb associated with UAN by linkage-disequilibrium mapping. After inspecting the genomic sequences available in public databases, we determined that a novel gene overlaps this interval. This gene is divided into 15 exons, spanning a region of similar to300 kb and generating at least four different proteins (407, 333, 462, and 216 amino acids). Interestingly, the last isoform was completely included in the 67-kb associated interval. Computer-assisted analysis of this isoform revealed at least one membrane-spanning domain and several N- and O-glycosylation consensus sites at N-termini, suggesting that it could be an integral membrane protein. Mutational analysis shows that a coding nucleotide variant (Ala62Thr), causing a missense in exon 12, is in strong association with UAN (P = .0051). Moreover, Ala62Thr modifies predicted protein secondary structure, suggesting that it may have a role in UAN etiology. The present study underscores the value of our small, genealogically well-characterized, isolated population as a model for the identification of susceptibility genes underlying complex diseases. Indeed, using a relatively small sample of affected and unaffected subjects, we identified a candidate gene for multifactorial UAN.	CNR, Ist Genet Popolaz, I-07041 Alghero SS, Italy; Shardna Life Sci, Cagliari, Italy; Osped Nostra Signora Mercede, Dipartimento Urol, Lanusei, Italy	Consiglio Nazionale delle Ricerche (CNR)	Gianfrancesco, F (corresponding author), CNR, Ist Genet Popolaz, Strada Prov 55 Porto Conte Capo Caccia,Km 8-400, I-07041 Alghero SS, Italy.		Forabosco, Paola/AAM-5540-2021; Esposito, Teresa/AAA-5488-2019; Falchi, Mario/F-5956-2013; Gianfrancesco, Fernando/P-6853-2014	Esposito, Teresa/0000-0002-7879-8441; Falchi, Mario/0000-0002-5646-1004; Gianfrancesco, Fernando/0000-0002-3812-2471; FORABOSCO, PAOLA/0000-0002-2006-2693; OMBRA, MARIA NEVE/0000-0002-2437-9276				Abney M, 2000, AM J HUM GENET, V66, P629, DOI 10.1086/302759; ABRAMSON RG, 1990, BASIC PRINCIPLES TRA, V3, P115; Angius A, 2001, HUM GENET, V109, P198, DOI 10.1007/s004390100557; Baggio B, 1999, J NEPHROL, V12, P371; BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; Broman KW, 1999, AM J HUM GENET, V65, P1493, DOI 10.1086/302661; BURGESS AW, 1974, ISRAEL J CHEM, V12, P239; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; Curhan GC, 1997, J AM SOC NEPHROL, V8, P1568; DUFTON MJ, 1977, J MOL BIOL, V115, P117; Enomoto A, 2002, NATURE, V417, P447, DOI 10.1038/nature742; Fu Q, 2000, GENOMICS, V66, P328, DOI 10.1006/geno.2000.6212; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; Genin E, 1996, AM J HUM GENET, V58, P861; Hampe J, 2002, P NATL ACAD SCI USA, V99, P321, DOI 10.1073/pnas.261567999; Jaeger P, 1996, Curr Opin Nephrol Hypertens, V5, P342, DOI 10.1097/00041552-199607000-00009; Jorde LB, 2000, HUM HERED, V50, P57, DOI 10.1159/000022891; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; Lahoud MH, 2001, GENOME RES, V11, P1327, DOI 10.1101/gr.168801; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; LIM VI, 1974, J MOL BIOL, V88, P873, DOI 10.1016/0022-2836(74)90405-7; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; NAGANO K, 1977, J MOL BIOL, V109, P235, DOI 10.1016/S0022-2836(77)80032-6; Nagase T, 1998, DNA Res, V5, P355, DOI 10.1093/dnares/5.6.355; Ombra MN, 2001, AM J HUM GENET, V68, P1119, DOI 10.1086/320105; Pasquier C, 1999, PROTEIN ENG, V12, P631, DOI 10.1093/protein/12.8.631; Peltonen L, 2000, NAT REV GENET, V1, P182, DOI 10.1038/35042049; Persson B, 1996, PROTEIN SCI, V5, P363; RISTALDI MS, 1989, PRENATAL DIAG, V9, P629, DOI 10.1002/pd.1970090906; Rivers K, 2000, UROL CLIN N AM, V27, P203, DOI 10.1016/S0094-0143(05)70251-2; Roch-Ramel F, 1999, NEWS PHYSIOL SCI, V14, P80; Scheinman SJ, 1999, SEMIN NEPHROL, V19, P381; Serio A, 1999, NEPHRON, V81, P26, DOI 10.1159/000046295; Sobel E, 1996, AM J HUM GENET, V58, P1323; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Wright AF, 1999, NAT GENET, V23, P397, DOI 10.1038/70501; WU XW, 1989, P NATL ACAD SCI USA, V86, P9412, DOI 10.1073/pnas.86.23.9412; WU XW, 1992, J MOL EVOL, V34, P78, DOI 10.1007/BF00163854; [No title captured]	41	58	63	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2003	72	6					1479	1491		10.1086/375628	http://dx.doi.org/10.1086/375628			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	685QV	12740763	Bronze, Green Published			2022-12-18	WOS:000183275500011
J	Allison, DB; Fernandez, JR; Heo, M; Zhu, SK; Etzel, C; Beasley, TM; Amos, CI				Allison, DB; Fernandez, JR; Heo, M; Zhu, SK; Etzel, C; Beasley, TM; Amos, CI			Bias in estimates of quantitative-trait-locus effect in genome scans: Demonstration of the phenomenon and a method-of-moments procedure for reducing bias	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISCORDANT SIB PAIRS; LINKAGE ANALYSIS; EMPIRICAL BAYES; PIMA-INDIANS; SIMULATION; PEDIGREES; INFERENCE; SAMPLES	An attractive feature of variance-components methods (including the Haseman-Elston tests) for the detection of quantitative-trait loci (QTL) is that these methods provide estimates of the QTL effect. However, estimates that are obtained by commonly used methods can be biased for several reasons. Perhaps the largest source of bias is the selection process. Generally, QTL effects are reported only at locations where statistically significant results are obtained. This conditional reporting can lead to a marked upward bias. In this article, we demonstrate this bias and show that its magnitude can be large. We then present a simple method-of-moments (MOM)-based procedure to obtain more-accurate estimates, and we demonstrate its validity via Monte Carlo simulation. Finally, limitations of the MOM approach are noted, and we discuss some alternative procedures that may also reduce bias.	Univ Alabama, Dept Biostat, Birmingham, AL 35294 USA; Univ Alabama, Ctr Res Clin Nutr, Birmingham, AL USA; Columbia Univ Coll Phys & Surg, Inst Human Nutr, St Lukes Roosevelt Hosp, Obes Res Ctr, New York, NY 10032 USA; Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Columbia University; Mount Sinai St. Luke's; Mount Sinai West; University of Texas System; UTMD Anderson Cancer Center	Allison, DB (corresponding author), Univ Alabama, Dept Biostat, Ryals Publ Hlth Bldg 327,1665 Univ Blvd, Birmingham, AL 35294 USA.			Heo, Moonseong/0000-0001-7711-1209; Allison, David/0000-0003-3566-9399	NHGRI NIH HHS [R01 HG002275, R01HG02275] Funding Source: Medline; NIDDK NIH HHS [R01DK51716, P30 DK026687, P30DK26687] Funding Source: Medline; NIEHS NIH HHS [R01 ES009912, R01ES09912] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026687, R01DK051716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009912] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1994, AM J HUM GENET, V54, P535; Beavis William D., 1998, P145; Blangero J, 1997, GENET EPIDEMIOL, V14, P959, DOI 10.1002/(SICI)1098-2272(1997)14:6<959::AID-GEPI66>3.0.CO;2-K; Carlin BP, 2000, J AM STAT ASSOC, V95, P1286, DOI 10.2307/2669771; CHERICK MR, 1999, BOOTSTRAP METHODS; COHEN AC, 1949, J AM STAT ASSOC, V44, P518, DOI 10.2307/2279903; Comuzzie AG, 1997, NAT GENET, V15, P273, DOI 10.1038/ng0397-273; Dolan CV, 1999, AM J HUM GENET, V64, P268, DOI 10.1086/302189; Elston RC, 2000, GENET EPIDEMIOL, V19, P1, DOI 10.1002/1098-2272(200007)19:1<1::AID-GEPI1>3.0.CO;2-E; Fulker DW, 1996, BEHAV GENET, V26, P527, DOI 10.1007/BF02359758; Gallant AR, 1999, J ECONOMETRICS, V92, P149; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; Guerra R, 1999, HUM HERED, V49, P146, DOI 10.1159/000022863; HASEMAN JK, 1972, BEHAV GENET, V2, P1584; Hopper J L, 1993, Stat Methods Med Res, V2, P199, DOI 10.1177/096228029300200302; KAERIAN ZA, 2000, FITTING STAT DISTRIB; Kearsey MJ, 1998, HEREDITY, V80, P137, DOI 10.1046/j.1365-2540.1998.00500.x; Kissebah AH, 2000, P NATL ACAD SCI USA, V97, P14478, DOI 10.1073/pnas.97.26.14478; Li WT, 2001, GENET EPIDEMIOL, V21, pS272, DOI 10.1002/gepi.2001.21.s1.s272; Liu B.H., 1998, STAT GENOMICS LINKAG; McCulloch C. E., 2000, GEN LINEAR MIXED MOD; Melchinger AE, 1998, GENETICS, V149, P383; Mood AM., 1950, INTRO THEORY STAT; MORRIS CN, 1983, J AM STAT ASSOC, V78, P47, DOI 10.2307/2287098; PAKES A, 1989, ECONOMETRICA, V57, P1027, DOI 10.2307/1913622; Pratley RE, 1998, J CLIN INVEST, V101, P1757, DOI 10.1172/JCI1850; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857; Risch NJ, 1996, AM J HUM GENET, V58, P836; Ross S.M, 2004, INTRO PROBABILITY ST; Stuart A., 1999, KENDALLS ADV THEORY, V2A; THOMAS DC, 1985, AM J EPIDEMIOL, V122, P1080, DOI 10.1093/oxfordjournals.aje.a114189; Utz HF, 2000, GENETICS, V154, P1839; Walder K, 2000, INT J OBESITY, V24, P559, DOI 10.1038/sj.ijo.0801197; Zhu G, 1999, AM J HUM GENET, V65, P483, DOI 10.1086/302494; [No title captured]	36	58	62	0	8	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2002	70	3					575	585		10.1086/339273	http://dx.doi.org/10.1086/339273			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	522DG	11836648	Green Published, Bronze			2022-12-18	WOS:000173880000002
J	Greenberg, DA; Hodge, SE; Sowinski, J; Nicoll, D				Greenberg, DA; Hodge, SE; Sowinski, J; Nicoll, D			Excess of twins among affected sibling pairs with autism: Implications for the etiology of autism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUSCEPTIBILITY GENE; GENOMIC SCREEN; PREGNANCIES; STOPPAGE; DISORDER; RISK	It is widely accepted that genes play a role in the etiology of autism. Evidence for this derives, in part, from twin data. However, despite converging evidence from gene-mapping studies, aspects of the genetic contribution remain obscure. In a sample of families selected because each had exactly two affected sibs, we observed a remarkably high proportion of affected twin pairs, both MZ and DZ. Of 166 affected sib pairs, 30 (12 MZ, 17 DZ, and 1 of unknown zygosity) were twin pairs. Deviation from expected values was statistically significant (P<10(-6) for all twins); in a similarly ascertained sample of individuals with type I diabetes, there was no deviation from expected values. We demonstrate that to ascribe the excess of twins with autism solely to ascertainment bias would require very large ascertainment factors; for example, affected twin pairs would need to be, on average, <similar to>10 times more likely to be ascertained than affected nontwin sib pairs (or 7 times more likely if "stoppage" plays a role). Either risk factors (related to twinning or to fetal development) or other factors (genetic or nongenetic) in the parents may contribute to autism.	New York State Psychiat Inst & Hosp, Unit 24, New York, NY 10032 USA; Columbia Univ, Dept Biostat, Div State Genet, New York, NY USA; Human Biol Data Interchange, Philadelphia, PA USA	New York State Psychiatry Institute; Columbia University	Greenberg, DA (corresponding author), New York State Psychiat Inst & Hosp, Unit 24, 1051 Riverside Dr, New York, NY 10032 USA.	dag@shallot.salad.mssm.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031813, R01DK031775, R55DK031813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027941] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK031813, DK31813, DK31775, R01 DK031775] Funding Source: Medline; NIMH NIH HHS [R01 MH048858, MH48858] Funding Source: Medline; NINDS NIH HHS [NS27941, R01 NS027941] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ashley-Koch A, 1999, GENOMICS, V61, P227, DOI 10.1006/geno.1999.5968; Auranen M, 2000, MOL PSYCHIATR, V5, P320, DOI 10.1038/sj.mp.4000708; Bailey A, 1998, HUM MOL GENET, V7, P571; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Barrett S, 1999, AM J MED GENET, V88, P609; Buxbaum JD, 2001, AM J HUM GENET, V68, P1514, DOI 10.1086/320588; Chitrit Y, 1999, EUR J OBSTET GYN R B, V86, P23, DOI 10.1016/S0301-2115(99)00037-8; Comi AM, 1999, J CHILD NEUROL, V14, P388, DOI 10.1177/088307389901400608; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; GILLBERG C, 1990, J CHILD PSYCHOL PSYC, V31, P813, DOI 10.1111/j.1469-7610.1990.tb00821.x; JONES MB, 1988, J AUTISM DEV DISORD, V18, P31, DOI 10.1007/BF02211816; LECOUTEUR A, 1989, J AUTISM DEV DISORD, V19, P363, DOI 10.1007/BF02212936; Minakami H, 1999, J REPROD MED, V44, P595; Palferman S, 2001, AM J HUM GENET, V69, P570; Philippe A, 1999, HUM MOL GENET, V8, P805, DOI 10.1093/hmg/8.5.805; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; Slager SL, 2001, GENET EPIDEMIOL, V20, P328, DOI 10.1002/gepi.4.abs; SMALLEY SL, 1988, ARCH GEN PSYCHIAT, V45, P953; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; Thompson MW, 1991, THOMPSON THOMPSON GE; TORREY EF, 1975, J AUTISM CHILD SCHIZ, V5, P287, DOI 10.1007/BF01540676; Trottier G, 1999, J PSYCHIATR NEUROSCI, V24, P103; Vogel F., 1979, HUMAN GENETICS PROBL	23	58	59	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2001	69	5					1062	1067		10.1086/324191	http://dx.doi.org/10.1086/324191			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	479PU	11590546	Bronze, Green Published			2022-12-18	WOS:000171413400014
J	Resendes, BL; Williamson, RE; Morton, CC				Resendes, BL; Williamson, RE; Morton, CC			At the speed of sound: Gene discovery in the auditory system	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							MYOSIN VIIA GENE; HUMAN NONSYNDROMIC DEAFNESS; WAARDENBURG SYNDROME TYPE-2; NON-SYNDROMIC DEAFNESS; SYNDROME TYPE-I; AUTOSOMAL-DOMINANT; HEARING-LOSS; DIABETES-MELLITUS; POTASSIUM CHANNEL; PENDRED-SYNDROME	As auditory genes and deafness-associated mutations are discovered at a rapid rate, exciting opportunities have arisen to uncover the molecular mechanisms underlying hearing and hearing impairment. Single genes have been identified to be pathogenic for dominant or recessive forms of nonsyndromic hearing loss, syndromic hearing loss, and, in some cases, even multiple forms of hearing loss. Modifier loci and genes have been found, and investigations into their role in the hearing process will yield valuable insight into the fundamental processes of the auditory system.	Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Morton, CC (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	cmorton@partners.org						Abdelhak S, 1997, HUM MOL GENET, V6, P2247, DOI 10.1093/hmg/6.13.2247; Adato A, 1997, AM J HUM GENET, V61, P813, DOI 10.1086/514899; Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Alagramam KN, 2001, HUM MOL GENET, V10, P1709, DOI 10.1093/hmg/10.16.1709; Alloisio N, 1999, EUR J HUM GENET, V7, P255, DOI 10.1038/sj.ejhg.5200273; ATTIE T, 1995, HUM MOL GENET, V4, P2407, DOI 10.1093/hmg/4.12.2407; Avraham KB, 2001, NAT GENET, V27, P136, DOI 10.1038/84743; Balciuniene J, 1999, HUM GENET, V105, P211, DOI 10.1007/s004390051091; BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; BERGER W, 1992, HUM MOL GENET, V1, P461, DOI 10.1093/hmg/1.7.461; BESPALOVA IN, IN PRESS HUM MOL GEN; Bitner-Glindzicz M, 2000, NAT GENET, V26, P56, DOI 10.1038/79178; Boggon TJ, 1999, SCIENCE, V286, P2119, DOI 10.1126/science.286.5447.2119; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; Campbell C, 2001, HUM MUTAT, V17, P403, DOI 10.1002/humu.1116; CHEN ZY, 1992, NAT GENET, V1, P204, DOI 10.1038/ng0692-204; DEKOK YJM, 1995, SCIENCE, V267, P685, DOI 10.1126/science.7839145; Denoyelle F, 1998, NATURE, V393, P319, DOI 10.1038/30639; Dixon MJ, 1996, HUM MOL GENET, V5, P1391, DOI 10.1093/hmg/5.Supplement_1.1391; Edery P, 1996, NAT GENET, V12, P442, DOI 10.1038/ng0496-442; Eudy JD, 1998, SCIENCE, V280, P1753, DOI 10.1126/science.280.5370.1753; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Everett LA, 1999, P NATL ACAD SCI USA, V96, P9727, DOI 10.1073/pnas.96.17.9727; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Friedman TB, 1999, AM J MED GENET, V89, P147, DOI 10.1002/(SICI)1096-8628(19990924)89:3<147::AID-AJMG5>3.0.CO;2-6; Gorlin RJ, 1995, HEREDITARY HEARING L; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; Grifa A, 1999, NAT GENET, V23, P16, DOI 10.1038/12612; HAO HL, 1995, AM J HUM GENET, V56, P1017; HOTH CF, 1993, AM J HUM GENET, V52, P455; Ikeda A, 1999, HUM MOL GENET, V8, P1761, DOI 10.1093/hmg/8.9.1761; Inoue H, 1998, NAT GENET, V20, P143, DOI 10.1038/2441; Janecke AR, 1999, HUM MUTAT, V13, P133, DOI 10.1002/(SICI)1098-1004(1999)13:2<133::AID-HUMU5>3.0.CO;2-U; Jin H, 1996, NAT GENET, V14, P177, DOI 10.1038/ng1096-177; Joensuu T, 2001, AM J HUM GENET, V69, P673, DOI 10.1086/323610; Johnson KR, 2000, GENOMICS, V70, P171, DOI 10.1006/geno.2000.6377; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Kovach MJ, 1999, AM J HUM GENET, V64, P1580, DOI 10.1086/302420; Kozel PJ, 1998, J BIOL CHEM, V273, P18693, DOI 10.1074/jbc.273.30.18693; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Lalwani AK, 2000, AM J HUM GENET, V67, P1121, DOI 10.1016/S0002-9297(07)62942-5; Lane PW, 1987, MOUSE NEWS LETT, V77, P129; Levy G, 1997, HUM MOL GENET, V6, P111, DOI 10.1093/hmg/6.1.111; Li XC, 1998, NAT GENET, V18, P215, DOI 10.1038/ng0398-215; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Liu XZ, 1998, AM J HUM GENET, V63, P909, DOI 10.1086/302026; Liu XZ, 1997, NAT GENET, V17, P268, DOI 10.1038/ng1197-268; Liu XZ, 1997, HUM MUTAT, V10, P168, DOI 10.1002/(SICI)1098-1004(1997)10:2<168::AID-HUMU10>3.3.CO;2-T; Lynch ED, 1997, SCIENCE, V278, P1315, DOI 10.1126/science.278.5341.1315; McGuirt WT, 1999, NAT GENET, V23, P413, DOI 10.1038/70516; Melchionda S, 2001, AM J HUM GENET, V69, P635, DOI 10.1086/323156; MOCHIZUKI T, 1994, NAT GENET, V8, P77, DOI 10.1038/ng0994-77; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; Mustapha M, 1999, HUM MOL GENET, V8, P409, DOI 10.1093/hmg/8.3.409; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; NobenTrauth K, 1997, GENOMICS, V44, P266, DOI 10.1006/geno.1997.4869; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; Potterf SB, 2000, HUM GENET, V107, P1, DOI 10.1007/s004390050001; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; Rabionet R, 2000, HUM MUTAT, V16, P190, DOI 10.1002/1098-1004(200009)16:3<190::AID-HUMU2>3.0.CO;2-I; REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311; Riazuddin S, 1999, AM J HUM GENET, V65, pA101; Richards AJ, 1996, HUM MOL GENET, V5, P1339, DOI 10.1093/hmg/5.9.1339; Robertson NG, 1998, NAT GENET, V20, P299, DOI 10.1038/3118; SchulzeBahr E, 1997, NAT GENET, V17, P267, DOI 10.1038/ng1197-267; Scott DA, 2000, HUM MOL GENET, V9, P1709, DOI 10.1093/hmg/9.11.1709; Scott HS, 2001, NAT GENET, V27, P59, DOI 10.1038/83768; Self T, 1999, DEV BIOL, V214, P331, DOI 10.1006/dbio.1999.9424; Seri M, 2000, NAT GENET, V26, P103; Sevior KB, 1998, AM J MED GENET, V75, P179, DOI 10.1002/(SICI)1096-8628(19980113)75:2<179::AID-AJMG11>3.3.CO;2-1; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; Steel KP, 1999, SCIENCE, V285, P1363, DOI 10.1126/science.285.5432.1363; Steel KP, 2001, NAT GENET, V27, P143, DOI 10.1038/84758; Street VA, 1998, NAT GENET, V19, P390, DOI 10.1038/1284; STREET VA, 1995, GENOMICS, V29, P123, DOI 10.1006/geno.1995.1222; Strom TM, 1998, HUM MOL GENET, V7, P2021, DOI 10.1093/hmg/7.13.2021; SYKES B, 1986, LANCET, V2, P69; Tachibana M, 1996, NAT GENET, V14, P50, DOI 10.1038/ng0996-50; TASSABEHJI M, 1994, NAT GENET, V8, P251, DOI 10.1038/ng1194-251; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; TIRANTI V, 1995, HUM MOL GENET, V4, P1421, DOI 10.1093/hmg/4.8.1421; Tyson J, 1997, HUM MOL GENET, V6, P2179, DOI 10.1093/hmg/6.12.2179; Vahava O, 1998, SCIENCE, V279, P1950, DOI 10.1126/science.279.5358.1950; Van Laer L, 1998, NAT GENET, V20, P194; VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368; Verhoeven K, 1998, NAT GENET, V19, P60, DOI 10.1038/ng0598-60; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; VIKKULA M, 1995, CELL, V80, P431, DOI 10.1016/0092-8674(95)90493-X; Vincent C, 1997, EUR J HUM GENET, V5, P242, DOI 10.1159/000484770; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; Wayne S, 2001, HUM MOL GENET, V10, P195, DOI 10.1093/hmg/10.3.195; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Weston MD, 1996, AM J HUM GENET, V59, P1074; Wilcox ER, 2001, CELL, V104, P165, DOI 10.1016/S0092-8674(01)00200-8; Williams CJ, 1996, AM J MED GENET, V63, P461, DOI 10.1002/(SICI)1096-8628(19960614)63:3<461::AID-AJMG9>3.0.CO;2-U; Xia JH, 1998, NAT GENET, V20, P370, DOI 10.1038/3845; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693	101	58	72	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2001	69	5					923	935		10.1086/324122	http://dx.doi.org/10.1086/324122			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	479PU	11577373	Green Published, Bronze			2022-12-18	WOS:000171413400001
J	Abel, L; Casanova, JL				Abel, L; Casanova, JL			Genetic predisposition to clinical tuberculosis: Bridging the gap between simple and complex inheritance	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							MYCOBACTERIUM-TUBERCULOSIS; SCHISTOSOMA-MANSONI; NATURAL-RESISTANCE; RECEPTOR GENE; INFECTION; SUSCEPTIBILITY; NRAMP1; LOCUS; CANDIDATE; AFRICANS		Univ Paris 06, INSERM, U436, Paris, France; Hop Necker Enfants Malad, INSERM, U429, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Abel, L (corresponding author), Fac Med Necker Enfants Malad, Lab Genet Humaine Malad Infect, 156 Rue Vaugirard, F-75015 Paris, France.	abel@biomath.jussieu.fr	Abel, Laurent/H-8888-2017; Casanova, Jean-Laurent/I-3418-2017	Abel, Laurent/0000-0001-7016-6493; Casanova, Jean-Laurent/0000-0002-7782-4169				Abel L, 1998, J INFECT DIS, V177, P133, DOI 10.1086/513830; ABEL L, 1988, AM J HUM GENET, V42, P256; ABEL L, 1991, AM J HUM GENET, V48, P959; Alcais A, 2000, J INFECT DIS, V181, P302, DOI 10.1086/315174; Altare F, 1998, CURR OPIN IMMUNOL, V10, P413, DOI 10.1016/S0952-7915(98)80114-3; Bellamy R, 1998, NEW ENGL J MED, V338, P640, DOI 10.1056/NEJM199803053381002; Bellamy R, 1999, J INFECT DIS, V179, P721, DOI 10.1086/314614; Bloom BR, 1998, NEW ENGL J MED, V338, P677, DOI 10.1056/NEJM199803053381008; Canonne-Hergaux F, 1999, P ASSOC AM PHYSICIAN, V111, P283, DOI 10.1046/j.1525-1381.1999.99236.x; CELLIER M, 1994, J EXP MED, V180, P1741, DOI 10.1084/jem.180.5.1741; COMSTOCK GW, 1978, AM REV RESPIR DIS, V117, P621; Dessein AJ, 1999, AM J HUM GENET, V65, P709, DOI 10.1086/302526; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Goldfeld AE, 1998, JAMA-J AM MED ASSOC, V279, P226, DOI 10.1001/jama.279.3.226; Govoni G, 1996, INFECT IMMUN, V64, P2923, DOI 10.1128/IAI.64.8.2923-2929.1996; Greenwood CMT, 2000, AM J HUM GENET, V67, P405, DOI 10.1086/303012; Jouanguy E, 1997, J CLIN INVEST, V100, P2658, DOI 10.1172/JCI119810; Marquet S, 1996, NAT GENET, V14, P181, DOI 10.1038/ng1096-181; Murray CJL, 1998, P NATL ACAD SCI USA, V95, P13881, DOI 10.1073/pnas.95.23.13881; North RJ, 1999, INFECT IMMUN, V67, P5811, DOI 10.1128/IAI.67.11.5811-5814.1999; Picard C, 2000, IMMUNOL ALLERGY CLIN, V20, P65, DOI 10.1016/S0889-8561(05)70134-X; Ravikumar M., 1999, Tubercle and Lung Disease, V79, P309, DOI 10.1054/tuld.1999.0213; Selvaraj P., 1999, Tubercle and Lung Disease, V79, P221, DOI 10.1054/tuld.1999.0204; Shaw MA, 1997, TUBERCLE LUNG DIS, V78, P35, DOI 10.1016/S0962-8479(97)90014-9; Stead WW, 1997, CLIN CHEST MED, V18, P65, DOI 10.1016/S0272-5231(05)70356-7; STEAD WW, 1992, ANN INTERN MED, V116, P937, DOI 10.7326/0003-4819-116-11-937; Vidal SM, 1996, J IMMUNOL, V157, P3559; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D; Wilkinson RJ, 1999, J EXP MED, V189, P1863, DOI 10.1084/jem.189.12.1863; Winfield JB, 1997, CLIN EXP IMMUNOL, V109, P1, DOI 10.1046/j.1365-2249.1997.00439.x	30	58	59	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2000	67	2					274	277		10.1086/303033	http://dx.doi.org/10.1086/303033			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354YA	10882573	Green Published, Bronze			2022-12-18	WOS:000089357800002
J	Lopes-Cendes, I; Scheffer, IE; Berkovic, SF; Rousseau, M; Andermann, E; Rouleau, GA				Lopes-Cendes, I; Scheffer, IE; Berkovic, SF; Rousseau, M; Andermann, E; Rouleau, GA			A new locus for generalized epilepsy with febrile seizures plus maps to chromosome 2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECEPTOR; MUTATION; SUBUNIT; GENE	Generalized epilepsy with febrile seizures plus (GEFS+) is a recently recognized but relatively common form of inherited childhood-onset epilepsy with heterogeneous epilepsy phenotypes. We genotyped 41 family members, including 21 affected individuals, to localize the gene causing epilepsy in a large family segregating an autosomal dominant form of GEFS+. A genomewide search examining 197 markers identified linkage of GEFS+ to chromosome 2, on the basis of an initial positive LOD score for marker D2S294 (Z = 4.4, recombination fraction [theta] = 0). A total of 24 markers were tested on chromosome 2q, to define the smallest candidate region for GEFS+. The highest two-point LOD score (Z(max) = 5.29; theta = 0) was obtained with marker D2S324. Critical recombination events mapped the GEFS+ gene to a 29-cM region flanked by markers D2S156 and D2S311, with the idiopathic generalized epilepsy locus thereby assigned to chromosome 2q23-q31. The existence of the heterogeneous epilepsy phenotypes in this kindred suggests that seizure predisposition determined by the GEFS+ gene on chromosome 2q could be modified by other genes and/or by environmental factors, to produce the different seizure types observed.	McGill Univ, Montreal Gen Hosp, Res Inst, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada; McGill Univ, Montreal Neurol Hosp & Inst, Neurogenet Unit, Montreal, PQ H3G 1A4, Canada; McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3G 1A4, Canada; McGill Univ, Dept Human Genet, Montreal, PQ H3G 1A4, Canada; Univ Melbourne, Epilepsy Res Inst, Austin & Repatriat Med Ctr, Dept Med Neurol, Melbourne, Vic, Australia; Royal Childrens Hosp, Melbourne, Vic, Australia	McGill University; McGill University; McGill University; McGill University; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Royal Children's Hospital Melbourne	Rouleau, GA (corresponding author), McGill Univ, Montreal Gen Hosp, Res Inst, Ctr Res Neurosci, Room L7-224,1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	mi32@musica.mcgill.ca	jiang, yu/HGU-0029-2022; Scheffer, Ingrid E/G-1668-2013; Lopes-Cendes, Iscia/B-9416-2013	Scheffer, Ingrid E/0000-0002-2311-2174; Lopes-Cendes, Iscia/0000-0002-6221-6822; Berkovic, Samuel/0000-0003-4580-841X				[Anonymous], 1981, Epilepsia, V22, P489; Baulac S, 1999, AM J HUM GENET, V65, P1078, DOI 10.1086/302593; Berkovic S F, 1999, Curr Opin Neurol, V12, P177, DOI 10.1097/00019052-199904000-00008; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; BLAIR LAC, 1988, SCIENCE, V242, P577, DOI 10.1126/science.2845583; BU DF, 1994, GENOMICS, V21, P222, DOI 10.1006/geno.1994.1246; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Lopes-Cendes Iscia, 1996, Epilepsia, V37, P127; Moulard B, 1999, AM J HUM GENET, V65, P1396, DOI 10.1086/302621; Peiffer A, 1999, ANN NEUROL, V46, P671, DOI 10.1002/1531-8249(199910)46:4<671::AID-ANA20>3.0.CO;2-5; Sambrooke J., 1989, MOL CLONING LAB MANU, pE3; Scheffer IE, 1997, BRAIN, V120, P479, DOI 10.1093/brain/120.3.479; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Singh R, 1999, ANN NEUROL, V45, P75, DOI 10.1002/1531-8249(199901)45:1<75::AID-ART13>3.0.CO;2-W; STEINLEIN OK, 1995, NAT GENET, V11, P201, DOI 10.1038/ng1095-201; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252	18	58	63	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					698	701		10.1086/302768	http://dx.doi.org/10.1086/302768			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	10677328	Green Published, Bronze			2022-12-18	WOS:000088373100035
J	Zollner, S; von Haeseler, A				Zollner, S; von Haeseler, A			A coalescent approach to study linkage disequilibrium between single-nucleotide polymorphisms	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN LIPOPROTEIN-LIPASE; DNA-SEQUENCE VARIATION; DEMOGRAPHIC HISTORY; POPULATIONS; REGION; HETEROZYGOSITY; CHROMOSOME; DISEASE; GENOME; GENES	We present the results of extensive simulations that emulate the development and distribution of linkage disequilibrium (LD) between single-nucleotide polymorphisms (SNPs) and a gene locus that is phenotypically stratified into two classes (disease phenotype and wildtype phenotype). Our approach, based on coalescence theory allows an explicit modeling of the demographic history of the population without conditioning on the age of the mutation, and serves as an efficient tool to carry out simulations, More specifically, we compare the influence that a constant population size or an exponentially growing population has on the amount of LD. These results indicate that attempts to locate single disease genes are most likely successful in small and constant populations. On the other hand, if we consider an exponentially growing population that started to expand from an initially constant population of reasonable size, then our simulations indicate a lower success rate. The power to detect association is enhanced if haplotypes constructed from several SNPs are used as markers. The versatility of the coalescence approach also allows the analysis of other relevant factors that influence the chances that a disease gene will be located. We show that several alleles leading to the same disease have no substantial influence on the amount of LD, as long as the differences between the disease-causing alleles are confined to the same region of the gene locus and as long as each allele occurs in an appreciable frequency. Our simulations indicate that mapping of less-frequent diseases is more likely to be successful. Moreover, we show that successful attempts to map complex diseases depend crucially on the phenotype-genotype correlations of all alleles at the disease locus. An analysis of lipoprotein lipase data indicates that our simulations capture the major features of LD occurring in biological data.	Max Planck Inst Evolut Anthropol, D-04103 Leipzig, Germany	Max Planck Society	von Haeseler, A (corresponding author), Max Planck Inst Evolut Anthropol, Inselstr 22, D-04103 Leipzig, Germany.		von Haeseler, Arndt/HCI-9958-2022; Peng, Bo/A-6920-2009	von Haeseler, Arndt/0000-0002-3366-4458; Peng, Bo/0000-0001-8225-2284				Burckhardt F, 1999, NUCLEIC ACIDS RES, V27, P138, DOI 10.1093/nar/27.1.138; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; COOPER DN, 1985, HUM GENET, V69, P201, DOI 10.1007/BF00293024; Donnelly P, 1995, ANNU REV GENET, V29, P401, DOI 10.1146/annurev.ge.29.120195.002153; GRIFFITHS RC, 1994, PHILOS T ROY SOC B, V344, P403, DOI 10.1098/rstb.1994.0079; GRIFFITHS RC, 1994, THEOR POPUL BIOL, V46, P131, DOI 10.1006/tpbi.1994.1023; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; Hammer MF, 1997, GENETICS, V145, P787; Hudson RR, 1991, OXF SURV EVOL BIOL, V7, P1; Kaessmann H, 1999, NAT GENET, V22, P78, DOI 10.1038/8785; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; KUHNER MK, 1995, GENETICS, V140, P1421; Laan M, 1997, NAT GENET, V17, P435, DOI 10.1038/ng1297-435; Landegren U, 1998, GENOME RES, V8, P769, DOI 10.1101/gr.8.8.769; LEWIN B, 1994, GENES, V5; Nei M, 1997, MOL EVOLUTIONARY GEN; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; Ott J, 1997, GENETICS, V147, P927; Rannala B, 1998, AM J HUM GENET, V62, P459, DOI 10.1086/301709; SLATKIN M, 1991, GENETICS, V129, P555; SLATKIN M, 1994, GENETICS, V137, P331; Terwilliger JD, 1998, HUM HERED, V48, P138, DOI 10.1159/000022794; Thompson EA, 1997, AM J HUM GENET, V60, P197; Weiss G, 1998, GENETICS, V149, P1539; Wiuf C, 1999, THEOR POPUL BIOL, V56, P183, DOI 10.1006/tpbi.1998.1411	26	58	60	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					615	628		10.1086/302766	http://dx.doi.org/10.1086/302766			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	10677321	Bronze, Green Published			2022-12-18	WOS:000088373100028
J	Gustavsson, P; Garelli, E; Draptchinskaia, N; Ball, S; Willig, TN; Tentler, D; Dianzani, I; Punnett, HH; Shafer, FE; Cario, H; Ramenghi, U; Glomstein, A; Pfeiffer, RA; Goringe, A; Olivieri, NF; Smibert, E; Tchernia, G; Elinder, G; Dahl, N				Gustavsson, P; Garelli, E; Draptchinskaia, N; Ball, S; Willig, TN; Tentler, D; Dianzani, I; Punnett, HH; Shafer, FE; Cario, H; Ramenghi, U; Glomstein, A; Pfeiffer, RA; Goringe, A; Olivieri, NF; Smibert, E; Tchernia, G; Elinder, G; Dahl, N			Identification of microdeletions spanning the Diamond-Blackfan anemia locus on 19q13 and evidence for genetic heterogeneity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL HYPOPLASTIC-ANEMIA; RED-CELL APLASIA; CLUSTER; FAMILY; HUMAN-CHROMOSOME-19; TRANSMISSION; MAP	Diamond-Blackfan anemia (DBA) is a rare pure red-cell hypoplasia of unknown etiology and pathogenesis. A major DBA locus has previously been localized to chromosome 19q13.2. Samples from additional families have been collected to identify key recombinations, microdeletions, and the possibility of heterogeneity for the disorder. In total, 29 multiplex DBA families and 50 families that comprise sporadic DBA cases have been analyzed with polymorphic 19q13 markers, including a newly identified short-tandem repeat in the critical gene region. The results from DNA analysis of 23 multiplex families revealed that 26 of these were consistent with a DBA gene on 19q localized to within a 4.1-cM interval restricted by loci D19S200 and D19S178; however, in three multiplex families, the DBA candidate region on 19q13 was excluded from the segregation of marker alleles. Our results suggest genetic heterogeneity for DBA, and we show that a gene region on chromosome 19q segregates with the disease in the majority of familial cases. Among the 50 families comprising sporadic DBA cases, we identified two novel and overlapping microdeletions on chromosome 19q13. In combination, the three known, microdeletions associated with. DBA restrict the critical gene region to similar to 1 Mb. The results indicate that a proportion of sporadic DBA cases are caused by deletions in the 19q13 region.	Uppsala Univ, Childrens Hosp, Dept Genet & Pathol, Clin Genet Unit, Uppsala, Sweden; Univ Turin, Dept Pediat, Turin, Italy; Univ Turin, Dept Genet, Turin, Italy; St George Hosp, Sch Med, Dept Haematol, London, England; Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA USA; Hop Bicetre, APHP, Fac Med, Dept Hematol, Bicetre, France; St Christophers Hosp Children, Dept Lab Med, Philadelphia, PA 19133 USA; St Christophers Hosp Children, Dept Pediat, Philadelphia, PA 19133 USA; Univ Ulm, Dept Pediat, D-7900 Ulm, Germany; Univ Oslo, Dept Pediat, Oslo, Norway; Univ Erlangen Nurnberg, Dept Human Genet, D-8520 Erlangen, Germany; Hosp Sick Children, Toronto, ON M5G 1X8, Canada; Royal Childrens Hosp, Dept Haematol Oncol, Melbourne, Vic, Australia; Sacchska Hosp, Dept Pediat, Stockholm, Sweden	Uppsala University; University of Turin; University of Turin; St Georges University London; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Bicetre - APHP; Ulm University; University of Oslo; University of Erlangen Nuremberg; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Royal Children's Hospital Melbourne	Dahl, N (corresponding author), Uppsala Univ, Childrens Hosp, Dept Genet & Pathol, Clin Genet Unit, Uppsala, Sweden.		Cario, Holger/AAH-6713-2019; Tentler, Dmitri/AAE-4519-2019; Olivieri, Nancy/AAI-2250-2020	Tentler, Dmitri/0000-0003-3976-1205; Cario, Holger/0000-0002-6923-488X	Telethon [E.0619] Funding Source: Medline	Telethon(Fondazione Telethon)		AASE JM, 1969, J PEDIATR, V74, P471, DOI 10.1016/S0022-3476(69)80208-8; ALTER BP, 1980, AM J PEDIAT HEMATOL, V2, P121; ALTMAN AC, 1983, AM J PEDIAT HEMATOL, V5, P99; ASHWORTH LK, 1995, NAT GENET, V11, P422, DOI 10.1038/ng1295-422; Ball SE, 1996, BRIT J HAEMATOL, V94, P645, DOI 10.1046/j.1365-2141.1996.d01-1839.x; CATHIE IAB, 1950, ARCH DIS CHILD, V25, P313, DOI 10.1136/adc.25.124.313; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Diamond L K, 1976, Adv Pediatr, V22, P349; Diamond L. K., 1938, AM J DIS CHILD, V56, P464; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; GLADER BE, 1988, BRIT J HAEMATOL, V68, P165, DOI 10.1111/j.1365-2141.1988.tb06184.x; GOJIC V, 1994, AM J MED GENET, V50, P87, DOI 10.1002/ajmg.1320500119; Gustavsson P, 1997, NAT GENET, V16, P368, DOI 10.1038/ng0897-368; Gustavsson P, 1997, J MED GENET, V34, P779, DOI 10.1136/jmg.34.9.779; HALPERIN DS, 1989, AM J PEDIAT HEMATOL, V11, P380; Janov AJ, 1996, MEDICINE, V75, P77, DOI 10.1097/00005792-199603000-00004; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LICHTER P, 1988, HUM GENET, V80, P224, DOI 10.1007/BF01790090; MADANAT F, 1994, AM J PEDIAT HEMATOL, V16, P260; Mohrenweiser Harvey, 1996, Cytogenetics and Cell Genetics, V74, P161, DOI 10.1159/000134408; MOTT MG, 1969, ARCH DIS CHILD, V44, P757, DOI 10.1136/adc.44.238.757; NEBERT DW, 1991, MOL ENDOCRINOL, V5, P1203, DOI 10.1210/mend-5-9-1203; Ott J., 1991, ANAL HUMAN GENETIC L; TEGLUND S, 1994, GENOMICS, V23, P669, DOI 10.1006/geno.1994.1556; THOMPSON J, 1992, GENOMICS, V12, P761, DOI 10.1016/0888-7543(92)90307-E; TSAI PH, 1989, BRIT J HAEMATOL, V73, P112, DOI 10.1111/j.1365-2141.1989.tb00229.x; VISKOCHIL DH, 1990, AM J MED GENET, V35, P251, DOI 10.1002/ajmg.1320350221; Young N. S., 1994, APLASTIC ANEMIA ACQU	28	58	59	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1998	63	5					1388	1395		10.1086/302100	http://dx.doi.org/10.1086/302100			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	138QZ	9792865	Bronze, Green Published			2022-12-18	WOS:000076985200014
J	Carella, M; Stewart, G; Ajetunmobi, JF; Perrotta, S; Grootenboer, S; Tchernia, G; Delaunay, J; Totaro, A; Zelante, L; Gasparini, P; Iolascon, A				Carella, M; Stewart, G; Ajetunmobi, JF; Perrotta, S; Grootenboer, S; Tchernia, G; Delaunay, J; Totaro, A; Zelante, L; Gasparini, P; Iolascon, A			Genomewide search for dehydrated hereditary stomatocytosis (hereditary xerocytosis): Mapping of locus to chromosome 16 (16q23-qter)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEMOLYTIC-ANEMIA; MEMBRANE-PROTEIN; ERYTHROCYTES; GENE; DISEASE; MAP	Dehydrated hereditary stomatocytosis, also known as "hereditary xerocytosis," is caused by a red blood cell-membrane defect characterized by stomatocytic morphology, increased mean corpuscular hemoglobin concentration, decreased osmotic fragility, increased permeability to the univalent cations Na+ and K+, and an increased proportion of phosphatidylcholine in the membrane. The clinical presentation is heterogeneous, ranging from mild to moderate hemolytic anemia associated with scleral icterus, splenomegaly, and choletithiasis. Iron overload may develop later in life. The disease is transmitted as an autosomal dominant trait. We recruited a large three-generation Irish family affected with DHS and comprising 23 members, of whom 14 were affected and 9 were healthy. Two additional, small families also were included in the study. The DNA samples from the family members were used in a genomewide search to identify, by linkage analysis, the DHS locus. After the exclusion of a portion of the human genome, we obtained conclusive evidence for linkage of DHS to microsatellite markers on the long arm of chromosome 16 (16q23-q24). A maximum two-point LOD score of 6.62 at recombination fraction .00 was obtained with marker D16S520. There are no recombination events defining the telomeric limit of the region, which therefore is quite large. No candidate genes map to this area.	IRCCS, CSS, Serv Genet Med, San Giovanni Rotondo, Fg, Italy; Rayne Inst, Dept Med, London, England; Univ Naples 2, Dipartimento Pediat, Naples, Italy; Hop Bicetre, Serv Hematol, Assistance Publ Hop, INSERM,U473, Le Kremlin Bicetre, France; Univ Bari, Dipartimento Biomed Eta Evolut, Bari, Italy	IRCCS Casa Sollievo Della Sofferenza; University of London; King's College London; Universita della Campania Vanvitelli; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Universita degli Studi di Bari Aldo Moro	Gasparini, P (corresponding author), IRCCS, CSS, Serv Genet Med, San Giovanni Rotondo, Fg, Italy.		Carella, Massimo/A-2804-2014; Gasparini, Paolo/B-6173-2014; Mignot, Sabine/J-4637-2017; Iolascon, Achille/A-4461-2014	Carella, Massimo/0000-0002-6830-6829; Perrotta, Silverio/0000-0001-6149-6845; Totaro, Antonio/0000-0002-9752-8471	Telethon [E.0783] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Telethon(Fondazione Telethon); Wellcome Trust(Wellcome TrustEuropean Commission)		Barnes TM, 1996, J NEUROCHEM, V67, P46; CALDWELL JH, 1992, NAT GENET, V2, P87, DOI 10.1038/ng1092-87; CLARK MR, 1993, AM J HEMATOL, V42, P25, DOI 10.1002/ajh.2830420107; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Entezami M, 1996, BLOOD, V87, P5392, DOI 10.1182/blood.V87.12.5392.bloodjournal87125392; GALLAGHER PG, 1993, GENOMICS, V18, P167, DOI 10.1006/geno.1993.1449; GALLAGHER PG, 1995, J BIOL CHEM, V270, P26358, DOI 10.1074/jbc.270.44.26358; GLADER BE, 1974, NEW ENGL J MED, V291, P491, DOI 10.1056/NEJM197409052911003; GROOTENBOER S, 1997, BLOOD S, V90, P14; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HUANG MX, 1995, NATURE, V378, P292, DOI 10.1038/378292a0; JAFFE ER, 1968, J CLIN INVEST, V47, P1375, DOI 10.1172/JCI105829; Johnson RM, 1996, J PEDIAT HEMATOL ONC, V18, P122, DOI 10.1097/00043426-199605000-00005; LANDE WM, 1982, J CLIN INVEST, V70, P1273, DOI 10.1172/JCI110726; LOCK SP, 1961, BRIT J HAEMATOL, V7, P303, DOI 10.1111/j.1365-2141.1961.tb00341.x; Lux SE, 1995, BLOOD PRINCIPLES PRA, P1701; MILLER DR, 1971, BLOOD-J HEMATOL, V38, P184, DOI 10.1182/blood.V38.2.184.184; NOLAN GR, 1984, PATHOLOGY, V16, P151, DOI 10.3109/00313028409059094; OTT J, 1992, ANAL HUMAN LINKAGE; SHOHET SB, 1971, BLOOD-J HEMATOL, V38, P445, DOI 10.1182/blood.V38.4.445.445; Stewart GW, 1996, BRIT J HAEMATOL, V93, P303, DOI 10.1046/j.1365-2141.1996.4881033.x; STEWART GW, 1985, CLIN SCI, V69, P309, DOI 10.1042/cs0690309; STEWART GW, 1993, BAILLIERE CLIN HAEM, V6, P371, DOI 10.1016/S0950-3536(05)80151-9; STEWART GW, 1988, J PHYSIOL-LONDON, V401, P1; Vives Corrons J. L., 1995, British Journal of Haematology, V90, P817; WANG D, 1992, BLOOD S, V80, pA275; WILEY JS, 1984, PATHOLOGY, V16, P115, DOI 10.3109/00313028409059086	27	58	58	0	3	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1998	63	3					810	816		10.1086/302024	http://dx.doi.org/10.1086/302024			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	119VN	9718354	Bronze, Green Published			2022-12-18	WOS:000075919000019
J	Wang, SM; Zwaan, J; Mullaney, PB; Jabak, MH; Al-Awad, A; Beggs, AH; Engle, EC				Wang, SM; Zwaan, J; Mullaney, PB; Jabak, MH; Al-Awad, A; Beggs, AH; Engle, EC			Congenital fibrosis of the extraocular muscles type 2, an inherited exotropic strabismus fixus, maps to distal 11q13	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DUANES RETRACTION SYNDROME; LINKAGE ANALYSIS; CHROMOSOME-12; MICE	The extraocular fibrosis syndromes are congenital ocular-motility disorders that arise from dysfunction of the oculomotor, trochlear, and abducens nerves and/or the muscles that they innervate. Each is marked by a specific form of restrictive paralytic ophthalmoplegia with or without ptosis. Individuals with the classic form of congenital fibrosis of the extraocular muscles (CFEOM1) are born with bilateral ptosis and a restrictive infraductive external ophthalmoplegia. We previously demonstrated that CFEOM1 is caused by an autosomal dominant locus on chromosome 12 and results from a developmental absence of the superior division of the oculomotor nerve. We now have mapped a variant of CFEOM, exotropic strabismus fixus ("CFEOM2"). Affected individuals are born with bilateral ptosis and restrictive ophthalmoplegia with the globes "frozen" in extreme abduction. This autosomal recessive disorder is present in members of three consanguineous Saudi Arabian families. Genetic analysis of 70 individuals (20 affected individuals) reveals linkage to markers on chromosome 11q13, with a combined LOD score of 12.3 at the single nonrecombinant marker, D11S1314. The 2.5-cM CFEOM2 critical region is flanked by D11S4196/D11S4162 and D11S4184/1369. Two of the three families share a common disease-associated haplotype, suggesting a founder effect for CFEOM2. We hypothesize that CFEOM2 results from an analogous developmental defect to CFEOM1, one that affects both the superior and inferior divisions of the oculomotor nerve and their corresponding alpha motoneurons and extrascular muscles.	Harvard Univ, Childrens Hosp, Sch Med, Div Genet, Boston, MA 02115 USA; Harvard Univ, Childrens Hosp, Sch Med, Dept Neurol, Boston, MA 02115 USA; King Khalid Eye Specialist Hosp, Riyadh 11462, Saudi Arabia	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; King Khaled Eye Specialist Hospital	Engle, EC (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Div Genet, 300 Longwood Ave,Enders 5, Boston, MA 02115 USA.			Beggs, Alan/0000-0001-8818-0568	NATIONAL EYE INSTITUTE [K11EY000336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K02AR002026] Funding Source: NIH RePORTER; NEI NIH HHS [K11-EY00336] Funding Source: Medline; NIAMS NIH HHS [K02-AR02026] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		APT L, 1978, AM J OPHTHALMOL, V85, P822, DOI 10.1016/S0002-9394(14)78112-7; Assaf AA, 1997, NEURO-OPHTHALMOLOGY, V17, P23, DOI 10.3109/01658109709009687; Brown HW., 1950, STRABISMUS OPHTHALMI, P205; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; COULLIN P, 1994, GENOMICS, V21, P379; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Engle EC, 1997, AM J HUM GENET, V60, P1150; ENGLE EC, 1994, NAT GENET, V7, P69, DOI 10.1038/ng0594-69; ENGLE EC, 1995, AM J HUM GENET, V57, P1086; Engle EC, 1997, ANN NEUROL, V41, P314, DOI 10.1002/ana.410410306; FRITZSCH B, 1995, J NEUROBIOL, V27, P457, DOI 10.1002/neu.480270403; Guru SC, 1997, GENOMICS, V42, P436, DOI 10.1006/geno.1997.4783; HARLEY RD, 1978, J PEDIAT OPHTH STRAB, V15, P346; HOTCHKISS MG, 1980, ARCH OPHTHALMOL-CHIC, V98, P870, DOI 10.1001/archopht.1980.01020030864013; HUBER A, 1984, STRABISMUS, V2, P345; JAMES MR, 1994, NAT GENET, V8, P70, DOI 10.1038/ng0994-70; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Merscher S, 1997, GENOMICS, V39, P340, DOI 10.1006/geno.1996.4460; MILLER NR, 1982, ARCH OPHTHALMOL-CHIC, V100, P1468; Porter JD, 1997, DEV BRAIN RES, V100, P121, DOI 10.1016/S0165-3806(97)00020-5; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Traboulsi EI, 1993, AM ORTHOPT J, V43, P45; WURST W, 1994, DEVELOPMENT, V120, P2065	26	58	68	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1998	63	2					517	525		10.1086/301980	http://dx.doi.org/10.1086/301980			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110CB	9683611	Green Published, Bronze			2022-12-18	WOS:000075360800027
J	Brinkmann, U				Brinkmann, U			CAS, the human homologue of the yeast chromosome-segregation gene CSE1, in proliferation, apoptosis, and cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUSCEPTIBILITY GENE; BREAST-CANCER; PROTEIN; CLONING; CELLS; 20Q13		NCI, Mol Biol Lab, Div Basic Sci, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Brinkmann, U (corresponding author), NCI, Mol Biol Lab, Div Basic Sci, NIH, Bldg 37-4B20,37 Convent Dr MSC 4255, Bethesda, MD 20892 USA.	uli@helix.nih.gov	Brinkmann, Ulrich/AAF-8216-2019	Brinkmann, Ulrich/0000-0002-5558-0212				Agarwal ML, 1998, J BIOL CHEM, V273, P1, DOI 10.1074/jbc.273.1.1; BRINKMANN U, 1995, MOL MED, V1, P206, DOI 10.1007/BF03401568; Brinkmann U, 1996, GENOME RES, V6, P187, DOI 10.1101/gr.6.3.187; Brinkmann U, 1996, BIOCHEMISTRY-US, V35, P6891, DOI 10.1021/bi952829+; BRINKMANN U, 1995, P NATL ACAD SCI USA, V92, P10427, DOI 10.1073/pnas.92.22.10427; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Gallant P, 1995, J CELL SCI, P21; IRNIGER S, 1995, CELL, V81, P269, DOI 10.1016/0092-8674(95)90337-2; KUSSEL P, 1995, J CELL BIOL, V129, P1491, DOI 10.1083/jcb.129.6.1491; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; LIEBERMANN DA, 1995, ONCOGENE, V11, P199; Middeler G, 1997, ONCOGENE, V14, P1407, DOI 10.1038/sj.onc.1200949; Nicklas RB, 1997, SCIENCE, V275, P632, DOI 10.1126/science.275.5300.632; Ogryzko VV, 1997, BIOCHEMISTRY-US, V36, P9493, DOI 10.1021/bi970236o; Ried T, 1996, GENE CHROMOSOME CANC, V15, P234, DOI 10.1002/(SICI)1098-2264(199604)15:4<234::AID-GCC5>3.0.CO;2-2; Rodriguez A, 1998, AM J HUM GENET, V62, P514, DOI 10.1086/301775; Savelieva E, 1997, ONCOGENE, V14, P551, DOI 10.1038/sj.onc.1200868; Schaar BT, 1997, J CELL BIOL, V139, P1373, DOI 10.1083/jcb.139.6.1373; Scherf U, 1996, P NATL ACAD SCI USA, V93, P2670, DOI 10.1073/pnas.93.7.2670; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; StJohn MAR, 1997, AM J HUM GENET, V61, P1006, DOI 10.1086/301619; TANNER MM, 1994, CANCER RES, V54, P4257; Thomas RC, 1996, EXP CELL RES, V223, P227, DOI 10.1006/excr.1996.0076; Ullman KS, 1997, CELL, V90, P967, DOI 10.1016/S0092-8674(00)80361-X; Wang HC, 1997, ONCOGENE, V15, P143, DOI 10.1038/sj.onc.1201252; Wellmann A, 1997, AM J PATHOL, V150, P25; XIAO ZX, 1993, MOL CELL BIOL, V13, P4691, DOI 10.1128/MCB.13.8.4691	27	58	58	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1998	62	3					509	513		10.1086/301773	http://dx.doi.org/10.1086/301773			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZF407	9497270	Bronze, Green Published			2022-12-18	WOS:000072894400002
J	Ferrero, GB; Gebbia, M; Pilia, G; Witte, D; Peier, A; Hopkin, RJ; Craigen, WJ; Shaffer, LG; Schlessinger, D; Ballabio, A; Casey, B				Ferrero, GB; Gebbia, M; Pilia, G; Witte, D; Peier, A; Hopkin, RJ; Craigen, WJ; Shaffer, LG; Schlessinger, D; Ballabio, A; Casey, B			A submicroscopic deletion in Xq26 associated with familial situs ambiguus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKED LATERALITY SEQUENCE; LEFT-RIGHT ASYMMETRY; NODAL EXPRESSION; ACTIVIN RECEPTOR; MOUSE EMBRYOS; GENE; DEFECTS; EMBRYOGENESIS; HNF-3-BETA; MUTATIONS	Abnormal left-right-axis formation results in heterotaxy, a multiple-malformation syndrome often characterized by severe heart defects, splenic abnormalities, and gastrointestinal malrotation. Previously we had studied a large family in which a gene for heterotaxy, HTX1, was mapped to a 19-cM region in Xq24-q27.1. Further analysis of this family has revealed two recombinations that place HTX1 between DXS300 and DXS1062, an interval spanning similar to 1.3 Mb in Xq26.2. In order to provide independent confirmation of HTX1 localization, a PCR-based search for submicroscopic deletions in this region was performed in unrelated males with sporadic or familial heterotaxy. A cluster of sequence-tagged sites failed to amplify in an individual who also had a deceased, affected brother. FISH identified the mother as a carrier of the deletion, which arose as a new mutation from the maternal grandfather. The deletion interval spans 600-1,100 kb and lies wholly within the 1.3-Mb region identified by recombination. Discovery of this deletion supports localization of HTX1 to Xq26.2 and reveals the first molecular-genetic abnormality associated with human left-right-asymmetry defects.	BAYLOR COLL MED, DEPT PATHOL, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT MOL & HUMAN GENET, HOUSTON, TX 77030 USA; UNIV WASHINGTON, DEPT MOL MICROBIOL, ST LOUIS, MO USA; CHILDRENS HOSP & MED CTR, CINCINNATI, OH USA	Baylor College of Medicine; Baylor College of Medicine; Washington University (WUSTL); Cincinnati Children's Hospital Medical Center			Ferrero, Giovanni Battista/K-5265-2018; BALLABIO, Andrea/AAL-2672-2020	Ferrero, Giovanni Battista/0000-0002-3793-5788; BALLABIO, Andrea/0000-0003-1381-4604; Hopkin, Robert/0000-0003-0770-5516	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD001078] Funding Source: NIH RePORTER; NICHD NIH HHS [5K08HD01078, P30 HD24064] Funding Source: Medline; Telethon [TGM06S01, TGM97000] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Telethon(Fondazione Telethon)		ADAMS MD, 1992, NATURE, V355, P632, DOI 10.1038/355632a0; AFZELIUS BA, 1994, METABOLIC MOL BASES, P3943; ALONSO S, 1995, AM J MED GENET, V56, P12, DOI 10.1002/ajmg.1320560105; ANG SL, 1994, CELL, V78, P561, DOI 10.1016/0092-8674(94)90522-3; AYLSWORTH AS, 1993, HUMAN MALFORMATIONS, P307; BRITZCUNNINGHAM SH, 1995, NEW ENGL J MED, V332, P1323, DOI 10.1056/NEJM199505183322002; BURN J, 1991, CIBA F SYMP, V162, P282; Casey B, 1996, AM J MED GENET, V61, P325, DOI 10.1002/(SICI)1096-8628(19960202)61:4<325::AID-AJMG5>3.0.CO;2-T; CASEY B, 1993, NAT GENET, V5, P403, DOI 10.1038/ng1293-403; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; EKKER SC, 1995, DEVELOPMENT, V121, P2337; FEIJEN A, 1994, DEVELOPMENT, V120, P3621; Freeman SB, 1996, AM J MED GENET, V61, P340; Gebbia M, 1996, CIRCULATION, V94, P1909, DOI 10.1161/01.CIR.94.8.1909; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HEMMATIBRIVANLOU A, 1992, DEV DYNAM, V194, P1, DOI 10.1002/aja.1001940102; Kondo M, 1996, BIOCHEM BIOPH RES CO, V218, P549, DOI 10.1006/bbrc.1996.0098; LEVIN M, 1995, CELL, V82, P803, DOI 10.1016/0092-8674(95)90477-8; Lowe LA, 1996, NATURE, V381, P158, DOI 10.1038/381158a0; Maniatis T, 1989, MOL CLONING; MATHIAS RS, 1987, AM J MED GENET, V28, P111, DOI 10.1002/ajmg.1320280116; MATZUK MM, 1995, NATURE, V374, P356, DOI 10.1038/374356a0; Meno C, 1996, NATURE, V381, P151, DOI 10.1038/381151a0; MIKKILA SP, 1994, AM J MED GENET, V49, P435, DOI 10.1002/ajmg.1320490417; NELSON DL, 1995, CYTOGENET CELL GENET, V71, P308; Pilia G, 1996, GENOMICS, V34, P55, DOI 10.1006/geno.1996.0240; SHAFFER LG, 1994, AM J HUM GENET, V55, P968; Splitt MP, 1997, HEART, V77, P369, DOI 10.1136/hrt.77.4.369; WAPENAAR MC, 1994, HUM MOL GENET, V3, P1155, DOI 10.1093/hmg/3.7.1155; WEINSTEIN DC, 1994, CELL, V78, P575, DOI 10.1016/0092-8674(94)90523-1; WINERMURAM HT, 1989, RADIOL CLIN N AM, V27, P1147; ZHOU XL, 1993, NATURE, V361, P543, DOI 10.1038/361543a0	33	58	62	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1997	61	2					395	401		10.1086/514857	http://dx.doi.org/10.1086/514857			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XX701	9311745	Green Published, Bronze			2022-12-18	WOS:A1997XX70100018
J	Gottlieb, S; Emanuel, BS; Driscoll, DA; Sellinger, B; Wang, ZL; Roe, B; Budarf, ML				Gottlieb, S; Emanuel, BS; Driscoll, DA; Sellinger, B; Wang, ZL; Roe, B; Budarf, ML			The DiGeorge syndrome minimal critical region contains a Goosecoid-like (GSCL) homeobox gene that is expressed early in human development	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOSOMAL SEX REVERSAL; SRY-RELATED GENE; CAMPOMELIC DYSPLASIA; MICE DEFICIENT; NEURAL CREST; SEARCH TOOL; MOUSE; 22Q11; MUTATIONS; EMBRYOS	The majority of patients with DiGeorge syndrome (DGS) and velocardiofacial syndrome (VCFS) have deletions of chromosomal region 22q11.2. The abnormalities observed in these patients include conotruncal cardiac defects, thymic hypoplasia or aplasia, hypocalcemia, and characteristic facial features. To understand the genetic basis of these disorders, are have characterized genes within the region that is most consistently deleted in patients with DGS/VCFS, the minimal DiGeorge critical region (MDGCR). In this report, present the identification and characterization of a novel GSCL, in the MDGCR, with homology to the homeodomain family of transcription factors. Further, we provide evidence that this gene is expressed in a limited number of adult tissues as well as in early human development. The identification of GSCL required a genomic sequence-based approach because of its restricted expression and high GC content. The early expression, together with the known role of homeobox-containing proteins in development, make GSCL an outstanding candidate for some of the abnormalities seen in DGS/VCFS.	CHILDRENS HOSP PHILADELPHIA, DIV HUMAN GENET & MOL BIOL, PHILADELPHIA, PA 19104 USA; UNIV PENN, SCH MED, DEPT OBSTET & GYNECOL, PHILADELPHIA, PA 19104 USA; UNIV PENN, SCH MED, DEPT PEDIAT, PHILADELPHIA, PA 19104 USA; UNIV OKLAHOMA, DEPT CHEM, NORMAN, OK 73019 USA; UNIV OKLAHOMA, DEPT BIOCHEM, NORMAN, OK 73019 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman					NATIONAL CANCER INSTITUTE [R01CA039926] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG000425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P01DC002027] Funding Source: NIH RePORTER; NCI NIH HHS [CA39926] Funding Source: Medline; NHGRI NIH HHS [HG00425] Funding Source: Medline; NIDCD NIH HHS [DC02027] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AUGUSSEAU S, 1986, HUM GENET, V74, P206, DOI 10.1007/BF00282098; Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; BLUM M, 1994, GENOMICS, V21, P388, DOI 10.1006/geno.1994.1281; BLUM M, 1992, CELL, V69, P1097, DOI 10.1016/0092-8674(92)90632-M; BLUMBERG B, 1991, SCIENCE, V253, P194, DOI 10.1126/science.1677215; Bodenteich A, 1993, AUTOMATED DNA SEQUEN, P42; Brunelli S, 1996, NAT GENET, V12, P94, DOI 10.1038/ng0196-94; BUDARF ML, 1995, NAT GENET, V10, P269, DOI 10.1038/ng0795-269; Budarf ML, 1996, GENOMICS, V35, P275, DOI 10.1006/geno.1996.0358; Burglin T.R, 1994, EVOLUTION HOMEOBOX G, P27; CAREY AH, 1992, AM J HUM GENET, V51, P964; CHISAKA O, 1991, NATURE, V350, P473, DOI 10.1038/350473a0; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DRISCOLL DA, 1993, J MED GENET, V30, P813, DOI 10.1136/jmg.30.10.813; Driscoll Deborah A., 1994, Current Opinion in Pediatrics, V6, P702, DOI 10.1097/00008480-199412000-00016; DUTTON CM, 1993, NUCLEIC ACIDS RES, V21, P2953, DOI 10.1093/nar/21.12.2953; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; GAUNT SJ, 1993, DEVELOPMENT, V117, P769; Goldmuntz E, 1996, GENOMICS, V33, P271, DOI 10.1006/geno.1996.0191; Gong WK, 1996, HUM MOL GENET, V5, P789, DOI 10.1093/hmg/5.6.789; Gong WL, 1997, HUM MOL GENET, V6, P267, DOI 10.1093/hmg/6.2.267; Goriely A, 1996, DEVELOPMENT, V122, P1641; HANES SD, 1989, CELL, V57, P1275, DOI 10.1016/0092-8674(89)90063-9; HECHT NB, 1995, DEV GENET, V16, P95, DOI 10.1002/dvg.1020160202; Holmes SE, 1997, HUM MOL GENET, V6, P357, DOI 10.1093/hmg/6.3.357; JAQUEZ M, IN PRESS AM J MED GE; KIRBY ML, 1984, ANAT RECORD, V209, P1, DOI 10.1002/ar.1092090102; KIRBY ML, 1983, SCIENCE, V220, P1059, DOI 10.1126/science.6844926; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Kurahashi H, 1996, AM J HUM GENET, V58, P1377; KURIHARA Y, 1994, NATURE, V368, P703, DOI 10.1038/368703a0; KURIHARA Y, 1995, J CLIN INVEST, V96, P293, DOI 10.1172/JCI118033; LAMMER EJ, 1986, AM J MED GENET, V29, P113; LEVY A, 1995, HUM MOL GENET, V4, P2417, DOI 10.1093/hmg/4.12.2417; NOLL M, 1993, CURR OPIN GENET DEV, V3, P595, DOI 10.1016/0959-437X(93)90095-7; RIVERAPEREZ JA, 1995, DEVELOPMENT, V121, P3005; Rizzu P, 1996, MAMM GENOME, V7, P639, DOI 10.1007/s003359900197; RUBIN MR, 1986, SCIENCE, V233, P663, DOI 10.1126/science.3726554; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; SHACKLEFORD GM, 1987, CELL, V50, P89, DOI 10.1016/0092-8674(87)90665-9; Smith ST, 1996, DEVELOPMENT, V122, P3141; TREISMAN J, 1989, CELL, V59, P553; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; WOODFORD K, 1995, NUCLEIC ACIDS RES, V23, P539, DOI 10.1093/nar/23.3.539; WORLEY KC, 1995, GENOME RES, V5, P173, DOI 10.1101/gr.5.2.173; YAMADA G, 1995, DEVELOPMENT, V121, P2917; Zhang JA, 1996, NATURE, V381, P238, DOI 10.1038/381238a0	49	58	66	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1997	60	5					1194	1201						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX760	9150167				2022-12-18	WOS:A1997WX76000020
J	Ramus, SJ; KoteJarai, Z; Friedman, LS; VanderLooij, M; Gayther, SA; Csokay, B; Ponder, BA; Olah, E				Ramus, SJ; KoteJarai, Z; Friedman, LS; VanderLooij, M; Gayther, SA; Csokay, B; Ponder, BA; Olah, E			Analysis of BRCA1 and BRCA2 mutations in Hungarian families with breast or breast-ovarian cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							SUSCEPTIBILITY GENE		NATL INST ONCOL,DEPT BIOL MOL,H-1525 BUDAPEST 114,HUNGARY; ADDENBROOKES HOSP,CRC,HUMAN CANC GENET RES GRP,CAMBRIDGE,ENGLAND	National Institute of Oncology Hungary; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge			Ramus, Susan/AAG-8352-2019; Susan, Ramus/C-1607-2008	Ramus, Susan/0000-0003-0005-7798; 	NCI NIH HHS [R01 CA66190-02] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA066190] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Couch FJ, 1996, HUM MUTAT, V8, P8, DOI 10.1002/humu.1380080102; Couch FJ, 1996, NAT GENET, V13, P123, DOI 10.1038/ng0596-123; EASTON DF, 1993, AM J HUM GENET, V52, P678; Friedman LS, 1997, AM J HUM GENET, V60, P313; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; Gayther SA, 1997, AM J HUM GENET, V60, P1239; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; Gayther SA, 1996, AM J HUM GENET, V58, P451; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Neuhausen S, 1996, NAT GENET, V13, P126, DOI 10.1038/ng0596-126; Neuhausen SL, 1996, AM J HUM GENET, V58, P271; Ramus SJ, 1997, NAT GENET, V15, P14, DOI 10.1038/ng0197-14; STRUEWING JP, 1995, AM J HUM GENET, V57, P1; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Thorlacius S, 1996, NAT GENET, V13, P117, DOI 10.1038/ng0596-117; TONIN P, 1995, AM J HUM GENET, V57, P189; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	18	58	58	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1997	60	5					1242	1246						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX760	9150174				2022-12-18	WOS:A1997WX76000027
J	Shimkets, R; Gailani, MR; Siu, VM; YangFeng, T; Pressman, CL; Levanat, S; Goldstein, A; Dean, M; Bale, AE				Shimkets, R; Gailani, MR; Siu, VM; YangFeng, T; Pressman, CL; Levanat, S; Goldstein, A; Dean, M; Bale, AE			Molecular analysis of chromosome 9q deletions in two Gorlin syndrome patients	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CELL CARCINOMA SYNDROME; BASAL; GENE; RETINOBLASTOMA	Gorlin syndrome is an autosomal dominant disorder characterized by multiple basal cell carcinomas, medulloblastomas, ovarian fibromas, and a variety of developmental defects. All affected individuals share certain key features, but there is significant phenotypic variability within and among kindreds with respect to malformations. The gene (NBCCS) maps to chromosome 9q22, and allelic loss at this location is common in tumors from Gorlin syndrome patients. Two recessive cancer-predisposition syndromes, xeroderma pigmentosum group A (XPAC) and Fanconi anemia group C (FACC), map to the NBCCS region; and unusual, dominant mutations in these genes have been proposed as the cause of Gorlin syndrome. This study presents cytogenetic and molecular characterization of germ-line deletions in one patient with a chromosome 9q22 deletion and in a second patient with a deletion of 9q22-q31. Both have typical features of Gorlin syndrome plus additional findings, including mental retardation, conductive hearing loss, and failure to thrive. That Gorlin syndrome can be caused by null mutations (deletions) rather than by activating mutations has several implications. First, in conjunction with previous analyses of allelic loss in tumors, this study provides evidence that associated neoplasms arise with homozygous inactivation of the gene. In addition, dominant mutations of the XPAC and FACC1 genes can be ruled out as the cause of Gorlin syndrome, since the two patients described have null mutations. Finally, phenotypic features that show variable expression must be influenced by genetic background, epigenetic effects, somatic mutations, or environmental factors, since these two patients with identical alterations (deletions) of the Gorlin syndrome gene have somewhat different manifestations of Gorlin syndrome.	YALE UNIV,SCH MED,DEPT GENET,NEW HAVEN,CT 06520; YALE UNIV,SCH MED,DEPT PEDIAT,NEW HAVEN,CT 06520; UNIV WESTERN ONTARIO,LONDON,ON,CANADA; NATL CANC INST,GENET EPIDEMIOL BRANCH,BETHESDA,MD; NATL CANC INST,FREDERICK CANC RES & DEV CTR,VIRAL CARCINOGENESIS LAB,FREDERICK,MD	Yale University; Yale University; Western University (University of Western Ontario); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick			Dean, Michael C/G-8172-2012; Dean, Michael/R-7501-2019	Dean, Michael C/0000-0003-2234-0631; 	NATIONAL CANCER INSTITUTE [R01CA057605, K11CA060199] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA57605, K11 CA 60199] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALBRECHT S, 1994, NEUROPATH APPL NEURO, V20, P74, DOI 10.1111/j.1365-2990.1994.tb00959.x; ANDERSON DE, 1967, AM J HUM GENET, V19, P12; BALE AE, 1994, J INVEST DERMATOL, V103, pS126, DOI 10.1111/1523-1747.ep12399438; Bare John W., 1995, American Journal of Human Genetics, V57, pA60; BIALER MG, 1994, LANCET, V344, P477, DOI 10.1016/S0140-6736(94)91810-4; BONIFAS JM, 1994, HUM MOL GENET, V3, P447, DOI 10.1093/hmg/3.3.447; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; EVANS DGR, 1991, BRIT J CANCER, V64, P959, DOI 10.1038/bjc.1991.435; FARNDON PA, 1992, LANCET, V339, P581, DOI 10.1016/0140-6736(92)90868-4; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; GAILANI MR, 1992, CELL, V69, P111, DOI 10.1016/0092-8674(92)90122-S; GOLDSTEIN AM, 1994, AM J MED GENET, V50, P272, DOI 10.1002/ajmg.1320500311; GORLIN RJ, 1960, NEW ENGL J MED, V262, P908, DOI 10.1056/NEJM196005052621803; GORLIN RJ, 1995, DERMATOL CLIN, V13, P113, DOI 10.1016/S0733-8635(18)30114-1; HOWELL JB, 1959, ARCH DERMATOL, V79, P67, DOI 10.1001/archderm.1959.01560130069008; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Levanat S, 1996, NAT GENET, V12, P85, DOI 10.1038/ng0196-85; MALKIN D, 1990, SCIENCE, V250, P1223; PERICAKVANCE MA, 1995, ANN HUM GENET, V59, P347, DOI 10.1111/j.1469-1809.1995.tb00756.x; QUINN AG, 1994, J INVEST DERMATOL, V102, P300, DOI 10.1111/1523-1747.ep12371786; REIS A, 1992, LANCET, V339, P617, DOI 10.1016/0140-6736(92)90903-G; Sambrook J, 1989, MOL CLONING LAB MANU; SHANLEY SM, 1995, HUM MOL GENET, V4, P129; SPRINGATE JE, 1986, J PEDIATR SURG, V21, P908, DOI 10.1016/S0022-3468(86)80023-9; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0; STRONG LC, 1977, CANCER, V40, P1861, DOI 10.1002/1097-0142(197710)40:4+<1861::AID-CNCR2820400815>3.0.CO;2-9; TANAKA K, 1990, NATURE, V348, P73, DOI 10.1038/348073a0; ZHOU J, 1993, SCIENCE, V261, P1167, DOI 10.1126/science.8356449	28	58	59	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1996	59	2					417	422						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VM288	8755929				2022-12-18	WOS:A1996VM28800018
J	MoranJimenez, MJ; Ged, C; Romana, M; deSalamanca, RE; Taieb, A; Topi, G; DAlessandro, L; deVerneuil, H				MoranJimenez, MJ; Ged, C; Romana, M; deSalamanca, RE; Taieb, A; Topi, G; DAlessandro, L; deVerneuil, H			Uroporphyrinogen decarboxylase: Complete human gene sequence and molecular study of three families with hepatoerythropoietic porphyria	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CUTANEA-TARDA; MUTATION; IDENTIFICATION; DELETION; CLONING	A deficiency in uroporphyrinogen decarboxylase (UROD) enzyme activity, the fifth enzyme of the heme biosynthetic pathway, is found in patients with sporadic porphyria cutanea tarda (s-PCT), familial porphyria cutanea tarda (f-PCT), and hepatoerythropoietic porphyria (HEP). Subnormal UROD activity is due to mutations of the UROD gene in both f-PCT and HEP, but no mutations have been found in s-PCT. Genetic analysis has determined that f-PCT is transmitted as an autosomal dominant trait. In contrast, HEP, a severe form of cutaneous porphyria, is transmitted as an autosomal recessive trait. HEP is characterized by a profound deficiency of UROD activity, and the disease is usually manifest in childhood. In this study, a strategy was designed to identify alleles responsible for the HEP phenotype in three unrelated families. Mutations of UROD were identified by direct sequencing of four amplified fragments that contained the entire coding sequence of the UROD gene. Two new missense mutations were observed at the homoallelic state: P62L (proline-to-leucine substitution at codon 62) in a Portuguese family and Y311C (tyrosine-to-cysteine substitution at codon 311) in an Italian family. A third mutation, G281E, was observed in a Spanish family. This mutation has been previously described in three families from Spain and one from Tunisia, In the Spanish family described in this report, a paternal uncle of the proband developed clinically overt PCT as an adult and proved to be heterozygous for the G281E mutation. Mutant cDNAs corresponding to the P62L and Y311C changes detected in these families were created by site-directed mutagenesis. Recombinant proteins proved to have subnormal enzyme activity, and the Y311C mutant was thermolabile.	UNIV BORDEAUX 2, DEPT BIOCHIM MED & BIOL MOLEC, UPR ES PATHOL MOLEC & THERAPIE GENIQUE, F-33076 BORDEAUX, FRANCE; HOP HENRI MONDOR, INSERM U91, F-94010 CRETEIL, FRANCE; HOP PELLEGRIN, UNITE DERMATOL PEDIAT, F-33076 BORDEAUX, FRANCE; UNIV MADRID, HOSP 12 OCTUBRE, MADRID 3, SPAIN; IST OSPITALIERO DERMOSIFILOPAT S MARIA & S GALLIC, CTR STUDI PORFIRIE, ROME, ITALY	UDICE-French Research Universities; Universite de Bordeaux; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Bordeaux; Hospital Universitario 12 de Octubre			Romana, Marc/K-6442-2017; TAIEB, ALAIN/AAB-1085-2021	Romana, Marc/0000-0002-8715-9836; Moran, Maria Jose/0000-0003-3755-5934				Ausubel FM, 1991, CURRENT PROTOCOLS MO, V1; CHANG CS, 1985, BLOOD, V65, P939; CHELSTOWSKA A, 1992, BIOCHEM J, V288, P753, DOI 10.1042/bj2880753; CRUCESPRADO MJ, 1980, 2 CASES INFANTILE FA, V161, P205; De Verneuil H, 1986, SCIENCE, V324, P232; DEVERNEUIL H, 1992, HUM GENET, V89, P548; DEVERNEUIL H, 1988, HUM GENET, V78, P101, DOI 10.1007/BF00291248; DEVERNEUIL H, 1984, AM J HUM GENET, V36, P613; DEVERNEUIL H, 1995, J BIOENERG BIOMEMBR, V27, P239, DOI 10.1007/BF02110039; DEVERNEUIL H, 1993, INT CONGR SER, V1029, P289; FUJITA H, 1987, J CLIN INVEST, V79, P1533, DOI 10.1172/JCI112985; GAREY JR, 1993, GASTROENTEROLOGY, V105, P165, DOI 10.1016/0016-5085(93)90022-5; GAREY JR, 1992, EUR J BIOCHEM, V205, P1011, DOI 10.1111/j.1432-1033.1992.tb16868.x; GAREY JR, 1989, BLOOD, V73, P892; GAREY JR, 1990, J CLIN INVEST, V86, P1416, DOI 10.1172/JCI114856; Kappas A, 1995, METABOLIC MOL BASES, P2103; KOSZO F, 1990, BRIT J DERMATOL, V122, P365, DOI 10.1111/j.1365-2133.1990.tb08285.x; MEGURO K, 1994, J INVEST DERMATOL, V102, P681, DOI 10.1111/1523-1747.ep12374134; NISHIMURA K, 1993, GENE, V133, P109; ROBERTS AG, 1995, J INVEST DERMATOL, V104, P500, DOI 10.1111/1523-1747.ep12605953; ROMANA M, 1991, EUR J CLIN INVEST, V21, P225, DOI 10.1111/j.1365-2362.1991.tb01814.x; ROMANA M, 1987, NUCLEIC ACIDS RES, V15, P7343, DOI 10.1093/nar/15.18.7343; ROMEO PH, 1986, J BIOL CHEM, V261, P9825; TOBACK AC, 1987, NEW ENGL J MED, V316, P645, DOI 10.1056/NEJM198703123161101	24	58	60	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1996	58	4					712	721						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UA380	8644733				2022-12-18	WOS:A1996UA38000007
J	Pellestor, F; Girardet, A; Coignet, L; Andreo, B; Charlieu, JP				Pellestor, F; Girardet, A; Coignet, L; Andreo, B; Charlieu, JP			Assessment of aneuploidy for chromosomes 8, 9, 13, 16, and 21 in human sperm by using primed in situ labeling technique	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FLUORESCENCE INSITU HYBRIDIZATION; ALPHA-SATELLITE DNA; PROBES; FREQUENCY; SEQUENCE	The incidence of aneuploidy was estimated for chromosomes 8, 9, 13, 16, and 21 in mature human spermatozoa by primed in situ (PRINS) labeling technique. This method allows us to perform a chromosome-specific detection by in situ annealing of a centromeric specific primer. A dual color PRINS protocol was adapted to human sperm. The decondensation and the denaturation of sperm nuclei were simultaneously performed by 3-M NaOH treatment. Double labeling of spermatozoa was obtained in <2 h. A total of 96,292 sperm nuclei were analyzed by two independent observers. The estimates of disomy were 0.31% for chromosome 8, 0.28% for chromosome 9, 0.28% for chromosome 13, 0.26% for chromosome 16, and 0.32% for chromosome 21. These homogeneous findings suggest an equal distribution of aneuploidies among all autosomal chromosomes in males.	WESTERN GEN HOSP,MRC,HUMAN GENET UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND	University of Edinburgh	Pellestor, F (corresponding author), CNRS UPR 9008,CRBM,ROUTE MENDE,BP 5051,F-34033 MONTPELLIER,FRANCE.							BISCHOFF FZ, 1994, CYTOGENET CELL GENET, V66, P237, DOI 10.1159/000133702; BOTTEMA CDK, 1993, MUTAT RES, V288, P93, DOI 10.1016/0027-5107(93)90211-W; CHOO KH, 1991, NUCLEIC ACIDS RES, V19, P1179, DOI 10.1093/nar/19.6.1179; CREMER T, 1988, HUM GENET, V80, P235, DOI 10.1007/BF01790091; GOSDEN J, 1994, HUM MOL GENET, V3, P931, DOI 10.1093/hmg/3.6.931; GUTTENBACH M, 1994, HUM GENET, V93, P7; GUTTENBACH M, 1991, HUM GENET, V87, P261; HAN TL, 1993, MOL REPROD DEV, V34, P308, DOI 10.1002/mrd.1080340311; KOCH J, 1992, CYTOGENET CELL GENET, V60, P1, DOI 10.1159/000133281; KOCH J, 1991, GENET ANAL-BIOMOL E, V8, P171, DOI 10.1016/1050-3862(91)90058-Y; KOCH JE, 1989, CHROMOSOMA, V98, P259, DOI 10.1007/BF00327311; LEBO RV, 1992, AM J MED GENET, V43, P848, DOI 10.1002/ajmg.1320430519; Martin R. H., 1994, American Journal of Human Genetics, V55, pA110; MARTIN RH, 1990, CYTOGENET CELL GENET, V53, P103, DOI 10.1159/000132905; MARTIN RH, 1993, CYTOGENET CELL GENET, V64, P23, DOI 10.1159/000133552; MARTINI E, 1995, HUM REPROD, V10, P855, DOI 10.1093/oxfordjournals.humrep.a136050; MUKHERJEE AB, 1992, CYTOGENET CELL GENET, V61, P91, DOI 10.1159/000133378; NEDERLOF PM, 1989, CYTOMETRY, V10, P20, DOI 10.1002/cyto.990100105; PELLESTOR F, 1994, HUM GENET, V94, P346; PELLESTOR F, 1991, HUM REPROD, V6, P1252, DOI 10.1093/oxfordjournals.humrep.a137522; PELLESTOR F, 1995, MOL REPROD DEV, V40, P333, DOI 10.1002/mrd.1080400309; PELLESTOR F, 1995, HUM GENET, V95, P12; ROBBINS WA, 1993, AM J HUM GENET, V52, P799; Therman E., 1986, HUMAN CHROMOSOMES ST; WILLIAMS BJ, 1993, HUM MOL GENET, V2, P1929, DOI 10.1093/hmg/2.11.1929; WYROBEK AJ, 1993, AM J HUM GENET, V53, P130	26	58	64	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1996	58	4					797	802						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UA380	8644744				2022-12-18	WOS:A1996UA38000018
J	CLARKE, RA; SINGH, S; MCKENZIE, H; KEARSLEY, JH; YIP, MY				CLARKE, RA; SINGH, S; MCKENZIE, H; KEARSLEY, JH; YIP, MY			FAMILIAL KLIPPEL-FEIL SYNDROME AND PARACENTRIC INVERSION INV(8)(Q22.2Q23.3)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HOX CODE; PATTERNS; HEAD	Klippel-Feil Syndrome (KFS) is characterized by congenital vertebral fusion believed to result from faulty segmentation along the embryo's developing axis. KFS appears to be a heterogeneous disease often associated with craniofacial malformation. Here we provide the first evidence of a familial KFS gene locus on 8q, where an inv(8)(q22.2q23.3) has been found segregating with congenital vertebral fusion. The four-generation KF2-01 family present with a dominant form of the KFS where the sequence of vertebral fusion was confined to the cervical spine (always including the C2-3 fusion and reduced expression of the C4-5 and C6-7 fusions) in association with malformation of laryngeal cartilages and mild-to-severe vocal impairment.	ROYAL PRINCE ALFRED HOSP,KANEMATSU LABS,CYTOGENET UNIT,CANC GENET RES GRP,SYDNEY,NSW,AUSTRALIA; PRINCE WALES HOSP,CYTOGENET UNIT,SYDNEY,NSW,AUSTRALIA	University of Sydney	CLARKE, RA (corresponding author), ST GEORGE HOSP,CTR CANC CARE,DIV CANC SERV,KOGARAH 2217,SYDNEY,NSW,AUSTRALIA.			Clarke, Raymond/0000-0002-7196-9623				ANG SL, 1993, DEVELOPMENT, V118, P139; BROWN MW, 1964, AMER J ROENTGENOL RA, V92, P1255; CLARKE RA, 1994, ANN OTO RHINOL LARYN, V103, P201, DOI 10.1177/000348949410300306; CONNOR JM, 1982, BRIT J RADIOL, V55, P492, DOI 10.1259/0007-1285-55-655-492; CORDES SP, 1994, CELL, V79, P1025, DOI 10.1016/0092-8674(94)90033-7; COULY GF, 1993, DEVELOPMENT, V117, P409; DEUTSCH U, 1988, CELL, V53, P617, DOI 10.1016/0092-8674(88)90577-6; FEIL A, 1919, THESIS SORBONNE U PA; Gorlin RJ, 1990, PLAST RECONSTR SURG; GUNDERSON CH, 1967, MEDICINE, V46, P491, DOI 10.1097/00005792-196711000-00003; HUNT P, 1991, CELL, V66, P1075, DOI 10.1016/0092-8674(91)90029-X; HUNT P, 1991, NATURE, V353, P861, DOI 10.1038/353861a0; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; Klippel M, 1912, B MEM SOC ANAT, V87, P185; LAWRY LB, 1977, TERATOLOGY, V16, P53; LUDECKE HJ, 1995, HUM MOL GENET, V4, P31, DOI 10.1093/hmg/4.1.31; MARTEL W, 1962, AMER J ROENTGENOL RA, V88, P400; MCBRIDE WZ, 1992, AM FAM PHYSICIAN, V45, P633; MCGINNIS W, 1992, CELL, V69, P283; MEINHARDT H, 1986, NATO ASI SER, V118, P161; MORGAN MK, 1989, J NEUROSURG, V70, P636, DOI 10.3171/jns.1989.70.4.0636; NGUYEN VD, 1993, SKELETAL RADIOL, V22, P519; Ohashi H., 1992, American Journal of Human Genetics, V51, pA294; PFEIFFER RA, 1992, GENET COUNSEL, V38, P133; RATANASIRI T, 1991, J JPN ORTHOP ASSOC, pS468; SHAVER K A, 1986, American Journal of Human Genetics, V39, pA81; SHEFFIELD LJ, 1982, 6TH ANN GEN M HUM GE; STERN CD, 1988, TRENDS NEUROSCI, V11, P190, DOI 10.1016/0166-2236(88)90120-8; STERN CD, 1988, DEVELOPMENT, V103, P413; TOMMERUP N, 1993, J MED GENET, V30, P713, DOI 10.1136/jmg.30.9.713; TUCKER JA, 1975, ANN OTO RHINOL LARYN, V84, P49, DOI 10.1177/000348947508400108; WOOD S, 1993, CYTOGENET CELL GENET, V64, P133	32	58	60	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1995	57	6					1364	1370						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TE655	8533765				2022-12-18	WOS:A1995TE65500013
J	HOGLUND, P; SISTONEN, P; NORIO, R; HOLMBERG, C; DIMBERG, A; GUSTAVSON, KH; DELACHAPELLE, A; KERE, J				HOGLUND, P; SISTONEN, P; NORIO, R; HOLMBERG, C; DIMBERG, A; GUSTAVSON, KH; DELACHAPELLE, A; KERE, J			FINE MAPPING OF THE CONGENITAL CHLORIDE DIARRHEA GENE BY LINKAGE DISEQUILIBRIUM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FINLAND; POPULATIONS; CHILDREN	Congenital chloride diarrhea is a recessively inherited intestinal disorder affecting electrolyte transportation. The clinical presentation is a life-threatening watery diarrhea with a high chloride content. Recently, the congenital chloride diarrhea gene (CLD) was assigned to chromosome 7 by linkage in eight Finnish families. In the present study, refined mapping of CLD was performed by studying linkage and linkage disequilibrium in 24 Finnish and 4 Swedish families. Recombination mapping assigned CLD to an similar to 10-cM region flanked by D7S515 and D7S799. Linkage disequilibrium was detected over this large genetic region, with the strongest allelic association at D7S496. Application of the Luria and Delbruck-derived analysis allowed for a further narrowing of the CLD region to similar to 0.37 cM from the marker D7S496. Haplotype analysis placed CLD unequivocally between D7S501 and D7S692, very close to D7S496 and most likely on the distal side of D7S496. This combined analytical approach allowed highly accurate mapping of CLD, each component adding complementary and consistent mapping information.	UNIV HELSINKI,CHILDRENS HOSP,HELSINKI,FINLAND; FINNISH RED CROSS & BLOOD TRANSFUS SERV,CTR BLOOD TRANSFUS,HELSINKI,FINLAND; FAMILY FEDERAT FINLAND,HELSINKI,FINLAND; GALLIVARE HOSP,GALLIVARE,SWEDEN; UNIV UPPSALA,DEPT CLIN GENET,UPPSALA,SWEDEN	University of Helsinki; Family Federation of Finland; Uppsala University	HOGLUND, P (corresponding author), UNIV HELSINKI,DEPT MED GENET,POB 21 HAARTMANINKATU 3,SF-00014 HELSINKI,FINLAND.		Kere, Juha/AAX-9117-2021; Kere, Juha/A-9179-2008	Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271				ALLTONEN J, 1994, NAT GENET, V8, P83; DARROW DC, 1945, J PEDIATR-US, V26, P519, DOI 10.1016/S0022-3476(45)80079-3; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; GAMBLE JL, 1945, J PEDIATR-US, V26, P509, DOI 10.1016/S0022-3476(45)80078-1; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HELLSTEN E, 1993, GENOMICS, V16, P720, DOI 10.1006/geno.1993.1253; HOLMBERG C, 1975, J CLIN INVEST, V56, P302, DOI 10.1172/JCI108094; HOLMBERG C, 1977, ARCH DIS CHILD, V52, P255, DOI 10.1136/adc.52.4.255; JORDE LB, 1994, AM J HUM GENET, V54, P884; JORDE LB, 1995, AM J HUM GENET, V56, P11; KERE J, 1993, P NATL ACAD SCI USA, V90, P10686, DOI 10.1073/pnas.90.22.10686; KESTILA M, 1994, AM J HUM GENET, V54, P757; KHAN SN, 1992, J PERINATOL, V2, P112; LANGER JC, 1991, J PEDIATR SURG, V11, P1282; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; LUBANI MM, 1989, EUR J PEDIATR, V148, P333, DOI 10.1007/BF00444128; Luria SE, 1943, GENETICS, V28, P491; Mckusick V.A., 1994, MENDELIAN INHERITANC; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; NORIO R, 1971, Clinical Genetics, V2, P182; NORIO R, 1973, ANN CLIN RES, V5, P109; PEARSON AJG, 1973, Q J MED, V167, P453; RAMSAY M, 1993, HUM MOL GENET, V7, P1007; SHALTOUT AA, 1989, ANN TROP PAEDIATR, V9, P30, DOI 10.1080/02724936.1989.11748591; SILISALO T, 1994, AM J HUM GENET, V55, P937; TOMASZEWSKI L, 1987, MAT MED POL, V4, P271; TURNBERG LA, 1971, GUT, V12, P544, DOI 10.1136/gut.12.7.544; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	32	58	58	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1995	57	1					95	102						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RE629	7611301				2022-12-18	WOS:A1995RE62900012
J	SNAREY, A; THOMAS, S; SCHNEIDER, MC; POUND, SE; BARTON, N; WRIGHT, AF; SOMLO, S; GERMINO, GG; HARRIS, PC; REEDERS, ST; FRISCHAUF, AM				SNAREY, A; THOMAS, S; SCHNEIDER, MC; POUND, SE; BARTON, N; WRIGHT, AF; SOMLO, S; GERMINO, GG; HARRIS, PC; REEDERS, ST; FRISCHAUF, AM			LINKAGE DISEQUILIBRIUM IN THE REGION OF THE AUTOSOMAL-DOMINANT POLYCYSTIC KIDNEY-DISEASE GENE (PKD1)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUNTINGTONS-DISEASE; CHROMOSOME-16; ONSET; LOCUS; IDENTIFICATION; LOCALIZATION; FAMILIES; MARKERS; ALLELES	The gene for autosomal dominant polycystic kidney disease (PKD1) is located on chromosome 16p, between the flanking markers D16S84 and D16S125 (26.6prox). This region is 750 kb long and has been cloned. We have looked at the association of 10 polymorphic markers from the region, with the disease and with each other. This was done in a set of Scottish families that had previously shown association with D16S94, a marker proximal to the PKD1 region. We report significant association between two CA repeat markers and the disease but have not found evidence for a single founder haplotype in these families, indicating the presence of several mutations in this population. Our results favor a location of the PKD1 gene in the proximal part of the candidate region.	IMPERIAL CANC RES FUND, LONDON WC2A 3PX, ENGLAND; JOHN RADCLIFFE HOSP, INST MOLEC MED, OXFORD, ENGLAND; BRIGHAM & WOMENS HOSP, DIV RENAL, BOSTON, MA 02115 USA; WESTERN GEN HOSP, MRC, HUMAN GENET UNIT, EDINBURGH, MIDLOTHIAN, SCOTLAND; HOWARD HUGHES MED INST, NEW HAVEN, CT 06510 USA; YALE UNIV, SCH MED, NEW HAVEN, CT USA	Cancer Research UK; University of Oxford; Harvard University; Brigham & Women's Hospital; University of Edinburgh; Howard Hughes Medical Institute; Yale University				Germino, Gregory/0000-0002-3609-5588	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040703, K11DK002216] Funding Source: NIH RePORTER; NIDDK NIH HHS [NIDDK 1 K11 DK02216-01, DK 40703] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission)		BEAR JC, 1984, AM J MED GENET, V18, P45, DOI 10.1002/ajmg.1320180108; BREUNING MH, 1990, NUCLEIC ACIDS RES, V18, P3106, DOI 10.1093/nar/18.10.3106-a; DALGAARD O Z, 1957, Acta Med Scand Suppl, V328, P1; DAVIES F, 1991, Q J MED, V79, P477; GERMINO GG, 1992, GENOMICS, V13, P144, DOI 10.1016/0888-7543(92)90214-D; GERMINO GG, 1990, AM J HUM GENET, V46, P925; HARRIS PC, 1991, LANCET, V338, P1484, DOI 10.1016/0140-6736(91)92300-Q; HIGASHIHARA E, 1992, J UROLOGY, V147, P329, DOI 10.1016/S0022-5347(17)37228-2; HYLAND VJ, 1990, HUM GENET, V84, P286; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; LIU G, 1991, CHUNG KUO HSUEH KO H, V13, P56; MACDONALD ME, 1992, NAT GENET, V1, P99, DOI 10.1038/ng0592-99; PARFREY PS, 1990, NEW ENGL J MED, V323, P1085, DOI 10.1056/NEJM199010183231601; PERAL B, 1994, AM J HUM GENET, V54, P899; PETERS DJM, 1992, CONTRIB NEPHROL, V97, P128; POUND SE, 1992, J MED GENET, V29, P247, DOI 10.1136/jmg.29.4.247; REEDERS ST, 1985, NATURE, V317, P542, DOI 10.1038/317542a0; SNELL RG, 1989, J MED GENET, V26, P673, DOI 10.1136/jmg.26.11.673; SOMLO S, 1992, GENOMICS, V13, P152, DOI 10.1016/0888-7543(92)90215-E; THEILMANN J, 1989, J MED GENET, V26, P676, DOI 10.1136/jmg.26.11.676; THOMPSON AD, 1992, GENOMICS, V13, P402, DOI 10.1016/0888-7543(92)90260-Y; WEIR BS, 1978, GENETICS, V88, P633; WRIGHT AF, 1993, HUM GENET, V90, P569, DOI 10.1007/BF00217461; 1989, MINITAB RELEASE 7 2; 1992, STATA REFERENCE MANU	25	58	58	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1994	55	2					365	371						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NZ336	8037213				2022-12-18	WOS:A1994NZ33600019
J	GERSHONIBARUCH, R; ROSENMANN, A; DROETTO, S; HOLMES, S; TRIPATHI, RK; SPRITZ, RA				GERSHONIBARUCH, R; ROSENMANN, A; DROETTO, S; HOLMES, S; TRIPATHI, RK; SPRITZ, RA			MUTATIONS OF THE TYROSINASE GENE IN PATIENTS WITH OCULOCUTANEOUS ALBINISM FROM VARIOUS ETHNIC-GROUPS IN ISRAEL	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TYR GENE; DNA; POLYMORPHISM; SEQUENCES; LOCUS; RFLP; PCR	We have analyzed the tyrosinase (TYR) gene in 38 unrelated patients with oculocutaneous albinism (OCA), derived from several different ethnic groups of the diverse population of Israel. We detected TYR gene mutations in 23 of the 34 patients with apparent type I(i.e., tyrosinase-deficient) OCA and in none of the patients with other clinical forms of albinism. Among Moroccan Jews with type IA (i.e., tyrosinase-negative) OCA, we detected a highly predominant mutant allele containing a missense substitution, Gly47Asp (G47D). This mutation occurs on the same haplotype as in patients from the Canary Islands and Puerto Rico, suggesting that the G47D mutation in these ethnically distinct populations may stem from a common origin.	HADASSAH MED CTR,MICHAELSON INST PREVENT BLINDNESS,JERUSALEM,ISRAEL; UNIV WISCONSIN,DEPT MED GENET,GENET LAB,MADISON,WI; UNIV WISCONSIN,DEPT PEDIAT,MADISON,WI	Hebrew University of Jerusalem; Hadassah University Medical Center; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	GERSHONIBARUCH, R (corresponding author), TECHNION ISRAEL INST TECHNOL,RAMBAM MED CTR,DEPT PEDIAT & MED GENET,POB 9602,IL-31096 HAIFA,ISRAEL.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039892] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR 39892] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BARTON D E, 1988, Genomics, V3, P17, DOI 10.1016/0888-7543(88)90153-X; BEINART H, 1992, SEPHARDIC JEWS 1492, P21; GIEBEL LB, 1990, NUCLEIC ACIDS RES, V18, P3103, DOI 10.1093/nar/18.10.3103-a; GIEBEL LB, 1991, GENOMICS, V9, P435, DOI 10.1016/0888-7543(91)90409-8; GIEBEL LB, 1991, J MED GENET, V28, P464, DOI 10.1136/jmg.28.7.464; GILBERT M, 1969, ATLAS JEWISH HIST; KWON BS, 1987, P NATL ACAD SCI USA, V84, P7473, DOI 10.1073/pnas.84.21.7473; LEE ST, 1994, IN PRESS N ENGL J ME; LERNER AB, 1950, PHYSIOL REV, V30, P91, DOI 10.1152/physrev.1950.30.1.91; OETTING WS, 1991, NUCLEIC ACIDS RES, V19, P5800, DOI 10.1093/nar/19.20.5800-a; OETTING WS, 1993, AM J HUM GENET, V52, P17; OETTING WS, 1993, HUM MUTAT, V2, P1, DOI 10.1002/humu.1380020102; OETTING WS, 1991, J INVEST DERMATOL, V97, P15, DOI 10.1111/1523-1747.ep12477808; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHIBAHARA S, 1988, TOHOKU J EXP MED, V156, P403, DOI 10.1620/tjem.156.403; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPRITZ RA, 1990, NUCLEIC ACIDS RES, V18, P3672, DOI 10.1093/nar/18.12.3672-a; SPRITZ RA, 1992, AM J HUM GENET, V51, P1058; SPRITZ RA, 1981, P NATL ACAD SCI-BIOL, V78, P2455, DOI 10.1073/pnas.78.4.2455; SPRITZ RA, 1990, NEW ENGL J MED, V322, P1724, DOI 10.1056/NEJM199006143222407; SPRITZ RA, 1993, SEMIN DERMATOL, V12, P167; TRIPATHI RK, 1991, GENE EXPRESSION, V1, P103; TRIPATHI RK, 1992, J BIOL CHEM, V267, P23707; TRIPATHI RK, 1992, AM J MED GENET, V43, P865, DOI 10.1002/ajmg.1320430523; TRIPATHI RK, 1993, AM J HUM GENET, V53, P1173; WEATHERALL DJ, 1989, METABOLIC BASIS INHE, P2281; [No title captured]	28	58	59	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1994	54	4					586	594						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NC836	8128955				2022-12-18	WOS:A1994NC83600002
J	SHIPLEY, JM; KLINKENBERG, M; WU, BM; BACHINSKY, DR; GRUBB, JH; SLY, WS				SHIPLEY, JM; KLINKENBERG, M; WU, BM; BACHINSKY, DR; GRUBB, JH; SLY, WS			MUTATIONAL ANALYSIS OF A PATIENT WITH MUCOPOLYSACCHARIDOSIS TYPE-VII, AND IDENTIFICATION OF PSEUDOGENES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BETA-GLUCURONIDASE DEFICIENCY; MESSENGER-RNA; NONSENSE MUTATIONS; DNA TRANSFECTION; GENE; EXPRESSION; CELLS; PURIFICATION; METABOLISM; VECTORS	PCR of cDNA produced from patient fibroblasts allowed us to determine the paternal mutation in the first patient reported with beta-glucuronidase-deficiency mucopolysaccharidosis type VII (MPS VII). The G-->T transversion 1,881 bp downstream of the ATG translation initiation codon destroys an MboII restriction site and converts Trp627 to Cys (W627C). Digestion of genomic DNA PCR fragments with MboII indicated that the patient and the father were heterozygous for this missense mutation in exon 12. Failure to find cDNAs from patient RNA which did not contain this mutation suggested that the maternal mutation leads to greatly reduced synthesis or reduced stability of mRNA from the mutant allele. In order to identify the maternal mutation, it was necessary to analyze genomic sequences. This approach was complicated by the finding of multiple unprocessed pseudogenes and/or closely related genes. Using PCR with a panel of human/rodent hybrid cell lines, we found that these pseudogenes were present over chromosomes 5-7, 20, and 22 and the Y chromosome. Conditions were defined which allowed us to amplify and characterize genomic sequences for the true beta-glucuronidase gene despite this background of related sequences. The patient proved to be heterozygous for a second mutation, in which a C-->T transition introduces a termination codon (R356STOP) in exon 7. The mother was also heterozygous for this mutation. Expression of a cDNA containing the maternal mutation produced no enzyme activity, as expected. Expression of the paternal mutation in COS-7 cells produced a surprisingly high (65% of control) level of activity. However, activity was 13% of control in transiently transfected murine MPS VII cells. The level of activity of this mutant allele appears to correlate with the level of overexpression, suggesting that high concentrations of mutant monomers can drive the folding and tetramerization of mutant enzyme to produce an active and stable enzyme.	ST LOUIS UNIV,SCH MED,EDWARD A DOISY DEPT BIOCHEM & MOLEC BIOL,1402 S GRAND BLVD,ST LOUIS,MO 63104	Saint Louis University					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034182, R37GM034182] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK40163] Funding Source: Medline; NIGMS NIH HHS [GM34182] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARTELT P, 1988, GENE, V68, P213, DOI 10.1016/0378-1119(88)90023-6; ATWEH GF, 1988, J CLIN INVEST, V82, P557, DOI 10.1172/JCI113632; BACHINSKY DR, 1991, THESIS ST LOUIS U SC; BARKER GF, 1991, MOL CELL BIOL, V11, P2760, DOI 10.1128/MCB.11.5.2760; BASERGA SJ, 1988, P NATL ACAD SCI USA, V85, P2056, DOI 10.1073/pnas.85.7.2056; BAUMANN B, 1985, EMBO J, V4, P351, DOI 10.1002/j.1460-2075.1985.tb03636.x; BROT FE, 1978, BIOCHEMISTRY-US, V17, P385, DOI 10.1021/bi00596a001; CHENG J, 1990, Molecular and Cellular Biology, V10, P5215; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DAAR IO, 1988, MOL CELL BIOL, V8, P802, DOI 10.1128/MCB.8.2.802; FOJO SS, 1988, J BIOL CHEM, V263, P17913; GENOVESE C, 1991, SOMAT CELL MOLEC GEN, V17, P69, DOI 10.1007/BF01233206; GLASER JH, 1973, J LAB CLIN MED, V82, P969; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; HALL CW, 1973, ARCH BIOCHEM BIOPHYS, V155, P32, DOI 10.1016/S0003-9861(73)80006-2; JACOBSON A, 1987, METHOD ENZYMOL, V152, P254; KADOWAKI T, 1990, P NATL ACAD SCI USA, V87, P658, DOI 10.1073/pnas.87.2.658; LEE JES, 1985, AM J DIS CHILD, V139, P57, DOI 10.1001/archpedi.1985.02140030059029; LIM SK, 1989, EMBO J, V8, P2613, DOI 10.1002/j.1460-2075.1989.tb08401.x; LOPATA MA, 1984, NUCLEIC ACIDS RES, V12, P5707, DOI 10.1093/nar/12.14.5707; LUTHMAN H, 1983, NUCLEIC ACIDS RES, V11, P1295, DOI 10.1093/nar/11.5.1295; MAHURAN DJ, 1991, 8TH P INT C HUM GEN; MASHIMA Y, 1992, AM J HUM GENET, V51, P81; MCCONLOGUE L, 1988, NUCLEIC ACIDS RES, V16, P9869, DOI 10.1093/nar/16.20.9869; MELLON P, 1981, CELL, V27, P279, DOI 10.1016/0092-8674(81)90411-6; MESSING J, 1983, METHOD ENZYMOL, V101, P20; NAKAMAYE KL, 1986, NUCLEIC ACIDS RES, V14, P9679, DOI 10.1093/nar/14.24.9679; NAKAMURA T, 1990, J BIOL CHEM, V265, P5390; OSHIMA A, 1987, P NATL ACAD SCI USA, V84, P685, DOI 10.1073/pnas.84.3.685; Sambrook J., 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHIPLEY JM, 1991, GENOMICS, V10, P1009, DOI 10.1016/0888-7543(91)90192-H; SLY WS, 1973, J PEDIATR-US, V82, P249, DOI 10.1016/S0022-3476(73)80162-3; SPRAGUE J, 1983, J VIROL, V45, P773, DOI 10.1128/JVI.45.2.773-781.1983; SUKEGAWA K, 1987, 4TH INT C INB ERR ME; TAKAGAKI K, 1988, J BIOL CHEM, V263, P7000; TOMATSU S, 1991, AM J HUM GENET, V48, P89; TOMATSU S, 1990, GENE, V89, P283, DOI 10.1016/0378-1119(90)90019-N; URLAUB G, 1989, MOL CELL BIOL, V9, P2868, DOI 10.1128/MCB.9.7.2868	39	58	59	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1993	52	3					517	526						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KR720	7680524				2022-12-18	WOS:A1993KR72000009
J	SPIRIO, L; NELSON, L; WARD, K; BURT, R; WHITE, R; LEPPERT, M				SPIRIO, L; NELSON, L; WARD, K; BURT, R; WHITE, R; LEPPERT, M			A CA-REPEAT POLYMORPHISM CLOSE TO THE ADENOMATOUS POLYPOSIS-COLI (APC) GENE OFFERS IMPROVED DIAGNOSTIC TESTING FOR FAMILIAL APC	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COLORECTAL-CANCER GENE; (LYNCH SYNDROME-I; IDENTIFICATION; CHROMOSOME-5Q21; LOCUS; LOCALIZATION; INHERITANCE; MUTATIONS; FAP	Presymptomatic genetic testing for the presence of a mutant allele causing familial adenomatous polyposis coli (APC) has been difficult to perform effectively in the past because DNA markers surrounding the APC gene on chromosome 5q have not been very informative. We report results of genetic linkage studies on both research families and clinical families by using D5S346, a highly polymorphic dinucleotide (CA)-repeat locus 30-70 kb from the APC gene. Linkage analysis with this marker in a large APC pedigree showed an increase of at least 9.0 LOD units, in likelihood of linkage of the disease-causing allele to the APC locus, when compared with the highest LOD score attained with any other closely linked marker. When the first 14 APC families that requested genotypic analysis by the DNA Diagnostic Laboratory at the University of Utah were tested with D5S346, 20 of the 31 at-risk individuals were identified as either carriers or noncarriers of an APC-predisposing allele. We see this marker as an important tool for research studies and for the presymptomatic diagnosis of APC.	UNIV UTAH,SCH MED,DEPT HUMAN GENET,SALT LAKE CITY,UT 84112; UNIV UTAH,SCH MED,DNA DIAGNOST LAB,SALT LAKE CITY,UT 84112; UNIV UTAH,SCH MED,DEPT OBSTET & GYNECOL,SALT LAKE CITY,UT 84112; UNIV UTAH,SCH MED,DIV GASTROENTEROL,SALT LAKE CITY,UT 84112; UNIV UTAH,SCH MED,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84112	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah					NHGRI NIH HHS [8 R01 HG00367] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000367] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BODMER WF, 1987, NATURE, V328, P614, DOI 10.1038/328614a0; BREUKEL C, 1991, NUCLEIC ACIDS RES, V19, P5804, DOI 10.1093/nar/19.20.5804; BURT RW, 1985, NEW ENGL J MED, V312, P1540, DOI 10.1056/NEJM198506133122403; BURT RW, 1988, GASTROENTEROL CLIN N, V17, P657; BURT RW, 1991, TXB GASTROENTEROLOGY, V2, P1674; CANNONALBRIGHT LA, 1988, NEW ENGL J MED, V319, P533, DOI 10.1056/NEJM198809013190902; FODDE R, 1992, GENOMICS, V13, P1162, DOI 10.1016/0888-7543(92)90032-N; GRODEN J, 1993, AM J HUM GENET, V52, P263; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; JOSLYN G, 1991, CELL, V66, P601, DOI 10.1016/0092-8674(81)90022-2; KINZLER KW, 1991, SCIENCE, V251, P1366, DOI 10.1126/science.1848370; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; KLINGER HP, 1990, CYTOGENET CELL GENET, V55, P505; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEPPERT M, 1987, SCIENCE, V238, P1411, DOI 10.1126/science.3479843; LEPPERT M, 1990, NEW ENGL J MED, V322, P904, DOI 10.1056/NEJM199003293221306; LYNCH HT, 1985, CANCER, V56, P934, DOI 10.1002/1097-0142(19850815)56:4<934::AID-CNCR2820560439>3.0.CO;2-I; LYNCH HT, 1985, CANCER, V56, P939, DOI 10.1002/1097-0142(19850815)56:4<939::AID-CNCR2820560440>3.0.CO;2-T; MIYOSHI Y, 1992, P NATL ACAD SCI USA, V89, P4452, DOI 10.1073/pnas.89.10.4452; NAKAMURA Y, 1988, AM J HUM GENET, V43, P638; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; OLSCHWANG S, 1993, AM J HUM GENET, V52, P273; PETERSEN GM, 1990, GASTROENTEROLOGY, V100, P1658; SPIRIO L, 1992, AM J HUM GENET, V51, P92; SPIRIO L, 1991, NUCLEIC ACIDS RES, V19, P6348, DOI 10.1093/nar/19.22.6348; VANLEEUWEN C, 1991, NUCLEIC ACIDS RES, V19, P5805, DOI 10.1093/nar/19.20.5805; VARESCO L, 1993, AM J HUM GENET, V52, P280	27	58	59	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1993	52	2					286	296						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KN275	8094265				2022-12-18	WOS:A1993KN27500006
J	LINDGREN, V; BRYKE, CR; OZCELIK, T; YANGFENG, TL; FRANCKE, U				LINDGREN, V; BRYKE, CR; OZCELIK, T; YANGFENG, TL; FRANCKE, U			PHENOTYPIC, CYTOGENETIC, AND MOLECULAR STUDIES OF 3 PATIENTS WITH CONSTITUTIONAL DELETIONS OF CHROMOSOME-5 IN THE REGION OF THE GENE FOR FAMILIAL ADENOMATOUS POLYPOSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTERSTITIAL DELETION; DNA MARKERS; LONG ARM; RECEPTOR; 5Q; LOCALIZATION; DOMAINS; COLI	We have studied three patients, one with extensive polyposis of the colon, who have constitutional interstitial deletions of the long arm of chromosome 5. High-resolution banding studies indicated that the deletion in the patient with polyposis spans the region 5q21-q22, which includes APC, a gene involved in familial adenomatous polyposis and sporadic colon cancer. Molecular analysis with probes for sequences flanking APC confirmed this conclusion. The deletions in the other two patients, who are too young to have developed polyposis, had breakpoints within this region, precluding the use of cytogenetic analysis alone in making definitive predictions about their risks. Molecular studies resolved the uncertainty; in situ and quantitative Southern hybridizations of four probes for polymorphic segments revealed that one of the patients has a deletion of MCC, a gene which is approximately 150 kb proximal to APC, and two flanking markers. He is at increased risk for polyposis, while the other patient is not. The physical descriptions of these patients, in conjunction with cases in the literature, begin to allow delineation of two distinct 5q- syndromes. These studies also provide precise physical mapping data for D5S71, D5S81, D5S84, and MCC on 5q.	YALE UNIV,DEPT HUMAN GENET,NEW HAVEN,CT 06520; STANFORD UNIV,MED CTR,SCH MED,BECKMAN CTR MOLEC & GENET MED,HOWARD HUGHES MED INST,STANFORD,CA 94305	Yale University; Howard Hughes Medical Institute; Stanford University					NHGRI NIH HHS [HG00298] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000298] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ARCHER BT, 1990, J BIOL CHEM, V265, P17267; BARTON DE, 1986, HUM GENET, V72, P221, DOI 10.1007/BF00291881; BODMER WF, 1987, NATURE, V328, P614, DOI 10.1038/328614a0; DEMICHELENA MI, 1990, AM J MED GENET, V36, P29, DOI 10.1002/ajmg.1320360107; DUNLOP MG, 1990, AM J HUM GENET, V47, P982; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FELDING I, 1980, HEREDITAS, V93, P337; FRANCKE U, 1978, HUM GENET, V45, P137, DOI 10.1007/BF00286957; Gardner EJ, 1972, BIRTH DEFECTS, V2, P48; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; HERRERA L, 1986, AM J MED GENET, V25, P473, DOI 10.1002/ajmg.1320250309; HOCKEY KA, 1989, J MED GENET, V26, P61, DOI 10.1136/jmg.26.1.61; JOSLYN G, 1991, CELL, V66, P601, DOI 10.1016/0092-8674(81)90022-2; KINZLER KW, 1991, SCIENCE, V251, P1366, DOI 10.1126/science.1848370; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; KOBILKA BK, 1987, P NATL ACAD SCI USA, V84, P46, DOI 10.1073/pnas.84.1.46; LEHRMAN MA, 1985, SCIENCE, V227, P140, DOI 10.1126/science.3155573; LEPPERT M, 1987, SCIENCE, V238, P1411, DOI 10.1126/science.3479843; NAKAMURA Y, 1988, AM J HUM GENET, V43, P638; NEUMAN WL, 1990, AM J HUM GENET S, V47, pA258; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; SASAKI M, 1989, CANCER RES, V49, P4402; SOLOMON E, 1987, NATURE, V328, P616, DOI 10.1038/328616a0; TOPS CMJ, 1989, LANCET, V2, P1361; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; YANGFENG TL, 1990, P NATL ACAD SCI USA, V87, P1516, DOI 10.1073/pnas.87.4.1516; YANGFENG TL, 1985, AM J HUM GENET, V37, P1117	27	58	58	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1992	50	5					988	997						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HR473	1315124				2022-12-18	WOS:A1992HR47300012
J	MEITINGER, T; HEYE, B; PETIT, C; LEVILLIERS, J; GOLLA, A; MORAINE, C; DALLAPICCOLA, B; SIPPELL, WG; MURKEN, J; BALLABIO, A				MEITINGER, T; HEYE, B; PETIT, C; LEVILLIERS, J; GOLLA, A; MORAINE, C; DALLAPICCOLA, B; SIPPELL, WG; MURKEN, J; BALLABIO, A			DEFINITIVE LOCALIZATION OF X-LINKED KALLMAN SYNDROME (HYPOGONADOTROPIC HYPOGONADISM AND ANOSMIA) TO XP22.3 - CLOSE LINKAGE TO THE HYPERVARIABLE REPEAT SEQUENCE CRI-S232	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									INST PASTEUR,F-75724 PARIS 15,FRANCE; HOP BRETONNEAU,TOURS,FRANCE; UNIV ROME 2,IST GENET,ROME,ITALY; UNIV KIEL,KINDERKLIN,W-2300 KIEL 1,GERMANY; BAYLOR UNIV,HOWARD HUGHES MED INST,HOUSTON,TX 77030; BAYLOR UNIV,INST MOLEC GENET,HOUSTON,TX 77030	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CHU Tours; University of Rome Tor Vergata; University of Kiel; Baylor University; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor University	MEITINGER, T (corresponding author), UNIV MUNICH,KINDERPOLIKLIN,PADIATR GENET ABT,GOETHESTR 29,W-8000 MUNICH 2,GERMANY.		BALLABIO, Andrea/AAL-2672-2020; Meitinger, Thomas/O-1318-2015; Dallapiccola, Bruno/K-8692-2016	BALLABIO, Andrea/0000-0003-1381-4604; Petit, Christine/0000-0002-9069-002X; Dallapiccola, Bruno/0000-0002-5031-1013; Meitinger, Thomas/0000-0002-8838-8403				ALITALO T, 1988, AM J HUM GENET, V43, P476; ANDRIA G, 1984, J INHERITED METAB S2, V7, P158; BALLABIO A, 1987, P NATL ACAD SCI USA, V84, P4519, DOI 10.1073/pnas.84.13.4519; BALLABIO A, 1986, HUM GENET, V72, P237, DOI 10.1007/BF00291885; BALLABIO A, 1989, P NATL ACAD SCI USA, V86, P10001, DOI 10.1073/pnas.86.24.10001; BALLABIO A, IN PRESS GENOMICS; BICK D, 1989, AM J MED GENET, V33, P100, DOI 10.1002/ajmg.1320330114; BURRIS AS, 1988, FERTIL STERIL, V50, P343; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; EVAINBRION D, 1982, ACTA PAEDIATR SCAND, V71, P937, DOI 10.1111/j.1651-2227.1982.tb09552.x; GOONEWARDENA P, 1989, CLIN GENET, V35, P5; HERMANUSSEN M, 1985, CLIN GENET, V28, P106; JOHNSON C, 1989, American Journal of Human Genetics, V45, pA145; Kallmann FJ, 1944, AM J MENT DEF, V48, P203; KLINGMULLER D, 1987, J CLIN ENDOCR METAB, V65, P581, DOI 10.1210/jcem-65-3-581; KNOWLTON RG, 1989, NUCLEIC ACIDS RES, V17, P423, DOI 10.1093/nar/17.1.423; LATHROP GM, 1984, AM J HUM GENET, V36, P460; MIDDLESWORTH W, 1985, NUCLEIC ACIDS RES, V13, P5723, DOI 10.1093/nar/13.15.5723; PARTSCH CJ, 1985, J CLIN ENDOCR METAB, V60, P1196, DOI 10.1210/jcem-60-6-1196; PETIT C, 1990, P NATL ACAD SCI USA, V87, P3680, DOI 10.1073/pnas.87.10.3680; ROSEN SW, 1979, ANN OTO RHINOL LARYN, V88, P288, DOI 10.1177/000348947908800223; ROSS MT, 1990, GENOMICS, V6, P528, DOI 10.1016/0888-7543(90)90482-A; SANTEN RJ, 1973, J CLIN ENDOCR METAB, V36, P47, DOI 10.1210/jcem-36-1-47; SCHNUR RE, 1989, AM J HUM GENET, V45, P706; SCHWANZELFUKUDA M, 1989, MOL BRAIN RES, V6, P311, DOI 10.1016/0169-328X(89)90076-4; SCHWANZELFUKUDA M, 1989, NATURE, V338, P161, DOI 10.1038/338161a0; SPRATT DI, 1987, J CLIN ENDOCR METAB, V64, P283, DOI 10.1210/jcem-64-2-283; SUNOHARA N, 1986, ANN NEUROL, V19, P174, DOI 10.1002/ana.410190211; WEGENKE JD, 1975, CLIN GENET, V7, P368; Weidenreich F, 1914, Z MORPHOL ANTHROPOL, V18, P157; WHITE BJ, 1983, AM J MED GENET, V15, P417, DOI 10.1002/ajmg.1320150307; WIRTH B, 1989, NUCLEIC ACIDS RES, V17, P3326, DOI 10.1093/nar/17.8.3326; WROGEMANN K, 1986, NUCLEIC ACIDS RES, V14, P4377, DOI 10.1093/nar/14.10.4377	33	58	61	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1990	47	4					664	669						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EB319	1977309				2022-12-18	WOS:A1990EB31900011
J	DAHL, HHM; MARAGOS, C; BROWN, RM; HANSEN, LL; BROWN, GK				DAHL, HHM; MARAGOS, C; BROWN, RM; HANSEN, LL; BROWN, GK			PYRUVATE-DEHYDROGENASE DEFICIENCY CAUSED BY DELETION OF A 7-BP REPEAT SEQUENCE IN THE EL-ALPHA GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MELBOURNE, DEPT PEDIAT, PARKVILLE, VIC 3052, AUSTRALIA	University of Melbourne	DAHL, HHM (corresponding author), ROYAL CHILDRENS HOSP, MURDOCH INST RES BIRTH DEFECTS, PARKVILLE, VIC 3052, AUSTRALIA.		Hansen, Lise Lotte/I-3377-2016	Hansen, Lise Lotte/0000-0001-7915-2506				BARRERA CR, 1972, ARCH BIOCHEM BIOPHYS, V148, P343, DOI 10.1016/0003-9861(72)90152-X; BROWN GK, 1987, J INHERIT METAB DIS, V10, P359, DOI 10.1007/BF01799978; BROWN GK, 1989, ANN NY ACAD SCI, V573, P360, DOI 10.1111/j.1749-6632.1989.tb15011.x; BROWN GK, 1988, EUR J PEDIATR, V147, P10, DOI 10.1007/BF00442603; BROWN RM, 1989, GENOMICS, V4, P174, DOI 10.1016/0888-7543(89)90297-8; BROWN RM, IN PRESS GENOMICS; CHANDLEY AC, 1989, J MED GENET, V26, P546, DOI 10.1136/jmg.26.9.546; CHOW CW, 1987, ACTA NEUROPATHOL, V74, P393, DOI 10.1007/BF00687218; DAHL HHM, 1989, ANAL BIOCHEM, V183, P263, DOI 10.1016/0003-2697(89)90477-6; DAHL HHM, 1987, J BIOL CHEM, V262, P7398; DEMEIRLEIR L, 1988, J BIOL CHEM, V263, P1991; ENDO H, 1989, AM J HUM GENET, V44, P358; FRASER NJ, 1989, GENOMICS, V5, P144, DOI 10.1016/0888-7543(89)90099-2; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; HO L, 1989, P NATL ACAD SCI USA, V86, P5330, DOI 10.1073/pnas.86.14.5330; KOIKE K, 1988, P NATL ACAD SCI USA, V85, P41, DOI 10.1073/pnas.85.1.41; LINN TC, 1969, P NATL ACAD SCI USA, V62, P234, DOI 10.1073/pnas.62.1.234; MARAGOS C, 1989, J BIOL CHEM, V264, P12294; MCKAY N, 1986, EUR J PEDIATR, V144, P445, DOI 10.1007/BF00441736; NAITO E, 1988, PEDIATR RES, V23, P561, DOI 10.1203/00006450-198806000-00005; REED LJ, 1974, ACCOUNTS CHEM RES, V7, P40, DOI 10.1021/ar50074a002; ROBINSON BH, 1987, J PEDIATR-US, V111, P525, DOI 10.1016/S0022-3476(87)80112-9; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; WEXLER ID, 1988, P NATL ACAD SCI USA, V85, P7336, DOI 10.1073/pnas.85.19.7336	24	58	60	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1990	47	2					286	293						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT871	2378353				2022-12-18	WOS:A1990DT87100014
J	GODFREY, M; HOLLISTER, DW				GODFREY, M; HOLLISTER, DW			TYPE-II ACHONDROGENESIS-HYPOCHONDROGENESIS - IDENTIFICATION OF ABNORMAL TYPE-II COLLAGEN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									SHRINERS HOSP CRIPPLED CHILDREN,3101 SW SAM JACKSON PK RD,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT BIOCHEM,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT MED,PORTLAND,OR 97201	Oregon Health & Science University; Oregon Health & Science University								BACHINGER HP, 1981, J BIOL CHEM, V256, P3193; BARSH GS, 1981, COLLAGEN REL RES, V1, P543; BARSH GS, 1981, P NATL ACAD SCI-BIOL, V78, P5142, DOI 10.1073/pnas.78.8.5142; BATEMAN JF, 1987, J BIOL CHEM, V262, P4445; BATEMAN JF, 1984, BIOCHEM J, V217, P103, DOI 10.1042/bj2170103; BATEMAN JF, 1987, J BIOL CHEM, V262, P7021; BONADIO J, 1985, NATURE, V316, P363, DOI 10.1038/316363a0; BOROCHOWITZ Z, 1986, AM J MED GENET, V24, P273, DOI 10.1002/ajmg.1320240208; BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9; BURGESON RE, 1979, BIOCHEM BIOPH RES CO, V87, P1124, DOI 10.1016/S0006-291X(79)80024-8; Burgeson RE, 1987, CONNECTIVE TISSUE DI, P3; BYERS PH, 1988, AM J HUM GENET, V42, P237; BYERS PH, 1979, HUM GENET, V47, P141, DOI 10.1007/BF00273196; CLARK JG, 1980, AM REV RESPIR DIS, V122, P971; CLICK EM, 1970, BIOCHEMISTRY-US, V9, P4699; EPSTEIN EH, 1971, J BIOL CHEM, V246, P1718; Eyre D, 1987, STRUCTURE FUNCTION C, P261; EYRE DR, 1986, AM J HUM GENET, V39, P52; FRANCOMANO C A, 1987, American Journal of Human Genetics, V41, pA97; GODFREY M, 1988, AM J HUM GENET, V43, P894; HOLBROOK KA, 1987, CONNECTIVE TISSUE DI, P101; HORTON WA, 1985, COLLAGEN REL RES, V5, P349; HORTON WA, 1987, PEDIATR RES, V22, P324, DOI 10.1203/00006450-198709000-00017; HORTON WA, 1984, COLLAGEN REL RES, V4, P231; HORTON WA, 1985, PEDIATR RES, V19, P248; KIVIRIKKO KI, 1984, EXTRACELLULAR MATRIX, P84; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAROTEAUX P, 1983, EUR J PEDIATR, V141, P14, DOI 10.1007/BF00445662; MAROTEAUX P, 1976, CLIN ORTHOP RELAT R, V114, P31; MILLER EJ, 1973, BIOCHEMISTRY-US, V12, P3153, DOI 10.1021/bi00741a003; MORRIS NP, 1986, J BIOL CHEM, V261, P5638; MORRIS NP, 1987, J BIOL CHEM, V262, P11345; MURRAY L W, 1987, American Journal of Human Genetics, V41, pA12; MURRAY LW, 1988, PATHOL IMMUNOPATH R, V7, P99, DOI 10.1159/000157111; POOLE AR, 1988, J CLIN INVEST, V81, P579, DOI 10.1172/JCI113356; PROCKOP DJ, 1984, AM J HUM GENET, V36, P499; PROCKOP DJ, 1986, RHEUMATOLOGY, V10, P246; SPRANGER J, 1985, ENDOCRINE GENETICS G, P315; STEINMANN B, 1986, J BIOL CHEM, V261, P8958; STEINMANN B, 1984, J BIOL CHEM, V259, P1129; STOLLE CA, 1985, J BIOL CHEM, V260, P1937; VOGEL BE, 1987, J BIOL CHEM, V262, P14737; WENSTRUP RJ, 1988, J BIOL CHEM, V263, P7734; WHITLEY CB, 1983, RADIOLOGY, V148, P693, DOI 10.1148/radiology.148.3.6878687; WILLIAMS CJ, 1983, J BIOL CHEM, V258, P5915	45	58	59	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1988	43	6					904	913						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	R3449	3195588				2022-12-18	WOS:A1988R344900011
J	RICH, SS; WILKIE, P; SCHUT, L; VANCE, G; ORR, HT				RICH, SS; WILKIE, P; SCHUT, L; VANCE, G; ORR, HT			SPINOCEREBELLAR ATAXIA - LOCALIZATION OF AN AUTOSOMAL DOMINANT LOCUS BETWEEN 2 MARKERS ON HUMAN CHROMOSOME-6	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MINNESOTA,INST HUMAN GENET,MINNEAPOLIS,MN 55455; VET ADM MED CTR,GERIATR RES EDUC & CLIN CTR,MINNEAPOLIS,MN 55417	University of Minnesota System; University of Minnesota Twin Cities; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	RICH, SS (corresponding author), UNIV MINNESOTA,DEPT LAB MED & PATHOL,BOX 511 MAYO,420 DELAWARE SE,MINNEAPOLIS,MN 55455, USA.			Orr, Harry/0000-0001-6118-741X; Rich, Stephen/0000-0003-3872-7793	NINDS NIH HHS [NS-22920] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022920, R37NS022920] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; GRAY RC, 1941, MINN MED, V24, P327; HAINES JL, 1984, NEUROLOGY, V34, P1542, DOI 10.1212/WNL.34.12.1542; JACKSON JF, 1977, NEW ENGL J MED, V296, P1138, DOI 10.1056/NEJM197705192962003; KONIGSMARK BW, 1970, MEDICINE, V49, P227, DOI 10.1097/00005792-197005000-00003; LANDIS DMD, 1974, ARCH NEUROL-CHICAGO, V31, P295, DOI 10.1001/archneur.1974.00490410043003; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEACH R, 1986, P NATL ACAD SCI USA, V83, P3909, DOI 10.1073/pnas.83.11.3909; MOLLER E, 1978, TISSUE ANTIGENS, V12, P357, DOI 10.1111/j.1399-0039.1978.tb01345.x; MORTON NE, 1980, AM J MED GENET, V6, P251, DOI 10.1002/ajmg.1320060309; NINO HE, 1980, NEUROLOGY, V30, P12, DOI 10.1212/WNL.30.1.12; OTT J, 1974, AM J HUM GENET, V26, P588; PEDERSEN L, 1980, HUM GENET, V54, P371, DOI 10.1007/BF00291585; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; STEERE K, 1986, HUM IMMUNOL, V16, P137, DOI 10.1016/0198-8859(86)90042-X; SUGDEN B, 1977, J VIROL, V23, P503, DOI 10.1128/JVI.23.3.503-508.1977; WHITTINGTON JE, 1980, CYTOGENET CELL GENET, V28, P145, DOI 10.1159/000131524; YAKURA H, 1974, NEW ENGL J MED, V291, P154	18	58	58	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1987	41	4					524	531						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	K4621	3477955				2022-12-18	WOS:A1987K462100002
J	MOHRENWEISER, HW; NOVOTNY, JE				MOHRENWEISER, HW; NOVOTNY, JE			ACP1GUA-1 - A LOW-ACTIVITY VARIANT OF HUMAN-ERYTHROCYTE ACID-PHOSPHATASE - ASSOCIATION WITH INCREASED GLUTATHIONE-REDUCTASE ACTIVITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											MOHRENWEISER, HW (corresponding author), UNIV MICHIGAN, SCH MED, DEPT HUMAN GENET, ANN ARBOR, MI 48104 USA.							BARRANTES R, 1982, AM J PHYS ANTHR; BARTHELMAI W, 1973, CURRENT ASPECTS PERI, P71; BOTTINI E, 1971, SCIENCE, V171, P409, DOI 10.1126/science.171.3969.409; BOTTINI E, 1980, AM J HUM GENET, V32, P764; BOTTINI E, 1972, J MED GENET, V9, P434, DOI 10.1136/jmg.9.4.434; BOTTINI E, 1976, LANCET, V1, P918; BREWSTER MA, 1974, BIOCHEM MED METAB B, V10, P229, DOI 10.1016/0006-2944(74)90026-X; CARAPELLA E, 1980, J PERINAT MED, V8, P42; EZE LC, 1974, ANN HUM GENET, V37, P333, DOI 10.1111/j.1469-1809.1974.tb01840.x; FIELEK S, 1979, CLIN CHEM, V25, P384; FISHER RA, 1971, ANN HUM GENET, V34, P439, DOI 10.1111/j.1469-1809.1971.tb00257.x; GLATZLE D, 1974, EXPERIENTIA, V30, P665; HELMERHORST E, 1980, ANAL BIOCHEM, V104, P130, DOI 10.1016/0003-2697(80)90287-0; HOPKINSON DA, 1964, AM J HUM GENET, V16, P141; HOPPE HH, 1972, HUMANGENETIK, V14, P224, DOI 10.1007/BF00278041; JENKINS T, 1972, ANN HUM GENET, V35, P379; LUFFMAN JE, 1967, ANN HUM GENET, V30, P387, DOI 10.1111/j.1469-1809.1967.tb00040.x; MANSFIELD E, 1977, LANCET, V2, P201; MANSFIELD E, 1978, RED CELL, V4, P233; MOHRENWEISER HW, 1981, P NATL ACAD SCI-BIOL, V78, P5046, DOI 10.1073/pnas.78.8.5046; MOHRENWEISER HW, 1981, AM J HEMATOL, V11, P125, DOI 10.1002/ajh.2830110203; MOHRENWEISER HW, 1981, P NATL ACAD SCI-BIOL, V78, P5729, DOI 10.1073/pnas.78.9.5729; NEEL JV, 1980, P NATL ACAD SCI-BIOL, V77, P6037, DOI 10.1073/pnas.77.10.6037; NEEL JV, 1978, AM J HUM GENET, V30, P465; NICHOALDS GE, 1974, CLIN CHEM, V20, P624; OSKI FA, 1975, SEMIN HEMATOL, V12, P209; SENSABAUGH GF, 1978, AM J HUM GENET, V30, P553; SENSABAUGH GF, 1975, ISOENZYMES, V1, P367; SPENCER N, 1964, NATURE, V201, P299, DOI 10.1038/201299a0; TANIS RJ, 1977, AM J HUM GENET, V29, P419; VALENTINE W, 1961, AM J CLIN PATHOL, V36, P328; YOSHIHARA CM, 1980, AM J HUM GENET, V32, P898	32	58	58	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1982	34	3					425	433						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NR133	7081221				2022-12-18	WOS:A1982NR13300007
J	SERJEANTSON, SW; RYAN, DP; THOMPSON, AR				SERJEANTSON, SW; RYAN, DP; THOMPSON, AR			THE COLONIZATION OF THE PACIFIC - THE STORY ACCORDING TO HUMAN-LEUKOCYTE ANTIGENS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											SERJEANTSON, SW (corresponding author), AUSTRALIAN NATL UNIV, JOHN CURTIN SCH MED RES, DEPT HUMAN BIOL, CANBERRA, ACT 2601, AUSTRALIA.							BALAKRISHNAN V, 1975, RRS3 AUSTR I AB STUD; BASHIR HV, 1973, HISTOCOMPATIBILITY T, P311; BATCHELOR JR, 1973, HISTOCOMPATIBILITY T, P283; BELLWOOD PS, 1977, MANS CONQUEST PACIFI; BHATIA KK, 1980, ANN HUM BIOL, V7, P45, DOI 10.1080/03014468000004041; BLAKE NM, 1978, MED J AUSTRALIA, V1, P183, DOI 10.5694/j.1326-5377.1978.tb107826.x; BODMER W, 1977, HLA DISEASE, P280; BODMER WF, 1978, BRIT MED BULL, V34, P309, DOI 10.1093/oxfordjournals.bmb.a071518; BOOTH PB, 1977, HUM HERED, V27, P412, DOI 10.1159/000152903; Clark Ross, 1979, PREHISTORY POLYNESIA, P249, DOI [10.4159/harvard.9780674181267.c11, DOI 10.4159/HARVARD.9780674181267.C11]; CROSIER PS, 1976, TISSUE ANTIGENS, V8, P173; CROSS RA, 1973, HISTOCOMPATIBILITY T, P303; DAUSSET J, 1977, HLA DISEASE; DEGOS L, 1974, IMMUNOGENETICS, V1, P195, DOI 10.1007/BF01564062; FELDMAN MW, 1974, GENET RES, V24, P151, DOI 10.1017/S0016672300015184; FROST EL, 1979, PREHISTORY POLYNESIA, P61; Golson J., 1977, SUNDA SAHUL PREHISTO, P601; GREEN R, 1966, J POLYNESIAN SOC, V75, P6; Green R.C., 1979, PREHISTORY POLYNESIA, P27; Kirk RL, 1979, 1ST AM ORIGINS AFFIN, P211; KIRK RL, 1980, POPULATION STRUCTURE, P113; Lalouel J. M., 1973, Genetic structure of populations. Proceedings of a conference sponsored by the University of Hawaii, 1973., P139; MACQUEEN JM, 1979, TISSUE ANTIGENS, V13, P121; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; MITTAL KK, 1973, HISTOCOMPATIBILITY T, P187; MORRIS PJ, 1973, HISTOCOMPATIBILITY T, P267; Morton N. E., 1973, Genetic structure of populations. Proceedings of a conference sponsored by the University of Hawaii, 1973., P158; Robbins RB, 1918, GENETICS, V3, P73; RYDER LP, 1978, HUM HERED, V28, P171, DOI 10.1159/000152958; SERJEANTSON S, 1983, J HUM EVOL; SERJEANTSON SW, 1982, ANN HUM BIOL, V9, P69, DOI 10.1080/03014468200005501; Simmons RT, 1955, AM J PHYS ANTHROP-NE, V13, P667, DOI 10.1002/ajpa.1330130409; SIMMONS RT, 1957, AM J PHYS ANTHROPOL, V15, P357, DOI 10.1002/ajpa.1330150315; SIMONS MJ, 1978, PAPUA NEW GUINEA MED, V21, P56; TERASAKI PI, 1980, HISTOCOMPATIBILITY T, P1127; Thorsby E., 1973, HISTOCOMPATIBILITY T, P287; TING A, 1972, TISSUE ANTIGENS, V2, P409; TSUJI K, 1979, 1ST P AS OC HIST WOR; WURM SA, 1967, J PAC HIST, V2, P25, DOI 10.1080/00223346708572100; WURM SA, 1983, J HUM EVOL; [No title captured]	41	58	58	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1982	34	6					904	918						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PU211	7180847				2022-12-18	WOS:A1982PU21100008
J	MOHANDAS, T; SPARKES, RS; SPARKES, MC; SHULKIN, JD; TOOMEY, KE; FUNDERBURK, SJ				MOHANDAS, T; SPARKES, RS; SPARKES, MC; SHULKIN, JD; TOOMEY, KE; FUNDERBURK, SJ			REGIONAL LOCALIZATION OF HUMAN-GENE LOCI ON CHROMOSOME-9 - STUDIES OF SOMATIC-CELL HYBRIDS CONTAINING HUMAN TRANSLOCATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF LOS ANGELES,SCH MED,DEPT MED,DIV MED GENET,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,DEPT PEDIAT,DIV MED GENET,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,DEPT PSYCHIAT,DIV MED GENET,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	MOHANDAS, T (corresponding author), UNIV CALIF LOS ANGELES,HARBOR GEN HOSP,MED CTR,DEPT PEDIAT,DIV MED GENET,TORRANCE,CA 90509, USA.							BEUTLER E, 1969, BIOCHEM GENET, V3, P189, DOI 10.1007/BF00520353; BRUNS GAP, CYTOGENET CELL GENET; CARRITT B, CYTOGENET CELL GENET; CASPERSS.T, 1970, EXP CELL RES, V60, P315, DOI 10.1016/0014-4827(70)90523-9; COOK PJL, 1978, ANN HUM GENET, V41, P365, DOI 10.1111/j.1469-1809.1978.tb01904.x; FERGUSONSMITH MA, 1976, HUM GENET, V34, P35, DOI 10.1007/BF00284432; FILDES RA, 1966, NATURE, V209, P261, DOI 10.1038/209261a0; FUNDERBURK SJ, 1977, AM J HUM GENET, V29, P136; GEE PA, 1974, CYTOGENET CELL GENET, V13, P437, DOI 10.1159/000130297; GILES RE, 1973, TISSUE CULTURE METHO, P475; LEISTI JT, 1975, AM J HUM GENET, V27, P441; LITTLEFIELD JW, 1964, SCIENCE, V145, P709, DOI 10.1126/science.145.3633.709; MCDOUGALL JK, 1973, NATURE-NEW BIOL, V245, P172, DOI 10.1038/newbio245172a0; MEERAKHAN P, CYTOGENET CELL GENET; MOHANDAS T, 1977, P NATL ACAD SCI USA, V74, P5628, DOI 10.1073/pnas.74.12.5628; MOHANDAS T, CYTOGENET CELL GENET; POVEY S, 1976, ANN HUM GENET, V39, P413, DOI 10.1111/j.1469-1809.1976.tb00145.x; RAPLEY S, 1967, ANN HUM GENET, V31, P237; RENWICK JH, 1955, ANN HUM GENET, V19, P312, DOI 10.1111/j.1469-1809.1955.tb01356.x; RICCIUTI F, 1973, NATURE-NEW BIOL, V241, P180, DOI 10.1038/newbio241180a0; ROBSON EB, 1977, ANN HUM GENET, V41, P53, DOI 10.1111/j.1469-1809.1977.tb01961.x; RUDDLE FH, 1975, ANNU REV GENET, V9, P407, DOI 10.1146/annurev.ge.09.120175.002203; SCHLEUTERMANN DA, 1969, AM J HUM GENET, V21, P606; SHOWS TB, 1977, CYTOGENET CELL GENET, V19, P26, DOI 10.1159/000130791; SLAUGHTER CA, 1975, ANN HUM GENET, V39, P193, DOI 10.1111/j.1469-1809.1975.tb00122.x; SPARKES MC, 1977, HUM GENET, V40, P93; SPARKES RS, 1969, J LAB CLIN MED, V73, P531; SUN NC, 1974, P NATL ACAD SCI USA, V71, P404, DOI 10.1073/pnas.71.2.404; TEDESCO TA, 1974, P NATL ACAD SCI USA, V71, P3483, DOI 10.1073/pnas.71.9.3483; VANCONG N, 1976, CYTOGENET CELL GENET, V16, P241, DOI 10.1159/000130601; WEITKAMP LR, 1969, AM J HUM GENET, V21, P600; WESTERVELD A, 1976, P NATL ACAD SCI USA, V73, P895, DOI 10.1073/pnas.73.3.895; WESTERVELD A, CYTOGENET CELL GENET; WILSON DE, 1976, ANN HUM GENET, V39, P305, DOI 10.1111/j.1469-1809.1976.tb00134.x; 1978, 4TH INT WORKSH HUM G	35	58	58	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1979	31	5					586	600						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HS030	292306				2022-12-18	WOS:A1979HS03000009
J	FRANCKE, U; FELSENSTEIN, J; GARTLER, SM; MIGEON, BR; DANCIS, J; SEEGMILLER, JE; BAKAY, F; NYHAN, WL				FRANCKE, U; FELSENSTEIN, J; GARTLER, SM; MIGEON, BR; DANCIS, J; SEEGMILLER, JE; BAKAY, F; NYHAN, WL			OCCURRENCE OF NEW MUTANTS IN X-LINKED RECESSIVE LESCH-NYHAN DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF,SCH MED,DEPT PEDIAT,SAN DIEGO,CA 92037; UNIV WASHINGTON,DEPT GENET,SEATTLE,WA 98105; JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21218; NYU,SCH MED,DEPT PEDIAT,NEW YORK,NY 10003; UNIV CALIF,SCH MED,DEPT MED,SAN DIEGO,CA 92037; UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98105	University of California System; University of California San Diego; University of Washington; University of Washington Seattle; Johns Hopkins University; New York University; University of California System; University of California San Diego; University of Washington; University of Washington Seattle								CHASE GA, 1973, HUM HERED, V23, P19, DOI 10.1159/000152548; DEBRUYN CHM, 1974, CLIN GENET, V5, P449; FELIX JS, 1971, J LAB CLIN MED, V77, P596; FRANCKE U, 1974, AM J HUM GENET, V26, P512; FRANCKE U, 1973, J PEDIATR-US, V82, P472, DOI 10.1016/S0022-3476(73)80123-4; FUJIMOTO WY, 1970, P NATL ACAD SCI USA, V65, P577, DOI 10.1073/pnas.65.3.577; GARTLER SM, 1975, AM J HUM GENET, V27, P218; GARTLER SM, 1971, SCIENCE, V172, P572, DOI 10.1126/science.172.3983.572; HAGEMEIJER AM, 1972, HUMANGENETIK, V15, P126, DOI 10.1007/BF00295739; HALDANE JBS, 1947, ANN EUGENIC, V13, P262; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; HOEFNAGEL D, 1965, NEW ENGL J MED, V273, P130, DOI 10.1056/NEJM196507152730303; ITIABA K, 1973, AM J HUM GENET, V25, P134; LESCH M, 1964, AM J MED, V36, P561, DOI 10.1016/0002-9343(64)90104-4; MAXWELL AE, 1961, ANALYSING QUALITATIV, P75; MCKERAN RO, 1975, QJ MED, V174, P189; MIGEON BR, 1970, BIOCHEM GENET, V4, P377, DOI 10.1007/BF00485754; MIGEON BR, 1968, SCIENCE, V160, P425, DOI 10.1126/science.160.3826.425; MIGEON BR, 1967, AM J HUM GENET, V23, P199; NYHAN WL, 1967, PEDIATR RES, V1, P5, DOI 10.1203/00006450-196701000-00001; ROSENBLOOM FM, 1967, LANCET, V2, P305; SALZMANN J, 1968, P NATL ACAD SCI USA, V60, P545, DOI 10.1073/pnas.60.2.545; SEEGMILLER JE, 1967, SCIENCE, V155, P1682, DOI 10.1126/science.155.3770.1682; SHAPIRO SL, 1966, P SOC EXP BIOL MED, V122, P609; SILVERS DN, 1972, NEW ENGL J MED, V286, P390, DOI 10.1056/NEJM197202242860802; 1966, VITAL STATISTICS US, V1, P1	26	58	58	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1976	28	2					123	137						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	BJ476	1266847				2022-12-18	WOS:A1976BJ47600002
J	GRUNDBACHER, FJ				GRUNDBACHER, FJ			HERITABILITY ESTIMATES AND GENETIC AND ENVIRONMENTAL CORRELATIONS FOR HUMAN IMMUNOGLOBULINS G, M, AND A	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									VIRGINIA COMM UNIV, MED COLL VIRGINIA, DEPT GENET, HLTH SCI DIV, RICHMOND, VA 23298 USA	Virginia Commonwealth University								ALLANSMI.M, 1967, P SOC EXP BIOL MED, V125, P404; ALLANSMITH M, 1969, J IMMUNOL, V102, P1504; BUCKLEY CE, 1970, J IMMUNOL, V105, P964; COLLINSWILLIAMS C, 1972, ANN ALLERGY, V30, P11; FAHEY JL, 1972, HEMATOLOGY; Falconer D.S., 1960, INTRO QUANTITATIVE G; GOLDSTEIN RA, 1969, J AMER MED ASSOC, V208, P1153, DOI 10.1001/jama.208.7.1153; GRUBB R, 1970, MOLECULAR BIOLOGY BI, V9; GRUNDBACHER FJ, 1972, SCIENCE, V176, P311, DOI 10.1126/science.176.4032.311; GRUNDBACHER FJ, 1967, Z IMMUNITATSFORSCH, V134, P317; GRUNDBACHER FJ, 1972, J MED GENET, V9, P344, DOI 10.1136/jmg.9.3.344; GRUNDBACHER FJ, 1970, AM J HUM GENET, V22, P194; GRUNDBACHER FJ, 1970, Z IMMUNITATSFORSCH, V141, P20; Hazel LN, 1943, GENETICS, V28, P476; HERZENBE.LA, 1964, COLD SPRING HARB SYM, V29, P455, DOI 10.1101/SQB.1964.029.01.048; HONG R, 1972, CLIN IMMUNOL, V1, P29; Hood L, 1971, Adv Immunol, V14, P291, DOI 10.1016/S0065-2776(08)60287-4; KALFF MW, 1969, CLIN EXP IMMUNOL, V5, P469; KALFF MW, 1970, CLIN CHIM ACTA, V28, P277, DOI 10.1016/0009-8981(70)90092-6; KUNKEL HG, 1969, NATURE, V223, P1247, DOI 10.1038/2231247a0; LICHTMAN MA, 1967, ARTHRITIS RHEUM, V10, P204, DOI 10.1002/art.1780100306; LITWIN SD, 1972, J IMMUNOL, V108, P991; REED TE, 1969, SCIENCE, V165, P762, DOI 10.1126/science.165.3895.762; ROWE D. S., 1968, CLIN EXP IMMUNOL, V3, P233; VANLOGHEM E, 1970, ANN HUM GENET, V33, P351; WALDMANN TA, 1969, PROG ALLERGY, V13, P1, DOI 10.1159/000287491; Walford R.L., 1969, IMMUNOL REV, V2, P171, DOI [10.1111/j.1600-065x.1969.tb00210.x, DOI 10.1111/J.1600-065X.1969.TB00210.X]	27	58	59	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1974	26	1					1	12						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	S0166	4204534				2022-12-18	WOS:A1974S016600001
J	SPARKES, RS; CARREL, RE; WRIGHT, SW				SPARKES, RS; CARREL, RE; WRIGHT, SW			ABSENT THUMBS WITH A RING D2 CHROMOSOME - A NEW DELETION SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ADAMS MS, 1965, LANCET, V2, P494; ATKINS L, 1966, ANN HUM GENET, V30, P1, DOI 10.1111/j.1469-1809.1966.tb00001.x; BAIKIE AG, 1959, LANCET, V2, P425; BAIN AD, 1963, LANCET, V2, P304; BENDER MA, 1962, RADIAT RES, V16, P44, DOI 10.2307/3571128; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; BEUTLER E, 1966, CLIN CHIM ACTA, V13, P369, DOI 10.1016/0009-8981(66)90217-8; BUCKTON KE, 1962, LANCET, V2, P676; DIGRADO F, 1964, LANCET, V2, P1243; GERALD PS, 1967, J PEDIATR-US, V70, P172, DOI 10.1016/S0022-3476(67)80411-6; GIANNELLI F, 1966, CYTOGENETICS, V5, P186, DOI 10.1159/000129897; HUSTINX TWJ, 1965, NATURE, V207, P327, DOI 10.1038/207327b0; KOUTRAS GA, 1964, J CLIN INVEST, V43, P323, DOI 10.1172/JCI104917; LEVAN A, 1956, HEREDITAS, V42, P366; MACINTYRE MN, 1964, ANAT RECORD, V148, P386; MICHEL HO, 1949, J LAB CLIN MED, V34, P1564; PENROSE LS, 1963, NATURE, V197, P933, DOI 10.1038/197933a0; PUCK TT, 1958, P NATL ACAD SCI USA, V44, P772, DOI 10.1073/pnas.44.8.772; REISMAN LE, 1965, LANCET, V2, P445; SANDBERG AA, 1962, CANCER RES, V22, P748; SCHMID W., 1963, CYTOGENETICS [BASEL], V2, P175, DOI 10.1159/000129778; SCHNEIDER AS, 1965, NEW ENGL J MED, V272, P229, DOI 10.1056/NEJM196502042720503; SCHWARTZ D, 1958, GENETICS, V43, P86; SHAW KNF, 1967, AM J DIS CHILD, V113, P119, DOI 10.1001/archpedi.1967.02090160169027; TOUGH IM, 1960, LANCET, V2, P849; TURNER B, 1963, P AUST ASSOC NEUROL, V1, P41; VALENTIN.WN, 1967, NEW ENGL J MED, V276, P1, DOI 10.1056/NEJM196701052760101; VALENTINE W, 1961, ACTA HAEMATOL-BASEL, V26, P303, DOI 10.1159/000206665; VALENTINE WN, 1951, J LAB CLIN MED, V38, P39; WACHSTEIN M, 1946, J LAB CLIN MED, V31, P1; WANG HC, 1962, NATURE, V195, P733, DOI 10.1038/195733a0; WILTSHAW E, 1955, BLOOD, V10, P1020; YUNIS JJ, 1966, AM J DIS CHILD, V111, P83, DOI 10.1001/archpedi.1966.02090040119017	33	58	58	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1967	19	5					644	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	99950	6050738				2022-12-18	WOS:A19679995000004
J	STEINBERG, AG; GOLDBLUM, R				STEINBERG, AG; GOLDBLUM, R			A GENETIC STUDY OF ANTIGENS ASSOCIATED WITH GM(B) FACTOR OF HUMAN GAMMA GLOBULIN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		COHEN S, 1963, BIOCHEM J, V89, P334, DOI 10.1042/bj0890334; HARBOE MORTEN, 1959, ACTA PATHOL ET MICROBIOL SCAND, V47, P191; MORTON NE, 1964, COLD SPRING HARBOR S, V29; NIELSEN JC, 1961, VOX SANG, V6, P634, DOI 10.1111/j.1423-0410.1961.tb03217.x; POLMAR SH, 1964, SCIENCE, V145, P928, DOI 10.1126/science.145.3635.928; ROPARTZ C, 1962, VOX SANG, V7, P233, DOI 10.1111/j.1423-0410.1962.tb03246.x; ROPARTZ C, 1963, VOX SANG, V8, P717, DOI 10.1111/j.1423-0410.1963.tb02378.x; STEINBERG AG, 1963, SCIENCE, V140, P303, DOI 10.1126/science.140.3564.303; STEINBERG AG, 1963, VOX SANG, V8, P51, DOI 10.1111/j.1423-0410.1963.tb04149.x; STEINBERG AG, 1963, AM J HUM GENET, V15, P96; STEINBERG AG, 1960, NATURE, V188, P169, DOI 10.1038/188169a0; STEINBERG AG, 1962, VOX SANG, V7, P89, DOI 10.1111/j.1423-0410.1962.tb03233.x; STEINBERG ARTHUR G., 1962, PROGR MED GENET, V2, P1	13	58	58	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1965	17	2					133	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	62357	14262131				2022-12-18	WOS:A19656235700006
J	MATSON, GA; SWANSON, J; NOADES, J; SANGER, R; RACE, RR				MATSON, GA; SWANSON, J; NOADES, J; SANGER, R; RACE, RR			A NEW ANTIGEN AND ANTIBODY BELONGING TO THE P-BLOOD GROUP SYSTEM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BIRD GWG, 1953, BRIT J EXP PATHOL, V34, P131; CAMERON GL, 1957, NATURE, V179, P147, DOI 10.1038/179147a0; COHEN C, 1958, J IMMUNOL, V80, P73; COHEN C, 1956, SCIENCE, V123, P935, DOI 10.1126/science.123.3204.935; DODD BE, 1952, BRIT J EXP PATHOL, V33, P1; Harley D, 1936, BRIT J EXP PATHOL, V17, P35; Landsteiner K, 1927, P SOC EXP BIOL MED, V24, P941; LEVINE P, 1951, P SOC EXP BIOL MED, V77, P403; SANGER R, 1955, NATURE, V176, P1163, DOI 10.1038/1761163a0; STAVELEY J M, 1958, Vox Sang, V3, P114	10	58	58	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1959	11	1					26	34						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF072	13626934				2022-12-18	WOS:A1959WF07200003
J	Calderon, D; Bhaskar, A; Knowles, DA; Golan, D; Raj, T; Fu, AQ; Pritchard, JK				Calderon, Diego; Bhaskar, Anand; Knowles, David A.; Golan, David; Raj, Towfique; Fu, Audrey Q.; Pritchard, Jonathan K.			Inferring Relevant Cell Types for Complex Traits by Using Single-Cell Gene Expression	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; RNA-SEQ; ALZHEIMERS-DISEASE; IDENTIFIES 11; SCHIZOPHRENIA; LOCI; RISK; HERITABILITY; AUTOIMMUNE	Previous studies have prioritized trait-relevant cell types by looking for an enrichment of genome-wide association study (GWAS) signal within functional regions. However, these studies are limited in cell resolution by the lack of functional annotations from difficult-tocharacterize or rare cell populations. Measurement of single-cell gene expression has become a popular method for characterizing novel cell types, and yet limited work has linked single-cell RNA sequencing (RNA-seq) to phenotypes of interest. To address this deficiency, we present RolyPoly, a regression-based polygenic model that can prioritize trait-relevant cell types and genes from GWAS summary statistics and gene expression data. RolyPoly is designed to use expression data from either bulk tissue or single-cell RNA-seq. In this study, we demonstrated RolyPoly's accuracy through simulation and validated previously known tissue-trait associations. We discovered a significant association between microglia and late-onset Alzheimer disease and an association between schizophrenia and oligodendrocytes and replicating fetal cortical cells. Additionally, RolyPoly computes a trait-relevance score for each gene to reflect the importance of expression specific to a cell type. We found that differentially expressed genes in the prefrontal cortex of individuals with Alzheimer disease were significantly enriched with genes ranked highly by RolyPoly gene scores. Overall, our method represents a powerful framework for understanding the effect of common variants on cell types contributing to complex traits.	[Calderon, Diego] Stanford Univ, Program Biomed Informat, Stanford, CA 94305 USA; [Bhaskar, Anand; Knowles, David A.; Pritchard, Jonathan K.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Bhaskar, Anand; Pritchard, Jonathan K.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Knowles, David A.] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Golan, David] Technion, Fac Ind Engn & Management, IL-3200003 Haifa, Israel; [Raj, Towfique] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Raj, Towfique] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Fu, Audrey Q.] Univ Idaho, Dept Stat Sci, Moscow, ID 83844 USA; [Pritchard, Jonathan K.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Technion Israel Institute of Technology; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Idaho; University of Idaho; Stanford University	Calderon, D (corresponding author), Stanford Univ, Program Biomed Informat, Stanford, CA 94305 USA.	dcal@stanford.edu	Raj, Towfique/ABD-7620-2021		National Library of Medicine Training Grant [T15LM007033]; NIH [R00HG007368, 1R01HG008140-01A1]; Howard Hughes Medical Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R00HG007368, R01HG008140] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	National Library of Medicine Training Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank Z. Gao, N. Latorraca, N. Sinnott- Armstrong, and anonymous reviewers for comments; A. Raj for technical assistance; and N. Telis for producing organ images. Support for D.C. was provided by National Library of Medicine Training Grant T15LM007033. Support for A.Q.F. was provided by NIH grant R00HG007368. This work was supported by NIH grant 1R01HG008140-01A1 and by the Howard Hughes Medical Institute.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Arsenio J, 2014, NAT IMMUNOL, V15, P365, DOI 10.1038/ni.2842; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Boyle EA, 2017, CELL, V169, P1177, DOI 10.1016/j.cell.2017.05.038; Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Campbell JN, 2017, NAT NEUROSCI, V20, P484, DOI 10.1038/nn.4495; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112; De Jager PL, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.033; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Efron B., 1986, STAT SCI, V1, P54, DOI https://doi.org/10.1214/ss/1177013815; Eugster EA, 1999, J CLIN ENDOCR METAB, V84, P4379, DOI 10.1210/jc.84.12.4379; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; FATOUROS M, 1995, BRIT J SURG, V82, P1675, DOI 10.1002/bjs.1800821230; Finucane H, 2017, HERITABILITY ENRICHM; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Fuzik J, 2016, NAT BIOTECHNOL, V34, P175, DOI 10.1038/nbt.3443; Gaffney DJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r7; Gjoneska E, 2015, NATURE, V518, P365, DOI 10.1038/nature14252; Grun D, 2015, CELL, V163, P799, DOI 10.1016/j.cell.2015.10.039; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Hall JE, 2003, HYPERTENSION, V41, P625, DOI 10.1161/01.HYP.0000052314.95497.78; Hormozdiari F, 2016, AM J HUM GENET, V99, P1245, DOI 10.1016/j.ajhg.2016.10.003; Hu XL, 2011, AM J HUM GENET, V89, P496, DOI 10.1016/j.ajhg.2011.09.002; Jaffe AE, 2015, NAT NEUROSCI, V18, P154, DOI 10.1038/nn.3898; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Junker JP, 2014, CELL, V157, P8, DOI 10.1016/j.cell.2014.02.010; Kahn RS, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.67; Kichaev G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004722; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Knudsen N, 2005, J CLIN ENDOCR METAB, V90, P4019, DOI 10.1210/jc.2004-2225; Kolodziejczyk AA, 2015, MOL CELL, V58, P610, DOI 10.1016/j.molcel.2015.04.005; Kowalczyk MS, 2015, GENOME RES, V25, P1860, DOI 10.1101/gr.192237.115; Kumasaka N, 2016, NAT GENET, V48, P206, DOI 10.1038/ng.3467; KUNSCH HR, 1989, ANN STAT, V17, P1217, DOI 10.1214/aos/1176347265; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lamparter D, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004714; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Mathai A.M., 1992, QUADRATIC FORMS RAND, P49; Montgomery SB, 2011, NAT REV GENET, V12, P277, DOI 10.1038/nrg2969; Nussey S. S., 2013, ENDOCRINOLOGY INTEGR; Okbay A, 2016, NATURE, V533, P539, DOI 10.1038/nature17671; Ongen H., 2016, ESTIMATING CAUSAL TI; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Price AL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001317; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raj T, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000125; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Regev A, 2017, THE HUMAN CELL ATLAS; Reinehr T, 2002, ARCH DIS CHILD, V87, P320, DOI 10.1136/adc.87.4.320; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rogers J, 2007, INT REV NEUROBIOL, V82, P235, DOI 10.1016/S0074-7742(07)82012-5; Saliba AE, 2014, NUCLEIC ACIDS RES, V42, P8845, DOI 10.1093/nar/gku555; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Sekar S, 2015, NEUROBIOL AGING, V36, P583, DOI 10.1016/j.neurobiolaging.2014.09.027; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shekhar K, 2016, CELL, V166, P1308, DOI 10.1016/j.cell.2016.07.054; Shi H, 2016, AM J HUM GENET, V99, P139, DOI 10.1016/j.ajhg.2016.05.013; Slowikowski K, 2014, BIOINFORMATICS, V30, P2496, DOI 10.1093/bioinformatics/btu326; Speed D, 2012, AM J HUM GENET, V91, P1011, DOI 10.1016/j.ajhg.2012.10.010; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Tkachev D, 2003, LANCET, V362, P798, DOI 10.1016/S0140-6736(03)14289-4; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Uranova NA, 2007, INT J NEUROPSYCHOPH, V10, P537, DOI 10.1017/S1461145707007626; Vallejos CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004333; Verkhratsky A, 2010, NEUROTHERAPEUTICS, V7, P399, DOI 10.1016/j.nurt.2010.05.017; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030	84	57	57	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 2	2017	101	5					686	699		10.1016/j.ajhg.2017.09.009	http://dx.doi.org/10.1016/j.ajhg.2017.09.009			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FL5DL	29106824	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000414251600003
J	Heimer, G; Keratar, JM; Riley, LG; Balasubramaniam, S; Eyal, E; Pietikainen, LP; Hiltunen, JK; Marek-Yagel, D; Hamada, J; Gregory, A; Rogers, C; Hogarth, P; Nance, MA; Shalva, N; Veber, A; Tzadok, M; Nissenkorn, A; Tonduti, D; Renaldo, F; Kraoua, I; Panteghini, C; Valletta, L; Garavaglia, B; Cowley, MJ; Gayevskiy, V; Roscioli, T; Silberstein, JM; Hoffmann, C; Raas-Rothschild, A; Tiranti, V; Anikster, Y; Christodoulou, J; Kastaniotis, AJ; Ben-Zeev, B; Hayflick, SJ				Heimer, Gali; Keraetaer, Juha M.; Riley, Lisa G.; Balasubramaniam, Shanti; Eyal, Eran; Pietikaeinen, Laura P.; Hiltunen, J. Kalervo; Marek-Yagel, Dina; Hamada, Jeffrey; Gregory, Allison; Rogers, Caleb; Hogarth, Penelope; Nance, Martha A.; Shalva, Nechama; Veber, Alvit; Tzadok, Michal; Nissenkorn, Andreea; Tonduti, Davide; Renaldo, Florence; Kraoua, Ichraf; Panteghini, Celeste; Valletta, Lorella; Garavaglia, Barbara; Cowley, Mark J.; Gayevskiy, Velimir; Roscioli, Tony; Silberstein, Jonathon M.; Hoffmann, Chen; Raas-Rothschild, Annick; Tiranti, Valeria; Anikster, Yair; Christodoulou, John; Kastaniotis, Alexander J.; Ben-Zeev, Bruria; Hayflick, Susan J.		U Of Washington Ctr For Mendelian	MECR Mutations Cause Childhood-Onset Dystonia and Optic Atrophy, a Mitochondrial Fatty Acid Synthesis Disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							2-ENOYL THIOESTER REDUCTASE; COLI SHUTTLE VECTORS; LIPOIC ACID; PROTEIN STABILITY; PREDICTION; GENE; INVOLVEMENT; MANAGEMENT; DIAGNOSIS; RECEPTOR	Mitochondrial fatty acid synthesis (mtFAS) is an evolutionarily conserved pathway essential for the function of the respiratory chain and several mitochondrial enzyme complexes. We report here a unique neurometabolic human disorder caused by defective mtFAS. Seven individuals from five unrelated families presented with childhood-onset dystonia, optic atrophy, and basal ganglia signal abnormalities on MRI. All affected individuals were found to harbor recessive mutations in MECR encoding the mitochondrial trans-2-enoyl-coenzyme A-reductase involved in human mtFAS. All six mutations are extremely rare in the general population, segregate with the disease in the families, and are predicted to be deleterious. The nonsense c.855T>G (p.Tyr285*), c.247_250del (p.Asn83Hisfs*4), and splice site c.830_2_830_3insT mutations lead to C-terminal truncation variants of MECR. The missense c.695G>A (p.Gly232Glu), c.854A>G (p.Tyr285Cys), and c.772C>T (p.Arg258Trp) mutations involve conserved amino acid residues, are located within the cofactor binding domain, and are predicted by structural analysis to have a destabilizing effect. Yeast modeling and complementation studies validated the pathogenicity of the MECR mutations. Fibroblast cell lines from affected individuals displayed reduced levels of both MECR and lipoylated proteins as well as defective respiration. These results suggest that mutations in MECR cause a distinct human disorder of the mtFAS pathway. The observation of decreased lipoylation raises the possibility of a potential therapeutic strategy.	[Heimer, Gali; Tzadok, Michal; Nissenkorn, Andreea; Ben-Zeev, Bruria] Edmond & Lily Childrens Hosp, Chaim Sheba Med Ctr, Pediat Neurol Unit, IL-52621 Ramat Gan, Israel; [Heimer, Gali] Chaim Sheba Med Ctr, Pinchas Borenstein Talpiot Med Leadership Program, IL-52621 Ramat Gan, Israel; [Keraetaer, Juha M.; Pietikaeinen, Laura P.; Hiltunen, J. Kalervo; Kastaniotis, Alexander J.] Univ Oulu, Fac Biochem & Mol Med, Oulu 90014, Finland; [Keraetaer, Juha M.; Pietikaeinen, Laura P.; Hiltunen, J. Kalervo; Kastaniotis, Alexander J.] Univ Oulu, Bioctr Oulu, Oulu 90014, Finland; [Riley, Lisa G.; Christodoulou, John] Childrens Hosp Westmead, Genet Metab Disorders Res Unit, Sydney, NSW 2145, Australia; [Riley, Lisa G.; Christodoulou, John] Univ Sydney, Sydney Med Sch, Discipline Paediat & Child Hlth, Sydney, NSW 2145, Australia; [Balasubramaniam, Shanti; Christodoulou, John] Childrens Hosp Westmead, Western Sydney Genet Program, Sydney, NSW 2145, Australia; [Balasubramaniam, Shanti] Princess Margaret Hosp, Dept Rheumatol & Metab Med, Perth, WA 6000, Australia; [Eyal, Eran] Edmond & Lily Childrens Hosp, Canc Res Ctr, Pediat Hemato Oncol Unit, Chaim Sheba Med Ctr, IL-52621 Ramat Gan, Israel; [Marek-Yagel, Dina; Shalva, Nechama; Veber, Alvit; Anikster, Yair] Edmond & Lily Childrens Hosp, Chaim Sheba Med Ctr, Metab Dis Unit, IL-52621 Ramat Gan, Israel; [Hamada, Jeffrey; Gregory, Allison; Rogers, Caleb; Hogarth, Penelope; Hayflick, Susan J.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA; [Hogarth, Penelope; Hayflick, Susan J.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97239 USA; [Nance, Martha A.] Struthers Parkinsons Ctr, Golden Valley, MN 55427 USA; [Heimer, Gali; Nissenkorn, Andreea; Raas-Rothschild, Annick; Anikster, Yair; Ben-Zeev, Bruria] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Tonduti, Davide] Neurol Inst C Besta, Fdn IRCCS, Child Neurol Dept, I-20133 Milan, Italy; [Renaldo, Florence] Hop Robert Debre, Dept Neuropediat & Metab Dis, F-75019 Paris, France; [Kraoua, Ichraf] Natl Inst Mongi Ben Hmida Neurol, Dept Child & Adolescent Neurol, Tunis 1007, Tunisia; [Panteghini, Celeste; Valletta, Lorella; Garavaglia, Barbara; Tiranti, Valeria] Fdn IRCCS Neurol Inst C Besta, Unit Mol Neurogenet, I-20126 Milan, Italy; [Cowley, Mark J.; Gayevskiy, Velimir; Roscioli, Tony] Garvan Inst Med Res, Kinghorn Ctr Clin Genom, Sydney, NSW 2010, Australia; [Cowley, Mark J.; Roscioli, Tony] Univ NSW, St Vincents Clin Sch, Sydney, NSW 2010, Australia; [Silberstein, Jonathon M.] Princess Margaret Hosp, Dept Neurol, Perth, WA 6000, Australia; [Hoffmann, Chen] Chaim Sheba Med Ctr, Diagnost Imaging Unit, IL-52621 Ramat Gan, Israel; [Raas-Rothschild, Annick] Chaim Sheba Med Ctr, Inst Rare Dis, Danek Gertner Inst Human Genet, IL-52621 Ramat Gan, Israel; [Christodoulou, John] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia; [Christodoulou, John] Royal Childrens Hosp, Victorian Clin Genet Serv, Melbourne, Vic 3052, Australia; [Christodoulou, John] Univ Melbourne, Dept Paediat, Melbourne, Vic 3052, Australia; [Hayflick, Susan J.] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97239 USA	Chaim Sheba Medical Center; Chaim Sheba Medical Center; University of Oulu; University of Oulu; University of Sydney; University of Sydney; University of Sydney; University of Western Australia; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Oregon Health & Science University; Oregon Health & Science University; Tel Aviv University; Sackler Faculty of Medicine; IRCCS Istituto Neurologico Besta; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Tunis-El-Manar; Institut National de Neurologie; Garvan Institute of Medical Research; University of New South Wales Sydney; University of Western Australia; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; Oregon Health & Science University	Ben-Zeev, B (corresponding author), Edmond & Lily Childrens Hosp, Chaim Sheba Med Ctr, Pediat Neurol Unit, IL-52621 Ramat Gan, Israel.; Hayflick, SJ (corresponding author), Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA.; Hayflick, SJ (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97239 USA.; Ben-Zeev, B (corresponding author), Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel.; Hayflick, SJ (corresponding author), Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97239 USA.	bruria.benzeev@sheba.health.gov.il; hayflick@ohsu.edu	Panteghini, Celeste/H-8544-2014; Tiranti, Valeria/AFN-5783-2022; Cowley, Mark/K-8731-2019; tonduti, davide/K-1673-2016; Christodoulou, John/M-3628-2019; Garavaglia, Barbara/J-5257-2018	Panteghini, Celeste/0000-0003-1341-7641; Tiranti, Valeria/0000-0002-3584-7338; Cowley, Mark/0000-0002-9519-5714; tonduti, davide/0000-0001-9371-7454; Christodoulou, John/0000-0002-8431-0641; Garavaglia, Barbara/0000-0003-4323-9145; Blue, Elizabeth/0000-0002-0633-0305; Chong, Jessica/0000-0002-1616-2448; Slattery, Krystal/0000-0003-2557-7589; Kastaniotis, Alexander/0000-0003-3624-9214	Israel Science Foundation [2023/14]; Sigrid Juselius Foundation; Academy of Finland; NBIA Disorders Association; National Human Genome Research Institute and the National Heart, Lung and Blood Institute [2UM1HG006493]; New South Wales Office of Health and Medical Research Council Sydney Genomics Collaborative NHMRC [1026891]; Cancer Institute NSW [13/ECF/1-46]; Kinghorn Foundation; Pierfranco and Luisa Mariani Foundation; TELETHON Italy [GTB09003]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006493] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); NBIA Disorders Association; National Human Genome Research Institute and the National Heart, Lung and Blood Institute; New South Wales Office of Health and Medical Research Council Sydney Genomics Collaborative NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute NSW; Kinghorn Foundation; Pierfranco and Luisa Mariani Foundation; TELETHON Italy(Fondazione Telethon); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors would like to acknowledge the families for their collaboration. The Israeli group was supported by funds from the Israel Science Foundation (grant number 2023/14) and the Pinchas Borenstein Talpiot Medical Leadership Program. The Finnish group was supported by the Sigrid Juselius Foundation and the Academy of Finland. The American group was funded by the NBIA Disorders Association and by philanthropic support. Sequencing for the American group was provided by the University of Washington Center for Mendelian Genomics (UW-CMG) and was funded by the National Human Genome Research Institute and the National Heart, Lung and Blood Institute grant 2UM1HG006493 to Drs. Debbie Nickerson, Michael Bamshad, and Suzanne Leal. The Australian group was supported by a New South Wales Office of Health and Medical Research Council Sydney Genomics Collaborative grant (J.C. and L.G.R.), NHMRC project grant 1026891 (J.C.), Cancer Institute NSW fellowship 13/ECF/1-46 (M.J.C.), and generous financial support from the Kinghorn Foundation. J.C. is also grateful to the Crane and Perkins families for their generous financial support. The Italian group was supported by Pierfranco and Luisa Mariani Foundation. They also thank the Cell lines and DNA Bank of Paediatric Movement Disorders and Mitochondrial Diseases of the Telethon Genetic Biobank Network, which is supported by TELETHON Italy (project no. GTB09003) and the Bank for the Diagnosis and Research of Movement Disorders (MDB) of the EuroBiobank.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brody S, 1997, FEBS LETT, V408, P217, DOI 10.1016/S0014-5793(97)00428-6; Campbell SE, 2004, J BIOL CHEM, V279, P36235, DOI 10.1074/jbc.M400566200; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Chen C, 2014, J BIOL CHEM, V289, P17184, DOI 10.1074/jbc.M114.550806; Chen ZJ, 2008, J MOL BIOL, V379, P830, DOI 10.1016/j.jmb.2008.04.041; Chen ZJ, 2009, FASEB J, V23, P3682, DOI 10.1096/fj.09-133587; Chen ZJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005589; Clay HB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151171; Cronan JE, 2016, MICROBIOL MOL BIOL R, V80, P429, DOI 10.1128/MMBR.00073-15; Eyal E, 2004, J COMPUT CHEM, V25, P712, DOI 10.1002/jcc.10420; Feng DJ, 2009, J BIOL CHEM, V284, P11436, DOI 10.1074/jbc.M806991200; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Gubellini P, 2010, BBA-MOL BASIS DIS, V1802, P151, DOI 10.1016/j.bbadis.2009.08.001; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hermes FA, 2013, YEAST, V30, P415, DOI 10.1002/yea.2979; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Hiltunen JK, 2010, BBA-BIOENERGETICS, V1797, P1195, DOI 10.1016/j.bbabio.2010.03.006; Hiltunen JK, 2009, J BIOL CHEM, V284, P9011, DOI 10.1074/jbc.R800068200; Hug N, 2016, NUCLEIC ACIDS RES, V44, P1483, DOI 10.1093/nar/gkw010; Kastaniotis AJ, 2004, MOL MICROBIOL, V53, P1407, DOI 10.1111/j.1365-2958.2004.04191.x; Kim DG, 2014, ENDOCRINOL METAB, V29, P185, DOI 10.3803/EnM.2014.29.2.185; Kolker S, 2011, J INHERIT METAB DIS, V34, P677, DOI 10.1007/s10545-011-9289-5; Kursu VAS, 2013, MOL MICROBIOL, V90, P824, DOI 10.1111/mmi.12402; Laimer J, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0548-6; Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551; Lappalainen I, 2002, PROTEIN ENG, V15, P1005, DOI 10.1093/protein/15.12.1005; LEE SM, 1985, BIOCHEM MED METAB B, V33, P104, DOI 10.1016/0006-2944(85)90132-2; Liu XM, 2016, HUM MUTAT, V37, P235, DOI 10.1002/humu.22932; Mayr JA, 2014, J INHERIT METAB DIS, V37, P553, DOI 10.1007/s10545-014-9705-8; Mayr JA, 2011, AM J HUM GENET, V89, P792, DOI 10.1016/j.ajhg.2011.11.011; Meyer E, 2015, ANNU REV GENOM HUM G, V16, P257, DOI 10.1146/annurev-genom-090314-025011; Miinalainen IJ, 2003, J BIOL CHEM, V278, P20154, DOI 10.1074/jbc.M302851200; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; NUSSINOV R, 1991, P NATL ACAD SCI USA, V88, P10495, DOI 10.1073/pnas.88.23.10495; Paila U, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003153; Pan A, 2013, BIOCHEM BIOPH RES CO, V441, P418, DOI 10.1016/j.bbrc.2013.10.072; Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177; Parthiban V, 2006, NUCLEIC ACIDS RES, V34, pW239, DOI 10.1093/nar/gkl190; Pires DEV, 2014, NUCLEIC ACIDS RES, V42, pW314, DOI 10.1093/nar/gku411; Pires DEV, 2014, BIOINFORMATICS, V30, P335, DOI 10.1093/bioinformatics/btt691; Platta H, 2004, BIOCHEM J, V384, P37, DOI 10.1042/BJ20040572; Rasool N, 2016, SEMIN OPHTHALMOL, V31, P107, DOI 10.3109/08820538.2015.1115251; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001; Schneider SA, 2010, EUR J NEUROL, V17, P52, DOI 10.1111/j.1468-1331.2010.03051.x; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Smith S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047196; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Torkko JM, 2001, MOL CELL BIOL, V21, P6243, DOI 10.1128/MCB.21.18.6243-6253.2001; Tort F, 2014, HUM MOL GENET, V23, P1907, DOI 10.1093/hmg/ddt585; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Wada H, 1997, P NATL ACAD SCI USA, V94, P1591, DOI 10.1073/pnas.94.4.1591; Wang M, 2006, GENE, V366, P219, DOI 10.1016/j.gene.2005.07.015; Worth CL, 2011, NUCLEIC ACIDS RES, V39, pW215, DOI 10.1093/nar/gkr363; Yi XW, 2005, MOL CELL BIOL, V25, P8387, DOI 10.1128/MCB.25.18.8387-8392.2005; Zuccoli G, 2015, NEURORADIOLOGY, V57, P973, DOI 10.1007/s00234-015-1568-7	58	57	60	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 1	2016	99	6					1229	1244		10.1016/j.ajhg.2016.09.021	http://dx.doi.org/10.1016/j.ajhg.2016.09.021			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ED8VI	27817865	Green Published, Bronze			2022-12-18	WOS:000389148600001
J	McEntagart, M; Williamson, KA; Rainger, JK; Wheeler, A; Seawright, A; De Baere, E; Verdin, H; Bergendahl, LT; Quigley, A; Rainger, J; Dixit, A; Sarkar, A; Laso, EL; Sanchez-Carpintero, R; Barrio, J; Bitoun, P; Prescott, T; Riise, R; McKee, S; Cook, J; McKie, L; Ceulemans, B; Meire, F; Temple, IK; Prieur, F; Williams, J; Clouston, P; Nemeth, AH; Banka, S; Bengani, H; Handley, M; Freyer, E; Ross, A; van Heyningen, V; Marsh, JA; Elmslie, F; FitzPatrick, DR				McEntagart, Meriel; Williamson, Kathleen A.; Rainger, Jacqueline K.; Wheeler, Ann; Seawright, Anne; De Baere, Elfride; Verdin, Hannah; Bergendahl, L. Therese; Quigley, Alan; Rainger, Joe; Dixit, Abhijit; Sarkar, Ajoy; Lopez Laso, Eduardo; Sanchez-Carpintero, Rocio; Barrio, Jesus; Bitoun, Pierre; Prescott, Trine; Riise, Ruth; McKee, Shane; Cook, Jackie; McKie, Lisa; Ceulemans, Berten; Meire, Francoise; Temple, I. Karen; Prieur, Fabienne; Williams, Jonathan; Clouston, Penny; Nemeth, Andrea H.; Banka, Siddharth; Bengani, Hemant; Handley, Mark; Freyer, Elisabeth; Ross, Allyson; van Heyningen, Veronica; Marsh, Joseph A.; Elmslie, Frances; FitzPatrick, David R.		DDD Study	A Restricted Repertoire of De Novo Mutations in ITPR1 Cause Gillespie Syndrome with Evidence for Dominant-Negative Effect	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE DELETION; MISSENSE MUTATIONS; CEREBELLAR-ATAXIA; ANIRIDIA; PHENOTYPE; CHANNEL; DYSFUNCTION; DISCOVERY; FAMILIES; NUCLEUS	Gillespie syndrome (GS) is characterized by bilateral iris hypoplasia, congenital hypotonia, non-progressive ataxia, and progressive cerebellar atrophy. Trio-based exome sequencing identified de novo mutations in ITPR1 in three unrelated individuals with GS recruited to the Deciphering Developmental Disorders study. Whole-exome or targeted sequence analysis identified plausible disease-causing ITPR1 mutations in 10/10 additional GS-affected individuals. These ultra-rare protein-altering variants affected only three residues in ITPR1: Glu2094 missense (one de novo, one co-segregating), Gly2539 missense (five de novo, one inheritance uncertain), and Lys2596 in-frame deletion (four de novo). No clinical or radiological differences were evident between individuals with different mutations. ITPR1 encodes an inositol 1,4,5-triphosphate-responsive calcium channel. The homo-tetrameric structure has been solved by cryoelectron microscopy. Using estimations of the degree of structural change induced by known recessive-and dominant-negative mutations in other disease-associated multimeric channels, we developed a generalizable computational approach to indicate the likely mutational mechanism. This analysis supports a dominant-negative mechanism for GS variants in ITPR1. In GS-derived lymphoblastoid cell lines (LCLs), the proportion of ITPR1-positive cells using immunofluorescence was significantly higher in mutant than control LCLs, consistent with an abnormality of nuclear calcium signaling feedback control. Super-resolution imaging supports the existence of an ITPR1-lined nucleoplasmic reticulum. Mice with Itpr1 heterozygous null mutations showed no major iris defects. Purkinje cells of the cerebellum appear to be the most sensitive to impaired ITPR1 function in humans. Iris hypoplasia is likely to result from either complete loss of ITPR1 activity or structure-specific disruption of multimeric interactions.	[McEntagart, Meriel; Elmslie, Frances] St Georges Univ Hosp NHS Fdn Trust, Med Genet, Cranmer Terrace, London SW17 0RE, England; [Williamson, Kathleen A.; Rainger, Jacqueline K.; Wheeler, Ann; Seawright, Anne; Bergendahl, L. Therese; Rainger, Joe; McKie, Lisa; Bengani, Hemant; Handley, Mark; Freyer, Elisabeth; Ross, Allyson; van Heyningen, Veronica; Marsh, Joseph A.; FitzPatrick, David R.] Univ Edinburgh, Western Gen Hosp, IGMM, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Rainger, Joe] Univ Edinburgh, Roslin Inst, Easter Bush EH25 9RG, Midlothian, Scotland; [Bitoun, Pierre] CHU Paris Seine St Denis, St Hop Jean Verdier, Serv Pediat, Ave 14 Juillet, F-93140 Bondy, France; [Prescott, Trine] Oslo Univ Hosp, Dept Med Genet, N-0424 Oslo, Norway; [Riise, Ruth] Innland Hosp, Dept Ophthalmol, N-2418 Elverum, Norway; [McKee, Shane] Belfast City Hosp, Northern Ireland Reg Genet Serv, Belfast BT9 7AB, Antrim, North Ireland; [Dixit, Abhijit; Sarkar, Ajoy] City Hosp Nottingham, Clin Genet, Hucknall Rd, Nottingham NG5 1PB, England; [De Baere, Elfride; Verdin, Hannah] Ghent Univ Hosp, CMGG, MRB,1st Floor,Room 110-029,Pinte Laan 185, B-9000 Ghent, Belgium; [Cook, Jackie] Sheffield Childrens Hosp, Sheffield Clin Genet Serv, Western Bank, Sheffield S10 2TH, S Yorkshire, England; [Temple, I. Karen] Univ Southampton, Southampton Univ Hosp, Human Dev & Hlth Acad Unit, Tremona Rd, Southampton SO16 6YD, Hants, England; [Prieur, Fabienne] CHU St Etienne, Serv Genet Plateau Biol, F-42055 St Etienne 2, France; [Lopez Laso, Eduardo] Reina Sofia Univ Hosp, Dept Pediat, Pediat Neurol Unit, Av Menendez Pidal S-N, Cordoba 14004, Spain; [Sanchez-Carpintero, Rocio] Univ Navarra Clin, Dept Paediat, Paediat Neurol Unit, Pamplona 31008, Spain; [DDD Study] Wellcome Trust Sanger Inst, DDD Study, Cambridge CB10 1SA, England; [Banka, Siddharth] Univ Manchester, St Marys Hosp, Manchester Ctr Genom Med, Oxford Rd, Manchester M13 9WL, Lancs, England; [Williams, Jonathan; Clouston, Penny] Churchill Hosp, Oxford Univ Hosp NHS Trust, Oxford Med Genet Labs, Old Rd, Oxford OX3 7LE, England; [Quigley, Alan] Royal Hosp Sick Children, Dept Radiol, Edinburgh EH9 1LF, Midlothian, Scotland; [Nemeth, Andrea H.] Univ Oxford, Nuffield Dept Clin Neurosci, S Parks Rd, Oxford OX3 7LJ, England; [Barrio, Jesus] Univ Navarra Clin, Dept Ophthalmol, Pamplona 31008, Spain; [Ceulemans, Berten] Univ & Univ Hosp Antwerp, Dept Neurol Pediat Neurol, B-2650 Antwerp, Belgium; [Meire, Francoise] Queen Fabiola Childrens Univ Hosp, Dept Ophthalmol, B-1020 Brussels, Belgium	University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Oslo; Innlandet Hospital Trust; Belfast City Hospital; Nottingham University Hospital NHS Trust; Nottingham City Hospital; Ghent University; Ghent University Hospital; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; University of Southampton; CHU de St Etienne; University of Navarra; Wellcome Trust Sanger Institute; University of Manchester; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford; University of Navarra; University of Antwerp	FitzPatrick, DR (corresponding author), Univ Edinburgh, Western Gen Hosp, IGMM, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland.	david.fitzpatrick@ed.ac.uk	De Baere, Elfride/E-7405-2017; VAN HEYNINGEN, Veronica/GYE-0531-2022; Sanchez-Carpintero, Rocio/C-4411-2012	De Baere, Elfride/0000-0002-5609-6895; Sanchez-Carpintero, Rocio/0000-0002-5058-0686; Handley, Mark/0000-0001-7200-747X; van Heyningen, Veronica/0000-0003-0359-0141; Williams, Jonathan/0000-0003-2672-2450; Wheeler, Ann/0000-0001-8617-827X; Temple, Isabel Karen/0000-0002-6045-1781; Bitoun, Pierre/0000-0001-6557-6826; FitzPatrick, David R./0000-0003-4861-969X; Nemeth, Andrea/0000-0002-2941-7657; Ceulemans, Berten/0000-0001-7818-0679; Marsh, Joseph/0000-0003-4132-0628; Banka, Siddharth/0000-0002-8527-2210; Rainger, Joe/0000-0003-1091-5100; McKie, Lisa/0000-0001-9350-4344	Wellcome Trust [HICF-1009-003]; Department of Health [HICF-1009-003]; Wellcome Trust Sanger Institute [WT098051]; National Institute for Health Research, through the Comprehensive Clinical Research Network; Action Medical Research; Henry Smith Charity; Medical Research Council (UK); Medical Research Council [MR/M02122X/1]; NewLife [14-15/07, 13-14/02]; MRC [MC_UP_1502/3, MR/M02122X/1, MC_PC_U127561093, MC_U127527199, MR/K01563X/1, MC_PC_U127527199, MC_U127561093] Funding Source: UKRI; Medical Research Council [MR/K01563X/1, MC_PC_U127527199, MC_U127527199, MC_U127561093, MC_PC_U127561093, MC_UP_1502/3] Funding Source: researchfish; Action Medical Research [2063] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Department of Health; Wellcome Trust Sanger Institute(Wellcome Trust); National Institute for Health Research, through the Comprehensive Clinical Research Network(National Institute for Health Research (NIHR)); Action Medical Research; Henry Smith Charity; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NewLife; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Action Medical Research	The DDD study presents independent research commissioned by the Health Innovation Challenge Fund (grant number HICF-1009-003), a parallel funding partnership between the Wellcome Trust and the Department of Health, and the Wellcome Trust Sanger Institute (grant number WT098051). The views expressed in this publication are those of the author(s) and not necessarily those of the Wellcome Trust or the Department of Health. The research team acknowledges the support of the National Institute for Health Research, through the Comprehensive Clinical Research Network. A.H.N. is funded by Action Medical Research and The Henry Smith Charity. K.A.W., A. Seawright, J.K.R., J.R., E.F., A.W., L.McK., A.R., V.v.H., and D.R.F. are funded by a program grant as part of the Medical Research Council (UK) grant to the University of Edinburgh for the MRC Human Genetics Unit. J.A.M. is supported by a Medical Research Council Career Development Award (MR/M02122X/1). H.B. and M.H. are funded by grants from NewLife (14-15/07 and 13-14/02, respectively).	Akawi N, 2015, NAT GENET, V47, P1363, DOI 10.1038/ng.3410; Ansari M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153757; Bennett DLH, 2014, LANCET NEUROL, V13, P587, DOI 10.1016/S1474-4422(14)70024-9; Chang TC, 2012, BRIT J OPHTHALMOL, V96, P318, DOI 10.1136/bjophthalmol-2011-300801; CRAWFURD MDA, 1979, J MED GENET, V16, P373, DOI 10.1136/jmg.16.5.373; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Dellis O, 2006, SCIENCE, V313, P229, DOI 10.1126/science.1125203; Di Gregorio E, 2010, CEREBELLUM, V9, P115, DOI 10.1007/s12311-009-0154-0; Echevarria W, 2003, NAT CELL BIOL, V5, P440, DOI 10.1038/ncb980; Fan GZ, 2015, NATURE, V527, P336, DOI 10.1038/nature15249; Firth HV, 2011, DEV MED CHILD NEUROL, V53, P702, DOI 10.1111/j.1469-8749.2011.04032.x; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; FRANCOIS J, 1984, OPHTHALMIC PAED GEN, V4, P29, DOI 10.3109/13816818409009891; Ganesamoorthy D, 2009, CLIN CHEM, V55, P1415, DOI 10.1373/clinchem.2009.124958; Gerber S, 2016, AM J HUM GENET, V98, P971, DOI 10.1016/j.ajhg.2016.03.004; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hingorani M, 2012, EUR J HUM GENET, V20, P1011, DOI 10.1038/ejhg.2012.100; Huang LJ, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-67; Ito YA, 2009, INVEST OPHTH VIS SCI, V50, P3573, DOI 10.1167/iovs.08-3032; Khan AO, 2011, MOL VIS, V17, P708; Koller A, 2003, BIOCHEM BIOPH RES CO, V300, P155, DOI 10.1016/S0006-291X(02)02799-7; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Lui PPY, 2003, BIOCHEM BIOPH RES CO, V308, P826, DOI 10.1016/S0006-291X(03)01469-4; Mann I C, 1925, Br J Ophthalmol, V9, P495, DOI 10.1136/bjo.9.10.495; Marelli C, 2011, ARCH NEUROL-CHICAGO, V68, P637, DOI 10.1001/archneurol.2011.81; Marien P, 2008, CORTEX, V44, P54, DOI 10.1016/j.cortex.2005.12.001; MIKOSHIBA K, 1992, CIBA F SYMP, V164, P17; Mulders SM, 1998, J CLIN INVEST, V102, P57, DOI 10.1172/JCI2605; Netland PA, 2011, J AAPOS, V15, P562, DOI 10.1016/j.jaapos.2011.07.009; Novak MJU, 2010, MOVEMENT DISORD, V25, P2176, DOI 10.1002/mds.23223; Obayashi M, 2012, J HUM GENET, V57, P202, DOI 10.1038/jhg.2012.5; Ramu A, 2013, NAT METHODS, V10, P985, DOI 10.1038/nmeth.2611; Roulez FMJ, 2014, J NEURO-OPHTHALMOL, V34, P137, DOI 10.1097/WNO.0000000000000090; Sadagopan KA, 2015, AM J MED GENET A, V167, P524, DOI 10.1002/ajmg.a.36890; Sasaki M, 2015, J NEUROL, V262, P1278, DOI 10.1007/s00415-015-7705-8; Schnekenberg RP, 2015, BRAIN, V138, P1817, DOI 10.1093/brain/awv117; Schug ZT, 2008, J BIOL CHEM, V283, P2939, DOI [10.1074/jbc.M706645200, 10.1074/jbc.M802716200]; Shadrina M I, 2016, Cerebellum Ataxias, V3, P2, DOI 10.1186/s40673-016-0040-8; Sisodiya SM, 2001, NAT GENET, V28, P214, DOI 10.1038/90042; Statland J, 2014, NEUROL CLIN, V32, P801, DOI 10.1016/j.ncl.2014.04.002; Synofzik M, 2011, J MED GENET, V48, P407, DOI 10.1136/jmg.2010.087023; TAYLOR CW, 1991, PHARMACOL THERAPEUT, V51, P97, DOI 10.1016/0163-7258(91)90043-L; VANHEYNINGEN V, 1985, P NATL ACAD SCI USA, V82, P8592; Verhulst S, 1993, Bull Soc Belge Ophtalmol, V250, P37; Webb SE, 2003, NAT REV MOL CELL BIO, V4, P539, DOI 10.1038/nrm1149; Webster G, 2013, CIRCULATION, V127, P126, DOI 10.1161/CIRCULATIONAHA.111.060343; Wells JN, 2015, BIOCHEM SOC T, V43, P1221, DOI 10.1042/BST20150159; Wright CF, 2015, LANCET, V385, P1305, DOI 10.1016/S0140-6736(14)61705-0; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108	49	57	60	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 5	2016	98	5					981	992		10.1016/j.ajhg.2016.03.018	http://dx.doi.org/10.1016/j.ajhg.2016.03.018			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DL8DF	27108798	Green Accepted, Green Published, hybrid			2022-12-18	WOS:000375869300015
J	Niihori, T; Ouchi-Uchiyama, M; Sasahara, Y; Kaneko, T; Hashii, Y; Irie, M; Sato, A; Saito-Nanjo, Y; Funayama, R; Nagashima, T; Inoue, S; Nakayama, K; Ozono, K; Kure, S; Matsubara, Y; Imaizumi, M; Aoki, Y				Niihori, Tetsuya; Ouchi-Uchiyama, Meri; Sasahara, Yoji; Kaneko, Takashi; Hashii, Yoshiko; Irie, Masahiro; Sato, Atsushi; Saito-Nanjo, Yuka; Funayama, Ryo; Nagashima, Takeshi; Inoue, Shin-ichi; Nakayama, Keiko; Ozono, Keiichi; Kure, Shigeo; Matsubara, Yoichi; Imaizumi, Masue; Aoki, Yoko			Mutations in MECOM, Encoding Oncoprotein EVI1, Cause Radioulnar Synostosis with Amegakaryocytic Thrombocytopenia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MYELOID-TRANSFORMING GENE; BONE-MARROW FAILURE; INTEGRATION SITE 1; CELL SELF-RENEWAL; CONGENITAL THROMBOCYTOPENIA; POINT MUTATIONS; HOXA11 MUTATION; ZINC FINGERS; EXPRESSION; PROTEIN	Radioulnar synostosis with amegakaryocytic thrombocytopenia (RUSAT) is an inherited bone marrow failure syndrome, characterized by thrombocytopenia and congenital fusion of the radius and ulna. A heterozygous HOXA11 mutation has been identified in two unrelated families as a cause of RUSAT. However, HOXA11 mutations are absent in a number of individuals with RUSAT, which suggests that other genetic loci contribute to RUSAT. In the current study, we performed whole exome sequencing in an individual with RUSAT and her healthy parents and identified a de novo missense mutation in MECOM, encoding EVI1, in the individual with RUSAT. Subsequent analysis of MECOM in two other individuals with RUSAT revealed two additional missense mutations. These three mutations were clustered within the 8th zinc finger motif of the C-terminal zinc finger domain of EVI1. Chromatin immunoprecipitation and qPCR assays of the regions harboring the ETS-like motif that is known as an EVI1 binding site showed a reduction in immunoprecipitated DNA for two EVI1 mutants compared with wild-type EVI1. Furthermore, reporter assays showed that MECOM mutations led to alterations in both AP-1-and TGF-beta-mediated transcriptional responses. These functional assays suggest that transcriptional dysregulation by mutant EVI1 could be associated with the development of RUSAT. We report missense mutations in MECOM resulting in a Mendelian disorder that provide compelling evidence for the critical role of EVI1 in normal hematopoiesis and in the development of forelimbs and fingers in humans.	[Niihori, Tetsuya; Inoue, Shin-ichi; Matsubara, Yoichi; Aoki, Yoko] Tohoku Univ, Sch Med, Dept Med Genet, Sendai, Miyagi 9808574, Japan; [Ouchi-Uchiyama, Meri; Sasahara, Yoji; Irie, Masahiro; Saito-Nanjo, Yuka; Kure, Shigeo] Tohoku Univ, Sch Med, Dept Pediat, Sendai, Miyagi 9808574, Japan; [Ouchi-Uchiyama, Meri; Irie, Masahiro; Sato, Atsushi; Saito-Nanjo, Yuka; Imaizumi, Masue] Miyagi Childrens Hosp, Dept Hematol & Oncol, Sendai, Miyagi 9893126, Japan; [Kaneko, Takashi] Tokyo Metropolitan Childrens Med Ctr, Dept Hematol Oncol, Fuchu, Tokyo 1838561, Japan; [Hashii, Yoshiko; Ozono, Keiichi] Osaka Univ, Grad Sch Med, Dept Pediat, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Funayama, Ryo; Nagashima, Takeshi; Nakayama, Keiko] Tohoku Univ, Grad Sch Med, United Ctr Adv Res & Translat Med, Div Cell Proliferat, Sendai, Miyagi 9808575, Japan; [Matsubara, Yoichi] Natl Res Inst Child Hlth & Dev, Tokyo 1578535, Japan	Tohoku University; Tohoku University; Tokyo Metropolitan Children's Medical Center; Osaka University; Tohoku University; National Center for Child Health & Development - Japan	Niihori, T (corresponding author), Tohoku Univ, Sch Med, Dept Med Genet, Sendai, Miyagi 9808574, Japan.	tniihori@med.tohoku.ac.jp	Niihori, Tetsuya/ABE-2350-2021	Niihori, Tetsuya/0000-0002-2118-9776	Practical Research Project for Rare/Intractable Diseases from Japan Agency for Medical Research and Development (AMED); Grants-in-Aid for Scientific Research [26461562, 26830064] Funding Source: KAKEN	Practical Research Project for Rare/Intractable Diseases from Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank the patients who participated in this study and their families and doctors. We are grateful to Dr. Joan Massague and Dr. Jeff Wrana for p3TP-lux (Addgene plasmid #11767). We also thank Yoko Tateda, Kumi Kato, Miyuki Tsuda, Mami Kikuchi, and Kiyotaka Kuroda for their technical assistance. This work was supported by the Practical Research Project for Rare/Intractable Diseases from Japan Agency for Medical Research and Development (AMED) to T. Niihori, Y.M., and Y.A.	Acuna-Hidalgo R, 2015, AM J HUM GENET, V97, P67, DOI 10.1016/j.ajhg.2015.05.008; Albers CA, 2012, NAT GENET, V44, P435, DOI 10.1038/ng.1083; Bard-Chapeau EA, 2012, P NATL ACAD SCI USA, V109, P2168, DOI 10.1073/pnas.1119229109; Brooks DJ, 1996, BRIT J CANCER, V74, P1518, DOI 10.1038/bjc.1996.583; Castillo-Caro P, 2010, J PEDIAT HEMATOL ONC, V32, P479, DOI 10.1097/MPH.0b013e3181e5129d; DELWEL R, 1993, MOL CELL BIOL, V13, P4291, DOI 10.1128/MCB.13.7.4291; Dutta P, 2013, MOL ONCOL, V7, P647, DOI 10.1016/j.molonc.2013.02.008; FUNABIKI T, 1994, ONCOGENE, V9, P1575; Glass C, 2014, BLOOD CELL MOL DIS, V53, P67, DOI 10.1016/j.bcmd.2014.01.002; Imanishi D, 2007, BLOOD, V110, P2231, DOI 10.1182/blood-2007-02-071423; Kataoka K, 2012, CANCER SCI, V103, P1371, DOI 10.1111/j.1349-7006.2012.02303.x; Kataoka K, 2011, J EXP MED, V208, P2402, DOI 10.1084/jem.20110447; Kurokawa M, 1998, NATURE, V394, P92, DOI 10.1038/27945; Laricchia-Robbio L, 2006, MOL CELL BIOL, V26, P7658, DOI 10.1128/MCB.00363-06; Laricchia-Robbio L, 2009, CANCER RES, V69, P1633, DOI 10.1158/0008-5472.CAN-08-2562; Liu Y, 2006, ONCOGENE, V25, P3565, DOI 10.1038/sj.onc.1209403; MORISHITA K, 1988, CELL, V54, P831, DOI 10.1016/S0092-8674(88)91175-0; Nielsen M, 2012, J MED GENET, V49, P598, DOI 10.1136/jmedgenet-2012-100990; Niihori T, 2011, J HUM GENET, V56, P707, DOI 10.1038/jhg.2011.85; Parkinson N, 2006, PLOS GENET, V2, P1556, DOI 10.1371/journal.pgen.0020149; PERKINS AS, 1991, DEVELOPMENT, V111, P479; Senyuk V, 2007, CANCER RES, V67, P5658, DOI 10.1158/0008-5472.CAN-06-3962; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Sugita M, 2007, HAEMATOL-HEMATOL J, V92, P280; TANAKA T, 1994, J BIOL CHEM, V269, P24020; Thiede C, 2000, BONE MARROW TRANSPL, V25, P575, DOI 10.1038/sj.bmt.1702170; Thompson AA, 2000, NAT GENET, V26, P397, DOI 10.1038/82511; Thompson AA, 2001, BRIT J HAEMATOL, V113, P866, DOI 10.1046/j.1365-2141.2001.02834.x; Wieser R, 2007, GENE, V396, P346, DOI 10.1016/j.gene.2007.04.012; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Yoshida H, 2010, INT J HEMATOL, V91, P331, DOI 10.1007/s12185-010-0494-z	32	57	59	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2015	97	6					848	854		10.1016/j.ajhg.2015.10.010	http://dx.doi.org/10.1016/j.ajhg.2015.10.010			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DB3UM	26581901	Green Published, Bronze			2022-12-18	WOS:000368437900006
J	Powel, CA; Kopajtich, R; D'Souza, AR; Rorbach, J; Kremer, LS; Husain, RA; Dallabona, C; Donnini, C; Alston, CL; Griffin, H; Pyle, A; Chinnery, PF; Strom, TM; Meitinger, T; Rodenburg, RJ; Schottmann, G; Schuelke, M; Romain, N; Haller, RG; Ferrero, I; Haack, TB; Taylor, RW; Prokisch, H; Minczukl, M				Powel, Christopher A.; Kopajtich, Robert; D'Souza, Aaron R.; Rorbach, Joanna; Kremer, Laura S.; Husain, Ralf A.; Dallabona, Cristina; Donnini, Claudia; Alston, Charlotte L.; Griffin, Helen; Pyle, Angela; Chinnery, Patrick F.; Strom, Tim M.; Meitinger, Thomas; Rodenburg, Richard J.; Schottmann, Gudrun; Schuelke, Markus; Romain, Nadine; Haller, Ronald G.; Ferrero, Ileana; Haack, Tobias B.; Taylor, Robert W.; Prokisch, Holger; Minczukl, Michal			TRMT5 Mutations Cause a Defect in Post-transcriptional Modification of Mitochondrial tRNA Associated with Multiple Respiratory-Chain Deficiencies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HYPERTROPHIC CARDIOMYOPATHY; SIDEROBLASTIC ANEMIA; LACTIC-ACIDOSIS; TRANSLATION; ANTICODON; MYOPATHY	Deficiencies in respiratory-chain complexes lead to a variety of clinical phenotypes resulting from inadequate energy production by the mitochondrial oxidative phosphorylation system. Defective expression of mtDNA-encoded genes, caused by mutations in either the mitochondrial or nuclear genome, represents a rapidly growing group of human disorders. By whole-exome sequencing, we identified two unrelated individuals carrying compound heterozygous variants in TRMT5 (tRNA methyltransferase 5). TRMT5 encodes a mitochondrial protein with strong homology to members of the class I-like methyltransferase superfamily. Both affected individuals presented with lactic acidosis and evidence of multiple mitochondrial respiratory-chain-complex deficiencies in skeletal muscle, although the clinical presentation of the two affected subjects was remarkably different; one presented in childhood with failure to thrive and hypertrophic cardiomyopathy, and the other was an adult with a life-long history of exercise intolerance. Mutations in TRMT5 were associated with the hypomodification of a guanosine residue at position 37 (G37) of mitochondrial tRNA; this hypomodification was particularly prominent in skeletal muscle. Deficiency of the G37 modification was also detected in human cells subjected to TRMT5 RNAi. The pathogenicity of the detected variants was further confirmed in a heterologous yeast model and by the rescue of the molecular phenotype after re-expression of wild-type TRMT5 cDNA in cells derived from the affected individuals. Our study highlights the importance of post-transcriptional modification of mitochondrial tRNAs for faithful mitochondrial function.	[Powel, Christopher A.; D'Souza, Aaron R.; Rorbach, Joanna; Minczukl, Michal] MRC, Mitochondrial Biol Unit, Cambridge CB2 OXY, England; [Kopajtich, Robert; Kremer, Laura S.; Strom, Tim M.; Meitinger, Thomas; Haack, Tobias B.; Prokisch, Holger] German Res Ctr Environm Hlth, Inst Human Genet Helmholtz Zent Munchen, D-85764 Neuherberg, Germany; [Kopajtich, Robert; Kremer, Laura S.; Strom, Tim M.; Meitinger, Thomas; Haack, Tobias B.] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Husain, Ralf A.] Jena Univ Hosp, Dept Neuropediatr, D-07740 Jena, Germany; [Dallabona, Cristina; Donnini, Claudia; Ferrero, Ileana] Univ Parma, Dept Life Sci, I-43124 Parma, Italy; [Alston, Charlotte L.; Taylor, Robert W.] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Griffin, Helen; Pyle, Angela; Chinnery, Patrick F.] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Meitinger, Thomas] German Ctr Cardiovasc Res, Munich Heart Alliance, D-81675 Munich, Germany; [Rodenburg, Richard J.] Radboud Univ Nijmegen Med Ctr, Dept Pediat, Nijmegen Ctr Mitochondrial Disorders, NL-6500HB Nijmegen, Netherlands; [Schottmann, Gudrun; Schuelke, Markus] Charite, Dept Neuropediatr, D-13353 Berlin, Germany; [Schottmann, Gudrun; Schuelke, Markus] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany; [Romain, Nadine; Haller, Ronald G.] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75231 USA; [Romain, Nadine; Haller, Ronald G.] Neuromuscular Ctr, Inst Exercise & Environm Med, Texas Hlth Presbyterian Hosp Dallas, Dallas, TX 75231 USA	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Friedrich Schiller University of Jena; University of Parma; Newcastle University - UK; Newcastle University - UK; German Centre for Cardiovascular Research; Munich Heart Alliance; Radboud University Nijmegen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Texas System; University of Texas Southwestern Medical Center Dallas	Prokisch, H (corresponding author), German Res Ctr Environm Hlth, Inst Human Genet Helmholtz Zent Munchen, D-85764 Neuherberg, Germany.	prokisch@helmholtz-muenchen.de; michal.minczuk@mrc-mbu.cam.ac.uk	Rodenburg, Richard/N-3579-2014; Husain, Ralf A./AAO-7658-2020; Meitinger, Thomas/O-1318-2015; Alston, Charlotte/ABG-9602-2020; rorbach, Joanna/AAM-5683-2021; Donnini, Claudia/B-5548-2015; Minczuk, Michal/G-1638-2014	Rodenburg, Richard/0000-0001-5227-3527; Husain, Ralf A./0000-0003-0798-6346; Alston, Charlotte/0000-0003-2095-5464; rorbach, Joanna/0000-0002-2891-2840; DALLABONA, Cristina/0000-0003-4397-9143; Meitinger, Thomas/0000-0002-8838-8403; Romain, Nadine/0000-0003-2492-549X; Schuelke, Markus/0000-0003-2824-3891; Prokisch, Holger/0000-0003-2379-6286; Donnini, Claudia/0000-0002-4901-2358; Minczuk, Michal/0000-0001-8242-1420; Chinnery, Patrick/0000-0002-7065-6617; Griffin, Helen R/0000-0002-5288-3322; Kremer, Laura/0000-0002-1647-7538; Powell, Christopher/0000-0001-7501-0586	Medical Research Council UK [MC_U105697135]; German Bundesministerium fur Bildung und Forschung through E-Rare project GENOMIT [01GM1207]; German Network or Mitochondrial Disorders [01GM1113C, 01GM0866]; Juniorverbund in der Systemmedizin "mitOmics" [FKZ 01ZX1405C]; German Center for Heart Research [Z76010017300, Z56010015300]; Wellcome Trust Strategic Award [096919/Z/11/Z]; Medical Research Council Centre for Neuromuscular Diseases [G0601943]; UK National Health Service Highly Specialised "Rare Mitochondrial Disorders of Adults and Children" Service; Lily Foundation; National Institute for Health Research doctoral fellowship [NIHR-HCS-D12-03-04]; Telethon Italy [GGP11011]; Medical Research Council [1372781, 1601055, G0601943, MC_U105697135] Funding Source: researchfish; National Institute for Health Research [NIHR-HCS-D12-03-04] Funding Source: researchfish; MRC [G0601943, MC_U105697135] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); German Bundesministerium fur Bildung und Forschung through E-Rare project GENOMIT(Federal Ministry of Education & Research (BMBF)); German Network or Mitochondrial Disorders; Juniorverbund in der Systemmedizin "mitOmics"; German Center for Heart Research; Wellcome Trust Strategic Award(Wellcome Trust); Medical Research Council Centre for Neuromuscular Diseases(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK National Health Service Highly Specialised "Rare Mitochondrial Disorders of Adults and Children" Service; Lily Foundation; National Institute for Health Research doctoral fellowship; Telethon Italy(Fondazione Telethon); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Medical Research Council UK (MC_U105697135 to J.R., C.A.P., A.D., and M.M.), the German Bundesministerium fur Bildung und Forschung through funding of the E-Rare project GENOMIT (01GM1207 to T.M. and H.P.), the German Network or Mitochondrial Disorders (01GM1113C and 01GM0866 to T.M., H.P., and M.S.), the Juniorverbund in der Systemmedizin "mitOmics" (FKZ 01ZX1405C to T.B.H.), the German Center for Heart Research (Z76010017300 and Z56010015300 to T.M.), the Wellcome Trust Strategic Award (096919/Z/11/Z to R.W.T. and P.F.C.), the Medical Research Council Centre for Neuromuscular Diseases (G0601943 to R.W.T. and P.F.C.), the UK National Health Service Highly Specialised "Rare Mitochondrial Disorders of Adults and Children" Service (C.L.A. and R.W.T.), the Lily Foundation (R.W.T.), a National Institute for Health Research doctoral fellowship (NIHR-HCS-D12-03-04 to C.L.A.), and Telethon Italy grant GGP11011 (C. Dallabona, C. Donnini, and I.F.). P.F.C. is a Wellcome Trust Senior Fellow in Clinical Science (101876/Z/13/Z) and a UK National Institute for Health Research Senior Investigator.	Acham-Roschitz B, 2009, MOL GENET METAB, V98, P300, DOI 10.1016/j.ymgme.2009.06.012; Becker L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114918; BJORK GR, 1989, SCIENCE, V244, P986, DOI 10.1126/science.2471265; Bjork GR, 2001, EMBO J, V20, P231, DOI 10.1093/emboj/20.1.231; Blakely EL, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.011296; Blakely E, 2008, NEUROMUSCULAR DISORD, V18, P557, DOI 10.1016/j.nmd.2008.04.014; Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358; Brule H, 1998, NUCLEIC ACIDS RES, V26, P537, DOI 10.1093/nar/26.2.537; Brule H, 2004, BIOCHEMISTRY-US, V43, P9243, DOI 10.1021/bi049671q; Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530; Chakraborty PK, 2014, BLOOD, V124, P2867, DOI 10.1182/blood-2014-08-591370; Christian T, 2007, J MOL BIOL, V373, P623, DOI 10.1016/j.jmb.2007.08.010; Christian T, 2013, RNA, V19, P1192, DOI 10.1261/rna.039503.113; Christian T, 2010, RNA, V16, P2484, DOI 10.1261/rna.2376210; Deutschmann AJ, 2014, HUM MOL GENET, V23, P3618, DOI 10.1093/hmg/ddu072; Euro L, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00021; Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011; Haack TB, 2013, AM J HUM GENET, V93, P211, DOI 10.1016/j.ajhg.2013.06.006; Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846; HAGERVALL TG, 1990, BIOCHIM BIOPHYS ACTA, V1050, P263, DOI 10.1016/0167-4781(90)90178-5; HALLER RG, 1989, J CLIN INVEST, V84, P155, DOI 10.1172/JCI114135; Helm M, 2014, CHEM BIOL, V21, P174, DOI 10.1016/j.chembiol.2013.10.015; Kirino Y, 2006, HUM MOL GENET, V15, P897, DOI 10.1093/hmg/ddl007; Kopajtich R, 2014, AM J HUM GENET, V95, P708, DOI 10.1016/j.ajhg.2014.10.017; Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501; Lee C, 2007, J BIOL CHEM, V282, P27744, DOI 10.1074/jbc.M704572200; Li JN, 1997, J MOL BIOL, V271, P209, DOI 10.1006/jmbi.1997.1176; Mayr J. A., 2015, J INHERIT METAB DIS; Minczuk M, 2010, NAT PROTOC, V5, P342, DOI 10.1038/nprot.2009.245; Nicholls TJ, 2014, HUM MOL GENET, V23, P6147, DOI 10.1093/hmg/ddu336; Nicholls TJ, 2013, INT J BIOCHEM CELL B, V45, P845, DOI 10.1016/j.biocel.2013.01.005; Paris Z, 2013, RNA, V19, P649, DOI 10.1261/rna.036665.112; Powell CA, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00079; PUTZ J, 1994, NAT STRUCT BIOL, V1, P580, DOI 10.1038/nsb0994-580; Rorbach J, 2014, MOL BIOL CELL, V25, P2542, DOI 10.1091/mbc.E14-01-0014; Sasarman F, 2015, HUM MOL GENET, V24, P2841, DOI 10.1093/hmg/ddv044; Suzuki T, 2014, NUCLEIC ACIDS RES, V42, P7346, DOI 10.1093/nar/gku390; Synofzik M, 2014, AM J HUM GENET, V95, P689, DOI 10.1016/j.ajhg.2014.10.013; Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184; Tischner C, 2015, HUM MOL GENET, V24, P2247, DOI 10.1093/hmg/ddu743; Urbonavicius J, 2001, EMBO J, V20, P4863, DOI 10.1093/emboj/20.17.4863; Van Haute L, 2015, J INHERIT METAB DIS, V38, P655, DOI 10.1007/s10545-015-9859-z; Wei FY, 2015, CELL METAB, V21, P428, DOI 10.1016/j.cmet.2015.01.019; Yarham JW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004424; Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27; Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004	46	57	58	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 6	2015	97	2					319	328		10.1016/j.ajhg.2015.06.011	http://dx.doi.org/10.1016/j.ajhg.2015.06.011			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CO7GY	26189817	Green Published, hybrid			2022-12-18	WOS:000359328800012
J	Cottenie, E; Kochanski, A; Jordanova, A; Bansagi, B; Zimon, M; Horga, A; Jaunmuktane, Z; Saveri, P; Rasic, VM; Baets, J; Bartsakoulia, M; Ploski, R; Teterycz, P; Nikolic, M; Quinlivan, R; Laura, M; Sweeney, MG; Taroni, F; Lunn, MP; Moroni, I; Gonzalez, M; Hanna, MG; Bettencourt, C; Chabrol, E; Franke, A; von Au, K; Schilhabel, M; Kabzinska, D; Hausmanowa-Petrusewicz, I; Brandner, S; Lim, SC; Song, HW; Choi, BO; Horvath, R; Chung, KW; Zuchner, S; Pareyson, D; Harms, M; Reilly, MM; Houlden, H				Cottenie, Ellen; Kochanski, Andrzej; Jordanova, Albena; Bansagi, Boglarka; Zimon, Magdalena; Horga, Alejandro; Jaunmuktane, Zane; Saveri, Paola; Rasic, Vedrana Milic; Baets, Jonathan; Bartsakoulia, Marina; Ploski, Rafal; Teterycz, Pawel; Nikolic, Milos; Quinlivan, Ros; Laura, Matilde; Sweeney, Mary G.; Taroni, Franco; Lunn, Michael P.; Moroni, Isabella; Gonzalez, Michael; Hanna, Michael G.; Bettencourt, Conceicao; Chabrol, Elodie; Franke, Andre; von Au, Katja; Schilhabel, Markus; Kabzinska, Dagmara; Hausmanowa-Petrusewicz, Irena; Brandner, Sebastian; Lim, Siew Choo; Song, Haiwei; Choi, Byung-Ok; Horvath, Rita; Chung, Ki-Wha; Zuchner, Stephan; Pareyson, Davide; Harms, Matthew; Reilly, Mary M.; Houlden, Henry			Truncating and Missense Mutations in IGHMBP2 Cause Charcot-Marie Tooth Disease Type 2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPINAL-MUSCULAR-ATROPHY; BINDING-PROTEIN; MOTOR-NEURONS; DIAPHRAGMATIC WEAKNESS; 1 DSMA1; GENE; SMARD1; GENOME; DOMAIN; PHENOTYPES	Using a combination of exome sequencing and linkage analysis, we investigated an English family with two affected siblings in their 40s with recessive Charcot-Marie Tooth disease type 2 (CMT2). Compound heterozygous mutations in the immunoglobulin-helicase-mu-binding protein 2 (IGHMBP2) gene were identified. Further sequencing revealed a total of 11 CMT2 families with recessively inherited IGHMBP2 gene mutations. IGHMBP2 mutations usually lead to spinal muscular atrophy with respiratory distress type 1 (SMARD1), where most infants die before 1 year of age. The individuals with CMT2 described here, have slowly progressive weakness, wasting and sensory loss, with an axonal neuropathy typical of CMT2, but no significant respiratory compromise. Segregating IGHMBP2 mutations in CMT2 were mainly loss-of-function nonsense in the 5' region of the gene in combination with a truncating frameshift, missense, or homozygous frameshift mutations in the last exon. Mutations in CMT2 were predicted to be less aggressive as compared to those in SMARD1, and fibroblast and lymphoblast studies indicate that the IGHMBP2 protein levels are significantly higher in CMT2 than SMARD1, but lower than controls, suggesting that the clinical phenotype differences are related to the IGHMBP2 protein levels.	[Cottenie, Ellen; Horga, Alejandro; Quinlivan, Ros; Laura, Matilde; Lunn, Michael P.; Hanna, Michael G.; Reilly, Mary M.; Houlden, Henry] UCL Inst Neurol, MRC Ctr Neuromuscular Dis, London WC1N 3BG, England; [Cottenie, Ellen; Horga, Alejandro; Laura, Matilde; Hanna, Michael G.; Bettencourt, Conceicao; Reilly, Mary M.; Houlden, Henry] UCL Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Sweeney, Mary G.; Houlden, Henry] Natl Hosp Neurol & Neurosurg, Neurogenet Lab, London WC1N 3BG, England; [Sweeney, Mary G.; Houlden, Henry] UCL Inst Neurol, London WC1N 3BG, England; [Kochanski, Andrzej; Kabzinska, Dagmara; Hausmanowa-Petrusewicz, Irena] Med Univ Warsaw, Ctr Biostruct, Polish Acad Sci, Neuromuscular Unit,Mossakowski Med Res Ctr, PL-02106 Warsaw, Poland; [Jordanova, Albena; Zimon, Magdalena] Univ Antwerp VIB, Dept Mol Genet, B-2610 Antwerp, Belgium; [Bansagi, Boglarka; Bartsakoulia, Marina; Horvath, Rita] Newcastle Univ, MRC Ctr Neuromuscular Dis, Inst Genet Med, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Jaunmuktane, Zane; Brandner, Sebastian] UCL Inst Neurol, Div Neuropathol, London WC1N 3BG, England; [Jaunmuktane, Zane; Brandner, Sebastian] UCL Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England; [Saveri, Paola; Pareyson, Davide] IRCCS Fdn, C Besta Neurol Inst, Clin Cent, I-20133 Milan, Italy; [Saveri, Paola; Pareyson, Davide] IRCCS Fdn, C Besta Neurol Inst, Peripheral Degenerat Neuropathies Unit, I-20133 Milan, Italy; [Rasic, Vedrana Milic] Univ Belgrade, Fac Med, Clin Neurol & Psychiat Children & Youth, Belgrade 11000, Serbia; [Baets, Jonathan] Univ Antwerp, Lab Neurogenet, B-2610 Antwerp, Belgium; [Baets, Jonathan] Univ Antwerp Hosp, Dept Neurol, Antwerp, Belgium; [Ploski, Rafal; Teterycz, Pawel] Med Univ Warsaw, Ctr Biostruct, Dept Med Genet, PL-02106 Warsaw, Poland; [Nikolic, Milos] Univ Belgrade, Fac Med, Belgrade 11000, Serbia; [Taroni, Franco] IRCCS Fdn, C Besta Neurol Inst, Unit Genet Neurodegenerat & Metab Dis, I-20133 Milan, Italy; [Moroni, Isabella] IRCCS Fdn, C Besta Neurol Inst, Child Neurol Unit, I-20133 Milan, Italy; [Gonzalez, Michael; Zuchner, Stephan] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [Chabrol, Elodie] UCL Inst Neurol, Dept Clin & Expt Epilepsy, London WC1N 3BG, England; [Franke, Andre; Schilhabel, Markus] Univ Kiel, D-24118 Kiel, Germany; [von Au, Katja] Charite, SPZ Pediat Neurol, D-13353 Berlin, Germany; [Lim, Siew Choo; Song, Haiwei] Inst Mol & Cell Biol, Singapore 138673, Singapore; [Lim, Siew Choo] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Choi, Byung-Ok] Sungkyunkwan Univ, Sch Med, Dept Neurol, Seoul 137710, South Korea; [Chung, Ki-Wha] Kongju Natl Univ, Dept Biol Sci, Chungnam 134701, South Korea; [Harms, Matthew] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	University of London; University College London; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; Medical University of Warsaw; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Flanders Institute for Biotechnology (VIB); University of Antwerp; Newcastle University - UK; University of London; University College London; University of London; University College London; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Belgrade; University of Antwerp; University of Antwerp; Medical University of Warsaw; University of Belgrade; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Miami; University of London; University College London; University of Kiel; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Zhejiang University; Sungkyunkwan University (SKKU); Kongju National University; Washington University (WUSTL)	Houlden, H (corresponding author), UCL Inst Neurol, MRC Ctr Neuromuscular Dis, Queen Sq, London WC1N 3BG, England.	h.houlden@ucl.ac.uk	Horvath, Rita/AAY-7042-2020; Jordanova, Albena/H-8323-2015; Saveri, Paola/C-8214-2019; Taroni, Franco/N-3879-2013; Jaunmuktane, Zane/ABC-9039-2020; Brandner, Sebastian/J-4562-2014; Houlden, Henry J/C-1532-2008; Moroni, Isabella/AAL-1336-2021; Pareyson, Davide/K-5890-2016; Horga, Alejandro/AAA-1086-2019; Franke, Andre/B-2151-2010	Jordanova, Albena/0000-0002-3833-3754; Saveri, Paola/0000-0002-5396-997X; Taroni, Franco/0000-0002-2420-5233; Jaunmuktane, Zane/0000-0001-7738-8881; Brandner, Sebastian/0000-0002-9821-0342; Houlden, Henry J/0000-0002-2866-7777; Moroni, Isabella/0000-0002-3322-1681; Pareyson, Davide/0000-0001-6854-765X; Franke, Andre/0000-0003-1530-5811; Ploski, Rafal/0000-0001-6286-5526; Hanna, Michael/0000-0003-0825-4075; Quinlivan, Rosaline/0000-0002-2306-4782; Chabrol, Elodie/0000-0002-8780-5375; Horga, Alejandro/0000-0002-2120-2213; Horvath, Rita/0000-0002-9841-170X; Teterycz, Pawel/0000-0001-7304-714X; Kochanski, Andrzej/0000-0002-8946-4877; Nikolic, Milos/0000-0002-3926-5394; Reilly, Mary/0000-0003-0686-905X; Bettencourt, Conceicao/0000-0001-9090-7690; Lunn, Michael/0000-0003-3174-6027	Medical Research Council (MRC UK); Wellcome Trust; Brain Research Trust (BRT); French Muscular Dystrophy Association (AFM); MRC Neuromuscular Diseases Centre grant [G0601943]; National Institutes of Neurological Diseases and Stroke and office of Rare Diseases [U54NS065712]; University of Antwerp [TOP BOF 29069]; Fund for Scientific Research-Flanders [FWO G054313N]; Ministry of Science and Technological Development, Republic of Serbia [17 3016, 17 508]; NIH [U54NS065712, R01NS075764]; CMT Association; Muscular Dystrophy Campaign (MDC); Muscular Dystrophy Association (MDA); European Research Council [309548]; Randerson Foundation; Association Belge contre les Maladies Neuromusculaires (ABMM); EU [2012-305121]; National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre (BRC); Medical Research Council [MR/K000608/1, G1001253, G0601943, G108/638, G0802760, MR/J004758/1] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS065712, R01NS075764] Funding Source: NIH RePORTER; MRC [G1001253, G0601943, G0802760, MR/J004758/1, MR/K000608/1, G108/638] Funding Source: UKRI	Medical Research Council (MRC UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Brain Research Trust (BRT); French Muscular Dystrophy Association (AFM)(Association Francaise contre les Myopathies); MRC Neuromuscular Diseases Centre grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Neurological Diseases and Stroke and office of Rare Diseases; University of Antwerp; Fund for Scientific Research-Flanders(FWO); Ministry of Science and Technological Development, Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CMT Association; Muscular Dystrophy Campaign (MDC)(Muscular Dystrophy Association); Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association); European Research Council(European Research Council (ERC)European Commission); Randerson Foundation; Association Belge contre les Maladies Neuromusculaires (ABMM); EU(European Commission); National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre (BRC); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors would like to thank all the participants of the study for their essential help with this work. This study was supported by the Medical Research Council (MRC UK), The Wellcome Trust, The Brain Research Trust (BRT), The French Muscular Dystrophy Association (AFM). We are also supported by the MRC Neuromuscular Diseases Centre grant (G0601943) and we thank the National Institutes of Neurological Diseases and Stroke and office of Rare Diseases (U54NS065712) for their support. This work was also partially funded by the University of Antwerp (TOP BOF 29069 to A.J.), the Fund for Scientific Research-Flanders (FWO G054313N to AJ.), The Ministry of Science and Technological Development, Republic of Serbia (project No. 17 3016 and 17 508), NIH (R01NS075764 and U54NS065712 S.Z.), the CMT Association (S.Z.), the Muscular Dystrophy Campaign (MDC), the Muscular Dystrophy Association (MDA), The European Research Council (309548), the Randerson Foundation, the Association Belge contre les Maladies Neuromusculaires (ABMM) and the EU FP7/2007-2013 under grant agreement number 2012-305121 (NEUROMICS). This study was also supported by the National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre (BRC).	BERTINI E, 1989, AM J MED GENET, V33, P328, DOI 10.1002/ajmg.1320330309; Bombelli F, 2014, JAMA NEUROL, V71, P1036, DOI 10.1001/jamaneurol.2014.629; Chalancon M, 2012, ARCH PEDIATRIE, V19, P1082, DOI 10.1016/j.arcped.2012.07.020; Chen NN, 1997, GENE, V185, P55, DOI 10.1016/S0378-1119(96)00630-0; Corti S, 2006, HUM MOL GENET, V15, P167, DOI 10.1093/hmg/ddi446; Corti S, 2009, J NEUROSCI, V29, P11761, DOI 10.1523/JNEUROSCI.2734-09.2009; de Planell-Saguer M, 2009, HUM MOL GENET, V18, P2115, DOI 10.1093/hmg/ddp134; Diers A, 2005, ACTA NEUROPATHOL, V110, P289, DOI 10.1007/s00401-005-1056-y; Eckart M, 2012, PEDIATRICS, V129, pE148, DOI 10.1542/peds.2011-0544; Fanos V, 2010, NEUROPEDIATRICS, V41, P132, DOI 10.1055/s-0030-1262852; FUKITA Y, 1993, J BIOL CHEM, V268, P17463; Grishin NV, 1998, TRENDS BIOCHEM SCI, V23, P329, DOI 10.1016/S0968-0004(98)01258-4; Grohmann K, 2001, NAT GENET, V29, P75, DOI 10.1038/ng703; Grohmann K, 2004, HUM MOL GENET, V13, P2031, DOI 10.1093/hmg/ddh222; Grohmann K, 2003, ANN NEUROL, V54, P719, DOI 10.1002/ana.10755; Guenther UP, 2007, HUM MUTAT, V28, P808, DOI 10.1002/humu.20525; Guenther UP, 2009, J MOL MED, V87, P31, DOI 10.1007/s00109-008-0402-7; Guenther UP, 2004, HUM GENET, V115, P319, DOI 10.1007/s00439-004-1156-0; Harel T., 2014, CLIN GENET; Hartley L, 2007, NEUROMUSCULAR DISORD, V17, P174, DOI 10.1016/j.nmd.2006.11.002; Jedrzejowska M, 2014, EUR J PAEDIATR NEURO, V18, P183, DOI 10.1016/j.ejpn.2013.11.006; Joseph S, 2009, NEUROMUSCULAR DISORD, V19, P193, DOI 10.1016/j.nmd.2008.11.013; Kaindl AM, 2008, ARCH PEDIATRIE, V15, P1568, DOI 10.1016/j.arcped.2008.07.014; Kaindl AM, 2008, J CHILD NEUROL, V23, P199, DOI 10.1177/0883073807310989; Krieger F, 2013, NEUROBIOL DIS, V54, P169, DOI 10.1016/j.nbd.2012.12.010; Lim SC, 2012, NUCLEIC ACIDS RES, V40, P11009, DOI 10.1093/nar/gks792; Lin X, 2014, J CHILD NEUROL, V29, pNP35, DOI 10.1177/0883073813497827; Litvinenko I, 2014, J CHILD NEUROL, V29, P799, DOI 10.1177/0883073813477203; Lorson CL, 1998, HUM MOL GENET, V7, P1269, DOI 10.1093/hmg/7.8.1269; Maystadt I, 2004, Hum Mutat, V23, P525, DOI 10.1002/humu.9241; Meister G, 2000, HUM MOL GENET, V9, P1977, DOI 10.1093/hmg/9.13.1977; Mendell JT, 2002, SCIENCE, V298, P419, DOI 10.1126/science.1074428; Messina MF, 2012, EUR J PAEDIATR NEURO, V16, P90, DOI 10.1016/j.ejpn.2011.10.005; Miao M, 2000, EUR J BIOCHEM, V267, P7237, DOI 10.1046/j.1432-1327.2000.01836.x; MIZUTA TR, 1993, NUCLEIC ACIDS RES, V21, P1761, DOI 10.1093/nar/21.8.1761; Molnar GM, 1997, P NATL ACAD SCI USA, V94, P7831, DOI 10.1073/pnas.94.15.7831; Pitt M, 2003, BRAIN, V126, P2682, DOI 10.1093/brain/awg278; Reilly MM, 2009, J NEUROL NEUROSUR PS, V80, P1304, DOI 10.1136/jnnp.2008.158295; Roberts RC, 2012, BRAIN, V135, P3527, DOI 10.1093/brain/aws311; Rudnik-Schoneborn S, 2004, NEUROPEDIATRICS, V35, P174, DOI 10.1055/s-2004-820994; Saporta MA, 2013, NEUROL CLIN, V31, P597, DOI 10.1016/j.ncl.2013.01.009; Shy Michael E, 2011, Continuum (Minneap Minn), V17, P294, DOI 10.1212/01.CON.0000396963.75069.66; Shy ME, 2011, CURR OPIN NEUROL, V24, P475, DOI 10.1097/WCO.0b013e32834aa331; SKRE H, 1974, CLIN GENET, V6, P98; Sumner CJ, 2013, AM J HUM GENET, V93, P976, DOI 10.1016/j.ajhg.2013.10.006; Timmerman V, 2014, GENES-BASEL, V5, P13, DOI 10.3390/genes5010013; Timmerman V, 2013, EXP NEUROL, V246, P14, DOI 10.1016/j.expneurol.2012.01.010; Trabzuni D, 2011, J NEUROCHEM, V119, P275, DOI 10.1111/j.1471-4159.2011.07432.x; Uchiumi F, 2010, GENE, V463, P8, DOI 10.1016/j.gene.2010.04.014; van der Heijde D, 1999, J RHEUMATOL, V26, P951; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wee CD, 2010, CURR OPIN NEUROL, V23, P450, DOI 10.1097/WCO.0b013e32833e1765	52	57	61	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 6	2014	95	5					590	601		10.1016/j.ajhg.2014.10.002	http://dx.doi.org/10.1016/j.ajhg.2014.10.002			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AT3OY	25439726	Green Published, hybrid			2022-12-18	WOS:000344845000010
J	Tamiya, G; Makino, S; Hayashi, M; Abe, A; Numakura, C; Ueki, M; Tanaka, A; Ito, C; Toshimori, K; Ogawa, N; Terashima, T; Maegawa, H; Yanagisawa, D; Tooyama, I; Tada, M; Onodera, O; Hayasaka, K				Tamiya, Gen; Makino, Satoshi; Hayashi, Makiko; Abe, Akiko; Numakura, Chikahiko; Ueki, Masao; Tanaka, Atsushi; Ito, Chizuru; Toshimori, Kiyotaka; Ogawa, Nobuhiro; Terashima, Tomoya; Maegawa, Hiroshi; Yanagisawa, Daijiro; Tooyama, Ikuo; Tada, Masayoshi; Onodera, Osamu; Hayasaka, Kiyoshi			A Mutation of COX6A1 Causes a Recessive Axonal or Mixed Form of Charcot-Marie-Tooth Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOMINANT HEREDITARY MOTOR; SENSORY NEUROPATHY; GENE; DYSFUNCTION; APOPTOSIS	Charcot-Marie-Tooth disease (CMT) is the most common inherited neuropathy characterized by clinical and genetic heterogeneity. Although more than 30 loci harboring CMT-causing mutations have been identified, many other genes still remain to be discovered for many affected individuals. For two consanguineous families with CMT (axonal and mixed phenotypes), a parametric linkage analysis using genome-wide SNP chip identified a 4.3 Mb region on 12q24 showing a maximum multipoint LOD score of 4.23. Subsequent whole-genome sequencing study in one of the probands, followed by mutation screening in the two families, revealed a disease-specific 5 bp deletion (c.247-10_247-6de1CACTC) in a splicing element (pyrimidine tract) of intron 2 adjacent to the third exon of cytochrome c oxidase subunit VIa polypeptide 1 (COX6A1), which is a component of mitochondrial respiratory complex IV (cytochrome c oxidase [COX]), within the autozygous linkage region. Functional analysis showed that expression of COX6A1 in peripheral white blood cells from the affected individuals and COX activity in their EB-virus-transformed lymphoblastoid cell lines were significantly reduced. In addition, Cox6a1-null mice showed significantly reduced COX activity and neurogenic muscular atrophy leading to a difficulty in walking. Those data indicated that COX6A1 mutation causes the autosomal-recessive axonal or mixed CMT.	[Tamiya, Gen; Makino, Satoshi; Ueki, Masao] Yamagata Univ Yamagata, Adv Mol Epidemiol Res Inst, Fac Med, Yamagata 9909585, Japan; [Hayashi, Makiko; Abe, Akiko; Numakura, Chikahiko; Hayasaka, Kiyoshi] Yamagata Univ Yamagata, Dept Pediat, Fac Med, Yamagata 9909585, Japan; [Tanaka, Atsushi] Yamagata Univ Yamagata, Res Inst Med Sci, Fac Med, Yamagata 9909585, Japan; [Ito, Chizuru; Toshimori, Kiyotaka] Chiba Univ, Grad Sch Med, Dept Reprod Biol & Med, Chiba 2608670, Japan; [Ogawa, Nobuhiro; Terashima, Tomoya; Maegawa, Hiroshi] Shiga Univ Med Sci, Dept Med, Otsu, Shiga 5202192, Japan; [Yanagisawa, Daijiro; Tooyama, Ikuo] Shiga Univ Med Sci, Mol Neurosci Res Ctr, Otsu, Shiga 5202192, Japan; [Tada, Masayoshi; Onodera, Osamu] Niigata Univ, Brain Res Inst, Dept Mol Neurosci, Niigata 9518585, Japan	Yamagata University; Yamagata University; Yamagata University; Chiba University; Shiga University of Medical Science; Shiga University of Medical Science; Niigata University	Tamiya, G (corresponding author), Yamagata Univ Yamagata, Adv Mol Epidemiol Res Inst, Fac Med, Yamagata 9909585, Japan.	gtamiya@genetix-h.com; hayasaka@med.id.yamagata-u.ac.jp	Hayasaka, Kiyoshi/H-5340-2012; Onodera, Osamu/K-7327-2013	Onodera, Osamu/0000-0003-3354-5472; Tamiya, Gen/0000-0002-0597-415X; Ito, Chizuru/0000-0003-2697-0382; Tooyama, Ikuo/0000-0001-8054-9666; Maegawa, Hiroshi/0000-0002-4611-8149; Hayasaka, Kiyoshi/0000-0003-3621-8901	Ministry of Education, Science, Sports and Culture of Japan [25461537, 25860842, 25129701]; Global Center of Excellence program of the Japan Society for the Promotion of Science, "Formation of an International Network for Education and Research of Molecular Epidemiology"; Grants-in-Aid for Scientific Research [25293041, 25870074, 24590400] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global Center of Excellence program of the Japan Society for the Promotion of Science, "Formation of an International Network for Education and Research of Molecular Epidemiology"; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We would like to thank Kaoru Honaga, Michiyuki Kawakami, Akio Kimura, and Keiko Murayama for clinical information. This work was supported by Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan to K.H. (grant number 25461537), A.A. (grant number 25860842), and G.T. (grant number 25129701) and Grant-in-Aid from the Global Center of Excellence program of the Japan Society for the Promotion of Science, "Formation of an International Network for Education and Research of Molecular Epidemiology."	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Echaniz-Laguna A, 2013, NEUROLOGY, V81, P1523, DOI 10.1212/WNL.0b013e3182a4a518; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; HAYASAKA K, 1993, NAT GENET, V5, P31, DOI 10.1038/ng0993-31; Hirose Y, 2008, AM J HUM GENET, V82, P1122, DOI 10.1016/j.ajhg.2008.03.013; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lee SS, 2013, JAMA NEUROL, V70, P607, DOI 10.1001/jamaneurol.2013.1250; Lim LP, 2001, P NATL ACAD SCI USA, V98, P11193, DOI 10.1073/pnas.201407298; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Maeda K, 2007, J HUM GENET, V52, P907, DOI 10.1007/s10038-007-0193-7; Makino S, 2007, AM J HUM GENET, V80, P393, DOI 10.1086/512129; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Pitceathly RDS, 2012, NEUROLOGY, V79, P1145, DOI 10.1212/WNL.0b013e3182698d8d; Raben N, 1996, HUM MOL GENET, V5, P995, DOI 10.1093/hmg/5.7.995; Rinaldi C, 2012, AM J HUM GENET, V91, P1095, DOI 10.1016/j.ajhg.2012.10.008; Sawa A, 1999, NAT MED, V5, P1194, DOI 10.1038/13518; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	24	57	59	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 4	2014	95	3					294	300		10.1016/j.ajhg.2014.07.013	http://dx.doi.org/10.1016/j.ajhg.2014.07.013			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AO5RX	25152455	Green Published, Bronze			2022-12-18	WOS:000341404100005
J	van Karnebeek, CD; Sly, WS; Ross, CJ; Salvarinova, R; Yaplito-Lee, J; Santra, S; Shyr, C; Horvath, GA; Eydoux, P; Lehman, AM; Bernard, V; Newlove, T; Ukpeh, H; Chakrapani, A; Preece, MA; Ball, S; Pitt, J; Vallance, HD; Coulter-Mackie, M; Nguyen, H; Zhang, LH; Bhavsar, AP; Sinclair, G; Waheed, A; Wasserman, WW; Stockler-Ipsiroglu, S				van Karnebeek, Clara D.; Sly, William S.; Ross, Colin J.; Salvarinova, Ramona; Yaplito-Lee, Joy; Santra, Saikat; Shyr, Casper; Horvath, Gabriella A.; Eydoux, Patrice; Lehman, Anna M.; Bernard, Virginie; Newlove, Theresa; Ukpeh, Henry; Chakrapani, Anupam; Preece, Mary Anne; Ball, Sarah; Pitt, James; Vallance, Hilary D.; Coulter-Mackie, Marion; Nguyen, Hien; Zhang, Lin-Hua; Bhavsar, Amit P.; Sinclair, Graham; Waheed, Abdul; Wasserman, Wyeth W.; Stockler-Ipsiroglu, Sylvia			Mitochondrial Carbonic Anhydrase VA Deficiency Resulting from CA5A Alterations Presents with Hyperammonemia in Early Childhood	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PYRUVATE-CARBOXYLASE DEFICIENCY; SUBCELLULAR-LOCALIZATION; TISSUE DISTRIBUTION; CDNA CLONING; EXPRESSION; METABOLISM; MUTATIONS; MUTAGENESIS; MOUSE; VB	Four children in three unrelated families (one consanguineous) presented with lethargy, hyperlactatemia, and hyperammonemia of unexplained origin during the neonatal period and early childhood. We identified and validated three different CA5A alterations, including a homozygous missense mutation (c.697T>C) in two siblings, a homozygous splice site mutation (c.555G>A) leading to skipping of exon 4, and a homozygous 4 kb deletion of exon 6. The deleterious nature of the homozygous mutation c.697T>C (p.Ser233Pro) was demonstrated by reduced enzymatic activity and increased temperature sensitivity. Carbonic anhydrase VA (CA-VA) was absent in liver in the child with the homozygous exon 6 deletion. The metabolite profiles in the affected individuals fit CA-VA deficiency, showing evidence of impaired provision of bicarbonate to the four enzymes that participate in key pathways in intermediary metabolism: carbamoylphosphate synthetase 1 (urea cycle), pyruvate carboxylase (anaplerosis, gluconeogenesis), propionyl-CoA carboxylase, and 3-methylcrotonyl-CoA carboxylase (branched chain amino acids catabolism). In the three children who were administered carglumic acid, hyperammonemia resolved. CA-VA deficiency should therefore be added to urea cycle defects, organic acidurias, and pyruvate carboxylase deficiency as a treatable condition in the differential diagnosis of hyperammonemia in the neonate and young child.	[van Karnebeek, Clara D.; Salvarinova, Ramona; Horvath, Gabriella A.; Stockler-Ipsiroglu, Sylvia] Univ British Columbia, BC Childrens Hosp, Div Biochem Dis, Vancouver, BC V6H 3V4, Canada; [van Karnebeek, Clara D.; Ross, Colin J.; Salvarinova, Ramona; Horvath, Gabriella A.; Ukpeh, Henry; Coulter-Mackie, Marion; Zhang, Lin-Hua; Stockler-Ipsiroglu, Sylvia] Univ British Columbia, BC Childrens Hosp, Dept Pediat, Vancouver, BC V6H 3V4, Canada; [van Karnebeek, Clara D.; Ross, Colin J.; Salvarinova, Ramona; Shyr, Casper; Horvath, Gabriella A.; Eydoux, Patrice; Lehman, Anna M.; Bernard, Virginie; Newlove, Theresa; Vallance, Hilary D.; Coulter-Mackie, Marion; Zhang, Lin-Hua; Bhavsar, Amit P.; Sinclair, Graham; Wasserman, Wyeth W.; Stockler-Ipsiroglu, Sylvia] Univ British Columbia, BC Childrens Hosp, Treatable Intellectual Disabil Endeavour British, Vancouver, BC V5Z 4H4, Canada; [van Karnebeek, Clara D.; Ross, Colin J.; Shyr, Casper; Bernard, Virginie; Zhang, Lin-Hua; Bhavsar, Amit P.; Wasserman, Wyeth W.] Univ British Columbia, BC Childrens Hosp, Ctr Mol Med & Therapeut, Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada; [Shyr, Casper; Eydoux, Patrice; Lehman, Anna M.; Bernard, Virginie; Bhavsar, Amit P.; Wasserman, Wyeth W.] Univ British Columbia, BC Childrens Hosp, Dept Med Genet, Vancouver, BC V6H 3N1, Canada; [Newlove, Theresa] Univ British Columbia, BC Childrens Hosp, Dept Psychol, Vancouver, BC V6H 3N1, Canada; [Vallance, Hilary D.; Sinclair, Graham] Univ British Columbia, BC Childrens Hosp, Biochem Genet Lab, Vancouver, BC V6H 3N1, Canada; [Eydoux, Patrice; Vallance, Hilary D.; Sinclair, Graham] Univ British Columbia, BC Childrens Hosp, Dept Pathol & Lab Med, Vancouver, BC V6H 3N1, Canada; [Sly, William S.; Nguyen, Hien; Waheed, Abdul] St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Yaplito-Lee, Joy; Pitt, James] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Santra, Saikat; Chakrapani, Anupam] Birmingham Childrens Hosp, Dept Clin Inherited Metab Disorders, Birmingham B4 6NH, W Midlands, England; [Preece, Mary Anne; Ball, Sarah] Birmingham Childrens Hosp, Dept Newborn Screening & Biochem Genet, Birmingham B4 6NH, W Midlands, England; [Pitt, James] Univ Melbourne, Dept Paediat, Melbourne, Vic 3010, Australia	BC Childrens Hospital; University of British Columbia; BC Childrens Hospital; University of British Columbia; BC Childrens Hospital; University of British Columbia; BC Childrens Hospital; Child & Family Research Institute; University of British Columbia; BC Childrens Hospital; University of British Columbia; BC Childrens Hospital; University of British Columbia; BC Childrens Hospital; University of British Columbia; BC Childrens Hospital; University of British Columbia; Saint Louis University; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Birmingham; University of Birmingham; University of Melbourne	van Karnebeek, CD (corresponding author), Univ British Columbia, BC Childrens Hosp, Div Biochem Dis, Vancouver, BC V6H 3V4, Canada.	cvankarnebeek@cw.bc.ca	Lehman, Anna/R-6706-2017; Wasserman, Wyeth/I-4866-2015; Wahhed, Abdul/AAA-3099-2020	Lehman, Anna/0000-0003-0636-123X; Bhavsar, Amit/0000-0003-3336-9288; Horvath, Gabriella/0000-0003-2573-2489; Salvarinova Zivkovic, Ramona/0000-0002-8132-9136; Vallance, Hilary/0000-0003-1734-1445; Santra, Saikat/0000-0002-7497-3556; Sinclair, Graham/0000-0002-3815-2005; Coulter-Mackie, Marion/0000-0002-9552-2930; Ross, Colin/0000-0003-1476-7037; Wasserman, Wyeth/0000-0001-6098-6412	B.C. Children's Hospital Foundation; British Columbia Clinical Genomics Network [BCCGN00031]; Genome British Columbia [SOF5-021]; Rare Diseases Foundation [2012-8]; National Institutes of Health [R01GM084875, DK40163]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084875] Funding Source: NIH RePORTER	B.C. Children's Hospital Foundation; British Columbia Clinical Genomics Network; Genome British Columbia; Rare Diseases Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge the families for their participation in this study, Xiahua Han for expert performance of CA5A molecular analyses, M. Higginson and M. Zhou for DNA extraction, sample handling, and technical data, M. Thomas and M. Lafek for consenting and data management, K. MacKenzie for psychological testing of the siblings, and J. Rilstone for text editing. This study is part of the Treatable Intellectual Disability Endeavour in British Columbia. This work was supported by funding from the B.C. Children's Hospital Foundation as "1st Collaborative Area of Innovation," the British Columbia Clinical Genomics Network (grant number BCCGN00031), Genome British Columbia (grant number SOF5-021), the Rare Diseases Foundation (grant number 2012-8) to C. D. v. K., National Institutes of Health (grant number R01GM084875) to W. W. W., and National Institutes of Health (grant number DK40163) to W.S.S.	Andresen BS, 2001, AM J HUM GENET, V68, P1408, DOI 10.1086/320602; Brownsey RW, 1997, BIOCHEM SOC T, V25, P1232, DOI 10.1042/bst0251232; Daniotti M, 2011, INT J GEN MED, V4, P21, DOI 10.2147/IJGM.S10490; Debray FG, 2008, J MED GENET, V45, P759, DOI 10.1136/jmg.2008.059097; DODGSON SJ, 1984, ANN NY ACAD SCI, V429, P516, DOI 10.1111/j.1749-6632.1984.tb12380.x; Garcia-Cazorla A, 2006, ANN NEUROL, V59, P121, DOI 10.1002/ana.20709; Haberle J, 2013, ARCH BIOCHEM BIOPHYS, V536, P101, DOI 10.1016/j.abb.2013.04.009; Martinez AI, 2010, MOL GENET METAB, V101, P311, DOI 10.1016/j.ymgme.2010.08.002; Klaus V, 2009, CLIN GENET, V76, P263, DOI 10.1111/j.1399-0004.2009.01216.x; Krawczak M, 2007, HUM MUTAT, V28, P150, DOI 10.1002/humu.20400; KREBS JF, 1993, J BIOL CHEM, V268, P948; Marin-Valencia I, 2010, MOL GENET METAB, V101, P9, DOI 10.1016/j.ymgme.2010.05.004; Mochel F, 2005, MOL GENET METAB, V84, P305, DOI 10.1016/j.ymgme.2004.09.007; NAGAO Y, 1993, P NATL ACAD SCI USA, V90, P7623, DOI 10.1073/pnas.90.16.7623; NAGAO Y, 1995, GENOMICS, V28, P477, DOI 10.1006/geno.1995.1177; NAGAO Y, 1994, P NATL ACAD SCI USA, V91, P10330, DOI 10.1073/pnas.91.22.10330; Narendra DP, 2013, HUM MOL GENET, V22, P2572, DOI 10.1093/hmg/ddt106; Ochrietor JD, 2005, EXP EYE RES, V81, P492, DOI 10.1016/j.exer.2005.03.010; Shah GN, 2000, P NATL ACAD SCI USA, V97, P1677, DOI 10.1073/pnas.97.4.1677; Shah GN, 2013, P NATL ACAD SCI USA, V110, P7423, DOI 10.1073/pnas.1305805110; SHIPLEY JM, 1993, J BIOL CHEM, V268, P12193; SLY WS, 1995, ANNU REV BIOCHEM, V64, P375, DOI 10.1146/annurev.bi.64.070195.002111; SUNDARAM V, 1986, AM J HUM GENET, V38, P125; Suzuki Y, 2005, HUM MUTAT, V26, P285, DOI 10.1002/humu.20204; Tong L, 2013, CELL MOL LIFE SCI, V70, P863, DOI 10.1007/s00018-012-1096-0; van Karnebeek CDM, 2012, MOL GENET METAB, V105, P368, DOI 10.1016/j.ymgme.2011.11.191; Wolf B., 2011, GENEREVIEWS 1993 200	27	57	58	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 6	2014	94	3					453	461		10.1016/j.ajhg.2014.01.006	http://dx.doi.org/10.1016/j.ajhg.2014.01.006			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AC6DK	24530203	Green Published, hybrid			2022-12-18	WOS:000332611400018
J	Huber, C; Wu, SL; Kim, AS; Sigaudy, S; Sarukhanov, A; Serre, V; Baujat, G; Le Quan Sang, KH; Rimoin, DL; Cohn, DH; Munnich, A; Krakow, D; Cormier-Daire, V				Huber, Celine; Wu, Sulin; Kim, Ashley S.; Sigaudy, Sabine; Sarukhanov, Anna; Serre, Valerie; Baujat, Genevieve; Le Quan Sang, Kim-Hanh; Rimoin, David L.; Cohn, Daniel H.; Munnich, Arnold; Krakow, Deborah; Cormier-Daire, Valerie			WDR34 Mutations that Cause Short-Rib Polydactyly Syndrome Type III/Severe Asphyxiating Thoracic Dysplasia Reveal a Role for the NF-kappa B Pathway in Cilia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CRANIOECTODERMAL DYSPLASIA; SENSENBRENNER-SYNDROME; TRANSPORT PROTEIN; DYSTROPHY; ABNORMALITIES; DYNC2H1; GENE	Short-rib polydactyly (SRP) syndrome type III, or Verma-Naumoff syndrome, is an autosomal-recessive chondrodysplasia characterized by short ribs, a narrow thorax, short long bones, an abnormal acetabulum, and numerous extraskeletal malformations and is lethal in the perinatal period. Presently, mutations in two genes, IFT80 and DYNC2H1, have been identified as being responsible for SPY type III. Via homozygosity mapping in three affected siblings, a locus for the disease was identified on chromosome 9q34.11, and homozygosity for three missense mutations in WDR34 were found in three independent families, as well as compound heterozygosity for mutations in one family. WDR34 encodes a member of the WD repeat protein family with five WD40 domains, which acts as a TAK1-associated suppressor of the IL-1R/TLR3/TLR4-induced NF-kappa B activation pathway. We showed, through structural modeling, that two of the three mutations altered specific structural domains of WDR34. We found that primary cilia in WDR34 mutant fibroblasts were significantly shorter than normal and had a bulbous tip. This report expands on the pathogenesis of SPY type III and demonstrates that a regulator of the NF-kappa B activation pathway is involved in the pathogenesis of the skeletal ciliopathies.	[Huber, Celine; Serre, Valerie; Baujat, Genevieve; Le Quan Sang, Kim-Hanh; Munnich, Arnold; Cormier-Daire, Valerie] Univ Paris 05, Hop Necker Enfants Malad, AP HP, INSERM U781,Dept Genet,Inst Imagine, F-75015 Paris, France; [Wu, Sulin; Kim, Ashley S.; Sarukhanov, Anna; Cohn, Daniel H.; Krakow, Deborah] Univ Calif Los Angeles, David Geffen Sch Med, Dept Orthoped Surg, Los Angeles, CA 90095 USA; [Sigaudy, Sabine] Hop La Timone, AP HM, CHU Marseille, Dept Med Genet,Clin Genet Unit, F-13385 Marseille, France; [Rimoin, David L.; Cohn, Daniel H.; Krakow, Deborah] Cedars Sinai Med Ctr, Int Skeletal Dysplasia Registry, Los Angeles, CA 90048 USA; [Rimoin, David L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Cohn, Daniel H.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Krakow, Deborah] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Cormier-Daire, V (corresponding author), Univ Paris 05, Hop Necker Enfants Malad, AP HP, INSERM U781,Dept Genet,Inst Imagine, F-75015 Paris, France.	valerie.cormier-daire@inserm.fr	LE QUAN SANG, Kim-Hanh/H-6186-2017; Krakow, Deborah/B-5778-2009; cormier-daire, valerie/H-6520-2017	LE QUAN SANG, Kim-Hanh/0000-0002-4280-4395; Krakow, Deborah/0000-0001-9906-4968; Serre, Valerie/0000-0001-5277-1120; cormier-daire, valerie/0000-0002-2839-9856; huber, celine/0000-0002-8601-9655	Programme Hospitalier de Recherche Clinique DRCD, Assistance Publique-Hopitaux de Paris [PHRC AOM06031]; National Institutes of Health [HD22657]; NIH [R01 DE019567]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019567] Funding Source: NIH RePORTER	Programme Hospitalier de Recherche Clinique DRCD, Assistance Publique-Hopitaux de Paris; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Part of this work has been supported by a national grant from Programme Hospitalier de Recherche Clinique (PHRC AOM06031) DRCD, Assistance Publique-Hopitaux de Paris. D.K., D.H.C., and D.L.R. are supported by National Institutes of Health grant HD22657 and D.H.C. and D.K. are supported by NIH grant R01 DE019567.	Amar MJA, 1997, AM J MED GENET, V70, P349, DOI 10.1002/(SICI)1096-8628(19970627)70:4<349::AID-AJMG3>3.0.CO;2-O; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Beales PL, 2007, NAT GENET, V39, P727, DOI 10.1038/ng2038; Bredrup C, 2011, AM J HUM GENET, V89, P634, DOI 10.1016/j.ajhg.2011.10.001; Cavalcanti DP, 2011, J MED GENET, V48, P88, DOI 10.1136/jmg.2009.069468; Cole DG, 2003, TRAFFIC, V4, P435, DOI 10.1034/j.1600-0854.2003.t01-1-00103.x; Dagoneau N, 2009, AM J HUM GENET, V84, P706, DOI 10.1016/j.ajhg.2009.04.016; Gao D, 2009, CELL MOL LIFE SCI, V66, P2573, DOI 10.1007/s00018-009-0059-6; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Ho NC, 2000, AM J MED GENET, V90, P310, DOI 10.1002/(SICI)1096-8628(20000214)90:4<310::AID-AJMG9>3.0.CO;2-N; Lee C, 2010, CELL, V142, P123, DOI 10.1016/j.cell.2010.05.030; LEVIN LS, 1977, J PEDIATR-US, V90, P55, DOI 10.1016/S0022-3476(77)80764-6; Merrill AE, 2009, AM J HUM GENET, V84, P542, DOI 10.1016/j.ajhg.2009.03.015; Mill P, 2011, AM J HUM GENET, V88, P508, DOI 10.1016/j.ajhg.2011.03.015; Sensenbrenner J A, 1975, Birth Defects Orig Artic Ser, V11, P372; Walczak-Sztulpa J, 2010, AM J HUM GENET, V86, P949, DOI 10.1016/j.ajhg.2010.04.012; Wann AKT, 2012, CELL MOL LIFE SCI, V69, P2967, DOI 10.1007/s00018-012-0980-y; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909	19	57	60	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 7	2013	93	5					926	931		10.1016/j.ajhg.2013.10.007	http://dx.doi.org/10.1016/j.ajhg.2013.10.007			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252HU	24183449	Bronze, Green Published			2022-12-18	WOS:000326996600013
J	Blaydon, DC; Lind, LK; Plagnol, V; Linton, KJ; Smith, FJD; Wilson, NJ; McLean, WHI; Munro, CS; South, AP; Leigh, IM; O'Toole, EA; Lundstrom, A; Kelsell, DP				Blaydon, Diana C.; Lind, Lisbet K.; Plagnol, Vincent; Linton, Kenneth J.; Smith, Francis J. D.; Wilson, Neil J.; McLean, W. H. Irwin; Munro, Colin S.; South, Andrew P.; Leigh, Irene M.; O'Toole, Edel A.; Lundstrom, Anita; Kelsell, David P.			Mutations in AQP5, Encoding a Water-Channel Protein, Cause Autosomal-Dominant Diffuse Nonepidermolytic Palmoplantar Keratoderma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEPHROGENIC DIABETES-INSIPIDUS; CHROMOSOME 12Q11-Q13; WOOLLY HAIR; CARDIOMYOPATHY; INSIGHTS; DISEASE	Autosomal-dominant diffuse nonepidermolytic palmoplantar keratoderma is characterized by the adoption of a white, spongy appearance of affected areas upon exposure to water. After exome sequencing, missense mutations were identified in AQP5, encoding water-channel protein aquaporin-5 (AQP5). Protein-structure analysis indicates that these AQP5 variants have the potential to elicit an effect on normal channel regulation. Immunofluorescence data reveal the presence of AQP5 at the plasma membrane in the stratum granulosum of both normal and affected palmar epidermis, indicating that the altered AQP5 proteins are trafficked in the normal manner. We demonstrate here a role for AQP5 in the palmoplantar epidermis and propose that the altered AQP5 proteins retain the ability to form open channels in the cell membrane and conduct water.	[Blaydon, Diana C.; Linton, Kenneth J.; O'Toole, Edel A.; Kelsell, David P.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Ctr Cutaneous Res, London E1 2AT, England; [Lind, Lisbet K.] Umea Univ Hosp, Dept Med Biosci Med Genet, SE-90187 Umea, Sweden; [Plagnol, Vincent] UCL, UCL Genet Inst, London WC1E 6BT, England; [Smith, Francis J. D.; Wilson, Neil J.; McLean, W. H. Irwin] Univ Dundee, Coll Life Sci, Ctr Dermatol & Genet Med, Dundee DD1 5EH, Scotland; [Smith, Francis J. D.; Wilson, Neil J.; McLean, W. H. Irwin] Univ Dundee, Coll Med Dent & Nursing, Dundee DD1 5EH, Scotland; [Munro, Colin S.] So Gen Hosp, Alan Lyell Ctr Dermatol, Glasgow G51 4TF, Lanark, Scotland; [South, Andrew P.; Leigh, Irene M.] Ninewells Hosp & Med Sch, Div Canc Res, Dundee DD1 9SY, Scotland; [Lundstrom, Anita] Umea Univ, Dept Publ Hlth & Clin Med, S-90185 Umea, Sweden	University of London; Queen Mary University London; Umea University; University of London; University College London; University of Dundee; University of Dundee; University of Glasgow; University of Dundee; Umea University	Kelsell, DP (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Ctr Cutaneous Res, London E1 2AT, England.	d.blaydon@qmul.ac.uk; d.p.kelsell@qmulac.uk	Kelsell, David P/F-8767-2011	Kelsell, David/0000-0002-9910-7144; Blaydon, Diana/0000-0002-9998-2563; O'Toole, Edel/0000-0002-4084-4836; McLean, William Henry Irwin/0000-0001-5539-5757; Plagnol, Vincent/0000-0002-5597-9215	Barts and the London Charity; UK Medical Research Council [G1001158]; National Institute for Health Research Moorfields Biomedical Research Council; Pachyonychia Congenita Project; Welander-Finsen Foundation; Medical Research Council [G0802780, G1001158, MC_U120088463] Funding Source: researchfish; MRC [G1001158, MC_U120088463, G0802780] Funding Source: UKRI	Barts and the London Charity; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Moorfields Biomedical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Pachyonychia Congenita Project; Welander-Finsen Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	D.P.K. is supported by Barts and the London Charity. V.P. is supported by a grant from the UK Medical Research Council (G1001158) and by the National Institute for Health Research Moorfields Biomedical Research Council. F.J.D.S. is supported by a project grant from the Pachyonychia Congenita Project. A.L. is supported by the Welander-Finsen Foundation. We thank the Barts and the London Genome Centre and the Blizard Advanced Light Microscopy core facilities.	Engel A, 2008, CURR OPIN STRUC BIOL, V18, P229, DOI 10.1016/j.sbi.2007.11.003; Hansel NN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014226; Heathcote K, 2000, J MED GENET, V37, P50, DOI 10.1136/jmg.37.1.50; Horsefield R, 2008, P NATL ACAD SCI USA, V105, P13327, DOI 10.1073/pnas.0801466105; Itin PH, 2005, CLIN DERMATOL, V23, P15, DOI 10.1016/j.clindermatol.2004.09.005; Janosi L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059897; JUNG JS, 1994, J BIOL CHEM, V269, P14648; Kelsell DP, 1999, EXP DERMATOL, V8, P388, DOI 10.1111/j.1600-0625.1999.tb00387.x; KELSELL DP, 1995, HUM MOL GENET, V4, P1021, DOI 10.1093/hmg/4.6.1021; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Kuwahara M, 2001, AM J HUM GENET, V69, P738, DOI 10.1086/323643; Lamartine J, 2000, NAT GENET, V26, P142, DOI 10.1038/79851; LIND L, 1994, HUM MOL GENET, V3, P1789, DOI 10.1093/hmg/3.10.1789; Liu JL, 2011, J CELL SCI, V124, P198, DOI 10.1242/jcs.072652; Loitto VM, 2002, J LEUKOCYTE BIOL, V71, P212; McKoy G, 2000, LANCET, V355, P2119, DOI 10.1016/S0140-6736(00)02379-5; Mulders SM, 1998, J CLIN INVEST, V102, P57, DOI 10.1172/JCI2605; Norgett EE, 2000, HUM MOL GENET, V9, P2761, DOI 10.1093/hmg/9.18.2761; Rongioletti F, 2012, BRIT J DERMATOL, V167, P575, DOI 10.1111/j.1365-2133.2012.11003.x; Sidhaye VK, 2008, P NATL ACAD SCI USA, V105, P3345, DOI 10.1073/pnas.0712287105; Sidhaye VK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038717; TAKEMURA R, 1992, J CELL SCI, V103, P953; Tornroth-Horsefield S, 2010, FEBS LETT, V584, P2580, DOI 10.1016/j.febslet.2010.04.037	23	57	61	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG 8	2013	93	2					330	335		10.1016/j.ajhg.2013.06.008	http://dx.doi.org/10.1016/j.ajhg.2013.06.008			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202AP	23830519	Green Published, Bronze			2022-12-18	WOS:000323186200013
J	Liu, H; Irwanto, A; Tian, HQ; Fu, X; Yu, YX; Yu, GQ; Low, H; Chu, TS; Li, Y; Shi, BQ; Chen, MF; Sun, YH; Yuan, CY; Lu, N; You, JB; Bao, FF; Li, JH; Liu, J; Liu, HX; Liu, DC; Yu, XL; Zhang, L; Yang, Q; Wang, N; Niu, GY; Ma, SS; Zhou, Y; Wang, C; Chen, SM; Zhang, XJ; Liu, JJ; Zhang, FR				Liu, Hong; Irwanto, Astrid; Tian, Hongqing; Fu, Xi'an; Yu, Yongxiang; Yu, Gongqi; Low, Huiqi; Chu, Tongsheng; Li, Yi; Shi, Benqing; Chen, Mingfei; Sun, Yonghu; Yuan, Chunying; Lu, Nan; You, Jiabao; Bao, Fangfang; Li, Jinghui; Liu, Jian; Liu, Huaxu; Liu, Dianchang; Yu, Xiulu; Zhang, Lin; Yang, Qing; Wang, Na; Niu, Guiye; Ma, Shanshan; Zhou, Yan; Wang, Chuan; Chen, Shumin; Zhang, Xuejun; Liu, Jianjun; Zhang, Furen			Identification of IL18RAP/IL18R1 and IL12B as Leprosy Risk Genes Demonstrates Shared Pathogenesis between Inflammation and Infectious Diseases	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CROHNS-DISEASE; MYCOBACTERIUM-TUBERCULOSIS; SUSCEPTIBILITY LOCI; ULCERATIVE-COLITIS; COMMON VARIANTS; PSORIASIS; CYTOKINE; MULTIPLE; CELLS	Of eight leprosy susceptibility loci identified by genome-wide association studies, five have been implicated in Crohn disease, suggesting a common genetic fingerprint between leprosy and inflammatory bowel disease (IBD). Here, we conducted a multiple-stage genetic association study of 133 IBD susceptibility loci in multiple leprosy samples (totaling 4,971 leprosy cases and 5,503 controls) from a Chinese population and discovered two associations at rs2058660 on 2q12.1 (p = 4.57 x 10(-19); odds ratio [OR] = 1.30) and rs6871626 on 5q33.3 (p = 3.95 x 10(-18); OR = 0.75), implicating 1L18RAP/IL18R1 and IL12B as susceptibility genes for leprosy. Our study reveals the important role of IL12/IL18-mediated transcriptional regulation of IFN-gamma production in leprosy, and together with previous findings, it demonstrates the shared genetic susceptibility between infectious and inflammatory diseases.	[Liu, Hong; Tian, Hongqing; Shi, Benqing; Zhang, Furen] Shandong Acad Med Sci, Shandong Prov Inst Dermatol & Venereol, Jinan 250022, Shandong, Peoples R China; [Liu, Hong; Fu, Xi'an; Yu, Yongxiang; Yu, Gongqi; Chu, Tongsheng; Chen, Mingfei; Sun, Yonghu; Yuan, Chunying; Lu, Nan; You, Jiabao; Bao, Fangfang; Li, Jinghui; Liu, Jian; Liu, Huaxu; Liu, Dianchang; Yu, Xiulu; Zhang, Lin; Yang, Qing; Wang, Na; Niu, Guiye; Ma, Shanshan; Zhou, Yan; Wang, Chuan; Chen, Shumin; Liu, Jianjun; Zhang, Furen] Shandong Univ, Shandong Prov Hosp Skin Dis, Jinan 250022, Shandong, Peoples R China; [Liu, Hong; Fu, Xi'an; Yu, Yongxiang; Yu, Gongqi; Chu, Tongsheng; Chen, Mingfei; Sun, Yonghu; Yuan, Chunying; Lu, Nan; You, Jiabao; Bao, Fangfang; Li, Jinghui; Liu, Jian; Liu, Huaxu; Liu, Dianchang; Yu, Xiulu; Zhang, Lin; Yang, Qing; Wang, Na; Niu, Guiye; Ma, Shanshan; Zhou, Yan; Wang, Chuan; Chen, Shumin; Zhang, Furen] Shandong Prov Key Lab Dermatovenereol, Jinan 250022, Shandong, Peoples R China; [Liu, Hong; Tian, Hongqing; Shi, Benqing; Zhang, Furen] Shandong Prov Med Ctr Dermatovenereol, Jinan 250022, Shandong, Peoples R China; [Irwanto, Astrid; Low, Huiqi; Li, Yi; Liu, Jianjun] Genome Inst Singapore, Singapore 138672, Singapore; [Irwanto, Astrid] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117597, Singapore; [Zhang, Xuejun] Anhui Med Univ, Hosp 1, Inst Dermatol, Hefei 230032, Anhui, Peoples R China; [Zhang, Xuejun] Anhui Med Univ, Hosp 1, Dept Dermatol, Hefei 230032, Anhui, Peoples R China; [Zhang, Xuejun] Minist Educ, Key Lab Gene Resource Utilizat Severe Dis, Hefei 230032, Anhui, Peoples R China; [Liu, Jianjun] Anhui Med Univ, Sch Biol Sci, Hefei 230032, Anhui, Peoples R China; [Zhang, Furen] Anhui Med Univ, Shandong Clin Coll, Jinan 250022, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui Medical University	Zhang, FR (corresponding author), Shandong Acad Med Sci, Shandong Prov Inst Dermatol & Venereol, Jinan 250022, Shandong, Peoples R China.	zhangfuren@hotmail.com	Liu, Jianjun/AAK-4989-2020; Chen, Gang/G-2722-2010	Liu, Jianjun/0000-0002-3255-3019; Sun, Yonghu/0000-0003-4553-2871	National Natural Science Foundation of China [81071288, 81072391, 81101187]; National 973 program [2011CB512105]; Project of Taishan scholar; Project of Medical leading scholar of Shandong Province; Natural Science Foundation of Shandong Province [ZR2011HQ003]; Innovative Research Team of the Ministry of Education of China [IRT-1046]; Agency for Science, Technology, and Research (A*STAR) of Singapore; Singapore International Graduate Award	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 program(National Basic Research Program of China); Project of Taishan scholar; Project of Medical leading scholar of Shandong Province; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Innovative Research Team of the Ministry of Education of China; Agency for Science, Technology, and Research (A*STAR) of Singapore(Agency for Science Technology & Research (A*STAR)); Singapore International Graduate Award	We thank the individuals who participated in this project. This work was funded by grants from the National Natural Science Foundation of China (81071288, 81072391, and 81101187), the National 973 program (2011CB512105), the Project of Taishan scholar (2008-present), the Project of Medical leading scholar of Shandong Province (2010-present), the Natural Science Foundation of Shandong Province (ZR2011HQ003), the Innovative Research Team of the Ministry of Education of China (IRT-1046), and the Agency for Science, Technology, and Research (A*STAR) of Singapore. A.I. was supported by the Singapore International Graduate Award.	Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Behr MA, 2006, INFLAMM BOWEL DIS, V12, P1000, DOI 10.1097/01.mib.0000228183.70197.dd; Casanova JL, 2009, J EXP MED, V206, P1839, DOI 10.1084/jem.20091683; Castellanos-Rubio A, 2009, AUTOIMMUNITY, V42, P69, DOI 10.1080/08916930802350789; Coimbra S, 2012, INT J DERMATOL, V51, P389, DOI 10.1111/j.1365-4632.2011.05154.x; Coulombe F, 2009, LANCET, V374, P769, DOI 10.1016/S0140-6736(09)61576-2; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Ellinghaus E, 2010, NAT GENET, V42, P991, DOI 10.1038/ng.689; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Garcia VE, 1999, J IMMUNOL, V162, P6114; Guan QD, 2011, MOL MED, V17, P646, DOI 10.2119/molmed.2010.00252; Hayakawa H, 2007, J BIOL CHEM, V282, P26369, DOI 10.1074/jbc.M704916200; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Huffmeier U, 2010, NAT GENET, V42, P996, DOI 10.1038/ng.688; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Khader SA, 2006, J EXP MED, V203, P1805, DOI 10.1084/jem.20052545; Kobayashi K, 1998, CLIN IMMUNOL IMMUNOP, V88, P226, DOI 10.1006/clin.1998.4533; Leach ST, 2008, INFLAMM BOWEL DIS, V14, P68, DOI 10.1002/ibd.20272; Lees CW, 2011, GUT, V60, P1739, DOI 10.1136/gut.2009.199679; Ma X, 2003, J INFECT DIS, V188, P1116, DOI 10.1086/378674; MODLIN RL, 1994, J INVEST DERMATOL, V102, P828, DOI 10.1111/1523-1747.ep12381958; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Morahan G, 2007, TISSUE ANTIGENS, V69, P234, DOI 10.1111/j.1399-0039.2006.773_3.x; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Patsopoulos NA, 2011, ANN NEUROL, V70, P897, DOI 10.1002/ana.22609; Pierce ES, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000234; Pizarro TT, 1999, J IMMUNOL, V162, P6829; Plagnol V, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002216; Schindler H, 2001, J IMMUNOL, V166, P3075, DOI 10.4049/jimmunol.166.5.3075; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Sivakumar PV, 2002, GUT, V50, P812, DOI 10.1136/gut.50.6.812; Tso HW, 2004, J INFECT DIS, V190, P913, DOI 10.1086/422693; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753; Zhang FR, 2011, NAT GENET, V43, P1247, DOI 10.1038/ng.973; Zhang XJ, 2009, NAT GENET, V41, P205, DOI 10.1038/ng.310	38	57	57	0	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV 2	2012	91	5					935	941		10.1016/j.ajhg.2012.09.010	http://dx.doi.org/10.1016/j.ajhg.2012.09.010			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	036FI	23103228	Green Published, Bronze			2022-12-18	WOS:000311011400017
J	Wang, LJ; He, F; Bu, J; Liu, XQ; Du, W; Dong, JM; Cooney, JD; Dubey, SK; Shi, Y; Gong, B; Li, J; McBride, PF; Jia, YL; Lu, F; Soltis, KA; Lin, Y; Namburi, P; Liang, C; Sundaresan, P; Paw, BH; Li, DY; Phillips, JD; Yang, ZL				Wang, Lejing; He, Fei; Bu, Juan; Liu, Xiaqi; Du, Wei; Dong, Jiamei; Cooney, Jeffrey D.; Dubey, Sushi Kumar; Shi, Yi; Gong, Bo; Li, Jing; McBride, Paul F.; Jia, Yanlei; Lu, Fang; Soltis, Kathleen A.; Lin, Ying; Namburi, Prasanthi; Liang, Chen; Sundaresan, Periasamy; Paw, Barry H.; Li, Dean Y.; Phillips, John D.; Yang, Zhenglin			ABCB6 Mutations Cause Ocular Coloboma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL EYE MALFORMATIONS; CONSECUTIVE BIRTHS; GENE; TRANSPORTERS; ANOPHTHALMIA; FAMILY; RESISTANCE; LOCALIZES; ANOMALIES; ANIRIDIA	Ocular coloboma is a developmental defect of the eye and is due to abnormal or incomplete closure of the optic fissure. This disorder displays genetic and clinical heterogeneity. Using a positional cloning approach, we identified a mutation in the ATP-binding cassette (ABC) transporter ABCB6 in a Chinese family affected by autosomal-dominant coloboma. The Leu811Val mutation was identified in seven affected members of the family and was absent in six unaffected members from three generations. A LOD score of 3.2 at theta = 0 was calculated for the mutation identified in this family. Sequence analysis was performed on the ABCB6 exons from 116 sporadic cases of microphthalmia with coloboma (MAC), isolated coloboma, and aniridia, and an additional mutation (A57T) was identified in three patients with MAC. These two mutations were not present in the ethnically matched control populations. Immunostaining of transiently transfected, Myc-tagged ABCB6 in retinal pigment epithelial (RPE) cells showed that it localized to the endoplasmic reticulum and Golgi apparatus of RPE cells. RT-PCR of ABCB6 mRNA in human cell lines and tissue indicated that ABCB6 is expressed in the retinae and RPE cells. Using zebrafish, we show that abcb6 is expressed in the eye and CNS. Morpholino knockdown of abcb6 in zebrafish produces a phenotype characteristic of coloboma and replicates the clinical phenotype observed in our index cases. The knockdown phenotype can be corrected with coinjection of the wild-type, but not mutant, ABCB6 mRNA, suggesting that the phenotypes observed in zebrafish are due to insufficient abcb6 function. Our results demonstrate that ABCB6 mutations cause ocular coloboma.	[Wang, Lejing; Bu, Juan; Du, Wei; Dong, Jiamei; Liang, Chen] Peking Univ, Hosp 3, Dept Ophthalmol, Beijing 100191, Peoples R China; [Dong, Jiamei] Peking Univ, Hosp 3, Party Sch, Cent Comm Communist Party China, Beijing 100091, Peoples R China; [Cooney, Jeffrey D.; McBride, Paul F.; Soltis, Kathleen A.; Paw, Barry H.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Hematol, Boston, MA 02115 USA; [Cooney, Jeffrey D.; McBride, Paul F.; Soltis, Kathleen A.; Paw, Barry H.] Harvard Univ, Childrens Hosp Boston, Sch Med, Div Hematol Oncol, Boston, MA 02115 USA; [Dubey, Sushi Kumar; Namburi, Prasanthi; Sundaresan, Periasamy] Aravind Eye Hosp, Aravind Med Res Fdn, Dept Genet, Dr G Venkataswamy Eye Res Inst, Madurai 625020, Tamil Nadu, India; [Jia, Yanlei] Municipal Hosp Zaozhuang, Dept Ophthalmol, Zaozhuang 277102, Shandong, Peoples R China; [Li, Dean Y.] Univ Utah, Sch Med, Program Mol Med, Salt Lake City, UT 84112 USA; [Li, Dean Y.] Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Li, Dean Y.] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; [Phillips, John D.] Univ Utah, Sch Med, Div Hematol, Salt Lake City, UT 84112 USA	Peking University; Peking University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Wang, LJ (corresponding author), Peking Univ, Hosp 3, Dept Ophthalmol, Beijing 100191, Peoples R China.	wanglefin@hotmail.com; zliny@yahoo.com	.P, Sundaresan/AAR-8426-2021; Dubey, Sushil/ABI-6894-2020	Paw, Barry/0000-0002-0492-1419	National Natural Science Foundation of China [81025006, 81170883, 30470975, 30540030, 30950007]; Department of Science and Technology of Sichuan Province, China; American Heart Association; American Society of Hematology; March of Dimes Foundation; National Institutes of Health [R01 DK070838, P01 HL032262, DK02503, DK083909]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL032262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070838, K08DK002503, U54DK083909] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Sichuan Province, China; American Heart Association(American Heart Association); American Society of Hematology; March of Dimes Foundation(March of Dimes); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the patients and their families for their participation and K.R. Thomas for helpful discussions. The zebrafish cDNA clone of abcb6 was a gift from John Schuetz (St. Jude Children's Research Hospital, Memphis, TN, USA). This research was supported by the National Natural Science Foundation of China (81025006, 81170883 [Z.Y.], 30470975, 30540030, and 30950007 [LW.]), the Department of Science and Technology of Sichuan Province, China (Z.Y.), the American Heart Association (J.D.C. and K.A.S.), the American Society of Hematology (P.F.M. and K.A.S.), the March of Dimes Foundation (B.H.P.), and National Institutes of Health grants R01 DK070838 (B.H.P.), P01 HL032262 (B.H.P.), and DK02503 and DK083909 (both to J.D.P).	Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Amigo JD, 2009, BLOOD, V114, P4654, DOI 10.1182/blood-2008-12-189910; Asai-Coakwell M, 2009, HUM MOL GENET, V18, P1110, DOI 10.1093/hmg/ddp008; Bermejo E, 1998, AM J MED GENET, V75, P497, DOI 10.1002/(SICI)1096-8628(19980217)75:5<497::AID-AJMG8>3.0.CO;2-K; Danno H, 2008, P NATL ACAD SCI USA, V105, P5408, DOI 10.1073/pnas.0710954105; Dean M, 2005, METHOD ENZYMOL, V400, P409, DOI 10.1016/S0076-6879(05)00024-8; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Dong Jia-mei, 2009, Zhonghua Yixue Yichuanxue Zazhi, V26, P263, DOI 10.3760/cma.j.issn.1003-9406.2009.03.006; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463; Gottesman MM, 2001, J BIOENERG BIOMEMBR, V33, P453, DOI 10.1023/A:1012866803188; Gregory-Evans CY, 2004, J MED GENET, V41, P881, DOI 10.1136/jmg.2004.025494; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Kelter G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000798; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; Maumenee I H, 1990, Trans Am Ophthalmol Soc, V88, P123; MAUMENEE IH, 1990, T AM OPHTHAL SOC, V88, P133; Paterson JK, 2007, BIOCHEMISTRY-US, V46, P9443, DOI 10.1021/bi700015m; Ragge NK, 2005, AM J HUM GENET, V76, P1008, DOI 10.1086/430721; SANYANUSIN P, 1995, NAT GENET, V9, P358, DOI 10.1038/ng0495-358; Schimmenti LA, 2003, AM J MED GENET A, V116A, P215, DOI 10.1002/ajmg.a.10884; SOLOMONS NW, 2001, PRESENT KNOWLEDGE NU, P127; Stoll C, 1997, ANN GENET-PARIS, V40, P122; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; Tsuchida M, 2008, BIOCHEM BIOPH RES CO, V369, P369, DOI 10.1016/j.bbrc.2008.02.027; van Heyningen V, 2002, HUM MOL GENET, V11, P1161, DOI 10.1093/hmg/11.10.1161; Voronina VA, 2004, HUM MOL GENET, V13, P315, DOI 10.1093/hmg/ddh025; Wallis DE, 1999, NAT GENET, V22, P196, DOI 10.1038/9718; Ye M, 2010, HUM MOL GENET, V19, P287, DOI 10.1093/hmg/ddp496	30	57	63	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN 13	2012	90	1					40	48		10.1016/j.ajhg.2011.11.026	http://dx.doi.org/10.1016/j.ajhg.2011.11.026			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	880LR	22226084	Green Published, Bronze			2022-12-18	WOS:000299409100003
J	Huigsloot, M; Nijtmans, LG; Szklarczyk, R; Baars, MJH; van den Brand, MAM; HendriksFranssen, MGM; van den Heuvel, LP; Smeitink, JAM; Huynen, MA; Rodenburg, RJT				Huigsloot, Merei; Nijtmans, Leo G.; Szklarczyk, Radek; Baars, Marieke J. H.; van den Brand, Mariel A. M.; HendriksFranssen, Marthe G. M.; van den Heuvel, Lambertus P.; Smeitink, Jan A. M.; Huynen, Martijn A.; Rodenburg, Richard J. T.			A Mutation in C2orf64 Causes Impaired Cytochrome c Oxidase Assembly and Mitochondrial Cardiomyopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTERMEMBRANE SPACE; RESPIRATORY-CHAIN; COX DEFICIENCY; LEIGH-SYNDROME; GENE; ELECTROPHORESIS; SCO1; SURF-1; IMPORT; PET191	The assembly of mitochondrial respiratory chain complex IV (cytochrome c oxidase) involves the coordinated action of several assembly chaperones. In Saccharomyces cerevisiae, at least 30 different assembly chaperones have been identified. To date, pathogenic mutations leading to a mitochondrial disorder have been identified in only seven of the corresponding human genes. One of the genes for which the relevance to human pathology is unknown is C2orf64, an ortholog of the S. cerevisiae gene PET191. This gene has previously been shown to be a complex IV assembly factor in yeast, although its exact role is still unknown. Previous research in a large cohort of complex IV deficient patients did not support an etiological role of C2orf64 in complex IV deficiency. In this report, a homozygous mutation in C2orf64 is described in two siblings affected by fatal neonatal cardiomyopathy. Pathogenicity of the mutation is supported by the results of a complementation experiment, showing that complex IV activity can be fully restored by retroviral transduction of wild-type C2orf64 in patient-derived fibroblasts. Detailed analysis of complex IV assembly intermediates in patient fibroblasts by 2D-BN PAGE revealed the accumulation of a small assembly intermediate containing subunit COX1 but not the COX2, COX4, or COX5b subunits, indicating that C2orf64 is involved in an early step of the complex IV assembly process. The results of this study demonstrate that C2orf64 is essential for human complex IV assembly and that C2orf64 mutational analysis should be considered for complex IV deficient patients, in particular those with hypertrophic cardiomyopathy.	[Huigsloot, Merei; Nijtmans, Leo G.; van den Brand, Mariel A. M.; HendriksFranssen, Marthe G. M.; van den Heuvel, Lambertus P.; Smeitink, Jan A. M.; Rodenburg, Richard J. T.] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, Nijmegen Ctr Mitochondrial Disorders, NL-6500 HB Nijmegen, Netherlands; [Huigsloot, Merei; Nijtmans, Leo G.; van den Brand, Mariel A. M.; HendriksFranssen, Marthe G. M.; van den Heuvel, Lambertus P.; Rodenburg, Richard J. T.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Lab Genet Endocrine & Metab Dis, NL-6500 HB Nijmegen, Netherlands; [Szklarczyk, Radek; Huynen, Martijn A.] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Baars, Marieke J. H.] Acad Med Ctr Amsterdam, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam	Rodenburg, RJT (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Pediat, Nijmegen Ctr Mitochondrial Disorders, POB 9101, NL-6500 HB Nijmegen, Netherlands.	r.rodenburg@cukz.umcn.nl	Huijnen, M.A./H-8051-2014; Huynen, Martijn A/A-1530-2014; Rodenburg, Richard/N-3579-2014; Smeitink, Jan A.M./D-6064-2011; van den Heuvel, L.P.W.J./H-8044-2014; Nijtmans, L.G.J./L-4549-2015; Smeitink, Jan/C-1351-2013; van den Heuvel, Lambertus/AAM-1772-2021	Huynen, Martijn A/0000-0001-6189-5491; Rodenburg, Richard/0000-0001-5227-3527; van den Heuvel, L.P.W.J./0000-0003-3917-6727; van den Heuvel, Lambertus/0000-0003-3917-6727	Senternovem [IGA05003]; Netherlands Genomics Initiative	Senternovem; Netherlands Genomics Initiative	Part of this work was supported by a grant from the Innovatiegerichte Onderzoeksprogramma's Genomics program of Senternovem (Grant IGA05003 to M.H.) and the Netherlands Genomics Initiative (Horizon Program to R.S.). The authors thank Cindy Dieteren for assistance with the Gateway cloning, Hanka Venselaar for helpful suggestions on structure-function relationship, and the colleagues of the muscle and tissue culture labs of the Laboratory of Genetic, Endocrine, and Metabolic Diseases for excellent technical assistance.	Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284; Arnesano F, 2005, STRUCTURE, V13, P713, DOI 10.1016/j.str.2005.02.015; Bohm M, 2006, PEDIATR RES, V59, P21, DOI 10.1203/01.pdr.0000190572.68191.13; Calvaruso MA, 2008, METHODS, V46, P281, DOI 10.1016/j.ymeth.2008.09.023; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Coenen MJH, 1999, BIOCHEM BIOPH RES CO, V265, P339, DOI 10.1006/bbrc.1999.1662; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Fornuskova D, 2010, BIOCHEM J, V428, P363, DOI 10.1042/BJ20091714; Herrmann JM, 2007, J CELL BIOL, V176, P559, DOI 10.1083/jcb.200611060; Hofmann S, 2005, J MOL BIOL, V353, P517, DOI 10.1016/j.jmb.2005.08.064; Horvath R, 2000, BIOCHEM BIOPH RES CO, V276, P530, DOI 10.1006/bbrc.2000.3495; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; Khalimonchuk O, 2008, EUKARYOT CELL, V7, P1427, DOI 10.1128/EC.00132-08; Leary SC, 2009, HUM MOL GENET, V18, P2230, DOI 10.1093/hmg/ddp158; Longen S, 2009, J MOL BIOL, V393, P356, DOI 10.1016/j.jmb.2009.08.041; Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002; Mick DU, 2011, NAT REV MOL CELL BIO, V12, P14, DOI 10.1038/nrm3029; MILLER AD, 1993, METHOD ENZYMOL, V217, P581; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Niers L, 2003, J INHERIT METAB DIS, V26, P647, DOI 10.1023/B:BOLI.0000005605.57420.b4; Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5; Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x; Papadopoulou LC, 1999, NAT GENET, V23, P333; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; RODENBURG RJ, 2010, J INHERIT M IN PRESS; Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378; Tay SKH, 2004, ARCH NEUROL-CHICAGO, V61, P1935, DOI 10.1001/archneur.61.12.1935; Tiranti V, 1999, HUM MOL GENET, V8, P2533, DOI 10.1093/hmg/8.13.2533; Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150; Valnot I, 2000, AM J HUM GENET, V67, P1104; Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245; Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390; WOOLFSON DN, 1990, FEBS LETT, V277, P185, DOI 10.1016/0014-5793(90)80839-B; Xu FH, 2004, BIOCHEM J, V382, P331, DOI 10.1042/BJ20040469; Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804	35	57	59	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR 8	2011	88	4					488	493		10.1016/j.ajhg.2011.03.002	http://dx.doi.org/10.1016/j.ajhg.2011.03.002			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	752BY	21457908	Green Published, Bronze			2022-12-18	WOS:000289664300009
J	Cornier, AS; Staehling-Hampton, K; Delventhal, KM; Saga, Y; Caubet, JF; Sasaki, N; Ellard, S; Young, E; Ramirez, N; Carlo, SE; Torres, J; Emans, JB; Turnpenny, PD; Pourquie, O				Cornier, Alberto S.; Staehling-Hampton, Karen; Delventhal, Kym M.; Saga, Yumiko; Caubet, Jean-Francois; Sasaki, Nobuo; Ellard, Sian; Young, Elizabeth; Ramirez, Norman; Carlo, Simon E.; Torres, Jose; Emans, John B.; Turnpenny, Peter D.; Pourquie, Olivier			Mutations in the MESP2 gene cause spondylothoracic dysostosis/Jarcho-Levin syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CAUSES SPONDYLOCOSTAL DYSOSTOSIS; ABNORMAL VERTEBRAL SEGMENTATION; NOTCH SIGNALING PATHWAY; SOMITE SEGMENTATION; DYSPLASIA; DLL3; PHENOTYPE; ANOMALIES; PATTERN; HUMANS	Spondylothoracic dysostosis (STD), also known as Jarcho-Levin syndrome (JLS), is an autosomal-recessive disorder characterized by abnormal vertebral segmentation and defects affecting spine formation, with complete bilateral fusion of the ribs at the costovertebral junction producing a "crab-like" configuration of the thorax. The shortened spine and trunk can severely affect respiratory function during early childhood. The condition is prevalent in the Puerto Rican population, although it is a panethnic disorder. By sequencing a set of candidate genes involved in mouse segmentation, we identified a recessive E103X nonsense mutation in the mesoderm posterior 2 homolog (MESP2) gene in a patient, of Puerto Rican origin and from the Boston area, who had been diagnosed with STD/JLS. We then analyzed 12 Puerto Rican families with STD probands for the MESP2 E103X mutation. Ten patients were homozygous for the E103X mutation, three patients were compound heterozygous for a second nonsense mutation, E230X, or a missense mutation, L125V, which affects a conserved leucine residue within the bHLH region. Thus, all affected probands harbored the E103X mutation. Our findings suggest a founder-effect mutation in the MESP2 gene as a major cause of the classical Puerto Rican form of STD/JLS.	[Pourquie, Olivier] Howard Hughes Med Inst, Kansas City, MO 64110 USA; [Pourquie, Olivier] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Cornier, Alberto S.; Carlo, Simon E.] Concepcion Hosp, Dept Mol Med, San German, PR 00683 USA; [Cornier, Alberto S.] Ponce Sch Med, Dept Biochem, Ponce, PR 00732 USA; [Staehling-Hampton, Karen; Delventhal, Kym M.] Stowers Inst Med Res, Mol Biol Facil, Kansas City, MO 64110 USA; [Saga, Yumiko; Sasaki, Nobuo] Natl Inst Genet, Div Mammalian Dev, Mishima, Shizuoka 4118540, Japan; [Caubet, Jean-Francois; Emans, John B.] Childrens Hosp, Dept Orthopaed Surg, Boston, MA 02115 USA; [Ellard, Sian; Young, Elizabeth] Royal Devon & Exeter Hosp, Dept Mol Genet, Exeter EX2 5DW, Devon, England; [Ramirez, Norman] Concepcion Hosp, Dept Orthopaed, San German, PR 00683 USA; [Carlo, Simon E.] San Juan Bautista Sch Med, Dept Genet, Caguas, PR 00726 USA; [Turnpenny, Peter D.] Royal Devon & Exeter Hosp, Dept Clin Genet, Exeter EX1 2ED, Devon, England	Howard Hughes Medical Institute; Stowers Institute for Medical Research; Stowers Institute for Medical Research; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Harvard University; Boston Children's Hospital; University of Exeter; University of Exeter	Pourquie, O (corresponding author), Howard Hughes Med Inst, Kansas City, MO 64110 USA.	olp@stowers-institute.org	Sasaki, Nobuo/HDO-8251-2022; Pourquié, Olivier/CAJ-5443-2022; Ramirez, Norman/AAI-1488-2020	Sasaki, Nobuo/0000-0002-8798-7244; Pourquié, Olivier/0000-0001-5189-1227; Ramirez, Norman/0000-0002-7254-6059; Ellard, Sian/0000-0002-7620-5526	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bessho Y, 2001, GENE DEV, V15, P2642, DOI 10.1101/gad.930601; Bonafe L, 2003, CLIN GENET, V64, P28, DOI 10.1034/j.1399-0004.2003.00085.x; Bulman MP, 2000, NAT GENET, V24, P438, DOI 10.1038/74307; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Cornier AS, 2004, AM J MED GENET A, V128A, P120, DOI 10.1002/ajmg.a.30011; Dequeant ML, 2008, NAT REV GENET, V9, P370, DOI 10.1038/nrg2320; Dimeglio A., 1989, PEDIAT SPINE, P39; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; GELLIS SS, 1976, AM J DIS CHILD, V130, P653, DOI 10.1001/archpedi.1976.02120070079015; Hirsinger E, 2000, INT REV CYTOL, V198, P1; Jarcho S, 1938, B JOHNS HOPKINS HOSP, V62, P216; Koizumi K, 2001, DEVELOPMENT, V128, P1391; LAVY NW, 1966, J PEDIATR-US, V69, P1121, DOI 10.1016/S0022-3476(66)80304-9; MCCALL CP, 1994, AM J MED GENET, V49, P328, DOI 10.1002/ajmg.1320490317; Morimoto M, 2005, NATURE, V435, P354, DOI 10.1038/nature03591; MOSELEY JE, 1969, AMER J ROENTGENOL RA, V106, P166, DOI 10.2214/ajr.106.1.166; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; POCHACZEVSKY R, 1971, RADIOLOGY, V98, P53, DOI 10.1148/98.1.53; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Saga Y, 2001, NAT REV GENET, V2, P835, DOI 10.1038/35098552; Saga Y, 1997, GENE DEV, V11, P1827, DOI 10.1101/gad.11.14.1827; Santiago-Comier A, 2001, AM J HUM GENET, V69, P514; SCHULMAN M, 1993, J MED GENET, V30, P875, DOI 10.1136/jmg.30.10.875; SOLOMON L, 1978, ARCH PATHOL LAB MED, V102, P201; Sparrow DB, 2006, AM J HUM GENET, V78, P28, DOI 10.1086/498879; TOLMIE JL, 1987, PRENATAL DIAG, V7, P129, DOI 10.1002/pd.1970070209; Turnpenny PD, 2003, J MED GENET, V40, P333, DOI 10.1136/jmg.40.5.333; Turnpenny PD, 2007, DEV DYNAM, V236, P1456, DOI 10.1002/dvdy.21182; van de Vosse E, 2005, HUM GENET, V118, P138, DOI 10.1007/s00439-005-0005-0; Whittock NV, 2004, AM J HUM GENET, V74, P1249, DOI 10.1086/421053; Williams TN, 2005, PLOS MED, V2, P441, DOI 10.1371/journal.pmed.0020128	31	57	68	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2008	82	6					1334	1341		10.1016/j.ajhg.2008.04.014	http://dx.doi.org/10.1016/j.ajhg.2008.04.014			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	312CP	18485326	Green Published, Bronze			2022-12-18	WOS:000256647000010
J	Ayodo, G; Price, AL; Keinan, A; Ajwang, A; Otieno, MF; Orago, ASS; Patterson, N; Reich, D				Ayodo, George; Price, Alkes L.; Keinan, Alon; Ajwang, Arthur; Otieno, Michael F.; Orago, Alloys S. S.; Patterson, Nick; Reich, David			Combining evidence of natural selection with association analysis increases power to detect malaria-resistance variants	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SICKLE-CELL TRAIT; PLASMODIUM-FALCIPARUM INFECTION; IIA CD32 POLYMORPHISM; HUMAN GENOME; CEREBRAL MALARIA; PROMOTER REGION; POSITIVE SELECTION; GENE; PROTECTION; DIVERSITY	Statistical power to detect disease variants can be increased by weighting candidates by their evidence of natural selection. To demonstrate that this theoretical idea works in practice, we performed an association study of 10 putative resistance variants in 471 severe malaria cases and 474 controls from the Luo in Kenya. We replicated associations at HBB (P =.0008) and CD36 (P =.03) but also showed that the same variants are unusually differentiated in frequency between the Luo and Yoruba (who historically have been exposed to malaria) and the Masai and Kikuyu (who have not been exposed). This empirically demonstrates that combining association analysis with evidence of natural selection can increase power to detect risk variants by orders of magnitude-up to P =.000018 for HBB and P =.00043 for CD36.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Broad Inst, Boston, MA 02115 USA; MIT, Broad Inst, Boston, MA USA; Kenyatta Univ, Dept Preclin Sci, Nairobi, Kenya	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Kenyatta University	Reich, D (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur,New Res Bldg, Boston, MA 02115 USA.	reich@genetics.med.harvard.edu	Peng, Bo/A-6920-2009	Peng, Bo/0000-0001-8225-2284; Keinan, Alon/0000-0002-9760-1122	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI064519] Funding Source: NIH RePORTER; NIAID NIH HHS [R21 AI064519, R21-AI64519] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aidoo M, 2002, LANCET, V359, P1311, DOI 10.1016/S0140-6736(02)08273-9; Aitman TJ, 2000, NATURE, V405, P1015, DOI 10.1038/35016636; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Aucan C, 2003, GENES IMMUN, V4, P275, DOI 10.1038/sj.gene.6363962; BARNSHAD M, 2003, NAT REV GENET, V4, P99; Burgner D, 1999, ARCH DIS CHILD, V81, P185, DOI 10.1136/adc.81.2.185; Burgner D, 2003, HUM GENET, V112, P379, DOI 10.1007/s00439-002-0882-4; Cavalli-Sforza LL, 2005, NAT REV GENET, V6, P333, DOI 10.1038/nrg1579; Clarke SE, 2004, AM J TROP MED HYG, V71, P732, DOI 10.4269/ajtmh.2004.71.732; Cooke GS, 2003, AM J TROP MED HYG, V69, P565, DOI 10.4269/ajtmh.2003.69.565; Flori L, 2005, GENES IMMUN, V6, P472, DOI 10.1038/sj.gene.6364231; Guerra CA, 2006, ADV PARASIT, V62, P157, DOI 10.1016/S0065-308X(05)62005-2; Hanchard NA, 2006, AM J HUM GENET, V78, P153, DOI 10.1086/499252; Hosmer D., 2000, APPL LOGISTIC REGRES, V2; Jeffares DC, 2007, NAT GENET, V39, P120, DOI 10.1038/ng1931; Knight JC, 1999, NAT GENET, V22, P145, DOI 10.1038/9649; Kraemer SM, 2003, MOL MICROBIOL, V50, P1527, DOI 10.1046/j.1365-2958.2003.03814.x; Kun JFJ, 1999, AM J TROP MED HYG, V61, P776, DOI 10.4269/ajtmh.1999.61.776; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; MCGUIRE W, 1994, NATURE, V371, P508, DOI 10.1038/371508a0; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Mockenhaupt FP, 2006, P NATL ACAD SCI USA, V103, P177, DOI 10.1073/pnas.0506803102; Modiano D, 2001, NATURE, V414, P305, DOI 10.1038/35104556; Moormann AM, 2003, T ROY SOC TROP MED H, V97, P513, DOI 10.1016/S0035-9203(03)80010-X; Murray SS, 2004, NAT METHODS, V1, P113, DOI 10.1038/NMETH712; Ndungu FM, 2006, J IMMUNOL, V176, P5504, DOI 10.4049/jimmunol.176.9.5504; Nicholson G, 2002, J ROY STAT SOC B, V64, P695, DOI 10.1111/1467-9868.00357; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Roeder K, 2006, AM J HUM GENET, V78, P243, DOI 10.1086/500026; Rottmann M, 2006, INFECT IMMUN, V74, P3904, DOI 10.1128/IAI.02073-05; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Shi YP, 2001, J INFECT DIS, V184, P107, DOI 10.1086/320999; Tang K, 1999, P NATL ACAD SCI USA, V96, P10016, DOI 10.1073/pnas.96.18.10016; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Urban BC, 2006, INFECT IMMUN, V74, P6700, DOI 10.1128/IAI.00861-06; Vallender EJ, 2004, HUM MOL GENET, V13, pR245, DOI 10.1093/hmg/ddh253; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Volkman SK, 2007, NAT GENET, V39, P113, DOI 10.1038/ng1930; Williams TN, 2005, PLOS MED, V2, P441, DOI 10.1371/journal.pmed.0020128; Williams TN, 2005, NAT GENET, V37, P1253, DOI 10.1038/ng1660; Xu WM, 2000, NITRIC OXIDE-BIOL CH, V4, P379, DOI 10.1006/niox.2000.0290	44	57	59	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2007	81	2					234	242		10.1086/519221	http://dx.doi.org/10.1086/519221			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	197FQ	17668374	Green Published, Bronze			2022-12-18	WOS:000248540400004
J	Field, M; Tarpey, PS; Smith, R; Edkins, S; O'Meara, S; Stevens, C; Tofts, C; Teague, J; Butler, A; Dicks, E; Barthorpe, S; Buck, G; Cole, J; Gray, K; Halliday, K; Hills, K; Jenkinson, A; Jones, D; Menzies, A; Mironenko, T; Perry, J; Raine, K; Richardson, D; Shepherd, R; Small, A; Varian, J; West, S; Widaa, S; Mallya, U; Wooster, R; Moon, J; Luo, Y; Hughes, H; Shaw, M; Friend, KL; Corbett, M; Turner, G; Partington, M; Mulley, J; Bobrow, M; Schwartz, C; Stevenson, R; Gecz, J; Stratton, MR; Futreal, PA; Raymond, FL				Field, Michael; Tarpey, Patrick S.; Smith, Raffaella; Edkins, Sarah; O'Meara, Sarah; Stevens, Claire; Tofts, Calli; Teague, Jon; Butler, Adam; Dicks, Ed; Barthorpe, Syd; Buck, Gemma; Cole, Jennifer; Gray, Kristian; Halliday, Kelly; Hills, Katy; Jenkinson, Andrew; Jones, David; Menzies, Andrew; Mironenko, Tatiana; Perry, Janet; Raine, Keiran; Richardson, David; Shepherd, Rebecca; Small, Alexandra; Varian, Jennifer; West, Sofie; Widaa, Sara; Mallya, Uma; Wooster, Richard; Moon, Jenny; Luo, Ying; Hughes, Helen; Shaw, Marie; Friend, Kathryn L.; Corbett, Mark; Turner, Gillian; Partington, Michael; Mulley, John; Bobrow, Martin; Schwartz, Charles; Stevenson, Roger; Gecz, Jozef; Stratton, Michael R.; Futreal, P. Andrew; Raymond, F. Lucy			Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BROMODOMAIN; CHILDREN; SUBUNIT; LINKAGE; OBESITY; AUTISM; FAMILY	In the course of systematic screening of the X-chromosome coding sequences in 250 families with nonsyndromic X-linked mental retardation (XLMR), two families were identified with truncating mutations in BRWD3, a gene encoding a bromodomain and WD-repeat domain-containing protein. In both families, the mutation segregates with the phenotype in affected males. Affected males have macrocephaly with a prominent forehead, large cupped ears, and mild-to-moderate intellectual disability. No truncating variants were found in 520 control X chromosomes. BRWD3 is therefore a new gene implicated in the etiology of XLMR associated with macrocephaly and may cause disease by altering intracellular signaling pathways affecting cellular proliferation.	Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 2XY, England; GOLD Serv, Hunter Genet, Waratah, Australia; Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, England; Ysbyty Gwynedd, Bangor, Gwynedd, Wales; Womens & Childrens Hosp, Dept Med Genet, Adelaide, SA, Australia; Univ Adelaide, Dept Paediat, Adelaide, SA 5005, Australia; Univ Adelaide, Dept Mol Biosci, Adelaide, SA 5005, Australia; Greenwood Genet Ctr, JC Self Res Inst Human Genet, Greenwood, SC USA	University of Cambridge; Wellcome Trust Sanger Institute; Womens & Childrens Hospital Australia; University of Adelaide; University of Adelaide; Greenwood Genetic Center	Raymond, FL (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Addenbrookes Hosp, Cambridge CB2 2XY, England.	flr24@cam.ac.uk	Corbett, Mark/A-8063-2010; Gecz, Jozef/X-3469-2019	Corbett, Mark/0000-0001-9298-3072; Gecz, Jozef/0000-0002-7884-6861; Raine, Keiran/0000-0002-5634-1539; Richardson, David/0000-0003-0247-9118; Gray, Kristian/0000-0002-7035-7107; Jenkinson, Andrew/0000-0002-0703-6984; Buck, Gemma/0000-0001-5289-1050	NICHD NIH HHS [R01 HD026202, HD26202] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026202] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ATKIN JF, 1985, AM J MED GENET, V21, P697, DOI 10.1002/ajmg.1320210411; BARAITSER M, 1995, AM J MED GENET, V57, P380, DOI 10.1002/ajmg.1320570303; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; CLARK R D, 1987, American Journal of Medical Genetics, V26, P13, DOI 10.1002/ajmg.1320260104; de la Cruz X, 2005, BIOESSAYS, V27, P164, DOI 10.1002/bies.20176; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Fombonne E, 1999, J AUTISM DEV DISORD, V29, P113, DOI 10.1023/A:1023036509476; GEDEON A, 1994, AM J MED GENET, V51, P553, DOI 10.1002/ajmg.1320510453; Hassan AH, 2002, CELL, V111, P369, DOI 10.1016/S0092-8674(02)01005-X; Hombria JCG, 2002, CURR BIOL, V12, pR569, DOI 10.1016/S0960-9822(02)01057-6; HU LJ, 1994, AM J MED GENET, V51, P569, DOI 10.1002/ajmg.1320510455; Johnson JP, 1998, J MED GENET, V35, P1026, DOI 10.1136/jmg.35.12.1026; Kalla C, 2005, GENE CHROMOSOME CANC, V42, P128, DOI 10.1002/gcc.20131; Miles JH, 2000, AM J MED GENET, V95, P339, DOI 10.1002/1096-8628(20001211)95:4<339::AID-AJMG9>3.3.CO;2-2; Muller P, 2005, NATURE, V436, P871, DOI 10.1038/nature03869; PROOPS R, 1983, CLIN GENET, V23, P81; SMITH RD, 1984, J DEV BEHAV PEDIATR, V5, P231; Syntichaki P, 2000, NATURE, V404, P414, DOI 10.1038/35006136; Tarpey PS, 2007, AM J HUM GENET, V80, P345, DOI 10.1086/511134; Tarpey PS, 2006, AM J HUM GENET, V79, P1119, DOI 10.1086/510137; TURNER G, 1994, AM J MED GENET, V51, P575, DOI 10.1002/ajmg.1320510456	21	57	62	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2007	81	2					367	374		10.1086/520677	http://dx.doi.org/10.1086/520677			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	197FQ	17668385	Green Published, Bronze			2022-12-18	WOS:000248540400015
J	Durham, SE; Samuels, DC; Cree, LM; Chinnery, PF				Durham, Steve E.; Samuels, David C.; Cree, Lynsey M.; Chinnery, Patrick F.			Normal levels of wild-type mitochondrial DNA maintain cytochrome c oxidase activity for two pathogenic mitochondrial DNA mutations but not for m.3243A -> G	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEFICIENT MUSCLE-FIBERS; STROKE-LIKE EPISODES; WOBBLE MODIFICATION; PROTEIN-SYNTHESIS; SKELETAL-MUSCLE; LACTIC-ACIDOSIS; MTDNA MUTATION; POINT MUTATION; TRANSFER-RNAS; MELAS	Mitochondrial DNA (mtDNA) mutations are a common cause of human disease and accumulate as part of normal ageing and in common neurodegenerative disorders. Cells express a biochemical defect only when the proportion of mutated mtDNA exceeds a critical threshold, but it is not clear whether the actual cause of this defect is a loss of wild-type mtDNA, an excess of mutated mtDNA, or a combination of the two. Here, we show that segments of human skeletal muscle fibers harboring two pathogenic mtDNA mutations retain normal cytochrome c oxidase (COX) activity by maintaining a minimum amount of wild- type mtDNA. For these mutations, direct measurements of mutated and wild- type mtDNA molecules within the same skeletal muscle fiber are consistent with the "maintenance of wild type" hypothesis, which predicts that there is nonselective proliferation of mutated and wild- type mtDNA in response to the molecular defect. However, for the m. 3243A -> G mutation, a superabundance of wild-type mtDNA was found in many muscle-fiber sections with negligible COX activity, indicating that the pathogenic mechanism for this particular mutation involves interference with the function of the wild- type mtDNA or wild-type gene products.	Newcastle Univ, Mitochondrial Res Grp, Newcastle Upon Tyne, Tyne & Wear, England; Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne, Tyne & Wear, England; Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA	Newcastle University - UK; Newcastle University - UK; Virginia Polytechnic Institute & State University	Chinnery, PF (corresponding author), Med Sch Newcastle Upon Tyne, M4014, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	P.F.Chinnery@ncl.ac.uk	Samuels, David C/A-5393-2008; Samuels, David/C-1365-2012; Samuels, David/AHC-8381-2022	Samuels, David C/0000-0003-3529-7791; Samuels, David/0000-0003-3529-7791; Chinnery, Patrick/0000-0002-7065-6617; Cree, Lynsey/0000-0003-2090-1589	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ATTARDI G, 1995, BBA-MOL BASIS DIS, V1271, P241, DOI 10.1016/0925-4439(95)00034-2; Aure K, 2006, BRAIN, V129, P1249, DOI 10.1093/brain/awl061; Bidooki SK, 1997, AM J HUM GENET, V60, P1430, DOI 10.1086/515460; BOULET L, 1992, AM J HUM GENET, V51, P1187; Capps GJ, 2003, J THEOR BIOL, V221, P565, DOI 10.1006/jtbi.2003.3207; Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311; CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221; Clark KM, 1999, AM J HUM GENET, V64, P1330, DOI 10.1086/302361; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Dubeau F, 2000, ANN NEUROL, V47, P179, DOI 10.1002/1531-8249(200002)47:2<179::AID-ANA7>3.0.CO;2-Z; Dunbar DR, 1996, HUM MOL GENET, V5, P123, DOI 10.1093/hmg/5.1.123; Durham SE, 2005, NEUROLOGY, V65, P453, DOI 10.1212/01.wnl.0000171861.30277.88; Elson JL, 2002, NEUROMUSCULAR DISORD, V12, P858, DOI 10.1016/S0960-8966(02)00047-0; Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1; HAMMANS SR, 1992, J NEUROL SCI, V107, P87, DOI 10.1016/0022-510X(92)90213-5; Hao R, 2004, FEBS LETT, V578, P135, DOI 10.1016/j.febslet.2004.11.004; HAYASHI JI, 1993, BIOCHEM BIOPH RES CO, V197, P1049, DOI 10.1006/bbrc.1993.2584; He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067; Kim JY, 2005, NEUROLOGY, V64, P966, DOI 10.1212/01.WNL.0000157282.76715.B1; KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480; Kirino Y, 2006, HUM MOL GENET, V15, P897, DOI 10.1093/hmg/ddl007; KOGA Y, 1995, MUSCLE NERVE, pS119; MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509; OLDFORS A, 1992, J NEUROL SCI, V110, P169, DOI 10.1016/0022-510X(92)90025-G; Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109; SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13; SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A; SUOMALAINEN A, 1993, HUM MOL GENET, V2, P525, DOI 10.1093/hmg/2.5.525; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; TOKUNAGA M, 1994, ANN NEUROL, V35, P413, DOI 10.1002/ana.410350407; Villani G, 1997, P NATL ACAD SCI USA, V94, P1166, DOI 10.1073/pnas.94.4.1166; Yasukawa T, 2005, FEBS LETT, V579, P2948, DOI 10.1016/j.febslet.2005.04.038; YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164; YONEDA M, 1994, MOL CELL BIOL, V14, P2699, DOI 10.1128/MCB.14.4.2699	34	57	57	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2007	81	1					189	195		10.1086/518901	http://dx.doi.org/10.1086/518901			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	175UO	17564976	Bronze, Green Published			2022-12-18	WOS:000247039700018
J	Nance, WE; Kearsey, MJ				Nance, WE; Kearsey, MJ			Relevance of connexin deafness (DFNB1) to human evolution	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							RECESSIVE DEAFNESS; UNITED-STATES; GENE; MUTATIONS; MARRIAGES; FREQUENCY; SELECTION; FEATURES; ORIGINS; SPEECH	The connexins are the subunits of a family of proteins that form gap junctions, allowing ions and small molecules to move between adjacent cells. At least four connexins are expressed in the ear, and, although there are known mutations at 1100 loci that can cause deafness, those involving DFNB1, in the interval 13q11-q12 containing the GJB2 and GJB6 genes coding for connexins 26 and 30, are the most frequent cause of recessive deafness in many populations. We have suggested that the combined effects of relaxed selection and linguistic homogamy can explain the high frequency of connexin deafness and may have doubled its incidence in this country during the past 200 years. In this report, we show by computer simulation that assortative mating, in fact, can accelerate dramatically the genetic response to relaxed selection. Along with the effects of gene drift and consanguinity, assortative mating also may have played a key role in the joint evolution and accelerated fixation of genes for speech after they first appeared in Homo sapiens 100,000-150,000 years ago.	Virginia Commonwealth Univ, Dept Human Genet, Richmond, VA 23298 USA; Univ Birmingham, Dept Biosci, Birmingham, W Midlands, England	Virginia Commonwealth University; University of Birmingham	Nance, WE (corresponding author), Virginia Commonwealth Univ, Dept Human Genet, 33 MCV Stn, Richmond, VA 23298 USA.	nance@hsc.vcu.edu			NIDCD NIH HHS [R01 DC006707, R01-DC0429, R01-DC006707] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006707] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Balciuniene J, 1998, AM J HUM GENET, V63, P786, DOI 10.1086/302012; BENDER RF, 1970, CONQUEST DEAFNESS, P1; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Cavalli-Sforza LL, 1998, TRENDS GENET, V14, P60, DOI 10.1016/S0168-9525(97)01327-9; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; CROW JF, 1982, SOC BIOL, V29, P22; del Castillo I, 2002, NEW ENGL J MED, V346, P243, DOI 10.1056/NEJMoa012052; del Castillo I, 2003, AM J HUM GENET, V73, P1452, DOI 10.1086/380205; Denniston C, 2000, ANN HUM GENET, V64, P61, DOI [10.1046/j.1469-1809.2000.6410061.x, 10.1017/S0003480099007964]; Denoyelle F, 1999, LANCET, V353, P1298, DOI 10.1016/S0140-6736(98)11071-1; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Forge A, 2003, J COMP NEUROL, V467, P207, DOI 10.1002/cne.10916; FRIEDMAN TB, 1995, NAT GENET, V9, P86, DOI 10.1038/ng0195-86; GOULD SJ, 1993, NATURE, V366, P223, DOI 10.1038/366223a0; Green GE, 1999, JAMA-J AM MED ASSOC, V281, P2211, DOI 10.1001/jama.281.23.2211; HALLOWAY RL, 1983, CAN J ANTHROPOL, V3, P215; Jaber L, 2000, CLIN GENET, V58, P106, DOI 10.1034/j.1399-0004.2000.580203.x; Kenan G, 2002, ANN HUM BIOL, V29, P398, DOI 10.1080/03014460210151480; Klein R. G., 1992, EVOLUTIONARY ANTHR, V1, P5, DOI DOI 10.1002/evan.1360010105; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; LEWIN RA, 1993, ORIGINS OF PLASTIDS, P1; MARAZITA ML, 1993, AM J MED GENET, V46, P486, DOI 10.1002/ajmg.1320460504; MCBRIDE G, 1963, GENET RES, V4, P356, DOI 10.1017/S001667230000375X; Morell R, 1997, HUM MOL GENET, V6, P659, DOI 10.1093/hmg/6.5.659; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; Nance WE, 2000, LANCET, V356, P500, DOI 10.1016/S0140-6736(00)02565-4; Nance WE, 2003, MENT RETARD DEV D R, V9, P109, DOI 10.1002/mrdd.10067; Pandya A, 2003, GENET MED, V5, P295, DOI 10.1097/01.GIM.0000078026.01140.68; Pandya A, 2001, AM J HUM GENET, V69, P590; SCOTT DA, 1995, AM J HUM GENET, V57, P965; Souter M, 1998, HEARING RES, V119, P81, DOI 10.1016/S0378-5955(98)00042-2; Van Laer L, 2001, J MED GENET, V38, P515, DOI 10.1136/jmg.38.8.515; White TD, 2003, NATURE, V423, P742, DOI 10.1038/nature01669; Wright S, 1921, GENETICS, V6, P144; Zhang JZ, 2002, GENETICS, V162, P1825	37	57	65	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2004	74	6					1081	1087		10.1086/420979	http://dx.doi.org/10.1086/420979			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	823ZB	15079193	Green Published, Bronze			2022-12-18	WOS:000221651900001
J	Allen, AS; Rathouz, PJ; Satten, GA				Allen, AS; Rathouz, PJ; Satten, GA			Informative missingness in genetic association studies: Case-parent designs	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSMISSION/DISEQUILIBRIUM TEST; MAXIMUM-LIKELIHOOD; TRANSMISSION; FAMILY; MODELS; TRIADS	We consider the effect of informative missingness on association tests that use parental genotypes as controls and that allow for missing parental data. Parental data can be informatively missing when the probability of a parent being available for study is related to that parent's genotype; when this occurs, the distribution of genotypes among observed parents is not representative of the distribution of genotypes among the missing parents. Many previously proposed procedures that allow for missing parental data assume that these distributions are the same. We propose association tests that behave well when parental data are informatively missing, under the assumption that, for a given trio of paternal, maternal, and affected offspring genotypes, the genotypes of the parents and the sex of the missing parents, but not the genotype of the affected offspring, can affect parental missingness. (This same assumption is required for validity of an analysis that ignores incomplete parent-offspring trios.) We use simulations to compare our approach with previously proposed procedures, and we show that if even small amounts of informative missingness are not taken into account, they can have large, deleterious effects on the performance of tests.	Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC USA; Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA	Duke University; Duke University; University of Chicago; Centers for Disease Control & Prevention - USA	Satten, GA (corresponding author), Ctr Dis Control & Prevent, Mailstop F-24,4770 Buford Highway, Chamblee, GA 30341 USA.			Allen, Andrew/0000-0002-7232-2143; Satten, Glen/0000-0001-7275-5371				Akaike H., 1985, CELEBRATION STAT, P1; BOOS DD, 1992, AM STAT, V46, P327, DOI 10.2307/2685328; Cervino ACL, 2000, AM J HUM GENET, V67, P120, DOI 10.1086/302992; Chagnon YC, 2000, J CLIN ENDOCR METAB, V85, P29, DOI 10.1210/jc.85.1.29; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; KENT JT, 1982, BIOMETRIKA, V69, P19, DOI 10.2307/2335849; Knapp M, 1999, AM J HUM GENET, V64, P861, DOI 10.1086/302285; Little R.J.A., 2002, STAT ANAL MISSING DA; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Rabinowitz D, 2002, J AM STAT ASSOC, V97, P742, DOI 10.1198/016214502388618528; Satten GA, 2000, BIOMETRICS, V56, P384, DOI 10.1111/j.0006-341X.2000.00384.x; SATTEN GA, 1993, J AM STAT ASSOC, V88, P200, DOI 10.2307/2290714; Sun FZ, 1999, AM J EPIDEMIOL, V150, P97; Weinberg CR, 1998, AM J HUM GENET, V62, P969, DOI 10.1086/301802; Weinberg CR, 1999, AM J HUM GENET, V64, P1186, DOI 10.1086/302337; WHITE H, 1982, ECONOMETRICA, V50, P1, DOI 10.2307/1912526; Wilcox AJ, 1998, AM J EPIDEMIOL, V148, P893; [No title captured]	20	57	59	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2003	72	3					671	680		10.1086/368276	http://dx.doi.org/10.1086/368276			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	648LJ	12592606	Bronze, Green Published			2022-12-18	WOS:000181152600016
J	Takei, T; Iida, A; Nitta, K; Tanaka, T; Ohnishi, Y; Yamada, R; Maeda, S; Tsunoda, T; Takeoka, S; Ito, K; Honda, K; Uchida, K; Tsuchiya, K; Suzuki, Y; Fujioka, T; Ujiie, T; Nagane, Y; Miyano, S; Narita, I; Gejyo, F; Nihei, H; Nakamura, Y				Takei, T; Iida, A; Nitta, K; Tanaka, T; Ohnishi, Y; Yamada, R; Maeda, S; Tsunoda, T; Takeoka, S; Ito, K; Honda, K; Uchida, K; Tsuchiya, K; Suzuki, Y; Fujioka, T; Ujiie, T; Nagane, Y; Miyano, S; Narita, I; Gejyo, F; Nihei, H; Nakamura, Y			Association between single-nucleotide polymorphisms in selectin genes and immunoglobulin a nephropathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							41 CANDIDATE GENES; IGA NEPHROPATHY; LINKAGE DISEQUILIBRIUM; JAPANESE POPULATION; ADHESION MOLECULES; IDENTIFICATION; DISEASE	Although intensive efforts have been undertaken to elucidate the genetic background of immunoglobulin A nephropathy (IgAN), genetic factors associated with the pathogenesis of this disease are still not well understood. We designed a case-control association study that was based on linkage disequilibrium among single-nucleotide polymorphisms (SNPs) in the selectin gene cluster on chromosome 1q24-25, and we found two SNPs in the E-selectin gene (SELE8 and SELE13) and six SNPs in the L-selectin gene (SELL1, SELL4, SELL5, SELL6, SELL10, and SELL11) that were significantly associated with IgAN in Japanese patients. All eight SNPs were in almost complete linkage disequilibrium. SELE8 and SELL10 caused amino acid substitutions from His to Tyr and from Pro to Ser (chi(2) = 9.02, P = .0026, odds ratio = 2.73 [95% confidence interval {CI} 1.38-5.38] for His-to-Tyr substitutions; chi(2) = 17.4, P = .000031, odds ratio = 3.61 [95% CI 1.91- 6. 83] for Pro-to-Ser substitutions), and SELL1 could affect promoter activity of the L-selectin gene (chi(2) = 19.5, P = .000010, odds ratio = 3.77 [95% CI 2.02- 7. 05]). The TGT haplotype at these three loci was associated significantly with IgAN (chi2 = 18.67, P = .000016, odds ratio = 1.88 [95% CI 1.41-2.51]). Our results suggest that these eight SNPs in selectin genes may be useful for screening populations susceptible to the IgAN phenotype that involves interstitial infiltration.	Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab,Minato Ku, Tokyo 1088639, Japan; Tokyo Womens Med Univ, Kidney Ctr, Dept Med, Tokyo, Japan; RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Lab Genotyping, Tokyo, Japan; RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Lab Cardiovasc Dis, Tokyo, Japan; RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Lab Rheumat Dis, Tokyo, Japan; RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Lab Med Informat, Tokyo, Japan; Iwate Med Univ, Dept Urol, Morioka, Iwate, Japan; Niigata Univ, Sch Med, Dept Med, Niigata, Japan	University of Tokyo; Tokyo Women's Medical University; RIKEN; RIKEN; RIKEN; RIKEN; Iwate Medical University; Niigata University	Nakamura, Y (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.		Iida, Aritoshi/CAA-1373-2022; Tanaka, Toshihiro/J-9310-2014; Tsunoda, Tatsuhiko/K-2061-2014; Narita, Ichiei/G-5204-2017	Iida, Aritoshi/0000-0001-7538-1651; Tanaka, Toshihiro/0000-0001-6201-9784; Tsunoda, Tatsuhiko/0000-0002-5439-7918; Narita, Ichiei/0000-0001-7692-3096; Miyano, Satoru/0000-0002-1753-6616; Yamada, Ryo/0000-0002-1587-630X				Abecasis GR, 2001, AM J HUM GENET, V68, P191, DOI 10.1086/316944; Adler S, 1999, AM J MED, V107, P371, DOI 10.1016/S0002-9343(99)00233-8; CHAUDRY PR, 1996, KIDNEY INT, V49, P127; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Dunning AM, 2000, AM J HUM GENET, V67, P1544, DOI 10.1086/316906; Gharavi AG, 2000, NAT GENET, V26, P354, DOI 10.1038/81677; Hsu SIH, 2000, KIDNEY INT, V57, P1818, DOI 10.1046/j.1523-1755.2000.00032.x; Kennel-De March A, 1999, CLIN EXP IMMUNOL, V115, P542; Koyama A, 1997, AM J KIDNEY DIS, V29, P526, DOI 10.1016/S0272-6386(97)90333-4; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; LAI KN, 1994, NEPHRON, V68, P294, DOI 10.1159/000188390; Maisonneuve P, 2000, AM J KIDNEY DIS, V35, P157, DOI 10.1016/S0272-6386(00)70316-7; Mein CA, 2000, GENOME RES, V10, P330, DOI 10.1101/gr.10.3.330; Ohnishi Y, 2000, HUM GENET, V106, P288, DOI 10.1007/s004390051039; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Takeoka S, 2001, J HUM GENET, V46, P57, DOI 10.1007/s100380170109; Terwilliger JD, 1994, HDB HUMAN GENETIC LI, P199; Wenzel K, 1996, HUM GENET, V97, P15; Yamada R, 2000, HUM GENET, V106, P293	20	57	65	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2002	70	3					781	786		10.1086/339077	http://dx.doi.org/10.1086/339077			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	522DG	11828340	Green Published, Bronze			2022-12-18	WOS:000173880000022
J	Olson, JM; Goddard, KAB; Dudek, DM				Olson, JM; Goddard, KAB; Dudek, DM			The amyloid precursor protein locus and very-late-onset Alzheimer disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE	Although mutations in the amyloid-beta precursor protein (APP) gene are known to confer high risk of Alzheimer disease (AD) to a small percentage of families in which it has early onset, convincing evidence of a major role for the APP locus in late-onset AD has not been forthcoming. In this report, we have used a covariate-based affected-sib-pair linkage method to analyze the chromosome 21 clinical and genetic data obtained on affected sibships by the National Institute of Mental Health Alzheimer Disease Genetics Initiative. The baseline model (without covariates) gave a LOD score of 0.02, which increases to 1.43 when covariates representing the additive effects of E2 and E4 are added. Larger increases in LOD scores were found when age at last examination/death (LOD score 5.54; P=.000002) or age at onset plus disease duration (LOD score 5.63; P=.000006) were included in the linkage model. We conclude that the APP locus may predispose to AD in the very elderly.	Case Western Reserve Univ, Dept Epidemiol & Biostat, Rammelkamp Ctr Educ & Res, Cleveland, OH 44109 USA	Case Western Reserve University; MetroHealth System	Olson, JM (corresponding author), Case Western Reserve Univ, Dept Epidemiol & Biostat, Rammelkamp Ctr Educ & Res, MetroHealth Campus,2500 MetroHealth Dr, R258, Cleveland, OH 44109 USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001577, R29HG001577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH046290, U01MH046373, U01MH046281] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR003655, RR03655] Funding Source: Medline; NHGRI NIH HHS [R01 HG001577, R29 HG001577, HG01577] Funding Source: Medline; NIMH NIH HHS [U01 MH046373, U01 MH046281, U01 MH046290] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bertram L, 2000, SCIENCE, V290, P2302, DOI 10.1126/science.290.5500.2302; Blacker D, 1997, NEUROLOGY, V48, P139, DOI 10.1212/WNL.48.1.139; Collins JS, 2000, AM J MED GENET, V96, P823, DOI 10.1002/1096-8628(20001204)96:6<823::AID-AJMG26>3.0.CO;2-I; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Goddard KAB, 2001, AM J HUM GENET, V68, P1197, DOI 10.1086/320103; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Kehoe P, 1999, HUM MOL GENET, V8, P237, DOI 10.1093/hmg/8.2.237; Myers A, 2000, SCIENCE, V290, P2304, DOI 10.1126/science.290.5500.2304; Olson JM, 1999, AM J HUM GENET, V65, P1760, DOI 10.1086/302662; PericakVance MA, 1997, JAMA-J AM MED ASSOC, V278, P1237, DOI 10.1001/jama.278.15.1237; Wavrant-De Vrieze F, 1999, NEUROSCI LETT, V269, P67, DOI 10.1016/S0304-3940(99)00417-6; Whittemore AS, 1998, AM J HUM GENET, V62, P1228, DOI 10.1086/301820	12	57	60	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2001	69	4					895	899		10.1086/323472	http://dx.doi.org/10.1086/323472			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	472WP	11500807	Green Published, Bronze			2022-12-18	WOS:000171008200023
J	Cheung, PK; McCormick, C; Crawford, BE; Esko, JD; Tufaro, F; Duncan, G				Cheung, PK; McCormick, C; Crawford, BE; Esko, JD; Tufaro, F; Duncan, G			Etiological point mutations in the hereditary multiple exostoses gene EXT1: A functional analysis of heparan sulfate polymerase activity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TUMOR SUPPRESSORS EXT1; HERPES-SIMPLEX VIRUS; OVARY CELL MUTANTS; TOUT-VELU; CYTOSKELETAL ABNORMALITIES; CAENORHABDITIS-ELEGANS; GOLGI-APPARATUS; INDIAN HEDGEHOG; IDENTIFICATION; FAMILY	Hereditary multiple exostoses (HME), a dominantly inherited genetic disorder characterized by multiple cartilaginous tumors, is caused by mutations in members of the EXT gene family, EXT1 or EXT2. The corresponding gene products, exostosin-1 (EXT1) and exostosin-2 (EXT2), are type II transmembrane glycoproteins which form a Golgi-localized heterooligomeric complex that catalyzes the polymerization of heparan sulfate (HS). Although the majority of the etiological mutations in EXT are splice-site, frameshift, or nonsense mutations that result in premature termination, 12 missense mutations have also been identified. Furthermore, two of the reported etiological missense mutations (G339D and R340C) have been previously shown to abrogate HS biosynthesis (McCormick et al. 1998). Here, a functional assay that detects HS expression on the cell surface of an EXT1-deficient cell line was used to test the remaining missense mutant exostosin proteins for their ability to rescue HS biosynthesis in vivo. Our results show that EXT1 mutants bearing six of these missense mutations (D164H, R280G/S, and R340S/ H/L) are also defective in HS expression, but surprisingly, four (Q27K, N316S, A486V, and P496L) are phenotypically indistinguishable from wild-type EXT1. Three of these four "active" mutations affect amino acids that are not conserved among vertebrates and invertebrates, whereas all of the HS-biosynthesis null mutations affect only conserved amino acids. Further, substitution or deletion of each of these four residues does not abrogate HS biosynthesis. Taken together, these results indicate that several of the reported etiological mutant EXT forms retain the ability to synthesize and express HS on the cell surface. The corresponding missense mutations may therefore represent rare genetic polymorphisms in the EXT1 gene or may interfere with as yet undefined functions of EXT1 that are involved in HME pathogenesis.	Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Program, La Jolla, CA 92093 USA	University of British Columbia; University of California System; University of California San Diego	Duncan, G (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, 6174 Univ Blvd,Wesbrook Bldg,Room 114, Vancouver, BC V6T 1Z3, Canada.	tufaro@interchange.ubc.ca; gduncan@interchange.ubc.ca	McCormick, Craig/AAH-9069-2019	McCormick, Craig/0000-0003-2794-3722	NCI NIH HHS [T32 CA067754, CA67754] Funding Source: Medline; NIGMS NIH HHS [R37 GM033063, R37 GM33063] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA067754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM033063] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHN J, 1995, NAT GENET, V11, P137, DOI 10.1038/ng1095-137; Bai XM, 1999, J BIOL CHEM, V274, P13017, DOI 10.1074/jbc.274.19.13017; BANFIELD BW, 1995, J VIROL, V69, P3290, DOI 10.1128/JVI.69.6.3290-3298.1995; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; Bernard MA, 2000, J BONE MINER RES, V15, P442, DOI 10.1359/jbmr.2000.15.3.442; Bernard MA, 2001, CELL MOTIL CYTOSKEL, V48, P149, DOI 10.1002/1097-0169(200102)48:2<149::AID-CM1005>3.0.CO;2-3; Bovee JVMG, 1999, AM J HUM GENET, V65, P689, DOI 10.1086/302532; Busch C, 1998, J BIOL CHEM, V273, P19566, DOI 10.1074/jbc.273.31.19566; Clines GA, 1997, GENOME RES, V7, P359, DOI 10.1101/gr.7.4.359; COOK A, 1993, AM J HUM GENET, V53, P71; Dobson-Stone C, 2000, EUR J HUM GENET, V8, P24, DOI 10.1038/sj.ejhg.5200409; GORDON VM, 1995, INFECT IMMUN, V63, P82, DOI 10.1128/IAI.63.1.82-87.1995; Griffiths G, 1998, J BIOL CHEM, V273, P11752, DOI 10.1074/jbc.273.19.11752; Hagen FK, 1999, J BIOL CHEM, V274, P6797, DOI 10.1074/jbc.274.10.6797; HECHT JT, 1995, AM J HUM GENET, V56, P1125; Hecht JT, 1997, AM J HUM GENET, V60, P80; Jing W, 2000, GLYCOBIOLOGY, V10, P883, DOI 10.1093/glycob/10.9.883; Kitagawa H, 1999, J BIOL CHEM, V274, P13933, DOI 10.1074/jbc.274.20.13933; Kitagawa H, 2001, J BIOL CHEM, V276, P4834, DOI 10.1074/jbc.C000835200; Kobayashi S, 2000, BIOCHEM BIOPH RES CO, V268, P860, DOI 10.1006/bbrc.2000.2219; Kobayashi S, 2000, J BIOL CHEM, V275, P10723, DOI 10.1074/jbc.275.15.10723; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Lazure C, 1998, J BIOL CHEM, V273, P8572, DOI 10.1074/jbc.273.15.8572; Legeai-Mallet L, 2000, J BONE MINER RES, V15, P1489, DOI 10.1359/jbmr.2000.15.8.1489; LEMERRER M, 1994, HUM MOL GENET, V3, P717, DOI 10.1093/hmg/3.5.717; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; Lin X, 1997, DNA SEQUENCE, V7, P199, DOI 10.3109/10425179709034035; Lind T, 1998, J BIOL CHEM, V273, P26265, DOI 10.1074/jbc.273.41.26265; Lohmann DR, 1997, CYTOGENET CELL GENET, V76, P164, DOI 10.1159/000134536; LUDECKE HJ, 1995, HUM MOL GENET, V4, P31, DOI 10.1093/hmg/4.1.31; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; McCormick C, 1998, NAT GENET, V19, P158, DOI 10.1038/514; MERTENS F, 1994, GENE CHROMOSOME CANC, V9, P8, DOI 10.1002/gcc.2870090103; Mizuno K, 2001, CELL SIGNAL, V13, P125, DOI 10.1016/S0898-6568(00)00144-3; NISHIYAMA Y, 1992, VIROLOGY, V190, P256, DOI 10.1016/0042-6822(92)91212-D; Philippe C, 1997, AM J HUM GENET, V61, P520, DOI 10.1086/515505; RASKIND WH, 1995, AM J HUM GENET, V56, P1132; Raskind WH, 1998, HUM MUTAT, V11, P231, DOI 10.1002/(SICI)1098-1004(1998)11:3<231::AID-HUMU8>3.0.CO;2-K; Saito T, 1998, BIOCHEM BIOPH RES CO, V243, P61, DOI 10.1006/bbrc.1997.8062; SCHMALE GA, 1994, J BONE JOINT SURG AM, V76A, P986, DOI 10.2106/00004623-199407000-00005; Senay C, 2000, EMBO REP, V1, P282, DOI 10.1093/embo-reports/kvd045; Seto NOL, 1997, J BIOL CHEM, V272, P14133, DOI 10.1074/jbc.272.22.14133; Simmons AD, 1999, HUM MOL GENET, V8, P2155, DOI 10.1093/hmg/8.12.2155; SOLOMON L, 1963, J BONE JOINT SURG BR, V45, P292, DOI 10.1302/0301-620X.45B2.292; Stickens D, 1997, BIOCHEM MOL MED, V61, P16, DOI 10.1006/bmme.1997.2588; Stickens D, 2000, DEV DYNAM, V218, P452, DOI 10.1002/1097-0177(200007)218:3<452::AID-DVDY1000>3.0.CO;2-P; Stickens D, 1996, NAT GENET, V14, P25, DOI 10.1038/ng0996-25; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Van Hul W, 1998, GENOMICS, V47, P230, DOI 10.1006/geno.1997.5101; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wei G, 2000, J BIOL CHEM, V275, P27733; WICKLUND CL, 1995, AM J MED GENET, V55, P43, DOI 10.1002/ajmg.1320550113; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Wise CA, 1997, GENOME RES, V7, P10, DOI 10.1101/gr.7.1.10; WU YQ, 1994, HUM MOL GENET, V3, P167, DOI 10.1093/hmg/3.1.167; Wuyts W, 1997, EUR J HUM GENET, V5, P382, DOI 10.1159/000484796; Wuyts W, 2000, HUM MUTAT, V15, P220, DOI 10.1002/(SICI)1098-1004(200003)15:3<220::AID-HUMU2>3.0.CO;2-K; Wuyts W, 1996, HUM MOL GENET, V5, P1547, DOI 10.1093/hmg/5.10.1547; Wuyts W, 1998, AM J HUM GENET, V62, P346, DOI 10.1086/301726; WUYTS W, 1995, AM J HUM GENET, V57, P382; Xu L, 1999, HUM GENET, V105, P45, DOI 10.1007/s004390051062; Xu XH, 1996, J BIOL CHEM, V271, P8818, DOI 10.1074/jbc.271.15.8818	64	57	69	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2001	69	1					55	66		10.1086/321278	http://dx.doi.org/10.1086/321278			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XM	11391482	Green Published, Bronze			2022-12-18	WOS:000170108100006
J	Malacarne, M; Gennaro, E; Madia, F; Pozzi, S; Vacca, D; Barone, B; dalla Bernardina, B; Bianchi, A; Bonanni, P; De Marco, P; Gambardella, A; Giordano, L; Lispi, ML; Romeo, A; Santorum, E; Vanadia, F; Vecchi, M; Veggiotti, P; Vigevano, F; Viri, F; Bricarelli, FD; Zara, F				Malacarne, M; Gennaro, E; Madia, F; Pozzi, S; Vacca, D; Barone, B; dalla Bernardina, B; Bianchi, A; Bonanni, P; De Marco, P; Gambardella, A; Giordano, L; Lispi, ML; Romeo, A; Santorum, E; Vanadia, F; Vecchi, M; Veggiotti, P; Vigevano, F; Viri, F; Bricarelli, FD; Zara, F			Benign familial infantile convulsions: Mapping of a novel locus on chromosome 2q24 and evidence for genetic heterogeneity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRONTAL-LOBE EPILEPSY; POTASSIUM CHANNEL GENE; LINKAGE ANALYSIS; SODIUM-CHANNEL; K+ CHANNEL; MUTATION; SUBUNIT; SCN1B	In 1997, a locus for benign familial infantile convulsions (BFIC) was mapped to chromosome 19q. Further data suggested that this locus is not involved in all families with BFIC. In the present report, we studied eight Italian families and mapped a novel BFIC locus within a 0.7-cM interval of chromosome 2q24, between markers D2S399 and D2S2330. A maximum multipoint HLOD score of 6.29 was obtained under the hypothesis of genetic heterogeneity. Furthermore, the clustering of chromosome 2q24-linked families in southern Italy may indicate a recent founder effect. In our series, 40% of the families are linked to neither chromosome 19q or 2q loci, suggesting that at least three loci are involved in BFIC. This finding is consistent with other autosomal dominant idiopathic epilepsies in which different genes were found to be implicated.	EO Osped Galliera, Lab Genet Umana, I-16128 Genoa, Italy; Ctr Biotechnol Avanzate, Immunogenet Lab, Genoa, Italy; Inst Neurol Nazl C Besta, Div Biochem & Genet, Milan, Italy; Italian League Epilepsy Collaborat Grp Genet, Trapani, Italy; USL Alcamo Castelvetrano 9, Unit Child Neuropsychiat, Trapani, Italy; Osped S Donato, Div Neurol, Arezzo, Italy; Univ Verona, Dept Child Neuropsychiat, I-37100 Verona, Italy; IRCCS Stella Maris, Inst Med Res, Pisa, Italy; Univ Pisa, Inst Dev Neurol & Psychiat, I-56100 Pisa, Italy; Osped S Chiara, Unit Child Neurol, Trento, Italy; Natl Res Council, Inst Expt Med & Biotechnol, Cosenza, Italy; Spedali Civili, Div Child Neuropsychiat, I-25125 Brescia, Italy; Osped Pediat Bambin Gesu, Div Neurol, Rome, Italy; Azienda Osped Fatebenefratelli & Oftalm, Ctr Child Epilepsy, Milan, Italy; Osped Civico E Benfratelli, Div Child Neuropsychiat, Palermo, Italy; Univ Padua, Dept Paediat, I-35100 Padua, Italy; Fdn Ist Neurol C Mondino, Div Child Neuropsychiat, Pavia, Italy	Ente Ospedaliero Ospedali Galliera; University of Verona; IRCCS Fondazione Stella Maris; University of Pisa; Hospital Spedali Civili Brescia; IRCCS Bambino Gesu; University of Padua; IRCCS Fondazione Casimiro Mondino	Zara, F (corresponding author), EO Osped Galliera, Lab Genet Umana, Via Volta 10R, I-16128 Genoa, Italy.		gennaro, elena/ABC-2425-2020; Zara, Federico/U-3477-2017; Gambardella, Antonio/F-5295-2012; Malacarne, Michela/AAA-7569-2020; bonanni, paolo/T-7360-2017; Madia, Francesca/AAA-7356-2020; Vigevano, Federico/K-9466-2016	Zara, Federico/0000-0001-9744-5222; Gambardella, Antonio/0000-0001-7384-3074; bonanni, paolo/0000-0002-9448-9059; Madia, Francesca/0000-0002-7807-1322; GAMBARDELLA, Antonio/0000-0002-4125-0618; Vigevano, Federico/0000-0001-7513-0051	Telethon [C.42] Funding Source: Medline	Telethon(Fondazione Telethon)		Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; CHEN Y, 1994, J BIOL CHEM, V269, P7839; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; De Fusco M, 2000, NAT GENET, V26, P275; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DUPRAT F, 1995, BIOCHEM BIOPH RES CO, V212, P657, DOI 10.1006/bbrc.1995.2019; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Gennaro E, 1999, EPILEPSIA, V40, P1799, DOI 10.1111/j.1528-1157.1999.tb01601.x; Giordano L, 1999, NEUROPEDIATRICS, V30, P99, DOI 10.1055/s-2007-973469; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Guipponi M, 1997, HUM MOL GENET, V6, P473, DOI 10.1093/hmg/6.3.473; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; LATHROP GM, 1985, AM J HUM GENET, V37, P482; Moulard B, 2000, HUM MUTAT, V16, P139, DOI 10.1002/1098-1004(200008)16:2<139::AID-HUMU6>3.0.CO;2-J; Ott J., 1991, ANAL HUMAN GENETIC L; PATIL N, 1995, NAT GENET, V11, P126, DOI 10.1038/ng1095-126; Phillips HA, 1998, AM J HUM GENET, V63, P1108, DOI 10.1086/302047; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; STEINLEIN OK, 1995, NAT GENET, V11, P201, DOI 10.1038/ng1095-201; Szepetowski P, 1997, AM J HUM GENET, V61, P889, DOI 10.1086/514877; VIGEVANO F, 1992, EUR J PEDIATR, V151, P608, DOI 10.1007/BF01957732; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252	23	57	69	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2001	68	6					1521	1526		10.1086/320596	http://dx.doi.org/10.1086/320596			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	439DB	11326335	Green Published, Bronze			2022-12-18	WOS:000169094600024
J	Moreira, MD; Barbot, C; Tachi, N; Kozuka, N; Mendonca, P; Barros, J; Coutinho, P; Sequeiros, J; Koenig, M				Moreira, MD; Barbot, C; Tachi, N; Kozuka, N; Mendonca, P; Barros, J; Coutinho, P; Sequeiros, J; Koenig, M			Homozygosity mapping of portuguese and Japanese forms of ataxia-oculomotor apraxia to 9p13, and evidence for genetic heterogeneity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CEREBELLAR ATROPHY HMSNCA; IRON-REGULATORY FACTOR; HEREDITARY MOTOR; ACONITASE; PROTEIN	Ataxia with oculomotor apraxia (AOA) is characterized by early-onset cerebellar ataxia, ocular apraxia, early areflexia, late peripheral neuropathy, slow progression, severe motor handicap, and absence of both telangiectasias and immunodeficiency. We studied 13 Portuguese families with AOA and found that the two largest families show linkage to 9p, with LOD scores of 4.13 and 3.82, respectively, at a recombination fraction of 0. These and three smaller families, all from northern Portugal, showed homozygosity and haplotype sharing over a 2-cM region on 9p13, demonstrating the existence of both a founding event and linkage to this locus, AOA1, in the five families. Three other families were excluded from this locus, demonstrating nonallelic heterogeneity in AOA. Early-onset cerebellar ataxia with hypoalbuminemia (EOCA-HA), so far described only in Japan, is characterized by marked cerebellar atrophy, peripheral neuropathy, mental retardation, and, occasionally, oculomotor apraxia. Two unrelated Japanese families with EOCA-HA were analyzed and appeared to show linkage to the AOA1 locus. Subsequently, hypoalbuminemia was found in all five Portuguese patients with AOA1 with a long disease duration, suggesting that AOA1 and EOCA-HA correspond to the same entity that accounts for a significant proportion of all recessive ataxias. The narrow localization of AOA1 should prompt the identification of the defective gene.	Univ Strasbourg 1, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, 1 Rue Laurent Fries BP 163, F-67404 Illkirch Graffenstaden, CU Strasbourg, France; Univ Porto, ICBAS, P-4100 Porto, Portugal; Hosp Maria Pia, Dept Neurol, Porto, Portugal; Hosp Geral Sto Antonio, Dept Neurol, Porto, Portugal; Sapporo Med Univ, Sch Hlth Sci, Sapporo, Hokkaido, Japan; Hosp S Sebastiao, Div Neurol, Santa Maria Feira, Portugal	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universidade do Porto; Sapporo Medical University	Koenig, M (corresponding author), Univ Strasbourg 1, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, 1 Rue Laurent Fries BP 163, F-67404 Illkirch Graffenstaden, CU Strasbourg, France.	mkoenig@igbmc.u-strasbg.fr	Barbot, Clara/K-6378-2013; Coutinho, Paula/K-6053-2013	Barbot, Clara/0000-0002-5597-107X; Coutinho, Paula/0000-0002-3461-230X; Sequeiros, Jorge/0000-0002-9846-1037; Barros, Jose/0000-0001-6183-5050; Franco Mendonca, Pedro/0000-0002-3850-2909				AICARDI J, 1988, ANN NEUROL, V24, P497, DOI 10.1002/ana.410240404; ARAIE M, 1977, JPN J OPHTHALMOL, V21, P355; AWAYA Y, 1985, JPN J PEDIAT, V89, P2651; AWAYA Y, 1986, ACTA PAEDIATR JPN, V28, P271; BARBOT C, IN PRESS ARCH NEUROL; BENHAMIDA C, 1993, NAT GENET, V5, P195, DOI 10.1038/ng1093-195; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FUKUHARA N, 1995, J NEUROL SCI, V133, P140, DOI 10.1016/0022-510X(95)00176-3; GRAY NK, 1993, EUR J BIOCHEM, V218, P657, DOI 10.1111/j.1432-1033.1993.tb18420.x; Hanihara T, 1995, Rinsho Shinkeigaku, V35, P83; HIRLING H, 1994, EMBO J, V13, P453, DOI 10.1002/j.1460-2075.1994.tb06280.x; INOUE N, 1971, RINSHO SHINKEIGAKU, V11, P855; Kubota H, 1995, No To Shinkei, V47, P289; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MORCOS R, 1982, NEUROLOGY, V32, pA82; MOREIRA MC, 1999, ARQ MED, V13, P39; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Sekijima Y, 1998, J NEUROL SCI, V158, P30, DOI 10.1016/S0022-510X(98)00103-8; Silva MC, 1997, J CLIN EPIDEMIOL, V50, P1377, DOI 10.1016/S0895-4356(97)00202-3; Tachi N, 2000, EUR NEUROL, V43, P82, DOI 10.1159/000008140; Uekawa K, 1992, Rinsho Shinkeigaku, V32, P1067	21	57	60	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2001	68	2					501	508		10.1086/318191	http://dx.doi.org/10.1086/318191			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	394LD	11170899	Green Published, Bronze			2022-12-18	WOS:000166524800021
J	Wilson, JF; Goldstein, DB				Wilson, JF; Goldstein, DB			Consistent long-range linkage disequilibrium generated by admixture in a Bantu-Semitic hybrid population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ADMIXED POPULATIONS; MAPPING GENES; HUMAN GENOME; ORIGINS; MARKERS; DISEASES; ALLELES; AFRICA; LOCUS	Both the optimal marker density for genome scans in case-control association studies and the appropriate study design for the testing of candidate genes depend on the genomic pattern of linkage disequilibrium (LD). In this study, we provide the first conclusive demonstration that the diverse demographic histories of human populations have produced dramatic differences in genomewide patterns of LD. Using a panel of 66 markers spanning the X chromosome, we show that, in the Lemba, a Bantu-Semitic hybrid population, markers less than or equal to similar to 21 cM apart have a significantly greater tendency to show LD than do unlinked markers. In three populations with less evidence of admixture, however, excess LD disappears >2 cM. Moreover, analysis of Bantu and Ashkenazi populations as putative parental populations of the Lemba shows a significant relationship between allele-frequency differentials and the LD observed in the Lemba, which demonstrates that much of the excess LD is due to admixture. Our results suggest that demographic history has such a profound effect on LD that it will not be possible to predict patterns a priori but that it will be necessary to empirically evaluate the patterns in all populations of interest.	UCL, Dept Biol, London NW1 2HE, England; Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of London; University College London; University of Oxford	Goldstein, DB (corresponding author), UCL, Dept Biol, Wolfson House,4 Stephenson Way, London NW1 2HE, England.	d.goldstein@ucl.ac.uk	Goldstein, David/AAY-8125-2020; Wilson, James F/A-5704-2009	Wilson, James F/0000-0001-5751-9178				BRISCOE D, 1994, J HERED, V85, P59; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Freimer NB, 1997, NAT GENET, V17, P371, DOI 10.1038/ng1297-371; Goddard KAB, 2000, AM J HUM GENET, V66, P216, DOI 10.1086/302727; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hamblin MT, 2000, AM J HUM GENET, V66, P1669, DOI 10.1086/302879; Huttley GA, 1999, GENETICS, V152, P1711; Kidd JR, 2000, AM J HUM GENET, V66, P1882, DOI 10.1086/302952; Kittles RA, 1998, AM J HUM GENET, V62, P1171, DOI 10.1086/301831; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Laan M, 1997, NAT GENET, V17, P435, DOI 10.1038/ng1297-435; Lautenberger JA, 2000, AM J HUM GENET, V66, P969, DOI 10.1086/302820; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; PETERSON AC, 1995, HUM MOL GENET, V4, P887, DOI 10.1093/hmg/4.5.887; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Reich DE, 1998, P NATL ACAD SCI USA, V95, P8119, DOI 10.1073/pnas.95.14.8119; REICH DE, IN PRESS GENET EPIDE; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; SCHNEIDER S, 1997, ARLEQUIN VERSION 1 1; Shriver MD, 1997, AM J HUM GENET, V60, P957; SLATKIN M, 1994, GENETICS, V137, P3331; Sokal R. R., 1995, BIOMETRY; Soodyall H, 1996, AM J HUM GENET, V58, P595; Spurdle AB, 1996, AM J HUM GENET, V59, P1126; STEPHENS JC, 1994, AM J HUM GENET, V55, P809; Taillon-Miller P, 2000, NAT GENET, V25, P324, DOI 10.1038/77100; Thomas MG, 2000, AM J HUM GENET, V66, P674, DOI 10.1086/302749; Tishkoff SA, 1998, AM J HUM GENET, V62, P1389, DOI 10.1086/301861; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; Wright AF, 1999, NAT GENET, V23, P397, DOI 10.1038/70501	36	57	57	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4					926	935		10.1086/303083	http://dx.doi.org/10.1086/303083			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	360DL	10961910	Green Published, Bronze			2022-12-18	WOS:000089651100014
J	Verzijl, HTFM; van den Helm, B; Veldman, B; Hamel, BCJ; Kuyt, LP; Padberg, GW; Kremer, H				Verzijl, HTFM; van den Helm, B; Veldman, B; Hamel, BCJ; Kuyt, LP; Padberg, GW; Kremer, H			A second gene for autosomal dominant Mobius syndrome is localized to chromosome 10q, in a Dutch family	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; MOEBIUS SYNDROME; TRANSLOCATION	Mobius syndrome (MIM 157900) consists of a congenital paresis or paralysis of the VIIth (facial) cranial nerve, frequently accompanied by dysfunction of other cranial nerves. The abducens nerve is typically affected, and often, also, the hypoglossal nerve. Zn addition, orofacial and limb malformations, defects of the musculoskeletal system, and mental retardation are seen in patients with Mobius syndrome. Most cases are sporadic, but familial recurrence can occur. Different modes of inheritance are suggested by different pedigrees. Genetic heterogeneity of Mobius syndrome has been suggested by cytogenetic studies and linkage analysis. Previously, we identified a locus on chromosome 3q21-22, in a large Dutch family with Mobius syndrome consisting essentially of autosomal dominant asymmetric bilateral facial paresis. Here we report linkage analysis in a second large Dutch family with autosomal dominant inherited facial paresis. After exclusion of >90% of the genome, we identified the locus on the long arm of chromosome 10 in this family, demonstrating genetic heterogeneity of this condition. The reduced penetrance suggests that at least some of the sporadic cases might be familial.	Univ Nijmegen Hosp, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Univ Nijmegen Hosp, Dept Neurol, NL-6500 HB Nijmegen, Netherlands; Free Univ Amsterdam, Dept Human Genet, Amsterdam, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Vrije Universiteit Amsterdam	Kremer, H (corresponding author), Univ Nijmegen Hosp, Dept Human Genet, POB 9101, NL-6500 HB Nijmegen, Netherlands.		Padberg, G.W.A.M./H-8079-2014; Kremer, Hannie/F-5126-2010	Kremer, Hannie/0000-0002-0841-8693				COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DONAHUE SP, 1993, OPHTHALMIC PAED GEN, V14, P17, DOI 10.3109/13816819309087618; FORTANIER A. H., 1935, GENETICA, V17, P471, DOI 10.1007/BF01508189; Henderson JL, 1939, BRAIN, V62, P381, DOI 10.1093/brain/62.4.381; Hicks AM, 1943, ARCH OPHTHALMOL-CHIC, V30, P38; KREMER H, 1994, HUM MOL GENET, V3, P299, DOI 10.1093/hmg/3.2.299; Kremer H, 1996, HUM MOL GENET, V5, P1367, DOI 10.1093/hmg/5.9.1367; KUMAR D, 1990, J MED GENET, V27, P122, DOI 10.1136/jmg.27.2.122; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1986, GENET EPIDEMIOL, V3, P39, DOI 10.1002/gepi.1370030105; LEGUM C, 1981, CLIN GENET, V20, P254; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NICOLAI JPA, 1986, SCAND J PLAST RECONS, V20, P37, DOI 10.3109/02844318609006289; Nishikawa M, 1997, CLIN GENET, V51, P122; Pastuszak AL, 1998, NEW ENGL J MED, V338, P1881, DOI 10.1056/NEJM199806253382604; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SCHNEIDERMAUNOURY S, 1993, CELL, V75, P1199, DOI 10.1016/0092-8674(93)90329-O; SLEE JJ, 1991, J MED GENET, V28, P413, DOI 10.1136/jmg.28.6.413; Sudarshan A, 1985, Pediatr Neurol, V1, P180, DOI 10.1016/0887-8994(85)90061-X; TOWFIGHI J, 1979, ACTA NEUROPATHOL, V48, P11, DOI 10.1007/BF00691785; WISHNICK MM, 1981, AM J HUM GENET, V33, pA96; ZITER FA, 1977, ARCH NEUROL-CHICAGO, V34, P437, DOI 10.1001/archneur.1977.00500190071011	23	57	63	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1999	65	3					752	756		10.1086/302539	http://dx.doi.org/10.1086/302539			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233KQ	10441582	Green Published, Bronze			2022-12-18	WOS:000082426400020
J	Sisodia, SS; Kim, SH; Thinakaran, G				Sisodia, SS; Kim, SH; Thinakaran, G			Function and dysfunction of the presenilins	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL ALZHEIMERS-DISEASE; AMYLOID PRECURSOR PROTEIN; CAENORHABDITIS-ELEGANS; MISSENSE MUTATIONS; SEL-12 PRESENILIN; BETA-CATENIN; IN-VIVO; GENE; CHROMOSOME-1; BRAIN		Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA	University of Chicago	Sisodia, SS (corresponding author), Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA.		Saftig, Paul/A-7966-2010; De Strooper, Bart/F-6507-2012	De Strooper, Bart/0000-0001-5455-5819	NIA NIH HHS [AG10491, AG05146] Funding Source: Medline; NINDS NIH HHS [NS20471] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS020471, P50NS020471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005146, P01AG010491] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baumeister R, 1997, Genes Funct, V1, P149; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Doan A, 1996, NEURON, V17, P1023, DOI 10.1016/S0896-6273(00)80232-9; Giulian D, 1999, AM J HUM GENET, V65, P13, DOI 10.1086/302477; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Kim TW, 1997, J BIOL CHEM, V272, P11006; Lah JJ, 1997, J NEUROSCI, V17, P1971; Lee MK, 1996, J NEUROSCI, V16, P7513, DOI 10.1523/jneurosci.16-23-07513.1996; Lemere CA, 1996, NAT MED, V2, P1146, DOI 10.1038/nm1096-1146; Levitan D, 1998, DEVELOPMENT, V125, P3599; Levitan D, 1996, P NATL ACAD SCI USA, V93, P14940, DOI 10.1073/pnas.93.25.14940; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Li XJ, 1996, NEURON, V17, P1015, DOI 10.1016/S0896-6273(00)80231-7; Li XJ, 1997, P NATL ACAD SCI USA, V94, P12204, DOI 10.1073/pnas.94.22.12204; Naruse S, 1998, NEURON, V21, P1213, DOI 10.1016/S0896-6273(00)80637-6; Nishimura M, 1999, NAT MED, V5, P164, DOI 10.1038/5526; Podlisny MB, 1997, NEUROBIOL DIS, V3, P325, DOI 10.1006/nbdi.1997.0129; Price DL, 1998, ANNU REV NEUROSCI, V21, P479, DOI 10.1146/annurev.neuro.21.1.479; Ray WJ, 1999, P NATL ACAD SCI USA, V96, P3263, DOI 10.1073/pnas.96.6.3263; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Saura CA, 1999, J BIOL CHEM, V274, P13818, DOI 10.1074/jbc.274.20.13818; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Stahl B, 1999, J BIOL CHEM, V274, P9141, DOI 10.1074/jbc.274.14.9141; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Tanzi RE, 1996, NEUROBIOL DIS, V3, P159, DOI 10.1006/nbdi.1996.0016; Thinakaran G, 1998, NEUROBIOL DIS, V4, P438, DOI 10.1006/nbdi.1998.0171; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Weidemann A, 1997, NAT MED, V3, P328, DOI 10.1038/nm0397-328; Westlund B, 1999, P NATL ACAD SCI USA, V96, P2497, DOI 10.1073/pnas.96.5.2497; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0; Xia WM, 1997, P NATL ACAD SCI USA, V94, P8208, DOI 10.1073/pnas.94.15.8208; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; Yu G, 1998, J BIOL CHEM, V273, P16470, DOI 10.1074/jbc.273.26.16470; Zhang ZH, 1998, NATURE, V395, P698, DOI 10.1038/27208; Zhou JH, 1997, NEUROREPORT, V8, P2085, DOI 10.1097/00001756-199705260-00054	44	57	57	1	6	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1999	65	1					7	12		10.1086/302475	http://dx.doi.org/10.1086/302475			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	212NZ	10364510	Green Published, Bronze			2022-12-18	WOS:000081224300002
J	Escamilla, MA; McInnes, LA; Spesny, M; Reus, VI; Service, SK; Shimayoshi, N; Tyler, DJ; Silva, S; Molina, J; Gallegos, A; Meza, L; Cruz, ML; Batki, S; Vinogradov, S; Neylan, T; Nguyen, JB; Fournier, E; Araya, C; Barondes, SH; Leon, P; Sandkuijl, LA; Freimer, NB				Escamilla, MA; McInnes, LA; Spesny, M; Reus, VI; Service, SK; Shimayoshi, N; Tyler, DJ; Silva, S; Molina, J; Gallegos, A; Meza, L; Cruz, ML; Batki, S; Vinogradov, S; Neylan, T; Nguyen, JB; Fournier, E; Araya, C; Barondes, SH; Leon, P; Sandkuijl, LA; Freimer, NB			Assessing the feasibility of linkage disequilibrium methods for mapping complex traits: An initial screen for bipolar disorder loci on chromosome 18	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COSTA-RICAN PEDIGREES; GENETIC DISSECTION; HUMAN GENOME; MAP; SUSCEPTIBILITY; POPULATIONS; SEGMENTS; MARKERS; ILLNESS; REGION	Linkage disequilibrium (LD) analysis:has been promoted as a method of mapping disease genes, particularly in isolated populations, but has not yet been used for genome-screening studies of complex disorders. We present results of a study to investigate the feasibility of LD methods for genome:screening using a sample of individuals affected with severe bipolar mood disorder (BP-I), from an isolated population of the Costa Rican central valley. Forty-eight patients with BP-I were genotyped for markers spaced at similar to 6-cM intervals across chromosome 18. Chromosome 18 was chosen because a previous genome-screening linkage study of two Costa Rican families had suggested a BP-I locus on this chromosome. Results of the current study suggest that LD methods will be useful for mapping BP-I in a larger sample. The results also support previously reported possible localizations (obtained from a separate collection of patients) of BP-I-susceptibility genes at two distinct sites on this chromosome. Current limitations of LD screening for identifying loci for complex traits are discussed, and recommendations are made for future research with these methods.	San Francisco Gen Hosp, Neurogenet Lab, San Francisco, CA 94110 USA; San Francisco Gen Hosp, Ctr Neurobiol & Psychiat, San Francisco, CA 94110 USA; San Francisco Gen Hosp, Dept Psychiat, San Francisco, CA 94110 USA; Univ Calif San Francisco, Vet Adm Med Ctr, Dept Psychiat, San Francisco, CA USA; Erasmus Univ, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands; Leiden Univ, Dept Human Genet, NL-2300 RA Leiden, Netherlands; Univ Groningen, Dept Med Genet, Groningen, Netherlands; Univ Costa Rica, Cell & Mol Biol Res Ctr, San Jose, Costa Rica; Univ Costa Rica, Escuela Med, San Jose, Costa Rica; Hosp Calderon Guardia, San Jose, Costa Rica	San Francisco General Hospital Medical Center; San Francisco General Hospital Medical Center; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Erasmus University Rotterdam; Leiden University; Leiden University - Excl LUMC; University of Groningen; Universidad Costa Rica; Universidad Costa Rica	Freimer, NB (corresponding author), Univ Calif San Francisco, Box F-0984,401 Parnassus Ave, San Francisco, CA 94143 USA.	nelson@ngl.ucsf.edu	reus, victor i/I-7923-2015	reus, victor i/0000-0002-8193-5697	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH049499, K21MH000916, R03MH048695] Funding Source: NIH RePORTER; NIMH NIH HHS [MH48695, MH00916, MH49499] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BERRETTINI WH, 1994, P NATL ACAD SCI USA, V91, P5918, DOI 10.1073/pnas.91.13.5918; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Durham LK, 1997, AM J HUM GENET, V61, P830, DOI 10.1086/514891; Escamilla MA, 1996, AM J MED GENET, V67, P244, DOI 10.1002/(SICI)1096-8628(19960531)67:3<244::AID-AJMG2>3.3.CO;2-8; ESCAMILLA MA, 1997, MOL GENETIC BASIS NE, P1343; FREIHERR G, 1996, MED DEVICE DIAGN IND, V18, P12; Freimer NB, 1996, AM J MED GENET, V67, P254, DOI 10.1002/(SICI)1096-8628(19960531)67:3<254::AID-AJMG3>3.0.CO;2-N; FRIEDMAN TB, 1995, NAT GENET, V9, P86, DOI 10.1038/ng0195-86; Goldin LR, 1997, GENET EPIDEMIOL, V14, P785, DOI 10.1002/(SICI)1098-2272(1997)14:6<785::AID-GEPI37>3.0.CO;2-K; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HOUWEN RHJ, 1994, NAT GENET, V8, P380, DOI 10.1038/ng1294-380; Kruglyak L, 1997, AM J HUM GENET, V61, P810, DOI 10.1086/514893; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; McInnes LA, 1996, P NATL ACAD SCI USA, V93, P13060, DOI 10.1073/pnas.93.23.13060; McMahon FJ, 1997, AM J HUM GENET, V61, P1397, DOI 10.1086/301630; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; Nurnberger JI, 1997, AM J MED GENET, V74, P227, DOI 10.1002/(SICI)1096-8628(19970531)74:3<227::AID-AJMG1>3.0.CO;2-N; PUFFETT D, 1994, MUSIC ANAL, V13, P3; Risch N, 1996, NAT GENET, V12, P351, DOI 10.1038/ng0496-351; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Saborio M, 1992, Birth Defects Orig Artic Ser, V28, P96; Service SK, 1999, AM J HUM GENET, V64, P1728, DOI 10.1086/302398; Shah AB, 1997, AM J HUM GENET, V61, P317, DOI 10.1086/514864; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; STINE OC, 1995, AM J HUM GENET, V57, P1384; Te Meerman Gerard J., 1994, American Journal of Human Genetics, V55, pA205; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; UHRHAMMER N, 1995, AM J HUM GENET, V57, P103; Yuan B, 1997, AM J HUM GENET, V60, P459	33	57	57	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1999	64	6					1670	1678		10.1086/302400	http://dx.doi.org/10.1086/302400			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	203FA	10330354	Green Published, Bronze			2022-12-18	WOS:000080696200019
J	Looijenga, LHJ; Gillis, AJM; Verkerk, AJMH; van Putten, WLJ; Oosterhuis, JW				Looijenga, LHJ; Gillis, AJM; Verkerk, AJMH; van Putten, WLJ; Oosterhuis, JW			Heterogeneous X inactivation in trophoblastic cells of human full-term female placentas	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOME INACTIVATION; CHORIONIC VILLI; MOUSE; EXPRESSION; MEMBRANES; METHYLATION; TISSUES; CANCERS; GROWTH; TUMORS	In female mammalian cells, one of the two X chromosomes is inactivated to compensate for gene-dose effects, which would be otherwise doubled compared with that in male cells. In somatic lineages in mice, the inactive X chromosome can be of either paternal or maternal origin, whereas the paternal X chromosome is specifically inactivated in placental tissue. In human somatic cells, X inactivation is mainly random, but both random and preferential paternal X inactivation have been reported in placental tissue. To shed more light on this issue, we used PCR to study the methylation status of the polymorphic androgen-receptor gene in full-term human female placentas. The sites investigated are specifically methylated on the inactive X chromosome. No methylation was found in microdissected stromal tissue, whether from placenta or umbilical cord. Of nine placentas for which two closely apposed samples were studied, X inactivation was preferentially maternal in three, was preferentially paternal in one, and was heterogeneous in the remaining five. Detailed investigation of two additional placentas demonstrated regions with balanced (1:1 ratio) preferentially maternal and preferentially paternal X inactivation. No differences in ratio were observed in samples microdissected to separate trophoblast and stromal tissues. We conclude that methylation of the androgen receptor in human full-term placenta is specific for trophoblastic cells and that the X chromosome can be of either paternal or maternal origin.	Acad Hosp Rotterdam Erasmus Rotterdam, Josephine Nefkens Inst, Daniel den Hoed Canc Ctr Pathol, Dept Stat, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute	Looijenga, LHJ (corresponding author), Erasmus Univ, FGG, Josephine Nefkens Inst,Lab Expt Pathooncol, Daniel den Hoed Canc Ctr Pathol, Bldg Be,Room 430B,POB 1738, NL-3000 DR Rotterdam, Netherlands.	looijenga@leph.azr.nl	Looijenga, Leendert/B-8145-2019	Looijenga, Leendert/0000-0002-8146-1911; Verkerk, Annemieke JMH/0000-0002-7523-3656				ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Belmont JW, 1996, AM J HUM GENET, V58, P1101; CATTANACH BM, 1970, GENET RES, V15, P183, DOI 10.1017/S0016672300001518; DISTECHE CM, 1995, TRENDS GENET, V11, P17, DOI 10.1016/S0168-9525(00)88981-7; Goto T, 1997, MOL HUM REPROD, V3, P77, DOI 10.1093/molehr/3.1.77; HARPER MI, 1982, J EMBRYOL EXP MORPH, V67, P127; HARRISON KB, 1986, CYTOGENET CELL GENET, V41, P163, DOI 10.1159/000132221; HARRISON KB, 1989, CYTOGENET CELL GENET, V52, P37, DOI 10.1159/000132835; JACOBS PA, 1988, ANN HUM GENET, V52, P93, DOI 10.1111/j.1469-1809.1988.tb01084.x; Li YH, 1998, NAT GENET, V20, P309, DOI 10.1038/3129; Looijenga LHJ, 1997, AM J PATHOL, V151, P581; LYON MF, 1992, ANNU REV GENET, V26, P17, DOI 10.1146/annurev.ge.26.120192.000313; MANIATIS T, 1982, MOL CLONING LABORATO, P280; MIGEON BR, 1985, P NATL ACAD SCI USA, V82, P3390, DOI 10.1073/pnas.82.10.3390; Migeon BR, 1998, CYTOGENET CELL GENET, V80, P142, DOI 10.1159/000014971; MIGEON BR, 1979, AM J HUM GENET, V31, P581; MOHANDAS TK, 1989, SOMAT CELL MOLEC GEN, V15, P131, DOI 10.1007/BF01535073; Mosselman S, 1996, P NATL ACAD SCI USA, V93, P2884, DOI 10.1073/pnas.93.7.2884; MROZEK JD, 1991, BIOCHEM MED METAB B, V45, P333, DOI 10.1016/0885-4505(91)90038-M; MUTTER GL, 1995, AM J PATHOL, V146, P501; Naumova AK, 1998, EUR J HUM GENET, V6, P552, DOI 10.1038/sj.ejhg.5200255; Plenge RM, 1997, NAT GENET, V17, P353, DOI 10.1038/ng1197-353; RICCIUTI FC, 1976, AM J HUM GENET, V28, P332; ROPERS HH, 1978, HUM GENET, V43, P265, DOI 10.1007/BF00278833; Skuse DH, 1997, NATURE, V387, P705, DOI 10.1038/42706; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; TAN SS, 1993, NAT GENET, V3, P170, DOI 10.1038/ng0293-170; Verkerk AJMH, 1997, ONCOGENE, V14, P95, DOI 10.1038/sj.onc.1200802; WEST JD, 1977, CELL, V12, P873, DOI 10.1016/0092-8674(77)90151-9	29	57	57	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1999	64	5					1445	1452		10.1086/302382	http://dx.doi.org/10.1086/302382			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192RP	10205278	Green Published, Bronze			2022-12-18	WOS:000080093000025
J	Veitia, RA; Nunes, M; Quintana-Murci, L; Rappaport, R; Thibaud, E; Jaubert, E; Fellous, M; McElreavey, K; Goncalves, J; Silva, M; Rodrigues, JC; Caspurro, M; Boieiro, F; Marques, R; Lavinha, J				Veitia, RA; Nunes, M; Quintana-Murci, L; Rappaport, R; Thibaud, E; Jaubert, E; Fellous, M; McElreavey, K; Goncalves, J; Silva, M; Rodrigues, JC; Caspurro, M; Boieiro, F; Marques, R; Lavinha, J			Swyer syndrome and 46,XY partial gonadal dysgenesis associated with 9p deletions in the absence of monosomy-9p syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							SEX REVERSAL; DETERMINING REGION; MUTATIONS; GENE		Inst Pasteur, INSERM, U276, F-75015 Paris, France; Hop Necker Enfants Malad, Serv Endocrinol, Paris, France; Hop Necker Enfants Malad, Serv Cent Antomie Pathol, Paris, France; Inst Nacl Saude Dr Ricardo Jorge, Dept Human Genet, Lisbon, Portugal; Hosp Criancas Maria Pia, Serv Cirurg Pediat, Oporto, Portugal; Hosp Santo Antonio, Serv Anat Patol, Porto, Portugal	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Instituto Nacional de Saude Dr. Ricardo Jorge	McElreavey, K (corresponding author), Inst Pasteur, INSERM, U276, 25 Rue Dr Roux, F-75015 Paris, France.		Quintana-Murci, Lluis/AAB-7468-2022	Quintana-Murci, Lluis/0000-0003-2429-6320; Lavinha, Joao/0000-0002-7474-6871; Duarte Silva, Marisa/0000-0003-3575-1261				ALFI O, 1973, ANN GENET-PARIS, V16, P17; BENNETT CP, 1993, J MED GENET, V30, P518, DOI 10.1136/jmg.30.6.518; CHINZEL A, 1984, CATALOGUE UNBALANCED; DEGROUCHY J, 1982, ATLAS MALADIES CHROM, P162; GERMAN JL, 1970, CLIN GENET, V1, P27; HURET JL, 1988, J MED GENET, V25, P741, DOI 10.1136/jmg.25.11.741; Ion R, 1998, HUM GENET, V102, P151, DOI 10.1007/s004390050669; McDonald MT, 1997, AM J MED GENET, V73, P321; Ogata T, 1997, J MED GENET, V34, P331, DOI 10.1136/jmg.34.4.331; PONTIGGIA A, 1994, EMBO J, V13, P6115, DOI 10.1002/j.1460-2075.1994.tb06958.x; Schwalm LA, 1997, J WOMENS HIST, V9, P9; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; SMITH CP, 1994, GENOMICS, V20, P335, DOI 10.1006/geno.1994.1183; Veitia R, 1997, HUM GENET, V99, P648, DOI 10.1007/s004390050422; Veitia R, 1997, GENOMICS, V41, P271, DOI 10.1006/geno.1997.4648	15	57	60	0	5	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1998	63	3					901	905		10.1086/302023	http://dx.doi.org/10.1086/302023			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	119VN	9718353	Green Published, Bronze			2022-12-18	WOS:000075919000032
J	Chambliss, KL; Hinson, DD; Trettel, F; Malaspina, P; Novelletto, A; Jakobs, C; Gibson, KM				Chambliss, KL; Hinson, DD; Trettel, F; Malaspina, P; Novelletto, A; Jakobs, C; Gibson, KM			Two exon-skipping mutations as the molecular basis of succinic semialdehyde dehydrogenase deficiency (4-hydroxybutyric aciduria)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EXPRESSION; DIAGNOSIS; BRAIN	Succinic semialdehyde dehydrogenase (SSADH) deficiency, a rare metabolic disorder of 4-aminobutyric acid degradation, has been identified in similar to 150 patients. Affected individuals accumulate large quantities of 4-hydroxybutyric acid, a compound with a wide range of neuropharmacological activities, in physiological fluids. As a first step in beginning an investigation of the molecular genetics of SSADH deficiency, we have utilized SSADH cDNA and genomic sequences to identify two point mutations in the SSADH genes derived from four patients. These mutations, identified by standard methods of reverse transcription, PCR, dideoxy-chain termination, and cycle sequencing, alter highly conserved sequences at intron/exon boundaries and prevent the RNA-splicing apparatus from properly recognizing the normal splice junction. Each family segregated a mutation in a different splice site, resulting in exon skipping and, in one case, a frameshift and premature termination and, in the other case, an in-frame deletion in the resulting protein. Family members, including parents and siblings of these patients, were shown to be heterozygotes for the splicing abnormality, providing additional evidence for autosomal recessive inheritance. Our results provide the first evidence that 4-hydroxybutyric aciduria, resulting from SSADH deficiency, is the result of genetic defects in the human SSADH gene.	Oregon Hlth Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; Baylor Univ, Med Ctr, Inst Metab Dis, Dallas, TX USA; Univ Texas, SW Med Ctr, Dept Neurol, Dallas, TX 75235 USA; Univ Rome Tor Vergata, Dipartimento Biol, Rome, Italy; Free Univ Amsterdam Hosp, Dept Clin Chem & Pediat, Amsterdam, Netherlands	Oregon Health & Science University; Baylor University; Baylor University Medical Center; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Rome Tor Vergata; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Gibson, KM (corresponding author), Oregon Hlth Sci Univ, Dept Mol & Med Genet, Baird Hall,Room 2029,Mail Code L473,3181 SW Sam J, Portland, OR 97201 USA.	gibsonm@ohsu.edu	; Malaspina, Patrizia/G-7772-2017	trettel, flavia/0000-0002-7983-2955; Novelletto, Andrea/0000-0002-1146-7680; Malaspina, Patrizia/0000-0002-0067-369X	Telethon [E.0433] Funding Source: Medline	Telethon(Fondazione Telethon)		CASH CD, 1979, J NEUROCHEM, V33, P1169, DOI 10.1111/j.1471-4159.1979.tb05261.x; CHAMBLISS KL, 1995, J BIOL CHEM, V270, P461, DOI 10.1074/jbc.270.1.461; CHAMBLISS KL, 1992, INT J BIOCHEM, V24, P1493, DOI 10.1016/0020-711X(92)90077-E; CHAMBLISS KL, 1993, J INHERIT METAB DIS, V16, P523, DOI 10.1007/BF00711671; DEVIVO DC, 1988, ANN NEUROL, V24, P304; GAVEL Y, 1990, PROTEIN ENG, V4, P33, DOI 10.1093/protein/4.1.33; GIBSON KM, 1989, J PEDIATR-US, V114, P607, DOI 10.1016/S0022-3476(89)80706-1; Gibson KM, 1997, PEDIATRICS, V99, P567, DOI 10.1542/peds.99.4.567; GIBSON KM, 1995, J INHERIT METAB DIS, V18, P143, DOI 10.1007/BF00711750; GIBSON KM, 1994, J INHERIT METAB DIS, V17, P732, DOI 10.1007/BF00712016; GIBSON KM, 1991, CLIN CHIM ACTA, V196, P219, DOI 10.1016/0009-8981(91)90076-O; HAAN EA, 1985, J INHERIT METAB DIS, V8, P99, DOI 10.1007/BF01819287; HEMPEL J, 1993, PROTEIN SCI, V2, P1890, DOI 10.1002/pro.5560021111; JAKOBS C, 1993, PRENATAL DIAG, V13, P150, DOI 10.1002/pd.1970130213; JAKOBS C, 1990, J INHERIT METAB DIS, V13, P341, DOI 10.1007/BF01799390; JAKOBS C, 1981, CLIN CHIM ACTA, V111, P169, DOI 10.1016/0009-8981(81)90184-4; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KRAWCZAK M, 1992, HUM GENET, V90, P41; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Matern D, 1996, J INHERIT METAB DIS, V19, P313, DOI 10.1007/BF01799261; Roe C. R., 1995, METABOLIC MOL BASES, P1501; Trettel F, 1997, ADV EXP MED BIOL, V414, P253; VASILIOU V, IN PRESS PHARMACOGEN	23	57	60	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1998	63	2					399	408		10.1086/301964	http://dx.doi.org/10.1086/301964			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110CB	9683595	Green Published, Bronze			2022-12-18	WOS:000075360800015
J	Cullen, LM; Gao, XJ; Easteal, S; Jazwinska, EC				Cullen, LM; Gao, XJ; Easteal, S; Jazwinska, EC			The hemochromatosis 845 G -> A and 187 C -> G mutations: Prevalence in non-Caucasian populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY HEMOCHROMATOSIS	Hemochromatosis, the inherited disorder of iron metabolism, leads, if untreated, to progressive iron overload and premature death. The hemochromatosis gene, HFE, recently has been identified, and characterization of this gene has shown that it contains two mutations that result in amino acid substitutions-cDNA nucleotides 845 G-->A (C282Y) and 187 C-->G (H63D). Although hemochromatosis is common in Caucasians, affecting greater than or equal to 1/300 individuals of northern European origin, it has not been recognized in other populations. The present study used PCR and restriction-enzyme digestion to analyze the frequency of the 845 G-->A and 187 C-->G mutations in HLA-typed samples from non-Caucasian populations, comprising Australian Aboriginal, Chinese, and Pacific Islanders. Results showed that the 845 G-->A mutation was present in these populations (allele frequency 0.32%), and, furthermore, it was always seen in conjunction with HLA haplotypes common in Caucasians, suggesting that 845 G-->A may have been introduced into these populations by Caucasian admixture. 187 C-->G was present at an allele frequency of 2.68% in the two populations analyzed (Australian Aboriginal and Chinese). In the Australian Aboriginal samples, 187 C-->G was found to be associated with HLA haplotypes common in Caucasians, suggesting that it was introduced by recent admixture. In the Chinese samples analyzed,:187 C-->G was present in association with a wide variety of HLA haplotypes, showing this mutation to be widespread and likely to predate the more genetically restricted 845 G-->A mutation.	Queensland Inst Med Res, Clin Sci Unit, Brisbane, Qld 4006, Australia; Australian Natl Univ, John Curtin Sch Med Res, Human Genet Grp, Canberra, ACT 2601, Australia	QIMR Berghofer Medical Research Institute; Australian National University; John Curtin School of Medical Research	Jazwinska, EC (corresponding author), SmithKline Beecham, NSFP N, Harlow CM19 5AW, Essex, England.			Easteal, Simon/0000-0002-0462-502X				Beutler E, 1997, AM J HUM GENET, V61, P762; Beutler E, 1997, LANCET, V349, P296, DOI 10.1016/S0140-6736(97)22005-2; Beutler Ernest, 1996, Blood Cells Molecules and Diseases, V22, P187, DOI 10.1006/bcmd.1996.0027; Calandro L, 1996, BLOOD CELL MOL DIS, V22, pA194; Chang JG, 1997, BLOOD, V89, P3492, DOI 10.1182/blood.V89.9.3492; Cullen LM, 1997, BLOOD, V90, P4236, DOI 10.1182/blood.V90.10.4236; EDWARDS CQ, 1988, NEW ENGL J MED, V318, P1355, DOI 10.1056/NEJM198805263182103; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Feder JN, 1997, J BIOL CHEM, V272, P14025, DOI 10.1074/jbc.272.22.14025; GAO XJ, 1994, HUM IMMUNOL, V41, P267, DOI 10.1016/0198-8859(94)90045-0; Jazwinska EC, 1996, NAT GENET, V14, P249, DOI 10.1038/ng1196-249; Jouanolle AM, 1996, NAT GENET, V14, P251, DOI 10.1038/ng1196-251; LEGGETT BA, 1990, BRIT J HAEMATOL, V74, P525, DOI 10.1111/j.1365-2141.1990.tb06345.x; Martinez PA, 1997, BLOOD CELL MOL DIS, V23, P269; MerryweatherClarke AT, 1997, J MED GENET, V34, P275, DOI 10.1136/jmg.34.4.275; Powell W.L., 1994, IRON METABOLISM HLTH; Risch N, 1997, NAT GENET, V17, P375, DOI 10.1038/ng1297-375; Sambrook J, 1989, MOL CLONING LAB MANU; Sham RL, 1997, BLOOD CELL MOL DIS, V23, P314, DOI 10.1006/bcmd.1997.0148; SIMON M, 1976, GUT, V17, P332, DOI 10.1136/gut.17.5.332	20	57	60	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1998	62	6					1403	1407		10.1086/301878	http://dx.doi.org/10.1086/301878			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZU224	9585606	Bronze, Green Published			2022-12-18	WOS:000074174700016
J	Naumova, AK; Leppert, M; Barker, DF; Morgan, K; Sapienza, C				Naumova, AK; Leppert, M; Barker, DF; Morgan, K; Sapienza, C			Parental origin-dependent, male offspring-specific transmission-ratio distortion at loci on the human X chromosome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NON-MENDELIAN INHERITANCE; SEGREGATION DISTORTION; INTERSPECIFIC CROSSES; INACTIVATION; MOUSE; RETINOBLASTOMA; DYSTROPHY; MARKERS; ALLELES; ESCAPE	We have analyzed the transmission of maternal alleles at loci spanning the length of the X chromosome in 47 normal, genetic disease-free families. We found a significant deviation from the expected Mendelian 1:1 ratio of grandpaternal:grandmaternal alleles at loci in Xp11.4-p21.1. The distortion in inheritance ratio was found only among male offspring and was manifested as a strong bias in favor of the inheritance of the alleles of the maternal grandfather. We found no evidence for significant heterogeneity among the families, which implies that the major determinant involved in the generation of the non-Mendelian ratio is epigenetic. Our analysis of recombinant chromosomes inherited by male offspring indicates that an 11.6-cM interval on the short arm of the X chromosome, bounded by DXS538 and DXS7, contains an imprinted gene that affects the survival of male embryos.	Temple Univ, Sch Med, Fels Inst Canc Res, Philadelphia, PA 19140 USA; Temple Univ, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19140 USA; Univ Utah, Dept Physiol, Salt Lake City, UT 84112 USA; McGill Univ, Dept Human Genet, Montreal, PQ H3A 2T5, Canada; McGill Univ, Dept Med, Montreal, PQ H3A 2T5, Canada; Montreal Gen Hosp, Res Inst, Montreal, PQ H3G 1A4, Canada	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Utah System of Higher Education; University of Utah; McGill University; McGill University; McGill University	Sapienza, C (corresponding author), Temple Univ, Sch Med, Fels Inst Canc Res, 3307 N Broad St, Philadelphia, PA 19140 USA.	CARMEN@SGI1.FELS.TEMPLE.EDU		Barker, David/0000-0002-1438-4100; Naumova, Anna K./0000-0001-8481-5765	NIDDK NIH HHS [DK43671] Funding Source: Medline; NIGMS NIH HHS [R01 GM52332] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052332] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARKER DF, 1989, CYTOGENET CELL GENET, V51, P958; BIDDLE FG, 1987, GENOME, V29, P389, DOI 10.1139/g87-067; Boyd Y, 1996, NAT GENET, V13, P393, DOI 10.1038/ng0896-393; Cattanach B. M., 1991, Mouse Genome, V89, P565; Chakraborty R, 1996, AM J HUM GENET, V59, P109; DEVOTO M, 1995, EUR J HUM GENET, V3, P324; DISTECHE CM, 1995, TRENDS GENET, V11, P17, DOI 10.1016/S0168-9525(00)88981-7; EVANS K, 1994, NAT GENET, V6, P210, DOI 10.1038/ng0294-210; FAIN PR, 1995, NAT GENET, V9, P261, DOI 10.1038/ng0395-261; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; GUO SW, 1989, 187 U WASH DEP STAT; Herman GE, 1996, MAMM GENOME, V6, pS317; Jones MH, 1996, HUM MOL GENET, V5, P1695, DOI 10.1093/hmg/5.11.1695; LAIRD CD, 1987, GENETICS, V117, P587; Mckusick V.A., 1994, MENDELIAN INHERITANC; MILLER AP, 1995, HUM MOL GENET, V4, P731, DOI 10.1093/hmg/4.4.731; Montagutelli X, 1996, GENETICS, V143, P1739; MUNIER F, 1992, HUM GENET, V89, P508, DOI 10.1007/BF00219175; NAUMOVA A, 1994, AM J HUM GENET, V54, P264; Naumova AK, 1996, AM J HUM GENET, V58, P1111; NAUMOVA AK, 1995, DEV GENET, V17, P198, DOI 10.1002/dvg.1020170304; Rubinsztein DC, 1997, J MED GENET, V34, P234, DOI 10.1136/jmg.34.3.234; Skuse DH, 1997, NATURE, V387, P705, DOI 10.1038/42706; vandenHurk JAJM, 1997, HUM MOL GENET, V6, P851, DOI 10.1093/hmg/6.6.851; Zechner U, 1997, GENETICS, V146, P1399; Zechner U, 1996, NAT GENET, V12, P398, DOI 10.1038/ng0496-398	26	57	59	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1998	62	6					1493	1499		10.1086/301860	http://dx.doi.org/10.1086/301860			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZU224	9585588	hybrid, Green Published			2022-12-18	WOS:000074174700027
J	Bianchi, DW				Bianchi, DW			Fetal DNA in maternal plasma: The plot thickens and the placental barrier thins	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							PERIPHERAL-BLOOD; NUCLEATED ERYTHROCYTES; PRENATAL-DIAGNOSIS; CELLS		Tufts Univ, Sch Med, Dept Pediat, Div Genet, Boston, MA 02111 USA; Tufts Univ, Sch Med, Dept Obstet & Gynecol, Div Genet, Boston, MA 02111 USA	Tufts University; Tufts University	Bianchi, DW (corresponding author), New England Med Ctr, Box 394,750 Washington St, Boston, MA 02111 USA.							Bianchi DW, 1997, AM J HUM GENET, V61, P822, DOI 10.1086/514885; CAMASCHELLA C, 1990, BLOOD, V75, P2102; Cheung MC, 1996, NAT GENET, V14, P264, DOI 10.1038/ng1196-264; GANSHIRTAHLERT D, 1990, CLIN GENET, V38, P38; HAMADA H, 1993, HUM GENET, V91, P427; Lewis DE, 1996, CYTOMETRY, V23, P218; LO YMD, 1993, LANCET, V341, P1147, DOI 10.1016/0140-6736(93)93161-S; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; READING JP, 1995, HUM REPROD, V10, P2510; Sohda S, 1997, PRENATAL DIAG, V17, P743, DOI 10.1002/(SICI)1097-0223(199708)17:8<743::AID-PD144>3.3.CO;2-V; THOMAS MR, 1995, PRENATAL DIAG, V15, P641, DOI 10.1002/pd.1970150709; Wachtel SS, 1996, HUM GENET, V98, P162, DOI 10.1007/s004390050181	13	57	76	0	3	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1998	62	4					763	764		10.1086/301809	http://dx.doi.org/10.1086/301809			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZM197	9529367	Green Published, Bronze			2022-12-18	WOS:000073514400004
J	Lazzeroni, LC				Lazzeroni, LC			Linkage disequilibrium and gene mapping: An empirical least-squares approach	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LIKELIHOOD; LOCALIZATION; MARKERS	This paper proposes a novel approach for fine-scale mapping of disease genes that is based on the well-known linkage-disequilibrium parameter delta. Using a very simple, very general model, I show how delta can be interpreted in terms of identity-by-descent probabilities. The value of delta follows a piecewise curve along the chromosome, with the maximum occurring at the disease locus where the two pieces intersect. A semiparametric, multilocus approach is used to fit this nonlinear regression curve in order to estimate the gene location. Using the bootstrap to empirically estimate much of the probability model from the data avoids the need for many detailed population assumptions. One advantage of the approach is its use of the observed covariance structure of the data, which can be highly informative as to the gene location. I illustrate the method on the cystic fibrosis data of Kerem et al.	Stanford Univ, Dept Stat, Stanford, CA 94305 USA	Stanford University	Lazzeroni, LC (corresponding author), Stanford Univ, Div Biostat, Stanford, CA 94305 USA.		Lazzeroni, Laura/F-2903-2010	Lazzeroni, Laura/0000-0002-1846-6920	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062628] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM062628] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; BENGTSSON BO, 1981, TISSUE ANTIGENS, V18, P356, DOI 10.1111/j.1399-0039.1981.tb01404.x; Devlin B, 1996, GENOMICS, V36, P1, DOI 10.1006/geno.1996.0419; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Efron B., 1993, INTRO BOOTSTRAP; Goddard KAB, 1996, AM J HUM GENET, V58, P1286; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; HILL WG, 1994, AM J HUM GENET, V54, P705; JORDE LB, 1995, AM J HUM GENET, V56, P11; KAPLAN NL, 1995, AM J HUM GENET, V56, P18; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; LAZZERONI LC, IN PRESS HUM HERED; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; Ott J., 1991, ANAL HUMAN GENETIC L; RAMSAY M, 1993, HUM MOL GENET, V2, P1007, DOI 10.1093/hmg/2.7.1007; Seber G.A.F., 1989, NONLINEAR REGRESSION, DOI DOI 10.1002/0471725315; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; Xiong MM, 1997, AM J HUM GENET, V60, P1513, DOI 10.1086/515475	19	57	58	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1998	62	1					159	170		10.1086/301678	http://dx.doi.org/10.1086/301678			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YY246	9490574	Bronze, Green Published			2022-12-18	WOS:000072127900021
J	Matsuura, S; Weemaes, C; Smeets, D; Takami, H; Kondo, N; Sakamoto, S; Yano, N; Nakamura, A; Tauchi, H; Endo, S; Oshimura, M; Komatsu, K				Matsuura, S; Weemaes, C; Smeets, D; Takami, H; Kondo, N; Sakamoto, S; Yano, N; Nakamura, A; Tauchi, H; Endo, S; Oshimura, M; Komatsu, K			Genetic mapping using microcell-mediated chromosome transfer suggests a locus for Nijmegen breakage syndrome at chromosome 8q21-24	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ATAXIA-TELANGIECTASIA CELLS; DNA-REPAIR; HYBRIDS; IMMUNODEFICIENCY; COMPLEMENTATION; RECOMBINATION; INSTABILITY; DEFECTS; KINASE; ATM	Nijmegen breakage syndrome (NBS) is an autosomal recessive disorder characterized by microcephaly, short stature, immunodeficiency, and a high incidence of cancer. Cultured cells from NBS show chromosome instability, an increased sensitivity to radiation-induced cell killing, and an abnormal cell-cycle regulation after irradiation. Hitherto, patients with NBS have been divided into the two complementation groups V1 and V2, on the basis of restoration of radioresistant DNA synthesis, suggesting that each group arises from a different gene, However, the presence of genetic heterogeneity in NBS has been considered to be controversial. To localize the NBS gene, we have performed functional complementation assays using somatic cell fusion between NBS-V1 and NBS-V2 cells, on the basis of hyper-radiosensitivity, and then have performed a genomewide search for the NBS locus, using microcell-mediated chromosome transfer followed by complementation assays based on radiosensitivity, We found that radiation resistance was not restored in the fused NBS-V1 and NBS-V2 cells and that only human chromosome 8 complements the sensitivity to ionizing radiation, in NBS cell lines. In complementation assays performed after the transfer of a reduced chromosome, merely the long arm of chromosome 8 was sufficient for restoring the defect. Our results strongly suggest that NBS is a homogeneous disorder and that the gene for NBS is located at 8q21-24.	HIROSHIMA UNIV,RES INST RADIAT BIOL & MED,DEPT RADIAT BIOL,MINAMI KU,HIROSHIMA 734,JAPAN; UNIV NIJMEGEN HOSP,DEPT HUMAN GENET,NL-6500 HB NIJMEGEN,NETHERLANDS; UNIV NIJMEGEN HOSP,DEPT PEDIAT,NL-6500 HB NIJMEGEN,NETHERLANDS; TOTTORI UNIV,SCH LIFE SCI,DEPT MOL & CELL GENET,YONAGO,TOTTORI,JAPAN	Hiroshima University; Radboud University Nijmegen; Radboud University Nijmegen; Tottori University			Weemaes, C.M.R./L-4747-2015; Endo, Satoru/D-9091-2012; Matsuura, Shinya/U-4182-2017	Endo, Satoru/0000-0001-5961-681X; Matsuura, Shinya/0000-0001-5294-081X; Sakamoto, Shuichi/0000-0001-9396-9475				BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; CANNIZZARO LA, 1988, CYTOGENET CELL GENET, V47, P121, DOI 10.1159/000132527; Cimprich KA, 1996, P NATL ACAD SCI USA, V93, P2850, DOI 10.1073/pnas.93.7.2850; CONLEY ME, 1986, BLOOD, V67, P1251; DOWDY SF, 1990, GENE CHROMOSOME CANC, V2, P318, DOI 10.1002/gcc.2870020410; GATTI RA, 1988, NATURE, V336, P577, DOI 10.1038/336577a0; GREEN AJ, 1995, ARCH DIS CHILD, V73, P431, DOI 10.1136/adc.73.5.431; JASPERS NGJ, 1988, AM J HUM GENET, V42, P66; JASPERS NGJ, 1982, P NATL ACAD SCI-BIOL, V79, P2641, DOI 10.1073/pnas.79.8.2641; JONGMANS W, 1995, AM J HUM GENET, V56, P438; JUNG M, 1995, SCIENCE, V268, P1619, DOI 10.1126/science.7777860; Kaur Gursurinder P., 1992, American Journal of Human Genetics, V51, pA51; KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50; KOMATSU K, 1993, HUM MOL GENET, V2, P1031, DOI 10.1093/hmg/2.7.1031; KOMATSU K, 1990, MUTAT RES, V235, P59, DOI 10.1016/0921-8777(90)90058-D; KOMATSU K, 1989, INT J RADIAT BIOL, V56, P863, DOI 10.1080/09553008914552331; Komatsu K, 1996, AM J HUM GENET, V58, P885; LAVIN MF, 1995, TRENDS BIOCHEM SCI, V20, P382, DOI 10.1016/S0968-0004(00)89083-0; LEACH RJ, 1989, GENOMICS, V5, P167, DOI 10.1016/0888-7543(89)90043-8; LEGERSKI RJ, 1994, GENOMICS, V21, P266, DOI 10.1006/geno.1994.1256; McConville CM, 1996, AM J HUM GENET, V59, P320; MEYN MS, 1993, AM J HUM GENET, V53, P1206; MURNANE JP, 1982, P NATL ACAD SCI USA, V79, P183; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; STUMM M, 1995, AM J HUM GENET, V57, P960; vanderBurgt I, 1996, J MED GENET, V33, P153, DOI 10.1136/jmg.33.2.153; WEEMAES CMR, 1981, ACTA PAEDIATR SCAND, V70, P557, DOI 10.1111/j.1651-2227.1981.tb05740.x; WHITNEY M, 1995, NAT GENET, V11, P341, DOI 10.1038/ng1195-341; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; ZAKIAN VA, 1995, CELL, V82, P685, DOI 10.1016/0092-8674(95)90463-8; ZDZIENICKA MZ, 1994, INT J RADIAT BIOL, V66, pS189	31	57	59	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1997	60	6					1487	1494		10.1086/515461	http://dx.doi.org/10.1086/515461			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XE294	9199571	Green Published, Bronze			2022-12-18	WOS:A1997XE29400028
J	Barker, DF; Pruchno, CJ; Jiang, X; Atkin, CL; Stone, EM; Denison, LC; Fain, PR; Gregory, MC				Barker, DF; Pruchno, CJ; Jiang, X; Atkin, CL; Stone, EM; Denison, LC; Fain, PR; Gregory, MC			A mutation causing Alport syndrome with tardive hearing loss is common in the western United States	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALPHA-5(IV) COLLAGEN CHAIN; SINGLE-BASE MUTATION; HUMAN-X-CHROMOSOME; IV COLLAGEN; OSTEOGENESIS IMPERFECTA; POINT MUTATIONS; GENOMIC DNA; GENE; DOMAIN; IDENTIFICATION	Mutations in the COL4A5 gene, located at Xq22, cause Alport syndrome (AS), a nephritis characterized by progressive deterioration of the glomerular basement membrane and usually associated with progressive hearing loss. We have identified a novel mutation, L1649R, present in 9 of 121 independently ascertained families. Affected males shared the same haplotype of eight polymorphic markers tightly linked to COL4A5, indicating common ancestry. Genealogical studies place the birth of this ancestor >200 years ago. The L1649R mutation is a relatively common cause of Alport syndrome in the western United States, in part because of the rapid growth and migratory expansion of mid-nineteenth-century pioneer populations carrying the gene. L1649R affects a highly conserved residue in the NC1 domain, which is involved in key inter- and intramolecular interactions, but results in a relatively mild disease phenotype. Renal failure in an L1649R male typically occurs in the 4th or 5th decade and precedes the onset of significant hearing loss by similar to 10 years.	UNIV UTAH,HLTH SCI CTR,DEPT MED,SALT LAKE CITY,UT 84108; UNIV UTAH,HLTH SCI CTR,DEPT BIOCHEM,SALT LAKE CITY,UT 84108; UNIV UTAH,HLTH SCI CTR,DEPT MED INFORMAT,SALT LAKE CITY,UT 84108; UNIV IOWA,DEPT INTERNAL MED,IOWA CITY,IA 52242; UNIV IOWA,DEPT OPHTHALMOL,IOWA CITY,IA 52242; VET ADM MED CTR,IOWA CITY,IA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Barker, DF (corresponding author), UNIV UTAH,HLTH SCI CTR,DEPT PHYSIOL,RES PK,410 CHIPETA WAY,SALT LAKE CITY,UT 84108, USA.			Stone, Edwin M./0000-0003-3343-4414; Barker, David/0000-0002-1438-4100	NCRR NIH HHS [MO1-RR00064] Funding Source: Medline; NIDDK NIH HHS [DK43761] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043761] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLEN RC, 1992, HUM MOL GENET, V1, P216, DOI 10.1093/hmg/1.3.216; ALPORT AC, 1927, BRIT MED J, V1, P504; ARNOTT EJ, 1966, BRIT J OPHTHALMOL, V50, P390, DOI 10.1136/bjo.50.7.390; BARKER DF, 1992, NUCLEIC ACIDS RES, V20, P929, DOI 10.1093/nar/20.4.929-a; BARKER DF, 1991, HUM GENET, V88, P189; BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; BARKER DF, 1993, GENOMICS, V18, P712, DOI 10.1016/S0888-7543(05)80381-7; BLUMBERG B, 1987, J BIOL CHEM, V262, P5947; BONADIO J, 1985, NATURE, V316, P363, DOI 10.1038/316363a0; CECCHINI JP, 1987, EUR J BIOCHEM, V165, P587, DOI 10.1111/j.1432-1033.1987.tb11480.x; COCHAT P, 1988, J PEDIATR-US, V113, P339, DOI 10.1016/S0022-3476(88)80280-4; Colton T., 1974, STAT MED, V1; CRAWFURD MD, 1968, Q J MED, V37, P563; ECKSTEIN JD, 1975, ANN INTERN MED, V82, P639, DOI 10.7326/0003-4819-82-5-639; EPSTEIN CJ, 1972, AM J MED, V52, P299, DOI 10.1016/0002-9343(72)90017-4; FAIN PR, 1991, GENOMICS, V11, P1155, DOI 10.1016/0888-7543(91)90045-G; GELISKEN O, 1988, ACTA OPHTHALMOL, V66, P713; GREGORY MC, 1993, DISEASES KIDNEY, P571; GUO XD, 1989, J BIOL CHEM, V264, P17574; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HASSTEDT SJ, 1983, AM J HUM GENET, V35, P1241; HASSTEDT SJ, 1986, AM J HUM GENET, V38, P940; HOSTIKKA SL, 1988, J BIOL CHEM, V263, P19488; HOSTIKKA SL, 1987, FEBS LETT, V216, P281, DOI 10.1016/0014-5793(87)80706-8; HOSTIKKA SL, 1990, P NATL ACAD SCI USA, V87, P1606, DOI 10.1073/pnas.87.4.1606; KAUFMAN DL, 1990, GENOMICS, V8, P656, DOI 10.1016/0888-7543(90)90252-P; KORNREICH R, 1992, GENOMICS, V13, P70, DOI 10.1016/0888-7543(92)90203-5; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LUTY JA, 1990, AM J HUM GENET, V46, P776; MILLINER DS, 1982, MAYO CLIN PROC, V57, P35; MYERS RM, 1985, NATURE, V313, P495, DOI 10.1038/313495a0; ONEILL WM, 1978, ANN INTERN MED, V88, P176, DOI 10.7326/0003-4819-88-2-176; PIHLAJANIEMI T, 1985, J BIOL CHEM, V260, P7681; PRUCHNO CJ, 1991, HUM GENET, V87, P33, DOI 10.1007/BF01213088; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; SMEETS HJM, 1992, KIDNEY INT, V42, P83, DOI 10.1038/ki.1992.264; SOININEN R, 1987, FEBS LETT, V225, P188; TRYGGVASON K, 1993, KIDNEY INT, V43, P38, DOI 10.1038/ki.1993.8; WALLIS GA, 1990, AM J HUM GENET, V46, P1034; Wester D C, 1995, J Am Acad Audiol, V6, P73; WILLARD HF, 1994, CYTOGENET CELL GENET, V67, P295; ZHOU J, 1992, AM J HUM GENET, V50, P1291; ZHOU J, 1991, GENOMICS, V9, P10, DOI 10.1016/0888-7543(91)90215-Z; ZHOU J, 1992, J BIOL CHEM, V267, P12475; ZHOU J, 1991, GENOMICS, V9, P1, DOI 10.1016/0888-7543(91)90214-Y	45	57	62	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1996	58	6					1157	1165						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UM271	8651292				2022-12-18	WOS:A1996UM27100008
J	HANSON, RL; ELSTON, RC; PETTITT, DJ; BENNETT, PH; KNOWLER, WC				HANSON, RL; ELSTON, RC; PETTITT, DJ; BENNETT, PH; KNOWLER, WC			SEGREGATION ANALYSIS OF NON-INSULIN-DEPENDENT DIABETES-MELLITUS IN PIMA-INDIANS - EVIDENCE FOR A MAJOR-GENE EFFECT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX SEGREGATION; FAMILY RESEMBLANCE; UNIFIED MODEL; GLUCOSE; OBESITY; TRAITS	Non-insulin-dependent diabetes mellitus (NIDDM) has a high prevalence in Pima Indians. The disorder is familial, but the extent to which genetic factors are involved in its etiology is largely unknown. Segregation analysis was used to determine whether familial aggregation of NIDDM in this population could reflect the action of a single major gene. The analysis included 2,697 subjects from 653 nuclear families in which both parents and at least one offspring had been examined in the course of a longitudinal epidemiological study. The REGTL program of the SAGE package was used to fit model in which age at onset of NIDDM is transmitted from parent to offspring under the unified model for segregation analysis, Likelihood-ratio tests were used to test hypotheses related to genetic transmission. The hypothesis of no major effect was strongly rejected (P < .01), as was that of no transmission of the major effect (P < .01). Mendelian transmission was not rejected (P = .91). Similar results were obtained when covariates for obesity and birth cohort were added to the models and when a power transformation of age at onset was estimated. A strong effect of birth cohort with earlier age at onset in the later born cohorts was observed (P < .01). The findings are consistent with the hypothesis that a major gene influences the risk for NIDDM in Pima Indians by affecting age at onset. The expression of this gene may depend on environmental factors that have become more prevalent in recent-birth cohorts.	LOUISIANA STATE UNIV,MED CTR,DEPT BIOMETRY & GENET,NEW ORLEANS,LA 70112; LOUISIANA STATE UNIV,MED CTR,CTR MOLEC & HUMAN GENET,NEW ORLEANS,LA 70112	Louisiana State University System; Louisiana State University System	HANSON, RL (corresponding author), NIDDK,DIABET & ARTHRIT EPIDEMIOL SECT,1550 E INDIAN SCH RD,PHOENIX,AZ 85014, USA.		Hanson, Robert L/O-3238-2015; Bennett, Peter/AAH-9605-2021	Hanson, Robert L/0000-0002-4252-7068; 	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NCRR NIH HHS [1 P41 RR03655] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BENNETT PH, 1971, LANCET, V2, P125; BONNEY GE, 1986, BIOMETRICS, V42, P611, DOI 10.2307/2531211; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; COOK JTE, 1994, DIABETOLOGIA, V37, P1231, DOI 10.1007/s001250050240; DEMENAIS F, 1986, AM J HUM GENET, V38, P228; Elston R C, 1981, Adv Hum Genet, V11, P63; ELSTON RC, 1975, ANN HUM GENET, V39, P67, DOI 10.1111/j.1469-1809.1975.tb00109.x; ELSTON RC, 1979, AM J HUM GENET, V31, P62; ELSTON RC, 1989, GENET EPIDEMIOL, V6, P217, DOI 10.1002/gepi.1370060138; ELSTON RC, 1974, AM J HUM GENET, V26, P13; ELSTON RC, 1978, NEUROPSYCHOBIOLOGY, V4, P193, DOI 10.1159/000117633; GO RCP, 1978, AM J HUM GENET, V30, P38; HANSON R, 1994, DIABETES, V43, pA223; HANSON RL, 1995, DIABETES, V44, P418, DOI 10.2337/diabetes.44.4.418; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KHOURY MJ, 1993, FUNDAMENTALS GENETIC, P233; KNOWLER WC, 1990, DIABETES METAB REV, V6, P1, DOI 10.1002/dmr.5610060101; KNOWLER WC, 1981, AM J EPIDEMIOL, V113, P144, DOI 10.1093/oxfordjournals.aje.a113079; KNOWLER WC, 1991, AM J CLIN NUTR, V53, pS1543, DOI 10.1093/ajcn/53.6.1543S; KNOWLER WC, 1978, AM J EPIDEMIOL, V108, P497, DOI 10.1093/oxfordjournals.aje.a112648; KNOWLER WC, 1993, CURRENT TOPICS DIABE, V12, P1; KRISKA AM, 1993, DIABETOLOGIA, V36, P863, DOI 10.1007/BF00400363; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; LEWIS CM, 1991, THESIS U SHEFFIELD S; MACLEAN CJ, 1975, AM J HUM GENET, V27, P365; MCCARTHY MI, 1994, DIABETOLOGIA, V37, P1221; MORTON NE, 1974, AM J HUM GENET, V26, P489; PETTITT DJ, 1988, DIABETES, V37, P622, DOI 10.2337/diabetes.37.5.622; PRICE RA, 1993, AM J PHYS ANTHROPOL, V92, P473, DOI 10.1002/ajpa.1330920406; PRICE RA, 1994, HUM BIOL, V66, P251; RICE T, 1992, AM J MED GENET, V44, P399, DOI 10.1002/ajmg.1320440402; RICH SS, 1990, DIABETES, V39, P1315, DOI 10.2337/diabetes.39.11.1315; SEPEHRNIA B, 1995, AM J MED GENET, V56, P198, DOI 10.1002/ajmg.1320560217; SERJEANTSON SW, 1991, BAILLIERE CLIN ENDOC, V5, P477, DOI 10.1016/S0950-351X(05)80143-0; TIRET L, 1993, GENET EPIDEMIOL, V10, P581, DOI 10.1002/gepi.1370100642; YAMASHITA T, 1984, American Journal of Human Genetics, V36, p183S; 1985, WHO TECH REP SER, V727; 1992, STATISTICAL ANAL GEN	39	57	59	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1995	57	1					160	170						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RE629	7611284				2022-12-18	WOS:A1995RE62900019
J	JIN, K; HO, HN; SPEED, TP; GILL, TJ				JIN, K; HO, HN; SPEED, TP; GILL, TJ			REPRODUCTIVE FAILURE AND THE MAJOR HISTOCOMPATIBILITY COMPLEX	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL ADRENAL-HYPERPLASIA; RECURRENT SPONTANEOUS-ABORTIONS; DEPENDENT DIABETES-MELLITUS; SHARED-EPITOPE HYPOTHESIS; NEURAL-TUBE DEFECTS; RHEUMATOID-ARTHRITIS; ANCESTRAL HAPLOTYPES; AUTOIMMUNE-DISEASES; CLASS-II; HLA-DR	The association between HLA sharing and recurrent spontaneous abortion (RSA) was tested in 123 couples and the association between HLA sharing, and the outcome of treatment for unexplained infertility by in vitro fertilization (IVF) was tested in 76 couples, by using a new shared-allele test in order to identify more precisely the region of the major histocompatibility complex (MHC) influencing these reproductive defects. The shared-allele test circumvents the problem of rare alleles at HLA loci and at the same time provides a substantial gain in power over the simple chi(2) test. Two statistical methods, a corrected homogeneity test and a bootstrap approach, were developed to compare the allele frequencies at each of the HLA-A, HLA-B, HLA-DR, and HLA-DQ loci; they were not statistically different among the three patient groups and the control group. There was a significant excess of HLA-DR sharing in couples with RSA and a significant excess of HLA-DQ sharing in couples with unexplained infertility who failed treatment by IVF. These findings indicate that genes located in different parts of the class II region of the MHC affect different aspects of reproduction and strongly suggest that the sharing of HLA antigens per se is not the mechanism involved in the reproductive defects. The segment of the MHC that has genes affecting reproduction also has genes associated with different autoimmune diseases, and this juxtaposition may explain the association between reproductive defects and autoimmune diseases.	UNIV PITTSBURGH, SCH MED, DEPT PATHOL, PITTSBURGH, PA 15261 USA; UNIV PITTSBURGH, SCH MED, DEPT FAMILY MED & CLIN EPIDEMIOL, PITTSBURGH, PA USA; NATL TAIWAN UNIV, SCH MED, DEPT OBSTET & GYNECOL, TAIPEI, TAIWAN; NATL TAIWAN UNIV HOSP, TAIPEI, TAIWAN; UNIV CALIF BERKELEY, DEPT STAT, BERKELEY, CA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Taiwan University; National Taiwan University; National Taiwan University Hospital; University of California System; University of California Berkeley			NTU, Ref07/AAX-7890-2021; Speed, Terence P/B-8085-2009	Speed, Terence P/0000-0002-5403-7998; Ho, Hong-Nerng/0000-0002-7207-0089				ALLEN M, 1994, HUM IMMUNOL, V39, P41, DOI 10.1016/0198-8859(94)90099-X; BEER AE, 1981, AM J OBSTET GYNECOL, V141, P987; BENJAMIN R, 1990, IMMUNOL TODAY, V11, P137, DOI 10.1016/0167-5699(90)90051-A; BODMER JG, 1992, IMMUNOGENETICS, V36, P135, DOI 10.1007/BF00661090; CAMPBELL RD, 1993, IMMUNOL TODAY, V14, P349, DOI 10.1016/0167-5699(93)90234-C; CLARK DA, 1991, CRIT REV IMMUNOL, V11, P215; CLERGETDARPOUX F, 1991, AM J HUM GENET, V49, P42; COHEN JE, 1976, J AM STAT ASSOC, V71, P665, DOI 10.2307/2285597; DEGLIESPOSTI MA, 1992, IMMUNOGENETICS, V35, P355; DEGLIESPOSTI MA, 1992, IMMUNOGENETICS, V36, P345; DIZIER MH, 1993, AM J HUM GENET, V53, P715; DIZIER MH, 1994, AM J HUM GENET, V55, P1042; DORMAN JS, 1990, P NATL ACAD SCI USA, V87, P7370, DOI 10.1073/pnas.87.19.7370; DUQUESNOY RJ, 1994, HUM IMMUNOL, V39, P96, DOI 10.1016/0198-8859(94)90107-4; FELLEGI IP, 1980, J AM STAT ASSOC, V75, P261, DOI 10.2307/2287444; FRANCIS DA, 1991, HUM IMMUNOL, V32, P119, DOI 10.1016/0198-8859(91)90108-L; Gill Thomas J. Iii, 1994, P783; GILL TJ, 1983, TRANSPLANTATION, V35, P1; GILL TJ, 1983, BIOCHIM BIOPHYS ACTA, V738, P93; GILL TJ, 1979, AM J PATHOL, V96, P185; GILL TJ, 1990, REPRODUCTIVE IMMUNOLOGY 1989, P3; GILL TJ, 1992, IMMUNOLOGICAL OBSTET, P103; HALL P, 1991, BIOMETRICS, V47, P757, DOI 10.2307/2532163; HANSEN JA, 1990, CRIT REV IMMUNOL, V10, P307; HARRIS ED, 1990, NEW ENGL J MED, V322, P1277, DOI 10.1056/nejm199005033221805; HASSETT ALC, 1986, J IMMUNOL, V137, P373; HO HN, 1990, AM J OBSTET GYNECOL, V163, P178, DOI 10.1016/S0002-9378(11)90696-6; HO HN, 1994, AM J OBSTET GYNECOL, V170, P63; HO HN, 1991, AM J OBSTET GYNECOL, V165, P461, DOI 10.1016/0002-9378(91)90117-A; JACKSON DG, 1993, P NATL ACAD SCI USA, V90, P11079, DOI 10.1073/pnas.90.23.11079; JIN K, IN PRESS BIOMETRICS; KANBOUR A, 1987, J EXP MED, V166, P1861, DOI 10.1084/jem.166.6.1861; KLITZ W, 1994, AM J HUM GENET, V54, P497; KOCKUM I, 1993, AM J HUM GENET, V53, P150; KOSTYU DD, 1993, HUM IMMUNOL, V37, P135, DOI 10.1016/0198-8859(93)90178-4; LEPAGE V, 1993, EUR J IMMUNOGENET, V20, P153, DOI 10.1111/j.1744-313X.1993.tb00106.x; LU D, 1993, CANCER RES, V53, P4089; MARSHALL B, 1994, IMMUNOGENETICS, V39, P15; MELHEM MF, 1993, P NATL ACAD SCI USA, V90, P1967, DOI 10.1073/pnas.90.5.1967; MOWBRAY JF, 1985, LANCET, V1, P941; NELSON JL, 1993, ARTHRITIS RHEUM, V36, P7; NEPOM GT, 1991, ANNU REV IMMUNOL, V9, P493; NISHIMURA Y, 1992, HLA 1991, P693; PARTANEN J, 1989, AM J HUM GENET, V44, P660; RAO JNK, 1981, J AM STAT ASSOC, V76, P221, DOI 10.2307/2287815; SCHACTER B, 1979, LANCET, V1, P796; SHELTON AJ, 1994, AM J REPROD IMMUNOL, V32, P82, DOI 10.1111/j.1600-0897.1994.tb01097.x; SINHA AA, 1990, SCIENCE, V248, P1380, DOI 10.1126/science.1972595; Thompson EA, 1986, PEDIGREE ANAL HUMAN; TIWARI JL, 1985, HLA DISEASE ASS; TODD JA, 1988, TRENDS GENET, V4, P129, DOI 10.1016/0168-9525(88)90135-7; VARDIMON D, 1992, IMMUNOGENETICS, V35, P166, DOI 10.1007/BF00185110; WEITKAMP LR, 1985, NEW ENGL J MED, V313, P925, DOI 10.1056/NEJM198510103131505; WHITE PC, 1984, P NATL ACAD SCI-BIOL, V81, P7505, DOI 10.1073/pnas.81.23.7505; WHITE PC, 1987, NEW ENGL J MED, V316, P1580, DOI 10.1056/NEJM198706183162506; WHITE PC, 1987, NEW ENGL J MED, V316, P1519, DOI 10.1056/NEJM198706113162406; WINCHESTER R, 1992, RHEUM DIS CLIN N AM, V18, P761; ZHOU S, IN PRESS AUST J STAT	58	57	60	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1995	56	6					1456	1467						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA794	7762569				2022-12-18	WOS:A1995RA79400025
J	TEH, BT; SILBURN, P; LINDBLAD, K; BETZ, R; BOYLE, R; SCHALLING, M; LARSSON, C				TEH, BT; SILBURN, P; LINDBLAD, K; BETZ, R; BOYLE, R; SCHALLING, M; LARSSON, C			FAMILIAL PERIODIC CEREBELLAR-ATAXIA WITHOUT MYOKYMIA MAPS TO A 19-CM REGION ON 19P13	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPINOCEREBELLAR ATAXIA; PAROXYSMAL ATAXIA; GENE; HLA; KINDREDS; LINKAGE; TYPE-1; LOCUS	Familial periodic cerebellar ataxia (FPCA) is a heterogenous group of rare autosomal dominant disorders characterized by episodic cerebellar disturbance, A potassium-channel gene (KCNA1) has been found to be responsible for one of its subgroups, familial periodic cerebellar ataxia with myokymia (FPCA/+M; MIM 160120). A different subgroup that is not associated with myokymia (FPCA/-M; MIM 108500) was recently mapped to chromosome 19p. Here we have performed linkage analysis in two large families with FPCA/-M that also demonstrated neurodegenerative pathology of the cerebellum. Three markers in 19p13 gave significant lod scores (>3.0), while linkage to KCNA1 and three known loci for spinocerebellar ataxia (SCAI, SCA2, and SCA3) was excluded. The highest lod score was obtained with the marker D19S413 (4.4 at recombination fraction 0), and identification of meiotic recombinants in affected individuals placed the locus between the flanking markers D19S406 and D19S226, narrowing the interval to 19 cM. A CAG trinucleotide-repeat expansion was detected in one family but did not cosegregate with the disease.	PRINCESS ALEXANDRA HOSP,DEPT NEUROL,BRISBANE,QLD,AUSTRALIA		TEH, BT (corresponding author), KAROLINSKA HOSP,DEPT MOLEC MED,L6 BLDG,S-17176 STOCKHOLM,SWEDEN.		Silburn, Peter A/A-3614-2011; Betz, Regina C/E-8591-2011; Schalling, Martin/F-1518-2015	Betz, Regina C/0000-0001-5024-3623; Schalling, Martin/0000-0001-5011-2922				BAIN PG, 1992, ANN NEUROL, V31, P147, DOI 10.1002/ana.410310205; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; BRUNT ERP, 1990, BRAIN, V113, P1361, DOI 10.1093/brain/113.5.1361; FEENEY GFX, 1989, AUST NZ J MED, V19, P113, DOI 10.1111/j.1445-5994.1989.tb00216.x; Friedman J H, 1987, Mov Disord, V2, P67, DOI 10.1002/mds.870020110; Gancher S T, 1986, Mov Disord, V1, P239, DOI 10.1002/mds.870010404; GARDNER K, 1994, NEUROLOGY, V44, pA361; GISPERT S, 1993, NAT GENET, V4, P295, DOI 10.1038/ng0793-295; GRIGGS RC, 1978, NEUROLOGY, V28, P1259, DOI 10.1212/WNL.28.12.1259; Gutman G.A., 1993, SEMIN NEUROSCI, P101; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HARDING AE, 1993, ADV NEUROL, V61, P1; JOUTEL A, 1993, NAT GENET, V5, P40, DOI 10.1038/ng0993-40; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KEATS BJB, 1991, AM J HUM GENET, V49, P972; KHATI C, 1993, NEUROLOGY, V43, P1131, DOI 10.1212/WNL.43.6.1131; Kramer P. L., 1994, American Journal of Human Genetics, V55, pA191; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LINDBLAD K, 1994, NAT GENET, V7, P124, DOI 10.1038/ng0694-124; LITT M, 1994, AM J HUM GENET, V55, P702; LOCK LF, 1994, GENOMICS, V20, P354, DOI 10.1006/geno.1994.1188; LOPESCENDES I, 1994, AM J HUM GENET, V54, P774; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PARKER HL, 1946, MAYO CLIN P, V38, P642; RANUM LPW, 1991, AM J HUM GENET, V49, P31; RANUM LPW, 1994, NAT GENET, V8, P280, DOI 10.1038/ng1194-280; SCHALLING M, 1993, NAT GENET, V4, P135, DOI 10.1038/ng0693-135; STEVANIN G, 1994, AM J HUM GENET, V54, P11; VIGHETTO A, 1988, ARCH NEUROL-CHICAGO, V45, P547, DOI 10.1001/archneur.1988.00520290083018; ZOGHBI HY, 1991, AM J HUM GENET, V49, P23	30	57	57	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1995	56	6					1443	1449						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA794	7762567				2022-12-18	WOS:A1995RA79400023
J	GISPERT, S; SANTOS, N; DAMEN, R; VOIT, T; SCHULZ, J; KLOCKGETHER, T; OROZCO, G; KREUZ, F; WEISSENBACH, J; AUBURGER, G				GISPERT, S; SANTOS, N; DAMEN, R; VOIT, T; SCHULZ, J; KLOCKGETHER, T; OROZCO, G; KREUZ, F; WEISSENBACH, J; AUBURGER, G			AUTOSOMAL-DOMINANT FAMILIAL SPASTIC PARAPLEGIA - REDUCTION OF THE FSPI CANDIDATE REGION ON CHROMOSOME 14Q TO 7-CM AND LOCUS HETEROGENEITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY ATAXIAS	Three large pedigrees of German descent with autosomal dominant ''pure'' familial spastic paraplegia (FSP) were characterized clinically and genetically. Haplotype and linkage analyses, with microsatellites covering the FSP region on chromosome 14q (locus FSP1), were performed. In pedigree W, we found a haplotype that cosegregates with the disease and observed three crossing-over events, reducing the FSP1 candidate region to 7 cM; in addition, the observation of apparent anticipation in this family suggests a trinucleotide repeat expansion as the mutation. In pedigrees D and S, the gene locus could be excluded from the whole FSP1 region, confirming the locus heterogeneity of autosomal dominant FSP.	UNIV HOSP DUSSELDORF,DEPT NEUROL,D-40001 DUSSELDORF,GERMANY; UNIV HOSP DUSSELDORF,DEPT PEDIAT,D-40001 DUSSELDORF,GERMANY; UNIV TUBINGEN HOSP,DEPT NEUROL,TUBINGEN,GERMANY; HOSP LENIN,SERV NEUROL,HOLGUIN,CUBA; TECH UNIV DRESDEN,INST CLIN GENET,O-8027 DRESDEN,GERMANY; UNITE GENET MOLEC HUMAINE,PARIS,FRANCE	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Technische Universitat Dresden			Schulz, Jörg B/D-9786-2012	Schulz, Jörg B/0000-0002-8903-0593				BRUYN RPM, 1993, CLIN NEUROL NEUROSUR, V95, P125, DOI 10.1016/0303-8467(93)90006-3; HARDING AE, 1983, LANCET, V1, P1151; HARDING AE, 1981, J NEUROL NEUROSUR PS, V44, P871, DOI 10.1136/jnnp.44.10.871; HAZAN J, 1993, NAT GENET, V5, P163, DOI 10.1038/ng1093-163; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; McKusick VA, 1990, MENDELIAN INHERITANC; MIWA S, 1994, NAT GENET, V6, P3, DOI 10.1038/ng0194-3; NYGAARD TG, 1993, NAT GENET, V5, P386, DOI 10.1038/ng1293-386; POLO JM, 1991, BRAIN, V114, P855, DOI 10.1093/brain/114.2.855; STRUMPELL A, 1888, ARCH PSYCHIAT NERVEN, V10, P676; SUTHERLAND JM, 1975, HDB CLIN NEUROLOGY, V22, P421	11	57	60	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					183	187						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QC101	7825576				2022-12-18	WOS:A1995QC10100023
J	RABEN, N; EXELBERT, R; SPIEGEL, R; SHERMAN, JB; NAKAJIMA, H; PLOTZ, P; HEINISCH, J				RABEN, N; EXELBERT, R; SPIEGEL, R; SHERMAN, JB; NAKAJIMA, H; PLOTZ, P; HEINISCH, J			FUNCTIONAL EXPRESSION OF HUMAN MUTANT PHOSPHOFRUCTOKINASE IN YEAST - GENETIC-DEFECTS IN FRENCH-CANADIAN AND SWISS PATIENTS WITH PHOSPHOFRUCTOKINASE DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RABBIT MUSCLE PHOSPHOFRUCTOKINASE; GRADIENT GEL-ELECTROPHORESIS; HEMOPHILIA-B; REGION; SUBSTITUTIONS; ASSIGNMENT; PROMOTER; ISOZYMES; MUTATION; CLONING	Human phosphofructokinase (PFK) is a tetrameric enzyme, encoded by muscle, liver, and platelet genes. Deficiency of muscle PFK (PFK-M), glycogenosis type VII (Tarui disease), is an autosomal recessive disorder characterized by an exertional myopathy and hemolytic syndrome. Several disease-causing mutations have been identified in the PFK-M gene in Japanese, Ashkenazi Jewish, and Italian patients. We describe the genetic defects in French Canadian and Swiss patients with the disease, and we use a genetically well-defined yeast system devoid of endogenous PFK for structure-function studies of the mutant PFKs. A G-to-A transition at codon 209-in exon 8 of the PFK-M gene, changing an encoded Gly to Asp, is responsible for the disease in a homozygous French Canadian patient. Gly-209-mutated protein is completely inactive in the yeast system. The Swiss patient is a genetic compound, carrying a G-to-A transition at codon 100 in exon 6 (Arg to Gin) and a G-to-A transition at codon 696 in exon 22 (Arg to His). The mutants expressed in yeast generate functional enzyme with modest changes in thermal stability. The advantages and limitations of the yeast system for expression of human mutant PFKs are discussed.	UNIV ZURICH, INST MED GENET, ZURICH, SWITZERLAND; OSAKA UNIV, SCH MED, DEPT INTERNAL MED 2, SUITA, OSAKA 565, JAPAN; INST MICROBIOL, DUSSELDORF, GERMANY	University of Zurich; Osaka University	RABEN, N (corresponding author), NIAMSD, ARTHRITIS & RHEUMATISM BRANCH, 10-9N244, 9000 ROCKVILLE PIKE, BETHESDA, MD 20892 USA.		Heinisch, Juergen J./G-3801-2017					AARONSON RP, 1972, J BIOL CHEM, V247, P7502; ARGOV Z, 1994, NEUROLOGY, V44, P1097; ARVANITIDIS A, 1994, J BIOL CHEM, V269, P8911; BLOXHAM DP, 1973, ENZYMES, P239; BREITENBACHSCHMITT I, 1984, MOL GEN GENET, V195, P530, DOI 10.1007/BF00341458; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CROSSLEY M, 1990, NATURE, V345, P444, DOI 10.1038/345444a0; DANON MJ, 1988, NEUROLOGY, V38, P956, DOI 10.1212/WNL.38.6.956; DUNAWAY GA, 1983, MOL CELL BIOCHEM, V52, P75; DUNAWAY GA, 1987, BIOCHEM J, V242, P667, DOI 10.1042/bj2420667; ENGLERBLUM G, 1993, ANAL BIOCHEM, V210, P235, DOI 10.1006/abio.1993.1189; EVANS PR, 1981, PHILOS T ROY SOC B, V293, P53, DOI 10.1098/rstb.1981.0059; HAMAGUCHI T, 1994, JUL INT S GLYC MIT D; HAYS AP, 1981, NEUROLOGY, V31, P1077, DOI 10.1212/WNL.31.9.1077; HEINISCH J, 1991, FEBS LETT, V289, P77, DOI 10.1016/0014-5793(91)80912-M; HEINISCH J, 1986, CURR GENET, V11, P227, DOI 10.1007/BF00420611; HEINISCH JJ, 1993, FEBS LETT, V328, P35, DOI 10.1016/0014-5793(93)80960-3; Higuchi R, 1989, PCR TECHNOLOGY PRINC, P31; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; JACOBY J, 1993, MOL MICROBIOL, V10, P867, DOI 10.1111/j.1365-2958.1993.tb00957.x; KEMP RG, 1983, MOL CELL BIOCHEM, V57, P147, DOI 10.1007/BF00849191; KUNDROT CE, 1991, BIOCHEMISTRY-US, V30, P1478, DOI 10.1021/bi00220a005; LAD PM, 1973, BIOCHEMISTRY-US, V12, P4303, DOI 10.1021/bi00746a001; LAYZER RB, 1967, ARCH NEUROL-CHICAGO, V17, P512, DOI 10.1001/archneur.1967.00470290066009; MEIENHOFER MC, 1979, BLOOD, V54, P389; MYERS RM, 1985, NUCLEIC ACIDS RES, V13, P3131, DOI 10.1093/nar/13.9.3131; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; NAKAJIMA H, 1990, BIOCHEM BIOPH RES CO, V166, P637, DOI 10.1016/0006-291X(90)90856-I; NAKAJIMA H, 1990, BIOCHEM BIOPH RES CO, V173, P1317, DOI 10.1016/S0006-291X(05)80931-3; NAKAJIMA H, 1987, FEBS LETT, V223, P113, DOI 10.1016/0014-5793(87)80519-7; NAKAJIMA H, 1990, J BIOL CHEM, V265, P9392; NICHOLS RC, 1994, BIOTECHNIQUES, V17, P412; POORMAN RA, 1984, NATURE, V309, P467, DOI 10.1038/309467a0; RABEN N, 1993, J BIOL CHEM, V268, P4963; ROWLAND LP, 1986, MYOLOGY, P1603; SHARMA PM, 1989, GENE, V77, P177, DOI 10.1016/0378-1119(89)90372-7; SHARMA PM, 1990, J BIOL CHEM, V265, P9006; SHERMAN JB, 1994, AM J HUM GENET, V55, P305; TARUI S, 1965, BIOCHEM BIOPH RES CO, V19, P517, DOI 10.1016/0006-291X(65)90156-7; TSUJINO S, 1994, AM J HUM GENET, V54, P812; VALDEZ BC, 1989, GENE, V76, P167, DOI 10.1016/0378-1119(89)90019-X; VANKEUREN M, 1986, HUM GENET, V74, P34, DOI 10.1007/BF00278782; VIDAUD D, 1993, HUM GENET, V91, P241; VORA S, 1987, J CLIN INVEST, V80, P1479, DOI 10.1172/JCI113229; VORA S, 1981, BLOOD, V57, P724; VORA S, 1983, HUM GENET, V63, P374, DOI 10.1007/BF00274765; VORA S, 1982, SOMAT CELL GENET, V8, P95, DOI 10.1007/BF01538653; YAMASAKI T, 1991, GENE, V104, P277, DOI 10.1016/0378-1119(91)90262-A	49	57	59	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					131	141						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QC101	7825568				2022-12-18	WOS:A1995QC10100017
J	VIELAND, VJ; HODGE, SE				VIELAND, VJ; HODGE, SE			INHERENT INTRACTABILITY OF THE ASCERTAINMENT PROBLEM FOR PEDIGREE DATA - A GENERAL LIKELIHOOD FRAMEWORK	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SAMPLING PROBLEM; RESOLUTION; MODELS	The problem of ascertainment in segregation analysis arises when families are selected for study through ascertainment of affected individuals, In this case, ascertainment must be corrected for in data analysis. However, methods for ascertainment correction are not available for many common sampling schemes, e.g., sequential sampling of extended pedigrees (except in the case of ''single'' selection). Concerns about whether ascertainment correction is even required for large pedigrees, about whether and how multiple probands in the same pedigree can be taken into account properly, and about how to apply sequential sampling strategies have occupied many investigators in recent years. We address these concerns by reconsidering a central issue, namely, how to handle pedigree structure (including size). We introduce a new distinction, between sampling in such a way that observed pedigree structure does not depend on which pedigree members are probands (proband-independent [PI] sampling) and sampling in such a way that observed pedigree structure does depend on who are the probands (proband-dependent [PD] sampling). This distinction corresponds roughly (but not exactly) to the distinction between fixed-structure and sequential sampling. We show chat conditioning on observed pedigree structure in ascertained data sets obtained under PD sampling is nor in general correct (with the exception of ''single'' selection), while PI sampling of pedigree structures larger than simple sibships is generally not possible. Yet, in practice one has little choice but to condition on observed pedigree structure. We conclude that the problem of genetic modeling in ascertained data sets is, in most situations, literally intractable. We recommend that future efforts focus on the development of robust approximate approaches to the problem.	COLUMBIA UNIV,DEPT PSYCHIAT,NEW YORK,NY 10027; COLUMBIA UNIV,DEPT BIOSTAT,NEW YORK,NY 10027	Columbia University; Columbia University	VIELAND, VJ (corresponding author), COLUMBIA UNIV,NEW YORK STATE PSYCHIAT INST,CLIN & GENET EPIDEMIOL UNIT 14,722 W 168TH ST,NEW YORK,NY 10032, USA.				NIMH NIH HHS [MH48858, MH43878, MH00884] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K21MH000884, R01MH048858, P30MH043878, P50MH043878] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		CANNINGS C, 1977, CLIN GENET, V12, P208; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; ELSTON RC, 1979, AM J HUM GENET, V31, P62; EWENS WJ, 1986, THEOR POPUL BIOL, V30, P388, DOI 10.1016/0040-5809(86)90042-0; FINEMAN RM, 1982, AM J MED GENET, V12, P457, DOI 10.1002/ajmg.1320120409; GEORGE VT, 1991, BIOMETRICAL J, V33, P741, DOI 10.1002/bimj.4710330617; HODGE SE, 1988, AM J HUM GENET, V43, P364; KALBFLEI.JD, 1970, J ROY STAT SOC B, V32, P175; MORTON NE, 1959, AM J HUM GENET, V11, P1; SHUTE NCE, 1988, AM J HUM GENET, V43, P387; STENE J, 1977, BIOMETRICS, V33, P523, DOI 10.2307/2529367; THOMPSON E, 1987, AM J HUM GENET, V41, P687; THOMPSON EA, 1979, GENETIC ANAL COMMON, P363; WEINBERG W, 1927, Z INDUKT ABSTAMM VER, V48, P179	14	57	57	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					33	43						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QC101	7825595				2022-12-18	WOS:A1995QC10100005
J	POUSI, B; HAUTALA, T; HEIKKINEN, J; PAJUNEN, L; KIVIRIKKO, KI; MYLLYLA, R				POUSI, B; HAUTALA, T; HEIKKINEN, J; PAJUNEN, L; KIVIRIKKO, KI; MYLLYLA, R			ALU-ALU RECOMBINATION RESULTS IN A DUPLICATION OF 7 EXONS IN THE LYSYL HYDROXYLASE GENE IN A PATIENT WITH THE TYPE-VI VARIANT OF EHLERS-DANLOS-SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEFICIENT COLLAGEN; UNIPARENTAL DISOMY; HUMAN CHROMOSOME-1; ASCORBIC-ACID; 2 SIBLINGS; FAMILY; ISODISOMY; CLONING; DISEASE; DNA	The type VI variant of the Ehlers-Danlos syndrome (EDS) is a recessively inherited connective-tissue disorder. The characteristic features of the variant are muscular hypotonia, kyphoscoliosis, ocular manifestations, joint hypermobility, skin fragility and hyperextensibility, and other signs of connective-tissue involvement. The biochemical defect in most but not all patients is a deficiency in lysyl hydroxylase activity. Lysyl hydroxylase is an enzyme that catalyzes the formation of hydroxylysine in collagens and other proteins with collagen-like amino acid sequences. We have recently reported an apparently homozygous large-duplication rearrangement in the gene for Iysyl hydroxylase, leading to the type VI variant of EDS in two siblings. We now report an identical, apparently homozygous barge duplication in an unrelated 49-year-old female originally analyzed by Sussman et al. Our simple-sequence-repeat-polymorphism analysis does not support uniparental isodisomy inheritance for either of the two duplications. Furthermore, we indicate in this study that the duplication in the lysyl hydroxylase gene is caused by an Alu-Alu recombination in both families. Cloning of the junction fragment of the duplication has allowed synthesis of appropriate primers for rapid screening for this rearrangement in other families with the type VI variant of EDS.	UNIV OULU,DEPT BIOCHEM,SF-90570 OULU,FINLAND; UNIV OULU,DEPT MED BIOCHEM,OULU,FINLAND; UNIV OULU,BIOCTR,COLLAGEN RES UNIT,OULU,FINLAND	Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; University of Oulu								Ausubel F.M., 1989, SHORT PROTOCOLS MOL; CHAMSON A, 1987, ARCH DERMATOL RES, V279, P303, DOI 10.1007/BF00431222; DEMBURE PP, 1984, AM J HUM GENET, V36, P783; DEVLIN RH, 1990, AM J HUM GENET, V46, P112; ELSAS LJ, 1978, J PEDIATR-US, V92, P378, DOI 10.1016/S0022-3476(78)80423-5; ENGELSTEIN M, 1993, GENOMICS, V15, P251, DOI 10.1006/geno.1993.1054; HA VT, 1994, J CLIN INVEST, V93, P1716, DOI 10.1172/JCI117155; HAUTALA T, 1992, GENOMICS, V13, P62, DOI 10.1016/0888-7543(92)90202-4; HAUTALA T, 1993, GENOMICS, V15, P399, DOI 10.1006/geno.1993.1074; Hu Xiuyuan, 1992, Human Mutation, V1, P3, DOI 10.1002/humu.1380010103; HU XY, 1991, EMBO J, V10, P2471, DOI 10.1002/j.1460-2075.1991.tb07786.x; HYLAND J, 1992, NAT GENET, V2, P228, DOI 10.1038/ng1192-228; IHME A, 1983, EUR J CLIN INVEST, V13, P357, DOI 10.1111/j.1365-2362.1983.tb00113.x; JEFFREYS AJ, 1985, NATURE, V316, P76, DOI 10.1038/316076a0; JUDISCH GF, 1976, ARCH OPHTHALMOL-CHIC, V94, P1489; JURKA J, 1988, P NATL ACAD SCI USA, V85, P4775, DOI 10.1073/pnas.85.13.4775; KIVIRIKKO KI, 1985, ANN NY ACAD SCI, V460, P187, DOI 10.1111/j.1749-6632.1985.tb51167.x; KIVIRIKKO KI, 1992, FOCUS POST TRANSLATI, P1; KIVIRIKKO KI, 1980, ENZYMOLOGY POST TRAN, P53; KRANE SM, 1972, P NATL ACAD SCI USA, V69, P2899, DOI 10.1073/pnas.69.10.2899; KRANE SM, 1984, EXTRACELLULAR MATRIX, P413; KRIEG T, 1979, HUM GENET, V46, P41, DOI 10.1007/BF00278900; LEHRMAN MA, 1987, CELL, V48, P827, DOI 10.1016/0092-8674(87)90079-1; MALCOLM S, 1991, LANCET, V337, P694, DOI 10.1016/0140-6736(91)90278-W; MARCUS S, 1993, HUM GENET, V90, P477; MYLLYLA R, 1991, J BIOL CHEM, V266, P2805; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; PATEL MS, 1992, HUM MOL GENET, V1, P65, DOI 10.1093/hmg/1.1.65-a; PINNELL SR, 1972, NEW ENGL J MED, V286, P1013, DOI 10.1056/NEJM197205112861901; ROYCE PM, 1989, MATRIX, V9, P147, DOI 10.1016/S0934-8832(89)80033-2; Sambrook J., 1989, MOL CLONING LAB MANU; SPENCE JE, 1988, AM J HUM GENET, V42, P217; SPOTILA LD, 1992, AM J HUM GENET, V51, P1396; STEINMANN B, 1992, CONNECTIVE TISSUE IT, P351; SUSSMAN M, 1974, J BONE JOINT SURG AM, VA 56, P1228, DOI 10.2106/00004623-197456060-00015; VANROY N, 1993, GENOMICS, V18, P71, DOI 10.1006/geno.1993.1427; VOSS R, 1989, AM J HUM GENET, V45, P373; WENSTRUP RJ, 1989, J PEDIATR-US, V115, P405, DOI 10.1016/S0022-3476(89)80839-X	38	57	57	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1994	55	5					899	906						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB682	7977351				2022-12-18	WOS:A1994QB68200008
J	MARTHA, A; FERRELL, RE; MINTZHITTNER, H; LYONS, LA; SAUNDERS, GF				MARTHA, A; FERRELL, RE; MINTZHITTNER, H; LYONS, LA; SAUNDERS, GF			PAIRED BOX MUTATIONS IN FAMILIAL AND SPORADIC ANIRIDIA PREDICTS TRUNCATED ANIRIDIA PROTEINS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOSOMAL DOMINANT ANIRIDIA; HOMEOBOX-CONTAINING GENE; WILMS TUMOR ASSOCIATION; HUMAN PAX6 GENE; 11P13; DELETION; LOCUS; MAP; LINKAGE; CLONING	Aniridia, an autosomal dominant ocular disorder characterized by iris hypoplasia, results from mutations in the PAX6 gene, which encodes paired box and homeobox motifs. In this report we describe five new mutations in the paired box region of the human PAX6 gene that are associated with aniridia. The paired box mutations that we detected were in both familial (three) and sporadic (two) cases. All five mutations predict truncated PAX6 proteins. Our study indicates that early premature translational termination mutations in the PAX6 gene result in haploinsufficiency and generate the aniridia phenotype.	UNIV TEXAS,MD ANDERSON CANC CTR,DEPT BIOCHEM & MOLEC BIOL,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT OPHTHALMOL,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; UNIV PITTSBURGH,GRAD SCH PUBL HLTH,DEPT HUMAN GENET,PITTSBURGH,PA 15261	University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Baylor College of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh					NCI NIH HHS [CA 16672] Funding Source: Medline; NEI NIH HHS [EY 09675] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY009675] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BALDWIN CT, 1992, HUM MOL GENET, V1, P243; BALLING R, 1988, CELL, V55, P531, DOI 10.1016/0092-8674(88)90039-6; DAVIS LM, 1989, SOMAT CELL MOLEC GEN, V15, P605, DOI 10.1007/BF01534921; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; FERRELL RE, 1980, P NATL ACAD SCI-BIOL, V77, P1580, DOI 10.1073/pnas.77.3.1580; FRANCKE U, 1979, CYTOGENET CELL GENET, V24, P185, DOI 10.1159/000131375; FRAUMENI JF, 1968, J AMER MED ASSOC, V206, P825, DOI 10.1001/jama.206.4.825; GESSLER M, 1989, SCIENCE, V244, P1575, DOI 10.1126/science.2544995; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; GRUNDY P, 1988, NATURE, V336, P374, DOI 10.1038/336374a0; HANSON IM, 1993, HUM MOL GENET, V2, P915; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; HITTNER HM, 1980, AM J OPHTHALMOL, V89, P531, DOI 10.1016/0002-9394(80)90062-8; HUFF V, 1988, NATURE, V336, P377, DOI 10.1038/336377a0; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; LYONS LA, 1992, GENOMICS, V13, P925, DOI 10.1016/0888-7543(92)90002-A; MARTHA A, IN PRESS GENET LIFE; MARTHA AD, 1993, HUM MOL GENET, V2, P1982, DOI 10.1093/hmg/2.11.1982-a; MATHA A, IN PRESS HUM MUTAT; MATSUO T, 1993, NAT GENET, V3, P299, DOI 10.1038/ng0493-299; MILLER RW, 1964, NEW ENGL J MED, V270, P922, DOI 10.1056/NEJM196404302701802; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MOORE JW, 1986, HUM GENET, V72, P297, DOI 10.1007/BF00290952; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; RICCARDI VM, 1978, PEDIATRICS, V61, P604; ROSE EA, 1990, CELL, V60, P495, DOI 10.1016/0092-8674(90)90600-J; SHAW MW, 1960, AM J HUM GENET, V12, P389; SIMOLA KOJ, 1983, HUM GENET, V63, P158, DOI 10.1007/BF00291536; SMITH KJ, 1993, P NATL ACAD SCI USA, V90, P2846, DOI 10.1073/pnas.90.7.2846; TON CCT, 1992, GENOMICS, V13, P251, DOI 10.1016/0888-7543(92)90239-O; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; WALTHER C, 1991, DEVELOPMENT, V113, P1435	32	57	59	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1994	54	5					801	811						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NH394	7909985				2022-12-18	WOS:A1994NH39400009
J	HOWELL, N; HALVORSON, S; BURNS, J; MCCULLOUGH, DA; POULTON, J				HOWELL, N; HALVORSON, S; BURNS, J; MCCULLOUGH, DA; POULTON, J			WHEN DOES BILATERAL OPTIC ATROPHY BECOME LEBER HEREDITARY OPTIC NEUROPATHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							GENETIC-HETEROGENEITY; 11778 MUTATION; COMPLEX-I; NEURORETINOPATHY; PEDIGREES; PROTEINS; CONSERVATION; SEQUENCE; RECOVERY; VARIANT		UNIV TEXAS,MED BRANCH,DEPT HUMAN BIOL CHEM & GENET,GALVESTON,TX 77550; JOHN RADCLIFFE HOSP,DEPT PAEDIAT,OXFORD OX3 9DU,ENGLAND	University of Texas System; University of Texas Medical Branch Galveston; University of Oxford	HOWELL, N (corresponding author), UNIV TEXAS,MED BRANCH,DEPT RADIAT THERAPY,GALVESTON,TX 77550, USA.		Poulton, Joanna/AAB-4828-2021		NICHD NIH HHS [P01HD08315] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD008315] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BORRUAT FX, 1992, BRIT J OPHTHALMOL, V76, P571, DOI 10.1136/bjo.76.9.571; BROWN MD, 1992, AM J HUM GENET, V51, P378; ESPOSTI MD, 1990, EUR J BIOCHEM, V190, P207; FEARNLEY IM, 1992, BIOCHIM BIOPHYS ACTA, V1140, P105, DOI 10.1016/0005-2728(92)90001-I; HOLT IJ, 1989, J MED GENET, V26, P739, DOI 10.1136/jmg.26.12.739; HOWELL N, 1989, J MOL EVOL, V29, P157, DOI 10.1007/BF02100114; HOWELL N, 1991, AM J HUM GENET, V48, P935; HOWELL N, 1991, AM J HUM GENET, V49, P939; HOWELL N, 1992, AM J HUM GENET, V50, P1333; HOWELL N, 1992, AM J HUM GENET, V50, P443; HOWELL N, 1993, GENETICS, V133, P133; HUOPONEN K, 1991, AM J HUM GENET, V48, P1147; JOHNS DR, 1992, BIOCHEM BIOPH RES CO, V187, P1551, DOI 10.1016/0006-291X(92)90479-5; JOHNS DR, 1991, BIOCHEM BIOPH RES CO, V174, P1324, DOI 10.1016/0006-291X(91)91567-V; JOHNS DR, 1993, ARCH OPHTHALMOL-CHIC, V111, P495, DOI 10.1001/archopht.1993.01090040087038; KLEIN P, 1985, BIOCHIM BIOPHYS ACTA, V815, P468, DOI 10.1016/0005-2736(85)90375-X; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MACKEY D, 1992, AM J HUM GENET, V51, P1218; MACKEY DA, 1992, AUST NZ J OPHTHALMOL, V20, P177, DOI 10.1111/j.1442-9071.1992.tb00937.x; NELSON MA, 1987, MOL GEN GENET, V206, P307, DOI 10.1007/BF00333589; NEWMAN NJ, 1991, AM J OPHTHALMOL, V111, P750, DOI 10.1016/S0002-9394(14)76784-4; NIKOSKELAINEN EK, 1987, ARCH OPHTHALMOL-CHIC, V105, P665, DOI 10.1001/archopht.1987.01060050083043; OZAWA T, 1991, BIOCHEM BIOPH RES CO, V177, P518, DOI 10.1016/0006-291X(91)92014-B; POULTON J, 1991, J MED GENET, V28, P765, DOI 10.1136/jmg.28.11.765; RAO JKM, 1986, BIOCHIM BIOPHYS ACTA, V869, P197, DOI 10.1016/0167-4838(86)90295-5; STONE EM, 1992, J CLIN NEURO-OPHTHAL, V12, P10; VILKKI J, 1989, AM J HUM GENET, V45, P206; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231	28	57	59	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1993	53	4					959	963						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LY627	8213825				2022-12-18	WOS:A1993LY62700022
J	MARKOW, T; HEDRICK, PW; ZUERLEIN, K; DANILOVS, J; MARTIN, J; VYVIAL, T; ARMSTRONG, C				MARKOW, T; HEDRICK, PW; ZUERLEIN, K; DANILOVS, J; MARTIN, J; VYVIAL, T; ARMSTRONG, C			HLA POLYMORPHISM IN THE HAVASUPAI - EVIDENCE FOR BALANCING SELECTION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-I LOCI; GENETIC-ANALYSIS; B ALLELES; POPULATIONS; NEUTRALITY; EVOLUTION; INDIANS; HUTTERITES; ANTIGENS	The characterization and analysis of genetic variation at the HLA loci provides important insight for population geneticists trying to understand the evolutionary forces that have shaped human populations. This study describes the HLA-A and HLA-B loci serotyping. and statistical analysis on an isolated Native American population, the Havasupai of Arizona. Four alleles at the HLA-A locus were identified, while eight alleles were found at the HLA-B locus. These variants were present as 20 of 32 potential two-locus haplotypes, with five of the six most common haplotypes exhibiting high positive linkage disequilibrium. Significant homozygote deficiency (heterozygosity excess) was detected both at HLA-A and at HLA-B. This deviation from Hardy-Weinberg proportions was not attributable to nonselective causes such as different allele frequencies in males and females or avoidance of consanguineous matings. In addition, the distribution of alleles at both HLA-A and HLA-B was more even than expected from neutrality theory; that is, the observed Hardy-Weinberg homozygosity was only 62.4% of that expected under neutrality. These observations suggest that balancing selection is of major importance in maintaining genetic variation at HLA-A and HLA-B.	ARIZONA STATE UNIV, DEPT ANTHROPOL, TEMPE, AZ 85287 USA; MARICOPA CTY GEN HOSP, PHOENIX, AZ USA; GENETRIX, SCOTTSDALE, AZ USA	Arizona State University; Arizona State University-Tempe; Maricopa County General Hospital	MARKOW, T (corresponding author), ARIZONA STATE UNIV, DEPT ZOOL, TEMPE, AZ 85287 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH048999] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM35326] Funding Source: Medline; NIMH NIH HHS [NIMH MH48999] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Baur M.P., 1980, HISTOCOMPATIBILITY T, P955; BAUR MP, 1984, HISTOCOMPATIBILITY T, P333; BELICH MP, 1992, NATURE, V357, P326, DOI 10.1038/357326a0; BLACK FL, 1981, AM J HUM GENET, V33, P894; BLACK FL, 1992, SCIENCE, V258, P1739, DOI 10.1126/science.1465610; Coues Elliott, 1900, TRAIL SPANISH PIONEE; DEGOS L, 1974, NATURE, V249, P62, DOI 10.1038/249062a0; EGID K, 1989, ANIM BEHAV, V38, P548, DOI 10.1016/S0003-3472(89)80051-X; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; HEDRICK PW, 1991, P NATL ACAD SCI USA, V88, P5897, DOI 10.1073/pnas.88.13.5897; HEDRICK PW, 1990, HUM HERED, V40, P213, DOI 10.1159/000153933; HEDRICK PW, 1992, GENETICS, V132, P575; HEDRICK PW, 1987, GENETICS, V117, P331; HEDRICK PW, 1983, GENETICS, V104, P449; HEDRICK PW, 1983, AM J HUM GENET, V35, P1055; HEDRICK PW, 1986, GENETICS, V112, P135; HEDRICK PW, 1991, EVOLUTION AT THE MOLECULAR LEVEL, P248; Hedrick PW, 1985, GENETICS POPULATIONS; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Jacquard A., 1974, GENETIC STRUCTURE PO; KLITZ W, 1986, AM J HUM GENET, V39, P340; KLITZ W, 1987, GENETICS, V116, P633; KOSTYU DD, 1989, AM J HUM GENET, V45, P261; KUHNER MK, 1991, TISSUE ANTIGENS, V38, P152, DOI 10.1111/j.1399-0039.1991.tb01889.x; LEWONTIN RC, 1964, GENETICS, V49, P49; MARKOW TA, 1993, ANN HUM BIOL, V20, P389, DOI 10.1080/03014469300002792; MARTIN JF, 1986, PLATEAU, V56, P1; MATTIUZ PL, 1970, HISTOCOMPATIBILITY T, P193; MORGAN K, 1980, AM J HUM GENET, V32, P246; MORGAN K, 1986, AM J HUM GENET, V38, P971; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1989, HUM HERED, V39, P276, DOI 10.1159/000153872; NEI M, 1991, EVOLUTION AT THE MOLECULAR LEVEL, P222; Nei M., 1987, MOL EVOLUTIONARY GEN; OBER C, 1992, AM J HUM GENET, V50, P6; POTTS WK, 1991, NATURE, V352, P619, DOI 10.1038/352619a0; PURSER AF, 1966, HEREDITY, V21, P322, DOI 10.1038/hdy.1966.28; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; ROBERTSON A, 1965, ANIM PROD, V7, P319, DOI 10.1017/S0003356100025770; STEWART FM, 1977, GENETICS, V86, P482; TERASAKI PI, 1978, AM J CLIN PATHOL, V69, P103; THOMPSON EA, 1980, AM J HUM GENET, V32, P445; THOMSON G, 1988, ANNU REV GENET, V22, P31; TIEARI JL, 1985, HLA DISEASE ASS; TROUP GM, 1982, TISSUE ANTIGENS, V20, P339; VRIES RRPD, 1979, J IMMUNOGENET, V6, P271; WATKINS DI, 1992, NATURE, V357, P329, DOI 10.1038/357329a0; WATTERSON GA, 1978, GENETICS, V88, P405; Weir BS, 1990, GENETIC DATA ANAL; WHEELER CJ, 1990, NATURE, V347, P192, DOI 10.1038/347192a0; WILLIAMS RC, 1992, HUM IMMUNOL, V33, P39, DOI 10.1016/0198-8859(92)90050-W; WILLIAMS RC, 1981, AM J PHYS ANTHROPOL, V56, P291, DOI 10.1002/ajpa.1330560309	52	57	57	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1993	53	4					943	952						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LY627	8213824				2022-12-18	WOS:A1993LY62700020
J	CITRON, BA; KAUFMAN, S; MILSTIEN, S; NAYLOR, EW; GREENE, CL; DAVIS, MD				CITRON, BA; KAUFMAN, S; MILSTIEN, S; NAYLOR, EW; GREENE, CL; DAVIS, MD			MUTATION IN THE 4A-CARBINOLAMINE DEHYDRATASE GENE LEADS TO MILD HYPERPHENYLALANINEMIA WITH DEFECTIVE COFACTOR METABOLISM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AMINO-ACID HYDROXYLASES; PHENYLALANINE-HYDROXYLASE; 7-SUBSTITUTED PTERINS; RAT-LIVER; PROTEIN; 7-TETRAHYDROBIOPTERIN; TETRAHYDROBIOPTERIN; PHENYLKETONURIA; DEFICIENCY; STIMULATOR	Hyperphenylalaninemias represent a major class of inherited metabolic disorders. They are most often cause by mutations in the phenylalanine hydroxylase gene and, less frequently but with usually more serious consequences, in genes necessary for the synthesis and regeneration of the cofactor, tetrahydrobiopterin. This cofactor is absolutely required for all aromatic amino acid hydroxylations, and, recently, nitric oxide production from L-arginine has also been found to be dependent on tetrahydrobiopterin. Phenylalanine hydroxylase catalyzes a coupled reaction in which phenylalanine is converted to tyrosine and in which tetrahydrobiopterin is converted to the unstable carbinolamine, 4a-hydroxytetrahydrobiopterin. The enzyme, carbinolamine dehydratase, catalyzes the dehydration of the carbinolamine to quinonoid dihydropterin. A decreased rate of dehydration of this compound has been hypothesized to be responsible for the production of 7-biopterin found in certain mildly hyperphenylalaninemic individuals. We have now identified nonsense and missense mutations in the 4a-carbinolamine dehydratase gene in a hyperphenylalaninemic child who excretes large amounts of 7-biopterin. This finding is consistent with the role of the carbinolamine dehydratase in the phenylalanine hydroxylation reaction. Together with previously identified inherited disorders in phenylalanine hydroxylase and dihydropteridine reductase, there are now identified mutations in the three enzymes involved in the phenylalanine hydroxylation system. In addition, the genetics of this system may have broader implications, since the product of the dehydratase gene has previously been shown to play an additional role (as dimerization cofactor for hepatocyte nuclear factor-1alpha) in the regulation of transcription, through interaction with hepatocyte nuclear factor-1alpha.	UNIV PITTSBURGH,DEPT HUMAN GENET,PITTSBURGH,PA 15260; UNIV COLORADO,CHILDRENS HOSP,DEPT PEDIAT,DENVER,CO 80202	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Children's Hospital Colorado; University of Colorado System; University of Colorado Denver	CITRON, BA (corresponding author), NIMH,NEUROCHEM LAB,BLDG 36,ROOM 3D30,BETHESDA,MD 20892, USA.							ADLER C, 1992, J INHERIT METAB DIS, V15, P405, DOI 10.1007/BF02435989; Ausubel F., 1992, MOL REPROD DEV, DOI DOI 10.1002/MRD.1080010210; AVIGAD S, 1987, American Journal of Human Genetics, V41, pA205; CITRON BA, 1992, P NATL ACAD SCI USA, V89, P11891, DOI 10.1073/pnas.89.24.11891; CLAU N, 1992, J INHERIT METAB DIS, V15, P409; CURTIUS HC, 1988, BIOCHEM BIOPH RES CO, V153, P715, DOI 10.1016/S0006-291X(88)81153-7; CURTIUS HC, 1990, BIOCHEM BIOPH RES CO, V172, P1060, DOI 10.1016/0006-291X(90)91554-6; DAVIS MD, 1992, P NATL ACAD SCI USA, V89, P10109, DOI 10.1073/pnas.89.21.10109; DAVIS MD, 1991, FEBS LETT, V285, P17, DOI 10.1016/0014-5793(91)80714-E; DAVIS MD, 1991, P NATL ACAD SCI USA, V88, P385, DOI 10.1073/pnas.88.2.385; DAVIS MD, 1992, FEBS LETT, V302, P73, DOI 10.1016/0014-5793(92)80288-R; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DILELLA AG, 1987, NATURE, V327, P333, DOI 10.1038/327333a0; DILELLA AG, 1986, NATURE, V322, P799, DOI 10.1038/322799a0; HANSEN LP, IN PRESS CURR OPIN G; HOWELLS DW, 1990, AM J HUM GENET, V47, P279; HUANG CY, 1973, J BIOL CHEM, V248, P4242; HUANG CY, 1973, J BIOL CHEM, V248, P4235; JERVIS GA, 1947, J BIOL CHEM, V169, P651; KAUFMAN S, 1963, P NATL ACAD SCI USA, V50, P1085, DOI 10.1073/pnas.50.6.1085; KAUFMAN S, 1958, SCIENCE, V128, P1506, DOI 10.1126/science.128.3337.1506; KAUFMAN S, 1970, J BIOL CHEM, V245, P4751; KAUFMAN S, 1964, J BIOL CHEM, V239, P332; Kaufman S., 1976, ADV NEUROCHEM, P1; KAUFMAN S, 1976, IRON COPPER PROTEINS, P91; KAUFMAN S, 1985, J BIOL CHEM, V230, P931; Kaufman S., 1974, MOL MECH OXYGEN ACTI, P285; Kawasaki E.S., 1990, PCR PROTOCOLS GUIDE, P146; LAZARUS RA, 1983, J BIOL CHEM, V258, P960; MENDEL DB, 1991, SCIENCE, V254, P1762, DOI 10.1126/science.1763325; Miller J.H., 1972, EXPT MOL GENETICS; MILSTIEN S, 1972, J BIOL CHEM, V250, P4782; Sambrook J., 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCRIVER CR, 1988, ANNU REV GENET, V22, P301; TANAKA K, 1989, P NATL ACAD SCI USA, V86, P5864, DOI 10.1073/pnas.86.15.5864	36	57	58	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1993	53	3					768	774						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LU559	8352282				2022-12-18	WOS:A1993LU55900021
J	NISHIMOTO, J; NANBA, E; INUI, K; OKADA, S; SUZUKI, K				NISHIMOTO, J; NANBA, E; INUI, K; OKADA, S; SUZUKI, K			GMI-GANGLIOSIDOSIS (GENETIC BETA-GALACTOSIDASE DEFICIENCY) - IDENTIFICATION OF 4 MUTATIONS IN DIFFERENT CLINICAL PHENOTYPES AMONG JAPANESE PATIENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EXPRESSION; CLONING; ENZYME; CDNA	GM1-gangliosidosis is a genetic neurological disorder caused by mutations in the lysosomal acid beta-galactosidase gene. While its phenotypic expression is complex, it is usually classified as being of infantile, juvenile, or adult form, on the basis of age at onset, the rate of symptomatic progression, and severity of central nervous system involvement. We have analyzed the acid beta-galactosidase gene in 12 Japanese patients from nine families. The aim was to identify mutations in individual patients and then to examine possible correlation between the mutations and the clinical phenotypes. Northern blotting studies with a full-length human beta-galactosidase cDNA showed that the mRNA ranged from undetectable to substantially decreased in the infantile patients but was normal in quantity and size in all juvenile and adult patients. Four distinct missense mutations have been identified, each limited to the respective clinical forms within our small-size samples. In the infantile patient with decreased but detectable mRNA, a point mutation was found resulting in Arg49 --> Cys. In the infantile patient with nearly undetectable mRNA, mutation Arg457 --> Ter was identified. The mutation Arg201 --> Cys was found in all four of the juvenile patients, while all six adult patients were homozygous for the point mutation Ile51 --> Thr. The mutations found in the juvenile and adult patients alter restriction sites in the normal gene and thus are amenable to quick screening. The prediction that these mutations are responsible for the clinical disease was confirmed by no expression of the catalytic activity of the mutant proteins in the COS-I cell expression system. Whether these mutations are characteristic of the respective clinical phenotypes must be answered with a larger sample size and by characterization of the other alleles in compound heterozygous conditions.	UNIV N CAROLINA,BRAIN & DEV RES CTR,SCH MED,DEPT NEUROL,CB 7250,CHAPEL HILL,NC 27599; UNIV N CAROLINA,BRAIN & DEV RES CTR,SCH MED,DEPT PSYCHIAT,CHAPEL HILL,NC 27599; OSAKA UNIV,SCH MED,DEPT PEDIAT,OSAKA,JAPAN	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Osaka University					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024289] Funding Source: NIH RePORTER; NICHD NIH HHS [P30 HD-03110] Funding Source: Medline; NINDS NIH HHS [R01 NS-24289] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARBISSER AI, 1977, AM J MED GENET, V1, P195, DOI 10.1002/ajmg.1320010205; MORREAU H, 1989, J BIOL CHEM, V264, P20655; NANBA E, 1990, BIOCHEM BIOPH RES CO, V173, P141, DOI 10.1016/S0006-291X(05)81033-2; NANBA E, IN PRESS BIOCH BIOPH; NISHIMOTO J, 1991, 22ND ANN M AM SOC NE; O'Brien JS, 1989, METABOLIC BASIS INHE, P1797; OBRIEN JS, 1976, CLIN GENET, V9, P495; OKADA S, 1968, SCIENCE, V160, P1002, DOI 10.1126/science.160.3831.1002; OSHIMA A, 1988, BIOCHEM BIOPH RES CO, V157, P238, DOI 10.1016/S0006-291X(88)80038-X; Sacrez R, 1967, Pediatrie, V22, P143; Sambrook J., 1989, MOL CLONING LAB MANU; Seringe P, 1968, Ann Pediatr (Paris), V15, P165; SUZUKI K, 1987, METHOD ENZYMOL, V138, P727; SUZUKI K, IN PRESS MOL GENETIC; TANAKA A, 1990, AM J HUM GENET, V46, P329; YOSHIDA K, 1991, AM J HUM GENET, V49, P435; YOSHIDA K, 1990, NOV INT S GEN INT DI	17	57	58	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1991	49	3					566	574						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GE367	1909089				2022-12-18	WOS:A1991GE36700009
J	ANTONARAKIS, SE; ADELSBERGER, PA; PETERSEN, MB; BINKERT, F; SCHINZEL, AA				ANTONARAKIS, SE; ADELSBERGER, PA; PETERSEN, MB; BINKERT, F; SCHINZEL, AA			ANALYSIS OF DNA POLYMORPHISMS SUGGESTS THAT MOST DENOVO DUP(21Q) CHROMOSOMES IN PATIENTS WITH DOWN-SYNDROME ARE ISOCHROMOSOMES AND NOT TRANSLOCATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,DEPT PEDIAT,BALTIMORE,MD 21205; UNIV ZURICH,INST MED GENET,CH-8006 ZURICH,SWITZERLAND	Johns Hopkins University; University of Zurich			Petersen, Michael Bjørn B/D-1483-2017; Antonarakis, Stylianos/N-8866-2014	Petersen, Michael Bjørn B/0000-0003-0316-8207; Antonarakis, Stylianos/0000-0001-8907-5823				BURMEISTER M, IN PRESS NUCLEIC ACI; ECONOMOU EP, 1990, P NATL ACAD SCI USA, V87, P2951, DOI 10.1073/pnas.87.8.2951; GARDINER K, 1990, EMBO J, V9, P25, DOI 10.1002/j.1460-2075.1990.tb08076.x; GIRAUD F, 1975, J GENET HUM, V23, P1; GRASSO M, 1989, HUM GENET, V84, P63, DOI 10.1007/BF00210673; HAMERTON JL, 1981, TRISOMY, V21, P99; HOOK EB, 1981, TRISOMY, V21, P3; KIDD KK, 1989, CYTOGENET CELL GENET, V51, P1; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LEWIS JG, IN PRESS GENOMICS; LITT M, 1989, AM J HUM GENET, V44, P397; MCCORMICK MK, 1989, GENOMICS, V5, P325, DOI 10.1016/0888-7543(89)90065-7; PETERSEN MB, 1990, GENOMICS, V7, P136, DOI 10.1016/0888-7543(90)90531-X; PETERSEN MB, 1990, IN PRESS AM J HUM GE; PETERSEN MB, UNPUB GENETIC LINKAG; PRIEST JH, 1988, HUM GENET, V81, P1, DOI 10.1007/BF00283718; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; WARREN AC, 1987, SCIENCE, V237, P652, DOI 10.1126/science.2955519; WARREN AC, 1989, GENOMICS, V4, P579, DOI 10.1016/0888-7543(89)90282-6; WEBER JL, 1989, AM J HUM GENET, V44, P388	21	57	60	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1990	47	6					968	972						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EK400	1978562				2022-12-18	WOS:A1990EK40000013
J	JOHNSON, K; SHELBOURNE, P; DAVIES, J; BUXTON, J; NIMMO, E; SICILIANO, MJ; BACHINSKI, LL; ANVRET, M; HARLEY, H; RUNDLE, S; MIKI, T; BRUNNER, H; WILLIAMSON, R				JOHNSON, K; SHELBOURNE, P; DAVIES, J; BUXTON, J; NIMMO, E; SICILIANO, MJ; BACHINSKI, LL; ANVRET, M; HARLEY, H; RUNDLE, S; MIKI, T; BRUNNER, H; WILLIAMSON, R			A NEW POLYMORPHIC PROBE WHICH DEFINES THE REGION OF CHROMOSOME-19 CONTAINING THE MYOTONIC-DYSTROPHY LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									ST MARYS HOSP,IMPERIAL COLL MED SCH,DEPT BIOCHEM & MOLEC GENET,LONDON,ENGLAND; UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT MOLEC GENET,HOUSTON,TX 77030; KAROLINSKA INST,DEPT CLIN GENET,S-10401 STOCKHOLM 60,SWEDEN; UNIV COLL CARDIFF,HOSP WALES,CARDIFF,WALES; OSAKA UNIV,SCH MED,DEPT GERIATR MED,OSAKA,JAPAN; CATHOLIC UNIV NIJMEGEN,DEPT HUMAN GENET,NIJMEGEN,NETHERLANDS	Imperial College London; University of Texas System; UTMD Anderson Cancer Center; Karolinska Institutet; Cardiff University; Osaka University; Radboud University Nijmegen			Buxton, Jessica L/I-4033-2014; Brunner, Han/C-9928-2013; Buxton, Jessica/L-9849-2019	Buxton, Jessica L/0000-0002-0918-9335; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019999] Funding Source: NIH RePORTER; NINDS NIH HHS [NS19999] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARTLETT RJ, 1987, SCIENCE, V235, P1648, DOI 10.1126/science.3029876; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BROOK JD, 1986, CYTOGENET CELL GENET, V41, P30, DOI 10.1159/000132192; BRUNNER HG, 1989, GENOMICS, V5, P589, DOI 10.1016/0888-7543(89)90027-X; BRUNNER HG, 1989, HUM GENET, V81, P308, DOI 10.1007/BF00283680; COERWINKELDRIESSEN M, 1988, NUCLEIC ACIDS RES, V16, P8743, DOI 10.1093/nar/16.17.8743; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FROSSARD PM, 1987, GENE, V51, P103, DOI 10.1016/0378-1119(87)90480-X; FROSSARD PM, 1986, NUCLEIC ACIDS RES, V14, P5120, DOI 10.1093/nar/14.12.5120; GIBSON TJ, 1987, GENE, V53, P283, DOI 10.1016/0378-1119(87)90017-5; GRIGGS RC, 1989, NEUROLOGY, V39, P420, DOI 10.1212/WNL.39.3.420; HARLEY HG, 1989, CYTOGENET CELL GENET, V51, P1011; Harper P.S., 1989, MYOTONIC DYSTROPHY; HULSEBOS T, 1986, CYTOGENET CELL GENET, V43, P47, DOI 10.1159/000132297; HUMPHRIES S, 1984, MOL BIOL MED, V1, P463; JOHNSON K, 1989, GENOMICS, V5, P746, DOI 10.1016/0888-7543(89)90116-X; JOHNSON KJ, 1988, CYTOGENET CELL GENET, V48, P13, DOI 10.1159/000132577; KORNELUK RG, 1989, GENOMICS, V4, P146, DOI 10.1016/0888-7543(89)90293-0; KORNELUK RG, 1989, GENOMICS, V5, P596, DOI 10.1016/0888-7543(89)90028-1; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEBEAU MM, 1989, CYTOGENET CELL GENET, V51, P338, DOI 10.1159/000132798; LITTLE PFR, 1985, P NATL ACAD SCI USA, V82, P3159, DOI 10.1073/pnas.82.10.3159; Maniatis T., 1982, MOL CLONING; MCKEITHAN TW, 1987, P NATL ACAD SCI USA, V84, P9257, DOI 10.1073/pnas.84.24.9257; MEREDITH AL, 1986, BRIT MED J, V293, P1353, DOI 10.1136/bmj.293.6558.1353; Mohr J, 1954, STUDY LINKAGE MAN; NAKAMURA Y, 1988, Genomics, V3, P67, DOI 10.1016/0888-7543(88)90161-9; PERICAKVANCE MA, 1986, NEUROLOGY, V36, P1418, DOI 10.1212/WNL.36.11.1418; PERRYMAN MB, 1988, NUCLEIC ACIDS RES, V16, P8744, DOI 10.1093/nar/16.17.8744; RENAUD JF, 1987, BIOCHIMIE, V69, P407, DOI 10.1016/0300-9084(87)90032-0; SCHONK D, 1989, GENOMICS, V4, P384, DOI 10.1016/0888-7543(89)90346-7; SEALEY PG, 1985, NUCLEIC ACIDS RES, V13, P1905, DOI 10.1093/nar/13.6.1905; SHAW DJ, 1989, HUM GENET, V83, P71, DOI 10.1007/BF00274152; SHAW DJ, 1985, HUM GENET, V70, P271; SMEETS H, 1989, CYTOGENET CELL GENET, V51, P1081; SMEETS H, 1990, AM J HUM GENET, V46, P492; STALLINGS RL, 1988, AM J HUM GENET, V43, P144; TAKEMOTO Y, 1990, GENOMICS, V6, P195; THOMPSON LH, 1989, GENOMICS, V5, P670, DOI 10.1016/0888-7543(89)90107-9; TODOROV A, 1970, J GENET HUM, V18, P387; WALLIS SC, 1984, HUM GENET, V68, P286, DOI 10.1007/BF00292585; WHITEHEAD AS, 1982, P NATL ACAD SCI-BIOL, V79, P5021, DOI 10.1073/pnas.79.16.5021	42	57	58	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1990	46	6					1073	1081						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DF202	1971149				2022-12-18	WOS:A1990DF20200007
J	JOHN, SWM; ROZEN, R; SCRIVER, CR; LAFRAMBOISE, R; LABERGE, C				JOHN, SWM; ROZEN, R; SCRIVER, CR; LAFRAMBOISE, R; LABERGE, C			RECURRENT MUTATION, GENE CONVERSION, OR RECOMBINATION AT THE HUMAN PHENYLALANINE-HYDROXYLASE LOCUS - EVIDENCE IN FRENCH-CANADIANS AND A CATALOG OF MUTATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MCGILL UNIV,MONTREAL CHILDRENS HOSP,RES INST,DEPT BIOL,DEBELLE LAB BIOCHEM GENET,2300 TUPPER ST,MONTREAL H3H 1P3,QUEBEC,CANADA; MCGILL UNIV,MONTREAL CHILDRENS HOSP,RES INST,DEPT PEDIAT,MONTREAL H3H 1P3,QUEBEC,CANADA; MCGILL UNIV,CTR HUMAN GENET,MONTREAL H3A 2T5,QUEBEC,CANADA; CHU LAVAL,LE CTR GENET HUMAINE,ST FOY,QUEBEC,CANADA	McGill University; McGill University; McGill University; Laval University			Rozen, Rima/AAE-9294-2020					ABADIE V, 1989, GENOMICS, V5, P936, DOI 10.1016/0888-7543(89)90137-7; AULEHLASCHOLZ C, 1988, HUM GENET, V78, P353, DOI 10.1007/BF00291734; AVIGAD S, 1987, American Journal of Human Genetics, V41, pA205; CHAKRABORTY R, 1987, HUM GENET, V76, P40; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; DEVOTO M, 1989, American Journal of Human Genetics, V45, pA183; DILELLA AG, 1988, LANCET, V1, P497; DILELLA AG, 1987, NATURE, V327, P333, DOI 10.1038/327333a0; DILELLA AG, 1986, NATURE, V322, P799, DOI 10.1038/322799a0; DWORNICZAK B, 1989, HUM GENET, V84, P95, DOI 10.1007/BF00210683; FORREST S M, 1989, American Journal of Human Genetics, V45, pA186; HOFMAN K, 1987, American Journal of Human Genetics, V41, pA256; HOFMAN KJ, 1989, MOL BIOL MED, V6, P245; JOHN SWM, 1989, AM J HUM GENET, V45, P905; KAPLAN F, 1990, AM J HUM GENET, V46, P126; KOEBERL DD, 1989, AM J HUM GENET, V45, P448; LICHTERKONECKI U, 1988, HUM GENET, V78, P347, DOI 10.1007/BF00291733; LICHTERKONECKI U, 1988, BIOCHEMISTRY-US, V27, P2881, DOI 10.1021/bi00408a032; LYONNET S, 1988, M S-MED SCI, V4, P544, DOI 10.4267/10608/3878; LYONNET S, 1989, AM J HUM GENET, V44, P511; MARVIT J, 1987, NUCLEIC ACIDS RES, V15, P5613, DOI 10.1093/nar/15.14.5613; MITCHELL GA, 1989, P NATL ACAD SCI USA, V86, P197, DOI 10.1073/pnas.86.1.197; MYEROWITZ R, 1988, P NATL ACAD SCI USA, V85, P3955, DOI 10.1073/pnas.85.11.3955; OKANO Y, 1990, AM J HUM GENET, V46, P18; OKANO Y, 1989, American Journal of Human Genetics, V45, pA211; REY F, 1988, AM J HUM GENET, V43, P914; RIESS O, 1988, HUM GENET, V78, P343, DOI 10.1007/BF00291732; SCRIVER CR, 1988, ANNU REV GENET, V22, P301; SULLIVAN S E, 1985, American Journal of Human Genetics, V37, pA177; SULLIVAN SE, 1989, AM J HUM GENET, V44, P652; VULLIAMY TJ, 1988, P NATL ACAD SCI USA, V85, P5171, DOI 10.1073/pnas.85.14.5171; WANG T, 1989, American Journal of Human Genetics, V45, pA228; WANG T, 1989, AM J HUM GENET, V45, P675; WOO SLC, 1988, AM J HUM GENET, V43, P781; YOUSSOUFIAN H, 1988, AM J HUM GENET, V42, P718	35	57	57	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1990	46	5					970	974						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DD896	1971147				2022-12-18	WOS:A1990DD89600016
J	SEPEHRNIA, B; KAMBOH, MI; ADAMSCAMPBELL, LL; BUNKER, CH; NWANKWO, M; MAJUMDER, PP; FERRELL, RE				SEPEHRNIA, B; KAMBOH, MI; ADAMSCAMPBELL, LL; BUNKER, CH; NWANKWO, M; MAJUMDER, PP; FERRELL, RE			GENETIC-STUDIES OF HUMAN APOLIPOPROTEINS .10. THE EFFECT OF THE APOLIPOPROTEIN-E POLYMORPHISM ON QUANTITATIVE LEVELS OF LIPOPROTEINS IN NIGERIAN BLACKS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV PITTSBURGH, GRAD SCH PUBL HLTH, DEPT BIOSTAT, DIV HUMAN GENET, PITTSBURGH, PA 15260 USA; UNIV BENIN, TEACHING HOSP, DEPT CHILD HLTH, Benin, NIGERIA	University of Benin				Kamboh, M. Ilyas/0000-0002-3453-1438	NHLBI NIH HHS [HL 39107, HL 24489] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL024489, R01HL039107] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADAMSCAMPBELL LL, 1988, ARTERIOSCLEROSIS, V8, P793, DOI 10.1161/01.ATV.8.6.793; ALLAIN CC, 1974, CLIN CHEM, V20, P470; ASAKAWA J, 1985, HUM GENET, V70, P222; ASSMANN G, 1984, CLIN CHEM, V30, P641; BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x; BOERWINKLE E, 1988, AM J HUM GENET, V42, P104; BUCOLO G, 1973, CLIN CHEM, V19, P476; BUNKER CH, UNPUB HYPERTENSION C; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; EHNHOLM C, 1986, J LIPID RES, V27, P227; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GIDEZ LI, 1977, NIS NIH791661 PUBL, P328; GREGG RE, 1986, J CLIN INVEST, V78, P815, DOI 10.1172/JCI112645; HAVEKES LM, 1987, J LIPID RES, V28, P455; HUI DY, 1984, J BIOL CHEM, V259, P860; INNERARITY TL, 1980, BIOCHEMISTRY-US, V19, P4359, DOI 10.1021/bi00559a032; INNERARITY TL, 1978, BIOCHEMISTRY-US, V17, P1440, DOI 10.1021/bi00601a013; INNERARITY TL, 1981, P NATL ACAD SCI-BIOL, V78, P4378, DOI 10.1073/pnas.78.7.4378; KAMBOH MI, 1988, J LIPID RES, V29, P1535; LEREN TP, 1985, CLIN GENET, V27, P458; MAHLEY RW, 1983, BIOCHIM BIOPHYS ACTA, V737, P197, DOI 10.1016/0304-4157(83)90001-1; PITAS E, 1981, P NATL ACAD SCI USA, V76, P2311; RALL SC, 1982, P NATL ACAD SCI-BIOL, V79, P4696, DOI 10.1073/pnas.79.15.4696; RALL SC, 1982, J BIOL CHEM, V257, P4171; SING CF, 1985, AM J HUM GENET, V37, P268; Sokal R.R., 1981, BIOMETRY, V2nd ed.; TEMPLETON AR, 1987, GENET RES, V49, P69, DOI 10.1017/S0016672300026756; UTERMANN G, 1978, CLIN GENET, V14, P351; UTERMANN G, 1987, AM HEART J, V113, P433, DOI 10.1016/0002-8703(87)90610-7; UTERMANN G, 1977, NATURE, V269, P604, DOI 10.1038/269604a0; WANG K, 1986, ACTA ACAD MED SINICA, V8, P192; WARWICK GR, 1978, J LIPID RES, V19, P65	32	57	58	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1989	45	4					586	591						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AW395	2491016				2022-12-18	WOS:A1989AW39500012
J	ZOGHBI, HY; SANDKUYL, LA; OTT, J; DAIGER, SP; POLLACK, M; OBRIEN, WE; BEAUDET, AL				ZOGHBI, HY; SANDKUYL, LA; OTT, J; DAIGER, SP; POLLACK, M; OBRIEN, WE; BEAUDET, AL			ASSIGNMENT OF AUTOSOMAL DOMINANT SPINOCEREBELLAR ATAXIA (SCAI) CENTROMERIC TO THE HLA REGION ON THE SHORT ARM OF CHROMOSOME-6, USING MULTILOCUS LINKAGE ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									BAYLOR COLL MED,HOWARD HUGHES MED INST,INST MOLEC GENET,HOUSTON,TX 77030; BAYLOR COLL MED,HOWARD HUGHES MED INST,DEPT MICROBIOL & IMMUNOL,HOUSTON,TX 77030; UNIV TEXAS,HLTH SCI CTR,GRAD SCH BIOMED SCI,HOUSTON,TX 77225; COLUMBIA UNIV,DEPT GENET,NEW YORK,NY 10027; COLUMBIA UNIV,DEPT PSYCHIAT,NEW YORK,NY 10027	Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Howard Hughes Medical Institute; University of Texas System; University of Texas Health Science Center Houston; Columbia University; Columbia University	ZOGHBI, HY (corresponding author), BAYLOR COLL MED,HOWARD HUGHES MED INST,DEPT PEDIAT,HOUSTON,TX 77030, USA.			Zoghbi, Huda/0000-0002-0700-3349	NIAID NIH HHS [AI 21289] Funding Source: Medline; NICHD NIH HHS [K11 HD00684] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K11HD000684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI021289] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAUR MP, 1980, HISTOCOMPATIBILITY T, P994; BERCIANO J, 1982, J NEUROL SCI, V53, P253, DOI 10.1016/0022-510X(82)90011-9; BOARD PG, 1988, AM J HUM GENET, V42, P712; BRAVERMAN MS, 1985, COMPUT BIOMED RES, V18, P24, DOI 10.1016/0010-4809(85)90004-7; CURRIER RD, 1972, NEUROLOGY, V22, P1040, DOI 10.1212/WNL.22.9.1040; CURRIER RD, 1984, OLIVOPONTOCEREBELLAR, P1; FUSCOE JC, 1983, MOL CELL BIOL, V3, P1086, DOI 10.1128/MCB.3.6.1086; HAINES JL, 1984, NEUROLOGY, V34, P1542, DOI 10.1212/WNL.34.12.1542; HAINES JL, 1986, GENET EPIDEMIOL, V3, P399, DOI 10.1002/gepi.1370030604; HYLDIGNIELSEN JJ, 1987, P NATL ACAD SCI USA, V84, P1644, DOI 10.1073/pnas.84.6.1644; JACKSON JF, 1977, NEW ENGL J MED, V296, P1138, DOI 10.1056/NEJM197705192962003; KOEPPEN AH, 1984, OLIVOPONTOCEREBELLAR, P13; LAMM LU, 1985, CYTOGENET CELL GENET, V40, P128, DOI 10.1159/000132172; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEACH R, 1986, P NATL ACAD SCI USA, V83, P3909, DOI 10.1073/pnas.83.11.3909; NINO HE, 1980, NEUROLOGY, V30, P12, DOI 10.1212/WNL.30.1.12; NUSSBAUM RL, 1983, HUM GENET, V64, P148, DOI 10.1007/BF00327113; OTT J, 1978, ANN HUM GENET, V42, P255, DOI 10.1111/j.1469-1809.1978.tb00657.x; PEDERSEN L, 1980, HUM GENET, V54, P371, DOI 10.1007/BF00291585; RICH SS, 1987, AM J HUM GENET, V41, P524; SCHUT JW, 1950, ARCH NEURO PSYCHIATR, V63, P535, DOI 10.1001/archneurpsyc.1950.02310220002001; YAKURA H, 1974, NEW ENGL J MED, V291, P154; ZOGHBI HY, 1988, AM J HUM GENET, V42, P877; ZOGHBI HY, 1988, ANN NEUROL, V23, P580, DOI 10.1002/ana.410230609	24	57	58	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1989	44	2					255	263						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	R9705	2563195				2022-12-18	WOS:A1989R970500011
J	WASMUTH, JJ; CARLOCK, LR; SMITH, B; IMMKEN, LL				WASMUTH, JJ; CARLOCK, LR; SMITH, B; IMMKEN, LL			A CELL HYBRID AND RECOMBINANT-DNA LIBRARY THAT FACILITATE IDENTIFICATION OF POLYMORPHIC LOCI IN THE VICINITY OF THE HUNTINGTON DISEASE GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note									UNIV TEXAS,SCH MED,DEPT PEDIAT,HOUSTON,TX 77025	University of Texas System	WASMUTH, JJ (corresponding author), UNIV CALIF IRVINE,CALIF COLL MED,DEPT BIOL CHEM,IRVINE,CA 92717, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025339] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-25339] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CARLOCK L, 1986, SOMAT CELL MOLEC GEN, V11, P163; CARLOCK LR, 1985, AM J HUM GENET, V37, P839; CARLOCK LR, 1985, SOMAT CELL MOLEC GEN, V11, P267, DOI 10.1007/BF01534683; DANA S, 1982, SOMAT CELL GENET, V8, P245, DOI 10.1007/BF01538680; DANA S, 1982, MOL CELL BIOL, V2, P1220, DOI 10.1128/MCB.2.10.1220; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRISCHAUF AM, 1983, J MOL BIOL, V170, P827, DOI 10.1016/S0022-2836(83)80190-9; GUSELLA J, 1985, American Journal of Human Genetics, V37, pA155; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; GUSELLA JF, 1984, SCIENCE, V225, P1320, DOI 10.1126/science.6089346; GUSELLA JF, 1985, NATURE, V318, P75, DOI 10.1038/318075a0; Hohn B, 1979, Methods Enzymol, V68, P299; SEALEY PG, 1985, NUCLEIC ACIDS RES, V13, P1905, DOI 10.1093/nar/13.6.1905; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; WASMUTH J, 1985, American Journal of Human Genetics, V37, pA181; WYMAN AR, 1985, P NATL ACAD SCI USA, V82, P2880, DOI 10.1073/pnas.82.9.2880	16	57	57	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1986	39	3					397	403						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	E3644	2945430				2022-12-18	WOS:A1986E364400012
J	TORFS, CP; KING, MC; HUEY, B; MALMGREN, J; GRUMET, FC				TORFS, CP; KING, MC; HUEY, B; MALMGREN, J; GRUMET, FC			GENETIC INTERRELATIONSHIP BETWEEN INSULIN-DEPENDENT DIABETES-MELLITUS, THE AUTOIMMUNE THYROID-DISEASES, AND RHEUMATOID-ARTHRITIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WASHINGTON, SCH PUBL HLTH & COMMUNITY MED, DEPT EPIDEMIOL, SEATTLE, WA 98195 USA; STANFORD UNIV, MED CTR, DEPT PATHOL, STANFORD, CA 94305 USA	University of Washington; University of Washington Seattle; Stanford University	TORFS, CP (corresponding author), UNIV CALIF BERKELEY, SCH PUBL HLTH, EPIDEMIOL PROGRAM, 140 WARREN HALL, BERKELEY, CA 94720 USA.			King, Mary-Claire/0000-0001-9426-1743	NATIONAL CANCER INSTITUTE [R01CA027632] Funding Source: NIH RePORTER; NCI NIH HHS [CA-27632] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALPER CA, 1972, J EXP MED, V135, P68, DOI 10.1084/jem.135.1.68; AMINO N, 1978, CLIN EXP IMMUNOL, V31, P30; ANDERSON CE, 1983, METABOLISM, V32, P471, DOI 10.1016/0026-0495(83)90009-4; BARBOSA J, 1980, J CLIN INVEST, V65, P592, DOI 10.1172/JCI109704; BARBOSA J, 1977, J CLIN INVEST, V60, P989, DOI 10.1172/JCI108879; BELL GI, 1983, BANBURY REPORT, V14; BENGSCH N, 1978, DIABETOLOGIA, V15, P447, DOI 10.1007/BF02342868; BERTRAMS J, 1984, HISTOCOMPATIBILITY T; BODE HH, 1973, J CLIN ENDOCR METAB, V37, P692, DOI 10.1210/jcem-37-5-692; BOTTAZZO GF, 1978, BRIT MED J, V2, P165, DOI 10.1136/bmj.2.6131.165; CHRISTIANSEN FT, 1984, HISTOCOMPATIBILITY T; CLERGETDARPOUX F, 1980, ANN HUM GENET, V44, P195, DOI 10.1111/j.1469-1809.1980.tb00958.x; CUDWORTH AG, 1978, BRIT MED BULL, V34, P285, DOI 10.1093/oxfordjournals.bmb.a071513; CUDWORTH AG, 1975, BRIT MED J, V3, P133, DOI 10.1136/bmj.3.5976.133; DEJONGH BM, 1984, TISSUE ANTIGENS, V23, P87; DELJUNCO DJ, 1984, AM J EPIDEMIOL, V119, P813; DESCHAMPS I, 1980, DIABETOLOGIA, V19, P189, DOI 10.1007/BF00275267; Dingle P R, 1966, Clin Exp Immunol, V1, P277; EISENBARTH G, 1978, NEW ENGL J MED, V298, P92, DOI 10.1056/NEJM197801122980209; EISENBARTH GS, 1981, HLA ENDOCRINE METABO, P235; EVANS AWH, 1967, LANCET, V1, P636; EWENS WJ, 1984, AM J HUM GENET, V36, P858; FARID NR, 1979, J CLIN INVEST, V63, P108, DOI 10.1172/JCI109263; FARID NR, 1980, TISSUE ANTIGENS, V16, P23; FARID NR, 1980, TISSUE ANTIGENS, V15, P492; GEHAN EA, 1969, J CHRON DIS, V21, P629, DOI 10.1016/0021-9681(69)90035-6; GOLDSTEIN DE, 1970, J PEDIATR-US, V77, P304, DOI 10.1016/S0022-3476(70)80342-0; GORDIN A, 1979, CLIN ENDOCRINOL, V11, P425, DOI 10.1111/j.1365-2265.1979.tb03094.x; GORDIN A, 1981, CLIN ENDOCRINOL, V15, P537, DOI 10.1111/j.1365-2265.1981.tb00699.x; GORSUCH AN, 1980, BRIT MED J, V280, P145, DOI 10.1136/bmj.280.6208.145; GRENNAN DM, 1983, J RHEUMATOL, V10, P584; KHAN MA, 1983, TISSUE ANTIGENS, V22, P182; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES PR, P106; KOMPF J, 1975, HUMANGENETIK, V27, P141; LAWRENCE JS, 1970, ANN RHEUM DIS, V29, P357, DOI 10.1136/ard.29.4.357; LINOS A, 1980, AM J EPIDEMIOL, V111, P87, DOI 10.1093/oxfordjournals.aje.a112878; LUDWIG H, 1977, DIABETES METAB, V3, P43; McKusick V.A., 1978, MENDELIAN INHERITANC; MICHALSKI JP, 1982, J RHEUMATOL, V9, P451; MOTRO U, 1985, GENETICS, V110, P525; MURPHY CC, 1983, HUM HERED, V33, P344, DOI 10.1159/000153402; NAGAOKA K, 1980, ENDOCRINOL J, V26, P589; PASQUALI JL, 1980, J CLIN INVEST, V66, P863, DOI 10.1172/JCI109927; RAFFOUX C, 1979, TISSUE ANTIGENS, V14, P274; ROSSEN RD, 1982, HUM IMMUNOL, V4, P183, DOI 10.1016/0198-8859(82)90034-9; ROTTER JI, 1981, AM J HUM GENET, V33, P835; RUBINSTEIN P, 1981, AM J HUM GENET, V33, P865; RYDER LP, 1981, ANNU REV GENET, V15, P169, DOI 10.1146/annurev.ge.15.120181.001125; RYDER PL, 1978, ADV EXPT MED BIOL, V119, P41; SHANAHAN F, 1982, Q J MED, V51, P329; SPIELMAN RS, 1980, ANN HUM GENET, V44, P135, DOI 10.1111/j.1469-1809.1980.tb00954.x; STASTNY P, 1980, HISTOCOMPATIBILITY T; STROM H, 1981, TISSUE ANTIGENS, V18, P92, DOI 10.1111/j.1399-0039.1981.tb01370.x; SUAREZ BK, 1978, TISSUE ANTIGENS, V12, P87, DOI 10.1111/j.1399-0039.1978.tb01303.x; SUCIUFOCA N, 1979, TRANSPLANT P, V11, P1309; THOMSON G, 1983, TISSUE ANTIGENS, V21, P81; THOMSON G, 1980, ANN HUM GENET, V43, P383, DOI 10.1111/j.1469-1809.1980.tb01572.x; THOMSON G, 1977, MEASURING SELECTION, P545; TUNBRIDGE WMG, 1979, CLIN ENDOCRINOL META, V8, P21, DOI 10.1016/S0300-595X(79)80006-7; TUNBRIDGE WMG, 1977, CLIN ENDOCRINOL, V7, P481, DOI 10.1111/j.1365-2265.1977.tb01340.x; UNO H, 1981, NATURE, V292, P768, DOI 10.1038/292768a0; WALKER A, 1980, DIABETES, V29, P1036, DOI 10.2337/diabetes.29.12.1036; WILLIAMS ED, 1962, J PATHOL BACTERIOL, V83, P255, DOI 10.1002/path.1700830127; WINEARLS BC, 1984, TISSUE ANTIGENS, V24, P234, DOI 10.1111/j.1399-0039.1984.tb02132.x; ZILKO PJ, 1982, IMMUNOGENETICS RHEUM, P142; 1979, MANUAL TISSUE TYPING, P39	66	57	60	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1986	38	2					170	187						18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	A3111	3456197				2022-12-18	WOS:A1986A311100006
J	HOEG, JM; DEMOSKY, SJ; PESCOVITZ, OH; BREWER, HB				HOEG, JM; DEMOSKY, SJ; PESCOVITZ, OH; BREWER, HB			CHOLESTERYL ESTER STORAGE DISEASE AND WOLMAN DISEASE - PHENOTYPIC VARIANTS OF LYSOSOMAL ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NICHHD,DEV ENDOCRINOL BRANCH,BETHESDA,MD 20205	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	HOEG, JM (corresponding author), NHLBI,MOLEC DIS BRANCH,BETHESDA,MD 20205, USA.							ASSMANN G, 1983, METABOLIC BASIS INHE, V5, P803; AUBERTTULKENS G, 1979, ACTA PAEDIATR BELG, V32, P239; BEAUDET AL, 1974, J LAB CLIN MED, V84, P54; BEAUDET AL, 1977, J PEDIATR-US, V90, P910, DOI 10.1016/S0022-3476(77)80557-X; BRADY RO, 1983, METABOLIC BASIS INHE, V5, P842; BURKE JA, 1972, SCIENCE, V176, P309, DOI 10.1126/science.176.4032.309; BURTON BK, 1980, CLIN CHIM ACTA, V101, P25, DOI 10.1016/0009-8981(80)90052-2; BURTON BK, 1981, AM J HUM GENET, V33, P203; CHROUSOS JP, 1984, N ENGL J MED, V310, P622; FOLCH J, 1957, J BIOL CHEM, V226, P497; FOSTER LB, 1974, CLIN CHEM, V20, P365; Fredrickson D S, 1972, Trans Assoc Am Physicians, V85, P109; GREGG RE, 1983, NIH831266 PUBL, P383; HEIDER JG, 1978, J LIPID RES, V19, P514; HILL SC, 1983, J COMPUT ASSIST TOMO, V7, P815, DOI 10.1097/00004728-198310000-00011; HOEG JM, 1982, BIOCHIM BIOPHYS ACTA, V711, P59, DOI 10.1016/0005-2760(82)90009-1; HOOGEVEEN AT, 1980, NATURE, V285, P500, DOI 10.1038/285500a0; ILLINGWORTH DR, 1982, J LAB CLIN MED, V100, P115; ITO T, 1972, J CLIN ENDOCR METAB, V34, P106, DOI 10.1210/jcem-34-1-106; KOLODNY EH, 1983, METABOLIC BASIS INHE, V5, P881; KYRIAKIDES EC, 1972, J LAB CLIN MED, V80, P810; LEE JES, 1981, AM J HUM GENET, V33, pA83; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCKUSICK VA, 1983, METABOLIC BASIS INHE, V5, P751; MENARD J, 1972, ENDOCRINOLOGY, V90, P430; MEYERS WF, UNPUB USE PARENTERAL; OBRIEN JS, 1983, METABOLIC BASIS INHE, V5, P945; Patrick A D, 1969, Nature, V222, P1067, DOI 10.1038/2221067a0; PITTMAN RC, 1979, BIOCHIM BIOPHYS ACTA, V575, P399, DOI 10.1016/0005-2760(79)90109-7; SANDO GN, 1982, J LIPID RES, V23, P114; SCHAEFER EJ, 1982, ARTERIOSCLEROSIS, V2, P16, DOI 10.1161/01.ATV.2.1.16; SCHIFF L, 1968, AM J MED, V44, P538, DOI 10.1016/0002-9343(68)90054-5; SLOAN HR, 1972, J CLIN INVEST, V51, P1923, DOI 10.1172/JCI106997; SLY WS, 1982, J CELL BIOCHEM, V18, P67, DOI 10.1002/jcb.1982.240180107; SUZUKI Y, 1976, CLIN CHIM ACTA, V69, P219; WARNER TG, 1981, J BIOL CHEM, V256, P2952; WARNICK GR, 1982, CLIN CHEM, V28, P1379; 1974, DHEW NIH75628 REP	38	57	61	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	6					1190	1203						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TZ590	6097111				2022-12-18	WOS:A1984TZ59000004
J	PROCKOP, DJ				PROCKOP, DJ			OSTEOGENESIS IMPERFECTA - PHENOTYPIC HETEROGENEITY, PROTEIN SUICIDE, SHORT AND LONG COLLAGEN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review											PROCKOP, DJ (corresponding author), UNIV MED & DENT NEW JERSEY,RUTGERS MED SCH,DEPT BIOCHEM,PISCATAWAY,NJ 08854, USA.							BARSH GS, 1981, P NATL ACAD SCI-BIOL, V78, P5142, DOI 10.1073/pnas.78.8.5142; BOYD CD, 1980, J BIOL CHEM, V255, P3212; BYERS PH, 1981, P NATL ACAD SCI-BIOL, V78, P7745, DOI 10.1073/pnas.78.12.7745; BYERS PH, 1983, J CLIN INVEST, V71, P689, DOI 10.1172/JCI110815; CHU ML, 1983, NATURE, V304, P78, DOI 10.1038/304078a0; DALGLEISH R, 1982, J BIOL CHEM, V257, P13816; DEAK SB, 1984, J BIOL CHEM; DEWET WJ, 1983, J BIOL CHEM, V258, P7721; HOLLISTER DW, 1981, COLLAGEN REL RES, V1, P228; HUERRE C, 1982, P NATL ACAD SCI-BIOL, V79, P6627, DOI 10.1073/pnas.79.21.6627; LICHTENSTEIN JR, 1973, SCIENCE, V182, P298, DOI 10.1126/science.182.4109.298; McKusick V.A., 1972, CLIN GENET; MYERS JC, 1984, J BIOL CHEM; NICHOLLS AC, 1979, LANCET, V1, P1193; PELTONEN L, 1980, P NATL ACAD SCI-BIOL, V77, P6179, DOI 10.1073/pnas.77.10.6179; PENTTINEN RP, 1975, P NATL ACAD SCI USA, V72, P586, DOI 10.1073/pnas.72.2.586; PROCKOP DJ, 1984, N ENGL J MED; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; SIPPOLA M, 1984, J CELL BIOL; STEINMANN B, 1980, J BIOL CHEM, V255, P8887; TREISMAN R, 1983, NATURE, V302, P591, DOI 10.1038/302591a0; UITTO J, 1983, CLIN RES, V31, pA468; UITTO J, 1981, PROGR DISEASES SKIN, P103; VOGELI G, 1980, NUCLEIC ACIDS RES, V8, P1823, DOI 10.1093/nar/8.8.1823; WILLIAMS CJ, 1983, J BIOL CHEM, V258, P5915; WOZNEY J, 1981, NATURE, V294, P129, DOI 10.1038/294129a0	26	57	59	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	3					499	505						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SY119	6375355				2022-12-18	WOS:A1984SY11900001
J	SCHACTER, B; WEITKAMP, LR; JOHNSON, WE				SCHACTER, B; WEITKAMP, LR; JOHNSON, WE			PARENTAL HLA COMPATIBILITY, FETAL WASTAGE AND NEURAL-TUBE DEFECTS - EVIDENCE FOR A T/T-LIKE LOCUS IN HUMANS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV ROCHESTER, SCH MED & DENT, DEPT PEDIAT, DIV GENET, ROCHESTER, NY 14624 USA; UNIV ROCHESTER, SCH MED & DENT, DEPT PSYCHIAT, ROCHESTER, NY 14624 USA	University of Rochester; University of Rochester	SCHACTER, B (corresponding author), CASE WESTERN RESERVE UNIV, SCH MED, INST PATHOL, CLEVELAND, OH 44106 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD014487] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-14487, HD-14633] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALBERT ED, 1973, TRANSPLANT P, V5, P215; AMOS DB, 1980, NIH83545 DHEW PUBL, P42; AWDEH ZL, 1983, P NATL ACAD SCI-BIOL, V80, P259, DOI 10.1073/pnas.80.1.259; BEER AE, 1981, AM J OBSTET GYNECOL, V141, P987; BENNETT D, 1975, CELL, V6, P441, DOI 10.1016/0092-8674(75)90033-1; BOBROW M, 1975, TISSUE ANTIGENS, V5, P234, DOI 10.1111/j.1399-0039.1975.tb01469.x; BRUYERE MD, 1977, TISSUE ANTIGENS, V10, P399; FAULK WP, 1976, NATURE, V262, P799, DOI 10.1038/262799a0; GERENCER M, 1978, TISSUE ANTIGENS, V12, P223, DOI 10.1111/j.1399-0039.1978.tb01327.x; GILL TJ, 1983, TRANSPLANTATION, V35, P1; GOODFELLOW PN, 1976, TRANSPLANTATION, V22, P595, DOI 10.1097/00007890-197612000-00009; HAMMERBERG C, 1975, NATURE, V258, P296, DOI 10.1038/258296a0; HOLMES LB, 1976, NEW ENGL J MED, V294, P365, DOI 10.1056/NEJM197602122940704; JAMES WH, 1979, J MED GENET, V16, P129, DOI 10.1136/jmg.16.2.129; KLEIN J, 1977, IMMUNOL REV, V33, P70, DOI 10.1111/j.1600-065X.1977.tb00363.x; KLEIN J, 1983, IMMUNOGENETICS, V17, P285; KOMLOS L, 1977, CLIN IMMUNOL IMMUNOP, V7, P330, DOI 10.1016/0090-1229(77)90066-6; LAURITSEN JG, 1976, CLIN GENET, V9, P575; LECK I, 1974, BRIT MED BULL, V30, P158, DOI 10.1093/oxfordjournals.bmb.a071187; LOWRY R, 1979, TISSUE ANTIGENS, V14, P325; MATIUZ O, 1970, HISTOCOMPATIBILITY T, P193; MAYR W, 1971, HUMANGENETIK, V12, P195, DOI 10.1007/BF00702775; MONTGOMERY B, 1983, J IMMUNOL, V131, P2348; OBER CL, 1983, AM J HUM GENET, V35, P994; PALM J, 1974, CANCER RES, V34, P2061; ROCKLIN RE, 1976, NEW ENGL J MED, V295, P1209, DOI 10.1056/NEJM197611252952201; SCHACTER B, 1979, LANCET, V1, P796; SEABRIGH.M, 1971, LANCET, V2, P971; SHERMAN MI, 1977, CONCEPTS MAMMALIAN E, P136; SMITHELLS RW, 1980, LANCET, V1, P339; STALLARD R, 1983, AM J HUM GENET, V35, pA155; SUNDERLAND CA, 1981, J IMMUNOL, V127, P2614; TAYLOR C, 1981, LANCET, V2, P68; VANNIER JP, 1980, TISSUE ANTIGENS, V15, P501; 1978, BIRTH DEFECTS ORIG A, V14	35	57	57	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1984	36	5					1082	1091						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TS302	6594042				2022-12-18	WOS:A1984TS30200013
J	GOLDIN, LR; GERSHON, ES; LAKE, CR; MURPHY, DL; MCGINNISS, M; SPARKES, RS				GOLDIN, LR; GERSHON, ES; LAKE, CR; MURPHY, DL; MCGINNISS, M; SPARKES, RS			SEGREGATION AND LINKAGE STUDIES OF PLASMA DOPAMINE-BETA-HYDROXYLASE (DBH), ERYTHROCYTE CATECHOL-0-METHYLTRANSFERASE (COMT), AND PLATELET MONOAMINE-OXIDASE (MAO) - POSSIBLE LINKAGE BETWEEN THE ABO LOCUS AND A GENE CONTROLLING DBH ACTIVITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF LOS ANGELES, SCH MED, DEPT MED, DIV MED GENET, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, SCH MED, DEPT PEDIAT, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, SCH MED, DEPT PSYCHIAT, LOS ANGELES, CA 90024 USA; NIMH, CLIN CTR BLOOD BANK, BETHESDA, MD 20205 USA; UNIFORMED SERV UNIV HLTH SCI, SCH MED, DEPT PSYCHIAT, BETHESDA, MD 20014 USA; UNIFORMED SERV UNIV HLTH SCI, SCH MED, DEPT PHARMACOL, BETHESDA, MD 20014 USA; NIMH, CLIN PHARMACOL BRANCH, BETHESDA, MD 20205 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); NIH National Institute of Mental Health (NIMH); Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	GOLDIN, LR (corresponding author), NIMH, BIOL PSYCHIAT BRANCH, PSYCHOGENET SECT, BETHESDA, MD 20205 USA.							CAVALLISFORZA LL, 1971, GENETICS HUMAN POPUL, P884; CAWTHON RM, 1979, NATURE, V281, P692, DOI 10.1038/281692a0; DUNNETTE J, 1977, J CLIN INVEST, V60, P1080, DOI 10.1172/JCI108859; DUNNETTE J, 1977, MOL PHARM, V115, P649; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; ELSTON RC, 1976, CYTOGENET CELL GENET, V16, P294, DOI 10.1159/000130613; ELSTON RC, 1975, ANN HUM GENET, V39, P67, DOI 10.1111/j.1469-1809.1975.tb00109.x; ELSTON RC, 1974, AM J HUM GENET, V26, P13; ELSTON RC, 1979, HUM HERED, V29, P284, DOI 10.1159/000153059; GERSHON ES, 1975, ARCH GEN PSYCHIAT, V32, P1351; GERSHON ES, 1980, ENZYMES NEUROTRANSMI, P281; Giblett ER., 1969, GENETIC MARKERS HUMA; Harris, 1976, HDB ENZYME ELECTROPH; JOHNSTON JP, 1968, BIOCHEM PHARMACOL, V17, P1285, DOI 10.1016/0006-2952(68)90066-X; KAPLAN EB, 1972, UNC I STATISTICS MIM, V823; KAPLAN EB, 1975, UNPUB GENPED GENERAL; KRAVITZ K, 1979, AM J HUM GENET, V31, P601; MERRITT AD, 1973, AM J HUM GENET, V25, P510; MOLINOFF PB, 1971, J PHARMACOL EXP THER, V178, P425; MORTON NE, 1955, AM J HUM GENET, V7, P277; MURPHY DL, 1976, BIOCHEM MED METAB B, V16, P254, DOI 10.1016/0006-2944(76)90031-4; NIES A, 1973, ARCH GEN PSYCHIAT, V28, P834; OTT J, 1974, AM J HUM GENET, V26, P588; PANDEY GN, 1979, LIFE SCI, V25, P1173, DOI 10.1016/0024-3205(79)90140-1; PINTAR JE, 1981, J NEUROSCI, V1, P166; SCANLON PD, 1979, SCIENCE, V203, P63, DOI 10.1126/science.758679; SPIELMAN RS, 1979, AM J HUM GENET, V31, pA63; WEINSHILBOUM RM, 1977, AM J HUM GENET, V29, P125; WEINSHILBOUM RM, 1975, AM J HUM GENET, V27, P573; WEINSHILBOUM RM, 1978, PHARMACOL REV, V30, P133; WINTER H, 1978, PSYCHOPHARMACOLOGY, V57, P63, DOI 10.1007/BF00426959	31	57	57	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1982	34	2					250	262						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NH732	6951409				2022-12-18	WOS:A1982NH73200009
J	GROEBE, H; KRINS, M; SCHMIDBERGER, H; VONFIGURA, K; HARZER, K; KRESSE, H; PASCHKE, E; SEWELL, A; ULLRICH, K				GROEBE, H; KRINS, M; SCHMIDBERGER, H; VONFIGURA, K; HARZER, K; KRESSE, H; PASCHKE, E; SEWELL, A; ULLRICH, K			MORQUIO SYNDROME (MUCOPOLYSACCHARIDOSIS-IV-B) ASSOCIATED WITH BETA-GALACTOSIDASE DEFICIENCY - REPORT OF 2 CASES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MUNSTER,INST PHYSIOL CHEM,D-4400 MUNSTER,FED REP GER; UNIV MAINZ,CHILDRENS HOSP,D-6500 MAINZ,FED REP GER; UNIV GRAZ,PREGL LAB,A-8010 GRAZ,AUSTRIA; UNIV GRAZ,INST IMMUNOL & MED MICROBIOL,A-8010 GRAZ,AUSTRIA; UNIV GRAZ,DEPT RADIOL,A-8010 GRAZ,AUSTRIA; UNIV TUBINGEN,INST BRAIN RES,D-7400 TUBINGEN 1,FED REP GER	University of Munster; Johannes Gutenberg University of Mainz; University of Graz; University of Graz; University of Graz; Eberhard Karls University of Tubingen	GROEBE, H (corresponding author), UNIV MUNSTER,CHILDRENS HOSP,D-4400 MUNSTER,FED REP GER.							ARBISSER AI, 1977, AM J MED GENET, V1, P195, DOI 10.1002/ajmg.1320010205; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; BOAS NF, 1953, J BIOL CHEM, V204, P553; Cantz M, 1972, METHOD ENZYMOL, V28, P884; DIFERRANTE N, 1978, SCIENCE, V199, P79, DOI 10.1126/science.199.4324.79; DULANEY JT, 1978, METABOLIC BASIS INHE, P770; FLUHARTY AL, 1971, BIOCHEM MED METAB B, V5, P158, DOI 10.1016/0006-2944(71)90083-4; GLOSSL J, 1978, CLIN CHIM ACTA, V88, P111, DOI 10.1016/0009-8981(78)90157-2; GREILING H, 1964, H-S Z PHYSIOL CHEM, V336, P149, DOI 10.1515/bchm2.1964.336.1.149; HARZER K, 1977, HUM GENET, V35, P193, DOI 10.1007/BF00393969; HO MW, 1971, CLIN CHIM ACTA, V32, P443; HOFSTEE BHJ, 1959, NATURE, V184, P1296, DOI 10.1038/1841296b0; HORWITZ AL, 1978, BIOCHEM BIOPH RES CO, V80, P819, DOI 10.1016/0006-291X(78)91318-9; HUMBEL R, 1972, CLIN CHIM ACTA, V40, P290, DOI 10.1016/0009-8981(72)90287-2; KALTWASSER F, 1967, CLIN CHIM ACTA, V15, P347, DOI 10.1016/0009-8981(67)90076-9; KANFER JN, 1972, BIOCHIM BIOPHYS ACTA, V289, P359, DOI 10.1016/0005-2744(72)90087-3; KINDLER A, 1977, H-S Z PHYSIOL CHEM, V358, P1431, DOI 10.1515/bchm2.1977.358.2.1431; Kurz G, 1970, METHODEN ENZYMATISCH, P1241; MATALON R, 1974, BIOCHEM BIOPH RES CO, V61, P759, DOI 10.1016/0006-291X(74)91022-5; MCKUSICK VA, 1978, METABOLIC BASIS INHE, P1282; MCKUSICK VA, 1972, HERITABLE DISORDERS, P521; MORELL AG, 1966, J BIOL CHEM, V241, P3745; OBRIEN JS, 1976, CLIN GENET, V9, P495; OBRIEN JS, 1978, METABOLIC BASIS INHE, P841; OKADA S, 1968, SCIENCE, V160, P1002, DOI 10.1126/science.160.3831.1002; RAGHAVAN S, 1977, CLIN CHIM ACTA, V81, P47, DOI 10.1016/0009-8981(77)90412-0; RAMPINI SU, 1976, KLINIK MUCOPOLYSACCH; SAITO H, 1968, J BIOL CHEM, V243, P1536; SEWELL AC, 1979, CLIN CHIM ACTA, V92, P411, DOI 10.1016/0009-8981(79)90221-3; SINGH J, 1976, J CLIN INVEST, V57, P1036, DOI 10.1172/JCI108345; SPRANGER JW, 1977, AM J MED GENET, V1, P207, DOI 10.1002/ajmg.1320010206; STOCKERT RJ, 1976, BIOCHEM BIOPH RES CO, V68, P988, DOI 10.1016/0006-291X(76)91243-2; VONFIGURA K, 1977, EUR J BIOCHEM, V80, P525	33	57	58	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	2					258	272						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JS405	6446239				2022-12-18	WOS:A1980JS40500013
J	RINALDI, A; FILIPPI, G; SINISCALCO, M				RINALDI, A; FILIPPI, G; SINISCALCO, M			VARIABILITY OF RED-CELL PHENOTYPES BETWEEN AND WITHIN INDIVIDUALS IN AN UNBIASED SAMPLE OF 77 HETEROZYGOTES FOR G6PD DEFICIENCY IN SARDINIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CAGLIARI, FAC SCI, DEPT GENET, I-09100 CAGLIARI, ITALY; UNIV TRIESTE, FAC MED, DEPT MED GENET, I-34127 TRIESTE, ITALY; SLOAN KETTERING INST CANC RES, NEW YORK, NY 10021 USA	University of Cagliari; University of Trieste; Memorial Sloan Kettering Cancer Center								ADINOLFI M, 1960, RC ACCAD LINCEI, V28, P716; ALBERTINI RJ, 1974, BIOCHEM GENET, V11, P397, DOI 10.1007/BF00486413; BERNINI L, 1964, BRIT J HAEMATOL, V10, P171, DOI 10.1111/j.1365-2141.1964.tb00692.x; FILIPPI G, TO BE PUBLISHED; GALL JC, 1965, AM J HUM GENET, V17, P359; GANDINI E, 1968, P NATL ACAD SCI USA, V61, P945, DOI 10.1073/pnas.61.3.945; GARTLER SM, 1964, COLD SPRING HARB SYM, V29, P253, DOI 10.1101/SQB.1964.029.01.028; GARTLER SM, 1969, ANN HUM GENET, V33, P171, DOI 10.1111/j.1469-1809.1969.tb01642.x; LENZERINI L, 1969, AM J HUM GENET, V21, P142; LINDER D, 1965, AM J HUM GENET, V17, P212; LUZZATTO L, 1969, SCIENCE, V164, P839, DOI 10.1126/science.164.3881.839; MCDONALD JA, 1972, BIOCHEM GENET, V6, P21, DOI 10.1007/BF00485961; MIGEON BR, 1971, AM J HUM GENET, V23, P199; Motulsky AG, 1961, P C GENETIC POLYMORP, P159; NANCE WE, 1964, COLD SPRING HARB SYM, V29, P415, DOI 10.1101/SQB.1964.029.01.043; NYHAN WL, 1970, P NATL ACAD SCI USA, V65, P214, DOI 10.1073/pnas.65.1.214; PIOMELLI S, 1969, BRIT J HAEMATOL, V16, P537, DOI 10.1111/j.1365-2141.1969.tb00435.x; PIOMELLI S, 1974, HEMATOLOGY, P346; RATTAZZI MC, 1967, NATURE, V213, P79, DOI 10.1038/213079b0; ROMEO G, 1976, AM J HUM GENET, V28, P506; SILVESTRONI E, 1948, Haematologica, V31, P135; SINISCALCO M, 1966, ANN HUM GENET, V29, P231, DOI 10.1111/j.1469-1809.1966.tb00518.x; SINISCALCO M, 1966, B WORLD HEALTH ORGAN, V34, P379	23	57	57	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1976	28	5					496	505						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CH661	984045				2022-12-18	WOS:A1976CH66100008
J	GARTLER, SM; FRANCKE, U				GARTLER, SM; FRANCKE, U			HALF CHROMATID MUTATIONS - TRANSMISSION IN HUMANS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195; UNIV CALIF,SAN DIEGO,DEPT PEDIAT,LA JOLLA,CA 92037; UNIV WASHINGTON,DEPT GENET,SEATTLE,WA 98195	University of Washington; University of Washington Seattle; University of California System; University of California San Diego; University of Washington; University of Washington Seattle								ATKINS JH, 1968, GENETICS, V60, P781; AUERBACH C, 1971, ANNU REV GENET, V5, P163, DOI 10.1146/annurev.ge.05.120171.001115; FRANCKE U, 1973, J PEDIATR-US, V82, P472, DOI 10.1016/S0022-3476(73)80123-4; FRANKE U, IN PRESS; GARTLER SM, 1971, SCIENCE, V172, P572, DOI 10.1126/science.172.3983.572; GOLDSTEIN JL, 1971, P NATL ACAD SCI USA, V68, P1425, DOI 10.1073/pnas.68.7.1425; HALDANE JBS, 1947, ANN EUGENIC, V13, P262; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; ITIABA K, 1973, AM J HUM GENET, V25, P134; KIMBALL RF, 1963, GENETICS TODAY, V2, P227; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; MIGEON BR, 1968, SCIENCE, V160, P425, DOI 10.1126/science.160.3826.425; NEEL J V, 1971, Perspectives in Biology and Medicine, V14, P522; NEEL JV, 1974, GENETICS, V76, P311; Russell WL, 1965, JAPAN J GENET      S, V40, P128; SALZMANN J, 1968, P NATL ACAD SCI USA, V60, P545, DOI 10.1073/pnas.60.2.545; SILVERS DN, 1972, NEW ENGL J MED, V286, P390, DOI 10.1056/NEJM197202242860802	17	57	57	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1975	27	2					218	223						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V9467	1124765				2022-12-18	WOS:A1975V946700008
J	ELSTON, RC; NAMBOODIRI, KK; NINO, HV; POLLITZER, WS				ELSTON, RC; NAMBOODIRI, KK; NINO, HV; POLLITZER, WS			STUDIES ON BLOOD AND URINE GLUCOSE IN SEMINOLE INDIANS - INDICATIONS FOR SEGREGATION OF A MAJOR GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV N CAROLINA, DEPT BIOSTATISTICS, CHAPEL HILL, NC 27514 USA; UNIV N CAROLINA, GENET TRAINING COMMITTEE, CHAPEL HILL, NC 27514 USA; CTR DIS CONTROL, NUTR BIOCHEM LAB, 1600 CLIFTON RD NE, ATLANTA, GA 30333 USA; UNIV N CAROLINA, DEPT ANAT, CHAPEL HILL, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Centers for Disease Control & Prevention - USA; University of North Carolina; University of North Carolina Chapel Hill								BARRAI I, 1965, J Med Genet, V2, P8, DOI 10.1136/jmg.2.1.8; Cammidge PJ, 1934, LANCET, V1, P393; CARTER CO, 1969, BRIT MED BULL, V25, P52, DOI 10.1093/oxfordjournals.bmb.a070671; DOEBLIN TD, 1969, HUM HERED, V19, P613, DOI 10.1159/000152276; EDWARDS J. H., 1960, ACTA GENET ET STATIST MED, V10, P63; EHRLICH RM, 1966, DIABETES, V15, P400, DOI 10.2337/diab.15.6.400; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; FALCONER DS, 1967, ANN HUM GENET, V31, P1; GEDDA L, 1967, ACTA GENET MED GEMEL, V16, P217, DOI 10.1017/S1120962300013068; GORDON T, 1964, 1000 PUBL HEALTH  11; GRONBERG A, 1967, ACTA MED SCANDI S477, P126; HARRIS H, 1950, ANN EUGENIC, V15, P95; HENRY RE, 1969, DIABETES, V18, P33, DOI 10.2337/diab.18.1.33; JOHNSON JE, 1964, TEX REP BIOL MED, V22, P110; KAPLAN EB, 1972, 823 DEP BIOST I STAT; LAMY M, 1961, Journ Annu Diabetol Hotel Dieu, V2, P5; LANDRE MF, 1971, EXCERPTA MEDICA  233, P107; LEVIN ME, 1967, ANN INTERN MED, V66, P69, DOI 10.7326/0003-4819-66-1-69; LEVIT SG, 1934, P MAXIM GORKY MED BI, V3, P132; MABERRY RH, 1963, AM J CLIN NUTR, V13, P127, DOI 10.1093/ajcn/13.3.127; MACCAULEY C, 1884, SEMINOLE INDIANS FLO; MILLER M, 1965, DIABETES, V14, P439; MORTON NE, 1958, SCIENCE, V127, P79, DOI 10.1126/science.127.3289.79; NEEL JV, 1962, AM J HUM GENET, V14, P353; NEEL JV, 1965, GENETICS EPIDEMIOLOG; NILSSON SE, 1964, ACTA GENET STAT MED, V14, P97; OBRIEN D, 1967, DIABETES, V16, P572, DOI 10.2337/diab.16.8.572; Pavel I, 1966, Diabetologia, V2, P281, DOI 10.1007/BF01268187; PENROSE LS, 1945, P AM DIABETES ASSOC, V5, P165; Pincus G, 1933, AM J MED SCI, V186, P1; POLLITZER WS, 1970, AM J PHYS ANTHROPOL, V33, P15, DOI 10.1002/ajpa.1330330104; POLLITZER WS, 1970, AM J PHYS ANTHROPOL, V32, P65, DOI 10.1002/ajpa.1330320109; POST RH, 1962, DIABETES, V11, P56; RIMOIN DL, 1967, DIABETES, V16, P346, DOI 10.2337/diab.16.5.346; Rimoin DL, 1971, GENETIC DISORDERS EN; ROY CC, 1966, LANCET, V2, P1433; RUSHFORT.NB, 1971, DIABETES, V20, P756, DOI 10.2337/diab.20.11.756; SIMPSON NE, 1962, ANN HUM GENET, V26, P1, DOI 10.1111/j.1469-1809.1962.tb01305.x; SIMPSON NE, 1964, DIABETES, V13, P462, DOI 10.2337/diab.13.5.462; SIMPSON NE, 1969, ANN HUM GENET, V32, P283, DOI 10.1111/j.1469-1809.1969.tb00077.x; STEIN JH, 1965, ARCH INTERN MED, V116, P842, DOI 10.1001/archinte.116.6.842; STEINBERG AG, 1968, POSTGRAD MED, V43, P145; STEINBERG AG, 1965, EXC MED INT C     83, P601; STEINBERG AG, 1970, NOBEL S, V13, P237; STEINBERG AG, 1970, ADV METAB DISORD  S1, P11; STIMMLER L, 1964, LANCET, V1, P956; SWIFT M, 1972, SCIENCE, V178, P308, DOI 10.1126/science.178.4058.308; THOMPSON G. S., 1965, J MED GENET, V2, P221, DOI 10.1136/jmg.2.4.221; VALLANCEOWEN J, 1964, DIABETES, V13, P241; 1970, DIABETES MELLITUS	50	57	57	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1974	26	1					13	34						22	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	S0166	4811752				2022-12-18	WOS:A1974S016600002
J	OTT, J; SCHROTT, HG; GOLDSTEIN, JL; HAZZARD, WR; ALLEN, FH; FALK, CT; MOTULSKY, AG				OTT, J; SCHROTT, HG; GOLDSTEIN, JL; HAZZARD, WR; ALLEN, FH; FALK, CT; MOTULSKY, AG			LINKAGE STUDIES IN A LARGE KINDRED WITH FAMILIAL HYPERCHOLESTEROLEMIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WASHINGTON, CTR INHERITED DIS, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT MED MED GENET, SEATTLE, WA 98195 USA; UNIV WASHINGTON, HARBORVIEW MED CTR, DEPT MED, NW LIPID RES CLIN, SEATTLE, WA 98195 USA; NEW YORK BLOOD CTR, NEW YORK, NY 10021 USA; UNIV WASHINGTON, SCH MED, DEPT GENET, SEATTLE, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle; New York Blood Center; University of Washington; University of Washington Seattle								Brown M. P., IN PRESS; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; FREDRICK.DS, 1967, NEW ENGL J MED, V276, P148, DOI 10.1056/NEJM196701192760305; FREDRICK.DS, 1967, NEW ENGL J MED, V276, P273, DOI 10.1056/NEJM196702022760507; FREDRICKSON DONALD S., 1967, N ENGL J MED, V276, P34, DOI 10.1056/NEJM196701052760107; FREDRICKSON DS, 1967, NEW ENGL J MED, V276, P94, DOI 10.1056/NEJM196701122760206; FREDRICKSON DS, 1967, NEW ENGL J MED, V276, P215, DOI 10.1056/NEJM196701262760406; Giblett ER., 1969, GENETIC MARKERS HUMA; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1533, DOI 10.1172/JCI107331; HARLAN WR, 1966, MEDICINE, V45, P77, DOI 10.1097/00005792-196603000-00001; HAZZARD WR, 1973, J CLIN INVEST, V52, P1569, DOI 10.1172/JCI107333; HEIKEN A, 1969, HUM HERED, V19, P419, DOI 10.1159/000152248; KAARSALO E, 1969, Acta Pathologica et Microbiologica Scandinavica Supplementum, P1; KOMPF J, 1971, HUMANGENETIK, V13, P358; OTT J, 1974, AM J HUM GENET, V26, P588; Race R. R, 1968, BLOOD GROUPS MAN; ROBSON EB, 1973, ANN HUM GENET, V36, P393, DOI 10.1111/j.1469-1809.1973.tb00603.x; SANGER R, 1973, ANN HUM GENET, V36, P353, DOI 10.1111/j.1469-1809.1973.tb00597.x; SCHROTT HG, 1972, ANN INTERN MED, V76, P711, DOI 10.7326/0003-4819-76-5-711	20	57	58	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1974	26	5					598	603						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	U0241	4213615				2022-12-18	WOS:A1974U024100007
J	HARPER, PS; HUTCHINSON, JR; BIAS, WB; DYKEN, PR; RIVAS, ML; MCKUSICK, VA				HARPER, PS; HUTCHINSON, JR; BIAS, WB; DYKEN, PR; RIVAS, ML; MCKUSICK, VA			GENETIC LINKAGE CONFIRMED BETWEEN LOCUS FOR MYOTONIC DYSTROPHY AND ABH-SECRETION AND LUTHERAN BLOOD-GROUP LOCI	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BOLLING DR, 1970, THESIS JOHNS HOPKINS; BOWEN P, 1968, AM J MED SCI, V255, P368, DOI 10.1097/00000441-196806000-00004; COOK PJL, 1965, ANN HUM GENET, V28, P393; EDWARDS JH, 1956, LANCET, V270, P579; GREENWALT T, 1961, AM J HUM GENET, V13, P69; HARPER P, 1971, J MED GENET, V8, P438, DOI 10.1136/jmg.8.4.438; HARPER P, 1970, American Journal of Human Genetics, V22, p41A; KLEIN D., 1958, JOUR GENET HUMAINE, V7, P1; MOHR J, 1951, ACTA PATHOL MIC SC, V29, P339; Mohr J, 1954, STUDY LINKAGE MAN; MORTON NE, 1959, AM J HUM GENET, V11, P1; RENWICK JH, 1971, J MED GENET, V8, P407, DOI 10.1136/jmg.8.4.407; RENWICK JH, 1968, B EUR SOC HUM GENET, V2, P7; RENWICK JH, 1969, BRIT MED BULL, V25, P65, DOI 10.1093/oxfordjournals.bmb.a070673; RENWICK JH, 1969, LANCET, V2, P386; RENWICK JH, 1971, J MED GENET, V8, P399, DOI 10.1136/jmg.8.4.399; RENWICK JH, 1965, ANN HUM GENET, V28, P379, DOI 10.1111/j.1469-1809.1965.tb00493.x; RENWICK JH, 1961, EXCERPTA MEDICA I 32, pE145; SMITH CAB, 1953, J R STAT SOC B, V15, P153; Thomasen E, 1948, MYOTONIA	20	57	57	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1972	24	3					310	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M6948	5063795				2022-12-18	WOS:A1972M694800009
J	DEGROUCHY, J; DENAVA, C; CANTU, JM; BILSKIPA.G; BOUSSER, J				DEGROUCHY, J; DENAVA, C; CANTU, JM; BILSKIPA.G; BOUSSER, J			MODELS FOR CLONAL EVOLUTIONS - A STUDY OF CHRONIC MYELOGENOUS LEUKEMIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ADAMS A, 1961, BRIT MED J, V2, P1474, DOI 10.1136/bmj.2.5265.1474; ATKIN N. B., 1962, CYTOGENETICS, V1, P97, DOI 10.1159/000129718; BAGUENACANDELA R, 1964, MED ESP, V298, P1; BENDER MA, 1962, RADIAT RES, V16, P44, DOI 10.2307/3571128; BERGER R, 1965, ANN GENET-PARIS, V8, pG70; BLOOM AD, 1964, NEW ENGL J MED, V270, P1341, DOI 10.1056/NEJM196406182702504; BOYD E, 1965, LANCET, V2, P444; BROWN WMC, 1963, ADV CANCER RES, V7, P351, DOI 10.1016/S0065-230X(08)60985-9; DE GROUCHY J, 1963, Ann Genet, V6, P9; DEGROUCH.J, 1966, ANN GENET-PARIS, V9, pG73; DEGROUCH.J, 1966, ANN GENET-PARIS, V9, pG55; DEGROUCHY J, 1964, ANN GENET-PARIS, V7, pG45; DEGROUCHY J, 1965, NOUV REV FR HEMATOL, V5, P565; DEGROUCHY J, 1965, NOUV REV FR HEMATOL, V5, P69; DEGROUCHY J, 1966, NOUV REV FR HEMATOL, V6, P367; DENAVA C, 1965, 10 P C EUR SOC HEM; DOUGAN L, 1965, NATURE, V205, P405, DOI 10.1038/205405a0; ENGEL E, 1965, NEW ENGL J MED, V273, P738, DOI 10.1056/NEJM196509302731404; ENGEL E, 1965, LANCET, V2, P291; ENGEL E, 1965, CYTOGENETICS, V4, P157, DOI 10.1159/000129852; ENGEL E, 1964, CYTOGENETICS, V3, P228, DOI 10.1159/000129814; ERKMAN B, 1966, LANCET, V1, P368; FISHBEIN M, 1963, 2 INT C CONG MALF ED; FITZGERALD PH, 1963, BLOOD, V21, P183, DOI 10.1182/blood.V21.2.183.183; FORD E, 1963, CANAD CANCER RES C P, V5, P129; GOH K, 1964, ARCH INTERN MED, V114, P439, DOI 10.1001/archinte.1964.03860090173021; GRUENWALD H, 1965, AM J MED, V39, P1003, DOI 10.1016/0002-9343(65)90123-3; HAMMOUDA F, 1964, BRIT MED J, V1, P1275, DOI 10.1136/bmj.1.5393.1275; HOUSTON EW, 1964, ANN INTERN MED, V61, P696, DOI 10.7326/0003-4819-61-4-696; HSU TC, 1961, INT REV CYTOL, V12, P69; KEMP NH, 1964, BRIT MED J, V1, P1010, DOI 10.1136/bmj.1.5389.1010; KIOSSOGLOU KA, 1965, LANCET, V2, P665; KIOSSOGLOU KA, 1965, CLIN RES, V12, P217; LEJEUNE J, 1965, ANN GENET-PARIS, V8, pG44; LEJEUNE J, 1963, CR HEBD ACAD SCI, V256, P1195; LEJEUNE J, 1963, 2 INT C CONG MALF; LEJEUNE J, 1965, CHROMOSOMES HUMAINS; LEVAN A, 1963, HEREDITAS, V49, P433; NOWELL PC, 1960, JNCI-J NATL CANCER I, V25, P85; OHNO S, 1961, LANCET, V2, P123; PEDERSEN B, 1965, SCAND J HAEMATOL, V2, P167; PEDERSEN B, 1964, ACTA PATHOL MIC SC, V61, P497, DOI 10.1111/apm.1964.61.4.497; PEDERSEN BENT, 1964, SCAND JHAEMATOL, V1, P129; REISMAN LE, 1964, NEW ENGL J MED, V270, P591, DOI 10.1056/NEJM196403192701201; REISMAN LE, 1963, J PEDIATR-US, V62, P710, DOI 10.1016/S0022-3476(63)80041-4; RUFFIE J, 1965, LANCET, V1, P609; RUFFIE J, 1962, REV FR ETUD CLIN BIO, V7, P644; RUFFIE J., 1964, NOUV REV FRANC HEMATOL, V4, P719; SANCHEZCASCOS A, 1964, Rev Clin Esp, V94, P10; SANDBERG AA, 1962, BLOOD, V20, P393, DOI 10.1182/blood.V20.4.393.393; SANDBERG AA, 1964, ANN NY ACAD SCI, V113, P663, DOI 10.1111/j.1749-6632.1964.tb40698.x; SPEED DE, 1964, LANCET, V1, P403; Stahl A, 1966, Presse Med, V74, P429; STAHL A, 1965, NOUV REV FR HEMATOL, V5, P879; TOUGH IM, 1961, LANCET, V1, P411; TOUGH IM, 1963, LANCET, V1, P844; TRUJILLO JM, 1963, ACTA HAEMATOL-BASEL, V29, P311, DOI 10.1159/000207975; TURPIN R, 1965, CHROMOSOMES HUMAI ED	58	57	57	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1966	18	5					485	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	83834	5224748				2022-12-18	WOS:A19668383400009
J	GARTLER, SM; ZIPRKOWSKI, L; KRAKOWSKI, A; EZRA, R; SZEINBERG, A; ADAM, A				GARTLER, SM; ZIPRKOWSKI, L; KRAKOWSKI, A; EZRA, R; SZEINBERG, A; ADAM, A			GLUCOSE-6-PHOSPHATE DEHYDROGENASE MOSAICISM AS A TRACER IN STUDY OF HEREDITARY MULTIPLE TRICHOEPITHELIOMA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BEUTLER E, 1964, LANCET, V1, P189; COLOWICK SP, 1955, METHODS ENZYMOLOG ED, V1, P323; DAVIDSON RG, 1963, P NATL ACAD SCI USA, V50, P481, DOI 10.1073/pnas.50.3.481; DEMARS R, 1964, RETENTION FUNCTIONAL, P35; DEMARS ROBERT, 1964, NAT CANCER INST MONOGR, V13, P181; DIXON WJ, 1957, INTRODUCTION STATIST, P286; GARTLER S. M., 1964, CYTOGENETICS, V3, P135, DOI 10.1159/000129804; GARTLER SM, 1964, COLD SPRING HARB SYM, V29, P253, DOI 10.1101/SQB.1964.029.01.028; KORNBERG A, 1955, METHOD ENZYMOL, V1, P323, DOI 10.1016/0076-6879(55)01046-X; LEVER WF, 1961, HISTOPATHOLOGY SKIN, P467; LINDER D, 1965, SCIENCE, V150, P67, DOI 10.1126/science.150.3692.67; LOWRY OH, 1951, J BIOL CHEM, V193, P265; SCOTT OLS, 1953, CLIN GENET, P210; SORSBY A, 1953, CLIN GENET, P210; SZEINBERG A, 1958, NATURE, V181, P1256, DOI 10.1038/1811256a0; SZEINBERG A, 1964, BIOCHIM BIOPHYS ACTA, V93, P564, DOI 10.1016/0304-4165(64)90340-X	16	57	57	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1966	18	3					282	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	77584	17948511				2022-12-18	WOS:A19667758400005
J	DEWEY, WJ; BARRAI, I; MORTON, NE; MI, MP				DEWEY, WJ; BARRAI, I; MORTON, NE; MI, MP			RECESSIVE GENES IN SEVERE MENTAL DEFECT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		[Anonymous], 1908, REPORT ROYAL COMMISS, P1908; BARRAI I, 1965, AM J HUM GENET, V17, P221; Bell J, 1940, ANN EUGENIC, V10, P370; BOOK JA, 1957, ANN HUM GENET, V21, P191; CHUNG CS, 1959, ANN HUM GENET, V23, P257; CROW JAMES F., 1958, HUMAN BIOL, V30, P1; DUNN HL, 1938, PATIENTS MENTAL INST; EDWARDS J. H., 1960, ACTA GENET ET STATIST MED, V10, P63; FERGUSON-SMITH MALCOLM A., 1961, PROGR MED GENET, V1, P292; FREIREMAIA N, 1957, EUGEN QUART, V4, P127, DOI 10.1080/19485565.1957.9987319; FRIEDMAN LD, 1963, GENETICS, V49, P689; GREENBERG R, 1960, GENETICS, V45, P1153; LERNER IM, 1961, AM J HUM GENET, V13, P103; Lerner IM, 1954, GENETIC HOMEOSTASIS; LEWIS EO, 1925, REPORT MENTAL DEFI 4; MORONI A, 1962, USE VITAL HLTH STATI, P109; MORTON NE, 1960, AM J HUM GENET, V12, P348; MORTON NE, 1959, AM J HUM GENET, V11, P1; MORTON NE, 1959, AM J HUM GENET, V11, P360; MORTON NE, 1962, EUGEN QUART, V9, P23, DOI 10.1080/19485565.1962.9987497; NEEL JV, 1949, AM J HUM GENET, V1, P156; NEEL JV, 1958, AM J HUM GENET, V10, P398; PATAU K, 1964, SCIENCE, V146, P429; PEARSON K, 1930, TABLES STATISTICIA 2; PENROSE LS, 1961, RECENT ADVANCES HUMA, P1; PENROSE LS, 1938, CLINICAL GENETIC 229; TREDGOLD AF, 1956, TEXTBOOK MENTAL DEFI; WOOLF CM, 1956, AM J HUM GENET, V8, P236; [No title captured]	29	57	57	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1965	17	3					237	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	65219	14295493				2022-12-18	WOS:A19656521900005
J	GERMAN, JL; BEARN, AG; DEMAYO, AP				GERMAN, JL; BEARN, AG; DEMAYO, AP			INHERITANCE OF AN ABNORMAL CHROMOSOME IN DOWNS SYNDROME (MONGOLISM) WITH LEUKEMIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALLEN G, 1961, LANCET, V1, P775; BAIKIE AG, 1959, LANCET, V2, P425; BUCKTON KE, 1961, LANCET, V1, P171; CARTER CO, 1960, LANCET, V2, P678; CLARKE CM, 1961, LANCET, V1, P1028; FORD CE, 1958, NATURE, V181, P1565, DOI 10.1038/1811565a0; FRACCARO M, 1960, LANCET, V1, P724; GERMAN J, UNPUBLISHED; GERMAN JL, 1960, J CLIN INVEST, V39, P989; HIRSCHHORN K, PERSONAL COMMUNICATI; JOHNSTON AW, 1961, NEW ENGL J MED, V264, P591, DOI 10.1056/NEJM196103232641204; KRIVIT W, 1957, J DIS CHILD, V94, P289; LANGERON M, 1925, PRECIS MICROSCOPIE, P522; LEA DE, 1956, ACTIONS RADIATIONS L, pCH6; LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P602; LEJEUNE J, 1959, ANN GENET-PARIS, V1, P41; LEJEUNE J, 1960, CR HEBD ACAD SCI, V250, P2468; LEJEUNE J, 1960, CR HEBD ACAD SCI, V250, P618; MERRIT DH, 1956, AMA J DIS CHILD, V92, P41, DOI 10.1001/archpedi.1956.02060030035009; MITTWOCH U, 1958, J MENT DEFIC RES, V2, P75, DOI 10.1111/j.1365-2788.1958.tb00389.x; MITTWOCH U, 1957, J MENT DEFIC RES, V1, P26; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; MOORHEAD PS, 1961, AM J HUM GENET, V13, P32; NOWELL P, 1960, SCIENCE, V132, P1947; NOWELL PC, 1958, P AM ASSOC CANC RES, V2, P331; PATAU K, 1960, LANCET, V1, P790; PENROSE LS, 1961, LANCET, V1, P1261; PENROSE LS, 1960, LANCET, V2, P409; POLANI PE, 1960, LANCET, V1, P721; STEWART A, 1958, BRIT MED J, V1, P1495, DOI 10.1136/bmj.1.5086.1495; TJIO JH, 1959, P NATL ACAD SCI USA, V45, P1008, DOI 10.1073/pnas.45.7.1008; TOUGH IM, 1961, LANCET, V1, P411; TURPIN R, 1959, CR HEBD ACAD SCI, V248, P3636; WALD N, 1961, LANCET, V1, P1228	34	57	57	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1962	14	1					31	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2966A	17948467				2022-12-18	WOS:A19622966A00005
J	MORTON, NE; CHUNG, CS				MORTON, NE; CHUNG, CS			ARE THE MN BLOOD GROUPS MAINTAINED BY SELECTION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ANDRESEN P. H., 1947, ACTA PATH ET MICROBIOL SCAND, V24, P545; BLOUROCK G, 1932, MUNCH MED WSCHR, V79, P1552; Boyd WC, 1941, ANN EUGENIC, V11, P1; BROWN SW, 1952, P NATL ACAD SCI USA, V38, P687, DOI 10.1073/pnas.38.8.687; CHEESEMAN EA, 1956, ANN HUM GENET, V21, P59, DOI 10.1111/j.1469-1809.1971.tb00265.x; CHU EHY, 1959, AM J HUM GENET, V11, P63; CHUNG CS, UNPUBLISHED; CLAUSEN J, 1932, HOSPITALSTID, V75, P196; Cotterman CW, 1943, ANN EUGENIC, V12, P158, DOI 10.1111/j.1469-1809.1943.tb02319.x; CROME W, 1933, DTSCH Z GES GERICHTL, V21, P435; Dahr P, 1938, DEUT MED WOCHENSCHR, V64, P818, DOI 10.1055/s-0028-1122201; DAHR P, 1940, ZSCHR IMMUNFORSCH, V97, P168; Dahr P., 1940, ZSCHR RASSENPHYSIOL, V11, P78; DUNSFORD I, 1953, NATURE, V172, P688; HAGUE M, 1954, ANN EUGEN, V18, P175; HALDANE JBS, 1948, PROC R SOC SER B-BIO, V135, P147, DOI 10.1098/rspb.1948.0002; HIRSZFELD L, 1938, SCHWEIZ ZSCHR AL PAT, V1, P23; Holford FE, 1938, J INFECT DIS, V63, P287, DOI 10.1093/infdis/63.3.287; Hyman HS, 1935, J IMMUNOL, V29, P223; IRWIN MR, 1951, GENETICS 20TH CENTUR, P173; JAMESON RJ, 1956, ANN HUM GENET, V20, P348; Landsteiner K, 1928, J EXP MED, V48, P731, DOI 10.1084/jem.48.5.731; Landsteiner K, 1941, J EXP MED, V74, P309, DOI 10.1084/jem.74.4.309; LATTES L, 1932, ATTI C NAZ MICROB, P146; LAUGHLIN W S, 1956, Acta Genet Stat Med, V6, P536; LAWLER SD, 1957, ANN HUM GENET, V21, P410, DOI 10.1111/j.1469-1809.1972.tb00294.x; LEJEUNE J, 1959, LANCET, V1, P885; LUDWIN I, 1952, AM J HUM GENET, V4, P182; MATSUNAGA E, 1957, ANN HUM GENET, V22, P111, DOI 10.1111/j.1469-1809.1957.tb01926.x; MATTA D, 1937, EGYPTIAN U FM PUB, V11; MOHR J, 1954, OP DOM BIOL HERED, V33, P1; MORTON NE, 1959, AM J HUM GENET, V11, P1; MORTON NE, 1954, AM J HUM GENET, V6, P38; MOUREAU P, 1935, REV BELGE SCI MED, V7, P540; MUSTAKALLIO E, 1937, ACTA SOC MED FENN  A, V20, P1; NEEL JV, 1951, GENETICS, V36, P84; Race RR, 1941, ANN EUGENIC, V11, P365, DOI 10.1111/j.1469-1809.1941.tb02300.x; RACE RR, 1949, HEREDITY, V3, P205, DOI 10.1038/hdy.1949.12; RACE RR, 1954, BLACKWELL SCI PUBLIC; RACE RR, 1942, ANN EUGEN LOND, V11, P385; RENWICK JH, 1955, ANN HUM GENET, V19, P312, DOI 10.1111/j.1469-1809.1955.tb01356.x; SANDLER L, 1957, AM NAT, V91, P105, DOI 10.1086/281969; SANGER R, 1951, AM J HUM GENET, V3, P332; SANGER R, 1948, HEREDITY, V2, P131, DOI 10.1038/hdy.1948.8; SCHIFF F, 1932, Z IMMUNITATSFORSCH, V77, P129; SCHIFF F, 1933, DTSCH Z GES GERICHTL, V21, P404; STEVENSON A. C., 1955, ANN HUMAN GENETICS, V19, P165, DOI 10.1111/j.1469-1809.1955.tb01341.x; Taylor GL, 1939, ANN EUGENIC, V9, P18, DOI 10.1111/j.1469-1809.1939.tb02194.x; Taylor GL, 1939, ANN EUGENIC, V9, P97, DOI 10.1111/j.1469-1809.1939.tb02200.x; Taylor GL, 1938, ANN EUGENIC, V8, P343, DOI 10.1111/j.1469-1809.1938.tb02186.x; WALTON JN, 1955, ANN HUM GENET, V20, P1, DOI 10.1111/j.1469-1809.1955.tb01274.x; WIENER A S, 1953, Acta Genet Med Gemellol (Roma), V2, P391; Wiener AS, 1944, J EXP MED, V79, P235, DOI 10.1084/jem.79.3.235; WIENER AS, 1949, AM J HUM GENET, V1, P127; WIENER AS, 1946, P SOC EXP BIOL MED, V61, P382; Wiener AS, 1943, GENETICS, V28, P157; Wiener AS, 1931, J IMMUNOL, V20, P371; Wiener AS, 1936, ANN EUGENIC, V7, P141, DOI 10.1111/j.1469-1809.1936.tb02135.x; WIENER AS, 1943, BLOOD GROUPS TRANSFU	59	57	57	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1959	11	3					237	251						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF075	14424474				2022-12-18	WOS:A1959WF07500002
J	STEVENSON, AC				STEVENSON, AC			ACHONDROPLASIA - ACCOUNT OF THE CONDITION IN NORTHERN-IRELAND	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		GREBE H, 1952, Z Kinderheilkd, V71, P437, DOI 10.1007/BF00464067; GREBE H, 1955, ANALECTA GENETICA CO; HALDANE JBS, 1949, 8TH P INT C GEN, P267; HELWEGLARSEN HF, 1950, NORDISK MED, P43; MORCH ET, 1941, BIOL HEREDITARIAE HU, V3; PENROSE LS, 1956, LANCET, V2, P312; SLATIS HM, 1955, AM J HUM GENET, V7, P76; STEVENSON AC, 1953, ANN EUGENIC, V18, P50; STEVENSON AC, 1956, ANN HUM GENET, V20, P177; STEVENSON AC, IN PRESS	10	57	57	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1957	9	1					81	91						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA214	13410903				2022-12-18	WOS:A1957WA21400007
J	Dimmock, DP; Clark, MM; Gaughran, M; Cakici, JA; Caylor, SA; Clarke, C; Feddock, M; Chowdhury, S; Salz, L; Cheung, C; Bird, LM; Hobbs, C; Wigby, K; Farnaes, L; Bloss, CS; Kingsmore, SF				Dimmock, David P.; Clark, Michelle M.; Gaughran, Mary; Cakici, Julie A.; Caylor, Sara A.; Clarke, Christina; Feddock, Michele; Chowdhury, Shimul; Salz, Lisa; Cheung, Cynthia; Bird, Lynne M.; Hobbs, Charlotte; Wigby, Kristen; Farnaes, Lauge; Bloss, Cinnamon S.; Kingsmore, Stephen F.		RCIGM Investigators	An RCT of Rapid Genomic Sequencing among Seriously Ill Infants Results in High Clinical Utility, Changes in Management, and Low Perceived Harm	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEONATAL INTENSIVE-CARE; DISORDERS	The second Newborn Sequencing in Genomic Medicine and Public Health (NSIGHT2) study was a randomized, controlled trial of rapid whole-genome sequencing (rWGS) or rapid whole-exome sequencing (rWES) in infants with diseases of unknown etiology in intensive care units (ICUs). Gravely ill infants were not randomized and received ultra-rapid whole-genome sequencing (urWGS). Herein we report results of clinician surveys of the clinical utility of rapid genomic sequencing (RGS). The primary end-point-clinician perception that RGS was useful- was met for 154 (77%) of 201 infants. Both positive and negative tests were rated as having clinical utility (42 of 45 [93%] and 112 of 156 [72%], respectively). Physicians reported that RGS changed clinical management in 57 (28%) infants, particularly in those receiving urWGS (p = 0.0001) and positive tests (p < 0.00001). Outcomes of 32 (15%) infants were perceived to be changed by RGS. Positive tests changed outcomes more frequently than negative tests (p < 0.00001). In logistic regression models, the likelihood that RGS was perceived as useful increased 6.7-fold when associated with changes in management (95% CI 1.8-43.3). Changes in management were 10.1-fold more likely when results were positive (95% CI 4.7-22.4) and turnaround time was shorter (odds ratio 0.92, 95% CI 0.85-0.99). RGS seldom led to clinician-perceived confusion or distress among families (6 of 207 [3%]). In summary, clinicians perceived high clinical utility and low likelihood of harm with first-tier RGS of infants in ICUs with diseases of unknown etiology. RGS was perceived as beneficial irrespective of whether results were positive or negative.	[Dimmock, David P.; Clark, Michelle M.; Gaughran, Mary; Cakici, Julie A.; Caylor, Sara A.; Clarke, Christina; Feddock, Michele; Chowdhury, Shimul; Salz, Lisa; Hobbs, Charlotte; Wigby, Kristen; Farnaes, Lauge; Kingsmore, Stephen F.] Rady Childrens Inst Genom Med, San Diego, CA 92123 USA; [Dimmock, David P.; Clark, Michelle M.; Gaughran, Mary; Cakici, Julie A.; Caylor, Sara A.; Clarke, Christina; Feddock, Michele; Chowdhury, Shimul; Salz, Lisa; Bird, Lynne M.; Hobbs, Charlotte; Wigby, Kristen; Farnaes, Lauge; Kingsmore, Stephen F.] Rady Childrens Hosp, San Diego, CA 92123 USA; [Cakici, Julie A.; Cheung, Cynthia; Bloss, Cinnamon S.] Univ Calif San Diego, Dept Family Med & Publ Hlth, San Diego, CA 92093 USA; [Cheung, Cynthia; Bloss, Cinnamon S.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92093 USA; [Bird, Lynne M.; Wigby, Kristen] Univ Calif San Diego, Dept Pediat, San Diego, CA 92093 USA	Rady Childrens Hospital San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Dimmock, DP (corresponding author), Rady Childrens Inst Genom Med, San Diego, CA 92123 USA.; Dimmock, DP (corresponding author), Rady Childrens Hosp, San Diego, CA 92123 USA.	ddimmock@rchsd.org	Bird, Lynne/AAG-9533-2021; Cakici, Julie/ABC-3574-2021	Cakici, Julie/0000-0001-5672-3396; Batalov, Sergey/0000-0002-0925-0554; Bird, Lynne/0000-0003-4833-3747; Bloss, Cinnamon/0000-0003-1315-8387; Prince, Lawrence/0000-0002-7010-4548; Coufal, Nicole/0000-0001-6547-1733; Sanford Kobayashi, Erica/0000-0002-3622-8141; Carroll, Jeanne/0000-0003-3673-0323; Del Campo, Miguel/0000-0001-7910-8855	NICHD [U19HD077693]; NCATS [UL1TR002550]; NHGRI	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was supported by grant U19HD077693 from NICHD and NHGRI to S.F.K., grant UL1TR002550 from NCATS to E.J. Topol, and gifts from the Liguori Family, John Motter and Effie Simanikas, Ernest and Evelyn Rady, and RCHSD.	[Anonymous], 2014, CURR PROTOC HUM GENE; [Anonymous], 2003, HUMAN GENOME EPIDEMI; Berg JS, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2252; Burke W., 2007, MOVING ACCE EXPANDED; Cakici JA, 2020, AM J HUM GENET, V107, P953, DOI 10.1016/j.ajhg.2020.10.004; Ceyhan-Birsoy O, 2019, AM J HUM GENET, V104, P76, DOI 10.1016/j.ajhg.2018.11.016; Clark MM, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat6177; Clark MM, 2018, NPJ GENOM MED, V3, DOI 10.1038/s41525-018-0053-8; Farnaes L, 2018, NPJ GENOM MED, V3, DOI 10.1038/s41525-018-0049-4; French CE, 2019, INTENS CARE MED, V45, P627, DOI 10.1007/s00134-019-05552-x; Friedman JM, 2019, GENET MED, V21, P498, DOI 10.1038/s41436-018-0055-z; Goodman DC, 2019, J PEDIATR-US, V209, P44, DOI 10.1016/j.jpeds.2019.02.014; Grosse SD, 2019, GENET MED, V21, P269, DOI 10.1038/s41436-018-0124-3; Gubbels CS, 2020, GENET MED, V22, P736, DOI 10.1038/s41436-019-0708-6; Harrison W, 2015, JAMA PEDIATR, V169, P855, DOI 10.1001/jamapediatrics.2015.1305; Harrison WN, 2018, J PEDIATR-US, V192, P73, DOI 10.1016/j.jpeds.2017.08.028; Health UDo Services H, 2000, FED REGISTER, V65, P76643; Kingsmore SF, 2020, CSH MOL CASE STUD, V6, DOI 10.1101/mcs.a004705; Kingsmore SF, 2019, AM J HUM GENET, V105, P719, DOI 10.1016/j.ajhg.2019.08.009; Knapp B, 2019, PEDIATRICS, V143, pS54, DOI 10.1542/peds.2018-1099J; Meng LY, 2017, JAMA PEDIATR, V171, DOI 10.1001/jamapediatrics.2017.3438; Mestek-Boukhibar L, 2018, J MED GENET, V55, P721, DOI 10.1136/jmedgenet-2018-105396; Murphy Sherry L, 2018, NCHS Data Brief, P1; PEEK K, 2020, PEDIATR RES, V27, DOI DOI 10.12968/IJTR.2018.0098; Petrikin JE, 2018, NPJ GENOM MED, V3, DOI 10.1038/s41525-018-0045-8; Petrikin JE, 2015, SEMIN PERINATOL, V39, P623, DOI 10.1053/j.semperi.2015.09.009; Sanford EF, 2019, PEDIATR CRIT CARE ME, V20, P1007, DOI 10.1097/PCC.0000000000002056; Saunders CJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004041; Schulman J, 2018, JAMA PEDIATR, V172, P17, DOI 10.1001/jamapediatrics.2017.3913; Soden SE, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010076; Stark Z, 2019, GENET MED, V21, P173, DOI 10.1038/s41436-018-0006-8; Stark Z, 2018, GENET MED, V20, P1554, DOI 10.1038/gim.2018.37; Stevenson DA, 2004, AM J MED GENET A, V126A, P393, DOI 10.1002/ajmg.a.20409; WALD N, 1989, BRIT J OBSTET GYNAEC, V96, P389, DOI 10.1111/j.1471-0528.1989.tb02411.x; Wang HJ, 2020, HUM GENET, V139, P473, DOI 10.1007/s00439-019-02103-8; Watson M, 2015, GENET MED, V17, P505, DOI 10.1038/gim.2015.41; Willig LK, 2015, LANCET RESP MED, V3, P377, DOI 10.1016/S2213-2600(15)00139-3; Wojcik MH, 2019, J PERINATOL, V39, P1611, DOI 10.1038/s41372-019-0451-5	38	56	57	2	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 5	2020	107	5					942	952		10.1016/j.ajhg.2020.10.003	http://dx.doi.org/10.1016/j.ajhg.2020.10.003			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	OP1QL	33157007	Green Published, Bronze			2022-12-18	WOS:000587855200012
J	Li, C; Stoma, S; Lotta, LA; Warner, S; Albrecht, E; Allione, A; Arp, PP; Broer, L; Buxton, JL; Alves, ADC; Deelen, J; Fedko, IO; Gordon, SD; Jiang, T; Karlsson, R; Kerrison, N; Loe, TK; Mangino, M; Milaneschi, Y; Miraglio, B; Pervjakova, N; Russo, A; Surakka, I; van der Spek, A; Verhoeven, JE; Amin, N; Beekman, M; Blakemore, AI; Canzian, F; Hamby, SE; Hottenga, JJ; Jones, PD; Jousilahti, P; Magi, R; Medland, SE; Montgomery, GW; Nyholt, DR; Perola, M; Pietilainen, KH; Salomaa, V; Sillanpaa, E; Suchiman, HE; van Heemst, D; Willemsen, G; Agudo, A; Boeing, H; Boomsma, DI; Chirlaque, MD; Fagherazzi, G; Ferrari, P; Franks, P; Gieger, C; Eriksson, JG; Gunter, M; Hagg, S; Hovatta, I; Imaz, L; Kaprio, J; Kaaks, R; Key, T; Krogh, V; Martin, NG; Melander, O; Metspalu, A; Moreno, C; Onland-Moret, NC; Nilsson, P; Ong, KK; Overvad, K; Palli, D; Panico, S; Pedersen, NL; Penninx, BWJH; Quiros, JR; Jarvelin, MR; Rodriguez-Barranco, M; Scott, RA; Severi, G; Slagboom, PE; Spector, TD; Tjonneland, A; Trichopoulou, A; Tumino, R; Uitterlinden, AG; van der Schouw, YT; van Duijn, CM; Weiderpass, E; Denchi, EL; Matullo, G; Butterworth, AS; Danesh, J; Samani, NJ; Wareham, NJ; Nelson, CP; Langenberg, C; Codd, V				Li, Chen; Stoma, Svetlana; Lotta, Luca A.; Warner, Sophie; Albrecht, Eva; Allione, Alessandra; Arp, Pascal P.; Broer, Linda; Buxton, Jessica L.; Alves, Alexessander Da Silva Couto; Deelen, Joris; Fedko, Iryna O.; Gordon, Scott D.; Jiang, Tao; Karlsson, Robert; Kerrison, Nicola; Loe, Taylor K.; Mangino, Massimo; Milaneschi, Yuri; Miraglio, Benjamin; Pervjakova, Natalia; Russo, Alessia; Surakka, Ida; van der Spek, Ashley; Verhoeven, Josine E.; Amin, Najaf; Beekman, Marian; Blakemore, Alexandra, I; Canzian, Federico; Hamby, Stephen E.; Hottenga, Jouke-Jan; Jones, Peter D.; Jousilahti, Pekka; Magi, Reedik; Medland, Sarah E.; Montgomery, Grant W.; Nyholt, Dale R.; Perola, Markus; Pietilainen, Kirsi H.; Salomaa, Veikko; Sillanpaa, Elina; Suchiman, H. Eka; van Heemst, Diana; Willemsen, Gonneke; Agudo, Antonio; Boeing, Heiner; Boomsma, Dorret, I; Chirlaque, Maria-Dolores; Fagherazzi, Guy; Ferrari, Pietro; Franks, Paul; Gieger, Christian; Eriksson, Johan Gunnar; Gunter, Marc; Hagg, Sara; Hovatta, Iiris; Imaz, Liher; Kaprio, Jaakko; Kaaks, Rudolf; Key, Timothy; Krogh, Vittorio; Martin, Nicholas G.; Melander, Olle; Metspalu, Andres; Moreno, Concha; Onland-Moret, N. Charlotte; Nilsson, Peter; Ong, Ken K.; Overvad, Kim; Palli, Domenico; Panico, Salvatore; Pedersen, Nancy L.; Penninx, Brenda W. J. H.; Ramon Quiros, J.; Riitta Jarvelin, Marjo; Rodriguez-Barranco, Miguel; Scott, Robert A.; Severi, Gianluca; Slagboom, P. Eline; Spector, Tim D.; Tjonneland, Anne; Trichopoulou, Antonia; Tumino, Rosario; Uitterlinden, Andre G.; van der Schouw, Yvonne T.; van Duijn, Cornelia M.; Weiderpass, Elisabete; Denchi, Eros Lazzerini; Matullo, Giuseppe; Butterworth, Adam S.; Danesh, John; Samani, Nilesh J.; Wareham, Nicholas J.; Nelson, Christopher P.; Langenberg, Claudia; Codd, Veryan			Genome-wide Association Analysis in Humans Links Nucleotide Metabolism to Leukocyte Telomere Length	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MENDELIAN RANDOMIZATION; RISK; VARIANTS; DISEASE; CANCER; LOCI; DATABASE; GENES; HEART; GWAS	Leukocyte telomere length (LTL) is a heritable biomarker of genomic aging. In this study, we perform a genome-wide meta-analysis of LTL by pooling densely genotyped and imputed association results across large-scale European-descent studies including up to 78,592 individuals. We identify 49 genomic regions at a false dicovery rate (FDR) < 0.05 threshold and prioritize genes at 31, with five highlighting nucleotide metabolism as an important regulator of LTL. We report six genome-wide significant loci in or near SENP7, MOB1B, CARMIL1 , PRRC2A, TERF2, and RFWD3, and our results support recently identified PARP1, POT1, ATM, and MPHOSPH6 loci. Phenome-wide analyses in >350,000 UK Biobank participants suggest that genetically shorter telomere length increases the risk of hypothyroidism and decreases the risk of thyroid cancer, lymphoma, and a range of proliferative conditions. Our results replicate previously reported associations with increased risk of coronary artery disease and lower risk for multiple cancer types. Our findings substantially expand current knowledge on genes that regulate LTL and their impact on human health and disease.	[Li, Chen; Lotta, Luca A.; Kerrison, Nicola; Ong, Ken K.; Scott, Robert A.; Wareham, Nicholas J.; Langenberg, Claudia] Univ Cambridge, MRC, Epidemiol Unit, Cambridge CB2 0SL, England; [Stoma, Svetlana; Warner, Sophie; Hamby, Stephen E.; Jones, Peter D.; Samani, Nilesh J.; Nelson, Christopher P.; Codd, Veryan] Univ Leicester, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Li, Chen; Stoma, Svetlana; Hamby, Stephen E.; Samani, Nilesh J.; Nelson, Christopher P.; Codd, Veryan] Glenfield Hosp, NIHR Leicester Biomed Res Ctr, Leicester LE3 9QP, Leics, England; [Albrecht, Eva; Gieger, Christian] Helmholtz Zentrum Munchen, Inst Epidemiol, German Res Ctr Environm Hlth, D-85764 Neuherberg, Germany; [Allione, Alessandra; Russo, Alessia; Matullo, Giuseppe] Univ Turin, Dept Med Sci, Genom Variat & Translat Res Unit, I-10126 Turin, Italy; [Allione, Alessandra; Russo, Alessia; Matullo, Giuseppe] Italian Inst Genom Med, I-10126 Turin, Italy; [Arp, Pascal P.; Broer, Linda; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Postbus 2040, NL-3000 CA Rotterdam, Netherlands; [Buxton, Jessica L.] Kingston Univ, Sch Life Sci Pharm & Chem, Kingston Upon Thames KT1 2EE, Surrey, England; [Buxton, Jessica L.] UCL Great Ormond St Inst Child Hlth, Genet & Genom Med Programme, London WC1N 1EH, England; [Alves, Alexessander Da Silva Couto; Riitta Jarvelin, Marjo] St Marys Hosp, Imperial Coll London, Sch Publ Hlth, London W2 1PG, England; [Alves, Alexessander Da Silva Couto] Univ Surrey, Sch Biosci & Med, Guildford GU2 7XH, England; [Deelen, Joris; Slagboom, P. Eline] Max Planck Inst Biol Ageing, D-50931 Cologne, Germany; [Deelen, Joris; Beekman, Marian; Suchiman, H. Eka; Slagboom, P. Eline] Leiden Univ, Dept Biomed Data Sci, Sect Mol Epidemiol, Med Ctr, POB 9600, NL-2300 Leiden, Netherlands; [Fedko, Iryna O.; Hottenga, Jouke-Jan; Willemsen, Gonneke; Boomsma, Dorret, I] Vrije Univ, Dept Biol Psychol, NL-1081 BT Amsterdam, Netherlands; [Gordon, Scott D.; Medland, Sarah E.; Nyholt, Dale R.; Martin, Nicholas G.] QIMR Berghofer Med Res Inst, Genet Epidemiol, Brisbane, Qld 4006, Australia; [Jiang, Tao; Butterworth, Adam S.; Danesh, John] Univ Cambridge, Dept Publ Hlth & Primary Care, BHF Cardiovasc Epidemiol Unit, Cambridge CB1 8RN, England; [Karlsson, Robert; Hagg, Sara; Pedersen, Nancy L.] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Loe, Taylor K.; Denchi, Eros Lazzerini] Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA; [Mangino, Massimo; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Mangino, Massimo] Guys & St Thomas Fdn Trust, NIHR Biomed Res Ctr, London SE1 9RT, England; [Milaneschi, Yuri; Verhoeven, Josine E.; Penninx, Brenda W. J. H.] Vrije Univ, Dept Psychiat, Amsterdam UMC, Amsterdam Publ Hlth, NL-1081 HJ Amsterdam, Netherlands; [Milaneschi, Yuri; Verhoeven, Josine E.; Penninx, Brenda W. J. H.] Vrije Univ, Dept Psychiat, Amsterdam UMC, Amsterdam Neurosci, NL-1081 HJ Amsterdam, Netherlands; [Miraglio, Benjamin; Surakka, Ida; Sillanpaa, Elina; Kaprio, Jaakko] Univ Helsinki, Inst Mol Med Finland FIMM, POB 20, FIN-00014 Helsinki, Finland; [Pervjakova, Natalia; Magi, Reedik; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, Inst Genom, EE-51010 Tartu, Estonia; [Surakka, Ida] Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [van der Spek, Ashley; Amin, Najaf; van Duijn, Cornelia M.] Erasmus MC, Dept Epidemiol, Postbus 2040, NL-3000 CA Rotterdam, Netherlands; [Blakemore, Alexandra, I] Brunel Univ London, Dept Life Sci, Uxbridge UB8 3PH, Middx, England; [Blakemore, Alexandra, I] Imperial Coll London, Dept Med, London W12 0HS, England; [Canzian, Federico] German Canc Res Ctr, Genom Epidemiol Grp, D-69120 Heidelberg, Germany; [Jousilahti, Pekka; Perola, Markus; Salomaa, Veikko] Finnish Inst Hlth & Welf, Dept Publ Hlth Solut, POB 30, FI-00271 Helsinki, Finland; [Montgomery, Grant W.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Nyholt, Dale R.] Queensland Univ Technol, Sch Biomed Sci, Brisbane, Qld 4059, Australia; [Nyholt, Dale R.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia; [Perola, Markus] Univ Helsinki, Fac Med, Res Program Clin & Mol Metab, Biomed 1,POB 63, FIN-00014 Helsinki, Finland; [Pietilainen, Kirsi H.] Univ Helsinki, Obes Res Unit, Res Program Clin & Mol Metab, Haartmaninkatun 8, FIN-00014 Helsinki, Finland; [Pietilainen, Kirsi H.] Helsinki Univ Hosp, Obes Ctr, Abdominal Ctr, Endocrinol, Haartmaninkatu 4, Helsinki 00029, Finland; [Pietilainen, Kirsi H.] Univ Helsinki, Haartmaninkatu 4, Helsinki 00029, Finland; [Sillanpaa, Elina] Univ Jyvaskyla, Fac Sport & Hlth Sci, Gerontol Res Ctr, POB 35, Jyvaskyla 40014, Finland; [van Heemst, Diana] Leiden Univ, Dept Internal Med, Sect Gerontol & Geriatr, Med Ctr, POB 9600, NL-2300 RC Leiden, Netherlands; [Agudo, Antonio] Bellvitge Biomed Res Inst IDIBELL, Catalan Inst Oncol ICO, Grp Res Nutr & Canc, Canc Epidemiol Res Program,Unit Nutr Environm & C, Barcelona 08908, Spain; [Boeing, Heiner] German Inst Human Nutr Potsdam Rehbrucke, D-14558 Nuthetal, Germany; [Chirlaque, Maria-Dolores] IMIB Arrixaca, Dept Epidemiol, Murcia Reg Hlth Council, Murcia 30008, Spain; [Chirlaque, Maria-Dolores] CIBER Epidemiol & Publ Hlth CIBERESP, Madrid 28029, Spain; [Fagherazzi, Guy; Rodriguez-Barranco, Miguel] Paris Sud Paris Saclay Univ, Ctr Res Epidemiol & Populat Hlth, INSERM, UMR 1018,Inst Gustave Roussy, F-94805 Villejuif, France; [Fagherazzi, Guy] Luxembourg Inst Hlth, Dept Populat Hlth, Digital Epidemiol Res Hub, L-1445 Strassen, Luxembourg; [Ferrari, Pietro; Gunter, Marc; Weiderpass, Elisabete] Int Agcy Res Canc, F-69372 Lyon, France; [Franks, Paul; Nilsson, Peter] Lund Univ, Skane Univ Hosp, Clin Res Ctr, Dept Clin Sci, S-20502 Malmo, Sweden; [Franks, Paul] Umea Univ, Dept Publ Hlth & Clin Med, S-90187 Umea, Sweden; [Gieger, Christian] Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, German Res Ctr Environm Hlth, D-85764 Neuherberg, Germany; [Gieger, Christian] German Ctr Diabet Res DZD EV, D-85764 Neuherberg, Germany; [Eriksson, Johan Gunnar] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan Gunnar] Univ Helsinki, Helsinki Univ Hosp, POB 20, FIN-00014 Helsinki, Finland; [Eriksson, Johan Gunnar] Univ Helsinki, Folkhalsan Res Ctr, POB 20, FIN-00014 Helsinki, Finland; [Eriksson, Johan Gunnar] Natl Univ Singapore, Yong Loo Lin Sch Med, Obstet & Gynaecol, Singapore 117597, Singapore; [Hovatta, Iiris] Univ Helsinki, SleepWell Res Program, Haartmaninkatu 3, FIN-00014 Helsinki, Finland; [Hovatta, Iiris] Univ Helsinki, Dept Psychol & Logoped, Haartmaninkatu 3, FIN-00014 Helsinki, Finland; [Imaz, Liher] Minist Hlth Basque Govt, Publ Hlth Div Gipuzkoa, Donostia San Sebastian 20013, Spain; [Imaz, Liher] Biodonostia Hlth Res Inst, Donostia San Sebastian 20014, Spain; [Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, POB 20, FIN-00014 Helsinki, Finland; [Kaaks, Rudolf] German Canc Res Ctr, Div Canc Epidemiol, D-69120 Heidelberg, Germany; [Key, Timothy] Univ Oxford, Nuffield Dept Populat Hlth, Canc Epidemiol Unit, Oxford OX3 7LF, England; [Krogh, Vittorio] Ist Nazl Tumori, Epidemiol & Prevent Unit, Fdn IRCCS, I-20133 Milan, Italy; [Melander, Olle] Lund Univ, Dept Clin Sci Hypertens & CardiovasC Dis, S-21428 Malmo, Sweden; [Moreno, Concha] Inst Salud Publ, Pamplona 31003, Spain; [Onland-Moret, N. Charlotte; van der Schouw, Yvonne T.] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3584 CG Utrecht, Netherlands; [Ong, Ken K.] Univ Cambridge, Dept Paediat, Cambridge CB2 0QQ, England; [Overvad, Kim] Aarhus Univ, Dept Publ Hlth, DK-8000 Aarhus, Denmark; [Overvad, Kim] Aalborg Univ Hosp, Dept Cardiol, DK-9000 Aalborg, Denmark; [Palli, Domenico] Inst Canc Res ISPRO, Canc Risk Factors & Life Style Epidemiol Unit, I-50139 Florence, Italy; [Panico, Salvatore] Univ Naples Federico II, Dipartimento Med Clin & Chirurgia, I-80131 Naples, Italy; [Ramon Quiros, J.] Publ Hlth Directorate, Consejeria Sanidad, Asturias 33006, Spain; [Riitta Jarvelin, Marjo] Imperial Coll London, Sch Epidemiol & Biostat, London SW7 2AZ, England; [Rodriguez-Barranco, Miguel] Andalusian Sch Publ Hlth EASP, Granada 18080, Spain; [Rodriguez-Barranco, Miguel] Inst Invest Biosanitaria IbsGRANADA, Granada 18012, Spain; [Severi, Gianluca] Univ Paris, Fac Med, CESP, F-94805 Villejuif, France; [Severi, Gianluca] Gustave Roussy, F-94805 Villejuif, France; [Severi, Gianluca] Univ Florence, Dept Stat Comp Sci Applicat G Parenti, I-50134 Florence, Italy; [Tjonneland, Anne] Danish Canc Soc Res Ctr, DK-2100 Copenhagen, Denmark; [Trichopoulou, Antonia] Hellen Hlth Fdn, Athens 11527, Greece; [Tumino, Rosario] Prov Hlth Author ASP, Canc Registry & Histopathol Dept, I-97100 Ragusa, Italy; [Tumino, Rosario] No Profit Org, Hyblean Assoc Res Epidemiol, I-97100 Ragusa, Italy; [van Duijn, Cornelia M.] Univ Oxford, Nuffield Dept Populat Hlth, Oxford OX3 7LF, England; [Denchi, Eros Lazzerini] NCI, Lab Chromosome Instabil, NIH, Bethesda, MD 20892 USA; [Butterworth, Adam S.; Danesh, John] Hlth Data Res UK Cambridge, Wellcome Genome Campus, Cambridge CB10 1SA, England; [Butterworth, Adam S.; Danesh, John] Univ Cambridge, Cambridge CB10 1SA, England; [Butterworth, Adam S.; Danesh, John] Univ Cambridge, Dept Publ Hlth & Primary Care, NIHR Blood & Transplant Res Unit Donor Hlth & Gen, Cambridge CB1 8RN, England; [Danesh, John] Wellcome Sanger Inst, Dept Human Genet, Hinxton CB10 1SA, England; [Butterworth, Adam S.; Danesh, John] Addenbrookes Hosp, BHF Cambridge Ctr Excellence, Sch Clin Med, Cambridge CB2 0QQ, England; [Butterworth, Adam S.; Danesh, John] Addenbrookes Hosp, NIHR Cambridge Biomed Res Ctr, Sch Clin Med, Cambridge CB2 0QQ, England	University of Cambridge; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Turin; Italian Institute for Genomic Medicine (IIGM); Erasmus University Rotterdam; Erasmus MC; Kingston University; University of London; University College London; Imperial College London; University of Surrey; Max Planck Society; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; QIMR Berghofer Medical Research Institute; University of Cambridge; Karolinska Institutet; Scripps Research Institute; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; University of Helsinki; University of Tartu; University of Michigan System; University of Michigan; Erasmus University Rotterdam; Erasmus MC; Brunel University; Imperial College London; Helmholtz Association; German Cancer Research Center (DKFZ); University of Queensland; Queensland University of Technology (QUT); Queensland University of Technology (QUT); University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Jyvaskyla; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Hospital Clinico Universitario Virgen de la Arrixaca; Murcia Regional Health Council; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Luxembourg Institute of Health; World Health Organization; International Agency for Research on Cancer (IARC); Lund University; Skane University Hospital; Umea University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; University of Helsinki; National University of Singapore; University of Helsinki; University of Helsinki; Basque Government; Instituto de Investigacion Sanitaria Biodonostia; University of Helsinki; Helmholtz Association; German Cancer Research Center (DKFZ); University of Oxford; Fondazione IRCCS Istituto Nazionale Tumori Milan; Lund University; Utrecht University; Utrecht University Medical Center; University of Cambridge; Aarhus University; Aalborg University; Aalborg University Hospital; University of Naples Federico II; Imperial College London; Escuela Andaluza de Salud Publica; Instituto de Investigacion Biosanitaria IBS Granada; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; UNICANCER; Gustave Roussy; University of Florence; Danish Cancer Society; University of Oxford; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Langenberg, C (corresponding author), Univ Cambridge, MRC, Epidemiol Unit, Cambridge CB2 0SL, England.; Codd, V (corresponding author), Univ Leicester, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England.; Codd, V (corresponding author), Glenfield Hosp, NIHR Leicester Biomed Res Ctr, Leicester LE3 9QP, Leics, England.	Claudia.Langenberg@mrc-epid.cam.ac.uk; vc15@leicester.ac.uk	Medland, Sarah/AAT-7595-2020; Severi, Gianluca/Q-1824-2019; Deelen, Joris/H-3201-2019; Fagherazzi, Guy/ABB-2555-2020; Weiderpass, Elisabete/AAP-2747-2021; Sillanpää, Elina/G-2602-2015; Fagherazzi, Guy/P-3534-2017; Gunter, Marc/AAP-8621-2020; Nyholt, Dale Robert/J-3174-2017; Buxton, Jessica/L-9849-2019; Li, Chen/GPX-2756-2022; Kaprio, Jaakko/A-1820-2008; Mägi, Reedik/AAJ-9679-2021; TRICHOPOULOU, ANTONIA/ABF-8727-2021; van der Schouw, Yvonne T./F-8327-2014; Boomsma, Dorret I/AAX-4470-2020; Mangino, Massimo/F-5134-2011; Krogh, Vittorio/K-2628-2016; Penninx, Brenda WJH/S-7627-2017; RODRIGUEZ-BARRANCO, MIGUEL/H-4541-2012; Hovatta, Iiris/D-6871-2012	Medland, Sarah/0000-0003-1382-380X; Severi, Gianluca/0000-0001-7157-419X; Deelen, Joris/0000-0003-4483-3701; Fagherazzi, Guy/0000-0001-5033-5966; Weiderpass, Elisabete/0000-0003-2237-0128; Sillanpää, Elina/0000-0001-6375-959X; Fagherazzi, Guy/0000-0001-5033-5966; Nyholt, Dale Robert/0000-0001-7159-3040; Li, Chen/0000-0002-6423-6325; Kaprio, Jaakko/0000-0002-3716-2455; TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; van der Schouw, Yvonne T./0000-0002-4605-435X; Mangino, Massimo/0000-0002-2167-7470; Krogh, Vittorio/0000-0003-0122-8624; Penninx, Brenda WJH/0000-0001-7779-9672; Overvad, Kim/0000-0001-6429-7921; RODRIGUEZ-BARRANCO, MIGUEL/0000-0002-9972-9779; Broer, Linda/0000-0003-0011-123X; Allione, Alessandra/0000-0001-9599-309X; Van Duijn, Cornelia/0000-0002-2374-9204; Kerrison, Nicola/0000-0002-1471-953X; Hovatta, Iiris/0000-0002-5990-7892; Fedko, Iryna/0000-0003-1962-916X; Pedersen, Nancy/0000-0001-8057-3543; Jones, Peter/0000-0002-6667-7562; Gordon, Scott/0000-0001-7623-328X; Gunter, Marc/0000-0001-5472-6761; Melander, Olle/0000-0002-2581-484X; Willemsen, Gonneke/0000-0003-3755-0236; Canzian, Federico/0000-0002-4261-4583; Surakka, Ida/0000-0002-6669-5541	European Union [HEALTH-F4-2007-201413]; European Union (Integrated Project of the European Community) [LSHM-CT-2006-037197]; UK Medical Research Council [MR/L003120/1]; British Heart Foundation [RG/13/13/30194, RG/18/13/33946]; European Commission Framework Programme 7 [HEALTH-F2-2012-279233]; National Institute for Health Research (Cambridge Biomedical Research Centre at the Cambridge University Hospitals National Health Service (NHS) Foundation Trust); British Heart Foundation (BHF); National Institute for Health Research (NIHR) Leicester Cardiovascular Biomedical Research Centre; Wellcome Trust; Medical Research Council [MC_UU_12015/1]; NIHR; MRC [MC_UU_12015/2, MC_UU_00006/2, MC_UU_12015/1, MR/L003120/1] Funding Source: UKRI	European Union(European Commission); European Union (Integrated Project of the European Community); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); European Commission Framework Programme 7; National Institute for Health Research (Cambridge Biomedical Research Centre at the Cambridge University Hospitals National Health Service (NHS) Foundation Trust); British Heart Foundation (BHF)(British Heart Foundation); National Institute for Health Research (NIHR) Leicester Cardiovascular Biomedical Research Centre; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The ENGAGE Project was funded under the European Union Framework 7-Health Theme (HEALTH-F4-2007-201413). The InterAct project received funding from the European Union (Integrated Project LSHM-CT-2006-037197 in the Framework Programme 6 of the European Community). The EPIC-CVD study was supported by core funding from the UK Medical Research Council (MR/L003120/1), the British Heart Foundation (RG/13/13/30194; RG/18/13/33946), the European Commission Framework Programme 7 (HEALTH-F2-2012-279233), and the National Institute for Health Research (Cambridge Biomedical Research Centre at the Cambridge University Hospitals National Health Service (NHS) Foundation Trust)[*]. C.P.N is funded by the British Heart Foundation (BHF). V.C., C.P.N., and N.J.S. are supported by the National Institute for Health Research (NIHR) Leicester Cardiovascular Biomedical Research Centre and N.J.S. holds an NIHR Senior Investigator award. Chen Li is support by a four-year Wellcome Trust PhD Studentship; C.L., L.A.L., and N.J.W. are funded by the Medical Research Council (MC_UU_12015/1). N.J.W. is an NIHR Senior Investigator. J.D. is funded by the NIHR (Senior Investigator Award).[*]. *The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care. Cohort-specific and further acknowledgments are given in the Supplemental Information.	Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Arnoult N, 2015, NAT STRUCT MOL BIOL, V22, P859, DOI 10.1038/nsmb.3092; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Austin WR, 2012, J EXP MED, V209, P2215, DOI 10.1084/jem.20121061; Barbeira AN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03621-1; Bartocci C, 2014, CELL REP, V7, P1320, DOI 10.1016/j.celrep.2014.04.002; BEBENEK K, 1992, J BIOL CHEM, V267, P3589; Beneke S, 2008, NUCLEIC ACIDS RES, V36, P6309, DOI 10.1093/nar/gkn615; Benetos A, 2004, HYPERTENSION, V43, P182, DOI 10.1161/01.HYP.0000113081.42868.f4; Blackburn EH, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003558; Blake JA, 2017, NUCLEIC ACIDS RES, V45, pD723, DOI 10.1093/nar/gkw1040; Bonder MJ, 2017, NAT GENET, V49, P131, DOI 10.1038/ng.3721; Bowden J, 2016, GENET EPIDEMIOL, V40, P304, DOI 10.1002/gepi.21965; Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080; Boyraz B, 2016, J CLIN INVEST, V126, P3377, DOI 10.1172/JCI87547; Broer L, 2013, EUR J HUM GENET, V21, P1163, DOI 10.1038/ejhg.2012.303; Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Burgess S, 2013, GENET EPIDEMIOL, V37, P658, DOI 10.1002/gepi.21758; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chen L, 2016, CELL, V167, P1398, DOI 10.1016/j.cell.2016.10.026; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; Codd V, 2010, NAT GENET, V42, P197, DOI 10.1038/ng.532; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Danesh J, 2007, EUR J EPIDEMIOL, V22, P129, DOI 10.1007/s10654-006-9096-8; Davidson MB, 2012, EMBO J, V31, P895, DOI 10.1038/emboj.2011.485; de Lange T, 2018, ANNU REV GENET, V52, P223, DOI 10.1146/annurev-genet-032918-021921; Delgado DA, 2018, J MED GENET, V55, P64, DOI 10.1136/jmedgenet-2017-104922; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Dorajoo R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10443-2; Nguyen D, 2015, CELL REP, V13, P2244, DOI 10.1016/j.celrep.2015.11.003; Egan ED, 2012, RNA, V18, P1747, DOI 10.1261/rna.034629.112; Elizabeth CL, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0547-4; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Fortune MD, 2015, NAT GENET, V47, P839, DOI 10.1038/ng.3330; Franzolin E, 2013, P NATL ACAD SCI USA, V110, P14272, DOI 10.1073/pnas.1312033110; Gamazon ER, 2015, NAT GENET, V47, P1091, DOI 10.1038/ng.3367; Garvin AJ, 2013, EMBO REP, V14, P975, DOI 10.1038/embor.2013.141; Gaunt TR, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0926-z; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Gomez M, 2006, MOL BIOL CELL, V17, P1686, DOI 10.1091/mbc.E05-07-0672; Guo H, 2015, HUM MOL GENET, V24, P3305, DOI 10.1093/hmg/ddv077; Gusev A, 2016, NAT GENET, V48, P245, DOI 10.1038/ng.3506; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Haycock PC, 2017, JAMA ONCOL, V3, P636, DOI 10.1001/jamaoncol.2016.5945; Hemani G, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007081; Holohan B, 2014, J CELL BIOL, V205, P289, DOI 10.1083/jcb.201401012; Iles MM, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju267; Irwin CR, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00229; Jin Y, 2016, NAT GENET, V48, P1418, DOI 10.1038/ng.3680; Jobert L, 2013, MOL CELL, V49, P339, DOI 10.1016/j.molcel.2012.11.010; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kim MK, 2008, J BIOL CHEM, V283, P14144, DOI 10.1074/jbc.M710065200; Knies K, 2017, J CLIN INVEST, V127, P3013, DOI 10.1172/JCI92069; Krenciute G, 2013, J BIOL CHEM, V288, P20547, DOI 10.1074/jbc.M112.443416; Kurz DJ, 2006, ARTERIOSCL THROM VAS, V26, pE114, DOI 10.1161/01.ATV.0000222961.24912.69; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Langenberg C, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001647; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Levy D, 2010, P NATL ACAD SCI USA, V107, P9293, DOI 10.1073/pnas.0911494107; Liu SF, 2011, J BIOL CHEM, V286, P22314, DOI 10.1074/jbc.M111.222802; Magi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-288; Mangino M, 2015, J MED GENET, V52, P157, DOI 10.1136/jmedgenet-2014-102681; Mangino M, 2012, HUM MOL GENET, V21, P5385, DOI 10.1093/hmg/dds382; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Mi HY, 2019, NUCLEIC ACIDS RES, V47, pD419, DOI 10.1093/nar/gky1038; Nelson CP, 2017, NAT GENET, V49, P1385, DOI 10.1038/ng.3913; Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; Ojha J, 2016, CANCER EPIDEM BIOMAR, V25, P1043, DOI 10.1158/1055-9965.EPI-15-1329; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Pooley KA, 2013, HUM MOL GENET, V22, P5056, DOI 10.1093/hmg/ddt355; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; Schilders G, 2005, NUCLEIC ACIDS RES, V33, P6795, DOI 10.1093/nar/gki982; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Staley JR, 2016, BIOINFORMATICS, V32, P3207, DOI 10.1093/bioinformatics/btw373; Steer SE, 2007, ANN RHEUM DIS, V66, P476, DOI 10.1136/ard.2006.059188; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Tong AS, 2015, CELL REP, V13, P1633, DOI 10.1016/j.celrep.2015.10.041; van der Harst P, 2007, J AM COLL CARDIOL, V49, P1459, DOI 10.1016/j.jacc.2007.01.027; Wang J, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gky057; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang XG, 2007, BIOCHEM BIOPH RES CO, V354, P122, DOI 10.1016/j.bbrc.2006.12.162; Wentzensen IM, 2011, CANCER EPIDEM BIOMAR, V20, P1238, DOI 10.1158/1055-9965.EPI-11-0005; Wright DJ, 2017, NAT GENET, V49, P674, DOI 10.1038/ng.3821; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhan YQ, 2015, JAMA NEUROL, V72, P1202, DOI 10.1001/jamaneurol.2015.1513; Zhang CA, 2015, HUM MOL GENET, V24, P5356, DOI 10.1093/hmg/ddv252; Zhao Q., 2018, ARXIV; Zheng J, 2017, BIOINFORMATICS, V33, P272, DOI 10.1093/bioinformatics/btw613; Zhu X, 2016, SCI REP-UK, V6, DOI 10.1038/srep22243	100	56	57	3	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 5	2020	106	3					389	404		10.1016/j.ajhg.2020.02.006	http://dx.doi.org/10.1016/j.ajhg.2020.02.006			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KT6CT	32109421	hybrid, Green Published, Green Submitted, Green Accepted			2022-12-18	WOS:000519101800015
J	Cox, LL; Cox, TC; Uribe, LMM; Zhu, Y; Richter, CT; Nidey, N; Standley, JM; Deng, M; Blue, E; Chong, JX; Yang, YQ; Carstens, RP; Anand, D; Lachke, SA; Smith, JD; Dorschner, MO; Bedell, B; Kirk, E; Hing, AV; Venselaar, H; Valencia-Ramirez, LC; Bamshad, MJ; Glass, IA; Cooper, JA; Haan, E; Nickerson, DA; van Bokhoven, H; Zhou, HQ; Krahn, KN; Buckley, MF; Murray, JC; Lidral, AC; Roscioli, T				Cox, Liza L.; Cox, Timothy C.; Uribe, Lina M. Moreno; Zhu, Ying; Richter, Chika T.; Nidey, Nichole; Standley, Jennifer M.; Deng, Mei; Blue, Elizabeth; Chong, Jessica X.; Yang, Yueqin; Carstens, Russ P.; Anand, Deepti; Lachke, Salil A.; Smith, Joshua D.; Dorschner, Michael O.; Bedell, Bruce; Kirk, Edwin; Hing, Anne, V; Venselaar, Hanka; Valencia-Ramirez, Luz C.; Bamshad, Michael J.; Glass, Ian A.; Cooper, Jonathan A.; Haan, Eric; Nickerson, Deborah A.; van Bokhoven, Hans; Zhou, Huiqing; Krahn, Katy N.; Buckley, Michael F.; Murray, Jeffrey C.; Lidral, Andrew C.; Roscioli, Tony			Mutations in the Epithelial Cadherin-p120-Catenin Complex Cause Mendelian Non-Syndromic Cleft Lip with or without Cleft Palate	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							E-CADHERIN; P120 CATENIN; MESENCHYMAL TRANSITION; RARE VARIANTS; CELL-ADHESION; ORAL CLEFTS; C-CADHERIN; GENE; CANCER; CDH1	Non-syndromic cleft lip with or without cleft palate (NS-CL/P) is one of the most common human birth defects and is generally considered a complex trait. Despite numerous loci identified by genome-wide association studies, the effect sizes of common variants are relatively small, with much of the presumed genetic contribution remaining elusive. We report exome-sequencing results in 209 people from 72 multi-affected families with pedigree structures consistent with autosomal-dominant inheritance and variable penetrance. Herein, pathogenic variants are described in four genes encoding components of the p120-catenin complex (CTNND1, PLEKHA7, PLEKHA5) and an epithelial splicing regulator (ESRP2), in addition to the known CL/P-associated gene, CDH1, which encodes E-cadherin. The findings were also validated in a second cohort of 497 people with NS-CL/P, comprising small families and singletons with pathogenic variants in these genes identified in 14% of multi-affected families and 2% of the replication cohort of smaller families. Enriched expression of each gene/protein in human and mouse embryonic oro-palatal epithelia, demonstration of functional impact of CTNND1 and ESRP2 variants, and recapitulation of the CL/P spectrum in Ctnnd1 knockout mice support a causative role in CL/P pathogenesis. These data show that primary defects in regulators of epithelial cell adhesion are the most significant contributors to NS-CL/P identified to date and that inherited and de novo single gene variants explain a substantial proportion of NS-CL/P.	[Cox, Liza L.; Cox, Timothy C.; Hing, Anne, V] Univ Washington, Dept Pediat, Div Craniofacial Med, Seattle, WA 98195 USA; [Cox, Liza L.; Cox, Timothy C.] Seattle Childrens Res Inst, Ctr Dev Biol & Regenerat Med, Seattle, WA 98101 USA; [Cox, Liza L.; Cooper, Jonathan A.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Cox, Timothy C.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia; [Uribe, Lina M. Moreno; Richter, Chika T.] Univ Iowa, Dept Orthodont, Iowa City, IA 52242 USA; [Uribe, Lina M. Moreno; Richter, Chika T.] Univ Iowa, Iowa Inst Oral Hlth Res, Iowa City, IA 52242 USA; [Zhu, Ying; Kirk, Edwin; Buckley, Michael F.] Prince Wales Hosp, New South Wales Hlth Pathol, Randwick, NSW 2031, Australia; [Zhu, Ying] Genet Learning Disabil Serv, Waratah, NSW 2298, Australia; [Nidey, Nichole; Standley, Jennifer M.; Bedell, Bruce; Murray, Jeffrey C.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Deng, Mei; Glass, Ian A.] Univ Washington, Birth Defects Res Lab, Seattle, WA 98195 USA; [Blue, Elizabeth] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Chong, Jessica X.; Bamshad, Michael J.; Glass, Ian A.] Univ Washington, Dept Pediat, Div Genet Med, Seattle, WA 98195 USA; [Yang, Yueqin; Carstens, Russ P.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Carstens, Russ P.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Anand, Deepti; Lachke, Salil A.] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA; [Smith, Joshua D.; Bamshad, Michael J.; Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Dorschner, Michael O.] Univ Washington, Ctr Precis Diagnost, Northwest Clin Genom Lab, Seattle, WA 98195 USA; [Dorschner, Michael O.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Kirk, Edwin; Roscioli, Tony] Sydney Childrens Hosp, Ctr Clin Genet, Sydney, NSW 2031, Australia; [Hing, Anne, V] Seattle Childrens Hosp, Seattle Craniofacial Ctr, Seattle, WA 98105 USA; [Venselaar, Hanka] Radboud Univ Nijmegen, Ctr Mol & Biomol Informat, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Valencia-Ramirez, Luz C.] Fdn Clin Noel, Medellin 050021, Colombia; [Haan, Eric] SA Pathol, Womens & Childrens Hosp, South Australian Clin Genet Serv, Adelaide, SA 5006, Australia; [Haan, Eric] Univ Adelaide, Sch Med, Adelaide, SA 5000, Australia; [van Bokhoven, Hans; Zhou, Huiqing] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [van Bokhoven, Hans] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, NL-6500 HB Nijmegen, Netherlands; [Zhou, Huiqing] Radboud Univ Nijmegen, Dept Mol Dev Biol, Radboud Inst Mol Life Sci, NL-6525 GA Nijmegen, Netherlands; [Krahn, Katy N.] Univ Virginia, Sch Med, UVA Ctr Adv Med Analyt, Charlottesville, VA 22908 USA; [Lidral, Andrew C.] Lidral Orthodont, Rockford, MI 49341 USA; [Roscioli, Tony] Univ New South Wales, Prince Wales Clin Sch, Randwick, NSW 2031, Australia; [Roscioli, Tony] Neurosci Res Australia, Sydney, NSW 2031, Australia	University of Washington; University of Washington Seattle; Seattle Children's Hospital; Fred Hutchinson Cancer Center; Monash University; University of Iowa; University of Iowa; University of Iowa; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Delaware; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Sydney; Seattle Children's Hospital; Radboud University Nijmegen; SA Pathology; University of Adelaide; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Virginia; University of New South Wales Sydney; Neuroscience Research Australia	Cox, TC (corresponding author), Univ Washington, Dept Pediat, Div Craniofacial Med, Seattle, WA 98195 USA.; Cox, TC (corresponding author), Seattle Childrens Res Inst, Ctr Dev Biol & Regenerat Med, Seattle, WA 98101 USA.; Cox, TC (corresponding author), Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia.; Roscioli, T (corresponding author), Sydney Childrens Hosp, Ctr Clin Genet, Sydney, NSW 2031, Australia.; Roscioli, T (corresponding author), Univ New South Wales, Prince Wales Clin Sch, Randwick, NSW 2031, Australia.; Roscioli, T (corresponding author), Neurosci Res Australia, Sydney, NSW 2031, Australia.	tccox@uw.edu; tony.roscioli@health.nsw.gov.au	Venselaar, Hanka/D-2009-2016; Zhou, Huiqing/B-1721-2013; Zhou, Jo Huiqing/ADR-5134-2022; Anand, Deepti/Y-5645-2019; Bokhoven, J.H.L.M. van van/H-8015-2014; Chong, Jessica/GZH-1625-2022	Venselaar, Hanka/0000-0001-9824-6559; Zhou, Huiqing/0000-0002-2434-3986; Zhou, Jo Huiqing/0000-0002-2434-3986; Anand, Deepti/0000-0003-1720-9962; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Kirk, Edwin/0000-0002-4662-0024; Chong, Jessica/0000-0002-1616-2448; Lachke, Salil/0000-0001-8845-010X; Blue, Elizabeth/0000-0002-0633-0305	Australian National Health & Medical Research Council [AU/1/BA51117]; Laurel Foundation for Pediatric Craniofacial Research; NIH [R01-DE014667, R37-DE008559, R24-HD000836, R03-DE024776, UM1-HG006493]; March of Dimes Basil O'Connor award [FY 98-0718, 6-FY01-616]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD000836] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE008559, R03DE024776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014667] Funding Source: NIH RePORTER	Australian National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Laurel Foundation for Pediatric Craniofacial Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Basil O'Connor award(March of Dimes); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank all families that put their faith in our research program for without them, none of this would be possible. We are grateful for the technical assistance of Bruce Bedell (University of Iowa), Ryan Anderson (Seattle Children's Research Institute), and Theresa Naluai-Cecchini (Birth Defects Research Laboratory, University of Washington). Many nurses, physicians, community health care workers, and laboratory staff who both provide care to the families and facilitated sample collection were essential to this study including Sandy Daack-Hirsch and Operation Smile. This work was supported by a project grant from the Australian National Health & Medical Research Council (AU/1/BA51117) to T.R., M.F.B., H.Z., H.v.B., T.C.C., J.C.M., D.A.N., E.K., and A.C.L., the Laurel Foundation for Pediatric Craniofacial Research (T.C.C.), NIH R01-DE014667 (A.C.L.), NIH R37-DE008559 (J.C.M.), the March of Dimes Basil O'Connor award #FY 98-0718 and research grant #6-FY01-616 (A.C.L.), NIH R24-HD000836 (I.A.G., T.C.C., M.D.), NIH R03-DE024776 (S.A.L.), and NIH UM1-HG006493 (D.A.N., M.J.B.). We would like to thank Aaron Quinlan for devising and assisting with the bioinformatics analysis platform, GEMINI. Mice were housed at the Seattle Children's Research Institute and all work approved by the Animal Care and Use Committee (#14614). Human fetal tissues were recovered under an approved protocol through the University of Washington (IRB# STUDY00000380). Families were enrolled into the study under the respective institutional review board protocols (AU/1/BA51117), Genetics of CL/P: a multicenter international consortium (PIROSTUDY10777), and the University of Iowa IRB (200109094).	Anastasiadis PZ, 2000, J CELL SCI, V113, P1319; Beaty Terri H, 2016, F1000Res, V5, P2800; Bebee TW, 2015, ELIFE, V4, DOI 10.7554/eLife.08954; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; Brito LA, 2015, HUM MUTAT, V36, P1029, DOI 10.1002/humu.22827; DANIEL JM, 1995, MOL CELL BIOL, V15, P4819; Davis MA, 2006, DEV CELL, V10, P21, DOI 10.1016/j.devcel.2005.12.004; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933; Ghoumid J, 2017, GENET MED, V19, P1013, DOI 10.1038/gim.2017.11; Hozyasz KK, 2014, FAM CANCER, V13, P415, DOI 10.1007/s10689-014-9727-2; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Ishiyama N, 2010, CELL, V141, P117, DOI 10.1016/j.cell.2010.01.017; Ittiwut R, 2016, GENET TEST MOL BIOMA, V20, P406, DOI 10.1089/gtmb.2015.0325; Kurita S, 2013, J BIOL CHEM, V288, P29356, DOI 10.1074/jbc.M113.453464; Lee YS, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-4-r55; Leslie EJ, 2013, AM J MED GENET C, V163, P246, DOI 10.1002/ajmg.c.31381; Leslie EJ, 2012, BIRTH DEFECTS RES A, V94, P934, DOI 10.1002/bdra.23076; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu H, 2017, BIRTH DEFECTS RES, V109, P27, DOI 10.1002/bdra.23596; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; MITCHELL LE, 1992, AM J HUM GENET, V51, P323; Mostowska A, 2018, CLIN GENET, V93, P784, DOI 10.1111/cge.13141; Nykamp K, 2017, GENET MED, V19, P1105, DOI 10.1038/gim.2017.37; Paila U, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003153; Paschoud S, 2014, TISSUE BARRIERS, V2, DOI 10.4161/tisb.28755; Peifer M, 2003, J CELL BIOL, V163, P437, DOI 10.1083/jcb.200310090; Petrova YI, 2016, MOL BIOL CELL, V27, P3233, DOI 10.1091/mbc.E16-01-0058; Phan M, 2016, HUM GENET, V135, P1299, DOI 10.1007/s00439-016-1733-z; Prakasam A, 2006, BIOCHEMISTRY-US, V45, P6930, DOI 10.1021/bi060213m; Pulimeno P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012207; Rafighdoost H, 2013, CLEFT PALATE-CRAN J, V50, pE98, DOI 10.1597/12-144; Rahimov F, 2012, CLEFT PALATE-CRAN J, V49, P73, DOI 10.1597/10-178; Reynolds AB, 2004, SEMIN CELL DEV BIOL, V15, P657, DOI 10.1016/j.semcdb.2004.09.003; Riley BM, 2007, AM J MED GENET A, V143A, P3228, DOI 10.1002/ajmg.a.31965; Riley BM, 2007, P NATL ACAD SCI USA, V104, P4512, DOI 10.1073/pnas.0607956104; Savastano CP, 2017, CLIN GENET, V91, P683, DOI 10.1111/cge.12823; Schock EN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174206; Shepard T.H., 1975, ENDOCRINE GENETIC DI, P1; Sotomayor M, 2008, BIOPHYS J, V94, P4621, DOI 10.1529/biophysj.107.125591; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Tamasas B, 2017, J DENT RES, V96, P315, DOI 10.1177/0022034516679376; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Warzecha CC, 2010, EMBO J, V29, P3286, DOI 10.1038/emboj.2010.195; Warzecha CC, 2009, RNA BIOL, V6, P546, DOI 10.4161/rna.6.5.9606; Yang YQ, 2016, MOL CELL BIOL, V36, P1704, DOI 10.1128/MCB.00019-16; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779; Yu YQ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14364; Zou Y, 2013, BIOCELL, V37, P55	51	56	56	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 7	2018	102	6					1143	1157		10.1016/j.ajhg.2018.04.009	http://dx.doi.org/10.1016/j.ajhg.2018.04.009			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GJ0LP	29805042	Green Published, Bronze			2022-12-18	WOS:000434946200011
J	Shen, QC; Cheng, FX; Song, HL; Lu, WQ; Zhao, JF; An, XL; Liu, MY; Chen, GQ; Zhao, ZM; Zhang, J				Shen, Qiancheng; Cheng, Feixiong; Song, Huili; Lu, Weiqiang; Zhao, Junfei; An, Xiaoli; Liu, Mingyao; Chen, Guoqiang; Zhao, Zhongming; Zhang, Jian			Proteome-Scale Investigation of Protein Allosteric Regulation Perturbed by Somatic Mutations in 7,000 Cancer Genomes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SIGNIFICANTLY MUTATED GENES; HUMAN PHOSPHODIESTERASE; MISSENSE MUTATION; DRIVER MUTATIONS; NETWORK; DATABASE; REVEALS; KINASE; MODELS; PRIORITIZATION	The allosteric regulation triggering the protein's functional activity via conformational changes is an intrinsic function of protein under many physiological and pathological conditions, including cancer. Identification of the biological effects of specific somatic variants on allosteric proteins and the phenotypes that they alter during tumor initiation and progression is a central challenge for cancer genomes in the post-genomic era. Here, we mapped more than 47,000 somatic missense mutations observed in approximately 7,000 tumor-normal matched samples across 33 cancer types into protein allosteric sites to prioritize the mutated allosteric proteins and we tested our prediction in cancer cell lines. We found that the deleterious mutations identified in cancer genomes were more significantly enriched at protein allosteric sites than tolerated mutations, suggesting a critical role for protein allosteric variants in cancer. Next, we developed a statistical approach, namely AlloDriver, and further identified 15 potential mutated allosteric proteins during pan-cancer and individual cancer-type analyses. More importantly, we experimentally confirmed that p.Pro360Ala on PDE10A played a potential oncogenic role in mediating tumorigenesis in non-small cell lung cancer (NSCLC). In summary, these findings shed light on the role of allosteric regulation during tumorigenesis and provide a useful tool for the timely development of targeted cancer therapies.	[Shen, Qiancheng; Song, Huili; An, Xiaoli; Chen, Guoqiang; Zhang, Jian] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Tumor Microenvironm & Inflammat, Minist Educ,Dept Pathophysiol,Key Lab Cell Differ, Shanghai 200025, Peoples R China; [Cheng, Feixiong] Sichuan Univ, West China Med Sch, West China Hosp, State Key Lab Biotherapy,Collaborat Innovat Ctr B, Chengdu 610041, Peoples R China; [Cheng, Feixiong; Zhao, Junfei] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37203 USA; [Lu, Weiqiang; Liu, Mingyao] East China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China; [Lu, Weiqiang; Liu, Mingyao] East China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China; [Zhao, Zhongming] Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Ctr Precis Hlth, Houston, TX 77030 USA; [Cheng, Feixiong] Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02215 USA; [Cheng, Feixiong] Northeastern Univ, Ctr Complex Networks Res, Boston, MA 02115 USA	Shanghai Jiao Tong University; Sichuan University; Vanderbilt University; East China Normal University; East China Normal University; University of Texas System; University of Texas Health Science Center Houston; Harvard University; Dana-Farber Cancer Institute; Northeastern University	Zhang, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Tumor Microenvironm & Inflammat, Minist Educ,Dept Pathophysiol,Key Lab Cell Differ, Shanghai 200025, Peoples R China.; Zhao, ZM (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Ctr Precis Hlth, Houston, TX 77030 USA.	zhongming.zhao@uth.tmc.edu; jian.zhang@sjtu.edu.cn	Zhao, Junfei/J-1425-2018; Zhang, Jian/GXA-1303-2022	Zhang, Jian/0000-0002-6558-791X; chen, guo qiang/0000-0003-4936-2363; Cheng, Feixiong/0000-0002-1736-2847; lu, weiqiang/0000-0003-1349-6597	National High-tech R&D Program of China (863 Program) [2015AA020108]; National Natural Science Foundation of China [81322046, 81473137, 81302698, 81573020]; NIH [R01LM011177]; NATIONAL LIBRARY OF MEDICINE [R01LM011177] Funding Source: NIH RePORTER	National High-tech R&D Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was partially supported by the National High-tech R&D Program of China (863 Program) (2015AA020108) and the National Natural Science Foundation of China (81322046, 81473137, and 81302698) to J.Z., the National Natural Science Foundation of China (81573020) to F.C., and the NIH (R01LM011177) to Z.Z. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Benita Y, 2010, BLOOD, V115, P5376, DOI 10.1182/blood-2010-01-263855; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bezginov A, 2013, MOL BIOL EVOL, V30, P332, DOI 10.1093/molbev/mss218; Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147; Cancer Genome Atlas Research Network, 2013, Nat Genet, V45, P1113, DOI 10.1038/ng.2764; Cancer Genome Atlas Research Network, 2018, Nature, V559, pE12, DOI [10.1038/nature13385, 10.1038/s41586-018-0228-6]; Capra JA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002567; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Chen X, 2004, CURR CANCER DRUG TAR, V4, P267, DOI 10.2174/1568009043333041; Cheng FX, 2016, BRIEF BIOINFORM, V17, P642, DOI 10.1093/bib/bbv068; Cheng FX, 2016, J AM MED INFORM ASSN, V23, P681, DOI 10.1093/jamia/ocw007; Cheng FX, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004497; Cheng FX, 2014, MOL BIOL EVOL, V31, P2156, DOI 10.1093/molbev/msu167; Cheng FX, 2014, ONCOTARGET, V5, P3697, DOI 10.18632/oncotarget.1984; Cheng FX, 2013, MOL BIOSYST, V9, P1316, DOI 10.1039/c3mb25309k; Cheng FX, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002503; Cowley MJ, 2012, NUCLEIC ACIDS RES, V40, pD862, DOI 10.1093/nar/gkr967; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; De Smet F, 2014, NAT BIOTECHNOL, V32, P1113, DOI 10.1038/nbt.3028; Dinkel H, 2011, NUCLEIC ACIDS RES, V39, pD261, DOI 10.1093/nar/gkq1104; Eisenberg D, 2000, NATURE, V405, P823, DOI 10.1038/35015694; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Fujishige K, 1999, J BIOL CHEM, V274, P18438, DOI 10.1074/jbc.274.26.18438; Goncearenco A, 2013, NUCLEIC ACIDS RES, V41, pW266, DOI 10.1093/nar/gkt460; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Handa N, 2008, J BIOL CHEM, V283, P19657, DOI 10.1074/jbc.M800595200; Hirsh AE, 2005, MOL BIOL EVOL, V22, P174, DOI 10.1093/molbev/msh265; Hobbs GA, 2016, J CELL SCI, V129, P1287, DOI 10.1242/jcs.182873; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hu JF, 2014, BIOINFORMATICS, V30, P141, DOI 10.1093/bioinformatics/btt627; Huang S, 2009, SEMIN CELL DEV BIOL, V20, P869, DOI 10.1016/j.semcdb.2009.07.003; Huang ZM, 2014, NUCLEIC ACIDS RES, V42, pD510, DOI 10.1093/nar/gkt1247; Huang ZM, 2011, NUCLEIC ACIDS RES, V39, pD663, DOI 10.1093/nar/gkq1022; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Kamburov A, 2015, P NATL ACAD SCI USA, V112, pE5486, DOI 10.1073/pnas.1516373112; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Le Guilloux V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-168; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Martin ACR, 2005, BIOINFORMATICS, V21, P4297, DOI 10.1093/bioinformatics/bti694; Mitternacht S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002148; Newman RH, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.12; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nussinov R, 2013, CELL, V153, P293, DOI 10.1016/j.cell.2013.03.034; Pe'er D, 2011, CELL, V144, P864, DOI 10.1016/j.cell.2011.03.001; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Schmidtke P, 2011, BIOINFORMATICS, V27, P3276, DOI 10.1093/bioinformatics/btr550; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Skora L, 2013, P NATL ACAD SCI USA, V110, pE4437, DOI 10.1073/pnas.1314712110; Slattery ML, 2012, CARCINOGENESIS, V33, P2398, DOI 10.1093/carcin/bgs305; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Tzoneva G, 2013, NAT MED, V19, P368, DOI 10.1038/nm.3078; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Vuong H, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0081-7; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wenthur CJ, 2014, ANNU REV PHARMACOL, V54, P165, DOI 10.1146/annurev-pharmtox-010611-134525; Yi KH, 2013, ONCOTARGET, V4, P29, DOI 10.18632/oncotarget.755; Zhang L, 2008, CIRC RES, V102, P1426, DOI 10.1161/CIRCRESAHA.107.167783; Zhang ML, 2011, AM J HUM GENET, V88, P755, DOI 10.1016/j.ajhg.2011.05.006; Zhao GC, 2004, EARTH-SCI REV, V67, P91, DOI 10.1016/j.earscirev.2004.02.003; Zhao JF, 2016, MOL CELL PROTEOMICS, V15, P642, DOI 10.1074/mcp.M115.053199; Zhao QN, 2015, CANCER BIOL THER, V16, P634, DOI 10.1080/15384047.2015.1029835; Zhong Q, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.80	69	56	57	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 5	2017	100	1					5	20		10.1016/j.ajhg.2016.09.020	http://dx.doi.org/10.1016/j.ajhg.2016.09.020			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EH6UX	27939638	Green Published, Bronze			2022-12-18	WOS:000391910500001
J	Kremer, LS; Danhauser, K; Herebian, D; Ramadza, DP; Piekutowska-Abramczuk, D; Seibt, A; Muller-Felber, W; Haack, TB; Ploski, R; Lohmeier, K; Schneider, D; Klee, D; Rokicki, D; Mayatepek, E; Strom, TM; Meitinger, T; Klopstock, T; Pronicka, E; Mayr, JA; Baric, I; Distelmaier, F; Prokisch, H				Kremer, Laura S.; Danhauser, Katharina; Herebian, Diran; Ramadza, Danijela Petkovic; Piekutowska-Abramczuk, Dorota; Seibt, Annette; Mueller-Felber, Wolfgang; Haack, Tobias B.; Ploski, Rafal; Lohmeier, Klaus; Schneider, Dominik; Klee, Dirk; Rokicki, Dariusz; Mayatepek, Ertan; Strom, Tim M.; Meitinger, Thomas; Klopstock, Thomas; Pronicka, Ewa; Mayr, Johannes A.; Baric, Ivo; Distelmaier, Felix; Prokisch, Holger			NAXE Mutations Disrupt the Cellular NAD(P)HX Repair System and Cause a Lethal Neurometabolic Disorder of Early Childhood	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HYPERTROPHIC CARDIOMYOPATHY; SKIN RASH; PELLAGRA; ACIDURIA; NADPH	To safeguard the cell from the accumulation of potentially harmful metabolic intermediates, specific repair mechanisms have evolved. APOA1BP, now renamed NAXE, encodes an epimerase essential in the cellular metabolite repair for NADHX and NADPHX. The enzyme catalyzes the epimerization of NAD(P)HX, thereby avoiding the accumulation of toxic metabolites. The clinical importance of the NAD(P)HX repair system has been unknown. Exome sequencing revealed pathogenic biallelic mutations in NAXE in children from four families with (sub-) acute-onset ataxia, cerebellar edema, spinal myelopathy, and skin lesions. Lactate was elevated in cerebrospinal fluid of all affected individuals. Disease onset was during the second year of life and clinical signs as well as episodes of deterioration were triggered by febrile infections. Disease course was rapidly progressive, leading to coma, global brain atrophy, and finally to death in all affected individuals. NAXE levels were undetectable in fibroblasts from affected individuals of two families. In these fibroblasts we measured highly elevated concentrations of the toxic metabolite cyclic-NADHX, confirming a deficiency of the mitochondrial NAD(P)HX repair system. Finally, NAD or nicotinic acid (vitamin B3) supplementation might have therapeutic implications for this fatal disorder.	[Kremer, Laura S.; Haack, Tobias B.; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Kremer, Laura S.; Haack, Tobias B.; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Danhauser, Katharina; Herebian, Diran; Seibt, Annette; Lohmeier, Klaus; Mayatepek, Ertan; Distelmaier, Felix] Univ Dusseldorf, Univ Childrens Hosp, Dept Gen Pediat Neonatol & Pediat Cardiol, D-40225 Dusseldorf, Germany; [Ramadza, Danijela Petkovic; Baric, Ivo] Univ Hosp Ctr, Dept Pediat, Zagreb 10000, Croatia; [Piekutowska-Abramczuk, Dorota; Pronicka, Ewa] Childrens Mem Hlth Inst, Dept Med Genet, PL-04730 Warsaw, Poland; [Mueller-Felber, Wolfgang] Univ Munich, Dept Pediat Neurol & Dev Med, D-80337 Munich, Germany; [Ploski, Rafal] Med Univ Warsaw, Dept Med Genet, PL-02106 Warsaw, Poland; [Schneider, Dominik] Clin Pediat, D-44137 Dortmund, Germany; [Klee, Dirk] Univ Dusseldorf, Fac Med, Dept Diagnost & Intervent Radiol, D-40225 Dusseldorf, Germany; [Rokicki, Dariusz; Pronicka, Ewa] Childrens Mem Hlth Inst, Dept Med Genet, Dept Pediat Nutr & Metab Dis, PL-04730 Warsaw, Poland; [Meitinger, Thomas; Klopstock, Thomas] Munich Cluster Syst Neurol SyNergy, D-81377 Munich, Germany; [Klopstock, Thomas] Univ Munich, Friedrich Baur Inst, Dept Neurol, D-80336 Munich, Germany; [Klopstock, Thomas] German Ctr Neurodegenerat Dis DZNE, D-80336 Munich, Germany; [Mayr, Johannes A.] Paracelsus Med Univ, Dept Pediat, A-5020 Salzburg, Austria; [Baric, Ivo] Univ Zagreb, Sch Med, Zagreb 10000, Croatia	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Heinrich Heine University Dusseldorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Zagreb; Children's Memorial Health Institute; University of Munich; Medical University of Warsaw; Heinrich Heine University Dusseldorf; Children's Memorial Health Institute; University of Munich; University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Paracelsus Private Medical University; University of Zagreb	Prokisch, H (corresponding author), Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany.; Prokisch, H (corresponding author), Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany.; Distelmaier, F (corresponding author), Univ Dusseldorf, Univ Childrens Hosp, Dept Gen Pediat Neonatol & Pediat Cardiol, D-40225 Dusseldorf, Germany.	felix.distelmaier@med.uni-duesseldorf.de; prokisch@helmholtz-muenchen.de	Herebian, Diran/A-1440-2017; Meitinger, Thomas/O-1318-2015; Ramadža, Danijela Petković/AAQ-7287-2021	Prokisch, Holger/0000-0003-2379-6286; Pronicka, Ewa/0000-0002-5705-4814; Rokicki, Dariusz/0000-0002-9736-2838; Mayr, Johannes/0000-0001-6970-336X; Meitinger, Thomas/0000-0002-8838-8403; Piekutowska-Abramczuk, Dorota/0000-0002-9786-3704; Schneider, Dominik T./0000-0001-8153-1601; Kremer, Laura/0000-0002-1647-7538; Dr. Herebian, Diran/0000-0002-8528-0122; Ploski, Rafal/0000-0001-6286-5526	German Bundesministerium fur Bildung and Forschung (BMBF) through the German Network for mitochondrial disorders (mitoNET) [01GM1113A-E]; E-Rare project GENOMIT [01GM1603]; Juniorverbund in der Systemmedizin "mitOmics" [FKZ 01ZX1405C]; Forschungskommission of the Medical Faculty of the Heinrich-Heine-University Dusseldorf; CMHI project [S136/13]	German Bundesministerium fur Bildung and Forschung (BMBF) through the German Network for mitochondrial disorders (mitoNET); E-Rare project GENOMIT; Juniorverbund in der Systemmedizin "mitOmics"; Forschungskommission of the Medical Faculty of the Heinrich-Heine-University Dusseldorf; CMHI project	We thank all families for their participation and for providing important samples for the present research study. For their work on individual #3, we thank Mrs. Ira Brandstetter (mitochondrial respiratory chain biochemistry), Mrs. Julia Emmerich (fibroblast isolation from muscle biopsy), and Dr. Benedikt Schoser (assessment of muscle morphology and ultrastructure). We thank Prof. Marjo van der Knaap for the assessment of the MRI from individual #2. The study was supported by the German Bundesministerium fur Bildung and Forschung (BMBF) through the German Network for mitochondrial disorders (mitoNET, 01GM1113A-E to L.S.K., K.D., W.M.-F., T.M., T.K., J.A.M., F.D., and H.P.), the E-Rare project GENOMIT (01GM1603 to J.A.M. and H.P.), the Juniorverbund in der Systemmedizin "mitOmics" (FKZ 01ZX1405C to T.B.H.), and the Forschungskommission of the Medical Faculty of the Heinrich-Heine-University Dusseldorf (F.D. and K.D.). This study was further supported by the CMHI project S136/13.	BARON DN, 1956, LANCET, V271, P421; Elstner M, 2008, MOL BIOTECHNOL, V40, P306, DOI 10.1007/s12033-008-9100-5; FREUNDLICH E, 1981, ARCH DIS CHILD, V56, P146, DOI 10.1136/adc.56.2.146; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Haack TB, 2013, AM J HUM GENET, V93, P211, DOI 10.1016/j.ajhg.2013.06.006; Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846; Hegyi J, 2004, INT J DERMATOL, V43, P1, DOI 10.1111/j.1365-4632.2004.01959.x; Kleta R, 2004, NAT GENET, V36, P999, DOI 10.1038/ng1405; Kranendijk M, 2010, SCIENCE, V330, P336, DOI 10.1126/science.1192632; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Linster CL, 2013, NAT CHEM BIOL, V9, P72, DOI [10.1038/NCHEMBIO.1141, 10.1038/nchembio.1141]; Marbaix AY, 2014, BIOCHEM J, V460, P49, DOI 10.1042/BJ20131482; Marbaix AY, 2011, J BIOL CHEM, V286, P41246, DOI 10.1074/jbc.C111.310847; Niehaus TD, 2014, PLANT PHYSIOL, V165, P52, DOI 10.1104/pp.114.236539; Ploski R, 2014, CIRC RES, V114, pE2, DOI 10.1161/CIRCRESAHA.114.302662; Prabhakar P, 1998, ARCH BIOCHEM BIOPHYS, V360, P195, DOI 10.1006/abbi.1998.0939; SALIH MAM, 1985, PEDIATRICS, V76, P787; Spiegel R, 2016, NEUROGENETICS, V17, P187, DOI 10.1007/s10048-016-0483-3; YOSHIDA A, 1975, ARCH BIOCHEM BIOPHYS, V169, P298, DOI 10.1016/0003-9861(75)90344-6	19	56	58	1	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 6	2016	99	4					894	902		10.1016/j.ajhg.2016.07.018	http://dx.doi.org/10.1016/j.ajhg.2016.07.018			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DY7UB	27616477	Bronze, Green Published			2022-12-18	WOS:000385333700009
J	Charlesworth, G; Angelova, PR; Bartolome-Robledo, F; Ryten, M; Trabzuni, D; Stamelou, M; Abramov, AY; Bhatia, KP; Wood, NW				Charlesworth, Gavin; Angelova, Plamena R.; Bartolome-Robledo, Fernando; Ryten, Mina; Trabzuni, Daniah; Stamelou, Maria; Abramov, Andrey Y.; Bhatia, Kailash P.; Wood, Nicholas W.			Mutations in HPCA Cause Autosomal-Recessive Primary Isolated Dystonia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRIMARY TORSION DYSTONIA; NEURONAL CALCIUM SENSOR; SLOW AFTERHYPERPOLARIZATION; SYNAPTIC PLASTICITY; BINDING-PROTEIN; HIPPOCALCIN; ACTIVATION; CELLS; EXPRESSION; DYNAMICS	Reports of primary isolated dystonia inherited in an autosomal-recessive (AR) manner, often lumped together as "DYT2 dystonia," have appeared in the scientific literature for several decades, but no genetic cause has been identified to date. Using a combination of homozygosity mapping and whole-exome sequencing in a consanguineous kindred affected by AR isolated dystonia, we identified homozygous mutations in HPCA, a gene encoding a neuronal calcium sensor protein found almost exclusively in the brain and at particularly high levels in the striatum, as the cause of disease in this family. Subsequently, compound-heterozygous mutations in HPCA were also identified in a second independent kindred affected by AR isolated dystonia. Functional studies suggest that hippocalcin might play a role in regulating voltage-dependent calcium channels. The identification of mutations in HPCA as a cause of AR primary isolated dystonia paves the way for further studies to assess whether "DYT2 dystonia" is a genetically homogeneous condition or not.	[Charlesworth, Gavin; Angelova, Plamena R.; Bartolome-Robledo, Fernando; Ryten, Mina; Trabzuni, Daniah; Abramov, Andrey Y.; Wood, Nicholas W.] UCL Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Ryten, Mina] Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England; [Trabzuni, Daniah] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Stamelou, Maria; Bhatia, Kailash P.; Wood, Nicholas W.] UCL Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England; [Stamelou, Maria] Univ Athens, Dept Neurol 2, Athens 15344, Greece; [Stamelou, Maria] Hygeia Hosp, Movement Disorders Dept, Athens 15123, Greece; [Bhatia, Kailash P.; Wood, Nicholas W.] UCL Genet Inst, London WC1E 6BT, England	University of London; University College London; University of London; King's College London; King Faisal Specialist Hospital & Research Center; University of London; University College London; National & Kapodistrian University of Athens; Hygeia Hospital; University of London; University College London	Bhatia, KP (corresponding author), UCL Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, Queen Sq, London WC1N 3BG, England.	k.bhatia@ucl.ac.uk; n.wood@ucl.ac.uk	Trabzuni, Daniah/AAI-2037-2021; Ryten, Mina/Q-8419-2016; Stroh, Plamena/K-4444-2013; Abramov, Andrey/AAC-6712-2019; Trabzuni, Daniah M/C-4034-2012; Bartolome, Fernando/D-4618-2011; Abramov, Andrey Y/H-9053-2012; Wood, Nicholas W/C-2505-2009	Trabzuni, Daniah/0000-0003-4826-9570; Stroh, Plamena/0000-0003-4596-9117; Abramov, Andrey/0000-0002-7646-7235; Trabzuni, Daniah M/0000-0003-4826-9570; Bartolome, Fernando/0000-0001-9322-8933; Abramov, Andrey Y/0000-0002-7646-7235; Wood, Nicholas W/0000-0002-9500-3348	Medical Research Council; Wellcome Trust [WT089698/Z/09/Z]; Bachman-Strauss Dystonia Parkinsonism Foundation; Department of Health's National Institute for Health Research Biomedical Research Centres; MRC [MC_G1000735, MC_G0901330, MC_PC_09003] Funding Source: UKRI; Medical Research Council [MC_PC_09003, MR/L501554/1, MC_G1000735, MC_G0901330] Funding Source: researchfish; National Institute for Health Research [ACF-2012-17-017, NF-SI-0507-10376, NF-SI-0513-10064] Funding Source: researchfish; Parkinson&quot;s UK [G-0612] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Bachman-Strauss Dystonia Parkinsonism Foundation; Department of Health's National Institute for Health Research Biomedical Research Centres(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Parkinson&quot;s UK(Parkinson&apos;s UK)	We would like to extend our thanks to the individuals whose participation made this research possible. This work was supported financially by a Strategic Award from the Medical Research Council and Wellcome Trust (WT089698/Z/09/Z) and a grant from the Bachman-Strauss Dystonia Parkinsonism Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The work was undertaken at University College London Hospitals (UCLH) and University College London (UCL), which receive support from the funding streams of the Department of Health's National Institute for Health Research Biomedical Research Centres. Expression data were provided by the UK Human Brain Expression Consortium (UKBEC), which comprises John A. Hardy, M.R., D.T., Michael Weale, Adaikalavan Ramasamy, Colin Smith, and Robert Walker. UKBEC members are affiliated with the UCL Institute of Neurology (J.A. Hardy, M.R., and D.T.), King's College London (M. Weale and A. Ramasamy), and the University of Edinburgh (C. Smith and R. Walker).	Ames JB, 2012, FRONT MOL NEUROSCI, V5, DOI [10.3389/fnmol.2012.00010, 10.1016/j.bbagen.2011.10.003]; Amici M, 2009, BIOCHEM SOC T, V37, P1359, DOI 10.1042/BST0371359; Avchalumov Y, 2013, NEUROSCIENCE, V250, P60, DOI 10.1016/j.neuroscience.2013.06.048; Braunewell KH, 2009, CELL TISSUE RES, V335, P301, DOI 10.1007/s00441-008-0716-3; Charlesworth G, 2012, AM J HUM GENET, V91, P1041, DOI 10.1016/j.ajhg.2012.10.024; Chouery E, 2008, NEUROGENETICS, V9, P287, DOI 10.1007/s10048-008-0142-4; Dang MT, 2012, BEHAV BRAIN RES, V226, P465, DOI 10.1016/j.bbr.2011.10.002; Fahn S, 1988, Adv Neurol, V50, P1; Fuchs T, 2013, NAT GENET, V45, P88, DOI 10.1038/ng.2496; Fuchs T, 2009, NAT GENET, V41, P286, DOI 10.1038/ng.304; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Gimenez-Roldan S, 1988, Adv Neurol, V50, P73; Hersheson J, 2013, ANN NEUROL, V73, P546, DOI 10.1002/ana.23832; Iwabuchi S, 2013, NEUROSCI LETT, V548, P61, DOI 10.1016/j.neulet.2013.05.047; Kerrigan TL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00057; Khan NL, 2003, NEUROLOGY, V61, P1801, DOI 10.1212/01.WNL.0000099076.17187.9A; Kim KS, 2012, BIOPHYS J, V103, P2446, DOI 10.1016/j.bpj.2012.11.002; Kobayashi M, 2005, NEUROSCIENCE, V133, P471, DOI 10.1016/j.neuroscience.2005.02.034; Lohmann K, 2013, ANN NEUROL, V73, P537, DOI 10.1002/ana.23829; Mamman A, 2004, BIOCHEM BIOPH RES CO, V322, P1131, DOI 10.1016/j.bbrc.2004.07.123; Markova O, 2008, NEUROSCI LETT, V442, P152, DOI 10.1016/j.neulet.2008.06.089; Moretti P, 2005, MOVEMENT DISORD, V20, P245, DOI 10.1002/mds.20228; O'Callaghan DW, 2003, J CELL BIOL, V163, P715, DOI 10.1083/jcb.200306042; Oh DY, 2008, J NEUROSCI RES, V86, P1557, DOI 10.1002/jnr.21602; Oh DY, 2006, J CELL BIOCHEM, V97, P1052, DOI 10.1002/jcb.20665; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Palmer CL, 2005, NEURON, V47, P487, DOI 10.1016/j.neuron.2005.06.014; Prescott IA, 2013, NEUROBIOL DIS, V51, P214, DOI 10.1016/j.nbd.2012.11.012; Santangelo G., 1934, G PSYCHIAT NEUROPATH, V62, P52; Suwanjang W, 2013, CELL CALCIUM, V53, P256, DOI 10.1016/j.ceca.2012.12.006; Trabzuni D, 2011, J NEUROCHEM, V119, P275, DOI 10.1111/j.1471-4159.2011.07432.x; Tzingounis AV, 2007, NEURON, V53, P487, DOI 10.1016/j.neuron.2007.01.011; Vemula SR, 2013, HUM MOL GENET, V22, P2510, DOI 10.1093/hmg/ddt102; Villalobos C, 2010, J NEUROSCI, V30, P14361, DOI 10.1523/JNEUROSCI.3440-10.2010; Weiergraber OH, 2006, J BIOL CHEM, V281, P37594, DOI 10.1074/jbc.M603700200; Xiao JF, 2012, ANN NEUROL, V71, P458, DOI 10.1002/ana.23547; ZOZULYA S, 1992, P NATL ACAD SCI USA, V89, P11569, DOI 10.1073/pnas.89.23.11569	37	56	59	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 2	2015	96	4					657	665		10.1016/j.ajhg.2015.02.007	http://dx.doi.org/10.1016/j.ajhg.2015.02.007			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CF0DJ	25799108	hybrid, Green Published			2022-12-18	WOS:000352212600013
J	Shaheen, R; Shamseldin, HE; Loucks, CM; Seidahmed, MZ; Ansari, S; Khali, MI; Al-Yacoub, N; Davis, EE; Mola, NA; Szymanska, K; Herridge, W; Chudley, AE; Chodirker, BN; Schwartzentruber, J; Majewski, J; Katsanis, N; Poizat, C; Johnson, CA; Parboosingh, J; Boycott, KM; Innes, AM; Akuraya, FS				Shaheen, Ranad; Shamseldin, Hanan E.; Loucks, Catrina M.; Seidahmed, Mohammed Zain; Ansari, Shinu; Khali, Mohamed Ibrahim; Al-Yacoub, Nadya; Davis, Erica E.; Mola, Natalie A.; Szymanska, Katarzyna; Herridge, Warren; Chudley, Albert E.; Chodirker, Bernard N.; Schwartzentruber, Jeremy; Majewski, Jacek; Katsanis, Nicholas; Poizat, Coralie; Johnson, Cohn A.; Parboosingh, Jillian; Boycott, Kym M.; Innes, A. Micheil; Akuraya, Fowzan S.			Mutations in CSPP1, Encoding a Core Centrosomal Protein, Cause a Range of Ciliopathy Phenotypes in Humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUTTERITE POPULATION; JOUBERT SYNDROME; SYSTEMS-BIOLOGY; PRIMARY CILIUM; INDIVIDUALS; BIOGENESIS; TRANSITION; CENTRIOLE; TTC7A	Ciliopathies are characterized by a pattern of multisystem involvement that is consistent with the developmental role of the primary cilium. Within this biological module, mutations in genes that encode components of the cilium and its anchoring structure, the basal body, are the major contributors to both disease causality and modification. However, despite rapid advances in this field, the majority of the genes that drive ciliopathies and the mechanisms that govern the pronounced phenotypic variability of this group of disorders remain poorly understood. Here, we show that mutations in CSPP1, which encodes a core centrosomal protein, are disease causing on the basis of the independent identification of two homozygous truncating mutations in three consanguineous families (one Arab and two Hutterite) affected by variable ciliopathy phenotypes ranging from Joubert syndrome to the more severe Meckel-Gruber syndrome with perinatal lethality and occipital encephalocele. Consistent with the recently described role of CSPP1 in ciliogenesis, we show that mutant fibroblasts from one affected individual have severely impaired ciliogenesis with concomitant defects in sonic hedgehog (SHH) signaling. Our results expand the list of centrosomal proteins implicated in human ciliopathies.	[Shaheen, Ranad; Shamseldin, Hanan E.; Ansari, Shinu; Akuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Loucks, Catrina M.; Parboosingh, Jillian; Innes, A. Micheil] Univ Calgary, Alberta Childrens Hosp, Dept Med Genet, Calgary, AB T3B 6A8, Canada; [Al-Yacoub, Nadya; Poizat, Coralie] King Faisal Specialist Hosp & Res Ctr, Cardiovasc Res Program, Riyadh 11211, Saudi Arabia; [Seidahmed, Mohammed Zain] Secur Forces Hosp, Dept Pediat, Riyadh 11481, Saudi Arabia; [Khali, Mohamed Ibrahim] Secur Forces Hosp, Dept Obstet & Gynecol, Riyadh 11481, Saudi Arabia; [Davis, Erica E.; Mola, Natalie A.; Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Durham, NC 27710 USA; [Szymanska, Katarzyna; Herridge, Warren; Johnson, Cohn A.] St James Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [Chudley, Albert E.; Chodirker, Bernard N.] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3A 1R9, Canada; [Chudley, Albert E.; Chodirker, Bernard N.] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB R3A 1R9, Canada; [Schwartzentruber, Jeremy; Majewski, Jacek] McGill Univ, Montreal, PQ H3A 0G4, Canada; [Schwartzentruber, Jeremy; Majewski, Jacek] Genome Quebec Innovat Ctr, Montreal, PQ H3A 0G4, Canada; [Parboosingh, Jillian; Innes, A. Micheil] Univ Calgary, Alberta Childrens Hosp, Res Inst Child & Maternal Hlth, Calgary, AB T3B 6A8, Canada; [Boycott, Kym M.] Univ Ottawa, Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada; [Akuraya, Fowzan S.] Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh 11533, Saudi Arabia	King Faisal Specialist Hospital & Research Center; Alberta Childrens Hospital; University of Calgary; King Faisal Specialist Hospital & Research Center; Security Forces Hospital - Saudi Arabia; Security Forces Hospital - Saudi Arabia; Duke University; Saint James's University Hospital; University of Leeds; University of Manitoba; University of Manitoba; McGill University; Alberta Childrens Hospital; University of Calgary; University of Ottawa; Children's Hospital of Eastern Ontario; Alfaisal University	Innes, AM (corresponding author), Univ Calgary, Alberta Childrens Hosp, Dept Med Genet, Calgary, AB T3B 6A8, Canada.	micheil.innes@albertahealthservices.ca; falkuraya@kfshrc.edu.sa	innes, allan micheil/A-9955-2017	Loucks, Catrina/0000-0003-1167-3721; Katsanis, Nicholas/0000-0002-2480-0171; Schwartzentruber, Jeremy/0000-0002-6183-2092; SHAHEEN, RANAD/0000-0002-2590-1759; Davis, Erica/0000-0002-2412-8397; Innes, Micheil/0000-0001-9881-5467; Johnson, Colin/0000-0002-2979-8234	Dubai Harvard Foundation for Medical Research Collaborative Research Grant; King Abdulaziz City for Science and Technology [10-BIO 1350-20]; SickKids Foundation; Canadian Institutes of Health Research (CIHR) Institute of Human Development, Child, and Youth Health [NI10-008]; National Institutes of Health [DK072301, HD042601, DK075972, EY021872]; European Union [241955]; CIHR Institute of Genetics; CIHR; Sir Jules Thorn Award for Biomedical Research [JTA/09]; Rosetrees Trust [M333]; MRC [MR/K011154/1] Funding Source: UKRI; Medical Research Council [MR/K011154/1] Funding Source: researchfish; The Sir Jules Thorn Charitable Trust [09JTA] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042601] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY021872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075972, R01DK072301] Funding Source: NIH RePORTER	Dubai Harvard Foundation for Medical Research Collaborative Research Grant; King Abdulaziz City for Science and Technology; SickKids Foundation; Canadian Institutes of Health Research (CIHR) Institute of Human Development, Child, and Youth Health(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); CIHR Institute of Genetics(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Sir Jules Thorn Award for Biomedical Research; Rosetrees Trust(Rosetrees Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Sir Jules Thorn Charitable Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the families for their enthusiastic participation. We also thank the genotyping and sequencing core facilities at King Faisal Specialist Hospital and Research Center for their technical help. This work was supported by a Dubai Harvard Foundation for Medical Research Collaborative Research Grant (F.S.A.), a grant from King Abdulaziz City for Science and Technology (10-BIO 1350-20 to C.P.), funding from the SickKids Foundation and Canadian Institutes of Health Research (CIHR) Institute of Human Development, Child, and Youth Health (NI10-008 to K.M.B.), grants from the National Institutes of Health (DK072301, HD042601, and DK075972 to N.K. and EY021872 to E.E.D.), and funding from the European Union Seventh Framework Programme (FP7/2009) under grant agreement 241955 (project SYSCILIA) to C.A.J., N.K., and E.E.D. K.M.B. was supported by a Clinical Investigator-ship Award from the CIHR Institute of Genetics. C.M.L. was supported by a CIHR Training Program in Genetics, Child Development, and Health. C.A.J. received a Sir Jules Thorn Award for Biomedical Research (JTA/09). N.K. is an Endowed Brumley Professor. W.H. receives funding from the Rosetrees Trust (grant M333).	Abu-Safieh L, 2012, EUR J HUM GENET, V20, P420, DOI 10.1038/ejhg.2011.205; Al-Dosari MS, 2010, J MED GENET, V47, P411, DOI 10.1136/jmg.2009.076646; Alazami AM, 2012, HUM MUTAT, V33, P1423, DOI 10.1002/humu.22134; Alkuraya FS, 2013, HUM GENET, V132, P1197, DOI 10.1007/s00439-013-1344-x; Alkuraya FS, 2010, GENET MED, V12, P236, DOI 10.1097/GIM.0b013e3181ceb95d; Alkuraya FS, 2012, CURR PROTOC HUM GENE, V6, P12, DOI DOI 10.1002/0471142905.HG0612S75; Asiedu M, 2009, MOL BIOL CELL, V20, P1428, DOI 10.1091/mbc.E08-01-0001; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Boycott KM, 2008, AM J MED GENET A, V146A, P1088, DOI 10.1002/ajmg.a.32245; Chen R, 2013, J ALLERGY CLIN IMMUN, V132, P656, DOI 10.1016/j.jaci.2013.06.013; Davis EE, 2012, CURR OPIN GENET DEV, V22, P290, DOI 10.1016/j.gde.2012.04.006; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Huang LJ, 2011, AM J HUM GENET, V89, P713, DOI 10.1016/j.ajhg.2011.11.005; Innes AM, 2010, CLIN GENET, V78, P424, DOI 10.1111/j.1399-0004.2010.01481.x; Kim J, 2008, HUM MOL GENET, V17, P3796, DOI 10.1093/hmg/ddn277; Kim K, 2011, J CELL SCI, V124, P338, DOI 10.1242/jcs.078329; Kobayashi T, 2011, J CELL BIOL, V193, P435, DOI 10.1083/jcb.201101005; Lee JE, 2011, GENOME MED, V3, DOI 10.1186/gm275; Nigg EA, 2011, NAT CELL BIOL, V13, P1154, DOI 10.1038/ncb2345; Parisi MA, 2004, AM J HUM GENET, V75, P82, DOI 10.1086/421846; Patzke S, 2005, ONCOGENE, V24, P1159, DOI 10.1038/sj.onc.1208267; Patzke S, 2010, MOL BIOL CELL, V21, P2555, DOI 10.1091/mbc.E09-06-0503; Rusan NM, 2009, TRAFFIC, V10, P472, DOI 10.1111/j.1600-0854.2009.00880.x; Samuels ME, 2013, J MED GENET, V50, P324, DOI 10.1136/jmedgenet-2012-101483; Shaheen R, 2013, EUR J HUM GENET, V21, P762, DOI 10.1038/ejhg.2012.254; Shaheen R, 2012, AM J HUM GENET, V91, P330, DOI 10.1016/j.ajhg.2012.05.025; Walczak-Sztulpa J, 2010, AM J HUM GENET, V86, P949, DOI 10.1016/j.ajhg.2010.04.012; Ware Stephanie M, 2011, Proc Am Thorac Soc, V8, P444, DOI 10.1513/pats.201103-025SD; Wu KS, 2012, BIOL OPEN, V1, P559, DOI 10.1242/bio.20121388	30	56	58	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 2	2014	94	1					73	79		10.1016/j.ajhg.2013.11.010	http://dx.doi.org/10.1016/j.ajhg.2013.11.010			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	292FU	24360803	Green Published, Bronze			2022-12-18	WOS:000329888400007
J	Dauber, A; Golzio, C; Guenot, C; Jodelka, FM; Kibaek, M; Kjaergaard, S; Leheup, B; Martinet, D; Nowaczyk, MJM; Rosenfeld, JA; Zeesman, S; Zunich, J; Beckmann, JS; Hirschhorn, JN; Hastings, ML; Jacquemont, S; Katsanis, N				Dauber, Andrew; Golzio, Christelle; Guenot, Cecile; Jodelka, Francine M.; Kibaek, Maria; Kjaergaard, Susanne; Leheup, Bruno; Martinet, Danielle; Nowaczyk, Malgorzata J. M.; Rosenfeld, Jill A.; Zeesman, Susan; Zunich, Janice; Beckmann, Jacques S.; Hirschhorn, Joel N.; Hastings, Michelle L.; Jacquemont, Sebastien; Katsanis, Nicholas			SCRIB and PUF60 Are Primary Drivers of the Multisystemic Phenotypes of the 8q24.3 Copy-Number Variant	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BARDET-BIEDL-SYNDROME; MEIER-GORLIN SYNDROME; INTERSTITIAL DELETION; MANDIBULOFACIAL DYSOSTOSIS; CARDIAC DEVELOPMENT; MENTAL-RETARDATION; HUMAN-DISEASE; HUMAN GENOME; ZEBRAFISH; MUTATIONS	Copy-number variants (CNVs) represent a significant interpretative challenge, given that each CNV typically affects the dosage of multiple genes. Here we report on five individuals with coloboma, microcephaly, developmental delay, short stature, and craniofacial, cardiac, and renal defects who harbor overlapping microdeletions on 8q24.3. Fine mapping localized a commonly deleted 78 kb region that contains three genes: SCRIB, NRBP2, and PUF60. In vivo dissection of the CNV showed discrete contributions of the planar cell polarity effector SCRIB and the splicing factor PUF60 to the syndromic phenotype, and the combinatorial suppression of both genes exacerbated some, but not all, phenotypic components. Consistent with these findings, we identified an individual with microcephaly, short stature, intellectual disability, and heart defects with a de novo c.505C>T variant leading to a p.His169Tyr change in PUF60. Functional testing of this allele in vivo and in vitro showed that the mutation perturbs the relative dosage of two PUF60 isoforms and, subsequently, the splicing efficiency of downstream PUF60 targets. These data inform the functions of two genes not associated previously with human genetic disease and demonstrate how CNVs can exhibit complex genetic architecture, with the phenotype being the amalgam of both discrete dosage dysfunction of single transcripts and also of binary genetic interactions.	[Dauber, Andrew] Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Dauber, Andrew] Broad Inst, Program Med & Populat Genet, Boston, MA 02115 USA; [Golzio, Christelle; Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Durham, NC 27710 USA; [Guenot, Cecile; Martinet, Danielle; Beckmann, Jacques S.; Jacquemont, Sebastien] Univ Lausanne, CHUV, Serv Med Genet, CH-1011 Lausanne, Switzerland; [Guenot, Cecile; Martinet, Danielle; Beckmann, Jacques S.; Jacquemont, Sebastien] Univ Lausanne, CHUV, Dept Clin Genet, CH-1011 Lausanne, Switzerland; [Jodelka, Francine M.; Hastings, Michelle L.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Cell Biol & Anat, N Chicago, IL 60064 USA; [Kibaek, Maria] Odense Univ Hosp, Dept Pediat, Odense 5230, Denmark; [Kjaergaard, Susanne] Univ Copenhagen Hosp, Dept Clin Genet, DK-2100 Copenhagen, Denmark; [Leheup, Bruno] Univ Lorraine, CHU Nancy, Dept Clin Genet, F-54511 Vandoeuvre Les Nancy, France; [Leheup, Bruno] Univ Lorraine, Sch Med, F-54511 Vandoeuvre Les Nancy, France; [Nowaczyk, Malgorzata J. M.; Zeesman, Susan] McMaster Univ, Dept Pathol, Hamilton, ON L8N 3Z5, Canada; [Nowaczyk, Malgorzata J. M.; Zeesman, Susan] McMaster Univ, Dept Mol Med, Hamilton, ON L8N 3Z5, Canada; [Nowaczyk, Malgorzata J. M.; Zeesman, Susan] McMaster Univ, Dept Pediat, Hamilton, ON L8N 3Z5, Canada; [Rosenfeld, Jill A.] PerkinElmer Inc, Signature Genom Labs, Spokane, WA 99207 USA; [Zunich, Janice] Indiana Univ, Genet Ctr, Sch Med Northwest, Gary, IN 46408 USA; [Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Duke University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Chicago Medical School; Rosalind Franklin University Medical & Science; University of Southern Denmark; Odense University Hospital; University of Copenhagen; CHU de Nancy; Universite de Lorraine; Universite de Franche-Comte; Universite de Lorraine; McMaster University; McMaster University; McMaster University; Indiana University System; Indiana University Northwest; Harvard University; Harvard Medical School	Katsanis, N (corresponding author), Duke Univ, Ctr Human Dis Modeling, Durham, NC 27710 USA.	nicholas.katsanis@duke.edu	Hastings, MICHELLE L./AAK-6627-2021; Beckmann, Jacques S/A-9772-2008; Jacquemont, Sebastien/AAS-5060-2021	Beckmann, Jacques S/0000-0002-9741-1900; Jacquemont, Sebastien/0000-0001-6838-8767; Hastings, Michelle L./0000-0002-4253-9261; Golzio, Christelle/0000-0002-4420-3921; Jodelka, Francine/0000-0001-9374-8437; Katsanis, Nicholas/0000-0002-2480-0171	Harvard Catalyst, The Harvard Clinical and Translational Science Center (National Institutes of Health) [UL1 RR 025758]; Harvard University; Simons Foundation SFARI [239983]; Eunice Kennedy Shriver National Institute of Child Health and Development [K23HD073351]; Swiss National Fund professorship grant [PP00P3_144902]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD073351] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK096415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069759] Funding Source: NIH RePORTER	Harvard Catalyst, The Harvard Clinical and Translational Science Center (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard University; Simons Foundation SFARI; Eunice Kennedy Shriver National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Swiss National Fund professorship grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Anthony Hinrich and Yangfan Phoebe Liu for technical assistance. This work was conducted with support from Harvard Catalyst, The Harvard Clinical and Translational Science Center (National Institutes of Health Award #UL1 RR 025758 and financial contributions from Harvard University and its affiliated academic health care centers). The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers, the National Center for Research Resources, or the National Institutes of Health. This work was also supported by the grant from the Simons Foundation SFARI # 239983 (N.K.) and the Eunice Kennedy Shriver National Institute of Child Health and Development grant K23HD073351 (A.D.). S.J. is supported by the Swiss National Fund professorship grant (PP00P3_144902). N.K. is a Distinguished Brumley Professor.	Bakkers J, 2011, CARDIOVASC RES, V91, P279, DOI 10.1093/cvr/cvr098; Bernier FP, 2012, AM J HUM GENET, V90, P925, DOI 10.1016/j.ajhg.2012.04.004; Beunders G, 2013, AM J HUM GENET, V92, P210, DOI 10.1016/j.ajhg.2012.12.011; Bicknell LS, 2011, NAT GENET, V43, P350, DOI 10.1038/ng.776; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; BUHLER EM, 1987, CLIN GENET, V31, P273; Burns CJ, 2008, DEV DYNAM, V237, P1614, DOI 10.1002/dvdy.21565; CHAMPIONARNAUD P, 1994, GENE DEV, V8, P1974, DOI 10.1101/gad.8.16.1974; Coe BP, 2012, AM J MED GENET C, V160C, P118, DOI 10.1002/ajmg.c.31327; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Courbard JR, 2009, DEV BIOL, V333, P67, DOI 10.1016/j.ydbio.2009.06.024; Dauber A, 2013, J PEDIATR-US, V162, P202, DOI 10.1016/j.jpeds.2012.07.055; Delio M, 2013, AM J MED GENET A, V161A, P527, DOI 10.1002/ajmg.a.35784; Doelken SC, 2013, DIS MODEL MECH, V6, P358, DOI 10.1242/dmm.010322; Fakhro KA, 2011, P NATL ACAD SCI USA, V108, P2915, DOI 10.1073/pnas.1019645108; Frangiskakis JM, 1996, CELL, V86, P59, DOI 10.1016/S0092-8674(00)80077-X; Golzio C, 2013, CURR OPIN GENET DEV, V23, P240, DOI 10.1016/j.gde.2013.04.013; Golzio C, 2012, NATURE, V485, P363, DOI 10.1038/nature11091; Gordon CT, 2012, J MED GENET, V49, P737, DOI 10.1136/jmedgenet-2012-101173; Greenway SC, 2009, NAT GENET, V41, P931, DOI 10.1038/ng.415; Halevy A, 2012, PEDIATR NEUROL, V46, P363, DOI 10.1016/j.pediatrneurol.2012.03.014; Hastings ML, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000538; Hentschel DM, 2007, AM J PHYSIOL-RENAL, V293, pF1746, DOI 10.1152/ajprenal.00009.2007; Hentschel DM, 2005, AM J PHYSIOL-RENAL, V288, pF923, DOI 10.1152/ajprenal.00386.2004; Horev G, 2011, P NATL ACAD SCI USA, V108, P17076, DOI 10.1073/pnas.1114042108; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Itsara A, 2010, GENOME RES, V20, P1469, DOI 10.1101/gr.107680.110; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Kuo AJ, 2012, NATURE, V484, P115, DOI 10.1038/nature10956; Labate A, 2013, EPILEPSY RES, V104, P280, DOI 10.1016/j.eplepsyres.2012.10.014; Lacaria M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002713; Liao J, 2004, HUM MOL GENET, V13, P1577, DOI 10.1093/hmg/ddh176; Lines MA, 2012, AM J HUM GENET, V90, P369, DOI 10.1016/j.ajhg.2011.12.023; Liu CQ, 2012, HUM MOL GENET, V21, P1848, DOI 10.1093/hmg/ddr616; Liu H, 2007, DEV BIOL, V308, P54, DOI 10.1016/j.ydbio.2007.04.052; Luquetti DV, 2013, AM J MED GENET A, V161A, P108, DOI 10.1002/ajmg.a.35696; Margolin DH, 2013, NEW ENGL J MED, V368, P1992, DOI 10.1056/NEJMoa1215993; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Micale L, 2010, EUR J HUM GENET, V18, P317, DOI 10.1038/ejhg.2009.181; Michaelis UR, 2013, CIRC RES, V112, P924, DOI 10.1161/CIRCRESAHA.112.300592; Mikami M, 1999, AM J HUM GENET, V65, P745, DOI 10.1086/302535; Mitchell IC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008807; NARITOMI K, 1989, HUM GENET, V82, P199, DOI 10.1007/BF00284059; Osmani N, 2006, CURR BIOL, V16, P2395, DOI 10.1016/j.cub.2006.10.026; Osoegawa K, 2008, J MED GENET, V45, P81, DOI 10.1136/jmg.2007.052191; Pieczynski J, 2011, AM J PHYSIOL-RENAL, V300, pF589, DOI 10.1152/ajprenal.00615.2010; Qu XH, 2008, DEV BIOL, V317, P486, DOI 10.1016/j.ydbio.2008.02.044; Roche JP, 2002, J NEUROSCI, V22, P6471, DOI 10.1523/jneurosci.22-15-06471.2002; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sanna-Cherchi S, 2012, AM J HUM GENET, V91, P987, DOI 10.1016/j.ajhg.2012.10.007; Santoriello C, 2012, J CLIN INVEST, V122, P2337, DOI 10.1172/JCI60434; Sarparanta J, 2012, NAT GENET, V44, P450, DOI 10.1038/ng.1103; Scott DA, 2007, HUM MOL GENET, V16, P424, DOI 10.1093/hmg/ddl475; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Serra-Juhe C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045530; Shanske AL, 2008, AM J MED GENET A, V146A, P3211, DOI 10.1002/ajmg.a.32615; Skouloudaki K, 2009, P NATL ACAD SCI USA, V106, P8579, DOI 10.1073/pnas.0811691106; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; STENGELRUTKOWSKI S, 1992, CLIN GENET, V42, P178; Sun XJ, 2008, CIRC RES, V102, P831, DOI 10.1161/CIRCRESAHA.107.166488; Talseth-Palmer BA, 2012, EUR J HUM GENET, V20, P487, DOI 10.1038/ejhg.2011.232; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Van Buskirk C, 2002, DEV CELL, V2, P343, DOI 10.1016/S1534-5807(02)00128-4; Verheij JBGM, 2009, EUR J MED GENET, V52, P353, DOI 10.1016/j.ejmg.2009.05.006; Walz K, 2003, MOL CELL BIOL, V23, P3646, DOI 10.1128/MCB.23.10.3646-3655.2003; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Wheeler PG, 2010, AM J MED GENET A, V152A, P459, DOI 10.1002/ajmg.a.33237; Wuyts W, 2002, AM J MED GENET, V113, P326, DOI 10.1002/ajmg.10845; YAMAMOTO Y, 1989, AM J MED GENET, V32, P133, DOI 10.1002/ajmg.1320320128; Yan J, 2004, HUM MOL GENET, V13, P2613, DOI 10.1093/hmg/ddh288; Yates LL, 2013, DEV BIOL, V373, P267, DOI 10.1016/j.ydbio.2012.11.012; Zaghloul NA, 2010, P NATL ACAD SCI USA, V107, P10602, DOI 10.1073/pnas.1000219107; Zhou CJ, 2008, DEV DYNAM, V237, P3681, DOI 10.1002/dvdy.21770	76	56	60	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 7	2013	93	5					798	811		10.1016/j.ajhg.2013.09.010	http://dx.doi.org/10.1016/j.ajhg.2013.09.010			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252HU	24140112	Green Published, Bronze			2022-12-18	WOS:000326996600002
J	McMillin, MJ; Below, JE; Shively, KM; Beck, AE; Gildersleeve, HI; Pinner, J; Gogola, GR; Hecht, JT; Grange, DK; Harris, DJ; Earl, DL; Jagadeesh, S; Mehta, SG; Robertson, SP; Swanson, JM; Faustman, EM; Mefford, HC; Shendure, J; Nickerson, DA; Bamshad, MJ				McMillin, Margaret J.; Below, Jennifer E.; Shively, Kathryn M.; Beck, Anita E.; Gildersleeve, Heidi I.; Pinner, Jason; Gogola, Gloria R.; Hecht, Jacqueline T.; Grange, Dorothy K.; Harris, David J.; Earl, Dawn L.; Jagadeesh, Sujatha; Mehta, Sarju G.; Robertson, Stephen P.; Swanson, James M.; Faustman, Elaine M.; Mefford, Heather C.; Shendure, Jay; Nickerson, Deborah A.; Bamshad, Michael J.		Univ Washington	Mutations in ECEL1 Cause Distal Arthrogryposis Type 5D	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ENDOTHELIN-CONVERTING ENZYME; ENDOPEPTIDASE; DISEASE	Distal arthrogryposis (DA) syndromes are the most common of the heritable congenital-contracture disorders, and similar to 50% of cases are caused by mutations in genes that encode contractile proteins of skeletal myofibers. DA type 5D (DASD) is a rare, autosomal-recessive DA previously defined by us and is characterized by congenital contractures of the hands and feet, along with distinctive facial features, including ptosis. We used linkage analysis and whole-genome sequencing of a multiplex consanguineous family to identify in endothelin-converting enzyme-like 1 (ECEL1) mutations that result in DA5D. Evaluation of a total of seven families affected by DA5D revealed in five families ECEL1 mutations that explain similar to 70% of cases overall. ECEL1 encodes a neuronal endopeptidase and is expressed in the brain and peripheral nerves. Mice deficient in Ecel1 exhibit perturbed terminal branching of motor neurons to the endplate of skeletal muscles, resulting in poor formation of the neuromuscular junction. Our results distinguish a second developmental pathway that causes congenital-contracture syndromes.	[McMillin, Margaret J.; Shively, Kathryn M.; Beck, Anita E.; Gildersleeve, Heidi I.; Mefford, Heather C.; Bamshad, Michael J.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [McMillin, Margaret J.; Beck, Anita E.; Earl, Dawn L.; Mefford, Heather C.; Bamshad, Michael J.] Seattle Childrens Hosp, Div Med Genet, Seattle, WA 98105 USA; [Below, Jennifer E.; Shendure, Jay; Nickerson, Deborah A.; Bamshad, Michael J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Pinner, Jason] Royal Prince Alfred Hosp, Dept Mol & Clin Genet, Camperdown, NSW 2050, Australia; [Gogola, Gloria R.] Shriners Hosp Children Houston, Houston, TX 77030 USA; [Hecht, Jacqueline T.] Univ Texas Med Sch, Dept Pediat, Houston, TX 77001 USA; [Grange, Dorothy K.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Harris, David J.] Boston Childrens Hosp, Div Genet, Dept Genet & Metab, Boston, MA 02115 USA; [Jagadeesh, Sujatha] MediScan, Madras 600004, Tamil Nadu, India; [Mehta, Sarju G.] Addenbrookes Hosp, E Anglian Med Genet Serv, Cambridge CB2 0QQ, England; [Robertson, Stephen P.] Univ Otago, Dunedin Sch Med, Dept Paediat & Child Hlth, Dunedin 9054, New Zealand; [Swanson, James M.] Univ Calif Irvine, Dept Pediat, Irvine, CA 92697 USA; [Faustman, Elaine M.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Sydney; University of Texas System; University of Texas Health Science Center Houston; Washington University (WUSTL); Harvard University; Boston Children's Hospital; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Otago; University of California System; University of California Irvine; University of Washington; University of Washington Seattle	Bamshad, MJ (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.	mbamshad@uw.edu	Below, Jennifer E/W-2179-2018; Shendure, Jay/AAU-3684-2021; Beck, Anita E./AAS-8775-2021	Below, Jennifer E/0000-0002-1346-1872; Beck, Anita E./0000-0002-7965-0326; Robertson, Stephen/0000-0002-5181-7809; Shendure, Jay/0000-0002-1516-1865; Below, Jennifer/0000-0002-6372-6402; Faustman, Elaine/0000-0002-3085-6403	National Institutes of Health National Human Genome Research Institute [1U54HG006493, 1RC2HG005608, 5RO1HG004316]; National Institute of Child Health and Development [HHSN27500503415C, HHSN267200700023C]; Life Sciences Discovery Fund [2065508, 0905001]; Washington Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD057331, R01HD048895] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K99HG004316, RC2HG005608, UM1HG006493, U54HG006493, R00HG004316] Funding Source: NIH RePORTER	National Institutes of Health National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Life Sciences Discovery Fund; Washington Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the families for their participation and support. Our work was supported in part by grants from the National Institutes of Health National Human Genome Research Institute (1U54HG006493 to M.B., D.N., and J.S.; 1RC2HG005608 to M.B., D.N., and J.S.; and 5RO1HG004316 to H.T.), the National Institute of Child Health and Development (HHSN27500503415C to J.M.S and HHSN267200700023C to E.M.F.), the Life Sciences Discovery Fund (2065508 and 0905001), and the Washington Research Foundation.	Bamshad M, 1996, AM J MED GENET, V65, P277, DOI 10.1002/(SICI)1096-8628(19961111)65:4<277::AID-AJMG6>3.0.CO;2-M; Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4; Hofstra RMW, 1999, AM J HUM GENET, V64, P304, DOI 10.1086/302184; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Morgan NV, 2006, AM J HUM GENET, V79, P390, DOI 10.1086/506256; Nagata K, 2010, J NEUROSCI, V30, P6954, DOI 10.1523/JNEUROSCI.4521-09.2010; Schweizer A, 1999, J BIOL CHEM, V274, P20450, DOI 10.1074/jbc.274.29.20450; Shirotani K, 2001, J BIOL CHEM, V276, P21895, DOI 10.1074/jbc.M008511200; Sung SS, 2003, AM J HUM GENET, V73, P212, DOI 10.1086/376418; Sung SS, 2003, AM J HUM GENET, V72, P681, DOI 10.1086/368294; Toydemir RM, 2006, AM J MED GENET A, V140A, P2387, DOI 10.1002/ajmg.a.31495; Toydemir RM, 2006, NAT GENET, V38, P561, DOI 10.1038/ng1775; Veugelers M, 2004, NEW ENGL J MED, V351, P460, DOI 10.1056/NEJMoa040584; Williams MS, 2007, AM J MED GENET A, V143A, P752, DOI 10.1002/ajmg.a.31648	14	56	59	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN 10	2013	92	1					150	156		10.1016/j.ajhg.2012.11.014	http://dx.doi.org/10.1016/j.ajhg.2012.11.014			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	073RA	23261301	Green Published, Bronze			2022-12-18	WOS:000313759000017
J	Franceschini, N; van Rooij, FJA; Prins, BP; Feitosa, MF; Karakas, M; Eckfeldt, JH; Folsom, AR; Kopp, J; Vaez, A; Andrews, JS; Baumert, J; Boraska, V; Broer, L; Hayward, C; Ngwa, JS; Okada, Y; Polasek, O; Westra, HJ; Wang, YA; Del Greco, F; Glazer, NL; Kapur, K; Id, P; Lopez, LM; Schillert, A; Smith, AV; Winkler, CA; Zgaga, L; Bandinelli, S; Bergmann, S; Boban, M; Bochud, M; Chen, YD; Davies, G; Dehghan, A; Ding, JZ; Doering, A; Durda, JP; Ferrucci, L; Franco, OH; Franke, L; Gunjaca, G; Hofman, A; Hsu, FC; Kolcic, I; Kraja, A; Kubo, M; Lackner, KJ; Launer, L; Loehr, LR; Li, G; Meisinger, C; Nakamura, Y; Schwienbacher, C; Starr, JM; Takahashi, A; Torlak, V; Uitterlinden, AG; Vitart, V; Waldenberger, M; Wild, PS; Kirin, M; Zeller, T; Zemunik, T; Zhang, QY; Ziegler, A; Blankenberg, S; Boerwinkle, E; Borecki, IB; Campbell, H; Deary, IJ; Frayling, TM; Gieger, C; Harris, TB; Hicks, AA; Koenig, W; O'Donnell, CJ; Fox, CS; Pramstaller, PP; Psaty, BM; Reiner, AP; Rotter, JI; Rudan, I; Snieder, H; Tanaka, T; van Duijn, CM; Vollenweider, P; Waeber, G; Wilson, JF; Witteman, JCM; Wolffenbuttel, BHR; Wright, AF; Wu, QY; Liu, YM; Jenny, NS; North, KE; Felix, JF; Alizadeh, BZ; Cupples, LA; Perry, JRB; Morris, AP				Franceschini, Nora; van Rooij, Frank J. A.; Prins, Bram P.; Feitosa, Mary F.; Karakas, Mahir; Eckfeldt, John H.; Folsom, Aaron R.; Kopp, Jeffrey; Vaez, Ahmad; Andrews, Jeanette S.; Baumert, Jens; Boraska, Vesna; Broer, Linda; Hayward, Caroline; Ngwa, Julius S.; Okada, Yukinori; Polasek, Ozren; Westra, Harm-Jan; Wang, Ying A.; Del Greco M, Fabiola; Glazer, Nicole L.; Kapur, Karen; Kema, Id P.; Lopez, Lorna M.; Schillert, Arne; Smith, Albert V.; Winkler, Cheryl A.; Zgaga, Lina; Bandinelli, Stefania; Bergmann, Sven; Boban, Mladen; Bochud, Murielle; Chen, Y. D.; Davies, Gail; Dehghan, Abbas; Ding, Jingzhong; Doering, Angela; Durda, J. Peter; Ferrucci, Luigi; Franco, Oscar H.; Franke, Lude; Gunjaca, Grog; Hofman, Albert; Hsu, Fang-Chi; Kolcic, Ivana; Kraja, Aldi; Kubo, Michiaki; Lackner, Karl J.; Launer, Lenore; Loehr, Laura R.; Li, Guo; Meisinger, Christa; Nakamura, Yusuke; Schwienbacher, Christine; Starr, John M.; Takahashi, Atsushi; Torlak, Vesela; Uitterlinden, Andre G.; Vitart, Veronique; Waldenberger, Melanie; Wild, Philipp S.; Kirin, Mirna; Zeller, Tanja; Zemunik, Tatijana; Zhang, Qunyuan; Ziegler, Andreas; Blankenberg, Stefan; Boerwinkle, Eric; Borecki, Ingrid B.; Campbell, Harry; Deary, Ian J.; Frayling, Timothy M.; Gieger, Christian; Harris, Tamara B.; Hicks, Andrew A.; Koenig, Wolfgang; O'Donnell, Christopher J.; Fox, Caroline S.; Pramstaller, Peter P.; Psaty, Bruce M.; Reiner, Alex P.; Rotter, Jerome I.; Rudan, Igor; Snieder, Harold; Tanaka, Toshihiro; van Duijn, Cornelia M.; Vollenweider, Peter; Waeber, Gerard; Wilson, James F.; Witteman, Jacqueline C. M.; Wolffenbuttel, Bruce H. R.; Wright, Alan F.; Wu, Qingyu; Liu, Yongmei; Jenny, Nancy S.; North, Karl E.; Felix, Janine F.; Alizadeh, Behrooz Z.; Cupples, L. Adrienne; Perry, John R. B.; Morris, Andrew P.		LifeLines Cohort Study	Discovery and Fine Mapping of Serum Protein Loci through Transethnic Meta-analysis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BIOCHEMICAL TRAITS; SMOKING-BEHAVIOR; FC-RECEPTOR; ALBUMIN; DETERMINANTS; POPULATION; IDENTIFY; RISK; SNPS	Many disorders are associated with altered serum protein concentrations, including malnutrition, cancer, and cardiovascular, kidney, and inflammatory diseases. Although these protein concentrations are highly heritable, relatively little is known about their underlying genetic determinants. Through transethnic meta-analysis of European-ancestry and Japanese genome-wide association studies, we identified six loci at genome-wide significance (p < 5 x 10(-8)) for serum albumin (HPN-SCN1B, GCKR-FNDC4, SERPINF2-WDR81, TNFRSF11A-ZCCHC2, FRMDS-WDR76, and RPS11-FCGRT, in up to 53,190 European-ancestry and 9,380 Japanese individuals) and three loci for total protein (TNFRS13B, 6q21.3, and ELL2, in up to 25,539 European-ancestry and 10,168 Japanese individuals). We observed little evidence of heterogeneity in allelic effects at these loci between groups of European and Japanese ancestry but obtained substantial improvements in the resolution of fine mapping of potential causal variants by leveraging transethnic differences in the distribution of linkage disequilibrium. We demonstrated a functional role for the most strongly associated serum albumin locus, HPN, for which Hpn knockout mice manifest low plasma albumin concentrations. Other loci associated with serum albumin harbor genes related to ribosome function, protein translation, and proteasomal degradation, whereas those associated with serum total protein include genes related to immune function. Our results highlight the advantages of transethnic meta-analysis for the discovery and fine mapping of complex trait loci and have provided initial insights into the underlying genetic architecture of serum protein concentrations and their association with human disease.	[Franceschini, Nora; Loehr, Laura R.; North, Karl E.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [van Rooij, Frank J. A.; Broer, Linda; Dehghan, Abbas; Franco, Oscar H.; Hofman, Albert; Uitterlinden, Andre G.; van Duijn, Cornelia M.; Witteman, Jacqueline C. M.; Felix, Janine F.] Erasmus Univ, Med Ctr, ErasmusAGE, NL-3000 CA Rotterdam, Netherlands; [van Rooij, Frank J. A.; Broer, Linda; Dehghan, Abbas; Franco, Oscar H.; Hofman, Albert; Uitterlinden, Andre G.; van Duijn, Cornelia M.; Witteman, Jacqueline C. M.; Felix, Janine F.] Erasmus Univ, Med Ctr, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands; [van Rooij, Frank J. A.; Broer, Linda; Dehghan, Abbas; Franco, Oscar H.; Hofman, Albert; Uitterlinden, Andre G.; van Duijn, Cornelia M.; Witteman, Jacqueline C. M.; Felix, Janine F.] Netherlands Genom Initiat, Netherlands Consortium Hlth Aging, NL-2300 RC Leiden, Netherlands; [Prins, Bram P.; Vaez, Ahmad; Snieder, Harold; Alizadeh, Behrooz Z.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9700 RB Groningen, Netherlands; [Feitosa, Mary F.; Kraja, Aldi; Zhang, Qunyuan; Borecki, Ingrid B.] Washington Univ, Sch Med, Dept Genet, Div Stat Genom, St Louis, MO 63108 USA; [Karakas, Mahir; Koenig, Wolfgang] Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, D-89081 Ulm, Germany; [Eckfeldt, John H.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Folsom, Aaron R.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA; [Kopp, Jeffrey] NIDDK, NIH, Bethesda, MD 20892 USA; [Andrews, Jeanette S.; Hsu, Fang-Chi] Wake Forest Univ, Bowman Gray Sch Med, Dept Biostat Sci, Winston Salem, NC 27157 USA; [Baumert, Jens; Doering, Angela; Meisinger, Christa; Gieger, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, D-85764 Neuherberg, Germany; [Boraska, Vesna; Zemunik, Tatijana] Univ Split, Sch Med, Dept Med Biol, Split 21000, Croatia; [Hayward, Caroline; Vitart, Veronique; Wright, Alan F.] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, MRC,Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Ngwa, Julius S.; Wang, Ying A.; Cupples, L. Adrienne] Harvard Univ, Sch Publ Hlth, Boston Univ, Sch Publ Hlth,Dept Biostat, Boston, MA 02115 USA; [Okada, Yukinori; Takahashi, Atsushi] RIKEN, CGM, Lab Stat Anal, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Okada, Yukinori] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Bunkyo Ku, Tokyo 1130033, Japan; [Polasek, Ozren; Kolcic, Ivana] Univ Split, Sch Med, Dept Publ Hlth, Split 21000, Croatia; [Westra, Harm-Jan; Franke, Lude] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9713 GZ Groningen, Netherlands; [Wang, Ying A.] Novartis Inst BioMed Res, Cambridge, MA 02139 USA; [Del Greco M, Fabiola; Schwienbacher, Christine; Hicks, Andrew A.; Pramstaller, Peter P.] Med Univ Lubeck, Affiliated Inst, Ctr Biomed, European Acad Bozen Bolzano EURAC, D-23562 Lubeck, Germany; [Glazer, Nicole L.] Boston Univ, Sch Med, Prevent Med & Epidemiol Sect, Boston, MA 02118 USA; [Kapur, Karen; Bergmann, Sven] Univ Lausanne, Univ Hosp Ctr, Dept Med Genet, CH-1005 Lausanne, Switzerland; [Kema, Id P.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, NL-9700 RB Groningen, Netherlands; [Lopez, Lorna M.; Starr, John M.; Deary, Ian J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Lopez, Lorna M.; Davies, Gail; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh EH8 9AD, Midlothian, Scotland; [Schillert, Arne; Ziegler, Andreas] Univ Hosp Schleswig Holstein, Inst Med Biometry & Stat, D-23538 Lubeck, Germany; [Smith, Albert V.] Iceland Heart Assoc, IS-201 Kopavogur, Iceland; [Smith, Albert V.] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; [Winkler, Cheryl A.] NCI, Mol Genet Epidemiol Sect, NIH, Frederick Natl Lab, Ft Detrick, MD 21702 USA; [Zgaga, Lina; Kirin, Mirna; Campbell, Harry; Rudan, Igor; Wilson, James F.] Univ Edinburgh, Queens Med Res Inst, Coll Med & Vet Med, Ctr Populat Hlth Sci, Edinburgh EH16 4TJ, Midlothian, Scotland; [Zgaga, Lina; Kirin, Mirna; Campbell, Harry; Rudan, Igor; Wilson, James F.] Univ Edinburgh, Queens Med Res Inst, Coll Med & Vet Med, Inst Genet & Mol Med, Edinburgh EH16 4TJ, Midlothian, Scotland; [Zgaga, Lina] Univ Zagreb, Sch Med, Dept Med Stat Epidemiol & Med Informat, Zagreb 10000, Croatia; [Bandinelli, Stefania; Gunjaca, Grog] Azienda Sanit Firenze, Geriatr Unit, I-50125 Florence, Italy; [Kapur, Karen; Bergmann, Sven] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Boban, Mladen] Univ Split, Sch Med, Dept Pharmacol, Split 21000, Croatia; [Bochud, Murielle] Univ Inst Social & Prevent Med, Community Prevent Unit, CH-1005 Lausanne, Switzerland; [Chen, Y. D.] Cedars Sinai Med Ctr, Dept Obstet & Gynecol, Los Angeles, CA 90048 USA; [Chen, Y. D.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Ding, Jingzhong] Wake Forest Sch Med, Dept Internal Med, Sect Gerontol & Geriatr Med, Winston Salem, NC 27157 USA; [Durda, J. Peter; Jenny, Nancy S.] Univ Vermont, Coll Med, Dept Pathol, Lab Clin Biochem Res, Burlington, VT 05405 USA; [Ferrucci, Luigi] NIA, Longitudinal Studies Sect, Clin Res Branch, Baltimore, MD 21225 USA; [Kubo, Michiaki] RIKEN, CGM, Lab Genotyping Dev, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Lackner, Karl J.] Univ Med Ctr Mainz, Inst Clin Chem & Lab Med, D-55131 Mainz, Germany; [Launer, Lenore; Harris, Tamara B.] NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Li, Guo] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Mol Med,Minato Ku, Tokyo 1088639, Japan; [Schwienbacher, Christine] Univ Ferrara, Dept Expt & Diagnost Med, I-44121 Ferrara, Italy; [Starr, John M.] Univ Edinburgh, Dept Psychol, Alzheimer Scotland Dementia Res Ctr, Edinburgh EH8 9JZ, Midlothian, Scotland; [Torlak, Vesela] Univ Hosp Split, Split 21000, Croatia; [Waldenberger, Melanie] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Epidemiol Res Unit, D-85764 Neuherberg, Germany; [Wild, Philipp S.] Univ Med Ctr Mainz, Dept Med 2, D-55131 Mainz, Germany; [Zeller, Tanja; Blankenberg, Stefan] Univ Heart Ctr Hamburg, Clin Gen & Intervent Cardiol, D-20246 Hamburg, Germany; [Boerwinkle, Eric] Univ Houston, Sch Publ Hlth, Div Epidemiol, Houston, TX 77030 USA; [Boerwinkle, Eric] Univ Houston, Sch Publ Hlth, Ctr Human Genet, Houston, TX 77030 USA; [Frayling, Timothy M.; Perry, John R. B.] Univ Exeter, Peninsula Med Sch, Exeter EX2 5DW, Devon, England; [O'Donnell, Christopher J.; Fox, Caroline S.; Cupples, L. Adrienne] Natl Heart Lung & Blood Inst NHLBI Framingham Hea, Div Intramural Res, Framingham, MA 01702 USA; [O'Donnell, Christopher J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med,Cardiol Div, Boston, MA 02114 USA; [Fox, Caroline S.] NHLBI, Ctr Populat Studies, Framingham, MA 01702 USA; [Pramstaller, Peter P.] Gen Cent Hosp, Dept Neurol, I-39100 Bolzano, Italy; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Epidemiol, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Hlth Serv, Seattle, WA 98101 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA 98101 USA; [Reiner, Alex P.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Tanaka, Toshihiro] RIKEN, Lab Cardiovasc Dis, CGM, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Vollenweider, Peter; Waeber, Gerard] Univ Lausanne Hosp, Dept Internal Med, CH-1011 Lausanne, Switzerland; [Wolffenbuttel, Bruce H. R.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, NL-9713 GZ Groningen, Netherlands; [Wu, Qingyu] Cleveland Clin, Mol Cardiol Nephrol & Hypertens Lerner Res Inst, Cleveland, OH 44195 USA; [Liu, Yongmei] Wake Forest Univ, Bowman Gray Sch Med, Dept Epidemiol & Prevent Med, Winston Salem, NC 27157 USA; [Morris, Andrew P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	University of North Carolina; University of North Carolina Chapel Hill; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Groningen; Washington University (WUSTL); Ulm University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Wake Forest University; Wake Forest Baptist Medical Center; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Split; University of Edinburgh; Boston University; Harvard University; Harvard T.H. Chan School of Public Health; RIKEN; University of Tokyo; University of Split; University of Groningen; Novartis; European Academy of Bozen-Bolzano; University of Lubeck; Boston University; University of Lausanne; University of Groningen; University of Edinburgh; University of Edinburgh; University of Kiel; Schleswig Holstein University Hospital; Icelandic Heart Association; University of Iceland; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Edinburgh; University of Edinburgh; University of Zagreb; Azienda Sanitaria di Firenze; Swiss Institute of Bioinformatics; University of Split; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Wake Forest University; University of Vermont; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); RIKEN; Johannes Gutenberg University of Mainz; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Washington; University of Washington Seattle; University of Tokyo; University of Ferrara; University of Edinburgh; University of Split; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Johannes Gutenberg University of Mainz; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Houston System; University of Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Houston System; University of Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Exeter; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Harvard Medical School; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Krankenhaus Bozen; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; University of Washington; University of Washington Seattle; Cedars Sinai Medical Center; RIKEN; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Groningen; Cleveland Clinic Foundation; Wake Forest University; Wake Forest Baptist Medical Center; University of Oxford; Wellcome Centre for Human Genetics	Franceschini, N (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA.	noraf@unc.edu; amorris@well.ox.ac.uk	Tanaka, Toshihiro/J-9310-2014; Vaez, Ahmad/B-4336-2018; Franke, Lude/P-7036-2016; Dehghan, Abbas/ABE-7377-2020; Smith, Albert Vernon/K-5150-2015; Kubo, Michiaki/N-7947-2015; Bochud, Murielle/A-3981-2010; Alizadeh, Behrooz Z Ziad/J-2921-2017; Kolcic, Ivana/E-2713-2017; Zgaga, Lina/Q-9415-2018; Pramstaller, Peter P/C-2357-2008; Feitosa, Mary F/K-8044-2012; Waldenberger, Melanie/B-5355-2014; Wilson, James F/A-5704-2009; Kirin, Mirna/AAZ-6587-2020; bandinelli, stefania/AAL-4570-2020; Hayward, Caroline/M-8818-2016; Campbell, Harry/E-2959-2010; Wolffenbuttel, Bruce/A-8419-2011; Lopez, Lorna/AAR-4912-2020; Perica, Vesna Boraska/D-8230-2017; Wild, Philipp S./M-2106-2019; Rudan, Igor/I-1467-2012; Colaus, PsyColaus/K-6607-2013; Deary, Ian J/C-6297-2009; Kopp, Jeffrey B/O-2681-2015; Franco, Óscar H/ABE-2305-2020; Boban, Mladen/E-2777-2017; Rotter, Jerome/AAY-6598-2021; Meisinger, Christine/B-5358-2014; Zemunik, Tatijana/D-8584-2017; Polasek, Ozren/B-6002-2011; Hicks, Andrew Anthony/E-9518-2017; Dehghan, Abbas/B-9896-2008; Ziegler, Andreas/G-4246-2012	Tanaka, Toshihiro/0000-0001-6201-9784; Vaez, Ahmad/0000-0001-9048-3795; Franke, Lude/0000-0002-5159-8802; Smith, Albert Vernon/0000-0003-1942-5845; Bochud, Murielle/0000-0002-5727-0218; Alizadeh, Behrooz Z Ziad/0000-0002-1415-8007; Kolcic, Ivana/0000-0001-7918-6052; Zgaga, Lina/0000-0003-4089-9703; Feitosa, Mary F/0000-0002-0933-2410; Waldenberger, Melanie/0000-0003-0583-5093; Wilson, James F/0000-0001-5751-9178; Hayward, Caroline/0000-0002-9405-9550; Campbell, Harry/0000-0002-6169-6262; Wolffenbuttel, Bruce/0000-0001-9262-6921; Lopez, Lorna/0000-0002-0241-9783; Perica, Vesna Boraska/0000-0003-3999-1529; Rudan, Igor/0000-0001-6993-6884; Deary, Ian J/0000-0002-1733-263X; Kopp, Jeffrey B/0000-0001-9052-186X; Franco, Óscar H/0000-0002-4606-4929; Boban, Mladen/0000-0003-1570-9621; Zemunik, Tatijana/0000-0001-8120-2891; Polasek, Ozren/0000-0002-5765-1862; Hicks, Andrew Anthony/0000-0001-6320-0411; Prins, Bram/0000-0001-5774-034X; Wu, Qingyu/0000-0003-0561-9315; Wild, Philipp/0000-0003-4413-9752; Dehghan, Abbas/0000-0001-6403-016X; Ziegler, Andreas/0000-0002-8386-5397; Waeber, Gerard/0000-0003-4193-788X; Broer, Linda/0000-0003-0011-123X; Gieger, Christian/0000-0001-6986-9554; Koenig, Wolfgang/0000-0002-2064-9603; Glazer, Nicole/0000-0002-6397-609X; Bergmann, Sven/0000-0002-6785-9034; Meisinger, Christa/0000-0002-9026-6544; Loehr, Laura/0000-0002-9054-1825; Felix, Janine/0000-0002-9801-5774; Pramstaller, Peter P/0000-0002-9831-8302; Van Duijn, Cornelia/0000-0002-2374-9204; Cupples, L. Adrienne/0000-0003-0273-7965; Zeller, Tanja/0000-0003-3379-2641	Wellcome Trust [WT081682, WT064890, WT098017, WT090532]; AHA [0675001N, R01HL089651, U01HG004803]; Biotechnology and Biological Sciences Research Council [BB/F019394/1] Funding Source: researchfish; Medical Research Council [G0700704B, MC_U127561128, G0700704, MC_PC_U127561128] Funding Source: researchfish; Chief Scientist Office [CZB/4/710] Funding Source: researchfish; BBSRC [BB/F019394/1] Funding Source: UKRI; MRC [G0700704, MC_PC_U127561128, MC_U127561128] Funding Source: UKRI; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105756, R01HL089651] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, ZIADK043308] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); AHA(American Heart Association); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	A.P.M acknowledges financial support from the Wellcome Trust, grant numbers WT081682, WT064890, WT098017, and WT090532. N.F. acknowledges financial support from AHA 0675001N, R01HL089651, and U01HG004803.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; [Anonymous], 1999, TIETZ TXB CLIN CHEM; Chaudhury C, 2003, J EXP MED, V197, P315, DOI 10.1084/jem.20021829; DALCOLLETTO GMD, 1983, ACTA GENET MED GEMEL, V32, P23; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Goldwasser P, 1997, J CLIN EPIDEMIOL, V50, P693, DOI 10.1016/S0895-4356(97)00015-2; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; KALOUSDIAN S, 1987, GENET EPIDEMIOL, V4, P1, DOI 10.1002/gepi.1370040102; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kim YJ, 2011, NAT GENET, V43, P990, DOI 10.1038/ng.939; Morris AP, 2011, GENET EPIDEMIOL, V35, P809, DOI 10.1002/gepi.20630; Nelson JJ, 2000, AM J EPIDEMIOL, V151, P468; Pankow JS, 2001, ATHEROSCLEROSIS, V154, P681, DOI 10.1016/S0021-9150(00)00586-4; Roopenian DC, 2003, J IMMUNOL, V170, P3528, DOI 10.4049/jimmunol.170.7.3528; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Wani MA, 2006, P NATL ACAD SCI USA, V103, P5084, DOI 10.1073/pnas.0600548103; WHITFIELD JB, 1984, ANN CLIN BIOCHEM, V21, P176, DOI 10.1177/000456328402100303; Wu QY, 1998, J CLIN INVEST, V101, P321, DOI 10.1172/JCI1617; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011	25	56	56	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT 5	2012	91	4					744	753		10.1016/j.ajhg.2012.08.021	http://dx.doi.org/10.1016/j.ajhg.2012.08.021			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	017CU	23022100	Green Published, Green Submitted, hybrid			2022-12-18	WOS:000309568500017
J	Majczenko, K; Davidson, AE; Camelo-Piragua, S; Agrawal, PB; Manfready, RA; Li, XL; Joshi, S; Xu, JS; Peng, WP; Beggs, AH; Li, JZ; Burmeister, M; Dowling, JJ				Majczenko, Karen; Davidson, Ann E.; Camelo-Piragua, Sandra; Agrawal, Pankaj B.; Manfready, Richard A.; Li, Xingli; Joshi, Sucheta; Xu, Jishu; Peng, Weiping; Beggs, Alan H.; Li, Jun Z.; Burmeister, Margit; Dowling, James J.			Dominant Mutation of CCDC78 in a Unique Congenital Myopathy with Prominent Internal Nuclei and Atypical Cores	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MYOTUBULAR MYOPATHY; SKELETAL-MUSCLE; DYNAMIN 2; DISEASE; DISORGANIZATION; MICE	Congenital myopathies are clinically and genetically heterogeneous diseases that typically present in childhood with hypotonia and weakness and are most commonly defined by changes observed in muscle biopsy. Approximately 40% of congenital myopathies are currently genetically unresolved. We identified a family with dominantly inherited congenital myopathy characterized by distal weakness and biopsy changes that included core-like areas and increased internalized nuclei. To identify the causative genetic abnormality in this family, we performed linkage analysis followed by whole-exome capture and next-generation sequencing. A splice-acceptor variant in previously uncharacterized CCDC78 was detected in affected individuals and absent in unaffected family members and > 10,000 controls. This variant alters RNA-transcript processing and results in a 222 bp in-frame insertion. CCDC78 is expressed in skeletal muscle, enriched in the perinuclear region and the triad, and found in intracellular aggregates in patient muscle. Modeling of the CCDC78 mutation in zebrafish resulted in changes mirroring the human disease that included altered motor function and abnormal muscle ultrastructure. Using a combination of linkage analysis, next-generation sequencing, and modeling in the zebrafish, we have identified a CCDC78 mutation associated with a unique myopathy with prominent internal nuclei and atypical cores.	[Majczenko, Karen; Burmeister, Margit] Univ Michigan, Ctr Med, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Davidson, Ann E.; Li, Xingli; Joshi, Sucheta; Dowling, James J.] Univ Michigan, Ctr Med, Dept Pediat, Ann Arbor, MI 48109 USA; [Camelo-Piragua, Sandra] Univ Michigan, Ctr Med, Dept Neuropathol, Ann Arbor, MI 48109 USA; [Agrawal, Pankaj B.; Manfready, Richard A.; Beggs, Alan H.] Harvard Univ, Sch Med, Boston Childrens Hosp, Manton Ctr Orphan Dis Res,Div Genet, Boston, MA 02115 USA; [Agrawal, Pankaj B.; Manfready, Richard A.; Beggs, Alan H.] Harvard Univ, Sch Med, Boston Childrens Hosp, Manton Ctr Orphan Dis Res,Program Genom, Boston, MA 02115 USA; [Xu, Jishu; Peng, Weiping; Li, Jun Z.; Burmeister, Margit] Univ Michigan, Ctr Med, Dept Human Genet, Ann Arbor, MI 48109 USA; [Dowling, James J.] Univ Michigan, Ctr Med, Dept Neurol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Burmeister, M (corresponding author), Univ Michigan, Ctr Med, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA.	margit@umich.edu; jamedowl@umich.edu	Burmeister, Margit/A-3157-2013; Agrawal, Pankaj/ABG-8957-2021	Burmeister, Margit/0000-0002-1914-2434; Camelopiragua, Sandra/0000-0002-9606-9402; Beggs, Alan/0000-0001-8818-0568; Li, Jun/0000-0001-6727-0812	Center for Computational Medicine and Bioinformatics; Microscopy and Imaging Laboratory Core Facility at the University of Michigan; Exome Sequencing Pilot Program of the University of Michigan Initiative on Rare Disease Research; National Institutes of Health [R21-DC-010074, K08AR054835, K08 AR055072, R01 AR044345]; Muscular Dystrophy Association [MDA186999, MDA201302]; Taubman Medical Research Institute; Anderson Family Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR062810, K08AR054835, K08AR055072, R01AR044345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC010074] Funding Source: NIH RePORTER	Center for Computational Medicine and Bioinformatics; Microscopy and Imaging Laboratory Core Facility at the University of Michigan; Exome Sequencing Pilot Program of the University of Michigan Initiative on Rare Disease Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Taubman Medical Research Institute; Anderson Family Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Elzbieta Sliwerska, Angela Busta, and Trent Waugh for technical assistance, Linda Gates for tissue culture, and Elizabeth DeChene for ascertainment and identification of congenital myopathy cases for CCDC78 analysis. We also acknowledge the University of Michigan DNA Sequencing Core (Director: Robert Lyons) for linkage chip hybridization and next-generation sequencing. This work was supported by the Center for Computational Medicine and Bioinformatics and the Microscopy and Imaging Laboratory Core Facility at the University of Michigan, the Exome Sequencing Pilot Program of the University of Michigan Initiative on Rare Disease Research; National Institutes of Health grants R21-DC-010074 (M.B.), K08AR054835 (J.J.D.), K08 AR055072 (P.B.A.), and R01 AR044345 (A.H.B.); the Muscular Dystrophy Association grants MDA186999 (J.J.D.) and MDA201302 (A.H.B.), the Taubman Medical Research Institute (J.J.D.), and the Anderson Family Foundation (A.H.B.).	Al-Qusairi L, 2009, P NATL ACAD SCI USA, V106, P18763, DOI 10.1073/pnas.0900705106; Amburgey K, 2011, ANN NEUROL, V70, P662, DOI 10.1002/ana.22510; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Beggs AH, 2010, P NATL ACAD SCI USA, V107, P14697, DOI 10.1073/pnas.1003677107; Bevilacqua JA, 2011, NEUROPATH APPL NEURO, V37, P271, DOI 10.1111/j.1365-2990.2010.01149.x; Cowling BS, 2011, AM J PATHOL, V178, P2224, DOI 10.1016/j.ajpath.2011.01.054; Dowling JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000372; Durieux AC, 2010, HUM MOL GENET, V19, P4820, DOI 10.1093/hmg/ddq413; Jones HR., 2003, NEUROMUSCULAR DISORD; Jungbluth H, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-25; Jungbluth Heinz, 2012, Neuromuscul Disord, V22, P453, DOI 10.1016/j.nmd.2011.12.003; Jungbluth Heinz, 2009, Neuromuscul Disord, V19, P721, DOI 10.1016/j.nmd.2009.06.373; Jungbluth H, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-31; Jungbluth H, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-26; Nance JR, 2012, CURR NEUROL NEUROSCI, V12, P165, DOI 10.1007/s11910-012-0255-x; Norton N, 2011, AM J HUM GENET, V88, P273, DOI 10.1016/j.ajhg.2011.01.016; Otto EA, 2010, NAT GENET, V42, P840, DOI 10.1038/ng.662; Toussaint A, 2011, ACTA NEUROPATHOL, V121, P253, DOI 10.1007/s00401-010-0754-2; Wallgren-Pettersson C, 2011, SEMIN PEDIATR NEUROL, V18, P230, DOI 10.1016/j.spen.2011.10.004; Zuchner S, 2011, AM J HUM GENET, V88, P201, DOI 10.1016/j.ajhg.2011.01.001	20	56	60	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG 10	2012	91	2					365	371		10.1016/j.ajhg.2012.06.012	http://dx.doi.org/10.1016/j.ajhg.2012.06.012			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	990CN	22818856	Green Published, Bronze			2022-12-18	WOS:000307608700016
J	Raj, T; Shulman, JM; Keenan, BT; Chibnik, LB; Evans, DA; Bennett, DA; Stranger, BE; De Jager, PL				Raj, Towfique; Shulman, Joshua M.; Keenan, Brendan T.; Chibnik, Lori B.; Evans, Denis A.; Bennett, David A.; Stranger, Barbara E.; De Jager, Philip L.			Alzheimer Disease Susceptibility Loci: Evidence for a Protein Network under Natural Selection	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; IDENTIFIES VARIANTS; COMMON VARIANTS; METAANALYSIS; CD2AP; EPHA1; CD33; CLU	Recent genome-wide association studies have identified a number of susceptibility loci for Alzheimer disease (AD). To understand the functional consequences and potential interactions of the associated loci, we explored large-scale data sets interrogating the human genome for evidence of positive natural selection. Our findings provide significant evidence for signatures of recent positive selection acting on several haplotypes carrying All susceptibility alleles; interestingly, the genes found in these selected haplotypes can be assembled, independently, into a molecular complex via a protein-protein interaction (PPI) network approach. These results suggest a possible coevolution of genes encoding physically-interacting proteins that underlie AD susceptibility and are coexpressed in different tissues. In particular, PICALM, BIN1, CD2AP and EPHA1 are interconnected through multiple interacting proteins and appear to have coordinated evidence of selection in the same human population, suggesting that they may be involved in the execution of a shared molecular function. This observation may be AD-specific, as the 12 loci associated with Parkinson disease do not demonstrate excess evidence of natural selection. The context for selection is probably unrelated to AD itself; it is likely that these genes interact in another context, such as in immune cells, where we observe cis-regulatory effects at several of the selected AD loci.	[Raj, Towfique; Shulman, Joshua M.; Keenan, Brendan T.; Chibnik, Lori B.; De Jager, Philip L.] Brigham & Womens Hosp, Program Translat NeuroPsychiat Genom, Inst Neurosci, Dept Neurol, Boston, MA 02115 USA; [Raj, Towfique; Stranger, Barbara E.] Brigham & Womens Hosp, Div Genet, Dept Med, Boston, MA 02115 USA; [Raj, Towfique; Shulman, Joshua M.; Chibnik, Lori B.; Stranger, Barbara E.; De Jager, Philip L.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Raj, Towfique; Shulman, Joshua M.; Keenan, Brendan T.; Chibnik, Lori B.; Stranger, Barbara E.; De Jager, Philip L.] 7 Cambridge Ctr, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Evans, Denis A.; Bennett, David A.] Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA; [Evans, Denis A.; Bennett, David A.] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Evans, Denis A.; Bennett, David A.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Rush University; Rush University; Rush University	De Jager, PL (corresponding author), Brigham & Womens Hosp, Program Translat NeuroPsychiat Genom, Inst Neurosci, Dept Neurol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	pdejager@rics.bwh.harvard.edu	Raj, Towfique/ABD-7620-2021	Stranger, Barbara/0000-0001-9021-7331; Chibnik, Lori/0000-0001-6293-806X	National Institutes of Health (NIH) [RC2 GM093080, R01 AG30146, R01 AG179917, R01 AG15819, K08 AG034290, P30 AG10161, R01 AG11101]; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM093080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011101, R01AG015819, R01AG030146, P30AG010161, K08AG034290] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by the National Institutes of Health (NIH) (RC2 GM093080, R01 AG30146, R01 AG179917, R01 AG15819, K08 AG034290, P30 AG10161 and R01 AG11101). J.M.S. was additionally supported by the Burroughs Wellcome Fund. We thank the Brigham and Women's Hospital PhenoGenetic Project for providing mRNA samples from healthy subjects that were used in the CD4+ T lymphocyte transcriptional analysis for this study. We thank Michelle Lee for sample collection, Katherine Rothamel for data generation, and Scott Davis for mRNA expression quality control. We thank Christophe Benoist for his leadership on RC2 GM093080. These analyses were conducted under the auspices of a protocol approved by the institutional review board of Partners Healthcare.	Avramopoulos D, 2009, GENOME MED, V1, DOI 10.1186/gm34; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Drenos F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010022; Fraser HB, 2004, P NATL ACAD SCI USA, V101, P9033, DOI 10.1073/pnas.0402591101; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Ikram MA, 2009, BIOL PSYCHIAT, V65, P995, DOI 10.1016/j.biopsych.2008.11.014; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Reiman EM, 2007, NEURON, V54, P713, DOI 10.1016/j.neuron.2007.05.022; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Tillier ERM, 2009, GENOME RES, V19, P1861, DOI 10.1101/gr.092452.109; Vamathevan JJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-273; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130	18	56	56	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR 6	2012	90	4					720	726		10.1016/j.ajhg.2012.02.022	http://dx.doi.org/10.1016/j.ajhg.2012.02.022			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	926LV	22482808	Green Published, Bronze			2022-12-18	WOS:000302833400016
J	Bloch-Zupan, A; Jamet, X; Etard, C; Laugel, V; Muller, J; Geoffroy, V; Strauss, JP; Pelletier, V; Marion, V; Poch, O; Strahle, U; Stoetzel, C; Dollfus, H				Bloch-Zupan, Agnes; Jamet, Xavier; Etard, Christelle; Laugel, Virginie; Muller, Jean; Geoffroy, Veronique; Strauss, Jean-Pierre; Pelletier, Valerie; Marion, Vincent; Poch, Olivier; Strahle, Uwe; Stoetzel, Corinne; Dollfus, Helene			Homozygosity Mapping and Candidate Prioritization Identify Mutations, Missed by Whole-Exome Sequencing, in SMOC2, Causing Major Dental Developmental Defects	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ZEBRAFISH TOOTH DEVELOPMENT; CALCIUM-BINDING PROTEIN; EXPRESSION; GENE; FAMILY; SPARC; CYPRINIDAE; DENTITIONS; MESENCHYME; EPITHELIUM	Inherited dental malformations constitute a clinically and genetically heterogeneous group of disorders. Here, we report on a severe developmental dental defect that results in a dentin dysplasia phenotype with major microdontia, oligodontia, and shape abnormalities in a highly consanguineous family. Homozygosity mapping revealed a unique zone on 6q27-ter. The two affected children were found to carry a homozygous mutation in SMOC2. Knockdown of smoc2 in zebrafish showed pharyngeal teeth that had abnormalities reminiscent of the human phenotype. Moreover, smoc2 depletion in zebrafish affected the expression of three major odontogenesis genes: dlx2, bmp2, and pitx2.	[Pelletier, Valerie; Dollfus, Helene] Hop Univ Strasbourg, Serv Genet Med, F-67000 Strasbourg, France; [Bloch-Zupan, Agnes; Jamet, Xavier] Univ Strasbourg, Fac Dent, F-67000 Strasbourg, France; [Bloch-Zupan, Agnes; Jamet, Xavier] Hop Univ Strasbourg, Serv Med & Chirurg Buccale, Reference Ctr Orodental Manifestat Rare Dis, F-67000 Strasbourg, France; [Bloch-Zupan, Agnes; Laugel, Virginie] INSERM, U964, IGBMC, Dev & Stem Cells Program, F-67400 Illkirch Graffenstaden, France; [Bloch-Zupan, Agnes; Laugel, Virginie] CNRS, UMR 7104, F-67400 Illkirch Graffenstaden, France; [Etard, Christelle; Strahle, Uwe] Karlsruher Inst Technol, Inst Genet & Toxikol, D-76344 Eggenstein Leopoldshafen, Germany; [Muller, Jean; Geoffroy, Veronique; Poch, Olivier] CNRS, UMR 7104, Integrat Genom & Bioinformat Lab, INSERM,U964, F-67400 Illkirch Graffenstaden, France; [Muller, Jean; Geoffroy, Veronique; Poch, Olivier] Univ Strasbourg, F-67400 Illkirch Graffenstaden, France; [Strauss, Jean-Pierre] Cabinet Dent, F-68100 Mulhouse, France; [Marion, Vincent; Stoetzel, Corinne; Dollfus, Helene] Univ Strasbourg, Fac Med, Lab Physiopathol Syndromes Rares Hereditaires, Inserm Avenir,Equipe Accueil 3949, F-67000 Strasbourg, France	CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Helmholtz Association; Karlsruhe Institute of Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Dollfus, H (corresponding author), Hop Univ Strasbourg, Serv Genet Med, F-67000 Strasbourg, France.	helene.dollfus@medecine.u-strasbg.fr	Bloch-Zupan, Agnes/N-7822-2016; Straehle, Uwe/K-7054-2013; Marion, Vincent/H-9730-2016; Muller, Jean/L-7412-2018	Bloch-Zupan, Agnes/0000-0002-6511-2615; Muller, Jean/0000-0002-7682-559X; Marion, Vincent/0000-0002-8271-7376; Dollfus, Helene/0000-0002-2249-895X; Geoffroy, Veronique/0000-0002-4149-0857	Hopitaux Universitaires de Strasbourg; French Ministry of Health; European Integrating Project Zebrafish Regulomics for Human Health (ZF-Health); European network on Fish Biomedical Models (EuFishBioMed); European Cooperation in Science and Technology [COST] Action [BM0804]; Helmholtz Association	Hopitaux Universitaires de Strasbourg; French Ministry of Health; European Integrating Project Zebrafish Regulomics for Human Health (ZF-Health); European network on Fish Biomedical Models (EuFishBioMed); European Cooperation in Science and Technology [COST] Action(European Cooperation in Science and Technology (COST)); Helmholtz Association(Helmholtz Association)	We would like to thank the family and, in particular, the children, who were very participative. Our work was supported by the 2008-2009 Appel a Projet intern program at the Hopitaux Universitaires de Strasbourg and by the 2008-2011 National Protocole Hospitalier de Recherche Clinique program from the French Ministry of Health. The Equipe d'Accueil 3949 laboratory has been part of the AVENIR INSERM program since 2007. Our work was also supported by the European Integrating Project Zebrafish Regulomics for Human Health (ZF-Health), the European network on Fish Biomedical Models (EuFishBioMed) (supported by the European Cooperation in Science and Technology [COST] Action BM0804), and the Helmholtz Association.	Abouzeid H, 2011, AM J HUM GENET, V88, P92, DOI 10.1016/j.ajhg.2010.12.002; Alkhateeb A, 2010, EUR J DERMATOL, V20, P701, DOI 10.1684/ejd.2010.1095; [Anonymous], DBSNP; Barron MJ, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-31; Birkholz DA, 2009, DEV DYNAM, V238, P2575, DOI 10.1002/dvdy.22090; Birlea SA, 2010, J INVEST DERMATOL, V130, P798, DOI 10.1038/jid.2009.347; Brekken Rolf A., 2001, Matrix Biology, V19, P816; *D 4 PHEN, D 4 PHEN DIAGN DENT; Debiais-Thibaud M, 2007, J EXP ZOOL PART B, V308B, P693, DOI 10.1002/jez.b.21183; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; Fleischmannova J, 2008, EUR J ORAL SCI, V116, P1, DOI 10.1111/j.1600-0722.2007.00504.x; GenBank, GENBANK; Gersdorff N, 2006, HISTOCHEM CELL BIOL, V126, P705, DOI 10.1007/s00418-006-0200-7; Huysseune A, 1998, ANAT EMBRYOL, V198, P289, DOI 10.1007/s004290050185; Idrees F, 2006, AM J MED GENET B, V141B, P184, DOI 10.1002/ajmg.b.30237; Jackman WR, 2006, P NATL ACAD SCI USA, V103, P19390, DOI 10.1073/pnas.0609575103; Jackman WR, 2004, DEV BIOL, V274, P139, DOI 10.1016/j.ydbio.2004.07.003; Kettunen P, 2010, GENE EXPR PATTERNS, V10, P140, DOI 10.1016/j.gep.2010.02.002; LANE TF, 1994, J CELL BIOL, V125, P929, DOI 10.1083/jcb.125.4.929; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Liu PJ, 2008, MOL BIOL CELL, V19, P248, DOI 10.1091/mbc.E07-05-0510; Mucchielli ML, 1997, DEV BIOL, V189, P275, DOI 10.1006/dbio.1997.8672; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nishida E, 2007, GENE, V404, P70, DOI 10.1016/j.gene.2007.09.009; Okada I, 2011, AM J HUM GENET, V88, P30, DOI 10.1016/j.ajhg.2010.11.012; Ozer L, 2004, ORAL SURG ORAL MED O, V98, P85, DOI 10.1016/j.tripleo.2004.01.005; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Pazin DE, 2009, DEV DYNAM, V238, P2877, DOI 10.1002/dvdy.22124; Rocnik EF, 2006, J BIOL CHEM, V281, P22855, DOI 10.1074/jbc.M513463200; Sharman AC, 1998, TRENDS GENET, V14, P211, DOI 10.1016/S0168-9525(98)01488-7; Stock DW, 2006, DEVELOPMENT, V133, P3127, DOI 10.1242/dev.02459; Stock DW, 1996, P NATL ACAD SCI USA, V93, P10858, DOI 10.1073/pnas.93.20.10858; Thomas BL, 2000, DEVELOPMENT, V127, P217; Thomas BL, 1997, DEVELOPMENT, V124, P4811; Tummers M, 2009, J EXP ZOOL PART B, V312B, P309, DOI 10.1002/jez.b.21280; Van der Heyden C, 2000, DEV DYNAM, V219, P486; Vannahme C, 2003, BIOCHEM J, V373, P805, DOI 10.1042/BJ20030532; Vannahme C, 2002, J BIOL CHEM, V277, P37977, DOI 10.1074/jbc.M203830200; Wise SB, 2006, EVOL DEV, V8, P511, DOI 10.1111/j.1525-142X.2006.00124.x; Wise SB, 2010, DEV DYNAM, V239, P2534, DOI 10.1002/dvdy.22411; HSF2 4 1; UNIGENE; GENEHUB GEPIS; GENE EXPRESSION TOOT	44	56	65	2	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC 9	2011	89	6					773	781		10.1016/j.ajhg.2011.11.002	http://dx.doi.org/10.1016/j.ajhg.2011.11.002			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	864AF	22152679	Green Published, Bronze			2022-12-18	WOS:000298208700009
J	Huebner, AK; Gandia, M; Frommolt, P; Maak, A; Wicklein, EM; Thiele, H; Altmuller, J; Wagner, F; Vinuela, A; Aguirre, LA; Moreno, F; Maier, H; Rau, I; Giesselmann, S; Nurnberg, G; Gal, A; Nurnberg, P; Hubner, CA; Del Castillo, I; Kurth, I				Huebner, Antje K.; Gandia, Marta; Frommolt, Peter; Maak, Anika; Wicklein, Eva M.; Thiele, Holger; Altmueller, Janine; Wagner, Florian; Vinuela, Antonio; Aguirre, Luis A.; Moreno, Felipe; Maier, Hannes; Rau, Isabella; Giesselmann, Sebastian; Nuernberg, Gudrun; Gal, Andreas; Nuernberg, Peter; Huebner, Christian A.; del Castillo, Ignacio; Kurth, Ingo			Nonsense Mutations in SMPX, Encoding a Protein Responsive to Physical Force, Result in X-Chromosomal Hearing Loss	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SENSORINEURAL DEAFNESS; GENE SMPX; MUSCLE; IDENTIFICATION; SEQUENCE; MAPS	The fact that hereditary hearing loss is the most common sensory disorder in humans is reflected by, among other things, an extraordinary allelic and nonallelic genetic heterogeneity. X-chromosomal hearing impairment represents only a minor fraction of all cases. In a study of a Spanish family the locus for one of the X-chromosomal forms was assigned to Xp22 (DFNX4). We mapped the disease locus in the same chromosomal region in a large German pedigree with X-chromosomal nonsyndrornic hearing impairment by using genome-wide linkage analysis. Males presented with postlingual hearing loss and onset at ages 3-7, whereas onset in female carriers was in the second to third decades. Targeted DNA capture with high-throughput sequencing detected a nonsense mutation in the small muscle protein, X-linked (SMPX) of affected individuals. We identified another nonsense mutation in SMPX in patients from the Spanish family who were previously analyzed to map DFNX4. SMPX encodes an 88 amino acid, cytoskeleton-associated protein that is responsive to mechanical stress. The presence of Smpx in hair cells and supporting cells of the murine cochlea indicates its role in the inner ear. The nonsense mutations detected in the two families suggest a loss-of-function mechanism underlying this form of hearing impairment. Results obtained after heterologous overexpression of SMPX proteins were compatible with this assumption. Because responsivity to physical force is a characteristic feature of the protein, we propose that long-term maintenance of mechanically stressed inner-ear cells critically depends on SMPX function.	[Rau, Isabella; Gal, Andreas; Kurth, Ingo] Univ Klinikum Hamburg Eppendorf, Inst Humangenet, D-20246 Hamburg, Germany; [Gandia, Marta; Vinuela, Antonio; Aguirre, Luis A.; Moreno, Felipe; del Castillo, Ignacio] Hosp Univ Ramon y Cajal, IRYCIS, Unidad Genet Mol, Madrid 28034, Spain; [Gandia, Marta; Vinuela, Antonio; Aguirre, Luis A.; Moreno, Felipe; del Castillo, Ignacio] CIBERER, Madrid 28034, Spain; [Frommolt, Peter; Thiele, Holger; Altmueller, Janine; Nuernberg, Gudrun; Nuernberg, Peter] Univ Cologne, CCG, D-50931 Cologne, Germany; [Frommolt, Peter; Nuernberg, Gudrun; Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Wicklein, Eva M.] Univ Klinikum Hamburg Eppendorf, Neurol Klin, D-20246 Hamburg, Germany; [Wagner, Florian; Nuernberg, Peter] ATLAS Biolabs GmbH, D-10117 Berlin, Germany; [Maier, Hannes] Hannover Med Sch, Dept Otolaryngol, D-30625 Hannover, Germany; [Nuernberg, Gudrun; Nuernberg, Peter] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Kurth, Ingo] Univ Hosp Jena, Inst Human Genet, Funct Genet Grp, D-07743 Jena, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Hospital Universitario Ramon y Cajal; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Cologne; University of Cologne; University of Hamburg; University Medical Center Hamburg-Eppendorf; Hannover Medical School; University of Cologne; Friedrich Schiller University of Jena	Kurth, I (corresponding author), Univ Klinikum Hamburg Eppendorf, Inst Humangenet, D-20246 Hamburg, Germany.	ingo.kurth@mti.uni-jena.de	del Castillo, Ignacio/B-4314-2013; Aguirre, Luis/ABD-8789-2021; Hannes, Maier/AAE-5070-2020; Hannes, Maier/A-9457-2012; Frommolt, Peter/L-9656-2016; Thiele, Holger/ABE-6792-2020; Hübner, Christian/A-2950-2017; Viñuela, antonio/S-1128-2019; Pérez, Luis Augusto Aguirre/J-2175-2015; Viñuela, antonio/AAD-7599-2020	del Castillo, Ignacio/0000-0003-1188-3665; Hannes, Maier/0000-0001-8457-5327; Hannes, Maier/0000-0001-8457-5327; Frommolt, Peter/0000-0002-1966-8014; Thiele, Holger/0000-0002-0169-998X; Hübner, Christian/0000-0002-1030-4943; Viñuela, antonio/0000-0003-4306-1607; Pérez, Luis Augusto Aguirre/0000-0003-0903-9385; Viñuela, antonio/0000-0003-4306-1607; Kurth, Ingo/0000-0002-5642-8378; Altmuller, Janine/0000-0003-4372-1521	Werner-Otto-Stiftung; Fonda de Investigaciones Sanitarias [PI 08/0818]; Fundacion Ramon Areces; Spanish Ministerio de Ciencia e Innovacion [SAF2008-03216]	Werner-Otto-Stiftung; Fonda de Investigaciones Sanitarias(Instituto de Salud Carlos III); Fundacion Ramon Areces; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	We sincerely thank all of the family members for their participation and their constant interest in and support of this study. The authors also wish to thank Ingelore Bassmann, Christian Kluck, and Christian Becker for expert technical assistance. Florian Wagner is an employee of ATLAS Biolabs GmbH. Peter Nurnberg is a founder, CEO, and shareholder of ATLAS Biolabs GmbH. ATLAS Biolabs GmbH is a service provider for genomic analyses. This work was supported by grants from the Werner-Otto-Stiftung (to I.K.), Fonda de Investigaciones Sanitarias (PI 08/0818 to I.d.C.), Fundacion Ramon Areces (to I.d.C.), and Spanish Ministerio de Ciencia e Innovacion (SAF2008-03216 to F.M.).	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Cediel R, 2006, EUR J NEUROSCI, V23, P587, DOI 10.1111/j.1460-9568.2005.04584.x; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; de Brouwer APM, 2010, AM J HUM GENET, V86, P506, DOI 10.1016/j.ajhg.2010.02.024; DEKOK YJM, 1995, SCIENCE, V267, P685, DOI 10.1126/science.7839145; delCastillo I, 1996, HUM MOL GENET, V5, P1383, DOI 10.1093/hmg/5.9.1383; Dror AA, 2009, ANNU REV GENET, V43, P411, DOI 10.1146/annurev-genet-102108-134135; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Geiger B, 2002, CELL, V110, P139, DOI 10.1016/S0092-8674(02)00831-0; Grimsley-Myers CM, 2009, J NEUROSCI, V29, P15859, DOI 10.1523/JNEUROSCI.3998-09.2009; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597; Kemp TJ, 2001, GENOMICS, V72, P260, DOI 10.1006/geno.2000.6461; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu XZ, 2010, AM J HUM GENET, V86, P65, DOI 10.1016/j.ajhg.2009.11.015; Manor U, 2008, SEMIN CELL DEV BIOL, V19, P502, DOI 10.1016/j.semcdb.2008.07.006; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Palmer S, 2001, J CELL BIOL, V153, P985, DOI 10.1083/jcb.153.5.985; Patzak D, 1999, HUM GENET, V105, P506, DOI 10.1007/s004390051138; Petersen MB, 2008, CLIN GENET, V73, P14, DOI 10.1111/j.1399-0004.2007.00913.x; Petit C, 2009, NAT NEUROSCI, V12, P703, DOI 10.1038/nn.2330; Schindeler A, 2005, EXP CELL RES, V307, P367, DOI 10.1016/j.yexcr.2005.04.006; Schraders M, 2011, AM J HUM GENET, V88, P628, DOI 10.1016/j.ajhg.2011.04.012; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; Wei X, 2005, NEUROSCIENCE, V131, P513, DOI 10.1016/j.neuroscience.2004.11.014; Woods KA, 1996, NEW ENGL J MED, V335, P1363, DOI 10.1056/NEJM199610313351805	29	56	66	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY 13	2011	88	5					621	627		10.1016/j.ajhg.2011.04.007	http://dx.doi.org/10.1016/j.ajhg.2011.04.007			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	767CE	21549336	Bronze, Green Published			2022-12-18	WOS:000290832100010
J	Yao, YG; Salas, A; Logan, I; Bandelt, HJ				Yao, Yong-Gang; Salas, Antonio; Logan, Ian; Bandelt, Hans-Juergen			mtDNA Data Mining in GenBank Needs Surveying	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							MITOCHONDRIAL GENOME VARIATION; MEDIAN-NETWORK ANALYSIS; DNA-SEQUENCE; EVOLUTIONARY HISTORY; PENETRANCE; PHYLOGENY; ANTIQUITY; SELECTION; LINEAGES; AFRICAN		[Bandelt, Hans-Juergen] Univ Hamburg, Dept Math, D-20146 Hamburg, Germany; [Yao, Yong-Gang] Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models & Human Dis Mech, Kunming Inst Zool, Kunming 650223, Peoples R China; [Salas, Antonio] Univ Santiago Compostela, Unidade Xenet, Inst Med Legal, Fac Med, Galicia 15782, Spain; [Salas, Antonio] Univ Santiago Compostela, Dept Anat Patolox & Ciencias Forenses, Fac Med, Galicia 15782, Spain	University of Hamburg; Chinese Academy of Sciences; Kunming Institute of Zoology; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela	Bandelt, HJ (corresponding author), Univ Hamburg, Dept Math, Martinistr 52, D-20146 Hamburg, Germany.	bandelt@math.uni-hamburg.de	Salas, Antonio/E-3977-2012; Yao, Yong-Gang/AAH-2303-2021; Salas, Antonio/U-2029-2019	Salas, Antonio/0000-0002-2336-702X; Yao, Yong-Gang/0000-0002-2955-0693; Salas, Antonio/0000-0002-2336-702X				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Annunen-Rasila J, 2006, NEUROGENETICS, V7, P185, DOI 10.1007/s10048-006-0049-x; Atkinson QD, 2008, MOL BIOL EVOL, V25, P468, DOI 10.1093/molbev/msm277; Bandelt HJ, 2006, NUCL ACID M, V18, P47; Bandelt HJ, 2007, EUR J HUM GENET, V15, P400, DOI 10.1038/sj.ejhg.5201781; Bandelt HJ, 2007, BIOCHEM BIOPH RES CO, V352, P283, DOI 10.1016/j.bbrc.2006.10.131; Bandelt HJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-113; Bandelt HJ, 2009, J HUM GENET, V54, P174, DOI 10.1038/jhg.2009.9; Bandelt HJ, 2006, ANN HUM GENET, V70, P314, DOI 10.1111/j.1469-1809.2005.00234.x; Bandelt HJ, 2005, J MED GENET, V42, P957, DOI 10.1136/jmg.2005.033589; Bandelt HJ, 2005, BIOCHEM BIOPH RES CO, V333, P122, DOI 10.1016/j.bbrc.2005.04.055; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Finnila S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591; Gasparre G, 2007, P NATL ACAD SCI USA, V104, P9001, DOI 10.1073/pnas.0703056104; Gonder MK, 2007, MOL BIOL EVOL, V24, P757, DOI 10.1093/molbev/msl209; Hartmann A, 2009, HUM MUTAT, V30, P115, DOI 10.1002/humu.20816; Herrnstadt C, 2003, AM J HUM GENET, V72, P1585, DOI 10.1086/375406; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Ingman M, 2003, GENOME RES, V13, P1600, DOI 10.1101/gr.686603; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kong QP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003016; Kumar S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-230; Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Montiel-Sosa F, 2006, GENE, V368, P21, DOI 10.1016/j.gene.2005.09.015; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; Parson W, 2007, ANN HUM GENET, V71, P276, DOI 10.1111/j.1469-1809.2006.00319.x; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Pereira L, 2009, AM J HUM GENET, V84, P628, DOI 10.1016/j.ajhg.2009.04.013; Rajkumar R, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-26; Salas A, 2005, PLOS MED, V2, P1158, DOI 10.1371/journal.pmed.0020296; Salas A, 2005, BIOCHEM BIOPH RES CO, V335, P891, DOI 10.1016/j.bbrc.2005.07.161; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Sun C, 2006, MOL BIOL EVOL, V23, P683, DOI 10.1093/molbev/msj078; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Yao YG, 2008, J MED GENET, V45, P769, DOI 10.1136/jmg.2008.059782; Yao YG, 2006, HUM GENET, V119, P505, DOI 10.1007/s00439-006-0154-9; Yao YG, 2003, AM J HUM GENET, V72, P1341, DOI 10.1086/375119	43	56	57	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 11	2009	85	6					929	933		10.1016/j.ajhg.2009.10.023	http://dx.doi.org/10.1016/j.ajhg.2009.10.023			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	533BN	20004768	Bronze, Green Published			2022-12-18	WOS:000272797100018
J	Hunter, JE; Allen, EG; Abramowitz, A; Rusin, M; Leslie, M; Novak, G; Hamilton, D; Shubeck, L; Charen, K; Sherman, SL				Hunter, Jessica Ezzell; Allen, Emily Graves; Abramowitz, Ann; Rusin, Michele; Leslie, Mary; Novak, Gloria; Hamilton, Debra; Shubeck, Lisa; Charen, Krista; Sherman, Stephanie L.			No Evidence for a Difference in Neuropsychological Profile among Carriers and Noncarriers of the FMR1 Premutation in Adults under the Age of 50	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRAGILE-X-SYNDROME; TREMOR/ATAXIA SYNDROME FXTAS; CGG REPEAT; MESSENGER-RNA; INTENTION TREMOR; GENE; EXPRESSION; ATAXIA; CEREBELLAR; MALES	The 5' untranslated region of the fragile X mental retardation gene, FMR1, contains a polymorphic CGG repeat. Expansions of this repeat are associated with a spectrum of disorders. Full mutation alleles, repeats >= 200, are associated with fragile X syndrome. Premutation alleles, repeats of similar to 55-199, are associated with a tremor-ataxia syndrome most commonly in older males and primary ovarian insufficiency in females. However, the neuropsychological impact of carrying a premutation allele is presently unclear in younger adults. In this study, we analyzed neuropsychological scores for 138 males and 506 females ascertained from the general population and from families with a history of fragile X syndrome. Subjects were age 18-50 years and had varying repeat lengths. Neuropsychological scores were obtained from measures of general intelligence, memory, and executive functioning, including attention. Principal component analysis followed by varimax rotation was used to create independent factors for analysis. These factors were modeled for males and females separately via a general linear model that accounted for correlation among related subjects. All models were adjusted for potential confounders, including age at testing, ethnicity, and household income. Among males, no repeat length associations were detected for any factor. Among females, only a significant association with repeat length and self-report attention (p < 0.01) was detected, with premutation carriers self-reporting significantly more attention-related problems compared to noncarriers. No significant interactions between repeat length and age were detected. Overall, these results indicate the lack of a global neuropsychological impact of carrying a premutation allele among adults under the age of 50.	[Hunter, Jessica Ezzell; Allen, Emily Graves; Leslie, Mary; Novak, Gloria; Hamilton, Debra; Shubeck, Lisa; Charen, Krista; Sherman, Stephanie L.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Abramowitz, Ann] Emory Univ, Sch Med, Dept Psychol, Atlanta, GA 30322 USA; [Rusin, Michele] Independent Practice 1776, Atlanta, GA 30306 USA	Emory University; Emory University	Sherman, SL (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.	ssherma@emory.edu		Hunter, Jessica/0000-0002-1117-1097	National Institutes of Health [R01 HD29909]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029909] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We would like to dedicate this work to Rick Letz who made this project possible with his significant input in the development of the testing battery and analysis the initial data. We would like to thank David Kleinbaum, Dwight Dickinson, and Michael Epstein for their assistance in the statistical analysis as well as Weiya He and Maneesha Yadav-Shah for their laboratory assistance. Finally we Would like to thank the study participants who made this work possible. This work was supported by the National Institutes of Health grant R01 HD29909.	Allen EG, 2005, BEHAV GENET, V35, P435, DOI 10.1007/s10519-005-2792-4; Allen EG, 2004, HUM GENET, V114, P439, DOI 10.1007/s00439-004-1086-x; ASHLEY CT, 1993, NAT GENET, V4, P244, DOI 10.1038/ng0793-244; Bacalman S, 2006, J CLIN PSYCHIAT, V67, P87, DOI 10.4088/JCP.v67n0112; Benton AL, 1976, MULTILINGUAL APHASIA; Berry-Kravis E, 2005, ANN NEUROL, V57, P144, DOI 10.1002/ana.20360; Berry-Kravis E, 2003, ANN NEUROL, V53, P616, DOI 10.1002/ana.10522; Biancalana V, 2005, ARCH NEUROL-CHICAGO, V62, P962, DOI 10.1001/archneur.62.6.962; BROWN WT, 1993, JAMA-J AM MED ASSOC, V270, P1569, DOI 10.1001/jama.270.13.1569; Brunberg JA, 2002, AM J NEURORADIOL, V23, P1757; Conners CK., 1999, CONNERS ADULT ADHD R, DOI DOI 10.1038/s41588-018-0269-7; Cornish KM, 2008, CORTEX, V44, P628, DOI 10.1016/j.cortex.2006.11.002; FENG Y, 1995, SCIENCE, V268, P731, DOI 10.1126/science.7732383; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Garcia-Alegria E, 2007, RNA, V13, P756, DOI 10.1261/rna.206307; Golden C.J., 1978, STROOP COLOR WORD TE; Greco CM, 2002, BRAIN, V125, P1760, DOI 10.1093/brain/awf184; Grigsby J, 2008, NEUROPSYCHOLOGY, V22, P48, DOI 10.1037/0894-4105.22.1.48; Hagerman RJ, 2004, AM J HUM GENET, V74, P1051, DOI 10.1086/420700; Hagerman RJ, 2001, NEUROLOGY, V57, P127, DOI 10.1212/WNL.57.1.127; HALPERIN JM, 1991, INT J NEUROSCI, V58, P171, DOI 10.3109/00207459108985433; HEATON RK, 1981, WISCONSIN CARD SORTI; HUNTER J, 2008, GENET MED IN PRESS; Hunter JE, 2008, BEHAV GENET, V38, P493, DOI 10.1007/s10519-008-9214-3; Jacquemont S, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.024190; Jacquemont S, 2004, JAMA-J AM MED ASSOC, V291, P460, DOI 10.1001/jama.291.4.460; Jacquemont S, 2003, AM J HUM GENET, V72, P869, DOI 10.1086/374321; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; Kenneson A, 2001, HUM MOL GENET, V10, P1449, DOI 10.1093/hmg/10.14.1449; Kogan CS, 2008, AM J MED GENET B, V147B, P859, DOI 10.1002/ajmg.b.30685; McConkie-Rosell A, 2000, AM J MED GENET, V92, P336, DOI 10.1002/1096-8628(20000619)92:5<336::AID-AJMG8>3.0.CO;2-L; Meadows KL, 1996, AM J MED GENET, V64, P428, DOI 10.1002/(SICI)1096-8628(19960809)64:2<428::AID-AJMG39>3.3.CO;2-7; Minguez M, 2009, AM J MED GENET B, V150B, P262, DOI 10.1002/ajmg.b.30803; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; Primerano B, 2002, RNA, V8, P1482, DOI 10.1017/s1355838202020642; Reitan R.M., 1992, TRAIL MAKING TEST MA; Roberts JE, 2009, AM J MED GENET B, V150B, P130, DOI 10.1002/ajmg.b.30786; Rodriguez-Revenga L, 2008, PSYCHIAT GENET, V18, P153, DOI 10.1097/YPG.0b013e3282f97e0b; Sherman S, 2005, GENET MED, V7, P584, DOI 10.1097/01.GIM.0000182468.22666.dd; Sherman SL, 2000, AM J MED GENET, V97, P189, DOI 10.1002/1096-8628(200023)97:3<189::AID-AJMG1036>3.0.CO;2-J; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; Tassone F, 2003, CYTOGENET GENOME RES, V100, P124, DOI 10.1159/000072846; Tassone F, 2000, AM J MED GENET, V91, P144, DOI 10.1002/(SICI)1096-8628(20000313)91:2<144::AID-AJMG14>3.0.CO;2-V; Tassone F, 2000, AM J HUM GENET, V66, P6, DOI 10.1086/302720; Tassone F, 2007, RNA, V13, P555, DOI 10.1261/rna.280807; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL; Welt CK, 2008, CLIN ENDOCRINOL, V68, P499, DOI 10.1111/j.1365-2265.2007.03073.x; Wittenberger MD, 2007, FERTIL STERIL, V87, P456, DOI 10.1016/j.fertnstert.2006.09.004; Zuhlke C, 2004, J NEUROL, V251, P1418, DOI 10.1007/s00415-004-0558-1	51	56	56	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 12	2008	83	6					692	702		10.1016/j.ajhg.2008.10.021	http://dx.doi.org/10.1016/j.ajhg.2008.10.021			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	385NY	19026394	Green Published, Bronze			2022-12-18	WOS:000261822100004
J	de Brouwer, APM; Williams, KL; Duley, JA; van Kuilenburg, ABP; Nabuurs, SB; Egmont-Petersen, M; Lugtenberg, D; Zoetekouw, L; Banning, MJG; Roeffen, M; Hamel, BCJ; Weaving, L; Ouvrier, RA; Donald, JA; Wevers, RA; Christodoulou, J; van Bokhoven, H				de Brouwer, Arjan P. M.; Williams, Kelly L.; Duley, John A.; van Kuilenburg, Andre B. P.; Nabuurs, Sander B.; Egmont-Petersen, Michael; Lugtenberg, Dorien; Zoetekouw, Lida; Banning, Martijn J. G.; Roeffen, Melissa; Hamel, Ben C. J.; Weaving, Linda; Ouvrier, Robert A.; Donald, Jennifer A.; Wevers, Ron A.; Christodoulou, John; van Bokhoven, Hans			Arts syndrome is caused by loss-of-function mutations in PRPS1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKED MENTAL-RETARDATION; HUMAN PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE-1; S-ADENOSYLHOMOCYSTEINE HYDROLASE; NONSELECTIVE CATION CHANNELS; URIC-ACID OVERPRODUCTION; PYROPHOSPHATE SYNTHETASE; HUMAN-ERYTHROCYTES; PURINE METABOLISM; ADENOSINE KINASE; EARLY-CHILDHOOD	Arts syndrome is an X-linked disorder characterized by mental retardation, early-onset hypotonia, ataxia, delayed motor development, hearing impairment, and optic atrophy. Linkage analysis in a Dutch family and an Australian family suggested that the candidate gene maps to Xq22.1-q24. Oligonucleotide microarray expression profiling of fibroblasts from two probands of the Dutch family revealed reduced expression levels of the phosphoribosyl pyrophosphate synthetase 1 gene (PRPS1). Subsequent sequencing of PRPS1 led to the identification of two different missense mutations, c.455T -> C (p.L152P) in the Dutch family and c.398A -> C (p.Q133P) in the Australian family. Both mutations result in a loss of phosphoribosyl pyrophosphate synthetase 1 activity, as was shown in silico by molecular modeling and was shown in vitro by phosphoribosyl pyrophosphate synthetase activity assays in erythrocytes and fibroblasts from patients. This is in contrast to the gain-of-function mutations in PRPS1 that were identified previously in PRPS-related gout. The loss-of-function mutations of PRPS1 likely result in impaired purine biosynthesis, which is supported by the undetectable hypoxanthine in urine and the reduced uric acid levels in serum from patients. To replenish low levels of purines, treatment with S-adenosylmethionine theoretically could have therapeutic efficacy, and a clinical trial involving the two affected Australian brothers is currently underway.	Univ Nijmegen St Radboud Hosp, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Univ Nijmegen St Radboud Hosp, Med Ctr, Dept Neurol, NL-6500 HB Nijmegen, Netherlands; Radboud Univ Nijmegen, Ctr Mol & Biomol Informat, Nijmegen, Netherlands; Macquarie Univ, Dept Biol, Sydney, NSW 2109, Australia; Western Sydney Genet Program, Sydney, NSW 2109, Australia; TY Nelson Dept Neurol & Neurosurg, Sydney, NSW 2109, Australia; Univ Sydney, Childrens Hosp Westmead, Sydney, NSW 2006, Australia; Univ Queensland, Sch Pharm, Brisbane, Qld, Australia; Mater Hosp, Dept Pathol, Brisbane, Qld, Australia; Univ Amsterdam, Emma Childrens Hosp, NL-1012 WX Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, NL-1012 WX Amsterdam, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Macquarie University; University of Sydney; University of Queensland; Emma Children's Hospital; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	de Brouwer, APM (corresponding author), Univ Nijmegen St Radboud Hosp, Med Ctr, Dept Human Genet, POB 9101, NL-6500 HB Nijmegen, Netherlands.	A.debrouwer@antrg.umcn.nl	Bokhoven, J.H.L.M. van van/H-8015-2014; Wevers, Ron A./H-8116-2014; Lugtenberg, Dorien/B-6338-2018; Duley, John/B-1806-2013; van Bokhoven, Hans/D-8764-2012; Christodoulou, John/E-5866-2015; de Brouwer, Arjan PM/P-5949-2015; Williams, Kelly L/A-5545-2010; Christodoulou, John/M-3628-2019	Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Wevers, Ron A./0000-0003-2278-9746; Williams, Kelly L/0000-0001-6319-9473; Christodoulou, John/0000-0002-8431-0641; Donald, Jennifer/0000-0002-2732-1379; van Kuilenburg, Andre/0000-0002-7989-4910				ARTS WFM, 1993, ANN NEUROL, V33, P535, DOI 10.1002/ana.410330519; BECKER MA, 1995, J CLIN INVEST, V96, P2133, DOI 10.1172/JCI118267; BECKER MA, 1980, J CLIN INVEST, V65, P109, DOI 10.1172/JCI109640; BECKER MA, 1987, J BIOL CHEM, V262, P5596; BECKER MA, 1986, BIOCHIM BIOPHYS ACTA, V882, P168, DOI 10.1016/0304-4165(86)90151-0; Becker MA, 2001, PROG NUCLEIC ACID RE, V69, P115, DOI 10.1016/S0079-6603(01)69046-9; Becker MA, 1996, J BIOL CHEM, V271, P19894, DOI 10.1074/jbc.271.33.19894; BECKER MA, 1988, AM J MED, V85, P383, DOI 10.1016/0002-9343(88)90591-8; BECKER MA, 1990, GENOMICS, V8, P555, DOI 10.1016/0888-7543(90)90043-T; BECROFT DMO, 1969, J PEDIATR, V75, P885; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bottiglieri T, 2002, AM J CLIN NUTR, V76, p1151S, DOI 10.1093/ajcn/76.5.1151S; CHRISTEN HJ, 1992, LANCET, V340, P1167, DOI 10.1016/0140-6736(92)93202-X; de Brouwer APM, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9482; de Brouwer APM, 2006, MOL DIAGN THER, V10, P197; Garcia-Pavia P, 2003, ARTHRITIS RHEUM, V48, P2036, DOI 10.1002/art.11058; Glick N, 2006, J INHERIT METAB DIS, V29, P687, DOI 10.1007/s10545-006-0229-8; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Kremer H, 1996, HUM GENET, V98, P513, DOI 10.1007/s004390050250; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Li S, 2007, BIOCHEM J, V401, P39, DOI 10.1042/BJ20061066; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lugtenberg D, 2006, J MED GENET, V43, P362, DOI 10.1136/jmg.2005.036178; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MONTERO C, 1995, CLIN CHIM ACTA, V238, P169, DOI 10.1016/0009-8981(95)06088-U; MONTERO C, 1990, BIOCHEM PHARMACOL, V40, P2617, DOI 10.1016/0006-2952(90)90579-A; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Nyhan WL, 2005, MOL GENET METAB, V86, P25, DOI 10.1016/j.ymgme.2005.07.027; Page T, 1997, P NATL ACAD SCI USA, V94, P11601, DOI 10.1073/pnas.94.21.11601; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plant TD, 2003, CELL CALCIUM, V33, P441, DOI 10.1016/S0143-4160(03)00055-1; Rees DC, 1996, BLOOD, V88, P2761, DOI 10.1182/blood.V88.7.2761.bloodjournal8872761; Riccio A, 2002, MOL BRAIN RES, V109, P95, DOI 10.1016/S0169-328X(02)00527-2; Ross BM, 1997, LIPIDS, V32, P351, DOI 10.1007/s11745-997-0044-x; Rozen S, 2000, Methods Mol Biol, V132, P365; Schaefer M, 2000, J BIOL CHEM, V275, P17517, DOI 10.1074/jbc.275.23.17517; Schuster S, 2005, FEBS J, V272, P5278, DOI 10.1111/j.1742-4658.2005.04924.x; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Simmonds H.A., 1990, TECHNIQUES DIAGNOSTI, P397; SIMMONDS HA, 1985, NEUROPEDIATRICS, V16, P106, DOI 10.1055/s-2008-1052552; SIMMONDS HA, 1989, BIOSCIENCE REP, V9, P75, DOI 10.1007/BF01117513; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SMOLENSKI RT, 1992, BIOCHEM PHARMACOL, V43, P2053, DOI 10.1016/0006-2952(92)90161-B; SMOLENSKI RT, 1991, BIOCHEM PHARMACOL, V42, P1767, DOI 10.1016/0006-2952(91)90514-6; Sossey-Alaoui K, 1999, GENOMICS, V60, P330, DOI 10.1006/geno.1999.5924; SPERLING O, 1972, REV EUR ETUD CL BIOL, V17, P703; STOW RA, 1993, J PHYSIOL-LONDON, V468, P311, DOI 10.1113/jphysiol.1993.sp019773; TAIRA M, 1989, BIOCHIM BIOPHYS ACTA, V1007, P203, DOI 10.1016/0167-4781(89)90040-7; Tarpey PS, 2007, AM J HUM GENET, V80, P345, DOI 10.1086/511134; Torres RJ, 1996, CLIN CHIM ACTA, V245, P105, DOI 10.1016/0009-8981(95)06178-9; WALL FE, 1995, IN VITRO CELL DEV-AN, V31, P156; Weaving LS, 2003, AM J MED GENET A, V118A, P103, DOI 10.1002/ajmg.a.10053; ZOREF E, 1975, J CLIN INVEST, V56, P1093, DOI 10.1172/JCI108183	53	56	58	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2007	81	3					507	518		10.1086/520706	http://dx.doi.org/10.1086/520706			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205PX	17701896	Bronze, Green Published			2022-12-18	WOS:000249128200007
J	Fukami, M; Kato, F; Tajima, T; Yokoya, S; Ogata, T				Fukami, M; Kato, F; Tajima, T; Yokoya, S; Ogata, T			Transactivation function of an similar to 800-bp evolutionarily conserved sequence at the SHOX 3 ' region: Implication for the downstream enhancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							HOMEOBOX GENE SHOX; LERI-WEILL DYSCHONDROSTEOSIS; TURNER-SYNDROME		Toranomon Gen Hosp, Dept Pediat, Tokyo, Japan; Hokkaido Univ, Sch Med, Dept Pediat, Sapporo, Hokkaido 060, Japan	Toranomon Hospital; Hokkaido University			Toshihiro, Tajima/A-5720-2012	Ogata, Tsutomu/0000-0001-7178-9991				Benito-Sanz S, 2005, AM J HUM GENET, V77, P533, DOI 10.1086/449313; Blaschke RJ, 2003, J BIOL CHEM, V278, P47820, DOI 10.1074/jbc.M306685200; Clement-Jones M, 2000, HUM MOL GENET, V9, P695, DOI 10.1093/hmg/9.5.695; Flanagan SF, 2002, J MED GENET, V39, P758, DOI 10.1136/jmg.39.10.758; Fukami M, 2005, AM J MED GENET A, V137A, P72, DOI 10.1002/ajmg.a.30852; Mercader N, 1999, NATURE, V402, P425, DOI 10.1038/46580; Rao E, 2001, HUM MOL GENET, V10, P3083, DOI 10.1093/hmg/10.26.3083; Shanmugam K, 1999, MOL CELL BIOL, V19, P7577; Zakany J, 1999, CELL TISSUE RES, V296, P19, DOI 10.1007/s004410051262	9	56	56	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2006	78	1					167	170		10.1086/499254	http://dx.doi.org/10.1086/499254			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	993CN	16385461	Green Published, Bronze			2022-12-18	WOS:000233930400018
J	Xue, YL; Zerjal, T; Bao, WD; Zhu, SL; Lim, SK; Shu, QF; Xu, JJ; Du, RF; Fu, SB; Li, P; Yang, HM; Tyler-Smith, C				Xue, YL; Zerjal, T; Bao, WD; Zhu, SL; Lim, SK; Shu, QF; Xu, JJ; Du, RF; Fu, SB; Li, P; Yang, HM; Tyler-Smith, C			Recent spread of a Y-chromosomal lineage in northern China and Mongolia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MUTATION-RATE; LOCI	We have identified a Y-chromosomal lineage that is unusually frequent in northeastern China and Mongolia, in which a haplotype cluster defined by 15 Y short tandem repeats was carried by similar to 3.3% of the males sampled from East Asia. The most recent common ancestor of this lineage lived 590 +/- 340 years ago (mean +/- SD), and it was detected in Mongolians and six Chinese minority populations. We suggest that the lineage was spread by Qing Dynasty (1644-1912) nobility, who were a privileged elite sharing patrilineal descent from Giocangga (died 1582), the grandfather of Manchu leader Nurhaci, and whose documented members formed similar to 0.4% of the minority population by the end of the dynasty.	Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; Harbin Med Univ, Dept Med Biol, Harbin, Peoples R China; Univ Oxford, Dept Biochem, Oxford OX1 2JD, England; Chinese Acad Sci, Inst Genet & Dev Biol, Beijing, Peoples R China	Wellcome Trust Sanger Institute; Harbin Medical University; University of Oxford; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Tyler-Smith, C (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England.	cts@sanger.ac.uk	zerjal, tatiana/AAO-9473-2020	Lim, Si-keun/0000-0003-4246-6223	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Du R., 1993, ETHNIC GROUPS CHINA; Dupuy BM, 2004, HUM MUTAT, V23, P117, DOI 10.1002/humu.10294; Elliott Mark C., 2001, MANCHU WAY 8 BANNERS; Hedman A, 2004, FORENSIC SCI INT, V142, P37, DOI 10.1016/j.forsciint.2003.07.003; Helgason A, 2000, AM J HUM GENET, V67, P697, DOI 10.1086/303046; JOBLING M, 2004, HUMAN EVOLUTIONARY G, P15253; Katoh T, 2005, GENE, V346, P63, DOI 10.1016/j.gene.2004.10.023; Kayser M, 2004, AM J HUM GENET, V74, P1183, DOI 10.1086/421531; Kayser M, 2000, AM J HUM GENET, V66, P1580, DOI 10.1086/302905; LI Z, 1997, AI XIN JUE LUO JIA Z; Zerjal T, 2002, AM J HUM GENET, V71, P466, DOI 10.1086/342096; Zerjal T, 2003, AM J HUM GENET, V72, P717, DOI 10.1086/367774; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911	14	56	56	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2005	77	6					1112	1116		10.1086/498583	http://dx.doi.org/10.1086/498583			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	983OE	16380921	Green Published, Bronze			2022-12-18	WOS:000233241200019
J	Pasmooij, AMG; Pas, HH; Deviaene, FCL; Nijenhuis, M; Jonkman, MF				Pasmooij, AMG; Pas, HH; Deviaene, FCL; Nijenhuis, M; Jonkman, MF			Multiple correcting COL17A1 mutations in patients with revertant mosaicism of epidermolysis bullosa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TYROSINEMIA TYPE-I; PEMPHIGOID ANTIGEN BPAG2; WISKOTT-ALDRICH-SYNDROME; HEREDITARY TYROSINEMIA; SOMATIC MOSAICISM; SKIN DISORDERS; GENETIC-DEFECT; VIVO REVERSION; MESSENGER-RNA; XVII COLLAGEN	Revertant mosaicism by somatic reversion of inherited mutations has been described for a number of genetic diseases. Several mechanisms can underlie this reversion process, such as gene conversion, crossing-over, true back mutation, and second-site mutation. Here, we report the occurrence of multiple corrections in two unrelated probands with revertant mosaicism of non-Herlitz junctional epidermolysis bullosa, an autosomal recessive genodermatosis due to mutations in the COL17A1 gene. Immunofluorescence microscopy and laser dissection microscopy, followed by DNA and RNA analysis, were performed on skin biopsy specimens. In patient 1, a true back mutation, 3781T -> C, was identified in the specimen from the arm, and a second-site mutation, 4463-1G -> A, which compensated for the frameshift caused by the inherited 4424-5insC mutation, was identified in the 3' splice site of exon 55 in a specimen from the middle finger. Patient 2 showed-besides two distinct gene conversion events in specimens from the arm and hand sites, both of which corrected the 1706delA mutation-a second-site mutation (3782G -> C) in an ankle specimen, which prevented the premature ending of the protein by the 3781C -> T nonsense mutation (R1226X). Thus, both inherited mutations, paternal as well as maternal, reverted at least once by different reversion events in distinct cell clusters in the described patients. The occurrence of multiple correcting mutations within the same patient indicates that in vivo reversion is less unusual than was generally thought. Furthermore, in the male patient, mosaic patterns of type XVII collagen-positive keratinocytes were present in clinically unaffected and affected skin. This latter observation makes it likely that reversion may be overlooked and may happen more often than expected.	Univ Groningen, Med Ctr, Dept Dermatol, Ctr Blistering Dis, NL-9713 GZ Groningen, Netherlands	University of Groningen	Jonkman, MF (corresponding author), Univ Groningen, Med Ctr, Dept Dermatol, Ctr Blistering Dis, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.	m.f.jonkman@derm.umcg.nl	Pas, Hendri H/G-9749-2011; Jonkman, Marcel F./H-4647-2011; Pasmooij, Anna/H-2419-2011	Pas, Hendri H/0000-0001-8823-2591; Pasmooij, Anna Maria Gerdina/0000-0003-0641-3829				Arin MJ, 2001, J CELL BIOL, V152, P645, DOI 10.1083/jcb.152.3.645; Bergeron A, 2004, GASTROENTEROLOGY, V127, P1381, DOI 10.1053/j.gastro.2004.08.013; BERGSTRESSER PR, 1978, J INVEST DERMATOL, V70, P280, DOI 10.1111/1523-1747.ep12541516; Bliksrud YT, 2005, J MOL MED-JMM, V83, P406, DOI 10.1007/s00109-005-0648-2; Cao TY, 2001, J CELL BIOL, V152, P651, DOI 10.1083/jcb.152.3.651; Chavanas S, 1999, HUM MOL GENET, V8, P2097, DOI 10.1093/hmg/8.11.2097; Darling TN, 1999, J CLIN INVEST, V103, P1371, DOI 10.1172/JCI4338; Demers SI, 2003, HUM PATHOL, V34, P1313, DOI 10.1016/S0046-8177(03)00406-4; Di Zenzo G, 2004, J INVEST DERMATOL, V122, P103, DOI 10.1046/j.0022-202X.2003.22126.x; ELLIS NA, 1995, AM J HUM GENET, V57, P1019; Gatalica B, 1997, AM J HUM GENET, V60, P352; GERMAN J, 1977, AM J HUM GENET, V29, P248; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HALL JG, 1988, AM J HUM GENET, V43, P355; HINTNER H, 1982, ARCH DERMATOL, V118, P375, DOI 10.1001/archderm.118.6.375; Hirschhorn R, 2003, J MED GENET, V40, P721, DOI 10.1136/jmg.40.10.721; Hirschhorn R, 1996, NAT GENET, V13, P290, DOI 10.1038/ng0796-290; Jonkman MF, 1996, ARCH DERMATOL, V132, P145, DOI 10.1001/archderm.132.2.145; Jonkman MF, 1997, CELL, V88, P543, DOI 10.1016/S0092-8674(00)81894-2; Jonkman MF, 2003, CLIN EXP DERMATOL, V28, P625, DOI 10.1046/j.1365-2230.2003.01400.x; JONKMAN MF, 1995, J CLIN INVEST, V95, P1345, DOI 10.1172/JCI117785; Jorquera R, 1999, FASEB J, V13, P2284, DOI 10.1096/fasebj.13.15.2284; KVITTINGEN EA, 1994, J CLIN INVEST, V94, P1657, DOI 10.1172/JCI117509; LI K, 1991, J BIOL CHEM, V266, P24064; LI KH, 1993, J BIOL CHEM, V268, P8825; Lolle SJ, 2005, NATURE, V434, P505, DOI 10.1038/nature03380; Majewski J, 2000, GENOME RES, V10, P1108, DOI 10.1101/gr.10.8.1108; MCGRATH JA, 1995, NAT GENET, V11, P83, DOI 10.1038/ng0995-83; Nachman MW, 2000, GENETICS, V156, P297; Overturf K, 1996, NAT GENET, V12, P266, DOI 10.1038/ng0396-266; Pulkkinen L., 1999, EPIDERMOLYSIS BULLOS; Smith FJD, 2004, J INVEST DERMATOL, V122, P73, DOI 10.1046/j.0022-202X.2003.22129.x; SMITHIES O, 1986, PHILOS T ROY SOC B, V312, P291, DOI 10.1098/rstb.1986.0008; Stephan V, 1996, NEW ENGL J MED, V335, P1563, DOI 10.1056/NEJM199611213352104; Wada T, 2004, BLOOD, V104, P1270, DOI 10.1182/blood-2004-03-0846; Wada T, 2003, J CLIN INVEST, V111, P1389, DOI 10.1172/JCI200315485; Waisfisz Q, 1999, NAT GENET, V22, P379, DOI 10.1038/11956	37	56	57	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2005	77	5					727	740		10.1086/497344	http://dx.doi.org/10.1086/497344			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	974CT	16252234	Green Published, Bronze			2022-12-18	WOS:000232569600004
J	McEvoy, B; Richards, M; Forster, P; Bradley, DG				McEvoy, B; Richards, M; Forster, P; Bradley, DG			The Longue duree of genetic ancestry: Multiple genetic marker systems and Celtic origins on the Atlantic facade of Europe	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MTDNA CONTROL REGION; DNA CONTROL REGION; MITOCHONDRIAL-DNA; D-LOOP; SEQUENCE DIVERSITY; POPULATION-DATA; LINEAGES; VARIABILITY; PATTERNS; POLYMORPHISMS	Celtic languages are now spoken only on the Atlantic facade of Europe, mainly in Britain and Ireland, but were spoken more widely in western and central Europe until the collapse of the Roman Empire in the first millennium A. D. It has been common to couple archaeological evidence for the expansion of Iron Age elites in central Europe with the dispersal of these languages and of Celtic ethnicity and to posit a central European "homeland" for the Celtic peoples. More recently, however, archaeologists have questioned this "migrationist" view of Celtic ethnogenesis. The proposition of a central European ancestry should be testable by examining the distribution of genetic markers; however, although Y-chromosome patterns in Atlantic Europe show little evidence of central European influence, there has hitherto been insufficient data to confirm this by use of mitochondrial DNA ( mtDNA). Here, we present both new mtDNA data from Ireland and a novel analysis of a greatly enlarged European mtDNA database. We show that mtDNA lineages, when analyzed in sufficiently large numbers, display patterns significantly similar to a large fraction of both Y-chromosome and autosomal variation. These multiple genetic marker systems indicate a shared ancestry throughout the Atlantic zone, from northern Iberia to western Scandinavia, that dates back to the end of the last Ice Age.	Univ Dublin Trinity Coll, Dept Genet, Dublin 2, Ireland; Univ Leeds, Sch Biol, Leeds, W Yorkshire, England; Univ Leeds, Sch Comp, Leeds, W Yorkshire, England; Univ Cambridge, McDonald Inst Archaeol Res, Cambridge, England	Trinity College Dublin; University of Leeds; University of Leeds; University of Cambridge	Bradley, DG (corresponding author), Univ Dublin Trinity Coll, Dept Genet, Dublin 2, Ireland.	dbradley@tcd.ie	Bradley, Daniel G/A-3240-2012	Bradley, Daniel G/0000-0001-7335-7092; RICHARDS, MARTIN/0000-0003-3118-0967				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; [Anonymous], 1996, HIST LINGUISTICS; Baasner A, 1998, FORENSIC SCI INT, V98, P169, DOI 10.1016/S0379-0738(98)00163-7; Bandelt HJ, 2002, AM J HUM GENET, V71, P1150, DOI 10.1086/344397; Belledi M, 2000, EUR J HUM GENET, V8, P480, DOI 10.1038/sj.ejhg.5200443; BERTRANPETIT J, 1995, ANN HUM GENET, V59, P63, DOI 10.1111/j.1469-1809.1995.tb01606.x; Calafell F, 1996, ANN HUM GENET, V60, P35, DOI 10.1111/j.1469-1809.1996.tb01170.x; Cali F, 2001, INT J LEGAL MED, V114, P229, DOI 10.1007/s004140000169; Capelli C, 2003, CURR BIOL, V13, P979, DOI 10.1016/S0960-9822(03)00373-7; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Coles B.J., 1998, P PREHIST SOC, V64, P45, DOI [10.1017/S0079497X00002176, DOI 10.1017/S0079497X00002176]; CorteReal HBSM, 1996, ANN HUM GENET, V60, P331, DOI 10.1111/j.1469-1809.1996.tb01196.x; Cunliffe, 2001, FACING OCEAN ATLANTI; Cunliffe Barry, 1997, ANCIENT CELTS; Decorte R, 1996, ADV FOREN H, V6, P17; Di Benedetto G, 2001, AM J PHYS ANTHROPOL, V115, P144, DOI 10.1002/ajpa.1064; Dimo-Simonin N, 2000, INT J LEGAL MED, V113, P89, DOI 10.1007/PL00007715; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; Dolukhanov P., 1993, CULTURAL TRANSFORMAT, P122; Dubut V, 2004, EUR J HUM GENET, V12, P293, DOI 10.1038/sj.ejhg.5201145; DUTILLEUL P, 1993, BIOMETRICS, V49, P305, DOI 10.2307/2532625; Ellis N, 2002, GENOME RES, V12, P339; Esmonde-Cleary AS., 1989, ENDING ROMAN BRITAIN; Forster P, 2002, INT J LEGAL MED, V116, P99, DOI 10.1007/s00414-001-0261-z; Francalacci P, 1996, AM J PHYS ANTHROPOL, V100, P443, DOI 10.1002/(SICI)1096-8644(199608)100:4<443::AID-AJPA1>3.0.CO;2-S; Gamble C, 2004, PHILOS T R SOC B, V359, P243, DOI 10.1098/rstb.2003.1396; Gonzalez AM, 2003, AM J PHYS ANTHROPOL, V120, P391, DOI 10.1002/ajpa.10168; Helgason A, 2000, AM J HUM GENET, V66, P999, DOI 10.1086/302816; Helgason A, 2001, AM J HUM GENET, V68, P723, DOI 10.1086/318785; Hill EW, 2000, NATURE, V404, P351, DOI 10.1038/35006158; Hofmann S, 1997, HUM MOL GENET, V6, P1835, DOI 10.1093/hmg/6.11.1835; Housley R.A., 1997, P PREHIST SOC, V63, P25, DOI DOI 10.1017/S0079497X0000236X; Hurles ME, 1999, AM J HUM GENET, V65, P1437, DOI 10.1086/302617; JAMES S, 1999, ATLANTIC CELTS; Kittles RA, 1999, AM J PHYS ANTHROPOL, V108, P381, DOI 10.1002/(SICI)1096-8644(199904)108:4<381::AID-AJPA1>3.0.CO;2-5; Kouvatsi A, 2001, HUM BIOL, V73, P855, DOI 10.1353/hub.2001.0085; Lahermo P, 2000, HEREDITAS, V132, P35, DOI 10.1111/j.1601-5223.2000.00035.x; Larruga JM, 2001, EUR J HUM GENET, V9, P708, DOI 10.1038/sj.ejhg.5200693; Lutz S, 1998, INT J LEGAL MED, V111, P67, DOI 10.1007/s004140050117; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Malyarchuk BA, 2002, ANN HUM GENET, V66, P261, DOI 10.1017/S0003480002001161; Malyarchuk BA, 2001, ANN HUM GENET, V65, P63, DOI 10.1046/j.1469-1809.2001.6510063.x; Megaw JVS, 1998, ANTIQUITY, V72, P432, DOI 10.1017/S0003598X00086749; Megaw JVS, 1996, ANTIQUITY, V70, P175, DOI 10.1017/S0003598X00083046; Meyer S, 1999, GENETICS, V152, P1103; Mogentale-Profizi N, 2001, ANN HUM GENET, V65, P153, DOI 10.1017/S0003480001008545; O'Donnell KA, 2002, EUR J HUM GENET, V10, P530, DOI 10.1038/sj.ejhg.5200841; ODONNABHAIN B, 2000, NEW AGENDAS IRISH PR, P189; Opdal SH, 1998, ACTA PAEDIATR, V87, P1039, DOI 10.1080/080352598750031347; Orekhov V, 1999, FEBS LETT, V445, P197, DOI 10.1016/S0014-5793(99)00115-5; Parson W, 1998, INT J LEGAL MED, V111, P124, DOI 10.1007/s004140050132; Passarino G, 2002, EUR J HUM GENET, V10, P521, DOI 10.1038/sj.ejhg.5200834; Pereira L, 2000, ANN HUM GENET, V64, P491, DOI 10.1046/j.1469-1809.2000.6460491.x; Pfeiffer H, 1999, INT J LEGAL MED, V112, P291, DOI 10.1007/s004140050252; PIERCY R, 1993, INT J LEGAL MED, V106, P85, DOI 10.1007/BF01225046; PULT I, 1994, BIOL CHEM H-S, V375, P837; Raftery B., 1994, PAGAN CELTIC IRELAND; Renfrew C., 1987, ARCHAEOLOGY LANGUAGE; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 2002, AM J HUM GENET, V71, P1168, DOI 10.1086/342930; Richards M, 1996, AM J HUM GENET, V59, P185; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; Rohl A, 2001, INT J LEGAL MED, V115, P29, DOI 10.1007/s004140100217; Rosenberg MS, 2001, PASSAGE PATTERN ANAL; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Rousselet F, 1998, INT J LEGAL MED, V111, P292, DOI 10.1007/s004140050174; SAJANTILA A, 1995, GENOME RES, V5, P42, DOI 10.1101/gr.5.1.42; Sajantila A, 1996, P NATL ACAD SCI USA, V93, P12035, DOI 10.1073/pnas.93.21.12035; Salas A, 1998, EUR J HUM GENET, V6, P365, DOI 10.1038/sj.ejhg.5200202; Schneider S., 2000, ARLEQUIN VERSION 200; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Simoni L, 2000, AM J HUM GENET, V66, P1177, DOI 10.1086/302790; Simoni L, 2000, AM J HUM GENET, V66, P262, DOI 10.1086/302706; SLATKIN M, 1995, GENETICS, V139, P457; Tagliabracci A, 2001, INT J LEGAL MED, V114, P224, DOI 10.1007/s004140000168; Torroni A, 2000, AM J HUM GENET, V66, P1173, DOI 10.1086/302789; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 1996, GENETICS, V144, P1835; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; Weale ME, 2002, MOL BIOL EVOL, V19, P1008, DOI 10.1093/oxfordjournals.molbev.a004160; Wilson JF, 2001, P NATL ACAD SCI USA, V98, P5078, DOI 10.1073/pnas.071036898	81	56	57	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2004	75	4					693	702		10.1086/424697	http://dx.doi.org/10.1086/424697			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	850SZ	15309688	Green Published, Bronze			2022-12-18	WOS:000223634100016
J	Morris, AP; Whittaker, JC; Balding, DJ				Morris, AP; Whittaker, JC; Balding, DJ			Little loss of information due to unknown phase for fine-scale linkage-disequilibrium mapping with single-nucleotide-polymorphism genotype data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HAPLOTYPE RECONSTRUCTION; RECOMBINATION; EFFICIENCY	We present the results of a simulation study that indicate that true haplotypes at multiple, tightly linked loci often provide little extra information for linkage-disequilibrium fine mapping, compared with the information provided by corresponding genotypes, provided that an appropriate statistical analysis method is used. In contrast, a two-stage approach to analyzing genotype data, in which haplotypes are inferred and then analyzed as if they were true haplotypes, can lead to a substantial loss of information. The study uses our COLDMAP software for fine mapping, which implements a Markov chain-Monte Carlo algorithm that is based on the shattered coalescent model of genetic heterogeneity at a disease locus. We applied COLDMAP to 100 replicate data sets simulated under each of 18 disease models. Each data set consists of haplotype pairs (diplotypes) for 20 SNPs typed at equal 50-kb intervals in a 950-kb candidate region that includes a single disease locus located at random. The data sets were analyzed in three formats: ( 1) as true haplotypes; ( 2) as haplotypes inferred from genotypes using an expectation-maximization algorithm; and ( 3) as unphased genotypes. On average, true haplotypes gave a 6% gain in efficiency compared with the unphased genotypes, whereas inferring haplotypes from genotypes led to a 20% loss of efficiency, where efficiency is defined in terms of root mean integrated square error of the location of the disease locus. Furthermore, treating inferred haplotypes as if they were true haplotypes leads to considerable overconfidence in estimates, with nominal 50% credibility intervals achieving, on average, only 19% coverage. We conclude that ( 1), given appropriate statistical analyses, the costs of directly measuring haplotypes will rarely be justified by a gain in the efficiency of fine mapping and that ( 2) a two-stage approach of inferring haplotypes followed by a haplotype-based analysis can be very inefficient for fine mapping, compared with an analysis based directly on the genotypes.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Imperial Coll Fac Med, Dept Epidemiol & Publ Hlth, London, England	University of Oxford; Wellcome Centre for Human Genetics; Imperial College London	Morris, AP (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	amorris@well.ox.ac.uk	Whittaker, John C/B-8609-2012; Balding, David/G-9898-2011	Whittaker, John C/0000-0002-3529-2379; Balding, David/0000-0002-1480-6115				Clayton D, 2000, INT STAT REV, V68, P23, DOI 10.2307/1403555; Douglas JA, 2001, NAT GENET, V28, P361, DOI 10.1038/ng582; Gamerman D., 2006, MARKOV CHAIN MONTE C, DOI DOI 10.1201/9781482296426; Griffiths R., 1997, PROGR POPULATION GEN, P257; Griffiths RC, 1996, J COMPUT BIOL, V3, P479, DOI 10.1089/cmb.1996.3.479; Hosking L. K., 2002, Pharmacogenomics Journal, V2, P165, DOI 10.1038/sj.tpj.6500096; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Kingman J, 1982, STOCHASTIC PROCESS A, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Liu JS, 2001, GENOME RES, V11, P1716, DOI 10.1101/gr.194801; Liu JS., 2001, MONTE CARLO STRATEGI, DOI DOI 10.1007/978-0-387-76371-2; Lu X, 2003, GENOME RES, V13, P2112, DOI 10.1101/gr.586803; McPeek MS, 1999, AM J HUM GENET, V65, P858, DOI 10.1086/302537; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Morris AP, 2003, P NATL ACAD SCI USA, V100, P13442, DOI 10.1073/pnas.2235031100; Morris AP, 2002, AM J HUM GENET, V70, P686, DOI 10.1086/339271; NORDBORG M, 2003, HDB STAT GENETICS, P602; Phillips MS, 2003, NAT GENET, V33, P382, DOI 10.1038/ng1100; Schaid DJ, 2002, GENET EPIDEMIOL, V23, P426, DOI 10.1002/gepi.10184; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501	21	56	57	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2004	74	5					945	953		10.1086/420773	http://dx.doi.org/10.1086/420773			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	813SF	15077198	Green Published, Bronze			2022-12-18	WOS:000220926100014
J	Conti, DV; Witte, JS				Conti, DV; Witte, JS			Hierarchical modeling of linkage disequilibrum: Genetic structure and spatial relations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EMPIRICAL-BAYES; QUANTITATIVE TRAITS; LEAST-SQUARES; HAPLOTYPE; ASSOCIATION; SUSCEPTIBILITY; TESTS; LIKELIHOOD; INFERENCE; SOFTWARE	Linkage disequilibrium (LD) mapping offers much promise for the positional cloning of disease-causing genes. However, conventional estimates of LD may fluctuate substantially across contiguous genomic regions, because of population-specific phenomena such as mutation, genetic drift, population structure, and variations in allele frequencies. This fluctuation makes it difficult to interpret patterns of LD and distinguish where a causal gene is located. To address this issue, we propose hierarchical modeling of LD (HLD) for fine-scale mapping. This approach incorporates information on haplotype block structure and chromosomal spatial relations to refine the pattern of LD, increasing the ability to localize disease genes. Here, we present a framework for HLD, a simulation study assessing the performance of HLD under various scenarios, and an application of HLD to existing data. This work demonstrates that hierarchical modeling of linkage disequilibrium is a valuable and flexible approach for fine-scale mapping.	Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA	Case Western Reserve University	Witte, JS (corresponding author), Case Western Reserve Univ, Dept Epidemiol & Biostat, 2109 Adelbert Rd, Cleveland, OH 44106 USA.	witte@darwin.cwru.edu			NCI NIH HHS [CA88164, R01 CA088164] Funding Source: Medline; NHLBI NIH HHS [T32 HL007567, HL07567] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA088164] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007567] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abecasis GR, 2001, AM J HUM GENET, V68, P191, DOI 10.1086/316944; Abecasis GR, 2000, EUR J HUM GENET, V8, P545, DOI 10.1038/sj.ejhg.5200494; Bader JS, 2001, PHARMACOGENOMICS, V2, P11, DOI 10.1517/14622416.2.1.11; Clayton D, 1999, AM J HUM GENET, V65, P1161, DOI 10.1086/302566; Clayton D, 2000, INT STAT REV, V68, P23, DOI 10.2307/1403555; Collins A, 2001, HUM MUTAT, V17, P255, DOI 10.1002/humu.21; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; Cordell HJ, 1999, GENET EPIDEMIOL, V17, P237, DOI 10.1002/(SICI)1098-2272(199911)17:4<237::AID-GEPI1>3.0.CO;2-P; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Diggle PJ, 1998, J R STAT SOC C-APPL, V47, P299, DOI 10.1111/1467-9876.00113; EDWARDS AWF, 1963, J R STAT SOC SER A-G, V126, P109, DOI 10.2307/2982448; Fallin D, 2000, AM J HUM GENET, V67, P947, DOI 10.1086/303069; Fallin D, 2001, GENOME RES, V11, P143, DOI 10.1101/gr.148401; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gelman A, 2013, BAYESIAN DATA ANAL; George V, 1999, AM J HUM GENET, V65, P236, DOI 10.1086/302444; Gilks WR, 1996, MARKOV CHAIN MONTE C; Goldstein DB, 2001, NAT GENET, V29, P109, DOI 10.1038/ng1001-109; Greenland S, 2000, INT J EPIDEMIOL, V29, P158, DOI 10.1093/ije/29.1.158; Greenland S, 2000, BIOMETRICS, V56, P915, DOI 10.1111/j.0006-341X.2000.00915.x; Greenland S, 2000, AM J EPIDEMIOL, V151, P531; GREENLAND S, 1993, STAT MED, V12, P717, DOI 10.1002/sim.4780120802; Greenland S, 1997, STAT MED, V16, P515; GREENLAND S, 1994, ARCH ENVIRON HEALTH, V49, P9, DOI 10.1080/00039896.1994.9934409; Guo G, 2002, BEHAV GENET, V32, P37, DOI 10.1023/A:1014455812027; HEDRICK PW, 1987, GENETICS, V117, P331; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Kaplan N, 2001, GENET EPIDEMIOL, V20, P432, DOI 10.1002/gepi.1012; Kim LL, 2001, GENET EPIDEMIOL, V21, pS668, DOI 10.1002/gepi.2001.21.s1.s668; Lazzeroni LC, 1998, AM J HUM GENET, V62, P159, DOI 10.1086/301678; LEWONTIN RC, 1988, GENETICS, V120, P849; Li HZ, 2000, GENET EPIDEMIOL, V19, pS43, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI7>3.0.CO;2-J; Liu JS, 2001, GENOME RES, V11, P1716, DOI 10.1101/gr.194801; McPeek MS, 1999, AM J HUM GENET, V65, P858, DOI 10.1086/302537; Morris AP, 2000, AM J HUM GENET, V67, P155, DOI 10.1086/302956; MORRIS CN, 1983, J AM STAT ASSOC, V78, P47, DOI 10.2307/2287098; Morris RW, 2002, GENET EPIDEMIOL, V23, P221, DOI 10.1002/gepi.10200; Neter J., 1990, APPL LINEAR STAT MOD; Nordborg M, 2002, TRENDS GENET, V18, P83, DOI 10.1016/S0168-9525(02)02557-X; Pascutto C, 2000, STAT MED, V19, P2493, DOI 10.1002/1097-0258(20000915/30)19:17/18<2493::AID-SIM584>3.0.CO;2-D; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Richardson S, 1992, STATISTICIAN, V41, P539; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Schaid DJ, 2002, AM J HUM GENET, V71, P992, DOI 10.1086/342666; Schaid DJ, 1996, GENET EPIDEMIOL, V13, P423, DOI 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3; SELF SG, 1991, BIOMETRICS, V47, P53, DOI 10.2307/2532495; Service SK, 1999, AM J HUM GENET, V64, P1728, DOI 10.1086/302398; Sillanpaa MJ, 2001, GENET EPIDEMIOL, V21, pS692, DOI 10.1002/gepi.2001.21.s1.s692; Spiegelhalter DJ, 1999, WINBUGS VERSION 1 2; Spielman RS, 1996, AM J HUM GENET, V59, P983; Thomas DC, 2001, GENET EPIDEMIOL, V21, pS712, DOI 10.1002/gepi.2001.21.s1.s712; WAKEFIELD JC, 2000, SPATIAL EPIDEMIOLOGY, P107; Witte JS, 1997, GENET EPIDEMIOL, V14, P1137, DOI 10.1002/(SICI)1098-2272(1997)14:6<1137::AID-GEPI96>3.0.CO;2-H; Witte JS, 2000, EPIDEMIOLOGY, V11, P684, DOI 10.1097/00001648-200011000-00012; Witte JS, 1998, EPIDEMIOLOGY, V9, P563, DOI 10.1097/00001648-199809000-00016; Witte JS, 1996, STAT MED, V15, P1161, DOI 10.1002/(SICI)1097-0258(19960615)15:11<1161::AID-SIM221>3.0.CO;2-7; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986	63	56	60	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2003	72	2					351	363		10.1086/346117	http://dx.doi.org/10.1086/346117			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	640GK	12525994	Green Published, Bronze			2022-12-18	WOS:000180680000015
J	Omi, K; Ohashi, J; Patarapotikul, J; Hananantachai, H; Naka, I; Looareesuwan, S; Tokunaga, K				Omi, K; Ohashi, J; Patarapotikul, J; Hananantachai, H; Naka, I; Looareesuwan, S; Tokunaga, K			CD36 polymorphism is associated with protection from cerebral malaria	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FALCIPARUM-INFECTED ERYTHROCYTES; PARASITIZED ERYTHROCYTES; MEIOTIC RECOMBINATION; ADHESION MOLECULE-1; RECEPTOR; GENE; BINDING; IDENTIFICATION; ATHEROSCLEROSIS; SEQUESTRATION	The human protein CD36 is a major receptor for Plasmodium falciparum-infected erythrocytes and contributes to the pathology of P. falciparum malaria. We performed variation screening of the CD36 gene and examined the possible association between CD36 polymorphisms and the severity of malaria in 475 adult Thai patients with P. falciparum malaria. Accordingly, we identified nine CD36 polymorphisms with a high-frequency ( 15%) minor allele. Of these, the frequencies of the 5 -14T-->C allele in the upstream promoter region and the -53G-->T allele in the downstream promoter region were significantly decreased in patients with cerebral malaria compared to those with mild malaria (P = .016 for -14T-->C and P = .050 for -53G-->T). The analysis of linkage disequilibrium (LD) between the nine common polymorphisms revealed that there are two blocks with strong LD in the CD36 gene and that the -14T-->C and -53G-->T polymorphisms are within the upstream block of 35 kb from the upstream promoter to exon 8. Further association testing after the second variation screening in the upstream block indicated that the in3(TG)(12) (i.e., 12 TG repeats in intron 3) allele is most strongly associated with the reduction in the risk of cerebral malaria (odds ratio 0.59; 95% confidence interval 0.40-0.87; P = .0069). We found, by reverse-transcriptase PCR amplification, that in3( TG) 12 is involved in the nonproduction of the variant CD36 transcript that lacks exons 4 and 5. Since exon 5 of the gene is known to encode the ligand-binding domain for P. falciparum-infected erythrocytes, in3( TG) 12 itself or a primary variant on the haplotype with in3(TG)(12) may be responsible for protection from cerebral malaria in Thailand. Results of the present study suggest that LD mapping has potential for detecting a disease-associated variant on the basis of haplotype blocks.	Univ Tokyo, Dept Human Genet, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; Mahidol Univ, Fac Trop Med, Bangkok, Thailand	University of Tokyo; Mahidol University	Ohashi, J (corresponding author), Univ Tokyo, Dept Human Genet, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	juno@m.u-tokyo.ac.jp	OHASHI, JUN/G-5907-2015; NAKA, IZUMI/G-5495-2015					Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Aitman TJ, 2000, NATURE, V405, P1015, DOI 10.1038/35016636; ARMESILLA AL, 1994, J BIOL CHEM, V269, P18985; Armesilla AL, 1996, J BIOL CHEM, V271, P7781, DOI 10.1074/jbc.271.13.7781; ASCH AS, 1993, SCIENCE, V262, P1436, DOI 10.1126/science.7504322; BARNWELL JW, 1985, J IMMUNOL, V135, P3494; Baruch DI, 1999, BLOOD, V94, P2121, DOI 10.1182/blood.V94.6.2121.418k09_2121_2127; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI14006; GREENWALT DE, 1992, BLOOD, V80, P1105; Griffin E, 2001, NAT MED, V7, P840, DOI 10.1038/89969; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; KASHIWAGI H, 1995, THROMB HAEMOSTASIS, V74, P758; Kern P, 1999, EUR J IMMUNOGENET, V26, P337, DOI 10.1046/j.1365-2370.1999.00167.x; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; LEWONTIN RC, 1988, GENETICS, V120, P849; LIPSKY RH, 1994, HUM MOL GENET, V3, P217, DOI 10.1093/hmg/3.1.217; McGilvray ID, 2000, BLOOD, V96, P3231, DOI 10.1182/blood.V96.9.3231; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; MILLER LH, 1994, SCIENCE, V264, P1878, DOI 10.1126/science.8009217; Moller LB, 2000, AM J HUM GENET, V66, P1211, DOI 10.1086/302857; Newbold C, 1997, AM J TROP MED HYG, V57, P389, DOI 10.4269/ajtmh.1997.57.389; OCKENHOUSE CF, 1991, J INFECT DIS, V164, P163, DOI 10.1093/infdis/164.1.163; OCKENHOUSE CF, 1992, J EXP MED, V176, P1183, DOI 10.1084/jem.176.4.1183; OCKENHOUSE CF, 1989, SCIENCE, V243, P1469, DOI 10.1126/science.2467377; Pain A, 2001, P NATL ACAD SCI USA, V98, P1805, DOI 10.1073/pnas.98.4.1805; Pain A, 2001, LANCET, V357, P1502, DOI 10.1016/S0140-6736(00)04662-6; PATNAIK JK, 1994, AM J TROP MED HYG, V51, P642, DOI 10.4269/ajtmh.1994.51.642; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; ROBERTS DD, 1985, NATURE, V318, P64, DOI 10.1038/318064a0; ROGERSON SJ, 1995, J EXP MED, V182, P15, DOI 10.1084/jem.182.1.15; Sato O, 2002, J BIOL CHEM, V277, P15703, DOI 10.1074/jbc.M110158200; Schneider S., 2000, ARLEQUIN VERSION 200; TANG YL, 1994, J BIOL CHEM, V269, P6011; Treutiger CJ, 1997, NAT MED, V3, P1405, DOI 10.1038/nm1297-1405; Urban BC, 1999, NATURE, V400, P73, DOI 10.1038/21900	37	56	61	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2003	72	2					364	374		10.1086/346091	http://dx.doi.org/10.1086/346091			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	640GK	12506336	Bronze, Green Published			2022-12-18	WOS:000180680000016
J	Shen, L; Pichel, JG; Mayeli, T; Sariola, H; Lu, B; Westphal, H				Shen, L; Pichel, JG; Mayeli, T; Sariola, H; Lu, B; Westphal, H			Gdnf haploinsufficiency causes Hirschsprung-like intestinal obstruction and early-onset lethality in mice	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ENTERIC NERVOUS-SYSTEM; SACRAL NEURAL CREST; ENDOTHELIN-B RECEPTOR; NEUROTROPHIC FACTOR; RET PROTOONCOGENE; TYROSINE KINASE; HUMAN-DISEASE; LACKING GDNF; GERMLINE MUTATIONS; MOUSE MODELS	Hirschsprung disease (HSCR) is a common congenital disorder that results in intestinal obstruction and lethality, as a result of defective innervation of the gastrointestinal (GI) tract. Despite its congenital origin, the molecular etiology of HSCR remains elusive for >70% of patients. Although mutations in the c-RET receptor gene are frequently detected in patients with HSCR, mutations in the gene encoding its ligand (glial cell line-derived neurotrophic factor [GDNF]), are rarely found. In an effort to establish a possible link between human HSCR and mutations affecting the Gdnf locus, we studied a large population of mice heterozygous for a Gdnf null mutation. This Gdnf(+/-) mutant cohort recapitulates complex features characteristic of HSCR, including dominant inheritance, incomplete penetrance, and variable severity of symptoms. The lack of one functioning Gdnf allele causes a spectrum of defects in gastrointestinal motility and predisposes the mutant mice to HSCR-like phenotypes. As many as one in five Gdnf(+/-) mutant mice die shortly after birth. Using a transgenic marking strategy, we identified hypoganglionosis of the gastrointestinal tract as a developmental defect that renders the mutant mice susceptible to clinical symptoms of HSCR. Our findings offer a plausible way to link an array of seemingly disparate features characteristic of a complex disease to a much more narrowly defined genetic cause. These findings may have general implications for the genetic analysis of cause and effect in complex human diseases.	NICHHD, Lab Mol Genet & Dev, NIH, Bethesda, MD 20814 USA; Hosp Merida, Unidad Invest, Merida, Spain; Univ Helsinki, Inst Biotechnol, Helsinki, Finland	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Helsinki	Westphal, H (corresponding author), NICHHD, Lab Mol Genet & Dev, NIH, Bldg 6B,Room 413, Bethesda, MD 20814 USA.	hw@helix.nih.gov	Lu, Bai/A-4018-2012; Pichel, Jose G/AAF-2255-2019	Pichel, Jose G/0000-0001-8580-0952; Lu, Bai/0000-0001-5418-9759	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000071] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000714, Z01HD000071] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANGRIST M, 1995, HUM MOL GENET, V4, P821, DOI 10.1093/hmg/4.5.821; Angrist M, 1996, NAT GENET, V14, P341, DOI 10.1038/ng1196-341; ATTIE T, 1995, HUM MOL GENET, V4, P1381, DOI 10.1093/hmg/4.8.1381; BADNER JA, 1990, AM J HUM GENET, V46, P568; Bar KJ, 1997, GASTROENTEROLOGY, V112, P1381, DOI 10.1016/S0016-5085(97)70154-9; BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3; Bedell MA, 1997, GENE DEV, V11, P11, DOI 10.1101/gad.11.1.11; Bedell MA, 1997, GENE DEV, V11, P1, DOI 10.1101/gad.11.1.1; BERRY C, 1996, PAEDIAT PATHOLOGY, P207; Burns AJ, 1998, DEVELOPMENT, V125, P4335; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; Chakravarti A, 1996, HUM MOL GENET, V5, P303; Durbec PL, 1996, DEVELOPMENT, V122, P349; EDERY P, 1994, NATURE, V367, P378, DOI 10.1038/367378a0; Edery P, 1996, NAT GENET, V12, P442, DOI 10.1038/ng0496-442; EHRENPREIS T, 1970, HIRSCHSPRUNG DIS; Enomoto H, 1998, NEURON, V21, P317, DOI 10.1016/S0896-6273(00)80541-3; GERSHON MD, 1995, CURR BIOL, V5, P601, DOI 10.1016/S0960-9822(95)00120-5; Gershon Michael D., 1994, P381; HOLSCHNEIDER AM, 1994, EUR J PEDIATR SURG, V4, P260, DOI 10.1055/s-2008-1066115; HOLSCHNEIDER AM, 1982, HIPPOKRATES; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; Ivanchuk SM, 1996, HUM MOL GENET, V5, P2023, DOI 10.1093/hmg/5.12.2023; Justice MJ, 2000, NAT REV GENET, V1, P109, DOI 10.1038/35038549; Kapur RP, 1999, CRIT REV CL LAB SCI, V36, P225, DOI 10.1080/10408369991239204; KAPUR RP, 1991, NEURON, V7, P717, DOI 10.1016/0896-6273(91)90275-5; Karaosmanoglu T, 1996, ANAT RECORD, V244, P470, DOI 10.1002/(SICI)1097-0185(199604)244:4<470::AID-AR5>3.0.CO;2-Z; Kusafuka T, 1996, PEDIATR SURG INT, V12, P19; Martucciello G, 1998, J PEDIATR SURG, V33, P99, DOI 10.1016/S0022-3468(98)90371-2; MERCER EH, 1991, NEURON, V7, P703, DOI 10.1016/0896-6273(91)90274-4; Milla PJ, 1996, PEDIATR CLIN N AM, V43, P511, DOI 10.1016/S0031-3955(05)70418-1; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Ohshiro K, 1998, J PEDIATR SURG, V33, P904, DOI 10.1016/S0022-3468(98)90671-6; Pasini B, 1996, TRENDS GENET, V12, P138, DOI 10.1016/0168-9525(96)10012-3; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; POMERANZ HD, 1991, DEVELOPMENT, V111, P647; POMERANZ HD, 1990, DEV BIOL, V137, P378, DOI 10.1016/0012-1606(90)90262-H; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; Puri P, 1998, Semin Pediatr Surg, V7, P140; QUALMAN SJ, 1994, HUM PATHOL, V25, P1141, DOI 10.1016/0046-8177(94)90030-2; ROMEO G, 1994, NATURE, V367, P377, DOI 10.1038/367377a0; Salomon R, 1996, NAT GENET, V14, P345, DOI 10.1038/ng1196-345; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; SERBEDZIJA GN, 1991, DEVELOPMENT, V111, P857; Szabolcs MJ, 1996, PEDIATR PATHOL LAB M, V16, P51, DOI 10.1080/107710496175877; Weinberg A G, 1975, Perspect Pediatr Pathol, V2, P207; Yin Luo, 1994, European Journal of Human Genetics, V2, P272	48	56	56	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2002	70	2					435	447		10.1086/338712	http://dx.doi.org/10.1086/338712			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	511FQ	11774071	Green Published, Bronze			2022-12-18	WOS:000173254300015
J	Camp, NJ; Neuhausen, SL; Tiobech, J; Polloi, A; Coon, H; Myles-Worsley, M				Camp, NJ; Neuhausen, SL; Tiobech, J; Polloi, A; Coon, H; Myles-Worsley, M			Genomewide multipoint linkage analysis of seven extended Palauan pedigrees with schizophrenia, by a Markov-chain Monte Carlo method	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUSCEPTIBILITY LOCUS; SEGREGATION ANALYSIS; VULNERABILITY LOCUS; AFFECTIVE-DISORDERS; DETECT LINKAGE; GENOMIC SCAN; GENETICS; FAMILIES; CHROMOSOMES; GENES	Palauans are an isolated population in Micronesia with lifetime prevalence of schizophrenia (SCZD) of 2%, compared to the world rate of similar to1%. The possible enrichment for SCZD genes, in conjunction with the potential for reduced etiological heterogeneity and the opportunity to ascertain statistically powerful extended pedigrees, makes Palauans a population of choice for the mapping of SCZD genes. We have used a Markov-chain Monte Carlo method to perform a genomewide multipoint analysis in seven extended pedigrees from Palau. Robust multipoint parametric and nonparametric linkage (NPL) analyses were performed under three nested diagnostic classifications-core, spectrum, and broad. We observed four regions of interest across the genome. Two of these regions-on chromosomes 2p13-14 (for which, under core diagnostic classification, NPL=65 and parametric LOD=4.8) and 13q12-22 (for which, under broad diagnostic classification, parametric LOD=3.6, and, under spectrum diagnostic classification, parametric LOD =3.5)-had evidence for linkage with genomewide significance, after correction for multiple testing; with the current pedigree resource and genotyping, these regions are estimated to be 4.3 cM and 19.75 cM in size, respectively. A third region, with intermediate evidence for linkage, was identified on chromosome 5q22-qter (for which, under broad diagnostic classification, parametric LOD=2.5). The fourth region of interest had only borderline suggestive evidence for linkage (on 3q24-28; for this region, under broad diagnostic classification, parametric LOD=2.0). All regions exhibited evidence for genetic heterogeneity. Our findings provide significant evidence for susceptibility loci on chromosomes 2p13-14 and 13q12-22 and support both a model of genetic heterogeneity and the utility of a broader set of diagnostic classifications in the population from Palau.	Intermt Hlth Care, Genet Res, Salt Lake City, UT 84108 USA; Univ Utah, Dept Med Informat, Sch Med, Salt Lake City, UT 84112 USA; Univ Utah, Dept Psychiat, Sch Med, Salt Lake City, UT 84112 USA; Belau Natl Hosp, Koror, Palau	Intermountain Healthcare; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Camp, NJ (corresponding author), Intermt Hlth Care, Genet Res, 391 Chipeta Way,Suite D, Salt Lake City, UT 84108 USA.	nicki@genepi.med.utah.edu		Coon, Hilary/0000-0002-8877-5446	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054186] Funding Source: NIH RePORTER; NIMH NIH HHS [R01-MH54186, R01-MH560908, R01 MH054186] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ABKEVICH V, IN PRESS GENET EPIDE; BARON M, 1982, ACTA PSYCHIAT SCAND, V65, P253, DOI 10.1111/j.1600-0447.1982.tb00845.x; Baron M, 2001, AM J HUM GENET, V68, P299, DOI 10.1086/318212; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; Bennett PJ, 2000, PSYCHIAT GENET, V10, P79, DOI 10.1097/00041444-200010020-00004; Berrettini WH, 2000, BIOL PSYCHIAT, V48, P531, DOI 10.1016/S0006-3223(00)00883-0; Blouin JL, 1998, NAT GENET, V20, P70, DOI 10.1038/1734; BOOK JA, 1978, CLIN GENET, V14, P373; Brzustowicz LM, 2000, SCIENCE, V288, P678, DOI 10.1126/science.288.5466.678; Brzustowicz LM, 1999, AM J HUM GENET, V65, P1096, DOI 10.1086/302579; CAMP NJ, IN PRESS GENET EPIDE; CAMP NJ, IN PRESS ANN HUM GEN; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; Coon H, 1998, MOL PSYCHIATR, V3, P521, DOI 10.1038/sj.mp.4000453; COON H, 1994, AM J MED GENET, V54, P59, DOI 10.1002/ajmg.1320540111; DAVISON K, 1983, PSYCHIAT DEV, V1, P1; DELISI L, 1997, 1997 PARK CIT MOL PS; Durner M, 1999, AM J HUM GENET, V64, P281, DOI 10.1086/302181; Edenberg HJ, 1997, AM J MED GENET, V74, P238, DOI 10.1002/(SICI)1096-8628(19970531)74:3<238::AID-AJMG2>3.0.CO;2-M; ELSTON RC, 1978, NEUROPSYCHOBIOLOGY, V4, P193, DOI 10.1159/000117633; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; Faraone SV, 1998, AM J MED GENET, V81, P290, DOI 10.1002/(SICI)1096-8628(19980710)81:4<290::AID-AJMG3>3.0.CO;2-Y; Garner C, 2001, AM J HUM GENET, V68, P1061, DOI 10.1086/319517; Goring HHH, 2000, AM J HUM GENET, V66, P1095, DOI 10.1086/302797; Gottesman II, 1991, SCHIZOPHRENIA GENESI; Greenberg DA, 1998, AM J HUM GENET, V63, P870, DOI 10.1086/301997; Gurling HMD, 2001, AM J HUM GENET, V68, P661, DOI 10.1086/318788; JENSEN CS, 1995, INT J HUM-COMPUT ST, V42, P647, DOI 10.1006/ijhc.1995.1029; Kelsoe JR, 2001, P NATL ACAD SCI USA, V98, P585, DOI 10.1073/pnas.011358498; KENDLER KS, 1993, SCHIZOPHRENIA BULL, V19, P261, DOI 10.1093/schbul/19.2.261; Kendler KS, 1996, AM J MED GENET, V67, P179, DOI 10.1002/(SICI)1096-8628(19960409)67:2<179::AID-AJMG8>3.0.CO;2-N; KENDLER KS, 1983, AM J PSYCHIAT, V140, P1413; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Levinson DF, 2000, AM J HUM GENET, V67, P652, DOI 10.1086/303041; Lin HK, 1997, ACTA PHYS-CHIM SIN, V13, P417, DOI 10.3866/PKU.WHXB19970507; Lin MW, 1995, PSYCHIATR GENET, V5, P117, DOI 10.1097/00041444-199505030-00004; MAIER W, 1993, EUR ARCH PSY CLIN N, V242, P279, DOI 10.1007/BF02190387; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; Myles-Worsley M, 1999, AM J MED GENET, V88, P4, DOI 10.1002/(SICI)1096-8628(19990205)88:1<4::AID-AJMG2>3.0.CO;2-H; OROURKE DH, 1982, AM J HUM GENET, V34, P630; OTT J, 1986, GENET EPIDEMIOL, P251; Paunio T, 2000, AM J MED GENET, V96, P460; RISCH N, 1984, AM J HUM GENET, V36, P1039; RISCH N, 1992, HUM HERED, V42, P77, DOI 10.1159/000154047; RISCH N, 1989, PROG CLIN BIOL RES, V329, P183; SACCONE S, 1992, P NATL ACAD SCI USA, V89, P4913, DOI 10.1073/pnas.89.11.4913; Schwab SG, 1997, MOL PSYCHIATR, V2, P156, DOI 10.1038/sj.mp.4000263; Shaw SH, 1998, AM J MED GENET, V81, P364, DOI 10.1002/(SICI)1096-8628(19980907)81:5<364::AID-AJMG4>3.0.CO;2-T; Shields J, 1982, SCHIZOPHRENIA EPIGEN; SIMMONS RT, 1965, OCEANIA, V36, P132, DOI 10.1002/j.1834-4461.1965.tb00282.x; SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773, DOI 10.1001/archpsyc.1978.01770300115013; Straub RE, 1997, MOL PSYCHIATR, V2, P148, DOI 10.1038/sj.mp.4000258; STRAUB RE, 1995, NAT GENET, V11, P287, DOI 10.1038/ng1195-287; SUAREZ BK, 1994, GENETIC APPROACHES M; Thomas A, 2000, STAT COMPUT, V10, P259, DOI 10.1023/A:1008947712763; TSUANG MT, 1982, BRIT J PSYCHIAT, V140, P595, DOI 10.1192/bjp.140.6.595; TSUANG MT, 1982, ARCH GEN PSYCHIAT, V39, P141; VIELAND VJ, 1993, HUM HERED, V43, P329, DOI 10.1159/000154155; WANG SB, 1995, NAT GENET, V10, P41, DOI 10.1038/ng0595-41; Wright AF, 1999, NAT GENET, V23, P397, DOI 10.1038/70501	62	56	59	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2001	69	6					1278	1289		10.1086/324590	http://dx.doi.org/10.1086/324590			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	491AY	11668428	Green Published, Bronze			2022-12-18	WOS:000172086900013
J	Reynolds, DM; Falk, CT; Li, AR; King, BF; Kamath, PS; Huston, J; Shub, C; Iglesias, DM; Martin, RS; Pirson, Y; Torres, VE; Somlo, S				Reynolds, DM; Falk, CT; Li, AR; King, BF; Kamath, PS; Huston, J; Shub, C; Iglesias, DM; Martin, RS; Pirson, Y; Torres, VE; Somlo, S			Identification of a locus for autosomal dominant polycystic liver disease, on chromosome 19p13.2-13.1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITRAL-VALVE PROLAPSE; KIDNEY-DISEASE; HEPATIC CYSTS; SIGNAL-TRANSDUCTION; LINKAGE ANALYSIS; FOLLOW-UP; GENE; RISK	Polycystic liver disease (PCLD) is characterized by the growth of fluid-filled cysts of biliary epithelial origin in the liver. Although the disease is often asymptomatic, it can, when severe, lead to complications requiring surgical therapy. PCLD is most often associated with autosomal dominant polycystic kidney disease (ADPKD); however, families with an isolated polycystic liver phenotype without kidney involvement have been described. The clinical presentation and histological features of polycystic liver disease in the presence or absence of ADPKD are indistinguishable, raising the possibility that the pathogenetic mechanisms in the diseases are interrelated. We ascertained two large families with polycystic liver disease without kidney cysts and performed a genomewide scan for genetic linkage. A causative gene, PCLD, was mapped to chromosome 19p13.2-13.1, with a maximum LOD score of 10.3. Haplotype analysis refined the PCLD interval to 12.5 cM flanked by D13S586/D19S583 and D13S593/D19S579. The discovery of genetic linkage will facilitate diagnosis and study of this underdiagnosed disease entity. Identification of PCLD will be instrumental to an understanding of the pathogenesis of cyst formation in the liver in isolated PCLD and in ADPKD.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Internal Med, New Haven, CT 06519 USA; Mayo Clin & Mayo Fdn, Dept Radiol, New Haven, CT 06519 USA; Mayo Clin & Mayo Fdn, Dept Internal Med, New Haven, CT 06519 USA; Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10467 USA; New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06519 USA; Univ Buenos Aires, Buenos Aires, DF, Argentina; Clin Univ St Luc, B-1200 Brussels, Belgium	Yale University; Mayo Clinic; Mayo Clinic; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; New York Blood Center; Yale University; University of Buenos Aires; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Somlo, S (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Internal Med, 295 Congress Ave, New Haven, CT 06519 USA.				NCRR NIH HHS [M01-RR00585, M01 RR000585] Funding Source: Medline; NIDDK NIH HHS [R01 DK051041, P50 DK057328, DK51041, T32 DK007356] Funding Source: Medline; NIGMS NIH HHS [GM29177, R01 GM029177] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK057328, T32DK007356, R01DK051041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029177] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEAR JC, 1992, AM J MED GENET, V43, P548, DOI 10.1002/ajmg.1320430309; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; CAREMANI M, 1993, J CLIN ULTRASOUND, V21, P115, DOI 10.1002/jcu.1870210207; Chaudhry AZ, 1997, DEV DYNAM, V208, P313; COMFORT MW, 1952, GASTROENTEROLOGY, V20, P60; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Emmons SW, 1999, NATURE, V401, P339, DOI 10.1038/43810; GABOW PA, 1990, HEPATOLOGY, V11, P1033, DOI 10.1002/hep.1840110619; GAINES PA, 1989, BRIT J RADIOL, V62, P335, DOI 10.1259/0007-1285-62-736-335; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Grunfeld J P, 1985, Adv Nephrol Necker Hosp, V14, P1; Hellgren G, 1999, GROWTH HORM IGF RES, V9, P212, DOI 10.1054/ghir.1999.0111; Huston J, 1996, J AM SOC NEPHROL, V7, P2135; Iglesias DM, 1999, DIGEST DIS SCI, V44, P385, DOI 10.1023/A:1026623005401; Jodice C, 1997, HUM MOL GENET, V6, P1973, DOI 10.1093/hmg/6.11.1973; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; KARHUNEN PJ, 1986, CLIN GENET, V30, P29; Kim H, 1997, J BIOL CHEM, V272, P30741, DOI 10.1074/jbc.272.49.30741; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MARKS AR, 1989, NEW ENGL J MED, V320, P1031, DOI 10.1056/NEJM198904203201602; MELNICK PJ, 1955, ARCH PATHOL, V59, P162; Michalak M, 1998, BIOCHEM CELL BIOL, V76, P779, DOI 10.1139/bcb-76-5-779; MILUTINOVIC J, 1980, AM J MED, V68, P741, DOI 10.1016/0002-9343(80)90266-1; NISHIMURA RA, 1985, NEW ENGL J MED, V313, P1305, DOI 10.1056/NEJM198511213132101; Pirson Y, 1996, HEPATOLOGY, V23, P249, DOI 10.1002/hep.510230208; RAVINE D, 1994, LANCET, V343, P824, DOI 10.1016/S0140-6736(94)92026-5; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SOTANIEMI EA, 1979, BRIT J CLIN PHARMACO, V8, P331, DOI 10.1111/j.1365-2125.1979.tb04714.x; Torres V., 1996, POLYCYSTIC KIDNEY DI, P500	29	56	59	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2000	67	6					1598	1604		10.1086/316904	http://dx.doi.org/10.1086/316904			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	378WE	11047756	Green Published, Bronze			2022-12-18	WOS:000165607600027
J	Chamberlin, ME; Ubagai, T; Mudd, SH; Thomas, J; Pao, VY; Nguyen, TK; Levy, HL; Greene, C; Freehauf, C; Chou, JY				Chamberlin, ME; Ubagai, T; Mudd, SH; Thomas, J; Pao, VY; Nguyen, TK; Levy, HL; Greene, C; Freehauf, C; Chou, JY			Methionine adenosyltransferase I/III deficiency: Novel mutations and clinical variations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							S-ADENOSYLMETHIONINE SYNTHETASE; ISOLATED PERSISTENT HYPERMETHIONINEMIA; DOMINANT INHERITANCE; MOLECULAR MECHANISMS; GENE; DEMYELINATION; EXPRESSION; CLONING; PATHWAY; BRAIN	Methionine adenosyltransferase (MAT) I/III deficiency, caused by mutations in the MAT1A gene, is characterized by persistent hypermethioninemia without elevated homocysteine or tyrosine. Clinical manifestations are variable and poorly understood, although a number of individuals with, homozygous null mutations in MAT1A have neurological problems, including brain demyelination. We analyzed MAT1A in seven hypermethioninemic individuals, to provide insight into the relationship between genotype and phenotype. We identified six novel mutations and demonstrated that mutations resulting in high plasma methionines may signal clinical difficulties. Two patients-a compound heterozygote for truncating and severely inactivating missense mutations and a homozygote for an aberrant splicing MAT1A mutation-have plasma methionine in the 1,226-1,870 mu M range (normal 5-35 mu M) and manifest abnormalities of the brain gray matter or signs of brain demyelination. Another compound heterozygote for truncating and inactivating missense mutations has 770-1,240 mu M plasma methionine and mild cognitive impairment. Four individuals carrying either two inactivating missense mutations or the single-allelic R264H mutation have 105-467 mu M plasma methionine and are clinically unaffected. Our data underscore the necessity of further studies to firmly establish the relationship between genotypes in MAT I/III deficiency and clinical phenotypes, to elucidate the molecular bases of variability in manifestations of MAT1A mutations.	NICHHD, Heritable Disorders Branch, NIH, Bethesda, MD 20892 USA; NIMH, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; Univ Colorado, Hlth Sci Ctr, Childrens Hosp, Denver, CO USA; Childrens Hosp, Boston, MA 02115 USA; Harvard Med Sch, Boston, MA USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Chou, JY (corresponding author), NICHHD, Heritable Disorders Branch, NIH, Bldg 10,Room 9S241, Bethesda, MD 20892 USA.	chou@helix.nih.gov						ALVAREZ L, 1993, BIOCHEM J, V293, P481, DOI 10.1042/bj2930481; BLOM HJ, 1992, J INHERIT METAB DIS, V15, P188, DOI 10.1007/BF01799629; CANTONI GL, 1953, J BIOL CHEM, V204, P403; Chamberlin ME, 1997, AM J HUM GENET, V60, P540; Chamberlin ME, 1996, J CLIN INVEST, V98, P1021, DOI 10.1172/JCI118862; DELAROSA J, 1995, J BIOL CHEM, V270, P21860; FINKELSTEIN JD, 1975, BIOCHEM BIOPH RES CO, V66, P1491, DOI 10.1016/0006-291X(75)90527-6; GAHL WA, 1988, J CLIN INVEST, V81, P390, DOI 10.1172/JCI113331; GAULL GE, 1981, J PEDIATR-US, V98, P734, DOI 10.1016/S0022-3476(81)80833-5; GOUT JP, 1977, ARCH FR PEDIATR, V34, P416; Hazelwood S, 1998, AM J MED GENET, V75, P395, DOI 10.1002/(SICI)1096-8628(19980203)75:4<395::AID-AJMG9>3.0.CO;2-P; HORIKAWA S, 1990, J BIOL CHEM, V265, P13683; HORIKAWA S, 1992, FEBS LETT, V312, P37, DOI 10.1016/0014-5793(92)81405-B; KOTB M, 1985, J BIOL CHEM, V260, P3923; Kotb M, 1997, TRENDS GENET, V13, P51, DOI 10.1016/S0168-9525(97)01013-5; KOTB M, 1993, PHARMACOL THERAPEUT, V59, P125, DOI 10.1016/0163-7258(93)90042-C; Mato JM, 1997, PHARMACOL THERAPEUT, V73, P265, DOI 10.1016/S0163-7258(96)00197-0; MITSUI KI, 1988, J BIOL CHEM, V263, P11211; Mudd S.H., 1995, METABOLIC MOL BASES, V1, P1279; MUDD SH, 1975, METABOLISM, V24, P721, DOI 10.1016/0026-0495(75)90040-2; MUDD SH, 1962, J BIOL CHEM, V237, P1372; MUDD SH, 1995, AM J HUM GENET, V57, P882; MUDD SH, 1998, METHIONINE METABOLIS, P3; Nagao M, 1997, ACTA PAEDIATR JAPON, V39, P601; SURTEES R, 1991, LANCET, V338, P1550, DOI 10.1016/0140-6736(91)92373-A; UBAGAI T, 1995, J CLIN INVEST, V96, P1943, DOI 10.1172/JCI118240	26	56	61	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					347	355		10.1086/302752	http://dx.doi.org/10.1086/302752			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	10677294	Bronze, Green Published			2022-12-18	WOS:000088373100001
J	Sperandeo, MP; Bassi, MT; Riboni, M; Parenti, G; Buoninconti, A; Manzoni, M; Incerti, B; Larocca, MR; Di Rocco, M; Strisciuglio, P; Dianzani, I; Parini, R; Candito, M; Endo, F; Ballabio, A; Andria, G; Sebastio, G; Borsani, G				Sperandeo, MP; Bassi, MT; Riboni, M; Parenti, G; Buoninconti, A; Manzoni, M; Incerti, B; Larocca, MR; Di Rocco, M; Strisciuglio, P; Dianzani, I; Parini, R; Candito, M; Endo, F; Ballabio, A; Andria, G; Sebastio, G; Borsani, G			Structure of the SLC7A7 gene and mutational analysis of patients affected by lysinuric protein intolerance	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MOLECULAR-BASIS; IDENTIFICATION; DEFICIENCY	Lysinuric protein intolerance (LPI) is a rare autosomal recessive defect of cationic amino acid transport caused by mutations in the SLC7A7 gene. We report the genomic structure of the gene and the results of the mutational analysis in Italian, Tunisian, and Japanese patients. The SLC7A7 gene consists of 10 exons; sequences of all of the exon-intron boundaries are reported here. All of the mutant alleles were characterized and eight novel mutations were detected, including two missense mutations, 242A-->C (M1L) and 1399C-->A (S386R); a nonsense mutation 9G7G-->A (W242X); two splice mutations IVS3 + 1G-->A and IVSG +1G-->T; a single-base insertion, 786insT; and two 4-bp deletions, 455del-CTCT and 1425delTTCT. In addition, a previously reported mutation, 1625insATCA, was found in one patient. It is noteworthy that 242A-->C causes the change of Met(1) to Leu, a rare mutational event previously found in a few inherited conditions. We failed to establish a genotype/phenotype correlation. In fact, both intrafamilial and interfamilial phenotypic variability were observed in homozygotes for the same mutation. The DNA-based tests are now easily accessible for molecular diagnosis, genetic counseling, and prenatal diagnosis of LPI.	Univ Naples Federico II, Dept Pediat, I-80131 Naples, Italy; Telethon Inst Genet & Med, Milan, Italy; Ist Clin Perfezionamento, Clin Pediat 2, Milan, Italy; Univ Vita & Salute, Milan, Italy; Ist Giannina Gaslini, Div Pediat 2, I-16148 Genoa, Italy; Univ Reggio Calabria, Dept Pediat, Catanzaro, Italy; Univ Piemonte Orientale, Dipartimento Sci Med, Novara, Italy; Hop Louis Pasteur, Biochim Lab, F-06002 Nice, France; Kumamoto Univ, Sch Med, Dept Pediat, Kumamoto 860, Japan	University of Naples Federico II; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Vita-Salute San Raffaele University; University of Genoa; IRCCS Istituto Giannina Gaslini; Universita Mediterranea di Reggio Calabria; University of Eastern Piedmont Amedeo Avogadro; CHU Nice; Kumamoto University	Sebastio, G (corresponding author), Univ Naples Federico II, Dept Pediat, Via Sergio Pansini 5, I-80131 Naples, Italy.	sebastio@unina.it; borsani@tigem.it	andria, generoso/V-7172-2019; Borsani, Giuseppe/B-1709-2010; Bassi, Maria Teresa T/A-3517-2014; Parini, Rossella/J-9202-2018; Melis, Daniela/AAD-3623-2019; BALLABIO, Andrea/AAL-2672-2020	Borsani, Giuseppe/0000-0003-0110-1148; Bassi, Maria Teresa T/0000-0002-8236-1197; Parini, Rossella/0000-0003-4505-1306; Melis, Daniela/0000-0002-9458-3926; BALLABIO, Andrea/0000-0003-1381-4604; parenti, giancarlo/0000-0002-6287-5748	Telethon [TGM00S01, TGM06S01, E.0652] Funding Source: Medline	Telethon(Fondazione Telethon)		Antonarakis SE, 1998, HUM MUTAT, V11, P1; BASSI MT, IN PRESS GENOMICS; Beckmann JS, 1996, AM J HUM GENET, V59, P1400; Borsani G, 1999, NAT GENET, V21, P297, DOI 10.1038/6815; CANDITO M, 1994, J INHERIT METAB DIS, V17, P252, DOI 10.1007/BF00711632; Daniele A, 1998, AM J HUM GENET, V62, P562, DOI 10.1086/301746; DIROCCO M, 1993, EUR J PEDIATR, V152, P437, DOI 10.1007/BF01955906; Guzzetta V, 1997, J INHERIT METAB DIS, V20, P619, DOI 10.1023/A:1005315106604; Huang CH, 1999, AM J HUM GENET, V64, P108, DOI 10.1086/302215; INCERTI B, 1993, AM J HUM GENET, V53, P908; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; Lauteala T, 1998, EUR J HUM GENET, V6, P612, DOI 10.1038/sj.ejhg.5200236; NORIO R, 1973, ANN CLIN RES, V5, P109; Palacin M, 1998, PHYSIOL REV, V78, P969, DOI 10.1152/physrev.1998.78.4.969; PARENTI G, 1995, J PEDIATR-US, V126, P246, DOI 10.1016/S0022-3476(95)70552-X; PARINI R, 1991, J INHERIT METAB DIS, V14, P833, DOI 10.1007/BF01799959; Pfeiffer R, 1999, EMBO J, V18, P49, DOI 10.1093/emboj/18.1.49; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; Santamaria F, 1996, AM J RESP CRIT CARE, V153, P731, DOI 10.1164/ajrccm.153.2.8564125; Santamaria R, 1996, J MED GENET, V33, P786, DOI 10.1136/jmg.33.9.786; SEBASTIO G, 1995, AM J HUM GENET, V56, P1324; SIMELL O, 1995, METABOLIC MOL BASES, V3, P3603; SINGER SJ, 1990, ANNU REV CELL BIOL, V6, P247, DOI 10.1146/annurev.cb.06.110190.001335; Sperandeo MP, 1999, PRENATAL DIAG, V19, P771, DOI 10.1002/(SICI)1097-0223(199908)19:8<771::AID-PD612>3.3.CO;2-A; Torrents D, 1998, J BIOL CHEM, V273, P32437, DOI 10.1074/jbc.273.49.32437; Torrents D, 1999, NAT GENET, V21, P293, DOI 10.1038/6809; Zlotogora J, 1996, AM J HUM GENET, V58, P241	27	56	59	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2000	66	1					92	99		10.1086/302700	http://dx.doi.org/10.1086/302700			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279FK	10631139	Green Published, Bronze			2022-12-18	WOS:000085033600010
J	Danan, C; Sternberg, D; Van Steirteghem, A; Cazeneuve, C; Duquesnoy, P; Besmond, C; Goossens, M; Lissens, W; Amselem, S				Danan, C; Sternberg, D; Van Steirteghem, A; Cazeneuve, C; Duquesnoy, P; Besmond, C; Goossens, M; Lissens, W; Amselem, S			Evaluation of parental mitochondrial inheritance in neonates born after intracytoplasmic sperm injection	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MATERNAL INHERITANCE; MALE-INFERTILITY; Y-CHROMOSOME; MULTIPLE DELETIONS; CYSTIC-FIBROSIS; CONTROL REGION; HUMAN OOCYTES; VAS-DEFERENS; DNA; GENE	Intracytoplasmic sperm injection (ICSI) is now used when severe male-factor infertility has been documented. Since defective mitochondrial functions may result in male hypofertility, it is of prime importance to evaluate the risk of paternal transmission of an mtDNA defect to neonates. DNA samples from the blood of 21 infertile couples and their 27 neonates born after ICSI were studied. The highly polymorphic mtDNA D-loop region was analyzed by four PCR-based approaches. With denaturing gradient gel electrophoresis (DGGE), which allows 2% of a minor mtDNA species to be detected, the 27 newborns had a DGGE pattern identical to that of their mother but different from that of their father. Heteroplasmy documented in several parents and children supported an exclusive maternal inheritance of mtDNA. The parental origin of the children's mtDNA molecules also was studied by more-sensitive assays: restriction-endonuclease analysis (REA) of alpha[P-32]-radiolabeled PCR products; paternal-specific PCR assay; and depletion of maternal mtDNA, followed by REA. We did not detect paternal mtDNA in nine neonates, with a sensitivity level of 0.01% in five children, 0.1% in two children, and 1% in two children. The estimated ratio of sperm-to-oocyte mtDNA molecules in humans is 0.1%-1.5%. Thus, we conclude that, in these families, the ICSI procedure performed with mature spermatozoa did not alter the uniparental pattern of inheritance of mtDNA.	Hop Henri Mondor, INSERM U468, Genet Mol Lab, F-94010 Creteil, France; Dutch Speaking Brussels Free Univ, Ctr Reprod Med, Brussels, Belgium	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Vrije Universiteit Brussel	Amselem, S (corresponding author), Hop Henri Mondor, INSERM U468, Genet Mol Lab, 51 Ave Marechal de Lattre de Tassigny, F-94010 Creteil, France.	amselem@im3.inserm.fr	Lissens, Willy/B-2892-2013; BESMOND, Claude/L-8451-2018	Lissens, Willy/0000-0003-3875-9955; BESMOND, Claude/0000-0001-9073-8225; STERNBERG, Damien/0000-0001-7877-7395				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Antinori S, 1997, HUM REPROD, V12, P286, DOI 10.1093/humrep/12.2.286; ATTREE O, 1989, GENOMICS, V4, P266, DOI 10.1016/0888-7543(89)90330-3; Barak Y, 1998, FERTIL STERIL, V70, P67, DOI 10.1016/S0015-0282(98)00106-X; BENDALL KE, 1995, AM J HUM GENET, V57, P248; BIRKY CW, 1995, P NATL ACAD SCI USA, V92, P11331, DOI 10.1073/pnas.92.25.11331; BIRKY CW, 1983, SCIENCE, V222, P468, DOI 10.1126/science.6353578; Blendy JA, 1996, NATURE, V380, P162, DOI 10.1038/380162a0; CHANDLEY AC, 1994, HUM MOL GENET, V3, P1449, DOI 10.1093/hmg/3.suppl_1.1449; CHEN X, 1995, AM J HUM GENET, V57, P239; CHILLON M, 1995, NEW ENGL J MED, V332, P1475, DOI 10.1056/NEJM199506013322204; COMAS D, 1995, GENOME RES, V5, P89, DOI 10.1101/gr.5.1.89; COSTES B, 1995, EUR J HUM GENET, V3, P285; CUMMINS JM, 1994, MOL REPROD DEV, V37, P345, DOI 10.1002/mrd.1080370314; FISHEL S, 1995, LANCET, V345, P1641, DOI 10.1016/S0140-6736(95)90149-3; FOLGERO T, 1993, HUM REPROD, V8, P1863, DOI 10.1093/oxfordjournals.humrep.a137950; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; GYLLENSTEN U, 1985, J HERED, V76, P321, DOI 10.1093/oxfordjournals.jhered.a110103; GYLLENSTEN U, 1991, NATURE, V352, P255, DOI 10.1038/352255a0; HAUSWIRTH WW, 1985, NUCLEIC ACIDS RES, V13, P8093, DOI 10.1093/nar/13.22.8093; HIRAOKA J, 1988, GAMETE RES, V19, P369, DOI 10.1002/mrd.1120190408; Houshmand M, 1997, J ASSIST REPROD GEN, V14, P223, DOI 10.1007/BF02766114; HUANG MM, 1992, NUCLEIC ACIDS RES, V20, P4567, DOI 10.1093/nar/20.17.4567; HUTCHINSON SA, 1974, NATURE, V251, P536; John JCS, 1997, NAT MED, V3, P124, DOI 10.1038/nm0297-124c; KANEDA H, 1995, P NATL ACAD SCI USA, V92, P4542, DOI 10.1073/pnas.92.10.4542; Kao SH, 1998, MOL HUM REPROD, V4, P657, DOI 10.1093/molehr/4.7.657; KAO SH, 1995, BIOL REPROD, V52, P729, DOI 10.1095/biolreprod52.4.729; Kaukonen JA, 1996, AM J HUM GENET, V58, P763; LERMAN LS, 1987, METHOD ENZYMOL, V155, P482; Lestienne P, 1997, MOL HUM REPROD, V3, P811, DOI 10.1093/molehr/3.9.811; Lissens W, 1997, BAILLIERE CLIN OB GY, V11, P797, DOI 10.1016/S0950-3552(97)80014-4; LUFT R, 1994, P NATL ACAD SCI USA, V91, P8731, DOI 10.1073/pnas.91.19.8731; MA K, 1993, CELL, V75, P1287, DOI 10.1016/0092-8674(93)90616-X; Manfredi G, 1997, AM J HUM GENET, V61, P953, DOI 10.1086/514887; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Reijo R, 1996, LANCET, V347, P1290, DOI 10.1016/S0140-6736(96)90938-1; Shitara H, 1998, GENETICS, V148, P851; SMITH LC, 1993, J REPROD FERTIL, P31; Sternberg D, 1998, HUM MOL GENET, V7, P33, DOI 10.1093/hmg/7.1.33; SZOLLOSI D, 1965, J EXP ZOOL, V159, P367, DOI 10.1002/jez.1401590309; Tapanainen JS, 1997, NAT GENET, V15, P205, DOI 10.1038/ng0297-205; Tesarik J, 1996, HUM REPROD, V11, P772; TESARIK JN, 1995, NEW ENGL J MED, V333, P525, DOI 10.1056/NEJM199508243330819; TORRONI A, 1994, AM J HUM GENET, V55, P760; Van Steirteghem A, 1998, HUM REPROD, V13, P134, DOI 10.1093/humrep/13.suppl_1.134; VANSTEIRTEGHEM A, 1995, HUM REPROD, V10, P2527, DOI 10.1093/oxfordjournals.humrep.a135737; VANSTEIRTEGHEM AC, 1993, HUM REPROD, V8, P1061, DOI 10.1093/oxfordjournals.humrep.a138192; Veld PAI, 1997, LANCET, V350, P490, DOI 10.1016/S0140-6736(05)63078-4; Vogt PH, 1998, MOL HUM REPROD, V4, P739, DOI 10.1093/molehr/4.8.739; WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739; Zeviani M, 1998, MEDICINE, V77, P59, DOI 10.1097/00005792-199801000-00006	53	56	62	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1999	65	2					463	473		10.1086/302484	http://dx.doi.org/10.1086/302484			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	223JA	10417289	Green Published, Bronze			2022-12-18	WOS:000081836900022
J	Gibbs, M; Chakrabarti, L; Stanford, JL; Goode, EL; Kolb, S; Schuster, EF; Buckley, VA; Shook, M; Hood, L; Jarvik, GP; Ostrander, EA				Gibbs, M; Chakrabarti, L; Stanford, JL; Goode, EL; Kolb, S; Schuster, EF; Buckley, VA; Shook, M; Hood, L; Jarvik, GP; Ostrander, EA			Analysis of chromosome 1q42.2-43 in 152 families with high risk of prostate cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ANDROGEN RECEPTOR GENE; VITAMIN-D-RECEPTOR; SUSCEPTIBILITY LOCUS; LINKAGE ANALYSIS; DOMINANT INHERITANCE; 1Q; HETEROGENEITY; ASSOCIATION; MARKERS; SUPPORT	One hundred fifty-two families with prostate cancer were analyzed for linkage to markers spanning a 20-cM region of 1q42.2-43, the location of a putative prostate cancer-susceptibility locus (PCAP). No significant evidence for linkage was found, by use of both parametric and nonparametric tests, in our total data set, which included 522 genotyped affected men. Rejection of linkage may reflect locus heterogeneity or the confounding effects of sporadic disease in older-onset cases; therefore, pedigrees were stratified into homogeneous subsets based on mean age at diagnosis of prostate cancer and number of affected men. Analyses of these subsets also detected no significant evidence for linkage, although LOD scores were positive at higher recombination fractions, which is consistent with the presence of a small proportion of families with linkage. The most suggestive evidence of linkage was in families with at least five affected men (nonparametric linkage score of 1.2; P = .1). If heterogeneity is assumed, an estimated 4%-9% of these 152 families may show linkage in this region. We conclude that the putative PCAP locus does not account for a large proportion of these families with prostate cancer, although the linkage of a small subset is compatible with these data.	Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; Univ Washington, Sch Publ Hlth & Community Med, Dept Mol Biotechnol, Seattle, WA 98195 USA; Univ Washington, Sch Publ Hlth & Community Med, Dept Epidemiol, Seattle, WA 98195 USA; Univ Washington, Med Ctr, Dept Med, Div Med Genet, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Ostrander, EA (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, D2-190,1100 Fairview Ave N,POB 19024, Seattle, WA 98109 USA.		Jarvik, Gail P/N-6476-2014; Chakrabarti, Lisa/G-4236-2011	Jarvik, Gail P/0000-0002-6710-8708; Ostrander, Elaine/0000-0001-6075-9738; Kolb, Suzanne/0000-0002-6443-644X; Chakrabarti, Lisa/0000-0001-7213-6837	NATIONAL CANCER INSTITUTE [T32CA009168, R01CA056678] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA56678, 5T32CA09168] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Berthon P, 1998, AM J HUM GENET, V62, P1416, DOI 10.1086/301879; Cairns P, 1997, CANCER RES, V57, P4997; CARTER BS, 1992, P NATL ACAD SCI USA, V89, P3367, DOI 10.1073/pnas.89.8.3367; Cooney KA, 1997, J NATL CANCER I, V89, P955, DOI 10.1093/jnci/89.13.955; Eeles RA, 1998, AM J HUM GENET, V62, P653, DOI 10.1086/301745; Feilotter HE, 1998, ONCOGENE, V16, P1743, DOI 10.1038/sj.onc.1200205; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Gibbs M, 1999, AM J HUM GENET, V64, P776, DOI 10.1086/302287; Giovannucci E, 1997, P NATL ACAD SCI USA, V94, P3320, DOI 10.1073/pnas.94.7.3320; Gronberg H, 1997, CANCER RES, V57, P4707; GRONBERG H, 1994, J UROLOGY, V152, P1484, DOI 10.1016/S0022-5347(17)32452-7; Gronberg H, 1997, AM J EPIDEMIOL, V146, P552, DOI 10.1093/oxfordjournals.aje.a009313; Hsieh CL, 1997, J NATL CANCER I, V89, P1893, DOI 10.1093/jnci/89.24.1893; Ingles SA, 1997, J NATL CANCER I, V89, P166, DOI 10.1093/jnci/89.2.166; IRVINE RA, 1995, CANCER RES, V55, P1937; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Landis SH, 1998, CA-CANCER J CLIN, V48, P6, DOI 10.3322/canjclin.48.1.6; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; McIndoe RA, 1997, AM J HUM GENET, V61, P347, DOI 10.1086/514853; MONROE KR, 1995, NAT MED, V1, P827, DOI 10.1038/nm0895-827; NAROD S, 1995, AM J HUM GENET, V57, P957; ROSS RK, 1987, JNCI-J NATL CANCER I, V78, P869; Schaid DJ, 1998, AM J HUM GENET, V62, P1425, DOI 10.1086/301862; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; Stanford JL, 1997, CANCER RES, V57, P1194; STANFORD JL, IN PRSS PROSTATE CAN; STEINBERG GD, 1990, PROSTATE, V17, P337, DOI 10.1002/pros.2990170409; Taylor JA, 1996, CANCER RES, V56, P4108; TERWILLIGER J, 1996, ANALYZE COMPUTER SOF; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; WHITTEMORE AS, 1995, AM J EPIDEMIOL, V141, P732, DOI 10.1093/oxfordjournals.aje.a117495; Xu JF, 1998, NAT GENET, V20, P175, DOI 10.1038/2477	32	56	58	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1999	64	4					1087	1095		10.1086/302342	http://dx.doi.org/10.1086/302342			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184UV	10090894	Bronze, Green Published			2022-12-18	WOS:000079632900020
J	Lalioti, MD; Scott, HS; Genton, P; Grid, D; Ouazzani, R; M'Rabet, A; Ibrahim, S; Gouider, R; Dravet, C; Chkili, T; Bottani, A; Buresi, C; Malafosse, A; Antonarakis, SE				Lalioti, MD; Scott, HS; Genton, P; Grid, D; Ouazzani, R; M'Rabet, A; Ibrahim, S; Gouider, R; Dravet, C; Chkili, T; Bottani, A; Buresi, C; Malafosse, A; Antonarakis, SE			A PCR amplification method reveals instability of the dodecamer repeat in progressive myoclonus epilepsy (EPM1) and no correlation between the size of the repeat and age at onset	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-DISEASE; POLYMERASE; MUTATIONS	Progressive myoclonus epilepsy of the Unverricht-Lundborg type (EPM1) is a rare, autosomal recessive disorder characterized by onset at age 6-16 years, generalized seizures, incapacitating myoclonus, and variable progression to cerebellar ataxia. The gene that causes EPM1, cystatin B, encodes a cysteine proteinase inhibitor. Only a minority of EPM1 patients carry a point mutation within the transcription unit. The majority of EPM1 alleles contain large expansions of a dodecamer repeat, CCC CGC CCC GCG, located upstream of the 5' transcription start site of the cystatin B gene; normal alleles contain two or three copies of this repeat. All EPM1 alleles with an expansion were resistant to standard PCR amplification. To precisely determine the size of the repeat in affected individuals, we developed a detection protocol involving PCR amplification and subsequent hybridization with an oligonucleotide containing the repeat. The largest detected expansion was similar to 75 copies; the smallest was similar to 30 copies. We identified affected siblings with repeat expansions, of different sizes, on the same haplotype, which confirms the repeat's instability during transmissions. Expansions were observed directly; contractions were deduced by comparison of allele sizes within a family. In a sample of 28 patients, we found no correlation between age at onset of EPM1 and the size of the expanded dodecamer. This suggests that once the dodecamer repeat expands beyond a critical threshold, cystatin B expression is reduced in certain cells, with pathological consequences.	Univ Geneva, Sch Med, Dept Genet & Microbiol, Lab Human Mol Genet, Geneve, Switzerland; Univ Geneva, Sch Med, Hosp Belle Idee, Div Neuropsychiat, Geneve, Switzerland; Cantonal Hosp Geneva, Div Med Genet, Geneva, Switzerland; Hop Specialites, Serv Neurol, Rabat, Morocco; EPS Charles Nicolle, Serv Neurol, Tunis, Tunisia; Ctr St Paul, Marseille, France; Hop Mustapha, Serv Neurol, Algiers, Algeria	University of Geneva; University of Geneva; University of Geneva; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Universite de Tunis-El-Manar; Hopital Charles Nicolle	Antonarakis, SE (corresponding author), CMU, Med Genet, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.		Scott, Hamish/B-2122-2009; Gouider, Riadh/AAX-2634-2020; Antonarakis, Stylianos E/N-8866-2014	Scott, Hamish/0000-0002-5813-631X; Gouider, Riadh/0000-0001-9615-3797; Antonarakis, Stylianos E/0000-0001-8907-5823				Ashley CT, 1995, ANNU REV GENET, V29, P703, DOI 10.1146/annurev.ge.29.120195.003415; BROWN WT, 1993, JAMA-J AM MED ASSOC, V270, P1569, DOI 10.1001/jama.270.13.1569; CHONG SS, 1994, AM J MED GENET, V51, P522, DOI 10.1002/ajmg.1320510447; Filla A, 1996, AM J HUM GENET, V59, P554; Lafreniere RG, 1997, NAT GENET, V15, P298, DOI 10.1038/ng0397-298; Lalioti MD, 1997, AM J HUM GENET, V60, P342; Lalioti MD, 1997, NATURE, V386, P847, DOI 10.1038/386847a0; Lalioti MD, 1997, NAT GENET, V17, P17, DOI 10.1038/ng0997-17; Lamont PJ, 1997, BRAIN, V120, P673, DOI 10.1093/brain/120.4.673; LEVINSON G, 1994, AM J MED GENET, V51, P527, DOI 10.1002/ajmg.1320510448; MALAFOSSE A, 1992, LANCET, V339, P1080, DOI 10.1016/0140-6736(92)90667-R; Monros E, 1997, AM J HUM GENET, V61, P101, DOI 10.1086/513887; Montermini L, 1997, ANN NEUROL, V41, P675, DOI 10.1002/ana.410410518; Paulson HL, 1996, ANNU REV NEUROSCI, V19, P79; Pennacchio LA, 1996, SCIENCE, V271, P1731, DOI 10.1126/science.271.5256.1731; RICHARDS RI, 1992, CELL, V70, P709, DOI 10.1016/0092-8674(92)90302-S; TURK V, 1991, FEBS LETT, V285, P213, DOI 10.1016/0014-5793(91)80804-C; Virtaneva K, 1997, NAT GENET, V15, P393, DOI 10.1038/ng0497-393	18	56	57	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1998	62	4					842	847		10.1086/301798	http://dx.doi.org/10.1086/301798			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZM197	9529356	Green Published, Bronze			2022-12-18	WOS:000073514400015
J	Brzustowicz, LM; Honer, WG; Chow, EWC; Hogan, J; Hodgkinson, K; Bassett, AS				Brzustowicz, LM; Honer, WG; Chow, EWC; Hogan, J; Hodgkinson, K; Bassett, AS			Use of a quantitative trait to map a locus associated with severity of positive symptoms in familial schizophrenia to chromosome 6p	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEGATIVE SYMPTOMS; LINKAGE ANALYSIS; COMPLEX TRAITS; SUSCEPTIBILITY; PHENOTYPES; STABILITY; GENETICS; ILLNESS; 6P24-22; FUTURE	A number of recent linkage studies have suggested the presence of a schizophrenia susceptibility locus on chromosome 6p. We evaluated 28 genetic markers, spanning chromosome 6; for linkage to schizophrenia in 10 moderately large Canadian families of Celtic ancestry. Parametric analyses of these families under autosomal dominant and recessive models, using broad and narrow definitions of schizophrenia, produced no significant evidence for linkage. A sib-pair analysis using categorical disease definitions also failed to produce significant evidence for linkage. We then conducted a separate sib-pair analysis using scores on positive-symptom (psychotic), negative-symptom (deficit), and general psychopathology-symptom scales as quantitative traits. With the positive symptom-scale scores, the marker D6S1960 produced P = 1.2 x 10(-5) under two-point and P = 5.4 x 10(-6) under multipoint analyses. Using simulation studies, we determined that these nominal P values correspond to empirical P values of .034 and .0085, respectively. These results suggest that a schizophrenia susceptibility locus on chromosome 6p may be related to the severity of psychotic symptoms. Assessment of behavioral quantitative traits may provide increased power over categorical phenotype assignment for detection of linkage in complex psychiatric disorders.	Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Psychiat, Newark, NJ 07103 USA; Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; Queen St Mental Ctr, Schizophrenia Res Program, Toronto, ON, Canada; Univ Toronto, Dept Psychiat, Toronto, ON, Canada	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of British Columbia; University of Toronto	Brzustowicz, LM (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, 197 Univ Ave, Newark, NJ 07102 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH001392] Funding Source: NIH RePORTER; NIMH NIH HHS [K08 MH01392] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDREASEN NC, 1994, ACTA PSYCHIAT SCAND, V90, P51, DOI 10.1111/j.1600-0447.1994.tb05891.x; ANTONARAKIS SE, 1995, NAT GENET, V11, P235, DOI 10.1038/ng1195-235; ARNDT S, 1995, ARCH GEN PSYCHIAT, V52, P352; BASSETT AS, 1993, SCHIZOPHR RES, V11, P9, DOI 10.1016/0920-9964(93)90033-F; BASSETT AS, 1994, AM J HUM GENET, V54, P864; DWORKIN RH, 1991, AM J PSYCHIAT, V148, P1182; EATON WW, 1995, ARCH GEN PSYCHIAT, V52, P127; FARAONE SV, 1995, AM J PSYCHIAT, V152, P1286; FARMER AE, 1994, AM J MED GENET, V54, P365, DOI 10.1002/ajmg.1320540416; GURLING H, 1995, NAT GENET, V11, P234, DOI 10.1038/ng1195-234; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; KENDLER KS, 1993, SCHIZOPHRENIA BULL, V19, P261, DOI 10.1093/schbul/19.2.261; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; MALLA AK, 1993, CAN J PSYCHIAT, V38, P617, DOI 10.1177/070674379303800910; MATTHYSSE S, 1992, J PSYCHIAT RES, V26, P461, DOI 10.1016/0022-3956(92)90046-Q; MCGUFFIN P, 1994, BRIT J PSYCHIAT, V164, P593, DOI 10.1192/bjp.164.5.593; MCGUFFIN P, 1991, NEGATIVE VERSUS POSI, P250; MOISES HW, 1995, NAT GENET, V11, P321, DOI 10.1038/ng1195-321; MOWRY BJ, 1995, NAT GENET, V11, P233, DOI 10.1038/ng1195-233; REY ER, 1994, ACTA PSYCHIAT SCAND, V90, P405, DOI 10.1111/j.1600-0447.1994.tb01615.x; RISCH N, 1990, AM J HUM GENET, V46, P229; RUTTER M, 1994, AM J MED GENET, V54, P185, DOI 10.1002/ajmg.1320540305; SCHWAB SG, 1995, NAT GENET, V11, P325, DOI 10.1038/ng1195-325; Shields J, 1982, SCHIZOPHRENIA EPIGEN; STRAUB RE, 1995, NAT GENET, V11, P287, DOI 10.1038/ng1195-287; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; TRAN LD, 1995, SIBPAIR LINKAGE PROG; Tsuang M.T., 1991, NEGATIVE VERSUS POSI, P265; TSUANG MT, 1993, BRIT J PSYCHIAT, V163, P299, DOI 10.1192/bjp.163.3.299; WANG SB, 1995, NAT GENET, V10, P41, DOI 10.1038/ng0595-41; Wang SB, 1996, AM J HUM GENET, V59, P731; YOUNG A, 1995, GAS 2 0 ANAL MODULES	33	56	61	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1997	61	6					1388	1396		10.1086/301623	http://dx.doi.org/10.1086/301623			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	YT019	9399881	Green Published, Bronze			2022-12-18	WOS:000071555900023
J	David, G; Abbas, N; Coullin, P; Stevanin, G; Horta, W; Gemmill, R; Weissenbach, J; Wood, N; Cunha, S; Drabkin, H; Harding, AE; Agid, Y; Brice, A				David, G; Abbas, N; Coullin, P; Stevanin, G; Horta, W; Gemmill, R; Weissenbach, J; Wood, N; Cunha, S; Drabkin, H; Harding, AE; Agid, Y; Brice, A			The gene for autosomal dominant cerebellar ataxia type II is located in a 5-cM region in 3p12-p13: Genetic and physical mapping of the SCA7 locus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PIGMENTARY MACULAR DYSTROPHY; RETINAL DEGENERATION; CHROMOSOME 3P12-P21.1; LINKAGE ANALYSIS; CAG REPEAT; EXPANSION; TRINUCLEOTIDE; ATROPHY; FAMILIES; DISEASE	Two families with autosomal dominant cerebellar ataxia with pigmentary macular dystrophy (ADCA typo II) were investigated. analysis of 23 parent-child couples demonstrated the existence of marked anticipation, greater in paternal Than in maternal transmissions, with earlier age at onset and a more rapid clinical course in successive generations. Clinical analysis revealed the presence of a great variability in age at onset, initial symptom, and associated signs, confirming the characteristic clinical heterogeneity of ADCA type II. The gene for ADCA type II previously was mapped to the spinocerebellar ataxia 7 (SCA7) locus on chromosome 3p12-p21.1. Linkage analysis of the two new families of different geographic origin confirmed the characteristic genetic homogeneity of ADCA type III distinguishing it from ADCA type I. Haplotype analysis permitted refinement of the SCA7 region to the 5-cM interval bet seen markers D3S1312 and D3S1600 on chromosome 3p12-p13. Eighteen sequence-tagged sites were used for the construction of an integrated map of the candidate region, based on a YACs contig. The entire candidate region is contained in a single non-chimeric YAC of 660 kb. The probable involvement of a CAG trinucleotide expansion, suggested by previous studies, should greatly facilitate the identification of the gene for ADCA type II.	HOP LA PITIE SALPETRIERE, INSERM, U289, F-75651 PARIS 13, FRANCE; INST NEUROL, LONDON WC1N 3BG, ENGLAND; HOP PAUL BROUSSE, INSERM, U178, VILLEJUIF, FRANCE; FED UNIV CEARA, HOSP UNIV WALTER CANDIDO, FORTALEZA, CEARA, BRAZIL; UNIV COLORADO, HLTH SCI CTR, DENVER, CO USA; GENETHON, CNRS, URA 1922, EVRY, FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universidade Federal do Ceara; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Centre National de la Recherche Scientifique (CNRS)			brice, alexis/AAE-8275-2019; Brice, Alexis/A-2170-2009; Wood, Nicholas W/C-2505-2009; Stevanin, Giovanni/E-5038-2016	brice, alexis/0000-0002-0941-3990; Wood, Nicholas W/0000-0002-9500-3348; Stevanin, Giovanni/0000-0001-9368-8657	NHGRI NIH HHS [R01 HG000358] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000358] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AMASINO RM, 1986, ANAL BIOCHEM, V152, P304, DOI 10.1016/0003-2697(86)90413-6; BENOMAR A, 1994, ANN NEUROL, V35, P439, DOI 10.1002/ana.410350411; BENOMAR A, 1995, NAT GENET, V10, P84, DOI 10.1038/ng0595-84; CHOU Q, 1992, NUCLEIC ACIDS RES, V20, P1717, DOI 10.1093/nar/20.7.1717; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DURR A, 1993, BRAIN, V116, P1497, DOI 10.1093/brain/116.6.1497; ENEVOLDSON TP, 1994, BRAIN, V117, P445, DOI 10.1093/brain/117.3.445; GEMMILL RM, 1995, NATURE, V377, P299; GOGUEL AF, IN PRESS ANN GENET; GOUW LG, 1995, NAT GENET, V10, P89, DOI 10.1038/ng0595-89; GOUW LG, 1994, NEUROLOGY, V44, P1441, DOI 10.1212/WNL.44.8.1441; HARDING AE, 1993, ADV NEUROL, V61, P1; HARDING AE, 1982, BRAIN, V105, P1, DOI 10.1093/brain/105.1.1; Harper PS, 1991, HUNTINGTONS DIS, P281; HOLMBERG M, 1995, HUM MOL GENET, V4, P1441, DOI 10.1093/hmg/4.8.1441; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KONIGSMARK BW, 1970, MEDICINE, V49, P227, DOI 10.1097/00005792-197005000-00003; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LINDBLAD K, IN PRESS GENOME RES; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MARTIN JJ, 1994, ACTA NEUROPATHOL, V88, P277; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Ott J., 1991, ANAL HUMAN GENETIC L; ROSENBERG RN, 1995, NEUROLOGY, V45, P1; ROSIER MF, 1994, GENOMICS, V24, P69, DOI 10.1006/geno.1994.1583; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SCHALLING M, 1993, NAT GENET, V4, P135, DOI 10.1038/ng0693-135; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0	33	56	58	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1996	59	6					1328	1336						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV315	8940279				2022-12-18	WOS:A1996VV31500020
J	Kato, MV; Shimizu, T; Nagayoshi, M; Kaneko, A; Sasaki, MS; Ikawa, Y				Kato, MV; Shimizu, T; Nagayoshi, M; Kaneko, A; Sasaki, MS; Ikawa, Y			Genomic imprinting of the human serotonin-receptor (HTR2) gene involved in development of retinoblastoma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MOUSE CHROMOSOME-14; HEREDITARY RETINOBLASTOMA; PARENTAL ORIGIN; OSTEO-SARCOMA; DNA; MUTATIONS; HETEROZYGOSITY; POLYMORPHISMS; SEQUENCE; TRANSCRIPTION	Epidemiological and genetic studies of retinoblastoma (RB) suggested that imprinted genes might be genetically linked to the RB gene. In this study, we found that the human serotonin-receptor, HTR2, gene, which had been mapped nearby the RB gene on chromosome 13, was expressed only in human fibroblasts with a maternal allele and not in cells without a maternal allele. The 5' genomic region of the human HTR2 gene was cloned by PCR-mediated method. Only the 5' region of the gene was methylated in cells with the maternal gene, and it was not methylated in cells without the maternal gene. A polymorphism of PvuII site of the gene was also found and useful for the segregation analysis in a family of a RB patient and for analysis of loss of heterozygosity on chromosome 13 in tumor and its parental origin. These results suggest that the human HTR2 gene might be affected by genomic imprinting and that exclusive expression of the maternal HTR2 gene may be associated with the delayed occurrence of RB, which had lost the maternal chromosome 13.	KYOTO UNIV,CTR RADIAT BIOL,KYOTO,JAPAN; NATL CANC CTR,DEPT OPHTHALMOL,TOKYO,JAPAN; TOKYO MED & DENT UNIV,DIV MED RES,DEPT RETROVIRAL REGULAT,TOKYO 113,JAPAN	Kyoto University; National Cancer Center - Japan; Tokyo Medical & Dental University (TMDU)	Kato, MV (corresponding author), INST PHYS & CHEM RES,TSUKUBA LIFE SCI CTR,ONCOL MOL LAB,3-1-1 KOYADAI,TSUKUBA,IBARAKI 305,JAPAN.		Kato, Mitsuo/D-5411-2009	Kato, Mitsuo/0000-0002-1783-1084				BANERJEE S, 1995, NAT GENET, V11, P237, DOI 10.1038/ng1195-237; BARLOW DP, 1995, SCIENCE, V270, P1610, DOI 10.1126/science.270.5242.1610; BOWCOCK A, 1993, CYTOGENET CELL GENET, V62, P89, DOI 10.1159/000133450; CATTANACH BM, 1990, DEVELOPMENT, P63; CAVENEE W, 1984, AM J HUM GENET, V36, P10; DEJONG R, 1993, NUCLEIC ACIDS RES, V21, P4711, DOI 10.1093/nar/21.20.4711; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; DRYJA TP, 1984, HUM GENET, V65, P320, DOI 10.1007/BF00291555; DRYJA TP, 1989, NATURE, V339, P556, DOI 10.1038/339556a0; DUNN JM, 1989, MOL CELL BIOL, V9, P4596, DOI 10.1128/MCB.9.11.4596; EJIMA Y, 1988, HUM GENET, V79, P118, DOI 10.1007/BF00280548; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FUNG YKT, 1987, SCIENCE, V236, P1657, DOI 10.1126/science.2885916; HARRISON DJ, 1995, ONCOGENE, V10, P1615; HSIEH CL, 1990, SOMAT CELL MOLEC GEN, V16, P567, DOI 10.1007/BF01233097; JULIUS D, 1990, P NATL ACAD SCI USA, V87, P928, DOI 10.1073/pnas.87.3.928; KATO MV, 1994, HUM GENET, V94, P31, DOI 10.1007/BF02272838; KATO MV, 1995, INT J CANCER, V64, P3, DOI 10.1002/ijc.2910640103; KATO MV, 1994, HUM MUTAT, V3, P44, DOI 10.1002/humu.1380030108; KATO MV, 1993, INT J CANCER, V54, P922, DOI 10.1002/ijc.2910540609; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; LIU J, 1991, GENOMICS, V11, P231, DOI 10.1016/0888-7543(91)90127-Z; NAKAMURA Y, 1988, AM J HUM GENET, V43, P854; NAUMOVA A, 1994, AM J HUM GENET, V54, P264; SEKIDO R, 1994, MOL CELL BIOL, V14, P5692, DOI 10.1128/MCB.14.9.5692; SIEBERT PD, 1995, NUCLEIC ACIDS RES, V23, P1087, DOI 10.1093/nar/23.6.1087; SPARKES RS, 1991, GENOMICS, V9, P461, DOI 10.1016/0888-7543(91)90411-7; STANOJEVIC D, 1989, NATURE, V341, P331, DOI 10.1038/341331a0; TOGUCHIDA J, 1989, NATURE, V338, P156, DOI 10.1038/338156a0; VOGEL F, 1975, ADV HUM GENET, V5, P223; WIGGS J, 1988, NEW ENGL J MED, V318, P151, DOI 10.1056/NEJM198801213180305; YANDELL DW, 1989, AM J HUM GENET, V45, P547; ZHU X, 1992, CYTOGENET CELL GENET, V59, P248, DOI 10.1159/000133261	33	56	57	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1996	59	5					1084	1090						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN900	8900237				2022-12-18	WOS:A1996VN90000016
J	AlMaghtheh, M; Vithana, E; Tarttelin, E; Jay, M; Evans, K; Moore, T; Bhattacharya, S; Inglehearn, CF				AlMaghtheh, M; Vithana, E; Tarttelin, E; Jay, M; Evans, K; Moore, T; Bhattacharya, S; Inglehearn, CF			Evidence for a major retinitis pigmentosa locus on 19q13.4 (RP11), and association with a unique bimodal expressivity phenotype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOME 19Q; LINKAGE ANALYSIS; GENETIC-LINKAGE; ONE FORM; MUTATIONS; LESS	Retinitis pigmentosa (RP) is the name given to a heterogeneous group of retinal degenerations mapping to at least 16 loci. The autosomal dominant form (adRP), accounting for similar to 25% of cases, can be caused by mutations in two genes, rhodopsin and peripherin/RDS, and by at least six other loci identified by linkage analysis. The RP11 locus for adRP has previously been mapped to chromosome 19q13.4 in a large English family. This linkage has been independently confirmed in a Japanese family, and we now report three additional unrelated linked U.K. families, suggesting that this is a major locus for RP. Linkage analysis in the U.K. families refines the RP11 interval to 5 cM between markers D19S180 and AFMc001yb1. All linked families exhibit incomplete penetrance; some obligate gene carriers remain asymptomatic throughout their lives, whereas symptomatic individuals experience night blindness and visual field loss in their teens and are generally registered as blind by their 30s. This ''bimodal expressivity'' contrasts with the variable-expressivity RP mapping to chromosome 7p (RP9) in another family, which has implications for diagnosis and counseling of RP11 families. These results may also imply that a proportion of sporadic RP, previously assumed to be recessive, might result from mutations at this locus.	INST OPHTHALMOL,DEPT MOL GENET,LONDON EC1V 9EL,ENGLAND; MOORFIELDS EYE HOSP,DEPT CLIN OPHTHALMOL,LONDON EC1V 2PD,ENGLAND	University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust			Gregory-Evans, Kevin/G-9551-2011		Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALMAGHTHEH M, 1994, HUM MOL GENET, V3, P351, DOI 10.1093/hmg/3.2.351; ATTWOOD J, 1988, ANN HUM GENET, V52, P259, DOI 10.1111/j.1469-1809.1988.tb01103.x; BARDIEN S, 1995, HUM MOL GENET, V4, P1459, DOI 10.1093/hmg/4.8.1459; BLANTON SH, 1991, GENOMICS, V11, P857, DOI 10.1016/0888-7543(91)90008-3; BOUGHMAN JA, 1980, AM J HUM GENET, V32, P223; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; EVANS K, 1994, NAT GENET, V6, P210, DOI 10.1038/ng0294-210; EVANS K, 1995, BRIT J OPHTHALMOL, V79, P841, DOI 10.1136/bjo.79.9.841; FARRAR GJ, 1991, NATURE, V354, P478, DOI 10.1038/354478a0; GREENBERG J, 1994, HUM MOL GENET, V3, P915, DOI 10.1093/hmg/3.6.915; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; INGLEHEARN CF, 1993, NAT GENET, V4, P51, DOI 10.1038/ng0593-51; Inglehearn CF, 1996, AM J HUM GENET, V58, P433; JAY M, 1982, BIRTH DEFECTS-ORIG, V18, P167; JORDAN SA, 1993, NAT GENET, V4, P54, DOI 10.1038/ng0593-54; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; KAJIWARA K, 1991, NATURE, V354, P480, DOI 10.1038/354480a0; KIM RY, 1995, BRIT J OPHTHALMOL, V79, P23, DOI 10.1136/bjo.79.1.23; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LYNESS AL, 1985, BRIT J OPHTHALMOL, V69, P326, DOI 10.1136/bjo.69.5.326; McKusick V.A., 1992, MENDELIAN INHERITANC; MOORE AT, 1993, BRIT J OPHTHALMOL, V77, P473, DOI 10.1136/bjo.77.8.473; ROSS CA, 1995, NEURON, V15, P493, DOI 10.1016/0896-6273(95)90138-8; RYSAVY FR, 1992, COMPUT APPL BIOSCI, V8, P149; XU SY, 1995, J MED GENET, V32, P915, DOI 10.1136/jmg.32.11.915	27	56	59	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1996	59	4					864	871						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL283	8808602				2022-12-18	WOS:A1996VL28300016
J	Langston, AA; Stanford, JL; Wicklund, KG; Thompson, JD; Blazej, RG; Ostrander, EA				Langston, AA; Stanford, JL; Wicklund, KG; Thompson, JD; Blazej, RG; Ostrander, EA			Germ-line BRCA1 mutations in selected men with prostate cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							FAMILIAL BREAST-CANCER; RELATIVES; LINKAGE; OVARIAN; RISKS		FRED HUTCHINSON CANC RES CTR,DIV CLIN RES,SEATTLE,WA 98104; FRED HUTCHINSON CANC RES CTR,DIV PUBL HLTH SCI,SEATTLE,WA 98104	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center				Ostrander, Elaine/0000-0001-6075-9738	NCI NIH HHS [R01 CA56678] Funding Source: Medline; NICHD NIH HHS [K11 HD00936] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K11HD000936] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA056678] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSON DE, 1992, J NATL CANCER I, V84, P1114, DOI 10.1093/jnci/84.14.1114; ANDERSON DE, 1993, CANCER, V72, P114, DOI 10.1002/1097-0142(19930701)72:1<114::AID-CNCR2820720122>3.0.CO;2-0; ARASON A, 1993, AM J HUM GENET, V52, P711; CARTER BS, 1992, P NATL ACAD SCI USA, V89, P3367, DOI 10.1073/pnas.89.8.3367; EASTON DF, 1995, AM J HUM GENET, V56, P265; FORD D, 1995, AM J HUM GENET, V57, P1457; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; FRIEDMAN LS, 1995, THESIS U CALIFORNIA; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HARLOW BL, 1988, AM J EPIDEMIOL, V127, P857, DOI 10.1093/oxfordjournals.aje.a114869; ISAACS SD, 1995, J NATL CANCER I, V87, P991, DOI 10.1093/jnci/87.13.991; Langston AA, 1996, NEW ENGL J MED, V334, P137, DOI 10.1056/NEJM199601183340301; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; SELLERS TA, 1994, J NATL CANCER I, V86, P1860, DOI 10.1093/jnci/86.24.1860; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; SIMARD J, 1994, NAT GENET, V8, P392, DOI 10.1038/ng1294-392; STRUEWING JP, 1995, AM J HUM GENET, V57, P1; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; TAKAHASHI H, 1995, CANCER RES, V55, P2998; THIESSEN EU, 1974, CANCER, V34, P1102, DOI 10.1002/1097-0142(197410)34:4<1102::AID-CNCR2820340421>3.0.CO;2-5; TONIN P, 1995, AM J HUM GENET, V57, P189; TULINIUS H, 1992, BRIT MED J, V305, P855, DOI 10.1136/bmj.305.6858.855; WAKSBERG J, 1978, J AM STAT ASSOC, V73, P40, DOI 10.2307/2286513; WHITTEMORE AS, 1995, AM J EPIDEMIOL, V141, P732, DOI 10.1093/oxfordjournals.aje.a117495; 1995, CANCER FACTS FIGURES	26	56	56	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1996	58	4					881	885						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UA380	8644752				2022-12-18	WOS:A1996UA38000026
J	KAEDA, JS; CHHOTRAY, GP; RANJIT, MR; BAUTISTA, JM; REDDY, PH; STEVENS, D; NAIDU, JM; BRITT, RP; VULLIAMY, TJ; LUZZATTO, L; MASON, PJ				KAEDA, JS; CHHOTRAY, GP; RANJIT, MR; BAUTISTA, JM; REDDY, PH; STEVENS, D; NAIDU, JM; BRITT, RP; VULLIAMY, TJ; LUZZATTO, L; MASON, PJ			A NEW GLUCOSE-6-PHOSPHATE-DEHYDROGENASE VARIANT, G6PD-ORISSA-(44-ALA-]GLY), IS THE MAJOR POLYMORPHIC VARIANT IN TRIBAL POPULATIONS IN INDIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE; MUTATIONS; DEFICIENCY; HAPLOTYPES; SEQUENCE; KALYAN; ORIGIN; ASIA; EAST	Deficiency of glucose-6-phosphate dehydrogenase (G6PD) is usually found at high frequencies in areas of the world where malaria has been endemic. The frequency and genetic basis of G6PD deficiency have been studied in Africa, around the Mediterranean, and in the Far East, but little such information is available about the situation in India. To determine the extent of heterogeneity of G6PD, we have studied several different Indian populations by screening for G6PD deficiency, followed by molecular analysis of deficient alleles. The frequency of G6PD deficiency varies between 3% and 15% in different tribal and urban groups. Remarkably, a previously unreported deficient variant, G6PD Orissa (44 Ala-->Gly), is responsible for most of the G6PD deficiency in tribal Indian populations but is not found in urban populations, where most of the G6PD deficiency is due to the G6PD Mediterranean (188 Ser-->Phe) variant. The K-m(NADP) of G6PD Orissa is fivefold higher than that of the normal enzyme. This may be due to the fact that the alanine residue that is replaced by glycine is part of a putative coenzyme-binding site.	HAMMERSMITH HOSP, ROYAL POSTGRAD MED SCH, DEPT HAEMATOL, LONDON W12 0NN, ENGLAND; UCL, SCH MED, CTR PEDIAT, LONDON W1N 8AA, ENGLAND; REG MED RES CTR, DEPT PATHOL, BHUBANESWAR, ORISSA, INDIA; ANDHRA UNIV COLL, DEPT ANTHROPOL, WALTAIR, ANDHRA PRADESH, INDIA; HILLINGDON HOSP, UXBRIDGE, MIDDX, ENGLAND	Imperial College London; University of London; University College London; UCL Medical School; Indian Council of Medical Research (ICMR); ICMR - Regional Medical Research Centre (RMRC), Bhubaneswar; Andhra University			Mason, Philip J/B-1087-2008; Bautista, José M./B-7899-2013	Bautista, José M./0000-0001-8926-881X				AHLUWALIA A, 1992, HUM MOL GENET, V1, P209, DOI 10.1093/hmg/1.3.209; BAUTISTA JM, 1992, BIOCHIM BIOPHYS ACTA, V1119, P74, DOI 10.1016/0167-4838(92)90237-8; BAXI A J, 1963, Indian J Med Sci, V17, P493; BETKE K, 1967, WHO366 TECH REP; BEUTLER E, 1991, ACTA HAEMATOL-BASEL, V86, P179; BEUTLER E, 1968, BLOOD, V32, P816, DOI 10.1182/blood.V32.5.816.816; BEUTLER E, 1994, BLOOD, V84, P3613, DOI 10.1182/blood.V84.11.3613.bloodjournal84113613; BEUTLER E, 1990, AM J HUM GENET, V47, P1008; Bhatia HM, 1986, GENETIC ATLAS INDIAN; CALABRO V, 1990, HUM GENET, V86, P49; CALABRO V, 1993, AM J HUM GENET, V52, P527; CHIU DTY, 1993, BLOOD, V81, P2150, DOI 10.1182/blood.V81.8.2150.2150; COHEN T, 1971, ISRAEL J MED SCI, V7, P1509; FILOSA S, 1993, GENOMICS, V17, P6, DOI 10.1006/geno.1993.1276; FURERHAIMENDORF C, 1982, TRIBES INDIA STRUGGL; GREENE LS, 1993, YEARB PHYS ANTHROPOL, V36, P153; HIRONO A, 1988, P NATL ACAD SCI USA, V85, P3951, DOI 10.1073/pnas.85.11.3951; ISHWAD CS, 1984, HUM GENET, V66, P171, DOI 10.1007/BF00286595; KAR BC, 1987, T ROY SOC TROP MED H, V81, P273, DOI 10.1016/0035-9203(87)90239-2; KHAN PM, 1986, GLUCOSE 6 PHOSPHATE, P245; KOTEA N, 1995, BLOOD, V86, P407, DOI 10.1182/blood.V86.1.407.bloodjournal861407; KURDIHAIDAR B, 1990, AM J HUM GENET, V47, P1013; LABIE D, 1989, HUM BIOL, V61, P479; LUZZATTO L, 1965, BIOCHEM BIOPH RES CO, V21, P547, DOI 10.1016/0006-291X(65)90520-6; LUZZATTO L, 1979, BLOOD, V54, P961; LUZZATTO L, 1985, ADV HUM GENET, V14, P217; LUZZATTO L, 1995, METABOLIC MOL BASES, P3367; NAGEL RL, 1990, SEMIN HEMATOL, V27, P342; ROWLAND P, 1994, STRUCTURE, V2, P1073, DOI 10.1016/S0969-2126(94)00110-3; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; SAHA N, 1994, HUM HERED, V44, P85, DOI 10.1159/000154196; Sambrook J., 1989, MOL CLONING LAB MANU; STEVENS DJ, 1990, NUCLEIC ACIDS RES, V18, P7190, DOI 10.1093/nar/18.23.7190; TOWN M, 1992, HUM MOL GENET, V1, P171, DOI 10.1093/hmg/1.3.171; VULLIAMY T, 1992, TRENDS GENET, V8, P138, DOI 10.1016/0168-9525(92)90372-B; VULLIAMY TJ, 1988, P NATL ACAD SCI USA, V85, P5171, DOI 10.1073/pnas.85.14.5171; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2	37	56	58	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1995	57	6					1335	1341						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TE655	8533762				2022-12-18	WOS:A1995TE65500010
J	KRAMER, PL; YUE, Q; GANCHER, ST; NUTT, JG; BALOH, R; SMITH, E; BROWNE, D; BUSSEY, K; LOVRIEN, E; NELSON, S; LITT, M				KRAMER, PL; YUE, Q; GANCHER, ST; NUTT, JG; BALOH, R; SMITH, E; BROWNE, D; BUSSEY, K; LOVRIEN, E; NELSON, S; LITT, M			A LOCUS FOR THE NYSTAGMUS-ASSOCIATED FORM OF EPISODIC ATAXIA MAPS TO AN II-CM REGION ON CHROMOSOME 19P	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							GENE		OREGON HLTH SCI UNIV, DEPT MOLEC & MED GENET, PORTLAND, OR 97201 USA; OREGON HLTH SCI UNIV, DEPT BIOCHEM & MOLEC BIOL, PORTLAND, OR 97201 USA; OREGON HLTH SCI UNIV, CTR CHILD DEV & REHABIL, PORTLAND, OR 97201 USA; UNIV CALIF LOS ANGELES, SCH MED, DEPT NEUROL, LOS ANGELES, CA 90024 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	KRAMER, PL (corresponding author), OREGON HLTH SCI UNIV, DEPT NEUROL, PORTLAND, OR 97201 USA.		Bussey, Kimberly J./D-2567-2011; Nelson, Stanley F/D-4771-2009	Nelson, Stanley F/0000-0002-2082-3114; Bussey, Kimberly/0000-0003-1001-8207	NHGRI NIH HHS [HG00022] Funding Source: Medline; NIDCD NIH HHS [DC01404] Funding Source: Medline; NINDS NIH HHS [NS25370] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P60DC001404] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ashcroft FM, 1993, CURR OPIN CELL BIOL, V5, P677, DOI 10.1016/0955-0674(93)90139-H; BAIN PG, 1992, ANN NEUROL, V31, P147, DOI 10.1002/ana.410310205; BALOH RW, 1991, NEUROLOGY, V41, P429; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; BUETOW KH, 1994, NAT GENET, V6, P391, DOI 10.1038/ng0494-391; Gancher S T, 1986, Mov Disord, V1, P239, DOI 10.1002/mds.870010404; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; JOUTEL A, 1993, NAT GENET, V5, P40, DOI 10.1038/ng0993-40; KRAMER P, 1994, ANN NEUROL, V36, P279; KRAMER PL, 1994, AM J HUM GENET, V55, P468; LITT M, 1994, AM J HUM GENET, V55, P702; LITT M, 1993, BIOTECHNIQUES, V15, P280; PTACEK L, 1994, NAT GENET, V8, P111, DOI 10.1038/ng1094-111; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; VAHEDI K, 1995, ANN NEUROL, V37, P289, DOI 10.1002/ana.410370304; VONBREDERLOW B, 1995, HUM MOL GENET, V4, P279, DOI 10.1093/hmg/4.2.279; ZASORIN NL, 1983, NEUROLOGY, V33, P1212, DOI 10.1212/WNL.33.9.1212	18	56	60	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1995	57	1					182	185						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RE629	7611286				2022-12-18	WOS:A1995RE62900021
J	FABER, JP; POLLER, W; WEIDINGER, S; KIRCHGESSER, M; SCHWAAB, R; BIDLINGMAIER, F; OLEK, K				FABER, JP; POLLER, W; WEIDINGER, S; KIRCHGESSER, M; SCHWAAB, R; BIDLINGMAIER, F; OLEK, K			IDENTIFICATION AND DNA-SEQUENCE ANALYSIS OF 15 NEW ALPHA(1)-ANTITRYPSIN VARIANTS, INCLUDING 2 PI-ASTERISK-Q0 ALLELES AND ONE DEFICIENT PI-ASTERISK-M ALLELE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALPHA-ANTITRYPSIN DEFICIENCY; ALPHA-1-ANTITRYPSIN DEFICIENCY; FRAMESHIFT MUTATION; LUNG-DISEASE; MOLECULAR ANALYSIS; LIVER-DISEASE; GENE; DELETION; HISTORY; SERPINS	We have investigated the molecular basis of 15 new alpha(1)-antitrypsin (alpha 1AT) variants. Phenotyping by isoelectric focusing (IEF) was used as a screening method to detect alpha 1AT variants at the protein level Genotyping was then performed by sequence analysis of all coding exons, exon-intron junctions, and the hepatocyte-specific promotor region including exon Ic. Three of these rare variants are alleles of clinical relevance, associated with undetectable or very low serum levels of alpha 1AT: the PI*QOsaarbruecken allele generated by a 1-bp C-nucleotide insertion within a stretch of seven cytosines spanning residues 360-362, resulting in a 3' frameshift and the acquisition of a stop codon at residue 376; a point mutation in the PI*QOlisbon allele, resulting in a single amino acid substitution Thr(68)(ACC)-->Ile(ATC); and an in-frame trinucleotide deletion Delta Phe(51) (TTC) in the highly deficient PI* Mpalermo allele. The remaining 12 alleles are associated with normal alpha 1AT serum levels and are characterized by point mutations causing single amino acid substitutions in all but one case. This exception is a silent mutation, which does not affect the amino acid sequence. The limitation of IEF compared with DNA sequence analysis, for identification of new variants, their generation by mutagenesis, and the clinical relevance of the three deficiency alleles are discussed.	UNIV BONN,INST KLIN BIOCHEM,BONN,GERMANY; UNIV WURZBURG,MED KLIN,WURZBURG,GERMANY; MED IMMUNOL LAB,MUNICH,GERMANY; INST MOLEK BIOL DIAGNOST,BORNHEIM,GERMANY	University of Bonn; University of Wurzburg	FABER, JP (corresponding author), UNIV BONN,INST EXPTL HAEMATOL & TRANSFUS MED,SIGMUND FREUD STR 25,D-53105 BONN,GERMANY.		Poller, Wolfgang/AAB-2185-2021	Poller, Wolfgang/0000-0002-2805-6634				BRANTLY ML, 1988, AM REV RESPIR DIS, V138, P327, DOI 10.1164/ajrccm/138.2.327; BRODBECK RM, 1992, J BIOL CHEM, V267, P294; CARRELL R, 1985, TRENDS BIOCHEM SCI, V10, P20, DOI 10.1016/0968-0004(85)90011-8; COX DW, 1980, HUM GENET, V53, P429, DOI 10.1007/BF00287070; COX DW, 1985, NATURE, V316, P79, DOI 10.1038/316079a0; COX DW, 1990, METABOLIC BASIS INHE, P2409; CRYSTAL RG, 1990, J CLIN INVEST, V85, P1343, DOI 10.1172/JCI114578; CURIEL D, 1989, J CLIN INVEST, V83, P1144, DOI 10.1172/JCI113994; CURIEL DT, 1989, J BIOL CHEM, V264, P13938; ERIKSSON S, 1964, ACTA MED SCAND, V175, P197; FABER JP, 1989, AM J HUM GENET, V45, P161; FABER JP, 1993, J HEPATOL, V18, P313, DOI 10.1016/S0168-8278(05)80275-2; FABER JP, 1990, AM J HUM GENET, V46, P1158; FRAIZER GC, 1989, AM J HUM GENET, V44, P894; FRAIZER GC, 1989, HUM GENET, V83, P377, DOI 10.1007/BF00291385; HAFEEZ W, 1992, J CLIN INVEST, V89, P1274; HOLMES MD, 1990, AM REV RESPIR DIS, V142, P1185, DOI 10.1164/ajrccm/142.5.1185; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; KUEHNL P, 1979, Human Genetics, V50, P221; KUNKEL TA, 1986, J BIOL CHEM, V261, P3581; LARSSON C, 1978, ACTA MED SCAND, V204, P345, DOI 10.1111/j.0954-6820.1978.tb08452.x; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; LONG GL, 1984, BIOCHEMISTRY-US, V23, P4828, DOI 10.1021/bi00316a003; MATSUNAGA E, 1990, AM J HUM GENET, V46, P602; NUKIWA T, 1987, BIOCHEMISTRY-US, V26, P5259, DOI 10.1021/bi00391a008; NUKIWA T, 1987, J BIOL CHEM, V262, P11999; PERLINO E, 1987, EMBO J, V6, P2767, DOI 10.1002/j.1460-2075.1987.tb02571.x; PERLMUTTER DH, 1985, P NATL ACAD SCI USA, V82, P6918, DOI 10.1073/pnas.82.20.6918; PERLMUTTER DH, 1989, J CLIN INVEST, V84, P1555, DOI 10.1172/JCI114332; POLLER W, 1990, KLIN WOCHENSCHR, V68, P857, DOI 10.1007/BF01662782; POLLER W, 1991, HUM GENET, V86, P522; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; STREISINGER G, 1985, GENETICS, V109, P633; WEIDINGER S, 1992, ELECTROPHORESIS, V13, P234, DOI 10.1002/elps.1150130148; WEIDINGER S, 1991, AM J HUM GENET, V49, P423; WEWERS MD, 1987, AM REV RESPIR DIS, V135, P539; WONG C, 1987, NATURE, V330, P384, DOI 10.1038/330384a0	37	56	58	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1994	55	6					1113	1121						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB684	7977369				2022-12-18	WOS:A1994QB68400006
J	BOURN, D; CARTER, SA; EVANS, DGR; GOODSHIP, J; COAKHAM, H; STRACHAN, T				BOURN, D; CARTER, SA; EVANS, DGR; GOODSHIP, J; COAKHAM, H; STRACHAN, T			A MUTATION IN THE NEUROFIBROMATOSIS TYPE-2 TUMOR-SUPPRESSOR GENE, GIVING RISE TO WIDELY DIFFERENT CLINICAL PHENOTYPES IN 2 UNRELATED INDIVIDUALS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EPIDERMAL GROWTH-FACTOR; TYROSINE PHOSPHORYLATION; GERMLINE DELETION; EZRIN-LIKE; NF2 GENE; PROTEIN; FAMILY; DNA; RADIXIN; MOESIN	We have sought mutations in the recently identified neurofibromatosis type 2 (NF2) tumor-suppressor gene in a large panel of NF2 patients, using PCR-based SSCP and heteroduplex analysis, followed by cloning and sequencing of appropriate PCR products. Two unrelated NF2 patients were found to have identical nonsense mutations caused by a C-to-T transition in a CpG dinucleotide that is a potential mutational hot spot in the NF2 tumor-suppresser gene. Unexpectedly, the two individuals had widely different clinical phenotypes, representing the severe Wishart and mild Gardner clinical subtypes. Analysis of DNA samples from different tissues of the mildly affected patient suggests that he is a somatic mosaic for the mutation.	UNIV NEWCASTLE UPON TYNE,DIV HUMAN GENET,MOLEC GENET UNIT,NEWCASTLE TYNE NE1 7RU,TYNE & WEAR,ENGLAND; ST MARYS HOSP,DEPT MED GENET,MANCHESTER M13 0JH,LANCS,ENGLAND; FRENCHAY HOSP,DEPT NEUROSURG,BRISTOL BS16 1LE,AVON,ENGLAND	Newcastle University - UK; University of Manchester			Evans, D Gareth/AAB-4308-2022	Evans, D Gareth/0000-0002-8482-5784				BRETSCHER A, 1989, J CELL BIOL, V108, P921, DOI 10.1083/jcb.108.3.921; CONBOY J, 1986, P NATL ACAD SCI USA, V83, P9512, DOI 10.1073/pnas.83.24.9512; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; DUNCAN BK, 1980, NATURE, V287, P560, DOI 10.1038/287560a0; ELDRIDGE R, 1991, AM J HUM GENET, V49, P133; EVANS DGR, 1992, Q J MED, V84, P603; FAZIOLI F, 1993, ONCOGENE, V8, P1335; FUNAYAMA N, 1991, J CELL BIOL, V115, P1039, DOI 10.1083/jcb.115.4.1039; Gardner WJ, 1930, ARCH NEURO PSYCHIATR, V23, P266, DOI 10.1001/archneurpsyc.1930.02220080050005; GARDNER WJ, 1933, J HERED, V22, P7; GOULD KL, 1989, EMBO J, V8, P4133, DOI 10.1002/j.1460-2075.1989.tb08598.x; KEEN J, 1991, TRENDS GENET, V7, P5; KRIEG J, 1992, J BIOL CHEM, V267, P19258; LANKES WT, 1991, P NATL ACAD SCI USA, V88, P8297, DOI 10.1073/pnas.88.19.8297; MARTUZA RL, 1988, NEW ENGL J MED, V318, P684, DOI 10.1056/NEJM198803173181106; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; SANSON M, 1993, HUM MOL GENET, V2, P1215, DOI 10.1093/hmg/2.8.1215; SATO N, 1992, J CELL SCI, V103, P131; Soto D, 1992, PCR Methods Appl, V2, P96; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; TURUNEN O, 1989, J BIOL CHEM, V264, P16727; WATSON CJ, 1993, HUM MOL GENET, V2, P701, DOI 10.1093/hmg/2.6.701; Wishart J H, 1822, Edinb Med Surg J, V18, P393; YANG Q, 1991, P NATL ACAD SCI USA, V88, P5943	26	56	56	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1994	55	1					69	73						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NW461	8023853				2022-12-18	WOS:A1994NW46100010
J	PETTY, EM; GREEN, JS; MARX, SJ; TAGGART, RT; FARID, N; BALE, AE				PETTY, EM; GREEN, JS; MARX, SJ; TAGGART, RT; FARID, N; BALE, AE			MAPPING THE GENE FOR HEREDITARY HYPERPARATHYROIDISM AND PROLACTINOMA (MEN1(BURIN)) TO CHROMOSOME 11Q - EVIDENCE FOR A FOUNDER EFFECT IN PATIENTS FROM NEWFOUNDLAND	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPLE ENDOCRINE NEOPLASIA; MEN1 LOCUS; RET PROTOONCOGENE; PHYSICAL MAP; SMALL REGION; LONG ARM; TYPE-1; LINKAGE; MARKERS; LOCALIZATION	An autosomal dominant syndrome of prolactinomas, carcinoids, and hyperparathyroidism was described in four Newfoundland kindreds in 1980 and in one kindred from the Pacific Northwest in 1983. Because this syndrome shares many features with multiple endocrine neoplasia type 1, the gene for which maps to proximal chromosome 11q, we performed linkage studies with chromosome 11 markers in prolactinoma families to determine whether the two genes map to the same location. All proximal chromosome 11q markers gave positive LOD scores, and no recombinants were seen with PYGM (LOD score 15.25, recombination fraction.0). All affected individuals from Newfoundland shared the same PYGM allele, providing evidence for a founder effect. The disease in the Pacific Northwest kindred cosegregated with a different PYGM allele.	YALE UNIV,SCH MED,DEPT GENET,NEW HAVEN,CT 06510; MEM UNIV NEWFOUNDLAND,ST JOHNS,NF,CANADA; NIDDKD,BETHESDA,MD; WAYNE STATE UNIV,DEPT MOLEC BIOL & GENET,DETROIT,MI 48201; KING FAISAL SPECIALIST HOSP & RES CTR,DEPT MED,RIYADH 11211,SAUDI ARABIA	Yale University; Memorial University Newfoundland; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Wayne State University; King Faisal Specialist Hospital & Research Center					NCI NIH HHS [CA50497] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA050497] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BALE AE, 1991, CANCER RES, V51, P1154; BALE SJ, 1989, GENOMICS, V4, P320, DOI 10.1016/0888-7543(89)90336-4; BEAR JC, 1985, HUM HERED, V35, P15, DOI 10.1159/000153508; BYSTROM C, 1990, P NATL ACAD SCI USA, V87, P1968, DOI 10.1073/pnas.87.5.1968; DONISKELLER H, 1993, HUM MOL GENET, V2, P851, DOI 10.1093/hmg/2.7.851; FARID NR, 1980, AM J MED, V69, P874, DOI 10.1016/S0002-9343(80)80013-1; FRIEDMAN E, 1989, NEW ENGL J MED, V321, P213, DOI 10.1056/NEJM198907273210402; FUJIMORI M, 1992, AM J HUM GENET, V50, P399; GERHARD DS, 1992, GENOMICS, V13, P1133, DOI 10.1016/0888-7543(92)90028-Q; HERSHON KS, 1983, AM J MED, V74, P713, DOI 10.1016/0002-9343(83)91032-X; HOFSTRA RMW, 1994, NATURE, V367, P375, DOI 10.1038/367375a0; IWASAKI H, 1992, GENOMICS, V13, P7, DOI 10.1016/0888-7543(92)90194-W; JANSON M, 1991, P NATL ACAD SCI USA, V88, P10609, DOI 10.1073/pnas.88.23.10609; JEANPIERRE M, 1987, NUCLEIC ACIDS RES, V15, P9611, DOI 10.1093/nar/15.22.9611; JULIER C, 1990, GENOMICS, V7, P335, DOI 10.1016/0888-7543(90)90167-S; KREBS CJ, 1993, HUM MOL GENET, V2, P825, DOI 10.1093/hmg/2.6.825-a; LARSSON C, 1988, NATURE, V332, P85, DOI 10.1038/332085a0; LARSSON C, 1992, HUM GENET, V89, P187; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LITT M, 1992, GENOMICS, V14, P820, DOI 10.1016/S0888-7543(05)80199-5; Metz David C., 1994, P591; MULLIGAN LM, 1993, NATURE, V363, P458, DOI 10.1038/363458a0; NAKAMURA Y, 1989, AM J HUM GENET, V44, P751; NORUM RA, 1990, GENOMICS, V8, P313, DOI 10.1016/0888-7543(90)90287-5; OZELIUS LJ, 1992, AM J HUM GENET, V50, P619; PETTY EM, 1993, GENOMICS, V15, P423, DOI 10.1006/geno.1993.1080; RICHARD CW, 1991, AM J HUM GENET, V49, P1189; SCHIMKE RN, 1984, ANNU REV MED, V35, P25, DOI 10.1146/annurev.me.35.020184.000325; SIMPSON NE, 1987, NATURE, V328, P528, DOI 10.1038/328528a0; TAGGART RT, 1993, HUM MOL GENET, V2, P336, DOI 10.1093/hmg/2.3.336; TANIGAMI A, 1992, GENOMICS, V13, P16, DOI 10.1016/0888-7543(92)90195-X; WILLIAMSON R, 1991, CYTOGENET CELL GENET, V58, P1190, DOI 10.1159/000133727	32	56	56	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1994	54	6					1060	1066						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NP053	7911003				2022-12-18	WOS:A1994NP05300015
J	MILEWICZ, DM; DUVIC, M				MILEWICZ, DM; DUVIC, M			SEVERE NEONATAL MARFAN-SYNDROME RESULTING FROM A DE-NOVO 3-BP INSERTION INTO THE FIBRILLIN GENE ON CHROMOSOME-15	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EPIDERMAL GROWTH-FACTOR; CONNECTIVE-TISSUE; MISSENSE MUTATION; RECEPTOR; LINKAGE; LOCUS; NOTCH	Severe neonatal Marfan syndrome has features of the Marfan syndrome and congenital contractural arachnodactyly present at birth, along with unique features such as loose, redundant skin and pulmonary emphysema. Since the Marfan syndrome and congenital contractural arachnodactyly are due to mutations in different genes, it has been uncertain whether neonatal Marfan syndrome is due to mutations in the fibrillin gene on chromosome 15 or in another gene. We studied an infant with severe neonatal Marfan syndrome. Dermal fibroblasts were metabolically labeled and found to secrete fibrillin inefficiently when compared with control cells. Reverse transcription and amplification of the proband's fibroblast RNA was used to identify a 3-bp insertion between nucleotides 480-481 or 481-482 of the fibrillin cDNA. The insertion maintains the reading frame of the protein and inserts a cysteine between amino acids 160 and 161 in an epidermal growth-factor-like motif of fibrillin. This 3-bp insertion was not found in the fibrillin gene in 70 unrelated, unaffected individuals and 11 unrelated individuals with the Marfan syndrome. We conclude that neonatal Marfan syndrome is the result of mutations in the fibrillin gene on chromosome 15 and is part of the Marfan syndrome spectrum.	UNIV TEXAS,SCH MED,DEPT PEDIAT,HOUSTON,TX 77030; UNIV TEXAS,SCH MED,DEPT DERMATOL,HOUSTON,TX 77030	University of Texas System; University of Texas System	MILEWICZ, DM (corresponding author), UNIV TEXAS,SCH MED,DEPT INTERNAL MED,6431 FANNIN,MSB 1614,HOUSTON,TX 77030, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD024427] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-24427] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BASSELDUBY R, 1992, J BIOL CHEM, V267, P9668; BEALS RK, 1971, J BONE JOINT SURG AM, VA 53, P987, DOI 10.2106/00004623-197153050-00013; BEIGHTON P, 1988, AM J MED GENET, V29, P581, DOI 10.1002/ajmg.1320290316; COOKE RM, 1987, NATURE, V327, P339, DOI 10.1038/327339a0; CORSON GM, 1993, GENOMICS, V17, P476, DOI 10.1006/geno.1993.1350; DAVIS CG, 1987, NATURE, V326, P760, DOI 10.1038/326760a0; DAY DL, 1986, PEDIATR RADIOL, V16, P518, DOI 10.1007/BF02387973; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; DIETZ HC, 1992, J CLIN INVEST, V89, P1674, DOI 10.1172/JCI115766; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; GREENWALD IS, 1983, CELL, V34, P435, DOI 10.1016/0092-8674(83)90377-X; GROSS DM, 1989, PEDIATRICS, V84, P83; HECHT F, 1972, PEDIATRICS, V49, P574; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; HUGGON IC, 1990, ARCH DIS CHILD, V65, P317, DOI 10.1136/adc.65.3.317; KAINULAINEN K, 1992, P NATL ACAD SCI USA, V89, P5917, DOI 10.1073/pnas.89.13.5917; KELLEY MR, 1987, CELL, V51, P539, DOI 10.1016/0092-8674(87)90123-1; LABABIDI Z, 1981, AM HEART J, V102, P943, DOI 10.1016/0002-8703(81)90051-X; LEE B, 1991, NATURE, V352, P330, DOI 10.1038/352330a0; MADDOX BK, 1989, J BIOL CHEM, V264, P21381; MAGENIS RE, 1991, GENOMICS, V11, P346, DOI 10.1016/0888-7543(91)90142-2; MASLEN CL, 1991, NATURE, V352, P334, DOI 10.1038/352334a0; MILEWICZ DM, 1992, J CLIN INVEST, V89, P79, DOI 10.1172/JCI115589; PEREIRA L, 1993, HUM MOL GENET, V2, P961, DOI 10.1093/hmg/2.7.961; PYERITZ RE, 1979, NEW ENGL J MED, V300, P772, DOI 10.1056/NEJM197904053001406; RAGHUNATH M, 1993, HUM GENET, V90, P511; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Royce PM, 1993, CONNECTIVE TISSUE IT; SHANKAR KR, 1967, AM J CARDIOL, V20, P122, DOI 10.1016/0002-9149(67)90117-8; SUPERTIFURGA A, 1992, J MED GENET, V29, P875, DOI 10.1136/jmg.29.12.875; TSIPOURAS P, 1992, NEW ENGL J MED, V326, P905, DOI 10.1056/NEJM199204023261401	31	56	56	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1994	54	3					447	453						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ158	8116614				2022-12-18	WOS:A1994MZ15800007
J	TSUJINO, S; SHANSKE, S; SAKODA, S; FENICHEL, G; DIMAURO, S				TSUJINO, S; SHANSKE, S; SAKODA, S; FENICHEL, G; DIMAURO, S			THE MOLECULAR GENETIC-BASIS OF MUSCLE PHOSPHOGLYCERATE MUTASE (PGAM) DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUBUNIT	The glycolytic enzyme phosphoglycerate mutase (PGAM) is a dimer, and mature human skeletal muscle contains almost exclusively the MM form of the enzyme, PGAM-M. In 1981, we identified a patient with PGAM-M deficiency, and three additional patients have since been described. All presented with exercise intolerance, cramps, and myoglobinuria. We report two new patients with PGAM-M deficiency and describe the molecular lesions in five patients-four African-Americans and one Caucasian. Three patients were homozygous for an identical G-to-A transition converting an encoded Trp to an in-frame stop codon (codon 78). A fourth patient was heterozygous for this mutation and also carried an A-to-C mutation converting Glu to Ala (codon 89). The fifth patient, the only Caucasian, was homozygous for a different point mutation, a C-to-T mutation, converting Arg to Trp (codon 90).	COLUMBIA PRESBYTERIAN MED CTR,DEPT NEUROL,NEW YORK,NY 10032; OSAKA UNIV,DEPT NEUROL,OSAKA,JAPAN; VANDERBILT UNIV,DEPT NEUROL,NASHVILLE,TN 37240	Columbia University; NewYork-Presbyterian Hospital; Osaka University; Vanderbilt University					NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS011766, P01NS011766] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 11766] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BRESOLIN N, 1983, NEUROLOGY, V33, P1049, DOI 10.1212/WNL.33.8.1049; CASTELLAESCOLA J, 1990, GENE, V91, P225, DOI 10.1016/0378-1119(90)90092-6; DIMAURO S, 1984, CRC CR REV CL NEUROB, V1, P83; DIMAURO S, 1982, NEUROLOGY, V32, P584, DOI 10.1212/WNL.32.6.584; DIMAURO S, 1981, SCIENCE, V212, P1277, DOI 10.1126/science.6262916; EDWARDS YH, 1989, GENOMICS, V5, P948, DOI 10.1016/0888-7543(89)90140-7; Grisolia S, 1975, Methods Enzymol, V42, P435; HAGGARTY NW, 1980, FEBS LETT, V109, P18, DOI 10.1016/0014-5793(80)81301-9; KISSEL JT, 1985, NEUROLOGY, V35, P828, DOI 10.1212/WNL.35.6.828; OMENN GS, 1975, ISOZYMES, V3, P1005; SHANSKE S, 1987, J BIOL CHEM, V262, P14612; TOSCANO A, IN PRESS NEUROLOGY; TSUJINO S, 1989, J BIOL CHEM, V264, P15334; UCHIDA K, 1991, ARCH BIOCHEM BIOPHYS, V288, P558, DOI 10.1016/0003-9861(91)90235-B; VITA G, 1990, Neurology, V40, P296; WINN SI, 1981, PHILOS T ROY SOC B, V293, P121, DOI 10.1098/rstb.1981.0066	16	56	58	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1993	52	3					472	477						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KR720	8447317				2022-12-18	WOS:A1993KR72000004
J	VERGA, V; HALL, BK; WANG, S; JOHNSON, S; HIGGINS, JV; GLOVER, TW				VERGA, V; HALL, BK; WANG, S; JOHNSON, S; HIGGINS, JV; GLOVER, TW			LOCALIZATION OF THE TRANSLOCATION BREAKPOINT IN A FEMALE WITH MENKES SYNDROME TO XQ13.2-Q13.3 PROXIMAL TO PGK-1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMERASE CHAIN-REACTION; X-LINKED DISEASE; PHOSPHOGLYCERATE KINASE; CHROMOSOME; MOUSE; PROBES; LENGTH; DNA	Menkes syndrome is a rare X-linked recessive disorder characterized by an inability to metabolize copper. A female patient with both this disease and an X; autosome translocation with karyotype 46,X,t(X;2)(q13; q32.2) has previously been described. The translocation breakpoint in Xq13 coincides with a previous assignment of the Menkes gene at Xq13 by linkage data in humans and by analogy to the mottled mutations which are models for Menkes disease in the mouse. Therefore, this translocation probably interrupts the gene for Menkes syndrome in band Xql3. We describe here experiments to precisely map the translocation breakpoint within this chromosomal band. We have established a lymphoblastoid cell line from this patient and have used it to isolate the der(2) translocation chromosome (2pter --> 2q32::Xq13 --> Xqter) in human/hamster somatic cell hybrids. Southern blot analyses using a number of probes specific for chromosomes X and 2 have been studied to define precisely the location of the translocation breakpoint. Our results show that the breakpoint in this patient-and, therefore, likely the Menkes gene-maps to a small subregion of band Xql3.2-ql3.3 proximal to the PGK1 locus and distal to all other Xq13 loci tested.	UNIV MICHIGAN,SCH MED,DEPT PEDIAT,ANN ARBOR,MI 48104; UNIV MICHIGAN,SCH MED,DEPT HUMAN GENET,ANN ARBOR,MI 48104; MICHIGAN STATE UNIV,DEPT PEDIAT & HUMAN GENET,E LANSING,MI 48824	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Michigan State University								BROWN CJ, 1991, NATURE, V349, P82, DOI 10.1038/349082a0; DANKS DM, 1972, LANCET, V1, P1100; Danks DM, 1989, METABOLIC BASIS INHE, P1411; FRANCKE U, 1978, HUM GENET, V45, P137, DOI 10.1007/BF00286957; HORN N, 1980, J MED GENET, V17, P262, DOI 10.1136/jmg.17.4.262; HORN N, 1983, J INHERIT METAB DIS, V6, P59, DOI 10.1007/BF01811325; HORN N, 1984, ANN HUM GENET, V48, P161, DOI 10.1111/j.1469-1809.1984.tb01011.x; HUNT DM, 1974, NATURE, V249, P852, DOI 10.1038/249852a0; HUTZ M, 1984, HUM GENET, V66, P214; KAPUR S, 1987, AM J MED GENET, V26, P503, DOI 10.1002/ajmg.1320260230; KEER JT, 1990, GENOMICS, V7, P566, DOI 10.1016/0888-7543(90)90200-E; KEITH DH, 1986, MOL CELL BIOL, V6, P4122, DOI 10.1128/MCB.6.11.4122; KIDD KK, 1989, CYTOGENET CELL GENET, V51, P1; LEDBETTER SA, 1990, GENOMICS, V6, P475, DOI 10.1016/0888-7543(90)90477-C; LICHTER P, 1990, P NATL ACAD SCI USA, V87, P6634, DOI 10.1073/pnas.87.17.6634; MENKES JH, 1962, PEDIATRICS, V29, P764; NELSON DL, 1989, P NATL ACAD SCI USA, V87, P6634; NIELSEN JT, 1977, GENETICS, V87, P319; ROPERS HH, 1983, HUM GENET, V65, P53, DOI 10.1007/BF00285028; TONNESEN T, 1986, 7TH INT C HUM GEN BE, P627; WIEACKER P, 1983, HUM GENET, V64, P139, DOI 10.1007/BF00327110; WYANDT HE, 1976, EXP CELL RES, V102, P85, DOI 10.1016/0014-4827(76)90302-5	22	56	57	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1991	48	6					1133	1138						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FP092	2035533				2022-12-18	WOS:A1991FP09200015
J	OZCELIK, T; LAFRENIERE, RG; ARCHER, BT; JOHNSTON, PA; WILLARD, HF; FRANCKE, U; SUDHOF, TC				OZCELIK, T; LAFRENIERE, RG; ARCHER, BT; JOHNSTON, PA; WILLARD, HF; FRANCKE, U; SUDHOF, TC			SYNAPTOPHYSIN - STRUCTURE OF THE HUMAN GENE AND ASSIGNMENT TO THE X-CHROMOSOME IN MAN AND MOUSE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									STANFORD UNIV,MED CTR,BECKMAN CTR,HOWARD HUGHES MED INST,STANFORD,CA 94305; STANFORD UNIV,MED CTR,DEPT GENET,STANFORD,CA 94305; STANFORD UNIV,MED CTR,DEPT PEDIAT,STANFORD,CA 94305; UNIV TEXAS,SW MED CTR,DEPT MOLEC GENET,DALLAS,TX 75230; UNIV TEXAS,SW MED CTR,HOWARD HUGHES MED INST,DALLAS,TX 75230	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026105] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM26105] Funding Source: Medline; PHS HHS [ER60689] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ARVEILER B, 1988, AM J MED GENET, V30, P473, DOI 10.1002/ajmg.1320300150; BARTLEY J, 1989, CYTOGENET CELL GENET, V51, P959; BARTON DE, 1986, HUM GENET, V72, P221, DOI 10.1007/BF00291881; BISHOP AE, 1988, PATHOL RES PRACT, V183, P119, DOI 10.1016/S0344-0338(88)80040-2; BROWN CJ, 1990, AM J HUM GENET, V46, P273; BUCKLEY KM, 1987, J CELL BIOL, V105, P2447, DOI 10.1083/jcb.105.6.2447; CANNIZZARO LA, 1987, CLIN GENET, V32, P66; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; FRANCKE U, 1986, COLD SPRING HARB SYM, V51, P855, DOI 10.1101/SQB.1986.051.01.099; FRANCKE U, 1979, P NATL ACAD SCI USA, V76, P5230, DOI 10.1073/pnas.76.10.5230; FRANCKE U, 1989, AM J HUM GENET, V45, P276; GREER WL, 1990, GENOMICS, V6, P568, DOI 10.1016/0888-7543(90)90489-H; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; INGLE C, 1985, AM J HUM GENET, V37, P451; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; JOHNSTON PA, 1990, J BIOL CHEM, V265, P8869; JOHNSTON PA, 1989, J BIOL CHEM, V264, P1268; JOHNSTON PA, 1989, EMBO J, V8, P2863, DOI 10.1002/j.1460-2075.1989.tb08434.x; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LAFRENIERE RG, 1989, CYTOGENET CELL GENET, V51, P1028; LASITER PS, 1989, DEV BRAIN RES, V48, P27, DOI 10.1016/0165-3806(89)90091-6; LECLERC N, 1989, J COMP NEUROL, V280, P197, DOI 10.1002/cne.902800204; LEHRMAN MA, 1985, SCIENCE, V227, P140, DOI 10.1126/science.3155573; LEUBE RE, 1987, EMBO J, V6, P3261, DOI 10.1002/j.1460-2075.1987.tb02644.x; LEUBE RE, 1989, CELL, V59, P433, DOI 10.1016/0092-8674(89)90028-7; Mahtani MM, 1988, GENOMICS, V2, P294, DOI 10.1016/0888-7543(88)90017-1; MAHTANI MM, 1989, CYTOGENET CELL GENET, V51, P1038; MANDEL JL, 1989, CYTOGENET CELL GENET, V51, P384, DOI 10.1159/000132801; MATHEWS KD, 1989, AM J MED GENET, V34, P470, DOI 10.1002/ajmg.1320340403; MCKUSICK VA, 1988, MENDELIAN INHERITANC; MILLER DC, 1990, HUM PATHOL, V21, P93, DOI 10.1016/0046-8177(90)90080-O; MIYAKE Y, 1986, ARCH OPHTHALMOL-CHIC, V104, P1013, DOI 10.1001/archopht.1986.01050190071042; MUSARELLA MA, 1989, GENOMICS, V5, P727, DOI 10.1016/0888-7543(89)90114-6; MUSARELLA MA, 1988, AM J HUM GENET, V43, P484; NAVONE F, 1989, J CELL BIOL, V109, P3425, DOI 10.1083/jcb.109.6.3425; NAVONE F, 1986, J CELL BIOL, V103, P2511, DOI 10.1083/jcb.103.6.2511; NGO JT, 1989, GENOMICS, V4, P539, DOI 10.1016/0888-7543(89)90277-2; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.biochem.55.1.1119; PANG DT, 1988, P NATL ACAD SCI USA, V85, P762, DOI 10.1073/pnas.85.3.762; REHM H, 1986, EMBO J, V5, P535, DOI 10.1002/j.1460-2075.1986.tb04243.x; SAMANNS C, 1989, CYTOGENET CELL GENET, V51, P1072; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHILLING K, 1989, J NEUROSCI RES, V24, P347, DOI 10.1002/jnr.490240302; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SUDHOF TC, 1990, J BIOL CHEM, V265, P7849; SUDHOF TC, 1985, SCIENCE, V228, P815, DOI 10.1126/science.2988123; SUDHOF TC, 1987, SCIENCE, V238, P1142, DOI 10.1126/science.3120313; SUDHOF TC, 1989, SCIENCE, V245, P1474, DOI 10.1126/science.2506642; SUDHOF TC, 1987, NUCLEIC ACIDS RES, V15, P9607, DOI 10.1093/nar/15.22.9607; SUTHERS GK, 1988, AM J MED GENET, V30, P485, DOI 10.1002/ajmg.1320300151; THOMAS L, 1988, SCIENCE, V242, P1050, DOI 10.1126/science.2461586; TURNER G, 1989, AM J MED GENET, V34, P463, DOI 10.1002/ajmg.1320340402; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; WILLARD HF, 1989, HUM GENET, V81, P234; WIRTH B, 1988, Genomics, V2, P263, DOI 10.1016/0888-7543(88)90011-0; WRIGHT AF, 1987, AM J HUM GENET, V41, P635; YANGFENG TL, 1986, P NATL ACAD SCI USA, V83, P8679, DOI 10.1073/pnas.83.22.8679	58	56	57	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1990	47	3					551	561						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX223	1975480				2022-12-18	WOS:A1990DX22300020
J	VIVESCORRONS, JL; KUHL, W; PUJADES, MA; BEUTLER, E				VIVESCORRONS, JL; KUHL, W; PUJADES, MA; BEUTLER, E			MOLECULAR-GENETICS OF THE GLUCOSE-6-PHOSPHATE-DEHYDROGENASE (G6PD) MEDITERRANEAN VARIANT AND DESCRIPTION OF A NEW G6PD MUTANT, G6PD ANDALUS1361A	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									SCRIPPS CLIN & RES FDN, RES INST, DEPT MOLEC & EXPTL MED, 10666 N TORREY PINES RD, LA JOLLA, CA 92037 USA; HOSP CLIN BARCELONA, FAC MED, BARCELONA 36, SPAIN	Scripps Research Institute; University of Barcelona; Hospital Clinic de Barcelona					NHLBI NIH HHS [HL25552] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL025552, R01HL025552] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BASSET P, 1978, BLOOD, V51, P971; BEUTLER E, 1988, MEDICINE, V67, P311, DOI 10.1097/00005792-198809000-00003; BEUTLER E, 1990, BIOMED BIOCHIM ACTA, V49, pS236; BEUTLER E, 1989, BLOOD, V74, P2550; Beutler E., 1984, GLUTATHIONE RED CELL; Beutler E, 1983, METABOLIC BASIS INHE, P1629; BEUTLER E, 1989, RED CELL, P39; BHATTACHARYA J, 1984, INDIAN J HEMATOLOGY, V2, P19; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P51; DEVITA G, 1989, AM J HUM GENET, V44, P233; FAIRBANKS VF, 1980, BLOOD, V55, P216; HIRONO A, 1988, P NATL ACAD SCI USA, V85, P3951, DOI 10.1073/pnas.85.11.3951; HIRONO A, 1989, J CLIN INVEST, V83, P343, DOI 10.1172/JCI113881; HIRONO A, 1989, P NATL ACAD SCI USA, V86, P10015, DOI 10.1073/pnas.86.24.10015; KIRKMAN HN, 1964, J LAB CLIN MED, V63, P726; KIRKMAN HN, 1965, J LAB CLIN MED, V65, P212; LUZZATTO L, 1978, CURRENT TOPICS HEMAT, P1; LUZZATTO L, 1990, METABOLIC BASIS INHE, P2237; MARTINI G, 1986, EMBO J, V5, P1849, DOI 10.1002/j.1460-2075.1986.tb04436.x; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MIWA S, 1977, HUM GENET, V36, P327, DOI 10.1007/BF00446284; PANICH V, 1980, J MED ASSOC THAILAND, V63, P537; PERSICO MG, 1986, NUCLEIC ACIDS RES, V14, P2511, DOI 10.1093/nar/14.6.2511; RATTAZZI MC, 1969, BIOCHIM BIOPHYS ACTA, V181, P1, DOI 10.1016/0005-2795(69)90221-9; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; STAMATOYANNOPOULOS G, 1971, J CLIN INVEST, V50, P1253, DOI 10.1172/JCI106603; VIVESCORRONS JL, 1980, HUM GENET, V60, P216; VULLIAMY TJ, 1988, P NATL ACAD SCI USA, V85, P5171, DOI 10.1073/pnas.85.14.5171; WAIKAN Y, 1978, P NATL ACAD SCI USA, V75, P5631, DOI 10.1073/pnas.75.11.5631; [No title captured]	30	56	56	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1990	47	3					575	579						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX223	2393028				2022-12-18	WOS:A1990DX22300023
J	PANDOLFO, M; SIRUGO, G; ANTONELLI, A; WEITNAUER, L; FERRETTI, L; LEONE, M; DONES, I; CERINO, A; FUJITA, R; HANAUER, A; MANDEL, JL; DIDONATO, S				PANDOLFO, M; SIRUGO, G; ANTONELLI, A; WEITNAUER, L; FERRETTI, L; LEONE, M; DONES, I; CERINO, A; FUJITA, R; HANAUER, A; MANDEL, JL; DIDONATO, S			FRIEDREICH ATAXIA IN ITALIAN FAMILIES - GENETIC HOMOGENEITY AND LINKAGE DISEQUILIBRIUM WITH THE MARKER LOCI D9S5 AND D9S15	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CNR,IDVGA,I-20133 MILAN,ITALY; INSERM,U184,F-67200 STRASBOURG,FRANCE; OSPED CIVILE,IVREA,ITALY	Consiglio Nazionale delle Ricerche (CNR); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	PANDOLFO, M (corresponding author), IST NEUROCHIRURG C BESTA,DIV BIOCHIM & GENET SIST NERVOSO,VIA CELORIA 11,I-20133 MILAN,ITALY.		Leone, Maurizio A./J-4130-2016; Sirugo, Giorgio/L-1628-2016; Pandolfo, Massimo/B-2853-2010; Sirugo, Giorgio/N-9056-2019; Ferretti, Luca/D-2337-2013	Leone, Maurizio A./0000-0002-6339-5738; Fujita, Ricardo/0000-0002-9617-5109; Ferretti, Luca/0000-0001-5044-8442				CARLSON M, 1987, NUCLEIC ACIDS RES, V15, P10614, DOI 10.1093/nar/15.24.10614-a; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; CHAMBERLAIN S, 1989, AM J HUM GENET, V44, P518; CHAMBERLAIN S, 1988, NATURE, V334, P248, DOI 10.1038/334248a0; DANGELO A, 1980, ITAL J NEUROL SCI, V4, P231; FUJITA R, 1989, GENOMICS, V4, P110, DOI 10.1016/0888-7543(89)90323-6; FUJITA R, 1990, P NATL ACAD SCI USA, V87, P1796, DOI 10.1073/pnas.87.5.1796; GEOFFROY G, 1976, Canadian Journal of Neurological Sciences, V3, P279; HANAUER A, 1990, AM J HUM GENET, V46, P133; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; JEFFREYS AJ, 1988, NATURE, V332, P278, DOI 10.1038/332278a0; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEONE M, 1988, NEUROLOGY, V38, P1433, DOI 10.1212/WNL.38.9.1433; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; ORZECHOWSKI HD, 1987, NUCLEIC ACIDS RES, V15, P6310, DOI 10.1093/nar/15.15.6310; RAIMONDI E, IN PRESS HUM GENET; RICHTER A, 1989, CYTOGENET CELL GENET, V51, P1066; ROMEO G, 1983, AM J HUM GENET, V35, P523; SMITH CL, 1986, NATURE, V319, P701, DOI 10.1038/319701a0; WEBER JL, 1989, AM J HUM GENET, V44, P388	20	56	56	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1990	47	2					228	235						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT871	2378348				2022-12-18	WOS:A1990DT87100007
J	HUGGINS, M; BLOCH, M; KANANI, S; QUARRELL, OWJ; THEILMAN, J; HEDRICK, A; DICKENS, B; LYNCH, A; HAYDEN, M				HUGGINS, M; BLOCH, M; KANANI, S; QUARRELL, OWJ; THEILMAN, J; HEDRICK, A; DICKENS, B; LYNCH, A; HAYDEN, M			ETHICAL AND LEGAL DILEMMAS ARISING DURING PREDICTIVE TESTING FOR ADULT-ONSET DISEASE - THE EXPERIENCE OF HUNTINGTON DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV BRITISH COLUMBIA,DEPT MED GENET,F168 UNIV HOSP,2211 WESBROOK MALL,VANCOUVER V6T 2B5,BC,CANADA; UNIV TORONTO,FAC LAW,TORONTO M5S 1A1,ONTARIO,CANADA; WESTMINSTER INST ETH HUMAN VALUES,LONDON,ONTARIO,CANADA	University of British Columbia; University of Toronto; Western University (University of Western Ontario)			Hayden, Michael R/D-8581-2011	Hayden, Michael R/0000-0001-5159-1419				Beauchamp TL, 1982, CONT ISSUES BIOETHIC, P1; BRANDT J, 1989, JAMA-J AM MED ASSOC, V261, P3108, DOI 10.1001/jama.261.21.3108; CRAUFURD DIO, 1986, BRIT MED J, V293, P249, DOI 10.1136/bmj.293.6541.249; FAHY M, 1989, J MED GENET, V26, P353, DOI 10.1136/jmg.26.6.353; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; HAYDEN MR, 1988, AM J HUM GENET, V43, P689; Hayden MR., 1981, HUNTINGTONS CHOREA, P45; HAYDEN MR, 1987, LANCET, P234; LAMPORT AT, 1987, AM J MED GENET, V26, P307, DOI 10.1002/ajmg.1320260208; MEISSEN GJ, 1988, NEW ENGL J MED, V318, P535, DOI 10.1056/NEJM198803033180903; QUARRELL OWJ, 1987, LANCET, V1, P1281; SHAW MW, 1987, AM J MED GENET, V26, P243, DOI 10.1002/ajmg.1320260202; WASMUTH JJ, 1988, NATURE, V332, P734, DOI 10.1038/332734a0; WEXLER NS, 1989, MOL GENETICS DISEASE; WHALEY WL, 1988, NUCLEIC ACIDS RES, V16, P11769, DOI 10.1093/nar/16.24.11769; 1983, SCREENING COUNSELING, V44	16	56	56	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1990	47	1					4	12						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	DK482	1971997				2022-12-18	WOS:A1990DK48200002
J	FIBISON, WJ; BUDARF, M; MCDERMID, H; GREENBERG, F; EMANUEL, BS				FIBISON, WJ; BUDARF, M; MCDERMID, H; GREENBERG, F; EMANUEL, BS			MOLECULAR STUDIES OF DIGEORGE SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CHILDRENS HOSP PHILADELPHIA, DIV HUMAN GENET & MOLEC BIOL, 34TH & CIVIC CTR BLVD, PHILADELPHIA, PA 19104 USA; UNIV PENN, SCH MED, DEPT PEDIAT, PHILADELPHIA, PA 19104 USA; UNIV PENN, SCH MED, DEPT HUMAN GENET, PHILADELPHIA, PA 19104 USA; BAYLOR UNIV, INST MOLEC GENET, HOUSTON, TX 77030 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Baylor College of Medicine; Baylor University					NATIONAL CANCER INSTITUTE [R01CA039926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM032592] Funding Source: NIH RePORTER; NCI NIH HHS [CA39926] Funding Source: Medline; NIGMS NIH HHS [GM32592] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARINAMI T, 1986, J MED GENET, V23, P178, DOI 10.1136/jmg.23.2.178; AUGUSSEAU S, 1986, HUM GENET, V74, P206, DOI 10.1007/BF00282098; BACK E, 1980, ANN GENET-PARIS, V23, P244; BOWEN P, 1986, CLIN GENET, V29, P174; BUDARF M, 1988, American Journal of Human Genetics, V43, pA139; BUDARF M, 1989, AM J HUM GENET, V45, P128; BUDARF M, 1988, Genomics, V3, P168, DOI 10.1016/0888-7543(88)90149-8; CANNIZZARO LA, 1984, CYTOGENET CELL GENET, V38, P308, DOI 10.1159/000132079; CANNIZZARO LA, 1985, CYTOGENET CELL GENET, V39, P173, DOI 10.1159/000132130; CANNIZZARO LA, 1985, CYTOGENET CELL GENET, V39, P179, DOI 10.1159/000132131; CONLEY ME, 1979, J PEDIATR-US, V94, P883, DOI 10.1016/S0022-3476(79)80207-3; CROCE CM, 1987, P NATL ACAD SCI USA, V84, P7174, DOI 10.1073/pnas.84.20.7174; DELACHAPELLE A, 1981, HUM GENET, V57, P253, DOI 10.1007/BF00278938; DOBYNS WB, 1983, J PEDIATR-US, V102, P552, DOI 10.1016/S0022-3476(83)80183-8; FAED MJW, 1987, J MED GENET, V24, P225, DOI 10.1136/jmg.24.4.225; FARAH LMS, 1975, HUMANGENETIK, V28, P357; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FIREMAN P, 1965, J PEDIATR-US, V67, P907; GREENBERG F, 1988, AM J HUM GENET, V43, P605; GREENBERG F, 1984, HUM GENET, V65, P317, DOI 10.1007/BF00291554; HUNTER AGW, 1977, CLIN GENET, V12, P239; KELLEY RI, 1982, J PEDIATR-US, V101, P197, DOI 10.1016/S0022-3476(82)80116-9; KIRKELS VGHJ, 1980, CLIN GENET, V18, P456; Lammer E J, 1986, Am J Med Genet Suppl, V2, P113, DOI 10.1002/ajmg.1320250615; LANGER LO, 1984, AM J MED GENET, V19, P81, DOI 10.1002/ajmg.1320190110; LEDBETTER DH, 1982, AM J HUM GENET, V34, P278; LELE KP, 1963, ANN HUM GENET, V27, P171, DOI 10.1111/j.1469-1809.1963.tb00209.x; LIFSHITZ B, 1988, ONCOGENE, V2, P113; MASCARELLO JT, 1989, AM J MED GENET, V32, P112, DOI 10.1002/ajmg.1320320124; MCDERMID HE, 1986, SCIENCE, V232, P646, DOI 10.1126/science.3961499; PALMER CG, 1980, CLIN GENET, V17, P418; RICCARDI VM, 1978, PEDIATRICS, V61, P604; Robinson H B Jr, 1975, Perspect Pediatr Pathol, V2, P173; ROULEAU GA, 1989, GENOMICS, V4, P1, DOI 10.1016/0888-7543(89)90306-6; SCHINZEL A, 1988, J MED GENET, V25, P454, DOI 10.1136/jmg.25.7.454; SCHMICKEL RD, 1986, J PEDIATR-US, V109, P231, DOI 10.1016/S0022-3476(86)80377-8; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STRATTON RF, 1984, HUM GENET, V67, P193, DOI 10.1007/BF00273000	38	56	58	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1990	46	5					888	895						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DD896	2339689				2022-12-18	WOS:A1990DD89600004
J	MIDDLETONPRICE, HR; HARDING, AE; MONTEIRO, C; BERCIANO, J; MALCOLM, S				MIDDLETONPRICE, HR; HARDING, AE; MONTEIRO, C; BERCIANO, J; MALCOLM, S			LINKAGE OF HEREDITARY MOTOR AND SENSORY NEUROPATHY TYPE-I TO THE PERICENTROMERIC REGION OF CHROMOSOME-17	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									INST CHILD HLTH,MOTHERCARE DEPT PAEDIAT GENET,30 GUILFORD ST,LONDON WC1N 1EH,ENGLAND; UNIV LONDON,INST NEUROL,DEPT CLIN NEUROL,LONDON,ENGLAND; HOSP NACL MARQUES VALDECILLA,SANTANDER,SPAIN	University of London; University College London; University of London; University College London; Hospital Universitario Marques de Valdecilla (HUMV)								BIRD TD, 1982, AM J HUM GENET, V34, P388; BIRD TD, 1983, ANN NEUROL, V14, P675; DYCK PJ, 1983, MAYO CLIN PROC, V58, P430; GOLDGAR DE, 1989, AM J HUM GENET, V44, P6; GRIFFITHS LR, 1988, CYTOGENET CELL GENET, V45, P231; GUILOFF RJ, 1982, J NEUROL NEUROSUR PS, V45, P669, DOI 10.1136/jnnp.45.8.669; HARDING AE, 1980, BRAIN, V103, P259, DOI 10.1093/brain/103.2.259; LEDBETTER DH, 1989, AM J HUM GENET, V44, P20; MIDDLETONPRICE HR, 1989, GENOMICS, V4, P192, DOI 10.1016/0888-7543(89)90299-1; STEBBINS NB, 1982, AM J HUM GENET, V34, pA195; VANCE JM, 1989, EXP NEUROL, V104, P186, DOI 10.1016/S0014-4886(89)80013-5	11	56	56	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1990	46	1					92	94						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ043	2294757				2022-12-18	WOS:A1990CJ04300011
J	BROWN, CJ; WILLARD, HF				BROWN, CJ; WILLARD, HF			NONINACTIVATION OF A SELECTABLE HUMAN X-LINKED GENE THAT COMPLEMENTS A MURINE TEMPERATURE-SENSITIVE CELL-CYCLE DEFECT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TORONTO,DEPT MED GENET,TORONTO M5S 1A1,ONTARIO,CANADA	University of Toronto			Brown, Carolyn J/A-5159-2014	Brown, Carolyn J/0000-0002-8959-0101				BROWN CJ, 1989, SOMAT CELL MOLEC GEN, V15, P173, DOI 10.1007/BF01535079; BURGOYNE PS, 1982, HUM GENET, V61, P85, DOI 10.1007/BF00274192; DAVIDSON RG, 1963, P NATL ACAD SCI USA, V50, P481, DOI 10.1073/pnas.50.3.481; ELLIS NA, 1989, NATURE, V337, P81, DOI 10.1038/337081a0; FEARON ER, 1987, NEW ENGL J MED, V316, P427, DOI 10.1056/NEJM198702193160802; Gartler S M, 1976, Adv Hum Genet, V7, P99; GARTLER SM, 1972, NATURE-NEW BIOL, V236, P149, DOI 10.1038/newbio236149a0; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; GEALY WJ, 1980, LANCET, V1, P63; GELLER RL, 1986, AM J HUM GENET, V38, P884; GOODFELLOW P, 1984, AM J HUM GENET, V36, P777; GOODFELLOW PJ, 1988, P NATL ACAD SCI USA, V85, P5605, DOI 10.1073/pnas.85.15.5605; GRAVES JAM, 1986, SOMAT CELL MOLEC GEN, V12, P275, DOI 10.1007/BF01570786; HARPER P, 1988, Cytogenetics and Cell Genetics, V49, P254, DOI 10.1159/000132670; KEITH DH, 1986, MOL CELL BIOL, V6, P4122, DOI 10.1128/MCB.6.11.4122; LYON MF, 1988, AM J HUM GENET, V42, P8; LYON MF, 1972, BIOL REV, V47, P1; MCKUSICK VA, 1988, MENDELIAN INHERITANC; Meera Khan P, 1971, Arch Biochem Biophys, V145, P470; MEYER WJ, 1975, P NATL ACAD SCI USA, V72, P1469, DOI 10.1073/pnas.72.4.1469; MIGEON BR, 1982, NATURE, V299, P838, DOI 10.1038/299838a0; MIGEON BR, 1982, CELL, V29, P595, DOI 10.1016/0092-8674(82)90175-1; MIGEON BR, 1981, P NATL ACAD SCI-BIOL, V78, P5066, DOI 10.1073/pnas.78.8.5066; MIGEON BR, 1968, SCIENCE, V160, P425, DOI 10.1126/science.160.3826.425; NADON N, 1988, SOMAT CELL MOLEC GEN, V14, P541, DOI 10.1007/BF01535309; PAGE DC, 1987, CELL, V51, P1091, DOI 10.1016/0092-8674(87)90595-2; PASSARGE E, 1973, NATURE-NEW BIOL, V245, P58, DOI 10.1038/newbio245058a0; RACE RR, 1975, BLOOD GROUPS MAN, P579; SALZMANN J, 1968, P NATL ACAD SCI USA, V60, P545, DOI 10.1073/pnas.60.2.545; SCHEMPP W, 1983, HUM GENET, V63, P171, DOI 10.1007/BF00291539; SCHNEIDERGADICK.A, IN PRESS CELL; SHAPIRO LJ, 1979, SCIENCE, V204, P1224, DOI 10.1126/science.156396; SHEININ R, 1976, CELL, V7, P49, DOI 10.1016/0092-8674(76)90254-3; TANTRAVAHI U, 1983, HUM GENET, V64, P33, DOI 10.1007/BF00289475; WILLARD HF, 1984, HUM GENET, V66, P272, DOI 10.1007/BF00286615; WILLARD HF, 1983, NUCLEIC ACIDS RES, V11, P2017, DOI 10.1093/nar/11.7.2017; WILLARD HF, 1976, AM J HUM GENET, V28, P213; WILLARD HF, 1977, CHROMOSOMA, V61, P61, DOI 10.1007/BF00292681; 1986, CATALOG CELL LINES	39	56	56	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1989	45	4					592	598						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AW395	2491017				2022-12-18	WOS:A1989AW39500013
J	EMANUEL, BS				EMANUEL, BS			MOLECULAR CYTOGENETICS - TOWARD DISSECTION OF THE CONTIGUOUS GENE SYNDROMES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material									UNIV PENN,SCH MED,DEPT PEDIAT,DIV HUMAN GENET & MOLEC BIOL,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT HUMAN GENET,DIV HUMAN GENET & MOLEC BIOL,PHILADELPHIA,PA 19104	University of Pennsylvania; University of Pennsylvania								BIEGEL J A, 1987, American Journal of Human Genetics, V41, pA22; BUDARF M, 1988, American Journal of Human Genetics, V43, pA139; BUTLER MG, 1986, AM J MED GENET, V23, P793, DOI 10.1002/ajmg.1320230307; DAVIS LM, 1988, SCIENCE, V241, P840, DOI 10.1126/science.2841760; EJIMA Y, 1988, HUM GENET, V79, P118, DOI 10.1007/BF00280548; FIBISON W J, 1987, American Journal of Human Genetics, V41, pA119; GREENBERG F, 1988, AM J HUM GENET, V43, P605; GRIFFIN CA, 1988, CANCER RES, V48, P175; LEDBETTER D H, 1988, American Journal of Human Genetics, V43, pA111; LINDSLEY DL, 1972, GENETICS, V71, P157; MCDERMID H E, 1988, American Journal of Human Genetics, V43, pA152; NIIKAWA N, 1985, HUM GENET, V69, P22, DOI 10.1007/BF00295524; ORKIN SH, 1986, CELL, V47, P845, DOI 10.1016/0092-8674(86)90799-3; SCHMICKEL RD, 1986, J PEDIATR-US, V109, P231, DOI 10.1016/S0022-3476(86)80377-8; SCHWARTZ CE, 1988, AM J HUM GENET, V43, P597; VANTUINEN P, 1988, AM J HUM GENET, V43, P587; VANTUINEN P, 1987, AM J HUM GENET S, V41, pA144	17	56	57	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1988	43	5					575	578						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q9336	3189328				2022-12-18	WOS:A1988Q933600001
J	MUSARELLA, MA; BURGHES, A; ANSONCARTWRIGHT, L; MAHTANI, MM; ARGONZA, R; TSUI, LC; WORTON, R				MUSARELLA, MA; BURGHES, A; ANSONCARTWRIGHT, L; MAHTANI, MM; ARGONZA, R; TSUI, LC; WORTON, R			LOCALIZATION OF THE GENE FOR X-LINKED RECESSIVE TYPE OF RETINITIS PIGMENTOSA (XLRP) TO XP21 BY LINKAGE ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HOSP SICK CHILDREN,RES INST,DEPT GENET,TORONTO M5G 1X8,ONTARIO,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	MUSARELLA, MA (corresponding author), HOSP SICK CHILDREN,RES INST,DEPT OPHTHALMOL,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA.		Tsui, Lap-chee/A-1081-2010	Burghes, Arthur/0000-0001-9031-1555				BAEHNER RL, 1986, P NATL ACAD SCI USA, V83, P3398, DOI 10.1073/pnas.83.10.3398; BAKKER E, 1985, LANCET, V1, P655; BAKKER E, 1987, NATURE, V329, P554, DOI 10.1038/329554a0; BARTLEY JA, 1986, J PEDIATR-US, V108, P189, DOI 10.1016/S0022-3476(86)80980-5; BERSON EL, 1980, AM J OPHTHALMOL, V89, P763, DOI 10.1016/0002-9394(80)90163-4; BERTELSON CJ, 1988, AM J HUM GENET, V42, P703; BHATTACHARYA SS, 1984, NATURE, V309, P253, DOI 10.1038/309253a0; BIRD AC, 1975, BRIT J OPHTHALMOL, V59, P177, DOI 10.1136/bjo.59.4.177; BIRD AC, 1970, T OPHTHALMOL SOC UK, V90, P1217; BOUGHMAN JA, 1980, AM J HUM GENET, V32, P223; BRUNS G, 1984, CYTOGENET CELL GENET, V37, P428; BUNKER CH, 1984, AM J OPHTHALMOL, V97, P357, DOI 10.1016/0002-9394(84)90636-6; BURGHES AHM, 1987, NATURE, V328, P434, DOI 10.1038/328434a0; CLAYTON JF, 1986, HUM GENET, V74, P168, DOI 10.1007/BF00282083; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; DARRAS BT, 1987, NATURE, V329, P556, DOI 10.1038/329556a0; DENTON MJ, 1988, HUM GENET, V78, P60, DOI 10.1007/BF00291236; DEUTMAN AF, 1977, HEREDITARY CHOROIDAL, V2, P480; DRAYNA D, 1985, SCIENCE, V230, P753, DOI 10.1126/science.4059909; FALLS HF, 1948, ARCH OPHTHALMOL-CHIC, V40, P685, DOI 10.1001/archopht.1948.00900030700009; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FISHMAN GA, 1978, ARCH OPHTHALMOL-CHIC, V96, P822, DOI 10.1001/archopht.1978.03910050428005; FISHMAN GA, 1986, ARCH OPHTHALMOL-CHIC, V104, P1329, DOI 10.1001/archopht.1986.01050210083030; FRANCKE U, 1985, AM J HUM GENET, V37, P250; FRANCKE U, 1987, AM J HUM GENET, V40, P212; FRANCOIS J, 1962, DOC OPHTHALMOL, V13, P111; FRIEDRICH U, 1985, HUM GENET, V71, P93; GINJAAR HB, 1987, CYTOGENET CELL GENET, V46, P620; GOODFELLOW PN, 1985, CYTOGENET CELL GENET, V40, P296, DOI 10.1159/000132178; HECKENLIVELY J, 1983, PRINCIPLES PRACTICE, V1, P522; HORWICH AL, 1984, SCIENCE, V224, P1068, DOI 10.1126/science.6372096; HURWITZ RL, 1985, J BIOL CHEM, V260, P568; Jay B, 1972, Trans Ophthalmol Soc U K, V92, P173; Johnson D. A., 1984, Gene Analysis Techniques, V1, P3, DOI 10.1016/0735-0651(84)90049-9; KENWRICK S, 1987, CELL, V48, P351, DOI 10.1016/0092-8674(87)90438-7; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; KOUSSEFF B, 1981, AM J DIS CHILD, V135, P1149, DOI 10.1001/archpedi.1981.02130360053025; KUNKEL LM, 1985, P NATL ACAD SCI USA, V82, P4778, DOI 10.1073/pnas.82.14.4778; KUNKEL LM, 1982, NUCLEIC ACIDS RES, V10, P1557, DOI 10.1093/nar/10.5.1557; KUNKEL LM, 1986, NATURE, V322, P842; LATHROP GM, 1986, GENET EPIDEMIOL, V3, P39, DOI 10.1002/gepi.1370030105; MACRAE WG, 1982, BIRTH DEFECTS-ORIG, V18, P175; MARTYN LJ, 1972, AM J OPHTHALMOL, V73, P403, DOI 10.1016/0002-9394(72)90070-0; MONACO AP, 1987, HUM GENET, V75, P221, DOI 10.1007/BF00281063; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; MUKAI S, 1985, AM J OPHTHALMOL, V100, P225, DOI 10.1016/0002-9394(85)90786-X; NUSSBAUM RL, 1985, HUM GENET, V70, P45, DOI 10.1007/BF00389458; OTT J, 1974, AM J HUM GENET, V26, P588; PATIL SR, 1985, CYTOGENET CELL GENET, V40, P720; RAY PN, 1985, NATURE, V318, P672, DOI 10.1038/318672a0; REINBERG M H, 1950, Calif Med, V73, P266; REINIER WO, 1982, CLIN GENET, V24, P243; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; ROYERPOKORA B, 1986, NATURE, V322, P32, DOI 10.1038/322032a0; SCHAPPERT-KIMMIJSER J, 1963, Bull Mem Soc Fr Ophtalmol, V76, P122; SIEVING PA, 1978, BRIT J OPHTHALMOL, V62, P163, DOI 10.1136/bjo.62.3.163; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SZAMIER RB, 1979, INVEST OPHTH VIS SCI, V18, P145; TASMAN W, 1971, RETINAL DISEASES CHI, P30; UNTERRICHTER LV, 1941, Z MENSCHLICHE VEREBU, V25, P539; VANOMMEN GJB, 1986, CELL, V47, P499, DOI 10.1016/0092-8674(86)90614-8; WAPENAAR MC, 1987, CYTOGENET CELL GENET; WIEACKER P, 1984, AM J HUM GENET, V36, P265; WIERINGA B, 1985, CLIN GENET, V27, P522; WILSON JM, 1982, J CLIN INVEST, V69, P706, DOI 10.1172/JCI110499; WRIGHT AF, 1983, T OPHTHAL SOC UK, V103, P467; WRIGHT AF, 1987, AM J HUM GENET, V41, P635	67	56	59	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1988	43	4					484	494						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q4736	2902787				2022-12-18	WOS:A1988Q473600016
J	ZONANA, J; CLARKE, A; SARFARAZI, M; THOMAS, NST; ROBERTS, K; MARYMEE, K; HARPER, PS				ZONANA, J; CLARKE, A; SARFARAZI, M; THOMAS, NST; ROBERTS, K; MARYMEE, K; HARPER, PS			X-LINKED HYPOHIDROTIC ECTODERMAL DYSPLASIA - LOCALIZATION WITHIN THE REGION XQ11-21.1 BY LINKAGE ANALYSIS AND IMPLICATIONS FOR CARRIER DETECTION AND PRENATAL-DIAGNOSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WALES COLL MED,INST MED GENET,CARDIFF CF4 4XN,S GLAM,WALES; OREGON HLTH SCI UNIV,DEPT MED GENET,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DIV CRIPPLED CHILDREN,PORTLAND,OR 97201	Cardiff University; Oregon Health & Science University; Oregon Health & Science University								ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; ARNOLD ML, 1984, PRENATAL DIAG, V4, P85, DOI 10.1002/pd.1970040202; ARVEILER B, 1987, NUCLEIC ACIDS RES, V15, P5903, DOI 10.1093/nar/15.14.5903; ARVEILER B, 1987, Genomics, V1, P60, DOI 10.1016/0888-7543(87)90105-4; BAILIT HL, 1975, DENT CLIN N AM, V19, P125; BLECHER SR, 1986, J INVEST DERMATOL, V87, P720, DOI 10.1111/1523-1747.ep12456718; BOYD Y, IN PRESS CYTOGENET C; BRUNS G, 1984, CYTOGENET CELL GENET, V37, P428; CLARKE A, 1987, ARCH DIS CHILD, V62, P989, DOI 10.1136/adc.62.10.989; CLARKE A, 1987, HUM GENET, V75, P378, DOI 10.1007/BF00284112; COHEN MM, 1972, AM J HUM GENET, V24, P583; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRIAS JL, 1968, J PEDIATR-US, V72, P606, DOI 10.1016/S0022-3476(68)80002-2; GERALD PS, 1974, CYTOGENET CELL GENET, V13, P29, DOI 10.1159/000130228; GRZESCHIK KH, 1976, CYTOGENET CELL GENET, V16, P149, DOI 10.1159/000130577; HAPPLE R, 1985, CLIN GENET, V27, P468; HODGSON SV, 1987, HUM GENET, V75, P286, DOI 10.1007/BF00281076; HUTZ MH, 1984, HUM GENET, V66, P217, DOI 10.1007/BF00286604; KEITH DH, 1986, MOL CELL BIOL, V6, P4122, DOI 10.1128/MCB.6.11.4122; KLEINEBRECHT J, 1981, HUM GENET, V57, P437, DOI 10.1007/BF00281701; KOENIG M, 1985, NUCLEIC ACIDS RES, V13, P5485, DOI 10.1093/nar/13.15.5485; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; KOLVRAA S, 1986, HUM GENET, V74, P284; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LESKO JG, 1987, AM J HUM GENET, V40, P303; MACDERMOT KD, 1986, HUM GENET, V74, P172, DOI 10.1007/BF00282084; NAKATA M, 1980, AM J HUM GENET, V32, P908; OBERLE I, 1986, HUM GENET, V72, P43, DOI 10.1007/BF00278816; OHNO S, 1973, NATURE, V244, P259, DOI 10.1038/244259a0; OTT J, 1983, ANN HUM GENET, V47, P311, DOI 10.1111/j.1469-1809.1983.tb01001.x; OTT J, 1985, ANAL HUMAN GENETIC L, P111; PAGE D, 1982, P NATL ACAD SCI-BIOL, V79, P5352, DOI 10.1073/pnas.79.17.5352; PINHEIRO M, 1981, HUM GENET, V57, P428, DOI 10.1007/BF00281698; Pinheiro M., 1984, ECTODERMAL DYSPLASIA, P33; RIDDELL DC, 1986, CYTOGENET CELL GENET, V42, P123, DOI 10.1159/000132264; SCHMECKPEPER BJ, 1985, NUCLEIC ACIDS RES, V13, P5724, DOI 10.1093/nar/13.15.5724; SCHWARTZ M, IN PRESS CYTOGENET C; SEARLE A G, 1987, Genomics, V1, P3, DOI 10.1016/0888-7543(87)90099-1; SHOWS TB, 1974, CYTOGENET CELL GENET, V13, P146, DOI 10.1159/000130259; SHOWS TB, 1975, P NATL ACAD SCI USA, V72, P2125, DOI 10.1073/pnas.72.6.2125; STEVENSON AC, 1967, MUTAT RES, V4, P339, DOI 10.1016/0027-5107(67)90029-2; VOGELSTEIN B, 1987, CANCER RES, V47, P4806; WIEACKER P, 1984, AM J HUM GENET, V36, P265; YANG HM, IN PRESS CYTOGENET C; ZONANA J, IN PRESS J MED GENET	47	56	57	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1988	43	1					75	85						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	N9863	3163892				2022-12-18	WOS:A1988N986300011
J	KESSLING, AM; RAJPUTWILIAMS, J; BAINTON, D; SCOTT, J; MILLER, NE; BAKER, I; HUMPHRIES, SE				KESSLING, AM; RAJPUTWILIAMS, J; BAINTON, D; SCOTT, J; MILLER, NE; BAKER, I; HUMPHRIES, SE			DNA POLYMORPHISMS OF THE APOLIPOPROTEIN-AII AND AI-CIII-AIV GENES - A STUDY IN MEN SELECTED FOR DIFFERENCES IN HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL CONCENTRATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CHARING CROSS SUNLEY RES CTR, LURGAN AVE, LONDON W6 8LW, ENGLAND; ST THOMAS HOSP, SCH MED, DEPT CHEM PATHOL & METAB DISORDERS, LONDON SE1 7EH, ENGLAND; BRISTOL & WESTON AREA HLTH AUTHOR, BRISTOL, AVON, ENGLAND; CLIN RES CTR, MOLEC MED RES GRP, HARROW HA1 3UJ, MIDDX, ENGLAND	Imperial College London; University of Oxford; Guy's & St Thomas' NHS Foundation Trust			Miller, Norman E/P-6032-2017	Miller, Norman E/0000-0001-7087-3390; Humphries, Stephen E/0000-0002-8221-6547				BERG K, 1976, LANCET, V1, P499; CHEN CH, 1983, ARTERIOSCLEROSIS, V3, pA489; CHEUNG P, 1984, P NATL ACAD SCI-BIOL, V81, P508, DOI 10.1073/pnas.81.2.508; COLEMAN RT, 1986, MOL BIOL MED, V3, P213; ELWOOD PC, 1984, J EPIDEMIOL COMMUN H, V38, P259, DOI 10.1136/jech.38.3.259; FAGER G, 1981, ARTERIOSCLEROSIS, V1, P273, DOI 10.1161/01.ATV.1.4.273; FIELDING CJ, 1972, BIOCHEM BIOPH RES CO, V46, P1493, DOI 10.1016/0006-291X(72)90776-0; Fisher R., 1930, GENETICAL THEORY NAT; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; JAHN CE, 1981, FEBS LETT, V131, P366, DOI 10.1016/0014-5793(81)80405-X; JEFFREYS AJ, 1979, CELL, V18, P1, DOI 10.1016/0092-8674(79)90348-9; KARATHANASIS SK, 1985, P NATL ACAD SCI USA, V82, P6374, DOI 10.1073/pnas.82.19.6374; KESSLING AM, 1986, CLIN GENET, V29, P485; KESSLING AM, 1985, CLIN GENET, V28, P296; KNOTT TJ, 1984, BIOCHEM BIOPH RES CO, V125, P299, DOI 10.1016/S0006-291X(84)80368-X; LACKNER KJ, 1984, BIOCHEM BIOPH RES CO, V122, P877, DOI 10.1016/0006-291X(84)91172-0; MACIEJKO JJ, 1983, NEW ENGL J MED, V309, P385, DOI 10.1056/NEJM198308183090701; MILLER NE, 1977, LANCET, V1, P965, DOI 10.1016/S0140-6736(77)92274-7; MYERS RM, 1986, SCIENCE, V232, P613, DOI 10.1126/science.3457470; ORDOVAS JM, 1986, NEW ENGL J MED, V314, P671, DOI 10.1056/NEJM198603133141102; REES A, 1985, J CLIN INVEST, V76, P1090, DOI 10.1172/JCI112062; REES A, 1983, LANCET, V1, P444; Ryan B. F., 1985, MINITAB HDB; SCHAEFER EJ, 1978, J LIPID RES, V19, P667; SCOTT J, 1985, LANCET, V1, P771; SING CF, 1985, AM J HUM GENET, V37, P268; Sokal R.R., 1981, BIOMETRY PRINCIPLES; TEMPLETON AR, IN PRESS GENET RES; UTERMANN G, 1984, HUM GENET, V65, P232, DOI 10.1007/BF00286508; WARNICK GR, 1978, J LIPID RES, V19, P65; YAARI S, 1981, LANCET, V1, P1011	31	56	56	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1988	42	3					458	467						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M6206	2894758				2022-12-18	WOS:A1988M620600008
J	RISCH, N				RISCH, N			A NEW STATISTICAL TEST FOR LINKAGE HETEROGENEITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510	Yale University	RISCH, N (corresponding author), YALE UNIV,SCH MED,DEPT EPIDEMIOL & PUBL HLTH,60 COLL ST,POB 3333,NEW HAVEN,CT 06510, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K04HD000648] Funding Source: NIH RePORTER; NICHD NIH HHS [HDO0648] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BROWN WT, 1987, HUM GENET, V75, P311, DOI 10.1007/BF00284100; Hartigan J. A, 2012, BAYES THEORY; HODGE SE, 1983, AM J HUM GENET, V35, P1139; MORTON NE, 1956, AM J HUM GENET, V8, P80; OTT J, 1983, ANN HUM GENET, V47, P311, DOI 10.1111/j.1469-1809.1983.tb01001.x; OTT J, 1977, ANN HUM GENET, V40, P443, DOI 10.1111/j.1469-1809.1977.tb02031.x; OTT J, 1985, ANAL HUMAN GENETIC L; RAO DC, 1978, AM J HUM GENET, V30, P516; RISCH N, 1982, ANN HUM GENET, V46, P153, DOI 10.1111/j.1469-1809.1982.tb00706.x; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; TITTERINGTON DM, 1985, STATISTICAL ANAL FIN	11	56	56	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1988	42	2					353	364						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M3133	3341384				2022-12-18	WOS:A1988M313300018
J	HSU, LC; BENDEL, RE; YOSHIDA, A				HSU, LC; BENDEL, RE; YOSHIDA, A			DIRECT DETECTION OF USUAL AND ATYPICAL ALLELES ON THE HUMAN ALDEHYDE DEHYDROGENASE-2 (ALDH2) LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CITY HOPE NATL MED CTR,BECKMAN RES INT,1450 E DUARTE RD,DUARTE,CA 91010	City of Hope; Beckman Research Institute of City of Hope					NIAAA NIH HHS [AA-05763] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA005763] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; CONNER BJ, 1983, P NATL ACAD SCI-BIOL, V80, P278, DOI 10.1073/pnas.80.1.278; GOEDDE HW, 1980, ENZYME, V25, P281, DOI 10.1159/000459265; GOEDDE HW, 1979, HUM GENET, V51, P331; GOEDDE HW, 1979, CLIN GENET, V16, P29; GREENFIELD NJ, 1977, BIOCHIM BIOPHYS ACTA, V483, P35, DOI 10.1016/0005-2744(77)90005-5; HSU LC, 1985, P NATL ACAD SCI USA, V82, P3771, DOI 10.1073/pnas.82.11.3771; IKAWA M, 1983, J BIOL CHEM, V258, P6282; IMPRAIM C, 1982, AM J HUM GENET, V34, P837; KIDD VJ, 1983, NATURE, V304, P230, DOI 10.1038/304230a0; LACY E, 1983, CELL, V34, P343, DOI 10.1016/0092-8674(83)90369-0; MANIATIS T, 1982, MOL CLONING LABORATO; MIYADA CG, 1987, METHOD ENZYMOL, V154, P94; PIRASTU M, 1983, NEW ENGL J MED, V309, P284, DOI 10.1056/NEJM198308043090506; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; TENG YS, 1981, BIOCHEM GENET, V19, P107, DOI 10.1007/BF00486141; YOSHIDA A, 1984, HUM GENET, V66, P296, DOI 10.1007/BF00287631; YOSHIDA A, 1983, AM J HUM GENET, V35, P1107	19	56	58	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1987	41	6					996	1001						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	L2984	3687946				2022-12-18	WOS:A1987L298400003
J	GATTI, RA; SHAKED, R; MOHANDAS, TK; SALSER, W				GATTI, RA; SHAKED, R; MOHANDAS, TK; SALSER, W			HUMAN FERRITIN GENES - CHROMOSOMAL ASSIGNMENTS AND POLYMORPHISMS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF LOS ANGELES,SCH MED,DEPT BIOL,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,HARBOR MED CTR,DEPT PEDIAT,TORRANCE,CA 90509	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	GATTI, RA (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,DEPT PATHOL,LOS ANGELES,CA 90024, USA.				NATIONAL CANCER INSTITUTE [R01CA035966, R01CA032186] Funding Source: NIH RePORTER; NCI NIH HHS [CA 32186, CA 18586, CA 35966] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		CASKEY JH, 1983, P NATL ACAD SCI-BIOL, V80, P482, DOI 10.1073/pnas.80.2.482; CHOU CC, 1986, MOL CELL BIOL, V6, P566, DOI 10.1128/MCB.6.2.566; CRAGG SJ, 1985, HUM GENET, V71, P108; DAVIS RC, 1987, DEV BIOL, V119, P164, DOI 10.1016/0012-1606(87)90218-1; GATTI R A, 1984, Biotechniques, V2, P148; GILBERT F, 1984, CANCER RES, V44, P5444; HANN HWL, 1985, CANCER RES, V45, P2843; HENTZE MW, 1986, P NATL ACAD SCI USA, V83, P7226, DOI 10.1073/pnas.83.19.7226; LEBO RV, 1985, HUM GENET, V71, P325, DOI 10.1007/BF00388458; LINDAHL T, 1976, J MOL BIOL, V102, P511, DOI 10.1016/0022-2836(76)90331-4; MCGILL JR, 1987, HUM GENET, V76, P66; MOHANDAS T, 1986, SOMAT CELL MOLEC GEN, V12, P89, DOI 10.1007/BF01560731; REED KC, 1985, NUCLEIC ACIDS RES, V13, P7207, DOI 10.1093/nar/13.20.7207; VANDERIJN M, 1983, CYTOGENET CELL GENET, V36, P525, DOI 10.1159/000131967; YANG FM, 1984, P NATL ACAD SCI-BIOL, V81, P2752, DOI 10.1073/pnas.81.9.2752	15	56	56	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1987	41	4					654	667						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	K4621	2821803				2022-12-18	WOS:A1987K462100014
J	BARTELS, I; GRZESCHIK, KH; COOPER, DN; SCHMIDTKE, J				BARTELS, I; GRZESCHIK, KH; COOPER, DN; SCHMIDTKE, J			REGIONAL MAPPING OF 6 CLONED DNA-SEQUENCES ON HUMAN CHROMOSOME-7	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MUNSTER,INST HUMAN GENET,D-4400 MUNSTER,FED REP GER	University of Munster	BARTELS, I (corresponding author), UNIV GOTTINGEN,INST HUMAN GENET,GOSSLERSTR 12D,D-3400 GOTTINGEN,FED REP GER.		Cooper, David N/H-4384-2011	Cooper, David N/0000-0002-8943-8484				BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; CACCIA N, 1984, CELL, V37, P1091, DOI 10.1016/0092-8674(84)90443-4; CAVENEE W, 1984, AM J HUM GENET, V36, P10; COLLINS MKL, 1984, EMBO J, V3, P2347, DOI 10.1002/j.1460-2075.1984.tb02137.x; COOPER DN, 1984, HUM GENET, V66, P1, DOI 10.1007/BF00275182; COOPER DN, 1985, HUM GENET, V69, P201, DOI 10.1007/BF00293024; CROCE CM, 1974, J EXP MED, V140, P1221, DOI 10.1084/jem.140.5.1221; CROCE CM, 1975, SCIENCE, V190, P1200, DOI 10.1126/science.173020; DENHARDT DT, 1966, BIOCHEM BIOPH RES CO, V23, P641, DOI 10.1016/0006-291X(66)90447-5; GREEN L, 1984, SCIENCE, V226, P838, DOI 10.1126/science.6494913; KHAN PM, 1984, CYTOGENET CELL GENET, V37, P71; KHAN PM, 1983, BIOCHEM GENET, V21, P123; KRUMLAUFF, 1982, P NATL ACAD SCI, V79, P2971; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; SOUTHERN EM, 1982, CYTOGENET CELL GENET, V32, P52, DOI 10.1159/000131686; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; WIEACKER P, 1984, AM J HUM GENET, V36, P265; WILLECKE K, 1984, HUM GENET, V66, P132, DOI 10.1007/BF00286587	18	56	58	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1986	38	3					280	287						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	A5781	3456704				2022-12-18	WOS:A1986A578100002
J	HANNAH, MC; HOPPER, JL; MATHEWS, JD				HANNAH, MC; HOPPER, JL; MATHEWS, JD			TWIN CONCORDANCE FOR A BINARY TRAIT .2. NESTED ANALYSIS OF EVER-SMOKING AND EX-SMOKING TRAITS AND UNNESTED ANALYSIS OF A COMMITTED-SMOKING TRAIT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											HANNAH, MC (corresponding author), UNIV MELBOURNE,ROYAL MELBOURNE HOSP,DEPT MED,MELBOURNE,VIC 3050,AUSTRALIA.			Mathews, John/0000-0001-9029-7140				BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; CHERRY N, 1976, BRIT J PREV SOC MED, V30, P123; CLAUSEN JA, 1968, SOC SCI MED, V1, P357, DOI 10.1016/0037-7856(68)90040-1; COX DR, 1973, THEORETICAL STATISTI, P279; EAVES LJ, 1977, J ROY STAT SOC A STA, V140, P324, DOI 10.2307/2344924; Eysenck H.J., 1980, CAUSES EFFECTS SMOKI; HANNAH MC, 1983, ACTA GENET MED GEMEL, V32, P127, DOI 10.1017/S0001566000006413; HANNAH MC, 1984, 1 U MELB FM EP UN TE; HIGGINS MW, 1967, AM J EPIDEMIOL, V86, P45, DOI 10.1093/oxfordjournals.aje.a120733; HOPPER JL, 1982, ANN HUM GENET, V46, P373, DOI 10.1111/j.1469-1809.1982.tb01588.x; KAPLAN B, 1972, U N CAROLINA I STATI, V823; KAPRIO J, 1983, INT J EPIDEMIOL, V11, P378; MARTIN NG, 1979, ACTA GENET MED GEMEL, V28, P197, DOI 10.1017/S0001566000009053; MARTIN NG, 1975, ANN HUM GENET, V39, P213, DOI 10.1111/j.1469-1809.1975.tb00124.x; OCONNELL DL, 1981, INT J EPIDEMIOL, V10, P223, DOI 10.1093/ije/10.3.223; SMITH C, 1974, AM J HUM GENET, V26, P454; SPIELBERGER CD, 1982, J PERS ASSESS, V46, P396, DOI 10.1207/s15327752jpa4604_11	17	56	56	1	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	1					153	165						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AGY57	4038848				2022-12-18	WOS:A1985AGY5700016
J	HASSTEDT, SJ; ATKIN, CL				HASSTEDT, SJ; ATKIN, CL			X-LINKED INHERITANCE OF ALPORT SYNDROME - FAMILY-P REVISITED	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV UTAH,DEPT INTERNAL MED,SALT LAKE CITY,UT 84132; UNIV UTAH,DEPT BIOCHEM,SALT LAKE CITY,UT 84132	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	HASSTEDT, SJ (corresponding author), UNIV UTAH,DEPT HUMAN GENET,SALT LAKE CITY,UT 84132, USA.				NCRR NIH HHS [RR-64] Funding Source: Medline; NIADDK NIH HHS [AM-26627] Funding Source: Medline; NICHD NIH HHS [HD-17463] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017463, R23HD017463] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		CANNINGS C, 1977, CLIN GENET, V12, P208; CASSADY G, 1965, PEDIATRICS, V35, P967; CHAZAN JA, 1971, AM J MED, V50, P764, DOI 10.1016/0002-9343(71)90184-7; CRAWFURD MD, 1968, Q J MED, V37, P563; DEMENAIS FM, 1981, HUM HERED, V31, P93, DOI 10.1159/000153185; EVANS SH, 1980, CLIN GENET, V17, P285; GLADSTIEN K, 1979, CLIN GENET, V15, P171; GRAHAM JB, 1959, AM J HUM GENET, V11, P333; GUBLER M, 1981, AM J MED, V70, P493, DOI 10.1016/0002-9343(81)90571-4; Habib R, 1982, Kidney Int Suppl, V11, pS20; Haldane JBS, 1936, ANN EUGENIC, V7, P28, DOI 10.1111/j.1469-1809.1936.tb02127.x; HASSTEDT SJ, 1979, AM J HUM GENET, V31, pA135; HASSTEDT SJ, UNPUB GENERAL AUTOSO; HASSTEDT SJ, 1979, 13 U UT DEP MED BIOP; HASSTEDT SJ, UNPUB INVESTIGATION; LALOUEL JM, 1979, 14 U UT DEP MED BIOP; LI CC, 1968, AM J HUM GENET, V20, P61; MACNEILL E, 1973, J MED GENET, V10, P23, DOI 10.1136/jmg.10.1.23; MORTON NE, 1957, AM J HUM GENET, V9, P55; MULROW PJ, 1963, AM J MED, V35, P737, DOI 10.1016/0002-9343(63)90237-7; ONEILL WM, 1980, PATHOL RES PRACT, V168, P146, DOI 10.1016/S0344-0338(80)80214-7; ONEILL WM, 1978, ANN INTERN MED, V88, P176, DOI 10.7326/0003-4819-88-2-176; PATTON RB, 1970, ANN OTO RHINOL LARYN, V79, P194, DOI 10.1177/000348947007900119; PERKOFF GT, 1951, ARCH INTERN MED, V88, P191, DOI 10.1001/archinte.1951.03810080059006; PERKOFF GT, 1958, ARCH INTERN MED, V102, P733, DOI 10.1001/archinte.1958.00260220049005; PREUS M, 1971, Clinical Genetics, V2, P331; PURRIEL P, 1970, American Journal of Medicine, V49, P753, DOI 10.1016/S0002-9343(70)80057-2; SHAW RF, 1961, AM J HUM GENET, V13, P89; STEPHENS FE, 1951, AM J HUM GENET, V3, P303; THOMPSON EA, 1979, GENETIC ANAL COMMON, P363; TISHLER P V, 1974, Birth Defects Original Article Series, V10, P93; TISHLER PV, 1979, CLIN GENET, V16, P291; 1979, UTAH VITAL STATISTIC	33	56	57	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	6					1241	1251						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RU705	6650503				2022-12-18	WOS:A1983RU70500017
J	WEITKAMP, LR; NEE, L; KEATS, B; POLINSKY, RJ; GUTTORMSEN, S				WEITKAMP, LR; NEE, L; KEATS, B; POLINSKY, RJ; GUTTORMSEN, S			ALZHEIMER-DISEASE - EVIDENCE FOR SUSCEPTIBILITY LOCI ON CHROMOSOME-6 AND CHROMOSOME-14	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV ROCHESTER,SCH MED & DENT,DIV GENET,ROCHESTER,NY 14642; NIMH,CLIN SCI LAB,BETHESDA,MD 20205; UNIV HAWAII,POPULAT GENET LAB,HONOLULU,HI 96822	University of Rochester; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Hawaii System	WEITKAMP, LR (corresponding author), UNIV ROCHESTER,SCH MED & DENT,DEPT PSYCHIAT,ROCHESTER,NY 14642, USA.				NIMH NIH HHS [9-K02-MH-00124] Funding Source: Medline; NINDS NIH HHS [5-R01-NS-14897] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALPER CA, 1972, J EXP MED, V135, P68, DOI 10.1084/jem.135.1.68; BRUNING JW, 1976, DHEW NIH76545 PUBL, P29; COOK RH, 1979, NEUROLOGY, V29, P1402, DOI 10.1212/WNL.29.10.1402; DRAKE C, 1976, DHEW NIH76545 PUBL, P35; GOUDSMIT J, 1981, J NEUROL SCI, V49, P79, DOI 10.1016/0022-510X(81)90190-8; HESTON LL, 1978, BEHAV GENET, V8, P315, DOI 10.1007/BF01067395; ISHII T, 1976, ACTA NEUROPATHOL, V36, P243, DOI 10.1007/BF00685368; LAMM LU, 1978, TISSUE ANTIGENS, V11, P132, DOI 10.1111/j.1399-0039.1978.tb01237.x; MOREAUDUBOIS MC, 1981, NEUROLOGY, V31, P323, DOI 10.1212/WNL.31.3.323; MORTON NE, 1981, HUM HERED, V31, P3, DOI 10.1159/000153168; NEE LE, 1983, ARCH NEUROL; SCHANFIELD MS, 1978, BASIC CLIN IMMUNOLOG; UNO, 1981, NATURE, V292, P768; WALFORD RL, 1980, HISTOCOMPATIBILITY T, P727; WEITKAMP LR, 1982, CYTOGENET CELL GENET, V32, P130, DOI 10.1159/000131693; WEITKAMP LR, 1983, 3RD ANN S ENV EP PIT; WHITTINGHAM S, 1981, TISSUE ANTIGENS, V17, P252	17	56	59	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	3					443	453						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QS160	6859040				2022-12-18	WOS:A1983QS16000010
J	NAYLOR, SL; ELLIOTT, RW; BROWN, JA; SHOWS, TB				NAYLOR, SL; ELLIOTT, RW; BROWN, JA; SHOWS, TB			MAPPING OF AMINOACYLASE-1 AND BETA-GALACTOSIDASE-A TO HOMOLOGOUS REGIONS OF HUMAN-CHROMOSOME 3 AND MOUSE CHROMOSOME-9 SUGGESTS LOCATION OF ADDITIONAL GENES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT MOLEC BIOL,BUFFALO,NY 14263; VIRGINIA COMMONWEALTH UNIV,RICHMOND,VA 23298	Roswell Park Cancer Institute; Virginia Commonwealth University	NAYLOR, SL (corresponding author), NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT GENET,BUFFALO,NY 14263, USA.				NICHD NIH HHS [HD-05196] Funding Source: Medline; NIGMS NIH HHS [GM-28464, GM-20454] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD005196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028464, R01GM020454] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY DW, 1971, TRANSPLANTATION, V11, P325, DOI 10.1097/00007890-197103000-00013; BOONE C, 1972, P NATL ACAD SCI USA, V69, P510, DOI 10.1073/pnas.69.2.510; BREEN GAM, 1977, GENETICS, V85, P73; DAVIDSON RL, 1976, SOMAT CELL GENET, V2, P165, DOI 10.1007/BF01542629; De La Chapelle A, 1975, Cytogenet Cell Genet, V15, P404, DOI 10.1159/000130541; DIZIK M, 1981, J NATL CANCER I, V66, P755; ELLIOTT RW, 1978, ELECTROPHORESIS 78, P261; Haldane JBS, 1931, GENETICS, V16, P0357; JOHANNSMANN R, 1979, CYTOGENET CELL GENET, V25, P167; KIT S, 1980, CYTOGENET CELL GENET, V26, P93, DOI 10.1159/000131430; LALLEY PA, 1978, P NATL ACAD SCI USA, V75, P2382, DOI 10.1073/pnas.75.5.2382; LALLEY PA, 1980, FED PROC, V39, P1915; LALLEY PA, 1980, ISOZYME B, V13, P29; LITTLEFIELD JW, 1964, SCIENCE, V145, P709, DOI 10.1126/science.145.3633.709; MEISLER MH, 1976, BIOCHEM GENET, V14, P921, DOI 10.1007/BF00485125; MOWBRAY S, 1972, ANN HUM GENET, V36, P153, DOI 10.1111/j.1469-1809.1972.tb00766.x; NAYLOR SL, 1978, P NATL ACAD SCI USA, V75, P6159, DOI 10.1073/pnas.75.12.6159; NAYLOR SL, 1979, SOMAT CELL GENET, V5, P11, DOI 10.1007/BF01538782; OHNO S, 1964, CHROMOSOMA, V15, P14, DOI 10.1007/BF00326912; OWERBACH D, 1980, SCIENCE, V209, P289, DOI 10.1126/science.7384802; OWERBACH D, 1981, SOMAT CELL GENET, V7, P359, DOI 10.1007/BF01538860; OWERBACH D, 1981, P NATL ACAD SCI-BIOL, V78, P3123, DOI 10.1073/pnas.78.5.3123; OWERBACH D, 1980, NATURE, V286, P82, DOI 10.1038/286082a0; PEARSON PL, 1979, CYTOGENET CELL GENET, V25, P82, DOI 10.1159/000131403; ROBSON EB, 1966, ANN HUM GENET, V29, P325, DOI 10.1111/j.1469-1809.1966.tb00528.x; SHOWS TB, 1975, P NATL ACAD SCI USA, V72, P2125, DOI 10.1073/pnas.72.6.2125; SHOWS TB, 1968, P NATL ACAD SCI USA, V61, P574, DOI 10.1073/pnas.61.2.574; SHOWS TB, 1978, CYTOGENET CELL GENET, V21, P99, DOI 10.1159/000130882; SHOWS TB, 1979, SOMAT CELL GENET, V5, P147, DOI 10.1007/BF01539157; TAYLOR BA, 1975, NATURE, V256, P644, DOI 10.1038/256644a0; TAYLOR BA, 1976, GENET RES, V26, P307; VOSS R, 1980, ANN HUM GENET, V44, P1, DOI 10.1111/j.1469-1809.1980.tb00940.x; WOMACK JE, 1975, BIOCHEM GENET, V13, P511, DOI 10.1007/BF00484910	33	56	56	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1982	34	2					235	244						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NH732	6803586				2022-12-18	WOS:A1982NH73200007
J	CAO, A; FURBETTA, M; GALANELLO, R; MELIS, MA; ANGIUS, A; XIMENES, A; ROSATELLI, C; RUGGERI, R; ADDIS, M; TUVERI, T; FALCHI, AM; PAGLIETTI, E; SCALAS, MT				CAO, A; FURBETTA, M; GALANELLO, R; MELIS, MA; ANGIUS, A; XIMENES, A; ROSATELLI, C; RUGGERI, R; ADDIS, M; TUVERI, T; FALCHI, AM; PAGLIETTI, E; SCALAS, MT			PREVENTION OF HOMOZYGOUS BETA-THALASSEMIA BY CARRIER SCREENING AND PRENATAL-DIAGNOSIS IN SARDINIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											CAO, A (corresponding author), UNIV CAGLIARI,PEDIAT CLIN 2,I-09100 CAGLIARI,ITALY.		Falchi, Angela Maria/C-4857-2015	Falchi, Angela Maria/0000-0001-7570-3737; ROSATELLI, MARIA CRISTINA/0000-0001-6821-3190	NHLBI NIH HHS [R01 HL-24173-01] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTER BP, 1976, NEW ENGL J MED, V295, P1437, DOI 10.1056/NEJM197612232952601; BARRAI I, 1980, J GENET HUM, V28, P97; BETKE K, 1959, NATURE, V184, P1877, DOI 10.1038/1841877a0; BEUTLER E, 1971, NEW ENGL J MED, V285, P1485; BOWMAN JE, 1972, NEW ENGL J MED, V287, P204; BOYER SH, 1976, BLOOD, V47, P883; Cao A, 1980, Ann N Y Acad Sci, V344, P165, DOI 10.1111/j.1749-6632.1980.tb33659.x; CAO A, 1978, J MED GENET, V15, P443, DOI 10.1136/jmg.15.6.443; CAO A, J MED GENET; FAIRWEATHER DVI, 1980, BRIT J OBSTET GYNAEC, V87, P87, DOI 10.1111/j.1471-0528.1980.tb04499.x; FAIRWEATHER DVI, 1978, BRIT MED J, V1, P350, DOI 10.1136/bmj.1.6109.350; FOST N, 1973, PEDIATRICS, V51, P742; FURBETTA M, 1980, BRIT J HAEMATOL, V44, P441, DOI 10.1111/j.1365-2141.1980.tb05914.x; FURBETTA M, 1978, ISRAEL J MED SCI, V14, P1107; GALANELLO R, 1977, ACTA HAEMATOL-BASEL, V57, P32, DOI 10.1159/000207857; GALANELLO R, 1979, HEMOGLOBIN, V3, P33, DOI 10.3109/03630267909069153; GALANELLO R, UNPUBLISHED; HAMPTON ML, 1974, AM J DIS CHILD, V128, P58, DOI 10.1001/archpedi.1974.02110260060010; HEADINGS V, 1975, AM J PUBLIC HEALTH, V65, P819, DOI 10.2105/AJPH.65.8.819; HUISMAN THJ, 1975, J LAB CLIN MED, V86, P700; KABACK MM, 1974, PROG MED GENET, V10, P103; KAN YW, 1977, LANCET, V1, P269; KAN YW, 1975, LANCET, V2, P790; KLEIHAUER E, 1957, KLIN WOCHENSCHR, V35, P637, DOI 10.1007/BF01481043; LAUBER K, 1965, Z KLIN CHEM KLIN BIO, V3, P96; MELIS MA, 1980, ACTA HAEMATOL-BASEL, V63, P32, DOI 10.1159/000207365; MODELL B, 1976, BRIT MED BULL, V32, P270, DOI 10.1093/oxfordjournals.bmb.a071374; MOTULSKY AG, 1974, SCIENCE, V185, P653, DOI 10.1126/science.185.4152.653; PEMBREY ME, 1972, J CLIN PATHOL, V25, P738, DOI 10.1136/jcp.25.8.738; ROWLEY PT, 1979, AM J HUM GENET, V31, P718; RUCKNAGEL DL, 1974, ARCH INTERN MED, V133, P595, DOI 10.1001/archinte.133.4.595; RUTKOW IM, 1974, AM J PUBLIC HEALTH, V64, P217, DOI 10.2105/AJPH.64.3.217; SCHMIDT RM, 1974, AM J PUBLIC HEALTH, V64, P799, DOI 10.2105/AJPH.64.8.799; SHINE I, 1977, LANCET, V1, P692; Stamatoyannoulos G., 1974, BIRTH DEFECTS, P268; Weatherall DJ, 1972, THALASSEMIA SYNDROME; WHITTEN CF, 1973, NEW ENGL J MED, V288, P318, DOI 10.1056/NEJM197302082880612; 1976, J AM MED ASS, V236, P1471	38	56	56	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	4					592	605						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LZ348	7258188				2022-12-18	WOS:A1981LZ34800013
J	RAUM, D; MARCUS, D; ALPER, CA				RAUM, D; MARCUS, D; ALPER, CA			GENETIC-POLYMORPHISM OF HUMAN-PLASMINOGEN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CHILDRENS HOSP MED CTR,DEPT MED,BOSTON,MA 02115	Harvard University; Boston Children's Hospital	RAUM, D (corresponding author), PETER BENT BRIGHAM HOSP,DEPT MED,CTR BLOOD RES,BOSTON,MA 02115, USA.				NHLBI NIH HHS [HL-11414] Funding Source: Medline; NIAID NIH HHS [AI-15033, AI-14157] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI014157, R37AI014157] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AOKI N, 1978, J CLIN INVEST, V61, P1186, DOI 10.1172/JCI109034; AWDEH ZL, 1968, NATURE, V219, P66, DOI 10.1038/219066a0; BROCKWAY WJ, 1972, ARCH BIOCHEM BIOPHYS, V151, P194, DOI 10.1016/0003-9861(72)90488-2; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; HAYES ML, 1979, J BIOL CHEM, V254, P8768; HOBART MJ, 1979, ANN HUM GENET, V42, P419, DOI 10.1111/j.1469-1809.1979.tb00675.x; IWAMOTO M, 1975, THROMB DIATH HAEMOST, V33, P573, DOI 10.1055/s-0038-1647851; RAUM D, 1979, CLIN RES, V27, pA458; RAUM D, 1979, AM J HUM GENET, V31, P35; Robbins K C, 1976, Methods Enzymol, V45, P257; Robbins K. C., 1970, METHOD ENZYMOL, V19, P184; ROBBINS KC, 1975, J BIOL CHEM, V250, P4044; ROBBINS KC, 1972, J BIOL CHEM, V247, P6757; ROBBINS KC, 1973, J BIOL CHEM, V248, P7242; ROBBINS KC, 1975, PROTEASES BIOL CONTR, P305; SIEFRING GE, 1975, J APPL PHYSIOL, V38, P114, DOI 10.1152/jappl.1975.38.1.114; SUMMARIA L, 1975, J BIOL CHEM, V250, P3988; SUMMARIA L, 1976, J BIOL CHEM, V251, P3693; SUMMARIA L, 1973, J BIOL CHEM, V248, P2984; SUMMARIA L, 1972, J BIOL CHEM, V247, P4694; WALLEN P, 1972, BIOCHIM BIOPHYS ACTA, V257, P122, DOI 10.1016/0005-2795(72)90261-9; [No title captured]	22	56	56	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	5					681	689						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KJ795	7424908				2022-12-18	WOS:A1980KJ79500006
J	CLONINGER, CR; RICE, J; REICH, T				CLONINGER, CR; RICE, J; REICH, T			MULTIFACTORIAL INHERITANCE WITH CULTURAL TRANSMISSION AND ASSORTATIVE MATING .3. FAMILY-STRUCTURE AND THE ANALYSIS OF SEPARATION EXPERIMENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JEWISH HOSP ST LOUIS,ST LOUIS,MO 63110	Barnes-Jewish Hospital	CLONINGER, CR (corresponding author), WASHINGTON UNIV,SCH MED,DEPT PSYCHIAT,ST LOUIS,MO 63110, USA.		Cloninger, Claude/F-5357-2012	Cloninger, Claude/0000-0003-3096-4807				Carter H, 1976, MARRIAGE DIVORCE SOC; CATTELL RB, 1967, J PERS SOC PSYCHOL, V7, P351, DOI 10.1037/h0025248; CLONINGER CR, 1979, AM J HUM GENET, V31, P176; CLONINGER CR, 1979, ALCOHOLISM AFFECTIVE; CLONINGER CR, UNPUBLISHED; FAST I, 1966, AM J ORTHOPSYCHIAT, V36, P485, DOI 10.1111/j.1939-0025.1966.tb02392.x; Jencks C, 1972, INEQUALITY REASSESSM; JUELNIELSEN N, 1965, ACTA PSYCHIATR  S183; LI CC, 1978, GENETIC EPIDEMIOLOGY; NANCE WE, 1976, GENETICS, V83, P811; NANCE WE, 1979, P GENETIC ANAL COMMO; NANCE WE, 1977, GENETICS, V85; Newman HH., 1937, TWINS STUDY HEREDITY; RAO DC, 1974, AM J HUM GENET, V26, P331; REEVE EC, 1961, GENET RES, V2, P195, DOI 10.1017/S0016672300000707; RICE J, 1978, AM J HUM GENET, V30, P618; Rudin E, 1923, Z GESAMTE NEUROL PSY, V81, P459; SCHUCKIT MA, 1972, AM J PSYCHIAT, V128, P122; Shields J., 1962, MONOZYGOTIC TWINS BR; Wright S., 1952, Quantitative inheritance. Papers read at a colloquium held at the Institute of Animal Genetics Edinburgh University under the auspices of the Agricultural Research Council April 4th to 6th, 1950., P5; [No title captured]; 1970 CENSUS POPULATI, V2	22	56	56	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1979	31	3					366	388						23	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	HE538	572636				2022-12-18	WOS:A1979HE53800010
J	MARTIN, AO; KURCZYNS.TW; STEINBER.AG				MARTIN, AO; KURCZYNS.TW; STEINBER.AG			FAMILIAL STUDIES OF MEDICAL AND ANTHROPOMETRIC VARIABLES IN A HUMAN ISOLATE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CASE WESTERN RESERVE UNIV,DEPT BIOMETRY,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,DEPT BIOL,CLEVELAND,OH 44106; UNIV MICHIGAN HOSP,DEPT INTERN MED,ANN ARBOR,MI 48104	Case Western Reserve University; Case Western Reserve University; University of Michigan System; University of Michigan								BLEIBTREU HK, 1964, THESIS HARVARD U; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; CRUZCOKE R, 1964, ACTA GENET STAT MED, V15, P87; EATON JOSEPH W., 1953, HUMAN BIOL, V25, P206; Falconer D.S., 1961, INTRO QUANTITATIVE G; HOWELLS WW, 1966, ANN NY ACAD SCI, V134, P624, DOI 10.1111/j.1749-6632.1966.tb43050.x; HOWELLS WW, 1970, HUTTERITE AGE DIFFER; JENSEN J, 1965, J LIPID RES, V6, P193; JOHNSON BC, 1965, J CHRON DIS, V18, P147, DOI 10.1016/0021-9681(65)90098-6; KENDALL MG, 1948, ADV THEORY STATISTIC; KRIEGER H, 1969, AM J HUM GENET, V21, P537; MANGE AP, 1964, HUM BIOL, V36, P104; MANGE AP, 1963, THESIS U WISCONSIN; MCCONOUGH JR, 1962, CIRCULATION, V25, P962; MIALL W E, 1963, Br Med J, V1, P75; NEEL JV, 1970, AM J HUM GENET, V22, P263; Osborne RH, 1959, GENETIC BASIS MORPHO; PETERS V, 1965, ALL THINGS COMMON HU; SCHAEFER LE, 1958, CIRCULATION, V17, P537, DOI 10.1161/01.CIR.17.4.537; SCHREIDER E, 1961, NATURE, V192, P1311, DOI 10.1038/1921311a0; SCHULL WJ, 1970, AM J HUM GENET, V22, P239; Schull WJ, 1965, EFFECTS INBREEDING J; SHEPS MC, 1965, POP STUD-J DEMOG, V19, P65, DOI 10.2307/2173165; SPUHLER JN, 1968, EUGEN QUART, V15, P128, DOI 10.1080/19485565.1968.9987763; Steel R. G., 1980, PRINCIPLES PROCEDURE, P481; STEINBERG AG, 1967, 3RD P INT C HUM GEN, P267; TAKKUNEN J, 1964, ANN ACAD SCI FENN  S, P1; ZIEGLESCHMID VTF, 1947, KLEIN GESCHICHTSBUCH	28	56	56	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1973	25	6					581	593						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	R7135	4797966				2022-12-18	WOS:A1973R713500001
J	SCHULL, WJ; NAGANO, H; YAMAMOTO, M; KOMATSU, I				SCHULL, WJ; NAGANO, H; YAMAMOTO, M; KOMATSU, I			EFFECTS OF PARNETAL CONSANGUINITY AND INBREEDING IN HIRADO, JAPAN .1. STILLBIRTHS AND PREREPRODUCTIVE MORTALITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		DICKERSON GE, 551 MISS RES B; HUSSELS I, IN PRESS; SCHULL WJ, 1968, P NATL ACAD SCI USA, V59, P671, DOI 10.1073/pnas.59.3.671; Schull WJ, 1965, EFFECTS INBREEDING J; SCHULL WJ, 1968, HALDANE MODERN BIOLO, P79; SPUHLER J. N., 1953, HUMAN BIOL, V25, P295; YANASE TOSHIYUKI, 1966, JAP J HUM GENET, V11, P125	7	56	57	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1970	22	3					239	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	G6436	5462919				2022-12-18	WOS:A1970G643600001
J	LABERGE, C				LABERGE, C			HEREDITARY TYROSINEMIA IN A FRENCH CANADIAN ISOLATE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BARBEAU A, 1966, S PROGR MUSKELDYSTRO, P102; BARBEAU ANDRE, 1964, UNION MED CAN, V93, P1178; BOWMAN HS, 1965, AM J HUM GENET, V17, P1; GENTZ J, 1965, J PEDIATR-US, V66, P670, DOI 10.1016/S0022-3476(65)80002-6; Haldane JBS, 1932, J GENET, V25, P251, DOI 10.1007/BF02983257; Haldane JBS, 1938, ANN EUGENIC, V8, P255, DOI 10.1111/j.1469-1809.1938.tb02179.x; HALVORSEN S, 1966, ARCH DIS CHILD, V41, P238, DOI 10.1136/adc.41.217.238; KUHN E, 1966, S PROGRESSIVE MUS ED, P102; LABERGE C., 1967, POPULATION, V22, P861; LADU BN, 1967, AM J DIS CHILD, V113, P54, DOI 10.1001/archpedi.1967.02090160104010; LAROCHELLE J, 1967, CAN MED ASSOC J, V97, P1051; LAROCHELLE J, 1965, 42 ANN M CAN PAED SO; LEJEUNE J, 1958, BIOMETRICS, V14, P513, DOI 10.2307/2527517; Li C, 1961, HUMAN GENETICS PRINC; LI CC, 1968, AM J HUM GENET, V20, P61; LI CC, 1965, AM J HUM GENET, V17, P343; MCKUSICK VA, 1964, B JOHNS HOPKINS HOSP, V115, P306; PRIVE L, 1967, CAN MED ASSOC J, V97, P1073; SASSKORTSAK A, 1967, CAN MED ASSOC J, V97, P1056; SCRIVER CR, 1967, AM J DIS CHILD, V113, P41, DOI 10.1001/archpedi.1967.02090160091008; SCRIVER CR, 1967, CAN MED ASSOC J, V97, P1073; SCRIVER CR, 1967, CANAD MED ASS J, V67, P1047; VESTERMARK S, 1964, Dan Med Bull, V11, P46; ZETTERSTROM R, 1963, ANN NY ACAD SCI, V111, P220, DOI 10.1111/j.1749-6632.1963.tb36962.x	24	56	56	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1969	21	1					36	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	D0848	5763606				2022-12-18	WOS:A1969D084800003
J	STAMATOYANNOPOULOS, G; FRASER, GR; MOTULSKY, AG; FESSAS, P; AKRIVAKIS, A; PAPAYANNOPOULOU, T				STAMATOYANNOPOULOS, G; FRASER, GR; MOTULSKY, AG; FESSAS, P; AKRIVAKIS, A; PAPAYANNOPOULOU, T			ON FAMILIAL PREDISPOSITION TO FAVISM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BLUMBERG BS, 1962, P C GENETIC POLYM ED, P159; COLOWICK SP, 1955, METHODS ENZYMOLOG ED, V1, P323; DOXIADIS SA, 1964, LANCET, V2, P1210; FESSAS P, 1962, BRIT MED J, P1359, DOI 10.1136/bmj.2.5316.1359; FLATZ G, 1963, ARCH DIS CHILD, V38, P566, DOI 10.1136/adc.38.202.566; FRASER GR, 1964, ANN HUM GENET, V27, P395; HARRIS JW, 1963, RED CELL, P280; KELLERMEYER RW, 1962, JAMA-J AM MED ASSOC, V180, P388, DOI 10.1001/jama.1962.03050180034008a; KORNBERG A, 1955, METHOD ENZYMOL, V1, P323, DOI 10.1016/0076-6879(55)01046-X; LARIZZA P, 1958, Haematologica, V43, P205; MAGER J, 1965, BIOCHEM BIOPH RES CO, V20, P235, DOI 10.1016/0006-291X(65)90352-9; MOTULSKY AG, 1964, AM J TROP MED HYG, V13, P147, DOI 10.4269/ajtmh.1964.13.147; MOTULSKY AG, 1962, P C GENETIC POLYMORP, P159; PANIZON F, 1962, Haematologica, V47, P205; SANSONE G, 1958, FAVISMO; STAMATOYANNOPOU.G, 1964, BRIT MED J, V1, P875, DOI 10.1136/bmj.1.5387.875; STAMATOYANNOPOU.G, 1964, LANCET, V2, P932; SZEINBERG A, 1957, BLOOD, V12, P603, DOI 10.1182/blood.V12.7.603.603; TARLOV AR, 1962, ARCH INTERN MED, V109, P209, DOI 10.1001/archinte.1962.03620140081013; WINTROBE MM, 1961, CLINICAL HEMATOLOGY, P612	20	56	57	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1966	18	3					253	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	77584	5944419				2022-12-18	WOS:A19667758400003
J	LYNCH, HT; OZER, F; MCNUTT, CW; JOHNSON, JE; JAMPOLSKY, NA				LYNCH, HT; OZER, F; MCNUTT, CW; JOHNSON, JE; JAMPOLSKY, NA			SECONDARY MALE HYPOGONADISM AND CONGENITAL ICHTHYOSIS - ASSOCIATION OF 2 RARE GENETIC DISEASES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALBERT A, 1953, P STAFF M MAYO CLIN, V28, P557; BIBEN RL, 1955, J CLIN ENDOCR METAB, V15, P931, DOI 10.1210/jcem-15-8-931; FERRIMAN D, 1950, BRIT MED J, V1, P162, DOI 10.1136/bmj.1.4646.162; GATES RR, 1948, HUMAN GENETICS, V1; HELLER CG, 1948, J CLIN ENDOCRINOL, V8, P345, DOI 10.1210/jcem-8-5-345; Hurxthal LW, 1943, J CLIN ENDOCRINOL, V3, P551, DOI 10.1210/jcem-3-10-551; KALLMAN FJ, 1944, AM J MEND DEFIC, V18, P203; KUPPERMAN HS, 1958, J AM GERIATR SOC, V6, P87, DOI 10.1111/j.1532-5415.1958.tb00690.x; LEMARQUAND HS, 1954, P ROY SOC MED, V47, P442; LESTER CW, 1957, J THORAC SURG, V34, P1; LESTER CW, 1958, J PEDIATR-US, V52, P82, DOI 10.1016/S0022-3476(58)80014-1; LEWIS GM, 1959, PRACTICAL DERMATOLOG; LUBS HA, 1959, J CLIN ENDOCR METAB, V19, P1110, DOI 10.1210/jcem-19-9-1110; LYNCH HT, 1960, 1960 M AM SOC HUM GE; MACGILLIVARY RC, 1954, AM J MENT DEFIC, V59, P62; UNFRDAHL LO, 1955, POSTGRAD M, V17, P251; WITSCHI W, 1957, J CLIN ENDOCR, V17, P737	17	56	55	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1960	12	4					440	447						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF080	13764559				2022-12-18	WOS:A1960WF08000005
J	GLASS, B				GLASS, B			UNLIKELIHOOD OF SIGNIFICANT ADMIXTURE OF GENES FROM THE NORTH AMERICAN INDIANS IN THE PRESENT COMPOSITION OF THE NEGROES OF THE UNITED-STATES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALLEN FH, 1951, NATURE, V167, P482, DOI 10.1038/167482b0; Armattoe REG, 1951, AM J PHYS ANTHROP-NE, V9, P371, DOI 10.1002/ajpa.1330090313; ARMATTOE R. E. G., 1953, WEST AFRICAN MED JOUR, V2, P89; ARMATTOE REG, 1950, MED WORLD       0825; Barnicot NA, 1953, AM J PHYS ANTHROP-NE, V11, P83, DOI 10.1002/ajpa.1330110116; BOYD WILLIAM C., 1939, TABULAE BIOL, V17, P113; CHALMERS JNM, 1953, ANN EUGENIC, V17, P168; Chown B, 1953, AM J PHYS ANTHROP-NE, V11, P369, DOI 10.1002/ajpa.1330110312; DONEGANI JA, 1950, HEREDITY, V4, P377, DOI 10.1038/hdy.1950.30; GLASS B, 1953, AM J HUM GENET, V5, P1; Herskovits MJ, 1933, SOC FORCES, V12, P247, DOI 10.2307/2569750; HERSKOVITS MJ, 1928, AM NEGRO STUDY RACIA, V14; HERSKOVITS MJ, 1941, MYTH NEGRO PAST, V16; HERSKOVITS MJ, 1930, COLUMBIA U CONTRIB A, V11; IKIN E. W., 1952, MAN, V52, P21; LANDSTEINER K, J IMMUNOL, V16, P123; LEVINE P, 1945, NATURE, V156, P418, DOI 10.1038/156418a0; Matson GA, 1954, AM J PHYS ANTHROP-NE, V12, P413, DOI 10.1002/ajpa.1330120315; Matson GA, 1933, J IMMUNOL, V25, P155; Meier A, 1949, AM J PHYS ANTHROP-NE, V7, P227, DOI 10.1002/ajpa.1330070206; Miller EB, 1951, AM J PHYS ANTHROP-NE, V9, P115, DOI 10.1002/ajpa.1330090202; Mourant A., 1954, DISTRIBUTION HUMAN B; NEEL JV, 1951, GENETICS, V36, P84; Potter EL, 1947, RH ITS RELATION CONG; ROSENFIELD RE, 1953, AM J CLIN PATHOL, V23, P1222; SHAPIRO M, 1951, S Afr Med J, V25, P165; Snyder LH, 1926, AM J PHYS ANTHROPOL, V9, P233, DOI 10.1002/ajpa.1330090216; STERN C, 1953, Acta Genet Stat Med, V4, P281; UNGER LJ, 1946, AM J CLIN PATHOL, V16, P498, DOI 10.1093/ajcp/16.8.498; WIENER A S, 1953, Acta Genet Med Gemellol (Roma), V2, P391; Wiener AS, 1944, AM J PHYS ANTHROP-NE, V2, P187, DOI 10.1002/ajpa.1330020206; Wiener AS, 1944, J EXP MED, V79, P235, DOI 10.1084/jem.79.3.235; WIENER AS, 1949, AM J CLIN PATHOL, V19, P621; WIENER AS, 1952, AM J HUM GENET, V4, P363; WIENER AS, 1945, J IMMUNOL, V50, P341; WIENER AS, 1945, P SOC EXP BIOL MED, V58, P89; Wiener AS, 1943, P SOC EXP BIOL MED, V54, P238; WIENER AS, 1943, BLOOD GROUPS TRANSFU; WIENER AS, 1944, AM J CLIN PATHOL, V14, P616	39	56	56	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1955	7	4					368	385						18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA213	13275460				2022-12-18	WOS:A1955WA21300003
J	Salpietro, V; Malintan, NT; Llano-Rivas, I; Spaeth, CG; Efthymiou, S; Striano, P; Vandrovcova, J; Cutrupi, MC; Chimenz, R; David, E; Di Rosa, G; Marce-Grau, A; Raspall-Chaure, M; Martin-Hernandez, E; Zara, F; Minetti, C; Bello, OD; De Zorzi, R; Fortuna, S; Dauber, A; Alkhawaja, M; Sultan, T; Mankad, K; Vitobello, A; Thomas, Q; Mau-Them, FT; Faivre, L; Martinez-Azorin, F; Prada, CE; Macaya, A; Kullmann, DM; Rothman, JE; Krishnakumar, SS; Houlden, H				Salpietro, Vincenzo; Malintan, Nancy T.; Llano-Rivas, Isabel; Spaeth, Christine G.; Efthymiou, Stephanie; Striano, Pasquale; Vandrovcova, Jana; Cutrupi, Maria C.; Chimenz, Roberto; David, Emanuele; Di Rosa, Gabriella; Marce-Grau, Anna; Raspall-Chaure, Miquel; Martin-Hernandez, Elena; Zara, Federico; Minetti, Carlo; Bello, Oscar D.; De Zorzi, Rita; Fortuna, Sara; Dauber, Andrew; Alkhawaja, Mariam; Sultan, Tipu; Mankad, Kshitij; Vitobello, Antonio; Thomas, Quentin; Mau-Them, Frederic Tran; Faivre, Laurence; Martinez-Azorin, Francisco; Prada, Carlos E.; Macaya, Alfons; Kullmann, Dimitri M.; Rothman, James E.; Krishnakumar, Shyam S.; Houlden, Henry		Deciphering Dev Disorders Study; SYNAPS Study Grp	Mutations in the Neuronal Vesicular SNARE VAMP2 Affect Synaptic Membrane Fusion and Impair Human Neurodevelopment	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DE-NOVO MUTATIONS; GENE; ENCEPHALOPATHY; IDENTIFICATION; LANDSCAPE; MUNC18-1; CHOREA; ATAXIA	VAMP2 encodes the vesicular SNARE protein VAMP2 (also called synaptobrevin-2). Together with its partners syntaxin-1A and synaptosomal-associated protein 25 (SNAP25), VAMP2 mediates fusion of synaptic vesicles to release neurotransmitters. VAMP2 is essential for vesicular exocytosis and activity-dependent neurotransmitter release. Here, we report five heterozygous de novo mutations in VAMP2 in unrelated individuals presenting with a neurodevelopmental disorder characterized by axial hypotonia (which had been present since birth), intellectual disability, and autistic features. In total, we identified two single-amino-acid deletions and three non-synonymous variants affecting conserved residues within the C terminus of the VAMP2 SNARE motif. Affected individuals carrying de novo non-synonymous variants involving the C-terminal region presented a more severe phenotype with additional neurological features, including central visual impairment, hyperkinetic movement disorder, and epilepsy or electroencephalography abnormalities. Reconstituted fusion involving a lipid-mixing assay indicated impairment in vesicle fusion as one of the possible associated disease mechanisms. The genetic synaptopathy caused by VAMP2 de novo mutations highlights the key roles of this gene in human brain development and function.	[Salpietro, Vincenzo; Striano, Pasquale; Minetti, Carlo] IRCCS Ist Giannina Gaslini, Pediat Neurol & Muscular Dis Unit, I-16147 Genoa, Italy; [Salpietro, Vincenzo; Striano, Pasquale; Minetti, Carlo] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, I-16132 Genoa, Italy; [Salpietro, Vincenzo; Efthymiou, Stephanie; Vandrovcova, Jana; Houlden, Henry] UCL, UCL Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Malintan, Nancy T.; Efthymiou, Stephanie; Bello, Oscar D.; Kullmann, Dimitri M.; Rothman, James E.; Krishnakumar, Shyam S.] UCL, Dept Clin & Expt Epilepsy, UCL Inst Neurol, London WC1N 3BG, England; [Llano-Rivas, Isabel] Hosp Univ Cruces, Dept Med Genet, Greater Bilbao 48903, Spain; [Spaeth, Christine G.; Prada, Carlos E.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Human Genet, Cincinnati, OH 45229 USA; [Cutrupi, Maria C.; Chimenz, Roberto] Univ Messina, Dept Adult & Dev Age Human Pathol, Div Human Genet, I-98125 Messina, Italy; [David, Emanuele] Papardo Univ Hosp, Viale Ferdinando Stagno dAlcontres, I-98158 Messina, Italy; [Di Rosa, Gabriella] Univ Messina, Dept Adult & Dev Age Human Pathol, Div Child Neurol & Psychiat, I-98125 Messina, Italy; [Marce-Grau, Anna; Raspall-Chaure, Miquel; Macaya, Alfons] Univ Hosp Vall dHebron, Dept Pediat Neurol, Barcelona 08035, Spain; [Martin-Hernandez, Elena] Hosp 12 Octubre, Dept Pediat, Unidad Enfermedades Mitocondriales Metab Heredita, E-28041 Madrid, Spain; [Zara, Federico] G Gaslini Inst Children, Lab Neurogenet & Neurosci, I-16147 Genoa, Italy; [De Zorzi, Rita] Univ Trieste, Dept Chem & Pharmaceut Sci, Ctr Excellence Biocrystallog, I-34127 Trieste, Italy; [Fortuna, Sara] Univ Trieste, Dept Chem & Pharmaceut Sci, I-34127 Trieste, Italy; [Dauber, Andrew] Cincinnati Childrens Hosp Med Ctr, Cincinnati Ctr Growth Disorders, Div Endocrinol, Cincinnati, OH 45229 USA; [Alkhawaja, Mariam] Minist Hlth, Prince Hamzah Hosp, Amman 11181, Jordan; [Sultan, Tipu] Inst Child Hlth, Dept Pediat Neurol, 381-D-2, Lahore 54600, Pakistan; [Sultan, Tipu] Childrens Hosp Lahore, 381-D-2, Lahore 54600, Pakistan; [Mankad, Kshitij] Great Ormond St Hosp Sick Children, Dept Neuroradiol, London WC1N 3JH, England; [Vitobello, Antonio; Mau-Them, Frederic Tran] Ctr Hosp Univ Dijon Bourgogne, Unite Fonct Innovat Diagnost Genom Malad Rares, F-21079 Dijon, France; [Vitobello, Antonio; Thomas, Quentin; Mau-Them, Frederic Tran; Faivre, Laurence] Univ Bourgogne, INSERM, UMR 1231, Genet Anomalies Dev, F-21079 Dijon, France; [Faivre, Laurence] Hop Enfants, Ctr Reference Anomalies Dev & Syndromes Malformat, F-21079 Dijon, France; [Martinez-Azorin, Francisco] Inst Invest Hosp 12 Octubre i 12, CIBERER, Madrid 28041, Spain; [Rothman, James E.; Krishnakumar, Shyam S.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; University of London; University College London; University of London; University College London; Hospital Universitario Cruces; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Messina; University of Messina; Hospital Universitari Vall d'Hebron; Hospital Universitario 12 de Octubre; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Trieste; University of Trieste; Cincinnati Children's Hospital Medical Center; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; CHU Dijon Bourgogne; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; CHU Dijon Bourgogne; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario 12 de Octubre; Yale University	Houlden, H (corresponding author), UCL, UCL Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England.; Krishnakumar, SS (corresponding author), UCL, Dept Clin & Expt Epilepsy, UCL Inst Neurol, London WC1N 3BG, England.; Krishnakumar, SS (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA.	s.krishnakumar@ucl.ac.uk; h.houlden@ucl.ac.uk	Striano, Pasquale/F-9117-2014; Minetti, Carlo/K-4666-2018; Borgione, Eugenia/D-9168-2017; Van Maldergem, Lionel/O-3242-2019; Garavaglia, Barbara/J-5257-2018; Fortuna, Sara/U-4744-2019; Thomas, Quentin/AGF-7307-2022; Mankad, Kshitij/ABD-4351-2020; Salpietro, Vincenzo/AAA-8706-2020; Kullmann, Dimitri M/A-3162-2009; Zara, Federico/U-3477-2017; DIPASQUALE, VALERIA/ABE-4607-2021; Houlden, Henry J/C-1532-2008; Di Rosa, Gabriella/ABE-8759-2020; Fortuna, Sara/G-2356-2014; Scuderi, Carmela/D-4734-2017; Vitobello, Antonio/ABC-2970-2021; Bello, Oscar/K-5605-2014; Aguennouz, M'hammed/U-7420-2017	Striano, Pasquale/0000-0002-6065-1476; Minetti, Carlo/0000-0002-0640-1804; Borgione, Eugenia/0000-0001-5458-7415; Van Maldergem, Lionel/0000-0001-8880-5214; Garavaglia, Barbara/0000-0003-4323-9145; Thomas, Quentin/0000-0003-1185-1663; Kullmann, Dimitri M/0000-0001-6696-3545; Zara, Federico/0000-0001-9744-5222; DIPASQUALE, VALERIA/0000-0003-3328-0734; Houlden, Henry J/0000-0002-2866-7777; Fortuna, Sara/0000-0002-8059-6064; Scuderi, Carmela/0000-0001-5901-0041; Vitobello, Antonio/0000-0003-3717-8374; Martinez-Azorin, Francisco/0000-0001-6250-7745; Tran Mau Them, Frederic/0000-0002-3795-9456; Bello, Oscar/0000-0001-5701-8365; Zanetti, Maria Natalia/0000-0002-3992-7167; DE ZORZI, Rita/0000-0001-7001-7498; Prada, Carlos/0000-0003-3348-3531; MARSEGLIA, GIAN LUIGI/0000-0003-3662-0159; Aguennouz, M'hammed/0000-0003-0440-0354; Raspall-Chaure, Miquel/0000-0002-3132-3342; Faivre, Laurence/0000-0001-9770-444X; Boesch, Sylvia/0000-0003-1657-7368; Munell Casadesus, Francina/0000-0001-8580-2819; Marce-Grau, Anna/0000-0001-5762-4023; Hanna, Michael/0000-0003-0825-4075; Efthymiou, Stephanie/0000-0003-4900-9877	Wellcome Trust [WT093205MA, WT104033AIA]; Medical Research Council; European Community [2012-305121]; Italian CINECA Awards [HP10CRVL7F]; Spanish Instituto de Salud Carlos III (ISCIII) [PI15/01791]; European Regional Development Fund (ERDF) [PI17/00487]; National Institute for Health Research (NIHR); University College London Hospitals (UCLH); Biomedical Research Center (BRC); MRC [G0400627, MR/L01095X/1, G0400136, G0600368, G0200373, G116/147, G0801316, G9805989, G0900613, G0601440] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Community(European Commission); Italian CINECA Awards(CINECA, Italy); Spanish Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos III); European Regional Development Fund (ERDF)(European Commission); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); University College London Hospitals (UCLH); Biomedical Research Center (BRC); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We gratefully acknowledge all the families for their enthusiastic participation in this study. This study was supported by the Wellcome Trust (WT093205MA, WT104033AIA); the Medical Research Council (H.H. and D.M.K.); the European Community's Seventh Framework Programme (FP7/2007-2013, under grant agreement No. 2012-305121 to H.H.); the Italian CINECA Awards (HP10CRVL7F, 2017), which made available high-performance computing resources and provided support; the Spanish Instituto de Salud Carlos III (ISCIII) (PI15/01791 A.M.); and the European Regional Development Fund (ERDF) (PI17/00487 to F.M-A.). We are also supported by the National Institute for Health Research (NIHR), the University College London Hospitals (UCLH), and the Biomedical Research Center (BRC).	Baker K, 2018, BRAIN, V141, P2576, DOI 10.1093/brain/awy209; Baker K, 2015, J CLIN INVEST, V125, P1670, DOI 10.1172/JCI79765; Bourassa CV, 2012, AM J HUM GENET, V91, P548, DOI 10.1016/j.ajhg.2012.07.018; Brunger AT, 2005, Q REV BIOPHYS, V38, P1, DOI 10.1017/S0033583505004051; Carecchio M, 2017, CURR NEUROL NEUROSCI, V17, P1, DOI 10.1007/s11910-017-0806-2; Chen DH, 2005, ARCH NEUROL-CHICAGO, V62, P597, DOI 10.1001/archneur.62.4.597; Chen WJ, 2011, NAT GENET, V43, P1252, DOI 10.1038/ng.1008; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Deak F, 2004, NAT CELL BIOL, V6, P1102, DOI 10.1038/ncb1185; Fukuda H, 2018, J HUM GENET, V63, P673, DOI 10.1038/s10038-018-0421-3; Gao Y, 2012, SCIENCE, V337, P1340, DOI 10.1126/science.1224492; Hernandez JM, 2012, SCIENCE, V336, P1581, DOI 10.1126/science.1221976; Hu C, 2003, SCIENCE, V300, P1745, DOI 10.1126/science.1084909; Huang Z, 2018, CELL PHYSIOL BIOCHEM, V49, P295, DOI 10.1159/000492879; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Li F, 2014, J AM CHEM SOC, V136, P3456, DOI 10.1021/ja410690m; Lipstein N, 2017, J CLIN INVEST, V127, P1005, DOI 10.1172/JCI90259; Liu Y, 2011, J PHYSIOL-LONDON, V589, P1603, DOI 10.1113/jphysiol.2010.201939; Martin-Hernandez E, 2016, NEUROGENETICS, V17, P259, DOI 10.1007/s10048-016-0496-y; McTague A, 2016, LANCET NEUROL, V15, P304, DOI 10.1016/S1474-4422(15)00250-1; Melia TJ, 2002, J CELL BIOL, V158, P929, DOI 10.1083/jcb.200112081; Mencacci NE, 2016, AM J HUM GENET, V98, P763, DOI 10.1016/j.ajhg.2016.02.015; Monies D, 2017, HUM GENET, V136, P921, DOI 10.1007/s00439-017-1821-8; Reijnders MRF, 2018, AM J HUM GENET, V102, P1195, DOI 10.1016/j.ajhg.2018.04.014; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Rothman JE, 1997, SCIENCE, V276, P1212, DOI 10.1126/science.276.5316.1212; Saitsu H, 2008, NAT GENET, V40, P782, DOI 10.1038/ng.150; Salpietro V, 2018, MOVEMENT DISORD, V33, P482, DOI 10.1002/mds.27286; Salpietro V, 2017, ANN NEUROL, V81, P597, DOI 10.1002/ana.24905; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Shen C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9852; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shen XM, 2017, ANN CLIN TRANSL NEUR, V4, P130, DOI 10.1002/acn3.387; Shen XM, 2014, NEUROLOGY, V83, P2247, DOI 10.1212/WNL.0000000000001079; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Sobreira N, 2015, HUM MUTAT, V36, P425, DOI 10.1002/humu.22769; Sorensen JB, 2002, P NATL ACAD SCI USA, V99, P1627, DOI 10.1073/pnas.251673298; Stamberger H, 2016, NEUROLOGY, V86, P954, DOI 10.1212/WNL.0000000000002457; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Trabzuni D, 2011, J NEUROCHEM, V119, P275, DOI 10.1111/j.1471-4159.2011.07432.x; Weber T, 2000, J CELL BIOL, V149, P1063, DOI 10.1083/jcb.149.5.1063; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Yin JN, 2018, AM J HUM GENET, V102, P296, DOI 10.1016/j.ajhg.2018.01.005; Zhang YL, 2017, PROTEIN SCI, V26, P1252, DOI 10.1002/pro.3116	44	55	55	2	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 4	2019	104	4					721	730		10.1016/j.ajhg.2019.02.016	http://dx.doi.org/10.1016/j.ajhg.2019.02.016			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HR9JE	30929742	Green Published, hybrid			2022-12-18	WOS:000463474700012
J	Son, JH; Xie, GC; Yuan, C; Ena, L; Li, ZR; Goldstein, A; Huang, LL; Wang, LW; Shen, FC; Liu, HF; Mehl, K; Groopman, EE; Marasa, M; Kiryluk, K; Gharavi, AG; Chung, WK; Hripcsak, G; Friedman, C; Weng, CH; Wang, K				Son, Jung Hoon; Xie, Gangcai; Yuan, Chi; Ena, Lyudmila; Li, Ziran; Goldstein, Andrew; Huang, Lulin; Wang, Liwei; Shen, Feichen; Liu, Hongfang; Mehl, Karla; Groopman, Emily E.; Marasa, Maddalena; Kiryluk, Krzysztof; Gharavi, Ali G.; Chung, Wendy K.; Hripcsak, George; Friedman, Carol; Weng, Chunhua; Wang, Kai			Deep Phenotyping on Electronic Health Records Facilitates Genetic Diagnosis by Clinical Exomes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL HEART-DISEASE; PRIORITIZATION; IDENTIFICATION; CHALLENGES	Integration of detailed phenotype information with genetic data is well established to facilitate accurate diagnosis of hereditary disorders. As a rich source of phenotype information, electronic health records (EHRs) promise to empower diagnostic variant interpretation. However, how to accurately and efficiently extract phenotypes from heterogeneous EHR narratives remains a challenge. Here, we present EHR-Phenolyzer, a high-throughput EHR framework for extracting and analyzing phenotypes. EHR-Phenolyzer extracts and normalizes Human Phenotype Ontology (HPO) concepts from EHR narratives and then prioritizes genes with causal variants on the basis of the HPO-coded phenotype manifestations. We assessed EHR-Phenolyzer on 28 pediatric individuals with confirmed diagnoses of monogenic diseases and found that the genes with causal variants were ranked among the top 100 genes selected by EHR-Phenolyzer for 16/28 individuals (p < 2.2 x 10(-16)), supporting the value of phenotype-driven gene prioritization in diagnostic sequence interpretation. To assess the generalizability, we replicated this finding on an independent EHR dataset of ten individuals with a positive diagnosis from a different institution. We then assessed the broader utility by examining two additional EHR datasets, including 31 individuals who were suspected of having a Mendelian disease and underwent different types of genetic testing and 20 individuals with positive diagnoses of specific Mendelian etiologies of chronic kidney disease from exome sequencing. Finally, through several retrospective case studies, we demonstrated how combined analyses of genotype data and deep phenotype data from EHRs can expedite genetic diagnoses. In summary, EHR-Phenolyzer leverages EHR narratives to automate phenotype-driven analysis of clinical exomes or genomes, facilitating the broader implementation of genomic medicine.	[Son, Jung Hoon; Xie, Gangcai; Yuan, Chi; Ena, Lyudmila; Li, Ziran; Goldstein, Andrew; Hripcsak, George; Friedman, Carol; Weng, Chunhua; Wang, Kai] Columbia Univ, Dept Biomed Informat, New York, NY 10032 USA; [Xie, Gangcai; Huang, Lulin; Wang, Kai] Columbia Univ, Inst Genom Med, New York, NY 10032 USA; [Xie, Gangcai; Huang, Lulin; Wang, Kai] Childrens Hosp Philadelphia, Raymond G Perelman Ctr Cellular & Mol Therapeut, Philadelphia, PA 19104 USA; [Wang, Liwei; Shen, Feichen; Liu, Hongfang] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN 55901 USA; [Mehl, Karla; Groopman, Emily E.; Marasa, Maddalena; Kiryluk, Krzysztof; Gharavi, Ali G.] Columbia Univ, Dept Med, Div Nephrol, New York, NY 10032 USA; [Chung, Wendy K.] Columbia Univ, Dept Pediat & Med, New York, NY 10032 USA; [Wang, Kai] Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA; [Wang, Kai] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA	Columbia University; Columbia University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Mayo Clinic; Columbia University; Columbia University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Weng, CH; Wang, K (corresponding author), Columbia Univ, Dept Biomed Informat, New York, NY 10032 USA.; Wang, K (corresponding author), Columbia Univ, Inst Genom Med, New York, NY 10032 USA.; Wang, K (corresponding author), Childrens Hosp Philadelphia, Raymond G Perelman Ctr Cellular & Mol Therapeut, Philadelphia, PA 19104 USA.; Wang, K (corresponding author), Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA.; Wang, K (corresponding author), Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA.	cw2384@cumc.columbia.edu; wangk@email.chop.edu	Xie, Gangcai/AAN-9197-2021	Xie, Gangcai/0000-0002-8286-2987	JPB Foundation; National Human Genome Research Institute [HG006465, HG008680]; National Institute of Mental Health [MH108728]; National Library of Medicine [R01LM009886]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK105124, UG3DK114926, RC2DK116690]; National Center for Advancing Translational Sciences [U01TR02062]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [U01TR002062] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006465, U01HG008680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UG3DK114926, R01DK105124, RC2DK116690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH108728] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009886] Funding Source: NIH RePORTER	JPB Foundation; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank the individuals and their family members who participated in this study to improve the diagnostic rates in clinical exome testing. We also thank the genetic counselors and clinical geneticists who provided the clinical notes that our algorithms used to infer automated phenotype terms. We thank colleagues at the Institute of Genomic Medicine, especially Dr. David Goldstein, Nick Stong, and Louise Bier, for suggesting phenotype-driven analysis and helpful discussion and comments on the study. We thank the developers of the Human Phenotype Ontology for continuous development of this ontology over the past few years, which greatly facilitated and standardized clinical diagnosis of individuals with suspected genetic disorders. This study was supported by grants from the JPB Foundation (to W.K.C), National Human Genome Research Institute (HG006465 to K.W. and HG008680 to A.G., G.H., and C.W.), National Institute of Mental Health (MH108728 to K.W.), National Library of Medicine (R01LM009886 to C.W.), National Institute of Diabetes and Digestive and Kidney Diseases (R01DK105124, UG3DK114926, and RC2DK116690 to K.K.), and National Center for Advancing Translational Sciences (U01TR02062 to H.L., F.S., and L.W.).	Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Aronson AR, 2010, J AM MED INFORM ASSN, V17, P229, DOI 10.1136/jamia.2009.002733; Aronson AR, 2001, J AM MED INFORM ASSN, P17; Buske OJ, 2015, HUM MUTAT, V36, P931, DOI 10.1002/humu.22851; Deans AR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002033; Devuyst O, 2014, LANCET, V383, P1844, DOI 10.1016/S0140-6736(14)60659-0; Dhombres F, 2016, J BIOMED SEMANT, V7, DOI 10.1186/s13326-016-0047-3; Eldomery MK, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0412-6; Fang H, 2017, BMC MED GENOMICS, V10, DOI 10.1186/s12920-017-0246-5; Friedman C, 1995, Proc Annu Symp Comput Appl Med Care, P347; FRIEDMAN C, 1994, J AM MED INFORM ASSN, V1, P161, DOI 10.1136/jamia.1994.95236146; Gilissen C, 2012, EUR J HUM GENET, V20, P490, DOI 10.1038/ejhg.2011.258; Graungaard AH, 2007, CHILD CARE HLTH DEV, V33, P296, DOI 10.1111/j.1365-2214.2006.00666.x; Homsy J, 2015, SCIENCE, V350, P1262, DOI 10.1126/science.aac9396; Jagadeesh KA, 2017, SCIENCE, V357, P692, DOI 10.1126/science.aam9710; Javed A, 2014, NAT METHODS, V11, P935, DOI [10.1038/NMETH.3046, 10.1038/nmeth.3046]; Jin SC, 2017, NAT GENET, V49, P1593, DOI 10.1038/ng.3970; Jonquet C., 2009, SUMMIT TRANSLAT BIOI, V2009, P36; Kleyner R, 2016, CSH MOL CASE STUD, V2, DOI 10.1101/mcs.a001131; Kohler S, 2017, NUCLEIC ACIDS RES, V45, pD865, DOI 10.1093/nar/gkw1039; Kohler S, 2009, AM J HUM GENET, V85, P457, DOI 10.1016/j.ajhg.2009.09.003; LACHMAN RS, 1988, PEDIATR RADIOL, V18, P93, DOI 10.1007/BF02387549; Lata S, 2018, ANN INTERN MED, V168, P100, DOI 10.7326/M17-1319; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Mungall CJ, 2017, NUCLEIC ACIDS RES, V45, pD712, DOI 10.1093/nar/gkw1128; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; R Core Development Team, 2017, R LANG ENV STAT COMP; Retterer K, 2016, GENET MED, V18, P696, DOI 10.1038/gim.2015.148; Robinson PN, 2011, CLIN GENET, V80, P127, DOI 10.1111/j.1399-0004.2011.01713.x; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Robinson PN, 2014, GENOME RES, V24, P340, DOI 10.1101/gr.160325.113; Sawyer SL, 2016, CLIN GENET, V89, P275, DOI 10.1111/cge.12654; Shashi V, 2014, GENET MED, V16, P176, DOI 10.1038/gim.2013.99; Shi LL, 2014, BMC MED GENOMICS, V7, DOI 10.1186/s12920-014-0066-9; Sifrim A, 2013, NAT METHODS, V10, P1083, DOI [10.1038/NMETH.2656, 10.1038/nmeth.2656]; Singleton MV, 2014, AM J HUM GENET, V94, P599, DOI 10.1016/j.ajhg.2014.03.010; Smedley D, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0199-2; Smedley D, 2014, BIOINFORMATICS, V30, P3215, DOI 10.1093/bioinformatics/btu508; Stessman HAF, 2017, NAT GENET, V49, P515, DOI 10.1038/ng.3792; Stokman MF, 2016, NAT REV NEPHROL, V12, P472, DOI 10.1038/nrneph.2016.87; Trujillano D, 2017, EUR J HUM GENET, V25, P176, DOI 10.1038/ejhg.2016.146; Valencia CA, 2015, FRONT PEDIATR, V3, DOI 10.3389/fped.2015.00067; van Nimwegen KJM, 2015, EUR J PAEDIATR NEURO, V19, P233, DOI 10.1016/j.ejpn.2014.12.014; Vissers LELM, 2017, GENET MED, V19, P1055, DOI 10.1038/gim.2017.1; Yang H, 2015, NAT METHODS, V12, P841, DOI [10.1038/nmeth.3484, 10.1038/NMETH.3484]; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Zemojtel T, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009262	47	55	56	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 5	2018	103	1					58	73		10.1016/j.ajhg.2018.05.010	http://dx.doi.org/10.1016/j.ajhg.2018.05.010			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GM5IG	29961570	Bronze, Green Published			2022-12-18	WOS:000438168800005
J	Lake, NJ; Webb, BD; Stroud, DA; Richman, TR; Ruzzenente, B; Compton, AG; Mountford, HS; Pulman, J; Zangarelli, C; Rio, M; Bodaert, N; Assouline, Z; Sherpa, MD; Schadt, EE; Houten, SM; Byrnes, J; McCormick, EM; Zolkipli-Cunningham, Z; Haude, K; Zhang, ZC; Retterer, K; Bai, R; Calvo, SE; Mootha, VK; Christodoulou, J; Rotig, A; Filipovska, A; Cristian, I; Falk, MJ; Metodiev, MD; Thorburn, DR				Lake, Nicole J.; Webb, Bryn D.; Stroud, David A.; Richman, Tara R.; Ruzzenente, Benedetta; Compton, Alison G.; Mountford, Hayley S.; Pulman, Juliette; Zangarelli, Coralie; Rio, Marlene; Bodaert, Nathalie; Assouline, Zahra; Sherpa, Mingma D.; Schadt, Eric E.; Houten, Sander M.; Byrnes, James; McCormick, Elizabeth M.; Zolkipli-Cunningham, Zarazuela; Haude, Katrina; Zhang, Zhancheng; Retterer, Kyle; Bai, Renkui; Calvo, Sarah E.; Mootha, Vamsi K.; Christodoulou, John; Rotig, Agnes; Filipovska, Aleksandra; Cristian, Ingrid; Falk, Marni J.; Metodiev, Metodi D.; Thorburn, David R.			Biallelic Mutations in MRPS34 Lead to Instability of the Small Mitoribosomal Subunit and Leigh Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL TRANSLATION; COMPUTATIONAL PLATFORM; CHAIN COMPLEXES; FRAMEWORK; VARIANT; DISEASE; MRPL44	The synthesis of all 13 mitochondrial DNA (mtDNA)-encoded protein subunits of the human oxidative phosphorylation (OXPHOS) system is carried out by mitochondrial ribosomes (mitoribosomes). Defects in the stability of mitoribosomal proteins or mitoribosome assembly impair mitochondrial protein translation, causing combined OXPHOS enzyme deficiency and clinical disease. Here we report four autosomal-recessive pathogenic mutations in the gene encoding the small mitoribosomal subunit protein, MRPS34, in six subjects from four unrelated families with Leigh syndrome and combined OXPHOS defects. Whole-exome sequencing was used to independently identify all variants. Two splice-site mutations were identified, including homozygous c.321+1G>T in a subject of Italian ancestry and homozygous c.322-10G>A in affected sibling pairs from two unrelated families of Puerto Rican descent. In addition, compound heterozygous MRPS34 mutations were identified in a proband of French ancestry; a missense (c.37G>A [p.Glu13Lys]) and a nonsense (c.94C>T [p.Gln32*]) variant. We demonstrated that these mutations reduce MRPS34 protein levels and the synthesis of OXPHOS subunits encoded by mtDNA. Examination of the mitoribosome profile and quantitative proteomics showed that the mitochondrial translation defect was caused by destabilization of the small mitoribosomal subunit and impaired monosome assembly. Lentiviral-mediated expression of wild-type MRPS34 rescued the defect in mitochondrial translation observed in skin fibroblasts from affected subjects, confirming the pathogenicity of MRPS34 mutations. Our data establish that MRPS34 is required for normal function of the mitoribosome in humans and furthermore demonstrate the power of quantitative proteomic analysis to identify signatures of defects in specific cellular pathways in fibroblasts from subjects with inherited disease.	[Lake, Nicole J.; Compton, Alison G.; Mountford, Hayley S.; Christodoulou, John; Thorburn, David R.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia; [Lake, Nicole J.; Compton, Alison G.; Mountford, Hayley S.; Christodoulou, John; Thorburn, David R.] Univ Melbourne, Dept Paediat, Melbourne, Vic 3052, Australia; [Webb, Bryn D.; Sherpa, Mingma D.; Schadt, Eric E.; Houten, Sander M.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Webb, Bryn D.] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Webb, Bryn D.; Sherpa, Mingma D.; Schadt, Eric E.; Houten, Sander M.] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Stroud, David A.] Monash Univ, Monash Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton Campus, Melbourne, Vic 3800, Australia; [Richman, Tara R.; Filipovska, Aleksandra] Univ Western Australia, Harry Perkins Inst Med Res, Nedlands, WA 6009, Australia; [Richman, Tara R.; Filipovska, Aleksandra] Univ Western Australia, Ctr Med Res, Nedlands, WA 6009, Australia; [Ruzzenente, Benedetta; Pulman, Juliette; Zangarelli, Coralie; Rotig, Agnes; Metodiev, Metodi D.] Univ Paris 05, INSERM, U1163, Inst Imaginem,Sorbonne Paris Cite, F-75015 Paris, France; [Mountford, Hayley S.] Oxford Brookes Univ, Fac Hlth Sci, Dept Biol & Med Sci, Oxford OX3 0BP, England; [Rio, Marlene; Assouline, Zahra] Hop Necker Enfants Malad, Dept Pediat Neurol & Genet, F-75015 Paris, France; [Bodaert, Nathalie] Univ Paris 05, Hop Necker Enfants Malad, Pediat Radiol Dept,INSERM U1000, AP HP,PRES Sorbonne Paris Cite, F-75015 Paris, France; [Bodaert, Nathalie] UMR 1163, Inst Imagine, F-75015 Paris, France; [Byrnes, James; McCormick, Elizabeth M.; Zolkipli-Cunningham, Zarazuela; Falk, Marni J.] Childrens Hosp Philadelphia, Dept Pediat, Div Human Genet, Philadelphia, PA 19104 USA; [Zolkipli-Cunningham, Zarazuela] Childrens Hosp Philadelphia, Dept Pediat, Div Neurol, Philadelphia, PA 19104 USA; [Haude, Katrina; Zhang, Zhancheng; Retterer, Kyle; Bai, Renkui] GeneDx, Gaithersburg, MD 20877 USA; [Calvo, Sarah E.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Mol Biol, Howard Hughes Med Inst, Boston, MA 02114 USA; [Calvo, Sarah E.; Mootha, Vamsi K.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Calvo, Sarah E.; Mootha, Vamsi K.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Filipovska, Aleksandra] Univ Western Australia, Sch Mol Sci, Crawley, WA 6009, Australia; [Cristian, Ingrid] Nemours Childrens Hosp, Orlando, FL 32827 USA; [Cristian, Ingrid] Amold Palmer Hosp Children, Div Genet, Orlando, FL 32806 USA; [Falk, Marni J.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Thorburn, David R.] Royal Childrens Hosp, Victorian Clin Genet Serv, Melbourne, Vic 3052, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Monash University; Harry Perkins Institute of Medical Research; University of Western Australia; University of Western Australia; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Oxford Brookes University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Western Australia; University of Pennsylvania; Pennsylvania Medicine; Royal Children's Hospital Melbourne	Thorburn, DR (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia.; Thorburn, DR (corresponding author), Univ Melbourne, Dept Paediat, Melbourne, Vic 3052, Australia.; Thorburn, DR (corresponding author), Royal Childrens Hosp, Victorian Clin Genet Serv, Melbourne, Vic 3052, Australia.	david.thorburn@mcri.edu.au	Metodiev, Metodi/C-4780-2015; Stroud, David Arthur/HGB-4331-2022; Houten, Sander/Y-3599-2019; Ruzzenente, Benedetta/H-4793-2017; Pulman, Juliette/AAX-6060-2021; Thorburn, David R/G-6266-2013; Christodoulou, John/M-3628-2019; ROTIG, AGNES/G-9592-2017	Metodiev, Metodi/0000-0002-9596-2434; Stroud, David Arthur/0000-0002-2048-3383; Houten, Sander/0000-0002-6167-9147; Ruzzenente, Benedetta/0000-0001-7366-114X; Pulman, Juliette/0000-0002-8282-434X; Christodoulou, John/0000-0002-8431-0641; thorburn, david/0000-0002-7725-9470; Mountford, Hayley/0000-0002-7663-6326; ROTIG, AGNES/0000-0003-0589-0703; Compton, Alison/0000-0002-2725-7055; Falk, Marni/0000-0002-1723-6728; Filipovska, Aleksandra/0000-0002-6998-8403; Lake, Nicole/0000-0003-4103-6387	Australian National Health and Medical Research Council (NHMRC) [1022896, 1068409, 1068056, 1058442, 1078273, 1125390, 1107094, 1070916]; Australian Research Council [DP170103000]; Jaxson Flynt Research Fund; Joseph and Pat Holveck Research Fund; Australian Postgraduate Award; NHMRC [1017174]; Australian Mitochondrial Disease Foundation; Victorian Government; Icahn Institute for Genomics and Multiscale Biology; NIH National Institute of Child Health and Human Development (NICHD) [K08HD086827]; NIH [R01GM077465, 1R35GM122455]; French Muscular Dystrophy Association (AFM) [19876]; Genomit [01GML1207]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD086827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122455, R01GM077465] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Jaxson Flynt Research Fund; Joseph and Pat Holveck Research Fund; Australian Postgraduate Award(Australian Government); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Mitochondrial Disease Foundation; Victorian Government; Icahn Institute for Genomics and Multiscale Biology; NIH National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French Muscular Dystrophy Association (AFM)(Association Francaise contre les Myopathies); Genomit; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by Australian National Health and Medical Research Council (NHMRC) fellowships and project grants to D.R.T., A.G.C., A.F., and D.A.S. (1022896, 1068409, 1068056, 1058442, 1078273, 1125390, 1107094, 1070916), the Australian Research Council (DP170103000 to A.F.), the Jaxson Flynt Research Fund (M.J.F. and J.B.), the Joseph and Pat Holveck Research Fund (M.J.F. and Z.Z.-C.), an Australian Postgraduate Award (N.J.L.), a NHMRC scholarship (1017174 to H.S.M.), Australian Mitochondrial Disease Foundation scholarship (N.J.L. and H.S.M.), the Victorian Government's Operational Infrastructure Support Program (D.R.T. and A.G.C.), the Icahn Institute for Genomics and Multiscale Biology, NIH National Institute of Child Health and Human Development (NICHD) (grant K08HD086827 to B.D.W.), the NIH (R01GM077465 and 1R35GM122455 to V.K.M.), the French Muscular Dystrophy Association (AFM grant #19876 to M.D.M.), and Genomit (01GML1207 to A.R.). We acknowledge the use of bioresources of the Necker Imagine DNA biobank (BB-033-00065). We thank the subjects, families, and multi-disciplinary clinical care providers for their involvement. The authors acknowledge the GeneMatcher tool, which enabled the identification of two of the families described in this study, and the Monash Biomedical Proteomics Facility, Monash University, for the provision of instrumentation, training, and technical support. We thank Associate Professor Susan Donath for her expert advice on appropriate statistical analyses. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.	Amunts A, 2015, SCIENCE, V348, P95, DOI 10.1126/science.aaa1193; Arroyo JD, 2016, CELL METAB, V24, P875, DOI 10.1016/j.cmet.2016.08.017; Boczonadi V, 2014, INT J BIOCHEM CELL B, V48, P77, DOI 10.1016/j.biocel.2013.12.011; Bursle C, 2017, JIMD REPORTS, VOL 34, P105, DOI 10.1007/8904_2016_13; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310; Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659; Carroll CJ, 2013, J MED GENET, V50, P151, DOI 10.1136/jmedgenet-2012-101375; Cooper ST, 2003, NEUROLOGY, V61, P93, DOI 10.1212/01.WNL.0000069460.53438.38; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Diodato Daria, 2014, Int J Cell Biol, V2014, P787956, DOI 10.1155/2014/787956; Distelmaier F, 2015, NEUROGENETICS, V16, P319, DOI 10.1007/s10048-015-0444-2; Frazier AE, 2012, METHODS MOL BIOL, V837, P49, DOI 10.1007/978-1-61779-504-6_4; Galmiche L, 2011, HUM MUTAT, V32, P1225, DOI 10.1002/humu.21562; Greber BJ, 2016, ANNU REV BIOCHEM, V85, P103, DOI 10.1146/annurev-biochem-060815-014343; Greber BJ, 2015, SCIENCE, V348, P303, DOI 10.1126/science.aaa3872; Greber BJ, 2014, NATURE, V515, P283, DOI 10.1038/nature13895; Haque ME, 2008, MITOCHONDRION, V8, P254, DOI 10.1016/j.mito.2008.04.004; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Johnston AJ, 2002, J BIOL CHEM, V277, P42197, DOI 10.1074/jbc.M205613200; Kohda M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005679; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lieber DS, 2013, NEUROLOGY, V80, P1762, DOI 10.1212/WNL.0b013e3182918c40; Mai N, 2017, CELL TISSUE RES, V367, P5, DOI 10.1007/s00441-016-2456-0; Mayr JA, 2015, J INHERIT METAB DIS, V38, P629, DOI 10.1007/s10545-015-9831-y; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McKenzie M, 2007, ANAL BIOCHEM, V364, P128, DOI 10.1016/j.ab.2007.02.022; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Menezes MJ, 2015, HUM MOL GENET, V24, P2297, DOI 10.1093/hmg/ddu747; Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282; Ott M, 2016, ANNU REV BIOCHEM, V85, P77, DOI 10.1146/annurev-biochem-060815-014334; Rackham O, 2009, NUCLEIC ACIDS RES, V37, P5859, DOI 10.1093/nar/gkp627; Retterer K, 2016, GENET MED, V18, P696, DOI 10.1038/gim.2015.148; Richman TR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11884; Richman TR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005089; Rorbach J, 2016, P NATL ACAD SCI USA, V113, P12198, DOI 10.1073/pnas.1609338113; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Saada A, 2007, J MED GENET, V44, P784, DOI 10.1136/jmg.2007.053116; Sanchez-Caballero L, 2016, AM J HUM GENET, V99, P208, DOI 10.1016/j.ajhg.2016.05.022; Sasarman F, 2015, HUM MOL GENET, V24, P480, DOI 10.1093/hmg/ddu468; Sasarman F, 2012, METHODS MOL BIOL, V837, P207, DOI 10.1007/978-1-61779-504-6_14; Serre V, 2013, BBA-MOL BASIS DIS, V1832, P1304, DOI 10.1016/j.bbadis.2013.04.014; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Stroud DA, 2016, NATURE, V538, P123, DOI 10.1038/nature19754; Stroud DA, 2015, HUM MOL GENET, V24, P5404, DOI 10.1093/hmg/ddv265; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/NMETH.3901, 10.1038/nmeth.3901]; Vedrenne V, 2012, AM J HUM GENET, V91, P912, DOI 10.1016/j.ajhg.2012.09.001; Webb BD, 2017, HUM MUTAT, V38, P373, DOI 10.1002/humu.23171; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yano N, 2016, J BIOL CHEM, V291, P23882, DOI 10.1074/jbc.M115.711770; Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095	58	55	55	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 3	2017	101	2					239	254		10.1016/j.ajhg.2017.07.005	http://dx.doi.org/10.1016/j.ajhg.2017.07.005			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FC5BD	28777931	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000406854800008
J	He, Y; Maier, K; Leppert, J; Hausser, I; Schwieger-Briel, A; Weibel, L; Theiler, M; Kiritsi, D; Busch, H; Boerries, M; Hannula-Jouppi, K; Heikkila, H; Tasanen, K; Castiglia, D; Zambruno, G; Has, C				He, Yinghong; Maier, Kristin; Leppert, Juna; Hausser, Ingrid; Schwieger-Briel, Agnes; Weibel, Lisa; Theiler, Martin; Kiritsi, Dimitra; Busch, Hauke; Boerries, Melanie; Hannula-Jouppi, Katariina; Heikkilae, Hannele; Tasanen, Kaisa; Castiglia, Daniele; Zambruno, Giovanna; Has, Cristina			Monoallelic Mutations in the Translation Initiation Codon of KLHL24 Cause Skin Fragility	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EPIDERMOLYSIS-BULLOSA SIMPLEX; KERATIN INTERMEDIATE-FILAMENTS; GIGAXONIN MUTATIONS; BTB/KELCH PROTEIN; NETWORK; DEGRADATION; PHENOTYPE; LIGASE; DOMAIN; KRIP6	The genetic basis of epidermolysis bullosa, a group of genetic disorders characterized by the mechanically induced formation of skin blisters, is largely known, but a number of cases still remain genetically unsolved. Here, we used whole-exome and targeted sequencing to identify monoallelic mutations, c.1A>G and c.2T>C, in the translation initiation codon of the gene encoding kelch-like protein 24 (KLHL24) in 14 individuals with a distinct skin-fragility phenotype and skin cleavage within basal keratinocytes. Remarkably, mutation c.1A>G occurred de novo and was recurrent in families originating from different countries. The striking similarities of the clinical features of the affected individuals point to a unique and very specific pathomechanism. We showed that mutations in the translation initiation codon of KLHL24 lead to the usage of a downstreamtranslation initiation site with the same reading frame and formation of a truncated polypeptide. The pathobiology was examined in keratinocytes and fibroblasts of the affected individuals and via expression of mutant KLHL24, and we found mutant KLHL24 to be associated with abnormalities of intermediate filaments in keratinocytes and fibroblasts. In particular, KLHL24 mutations were associated with irregular and fragmented keratin 14. Recombinant overexpression of normal KLHL24 promoted keratin 14 degradation, whereas mutant KLHL24 showed less activity than the normal molecule. These findings identify KLHL24 mutations as a cause of skin fragility and identify a role for KLHL24 in maintaining the balance between intermediate filament stability and degradation required for skin integrity.	[He, Yinghong; Maier, Kristin; Leppert, Juna; Kiritsi, Dimitra; Has, Cristina] Univ Med Ctr Freiburg, Dept Dermatol, D-79104 Freiburg, Germany; [Hausser, Ingrid] Heidelberg Univ, Dept Pathol, D-69120 Heidelberg, Germany; [Schwieger-Briel, Agnes; Weibel, Lisa; Theiler, Martin] Univ Childrens Hosp Zurich, Dept Paediat Dermatol, CH-8091 Zurich, Switzerland; [Schwieger-Briel, Agnes; Weibel, Lisa; Theiler, Martin] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland; [Busch, Hauke; Boerries, Melanie] Albert Ludwigs Univ Freiburg, Syst Biol Cellular Microenvironm Grp, Inst Mol Med & Cell Res, D-79104 Freiburg, Germany; [Busch, Hauke; Boerries, Melanie] German Canc Res Ctr, German Canc Consortium DKTK, D-69120 Heidelberg, Germany; [Busch, Hauke; Boerries, Melanie] Comprehens Canc Ctr Freiburg, D-79106 Freiburg, Germany; [Hannula-Jouppi, Katariina; Heikkilae, Hannele] Univ Helsinki, Dept Dermatol & Allergol, FIN-00014 Helsinki, Finland; [Hannula-Jouppi, Katariina; Heikkilae, Hannele] Helsinki Univ Hosp, Helsinki 00014, Finland; [Hannula-Jouppi, Katariina] Univ Helsinki, Folkhalsan Inst Genet, FIN-00014 Helsinki, Finland; [Tasanen, Kaisa] Oulu Univ Hosp, Med Res Ctr Oulu, PEDEGO Res Unit, Dept Dermatol, Oulu 90014, Finland; [Tasanen, Kaisa] Univ Oulu, Oulu 90014, Finland; [Castiglia, Daniele] Ist Ricovero & Cura Carattere Sci, Ist Dermopat Immacolata, Lab Mol & Cell Biol, I-00167 Rome, Italy; [Zambruno, Giovanna] Bambino Gesu Pediat Hosp, Genet & Rare Dis Res Area, Ist Ricovero & Cura Carattere Sci, I-00165 Rome, Italy	University of Freiburg; Ruprecht Karls University Heidelberg; University Children's Hospital Zurich; University of Zurich; University Zurich Hospital; University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Oulu; University of Oulu; IRCCS Istituto Dermopatico dell'Immacolata (IDI); IRCCS Bambino Gesu	Has, C (corresponding author), Univ Med Ctr Freiburg, Dept Dermatol, D-79104 Freiburg, Germany.	cristina.has@uniklinik-freiburg.de	Kiritsi, Dimitra/AAL-4762-2020; Boerries, Melanie/AAM-2602-2021; Busch, Hauke/R-6452-2016; Has, Cristina/AGF-7185-2022; Zambruno, Giavanna/K-2933-2018; Has, Cristina/V-2132-2019; Has, Cristina/B-3310-2017; Hannula-Jouppi, Katariina SE/F-4476-2011	Kiritsi, Dimitra/0000-0002-2331-8981; Busch, Hauke/0000-0003-4763-4521; Has, Cristina/0000-0001-6066-507X; Has, Cristina/0000-0001-6066-507X; Has, Cristina/0000-0001-6066-507X; Maier, Kristin/0000-0001-6546-5341; Hannula-Jouppi, Katariina/0000-0003-3864-2853; Weibel, Lisa/0000-0002-8696-8164; Zambruno, Giovanna/0000-0002-1295-056X; Schwieger-Briel, Agnes/0000-0001-7679-3981; Theiler, Martin/0000-0001-7160-3958; Tasanen, Kaisa/0000-0001-8056-5949	Debra International; Collaborative Research Centre [1140]	Debra International; Collaborative Research Centre	The research was funded by a grant (Has 1) from Debra International to C.H. Y.H. was partially supported by Collaborative Research Centre 1140. We thank the families for their participation; Leena Bruckner-Tuderman for critical reading of the manuscript and discussions; Amelie Honinger, Gabriele Gruninger, Amelie Gruler, Kathe Thoma, Vera Morand, and Jannis Athanasiou for excellent support; Dr. Fernando Larcher (CIEMAT-CIBER, Madrid, Spain) for the E6E7 construct; Dr. Stefanie Loffek for reagents; Dr. Jurgen Kohlhase (Center for Human Genetics Freiburg); BGI Genomics for sequencing; and the Life Imaging Center's Center for Biological Systems Analysis (ZBSA) of the Albert-Ludwigs-University microscopy platform for excellent support.	Angius A, 2016, AM J HUM GENET, V99, P236, DOI 10.1016/j.ajhg.2016.05.026; Bolling MC, 2011, BRIT J DERMATOL, V164, P637, DOI 10.1111/j.1365-2133.2010.10146.x; Bolling MC, 2014, J INVEST DERMATOL, V134, P273, DOI 10.1038/jid.2013.277; Bomont P, 2016, METHOD ENZYMOL, V569, P215, DOI 10.1016/bs.mie.2015.07.009; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Chamcheu JC, 2011, J INVEST DERMATOL, V131, P1684, DOI 10.1038/jid.2011.93; Cirak S, 2010, BRAIN, V133, P2123, DOI 10.1093/brain/awq108; Dhanoa BS, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-13; Fine JD, 2014, J AM ACAD DERMATOL, V70, P1103, DOI 10.1016/j.jaad.2014.01.903; Friedman JS, 2009, AM J HUM GENET, V84, P792, DOI 10.1016/j.ajhg.2009.05.007; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Groves RW, 2010, J INVEST DERMATOL, V130, P1551, DOI 10.1038/jid.2010.19; Has C, 2016, J INVEST DERMATOL, V136, pE65, DOI 10.1016/j.jid.2016.05.093; Has C, 2014, ANNU REV GENOM HUM G, V15, P245, DOI 10.1146/annurev-genom-090413-025540; He YH, 2011, AM J PATHOL, V178, P975, DOI 10.1016/j.ajpath.2010.11.053; Jaitovich A, 2008, J BIOL CHEM, V283, P25348, DOI 10.1074/jbc.M801635200; Johnson-Kerner BL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140157; Jonkman MF, 1996, J INVEST DERMATOL, V107, P764, DOI 10.1111/1523-1747.ep12365805; Kang JJ, 2016, HUM GENET, V135, P675, DOI 10.1007/s00439-016-1659-5; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kopeckova L, 2016, BRIT J DERMATOL, V174, P1388, DOI 10.1111/bjd.14370; Laezza F, 2007, MOL CELL NEUROSCI, V34, P539, DOI 10.1016/j.mcn.2006.12.003; Laezza F, 2008, NEUROPHARMACOLOGY, V55, P1131, DOI 10.1016/j.neuropharm.2008.07.021; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liovic M, 2008, EXP CELL RES, V314, P2066, DOI 10.1016/j.yexcr.2008.02.020; LLOYD C, 1995, J CELL BIOL, V129, P1329, DOI 10.1083/jcb.129.5.1329; Loschke F, 2015, CURR OPIN CELL BIOL, V32, P56, DOI 10.1016/j.ceb.2014.12.006; Louis-Dit-Picard H, 2012, NAT GENET, V44, P456, DOI 10.1038/ng.2218; Lugassy J, 2006, AM J HUM GENET, V79, P724, DOI 10.1086/507792; Mahammad S, 2013, J CLIN INVEST, V123, P1964, DOI 10.1172/JCI66387; McGrath JA, 2012, AM J HUM GENET, V91, P1115, DOI 10.1016/j.ajhg.2012.10.012; Moch M, 2013, P NATL ACAD SCI USA, V110, P10664, DOI 10.1073/pnas.1306020110; Prag S, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-42; Ridge KM, 2005, J BIOL CHEM, V280, P30400, DOI 10.1074/jbc.M504239200; Rogel Micah R, 2010, Proc Am Thorac Soc, V7, P71, DOI 10.1513/pats.200908-089JS; Rugg EL, 2007, J INVEST DERMATOL, V127, P574, DOI 10.1038/sj.jid.5700571; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Schwarz N, 2015, SCI REP-UK, V5, DOI 10.1038/srep09007; Sivaramakrishnan S, 2009, MOL BIOL CELL, V20, P2755, DOI 10.1091/mbc.E08-10-1028; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Tan TS, 2016, METHOD ENZYMOL, V568, P219, DOI 10.1016/bs.mie.2015.09.030; Wang FR, 2016, METHOD ENZYMOL, V568, P303, DOI 10.1016/bs.mie.2015.09.032; Woll S, 2007, J CELL BIOL, V177, P795, DOI 10.1083/jcb.200703174; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Yalcin EG, 2015, HUM MOL GENET, V24, P3679, DOI 10.1093/hmg/ddv111	47	55	59	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 1	2016	99	6					1395	1404		10.1016/j.ajhg.2016.11.005	http://dx.doi.org/10.1016/j.ajhg.2016.11.005			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ED8VI	27889062	Green Published, Bronze			2022-12-18	WOS:000389148600015
J	Flex, E; Niceta, M; Cecchetti, S; Thiffault, I; Au, MG; Capuano, A; Piermarini, E; Ivanova, AA; Francis, JW; Chillemi, G; Chandramouli, B; Carpentieri, G; Haaxma, CA; Ciolfi, A; Pizzi, S; Douglas, GV; Levine, K; Sferra, A; Dentici, ML; Pfundt, RR; Le Pichon, JB; Farrow, E; Baas, F; Piemonte, F; Dallapiccola, B; Graham, JM; Saunders, CJ; Bertini, E; Kahn, RA; Koolen, DA; Tartaglia, M				Flex, Elisabetta; Niceta, Marcello; Cecchetti, Serena; Thiffault, Isabelle; Au, Margaret G.; Capuano, Alessandro; Piermarini, Emanuela; Ivanova, Anna A.; Francis, Joshua W.; Chillemi, Giovanni; Chandramouli, Balasubramanian; Carpentieri, Giovanna; Haaxma, Charlotte A.; Ciolfi, Andrea; Pizzi, Simone; Douglas, Ganka V.; Levine, Kara; Sferra, Antonella; Dentici, Maria Lisa; Pfundt, Rolph R.; Le Pichon, Jean-Baptiste; Farrow, Emily; Baas, Frank; Piemonte, Fiorella; Dallapiccola, Bruno; Graham, John M., Jr.; Saunders, Carol J.; Bertini, Enrico; Kahn, Richard A.; Koolen, David A.; Tartaglia, Marco			Biallelic Mutations in TBCD, Encoding the Tubulin Folding Cofactor D, Perturb Microtubule Dynamics and Cause Early-Onset Encephalopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTELLECTUAL DISABILITY; BETA-TUBULIN; PONTOCEREBELLAR HYPOPLASIA; CEREBRAL HYPOMYELINATION; PARKINSONS-DISEASE; AGC1 DEFICIENCY; PROTEIN; SPASTIN; VARIANTS; SYSTEM	Microtubules are dynamic cytoskeletal elements coordinating and supporting a variety of neuronal processes, including cell division, migration, polarity, intracellular trafficking, and signal transduction. Mutations in genes encoding tubulins and microtubule-associated proteins are known to cause neurodevelopmental and neurodegenerative disorders. Growing evidence suggests that altered microtubule dynamics may also underlie or contribute to neurodevelopmental disorders and neurodegeneration. We report that biallelic mutations in TBCD, encoding one of the five co-chaperones required for assembly and disassembly of the alpha beta-tubulin heterodimer, the structural unit of microtubules, cause a disease with neurodevelopmental and neurodegenerative features characterized by early-onset cortical atrophy, secondary hypomyelination, microcephaly, thin corpus callosum, developmental delay, intellectual disability, seizures, optic atrophy, and spastic quadriplegia. Molecular dynamics simulations predicted long-range and/or local structural perturbations associated with the disease-causing mutations. Biochemical analyses documented variably reduced levels of TBCD, indicating relative instability of mutant proteins, and defective beta-tubulin binding in a subset of the tested mutants. Reduced or defective TBCD function resulted in decreased soluble alpha/beta-tubulin levels and accelerated microtubule polymerization in fibroblasts from affected subjects, demonstrating an overall shift toward a more rapidly growing and stable microtubule population. These cells displayed an aberrant mitotic spindle with disorganized, tangle-shaped microtubules and reduced aster formation, which however did not alter appreciably the rate of cell proliferation. Our findings establish that defective TBCD function underlies a recognizable encephalopathy and drives accelerated microtubule polymerization and enhanced microtubule stability, underscoring an additional cause of altered microtubule dynamics with impact on neuronal function and survival in the developing brain.	[Flex, Elisabetta; Carpentieri, Giovanna] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Niceta, Marcello; Capuano, Alessandro; Piermarini, Emanuela; Ciolfi, Andrea; Pizzi, Simone; Sferra, Antonella; Dentici, Maria Lisa; Piemonte, Fiorella; Dallapiccola, Bruno; Bertini, Enrico; Tartaglia, Marco] Osped Pediat Bambino Gesu, Genet & Rare Dis Res Div, I-00146 Rome, Italy; [Cecchetti, Serena] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Thiffault, Isabelle; Farrow, Emily; Saunders, Carol J.] Childrens Mercy Hosp, Ctr Pediat Genom Med, Kansas City, MO 64108 USA; [Thiffault, Isabelle; Saunders, Carol J.] Childrens Mercy Hosp, Dept Pathol & Lab Med, Kansas City, MO 64108 USA; [Thiffault, Isabelle; Saunders, Carol J.] Univ Missouri, Sch Med, Kansas City, MO 64108 USA; [Au, Margaret G.; Graham, John M., Jr.] Cedars Sinai Med Ctr, Dept Pediat, Med Genet, Los Angeles, CA 90048 USA; [Ivanova, Anna A.; Francis, Joshua W.; Kahn, Richard A.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Chillemi, Giovanni] SCAI SuperComp Applicat & Innovat Dept, CINECA, I-00185 Rome, Italy; [Chandramouli, Balasubramanian] Scuola Normale Super Pisa, I-56126 Pisa, Italy; [Carpentieri, Giovanna] Sapienza Univ Roma, Dipartimento Med Sperimentale, I-00161 Rome, Italy; [Haaxma, Charlotte A.; Pfundt, Rolph R.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol, NL-1105 Amsterdam, Netherlands; [Ciolfi, Andrea] CREA, Ctr Ric Alimenti & Nutr, I-00178 Rome, Italy; [Douglas, Ganka V.; Levine, Kara] GeneDx, Gaithersburg, MD 20877 USA; [Le Pichon, Jean-Baptiste] Childrens Mercy Hosp, Dept Pediat, Kansas City, MO 64108 USA; [Baas, Frank] Acad Med Ctr, Dept Genome Anal, NL-1105 Amsterdam, Netherlands; [Koolen, David A.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Human Genet, NL-1105 Nijmegen, Netherlands	Istituto Superiore di Sanita (ISS); IRCCS Bambino Gesu; Istituto Superiore di Sanita (ISS); Children's Mercy Hospital; Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; Cedars Sinai Medical Center; Emory University; CINECA, Italy; Scuola Normale Superiore di Pisa; Sapienza University Rome; Radboud University Nijmegen; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Children's Mercy Hospital; Radboud University Nijmegen	Tartaglia, M (corresponding author), Osped Pediat Bambino Gesu, Genet & Rare Dis Res Div, I-00146 Rome, Italy.	marco.tartaglia@opbg.net	Graham, John M./J-1429-2019; Dentici, Maria Lisa/AAC-7654-2022; Ciolfi, Andrea/J-4954-2018; Pizzi, Simone/AAI-1767-2019; Cecchetti, Serena/N-1061-2015; Bertini, Enrico/ABG-1278-2020; Chillemi, Giovanni/O-2825-2019; Chillemi, Giovanni/E-5201-2010; Baas, Frank/F-9574-2010; Pfundt, Rolph/L-4576-2015; Flex, Elisabetta/A-5958-2017; Ivanova, Anna/GZK-6458-2022; Piemonte, Fiorella/A-2809-2014; Capuano, Alessandro/K-5762-2016; Bertini, Enrico/A-2284-2014; Tartaglia, Marco/K-2955-2018; Niceta, Marcello/V-1557-2019; Kahn, Richard/ABD-2666-2020; CHANDRAMOULI, BALASUBRAMANIAN/L-9556-2018; Koolen, D.A./L-4448-2015; Sferra, Antonella/J-2774-2018; Dallapiccola, Bruno/K-8692-2016	Dentici, Maria Lisa/0000-0002-9505-5906; Ciolfi, Andrea/0000-0002-6191-0978; Cecchetti, Serena/0000-0002-3601-176X; Chillemi, Giovanni/0000-0003-3901-6926; Chillemi, Giovanni/0000-0003-3901-6926; Baas, Frank/0000-0003-3912-5428; Flex, Elisabetta/0000-0002-6802-1356; Piemonte, Fiorella/0000-0003-1825-9347; Capuano, Alessandro/0000-0002-7729-7952; Bertini, Enrico/0000-0001-9276-4590; Tartaglia, Marco/0000-0001-7736-9672; Niceta, Marcello/0000-0003-4766-7753; Kahn, Richard/0000-0002-0259-0601; CHANDRAMOULI, BALASUBRAMANIAN/0000-0002-6837-4709; Sferra, Antonella/0000-0001-8701-3696; Dallapiccola, Bruno/0000-0002-5031-1013; Au, Margaret/0000-0001-8528-0387	Fondazione Bambino Gesu (Vite Coraggiose); Bulgari (GeneRare); Ministero della Salute [RC2016]; Marion Merrell Dow Foundation; W.T. Kemper Foundation; Pat & Gil Clements Foundation; Claire Giannini Foundation; Black Veatch; NIH [R01GM090158, F31CA189672]; CINECA; NATIONAL CANCER INSTITUTE [F31CA189672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090158] Funding Source: NIH RePORTER	Fondazione Bambino Gesu (Vite Coraggiose); Bulgari (GeneRare); Ministero della Salute(Ministry of Health, Italy); Marion Merrell Dow Foundation; W.T. Kemper Foundation; Pat & Gil Clements Foundation; Claire Giannini Foundation; Black Veatch; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CINECA(CINECA, Italy); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the participating individuals and their families. We thank colleagues in the Center for Pediatric Genomic Medicine, Children's Mercy Kansas City, for WES sequencing data, and Megan Truitt Cho, GeneDx, for WES data analysis. This work was supported, in part, by the following grants: Fondazione Bambino Gesu (Vite Coraggiose to M.T.); Bulgari (GeneRare to B.D.); Ministero della Salute (RC2016 to M.N., M.L.D., E.B., and M.T.); CINECA (computational resources to M.T.); Marion Merrell Dow Foundation, W.T. Kemper Foundation, Pat & Gil Clements Foundation, Claire Giannini Foundation, and Black & Veatch (to I.T., E. Farrow, and C.J.S.); and NIH (R01GM090158 to R.A.K. and F31CA189672 to J.W.F.).	Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Baird Fiona J, 2013, J Genet Syndr Gene Ther, V4, P203; Berendsen H., 1981, INTERMOLECULAR FORCE, V331, P331, DOI DOI 10.1007/978-94-015-7658-1_21; Bizzi A, 2008, AM J NEURORADIOL, V29, P1270, DOI 10.3174/ajnr.A1106; Breuss M, 2014, ADV EXP MED BIOL, V800, P75, DOI 10.1007/978-94-007-7687-6_5; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cappelletti G, 2005, FEBS LETT, V579, P4781, DOI 10.1016/j.febslet.2005.07.058; Chakraborti S., 2016, CYTOSKELETON HOBOKEN; Choi WS, 2011, J CELL BIOL, V192, P873, DOI 10.1083/jcb.201009132; Chong JX, 2016, AM J HUM GENET, V98, P772, DOI 10.1016/j.ajhg.2016.01.016; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cordeddu V, 2014, NAT GENET, V46, P815, DOI 10.1038/ng.3035; Cunningham LA, 2008, J BIOL CHEM, V283, P7155, DOI 10.1074/jbc.M706753200; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dong CL, 2015, HUM MOL GENET, V24, P2125, DOI 10.1093/hmg/ddu733; Dubey J, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00343; Eggens VRC, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-23; Evans KJ, 2005, J CELL BIOL, V168, P599, DOI 10.1083/jcb.200409058; Fanarraga Monica Lopez, 2010, Commun Integr Biol, V3, P306; Fassier C, 2013, DIS MODEL MECH, V6, P72, DOI 10.1242/dmm.008946; Grynberg M, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-46; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Howard J, 2009, NAT REV MOL CELL BIO, V10, P569, DOI 10.1038/nrm2713; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Janke C, 2014, J CELL BIOL, V206, P461, DOI 10.1083/jcb.201406055; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Kapitein LC, 2015, NEURON, V87, P492, DOI 10.1016/j.neuron.2015.05.046; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kortum F, 2015, NAT GENET, V47, P661, DOI 10.1038/ng.3282; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Fanarraga ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008846; Lopez-Fanarraga M, 2001, J STRUCT BIOL, V135, P219, DOI 10.1006/jsbi.2001.4386; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Martin L, 2000, FEBS LETT, V470, P93, DOI 10.1016/S0014-5793(00)01293-X; Martin N, 2002, NAT GENET, V32, P443, DOI 10.1038/ng1016; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mochel F, 2010, BBA-MOL BASIS DIS, V1802, P1112, DOI 10.1016/j.bbadis.2010.07.005; Montesinos Maria Luz, 2014, Adv Neurobiol, V8, P249; Namavar Y, 2011, BRAIN, V134, P143, DOI 10.1093/brain/awq287; Neveling K, 2013, HUM MUTAT, V34, P1721, DOI 10.1002/humu.22450; Niceta M, 2015, AM J HUM GENET, V96, P816, DOI 10.1016/j.ajhg.2015.03.001; Nithianantham S, 2015, ELIFE, V4, DOI 10.7554/eLife.08811; Okumura M, 2015, J NEUROSCI, V35, P1979, DOI 10.1523/JNEUROSCI.0973-14.2015; Parvari R, 2002, NAT GENET, V32, P448, DOI 10.1038/ng1012; Patel VP, 2014, EXP NEUROL, V257, P170, DOI 10.1016/j.expneurol.2014.04.024; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poirier K, 2010, HUM MOL GENET, V19, P4462, DOI 10.1093/hmg/ddq377; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Ren Y, 2015, STEM CELLS, V33, P68, DOI 10.1002/stem.1854; Romaniello R, 2015, BRAIN DEV-JPN, V37, P273, DOI 10.1016/j.braindev.2014.06.002; Saunders C, 2015, AM J HUM GENET, V96, P258, DOI 10.1016/j.ajhg.2014.12.020; Saunders CJ, 2015, HUM MUTAT, V36, P301, DOI 10.1002/humu.22743; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Sferra A., 2016, IMMUNITY, V45; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Soden SE, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010076; Stephan R, 2015, DEV CELL, V33, P5, DOI 10.1016/j.devcel.2015.02.003; Tanaka AJ, 2015, AM J HUM GENET, V97, P457, DOI 10.1016/j.ajhg.2015.07.014; Tarrade A, 2006, HUM MOL GENET, V15, P3544, DOI 10.1093/hmg/ddl431; Tian GL, 1996, CELL, V86, P287, DOI 10.1016/S0092-8674(00)80100-2; Tian GL, 2010, CYTOSKELETON, V67, P706, DOI 10.1002/cm.20480; Tischfield MA, 2011, CURR OPIN GENET DEV, V21, P286, DOI 10.1016/j.gde.2011.01.003; Wibom R, 2009, NEW ENGL J MED, V361, P489, DOI 10.1056/NEJMoa0900591; Wolf NI, 2009, NEW ENGL J MED, V361, P1997, DOI 10.1056/NEJMc091723; Zanni G, 2013, NEUROGENETICS, V14, P247, DOI 10.1007/s10048-013-0371-z; Zhou CJ, 2006, MOL BIOL CELL, V17, P2476, DOI 10.1091/mbc.E05-10-0929	66	55	57	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 6	2016	99	4					962	973		10.1016/j.ajhg.2016.08.003	http://dx.doi.org/10.1016/j.ajhg.2016.08.003			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DY7UB	27666370	Green Published, Bronze			2022-12-18	WOS:000385333700017
J	Colin, E; Daniel, J; Ziegler, A; Wakim, J; Scrivo, A; Haack, TB; Khiati, S; Denomme, AS; Amati-Bonneau, P; Charif, M; Procaccio, V; Reynier, P; Aleck, KA; Botto, LD; Herper, CL; Kaiser, CS; Nabbout, R; N'Guyen, S; Mora-Lorca, JA; Assmann, B; Christ, S; Meitinger, T; Strom, TM; Prokisch, H; Miranda-Vizuete, A; Hoffmann, GF; Lenaers, G; Bomont, P; Liebau, E; Bonneau, D				Colin, Estelle; Daniel, Jens; Ziegler, Alban; Wakim, Jamal; Scrivo, Aurora; Haack, Tobias B.; Khiati, Salim; Denomme, Anne-Sophie; Amati-Bonneau, Patrizia; Charif, Majida; Procaccio, Vincent; Reynier, Pascal; Aleck, Kyrieckos A.; Botto, Lorenzo D.; Herper, Claudia Lena; Kaiser, Charlotte Sophia; Nabbout, Rima; N'Guyen, Sylvie; Antonio Mora-Lorca, Jose; Assmann, Birgit; Christ, Stine; Meitinger, Thomas; Strom, Tim M.; Prokisch, Holger; Miranda-Vizuete, Antonio; Hoffmann, Georg F.; Lenaers, Guy; Bomont, Pascale; Liebau, Eva; Bonneau, Dominique		FREX Consortium	Biallelic Variants in UBAS Reveal that Disruption of the UFM1 Cascade Can Result in Early-Onset Encephalopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEIN; RECEPTORS; REGULATOR; MUTATION; NLBP	Via whole-exome sequencing, we identified rare autosomal-recessive variants in UBAS in five children from four unrelated families affected with a similar pattern of severe intellectual deficiency, microcephaly, movement disorders, and/or early-onset intractable epilepsy. UBA5 encodes the El-activating enzyme of ubiquitin-fold modifier 1 (UFM1), a recently identified ubiquitin-like protein. Biochemical studies of mutant UBA5 proteins and studies in fibroblasts from affected individuals revealed that UBA5 mutations impair the process of ufmylation, resulting in an abnormal endoplasmic reticulum structure. In Caenorhabditis elegans, knockout of uba-5 and of human orthologous genes in the UFM1 cascade alter cholinergic, but not glutamatergic, neurotransmission. In addition, uba5 silencing in zebrafish decreased motility while inducing abnormal movements suggestive of seizures. These clinical, biochemical, and experimental findings support our finding of UBA5 mutations as a pathophysiological cause for early-onset encephalopathies due to abnormal protein ufmylation.	[Colin, Estelle; Ziegler, Alban; Denomme, Anne-Sophie; Amati-Bonneau, Patrizia; Procaccio, Vincent; Reynier, Pascal; Bonneau, Dominique] Univ Hosp, Dept Biochem & Genet, F-49933 Angers 9, France; [Colin, Estelle; Ziegler, Alban; Wakim, Jamal; Khiati, Salim; Denomme, Anne-Sophie; Amati-Bonneau, Patrizia; Charif, Majida; Procaccio, Vincent; Reynier, Pascal; Lenaers, Guy; Bonneau, Dominique] Univ Angers, INSERM 1083, UMR CNRS 6214, F-49933 Angers 9, France; [Daniel, Jens; Herper, Claudia Lena; Kaiser, Charlotte Sophia; Liebau, Eva] Univ Munster, Dept Mol Physiol, D-48143 Munster, Germany; [Scrivo, Aurora; Bomont, Pascale] Univ Montpellier, Avenir Atip Team, INSERM, Inst Neurosci Montpellier,U1051, F-34091 Montpellier 5, France; [Haack, Tobias B.; Meitinger, Thomas; Strom, Tim M.; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Aleck, Kyrieckos A.] Phoenix Childrens Med Grp, Dept Genet & Metab, Phoenix, AZ 85016 USA; [Botto, Lorenzo D.] Univ Utah, Div Med Genet, Dept Pediat, Salt Lake City, UT 84132 USA; [Nabbout, Rima] Univ Hosp Necker Enfants Malad, Dept Pediat Neurol, Natl Reference Ctr Rare Epilepsies, F-75015 Paris, France; [N'Guyen, Sylvie] Univ Hosp, Dept Pediat Neurol, F-49933 Angers 9, France; [Antonio Mora-Lorca, Jose; Miranda-Vizuete, Antonio] Univ Seville, Inst Biomed Seville, CSIC, Univ Hosp Virgen del Rocio, Seville 41013, Spain; [Assmann, Birgit; Christ, Stine; Hoffmann, Georg F.] Univ Hosp Heidelberg, Dept Gen Pediat, Div Pediat Metab Med & Neuropediat, D-69120 Heidelberg, Germany; [Meitinger, Thomas; Strom, Tim M.; Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; University of Munster; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Technical University of Munich; Phoenix Children's Hospital; Utah System of Higher Education; University of Utah; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Ruprecht Karls University Heidelberg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Bonneau, D (corresponding author), Univ Hosp, Dept Biochem & Genet, F-49933 Angers 9, France.; Bonneau, D (corresponding author), Univ Angers, INSERM 1083, UMR CNRS 6214, F-49933 Angers 9, France.	dobonneau@chu-angers.fr	Bomont, Pascale/GLS-8721-2022; Bomont, Pascale L/Y-5517-2018; IBIS, REDOX/J-7473-2017; Scrivo, Aurora/ABA-4113-2021; LETENNEUR, Luc/T-4424-2019; Lenaers, guy/X-4727-2019; Miranda-Vizuete, Antonio/D-6927-2012; IBIS, FISIOLOGIA/O-9485-2015; Redon, Richard/F-3303-2014; CHATEL, Stephanie/D-2536-2015; Le Marec, Hervé/D-2718-2015; Meitinger, Thomas/O-1318-2015; Ziegler, Alban/AGY-4798-2022; Bellenguez, Céline/X-4004-2019; Belllenguez, Céline/Y-3183-2018; colin, estelle/AAI-2447-2019; lenaers, guy/K-2421-2015	Bomont, Pascale/0000-0001-7216-3261; Bomont, Pascale L/0000-0001-7216-3261; LETENNEUR, Luc/0000-0002-3274-937X; Miranda-Vizuete, Antonio/0000-0002-6856-5396; Redon, Richard/0000-0001-7751-2280; CHATEL, Stephanie/0000-0003-0677-5627; Le Marec, Hervé/0000-0002-8288-8693; Bellenguez, Céline/0000-0002-1240-7874; Belllenguez, Céline/0000-0002-1240-7874; ROUAULT, Karen/0000-0001-7586-3212; procaccio, Vincent/0000-0002-1537-4684; Scrivo, Aurora/0000-0001-7511-035X; lenaers, guy/0000-0003-2736-3349; Dina, Christian/0000-0002-7722-7348; Nicolas, Gael/0000-0001-9391-7800; Bonneau, Dominique/0000-0002-6886-0969; Reynier, Pascal/0000-0003-0802-4608; Meitinger, Thomas/0000-0002-8838-8403; Denomme-Pichon, Anne-Sophie/0000-0002-8986-8222; Ludwig, Thomas/0000-0002-9996-1084; Prokisch, Holger/0000-0003-2379-6286	INSERM; CNRS; Region Pays de la Loire; Angers Loire-Metropole; University of Angers; University Hospital of Angers; E-Rare project GENOMIT [01GM1207]; BMBF through the Juniorverbund in der Systemmedizin "mitOmics" [FKZ 01ZX1405C]; France Genomique National infrastructure; "Investissement d'avenir" program; Region Languedoc-Roussillon; Avenir-Atip program from INSERM; Association Francaise contre les Myopathies	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Region Pays de la Loire(Region Pays de la Loire); Angers Loire-Metropole(Region Pays de la Loire); University of Angers; University Hospital of Angers; E-Rare project GENOMIT; BMBF through the Juniorverbund in der Systemmedizin "mitOmics"(Federal Ministry of Education & Research (BMBF)); France Genomique National infrastructure; "Investissement d'avenir" program(French National Research Agency (ANR)); Region Languedoc-Roussillon(Region OccitanieRegion Ile-de-France); Avenir-Atip program from INSERM; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	We thank all the families for their participation in this study. We thank INSERM and CNRS, the Region Pays de la Loire, Angers Loire-Metropole, University of Angers, and University Hospital of Angers for their financial support to the PREMMI project, the University of Montpellier for institutional support, the German Bundesministerium fur Bildung and Forschung through the German Network for mitochondrial disorders (mitoNET, 01GM1113C to T.M. and H.P.), and the E-Rare project GENOMIT (01GM1207 for T.M. and H.P.). T.B.H. was supported by the BMBF through the Juniorverbund in der Systemmedizin "mitOmics" (FKZ 01ZX1405C). This work was also supported by France Genomique National infrastructure, funded as part of "Investissement d'avenir" program managed by Agence Nationale pour la Recherche. We thank the Caenorhabditis Genetics Center and the National Bioresource Project for the Experimental Animal Nematode C. elegans (NBRP) for providing us with knockout strains. We thank C. Klambt, B. Risse, N. Otto, and D. Berh for the opportunity to use the FIMtrack system for chemotaxis assay on C. elegans and for their support in data analysis. We thank Mr. Cubedo and Dr. Rossel for hosting zebrafish (INSERM U710) and C. Conan for performing the touch-response test. A.S. is funded by the Region Languedoc-Roussillon and P.B. is supported by grants from the Avenir-Atip program from INSERM and the CNRS, the Region Languedoc-Roussillon, and the Association Francaise contre les Myopathies. We thank Delphine Heron for having tested UBA5 in children affected with early encephalopathy and Joanne Walker and Kanaya Malkani for critical reading of the manuscript.	Aridon P, 2006, AM J HUM GENET, V79, P342, DOI 10.1086/506459; Azfer A, 2006, AM J PHYSIOL-HEART C, V291, pH1411, DOI 10.1152/ajpheart.01378.2005; Baraban SC, 2005, NEUROSCIENCE, V131, P759, DOI 10.1016/j.neuroscience.2004.11.031; Becchetti A, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00022; BRENNER S, 1974, GENETICS, V77, P71; Cai YF, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005643; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Daniel J, 2014, CELLS-BASEL, V3, P627, DOI 10.3390/cells3020627; Duan RH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149039; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Hayashi Masaharu, 2012, ISRN Neurol, V2012, P404263, DOI 10.5402/2012/404263; Hertel P, 2013, J BIOL CHEM, V288, P10661, DOI 10.1074/jbc.M113.458000; Homan CC, 2014, AM J HUM GENET, V94, P470, DOI 10.1016/j.ajhg.2014.02.004; Homrich M, 2014, EXP CELL RES, V324, P192, DOI 10.1016/j.yexcr.2014.04.003; Kim CH, 2013, CELL CYCLE, V12, P2443, DOI 10.4161/cc.25451; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; Kwon J, 2010, J BIOL CHEM, V285, P12232, DOI 10.1074/jbc.M109.065920; Lemaire K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018517; Liu H, 2014, EXP MOL PATHOL, V97, P81, DOI 10.1016/j.yexmp.2014.05.010; Locke C., 2008, JOVE-J VIS EXP, V18, pe837; Magen D, 2015, HUM GENET, V134, P305, DOI 10.1007/s00439-014-1522-5; Martin RJ, 2012, TRENDS PARASITOL, V28, P289, DOI 10.1016/j.pt.2012.04.003; Risse B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053963; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Shiwaku H, 2010, EMBO J, V29, P2446, DOI 10.1038/emboj.2010.116; STEINLEIN OK, 1995, NAT GENET, V11, P201, DOI 10.1038/ng1095-201; Stewart AM, 2012, BRAIN RES BULL, V87, P135, DOI 10.1016/j.brainresbull.2011.11.020; Tatsumi K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1182; van der Veen AG, 2012, ANNU REV BIOCHEM, V81, P323, DOI 10.1146/annurev-biochem-093010-153308; Vashlishan AB, 2008, NEURON, V58, P346, DOI 10.1016/j.neuron.2008.02.019; Wu JC, 2010, J BIOL CHEM, V285, P15126, DOI 10.1074/jbc.M110.110619; Yoo HM, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00036; Zhang M, 2015, CELL DEATH DIFFER, V22, P1922, DOI 10.1038/cdd.2015.51	33	55	60	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 1	2016	99	3					695	703		10.1016/j.ajhg.2016.06.030	http://dx.doi.org/10.1016/j.ajhg.2016.06.030			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DV7KM	27545681	Bronze, Green Published			2022-12-18	WOS:000383114800014
J	Twigg, SRF; Hufnagel, RB; Miller, KA; Zhou, Y; McGowan, SJ; Taylor, J; Craft, J; Taylor, JC; Santoro, SL; Huang, TS; Hopkin, RJ; Brady, AF; Clayton-Smith, J; Clericuzio, CL; Grange, DK; Groesser, L; Hafner, C; Horn, D; Temple, IK; Dobyns, WB; Curry, CJ; Jones, MC; Wilkie, AOM				Twigg, Stephen R. F.; Hufnagel, Robert B.; Miller, Kerry A.; Zhou, Yan; McGowan, Simon J.; Taylor, John; Craft, Jude; Taylor, Jenny C.; Santoro, Stephanie L.; Huang, Taosheng; Hopkin, Robert J.; Brady, Angela F.; Clayton-Smith, Jill; Clericuzio, Carol L.; Grange, Dorothy K.; Groesser, Leopold; Hafner, Christian; Horn, Denise; Temple, I. Karen; Dobyns, William B.; Curry, Cynthia J.; Jones, Marilyn C.; Wilkie, Andrew O. M.			A Recurrent Mosaic Mutation in SMO, Encoding the Hedgehog Signal Transducer Smoothened, Is the Major Cause of Curry-Jones Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BASAL-CELL CARCINOMA; GENOMIC ANALYSIS; NEVUS SYNDROME; HUMAN HOMOLOG; MEDULLOBLASTOMA; SPECTRUM; RECEPTOR; ABNORMALITIES; MALFORMATIONS; OVERGROWTH	Curry-Jones syndrome (CJS) is a multisystem disorder characterized by patchy skin lesions, polysyndactyly, diverse cerebral malformations, unicoronal craniosynostosis, iris colobomas, microphthalmia, and intestinal malrotation with myofibromas or hamartomas. Cerebellar medulloblastoma has been described in a single affected individual; in another, biopsy of skin lesions showed features of trichoblastoma. The combination of asymmetric clinical features, patchy skin manifestations, and neoplastic association previously led to the suggestion that this could be a mosaic condition, possibly involving hedgehog (Hh) signaling. Here, we show that CJS is caused by recurrent somatic mosaicism for a nonsynonymous variant in SMO (c.1234C>T [p.Leu412Phe]), encoding smoothened (SMO), a G-protein-coupled receptor that transduces Hh signaling. We identified eight mutation-positive individuals (two of whom had not been reported previously) with highly similar phenotypes and demonstrated varying amounts of the mutant allele in different tissues. We present detailed findings from brain MRI in three mutation-positive individuals. Somatic SMO mutations that result in constitutive activation have been described in several tumors, including medulloblastoma, ameloblastoma, and basal cell carcinoma. Strikingly, the most common of these mutations is the identical nonsynonymous variant encoding p.Leu412Phe. Furthermore, this substitution has been shown to activate SMO in the absence of Hh signaling, providing an explanation for tumor development in CJS. This raises therapeutic possibilities for using recently generated Hh-pathway inhibitors. In summary, our work uncovers the major genetic cause of CJS and illustrates strategies for gene discovery in the context of low-level tissue-specific somatic mosaicism.	[Twigg, Stephen R. F.; Miller, Kerry A.; Zhou, Yan; Wilkie, Andrew O. M.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Clin Genet Grp, Oxford OX3 9DS, England; [Hufnagel, Robert B.; Santoro, Stephanie L.; Huang, Taosheng; Hopkin, Robert J.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Human Genet, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Hufnagel, Robert B.; Santoro, Stephanie L.; Huang, Taosheng; Hopkin, Robert J.] Univ Cincinnati, Coll Med, MLC 4006, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [McGowan, Simon J.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Computat Biol Res Grp, Oxford OX3 9DS, England; [Taylor, John; Craft, Jude; Taylor, Jenny C.] Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England; [Taylor, John] Oxford Univ Hosp NHS Fdn Trust, Churchill Hosp, Genet Labs, Oxford OX3 7LE, England; [Taylor, Jenny C.] Natl Inst Hlth Res, Oxford Biomed Res Ctr, Oxford OX3 7BN, England; [Brady, Angela F.] Northwick Pk Hosp & Clin Res Ctr, Kennedy Galton Ctr, North West Thames Reg Genet Serv, Harrow HA1 3UJ, Middx, England; [Clayton-Smith, Jill] Univ Manchester, St Marys Hosp, Manchester Ctr Genom Med, Manchester M13 9WL, Lancs, England; [Clericuzio, Carol L.] Univ New Mexico, Dept Pediat, Div Genet Dysmorphol, Albuquerque, NM 87131 USA; [Grange, Dorothy K.] Washington Univ, Sch Med, Div Genet & Genom Med, Dept Pediat, St Louis, MO 63110 USA; [Groesser, Leopold; Hafner, Christian] Univ Regensburg, Dept Dermatol, D-93053 Regensburg, Germany; [Horn, Denise] Charite, Inst Med Genet & Human Genet, D-13353 Berlin, Germany; [Temple, I. Karen] Univ Southampton, Fac Med, Human Dev & Hlth, Southampton SO17 1BJ, Hants, England; [Temple, I. Karen] Univ Hosp Southampton NHS Fdn Trust, Princess Anne Hosp, Wessex Clin Genet Serv, Southampton SO16 6YD, Hants, England; [Dobyns, William B.] Seattle Childrens Hosp, Ctr Integrat Brain Res, Seattle, WA 98105 USA; [Curry, Cynthia J.] Univ Calif San Francisco, Genet Med, Fresno, CA 93701 USA; [Jones, Marilyn C.] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA; [Jones, Marilyn C.] Rady Childrens Hosp, San Diego, CA 92123 USA	University of Oxford; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford; Imperial College London; University of Manchester; University of New Mexico; Washington University (WUSTL); University of Regensburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; Seattle Children's Hospital; University of California System; University of California San Francisco; University of California San Francisco at Fresno; University of California System; University of California San Diego; Rady Childrens Hospital San Diego	Wilkie, AOM (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Clin Genet Grp, Oxford OX3 9DS, England.	andrew.wilkie@imm.ox.ac.uk	Wilkie, Andrew/AAC-3820-2020; Dobyns, William Brian/ABC-6525-2021; Twigg, Stephen/AAU-1135-2021; Dobyns, William/AAI-2768-2020; Santoro, Stephanie L./AAM-4696-2021	Wilkie, Andrew/0000-0002-2972-5481; Twigg, Stephen/0000-0001-5024-049X; Dobyns, William/0000-0002-7681-2844; Santoro, Stephanie L./0000-0002-4172-0288; Taylor, Jenny/0000-0003-3602-5704; Temple, Isabel Karen/0000-0002-6045-1781; McGowan, Simon/0000-0001-9720-1914; Huang, Taosheng/0000-0001-6601-6687	National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme; Medical Research Council through the Weatherall Institute of Molecular Medicine Strategic Alliance [G0902418, MC_UU_12025]; Wellcome Trust [093329, 102731]; MRC [G0902418] Funding Source: UKRI; Medical Research Council [G0902418] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050375, R01NS092772] Funding Source: NIH RePORTER	National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme(National Institute for Health Research (NIHR)); Medical Research Council through the Weatherall Institute of Molecular Medicine Strategic Alliance(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to all the families for their participation in this study. We thank the staff at the high-throughput genomics facility at the Wellcome Trust Centre for Human Genetics (Oxford Genomics Centre) for exome sequencing and Sue Butler, John Frankland, and Tim Rostron for help with cell culture and DNA sequencing. This work was supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme (J.C.T. and A.O.M.W.), the Medical Research Council through the Weatherall Institute of Molecular Medicine Strategic Alliance (G0902418 and MC_UU_12025), and the Wellcome Trust (project grant 093329 to A.O.M.W. and S.R.F.T. and Senior Investigator Award 102731 to A.O.M.W.). The views expressed in this publication are those of the authors and not necessarily those of the National Health Service, NIHR, or Department of Health.	Anderson E, 2012, TRENDS GENET, V28, P364, DOI 10.1016/j.tig.2012.03.012; Arensdorf AM, 2016, TRENDS PHARMACOL SCI, V37, P62, DOI 10.1016/j.tips.2015.09.001; Athar M, 2014, CANCER RES, V74, P4967, DOI 10.1158/0008-5472.CAN-14-1666; Atwood SX, 2015, CANCER CELL, V27, P342, DOI 10.1016/j.ccell.2015.02.002; Brastianos PK, 2013, NAT GENET, V45, P285, DOI 10.1038/ng.2526; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Brown NA, 2014, CLIN CANCER RES, V20, P5517, DOI 10.1158/1078-0432.CCR-14-1069; Clark VE, 2013, SCIENCE, V339, P1077, DOI 10.1126/science.1233009; Cohen M M Jr, 1988, Am J Med Genet Suppl, V4, P99; Gorlin RJ, 1990, SYNDROMES HEAD NECK, P519; Grange DK, 2008, AM J MED GENET A, V146A, P2589, DOI 10.1002/ajmg.a.32503; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Happle R, 2016, AM J MED GENET A, V170, P452, DOI 10.1002/ajmg.a.37439; Hevner RF, 2015, SEMIN PERINATOL, V39, P36, DOI 10.1053/j.semperi.2014.10.006; Huang H, 2013, J BIOL CHEM, V288, P17589, DOI 10.1074/jbc.M113.467498; Jansen LA, 2015, BRAIN, V138, P1613, DOI 10.1093/brain/awv045; Jenkins D, 2007, AM J HUM GENET, V80, P1162, DOI 10.1086/518047; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Johnston JJ, 2010, HUM MUTAT, V31, P1142, DOI 10.1002/humu.21328; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Keppler-Noreuil KM, 2015, AM J MED GENET A, V167, P287, DOI 10.1002/ajmg.a.36836; Khamaysi Z., 2016, BR J DERMATOL; Klopocki E, 2011, AM J HUM GENET, V88, P70, DOI 10.1016/j.ajhg.2010.11.006; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Mao J, 2010, DEVELOPMENT, V137, P1721, DOI 10.1242/dev.044586; McCabe JM, 2015, J BIOL CHEM, V290, P3500, DOI 10.1074/jbc.R114.617936; McGowan SJ, 2013, BIOINFORMATICS, V29, P2477, DOI 10.1093/bioinformatics/btt406; Ming JE, 2002, HUM GENET, V110, P297, DOI 10.1007/s00439-002-0695-5; Mingarelli R, 1999, CLIN DYSMORPHOL, V8, P73; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Putoux A, 2011, NAT GENET, V43, P601, DOI 10.1038/ng.826; Rahbari R, 2016, NAT GENET, V48, P126, DOI 10.1038/ng.3469; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; Rimmer A, 2014, NAT GENET, V46, P912, DOI 10.1038/ng.3036; Sharpe HJ, 2015, CANCER CELL, V27, P327, DOI 10.1016/j.ccell.2015.02.001; Smith MJ, 2014, J CLIN ONCOL, V32, P4155, DOI 10.1200/JCO.2014.58.2569; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Sweeney RT, 2014, NAT GENET, V46, P722, DOI 10.1038/ng.2986; Temple I K, 1995, Clin Dysmorphol, V4, P116; Thomas ERA, 2006, CLIN DYSMORPHOL, V15, P115, DOI 10.1097/01.mcd.0000194406.85052.de; Twigg SRF, 2015, AM J HUM GENET, V97, P359, DOI 10.1016/j.ajhg.2015.07.006; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; Wang C, 2013, NATURE, V497, P338, DOI 10.1038/nature12167; Wang Y, 2012, CANCER CELL, V21, P374, DOI 10.1016/j.ccr.2011.12.028	46	55	55	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 2	2016	98	6					1256	1265		10.1016/j.ajhg.2016.04.007	http://dx.doi.org/10.1016/j.ajhg.2016.04.007			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DN7US	27236920	Green Published, hybrid, Green Accepted			2022-12-18	WOS:000377286000020
J	Metodiev, MD; Thompson, K; Alston, CL; Morris, AAM; He, LP; Assouline, Z; Rio, M; Bahi-Buisson, N; Pyle, A; Griffin, H; Siira, S; Filipovska, A; Munnich, A; Chinnery, PF; McFarland, R; Rotig, A; Taylor, RW				Metodiev, Metodi D.; Thompson, Kyle; Alston, Charlotte L.; Morris, Andrew A. M.; He, Langping; Assouline, Zarah; Rio, Marlene; Bahi-Buisson, Nadia; Pyle, Angela; Griffin, Helen; Siira, Stefan; Filipovska, Aleksandra; Munnich, Arnold; Chinnery, Patrick F.; McFarland, Robert; Rotig, Agnes; Taylor, Robert W.			Recessive Mutations in TRMT10C Cause Defects in Mitochondrial RNA Processing and Multiple Respiratory Chain Deficiencies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HYPERTROPHIC CARDIOMYOPATHY; SIDEROBLASTIC ANEMIA; LACTIC-ACIDOSIS; ENCODES	Mitochondrial disorders are clinically and genetically diverse, with mutations in mitochondrial or nuclear genes able to cause defects in mitochondrial gene expression. Recently, mutations in several genes encoding factors involved in mt-tRNA processing have been identified to cause mitochondrial disease. Using whole-exome sequencing, we identified mutations in TRMT10C (encoding the mitochondrial RNase P protein 1 [MRPP1]) in two unrelated individuals who presented at birth with lactic acidosis, hypotonia, feeding difficulties, and deafness. Both individuals died at 5 months after respiratory failure. MRPP1, along with MRPP2 and MRPP3, form the mitochondrial ribonuclease P (mt-RNase P) complex that cleaves the 50 ends of mt-tRNAs from polycistronic precursor transcripts. Additionally, a stable complex of MRPP1 and MRPP2 has m(1)R9 methyltransferase activity, which methylates mt-tRNAs at position 9 and is vital for folding mt-tRNAs into their correct tertiary structures. Analyses of fibroblasts from affected individuals harboring TRMT10C missense variants revealed decreased protein levels of MRPP1 and an increase in mt-RNA precursors indicative of impaired mt-RNA processing and defective mitochondrial protein synthesis. The pathogenicity of the detected variants-compound heterozygous c.542G>T (p.Arg181Leu) and c.814A>G (p.Thr272Ala) changes in subject 1 and a homozygous c.542G>T (p.Arg181Leu) variant in subject 2-was validated by the functional rescue of mt-RNA processing and mitochondrial protein synthesis defects after lentiviral transduction of wild-type TRMT10C. Our study suggests that these variants affect MRPP1 protein stability and mt-tRNA processing without affecting m(1)R9 methyltransferase activity, identifying mutations in TRMT10C as a cause of mitochondrial disease and highlighting the importance of RNA processing for correct mitochondrial function.	[Metodiev, Metodi D.; Munnich, Arnold; Rotig, Agnes] Univ Paris 05, Sorbonne Paris Cite, INSERM, Inst Imagine,U1163, F-75015 Paris, France; [Thompson, Kyle; Alston, Charlotte L.; He, Langping; McFarland, Robert; Taylor, Robert W.] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Morris, Andrew A. M.] Univ Manchester, Inst Human Dev, Manchester M13 9WL, Lancs, England; [Morris, Andrew A. M.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester M13 9WL, Lancs, England; [Assouline, Zarah; Rio, Marlene; Bahi-Buisson, Nadia; Munnich, Arnold] Hop Necker Enfants Malad, Dept Pediat, F-75015 Paris, France; [Assouline, Zarah; Rio, Marlene; Bahi-Buisson, Nadia; Munnich, Arnold] Hop Necker Enfants Malad, Dept Neurol, F-75015 Paris, France; [Assouline, Zarah; Rio, Marlene; Bahi-Buisson, Nadia; Munnich, Arnold] Hop Necker Enfants Malad, Dept Genet, F-75015 Paris, France; [Griffin, Helen; Chinnery, Patrick F.] Newcastle Univ, Inst Med Genet, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Siira, Stefan; Filipovska, Aleksandra] Univ Western Australia, Harry Perkins Inst Med Res, Med Res Ctr, Nedlands, WA 6009, Australia; [Siira, Stefan; Filipovska, Aleksandra] Univ Western Australia, Sch Chem & Biochem, Nedlands, WA 6009, Australia; [Chinnery, Patrick F.] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England; [Chinnery, Patrick F.] Univ Cambridge, Dept Clin Neurosci, Sch Clin Med, Cambridge CB2 0SP, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Newcastle University - UK; University of Manchester; University of Manchester; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Newcastle University - UK; Harry Perkins Institute of Medical Research; University of Western Australia; University of Western Australia; University of Cambridge	Rotig, A (corresponding author), Univ Paris 05, Sorbonne Paris Cite, INSERM, Inst Imagine,U1163, F-75015 Paris, France.; Taylor, RW (corresponding author), Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	agnes.rotig@inserm.fr; robert.taylor@ncl.ac.uk	Rötig, Agnès/G-9592-2017; Metodiev, Metodi/C-4780-2015; Alston, Charlotte/ABG-9602-2020	Rötig, Agnès/0000-0003-0589-0703; Metodiev, Metodi/0000-0002-9596-2434; Alston, Charlotte/0000-0003-2095-5464; McFarland, Robert/0000-0002-8833-2688; Filipovska, Aleksandra/0000-0002-6998-8403; Rio, Marlene/0000-0003-2049-5058; Chinnery, Patrick/0000-0002-7065-6617; Griffin, Helen R/0000-0002-5288-3322; Siira, Stefan/0000-0002-8391-0143	Wellcome Trust [096919/Z/11/Z]; MRC Centre for Neuromuscular Diseases [G0601943]; UK NHS Highly Specialised "Rare Mitochondrial Disorders of Adults and Children" Service; Lily Foundation; UK National Institute for Health Research (NIHR) [NIHR-HCS-D12-03-04]; Medical Research Council Mitochondrial Biology Unit [MC_UP_1501/2]; EU; National Institute for Health Research (NIHR) Biomedical Research Centre based at Cambridge University Hospitals NHS Foundation Trust; University of Cambridge; AFM [16615]; NHMRC [APP1078273, APP1041582]; Alexander von Humboldt Fellowship for experienced researchers; Association Francaise contre les Myopathies; E-Rare project GENOMIT [01GM1207]; MRC [MC_PC_13047, G0601943] Funding Source: UKRI; Medical Research Council [MC_PC_13047, G0601943, MC_UP_1501/2] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10011, NF-SI-0514-10016, NIHR-HCS-D12-03-04] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); MRC Centre for Neuromuscular Diseases(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK NHS Highly Specialised "Rare Mitochondrial Disorders of Adults and Children" Service; Lily Foundation; UK National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Medical Research Council Mitochondrial Biology Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU(European Commission); National Institute for Health Research (NIHR) Biomedical Research Centre based at Cambridge University Hospitals NHS Foundation Trust; University of Cambridge(University of Cambridge); AFM(Association Francaise contre les Myopathies); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Alexander von Humboldt Fellowship for experienced researchers(Alexander von Humboldt Foundation); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); E-Rare project GENOMIT; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by a Wellcome Trust Strategic Award (096919/Z/11/Z) (R.W.T., R.M., and P.F.C.); MRC Centre for Neuromuscular Diseases (G0601943) (R.W.T., R.M., and P.F.C.); UK NHS Highly Specialised "Rare Mitochondrial Disorders of Adults and Children" Service (R.M. and R.W.T.), and The Lily Foundation (R.W.T., R.M., and K.T.). C.L.A. is supported by a UK National Institute for Health Research (NIHR) doctoral fellowship (NIHR-HCS-D12-03-04). P.F.C. is a Wellcome Trust Senior Fellow in Clinical Science (101876/Z/13/Z) and a UK NIHR Senior Investigator who receives additional support from the Medical Research Council Mitochondrial Biology Unit (MC_UP_1501/2), EU FP7 TIRCON, the National Institute for Health Research (NIHR) Biomedical Research Centre based at Cambridge University Hospitals NHS Foundation Trust, and the University of Cambridge. M.D.M. is supported by a fellowship from AFM (16615). A.F. is a National Health and Medical Research Council (NHMRC) Senior Research Fellow (APP 1058442) and is supported by grants from the NHMRC (APP1078273 and APP1041582) an Alexander von Humboldt Fellowship for experienced researchers. A.R. is supported by the Association Francaise contre les Myopathies and E-Rare project GENOMIT (01GM1207). RNA library construction and sequencing were performed at the Cologne Center for Genomics, Cologne, Germany.	Almalki A, 2014, BBA-MOL BASIS DIS, V1842, P56, DOI 10.1016/j.bbadis.2013.10.008; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Baruffini E, 2013, HUM MUTAT, V34, P1501, DOI 10.1002/humu.22393; Brzezniak LK, 2011, RNA BIOL, V8, P616, DOI 10.4161/rna.8.4.15393; Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530; Chakraborty PK, 2014, BLOOD, V124, P2867, DOI 10.1182/blood-2014-08-591370; Deutschmann AJ, 2014, HUM MOL GENET, V23, P3618, DOI 10.1093/hmg/ddu072; Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011; Haack TB, 2013, AM J HUM GENET, V93, P211, DOI 10.1016/j.ajhg.2013.06.006; Helm M, 1998, NUCLEIC ACIDS RES, V26, P1636, DOI 10.1093/nar/26.7.1636; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; Kopajtich R, 2014, AM J HUM GENET, V95, P708, DOI 10.1016/j.ajhg.2014.10.017; Leary SC, 2009, METHODS MOL BIOL, V554, P143, DOI 10.1007/978-1-59745-521-3_10; Li FZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09878; Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516; Metodiev MD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004110; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Powel CA, 2015, AM J HUM GENET, V97, P319, DOI 10.1016/j.ajhg.2015.06.011; Powell CA, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00079; Reinhard L, 2015, NUCLEIC ACIDS RES, V43, P5664, DOI 10.1093/nar/gkv481; Rossmanith W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019152; Sakurai M, 2005, NUCLEIC ACIDS RES, V33, P1653, DOI 10.1093/nar/gki309; Sanchez MIGL, 2015, MOL ENDOCRINOL, V29, P14, DOI 10.1210/me.2014-1077; Sanchez MIGL, 2011, CELL CYCLE, V10, P2904, DOI 10.4161/cc.10.17.17060; Suzuki T, 2014, NUCLEIC ACIDS RES, V42, P7346, DOI 10.1093/nar/gku390; Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531; Takaku H, 2003, NUCLEIC ACIDS RES, V31, P2272, DOI 10.1093/nar/gkg337; Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184; Vedrenne V, 2012, AM J HUM GENET, V91, P912, DOI 10.1016/j.ajhg.2012.09.001; Vilardo E, 2012, NUCLEIC ACIDS RES, V40, P11583, DOI 10.1093/nar/gks910; Voigts-Hoffmann F, 2007, J AM CHEM SOC, V129, P13382, DOI 10.1021/ja075520+; Yarham JW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004424; Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004	33	55	56	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 5	2016	98	5					993	1000		10.1016/j.ajhg.2016.03.010	http://dx.doi.org/10.1016/j.ajhg.2016.03.010			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DL8DF	27132592	Green Published, hybrid			2022-12-18	WOS:000375869300016
J	Brandler, WM; Antaki, D; Gujral, M; Noor, A; Rosanio, G; Chapman, TR; Barrera, DJ; Lin, GN; Malhotra, D; Watts, AC; Wong, LC; Estabillo, JA; Gadomski, TE; Hong, O; Fajardo, KVF; Bhandari, A; Owen, R; Baughn, M; Yuan, J; Solomon, T; Moyzis, AG; Maile, MS; Sanders, SJ; Reiner, GE; Vaux, KK; Strom, CM; Zhang, K; Muotri, AR; Akshoomoff, N; Leal, SM; Pierce, K; Courchesne, E; Iakoucheva, LM; Corse, C; Sebat, J				Brandler, William M.; Antaki, Danny; Gujral, Madhusudan; Noor, Amina; Rosanio, Gabriel; Chapman, Timothy R.; Barrera, Daniel J.; Lin, Guan Ning; Malhotra, Dheeraj; Watts, Amanda C.; Wong, Lawrence C.; Estabillo, Jasper A.; Gadomski, Therese E.; Hong, Oanh; Fajardo, Karin V. Fuentes; Bhandari, Abhishek; Owen, Renius; Baughn, Michael; Yuan, Jeffrey; Solomon, Terry; Moyzis, Alexandra G.; Maile, Michelle S.; Sanders, Stephan J.; Reiner, Gail E.; Vaux, Keith K.; Strom, Charles M.; Zhang, Kang; Muotri, Alysson R.; Akshoomoff, Natacha; Leal, Suzanne M.; Pierce, Karen; Courchesne, Eric; Iakoucheva, Lilia M.; Corse, Christina; Sebat, Jonathan			Frequency and Complexity of De Novo Structural Mutation in Autism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COPY NUMBER VARIATION; DNA-SEQUENCING DATA; SPECTRUM DISORDERS; VARIANT DISCOVERY; GENOME ANALYSIS; FRAMEWORK; GENES; ASSOCIATION; MECHANISMS; DISABILITY	Genetic studies of autism spectruni disorder (ASD) have established that de novo duplications and deletions contribute to risk. However, ascertainment of structural variants (SVs) has been restricted by the coarse resolution of current approaches. By applying a custom pipeline for SV discovery, genotyping, and de novo assembly to genome sequencing of 235 subjects (71 affected individuals, 26 healthy siblings, and their parents), we compiled an atlas of 29,719 SV loci (5,213/genome), comprising 11 different classes. We found a high diversity of de novo mutations, the majority of which were undetectable by previous methods. In addition, we observed complex mutation clusters where combinations of de novo SVs, nucleotide substitutions, and indels occurred as a single event. We estimate a high rate of structural mutation in humans (20%) and propose that genetic risk for ASD is attributable to an elevated frequency of gene-disrupting de novo SVs, but not an elevated rate of genome rearrangement.	[Brandler, William M.; Antaki, Danny; Gujral, Madhusudan; Noor, Amina; Rosanio, Gabriel; Chapman, Timothy R.; Barrera, Daniel J.; Malhotra, Dheeraj; Gadomski, Therese E.; Hong, Oanh; Fajardo, Karin V. Fuentes; Bhandari, Abhishek; Maile, Michelle S.; Sebat, Jonathan] Univ Calif San Diego, Beyster Ctr Genom Psychiat Dis, La Jolla, CA 92093 USA; [Brandler, William M.; Antaki, Danny; Gujral, Madhusudan; Noor, Amina; Rosanio, Gabriel; Chapman, Timothy R.; Barrera, Daniel J.; Lin, Guan Ning; Malhotra, Dheeraj; Gadomski, Therese E.; Hong, Oanh; Fajardo, Karin V. Fuentes; Bhandari, Abhishek; Maile, Michelle S.; Iakoucheva, Lilia M.; Sebat, Jonathan] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Brandler, William M.; Antaki, Danny; Gujral, Madhusudan; Noor, Amina; Rosanio, Gabriel; Chapman, Timothy R.; Barrera, Daniel J.; Malhotra, Dheeraj; Gadomski, Therese E.; Hong, Oanh; Fajardo, Karin V. Fuentes; Bhandari, Abhishek; Maile, Michelle S.; Muotri, Alysson R.; Sebat, Jonathan] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Antaki, Danny; Watts, Amanda C.; Baughn, Michael; Yuan, Jeffrey; Solomon, Terry; Moyzis, Alexandra G.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Wong, Lawrence C.; Estabillo, Jasper A.; Akshoomoff, Natacha; Corse, Christina] Rady Childrens Hosp, San Diego, CA 92123 USA; [Owen, Renius; Strom, Charles M.] Quest Diagnost Nichols Inst, San Juan Capistrano, CA 92657 USA; [Sanders, Stephan J.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Reiner, Gail E.; Vaux, Keith K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Zhang, Kang] Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92093 USA; [Leal, Suzanne M.] Baylor Coll Med, Ctr Stat Genet, Houston, TX 77030 USA; [Pierce, Karen; Courchesne, Eric] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; Nichols Institute; University of California System; University of California San Francisco; University of California System; University of California San Diego; University of California System; University of California San Diego; Baylor College of Medicine; University of California System; University of California San Diego	Sebat, J (corresponding author), Univ Calif San Diego, Beyster Ctr Genom Psychiat Dis, La Jolla, CA 92093 USA.; Sebat, J (corresponding author), Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.; Sebat, J (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	jsebat@ucsd.edu	Solomon, Terry/J-8383-2017; Zhang, Kang/Y-2740-2019; Sanders, Stephan/S-8645-2019; Vaux, Keith/R-2716-2019	Solomon, Terry/0000-0001-5375-1869; Zhang, Kang/0000-0002-4549-1697; Vaux, Keith/0000-0001-8738-5940; Iakoucheva, Lilia/0000-0002-4542-5219; Baughn, Michael/0000-0001-8525-8024; Antaki, Danny/0000-0003-0381-7801; Gadomski, Therese/0000-0003-3286-9942; Sanders, Stephan/0000-0001-9112-5148; Estabillo, Jasper/0000-0003-2905-7273	NIH [MH076431, HG007497, HD065288, MH104766, MH105524, T32 GM008666]; Simons foundation [SFARI 275724]; Autism Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD065288] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG007497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH105524, R01MH109885, R01MH076431, R21MH104766] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons foundation; Autism Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank the families who volunteered for the study. J.S. received grants from the NIH (MH076431 and HG007497) and the Simons foundation (SFARI 275724). L.M.I. received grants from the NIH (HD065288, MH104766, and MH105524). W.M.B. was supported by a fellowship from the Autism Science Foundation. D.A. was supported by NIH predoctoral training grant T32 GM008666. We would like to thank Wayne Pfeiffer, Mahidhar Tatineni, and the San Diego Supercomputer Center for hosting the computing infrastructure necessary for completing this project.	Abraham A, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00014; Abrahams BS, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-36; Abyzov A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8256; Brand H, 2015, AM J HUM GENET, V97, P170, DOI 10.1016/j.ajhg.2015.05.012; Chen R, 2015, BIOINFORMATICS, V31, P1452, DOI 10.1093/bioinformatics/btu860; Chiang C, 2015, NAT METHODS, V12, P966, DOI [10.1038/NMETH.3505, 10.1038/nmeth.3505]; Coe BP, 2014, NAT GENET, V46, P1063, DOI 10.1038/ng.3092; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Deem A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000594; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Thung DT, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0488-x; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Jiang YH, 2013, AM J HUM GENET, V93, P249, DOI 10.1016/j.ajhg.2013.06.012; Kloosterman WP, 2015, GENOME RES, V25, P792, DOI 10.1101/gr.185041.114; Layer RM, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r84; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Michaelson JJ, 2012, NAT METHODS, V9, P819, DOI [10.1038/NMETH.2085, 10.1038/nmeth.2085]; Narzisi G, 2014, NAT METHODS, V11, P1033, DOI [10.1038/NMETH.3069, 10.1038/nmeth.3069]; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Pagnamenta AT, 2011, J NEURODEV DISORD, V3, P124, DOI 10.1007/s11689-011-9076-5; Pagnamenta AT, 2011, J MED GENET, V48, P48, DOI 10.1136/jmg.2010.079426; Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rimmer A, 2014, NAT GENET, V46, P912, DOI 10.1038/ng.3036; Sanders SJ, 2015, NEURON, V87, P1215, DOI 10.1016/j.neuron.2015.09.016; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Sudmant PH, 2015, SCIENCE, V349, DOI 10.1126/science.aab3761; van Dijk EL, 2014, TRENDS GENET, V30, P418, DOI 10.1016/j.tig.2014.07.001; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wu TF, 2004, J MACH LEARN RES, V5, P975; Xu Jie, 2004, Current Genomics, V5, P347, DOI 10.2174/1389202043349246; Yuen RKC, 2015, NAT MED, V21, P185, DOI 10.1038/nm.3792; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	44	55	55	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 7	2016	98	4					667	679		10.1016/j.ajhg.2016.02.018	http://dx.doi.org/10.1016/j.ajhg.2016.02.018			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DJ4UO	27018473	Bronze, Green Submitted, Green Published			2022-12-18	WOS:000374203800006
J	Alby, C; Piquand, K; Huber, C; Megarbane, A; Ichkou, A; Legendre, M; Pelluard, F; Encha-Ravazi, F; Abi-Tayeh, G; Bessieres, B; El Chehadeh-Djebbar, S; Laurent, N; Faivre, L; Sztriha, L; Zombor, M; Szabo, H; Failler, M; Garfa-Traore, M; Bole, C; Nitschke, P; Nizon, M; Elkhartoufi, N; Clerget-Darpoux, F; Munnich, A; Lyonnet, S; Vekemans, M; Saunier, S; Cormier-Daire, V; Attie-Bitach, T; Thomas, S				Alby, Caroline; Piquand, Kevin; Huber, Celine; Megarbane, Andre; Ichkou, Amale; Legendre, Marine; Pelluard, Fanny; Encha-Ravazi, Ferechte; Abi-Tayeh, Georges; Bessieres, Bettina; El Chehadeh-Djebbar, Salima; Laurent, Nicole; Faivre, Laurence; Sztriha, Laszlo; Zombor, Melinda; Szabo, Hajnalka; Failler, Marion; Garfa-Traore, Meriem; Bole, Christine; Nitschke, Patrick; Nizon, Mathilde; Elkhartoufi, Nadia; Clerget-Darpoux, Francoise; Munnich, Arnold; Lyonnet, Stanislas; Vekemans, Michel; Saunier, Sophie; Cormier-Daire, Valerie; Attie-Bitach, Tania; Thomas, Sophie			Mutations in KIAA0586 Cause Lethal Ciliopathies Ranging from a Hydrolethalus Phenotype to Short-Rib Polydactyly Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TALPID3 GENE; JOUBERT; MECKEL; CILIOGENESIS; PROTEIN; ENCODES	KIAA0586, the human ortholog of chicken TALPID3, is a centrosomal protein that is essential for primary ciliogenesis. Its disruption in animal models causes defects attributed to abnormal hedgehog signaling; these defects include polydactyly and abnormal dorsoventral patterning of the neural tube. Here, we report homozygous mutations of KIAA0586 in four families affected by lethal ciliopathies ranging from a hydrolethalus phenotype to short-rib polydactyly. We show defective ciliogenesis, as well as abnormal response to SHH-signaling activation in cells derived from affected individuals, consistent with a role of KIAA0586 in primary cilia biogenesis. Whereas centriolar maturation seemed unaffected in mutant cells, we observed an abnormal extended pattern of CEP290, a centriolar satellite protein previously associated with ciliopathies. Our data show the crucial role of KIAA0586 in human primary ciliogenesis and subsequent abnormal hedgehog signaling through abnormal GLI3 processing. Our results thus establish that KIAA0586 mutations cause lethal ciliopathies.	[Alby, Caroline; Huber, Celine; Encha-Ravazi, Ferechte; Elkhartoufi, Nadia; Clerget-Darpoux, Francoise; Munnich, Arnold; Lyonnet, Stanislas; Vekemans, Michel; Attie-Bitach, Tania; Thomas, Sophie] Paris Descartes Univ, ISERM, Lab Embryol & Genet Congenital Malformat, Sorbonne Paris Cite & Imagine Inst,U1163, F-75015 Paris, France; [Alby, Caroline; Megarbane, Andre; Encha-Ravazi, Ferechte; Bessieres, Bettina; Nizon, Mathilde; Elkhartoufi, Nadia; Munnich, Arnold; Lyonnet, Stanislas; Vekemans, Michel; Cormier-Daire, Valerie; Attie-Bitach, Tania] Assistance Publ Hop Paris, Dept Genet, Hop Necker Enfants Malades3, F-75015 Paris, France; [Huber, Celine; Nizon, Mathilde; Munnich, Arnold] Paris Descartes Univ, INSERM, Lab Mol & Physiopathol Bases Osteochondrodysplasi, Sorbonne Paris Cite & Imagine Inst,U1163, F-75015 Paris, France; [Megarbane, Andre] St Josephs Univ, Med Genet Unit, Mar Mikhael 1104, Beyrouth, Lebanon; [Legendre, Marine] Univ Poitiers Hosp, Dept Genet, F-86021 Poitiers, France; [Pelluard, Fanny] Ctr Hosp Univ, Unite Pathol Fcetoplacentaire, Grp Hosp Pellegrin, F-33076 Bordeaux, France; [Abi-Tayeh, Georges] Serv Gynecol & Obstet, Hotel Dieu France, Achrafieh 1100, Beyrouth, Lebanon; [Laurent, Nicole; Faivre, Laurence; Sztriha, Laszlo] Univ Bourgogne, Genet & Anomalies Dev EA4271, F-21000 Dijon, France; [Zombor, Melinda; Szabo, Hajnalka] Univ Szeged, Dept Paediat, Fac Med, H-6725 Szeged, Hungary; [Failler, Marion; Saunier, Sophie] Paris Descartes Univ, INSERM, Lab Inherited Kidney Dis, Sorbonne Paris Cite & Imagine Inst,U1163, F-75015 Paris, France; [Garfa-Traore, Meriem] Paris Descartes Univ, Cell Imaging Platform, Sorbonne Paris Cite & Imagine Inst, F-75015 Paris, France; [Bole, Christine] Paris Descartes Univ, Gen Core Facil, Sorbonne Paris Cite & Imagine Inst, F-75015 Paris, France; [Zombor, Melinda] Paris Descartes Univ, Bioinformat Core Facil, Sorbonne Paris Cite, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Saint Joseph University Beirut; CHU Poitiers; Universite de Poitiers; CHU Bordeaux; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Szeged University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Thomas, S (corresponding author), Paris Descartes Univ, ISERM, Lab Embryol & Genet Congenital Malformat, Sorbonne Paris Cite & Imagine Inst,U1163, F-75015 Paris, France.	sophie.thomas@inserm.fr	THOMAS, Sophie/F-4492-2017; Megarbane, Andre/ABD-5574-2021; Lyonnet, Stanislas/H-5483-2017; ATTIE-BITACH, Tania/K-1453-2017; Saunier, Sophie/G-6044-2015; thomas, sophie/GVS-1279-2022; cormier-daire, valerie/H-6520-2017; Clerget-Darpoux, Francoise/I-4825-2017	THOMAS, Sophie/0000-0002-8569-3277; Lyonnet, Stanislas/0000-0001-5426-9417; ATTIE-BITACH, Tania/0000-0002-1155-3626; Saunier, Sophie/0000-0002-1069-0047; GARFA TRAORE, Meriem/0000-0001-8597-6472; cormier-daire, valerie/0000-0002-2839-9856; abi tayeh, Georges/0000-0002-2799-0222; huber, celine/0000-0002-8601-9655; Clerget-Darpoux, Francoise/0000-0003-4816-6619; Faivre, Laurence/0000-0001-9770-444X	Agence Nationale de la Recherche (ANR) [BLAN-1122-01, ANR-13-BSV1-0027]; Fondation pour la Recherche Medicale; ANR [ANR-A0-IAHU-01]	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); ANR(French National Research Agency (ANR))	We thank the families for their participation. We also thank Leila Hakkakian, Judite De Oliveira, and Nadege Gigot for technical assistance and Prof. Andrew Green for referral of affected subjects, and we are grateful to the French Society of Fetal Pathology for participating in the study. This work was supported by grants from the Agence Nationale de la Recherche (ANR; 2010 fetal ciliopathies grant BLAN-1122-01 and 2013 cilia, axonal guidance, and corpus callosum grant ANR-13-BSV1-0027 to T.A.B.). C.A. is funded by the Fondation pour la Recherche Medicale and K.P. by grants from ANR. The Institut Imagine is supported by an ANR grant (ANR-A0-IAHU-01).	Baala L, 2007, AM J HUM GENET, V80, P186, DOI 10.1086/510499; Bangs F, 2011, DEVELOPMENT, V138, P3261, DOI 10.1242/dev.063602; Ben J, 2011, DEVELOPMENT, V138, P4969, DOI 10.1242/dev.070862; Davey MG, 2006, GENE DEV, V20, P1365, DOI 10.1101/gad.369106; Davey MG, 2014, ORGANOGENESIS, V10, P177, DOI 10.4161/org.28819; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; El Hokayem J, 2012, J MED GENET, V49, P227, DOI 10.1136/jmedgenet-2011-100717; Failler M, 2014, AM J HUM GENET, V94, P905, DOI 10.1016/j.ajhg.2014.05.002; Genin E, 2004, J MED GENET, V41, P445, DOI 10.1136/jmg.2003.017962; Huber C, 2012, AM J MED GENET C, V160C, P165, DOI 10.1002/ajmg.c.31336; Kobayashi T, 2014, J CELL BIOL, V204, P215, DOI 10.1083/jcb.201304153; Picard C, 2002, AM J HUM GENET, V70, P336, DOI 10.1086/338625; Putoux A, 2011, NAT GENET, V43, P601, DOI 10.1038/ng.826; Schmidts M, 2014, J PEDIATR GENET, V3, P49, DOI 10.3233/PGE-14089; Tanos BE, 2013, GENE DEV, V27, P163, DOI 10.1101/gad.207043.112; Thomas S, 2012, AM J HUM GENET, V91, P372, DOI 10.1016/j.ajhg.2012.06.017; Tsang William Y, 2013, Cilia, V2, P9, DOI 10.1186/2046-2530-2-9; Valente EM, 2010, NAT GENET, V42, P619, DOI 10.1038/ng.594; Yin YL, 2009, DEVELOPMENT, V136, P655, DOI 10.1242/dev.028464	19	55	57	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 6	2015	97	2					311	318		10.1016/j.ajhg.2015.06.003	http://dx.doi.org/10.1016/j.ajhg.2015.06.003			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CO7GY	26166481	Green Published, Bronze			2022-12-18	WOS:000359328800011
J	Bunn, KJ; Daniel, P; Rosken, HS; O'Neill, AC; Cameron-Christie, SR; Morgan, T; Brunner, HG; Lai, A; Kunst, HPM; Markie, DM; Robertson, SP				Bunn, Kieran J.; Daniel, Phil; Roesken, Heleen S.; O'Neill, Adam C.; Cameron-Christie, Sophia R.; Morgan, Tim; Brunner, Han G.; Lai, Angeline; Kunst, Henricus P. M.; Markie, David M.; Robertson, Stephen P.			Mutations in DVL1 Cause an Osteosclerotic Form of Robinow Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOSOMAL-DOMINANT; DROSOPHILA-MELANOGASTER; SOST GENE; WNT; LIGASE; DOMAIN; DOWNSTREAM; PROGRAM; DENSITY; FAMILY	Robinow syndrome (RS) is a phenotypically and genetically heterogeneous condition that can be caused by mutations in genes encoding components of the non-canonical Wnt signaling pathway. In contrast, germline mutations that act to increase canonical Wnt signaling lead to distinctive osteosclerotic phenotypes. Here, we identified de novo frameshift mutations in DVL1, a mediator of both canonical and non-canonical Wnt signaling, as the cause of RS-OS, an RS subtype involving osteosclerosis, in three unrelated individuals. The mutations all delete the DVL1 C terminus and replace it, in each instance, with a novel, highly basic sequence. We showed the presence of mutant transcript in fibroblasts from one individual with RS-OS and demonstrated unimpaired protein stability with transfected GFP-tagged constructs bearing a frameshift mutation. In vitro TOPFlash assays, in apparent contradiction to the osteosclerotic phenotype, revealed that the mutant allele was less active than the wild-type allele in the canonical Wnt signaling pathway. However, when the mutant and wild-type alleles were co-expressed, canonical Wnt activity was 2-fold higher than that in the wild-type construct alone. This work establishes that DVL1 mutations cause a specific RS subtype, RS-OS, and that the osteosclerosis associated with this subtype might be the result of an interaction between the wild-type and mutant alleles and thus lead to elevated canonical Wnt signaling.	[Bunn, Kieran J.; Daniel, Phil; Roesken, Heleen S.; O'Neill, Adam C.; Cameron-Christie, Sophia R.; Morgan, Tim; Robertson, Stephen P.] Univ Otago, Dunedin Sch Med, Dept Womens & Childrens Hlth, Dunedin 9054, New Zealand; [Brunner, Han G.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Brunner, Han G.] Maastricht Univ, Dept Clin Genet, Med Ctr, NL-6200 MD Maastricht, Netherlands; [Lai, Angeline] KK Womens & Childrens Hosp, Dept Paediat, Genet Serv, Singapore 229899, Singapore; [Kunst, Henricus P. M.] Radboud Univ Nijmegen, Med Ctr, Dept Otorhinolaryngol, NL-6525 GA Nijmegen, Netherlands; [Kunst, Henricus P. M.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, NL-6525 GA Nijmegen, Netherlands; [Markie, David M.] Univ Otago, Dunedin Sch Med, Dept Pathol, Dunedin 9054, New Zealand	University of Otago; Radboud University Nijmegen; Maastricht University; KK Women's & Children's Hospital; Radboud University Nijmegen; Radboud University Nijmegen; University of Otago	Robertson, SP (corresponding author), Univ Otago, Dunedin Sch Med, Dept Womens & Childrens Hlth, Dunedin 9054, New Zealand.	stephen.robertson@otago.ac.nz	Markie, David/I-7893-2019; Kunst, Henricus P.M./J-6456-2012; Brunner, Han/C-9928-2013	Kunst, Henricus P.M./0000-0003-1162-6394; Markie, David/0000-0001-5452-9194; Robertson, Stephen/0000-0002-5181-7809	NHLBI Exome Sequencing Project [ESP6500]; Cure Kids New Zealand; Maurice and Phyllis Paykel Trust	NHLBI Exome Sequencing Project; Cure Kids New Zealand; Maurice and Phyllis Paykel Trust	We gratefully acknowledge the participation of the families in this research, A. Al-Ani and M. Farella for images and clinical assistance, A. Carne for assistance with the protein analysis, and A.O.M. Wilkie for discussions. This work used data from the Decipher Consortium and the NHLBI Exome Sequencing Project ESP6500 dataset. This work was funded through support from Cure Kids New Zealand (to S.R.) and from the Maurice and Phyllis Paykel Trust (to K.B.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Afzal AR, 2000, NAT GENET, V25, P419, DOI 10.1038/78107; Al Kaissi A, 2007, AUSTRALAS RADIOL, V51, P83, DOI 10.1111/j.1440-1673.2006.01668.x; BAIN MD, 1986, J MED GENET, V23, P350, DOI 10.1136/jmg.23.4.350; Balemans W, 2002, J MED GENET, V39, P91, DOI 10.1136/jmg.39.2.91; Bernatik O, 2011, J BIOL CHEM, V286, P10396, DOI 10.1074/jbc.M110.169870; Boudin E, 2013, BONE, V53, P414, DOI 10.1016/j.bone.2013.01.014; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Bunn KJ, 2014, AM J MED GENET A, V164, P2638, DOI 10.1002/ajmg.a.36677; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cingolani Pablo, 2012, Frontiers in Genetics, V3, P35, DOI 10.3389/fgene.2012.00035; Dillman AR, 2013, G3-GENES GENOM GENET, V3, P251, DOI 10.1534/g3.112.005314; Ding Y, 2013, J BIOL CHEM, V288, P8289, DOI 10.1074/jbc.M112.433185; Eijkenboom DF, 2012, ARCH OTOLARYNGOL, V138, P309, DOI 10.1001/archoto.2011.1459; Etheridge SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000259; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gonzalez-Sancho JM, 2013, J BIOL CHEM, V288, P9428, DOI 10.1074/jbc.M112.448480; Goto T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060865; Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164; Jung H, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.28; Jung H, 2009, EXP MOL MED, V41, P695, DOI 10.3858/emm.2009.41.10.076; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kokubu C, 2004, DEVELOPMENT, V131, P5469, DOI 10.1242/dev.01405; Korinek V, 1998, MOL CELL BIOL, V18, P1248, DOI 10.1128/MCB.18.3.1248; Leupin O, 2011, J BIOL CHEM, V286, P19489, DOI 10.1074/jbc.M110.190330; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Lijam N, 1997, CELL, V90, P895, DOI 10.1016/S0092-8674(00)80354-2; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Liu CQ, 2014, BIOL OPEN, V3, P861, DOI 10.1242/bio.20148375; Mazzeu JF, 2007, AM J MED GENET A, V143A, P320, DOI 10.1002/ajmg.a.31592; Miyazaki K, 2004, J BIOL CHEM, V279, P11327, DOI 10.1074/jbc.M312389200; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Person AD, 2010, DEV DYNAM, V239, P327, DOI 10.1002/dvdy.22156; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Tauriello DVF, 2012, P NATL ACAD SCI USA, V109, pE812, DOI 10.1073/pnas.1114802109; Tree DRP, 2002, CELL, V109, P371, DOI 10.1016/S0092-8674(02)00715-8; van Bokhoven H, 2000, NAT GENET, V25, P423, DOI 10.1038/78113; Wang JY, 2014, DEV CELL, V28, P670, DOI 10.1016/j.devcel.2014.02.009; Wang YP, 2014, FRONT BIOSCI-LANDMRK, V19, P379, DOI 10.2741/4214; Wei W, 2012, MOL CELL BIOL, V32, P3903, DOI 10.1128/MCB.00251-12; Wilkins MR, 1999, METH MOL B, V112, P531; Wynshaw-Boris A, 2012, CURR TOP DEV BIOL, V101, P213, DOI 10.1016/B978-0-12-394592-1.00007-7	48	55	58	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 2	2015	96	4					623	630		10.1016/j.ajhg.2015.02.010	http://dx.doi.org/10.1016/j.ajhg.2015.02.010			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CF0DJ	25817014	Bronze, Green Published			2022-12-18	WOS:000352212600009
J	Poulter, JA; Al-Araimi, M; Conte, I; van Genderen, MM; Sheridan, E; Carr, IM; Parry, DA; Shires, M; Carrella, S; Bradbury, J; Khan, K; Lakeman, P; Sergouniotis, PI; Webster, AR; Moore, AT; Pal, B; Mohamed, MD; Venkataramana, A; Ramprasad, V; Shetty, R; Saktivel, M; Kumaramanickavel, G; Tan, A; Mackey, DA; Hewitt, AW; Banfi, S; Ali, M; Inglehearn, CF; Toomes, C				Poulter, James A.; Al-Araimi, Musallam; Conte, Ivan; van Genderen, Maria M.; Sheridan, Eamonn; Carr, Ian M.; Parry, David A.; Shires, Mike; Carrella, Sabrina; Bradbury, John; Khan, Kamron; Lakeman, Phillis; Sergouniotis, Panagiotis I.; Webster, Andrew R.; Moore, Anthony T.; Pal, Bishwanath; Mohamed, Moin D.; Venkataramana, Anandula; Ramprasad, Vedam; Shetty, Rohit; Saktivel, Murugan; Kumaramanickavel, Govindasamy; Tan, Alex; Mackey, David A.; Hewitt, Alex W.; Banfi, Sandro; Ali, Manir; Inglehearn, Chris F.; Toomes, Carmel			Recessive Mutations in SLC38A8 Cause Foveal Hypoplasia and Optic Nerve Misrouting without Albinism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEGMENT DYSGENESIS MAPS; LINKED OCULAR ALBINISM; ORYZIAS-LATIPES; MEDAKA; ASSOCIATION; DISORDERS; FEATURES; DEFECTS; PROTEIN; CHIASM	Foveal hypoplasia and optic nerve misrouting are developmental defects of the visual pathway and only co-occur in connection with albinism; to date, they have only been associated with defects in the melanin-biosynthesis pathway. Here, we report that these defects can occur independently of albinism in people with recessive mutations in the putative glutamine transporter gene SLC38A8. Nine different mutations were identified in seven Asian and European families. Using morpholino-mediated ablation of Slc38a8 in medaka fish, we confirmed that pigmentation is unaffected by loss of SLC38A8. Furthermore, by undertaking an association study with SNPs at the SLC38A8 locus, we showed that common variants within this gene modestly affect foveal thickness in the general population. This study reveals a melanin-independent component underpinning the development of the visual pathway that requires a functional role for SLC38A8.	[Poulter, James A.; Al-Araimi, Musallam; Sheridan, Eamonn; Carr, Ian M.; Parry, David A.; Shires, Mike; Khan, Kamron; Ali, Manir; Inglehearn, Chris F.; Toomes, Carmel] Univ Leeds, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [Conte, Ivan; Carrella, Sabrina; Banfi, Sandro] Telethon Inst Genet & Med, I-80131 Naples, Italy; [van Genderen, Maria M.] Inst Visually Imapired, NL-3700 BA Zeist, Netherlands; [Sheridan, Eamonn] St James Univ Hosp, Dept Clin Genet, Leeds LS9 7TF, W Yorkshire, England; [Bradbury, John] Bradford Royal Infirm, Dept Ophthalmol, Bradford BD9 6RJ, W Yorkshire, England; [Lakeman, Phillis] Vrije Univ Amsterdam, Dept Clin Genet, Med Ctr, NL-1081 HV Amsterdam, Netherlands; [Sergouniotis, Panagiotis I.; Webster, Andrew R.; Moore, Anthony T.] UCL, Div Inherited Eye Dis, Inst Ophthalmol, London EC1V 9EL, England; [Sergouniotis, Panagiotis I.; Webster, Andrew R.; Moore, Anthony T.; Pal, Bishwanath] Moorfields Eye Hosp, London EC1V 2PD, England; [Mohamed, Moin D.] St Thomas Hosp, Dept Ophthalmol, London SE1 9RT, England; [Venkataramana, Anandula; Shetty, Rohit; Kumaramanickavel, Govindasamy] Narayana Nethralaya, Dept Ocular Genet, Bangalore 560099, Karnataka, India; [Ramprasad, Vedam; Saktivel, Murugan] SciGenom Labs, Cochin 682037, Kerala, India; [Tan, Alex; Mackey, David A.; Hewitt, Alex W.] Univ Western Australia, Ctr Ophthalmol & Visual Sci, Perth, WA 6009, Australia; [Banfi, Sandro] Univ Naples 2, Dept Biochem Biophys & Gen Pathol, I-80138 Naples, Italy	University of Leeds; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Saint James's University Hospital; Bradford Royal Infirmary; Vrije Universiteit Amsterdam; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of Western Australia; Universita della Campania Vanvitelli	Inglehearn, CF (corresponding author), Univ Leeds, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England.	c.inglehearn@leeds.ac.uk; c.toomes@leeds.ac.uk	KUMARAMANICKAVEL, GOVINDASAMY/AAN-9203-2021; Mackey, David A/H-5340-2014; Ali, Manir/ABE-5251-2020; Poulter, James A/A-8190-2013; Carrella, Sabrina/AAD-3103-2020; Study, Raine/G-9547-2015; Inglehearn, Chris/GYD-9783-2022; Banfi, Sandro/K-3963-2018; Hewitt, Alex W/D-1936-2013	KUMARAMANICKAVEL, GOVINDASAMY/0000-0001-8516-8301; Mackey, David A/0000-0001-7914-4709; Ali, Manir/0000-0003-3204-3788; Poulter, James A/0000-0003-2048-5693; Banfi, Sandro/0000-0002-6541-8833; Hewitt, Alex W/0000-0002-5123-5999; Conte, Ivan/0000-0002-8968-9021; Carrella, Sabrina/0000-0002-3302-1698; Parry, David/0000-0003-0376-7736; Toomes, Carmel/0000-0001-8373-9545	Royal Society University Research Fellowship; University of Leeds Emma and Leslie Reid Scholarship; Omani Government scholarship; Yorkshire Eye Research; Italian Telethon Foundation [TGM11SB2]; Italian Ministry of Research [PONA3_00311]; RP Fighting Blindness; Fight For Sight; Foundation Fighting Blindness; National Institute for Health Research Moorfields Eye Hospital Biomedical Research Centre; Sir Jules Thorn Award for Biomedical Research [JTA/09]; National Health and Medical Research Council (NHMRC) [572613]; NHMRC [1021105]; Lions Eye Institute; Australian Foundation for the Prevention of Blindness; Ophthalmic Research Institute of Australia; Alcon Research Institute; National Institute for Health Research [NF-SI-0507-10204] Funding Source: researchfish	Royal Society University Research Fellowship(Royal Society of London); University of Leeds Emma and Leslie Reid Scholarship; Omani Government scholarship; Yorkshire Eye Research; Italian Telethon Foundation(Fondazione Telethon); Italian Ministry of Research(Ministry of Education, Universities and Research (MIUR)); RP Fighting Blindness; Fight For Sight; Foundation Fighting Blindness(European Commission); National Institute for Health Research Moorfields Eye Hospital Biomedical Research Centre(National Institute for Health Research (NIHR)); Sir Jules Thorn Award for Biomedical Research; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Lions Eye Institute; Australian Foundation for the Prevention of Blindness; Ophthalmic Research Institute of Australia; Alcon Research Institute(Novartis); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank the families who participated in this study. We thank J. Deuchars and M. Singh for advice with immunohistochemistry and A. Hindley and the Leeds Tissue Bank for providing and processing samples. We thank J. Wittbrodt for providing the ATH5::GFP medaka transgenic line and A.E. Davidson and Z. Li for supporting genetic analysis. This work was supported by a Royal Society University Research Fellowship (C.T.), University of Leeds Emma and Leslie Reid Scholarship (J.A.P.), Omani Government scholarship (M.A.-A.), Yorkshire Eye Research, the Italian Telethon Foundation (project grant TGM11SB2), the Italian Ministry of Research (PONA3_00311), RP Fighting Blindness, Fight For Sight, Foundation Fighting Blindness, National Institute for Health Research Moorfields Eye Hospital Biomedical Research Centre, and the Sir Jules Thorn Award for Biomedical Research (#JTA/09). We thank the Raine Study participants and staff for cohort coordination and data collection, particularly Jenny Mountain, Wei Ang, Craig Pennell, Hannah Forward, Charlotte McKnight, Seyhan Yazar, Alla Soloshenko, Sandra Oates, and Diane Wood. The core management of the Raine Study is funded by the University of Western Australia (UWA), Telethon Institute for Child Health Research, Raine Medical Research Foundation, UWA Faculty of Medicine, Dentistry and Health Sciences, Women's and Infant's Research Foundation, and Curtin University. Genotyping was funded by National Health and Medical Research Council (NHMRC) grant 572613. The Raine Eye Health Study was supported by NHMRC grant 1021105, the Lions Eye Institute, the Australian Foundation for the Prevention of Blindness, the Ophthalmic Research Institute of Australia, and the Alcon Research Institute.	Al-Araimi M, 2013, MOL VIS, V19, P2165; Anandula V.R., 2011, J MED GENETICS GENOM, V3, P122; CHARLES SJ, 1993, BRIT J OPHTHALMOL, V77, P222, DOI 10.1136/bjo.77.4.222; Conte I, 2010, P NATL ACAD SCI USA, V107, P15491, DOI 10.1073/pnas.0914785107; CURRAN RE, 1976, ARCH OPHTHALMOL-CHIC, V94, P48; Del Bene F, 2007, PLOS GENET, V3, P1661, DOI 10.1371/journal.pgen.0030159; Dessinioti C, 2009, EXP DERMATOL, V18, P741, DOI 10.1111/j.1600-0625.2009.00896.x; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Fukamachi S, 2001, NAT GENET, V28, P381, DOI 10.1038/ng584; Hagglund MGA, 2011, J BIOL CHEM, V286, P20500, DOI 10.1074/jbc.M110.162404; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; Jeffery G, 2001, PHYSIOL REV, V81, P1393, DOI 10.1152/physrev.2001.81.4.1393; Koch SM, 2011, NEURON, V71, P235, DOI 10.1016/j.neuron.2011.05.045; Loges NT, 2009, AM J HUM GENET, V85, P883, DOI 10.1016/j.ajhg.2009.10.018; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; Martins RAP, 2008, BRAIN RES, V1192, P37, DOI 10.1016/j.brainres.2007.04.076; Michaelides M, 2012, BRIT J OPHTHALMOL, V96, P917, DOI 10.1136/bjophthalmol-2011-300994; OLIVER MD, 1987, BRIT J OPHTHALMOL, V71, P926, DOI 10.1136/bjo.71.12.926; Pal B, 2004, J MED GENET, V41, P772, DOI 10.1136/jmg.2004.020040; Petros TJ, 2008, ANNU REV NEUROSCI, V31, P295, DOI 10.1146/annurev.neuro.31.060407.125609; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Schiaffino MV, 2010, INT J BIOCHEM CELL B, V42, P1094, DOI 10.1016/j.biocel.2010.03.023; Schioth HB, 2013, MOL ASPECTS MED, V34, P571, DOI 10.1016/j.mam.2012.07.012; SHIONO T, 1995, BRIT J OPHTHALMOL, V79, P139, DOI 10.1136/bjo.79.2.139; Sjostrom A., 2001, Documenta Ophthalmologica, V103, P35, DOI 10.1023/A:1017969301170; van Genderen MM, 2006, BRIT J OPHTHALMOL, V90, P1098, DOI 10.1136/bjo.2006.091702; Vincent A, 2009, EYE, V23, P1735, DOI 10.1038/eye.2009.180; Yazar S, 2013, OPHTHALMIC GENET; Yoda H, 2004, MECH DEVELOP, V121, P715, DOI 10.1016/j.mod.2004.03.021	31	55	56	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 5	2013	93	6					1143	1150		10.1016/j.ajhg.2013.11.002	http://dx.doi.org/10.1016/j.ajhg.2013.11.002			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	273FS	24290379	Bronze, Green Published			2022-12-18	WOS:000328521300014
J	Richardson, K; Nettleton, JA; Rotllan, N; Tanaka, T; Smith, CE; Lai, CQ; Parne, LD; Lee, YC; Lahti, J; Lemaitre, RN; Manichaikul, A; Keller, M; Mikkila, V; Ngwa, J; van Rooij, FJA; Ballentyne, CM; Borecki, IB; Cupples, LA; Garcia, M; Hofman, A; Ferrucci, L; Mozaffarian, D; Perala, MM; Raitakari, O; Tracy, RP; Arnett, DK; Bandinelli, S; Boerwinkle, E; Eriksson, JG; Franco, OH; Kahonen, M; Nalls, M; Siscovick, DS; Houston, DK; Psaty, BM; Viikari, J; Witteman, JCM; Goodarzi, MO; Lehtimaki, T; Liu, YM; Zillikens, MC; Chen, YDI; Uitterlinden, AG; Rotter, JI; Fernandez-Hernando, C; Ordovas, JM				Richardson, Kris; Nettleton, Jennifer A.; Rotllan, Noemi; Tanaka, Toshiko; Smith, Caren E.; Lai, Chao-Qiang; Parne, Laurence D.; Lee, Yu-Chi; Lahti, Jari; Lemaitre, Rozenn N.; Manichaikul, Ani; Keller, Margaux; Mikkila, Vera; Ngwa, Julius; van Rooij, Frank J. A.; Ballentyne, Christie M.; Borecki, Ingrid B.; Cupples, L. Adrienne; Garcia, Melissa; Hofman, Albert; Ferrucci, Luigi; Mozaffarian, Dariush; Perala, Mia-Maria; Raitakari, Olli; Tracy, Russell P.; Arnett, Donna K.; Bandinelli, Stefania; Boerwinkle, Eric; Eriksson, Johan G.; Franco, Oscar H.; Kahonen, Mika; Nalls, Michael; Siscovick, David S.; Houston, Denise K.; Psaty, Bruce M.; Viikari, Jorma; Witteman, Jacqueline C. M.; Goodarzi, Mark O.; Lehtimaki, Terho; Liu, Yongmei; Zillikens, M. Carola; Chen, Yii-Der I.; Uitterlinden, Andre G.; Rotter, Jerome I.; Fernandez-Hernando, Carlos; Ordovas, Jose M.			Gain-of-Function Lipoprotein Lipase Variant rs13702 Modulates Lipid Traits through Disruption of a MicroRNA-410 Seed Site	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-HEART-DISEASE; ADIPOSE-TISSUE; GENE; EXPRESSION; RISK; POLYMORPHISMS; LOCI; METAANALYSIS; CHOLESTEROL	Genome-wide association studies (GWAS) have identified hundreds of genetic variants that are associated with lipid phenotypes. However, data supporting a functional role for these variants in the context of lipid metabolism are scarce. We investigated the association of the lipoprotein lipase (LPL) variant rs13702 with plasma lipids and explored its potential for functionality The rs13702 minor allele had been predicted to disrupt a microRNA (miR) recognition element (MRE) seed site (MRESS) for the human microRNA-410 (miR-410). Furthermore, rs13702 is in linkage disequilibrium (LD) with several SNPs identified by GWAS. We performed a meta-analysis across ten cohorts of participants that showed a statistically significant association of rs13702 with triacylglycerols (TAG) (p = 3.18 x 10(-42))and high-density lipoprotein cholesterol (HDL-C) (p = 1.35 x 10(-32)) with each copy of the minor allele associated with 0.060 mmol/l lower TAG and 0.041 mmol/l higher HDL-C. Our data showed that an LPL 3' UTR luciferase reporter carrying the rs13702 major T allele was reduced by 40% in response to a miR-410 mimic. We also evaluated the interaction between intake of dietary fatty acids and rs13702. Meta-analysis demonstrated a significant interaction between rs13702 and dietary polyunsaturated fatty acid (PUFA) with respect to TAG concentrations (p = 0.00153), with the magnitude of the inverse association between dietary PUFA intake and TAG concentration showing -0.007 mmol/l greater reduction. Our results suggest that rs13702 induces the allele-specific regulation of LPL by miR-410 in humans. This work provides biological and potential clinical relevance for previously reported GWAS variants associated with plasma lipid phenotypes.	[Richardson, Kris; Smith, Caren E.; Lai, Chao-Qiang; Parne, Laurence D.; Lee, Yu-Chi; Ordovas, Jose M.] Tufts Univ, Human Nutr Res Ctr Aging, Nutr & Genom Lab, Jean Mayer United States Dept Agr, Boston, MA 02111 USA; [Nettleton, Jennifer A.; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA; [Rotllan, Noemi; Fernandez-Hernando, Carlos] NYU, Sch Med, Dept Med, Leon H Charney Div Cardiol, New York, NY 10016 USA; [Rotllan, Noemi; Fernandez-Hernando, Carlos] NYU, Sch Med, Dept Cell Biol, Leon H Charney Div Cardiol, New York, NY 10016 USA; [Rotllan, Noemi; Fernandez-Hernando, Carlos] NYU, Sch Med, Marc & Ruti Bell Program, Vasc Biol & Dis Program, New York, NY 10016 USA; [Tanaka, Toshiko; Ferrucci, Luigi] NIA, Longitudinal Studies Sect, Clin Res Branch, NIH, Baltimore, MD 21225 USA; [Lahti, Jari] Univ Helsinki, Inst Behav Sci, FIN-00014 Helsinki, Finland; [Lemaitre, Rozenn N.; Siscovick, David S.; Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Lemaitre, Rozenn N.; Siscovick, David S.] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Lemaitre, Rozenn N.; Siscovick, David S.] Univ Washington, Dept Hlth Serv, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Manichaikul, Ani] Univ Virginia, Div Biostat & Epidemiol, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA; [Keller, Margaux] Temple Univ, Dept Biol Anthropol, Philadelphia, PA 19122 USA; [Keller, Margaux; Nalls, Michael] NIA, Mol Genet Sect, Neurogenet Lab, Intramural Res Program,NIH, Bethesda, MD 20892 USA; [Mikkila, Vera] Univ Helsinki, Dept Food & Environm Sci, Div Nutr, FIN-00014 Helsinki, Finland; [Ngwa, Julius; Cupples, L. Adrienne] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [van Rooij, Frank J. A.; Hofman, Albert; Franco, Oscar H.; Witteman, Jacqueline C. M.; Zillikens, M. Carola; Uitterlinden, Andre G.] Erasmus MC, Dept Epidemiol, NL-3000 Rotterdam, Netherlands; [van Rooij, Frank J. A.; Hofman, Albert; Franco, Oscar H.; Witteman, Jacqueline C. M.; Zillikens, M. Carola; Uitterlinden, Andre G.] NGI NCHA, NL-2300 Leiden, Netherlands; [Ballentyne, Christie M.] Baylor Coll Med, Houston, TX 77030 USA; [Borecki, Ingrid B.] Washington Univ, Sch Med, Div Stat Genom, St Louis, MO 63108 USA; [Cupples, L. Adrienne] Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA; [Mozaffarian, Dariush] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Mozaffarian, Dariush] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Mozaffarian, Dariush] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Perala, Mia-Maria] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki 00271, Finland; [Raitakari, Olli] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, Turku 20014, Finland; [Raitakari, Olli] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku 20014, Finland; [Tracy, Russell P.] Univ Vermont, Coll Med, Dept Pathol & Biochem, Burlington, VT 05405 USA; [Arnett, Donna K.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; [Arnett, Donna K.] Univ Alabama Birmingham, Clin Nutr Res Ctr, Birmingham, AL 35294 USA; [Bandinelli, Stefania] ASF, Geriatr Unit, I-50123 Florence, Italy; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Ctr Human Genet, Houston, TX 77030 USA; [Eriksson, Johan G.] Univ Helsinki, Inst Clin Med, Dept Gen Practice & Primary Hlth Care, FIN-00014 Helsinki, Finland; [Eriksson, Johan G.] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki 00300, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki 00014, Finland; [Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki 00014, Finland; [Kahonen, Mika] Tampere Univ Hosp, Dept Clin Physiol, Tampere 33014, Finland; [Kahonen, Mika; Lehtimaki, Terho] Univ Tampere, Sch Med, Tampere 33014, Finland; [Houston, Denise K.; Liu, Yongmei] Wake Forest Sch Med, Winston Salem, NC 27106 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA 98101 USA; [Viikari, Jorma] Turku Univ Hosp, Dept Med, Turku 20014, Finland; [Goodarzi, Mark O.; Chen, Yii-Der I.; Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Goodarzi, Mark O.] Cedars Sinai Med Ctr, Div Endocrinol Diabet & Metab, Los Angeles, CA 90048 USA; [Lehtimaki, Terho] Tampere Univ Hosp, Dept Clin Chem, Fimlab Labs, Tampere 33014, Finland; [Zillikens, M. Carola; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, NL-3000 Rotterdam, Netherlands; [Ordovas, Jose M.] CNIC, Dept Cardiovasc Epidemiol & Populat Genet, Madrid 28029, Spain; [Ordovas, Jose M.] Inst Madrileno Estudios Avanzados IMDEA Alimentac, Madrid 28049, Spain	Tufts University; United States Department of Agriculture (USDA); University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; New York University; New York University; New York University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Helsinki; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Virginia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Helsinki; Boston University; Erasmus University Rotterdam; Erasmus MC; Baylor College of Medicine; Washington University (WUSTL); Framingham Heart Study; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Finland National Institute for Health & Welfare; University of Turku; University of Turku; University of Vermont; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; Tampere University; Tampere University Hospital; Tampere University; Wake Forest University; Group Health Cooperative; University of Turku; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Tampere University; Tampere University Hospital; Erasmus University Rotterdam; Erasmus MC; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Richardson, K (corresponding author), Tufts Univ, Human Nutr Res Ctr Aging, Nutr & Genom Lab, Jean Mayer United States Dept Agr, Boston, MA 02111 USA.	kris.richardson@ars.usda.gov	Franco, Óscar H/ABE-2305-2020; Lahti, Jari/P-7987-2018; Raitakari, Olli/AAQ-7389-2021; Rotllan, Noemi/P-1375-2014; Rotter, Jerome/AAY-6598-2021; Lehtimäki, Terho/AAD-1094-2022; Goodarzi, Mark/AAH-7106-2021; Vila, Noemi Rotllan/AAQ-8050-2020; bandinelli, stefania/AAL-4570-2020; Lahti, Jari/P-2283-2019; Ordovas, Jose/B-8727-2013	Franco, Óscar H/0000-0002-4606-4929; Lahti, Jari/0000-0002-4310-5297; Rotllan, Noemi/0000-0002-0587-8045; Lehtimäki, Terho/0000-0002-2555-4427; Goodarzi, Mark/0000-0001-6364-5103; Vila, Noemi Rotllan/0000-0002-0587-8045; Lahti, Jari/0000-0002-4310-5297; Kahonen, Mika/0000-0002-4510-7341; Perala, Mia-Maria/0000-0002-6349-6301; Lai, Chao-Qiang/0000-0003-1107-8375; Ordovas, Jose/0000-0002-7581-5680; Eriksson, Johan/0000-0002-2516-2060; Cupples, L. Adrienne/0000-0003-0273-7965; Manichaikul, Ani/0000-0002-5998-795X; Houston, Denise/0000-0002-3355-4304	NATIONAL INSTITUTE ON AGING [ZIAAG000965] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000124] Funding Source: Medline; NHLBI NIH HHS [R01 HL105756, R01 HL091357, U01 HL072524] Funding Source: Medline; NIDDK NIH HHS [P30 DK063491] Funding Source: Medline; NIMHD NIH HHS [L60 MD003562] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; [Anonymous], 2010, NAT GENET, V42, P551, DOI 10.1038/ng0710-551; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Benoit ME, 2011, J NEUROSCI, V31, P3459, DOI 10.1523/JNEUROSCI.3932-10.2011; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Chen T, 2011, FEBS LETT, V585, P657, DOI 10.1016/j.febslet.2011.01.027; Deo RC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000342; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Freedman ML, 2011, NAT GENET, V43, P513, DOI 10.1038/ng.840; Gagne SE, 1999, CLIN GENET, V55, P450, DOI 10.1034/j.1399-0004.1999.550609.x; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goldberg IJ, 2001, FRONT BIOSCI-LANDMRK, V6, pD388, DOI 10.2741/Goldberg; Goodarzi MO, 2005, J CLIN ENDOCR METAB, V90, P4816, DOI 10.1210/jc.2005-0389; Hennessy E, 2010, BIOCHEM BIOPH RES CO, V396, P457, DOI 10.1016/j.bbrc.2010.04.116; Hensley LL, 2003, J BIOL CHEM, V278, P32702, DOI 10.1074/jbc.M304200200; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Khan S, 2002, J LIPID RES, V43, P979; Kooner JS, 2008, NAT GENET, V40, P149, DOI 10.1038/ng.2007.61; Kraja AT, 2011, DIABETES, V60, P1329, DOI 10.2337/db10-1011; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee Yu-Chi, 2011, J Data Mining Genomics Proteomics, V2; Lu B, 2010, BIOCHEM BIOPH RES CO, V391, P1737, DOI 10.1016/j.bbrc.2009.12.145; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9; Merkel M, 2002, J LIPID RES, V43, P1997, DOI 10.1194/jlr.R200015-JLR200; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Nettleton JA, 2007, ATHEROSCLEROSIS, V194, pE131, DOI 10.1016/j.atherosclerosis.2006.11.025; Nettleton JA, 2010, DIABETES CARE, V33, P2684, DOI 10.2337/dc10-1150; Ordovas JM, 2004, ANNU REV GENOM HUM G, V5, P71, DOI 10.1146/annurev.genom.5.061903.180008; Ordovas JM, 1995, ATHEROSCLEROSIS, V118, pS11; Ortega FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009022; Pepini T, 2010, J VIROL, V84, P11929, DOI 10.1128/JVI.01658-10; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Ramirez CM, 2011, ARTERIOSCL THROM VAS, V31, P2707, DOI 10.1161/ATVBAHA.111.232066; Ranganathan G, 1997, J BIOL CHEM, V272, P2515; Ranganathan G, 2012, ATHEROSCLEROSIS, V221, P143, DOI 10.1016/j.atherosclerosis.2011.12.028; Richardson K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-504; Richardson K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017944; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Sethupathy P, 2008, TRENDS GENET, V24, P489, DOI 10.1016/j.tig.2008.07.004; Tang WH, 2010, CIRC-CARDIOVASC GENE, V3, P179, DOI 10.1161/CIRCGENETICS.109.913426; Templeton AR, 2000, AM J HUM GENET, V66, P69, DOI 10.1086/302699; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Waterworth DM, 2010, ARTERIOSCL THROM VAS, V30, P2264, DOI 10.1161/ATVBAHA.109.201020; Wilkie GS, 2003, TRENDS BIOCHEM SCI, V28, P182, DOI 10.1016/S0968-0004(03)00051-3; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290; Zhang HF, 1996, BBA-LIPID LIPID MET, V1302, P159, DOI 10.1016/0005-2760(96)00059-8	53	55	55	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 10	2013	92	1					5	14		10.1016/j.ajhg.2012.10.020	http://dx.doi.org/10.1016/j.ajhg.2012.10.020			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	073RA	23246289	Green Published, Bronze			2022-12-18	WOS:000313759000001
J	Guergueltcheva, V; Azmanov, DN; Angelicheva, D; Smith, KR; Chamova, T; Florez, L; Bynevelt, M; Nguyen, T; Cherninkova, S; Bojinova, V; Kaprelyan, A; Angelova, L; Morar, B; Chandler, D; Kaneva, R; Bahlo, M; Tournev, I; Kalaydjieva, L				Guergueltcheva, Velina; Azmanov, Dimitar N.; Angelicheva, Dora; Smith, Katherine R.; Chamova, Teodora; Florez, Laura; Bynevelt, Michael; Thai Nguyen; Cherninkova, Sylvia; Bojinova, Veneta; Kaprelyan, Ara; Angelova, Lyudmila; Morar, Bharti; Chandler, David; Kaneva, Radka; Bahlo, Melanie; Tournev, Ivailo; Kalaydjieva, Luba			Autosomal-Recessive Congenital Cerebellar Ataxia Is Caused by Mutations in Metabotropic Glutamate Receptor 1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LONG-TERM DEPRESSION; GENE; EXPRESSION; HYPOPLASIA; VARIANTS; PATTERNS; DISORDER; MGLUR1; MAPS; ROMA	Autosomal-recessive congenital cerebellar ataxia was identified in Roma patients originating from a small subisolate with a known strong founder effect. Patients presented with global developmental delay, moderate to severe stance and gait ataxia, dysarthria, mild dysdiadochokinesia, dysmetria and tremors, intellectual deficit, and mild pyramidal signs. Brain imaging revealed progressive generalized cerebellar atrophy, and inferior vermian hypoplasia and/or a constitutionally small brain were observed in some patients. Exome sequencing, used for linkage analysis on extracted SNP genotypes and for mutation detection, identified two novel (i.e., not found in any database) variants located 7 bp apart within a unique 6q24 linkage region. Both mutations cosegregated with the disease in five affected families, in which all ten patients were homozygous. The mutated gene, GRM1 encodes metabotropic glutamate receptor mGluR1, which is highly expressed in cerebellar Purkinje cells and plays an important role in cerebellar development and synaptic plasticity. The two mutations affect a gene region critical for alternative splicing and the generation of receptor isoforms; they are a 3 bp exon 8 deletion and an intron 8 splicing mutation (c.2652_2654del and c.2660+2T>G, respectively [RefSeq accession number NM_000838.3]). The functional impact of the deletion is unclear and is overshadowed by the splicing defect. Although ataxia lymphoblastoid cell lines expressed GRM1 at levels comparable to those of control cells, the aberrant transcripts skipped exon 8 or ended in intron 8 and encoded various species of nonfunctional receptors either lacking the transmembrane domain and containing abnormal intracellular tails or completely missing the tail. The study implicates mGluR1 in human hereditary ataxia. It also illustrates the potential of the Roma founder populations for mutation identification by exome sequencing.	[Smith, Katherine R.; Bahlo, Melanie] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Melbourne, Vic 3052, Australia; [Guergueltcheva, Velina; Chamova, Teodora; Cherninkova, Sylvia; Bojinova, Veneta; Tournev, Ivailo] Med Univ Sofia, Dept Neurol, Sofia 1431, Bulgaria; [Azmanov, Dimitar N.; Angelicheva, Dora; Florez, Laura; Morar, Bharti; Kalaydjieva, Luba] Univ Western Australia, Lab Mol Genet, Med Res Ctr, Perth, WA 6009, Australia; [Azmanov, Dimitar N.; Angelicheva, Dora; Florez, Laura; Morar, Bharti; Kalaydjieva, Luba] Univ Western Australia, Western Australian Inst Med Res, Perth, WA 6009, Australia; [Bynevelt, Michael] Univ Western Australia, Dept Surg, Sch Med, Perth, WA 6009, Australia; [Bynevelt, Michael] Sir Charles Gairdner Hosp, Neurol Intervent & Imaging Serv WA, Perth, WA 6009, Australia; [Thai Nguyen] Princess Margaret Hosp Children, Dept Radiol, Perth, WA 6840, Australia; [Kaprelyan, Ara] Med Univ, Dept Neurol, Varna 9002, Bulgaria; [Angelova, Lyudmila] Med Univ, Dept Pediat & Med Genet, Varna 9002, Bulgaria; [Chandler, David] Australian Genome Res Facil, Perth, WA 6000, Australia; [Kaneva, Radka] Med Univ Sofia, Mol Med Ctr, Sofia 1431, Bulgaria; [Kaneva, Radka] Med Univ Sofia, Dept Med Chem & Biochem, Sofia 1431, Bulgaria; [Tournev, Ivailo] New Bulgarian Univ, Dept Cognit Sci & Psychol, Sofia 1618, Bulgaria; [Smith, Katherine R.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Bahlo, Melanie] Univ Melbourne, Dept Math & Stat, Parkville, Vic 3010, Australia	Walter & Eliza Hall Institute; Medical University Sofia; University of Western Australia; University of Western Australia; University of Western Australia; Medical University Varna; Medical University Varna; Medical University Sofia; Medical University Sofia; New Bulgarian University; University of Melbourne; University of Melbourne	Bahlo, M (corresponding author), Walter & Eliza Hall Inst Med Res, Bioinformat Div, Melbourne, Vic 3052, Australia.	bahlo@wehi.edu.au; luba.kalaydjieva@uwa.edu.au	Kaneva, Radka P/AGS-5076-2022; Kaneva, Radka/AAT-5322-2021; Chamova, Teodora/AAS-2081-2020; Morar, Bharti/O-8697-2014; Kaneva, Radka P/V-6535-2017	Kaneva, Radka P/0000-0002-1437-1393; Morar, Bharti/0000-0003-3897-1403; Kaneva, Radka P/0000-0002-1437-1393; Bahlo, Melanie/0000-0001-5132-0774	National Health and Medical Research Council (NHMRC) [634551]; Pratt Foundation; Australian Research Council [FT100100764]; NHMRC Program Grant [490037]; Victorian State Government Operational Infrastructure Support; Australian Government NHMRC Independent Research Institute Infrastructure Support Scheme; National Science Fund; Ministry of Education, Youth, and Science [DUNK01-2/2009]; Science Fund of the Medical University of Sofia [8I/2009]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Pratt Foundation; Australian Research Council(Australian Research Council); NHMRC Program Grant(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Support; Australian Government NHMRC Independent Research Institute Infrastructure Support Scheme(Australian GovernmentNational Health and Medical Research Council (NHMRC) of Australia); National Science Fund; Ministry of Education, Youth, and Science; Science Fund of the Medical University of Sofia	We are grateful to the affected families participating in this study. D.N.A. is supported by National Health and Medical Research Council (NHMRC) Training Fellowship 634551; K.R.S. is supported by a PhD scholarship funded by the Pratt Foundation; and M.B. is supported by Australian Research Council Future Fellowship FT100100764 and NHMRC Program Grant 490037. The work of K.R.S. and M.B. is supported by Victorian State Government Operational Infrastructure Support and the Australian Government NHMRC Independent Research Institute Infrastructure Support Scheme. The Molecular Medicine Center is supported by grants from the National Science Fund; the Ministry of Education, Youth, and Science (DUNK01-2/2009); and the Science Fund of the Medical University of Sofia (grant 8I/2009). We thank Daniela Dacheva and Reni Tzveova for technical assistance.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Angelicheva D, 1999, EUR J HUM GENET, V7, P560, DOI 10.1038/sj.ejhg.5200319; Ayoub MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032849; Bomar JM, 2003, NAT GENET, V35, P264, DOI 10.1038/ng1255; Coates JR, 2002, J VET INTERN MED, V16, P680, DOI 10.1111/j.1939-1676.2002.tb02408.x; Crepaldi L, 2007, J BIOL CHEM, V282, P17877, DOI 10.1074/jbc.M700149200; Enz R, 2007, BIOESSAYS, V29, P60, DOI 10.1002/bies.20518; Ferraguti F, 2008, PHARMACOL REV, V60, P536, DOI 10.1124/pr.108.000166; Fogel BL, 2007, LANCET NEUROL, V6, P245, DOI 10.1016/S1474-4422(07)70054-6; Francesconi A, 2002, J NEUROSCI, V22, P2196, DOI 10.1523/JNEUROSCI.22-06-02196.2002; Frank RAW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019011; Gil-Sanz C, 2008, CEREB CORTEX, V18, P1653, DOI 10.1093/cercor/bhm193; Glass HC, 2005, DEV MED CHILD NEUROL, V47, P691, DOI 10.1017/S0012162205001404; Gresham D, 2001, AM J HUM GENET, V69, P1314, DOI 10.1086/324681; Kaaydjieva L, 2005, BIOESSAYS, V27, P1084, DOI 10.1002/bies.20287; Kalaydjieva L, 2001, EUR J HUM GENET, V9, P97, DOI 10.1038/sj.ejhg.5200597; Kano M, 2008, PHILOS T R SOC B, V363, P2173, DOI 10.1098/rstb.2008.2270; Knoflach F, 2001, P NATL ACAD SCI USA, V98, P13402, DOI 10.1073/pnas.231358298; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024; Leutenegger AL, 2003, AM J HUM GENET, V73, P516, DOI 10.1086/378207; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2011, BIOINFORMATICS, V27, P1157, DOI 10.1093/bioinformatics/btr076; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Makoff AJ, 1997, NEUROREPORT, V8, P2943, DOI 10.1097/00001756-199709080-00027; Marignier R, 2010, ARCH NEUROL-CHICAGO, V67, P627, DOI 10.1001/archneurol.2010.51; Mary S, 1998, J BIOL CHEM, V273, P425, DOI 10.1074/jbc.273.1.425; Megarbane A, 2001, AM J MED GENET, V101, P135, DOI 10.1002/1096-8628(20010615)101:2<135::AID-AJMG1134>3.0.CO;2-J; Morar B, 2004, AM J HUM GENET, V75, P596, DOI 10.1086/424759; Nicoletti E, 2011, NEUROPHARMACOLOGY, V60, P1017, DOI 10.1016/j.neuropharm.2010.10.022; Norman RM, 1940, BRAIN, V63, P365, DOI 10.1093/brain/63.4.365; Pacheco R, 2004, J BIOL CHEM, V279, P33352, DOI 10.1074/jbc.M401761200; Palau F, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-47; PIN JP, 1994, EMBO J, V13, P342, DOI 10.1002/j.1460-2075.1994.tb06267.x; PIN JP, 1992, P NATL ACAD SCI USA, V89, P10331, DOI 10.1073/pnas.89.21.10331; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rossi PIA, 2010, J NEUROL, V257, P598, DOI 10.1007/s00415-009-5380-3; Schmitz-Hubsch T, 2006, NEUROLOGY, V66, P1717, DOI 10.1212/01.wnl.0000219042.60538.92; Smith KR, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r85; Smitt PS, 2000, NEW ENGL J MED, V342, P21, DOI 10.1056/NEJM200001063420104; Steinlin M, 1998, BRAIN DEV-JPN, V20, P199, DOI 10.1016/S0387-7604(98)00019-9; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; Turkmen S, 2008, EUR J HUM GENET, V16, P1070, DOI 10.1038/ejhg.2008.73; Turkmen S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000487; Varon R, 2003, NAT GENET, V35, P185, DOI 10.1038/ng1243; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	49	55	57	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 7	2012	91	3					553	564		10.1016/j.ajhg.2012.07.019	http://dx.doi.org/10.1016/j.ajhg.2012.07.019			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	004LL	22901947	Bronze, Green Published			2022-12-18	WOS:000308683100017
J	Weber, S; Thiele, H; Mir, S; Toliat, MR; Sozeri, B; Reutter, H; Draaken, M; Ludwig, M; Altmuller, J; Frommolt, P; Stuart, HM; Ranjzad, P; Hanley, NA; Jennings, R; Newman, WG; Wilcox, DT; Thiel, U; Schlingmann, KP; Beetz, R; Hoyer, PF; Konrad, M; Schaefer, F; Nurnberg, P; Woolf, AS				Weber, Stefanie; Thiele, Holger; Mir, Sevgi; Toliat, Mohammad Reza; Sozeri, Betuel; Reutter, Heiko; Draaken, Markus; Ludwig, Michael; Altmueller, Janine; Frommolt, Peter; Stuart, Helen M.; Ranjzad, Parisa; Hanley, Neil A.; Jennings, Rachel; Newman, William G.; Wilcox, Duncan T.; Thiel, Uwe; Schlingmann, Karl Peter; Beetz, Rolf; Hoyer, Peter F.; Konrad, Martin; Schaefer, Franz; Nuernberg, Peter; Woolf, Adrian S.			Muscarinic Acetylcholine Receptor M3 Mutation Causes Urinary Bladder Disease and a Prune-Belly-like Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MICE LACKING; EXPRESSION; GENE; RAT; M-2	Urinary bladder malformations associated with bladder outlet obstruction are a frequent cause of progressive renal failure in children. We here describe a muscarinic acetylcholine receptor M3 (CHRM3) (1q41-q44) homozygous frameshift mutation in familial congenital bladder malformation associated with a prune-belly-like syndrome, defining an isolated gene defect underlying this sometimes devastating disease. CHRM3 encodes the M3 muscarinic acetylcholine receptor, which we show is present in developing renal epithelia and bladder muscle. These observations may imply that M3 has a role beyond its known contribution to detrusor contractions. This Mendelian disease caused by a muscarinic acetylcholine receptor mutation strikingly phenocopies Chrm3 null mutant mice.	[Weber, Stefanie; Hoyer, Peter F.] Univ Childrens Hosp Essen, D-45122 Essen, Germany; [Thiele, Holger; Toliat, Mohammad Reza; Altmueller, Janine; Frommolt, Peter; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Mir, Sevgi; Sozeri, Betuel] Univ Childrens Hosp Izmir, TR-35030 Izmir, Turkey; [Reutter, Heiko; Draaken, Markus] Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany; [Reutter, Heiko] Univ Bonn, Childrens Hosp, Dept Neonatol, D-53127 Bonn, Germany; [Draaken, Markus] Univ Bonn, Life & Brain Ctr, Dept Genom, D-53127 Bonn, Germany; [Ludwig, Michael] Univ Bonn, Dept Clin Chem & Clin Pharmacol, D-53127 Bonn, Germany; [Frommolt, Peter; Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Stuart, Helen M.; Ranjzad, Parisa; Hanley, Neil A.; Jennings, Rachel; Woolf, Adrian S.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Sch Biomed, Dev Biomed Res Grp, Manchester M13 9PT, Lancs, England; [Stuart, Helen M.; Ranjzad, Parisa; Hanley, Neil A.; Jennings, Rachel; Woolf, Adrian S.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester M13 9PT, Lancs, England; [Newman, William G.] Univ Manchester, St Marys Hosp, Manchester M13 9PT, Lancs, England; [Wilcox, Duncan T.] Childrens Hosp, Aurora, CO 80045 USA; [Schlingmann, Karl Peter; Konrad, Martin] Univ Childrens Hosp Munster, D-48149 Munster, Germany; [Beetz, Rolf] Univ Childrens Hosp Mainz, D-55131 Mainz, Germany; [Schaefer, Franz] Univ Childrens Hosp Heidelberg, D-69120 Heidelberg, Germany; [Nuernberg, Peter] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Thiel, Uwe] Pediat Hosp Munich Schwabing, D-81664 Munich, Germany	University of Duisburg Essen; University of Cologne; University of Bonn; University of Bonn; University of Bonn; University of Bonn; University of Cologne; University of Manchester; University of Manchester; University of Manchester; Children's Hospital Colorado; University of Munster; Ruprecht Karls University Heidelberg; University of Cologne	Weber, S (corresponding author), Univ Childrens Hosp Essen, D-45122 Essen, Germany.	stefanie.weber@uk-essen.de	Thiele, Holger/ABE-6792-2020; Stuart, Helen/G-3535-2015; Frommolt, Peter/L-9656-2016; Schaefer, Franz/G-4365-2010; Wilcox, Duncan/AAO-9922-2020; Woolf, Adrian S./AAZ-1075-2020	Thiele, Holger/0000-0002-0169-998X; Stuart, Helen/0000-0003-2569-235X; Frommolt, Peter/0000-0002-1966-8014; Woolf, Adrian S./0000-0001-5541-1358; sozeri, betul/0000-0003-0358-6409; Ranjzad, Parisa/0000-0001-7413-4157; Newman, William/0000-0002-6382-4678; Draaken, Markus/0000-0002-4546-0786; Hanley, Neil/0000-0003-3234-4038; Altmuller, Janine/0000-0003-4372-1521	Kidney Research UK; Kids Kidney Research; Kidneys for Life; Manchester NIHR Biomedical Research Centre; Wellcome Trust; Fritz Thyssen; German Federal Ministry of Education and Research [01GM08107]; KfH Foundation for Preventive Medicine; ERA-EDTA; IFB Transplantation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008107] Funding Source: NIH RePORTER; Kidney Research UK [RP33/2010] Funding Source: researchfish	Kidney Research UK(Kidney Research UK (KRUK)); Kids Kidney Research(Kidney Research UK (KRUK)); Kidneys for Life; Manchester NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); Fritz Thyssen; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); KfH Foundation for Preventive Medicine; ERA-EDTA; IFB Transplantation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Kidney Research UK(Kidney Research UK (KRUK))	We thank the patients and their family for participating in this study, Bettina Cirkel and Christian Becker for excellent technical support and Anne Deix for critical advice. Financial grant support was received from the Kidney Research UK (W.G.N. and A.S.W.), Kids Kidney Research and Kidneys for Life (A.S.W.), Manchester NIHR Biomedical Research Centre (A.S.W., R.J., N.A.H., H.S., and W.G.N.), and The Wellcome Trust (A.S.W. and N.A.H.). S.W. and F.S. received financial support from the Fritz Thyssen grant. H.R. and M.D. are members of the German network for congenital uro-rectal malformations (CURE-Net), which is supported by a research grant (01GM08107) from the German Federal Ministry of Education and Research. The 4C-Kidney Disease Study is supported by research grants of the KfH Foundation for Preventive Medicine, ERA-EDTA and IFB Transplantation.	Adalat S, 2009, J AM SOC NEPHROL, V20, P1123, DOI 10.1681/ASN.2008060633; [Anonymous], MOUSE GENOME INFORM; [Anonymous], EXOME VARIANT SERVER; Azuma M, 2006, J BIOL CHEM, V281, P13309, DOI 10.1074/jbc.M601892200; Borroto-Escuela DO, 2010, CELL PHYSIOL BIOCHEM, V25, P397, DOI 10.1159/000303044; Chen CC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-366; Collins JS, 2002, AM J HUM GENET, V71, P1251, DOI 10.1086/344344; Creed Kate E., 2010, Journal of Smooth Muscle Research, V46, P201; Daly SB, 2010, AM J HUM GENET, V86, P963, DOI 10.1016/j.ajhg.2010.05.006; Farrugia MK., 2010, FETAL MATERN MED REV, V21, P55; Fowler CJ, 2008, NAT REV NEUROSCI, V9, P453, DOI 10.1038/nrn2401; GABOARDI F, 1982, HELV PAEDIATR ACTA, V37, P283; Giuliani S, 2010, J PEDIATR SURG, V45, pE39, DOI 10.1016/j.jpedsurg.2010.07.054; Jenkins D, 2007, J ANAT, V211, P620, DOI 10.1111/j.1469-7580.2007.00808.x; KING CR, 1978, J PEDIATR-US, V93, P273, DOI 10.1016/S0022-3476(78)80519-8; Kories C, 2003, N-S ARCH PHARMACOL, V367, P524, DOI 10.1007/s00210-003-0713-8; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mansfield KJ, 2007, BJU INT, V99, P1433, DOI 10.1111/j.1464-410X.2007.06866.x; Matsui M, 2000, P NATL ACAD SCI USA, V97, P9579, DOI 10.1073/pnas.97.17.9579; Michalk A, 2008, AM J HUM GENET, V82, P464, DOI 10.1016/j.ajhg.2007.11.006; Murray PJ, 2008, NEPHROL DIAL TRANSPL, V23, P2412, DOI 10.1093/ndt/gfn169; North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS), 2010, ANN TRANSPL REP; Pomper JK, 2011, NEUROLOGY, V76, P451, DOI 10.1212/WNL.0b013e31820a0a75; Ramasamy Ranjith, 2005, Urology, V65, P1227, DOI 10.1016/j.urology.2004.12.050; Schneider T, 2005, N-S ARCH PHARMACOL, V372, P71, DOI 10.1007/s00210-005-1084-0; Shakirova Y, 2010, EUR J PHARMACOL, V634, P142, DOI 10.1016/j.ejphar.2010.02.017; Weber S, 2005, PEDIATR NEPHROL, V20, P1036, DOI 10.1007/s00467-005-1977-7; Weber S, 2006, J AM SOC NEPHROL, V17, P2864, DOI 10.1681/ASN.2006030277; Xu W, 1999, P NATL ACAD SCI USA, V96, P5746, DOI 10.1073/pnas.96.10.5746; Xu W, 1999, J NEUROSCI, V19, P9298; Zarghooni S, 2007, LIFE SCI, V80, P2308, DOI 10.1016/j.lfs.2007.01.046; CARDIOVASCULAR COMOR	34	55	58	1	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV 11	2011	89	5					668	674		10.1016/j.ajhg.2011.10.007	http://dx.doi.org/10.1016/j.ajhg.2011.10.007			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	848YD	22077972	Green Published, hybrid			2022-12-18	WOS:000297090100009
J	Khan, K; Rudkin, A; Parry, DA; Burdon, KP; McKibbin, M; Logan, CV; Abdelhamed, ZIA; Muecke, JS; Fernandez-Fuentes, N; Laurie, KJ; Shires, M; Fogarty, R; Carr, IM; Poulter, JA; Morgan, JE; Mohamed, MD; Jafri, H; Raashid, Y; Meng, N; Piseth, H; Toomes, C; Casson, RJ; Taylor, GR; Hammerton, M; Sheridan, E; Johnson, CA; Inglehearn, CF; Craig, JE; Ali, M				Khan, Kamron; Rudkin, Adam; Parry, David A.; Burdon, Kathryn P.; McKibbin, Martin; Logan, Clare V.; Abdelhamed, Zakia I. A.; Muecke, James S.; Fernandez-Fuentes, Narcis; Laurie, Kate J.; Shires, Mike; Fogarty, Rhys; Carr, Ian M.; Poulter, James A.; Morgan, Joanne E.; Mohamed, Moin D.; Jafri, Hussain; Raashid, Yasmin; Meng, Ngy; Piseth, Horm; Toomes, Carmel; Casson, Robert J.; Taylor, Graham R.; Hammerton, Michael; Sheridan, Eamonn; Johnson, Cohn A.; Inglehearn, Chris F.; Craig, Jamie E.; Ali, Manir			Homozygous Mutations in PXDN Cause Congenital Cataract, Corneal Opacity, and Developmental Glaucoma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ANTERIOR SEGMENT DYSGENESIS; TRANSCRIPTION FACTOR GENE; OXIDATIVE STRESS; MICROCORNEA SYNDROME; NUCLEAR CATARACTS; RIEGER-SYNDROME; KNOCKOUT MICE; PROTEIN; LENS; DAMAGE	Anterior segment dysgenesis describes a group of heterogeneous developmental disorders that affect the anterior chamber of the eye and are associated with an increased risk of glaucoma. Here, we report homozygous mutations in peroxidasin (PXDN) in two consanguineous Pakistani families with congenital cataract-microcornea with mild to moderate corneal opacity and in a consanguineous Cambodian family with developmental glaucoma and severe corneal pacification. These results highlight the diverse ocular phenotypes caused by PXDN mutations, which are likely due to differences in genetic background and environmental factors. Peroxidasin is an extracellular matrix-associated protein with peroxidase catalytic activity, and we confirmed localization of the protein to the cornea and lens epithelial layers. Our findings imply that peroxidasin is essential for normal development of the anterior chamber of the eye, where it may have a structural role in supporting cornea and lens architecture as well as an enzymatic role as an antioxidant enzyme in protecting the lens, trabecular meshwork, and cornea against oxidative damage.	[Rudkin, Adam; Burdon, Kathryn P.; Laurie, Kate J.; Fogarty, Rhys; Craig, Jamie E.] Flinders Univ S Australia, Dept Ophthalmol, Flinders Med Ctr, Adelaide, SA 5042, Australia; [Khan, Kamron; Parry, David A.; McKibbin, Martin; Logan, Clare V.; Abdelhamed, Zakia I. A.; Fernandez-Fuentes, Narcis; Shires, Mike; Carr, Ian M.; Poulter, James A.; Morgan, Joanne E.; Mohamed, Moin D.; Toomes, Carmel; Taylor, Graham R.; Sheridan, Eamonn; Johnson, Cohn A.; Inglehearn, Chris F.; Ali, Manir] Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [Khan, Kamron; McKibbin, Martin] St James Univ Hosp, Eye Dept, Leeds LS9 7TF, W Yorkshire, England; [Abdelhamed, Zakia I. A.] Al Azhar Univ, Dept Anat & Embryol, Cairo, Egypt; [Muecke, James S.; Casson, Robert J.; Hammerton, Michael] Royal Adelaide Hosp, S Australian Inst Ophthalmol, Adelaide, SA 5000, Australia; [Mohamed, Moin D.] St Thomas Hosp, London SE1 7EH, England; [Jafri, Hussain] Gene Technol Labs 146 1, Lahore 54000, Pakistan; [Raashid, Yasmin] King Edward Med Univ, Dept Obstet & Gynaecol, Lahore 54000, Pakistan; [Meng, Ngy] Preah Ang Duong Eye Hosp, Phnom Penh 855, Cambodia; [Piseth, Horm] Fred Hollows Fdn, Phnom Penh 518, Cambodia	Flinders Medical Centre; Flinders University South Australia; University of Leeds; Saint James's University Hospital; Egyptian Knowledge Bank (EKB); Al Azhar University; Royal Adelaide Hospital; Guy's & St Thomas' NHS Foundation Trust	Craig, JE (corresponding author), Flinders Univ S Australia, Dept Ophthalmol, Flinders Med Ctr, Adelaide, SA 5042, Australia.	jamie.criag@flinders.edu.au; medma@leeds.ac.uk	Burdon, Kathryn/A-5026-2009; Poulter, James A/A-8190-2013; Ali, Manir/ABE-5251-2020; Inglehearn, Chris/GYD-9783-2022; Burdon, Kathryn/AAD-2334-2022	Burdon, Kathryn/0000-0001-8217-1249; Poulter, James A/0000-0003-2048-5693; Ali, Manir/0000-0003-3204-3788; Burdon, Kathryn/0000-0001-8217-1249; Johnson, Colin/0000-0002-2979-8234; Rudkin, Adam/0000-0003-2508-8574; Fernandez-Fuentes, Narcis/0000-0002-6421-1080; Parry, David/0000-0003-0376-7736; Toomes, Carmel/0000-0001-8373-9545; Craig, Jamie/0000-0001-9955-9696; Logan, Clare/0000-0003-4323-1602	Wellcome Trust [090224]; The Sir Jules Thorn Charitable Trust [09/JTA]; Yorkshire Eye Research [022]; Ophthalmic Research Institute of Australia; The Eye Foundation; Egyptian Government; The Sir Jules Thorn Charitable Trust [09JTA] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); The Sir Jules Thorn Charitable Trust; Yorkshire Eye Research; Ophthalmic Research Institute of Australia; The Eye Foundation; Egyptian Government; The Sir Jules Thorn Charitable Trust	We wish to thank the families for participating in this study and the Wellcome Trust (grant 090224), The Sir Jules Thorn Charitable Trust (grant 09/JTA), Yorkshire Eye Research (grant 022), The Ophthalmic Research Institute of Australia, and The Eye Foundation and Sight for All for providing financial support. K.P.B. and J.E.C. are research fellows of the National Health and Medical Research Council of Australia. Z.I.A.A. is funded by a scholarship from the Egyptian Government. We would also like to thank Graeme Black (School of Medicine, University of Manchester, Manchester, UK), Veronica van Heyningen (Human Genetics Unit, Western General Hospital, Edinburgh, UK), Colin E. Willoughby (Centre for Vision Science, Queen's University, Belfast, Northern Ireland), Ordan J. Lehmann (Department of Ophthalmology, University of Alberta, Edmonton, Canada), and Juan Carlos Zenteno (Instituto de Oftalmologia, "Conde de Valenciana," Mexico City, Mexico) for sending DNA samples from patients with anterior segment dysgenesis for mutation screening.	Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Ali M, 2009, AM J HUM GENET, V84, P664, DOI 10.1016/j.ajhg.2009.03.017; BABIZHAYEV MA, 1994, BBA-MOL BASIS DIS, V1225, P326, DOI 10.1016/0925-4439(94)90014-0; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Beebe DC, 2000, DEV BIOL, V220, P424, DOI 10.1006/dbio.2000.9638; Berthoud VM, 2009, ANTIOXID REDOX SIGN, V11, P339, DOI 10.1089/ars.2008.2119; Cejkova J, 2004, PHYSIOL RES, V53, P1; Cheng GJ, 2008, FREE RADICAL BIO MED, V45, P1682, DOI 10.1016/j.freeradbiomed.2008.09.009; Desir J, 2010, EUR J HUM GENET, V18, P761, DOI 10.1038/ejhg.2010.11; Devi RR, 2006, MOL VIS, V12, P190; Doucette L, 2011, EUR J HUM GENET, V19, P293, DOI 10.1038/ejhg.2010.210; Fernandez-Fuentes N, 2007, NUCLEIC ACIDS RES, V35, pW363, DOI 10.1093/nar/gkm341; Fernandez-Fuentes N, 2007, BIOINFORMATICS, V23, P2558, DOI 10.1093/bioinformatics/btm377; Ferreira SM, 2004, AM J OPHTHALMOL, V137, P62, DOI 10.1016/S0002-9394(03)00788-8; Gotenstein JR, 2010, DEVELOPMENT, V137, P3603, DOI 10.1242/dev.049189; Gould DB, 2002, HUM MOL GENET, V11, P1185, DOI 10.1093/hmg/11.10.1185; Halaby DM, 1998, J MOL EVOL, V46, P389, DOI 10.1007/PL00006318; Hansen L, 2007, MOL VIS, V13, P2019; Hansen L, 2007, INVEST OPHTH VIS SCI, V48, P3937, DOI 10.1167/iovs.07-0013; Homma S, 2009, GENE EXPR PATTERNS, V9, P1, DOI 10.1016/j.gep.2008.09.004; Horikoshi N, 1999, BIOCHEM BIOPH RES CO, V261, P864, DOI 10.1006/bbrc.1999.1123; Hu SS, 2010, MOL VIS, V16, P1585; HUNT LT, 1987, BIOCHEM BIOPH RES CO, V144, P876, DOI 10.1016/S0006-291X(87)80046-3; Idrees F, 2006, SURV OPHTHALMOL, V51, P213, DOI 10.1016/j.survophthal.2006.02.006; Iseri SU, 2009, HUM MUTAT, V30, P1378, DOI 10.1002/humu.21079; Izzotti A, 2006, MUTAT RES-REV MUTAT, V612, P105, DOI 10.1016/j.mrrev.2005.11.001; Izzotti A, 2009, INVEST OPHTH VIS SCI, V50, P5251, DOI 10.1167/iovs.09-3871; Jamieson RV, 2002, HUM MOL GENET, V11, P33, DOI 10.1093/hmg/11.1.33; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; Khan AO, 2007, AM J OPHTHALMOL, V144, P949, DOI 10.1016/j.ajo.2007.08.005; Khan K, 2011, INVEST OPHTH VIS SCI, V52, P4294, DOI 10.1167/iovs.10-6776; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Lehmann OJ, 2000, AM J HUM GENET, V67, P1129; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mitchell MS, 2000, CANCER RES, V60, P6448; Nagase T, 1997, DNA Res, V4, P141, DOI 10.1093/dnares/4.2.141; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; Perveen R, 2000, INVEST OPHTH VIS SCI, V41, P2456; Peterfi Z, 2009, AM J PATHOL, V175, P725, DOI 10.2353/ajpath.2009.080693; Reddy VN, 2001, INVEST OPHTH VIS SCI, V42, P3247; Sacca SC, 2005, ARCH OPHTHALMOL-CHIC, V123, P458, DOI 10.1001/archopht.123.4.458; Sale Michele M, 2002, Hum Mutat, V20, P322, DOI 10.1002/humu.9066; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Semina EV, 2001, HUM MOL GENET, V10, P231, DOI 10.1093/hmg/10.3.231; Sia DIT, 2010, OPHTHAL EPIDEMIOL, V17, P225, DOI 10.3109/09286586.2010.489250; Sowden JC, 2007, EYE, V21, P1310, DOI 10.1038/sj.eye.6702852; Spector A, 1998, EXP EYE RES, V67, P457, DOI 10.1006/exer.1998.0548; SPECTOR A, 1978, P NATL ACAD SCI USA, V75, P3244, DOI 10.1073/pnas.75.7.3244; Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641; Tauber S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-200; Thut CJ, 2001, DEV BIOL, V231, P63, DOI 10.1006/dbio.2000.0140; Vanita V, 2006, AM J MED GENET A, V140A, P558, DOI 10.1002/ajmg.a.31126; Vanita V, 2008, MOL VIS, V14, P323; Wang KJ, 2011, ARCH OPHTHALMOL-CHIC, V129, P337, DOI 10.1001/archophthalmol.2011.11; WEILER SR, 1994, GENOMICS, V22, P243, DOI 10.1006/geno.1994.1374; Willoughby CE, 2005, MOL VIS, V11, P587; Zhang L, 2009, MOL VIS, V15, P276; Zhou GK, 2010, MOL VIS, V16, P1019; ZIGLER JS, 1989, FREE RADICAL BIO MED, V7, P499	60	55	56	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP 9	2011	89	3					464	473		10.1016/j.ajhg.2011.08.005	http://dx.doi.org/10.1016/j.ajhg.2011.08.005			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	820XQ	21907015	Green Published, hybrid			2022-12-18	WOS:000294939800013
J	Schraders, M; Oostrik, J; Huygen, PLM; Strom, TM; van Wijk, E; Kunst, HPM; Hoefsloot, LH; Cremers, CWRJ; Admiraal, RJC; Kremer, H				Schraders, Margit; Oostrik, Jaap; Huygen, Patrick L. M.; Strom, Tim M.; van Wijk, Erwin; Kunst, Henricus P. M.; Hoefsloot, Lies H.; Cremers, Cor W. R. J.; Admiraal, Ronald J. C.; Kremer, Hannie			Mutations in PTPRQ Are a Cause of Autosomal-Recessive Nonsyndromic Hearing Impairment DFNB84 and Associated with Vestibular Dysfunction	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; PHOSPHATIDYLINOSITOL PHOSPHATASE; DOMAIN	We identified overlapping homozygous regions within the DFNB84 locus in a nonconsanguineous Dutch family and a consanguineous Moroccan family with sensorineural autosomal-recessive nonsyndromic hearing impairment (arNSHI). The critical region of 3.17 Mb harbored the PTPRQ gene and mouse models with homozygous mutations in the orthologous gene display severe hearing loss. We show that the human PTPRQ gene was not completely annotated and that additional, alternatively spliced exons are present at the 5' end of the gene. Different PTPRQ isoforms are encoded with a varying number of fibronectin type 3 (FN3) domains, a transmembrane domain, and a phosphatase domain. Sequence analysis of the PTPRQ gene in members of the families revealed a nonsense mutation in the Dutch family and a missense mutation in the Moroccan family. The missense mutation is located in one of the FN3 domains. The nonsense mutation results in a truncated protein with only a small number of FN3 domains and no transmembrane or phosphatase domain. Hearing loss in the patients with PTPRQ mutations is likely to be congenital and moderate to profound and most severe in the family with the nonsense mutation. Progression of the hearing loss was observed in both families. The hearing loss is accompanied by vestibular dysfunction in all affected individuals. Although we show that PTPRQ is expressed in many tissues, no symptoms other than deafness were observed in the patients.	[Schraders, Margit; Oostrik, Jaap; Huygen, Patrick L. M.; van Wijk, Erwin; Kunst, Henricus P. M.; Cremers, Cor W. R. J.; Admiraal, Ronald J. C.; Kremer, Hannie] Radboud Univ Nijmegen, Dept Otorhinolaryngol Head & Neck Surg, Med Ctr, NL-6525 GA Nijmegen, Netherlands; [Schraders, Margit; Oostrik, Jaap; van Wijk, Erwin; Kremer, Hannie] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, NL-6525 GA Nijmegen, Netherlands; [Schraders, Margit; Oostrik, Jaap; van Wijk, Erwin; Kunst, Henricus P. M.; Cremers, Cor W. R. J.; Admiraal, Ronald J. C.; Kremer, Hannie] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 GA Nijmegen, Netherlands; [Strom, Tim M.] German Res Ctr Environm Hlth, Inst Human Genet, Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany; [Hoefsloot, Lies H.] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, NL-6525 GA Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Radboud University Nijmegen	Kremer, H (corresponding author), Radboud Univ Nijmegen, Dept Otorhinolaryngol Head & Neck Surg, Med Ctr, NL-6525 GA Nijmegen, Netherlands.	h.kremer@antrg.umcn.nl	Huygen, P.L.M./L-4401-2015; Admiraal, R.J.C./L-4171-2015; Oostrik, Jaap/A-1703-2016; Kremer, Hannie/F-5126-2010; van Wijk, Erwin/J-8913-2014; Schraders, Margit/A-1607-2016; Cremers, C.W.R.J./L-4254-2015; Kunst, Henricus P.M./J-6456-2012	Kremer, Hannie/0000-0002-0841-8693; van Wijk, Erwin/0000-0002-5702-3460; Kunst, Henricus P.M./0000-0003-1162-6394	RNID [GR36]; Fonds NutsOhra [SNO-T-0702-102]; EUROHEAR [LSHG-CT-2004-512063]; Janivo stichting; Heinsius Houbolt Foundation; Christine Bader Stichting Irene Kinderziekenhuis	RNID; Fonds NutsOhra; EUROHEAR; Janivo stichting; Heinsius Houbolt Foundation; Christine Bader Stichting Irene Kinderziekenhuis	We thank Suzanne Keijzers-Vloet, Saskia van der Velde-Visser, and Christel Beumer for excellent technical assistance and Dr. A. Beynon and Dr. K.P. Krommenhoek for evaluation of vestibular function. We thank Dr. A.M. Bertoli Avella for providing DNA samples. This work was financially supported by the RNID (GR36 to H.K.), Fonds NutsOhra (Project SNO-T-0702-102 to H.K.), EUROHEAR (LSHG-CT-2004-512063 to H.K. and C.W.R.J.C.), The Janivo stichting, The Heinsius Houbolt Foundation, and The Christine Bader Stichting Irene Kinderziekenhuis (to H.K.). None of the authors has any financial interests related to the contents of this manuscript.	ChiRosso G, 1997, J BIOL CHEM, V272, P31447, DOI 10.1074/jbc.272.50.31447; Cohen-Salmon M, 1997, P NATL ACAD SCI USA, V94, P14450, DOI 10.1073/pnas.94.26.14450; Collin RWJ, 2008, AM J HUM GENET, V83, P594, DOI 10.1016/j.ajhg.2008.10.014; Goodyear RJ, 2003, J NEUROSCI, V23, P9208; Hirono M, 2004, NEURON, V44, P309, DOI 10.1016/j.neuron.2004.09.020; Iuliano R, 2009, J BIOCHEM, V145, P377, DOI 10.1093/jb/mvn175; Kunst H, 1999, AUDIOLOGY, V38, P165; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; Napper CE, 2006, BIOCHEM J, V395, P579, DOI 10.1042/BJ20052027; Oganesian A, 2003, P NATL ACAD SCI USA, V100, P7563, DOI 10.1073/pnas.1336511100; Sakaguchi H, 2008, CELL MOTIL CYTOSKEL, V65, P528, DOI 10.1002/cm.20275; Schraders M, 2010, AM J HUM GENET, V86, P138, DOI 10.1016/j.ajhg.2009.12.017; Seifert RA, 2003, EXP CELL RES, V287, P374, DOI 10.1016/S0014-4827(03)00121-6; SHAHIN H, 2009, EUR J HUM G IN PRESS; Thiadens AAHJ, 2009, AM J HUM GENET, V85, P240, DOI 10.1016/j.ajhg.2009.06.016; Tranebjaerg L, 2008, INT J AUDIOL, V47, P535, DOI 10.1080/14992020802249259; WEBER P, 1995, J BIOL CHEM, V270, P4619, DOI 10.1074/jbc.270.9.4619; Wright MB, 1998, J BIOL CHEM, V273, P23929, DOI 10.1074/jbc.273.37.23929; Zelante L, 1997, HUM MOL GENET, V6, P1605, DOI 10.1093/hmg/6.9.1605	19	55	61	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 9	2010	86	4					604	610		10.1016/j.ajhg.2010.02.015	http://dx.doi.org/10.1016/j.ajhg.2010.02.015			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	583YP	20346435	Bronze, Green Published			2022-12-18	WOS:000276716800011
J	Shimomura, Y; Wajid, M; Petukhova, L; Kurban, M; Christiano, AM				Shimomura, Yutaka; Wajid, Muhammad; Petukhova, Lynn; Kurban, Mazen; Christiano, Angela M.			Autosomal-Dominant Woolly Hair Resulting from Disruption of Keratin 74 (KRT74), a Potential Determinant of Human Hair Texture	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEIN-COUPLED RECEPTOR; CONGENITAL ICHTHYOSIFORM ERYTHRODERMA; HELIX INITIATION MOTIF; PACHYONYCHIA-CONGENITA; EPIDERMOLYTIC HYPERKERATOSIS; LYSOPHOSPHATIDIC ACID; 1A DOMAIN; MUTATIONS; GENE; IDENTIFICATION	Autosomal-dominant woolly hair (ADWH) is a rare disorder characterized by tightly curled hair. The molecular basis of ADWH has not previously been reported. In this study, we identified a Pakistani family with ADWH. The family showed linkage to chromosome 12q12-q14.1, containing the type II keratin gene cluster. We discovered a heterozygous mutation, p.Asn148Lys, within the helix initiation motif of the keratin 74 (KR7'74) gene in all affected family members. KRT74 encodes the inner root sheath (IRS)-specific epithelial (soft) keratin 74. We demonstrate that the mutant K74 protein results in disruption of keratin intermediate filament formation in cultured cells, most likely in a dominant-negative manner. Furthermore, we sequenced the mouse Krt71-74 genes in the dominant Caracul-like 4 (Ca14) allele, which is characterized by a wavy-coat phenotype and maps to the same region of mouse chromosome 15 as the Caracul (Ca) and Reduced coat (Rco) alleles. We identified a heterozygous mutation, p.Glu440Lys, not in Krt74 but in the neighboring gene, Krt71. Krt71 was previously reported to harbor Ca and Rco mutations, as well as a coding SNP that is associated with curly-coated dogs. In this study, we define the ADWH phenotype resulting from a mutation in a hair-follicle-specific epithelial keratin in humans. Our findings not only further underscore the crucial roles of the IRS-specific epithelial keratin genes Krt71-74 in hair disorders but also open the possibility that these genes might function as genetic determinants of normal variation in hair texture across mammalian species.	[Shimomura, Yutaka; Wajid, Muhammad; Petukhova, Lynn; Kurban, Mazen; Christiano, Angela M.] Columbia Univ Coll Phys & Surg, Dept Dermatol, New York, NY 10032 USA; [Christiano, Angela M.] Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA	Columbia University; Columbia University	Christiano, AM (corresponding author), Columbia Univ Coll Phys & Surg, Dept Dermatol, New York, NY 10032 USA.	amc65@columbia.edu	Petukhova, Lynn/W-6858-2019; Wajid, Muhammad/F-5087-2015		National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR44924]; Dermatology Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044924] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Dermatology Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful to the family members for their participation in this study and to Helen Lam, Ming Zhang, Yuki Kobayashi, Claire Higgins, and Munenari Itoh (Columbia University) for technical assistance. We thank Dr. Lutz Langbein (German Cancer Research Center, Heidelberg, Germany) for generously sharing the K74 antibody and Noah A. Rosenberg (University of Michigan) and David Reich (Harvard Medical School) for helpful discussions. We thank Satoshi Ishii (Tokyo University, Tokyo, Japan) and Junichi Miyazaki (Osaka University, Osaka, Japan) for supplying the pCXN2.1 vector. This work was supported in part by United States Public Health Service National Institutes of Health grant R01AR44924 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (to A.M.C.). Y.S. is supported by a Research Career Development Award from the Dermatology Foundation.	Arin MJ, 1999, EXP DERMATOL, V8, P124, DOI 10.1111/j.1600-0625.1999.tb00359.x; Cadieu E, 2009, SCIENCE, V326, P150, DOI 10.1126/science.1177808; Chien AJ, 2006, J AM ACAD DERMATOL, V54, pS35, DOI 10.1016/j.jaad.2005.01.092; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; HUTCHINSON P E, 1974, Transactions of the St. John's Hospital Dermatological Society, V60, P160; Kazantseva A, 2006, SCIENCE, V314, P982, DOI 10.1126/science.1133276; Kikkawa Y, 2003, GENETICS, V165, P721; Korge BP, 1999, J INVEST DERMATOL, V113, P607, DOI 10.1046/j.1523-1747.1999.00722.x; Langbein L, 2003, J INVEST DERMATOL, V120, P512, DOI 10.1046/j.1523-1747.2003.12087.x; Langbein L, 2002, J INVEST DERMATOL, V118, P789, DOI 10.1046/j.1523-1747.2002.01711.x; Lee DY, 2002, J INVEST DERMATOL, V119, P976, DOI 10.1046/j.1523-1747.2002.00061.x; Liao H, 2007, J DERMATOL SCI, V48, P199, DOI 10.1016/j.jdermsci.2007.07.003; Lin MTS, 1999, EXP DERMATOL, V8, P115, DOI 10.1111/j.1600-0625.1999.tb00357.x; MCLEAN WHI, 1994, J INVEST DERMATOL, V102, P24, DOI 10.1111/1523-1747.ep12371726; Medland SE, 2009, AM J HUM GENET, V85, P750, DOI 10.1016/j.ajhg.2009.10.009; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Mou C, 2008, HUM MUTAT, V29, P1405, DOI 10.1002/humu.20795; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; Peters T, 2003, J INVEST DERMATOL, V121, P674, DOI 10.1046/j.1523-1747.2003.12491.x; Runkel F, 2006, MAMM GENOME, V17, P1172, DOI 10.1007/s00335-006-0084-9; SALAMON T, 1963, Hautarzt, V14, P540; Shimomura Y, 2008, NAT GENET, V40, P335, DOI 10.1038/ng.100; Shimomura Y, 2009, J INVEST DERMATOL, V129, P622, DOI 10.1038/jid.2008.290; Smith FJD, 2005, J INVEST DERM SYMP P, V10, P21, DOI 10.1111/j.1087-0024.2005.10204.x; Smith FJD, 1998, J INVEST DERMATOL, V111, P817, DOI 10.1046/j.1523-1747.1998.00371.x; Smith FJD, 1999, EXP DERMATOL, V8, P109, DOI 10.1111/j.1600-0625.1999.tb00356.x; Sonoda H, 2002, J BIOL CHEM, V277, P34254, DOI 10.1074/jbc.M201659200; Stephens K, 1997, J INVEST DERMATOL, V108, P349, DOI 10.1111/1523-1747.ep12286486; Whittock NV, 2001, BRIT J DERMATOL, V145, P330, DOI 10.1046/j.1365-2133.2001.04327.x; Winter H, 1999, J INVEST DERMATOL, V113, P263, DOI 10.1046/j.1523-1747.1999.00685.x; Winter H, 2004, J INVEST DERMATOL, V122, P652, DOI 10.1111/j.0022-202X.2004.22309.x; Winter H, 1997, NAT GENET, V16, P372, DOI 10.1038/ng0897-372; Yanagida K, 2009, J BIOL CHEM, V284, P17731, DOI 10.1074/jbc.M808506200; YANG JM, 1994, J INVEST DERMATOL, V102, P17, DOI 10.1111/1523-1747.ep12371725	36	55	62	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 9	2010	86	4					632	638		10.1016/j.ajhg.2010.02.025	http://dx.doi.org/10.1016/j.ajhg.2010.02.025			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	583YP	20346438	Green Published, Bronze			2022-12-18	WOS:000276716800015
J	Ko, DC; Shukla, KP; Fong, C; Wasnick, M; Brittnacher, MJ; Wurfel, MM; Holden, TD; O'Keefe, GE; Van Yserloo, B; Akey, JM; Miller, SI				Ko, Dennis C.; Shukla, Kajal P.; Fong, Christine; Wasnick, Michael; Brittnacher, Mitchell J.; Wurfel, Mark M.; Holden, Tarah D.; O'Keefe, Grant E.; Van Yserloo, Brian; Akey, Joshua M.; Miller, Samuel I.			A Genome-wide In Vitro Bacterial-Infection Screen Reveals Human Variation in the Host Response Associated with Inflammatory Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NF-KAPPA-B; FACTOR-H POLYMORPHISM; CELL-DEATH; RHEUMATOID-ARTHRITIS; EVOLUTIONARY GENETICS; MACROPHAGE APOPTOSIS; CASPASE-1 ACTIVATION; POSITIVE SELECTION; CROHN-DISEASE; SALMONELLA	Recent progress in cataloguing common genetic variation has made possible genome-wide studies that are beginning to elucidate the causes and consequences of our genetic differences. Approaches that provide a mechanistic understanding of how genetic variants function to alter disease susceptibility and why they were substrates of natural selection would complement other approaches to human-genome analysis. Here we use a novel cell-based screen of bacterial infection to identify human variation in Salmonella-induced cell death. A loss-of-function allele of CARD8, a reported inhibitor of the proinflammatory protease caspase-1, was associated with increased cell death in vitro (p = 0.013). The validity of this association was demonstrated through overexpression of alternative alleles and RNA interference in cells of varying genotype. Comparison of mammalian CARD8 orthologs and examination of variation among different human populations suggest that the increase in infectious-disease burden associated with larger animal groups (i.e., herds and colonies), and possibly human population expansion, may have naturally selected for loss of CARD8. We also find that the loss-of-function CARD8 allele shows a modest association with an increased risk of systemic inflammatory response syndrome in a small study (p = 0.05). Therefore, a by-product of the selected benefit of loss of CARD8 could be increased inflammatory diseases. These results demonstrate the utility of genome-wide cell-based association screens with microbes in the identification of naturally selected variants that can impact human health.	[Ko, Dennis C.; Shukla, Kajal P.; Fong, Christine; Wasnick, Michael; Brittnacher, Mitchell J.; Miller, Samuel I.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Wurfel, Mark M.; Holden, Tarah D.; Van Yserloo, Brian; Miller, Samuel I.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Akey, Joshua M.; Miller, Samuel I.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Miller, Samuel I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [O'Keefe, Grant E.] Univ Washington, Harborview Med Ctr, Dept Surg, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle	Miller, SI (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	millersi@u.washington.edu	O'KEEFE, GRANT/GON-5797-2022	Akey, Joshua/0000-0002-4411-1330	National Institute of Allergy and Infectious Diseases [U54 A1057141]; UW Bacterial Pathogenesis Training Grant; Wyeth Fellow of the Life Sciences Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057141] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UW Bacterial Pathogenesis Training Grant; Wyeth Fellow of the Life Sciences Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank James Bliska, Jose Fernandez-Luna, and Seamus Martin for kindly providing reagents. This project was funded by an award from the National Institute of Allergy and Infectious Diseases to the Northwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (U54 A1057141). D.C.K was funded by the UW Bacterial Pathogenesis Training Grant and is a Wyeth Fellow of the Life Sciences Research Foundation.	Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; Amigo J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-428; Amrani N, 2006, NAT REV MOL CELL BIO, V7, P415, DOI 10.1038/nrm1942; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Bagnall RD, 2008, EUR J HUM GENET, V16, P619, DOI 10.1038/sj.ejhg.5201996; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Boost KA, 2007, INTENS CARE MED, V33, P863, DOI 10.1007/s00134-007-0588-0; Bouchier-Hayes L, 2001, J BIOL CHEM, V276, P44069, DOI 10.1074/jbc.M107373200; Bresnihan B, 1998, ARTHRITIS RHEUM, V41, P2196, DOI 10.1002/1529-0131(199812)41:12<2196::AID-ART15>3.0.CO;2-2; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Coburn B, 2007, IMMUNOL CELL BIOL, V85, P112, DOI 10.1038/sj.icb.7100007; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Cooke GS, 2001, NAT REV GENET, V2, P967, DOI 10.1038/35103577; Craddock N, 2006, MOL PSYCHIATR, V11, P446, DOI 10.1038/sj.mp.4001808; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Ding KY, 2005, MOL BIOL EVOL, V22, P148, DOI 10.1093/molbev/msh266; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Falconer D. S., 1996, Introduction to quantitative genetics.; Fink SL, 2007, CELL MICROBIOL, V9, P2562, DOI 10.1111/j.1462-5822.2007.01036.x; Fontalba A, 2007, J IMMUNOL, V179, P4867, DOI 10.4049/jimmunol.179.7.4867; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Grabarek Jerzy, 2002, Hum Cell, V15, P1, DOI 10.1111/j.1749-0774.2002.tb00094.x; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hersh D, 1999, P NATL ACAD SCI USA, V96, P2396, DOI 10.1073/pnas.96.5.2396; Hill NJ, 2008, FRONT BIOSCI-LANDMRK, V13, P4838, DOI 10.2741/3043; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Hotchkiss RS, 1999, P NATL ACAD SCI USA, V96, P14541, DOI 10.1073/pnas.96.25.14541; Hotchkiss RS, 2005, CLIN INFECT DIS, V41, pS465, DOI 10.1086/431998; Hothorn T, 2008, J STAT SOFTW, V28, P1; Huang RS, 2007, P NATL ACAD SCI USA, V104, P9758, DOI 10.1073/pnas.0703736104; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Jiang JL, 2007, J NEUROIMMUNOL, V192, P79, DOI 10.1016/j.jneuroim.2007.09.012; JOBLING M, 2004, HUMAN EVOLUTIONARY G, P15253; Kastbom A, 2008, RHEUMATOLOGY, V47, P415, DOI 10.1093/rheumatology/kem372; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Loeuillet C, 2008, PLOS BIOL, V6, P319, DOI 10.1371/journal.pbio.0060032; Losick VP, 2006, J EXP MED, V203, P2177, DOI 10.1084/jem.20060766; Maddison W.P., 2008, EVOLUTION, V62, P1103, DOI DOI 10.1111/J.1558-5646.2008.00349.X; Maki DG, 2009, NEW ENGL J MED, V360, P949, DOI 10.1056/NEJMp0806575; Mathiak G, 2000, BRIT J PHARMACOL, V131, P383, DOI 10.1038/sj.bjp.0703629; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Moffitt KL, 2007, BIOCHEM SOC T, V35, P559, DOI 10.1042/BST0350559; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Park JM, 2005, IMMUNITY, V23, P319, DOI 10.1016/j.immuni.2005.08.010; Pathan N, 2001, J BIOL CHEM, V276, P32220, DOI 10.1074/jbc.M100433200; Prasad AB, 2008, MOL BIOL EVOL, V25, P1795, DOI 10.1093/molbev/msn104; Pujol C, 2003, INFECT IMMUN, V71, P5892, DOI 10.1128/IAI.71.10.5892-5899.2003; Purcell S, 2005, AM J HUM GENET, V76, P249, DOI 10.1086/427886; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quintana-Murci L, 2007, NAT IMMUNOL, V8, P1165, DOI 10.1038/ni1535; Razmara M, 2002, J BIOL CHEM, V277, P13952, DOI 10.1074/jbc.M107811200; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Rosales-Reyes R, 2005, INFECT IMMUN, V73, P3937, DOI 10.1128/IAI.73.7.3937-3944.2005; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Saleh M, 2004, NATURE, V429, P75, DOI 10.1038/nature02451; Sansonetti PJ, 2000, IMMUNITY, V12, P581, DOI 10.1016/S1074-7613(00)80209-5; Sarkar A, 2006, AM J RESP CRIT CARE, V174, P1003, DOI 10.1164/rccm.200604-546OC; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Shalhub S, 2009, J TRAUMA, V66, P115, DOI 10.1097/TA.0b013e3181938d50; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tsuji NM, 2004, INT IMMUNOL, V16, P335, DOI 10.1093/intimm/dxh041; van der Velden AWM, 2003, J IMMUNOL, V171, P6742, DOI 10.4049/jimmunol.171.12.6742; Vincent JL, 2003, INTENS CARE MED, V29, pS74; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wurfel MM, 2008, AM J RESP CRIT CARE, V178, P710, DOI 10.1164/rccm.200803-462OC; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	76	55	59	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 14	2009	85	2					214	227		10.1016/j.ajhg.2009.07.012	http://dx.doi.org/10.1016/j.ajhg.2009.07.012			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488EV	19664744	Green Published, Bronze			2022-12-18	WOS:000269332900010
J	Compton, AG; Albrecht, DE; Seto, JT; Cooper, ST; Ilkovski, B; Jones, KJ; Challis, D; Mowat, D; Ranscht, B; Bahlo, M; Froehner, SC; North, KN				Compton, Alison G.; Albrecht, Douglas E.; Seto, Jane T.; Cooper, Sandra T.; Ilkovski, Biljana; Jones, Kristi J.; Challis, Daniel; Mowat, David; Ranscht, Barbara; Bahlo, Melanie; Froehner, Stanley C.; North, Kathryn N.			Mutations in Contactin-1, a Neural Adhesion and Neuromuscular Junction Protein, Cause a Familial Form of Lethal Congenital Myopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DYSTROPHIN-GLYCOPROTEIN COMPLEX; SKELETAL-MUSCLE; ALPHA-DYSTROBREVIN; MUSCULAR-DYSTROPHIES; MOLECULE CONTACTIN; CELL-SURFACE; SYNTROPHIN ISOFORMS; SODIUM-CHANNELS; EXPRESSION; LOCALIZATION	We have previously reported a group of patients with congenital onset weakness associated with a deficiency of members of the syntrophin-alpha-dystrobrevin subcomplex and have demonstrated that loss of syntrophin and dystrobrevin from the sarcolemma of skeletal muscle can also be associated with denervation. Here, we have further studied four individuals from a consanguineous Egyptian family with a lethal congenital myopathy inherited in an autosomal-recessive fashion and characterized by a secondary loss of beta 2-syntrophin and a-dystrobrevin from the muscle sarcolemma, central nervous system involvement, and fetal akinesia. We performed homozygosity mapping and candidate gene analysis and identified a mutation that segregates with disease within CNTN1, the gene encoding for the neural immunoglobulin family adhesion molecule, contactin-1. Contactin-1 transcripts were markedly decreased on gene-expression arrays of muscle from affected family members compared to controls. We demonstrate that contactin-1 is expressed at the neuromuscular junction (NMJ) in mice and man in addition to the previously documented expression in the central and peripheral nervous system. In patients with secondary dystroglycanopathies, we show that contactin-1 is abnormally localized to the sarcolemma instead of exclusively at the NMJ. The cntn1 null mouse presents with ataxia, progressive muscle weakness, and postnatal lethality, similar to the affected members in this family. We propose that loss of contactin-1 from the NMJ impairs communication or adhesion between nerve and muscle resulting in the severe myopathic phenotype. This disorder is part of the continuum in the clinical spectrum of congenital myopathies and congenital myasthenic syndromes.	[Compton, Alison G.; Seto, Jane T.; Cooper, Sandra T.; Ilkovski, Biljana; Jones, Kristi J.; North, Kathryn N.] Childrens Hosp Westmead, Inst Neuromuscular Res, Sydney, NSW 2145, Australia; [Albrecht, Douglas E.; Froehner, Stanley C.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Seto, Jane T.; Cooper, Sandra T.; North, Kathryn N.] Univ Sydney, Fac Med, Discipline Pediat & Child Hlth, Sydney, NSW 2006, Australia; [Challis, Daniel; Mowat, David] Univ New S Wales, Sch Womens & Childrens Hlth, Dept Pediat, Sydney, NSW 2052, Australia; [Challis, Daniel] Royal Hosp Women, Div Obstet & Maternal Fetal Med, Randwick, NSW 2031, Australia; [Mowat, David] Royal Hosp Women, Dept Med Genet, Randwick, NSW 2031, Australia; [Ranscht, Barbara] Burnham Inst Med Res, La Jolla, CA 92037 USA; [Bahlo, Melanie] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia	University of Sydney; University of Washington; University of Washington Seattle; University of Sydney; University of New South Wales Sydney; Sanford Burnham Prebys Medical Discovery Institute; Walter & Eliza Hall Institute	North, KN (corresponding author), Childrens Hosp Westmead, Inst Neuromuscular Res, Sydney, NSW 2145, Australia.	kathryn@chw.edu.au	Seto, Jane/AAN-4581-2021; North, Kathryn N/K-6476-2012	North, Kathryn N/0000-0003-0841-8009; Cooper, Sandra/0000-0002-7314-5097; Seto, Jane/0000-0003-2864-6199; Bahlo, Melanie/0000-0001-5132-0774; Compton, Alison/0000-0002-2725-7055	Muscular Dystrophy Association of USA; NHMRC; NIH [PO1 NS046788, NS038297]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS046788, R01NS038297] Funding Source: NIH RePORTER	Muscular Dystrophy Association of USA(Muscular Dystrophy Association); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the Muscular Dystrophy Association of USA (S.C.F. and K.N.N.) and the NHMRC (K.N.N.) and the NIH (PO1 NS046788 to S.C.F. and NS038297 to B.R.). M.B. is supported by an NHMRC Career Development Award. We thank Dr. Alex Kan, Department of Anatomical Pathology, The Children's Hospital at Westmead, for interpretation of muscle electron microscopy. We acknowledge and thank Joanna Raftery, Dr. Nan Yang, and Dr. Daniel MacArthur for input into prioritization and sequence analysis of candidate disease genes and Vivienne Tobias, Department of Anatomical Pathology, South Eastern Area Laboratory Services, Sydney for initial muscle histology and sample handling collection (V:2, V:3, and V:4).	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Adams ME, 2000, J CELL BIOL, V150, P1385, DOI 10.1083/jcb.150.6.1385; Adams ME, 2004, J NEUROSCI, V24, P10302, DOI 10.1523/JNEUROSCI.3408-04.2004; Akaaboune M, 2002, NEURON, V34, P865, DOI 10.1016/S0896-6273(02)00739-0; BERGLUND EO, 1994, GENOMICS, V21, P571, DOI 10.1006/geno.1994.1316; Berglund EO, 1999, NEURON, V24, P739, DOI 10.1016/S0896-6273(00)81126-5; Boyle MET, 2001, NEURON, V30, P385, DOI 10.1016/S0896-6273(01)00296-3; BRUMMENDORF T, 1993, NEURON, V10, P711; BURGESS DL, 1995, NAT GENET, V10, P461, DOI 10.1038/ng0895-461; Burkin DJ, 1999, CELL TISSUE RES, V296, P183, DOI 10.1007/s004410051279; Cifuentes-Diaz C, 2002, J NEUROSCI RES, V67, P93; Compton AG, 2005, J NEUROPATH EXP NEUR, V64, P350, DOI 10.1093/jnen/64.4.350; Cooper ST, 2003, NEUROLOGY, V61, P93, DOI 10.1212/01.WNL.0000069460.53438.38; DANILOFF JK, 1986, J CELL BIOL, V103, P929, DOI 10.1083/jcb.103.3.929; De Repentigny Y, 2001, HUM MOL GENET, V10, P1819, DOI 10.1093/hmg/10.17.1819; Ervasti JM, 2008, INT REV CYTOL, V265, P191, DOI 10.1016/S0074-7696(07)65005-0; ERVASTI JM, 1991, J BIOL CHEM, V266, P9161; Faivre-Sarrailh C, 2004, DEVELOPMENT, V131, P4931, DOI 10.1242/dev.01372; FAIVRESARRAILH C, 1992, J NEUROSCI, V12, P257; Falk J, 2002, BIOL CELL, V94, P327, DOI 10.1016/S0248-4900(02)00006-0; Fujita N, 2000, DEV BIOL, V221, P308, DOI 10.1006/dbio.2000.9692; Gee SH, 1998, J NEUROSCI, V18, P128; Grady RM, 2006, J NEUROSCI, V26, P2841, DOI 10.1523/JNEUROSCI.4823-05.2006; Grady RM, 2000, NEURON, V25, P279, DOI 10.1016/S0896-6273(00)80894-6; Grady RM, 2003, J CELL BIOL, V160, P741, DOI 10.1083/jcb.200209045; Grady RM, 1999, NAT CELL BIOL, V1, P215, DOI 10.1038/12034; Jones KJ, 2003, NEUROMUSCULAR DISORD, V13, P456, DOI 10.1016/S0960-8966(03)00066-X; Kameya S, 1999, J BIOL CHEM, V274, P2193, DOI 10.1074/jbc.274.4.2193; Kazarinova-Noyes K, 2001, J NEUROSCI, V21, P7517, DOI 10.1523/JNEUROSCI.21-19-07517.2001; Kramarcy NR, 2000, MOL CELL NEUROSCI, V15, P262, DOI 10.1006/mcne.1999.0823; Leschziner A, 2000, J NEUROCHEM, V74, P70, DOI 10.1046/j.1471-4159.2000.0740070.x; Liu CJ, 2001, J BIOL CHEM, V276, P46553, DOI 10.1074/jbc.M108699200; McEwen DP, 2004, J BIOL CHEM, V279, P16044, DOI 10.1074/jbc.M400856200; Mercado ML, 2006, FASEB J, V20, P1724, DOI 10.1096/fj.05-5124fje; Michalk A, 2008, AM J HUM GENET, V82, P464, DOI 10.1016/j.ajhg.2007.11.006; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Murai KK, 2002, CURR BIOL, V12, P181, DOI 10.1016/S0960-9822(02)00680-2; North K, 2008, NEUROMUSCULAR DISORD, V18, P433, DOI 10.1016/j.nmd.2008.04.002; Peat RA, 2008, NEUROLOGY, V71, P312, DOI 10.1212/01.wnl.0000284605.27654.5a; Peat RA, 2008, NEUROMUSCULAR DISORD, V18, P606, DOI 10.1016/j.nmd.2008.05.013; Pegoraro E, 2002, AM J PATHOL, V160, P2135, DOI 10.1016/S0002-9440(10)61162-5; Perrin FE, 2001, NEURON, V30, P707, DOI 10.1016/S0896-6273(01)00315-4; Peters MF, 1998, J CELL BIOL, V142, P1269, DOI 10.1083/jcb.142.5.1269; PETERS MF, 1994, NEUROREPORT, V5, P1577, DOI 10.1097/00001756-199408150-00009; Peters MF, 1997, J CELL BIOL, V138, P81, DOI 10.1083/jcb.138.1.81; RANSCHT B, 1988, J CELL BIOL, V107, P1561, DOI 10.1083/jcb.107.4.1561; REID RA, 1994, MOL BRAIN RES, V21, P1, DOI 10.1016/0169-328X(94)90372-7; Rush AM, 2005, EUR J NEUROSCI, V22, P39, DOI 10.1111/j.1460-9568.2005.04186.x; Schneider M, 2006, DEVELOPMENT, V133, P3805, DOI 10.1242/dev.02549; Shah BS, 2004, J NEUROSCI, V24, P7387, DOI 10.1523/JNEUROSCI.0322-04.2004; SONG WK, 1993, J CELL SCI, V106, P1139; Taniguchi M, 2006, HUM MOL GENET, V15, P1279, DOI 10.1093/hmg/ddl045; Vogt J, 2008, AM J HUM GENET, V82, P222, DOI 10.1016/j.ajhg.2007.09.016; Zatz M, 2003, NEUROMUSCULAR DISORD, V13, P532, DOI 10.1016/S0960-8966(03)00100-7; ZISCH AH, 1992, J CELL BIOL, V119, P203, DOI 10.1083/jcb.119.1.203	55	55	57	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 12	2008	83	6					714	724		10.1016/j.ajhg.2008.10.022	http://dx.doi.org/10.1016/j.ajhg.2008.10.022			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	385NY	19026398	Green Published, Bronze			2022-12-18	WOS:000261822100006
J	Wonnapinij, P; Chinnery, PF; Samuels, DC				Wonnapinij, Passorn; Chinnery, Patrick F.; Samuels, David C.			The Distribution of Mitochondrial DNA Heteroplasmy Due to Random Genetic Drift	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY OPTIC NEUROPATHY; PRENATAL-DIAGNOSIS; RAPID SEGREGATION; MTDNA DISEASE; MUTATION; INHERITANCE; POPULATION; SELECTION; TRANSMISSION; EXPRESSION	Cells containing pathogenic mutations in mitochondrial DNA (mtDNA) generally also contain the wild-type mtDNA, a condition called heteroplasmy. The amount of mutant mtDNA in a cell, called the heteroplasmy level, is an important factor in determining the amount of mitochondrial dysfunction and therefore the disease severity. mtDNA is inherited maternally, and there are large random shifts in heteroplasmy level between mother and offspring. Understanding the distribution in heteroplasmy levels across a group of off-spring is an important step in understanding the inheritance of diseases caused by mtDNA mutations. Previously, our understanding of the heteroplasmy distribution has been limited to just the mean and variance of the distribution. Here we give equations, adapted from the work of Kimura on random genetic drift, for the full mtDNA heteroplasmy distribution. We describe how to use the Kimura distribution in mitochondrial genetics, and we test the Kimura distribution against human, mouse, and Drosophila data sets.	[Wonnapinij, Passorn; Samuels, David C.] Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Chinnery, Patrick F.] Univ Newcastle, Sch Med, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Chinnery, Patrick F.] Univ Newcastle, Sch Med, Inst Human Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Virginia Polytechnic Institute & State University; Newcastle University - UK; Newcastle University - UK	Samuels, DC (corresponding author), Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA.	dsamuels@vbi.vt.edu	Samuels, David/AHC-8381-2022; Samuels, David C/A-5393-2008; Samuels, David/C-1365-2012	Samuels, David/0000-0003-3529-7791; Samuels, David C/0000-0003-3529-7791; Chinnery, Patrick/0000-0002-7065-6617	Thailand's Commission on Higher Education; Royal Thai Government; Welcome Trust	Thailand's Commission on Higher Education(Office of Higher Education Commission (OHEC)); Royal Thai Government; Welcome Trust(Wellcome Trust)	P.W. is supported by Thailand's Commission on Higher Education, Royal Thai Government under the program "Strategic Scholarship for Frontier Research Network." P.F.C. is a Welcome Trust Senior Clinical Research Fellow.	Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; Brown DT, 2006, LANCET, V368, P87, DOI 10.1016/S0140-6736(06)68972-1; Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190; Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311; Chinnery PF, 2001, AM J MED GENET, V98, P235, DOI 10.1002/1096-8628(20010122)98:3<235::AID-AJMG1086>3.0.CO;2-O; Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X; Chinnery PF, 1998, AM J HUM GENET, V63, P1908, DOI 10.1086/302157; Coller HA, 2005, MUTAT RES-FUND MOL M, V578, P256, DOI 10.1016/j.mrfmmm.2005.05.014; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; DESTORDEUR E, 1989, MOL GEN GENET, V220, P127, DOI 10.1007/BF00260866; Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; Hoang-Binh D, 2005, COMPUT PHYS COMMUN, V166, P191, DOI 10.1016/j.cpc.2004.11.005; HOLT IJ, 1990, AM J HUM GENET, V46, P428; HOWELL N, 1991, AM J HUM GENET, V49, P939; Iizuka M, 2001, THEOR POPUL BIOL, V59, P281, DOI 10.1006/tpbi.2001.1521; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; JOHNSON AM, 1992, INT CLIN PSYCHOPHARM, V6, P15, DOI 10.1097/00004850-199206004-00005; KIMURA M, 1955, P NATL ACAD SCI USA, V41, P144, DOI 10.1073/pnas.41.3.144; LARSSON NG, 1992, AM J HUM GENET, V51, P1201; MARUYAMA T, 1980, P NATL ACAD SCI-BIOL, V77, P6710, DOI 10.1073/pnas.77.11.6710; Poulton J, 1998, AM J HUM GENET, V62, P752, DOI 10.1086/301811; Poulton J, 2002, REPRODUCTION, V123, P751, DOI 10.1530/rep.0.1230751; Press W. H., 2007, NUMERICAL RECIPES C, V3rd; Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007; Sekiguchi K, 2003, MITOCHONDRION, V2, P401, DOI 10.1016/S1567-7249(03)00028-X; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; SOLIGNAC M, 1984, MOL GEN GENET, V197, P183, DOI 10.1007/BF00330961; Thorburn DR, 2001, AM J MED GENET, V106, P102, DOI 10.1002/ajmg.1380; Uziel G, 1997, J NEUROL NEUROSUR PS, V63, P16, DOI 10.1136/jnnp.63.1.16; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Wright S., 1942, Bull Amer Math Soc, V48, P223, DOI 10.1090/S0002-9904-1942-07641-5	33	55	60	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV 7	2008	83	5					582	593		10.1016/j.ajhg.2008.10.007	http://dx.doi.org/10.1016/j.ajhg.2008.10.007			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	373XN	18976726	Green Published, Bronze			2022-12-18	WOS:000261006900004
J	Cheung, VG; Burdick, JT; Hirschmann, D; Morley, M				Cheung, Vivian G.; Burdick, Joshua T.; Hirschmann, Deborah; Morley, Michael			Polymorphic variation in human meiotic recombination	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; HUMAN GENOME; LINKAGE MAP; HUMAN MALES; CROSSOVER; HOTSPOTS; OOCYTES; MLH1; SEX	In this study, our phenotype of interest is meiotic recombination. Using genotypes of similar to 6,000 SNP markers in members of the Centre d'Etude du Polymorphisme Humain Utah pedigrees, we found extensive individual variation in the number of female and male recombination events. The locations and frequencies of these recombination events vary along the genome. In both female and male meiosis, the regions with the most recombination events are found at the ends of the chromosomes. Our analysis also shows that there are polymorphic differences among individuals in the activity of the recombination "jungles"; these preferred sites of meiotic recombination differ greatly among individuals. These findings have important implications for understanding genetic disorders that result from improper chromosome segregation.	Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Vet Med Program, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Cheung, VG (corresponding author), Univ Penn, Dept Pediat, 3516 Civ Ctr Blvd,ARC 516G, Philadelphia, PA 19104 USA.	vcheung@mail.med.upenn.edu	Cheung, Vivian G./AAT-3115-2020	Morley, Michael/0000-0002-0958-7376	NHGRI NIH HHS [R01-HG01880, R01 HG001880-09S1, R01 HG001880] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001880] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; CUI XF, 1989, P NATL ACAD SCI USA, V86, P9389, DOI 10.1073/pnas.86.23.9389; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; Jeffreys AJ, 2005, HUM MOL GENET, V14, P2277, DOI 10.1093/hmg/ddi232; Jeffreys AJ, 2000, HUM MOL GENET, V9, P725, DOI 10.1093/hmg/9.5.725; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Jeffreys AJ, 1998, MOL CELL, V2, P267, DOI 10.1016/S1097-2765(00)80138-0; Kelmenson PM, 2005, GENETICS, V169, P833, DOI 10.1534/genetics.104.035063; Koehler KE, 1996, NAT GENET, V14, P406, DOI 10.1038/ng1296-406; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2004, NAT GENET, V36, P1203, DOI 10.1038/ng1445; Lamb NE, 2005, CYTOGENET GENOME RES, V111, P250, DOI 10.1159/000086896; Lynn A, 2004, ANNU REV GENOM HUM G, V5, P317, DOI 10.1146/annurev.genom.4.070802.110217; Lynn A, 2002, SCIENCE, V296, P2222, DOI 10.1126/science.1071220; Matise TC, 2003, AM J HUM GENET, V73, P271, DOI 10.1086/377137; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Neumann R, 2006, HUM MOL GENET, V15, P1401, DOI 10.1093/hmg/ddl063; SEARS DD, 1995, GENETICS, V139, P1159; STEINMETZ M, 1986, CELL, V44, P895, DOI 10.1016/0092-8674(86)90012-7; Sun F, 2006, HUM MOL GENET, V15, P2376, DOI 10.1093/hmg/ddl162; TANZI RE, 1992, AM J HUM GENET, V50, P551; Tease C, 2002, AM J HUM GENET, V70, P1469, DOI 10.1086/340734; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185; Yu J, 1996, AM J HUM GENET, V59, P1186	25	55	58	0	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2007	80	3					526	530		10.1086/512131	http://dx.doi.org/10.1086/512131			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	139AB	17273974	Green Published, Bronze			2022-12-18	WOS:000244403300014
J	Schaid, DJ; Batzler, AJ; Jenkins, GD; Hildebrandt, MAT				Schaid, Daniel J.; Batzler, Anthony J.; Jenkins, Gregory D.; Hildebrandt, Michelle A. T.			Exact tests of Hardy-Weinberg equilibrium and homogeneity of disequilibrium across strata	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME; LAW; POPULATIONS; ASSOCIATION; PATTERNS; MAP	Detecting departures from Hardy-Weinberg equilibrium (HWE) of marker-genotype frequencies is a crucial first step in almost all human genetic analyses. When a sample is stratified by multiple ethnic groups, it is important to allow the marker-allele frequencies to differ over the strata. In this situation, it is common to test for HWE by using an exact test within each stratum and then using the minimum P value as a global test. This approach does not account for multiple testing, and, because it does not combine information over strata, it does not have optimal power. Several approximate methods to combine information over strata have been proposed, but most of them sum over strata a measure of departure from HWE; if the departures are in different directions, then summing can diminish the overall evidence of departure from HWE. An exact stratified test is more appealing because it uses the probability of genotype configurations across the strata as evidence for global departures from HWE. We developed an exact stratified test for HWE for diallelic markers, such as single-nucleotide polymorphisms (SNPs), and an exact test for homogeneity of Hardy-Weinberg disequilibrium. By applying our methods to data from Perlegen and HapMap - a combined total of more than five million SNP genotypes, with three to four strata and strata sizes ranging from 23 to 60 subjects - we illustrate that the exact stratified test provides more-robust and more-powerful results than those obtained by either the minimum of exact test P values over strata or approximate stratified tests that sum measures of departure from HWE. Hence, our new methods should be useful for samples composed of multiple ethnic groups.	Mayo Clin, Coll Med, Biostat Sect, Div Biostat, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Div Clin Pharmacol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Schaid, DJ (corresponding author), Mayo Clin, Coll Med, Biostat Sect, Div Biostat, Harwick 775,200 1st St SW, Rochester, MN 55905 USA.	schaid@mayo.edu			NIGMS NIH HHS [GM61388, GM065450, U19 GM061388, R01 GM065450, U01 GM061388] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065450, U01GM061388, U19GM061388] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; HALDANE JBS, 1954, J GENET, V52, P631, DOI 10.1007/BF02985085; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; MANTEL N, 1959, J NATL CANCER I, V22, P719; McPeek MS, 1999, GENET EPIDEMIOL, V16, P225, DOI 10.1002/(SICI)1098-2272(1999)16:3<225::AID-GEPI1>3.0.CO;2-#; Nam JM, 1997, ANN HUM GENET, V61, P163, DOI 10.1017/S0003480097006052; Olson JM, 1996, BIOMETRICS, V52, P971, DOI 10.2307/2533058; OLSON JM, 1993, ANN HUM GENET, V57, P291, DOI 10.1111/j.1469-1809.1993.tb00903.x; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; SMITH CAB, 1970, ANN HUM GENET, V33, P377, DOI 10.1111/j.1469-1809.1970.tb01664.x; TROENDLE JF, 1994, ANN HUM GENET, V58, P397, DOI 10.1111/j.1469-1809.1994.tb00735.x; Weir B., 1996, GENETIC DATA ANAL; Weir BS, 2004, GENET EPIDEMIOL, V27, P442, DOI 10.1002/gepi.20038; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864	14	55	56	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2006	79	6					1071	1080		10.1086/510257	http://dx.doi.org/10.1086/510257			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106WB	17186465	Green Published, Bronze			2022-12-18	WOS:000242131600008
J	Meng, Y; Baldwin, CT; Bowirrat, A; Waraska, K; Inzelberg, R; Friedland, RP; Farrer, LA				Meng, Y; Baldwin, CT; Bowirrat, A; Waraska, K; Inzelberg, R; Friedland, RP; Farrer, LA			Association of Polymorphisms in the angiotensin-converting enzyme gene with Alzheimer disease in an Israeli Arab community	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INSERTION-DELETION POLYMORPHISM; APOLIPOPROTEIN-E GENOTYPE; AMYLOID BETA-PEPTIDE; ACE GENE; MYOCARDIAL-INFARCTION; CLINICAL-DIAGNOSIS; VASCULAR DEMENTIA; RISK-FACTORS; METAANALYSIS; POPULATION	Several lines of evidence support for a role of angiotensin converting enzyme (ACE) in Alzheimer disease (AD). Most genetic studies have focused on an Alu insertion/deletion (I/D) polymorphism in the ACE gene (DCP1) and have yielded conflicting results. We evaluated the association between 15 single-nucleotide polymorphisms (SNPs) in DCP1, including the I/D variant, and AD in a sample of 92 patients with AD and 166 nondemented controls from an inbred Israeli Arab community. Although there was no evidence for association between AD and I/D, we observed significant association with SNPs rs4343 (P = .00001) and rs4351 (P = .01). Haplotype analysis revealed remarkably significant evidence of association with the SNP combination rs4343 and rs4351 (global P = 7.5 x 10(-7)). Individuals possessing the haplotype "GA" (frequency 0.21 in cases and 0.01 in controls) derived from these 10 SNPs had a 45-fold increased risk of developing AD (95% CI 6.0-343.2) compared with those possessing any of the other three haplotypes. Longer range haplotypes including I/D were even more significant (lowest global P = 1.1 x 10(-12)), but the only consistently associated alleles were in rs4343 and rs4351. These results suggest that a variant in close proximity to rs4343 and rs4351 modulates susceptibility to AD in this community.	Boston Univ, Sch Med, Genet Program L320, Dept Med, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Genet & Genom, Boston, MA 02118 USA; Boston Univ, Sch Med, Ctr Human Genet, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; Hillel Yaffe Med Ctr, Dept Neurol, Hadera, Israel; Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel; Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA	Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Case Western Reserve University	Farrer, LA (corresponding author), Boston Univ, Sch Med, Genet Program L320, Dept Med, 715 Albany St, Boston, MA 02118 USA.	farrer@bu.edu	Bowirrat, Abdalla/AAT-8980-2021; Friedland, Robert/A-2834-2010; Inzelberg, Rivka/E-5861-2010; Farrer, Lindsay/AAS-1035-2020	Bowirrat, Abdalla/0000-0001-8185-0688; Friedland, Robert/0000-0001-5721-1843; Inzelberg, Rivka/0000-0002-0720-0502; Baldwin, Clinton/0000-0002-3275-9463; Farrer, Lindsay/0000-0001-5533-4225	NATIONAL INSTITUTE ON AGING [P30AG013846, U01AG017173, R01AG009029] Funding Source: NIH RePORTER; NIA NIH HHS [P30 AG013846, R01 AG009029, U01 AG017173, P30-AG13846, U01-AG17173, R01-AG09029] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bowirrat A, 2000, NEUROLOGY, V55, P731, DOI 10.1212/WNL.55.5.731; Bowirrat A, 2001, EUR J NEUROL, V8, P119, DOI 10.1046/j.1468-1331.2001.00183.x; Bowirrat Abdalla, 2005, Neuropsychiatr Dis Treat, V1, P73, DOI 10.2147/nedt.1.1.73.52302; Cox R, 2002, HUM MOL GENET, V11, P2969, DOI 10.1093/hmg/11.23.2969; Das UN, 2005, MED SCI MONITOR, V11, pRA155; Elkins JS, 2004, NEUROLOGY, V62, P363, DOI 10.1212/01.WNL.0000106823.72493.FF; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Farrer LA, 2003, HUM MOL GENET, V12, P415, DOI 10.1093/hmg/ddg037; Galasko D, 1998, ARCH NEUROL-CHICAGO, V55, P937, DOI 10.1001/archneur.55.7.937; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gorelick PB, 2004, STROKE, V35, P2620, DOI 10.1161/01.STR.0000143318.70292.47; Hemming ML, 2005, J BIOL CHEM, V280, P37644, DOI 10.1074/jbc.M508460200; Hu JG, 2001, J BIOL CHEM, V276, P47863, DOI 10.1074/jbc.M104068200; Jeffreys AJ, 2005, NAT GENET, V37, P601, DOI 10.1038/ng1565; Keavney B, 2000, LANCET, V355, P434; Kehoe PG, 2004, HUM GENET, V114, P478, DOI 10.1007/s00439-004-1093-y; Kehoe PG, 2003, HUM MOL GENET, V12, P859, DOI 10.1093/hmg/ddg094; Kivipelto M, 2001, BMJ-BRIT MED J, V322, P1447, DOI 10.1136/bmj.322.7300.1447; Kolsch H, 2005, NEUROSCI LETT, V377, P37, DOI 10.1016/j.neulet.2004.11.062; Lehmann DJ, 2005, AM J EPIDEMIOL, V162, P305, DOI 10.1093/aje/kwi202; Lei HX, 2005, NUCLEIC ACIDS RES, V33, P3897, DOI 10.1093/nar/gki707; Manelli AM, 2004, J MOL NEUROSCI, V23, P235, DOI 10.1385/JMN:23:3:235; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Narain Y, 2000, J MED GENET, V37, P695, DOI 10.1136/jmg.37.9.695; Newman DL, 2001, AM J HUM GENET, V69, P1146, DOI 10.1086/323659; Oba R, 2005, EUR J NEUROSCI, V21, P733, DOI 10.1111/j.1460-9568.2005.03912.x; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Rozemuller AJM, 2005, CNS NEUROL DISORD-DR, V4, P223, DOI 10.2174/1568007054038229; Samani NJ, 1996, CIRCULATION, V94, P708, DOI 10.1161/01.CIR.94.4.708; Sayed-Tabatabaei FA, 2003, STROKE, V34, P1634, DOI 10.1161/01.STR.0000077926.49330.64; Scacchi R, 2001, NEUROBIOL AGING, V22, P413, DOI 10.1016/S0197-4580(00)00246-3; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Sharma P, 1998, J NEUROL NEUROSUR PS, V64, P227, DOI 10.1136/jnnp.64.2.227; Sjogren M, 2005, WORLD J BIOL PSYCHIA, V6, P85, DOI 10.1080/15622970510029795; Skoog I, 1996, LANCET, V347, P1141, DOI 10.1016/S0140-6736(96)90608-X; Sleegers K, 2005, NEUROBIOL AGING, V26, P1153, DOI 10.1016/j.neurobiolaging.2004.09.011; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Staessen JA, 1997, J HYPERTENS, V15, P1579, DOI 10.1097/00004872-199715120-00059; TIRET L, 1992, AM J HUM GENET, V51, P197	42	55	57	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2006	78	5					871	877		10.1086/503687	http://dx.doi.org/10.1086/503687			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032EH	16642441	Green Published, Bronze			2022-12-18	WOS:000236756200012
J	Hennies, HC; Rauch, A; Seifert, W; Schumi, C; Moser, E; Al-Taji, E; Tariverdian, G; Chrzanowska, KH; Krajewska-Walasek, M; Rajab, A; Giugliani, R; Neumann, TE; Eckl, KM; Karbasiyan, M; Reis, A; Horn, D				Hennies, HC; Rauch, A; Seifert, W; Schumi, C; Moser, E; Al-Taji, E; Tariverdian, G; Chrzanowska, KH; Krajewska-Walasek, M; Rajab, A; Giugliani, R; Neumann, TE; Eckl, KM; Karbasiyan, M; Reis, A; Horn, D			Allelic heterogeneity in the COH1 gene explains clinical variability in Cohen syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HOLMES-WALTON SYNDROME; MENTAL-RETARDATION; NATURAL-HISTORY; PROTEIN; DATABASE; LOCALIZATION; DEGENERATION; FEATURES; KEX2P	Cohen syndrome is a rare autosomal recessive disorder with a variable clinical picture mainly characterized by developmental delay, mental retardation, microcephaly, typical facial dysmorphism, progressive pigmentary retinopathy, severe myopia, and intermittent neutropenia. A Cohen syndrome locus was mapped to chromosome 8q22 in Finnish patients, and, recently, mutations in the gene COH1 were reported in patients with Cohen syndrome from Finland and other parts of northern and western Europe. Here, we describe clinical and molecular findings in 20 patients with Cohen syndrome from 12 families, originating from Brazil, Germany, Lebanon, Oman, Poland, and Turkey. All patients were homozygous or compound heterozygous for mutations in COH1. We identified a total of 17 novel mutations, mostly resulting in premature termination codons. The clinical presentation was highly variable. Developmental delay of varying degree, early-onset myopia, joint laxity, and facial dysmorphism were the only features present in all patients; however, retinopathy at school age, microcephaly, and neutropenia are not requisite symptoms of Cohen syndrome. The identification of novel mutations in COH1 in an ethnically diverse group of patients demonstrates extensive allelic heterogeneity and explains the intriguing clinical variability in Cohen syndrome.	Univ Med Berlin, Charite, Inst Med Genet, D-13353 Berlin, Germany; Max Delbruck Ctr Mol Med, Gene Mapping Ctr, Berlin, Germany; Max Delbruck Ctr Mol Med, Dept Mol Genet, Berlin, Germany; Univ Med Berlin, Charite, Inst Human Genet, D-13353 Berlin, Germany; Univ Erlangen Nurnberg, Inst Human Genet, D-8520 Erlangen, Germany; Univ Hosp Vienna, Dept Ophthalmol, Vienna, Austria; Univ Hosp Vienna, Dept Paediat, Vienna, Austria; Heidelberg Univ, Inst Human Genet, Heidelberg, Germany; Childrens Mem Hlth Inst, Dept Med Genet, Warsaw, Poland; Minist Hlth, DGHA, Genet Unit, Muscat, Oman; Hosp Clin Porto Alegre, Med Genet Serv, Porto Alegre, RS, Brazil; Univ Munster, Inst Human Genet, D-4400 Munster, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Erlangen Nuremberg; University Hospital Vienna; University Hospital Vienna; Ruprecht Karls University Heidelberg; Children's Memorial Health Institute; University of Munster	Horn, D (corresponding author), Univ Med Berlin, Charite, Inst Med Genet, Augustenburger Pl 1, D-13353 Berlin, Germany.	denise.horn@charite.de	Giugliani, Roberto/G-4790-2015; Reis, André/D-2309-2009; Seifert, Wenke/B-8772-2011; Rauch, Anita/C-5568-2014; Hennies, Hans C/G-9424-2014; Eckl, Katja/C-3581-2014	Giugliani, Roberto/0000-0001-9655-3686; Reis, André/0000-0002-6301-6363; Rauch, Anita/0000-0003-2930-3163; Hennies, Hans C/0000-0001-7210-2389; Eckl, Katja/0000-0001-8838-3998; Seifert, Wenke/0000-0003-1432-9862; Krajewska-Walasek, Malgorzata/0000-0001-8721-210X; Chrzanowska, Krystyna/0000-0003-3888-0624				ALIMIRHO.S, 1972, J MED GENET, V9, P193, DOI 10.1136/jmg.9.2.193; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Brickner JH, 1997, J CELL BIOL, V139, P23, DOI 10.1083/jcb.139.1.23; Chandler KE, 2003, J MED GENET, V40, P233, DOI 10.1136/jmg.40.4.233; COHEN MM, 1973, J PEDIATR-US, V83, P280; Corpet F, 2000, NUCLEIC ACIDS RES, V28, P267, DOI 10.1093/nar/28.1.267; Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235; Horn D, 2000, AM J MED GENET, V92, P285, DOI 10.1002/(SICI)1096-8628(20000605)92:4<285::AID-AJMG13>3.3.CO;2-4; Kivitie-Kallio S, 1999, CLIN GENET, V56, P41, DOI 10.1034/j.1399-0004.1999.560106.x; Kivitie-Kallio S, 2001, AM J MED GENET, V102, P125, DOI 10.1002/1096-8628(20010801)102:2<125::AID-AJMG1439>3.0.CO;2-0; Kolehmainen J, 1997, EUR J HUM GENET, V5, P206, DOI 10.1159/000484765; Kolehmainen J, 2003, AM J HUM GENET, V72, P1359, DOI 10.1086/375454; MENDEZ HMM, 1985, AM J MED GENET, V22, P223, DOI 10.1002/ajmg.1320220202; NORIO R, 1984, CLIN GENET, V25, P1; NORIO R, 1986, AM J MED GENET, V25, P397, DOI 10.1002/ajmg.1320250227; Redding K, 1996, MOL CELL BIOL, V16, P6208; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; STEINLEIN O, 1991, AM J MED GENET, V41, P196, DOI 10.1002/ajmg.1320410213; TAHVANAINEN E, 1994, NAT GENET, V7, P201, DOI 10.1038/ng0694-201	20	55	56	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2004	75	1					138	145		10.1086/422219	http://dx.doi.org/10.1086/422219			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	829FG	15154116	Bronze, Green Accepted, Green Published			2022-12-18	WOS:000222031300017
J	Buttin, BM; Powell, MA; Mutch, DG; Babb, SA; Huettner, PC; Edmonston, TB; Herzog, TJ; Rader, JS; Gibb, RK; Whelan, AJ; Goodfellow, PJ				Buttin, BM; Powell, MA; Mutch, DG; Babb, SA; Huettner, PC; Edmonston, TB; Herzog, TJ; Rader, JS; Gibb, RK; Whelan, AJ; Goodfellow, PJ			Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; MLH1 PROMOTER METHYLATION; DNA MISMATCH REPAIR; MICROSATELLITE INSTABILITY; ENDOMETRIAL CARCINOMA; COLON-CANCER; GENE; ASSOCIATION; TUMORS; HMSH6	Hereditary nonpolyposis colorectal cancer (HNPCC) is caused by inherited mutations in DNA mismatch-repair genes, most commonly MLH1 or MSH2. The role MSH6 plays in inherited cancer susceptibility is less well defined. The aim of this study was to investigate the penetrance and expressivity of MSH6 mutations in kindreds ascertained through endometrial cancer probands unselected for family history. Detailed pedigrees were constructed for six MSH6 mutation carriers. All reported cancers and precancers were confirmed, and tissues were obtained when available. Tumors were analyzed for microsatellite instability (MSI) and for expression of MSH2, MLH1, and MSH6. MSH6 mutation status was determined for 59 family members. Of these 59 individuals, 19 (32%) had confirmed cancers and precancers. There was an excess of mutation carriers among the 19 affected family members (11[58%] of 19) compared with those among the 40 unaffecteds (8[20%] of 40 P = .0065, odds ratio = 5.5, 95% CI = 1.66-18.19). In four of the seven tumors analyzed from mutation carriers other than the probands, MSI and/or MMR protein expression was consistent with the involvement of MSH6. Overall estimated penetrance of the MHS6 mutations was 57.7%. Of the tumors in mutation carriers, 78% were part of the extended HNPCC spectrum. This study demonstrates that MSH6 germline mutations are, indeed, associated with increased cancer risk and that the penetrance of mutations may be higher than appreciated elsewhere. A combination of MSI and immunohistochemistry analyses may be helpful in screening for MSH6 mutation carriers.	Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Obstet & Gynecol, Div Gynecol Oncol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; Thomas Jefferson Univ, Dept Pathol, Philadelphia, PA 19107 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Jefferson University	Goodfellow, PJ (corresponding author), Washington Univ, Sch Med, Dept Surg, Campus Box 8109,660 S Euclid Ave, St Louis, MO 63110 USA.	goodfellowp@msnotes.wustl.edu			NATIONAL CANCER INSTITUTE [P30CA091842, R01CA071754] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA91842, R01-CA71754, P30 CA091842, R01 CA071754] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Berends MJW, 2002, AM J HUM GENET, V70, P26, DOI 10.1086/337944; Boland CR, 1998, CANCER RES, V58, P5248; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; Buttin BA, 2004, CLIN CANCER RES, V10, P481, DOI 10.1158/1078-0432.CCR-1110-03; de Leeuw WJF, 2000, J PATHOL, V192, P328, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH701>3.0.CO;2-2; Desai DC, 2000, J MED GENET, V37, P646, DOI 10.1136/jmg.37.9.646; Edelmann W, 1997, CELL, V91, P467, DOI 10.1016/S0092-8674(00)80433-X; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Fujiwara T, 1998, AM J PATHOL, V153, P1063, DOI 10.1016/S0002-9440(10)65651-9; Goodfellow PJ, 2003, P NATL ACAD SCI USA, V100, P5908, DOI 10.1073/pnas.1030231100; Kariola R, 2002, HUM MOL GENET, V11, P1303, DOI 10.1093/hmg/11.11.1303; Kolodner RD, 1999, CANCER RES, V59, P5068; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; Miyaki M, 1997, NAT GENET, V17, P271, DOI 10.1038/ng1197-271; RISINGER JI, 1993, CANCER RES, V53, P5100; Shin KH, 1999, J HUM GENET, V44, P18, DOI 10.1007/s100380050099; Soravia C, 2003, AM J MED GENET A, V121A, P159, DOI 10.1002/ajmg.a.20106; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; Wagner A, 2001, J MED GENET, V38, P318, DOI 10.1136/jmg.38.5.318; Whelan AJ, 2002, INT J CANCER, V99, P697, DOI 10.1002/ijc.10429; Wijnen J, 1999, NAT GENET, V23, P142, DOI 10.1038/13773; Wu Y, 1999, AM J HUM GENET, V65, P1291, DOI 10.1086/302612	25	55	55	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2004	74	6					1262	1269		10.1086/421332	http://dx.doi.org/10.1086/421332			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	823ZB	15098177	Bronze, Green Published			2022-12-18	WOS:000221651900019
J	Rahman, N; Dunstan, M; Teare, MD; Hanks, S; Edkins, SJ; Hughes, J; Bignell, GR; Mancini, G; Kleijer, W; Campbell, M; Keser, G; Black, C; Williams, N; Arbour, L; Warman, M; Superti-Furga, A; Futreal, PA; Pope, FM				Rahman, N; Dunstan, M; Teare, MD; Hanks, S; Edkins, SJ; Hughes, J; Bignell, GR; Mancini, G; Kleijer, W; Campbell, M; Keser, G; Black, C; Williams, N; Arbour, L; Warman, M; Superti-Furga, A; Futreal, PA; Pope, FM			The gene for juvenile hyaline fibromatosis maps to chromosome 4q21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INFANTILE SYSTEMIC HYALINOSIS; ULTRASTRUCTURAL FINDINGS; WINCHESTER SYNDROME; SKIN FIBROBLASTS; COLLAGEN; SIBLINGS	Juvenile hyaline fibromatosis (JHF) is an autosomal recessive condition characterized by multiple subcutaneous nodular tumors, gingival fibromatosis, flexion contractures of the joints, and an accumulation of hyaline in the dermis. We performed a genomewide linkage search in two families with JHF from the same region of the Indian state of Gujarat and identified a region of homozygosity on chromosome 4q21. Dense microsatellite analyses within this interval in five families with JHF who were from diverse origins demonstrate that all are compatible with linkage to chromosome 4q21 (multipoint LOD score 5.5). Meiotic recombinants place the gene for JHF within a 7-cM interval bounded by D4S2393 and D4S395.	Inst Canc Res, Haddow Labs, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; Univ Wales Hosp, Dept Psychol Med, Coll Med, Cardiff CF4 4XW, S Glam, Wales; Univ Sheffield, Math Modelling & Genet Epidemiol Grp, Sheffield, S Yorkshire, England; Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, Cambs, England; Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; Kings Coll London, Connect Tissue Matrix Genet Grp, Div Life Sci, London, England; Royal Free Hosp, Dept Rheumatol, London, England; Ege Univ, Dept Rheumatol, Izmir, Turkey; Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; Case Western Reserve Univ, Howard Hughes Med Inst, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Ctr Human Genet, Cleveland, OH 44106 USA; Univ Zurich, Dept Pediat, Div Metab & Mol Pediat, Zurich, Switzerland	University of London; Institute of Cancer Research - UK; Cardiff University; University of Sheffield; Wellcome Trust Sanger Institute; Erasmus University Rotterdam; Erasmus MC; University of London; King's College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Ege University; University of British Columbia; Case Western Reserve University; Howard Hughes Medical Institute; Case Western Reserve University; University of Zurich	Rahman, N (corresponding author), Inst Canc Res, Haddow Labs, Sect Canc Genet, 15 Cotswold Rd, Sutton SM2 5NG, Surrey, England.	nazneen@icr.ac.uk	Rahman, Nazneen/B-8890-2012; superti-furga, andrea/E-9162-2015; Keser, Gokhan/I-4282-2019; Rahman, Nazneen/D-2802-2013	superti-furga, andrea/0000-0002-3543-7531; Rahman, Nazneen/0000-0003-4376-0440; Hughes, Jaime/0000-0001-6045-4053; Newton-Bishop, Julia/0000-0001-9147-6802; Arbour, Laura/0000-0002-9589-0880; Edkins, Sarah/0000-0003-0717-1972				Allen PW, 2001, ADV ANAT PATHOL, V8, P173, DOI 10.1097/00125480-200105000-00006; Breier F, 1997, ARCH DIS CHILD, V77, P436, DOI 10.1136/adc.77.5.436; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DUNGER DB, 1987, EUR J PEDIATR, V146, P615, DOI 10.1007/BF02467370; GLOVER MT, 1991, PEDIATRICS, V87, P228; GLOVER MT, 1992, PEDIATR DERMATOL, V9, P255, DOI 10.1111/j.1525-1470.1992.tb00342.x; ISHIKAWA H, 1979, ARCH DERMATOL RES, V265, P195, DOI 10.1007/BF00407885; IWATA S, 1980, ARCH DERMATOL RES, V267, P115, DOI 10.1007/BF00569097; KAYASHIMA K, 1994, INT CONGR SER, V1045, P329; Keser G, 1999, CLIN RHEUMATOL, V18, P248, DOI 10.1007/s100670050094; KITANO Y, 1972, ARCH DERMATOL, V106, P877, DOI 10.1001/archderm.106.6.877; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDING B H, 1986, Pediatric Pathology, V6, P55; LUBEC B, 1995, ARCH DIS CHILD, V73, P246, DOI 10.1136/adc.73.3.246; Mancini GMS, 1999, DERMATOLOGY, V198, P18, DOI 10.1159/000018058; MAYERDASILVA A, 1988, ARCH PATHOL LAB MED, V112, P928; Murray J, 1873, Med Chir Trans, V56, P235; PRAPANPOCH S, 1992, ORAL SURG ORAL MED O, V74, P671, DOI 10.1016/0030-4220(92)90363-U; PURETIC S, 1962, BRIT J DERMATOL, V74, P8, DOI 10.1111/j.1365-2133.1962.tb13905.x; REMBERGER K, 1985, CANCER-AM CANCER SOC, V56, P614, DOI 10.1002/1097-0142(19850801)56:3<614::AID-CNCR2820560331>3.0.CO;2-T; RIMBAUD P, 1974, B SOC FR DERMATOL SY, V80, P435; SAHN EE, 1994, PEDIATR DERMATOL, V11, P52, DOI 10.1111/j.1525-1470.1994.tb00076.x; Stucki U, 2001, AM J MED GENET, V100, P122, DOI 10.1002/1096-8628(20010422)100:2<122::AID-AJMG1236>3.0.CO;2-0	23	55	58	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2002	71	4					975	980		10.1086/342776	http://dx.doi.org/10.1086/342776			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	604HT	12214284	Bronze, Green Published			2022-12-18	WOS:000178613800026
J	Ophoff, RA; Escamilla, MA; Service, SK; Spesny, M; Meshi, D; Poon, W; Molina, J; Fournier, E; Gallegos, A; Mathews, C; Neylan, T; Batki, SL; Roche, E; Ramirez, M; Silva, S; De Mille, MC; Dong, P; Leon, PE; Reus, VI; Sandkuijl, LA; Freimer, NB				Ophoff, RA; Escamilla, MA; Service, SK; Spesny, M; Meshi, D; Poon, W; Molina, J; Fournier, E; Gallegos, A; Mathews, C; Neylan, T; Batki, SL; Roche, E; Ramirez, M; Silva, S; De Mille, MC; Dong, P; Leon, PE; Reus, VI; Sandkuijl, LA; Freimer, NB			Genomewide linkage disequilibrium mapping of severe bipolar disorder in a population isolate	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUSCEPTIBILITY LOCI; SCHIZOPHRENIA; GENES; FEATURES; SCREEN; SCANS; MAP	Genomewide association studies may offer the best promise for genetic mapping of complex traits. Such studies in outbred populations require very densely spaced single-nucleotide polymorphisms. In recently founded population isolates, however, extensive linkage disequilibrium (LD) may make these studies feasible with currently available sets of short tandem repeat markers, spaced at intervals as large as a few centimorgans. We report the results of a genomewide association study of severe bipolar disorder (BP-I), using patients from the isolated population of the central valley of Costa Rica. We observed LD with BP-I on several chromosomes; the most striking results were in proximal 8p, a region that has previously shown linkage to schizophrenia. This region could be important for severe psychiatric disorders, rather than for a specific phenotype.	Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Neurobiol & Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, San Francisco Gen Hosp, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Vet Adm Med Ctr, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Neurogenet Lab, San Francisco, CA 94143 USA; Univ Costa Rica, Ctr Biol Mol & Celular, San Jose, Costa Rica; Hosp Calderon Guardia, San Jose, Costa Rica; Univ Costa Rica, Escuela Med, San Jose, Costa Rica; Ctr Int Control Estres, Guatemala City, Guatemala; Appl Biosyst Inc, Foster City, CA USA; Leiden Univ, Ctr Med, Dept Med Stat, Leiden, Netherlands	University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; Universidad Costa Rica; Universidad Costa Rica; Thermo Fisher Scientific; Applied Biosystems; Leiden University; Leiden University - Excl LUMC	Freimer, NB (corresponding author), Univ Calif Los Angeles, Ctr Neurobehav Genet, Gonda Ctr, Room 3506,695 Charles E Young Dr S,Box 951761, Los Angeles, CA 90095 USA.	nfreimer@mednet.ucla.edu	Mathews, Carol A A/M-8922-2017; reus, victor i/I-7923-2015	Mathews, Carol A A/0000-0003-2208-7058; reus, victor i/0000-0002-8193-5697; Meshi, Dar/0000-0003-0772-037X				BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blouin JL, 1998, NAT GENET, V20, P70, DOI 10.1038/1734; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Brzustowicz LM, 1999, AM J HUM GENET, V65, P1096, DOI 10.1086/302579; Chapman NH, 2001, ADV GENET, V42, P413, DOI 10.1016/S0065-2660(01)42034-7; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Escamilla MA, 1996, AM J MED GENET, V67, P244, DOI 10.1002/(SICI)1096-8628(19960531)67:3<244::AID-AJMG2>3.3.CO;2-8; Escamilla MA, 1999, AM J HUM GENET, V64, P1670, DOI 10.1086/302400; Escamilla MA, 2001, AM J MED GENET, V105, P207, DOI 10.1002/ajmg.1205; Gurling HMD, 2001, AM J HUM GENET, V68, P661, DOI 10.1086/318788; HOUWEN RHJ, 1994, NAT GENET, V8, P380, DOI 10.1038/ng1294-380; Kaufmann CA, 1998, AM J MED GENET, V81, P282, DOI 10.1002/(SICI)1096-8628(19980710)81:4<282::AID-AJMG2>3.3.CO;2-R; Kendler KS, 2000, AM J PSYCHIAT, V157, P402, DOI 10.1176/appi.ajp.157.3.402; Kruglyak L, 1997, AM J HUM GENET, V61, P810, DOI 10.1086/514893; McInnes LA, 1996, P NATL ACAD SCI USA, V93, P13060, DOI 10.1073/pnas.93.23.13060; McPeek MS, 1999, AM J HUM GENET, V65, P858, DOI 10.1086/302537; Mohlke KL, 2001, GENOME RES, V11, P1221, DOI 10.1101/gr.173201; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; Peltonen L, 2000, NAT REV GENET, V1, P182, DOI 10.1038/35042049; Prathikanti S, 2001, ANN MED, V33, P257, DOI 10.3109/07853890108998754; Pritchard JK, 2000, GENETICS, V155, P945; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Schork NJ, 1998, TRENDS GENET, V14, P266, DOI 10.1016/S0168-9525(98)01497-8; Service SK, 2001, HUM MOL GENET, V10, P545, DOI 10.1093/hmg/10.5.545; Service SK, 1999, AM J HUM GENET, V64, P1728, DOI 10.1086/302398; Shifman S, 2001, NAT GENET, V28, P309, DOI 10.1038/91060; Tanzi RE, 2001, NEURON, V32, P181, DOI 10.1016/S0896-6273(01)00476-7; Terwilliger JD, 1997, AM J HUM GENET, V61, P430, DOI 10.1086/514855; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; Varilo T, 2001, AM J HUM GENET, V69, P197	31	55	58	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2002	71	3					565	574		10.1086/342291	http://dx.doi.org/10.1086/342291			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	584VN	12119601	Bronze, Green Published			2022-12-18	WOS:000177489600010
J	Leal, A; Morera, B; Del Valle, G; Heuss, D; Kayser, C; Berghoff, M; Villegas, R; Hernandez, E; Mendez, M; Hennies, HC; Neundorfer, B; Barrantes, R; Reis, A; Rautenstrauss, B				Leal, A; Morera, B; Del Valle, G; Heuss, D; Kayser, C; Berghoff, M; Villegas, R; Hernandez, E; Mendez, M; Hennies, HC; Neundorfer, B; Barrantes, R; Reis, A; Rautenstrauss, B			A second locus for an axonal form of autosomal recessive Charcot-Marie-Tooth disease maps to chromosome 19q13.3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INHERITED PERIPHERAL NEUROPATHIES; PROTEIN ZERO GENE; LINKAGE ANALYSIS; MUTATION; TYPE-2; HETEROGENEITY; PHENOTYPE	Autosomal recessive Charcot-Marie-Tooth disease (CMT) represents a heterogeneous group of disorders affecting the peripheral nervous system. The axonal form of the disease is designated as "CMT type 2" (CMT2), and one locus (1q21.2-q21.3) has been reported for the autosomal recessive form. Here we report the results of a genomewide search in an inbred Costa Rican family (CR-I) affected with autosomal recessive CMT2. By analyzing three branches of the family we detected linkage to the 19q13.3 region, and subsequent homozygosity mapping defined shared haplotypes between markers D13S902 and D19S907 in a 5.5-cM range. A maximum two-point LOD score of 9.08 was obtained for marker D19S867, at a recombination fraction of .00, which strongly supports linkage to this locus. The epithelial membrane protein 3 gene, encoding a PMP22 homologous protein and located on 19q13.3, was ruled out as being responsible for this form of CMT. The age at onset of chronic symmetric sensory-motor polyneuropathy was 28-42 years (mean 33.8 years); the electrophysiological data clearly reflect an axonal degenerative process. The phenotype and locus are different from those of demyelinating CMT4F, recently mapped to 19q13.1-13.3; hence, the disease affecting the Costa Rican family constitutes an axonal, autosomal recessive CMT subtype (ARCMT2B).	Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany; Univ Erlangen Nurnberg, Dept Neurol, D-91054 Erlangen, Germany; Univ Costa Rica, INISA, Inst Hlth Res, San Jose, Costa Rica; Univ Costa Rica, Sch Biol, San Jose, Costa Rica; San Juan Dios Hosp, Dept Neurol, Caja Costarricense Seguro Social, San Jose, Costa Rica; Asociac Geneal & Hist Costa Rica, San Jose, Costa Rica; Max Delbruck Ctr Mol Med, Gene Mapping Ctr, Berlin, Germany; Univ Pompeu Fabra, Unitat Biol Evolutiva, Barcelona, Spain	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Universidad Costa Rica; Universidad Costa Rica; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Pompeu Fabra University	Rautenstrauss, B (corresponding author), Univ Erlangen Nurnberg, Inst Human Genet, Schwabachanlage 10, D-91054 Erlangen, Germany.	berndwr@humgenet.uni-erlangen.de	Reis, André/D-2309-2009; Morera, Bernal/B-8671-2012; Morera, Bernal/B-3227-2013; Hennies, Hans C/G-9424-2014	Reis, André/0000-0002-6301-6363; Morera, Bernal/0000-0001-8042-4265; Hennies, Hans C/0000-0001-7210-2389; Leal, Alejandro/0000-0002-5384-8166; Hernandez-Carvajal, Erick/0000-0002-5585-9125				Ben Othmane K, 1999, GENOMICS, V62, P344, DOI 10.1006/geno.1999.6028; BENOTHMANE K, 1993, GENOMICS, V17, P370; Birouk N, 1998, NEUROLOGY, V50, P1074, DOI 10.1212/WNL.50.4.1074; Bolino A, 2000, NAT GENET, V25, P17, DOI 10.1038/75542; Bouhouche A, 1999, AM J HUM GENET, V65, P722, DOI 10.1086/302542; Chapon F, 1999, J NEUROL NEUROSUR PS, V66, P779, DOI 10.1136/jnnp.66.6.779; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; De Jonghe P, 1999, BRAIN, V122, P281, DOI 10.1093/brain/122.2.281; Delague V, 2000, AM J HUM GENET, V67, P236, DOI 10.1086/302980; Dyck P.J, 1993, PNP, P1094; GREEN P, 1992, CYTOGENET CELL GENET, V59, P122, DOI 10.1159/000133221; Ionasescu V, 1996, HUM MOL GENET, V5, P1373, DOI 10.1093/hmg/5.9.1373; Kalaydjieva L, 2000, AM J HUM GENET, V67, P47, DOI 10.1086/302978; Kuklin A, 1997, GENET TEST, V1, P201, DOI 10.1089/gte.1997.1.201; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LeGuern E, 1996, HUM MOL GENET, V5, P1685, DOI 10.1093/hmg/5.10.1685; Liehr T, 1999, GENOMICS, V58, P106, DOI 10.1006/geno.1999.5803; Lupski JR, 1999, PEDIATR RES, V45, P159, DOI 10.1203/00006450-199902000-00001; Marrosu MG, 1998, NEUROLOGY, V50, P1397, DOI 10.1212/WNL.50.5.1397; Mersiyanova IV, 2000, AM J HUM GENET, V67, P37, DOI 10.1086/302962; Nelis E, 1999, NEUROGENETICS, V2, P137, DOI 10.1007/s100480050074; Nelis E, 1999, HUM MUTAT, V13, P11, DOI 10.1002/(SICI)1098-1004(1999)13:1<11::AID-HUMU2>3.0.CO;2-A; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OTHMANE KB, 1993, HUM MOL GENET, V2, P1625, DOI 10.1093/hmg/2.10.1625; Ott J., 1991, ANAL HUMAN GENETIC L; Rogers T, 2000, AM J HUM GENET, V67, P664, DOI 10.1086/303053; Senderek J, 2000, BRAIN PATHOL, V10, P235, DOI 10.1111/j.1750-3639.2000.tb00257.x; Taylor V, 1996, GENE, V175, P115, DOI 10.1016/0378-1119(96)00134-5; Timmerman V, 1996, NEUROLOGY, V46, P1311, DOI 10.1212/WNL.46.5.1311; Vance JM, 2000, ARCH NEUROL-CHICAGO, V57, P638, DOI 10.1001/archneur.57.5.638; Warner LE, 1998, NAT GENET, V18, P382, DOI 10.1038/ng0498-382	31	55	60	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2001	68	1					269	274		10.1086/316934	http://dx.doi.org/10.1086/316934			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	392FG	11112660	Green Published, Bronze			2022-12-18	WOS:000166399900030
J	Leegwater, PAJ; Konst, AAM; Kuyt, B; Sandkuijl, LA; Naidu, S; Oudejans, CBM; Schutgens, RBH; Pronk, JC; van der Knaap, MS				Leegwater, PAJ; Konst, AAM; Kuyt, B; Sandkuijl, LA; Naidu, S; Oudejans, CBM; Schutgens, RBH; Pronk, JC; van der Knaap, MS			The gene for leukoencephalopathy with vanishing white matter is located on chromosome 3q27	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OLIGODENDROCYTE-SPECIFIC PROTEIN; NERVOUS-SYSTEM HYPOMYELINATION; CHILDHOOD ATAXIA; POINT MUTATION; PMP22 GENE; DISEASE; MYELIN	Leukoencephalopathy with vanishing white matter (VWM) is an autosomal recessive disorder with normal early development and, usually, childhood-onset neurological deterioration. At present, diagnosis of VWM is based on clinical examination and the results of repeat magnetic resonance imaging and magnetic resonance spectroscopy, which show that,with time, increasing amounts of the cerebral white matter vanish and are replaced by cerebrospinal fluid. We have performed a genome linkage screening of a panel of 19 families of different ethnic origins. Significant linkage to chromosome 3q27 was observed in a 7-cM interval between markers D3S3730 and D3S3592, with a maximum multipoint LOD score of 5.1 calculated from the entire data set. The results of genealogical studies have suggested that seven parents in four Dutch families with VWM may have inherited an allele for the disease from a common ancestor who lived at least eight generations ago. Analysis of these families provided further evidence for the localization of the gene for VWM to 3q27. The patients shared a haplotype spanning 5 cM between markers D3S1618 and D3S3592. In one family of a different ethnic background, the patient had, in the same region, homozygosity for 13 consecutive markers spanning at least 12 cM, suggesting consanguinity between the parents. A healthy sibling of this patient had the same homozygous haplotype, which suggests that the healthy sibling is presymptomatic for the disease.	Free Univ Amsterdam Hosp, Dept Clin Chem, Mol Biol Lab, NL-1007 MB Amsterdam, Netherlands; Free Univ Amsterdam Hosp, Dept Child Neurol, NL-1007 MB Amsterdam, Netherlands; Free Univ Amsterdam, Dept Human Genet, Amsterdam, Netherlands; Univ Utrecht, Div Med Genet, Utrecht, Netherlands; Kennedy Krieger Inst, Dept Neurogenet, Baltimore, MD USA	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; Utrecht University; Kennedy Krieger Institute	Leegwater, PAJ (corresponding author), Free Univ Amsterdam Hosp, Dept Clin Chem, Mol Biol Lab, POB 7057, NL-1007 MB Amsterdam, Netherlands.			Oudejans, Cees/0000-0003-0717-4946; Leegwater, Peter/0000-0002-4100-015X				Bronstein JM, 1996, GENOMICS, V34, P255, DOI 10.1006/geno.1996.0278; Bronstein JM, 1996, NEUROLOGY, V47, P772, DOI 10.1212/WNL.47.3.772; Bronstein JM, 1997, J NEUROSCI RES, V50, P713, DOI 10.1002/(SICI)1097-4547(19971201)50:5<713::AID-JNR8>3.3.CO;2-Q; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; HANEFELD F, 1993, NEUROPEDIATRICS, V24, P244, DOI 10.1055/s-2008-1071551; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; NICHOLSON GA, 1994, NAT GENET, V6, P263, DOI 10.1038/ng0394-263; ROA BB, 1993, NAT GENET, V5, P189, DOI 10.1038/ng1093-189; ROA BB, 1993, NAT GENET, V5, P269, DOI 10.1038/ng1193-269; SCHIFFMANN R, 1994, ANN NEUROL, V35, P331, DOI 10.1002/ana.410350314; TEDESCHI G, 1995, NEUROLOGY, V45, P1526, DOI 10.1212/WNL.45.8.1526; TEMEERMAN GJ, 1995, CLIN EXP ALLERGY, V25, P97; van der Knaap MS, 1998, NEUROLOGY, V51, P540, DOI 10.1212/WNL.51.2.540; vanderKnaap MS, 1997, NEUROLOGY, V48, P845, DOI 10.1212/WNL.48.4.845; WALTER MA, 1994, NAT GENET, V7, P22, DOI 10.1038/ng0594-22; WANDERS RJA, 1990, J INHERIT METAB DIS, V13, P375, DOI 10.1007/BF01799399; WATKINS PA, 1989, J CLIN INVEST, V83, P771, DOI 10.1172/JCI113956	17	55	56	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1999	65	3					728	734		10.1086/302548	http://dx.doi.org/10.1086/302548			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233KQ	10441579	Green Published, Bronze			2022-12-18	WOS:000082426400017
J	Brewer, CM; Leek, JP; Green, AJ; Holloway, S; Bonthron, DT; Markham, AF; FitzPatrick, DR				Brewer, CM; Leek, JP; Green, AJ; Holloway, S; Bonthron, DT; Markham, AF; FitzPatrick, DR			A locus for isolated cleft palate, located on human chromosome 2q32	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FACIAL CLEFTS; MAP; COMPONENTS; ASSIGNMENT; HEDGEHOG; DIGEORGE; INSULIN; BANDS; CELLS	We present evidence for the existence of a novel chromosome 2q32 locus involved in the pathogenesis of isolated cleft palate. We have studied two unrelated patients with strikingly similar clinical features, in whom there are apparently balanced, de novo cytogenetic rearrangements involving the same region of chromosome 2q. Both children have cleft palate, facial dysmorphism, and mild learning disability. Their karyotypes were originally reported as 46, XX, t(2;7)(q33;p21) and 46, XX, t(2;11)(q33;p14). However, our molecular cytogenetic analyses localize both translocation breakpoints to a small region between markers D2S311 and D2S116. This suggests that the true location of these breakpoints is 2q32 rather than 2q33. To obtain independent support for the existence of a cleft-palate locus in 2q32, we performed a detailed statistical analysis for all cases in the human cytogenetics database of nonmosaic, single, contiguous autosomal deletions associated with orofacial clefting. This revealed 2q32 to be one of only three chromosomal regions in which haploinsufficiency is significantly associated with isolated cleft palate. In combination, our data provide strong evidence for the location at 2q32 of a gene that is critical to the development of the secondary palate. The close proximity of these two translocation breakpoints should also allow rapid progress toward the positional cloning of this cleft-palate gene.	Univ Edinburgh, Western Gen Hosp, Human Genet Unit, Mol Med Ctr, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Edinburgh, Western Gen Hosp, Dept Clin Genet, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Leeds, St James Hosp, Mol Med Unit, Leeds LS9 7TF, W Yorkshire, England; Univ Cambridge, Addenbrookes Hosp, Dept Med Genet, Cambridge CB2 1TN, England	University of Edinburgh; University of Edinburgh; Saint James's University Hospital; University of Leeds; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Bonthron, DT (corresponding author), Univ Edinburgh, Western Gen Hosp, Human Genet Unit, Mol Med Ctr, Edinburgh EH4 2XU, Midlothian, Scotland.	D.Bonthron@ed.ac.uk	FitzPatrick, David R/B-8311-2008; FitzPatrick, David R/C-7301-2013	Green, Andrew/0000-0002-1077-7417; Bonthron, David/0000-0001-8132-8179; FitzPatrick, David R./0000-0003-4861-969X				ANAND R, 1990, NUCLEIC ACIDS RES, V18, P1951, DOI 10.1093/nar/18.8.1951; Bader BL, 1998, CELL, V95, P507, DOI 10.1016/S0092-8674(00)81618-9; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Brewer C, 1998, AM J HUM GENET, V63, P1153, DOI 10.1086/302041; CARTER CO, 1982, J MED GENET, V19, P329, DOI 10.1136/jmg.19.5.329; Christensen K, 1996, AM J HUM GENET, V58, P182; CHRISTENSEN K, 1993, CLEFT PALATE-CRAN J, V30, P469, DOI 10.1597/1545-1569(1993)030<0469:ICPIDM>2.3.CO;2; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; Daw SCM, 1996, NAT GENET, V13, P458, DOI 10.1038/ng0896-458; DELAROSA EJ, 1994, EUR J NEUROSCI, V6, P1801; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FITZPATRICK D, 1993, J CRAN GENET DEV BIO, V13, P230; FITZPATRICK DR, 1994, J MED GENET, V31, P126, DOI 10.1136/jmg.31.2.126; Fogh-Andersen, 1942, INHERITANCE HARELIP; Gosden J R, 1990, Methods Mol Biol, V5, P487, DOI 10.1385/0-89603-150-0:487; Hadano S, 1999, GENOMICS, V55, P106, DOI 10.1006/geno.1998.5637; Iamaroon A, 1996, J CRAN GENET DEV BIO, V16, P48; Leek JP, 1997, CYTOGENET CELL GENET, V76, P187, DOI 10.1159/000134545; LIU HC, 1995, J ASSIST REPROD GEN, V12, P78, DOI 10.1007/BF02211374; OHSAKI Y, 1995, ACTA ANAT, V153, P161; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; ROSSI E, 1994, GENOMICS, V24, P34, DOI 10.1006/geno.1994.1579; SAVAGE JRK, 1977, NATURE, V270, P513, DOI 10.1038/270513a0; SCAMBLER PJ, 1992, LANCET, V339, P1138, DOI 10.1016/0140-6736(92)90734-K; SCHINZEL A, 1994, HUM CYTOGENETICS DAT; SHIELDS ED, 1979, CLEFT PALATE J, V16, P1; SHIELDS ED, 1981, CLIN GENET, V20, P13; SIMEONE A, 1994, P NATL ACAD SCI USA, V91, P2250, DOI 10.1073/pnas.91.6.2250; VASARHELYI K, 1989, ANN HUM GENET, V53, P375, DOI 10.1111/j.1469-1809.1989.tb01805.x; Winter RM, 1996, LONDON DYSMORPHOLOGY	31	55	55	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1999	65	2					387	396		10.1086/302498	http://dx.doi.org/10.1086/302498			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	223JA	10417281	Green Published, Bronze			2022-12-18	WOS:000081836900014
J	Wohlers, TM; Christacos, NC; Harreman, MT; Fridovich-Keil, JL				Wohlers, TM; Christacos, NC; Harreman, MT; Fridovich-Keil, JL			Identification and characterization of a mutation, in the human UDP-galactose-4-epimerase gene, associated with generalized epimerase-deficiency galactosemia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DIPHOSPHATE GALACTOSE-4-EPIMERASE DEFICIENCY; YEAST EXPRESSION SYSTEM; GALACTOSE-1-PHOSPHATE URIDYLYLTRANSFERASE; CATARACT	Epimerase-deficiency galactosemia results from impairment of the human enzyme UDP-galactose-4-epimerase (hGALE). We and others have identified substitution mutations in the hGALE alleles of patients with the clinically mild, peripheral form of epimerase deficiency. We report here the first identification of an hGALE mutation in a patient with the clinically severe, generalized form of epimerase deficiency. The mutation, V94M, was found on both GALE alleles of this patient. This same mutation also was found in the homozygous state in two additional patients with generalized epimerase deficiency. The specific activity of the V94M-hGALE protein expressed in yeast was severely reduced with regard to UDP-galactose and partially reduced with regard to UDP-N-acetylgalactosamine. In contrast, two GALE-variant proteins associated with peripheral epimerase deficiency, L313M-hGALE and D103G-hGALE, demonstrated near-normal levels of activity with regard to both substrates, but a third allele, G90E-hGALE, demonstrated little, if any, detectable activity, despite near-normal abundance. G90E originally was identified in a heterozygous patient whose other allele remains uncharacterized. Thermal lability and protease-sensitivity studies demonstrated compromised stability in all of the partially active mutant enzymes.	Emory Univ, Sch Med, Dept Genet, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Grad Program Genet & Mol Biol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Grad Program Biochem Cell & Dev Biol, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Fridovich-Keil, JL (corresponding author), Emory Univ, Sch Med, Dept Genet, Room 431C Dent Bldg,1462 Clifton Rd NE, Atlanta, GA 30322 USA.	jfridov@emory.edu			NIDDK NIH HHS [DK46403] Funding Source: Medline; NIGMS NIH HHS [T32 GM008490, GM08490-06] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046403, R29DK046403] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alano A, 1998, J INHERIT METAB DIS, V21, P341, DOI 10.1023/A:1005342306080; Alano A., 1997, Journal of Investigative Medicine, V45, p191A; DAUDE N, 1995, BIOCHEM MOL MED, V56, P1, DOI 10.1006/bmme.1995.1048; Elsevier JP, 1996, P NATL ACAD SCI USA, V93, P7166, DOI 10.1073/pnas.93.14.7166; ENDRES W, 1990, J INHERIT METAB DIS, V13, P509, DOI 10.1007/BF01799508; FRIDOVICHKEIL JL, 1995, AM J HUM GENET, V56, P640; FRIDOVICHKEIL JL, 1991, CELL GROWTH DIFFER, V2, P67; FridovichKeil JL, 1995, BIOCHEM MOL MED, V56, P121, DOI 10.1006/bmme.1995.1067; HENDERSON MJ, 1983, J INHERIT METAB DIS, V6, P17, DOI 10.1007/BF02391187; HOLTON JB, 1990, J INHERIT METAB DIS, V13, P476, DOI 10.1007/BF01799505; HOLTON JB, 1981, ARCH DIS CHILD, V56, P885, DOI 10.1136/adc.56.11.885; JAKOBS C, 1990, J INHERIT METAB DIS, V13, P517, DOI 10.1007/BF01799509; KINGSLEY DM, 1986, CELL, V44, P749, DOI 10.1016/0092-8674(86)90841-X; KINGSLEY DM, 1986, NEW ENGL J MED, V314, P1257; Maceratesi P, 1998, MOL GENET METAB, V63, P26, DOI 10.1006/mgme.1997.2645; MALEY F, 1959, BIOCHIM BIOPHYS ACTA, V31, P577, DOI 10.1016/0006-3002(59)90047-2; MITCHELL B, 1975, P NATL ACAD SCI USA, V72, P5026, DOI 10.1073/pnas.72.12.5026; PILLER F, 1983, J BIOL CHEM, V258, P774; Quimby BB, 1997, AM J HUM GENET, V61, P590, DOI 10.1086/515517; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; SARDHARWALLA IB, 1988, J INHERIT METAB DIS, V11, P249, DOI 10.1007/BF01804249; SCHULPIS KH, 1993, J INHERIT METAB DIS, V16, P903, DOI 10.1007/BF00714292; Segal S, 1995, METABOLIC MOL BASIS, P967; Thoden JB, 1997, BIOCHEMISTRY-US, V36, P10685, DOI 10.1021/bi9704313; WALTER JH, IN PRESS ARCH DIS CH; ZYDOWSKY LD, 1992, PROTEIN SCI, V1, P961, DOI 10.1002/pro.5560010801	26	55	56	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1999	64	2					462	470		10.1086/302263	http://dx.doi.org/10.1086/302263			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	169HA	9973283	Green Published, Bronze			2022-12-18	WOS:000078740600015
J	Rowley, PT; Loader, S; Kaplan, RM				Rowley, PT; Loader, S; Kaplan, RM			Prenatal screening for cystic fibrosis carriers: An economic evaluation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COST-BENEFIT-ANALYSIS; NEURAL-TUBE DEFECTS; WILLINGNESS-TO-PAY; GENETICS SERVICES; DOWNS-SYNDROME; HEALTH; DIAGNOSIS; PROGRAM; IDENTIFICATION; THALASSEMIA	The cloning of the CFTR gene has made it technically possible to avert the unwanted birth of a child with cystic fibrosis (CF). Several large trials offering prenatal CF carrier screening suggest that such screening is practical and that identified carriers generally use the information obtained. Therefore, a critical question is whether the cost of such screening is justified. Decision analysis was performed that used information about choices that pregnant women were observed to make at each stage in the Rochester prenatal carrier-screening trial. The cost of screening per CF birth voluntarily averted was estimated to be $1,320,000-$1,400,000. However, the lifetime medical cost of the care of a CF child in today's dollars was estimated to be slightly >$1,000,000. Therefore, despite both the high cost of carrier testing and the relative infrequency of CF conceptions in the general population, the averted medical-care cost resulting from choices freely made are estimated to offset similar to 74%-78% of the costs of a screening program. At present, if it is assumed that a pregnancy terminated because of CF is replaced, the marginal cost for prenatal CF carrier screening is estimated to be $8,290 per quality-adjusted life-year. This value compares favorably with that of many accepted medical services. The cost of prenatal CF carrier screening could fall to equal the averted costs of CF patient care if the cost of carrier testing were to fall to $100.	Univ Rochester, Sch Med, Div Genet, Dept Med, Rochester, NY 14642 USA; Univ Calif San Diego, Dept Family & Prevent Med, Div Hlth Care Sci, San Diego, CA 92103 USA	University of Rochester; University of California System; University of California San Diego	Rowley, PT (corresponding author), Univ Rochester, Sch Med, Div Genet, Dept Med, Box 641, Rochester, NY 14642 USA.	peter_rowley@urmc.rochester.edu			NINR NIH HHS [NR03125] Funding Source: Medline; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR003125] Funding Source: NIH RePORTER	NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		[Anonymous], 1976, JAMA-J AM MED ASSOC, V236, P1471; ASCH DA, 1993, AM J OBSTET GYNECOL, V168, P1; Asch DA, 1996, AM J PUBLIC HEALTH, V86, P684, DOI 10.2105/AJPH.86.5.684; ATTANASIO E, 1980, PREVENTIONE MALATTIE; BARDEN HS, 1984, SOC BIOL, V31, P1; BOTKIN JR, 1990, OBSTET GYNECOL, V75, P875; Brock DJH, 1996, LANCET, V347, P148, DOI 10.1016/S0140-6736(96)90340-2; BUSH JW, 1972, SOCIO ECON PLAN SCI, V6, P49, DOI 10.1016/0038-0121(72)90006-7; BUSH JW, 1973, HLTH STATUS INDEXES, P172; CHAMBERLAIN J, 1978, LANCET, V2, P1293; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; CUCKLE HS, 1995, BRIT MED J, V311, P1460, DOI 10.1136/bmj.311.7018.1460; CUTTING GR, 1997, NAT I HLTH CONS DEV; Donaldson C, 1997, HEALTH ECON, V6, P145, DOI 10.1002/(SICI)1099-1050(199703)6:2<145::AID-HEC253>3.3.CO;2-E; Drummond M F, 1991, Int J Technol Assess Health Care, V7, P561; EDDY DM, 1989, ANN INTERN MED, V111, P389, DOI 10.7326/0003-4819-111-5-389; EPSTEIN KA, 1981, J CHRON DIS, V34, P175, DOI 10.1016/0021-9681(81)90063-1; EVERSKIEBOOMS G, 1990, CLIN GENET, V37, P207; Ganiats TG, 1996, MED DECIS MAKING, V16, P45, DOI 10.1177/0272989X9601600112; GARBER AM, 1991, MED CARE, V29, P473, DOI 10.1097/00005650-199105000-00007; GILL M, 1987, SOC SCI MED, V24, P725, DOI 10.1016/0277-9536(87)90109-2; GINSBERG G, 1994, HEALTH ECON, V3, P5, DOI 10.1002/hec.4730030104; HAGARD S, 1976, BRIT MED J, V1, P753, DOI 10.1136/bmj.1.6012.753; HENDERSON JB, 1982, J EPIDEMIOL COMMUN H, V36, P214, DOI 10.1136/jech.36.3.214; HILGERS T, 1972, ABORTION SOCIAL JUST; HOLLENBERG J, 1988, SMLTREE VERSION 2 9; KLINGER KW, 1997, NAT I HLTH CONS DEV; Levenkron JC, 1997, AM J MED GENET, V73, P378, DOI 10.1002/(SICI)1096-8628(19971231)73:4<378::AID-AJMG2>3.0.CO;2-K; LIEU TA, 1994, OBSTET GYNECOL, V84, P903; Loader S, 1996, AM J HUM GENET, V59, P234; MENNIE ME, 1992, LANCET, V340, P214, DOI 10.1016/0140-6736(92)90476-J; MIEDZYBRODZKA Z, 1995, J MED GENET, V32, P282, DOI 10.1136/jmg.32.4.282; MODELL B, 1991, J INHERIT METAB DIS, V14, P640, DOI 10.1007/BF01797934; MODELL B, 1993, TRENDS GENET, V9, P46, DOI 10.1016/0168-9525(93)90186-L; MORRIS DT, 1994, AM J LAW MED, V20, P295; *NAT I HLTH, 1997, NAT I HLTH CONS DEV; NELSON WB, 1978, AM J HUM GENET, V30, P663; OLD JM, 1986, LANCET, V2, P763; OSTROWSKY JT, 1985, AM J PUBLIC HEALTH, V75, P732, DOI 10.2105/AJPH.75.7.732; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Rowley PT, 1997, GENET TEST, V1, P53, DOI 10.1089/gte.1997.1.53; ROWLEY PT, 1993, AM J PREV MED, V9, P261, DOI 10.1016/S0749-3797(18)30701-3; SADOVNICK AD, 1981, AM J MED GENET, V10, P367, DOI 10.1002/ajmg.1320100409; Schulman KA, 1997, ANNU REV PUBL HEALTH, V18, P529, DOI 10.1146/annurev.publhealth.18.1.529; Schwartz Marianne, 1993, European Journal of Human Genetics, V1, P239; TORRANCE GW, 1984, CLIN PERINATOL, V11, P267, DOI 10.1016/S0095-5108(18)30920-5; *US C OFF TECHN AS, 1979, REV SEL FED VACC IMM; *US C OFF TECHN AS, 1992, CYST FIBR DNA TESTS; WATSON EK, 1991, BRIT MED J, V303, P504, DOI 10.1136/bmj.303.6801.504; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; WEINSTEIN MC, 1980, NEW ENGL J MED, V303, P308, DOI 10.1056/NEJM198008073030604; WEINSTEIN MC, 1977, NEW ENGL J MED, V296, P716, DOI 10.1056/NEJM197703312961304; Welsh MJ, 1995, METABOLIC MOL BASES, V3, P3799; WERTZ DC, 1992, AM J HUM GENET, V50, P1077; WILFOND BS, 1992, MILBANK Q, V70, P629, DOI 10.2307/3350214	56	55	56	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1998	63	4					1160	1174		10.1086/302042	http://dx.doi.org/10.1086/302042			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	131LP	9758600	Green Published, hybrid			2022-12-18	WOS:000076577800030
J	Jaarola, M; Martin, RH; Ashley, T				Jaarola, M; Martin, RH; Ashley, T			Direct evidence for suppression of recombination within two pericentric inversions in humans: A new sperm-FISH technique	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IN-SITU HYBRIDIZATION; CHROMOSOME COMPLEMENTS; ANEUPLOIDY; NONDISJUNCTION; PROBES; CHILD	Crossover within a pericentric inversion produces reciprocal recombinant chromosomes that are duplicated/deficient for all chromatin distal to the breakpoints. In view of this fact, a new technique is presented for estimating the frequency of recombination within pericentric inversions. YAC probes were selected from within the q- and p-arm flanking regions of two human inversions, and two-color FISH analysis was performed on sperm from heterozygous inversion carriers. A total of 6,006 sperm were analyzed for chromosome 1 inversion (p31q12), and 3,168 were analyzed for chromosome 8 inversion (p23q22). Both inversions displayed suppression of crossing-over, although the amount of suppression differed between the two inversions. The recombination frequency of 13.1% recorded for chromosome 8 inversion was similar to the frequency of 11.4% previously estimated by the human/hamster-fusion method. For chromosome 1 inversion, the recombination frequency of 0.4% reported here was below the limits of detection of the fusion technique. The simplicity of the FISH technique and the ease of scoring facilitate analysis of a sample-population size much larger than previously had been possible.	Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; Univ Lund, Dept Genet, S-22362 Lund, Sweden; Alberta Childrens Prov Gen Hosp, Dept Genet, Calgary, AB T2T 5C7, Canada	Yale University; Lund University; Alberta Childrens Hospital; University of Calgary	Ashley, T (corresponding author), Yale Univ, Sch Med, Dept Genet, 333 Cedar St, New Haven, CT 06510 USA.				NIGMS NIH HHS [GM-49779] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049779] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDRLE M, 1987, WIEN KLIN WOCHENSCHR, V99, P638; ASHLEY T, 1988, GENETICS, V118, P307; ASHLEY T, 1990, GENETICA, V83, P1; AVELING JV, 1977, CAN J GENET CYTOL, V19, pA569; BALKAN W, 1983, CYTOGENET CELL GENET, V35, P295, DOI 10.1159/000131882; BrayWard P, 1996, GENOMICS, V32, P1, DOI 10.1006/geno.1996.0070; DANIEL A, 1981, HUM GENET, V56, P321, DOI 10.1007/BF00274687; DELACHAPELLE A, 1974, AM J HUM GENET, V26, P746; DUTRILLAUX B, 1980, CR SOC BIOL, V174, P730; JENDERNY J, 1992, HUM GENET, V89, P117, DOI 10.1007/BF00207058; KAISER P, 1984, HUM GENET, V68, P1, DOI 10.1007/BF00293869; LOVELL M, 1982, MEDICINA-BUENOS AIRE, V42, P359; MARTIN RH, 1991, AM J HUM GENET, V48, P856; MARTIN RH, 1994, HUM GENET, V93, P135; MARTIN RH, 1995, MOL REPROD DEV, V42, P89, DOI 10.1002/mrd.1080420112; MARTIN RH, 1991, MOL REPROD DEV, V30, P159, DOI 10.1002/mrd.1080300213; MARTIN RH, 1993, CYTOGENET CELL GENET, V62, P199, DOI 10.1159/000133475; MARTIN RH, 1994, HUMAN CHROMOSOMES MA, P223; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; RUDAK E, 1978, NATURE, V274, P911, DOI 10.1038/274911a0; SMITH ACM, 1987, AM J HUM GENET, V41, P1083; Spriggs EL, 1996, AM J HUM GENET, V58, P356; SPRIGGS EL, 1995, CYTOGENET CELL GENET, V71, P47, DOI 10.1159/000134060; WILLIAMS BJ, 1993, HUM MOL GENET, V2, P1929, DOI 10.1093/hmg/2.11.1929; WINSOR EJT, 1978, CYTOGENET CELL GENET, V20, P169, DOI 10.1159/000130849	25	55	57	0	6	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1998	63	1					218	224		10.1086/301900	http://dx.doi.org/10.1086/301900			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZZ726	9634501	Green Published, hybrid			2022-12-18	WOS:000074761000030
J	Kelsell, RE; Gregory-Evans, K; Gregory-Evans, CY; Holder, GE; Jay, MR; Weber, BHF; Moore, AT; Bird, AC; Hunt, DM				Kelsell, RE; Gregory-Evans, K; Gregory-Evans, CY; Holder, GE; Jay, MR; Weber, BHF; Moore, AT; Bird, AC; Hunt, DM			Localization of a gene (CORD7) for a dominant cone-rod dystrophy to chromosome 6q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							CAROLINA MACULAR DYSTROPHY; PERIPHERIN/RDS GENE; RDS GENE; RETINITIS-PIGMENTOSA; LINKAGE ANALYSIS; POINT MUTATION; DEGENERATION; ASN244HIS; DELETION; PATTERN		UCL, Inst Ophthalmol, Dept Mol Genet, London EC1V 9EL, England; UCL, Inst Ophthalmol, Dept Clin Ophthalmol, London EC1V 9EL, England; Moorfields Eye Hosp, London, England; Univ Wurzburg, Bioctr, Inst Human Genet, Wurzburg, Germany; Addenbrookes Hosp, Dept Ophthalmol, Cambridge, England	University of London; University College London; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Wurzburg; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Hunt, DM (corresponding author), UCL, Inst Ophthalmol, Dept Mol Genet, Bath St, London EC1V 9EL, England.	d.hunt@ucl.ac.uk	Hunt, David M/K-6024-2012; Gregory-Evans, Cheryl Y/G-9550-2011; Gregory-Evans, Kevin/G-9551-2011	Hunt, David M/0000-0002-9264-3948; Weber, Bernhard H.F./0000-0002-8808-7723; Gregory-Evans, Kevin/0000-0002-0104-7893				Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; ATTWOOD J, 1988, ANN HUM GENET, V52, P259, DOI 10.1111/j.1469-1809.1988.tb01103.x; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; EVANS K, 1994, NAT GENET, V6, P210, DOI 10.1038/ng0294-210; FELBOR U, IN PRESS CYTOGENET C; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; GEHRIG A, IN PRESS J MED GENET; HAGEMEIJER A, 1977, CYTOGENET CELL GENET, V18, P333, DOI 10.1159/000130780; KELSELL RE, 1995, HUM MOL GENET, V4, P1653, DOI 10.1093/hmg/4.9.1653; Kelsell RE, 1997, HUM MOL GENET, V6, P597, DOI 10.1093/hmg/6.4.597; KELSELL RE, IN PRESS HUM MOL GEN; Kohl S, 1997, J MED GENET, V34, P620, DOI 10.1136/jmg.34.8.620; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Martinez-Mir A, 1998, NAT GENET, V18, P11, DOI 10.1038/ng0198-11; MILOSEVIC J, 1975, J MENT DEFIC RES, V19, P139; Nakazawa M, 1996, RETINA-J RET VIT DIS, V16, P405, DOI 10.1097/00006982-199616050-00007; Nakazawa M, 1996, ARCH OPHTHALMOL-CHIC, V114, P72, DOI 10.1001/archopht.1996.01100130068011; NAKAZAWA M, 1994, HUM MOL GENET, V3, P1195, DOI 10.1093/hmg/3.7.1195; NICHOLS BE, 1993, NAT GENET, V3, P202, DOI 10.1038/ng0393-202; PIERPONT MEM, 1986, OPHTHALMIC PAED GEN, V7, P175, DOI 10.3109/13816818609004135; REIG C, 1995, OPHTHALMIC GENET, V16, P39, DOI 10.3109/13816819509056911; SMALL KW, 1992, GENOMICS, V13, P681, DOI 10.1016/0888-7543(92)90141-E; SMALL KW, 1993, OPHTHALMIC PAED GEN, V14, P143, DOI 10.3109/13816819309042913; STONE EM, 1994, ARCH OPHTHALMOL-CHIC, V112, P765, DOI 10.1001/archopht.1994.01090180063036; TRANEBJAERG L, 1986, OPHTHALMIC PAED GEN, V7, P167, DOI 10.3109/13816818609004134; WELEBER RG, 1993, ARCH OPHTHALMOL-CHIC, V111, P1531, DOI 10.1001/archopht.1993.01090110097033; WELLS J, 1993, NAT GENET, V3, P213, DOI 10.1038/ng0393-213	27	55	58	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1998	63	1					274	279		10.1086/301905	http://dx.doi.org/10.1086/301905			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZZ726	9634506	Bronze, Green Published			2022-12-18	WOS:000074761000040
J	Bodmer, D; Eleveld, MJ; Ligtenberg, MJL; Weterman, MAJ; Janssen, BAP; Smeets, DFCM; de Wit, PEJ; van den Berg, A; van den Berg, E; Koolen, MI; van Kessel, AG				Bodmer, D; Eleveld, MJ; Ligtenberg, MJL; Weterman, MAJ; Janssen, BAP; Smeets, DFCM; de Wit, PEJ; van den Berg, A; van den Berg, E; Koolen, MI; van Kessel, AG			An alternative route for multistep tumorigenesis in a novel case of hereditary renal cell cancer and a t(2;3)(q35;q21) chromosome translocation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VON-HIPPEL-LINDAU; TUMOR-SUPPRESSOR GENE; SOMATIC MUTATIONS; T(3-8) BREAKPOINT; CARCINOMA; HETEROZYGOSITY; EXPRESSION	Through allele-segregation and loss-of-heterozygosity analyses, we demonstrated loss of the translocation-derivative chromosome 3 in five independent renal cell tumors of the clear-cell type, obtained from three members of a family in which a constitutional t(2;3)(q35;q21) was encountered. In addition, analysis of the von Hippel-Lindau gene, VHL, revealed distinct insertion, deletion, and substitution mutations in four of the five tumors tested. On the basis of these results, we conclude that, in this familial case, an alternative route for renal cell carcinoma development is implied. In contrast to the first hit in the generally accepted two-hit tumor-suppressor model proposed by Knudson, the familial translocation in this case may act as a primary oncogenic event leading to (nondisjunctional) loss of the der(3) chromosome harboring the VHL tumor-suppressor gene. The risk of developing renal cell cancer may be correlated directly with the extent of somatic (kidney) mosaicism resulting from this loss.	Univ Nijmegen Hosp, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Univ Nijmegen Hosp, Dept Pathol, NL-6500 HB Nijmegen, Netherlands; Univ Groningen, Dept Med Genet, Groningen, Netherlands; Bosch Med Ctr, Dept Internal Med, Den Bosch, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; University of Groningen	Bodmer, D (corresponding author), Univ Nijmegen Hosp, Dept Human Genet, POB 9101, NL-6500 HB Nijmegen, Netherlands.	D.Bodmer@antrg.azn.nl	Smeets, D.F.C.M./L-4653-2015; Eleveld, Marc J/J-9146-2016; van den Berg, Anke/H-1718-2011; Ligtenberg, Marjolijn/N-9666-2013; Bodmer, D./L-4207-2015; van Kessel, Ad Geurts/A-2810-2010	van den Berg, Anke/0000-0002-8894-2638; Ligtenberg, Marjolijn/0000-0003-1290-1474; 				BEAUDET AL, 1993, HUM MUTAT, V2, P245, DOI 10.1002/humu.1380020402; COHEN AJ, 1979, NEW ENGL J MED, V301, P592, DOI 10.1056/NEJM197909133011107; Decker HJH, 1997, CANCER GENET CYTOGEN, V93, P74, DOI 10.1016/S0165-4608(96)00296-8; FOSTER K, 1994, HUM MOL GENET, V3, P2169, DOI 10.1093/hmg/3.12.2169; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; GNARRA JR, 1995, SEMIN ONCOL, V22, P3; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Knudson A G, 1995, Cancer J Sci Am, V1, P180; KNUDSON AG, 1993, P NATL ACAD SCI USA, V90, P10914, DOI 10.1073/pnas.90.23.10914; KNUDSON AG, 1996, CANC RES CLIN ONCOLO, V122, P135; Kok K, 1997, ADV CANCER RES, V71, P27, DOI 10.1016/S0065-230X(08)60096-2; Koolen MI, 1998, KIDNEY INT, V53, P273, DOI 10.1046/j.1523-1755.1998.00762.x; KOVACS G, 1988, HUM GENET, V78, P148, DOI 10.1007/BF00278186; KOVACS G, 1991, P NATL ACAD SCI USA, V88, P194, DOI 10.1073/pnas.88.1.194; KOVACS G, 1989, INT J CANCER, V43, P422, DOI 10.1002/ijc.2910430313; KOVACS G, 1989, CANCER RES, V49, P651; KOVACS G, 1993, ADV CANCER RES, V6, P89; LI FP, 1993, ANN INTERN MED, V118, P106, DOI 10.7326/0003-4819-118-2-199301150-00005; MELONI AM, 1992, J UROLOGY, V148, P253, DOI 10.1016/S0022-5347(17)36565-5; Motzer RJ, 1996, NEW ENGL J MED, V335, P865, DOI 10.1056/NEJM199609193351207; Ohta M, 1996, CELL, V84, P587, DOI 10.1016/S0092-8674(00)81034-X; Schmidt L, 1995, Cancer J Sci Am, V1, P191; Schmidt L, 1997, NAT GENET, V16, P68, DOI 10.1038/ng0597-68; SHUIN T, 1994, CANCER RES, V54, P2852; Sidhar SK, 1996, HUM MOL GENET, V5, P1333, DOI 10.1093/hmg/5.9.1333; SMITH DI, 1995, CYTOGENET CELL GENET, V68, P126; Spurr NK, 1996, CYTOGENET CELL GENET, V73, P256; STEIN WD, 1995, J CLIN EPIDEMIOL, V48, P767, DOI 10.1016/0895-4356(94)00192-S; vandenBerg A, 1997, GENE CHROMOSOME CANC, V19, P59, DOI 10.1002/(SICI)1098-2264(199706)19:2<59::AID-GCC1>3.3.CO;2-O; vandenBerg A, 1996, GENE CHROMOSOME CANC, V15, P64, DOI 10.1002/(SICI)1098-2264(199601)15:1<64::AID-GCC9>3.0.CO;2-2; vandenBerg A, 1997, GENE CHROMOSOME CANC, V19, P220, DOI 10.1002/(SICI)1098-2264(199708)19:4<220::AID-GCC3>3.0.CO;2-Z; vandenBerg E, 1997, CANCER GENET CYTOGEN, V95, P103, DOI 10.1016/S0165-4608(96)00289-0; VANKESSEL AHMG, 1983, P NATL ACAD SCI-BIOL, V80, P3748; Weterman MAJ, 1996, P NATL ACAD SCI USA, V93, P15294, DOI 10.1073/pnas.93.26.15294; Weterman MAJ, 1996, CYTOGENET CELL GENET, V75, P2, DOI 10.1159/000134444; Zbar B, 1996, HUM MUTAT, V8, P348, DOI 10.1002/(SICI)1098-1004(1996)8:4<348::AID-HUMU8>3.3.CO;2-9; Zhuang ZP, 1996, MODERN PATHOL, V9, P838	37	55	56	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1998	62	6					1475	1483		10.1086/301888	http://dx.doi.org/10.1086/301888			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZU224	9585616	Green Published, Bronze			2022-12-18	WOS:000074174700025
J	Hazelwood, S; Shotelersuk, V; Wildenberg, SC; Chen, D; Iwata, F; KaiserKupfer, MI; White, JG; King, RA; Gahl, WA				Hazelwood, S; Shotelersuk, V; Wildenberg, SC; Chen, D; Iwata, F; KaiserKupfer, MI; White, JG; King, RA; Gahl, WA			Evidence for locus heterogeneity in Puerto Ricans with Hermansky-Pudlak syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							STORAGE POOL DEFICIENCY	Hermansky-Pudlak syndrome (HPS) consists of oculocutaneous albinism, a platelet storage-pool deficiency, and ceroid lipofuscinosis. In a recent report on the cloning of an HPS gene, all 22 Puerto Rican HPS patients were homozygous for a 16-bp duplication in exon 15. This presumably reflected a founder effect for the HPS mutation in Puerto Rico. Nevertheless, we ascertained two individuals from central Puerto Rico who lacked the 16-bp duplication, exhibited significant amounts of normal-size HPS mRNA by northern blot analysis, and had haplotypes in the HPS region that were different from the haplotype of every 16-bp-duplication patient. Moreover, these two individuals displayed no mutations in their cDNA sequences, throughout the entire HPS gene. Both patients exhibited pigment dilution, impaired visual acuity, nystagmus, a bleeding diathesis, and absent platelet dense bodies, confirming the diagnosis of HPS. These findings indicate that analysis of Puerto Rican patients for the 16-bp duplication in HPS cannot exclude the diagnosis of HPS. In addition, HPS most likely displays locus heterogeneity, consistent with the existence of several mouse strains manifesting both pigment dilution and a platelet storage-pool deficiency.	NEI,SECT HUMAN BIOCHEM GENET,HERITABLE DISORDERS BRANCH,NICHHD,BETHESDA,MD 20892; NEI,HOWARD HUGHES MED INST,RES SCHOLARS PROGRAM,NIH,BETHESDA,MD 20892; NEI,OPHTHALM GENET & CLIN SERV BRANCH,BETHESDA,MD 20892; UNIV MINNESOTA,DEPT MED,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,DEPT PEDIAT,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,INST HUMAN GENET,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,DEPT LAB MED,MINNEAPOLIS,MN 55455	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); NIH National Eye Institute (NEI); Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities				Shotelersuk, Vorasuk/0000-0002-1856-0589				Bailin T, 1997, J INVEST DERMATOL, V108, P923, DOI 10.1111/1523-1747.ep12294634; Feng GH, 1997, HUM MOL GENET, V6, P793, DOI 10.1093/hmg/6.5.793; GARAY SM, 1979, AM J MED, V66, P737, DOI 10.1016/0002-9343(79)91111-2; Gardner JM, 1997, P NATL ACAD SCI USA, V94, P9238, DOI 10.1073/pnas.94.17.9238; HARMON KR, 1994, J LAB CLIN MED, V123, P617; HERMANSKY F, 1959, BLOOD, V14, P162, DOI 10.1182/blood.V14.2.162.162; LATTION F, 1983, HELV PAEDIATR ACTA, V38, P495; LAZAROW PB, 1995, METABOLIC MOL BASES, V2, P2287; NOVAK EK, 1984, BLOOD, V63, P536; NOVAK EK, 1981, BLOOD, V57, P38; Oh J, 1996, NAT GENET, V14, P300, DOI 10.1038/ng1196-300; Sambrook J, 1989, MOL CLONING LAB MANU; SCHINELLA RA, 1980, ANN INTERN MED, V92, P20, DOI 10.7326/0003-4819-92-1-20; SUMMERS CG, 1988, OPHTHALMOLOGY, V95, P545; WILDENBERG SC, 1995, AM J HUM GENET, V57, P755; Witkop C J, 1990, Bol Asoc Med P R, V82, P333; Witkop C J Jr, 1987, Am J Med, V82, P463; WITKOP CJ, 1987, AM J HEMATOL, V26, P305, DOI 10.1002/ajh.2830260403; WITKOP CJ, 1989, METABOLIC BASIS INHE, V2, P2905	19	55	55	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1997	61	5					1088	1094		10.1086/301611	http://dx.doi.org/10.1086/301611			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YH017	9345105	Bronze, Green Published			2022-12-18	WOS:A1997YH01700013
J	Fujita, R; Buraczynska, M; Gieser, L; Wu, WP; Forsythe, P; Abrahamson, M; Jacobson, SG; Sieving, PA; Andreasson, S; Swaroop, A				Fujita, R; Buraczynska, M; Gieser, L; Wu, WP; Forsythe, P; Abrahamson, M; Jacobson, SG; Sieving, PA; Andreasson, S; Swaroop, A			Analysis of the RPGR gene in 11 pedigrees with the retinitis pigmentosa type 3 genotype: Paucity of mutations in the coding region but splice defects in two families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; SITE SELECTION; LOCUS RP3; LINKAGE; MECHANISM; HOMOLOGY; PATIENT; RCC1	X-linked retinitis pigmentosa (XLRP) is a severe form of inherited progressive retinal degeneration. The RP3 (retinitis pigmentosa type (3) under bar locus at Xp21.1 is believed to account for the disease in the majority of XLRP families. Linkage analysis and identification of patients with chromosomal deletion have refined the location of the RP3 locus and recently have led to the cloning of the RPGR (retinitis pigmentosa GTPase regulator) gene, which has been shown to be mutated in 10%-15% of XLRP patients. In order to systematically characterize the RPGR mutations, we identified 11 retinitis pigmentosa type III (RP3) families by haplotype analysis. Sequence analysis of the PCR-amplified genomic DNA from patients representing these RP3 families did not reveal any causative mutation in RPGR exons 2-19, spanning >98% of the coding region. In patients from two families, we identified transition mutations in the intron region near splice sites (IVS10+3 and IVS13-8). RNA analysis showed that both splice-site mutations resulted in the generation of aberrant RPGR transcripts. Our results support the hypothesis that mutations in the reported RPGR gene are not a common defect in the RP3 subtype of XLRP and that a majority of causative mutations may reside either in as yet unidentified RPGR exons or in another nearby gene at Xp21.1.	UNIV MICHIGAN,WK KELLOGG EYE CTR,DEPT OPHTHALMOL,ANN ARBOR,MI 48105; UNIV MICHIGAN,WK KELLOGG EYE CTR,DEPT HUMAN GENET,ANN ARBOR,MI 48105; LUND UNIV,DEPT CLIN CHEM,LUND,SWEDEN; LUND UNIV,DEPT OPHTHALMOL,LUND,SWEDEN; UNIV PENN,SCHEIE EYE INST,DEPT OPHTHALMOL,PHILADELPHIA,PA 19104	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Lund University; Lund University; University of Pennsylvania; Pennsylvania Medicine			Abrahamson, Magnus/CAG-9507-2022	Jacobson, Samuel/0000-0003-2122-169X; Fujita, Ricardo/0000-0002-9617-5109; Swaroop, Anand/0000-0002-1975-1141	NATIONAL EYE INSTITUTE [R01EY005627, R29EY007961, R01EY007961] Funding Source: NIH RePORTER; NEI NIH HHS [EY05627, EY07003, EY07961] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aldred MA, 1994, MOL GENETICS INHERIT, P259; ANDREASSON S, 1993, ACTA OPHTHALMOL, V71, P487; Andreasson S, 1997, AM J OPHTHALMOL, V124, P95; BHATTACHARYA SS, 1984, NATURE, V309, P253, DOI 10.1038/309253a0; CHIARA MD, 1995, NATURE, V375, P510, DOI 10.1038/375510a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Egan SE, 1996, NATURE, V381, P194, DOI 10.1038/381194a0; Fujita R, 1996, AM J HUM GENET, V59, P152; FUJITA R, 1996, RPGR 1; Heckenlively J. R., 1988, RETINITIS PIGMENTOSA; JACOBSON SG, 1989, EXP EYE RES, V48, P679, DOI 10.1016/0014-4835(89)90009-2; LANG KM, 1983, SCIENCE, V220, P1351, DOI 10.1126/science.6304877; Maquat LE, 1996, AM J HUM GENET, V59, P279; MCGUIRE RE, 1995, AM J HUM GENET, V57, P87; Meindl A, 1996, NAT GENET, V13, P35, DOI 10.1038/ng0596-35; MEINDL A, 1995, HUM MOL GENET, V4, P2339, DOI 10.1093/hmg/4.12.2339; MUSARELLA MA, 1990, GENOMICS, V8, P286, DOI 10.1016/0888-7543(90)90284-2; MUSARELLA MA, 1991, GENOMICS, V11, P263, DOI 10.1016/0888-7543(91)90132-X; OTT J, 1990, P NATL ACAD SCI USA, V87, P701, DOI 10.1073/pnas.87.2.701; Pasman Z, 1996, NUCLEIC ACIDS RES, V24, P1638, DOI 10.1093/nar/24.9.1638; Roepman R, 1996, HUM MOL GENET, V5, P1035, DOI 10.1093/hmg/5.7.1035; Roepman R, 1996, HUM MOL GENET, V5, P827, DOI 10.1093/hmg/5.6.827; Sieving P A, 1995, Semin Ophthalmol, V10, P279, DOI 10.3109/08820539509063799; SMITH CWJ, 1993, MOL CELL BIOL, V13, P4939, DOI 10.1128/MCB.13.8.4939; TEAGUE PW, 1994, AM J HUM GENET, V55, P105; Thiselton DL, 1996, GENOME RES, V6, P1093, DOI 10.1101/gr.6.11.1093	26	55	56	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1997	61	3					571	580		10.1086/515523	http://dx.doi.org/10.1086/515523			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XY523	9326322	Green Published, Bronze			2022-12-18	WOS:A1997XY52300014
J	Yu, J; Lazzeroni, L; Qin, J; Huang, MM; Navidi, W; Erlich, H; Arnheim, N				Yu, J; Lazzeroni, L; Qin, J; Huang, MM; Navidi, W; Erlich, H; Arnheim, N			Individual variation in recombination among human males	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PSEUDOAUTOSOMAL REGION; HUMAN GENOME; LINKAGE MAP; SPERM; FREQUENCY; RATES	Studies of recombination between the markers D6S291 and D6S109 in individuals by sperm typing provide direct. evidence for significant variation in recombination among humans. A statistically significant difference in the recombination fraction (range 5.1%-11.2%) was detected among Rye donors, This variation could reflect polymorphisms in genes affecting recombination or in chromosome structure, Ignoring this variability in studies designed to examine the relationship between physical and genetic distances could lead to incorrect inferences, Individual variation in recombination makes it difficult to predict the recombination fraction for an interval in any particular individual, This could be important in certain genetic counseling situations.	UNIV SO CALIF,PROGRAM MOL BIOL,LOS ANGELES,CA 90089; UNIV SO CALIF,SCH MED,LOS ANGELES,CA; STANFORD UNIV,DEPT STAT,STANFORD,CA 94305; ROCHE MOL SYST,ALAMEDA,CA	University of Southern California; University of Southern California; Stanford University; Roche Holding			Yu, Jian/A-8301-2009; Lazzeroni, Laura/F-2903-2010	Yu, Jian/0000-0002-4021-1000; Lazzeroni, Laura/0000-0002-1846-6920; Arnheim, Norman/0000-0003-1247-1347	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM036745, R01GM053275] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM-53275, R37-GM-36745] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BABRON MC, 1990, ANN HUM GENET, V54, P107, DOI 10.1111/j.1469-1809.1990.tb00366.x; Brooks LD., 1988, EVOLUTION SEX, P87; BUETOW KH, 1991, AM J HUM GENET, V48, P911; CUI XF, 1989, P NATL ACAD SCI USA, V86, P9389, DOI 10.1073/pnas.86.23.9389; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; GEDDEDAHL T, 1972, ANN HUM GENET, V35, P393; GORADIA TM, 1991, GENOMICS, V10, P748, DOI 10.1016/0888-7543(91)90459-R; GUYER MS, 1995, P NATL ACAD SCI USA, V92, P10841, DOI 10.1073/pnas.92.24.10841; HASSOLD TJ, 1991, AM J HUM GENET, V49, P253; HUBERT R, 1992, AM J HUM GENET, V51, P985; LAURIE DA, 1985, ANN HUM GENET, V49, P189, DOI 10.1111/j.1469-1809.1985.tb01693.x; LAZZERONI LC, 1994, AM J HUM GENET, V55, P431; LEEFLANG EP, 1994, CURRENT PROTOCOLS S, V3; LI HH, 1988, NATURE, V335, P414, DOI 10.1038/335414a0; MACDONALD ME, 1989, NEURON, V3, P183, DOI 10.1016/0896-6273(89)90031-7; Neter J., 1990, APPL LINEAR STAT MOD; PARK C, 1995, GENOMICS, V27, P113, DOI 10.1006/geno.1995.1012; REEVES RH, 1990, GENOMICS, V8, P141, DOI 10.1016/0888-7543(90)90236-N; RODERICK TH, 1990, MOUSE NEWS LETT, V85, P87; SCHMITT K, 1994, AM J HUM GENET, V55, P423; THOMSEN M, 1994, EUR J IMMUNOGENET, V21, P33, DOI 10.1111/j.1744-313X.1994.tb00174.x; WEITKAMP LR, 1978, CYTOGENET CELL GENET, V22, P648; YOSHINO M, 1995, GENOMICS, V27, P298, DOI 10.1006/geno.1995.1046; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	24	55	56	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1996	59	6					1186	1192						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV315	8940263				2022-12-18	WOS:A1996VV31500004
J	Brown, WT				Brown, WT			The FRAXE syndrome: Is it time for routine screening?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							FRAGILE-X SYNDROME; DIAGNOSIS				Brown, WT (corresponding author), NEW YORK STATE INST BASIC RES DEV DISABIL,DEPT HUMAN GENET,1050 FOREST HILL RD,STATEN ISL,NY 10314, USA.		Brown, William/GXN-2777-2022					ALLINGHAMHAWKIN.DJ, 1995, AM J HUM GENET, V57, P72; BROOKS SS, 1991, AM J MED GENET, V38, P370, DOI 10.1002/ajmg.1320380242; Brown W T, 1992, Mol Genet Med, V2, P39; BROWN WT, 1993, JAMA-J AM MED ASSOC, V270, P1569, DOI 10.1001/jama.270.13.1569; Brown WT, 1996, AM J HUM GENET, V58, P641; BROWN WT, IN PRESS AM J MED GE; BROWN WT, 1990, AM J HUM GENET, V15, P175; Chakrabarti L, 1996, HUM MOL GENET, V5, P275, DOI 10.1093/hmg/5.2.275; CHEN YT, 1990, P NATL ACAD SCI USA, V87, P3077, DOI 10.1073/pnas.87.8.3077; COY JF, 1995, HUM MOL GENET, V4, P2209, DOI 10.1093/hmg/4.12.2209; GECZ J, IN PRESS NAT GENET; GU Y, IN PRESS NAT GENET; GUSTAVSON KH, 1986, AM J MED GENET, V23, P581, DOI 10.1002/ajmg.1320230152; HAATAJA R, 1994, HUM GENET, V94, P479; HAMEL BCJ, 1994, AM J HUM GENET, V55, P923; HOLDEN JJA, IN PRESS AM J MED GE; KNIGHT SJL, 1994, AM J HUM GENET, V55, P81; Knight SJL, 1996, AM J HUM GENET, V58, P906; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; MCCABE NR, 1992, P NATL ACAD SCI USA, V89, P11794, DOI 10.1073/pnas.89.24.11794; MULLEY JC, 1995, J MED GENET, V32, P162, DOI 10.1136/jmg.32.3.162; Oudet C., 1993, European Journal of Human Genetics, V1, P181; ROUSSEAU F, 1995, AM J HUM GENET, V57, P1006; SHERMAN S, FRAGILE X SYNDROME D, P165; SIOMI MC, 1995, EMBO J, V14, P2401, DOI 10.1002/j.1460-2075.1995.tb07237.x; TRANEBJAERG L, IN PRESS AM J MED GE; TURNER G, IN PRESS AM J MED GE; WANG Q, 1995, J MED GENET, V32, P170, DOI 10.1136/jmg.32.3.170; WANG Q, 1993, LANCET, V342, P1025, DOI 10.1016/0140-6736(93)92882-T; WEBB TP, 1986, AM J MED GENET, V23, P573, DOI 10.1002/ajmg.1320230151; ZHANG Y, 1995, EMBO J, V14, P5358, DOI 10.1002/j.1460-2075.1995.tb00220.x; ZHONG N, IN PRESS AM J MED GE	32	55	55	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1996	58	5					903	905						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UH192	8651273				2022-12-18	WOS:A1996UH19200001
J	Auricchio, A; Brancolini, V; Casari, G; Milla, PJ; Smith, VV; Devoto, M; Ballabio, A				Auricchio, A; Brancolini, V; Casari, G; Milla, PJ; Smith, VV; Devoto, M; Ballabio, A			Locus for a novel syndromic form of neuronal intestinal pseudoobstruction maps to Xq28	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GTP-BINDING PROTEIN; HUMAN X-CHROMOSOME; SMG P25A; REGULATORY PROTEIN; REGION; IDENTIFICATION; GENE; G6PD	The neuronal type of primary chronic idiopathic intestinal pseudoobstruction (CIIP) results from the developmental failure of enteric neurons to migrate or differentiate correctly. This leads to intestinal motility disorders, which are characterized by symptoms and signs of bowel obstruction in the absence of a mechanical obstacle. Most of these conditions are congenital, and among them some are inherited. One syndromic condition characterized by intestinal pseudoobstruction with morphological abnormalities of the argyrophil neurons in the myenteric plexus, associated with short small bowel, malrotation, and pyloric hypertrophy, has been previously described. We have studied a family affected by this disorder, in which the disease appeared to segregate as an X-linked recessive trait. In order to map the CIIP locus in this family, we performed linkage analysis in 26 family members by use of highly polymorphic microsatellite markers from the X chromosome. One of these markers, DXYS154, located in the distal part of Xq28, shows no recombination with a maximum lod score of 2.32. Multipoint analysis excluded linkage with markers spanning other regions of the X chromosome. Our results, integrated with the current genetic and physical map of Xq28, determine the order of loci as cen-DXS15-(CIIPX)-DXS1108/DXYS154-tel. This study establishes, for the first time, the mapping assignment of a neuropathic form of CIIP other than Hirschsprung disease.	TELETHON INST GENET & MED,I-20132 MILAN,ITALY; UNIV NAPLES FEDERICO II,DEPT PEDIAT,NAPLES,ITALY; COLUMBIA UNIV,DEPT PSYCHIAT,NEW YORK,NY 10027; HOSP SICK CHILDREN,GASTROENTEROL UNIT,LONDON WC1N 3JH,ENGLAND; UNIV SIENA,DEPT MOLEC BIOL,I-53100 SIENA,ITALY	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Naples Federico II; Columbia University; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Siena			Devoto, Marcella/AAP-7595-2021; Smith, Virpi/C-2159-2008; Casari, Giorgio/J-3070-2018	Casari, Giorgio/0000-0002-0115-8980; BALLABIO, Andrea/0000-0003-1381-4604; AURICCHIO, Alberto/0000-0002-0832-2472; DEVOTO, MARCELLA/0000-0002-4431-5114; Brancolini, Valeria/0000-0003-0871-537X	NHGRI NIH HHS [HG00008] Funding Source: Medline; Telethon [TGM06S01, TGM94000] Funding Source: Medline	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Telethon(Fondazione Telethon)		ANGRIST M, 1995, HUM MOL GENET, V4, P821, DOI 10.1093/hmg/4.5.821; ARAKI S, 1990, J BIOL CHEM, V265, P13007; ATTIE T, 1995, HUM MOL GENET, V4, P1381, DOI 10.1093/hmg/4.8.1381; ATTIE T, 1995, HUM MOL GENET, V4, P2407, DOI 10.1093/hmg/4.12.2407; BADNER JA, 1990, AM J HUM GENET, V46, P568; BIONE S, 1993, P NATL ACAD SCI USA, V90, P10977, DOI 10.1073/pnas.90.23.10977; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; DONNELLY A, 1994, GENOMICS, V20, P363, DOI 10.1006/geno.1994.1189; EDERY P, 1994, NATURE, V367, P378, DOI 10.1038/367378a0; FAIN PR, 1995, NAT GENET, V9, P261, DOI 10.1038/ng0395-261; FREIJE D, 1992, SCIENCE, V258, P1784, DOI 10.1126/science.1465614; GORLIN JB, 1993, GENOMICS, V17, P496, DOI 10.1006/geno.1993.1354; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Maestrini Elena, 1992, Human Molecular Genetics, V1, P275, DOI 10.1093/hmg/1.4.275; MATSUI Y, 1990, MOL CELL BIOL, V10, P4116, DOI 10.1128/MCB.10.8.4116; Metzenberg Aida B., 1992, Human Molecular Genetics, V1, P97, DOI 10.1093/hmg/1.2.97; MILLA PJ, 1994, CONSTIPATION, P251; MOSSER J, 1994, GENOMICS, V22, P469, DOI 10.1006/geno.1994.1413; MULLIGAN LM, 1994, HUM MOL GENET, V3, P2163, DOI 10.1093/hmg/3.12.2163; OTT J, 1986, AM J HUM GENET, V38, P891; PARRISH JE, 1995, HUM MOL GENET, V4, P1557, DOI 10.1093/hmg/4.9.1557; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; ROMEO G, 1994, NATURE, V367, P377, DOI 10.1038/367377a0; Sambrook J, 1989, MOL CLONING LAB MANU; SEDLACEK Z, 1993, HUM MOL GENET, V2, P1865; SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061; STAIANO A, 1996, BAILLIERS CLIN GASTR, P153; TANNER MS, 1976, ARCH DIS CHILD, V51, P837, DOI 10.1136/adc.51.11.837; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; WILLARD HF, 1994, CYTOGENET CELL GENET, V67, P296	31	55	56	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1996	58	4					743	748						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UA380	8644737				2022-12-18	WOS:A1996UA38000011
J	Betty, DJ; ChinAtkins, AN; Croft, L; Sraml, M; Easteal, S				Betty, DJ; ChinAtkins, AN; Croft, L; Sraml, M; Easteal, S			Multiple independent origins of the COII/tRNA(Lys) intergenic 9-bp mtDNA deletion in Aboriginal Australians	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							HUMAN MITOCHONDRIAL-DNA; LENGTH MUTATIONS; AMPLIFIED DNA; POPULATIONS; DIVERSITY; SUBSTITUTIONS; MIGRATIONS; DIVERGENCE; SEQUENCES; LINEAGES				Betty, DJ (corresponding author), AUSTRALIAN NATL UNIV,JOHN CURTIN SCH MED RES,HUMAN GENET GRP,GPO BOX 334,CANBERRA,ACT 2601,AUSTRALIA.			Easteal, Simon/0000-0002-0462-502X				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; [Anonymous], 1993, MEGA MOL EVOLUTIONAR; BALLINGER SW, 1992, GENETICS, V130, P139; CANN RL, 1983, GENETICS, V104, P699; CANN RL, 1993, TRENDS ECOL EVOL, V8, P27, DOI 10.1016/0169-5347(93)90127-B; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Flood, 1995, ARCHAEOLOGY DREAMTIM; GAO X, 1991, HUM IMMUNOL, V32, P269, DOI 10.1016/0198-8859(91)90090-V; GAO XJ, 1992, IMMUNOGENETICS, V36, P333; GREENBERG JH, 1992, SCI AM           NOV, P60; HAGELBERG E, 1993, P ROY SOC B-BIOL SCI, V252, P163, DOI 10.1098/rspb.1993.0061; HAGELBERG E, 1994, NATURE, V369, P25, DOI 10.1038/369025a0; HARIHARA S, 1992, HUM BIOL, V64, P161; HENDY MD, 1982, MATH BIOSCI, V59, P277, DOI 10.1016/0025-5564(82)90027-X; HERTZBERG M, 1989, AM J HUM GENET, V44, P504; HORAI S, 1986, HUM GENET, V72, P105; HORAI S, 1993, MOL BIOL EVOL, V10, P23; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; LUM JK, 1994, HUM BIOL, V66, P567; MAEDA M, 1989, TISSUE ANTIGENS, V34, P290, DOI 10.1111/j.1399-0039.1989.tb01745.x; NOMURA N, 1991, TISSUE ANTIGENS, V38, P53, DOI 10.1111/j.1399-0039.1991.tb01881.x; PASSARINO G, 1993, AM J HUM GENET, V53, P609; REDD AJ, IN PRESS MOL BIOL EV; ROBERTS RG, 1990, NATURE, V345, P153, DOI 10.1038/345153a0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHURR TG, 1990, AM J HUM GENET, V46, P613; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; SHIELDS GF, 1992, AM J HUM GENET, V50, P758; STONEKING M, 1990, GENETICS, V124, P717; STONEKING M, 1989, COLONIZATION PACIFIC, P215; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; TORRONI A, 1992, GENETICS, V130, P153; VIGILANT L, 1990, THESIS U CALIFORNIA; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; WRISCHNIK LA, 1987, NUCLEIC ACIDS RES, V15, P529, DOI 10.1093/nar/15.2.529	36	55	58	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1996	58	2					428	433						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TR791	8571972				2022-12-18	WOS:A1996TR79100023
J	HABERHAUSEN, G; SCHMITT, I; KOHLER, A; PETERS, U; RIDER, S; CHELLY, J; TERWILLIGER, JD; MONACO, AP; MULLER, U				HABERHAUSEN, G; SCHMITT, I; KOHLER, A; PETERS, U; RIDER, S; CHELLY, J; TERWILLIGER, JD; MONACO, AP; MULLER, U			ASSIGNMENT OF THE DYSTONIA-PARKINSONISM SYNDROME LOCUS, DYT3, TO A SMALL REGION WITHIN A 1.8-MB YAC CONTIG OF XQ13.1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; SYNDROME XDP; POLYMORPHISMS; CLONING; GENE; CONSTRUCTION; MARKERS; DISEASE	A YAC contig was constructed of Xq13.1 in order to sublocalize the X-linked dystonia-parkinsonism (XDP) syndrome locus, DYT3. The contig spans a region of similar to 1.8 Mb and includes loci DXS453/DXS348/IL2R gamma/GJB1/CCG1/DXS559. For the construction of the contig, nine sequence-tagged sites and four short tandem repeat polymorphisms (STRPs) were isolated. The STRPs, designated as 4704#6 (DXS7113), 4704#7 (DXS7114), 67601 (DXS7117), and B4Pst (DXS7119) were assigned to a region Banked by DXS348 proximally and by DXS559 distally. Their order was DXS348/4704 #6/4704 #7/67601/B4Pst/DXS559. They were applied to the analysis of allelic association and of haplotypes in 47 not-obviously-related XDP patients and in 105 Filipino male controls. The same haplotype was found at loci 67601 (DXS7117) and B4Pst (DXS7119) in 42 of 47 patients. This percentage of common haplotypes decreased at the adjacent loci. The findings, together with the previous demonstration of DXS559 being the distal nanking marker of DYT3, assign the disease locus to a small region in Xq13.1 defined by loci 67601 (DXS7117) and B4Pst (DXS7119). The location of DYT3 was born out by the application of a newly developed likelihood method for the analysis of linkage disequilibrium.	UNIV GIESSEN,INST HUMAN GENET,D-35392 GIESSEN,GERMANY; UNIV OXFORD,WELLCOME TRUST CTR HUMAN GENET,OXFORD,ENGLAND; INST COCHIN GENET MOLEC,F-75014 PARIS,FRANCE	Justus Liebig University Giessen; University of Oxford; Wellcome Centre for Human Genetics; Institut National de la Sante et de la Recherche Medicale (Inserm)			Monaco, Anthony P/A-4495-2010; Chelly, Jamel/J-7528-2015	Monaco, Anthony P/0000-0001-7480-3197; Chelly, Jamel/0000-0002-0939-8719	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BARKER DF, 1989, CYTOGENET CELL GENET, V51, P958; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; FAIRWEATHER N, 1994, HUM MOL GENET, V3, P29, DOI 10.1093/hmg/3.1.29; GRAEBER MB, 1992, BRAIN PATHOL, V2, P287, DOI 10.1111/j.1750-3639.1992.tb00706.x; GRAEBER MB, 1992, P NATL ACAD SCI USA, V89, P8245, DOI 10.1073/pnas.89.17.8245; GRAEBER MB, 1992, HUM GENET, V90, P270; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HISATAKE K, 1993, NATURE, V362, P179, DOI 10.1038/362179a0; KOHLER A, 1994, J MED GENET, V31, P712, DOI 10.1136/jmg.31.9.712; KUMAR NM, 1986, J CELL BIOL, V103, P767, DOI 10.1083/jcb.103.3.767; KUPKE KG, 1992, AM J HUM GENET, V50, P808; KUPKE KG, 1990, NEUROLOGY, V40, P1438, DOI 10.1212/WNL.40.9.1438; LAFRENIERE RG, 1993, HUM MOL GENET, V2, P1105, DOI 10.1093/hmg/2.8.1105; LEE LV, 1991, MEDICINE, V70, P179, DOI 10.1097/00005792-199105000-00002; MACDONALD ME, 1991, AM J HUM GENET, V49, P723; MULLER U, 1994, GENOMICS, V23, P114, DOI 10.1006/geno.1994.1465; MULLER U, 1993, ENCY NEUROSCI S, V3, P43; NIZETIC D, 1991, P NATL ACAD SCI USA, V88, P3233, DOI 10.1073/pnas.88.8.3233; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; Roustan P., 1992, Human Molecular Genetics, V1, P778, DOI 10.1093/hmg/1.9.778; RUPPERT S, 1993, NATURE, V362, P175, DOI 10.1038/362175a0; SEKIGUCHI T, 1988, EMBO J, V7, P1683, DOI 10.1002/j.1460-2075.1988.tb02996.x; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; TRIGLIA T, 1988, NUCLEIC ACIDS RES, V16, P8186, DOI 10.1093/nar/16.16.8186; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4037, DOI 10.1093/nar/18.13.4037; WILLARD HF, 1994, CYTOGENET CELL GENET, V67, P296	28	55	56	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1995	57	3					644	650						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR605	7668293				2022-12-18	WOS:A1995RR60500014
J	KAJIHARA, S; MATSUHASHI, S; YAMAMOTO, K; KIDO, K; TSUJI, K; TANAE, A; FUJIYAMA, S; ITOH, T; TANIGAWA, K; UCHIDA, M; SETOGUCHI, Y; MOTOMURA, M; MIZUTA, T; SAKAI, T				KAJIHARA, S; MATSUHASHI, S; YAMAMOTO, K; KIDO, K; TSUJI, K; TANAE, A; FUJIYAMA, S; ITOH, T; TANIGAWA, K; UCHIDA, M; SETOGUCHI, Y; MOTOMURA, M; MIZUTA, T; SAKAI, T			EXON REDEFINITION BY A POINT MUTATION WITHIN EXON-5 OF THE GLUCOSE-6-PHOSPHATASE GENE IS THE MAJOR CAUSE OF GLYCOGEN-STORAGE-DISEASE TYPE-1A IN JAPAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RNA; INVITRO; DNA	Glycogen storage disease (GSD) type la (von Gierke disease) is an autosomal recessive disorder caused by a deficiency in microsomal glucose-6-phosphatase (G6Pase). We have identified a novel mutation in the G6Pase gene of a individual with GSD type 1a. The cDNA from the patient's liver revealed a 91-nt deletion in exon 5. The genomic DNA from the patient's white blood cells revealed no deletion or mutation at the splicing junction of intron 4 and exon 5. The 3' splicing occurred 91 bp from the 5' site of exon 5 (at position 732 in the coding region), causing a substitution of a single nucleotide (G to T) at position 727 in the coding region. Further confirmation of the missplicing was obtained by transient expression of allelic minigene constructs into animal cells. Another eight unrelated families of nine Japanese patients were all found to have this mutation. This mutation is a new type of splicing mutation in the G6Pase gene, and 91% of patients and carriers suffering from GSD1a in Japan are detectable with this splicing mutation.	SAGA MED SCH, DEPT BIOCHEM, SAGA 849, JAPAN; ST MARIANNA MED SCH, DEPT INTERNAL MED 1, KAWASAKI, KANAGAWA, JAPAN; NATL CHILDRENS HOSP, DEPT ENDOCRINOL, TOKYO 154, JAPAN; KUMAMOTO UNIV, SCH MED, DEPT INTERNAL MED 3, KUMAMOTO 860, JAPAN; KINKI UNIV, SCH MED, DEPT INTERNAL MED 2, OSAKA 589, JAPAN; DEPT INTERNAL MED 1, SHIMANE, JAPAN	Saga University; Saint Marianna University; National Center for Child Health & Development - Japan; Kumamoto University; Kindai University (Kinki University)	KAJIHARA, S (corresponding author), SAGA MED SCH, DEPT INTERNAL MED, DIV ENDOCRINOL & METAB, 5-1-1 NABESHIMA, SAGA 849, JAPAN.							BEAUDET AL, 1991, HARRISONS PRINCIPLES, P1854; BURCHELL A, 1988, CLIN CHIM ACTA, V173, P183, DOI 10.1016/0009-8981(88)90256-2; CHENG S, 1994, P NATL ACAD SCI USA, V91, P5695, DOI 10.1073/pnas.91.12.5695; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chou Janice Yang, 1994, American Journal of Human Genetics, V55, pA5; FUKUMAKI Y, 1982, CELL, V28, P585, DOI 10.1016/0092-8674(82)90213-6; GRANDCHAMP B, 1989, NUCLEIC ACIDS RES, V17, P6637, DOI 10.1093/nar/17.16.6637; GREEN MR, 1986, ANNU REV GENET, V20, P671, DOI 10.1146/annurev.ge.20.120186.003323; HORST K, 1993, J CLIN INVEST, V92, P2713; HOSHIDE R, 1993, J CLIN INVEST, V91, P1884, DOI 10.1172/JCI116405; HRS HG, 1989, METABLIC BASIS INHER, P425; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; KATRIN W, 1994, J CLIN INVEST, V93, P1852; KINGSTON RE, 1987, CURRENT PROTOCOLS MO; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LEE B, 1991, J BIOL CHEM, V266, P5256; LEI KJ, 1994, J CLIN INVEST, V93, P1994, DOI 10.1172/JCI117192; LEI KJ, 1993, SCIENCE, V262, P580, DOI 10.1126/science.8211187; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; NAKAI K, 1994, GENE, V141, P171, DOI 10.1016/0378-1119(94)90567-3; NORDLIE RC, 1985, ENZYMES BIOL MEMBR, P349; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.biochem.55.1.1119; PIKIELNY CW, 1985, CELL, V41, P119, DOI 10.1016/0092-8674(85)90066-2; RUSKIN B, 1985, CELL, V41, P833, DOI 10.1016/S0092-8674(85)80064-7; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SUKALSKI KA, 1989, ADV ENZYMOL RAMB, V62, P93; TSUJINO S, 1994, AM J HUM GENET, V54, P812	28	55	67	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1995	57	3					549	555						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR605	7668282				2022-12-18	WOS:A1995RR60500003
J	EISENSMITH, RC; GOLTSOV, AA; ONEILL, C; TYFIELD, LA; SCHWARTZ, EI; KUZMIN, AI; BARANOVSKAYA, SS; TSUKERMAN, GL; TREACY, E; SCRIVER, CR; GUTTLER, F; GULDBERG, P; EIKEN, HG; APOLD, J; SVENSSON, E; NAUGHTEN, E; CAHALANE, SF; CROKE, DT; COCKBURN, F; WOO, SLC				EISENSMITH, RC; GOLTSOV, AA; ONEILL, C; TYFIELD, LA; SCHWARTZ, EI; KUZMIN, AI; BARANOVSKAYA, SS; TSUKERMAN, GL; TREACY, E; SCRIVER, CR; GUTTLER, F; GULDBERG, P; EIKEN, HG; APOLD, J; SVENSSON, E; NAUGHTEN, E; CAHALANE, SF; CROKE, DT; COCKBURN, F; WOO, SLC			RECURRENCE OF THE R408W MUTATION IN THE PHENYLALANINE-HYDROXYLASE LOCUS IN EUROPEANS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMORPHIC DNA HAPLOTYPES; FRAGILE-X SYNDROME; PHENYLKETONURIA MUTATION; MITOCHONDRIAL-DNA; FRENCH-CANADIANS; LINKAGE DISEQUILIBRIUM; MOLECULAR ANALYSIS; MULTIPLE ORIGINS; NATIVE-AMERICANS; RFLP HAPLOTYPES	The relative frequency of the common phenylalanine hydroxylase (PAH) mutation R408W and its associations with polymorphic RFLP, VNTR, and short-tandem-repeat (STR) sites in the PAH gene were examined in many European populations and one representative North American population of defined European descent. This mutation was found to cluster in two regions: in northwest Europe among Irish and Scottish peoples, and in eastern Europe, including the Commonwealth of Independent States. This allele was significantly less frequent in intervening populations. In eastern European populations, the R408W mutation is strongly associated with RFLP haplotype 2, the three-copy VNTR allele (VNTR 3), and the 240-bp STR allele. In northwestern European populations, it is strongly associated with RFLP haplotype 1, the VNTR allele containing eight repeats (VNTR 8), and the 244-bp STR allele. An examination of the linkage between the R408W mutation and highly polymorphic RFLP, VNTR, and STR haplotypes suggests that recurrence is the most likely mechanism to account for the two different major haplotype associations of R408W in Europe.	BAYLOR COLL MED, INST MOLEC GENET, HOUSTON, TX 77030 USA; OUR LADYS HOSP SICK CHILDREN, METAB UNIT, DUBLIN, IRELAND; ROYAL COLL SURGEONS IRELAND, DUBLIN, IRELAND; SOUTHMEAD GEN HOSP, DEPT CLIN CHEM, BRISTOL, AVON, ENGLAND; ST PETERSBURG INST NUCL PHYS, CTR MOLEC DIAGNOST, GATCHINA, RUSSIA; ST PETERSBURG INST NUCL PHYS, LAB HUMAN MOLEC GENET, GATCHINA, RUSSIA; BYELORUSSIA INST HEREDITARY DIS, MINSK, BELARUS; MCGILL UNIV, CHILDRENS HOSP,CTR HUMAN GENET,RES INST, DEBELLE LAB, MONTREAL, PQ H3H 1P3, CANADA; MCGILL UNIV, DEPT BIOL, MONTREAL, PQ H3H 1P3, CANADA; JOHN F KENNEDY INST, GLOSTRUP, DENMARK; UNIV BERGEN, AVDELING MEDISINSK GENET, BERGEN, NORWAY; HUDDINGE UNIV HOSP, DEPT CLIN CHEM, HUDDINGE, SWEDEN; UNIV GLASGOW, ROYAL HOSP SICK CHILDREN, DEPT CHILD HLTH, GLASGOW, LANARK, SCOTLAND	Baylor College of Medicine; Our Ladys Children Hospital Crumlin; Royal College of Surgeons - Ireland; Southmead Hospital; McGill University; McGill University; University of Bergen; Karolinska Institutet; University of Glasgow	EISENSMITH, RC (corresponding author), BAYLOR COLL MED, HOWARD HUGHES MED INST, DEPT CELL BIOL, 1 BAYLOR PLAZA, HOUSTON, TX 77030 USA.			Croke, David/0000-0003-2718-3583; Treacy, Eileen/0000-0002-6226-1615				ABADIE V, 1989, GENOMICS, V5, P936, DOI 10.1016/0888-7543(89)90137-7; Abadie V., 1993, Developmental Brain Dysfunction, V6, P120; APOLD J, 1993, HUM GENET, V51, P1355; AVIGAD S, 1990, NATURE, V344, P168, DOI 10.1038/344168a0; BALLINGER SW, 1992, GENETICS, V130, P139; BARIC I, 1992, HUM GENET, V90, P155, DOI 10.1007/BF00210763; BERTHELON M, 1991, HUM GENET, V86, P355, DOI 10.1007/BF00201832; BICKEL H, 1981, EUR J PEDIATR, V137, P133; CAILLAUD C, 1992, HUM GENET, V89, P69, DOI 10.1007/BF00207045; CHAKRABORTY R, 1987, HUM GENET, V76, P40; CHARIKOVA EV, 1993, HUM HERED, V43, P244, DOI 10.1159/000154138; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; DILELLA AG, 1988, LANCET, V1, P497; DILELLA AG, 1987, NATURE, V327, P333, DOI 10.1038/327333a0; EIKEN HG, 1992, HUM GENET, V88, P608, DOI 10.1007/BF02265283; EIKEN HG, 1991, NUCLEIC ACIDS RES, V19, P1427, DOI 10.1093/nar/19.7.1427; EIKEN HG, 1993, 25TH ANN M EUR SOC H, pA211; Eisensmith Randy C., 1992, Human Mutation, V1, P13, DOI 10.1002/humu.1380010104; EISENSMITH RC, 1992, AM J HUM GENET, V51, P1355; EISENSMITH RC, 1991, MOL BIOL MED, V8, P3; Gimbutas M., 1971, SLAVS; GOLTSOV AA, 1992, AM J HUM GENET, V51, P627; GOLTSOV AA, 1993, HUM MOL GENET, V2, P577, DOI 10.1093/hmg/2.5.577; GULDBERG P, 1993, GENOMICS, V17, P141, DOI 10.1006/geno.1993.1295; GULDBERG P, 1993, HUM MOL GENET, V2, P1703, DOI 10.1093/hmg/2.10.1703; HIRST MC, 1993, J MED GENET, V30, P647, DOI 10.1136/jmg.30.8.647; HORAI S, 1993, MOL BIOL EVOL, V10, P23; IVASCHENKO T, 1993, J MED GENET, V30, P153, DOI 10.1136/jmg.30.2.153; JARUZELSKA J, 1993, J MED GENET, V30, P232, DOI 10.1136/jmg.30.3.232; JOHN SWM, 1990, AM J HUM GENET, V46, P970; JOHN SWM, 1989, AM J HUM GENET, V45, P905; KALAYDJIEVA L, 1990, J MED GENET, V27, P742, DOI 10.1136/jmg.27.12.742; Kalaydjieva L., 1993, Developmental Brain Dysfunction, V6, P39; KALAYDJIEVA L, 1991, HUM GENET, V86, P411; Laing L., 1979, CELTIC BRITAIN; LICHTERKONECKI U, 1989, EUR J PEDIATR, V149, P120, DOI 10.1007/BF01995861; LIN CH, 1992, HUM GENET, V89, P593; LOGAN FD, 1983, VIKINGS HIST; LYONNET S, 1992, AM J HUM GENET, V51, P191; MATSUMOTO H, 1988, HUM GENET, V80, P207, DOI 10.1007/BF01790088; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; OKANO Y, 1990, AM J HUM GENET, V46, P919; PEREZ B, 1992, HUM GENET, V89, P341; PIAZZA A, 1993, SCIENCE, V260, P1767, DOI 10.1126/science.8511584; POWELL TGE, 1966, CELTS; RAMUS SJ, 1992, HUM GENET, V90, P147; RICHARDS RI, 1992, NAT GENET, V1, P257, DOI 10.1038/ng0792-257; SAUGSTAD LF, 1975, CLIN GENET, V7, P52; SCHANFIELD MS, 1992, HUM BIOL, V64, P381; Scriver Charles R., 1993, Developmental Brain Dysfunction, V6, P11; SOKAL RR, 1989, AM J PHYS ANTHROPOL, V80, P267, DOI 10.1002/ajpa.1330800302; SOKAL RR, 1991, NATURE, V351, P143, DOI 10.1038/351143a0; SVENSSON E, 1993, EUR J PEDIATR, V152, P132, DOI 10.1007/BF02072490; Svensson Elisabeth, 1992, Human Mutation, V1, P129; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; Treacy Eileen, 1993, European Journal of Human Genetics, V1, P220; TSAI TF, 1990, HUM GENET, V84, P409; TYFIELD LA, 1991, J MED GENET, V28, P244, DOI 10.1136/jmg.28.4.244; Verelst P., 1993, Developmental Brain Dysfunction, V6, P97; WANG T, 1991, AM J HUM GENET, V48, P628; WANG T, 1991, P NATL ACAD SCI USA, V88, P2146, DOI 10.1073/pnas.88.6.2146; WOOD N, 1993, HUM MUTAT, V2, P131, DOI 10.1002/humu.1380020213; WOOD S, 1993, HUM GENET, V91, P312; ZYGULSKA M, 1991, HUM GENET, V86, P292; ZYGULSKA M, 1991, HUM GENET, V88, P91, DOI 10.1007/BF00204935; 1994, PAH GENE MUTATION AN	69	55	58	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					278	286						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QC101	7825588				2022-12-18	WOS:A1995QC10100036
J	JULIER, C; LUCASSEN, A; VILLEDIEU, P; DELEPINE, M; LEVYMARCHAL, C; DANZE, PM; BIANCHI, F; BOITARD, C; FROGUEL, P; BELL, J; LATHROP, GM				JULIER, C; LUCASSEN, A; VILLEDIEU, P; DELEPINE, M; LEVYMARCHAL, C; DANZE, PM; BIANCHI, F; BOITARD, C; FROGUEL, P; BELL, J; LATHROP, GM			MULTIPLE DNA VARIANT ASSOCIATION ANALYSIS - APPLICATION TO THE INSULIN GENE REGION IN TYPE-I DIABETES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUSCEPTIBILITY; MELLITUS; EXPRESSION; ELEMENTS; LOCUS; HLA	Association and linkage studies have shown that at least one of the genetic factors involved in susceptibility to insulin-dependent diabetes mellitus (IDDM) is contained within a 4.1-kb region of the insulin gene. Sequence analysis has led to the identification of 10 DNA variants in this region that are associated with increased risk for IDDM. These variants are in strong linkage disequilibrium with each other, and previous studies have failed to distinguish between the variant(s) that cause increased susceptibility to IDDM and others that are associated with the disease because of linkage disequilibrium. To address this problem, we have undertaken a large population study of French diabetics and controls and have analyzed genotype patterns for several of the variant sites simultaneously. This has led to the identification of a subset consisting of four variants (-2733AC, -23HphI, -365VNTR, and +1140AC), at least one of which appears to be directly implicated in disease susceptibility. The multiple-DNA-variant association-analysis approach that is applied here to the problem of identifying potential susceptibility variants in IDDM is likely to be important in studies of many other multifactorial diseases.	HOP NECKER ENFANTS MALAD,INSERM,U125,PARIS,FRANCE; HOP ROBERT DEBRE,INSERM,U358,F-75019 PARIS,FRANCE; HOP ROBERT DEBRE,INSERM,CJF93 13,F-75019 PARIS,FRANCE; JOHN RADCLIFFE HOSP,INST MOLEC MED,OXFORD OX3 9DU,ENGLAND; JOHN RADCLIFFE HOSP,NUFFIELD DEPT CLIN MED,OXFORD OX3 9DU,ENGLAND; CTR HOSP REG & UNIV LILLE,HOP B,BIOCHIM LAB,LILLE,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Oxford; University of Oxford; Universite de Lille - ISITE; CHU Lille	JULIER, C (corresponding author), WELLCOME TRUST CTR HUMAN GENET,WINDMILL RD,OXFORD OX3 7BN,ENGLAND.		Villedieu, Philippe/GNM-8071-2022; FROGUEL, Philippe/O-6799-2017; JULIER, Cécile/M-9824-2017; Lucassen, Anneke/D-7764-2017	FROGUEL, Philippe/0000-0003-2972-0784; JULIER, Cécile/0000-0002-1538-0240; BOITARD, Christian/0000-0003-3985-9405; Lucassen, Anneke/0000-0003-3324-4338	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BAIN SC, 1992, NAT GENET, V2, P212, DOI 10.1038/ng1192-212; BELL G I, 1985, American Journal of Human Genetics, V37, pA188; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; DOCHERTY K, 1992, DIABETIC MED, V9, P792, DOI 10.1111/j.1464-5491.1992.tb01896.x; DOMINSKI Z, 1992, MOL CELL BIOL, V12, P2108, DOI 10.1128/MCB.12.5.2108; GANDELMAN KY, 1990, J NEUROCHEM, V55, P2149, DOI 10.1111/j.1471-4159.1990.tb05811.x; HAMMONDKOSACK MCU, 1993, J MOL ENDOCRINOL, V10, P121, DOI 10.1677/jme.0.0100121; HAMMONDKOSACK MCU, 1992, J MOL ENDOCRINOL, V9, P221, DOI 10.1677/jme.0.0090221; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KOCKUM I, 1993, AM J HUM GENET, V53, P150; LUCASSEN AM, 1993, NAT GENET, V4, P305, DOI 10.1038/ng0793-305; MACDONALD ME, 1992, NAT GENET, V1, P99, DOI 10.1038/ng0592-99; OWERBACH D, 1993, DIABETES, V42, P1708, DOI 10.2337/diabetes.42.12.1708; OWERBACH D, 1983, GENETICS, V32, P475; TAKEDA J, 1989, FEBS LETT, V247, P41, DOI 10.1016/0014-5793(89)81236-0; THOMSON G, 1988, AM J HUM GENET, V43, P799; THOMSON G, 1984, AM J HUM GENET, V36, P1309	18	55	56	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1994	55	6					1247	1254						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB684	7977386				2022-12-18	WOS:A1994QB68400023
J	SULISALO, T; KLOCKARS, J; MAKITIE, O; FRANCOMANO, CA; DELACHAPELLE, A; KAITILA, I; SISTONEN, P				SULISALO, T; KLOCKARS, J; MAKITIE, O; FRANCOMANO, CA; DELACHAPELLE, A; KAITILA, I; SISTONEN, P			HIGH-RESOLUTION LINKAGE DISEQUILIBRIUM MAPPING OF THE CARTILAGE HAIR HYPOPLASIA GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOME-9; FINLAND; MAP; POLYMORPHISMS; POPULATIONS; LOCUS	We recently assigned the gene for an autosomal recessive skeletal dysplasia, cartilage-hair hypoplasia (CHH), to 9p21-p13 in Finnish and Amish families. An association was observed between CHH and alleles at D9S163 in both family series, suggesting that these loci are in linkage disequilibrium and close to each other. Here we extended these studies by exploiting the linkage-disequilibrium information that can be obtained from families with a single affected child, and we studied 66 Finnish CHH families with seven microsatellite markers. The analysis based on the Luria and Delbruck (1943) method and adapted to the study of human founder populations suggests that the distance between CHH and D3S163 is similar to 0.3 cM. An eight-point linkage analysis modified to take advantage of all possible information in 15 Finnish and 17 Amish families was capable of narrowing the likely location of CHH to within an interval of 1.7 cM on a male map. The peak lod score of 54.92 was attained 0.03 and 0.1 cM proximal to D9S163 on the male and female maps, respectively. These results confirm the power of genetic resolution, that lies in the study of linkage disequilibrium in well-defined founder populations with one major ancestral disease mutation.	UNIV HELSINKI,CENT HOSP,DEPT MED GENET,HELSINKI,FINLAND; UNIV HELSINKI,CENT HOSP,CHILDRENS HOSP,HELSINKI,FINLAND; FINNISH RED CROSS & BLOOD TRANSFUS SERV,SF-00310 HELSINKI,FINLAND; JOHNS HOPKINS UNIV HOSP,CTR MED GENET,BALTIMORE,MD 21205	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Johns Hopkins University; Johns Hopkins Medicine	SULISALO, T (corresponding author), UNIV HELSINKI,DEPT MED GENET,HAARTMANINKATU 3,POB 21,SF-00014 HELSINKI,FINLAND.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000373] Funding Source: NIH RePORTER; NHGRI NIH HHS [P01-HG00373] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		CAVALLISFORZA LL, 1993, EUR J HUM GENET, V1, P3; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; GRAW SL, 1993, HUM MOL GENET, V2, P614, DOI 10.1093/hmg/2.5.614-a; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HELLSTEN E, 1993, GENOMICS, V16, P720, DOI 10.1006/geno.1993.1253; KWIATKOWSKI DJ, 1993, AM J HUM GENET, V53, P1279; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; Luria SE, 1943, GENETICS, V28, P491; MAKITIE O, 1992, J MED GENET, V29, P652, DOI 10.1136/jmg.29.9.652; MAKITIE O, 1992, EUR J PEDIATR, V152, P211; MCKUSICK VA, 1965, B J HOPKINS HOSP, V116, P232; Meinander C.F., 1984, SUOMEN VAESTON ESIHI, P21; NEVANLINNA HR, 1972, HEREDITAS-GENETISK A, V71, P195; SHARMA V, 1991, NUCLEIC ACIDS RES, V19, P4023, DOI 10.1093/nar/19.14.4023-a; SULISALO T, 1993, NAT GENET, V3, P338, DOI 10.1038/ng0493-338; SULISALO T, 1994, GENOMICS, V20, P347, DOI 10.1006/geno.1994.1187; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; WEBER JL, 1991, NUCLEIC ACIDS RES, V18, P2203; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WILKIE PJ, 1992, GENOMICS, V12, P607, DOI 10.1016/0888-7543(92)90456-3	21	55	55	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1994	55	5					937	945						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB682	7977356				2022-12-18	WOS:A1994QB68200013
J	BOESPFLUGTANGUY, O; MIMAULT, C; MELKI, J; CAVAGNA, A; GIRAUD, G; DINH, DP; DASTUGUE, B; DAUTIGNY, A; AICARDI, J; GOUTTIERES, F; BAUMANN, N; BERTINI, E; DAVID, A; HENOCQ, A; LANDRIEU, P; TARDIEU, M; LEBERRE, C; LEMAREC, B; LYON, G; MAYER, M; PINARD, JM; PONSOT, G; MATHIEU, M; SAINTIVE, JP; SAURA, R; VALLEE, L				BOESPFLUGTANGUY, O; MIMAULT, C; MELKI, J; CAVAGNA, A; GIRAUD, G; DINH, DP; DASTUGUE, B; DAUTIGNY, A; AICARDI, J; GOUTTIERES, F; BAUMANN, N; BERTINI, E; DAVID, A; HENOCQ, A; LANDRIEU, P; TARDIEU, M; LEBERRE, C; LEMAREC, B; LYON, G; MAYER, M; PINARD, JM; PONSOT, G; MATHIEU, M; SAINTIVE, JP; SAURA, R; VALLEE, L			GENETIC HOMOGENEITY OF PELIZAEUS-MERZBACHER-DISEASE - TIGHT LINKAGE TO THE PROTEOLIPOPROTEIN LOCUS IN 16 AFFECTED FAMILIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEOLIPID PROTEIN GENE; HUMAN X-CHROMOSOME; PLP GENE; PRENATAL-DIAGNOSIS; MUTATION; DNA; DISORDER; DELETION; VARIANT; CDNA	Among the numerous leukodystrophies that have an early onset and no biochemical markers, Pelizaeus-Merzbacher disease (PMD) is one that can be identified using strict clinical criteria and demonstrating an abnormal formation of myelin that is restricted to the CNS in electrophysiological studies and brain magnetic resonance imaging (MRI). In PMD, 12 different base substitutions and one total deletion of the genomic region containing the PLP gene have been reported, but, despite extensive analysis, PLP exon mutations have been found in only 10%-25% of the families analyzed. To test the genetic homogeneity of this disease, we have carried out linkage analysis with polymorphic markers of the PLP genomic region in 16 families selected on strict diagnostic criteria of PMD. We observed a tight linkage of the PMD locus with markers of the PLP gene (cDNA PLP, exon IV polymorphism) and of the Xq22 region (DXS17, DXS94, and DXS287), whereas the markers located more proximally (DXYS1X and DXS3) or distally (DXS11) were not linked to the PMD locus. Multipoint analysis gave a maximal location score for the PMD locus (13.38) and the PLP gene (8.32) in the same interval between DXS94 and DXS287, suggesting that in all families PMD is linked to the PLP locus. Mutations of the extraexonic PLP gene sequences or of another unknown close gene could be involved in PMD. In an attempt to identify molecular defects of this genomic region that are responsible for PMD, these results meant that RFLP analysis could be used to improve genetic counseling for the numerous affected families in which a PLP exon mutation could not be demonstrated.	HOP NECKER ENFANTS MALAD,INSERM,U393,F-75743 PARIS,FRANCE; UNIV PARIS 06,INST NEUROSCI,EQUIPE ATIPE,URA 1488,PARIS,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite	BOESPFLUGTANGUY, O (corresponding author), FAC MED CLERMONT FERRAND,INSERM,U384,28 PL HENRI DUNANT,BP 38,F-63001 CLERMONT FERRAND,FRANCE.		Bertini, Enrico/ABG-1278-2020; Bertini, Enrico/A-2284-2014	Bertini, Enrico/0000-0001-9276-4590				BOULLOCHE J, 1986, J CHILD NEUROL, V1, P233, DOI 10.1177/088307388600100310; BRIDGE PJ, 1991, AM J MED GENET, V38, P616, DOI 10.1002/ajmg.1320380423; BRIDGE PJ, 1992, AM J HUM GENET, V209, P823; BRIDGE PJ, 1991, AM J HUM GENET, V49, pA183; CAMPAGNONI AT, 1988, MOL NEUROBIOL, V2, P41, DOI 10.1007/BF02935632; CARO PA, 1990, MAGN RESON IMAGING, V8, P8128; DINH DP, 1991, P NATL ACAD SCI USA, V88, P7562; DINH DP, 1993, HUM MOL GENET, V4, P465; DINH DP, 1991, NEUROREPORT, V2, P89; DOLL R, 1992, AM J HUM GENET, V51, P161; GENCIC S, 1989, AM J HUM GENET, V45, P435; HUDSON LD, 1989, P NATL ACAD SCI USA, V86, P8128, DOI 10.1073/pnas.86.20.8128; Hudson Lynn D., 1992, P677; IWAKI A, 1993, HUM MOL GENET, V2, P19, DOI 10.1093/hmg/2.1.19; JEANPIERRE M, 1987, NUCLEIC ACIDS RES, V15, P9611, DOI 10.1093/nar/15.22.9611; JOHNSON VP, 1991, AM J MED GENET, V41, P355, DOI 10.1002/ajmg.1320410318; KEATS B, 1989, CYTOGENET CELL GENET, V51, P459, DOI 10.1159/000132805; KLEINDORFER DO, 1993, AM J HUM GENET, V53, P1171; KORNREICH R, 1992, GENOMICS, V13, P70, DOI 10.1016/0888-7543(92)90203-5; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MAENPAA J, 1990, CLIN GENET, V37, P141; MATTEI MG, 1986, HUM GENET, V72, P352, DOI 10.1007/BF00290964; McKusick V.A., 1992, MENDELIAN INHERITANC; Merzbacher L., 1910, Z F R GESAMTE NEUROL, V3, P1, DOI [10.1007/BF02893591, DOI 10.1007/BF02893591]; MORTON NE, 1956, AM J HUM GENET, V8, P80; MRAD R, 1992, HUM GENET, V90, P420; NISENBAU.C, 1965, ANN PAEDIATR-BASEL, V204, P365; PAROLINI O, 1993, GENOMICS, V15, P342, DOI 10.1006/geno.1993.1066; Pelizaeus F., 1885, ARCH PSYCHIAT NERVEN, V16, P698; PRATT VM, 1992, AM J MED GENET, V43, P642, DOI 10.1002/ajmg.1320430335; PRATT VM, 1991, AM J MED GENET, V38, P136, DOI 10.1002/ajmg.1320380129; PRATT VM, 1993, AM J HUM GENET, V52, P1053; RASKIND WH, 1991, AM J HUM GENET, V49, P1355; Seitelberger F., 1970, HDB CLINICAL NEUROLO, V10, P150; TROFATTER JA, 1989, P NATL ACAD SCI USA, V86, P9427, DOI 10.1073/pnas.86.23.9427; TROFATTER JA, 1990, NUCLEIC ACIDS RES, V19, P6057; WILKUS RJ, 1976, NEUROLOGY, V26, P1042, DOI 10.1212/WNL.26.11.1042; WILLIAMSON R, 1991, CYTOGENET CELL GENET, V58, P1624; WU JS, 1987, NUCLEIC ACIDS RES, V15, P1882, DOI 10.1093/nar/15.4.1882	39	55	56	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1994	55	3					461	467						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PF509	7915877				2022-12-18	WOS:A1994PF50900007
J	YAOUANQ, J; PERICHON, M; CHORNEY, M; PONTAROTTI, P; LETREUT, A; ELKAHLOUN, A; MAUVIEUX, V; BLAYAU, M; JOUANOLLE, AM; CHAUVEL, B; MOIRAND, R; NOUEL, O; LEGALL, JY; FEINGOLD, J; DAVID, V				YAOUANQ, J; PERICHON, M; CHORNEY, M; PONTAROTTI, P; LETREUT, A; ELKAHLOUN, A; MAUVIEUX, V; BLAYAU, M; JOUANOLLE, AM; CHAUVEL, B; MOIRAND, R; NOUEL, O; LEGALL, JY; FEINGOLD, J; DAVID, V			ANONYMOUS MARKER LOCI WITHIN 400 KB OF HLA-A GENERATE HAPLOTYPES IN LINKAGE DISEQUILIBRIUM WITH THE HEMOCHROMATOSIS GENE (HFE)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CLASS-I REGION; CYSTIC-FIBROSIS MUTATIONS; HEREDITARY HEMOCHROMATOSIS; IDIOPATHIC HEMOCHROMATOSIS; NONRANDOM ASSOCIATION; HUNTINGTON DISEASE; DNA MARKERS; SERUM IRON; HUMAN MHC; POLYMORPHISMS	The hemochromatosis gene (HFE) maps to 6p21.3 and is less than 1 cM from the HLA class I genes; however, the precise physical location of the gene has remained elusive and controversial. The unambiguous identification of a crossover event within hemochromatosis families is very difficult; it is particularly hampered by the variability of the phenotypic expression as well as by the sex- and age-related penetrance of the disease. For these practical considerations, traditional linkage analysis could prove of limited value in further refining the extrapolated physical position of HFE. We therefore embarked upon a linkage-disequilibrium analysis of HFE and normal chromosomes from the Brittany population. In the present report, 66 hemochromatosis families yielding 151 hemochromatosis chromosomes and 182 normal chromosomes were RFLP-typed with a battery of probes, including two newly derived polymorphic markers from the 6.7 and HLA-F loci located 150 and 250 kb telomeric to HLA-A, respectively. The results suggest a strong peak of existing linkage disequilibrium focused within the i82-to-6.7 interval (approximately 250 kb). The zone of linkage disequilibrium is flanked by the i97 locus, positioned 30 kb proximal to i82, and the HLA-F gene, found 250 kb distal to HLA-A, markers of which display no significant association with HFE. These data support the possibility that HFE resides within the 400-kb expanse of DNA between i97 and HLA-F. Alternatively, the very tight association of HLA-AS and allele 1 of the 6.7 locus, both of which are comprised by the major ancestral or founder HFE haplotype in Brittany, supports the possibility that the disease gene may reside immediately telomeric to the 6.7 locus within the linkage-disequilibrium zone. Additionally, hemochromatosis haplotypes possessing HLA-A11 and the low-frequency HLA-F polymorphism (allele 2) are supportive of a separate founder chromosome containing a second, independently arising mutant allele. Overall, the establishment of a likely ''hemochromatosis critical region'' centromeric boundary and the identification of a linkage-disequilibrium zone both significantly contribute to a reduction in the amount of DNA required to be searched for novel coding sequences constituting the HFE defect.	CHU RENNES, SERV EPIDEMIOL & HYG HOSP, RENNES, FRANCE; CHU RENNES, BIOCHIM MED LAB B, RENNES, FRANCE; CHU RENNES, MED CLIN A, RENNES, FRANCE; PENN STATE UNIV, COLL MED, DEPT MICROBIOL & IMMUNOL, HERSHEY, PA USA; HOP PURPAN, CRPG, CNRS, TOULOUSE, FRANCE; INSERM, UNITE EPIDEMIOL GENET 155, PARIS, FRANCE; CH, SERV HEPATOL & GASTROENTEROL, ST BRIEUC, FRANCE	CHU Rennes; CHU Rennes; CHU Rennes; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Centre National de la Recherche Scientifique (CNRS); CHU de Toulouse; Universite de Lorraine; Institut National de la Sante et de la Recherche Medicale (Inserm)			, pontarotti/ABB-1753-2021	Moirand, Romain/0000-0002-5346-5755; Pierre, Pontarotti/0000-0001-7202-3648				ADAMS PC, 1991, GASTROENTEROLOGY, V101, P368, DOI 10.1016/0016-5085(91)90013-B; ANDREW S, 1992, GENOMICS, V13, P301, DOI 10.1016/0888-7543(92)90246-O; ANTONARAKIS SE, 1982, P NATL ACAD SCI-BIOL, V79, P137, DOI 10.1073/pnas.79.1.137; BARKER D, 1984, AM J HUM GENET, V36, P1159; BORECKI IB, 1990, AM J HUM GENET, V47, P542; BORECKI IB, 1990, HUM HERED, V40, P159, DOI 10.1159/000153924; BORETTO J, 1992, HUM GENET, V89, P33, DOI 10.1007/BF00207038; CHAKRABORTY R, 1987, HUM GENET, V76, P40; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; CHORNEY MJ, 1990, MOL CELL BIOL, V10, P243, DOI 10.1128/MCB.10.1.243; CRAGG SJ, 1988, HUM GENET, V80, P63, DOI 10.1007/BF00451458; CUTTING GR, 1992, AM J HUM GENET, V50, P1185; DAVID V, 1989, HUM GENET, V81, P123, DOI 10.1007/BF00293887; DAWKINS RL, 1983, IMMUNOL REV, V70, P5, DOI 10.1111/j.1600-065X.1983.tb00707.x; EDWARDS CQ, 1986, AM J HUM GENET, V38, P805; ELKAHLOUN A, 1992, IMMUNOGENETICS, V35, P183; ELKAHLOUN A, 1993, HUM MOL GENET, V2, P55; ESTIVILL X, 1988, AM J HUM GENET, V43, P23; FEREC C, 1992, NAT GENET, V1, P188, DOI 10.1038/ng0692-188; FUJITA R, 1990, P NATL ACAD SCI USA, V87, P1796, DOI 10.1073/pnas.87.5.1796; GASPARINI P, 1993, HUM MOL GENET, V2, P571, DOI 10.1093/hmg/2.5.571; GERAGHTY DE, 1992, P NATL ACAD SCI USA, V89, P2669, DOI 10.1073/pnas.89.7.2669; GERAGHTY DE, 1990, J EXP MED, V171, P1, DOI 10.1084/jem.171.1.1; GRUEN JR, 1992, GENOMICS, V14, P232, DOI 10.1016/S0888-7543(05)80211-3; HALLIDAY JW, 1992, GASTROENTEROLOGY, V102, P1071, DOI 10.1016/0016-5085(92)90201-9; HANSEN JL, 1989, CYTOGENET CELL GENET, V50, P216, DOI 10.1159/000132763; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; JOUANOLLE AM, 1990, HUM GENET, V85, P279, DOI 10.1007/BF00206746; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KOLLER BH, 1989, J EXP MED, V169, P469, DOI 10.1084/jem.169.2.469; LALOUEL JM, 1988, ANN NY ACAD SCI, V526, P34, DOI 10.1111/j.1749-6632.1988.tb55490.x; LALOUEL JM, 1985, AM J HUM GENET, V37, P700; LEMIGNON L, 1983, CLIN GENET, V24, P171; LITT M, 1986, AM J HUM GENET, V39, P166; LORD DK, 1990, HUM GENET, V85, P531; LOVETT M, 1991, P NATL ACAD SCI USA, V88, P9628, DOI 10.1073/pnas.88.21.9628; MACDONALD ME, 1992, NAT GENET, V1, P99, DOI 10.1038/ng0592-99; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MACDONALD ME, 1989, NEURON, V3, P183, DOI 10.1016/0896-6273(89)90031-7; MISEREZ AR, 1993, AM J HUM GENET, V52, P808; NIEDERAU C, 1985, NEW ENGL J MED, V313, P1256, DOI 10.1056/NEJM198511143132004; OKANO Y, 1991, NEW ENGL J MED, V324, P1232, DOI 10.1056/NEJM199105023241802; PAGE RCL, 1995, DIABETIC MED, V12, P209, DOI 10.1111/j.1464-5491.1995.tb00460.x; PARIMOO S, 1991, P NATL ACAD SCI USA, V88, P9623, DOI 10.1073/pnas.88.21.9623; POWELL LW, 1990, GASTROENTEROLOGY, V98, P1625, DOI 10.1016/0016-5085(90)91100-K; POWELL LW, 1988, ANN NY ACAD SCI, V526, P23, DOI 10.1111/j.1749-6632.1988.tb55489.x; PRITCHARD C, 1992, AM J HUM GENET, V50, P1218; RENWICK JH, 1968, B EUR SOC HUM GENET, V2, P7; SATYANARAYANA K, 1992, IMMUNOGENETICS, V35, P235, DOI 10.1007/BF00166828; SHUKLA H, 1991, GENOMICS, V10, P905, DOI 10.1016/0888-7543(91)90178-H; SIMON M, 1988, ANN NY ACAD SCI, V526, P11, DOI 10.1111/j.1749-6632.1988.tb55488.x; SIMON M, 1977, NEW ENGL J MED, V297, P1017, DOI 10.1056/NEJM197711102971901; SIMON M, 1974, NOUV PRESSE MED, V4, P1432; SIMON M, 1976, GUT, V17, P332, DOI 10.1136/gut.17.5.332; SIMON M, 1987, AM J HUM GENET, V41, P89; SIMON M, 1980, PROGR MED GENETICS, P135; SIMON M, 1988, IMMUNOGENETICS ENDOC, P345; SIMON M, 1985, SEP EUR IR CLUB M AM; SIMON M, 1990, PRINCIPLE PRACTICE M, P1783; SUTTER J, 1968, POPULATION, V23, P303, DOI 10.2307/1527490; SUTTER J, 1972, LUXATION CONGENITALE; Sutter J, 1952, POPULATION, V7, P249, DOI 10.2307/1524207; THOMPSON EA, 1988, AM J HUM GENET, V42, P113; VENDITTI CP, 1992, GENOMICS, V14, P1003, DOI 10.1016/S0888-7543(05)80123-5; VENDITTI CP, UNPUB TAQI POLYMORPH; YAOUANQ J, 1992, J MED GENET, V29, P320, DOI 10.1136/jmg.29.5.320; YAOUANQ J, 1989, JUL POSTGR COURS CLI; ZIMMERER EJ, 1991, IMMUNOGENETICS, V33, P132, DOI 10.1007/BF00210827	69	55	55	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1994	54	2					252	263						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU315	8304342				2022-12-18	WOS:A1994MU31500010
J	SHAW, D; RAY, A; MARAZITA, M; FIELD, L				SHAW, D; RAY, A; MARAZITA, M; FIELD, L			FURTHER EVIDENCE OF A RELATIONSHIP BETWEEN THE RETINOIC ACID RECEPTOR ALPHA-LOCUS AND NONSYNDROMIC CLEFT-LIP WITH OR WITHOUT CLEFT-PALATE (CL PLUS-OR-MINUS P)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter											SHAW, D (corresponding author), UNIV CALGARY,DEPT PEDIAT,DIV MED GENET,CALGARY T2N 1N4,ALBERTA,CANADA.				NIDCR NIH HHS [R01 DE016148] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016148] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ABBOTT BD, 1990, TERATOLOGY, V42, P597, DOI 10.1002/tera.1420420604; BLACK DM, 1993, AM J HUM GENET, V52, P702; BOWCOCK AM, 1993, AM J HUM GENET, V52, P718; CHENEVIXTRENCH G, 1992, AM J HUM GENET, V51, P1377; GREENBERG DA, 1993, AM J HUM GENET, V52, P135; HALL JM, 1992, AM J HUM GENET, V50, P1235; RAY AK, 1993, AM J HUM GENET, V52, P1006	7	55	56	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1993	53	5					1156	1157						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MC333	8213839				2022-12-18	WOS:A1993MC33300021
J	DIXON, MJ; DIXON, J; HOUSEAL, T; BHATT, M; WARD, DC; KLINGER, K; LANDES, GM				DIXON, MJ; DIXON, J; HOUSEAL, T; BHATT, M; WARD, DC; KLINGER, K; LANDES, GM			NARROWING THE POSITION OF THE TREACHER-COLLINS SYNDROME LOCUS TO A SMALL INTERVAL BETWEEN 3 NEW MICROSATELLITE MARKERS AT 5Q32-33.1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; MANDIBULOFACIAL DYSOSTOSIS; LONG ARM; POLYMORPHISMS; CHROMOSOME-5; REGIONS; GENOME; HUMANS; MAPS	Treacher Collins syndrome (TCOF1) is an autosomal dominant disorder of craniofacial development, the features of which include conductive hearing loss and cleft palate. The TCOF1 locus has been localized to chromosome 5q32-33.2. In the present study we have used the combined techniques of genetic linkage analysis and fluorescence in situ hybridization (FISH) to more accurately define the TCOF1 critical region. Cosmids IG90 and SPARC, which map to distal 5q, encompass two and one hypervariable microsatellite markers, respectively. The heterozygosity values of these three markers range from .72 to .81. Twenty-two unrelated TCOF1 families have been analyzed for linkage to these markers. There is strong evidence demonstrating linkage to all three markers, the strongest support for positive linkage being provided by haplotyping those markers at the locus encompassed by the cosmid IG90 (Z(max) = 19.65; theta = .010). FISH to metaphase chromosomes and interphase nuclei established that IG90 lies centromeric to SPARC. This information combined with the data generated by genetic linkage analysis demonstrated that the TCOF1 locus is closely flanked proximally by IG90 and distally by SPARC.	INTEGRAT GENET INC,FRAMINGHAM,MA; YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT MOLEC BIOPHYS,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT BIOCHEM,NEW HAVEN,CT 06510	Yale University; Yale University; Yale University	DIXON, MJ (corresponding author), UNIV MANCHESTER,DEPT CELL & STRUCT BIOL,3D FLOOR,STOPFORD BLDG,OXFORD RD,MANCHESTER M13 9PL,LANCS,ENGLAND.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANAND R, 1990, NUCLEIC ACIDS RES, V18, P1951, DOI 10.1093/nar/18.8.1951; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; CONNOR JM, 1988, ESSENTIAL MED GENETI; CURRAN ME, 1992, GENOMICS, V12, P729, DOI 10.1016/0888-7543(92)90302-9; Dixon Michael J., 1992, Human Molecular Genetics, V1, P249, DOI 10.1093/hmg/1.4.249; DIXON MJ, 1991, AM J HUM GENET, V49, P17; DIXON MJ, 1991, AM J HUM GENET, V48, P274; FERGUSON MWJ, 1988, DEVELOPMENT, V103, P41; HASTBACKA J, 1991, GENOMICS, V11, P968, DOI 10.1016/0888-7543(91)90021-6; JABS EW, 1991, GENOMICS, V11, P193; KAY ED, 1989, AM J MED GENET, V32, P27, DOI 10.1002/ajmg.1320320107; KLINGER K, 1991, 11TH INT WORKSH HUM, P50; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEBEAU MM, IN PRESS NUCLEIC ACI; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; NICOLAIDES KH, 1984, PRENATAL DIAG, V4, P201, DOI 10.1002/pd.1970040307; OLSON M, 1989, SCIENCE, V245, P1434, DOI 10.1126/science.2781285; OTT J, 1978, ANN HUM GENET, V42, P225; PHELPS PD, 1981, CLIN OTOLARYNGOL, V6, P15, DOI 10.1111/j.1365-2273.1981.tb01782.x; ROYLE NJ, 1988, GENOMICS, V3, P352, DOI 10.1016/0888-7543(88)90127-9; RYAN SG, 1992, ANN NEUROL, V31, P663, DOI 10.1002/ana.410310615; Sambrook J., 1989, MOL CLONING LAB MANU; VILLARREAL XC, 1989, BIOCHEMISTRY-US, V28, P6483, DOI 10.1021/bi00441a049; WARRINGTON JA, 1992, GENOMICS, V13, P803, DOI 10.1016/0888-7543(92)90156-M; WARRINGTON JA, 1991, GENOMICS, V11, P701, DOI 10.1016/0888-7543(91)90078-S; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; WEBER JL, 1989, AM J HUM GENET, V44, P388; WILLARD HF, 1986, P NATL ACAD SCI USA, V83, P5611, DOI 10.1073/pnas.83.15.5611; YOUNG MF, 1990, CONNECT TISSUE RES, V24, P17, DOI 10.3109/03008209009152419	30	55	57	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1993	52	5					907	914						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LB889	8488840				2022-12-18	WOS:A1993LB88900007
J	VOOIJS, M; YU, LC; TKACHUK, D; PINKEL, D; JOHNSON, D; GRAY, JW				VOOIJS, M; YU, LC; TKACHUK, D; PINKEL, D; JOHNSON, D; GRAY, JW			LIBRARIES FOR EACH HUMAN-CHROMOSOME, CONSTRUCTED FROM SORTER-ENRICHED CHROMOSOMES BY USING LINKER-ADAPTER PCR	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FLUORESCENCE INSITU HYBRIDIZATION; CELL HYBRIDS; DNA; INTERPHASE; METAPHASE; REGIONS; GENE; MICRODISSECTION; COMPLEMENTATION; AMPLIFICATION	We describe here the production of complex libraries enriched in sequences from each human chromosome type, starting with only a few thousand sorter-purified chromosomes. In this procedure, DNA is extracted from the sorted chromosomes, digested to completion by using the frequently cutting restriction endonuclease Sau3A1, and ligated, on each end, to an adaptor oligonucleotide. These fragments are then amplified using PCR with a sequence homologous to the adaptor oligonucleotide as a primer. We have used this procedure to produce PCR libraries for each of the 24 human chromosomes. These libraries were characterized by gel electrophoresis and found to be composed of a continuum of sequences ranging in size from a few hundred to approximately 1,000 bp. The libraries, when used as probes for fluorescence in situ hybridization, stained the target chromosomes more or less continuously, even after PCR amplification for more than 200 cycles. These libraries are useful as hybridization probes to facilitate molecular cytogenetic studies and as sources of probes either for identification of polymorphic short tandemly repeated sequences or for development of sequence-tagged sites.	UNIV CALIF SAN FRANCISCO,LAB MED LAB,DIV MOLEC CYTOMETRY,SAN FRANCISCO,CA 94143; STANFORD UNIV,MED CTR,SCH MED,MED CTR,DEPT PATHOL,STANFORD,CA 94305; UNIV MIAMI,SCH MED,DEPT BIOCHEM & MOLEC BIOL,MIAMI,FL 33152	University of California System; University of California San Francisco; Stanford University; University of Miami			Vooijs, Marc/K-3522-2019		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017665] Funding Source: NIH RePORTER; NICHD NIH HHS [HD 00081, HD 17665] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ATHWAL RS, 1985, SOMAT CELL MOLEC GEN, V11, P177, DOI 10.1007/BF01534706; CHANG KS, 1992, GENOMICS, V12, P307, DOI 10.1016/0888-7543(92)90378-6; CIRULLO RE, 1984, SOMAT CELL MOLEC GEN, V10, P225, DOI 10.1007/BF01535245; COLLINS C, 1991, GENOMICS, V11, P997, DOI 10.1016/0888-7543(91)90025-A; CREMER T, 1990, CYTOMETRY, V11, P110, DOI 10.1002/cyto.990110113; CREMER T, 1988, HUM GENET, V80, P235, DOI 10.1007/BF01790091; DAVIES KE, 1987, CYTOGENET CELL GENET, V46, P277, DOI 10.1159/000132481; GRAY JW, 1987, SCIENCE, V238, P323, DOI 10.1126/science.2443974; HENDERSON AS, 1972, P NATL ACAD SCI USA, V69, P3394, DOI 10.1073/pnas.69.11.3394; JOHNSON DH, 1990, GENOMICS, V6, P243, DOI 10.1016/0888-7543(90)90563-A; KUO WL, 1991, AM J HUM GENET, V49, P112; KURNIT DM, 1986, CYTOGENET CELL GENET, V43, P109, DOI 10.1159/000132305; LATT SA, 1989, FLOW CYTOGENETICS, P243; LENGAUER C, 1990, HUM GENET, V96, P1; LICHTER P, 1990, P NATL ACAD SCI USA, V87, P6634, DOI 10.1073/pnas.87.17.6634; LICHTER P, 1988, HUM GENET, V80, P224, DOI 10.1007/BF01790090; LUCAS JN, 1992, INT J RADIAT BIOL, V62, P53, DOI 10.1080/09553009214551821; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; RASHIDBAIGI A, 1986, P NATL ACAD SCI USA, V83, P384, DOI 10.1073/pnas.83.2.384; RAZIUDDIN A, 1984, P NATL ACAD SCI-BIOL, V81, P5504, DOI 10.1073/pnas.81.17.5504; SAUNDERS RDC, 1989, NUCLEIC ACIDS RES, V17, P9027, DOI 10.1093/nar/17.22.9027; SILLAR R, 1981, J HISTOCHEM CYTOCHEM, V29, P74, DOI 10.1177/29.1.6162882; THOMPSON LH, 1985, SOMAT CELL MOLEC GEN, V11, P87, DOI 10.1007/BF01534738; THOMPSON LH, 1987, SOMAT CELL MOLEC GEN, V13, P539, DOI 10.1007/BF01534495; THOMPSON LH, 1989, GENOMICS, V5, P670, DOI 10.1016/0888-7543(89)90107-9; TRASK B, 1988, HUM GENET, V78, P251, DOI 10.1007/BF00291672; TRASK BJ, 1991, SOMAT CELL MOLEC GEN, V17, P117, DOI 10.1007/BF01232970; VANDENENGH GJ, 1985, CYTOMETRY, V6, P92, DOI 10.1002/cyto.990060203; VANDILLA M, 1989, FLOW CYTOGENETICS, P257; WESLEY CS, 1990, NUCLEIC ACIDS RES, V18, P599, DOI 10.1093/nar/18.3.599; 1991, NIH912011	31	55	72	1	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1993	52	3					586	597						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KR720	8447324				2022-12-18	WOS:A1993KR72000016
J	PETERSEN, MB; FRANTZEN, M; ANTONARAKIS, SE; WARREN, AC; VAN BROECKHOVEN, C; CHAKRAVARTI, A; COX, TK; LUND, C; OLSEN, B; POULSEN, H; SAND, A; TOMMERUP, N; MIKKELSEN, M				PETERSEN, MB; FRANTZEN, M; ANTONARAKIS, SE; WARREN, AC; VAN BROECKHOVEN, C; CHAKRAVARTI, A; COX, TK; LUND, C; OLSEN, B; POULSEN, H; SAND, A; TOMMERUP, N; MIKKELSEN, M			COMPARATIVE-STUDY OF MICROSATELLITE AND CYTOGENETIC MARKERS FOR DETECTING THE ORIGIN OF THE NONDISJOINED CHROMOSOME-21 IN DOWN-SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GT DINUCLEOTIDE REPEAT; DNA POLYMORPHISMS; PARENTAL ORIGIN; DOWN-SYNDROME; MEIOTIC RECOMBINATION; REDUCED RECOMBINATION; NON-DISJUNCTION; HUMAN GENOME; NONDISJUNCTION; TRISOMY-21	Nondisjunction in trisomy 21 has traditionally been studied by cytogenetic heteromorphisms. Those studies assumed no crossing-over on the short arm of chromosome 21. Recently, increased accuracy of detection of the origin of nondisjunction has been demonstrated by DNA polymorphism analysis. We describe a comparative study of cytogenetic heteromorphisms and seven PCR-based DNA polymorphisms for detecting the origin of the additional chromosome 21 in 68 cases of Down syndrome. The polymorphisms studied were the highly informative microsatellites at loci D21S215, D21S120, D21S192, IFNAR, D21S156, HMG14, and D21S171. The meiotic stage of nondisjunction was assigned on the basis of the pericentromeric markers D21S215, D21S120, and D21S192. Only unequivocal cytogenetic results were compared with the results of the DNA analysis. The parental and meiotic division origin could be determined in 51% of the cases by using the cytogenetic markers and in 88% of the cases by using the DNA markers. Although there were no discrepancies between the two scoring systems regarding parental origin, there were eight discrepancies regarding melotic stage of nondisjunction. Our results raise the possibility of recombination between the two marker systems, particularly on the short arm.	DANISH CTR HUMAN GENOME RES, GLOSTRUP, DENMARK; JOHNS HOPKINS UNIV, SCH MED, CTR MED GENET, DEPT PEDIAT, BALTIMORE, MD 21205 USA; UNIV ANTWERP, DEPT BIOCHEM, ANTWERP, BELGIUM; UNIV PITTSBURGH, DEPT HUMAN GENET, PITTSBURGH, PA 15260 USA	Aarhus University; Johns Hopkins University; University of Antwerp; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	PETERSEN, MB (corresponding author), JOHN F KENNEDY INST, DEPT MED GENET, 7 GL LANDEVEJ, DK-2600 GLOSTRUP, DENMARK.		Antonarakis, Stylianos E/N-8866-2014; Van Broeckhoven, Christine/M-7853-2019; Petersen, Michael Bjørn B/D-1483-2017	Antonarakis, Stylianos E/0000-0001-8907-5823; Van Broeckhoven, Christine/0000-0003-0183-7665; Petersen, Michael Bjørn B/0000-0003-0316-8207	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD024605] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000373] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG 00373] Funding Source: Medline; NICHD NIH HHS [N01-HD92707, HD 24605] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANTONARAKIS SE, 1991, NEW ENGL J MED, V324, P872, DOI 10.1056/NEJM199103283241302; ANTONARAKIS SE, 1992, AM J HUM GENET, V50, P544; ANTONARAKIS SE, 1985, P NATL ACAD SCI USA, V82, P3360, DOI 10.1073/pnas.82.10.3360; BRICARELLI FD, 1989, HUM GENET, V82, P20, DOI 10.1007/BF00288265; BRICARELLI FD, 1990, AM J MED GENET, P129; BURMELSTER M, 1990, NUCLEIC ACIDS RES, V18, P4969, DOI 10.1093/nar/18.16.4969; CHAKRAVARTI A, 1987, Genomics, V1, P35, DOI 10.1016/0888-7543(87)90102-9; CHAKRAVARTI A, 1989, AM J HUM GENET, V44, P639; DAGNABRICARELLI F, 1988, HUM GENET, V79, P124, DOI 10.1007/BF00280549; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; DAVIES KE, 1984, HUM GENET, V66, P54, DOI 10.1007/BF00275186; DELMAZO J, 1982, HUM GENET, V62, P316, DOI 10.1007/BF00304546; ECONOMOU EP, 1990, P NATL ACAD SCI USA, V87, P2951, DOI 10.1073/pnas.87.8.2951; GALT J, 1989, HUM GENET, V81, P113, DOI 10.1007/BF00293885; HAMERS AJH, 1990, CLIN GENET, V37, P463; HASSOLD TJ, 1991, AM J HUM GENET, V49, P253; HASSOLD TJ, 1984, ANNU REV GENET, V18, P69, DOI 10.1146/annurev.genet.18.1.69; JABS EW, 1991, GENOMICS, V9, P141, DOI 10.1016/0888-7543(91)90231-3; JUBERG RC, 1983, AM J MED GENET, V16, P111, DOI 10.1002/ajmg.1320160117; LAURIE DA, 1985, ANN HUM GENET, V49, P189, DOI 10.1111/j.1469-1809.1985.tb01693.x; LEWIS JG, 1990, GENOMICS, V8, P400, DOI 10.1016/0888-7543(90)90300-J; LITT M, 1989, AM J HUM GENET, V44, P397; MCINNIS MG, 1991, GENOMICS, V11, P573, DOI 10.1016/0888-7543(91)90064-L; MEIJER H, 1989, HUM GENET, V83, P280, DOI 10.1007/BF00285173; MIKKELSEN M, 1980, ANN HUM GENET, V44, P17, DOI 10.1111/j.1469-1809.1980.tb00942.x; MILLINGTONWARD AM, 1988, HUM GENET, V80, P362, DOI 10.1007/BF00273652; MORTON NE, 1990, ANN HUM GENET, V54, P39, DOI 10.1111/j.1469-1809.1990.tb00359.x; NIELSEN KG, 1988, HUM GENET, V78, P103, DOI 10.1007/BF00291249; PERRONI L, 1990, AM J MED GENET, P141; PETERSEN MB, 1990, GENOMICS, V7, P136, DOI 10.1016/0888-7543(90)90531-X; PETERSEN MB, 1991, AM J HUM GENET, V48, P65; PETERSEN MB, 1991, GENOMICS, V9, P407, DOI 10.1016/0888-7543(91)90406-5; PETERSEN MB, 1991, HUM GENET, V87, P401; RUDD NL, 1988, HUM GENET, V78, P175, DOI 10.1007/BF00278191; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SHERMAN SL, 1991, AM J HUM GENET, V49, P608; SMEETS HJM, 1989, HUM GENET, V83, P245, DOI 10.1007/BF00285165; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STEWART GD, 1988, AM J HUM GENET, V42, P227; STEWART GD, 1985, NUCLEIC ACIDS RES, V13, P4125, DOI 10.1093/nar/13.11.4125; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; VANCAMP G, 1991, HUM GENET, V87, P649, DOI 10.1007/BF00201718; WARREN AC, 1987, SCIENCE, V237, P652, DOI 10.1126/science.2955519; WARREN AC, IN PRESS GENOMICS; WEBER JL, 1989, AM J HUM GENET, V44, P388; ZULIANI G, 1990, AM J HUM GENET, V46, P963	46	55	56	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1992	51	3					516	525						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JJ828	1386710				2022-12-18	WOS:A1992JJ82800008
J	UPADHYAYA, M; LUNT, P; SARFARAZI, M; BROADHEAD, W; FARNHAM, J; HARPER, PS				UPADHYAYA, M; LUNT, P; SARFARAZI, M; BROADHEAD, W; FARNHAM, J; HARPER, PS			THE MAPPING OF CHROMOSOME-4Q MARKERS IN RELATION TO FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY (FSHD)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LANDOUZY-DEJERINE DISEASE; LONG ARM; HUNTINGTONS-DISEASE; DNA MARKER; GENE; LINKAGE; LOCUS	Four DNA markers on the distal long arm of chromosome 4 have been analyzed for their linkage relationship to facioscapulohumeral muscular dystrophy (FSHD) in a series of 23 families with this disease. Two hypervariable markers, pH30 (D4S139) and EFD 139.1 (D4S184), both show close linkage with the disorder, with a maximum recombination fraction (theta(max)) of .02 and a maximum lod score (Z(max)) of 36.77 and 34.50, respectively; two other markers, the locus for factor XI (F11) and the microsatellite marker Mfd22 (D4S171), both show less close linkage, with respective theta(max) of .16 (Z(max) = 3.40) for F11 and .24 (Z(max) = 1.61) for D4S171. While the relative ordering and orientation of the loci on the chromosome remain provisional, analysis of 15 individual recombination events in seven families supports the order D4S171-F11-D4S184-D4S139-FSHD, with the disease locus telomeric to all four markers.	CHILDRENS HOSP,CLIN GENET UNIT,BRISTOL,ENGLAND; UNIV CONNECTICUT,CTR HLTH,DEPT PEDIAT,FARMINGTON,CT 06032	Bristol Royal Hospital For Children; University of Connecticut	UPADHYAYA, M (corresponding author), UNIV WALES COLL MED,INST MED GENET,HEATH PK,CARDIFF CF4 4XN,S GLAM,WALES.		Lunt, Peter/AAF-8265-2020					ALTHERR MR, 1991, NUCLEIC ACIDS RES, V19, P1168, DOI 10.1093/nar/19.5.1168; BUETOW KH, 1991, AM J HUM GENET, V48, P911; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V44, P63; Dystrophia musculorum progressiva, 1954, J AMER MED ASSOC, V154, DOI [10.1001/jama.1954.02940490080030, DOI 10.1001/JAMA.1954.02940490080030]; KATO A, 1989, CYTOGENET CELL GENET, V52, P77, DOI 10.1159/000132844; LUNT PW, 1989, J MED GENET, V26, P535, DOI 10.1136/jmg.26.8.535; LUNT PW, 1989, J MED GENET, V26, P755, DOI 10.1136/jmg.26.12.755; LUNT PW, 1988, J NEUROL SCI, V88, P287, DOI 10.1016/0022-510X(88)90225-0; LUNT PW, 1991, J MED GENET, V28, P655, DOI 10.1136/jmg.28.10.655; MACDONALD ME, 1989, NEURON, V3, P183, DOI 10.1016/0896-6273(89)90031-7; MILLS KA, 1992, AM J HUM GENET, V51, P432; MILNER ECB, 1989, NUCLEIC ACIDS RES, V17, P4002, DOI 10.1093/nar/17.10.4002; Padberg G., 1982, THESIS U LEIDEN LEID; SARFARAZI M, 1989, J MED GENET, V26, P481, DOI 10.1136/jmg.26.8.481; SARFARAZI M, 1992, AM J HUM GENET, V51, P396; SNELL RG, 1989, CYTOGENET CELL GENET, V51, P1083; UPADHYAYA M, 1989, J MED GENET, V26, P490, DOI 10.1136/jmg.26.8.490; UPADHYAYA M, 1990, LANCET, V336, P1320, DOI 10.1016/0140-6736(90)93005-A; UPADHYAYA M, 1991, J MED GENET, V28, P665, DOI 10.1136/jmg.28.10.665; WEBER B, 1990, NUCLEIC ACIDS RES, V18, P3353, DOI 10.1093/nar/18.11.3353; Wijmenga C, 1990, LANCET, V336, P651, DOI 10.1016/0140-6736(90)92148-B; WIJMENGA C, 1991, GENOMICS, V9, P570, DOI 10.1016/0888-7543(91)90348-I; [No title captured]; [No title captured]; [No title captured]	25	55	56	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1992	51	2					404	410						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JF776	1642238				2022-12-18	WOS:A1992JF77600021
J	FUJIMORI, M; WELLS, SA; NAKAMURA, Y				FUJIMORI, M; WELLS, SA; NAKAMURA, Y			FINE-SCALE MAPPING OF THE GENE RESPONSIBLE FOR MULTIPLE ENDOCRINE NEOPLASIA TYPE-I (MENI)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; SMALL REGION; CHROMOSOME-11; LOCALIZATION; TUMORS; HUMANS; DEFECT	We have constructed a high-resolution genetic linkage map in the vicinity of the gene responsible for multiple endocrine neoplasia type 1 (MEN1). The mutation causing this disease, inherited as an autosomal dominant, predisposes carriers to development of neoplastic tumors in the parathyroid, the endocrine pancreas, and the anterior lobe of the pituitary. The 12 markers on the genetic linkage map reported here span nearly 20 cM, and linkage analysis of MEN1 pedigrees has placed the MEN1 locus within the 8-cM region between D11S480 and D11S546. The markers on this map will be useful for prenatal or presymptomatic diagnosis of individuals in families that segregate a mutant allele of the MEN1 gene.	JAPANESE FDN CANC RES,INST CANC,DEPT BIOCHEM,1-37-1 KAMI IKEBUKURO,TOKYO 170,JAPAN; WASHINGTON UNIV,SCH MED,DEPT SURG,ST LOUIS,MO 63110	Japanese Foundation for Cancer Research; Washington University (WUSTL)								BALE AE, 1991, CANCER RES, V51, P1154; BYSTROM C, 1990, P NATL ACAD SCI USA, V87, P1968, DOI 10.1073/pnas.87.5.1968; CARLSON M, 1988, NUCLEIC ACIDS RES, V16, P10403, DOI 10.1093/nar/16.21.10403; JULIER C, 1990, CYTOGEENT CELL GENET, V51, P226; LARSSON C, 1988, NATURE, V332, P85, DOI 10.1038/332085a0; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LATHROP GM, 1988, GENOMICS, V2, P157; MATHEW CGP, 1991, LANCET, V337, P7, DOI 10.1016/0140-6736(91)93329-8; NAKAMURA Y, 1988, AM J HUM GENET, V43, P638; NAKAMURA Y, 1989, AM J HUM GENET, V44, P751; SKOGSEID B, 1987, J CLIN ENDOCR METAB, V64, P1233, DOI 10.1210/jcem-64-6-1233; TANIGAMI A, 1992, AM J HUM GENET, V50, P56; TOKINO T, 1991, AM J HUM GENET, V48, P258	14	55	56	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1992	50	2					399	403						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HD001	1734719				2022-12-18	WOS:A1992HD00100016
J	GIESELMANN, V; FLUHARTY, AL; TONNESEN, T; VONFIGURA, K				GIESELMANN, V; FLUHARTY, AL; TONNESEN, T; VONFIGURA, K			MUTATIONS IN THE ARYLSULFATASE-A PSEUDODEFICIENCY ALLELE CAUSING METACHROMATIC LEUKODYSTROPHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EXPRESSION; DEFICIENCY; FAMILY	We identified a patient suffering from late infantile metachromatic leukodystrophy who genetically seemed to be homozygous for the mutations signifying the arylsulfatase A pseudodeficiency allele. Homozygosity for the pseudodeficiency allele is associated with low arylsulfatase A activity but does not cause a disease. Analysis of the arylsulfatase A gene in this patient revealed a C --> T transition in exon 2, causing a Ser 96 --> Phe substitution in addition to the sequence alterations causing arylsulfatase A pseudodeficiency. Although this mutation was found only in 1 of 78 metachromatic leukodystrophy patients tested, five more patients were identified who seemed hetero- or homozygous for the pseudodeficiency allele. The existence of nonfunctional arylsulfatase A alleles derived from the pseudodeficiency allele calls for caution when the diagnosis of arylsulfatase A pseudodeficiency is based solely on the identification of the mutations characterizing the pseudodeficiency allele.	UNIV CALIF LOS ANGELES,SCH MED,LANTERMAN DEV CTR RES GRP,POMONA,CA; JOHN F KENNEDY INST,GLOSTRUP,DENMARK	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	GIESELMANN, V (corresponding author), UNIV GOTTINGEN,INST BIOCHEM 2,DEPT BIOCHEM 2,GOSSLERSTR 12D,W-3400 GOTTINGEN,GERMANY.							ARTELT P, 1988, GENE, V68, P213, DOI 10.1016/0378-1119(88)90023-6; GIESELMANN V, 1991, HUM GENET, V86, P251; GIESELMANN V, 1989, P NATL ACAD SCI USA, V86, P9436, DOI 10.1073/pnas.86.23.9436; GUSTAVSON KH, 1971, ACTA PAEDIATR SCAND, V60, P585, DOI 10.1111/j.1651-2227.1971.tb06994.x; HERZ B, 1984, HUM GENET, V66, P147, DOI 10.1007/BF00286589; HOHENSCHUTZ C, 1989, HUM GENET, V82, P45, DOI 10.1007/BF00288270; KAPPLER J, 1991, EUR J PEDIATR, V150, P287, DOI 10.1007/BF01955534; KIHARA H, 1980, PEDIATR RES, V14, P224, DOI 10.1203/00006450-198003000-00009; KOLODNY EH, 1989, METABOLIC BASIS INHE, V2, P1721; KREYSING J, 1990, EUR J BIOCHEM, V191, P627, DOI 10.1111/j.1432-1033.1990.tb19167.x; NAKAMAYE KL, 1986, NUCLEIC ACIDS RES, V14, P9679, DOI 10.1093/nar/14.24.9679; POLTEN A, 1991, NEW ENGL J MED, V324, P18, DOI 10.1056/NEJM199101033240104; Sambrook J., 1989, MOL CLONING LAB MANU; STEIN C, 1989, J BIOL CHEM, V264, P1252; TABOR S, 1987, CURRENT PROTOCOLS MO; TONNESEN T, 1983, ACTA PAEDIATR SCAND, V72, P175, DOI 10.1111/j.1651-2227.1983.tb09692.x	16	55	57	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1991	49	2					407	413						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GA866	1678251				2022-12-18	WOS:A1991GA86600018
J	CHEHAB, FF; JOHNSON, J; LOUIE, E; GOOSSENS, M; KAWASAKI, E; ERLICH, H				CHEHAB, FF; JOHNSON, J; LOUIE, E; GOOSSENS, M; KAWASAKI, E; ERLICH, H			A DIMORPHIC 4-BP REPEAT IN THE CYSTIC-FIBROSIS GENE IS IN ABSOLUTE LINKAGE DISEQUILIBRIUM WITH THE DELTA-F508 MUTATION - IMPLICATIONS FOR PRENATAL-DIAGNOSIS AND MUTATION ORIGIN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA; AMPLIFICATION; IDENTIFICATION; SEQUENCE; POLYMERASE	The gene causing cystic fibrosis (CF) has been recently cloned, and the major mutation (DELTA-F508) accounting for approximately 70% of CF chromosomes has been uncovered. We have identified at the 3' end of intron 6 in the CF gene a 4-bp tandem repeat (GATT) that exhibits interesting features. First, PCR screening of 103 normal individuals revealed that the repeat exists only in two polymorphic allelic forms, either as a hexamer or a heptamer. These two alleles are in Hardy-Weinberg equilibrium and predict a heterozygote frequency of 41% (rho[seven repeats] = .71; q [six repeats] = .29). Second, the allele with six repeats was found linked to DELTA-F508 on all 76 CF chromosomes investigated, demonstrating strong linkage disequilibrium and suggesting that DELTA-F508 had originated on the gene bearing six repeats. Third, when the repeat alleles are linked to the DNA markers XV2c and KM19, extended haplotypes are generated. These new haplotypes become informative in situations in which prenatal diagnosis cannot be performed solely with XV2c and KM19. Since this repeat marker is located in the CF gene and would be very less likely to recombine with the gene, it can serve as a valuable DNA marker for haplotype analysis. A possible crossover, however, was identified between XV2c and KM19, transferring DELTA-F508 to a different haplotype.	HOP HENRI MONDOR,F-94010 CRETEIL,FRANCE; CETUS CORP,EMERYVILLE,CA 94608; CHILDRENS HOSP,DIV MED GENET,OAKLAND,CA	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	CHEHAB, FF (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT LAB MED,SAN FRANCISCO,CA 94143, USA.							BEAUDET AL, 1988, NEW ENGL J MED, V318, P50; CHEHAB FF, 1989, P NATL ACAD SCI USA, V86, P9178, DOI 10.1073/pnas.86.23.9178; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; DEAN M, 1990, CELL, V61, P863, DOI 10.1016/0092-8674(90)90196-L; ESTIVILL X, 1987, Genomics, V1, P257, DOI 10.1016/0888-7543(87)90052-8; FELDMAN GL, 1988, LANCET, V2, P102; Kawasaki E.S., 1990, PCR PROTOCOLS GUIDE, P146; KELLER EB, 1984, P NATL ACAD SCI-BIOL, V81, P7417, DOI 10.1073/pnas.81.23.7417; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KEREM BS, IN PRESS P NATL ACAD; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LEMNA WK, 1990, NEW ENGL J MED, V322, P291, DOI 10.1056/NEJM199002013220503; NEWTON CR, 1989, LANCET, V2, P1481; REED R, 1988, GENE DEV, V2, P1268, DOI 10.1101/gad.2.10.1268; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; ROSENBLOOM CL, 1989, NUCLEIC ACIDS RES, V17, P7117, DOI 10.1093/nar/17.17.7117; SAIKI RK, 1989, P NATL ACAD SCI USA, V86, P6230, DOI 10.1073/pnas.86.16.6230; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232	20	55	58	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1991	48	2					223	226						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EV744	1990833				2022-12-18	WOS:A1991EV74400006
J	EMI, M; HATA, A; ROBERTSON, M; IVERIUS, PH; HEGELE, R; LALOUEL, JM				EMI, M; HATA, A; ROBERTSON, M; IVERIUS, PH; HEGELE, R; LALOUEL, JM			LIPOPROTEIN-LIPASE DEFICIENCY RESULTING FROM A NONSENSE MUTATION IN EXON-3 OF THE LIPOPROTEIN-LIPASE GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV UTAH, HLTH SCI CTR,HOWARD HUGHES MED INST,WINTROBE BLDG, 6TH FLOOR, SALT LAKE CITY, UT 84132 USA; UNIV UTAH, DEPT HUMAN GENET, SALT LAKE CITY, UT 84132 USA; VET ADM MED CTR, SALT LAKE CITY, UT USA; UNIV UTAH, HLTH SCI CTR, DEPT INTERNAL MED, SALT LAKE CITY, UT 84132 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA); Utah System of Higher Education; University of Utah			Hegele, Robert/G-3301-2011; Hegele, Robert/AAF-6482-2020	Hegele, Robert/0000-0003-2861-5325				BRUNZELL JD, 1989, METABOLIC BASIS INHE, P1128; DEEB SS, 1989, BIOCHEMISTRY-US, V28, P4132, DOI 10.1021/bi00436a001; DEVLIN RH, 1990, AM J HUM GENET, V46, P112; EMI M, 1990, J BIOL CHEM, V265, P5910; EMI M, 1988, GENOMICS, V3, P373, DOI 10.1016/0888-7543(88)90130-9; GARFINKEL AS, 1987, PLASMA LIPOPROTEINS, P335; LANGLOIS S, 1989, P NATL ACAD SCI USA, V86, P948, DOI 10.1073/pnas.86.3.948; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NAKAMURA Y, 1988, AM J HUM GENET, V43, P638; NIKKILA EA, 1983, METABOLIC BASIS INHE, P622; Saiki R. K., 1988, Genome analysis: a practical approach., P141; WION KL, 1987, SCIENCE, V235, P1638, DOI 10.1126/science.3823907	12	55	55	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1990	47	1					107	111						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DK482	2349938				2022-12-18	WOS:A1990DK48200015
J	FIRON, N; EYAL, N; KOLODNY, EH; HOROWITZ, M				FIRON, N; EYAL, N; KOLODNY, EH; HOROWITZ, M			GENOTYPE ASSIGNMENT IN GAUCHER DISEASE BY SELECTIVE AMPLIFICATION OF THE ACTIVE GLUCOCEREBROSIDASE GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									WEIZMANN INST SCI,DEPT CHEM IMMUNOL,IL-76100 REHOVOT,ISRAEL; EUNICE KENNEDY SHRIVER CTR MENT RETARDAT,WALTHAM,MA	Weizmann Institute of Science				, Nurit/0000-0002-1096-1425				Barranger J. A., 1989, METABOLIC BASIS INHE, P1677; BRADY RO, 1965, BIOCHEM BIOPH RES CO, V18, P221, DOI 10.1016/0006-291X(65)90743-6; BRADY RO, 1973, LYSOSOMES STORAGE DI; BRADY RO, 1983, METABOLIC BASIS INHE, P841; CONNER BJ, 1983, P NATL ACAD SCI-BIOL, V80, P278, DOI 10.1073/pnas.80.1.278; DINUR T, 1986, P NATL ACAD SCI USA, V83, P1660, DOI 10.1073/pnas.83.6.1660; GRAVES PN, 1988, DNA-J MOLEC CELL BIO, V7, P521, DOI 10.1089/dna.1.1988.7.521; HOROWITZ M, 1989, GENOMICS, V4, P87, DOI 10.1016/0888-7543(89)90319-4; KIDD VJ, 1983, NATURE, V304, P230, DOI 10.1038/304230a0; KOGAN SC, 1987, NEW ENGL J MED, V317, P985, DOI 10.1056/NEJM198710153171603; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; PATRICK AD, 1965, BIOCHEM J, V97, pC17, DOI 10.1042/bj0970017C; PIRASTU M, 1983, NEW ENGL J MED, V309, P284, DOI 10.1056/NEJM198308043090506; RAGHAVAN SS, 1980, AM J HUM GENET, V32, P158; REINER O, 1988, DNA-J MOLEC CELL BIO, V7, P107, DOI 10.1089/dna.1988.7.107; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; STUDENCKI AB, 1984, DNA-J MOLEC CELL BIO, V3, P7, DOI 10.1089/dna.1.1984.3.7; TSUJI S, 1988, P NATL ACAD SCI USA, V85, P2349, DOI 10.1073/pnas.85.7.2349; TSUJI S, 1987, NEW ENGL J MED, V316, P570, DOI 10.1056/NEJM198703053161002; WIGDERSON M, 1989, AM J HUM GENET, V44, P365; WONG C, 1987, NATURE, V330, P384, DOI 10.1038/330384a0	23	55	55	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1990	46	3					527	532						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CT668	2309702				2022-12-18	WOS:A1990CT66800015
J	CURRY, CJR; TSAI, J; HUTCHINSON, HT; JASPERS, NGJ; WARA, D; GATTI, RA				CURRY, CJR; TSAI, J; HUTCHINSON, HT; JASPERS, NGJ; WARA, D; GATTI, RA			ATFRESNO - A PHENOTYPE LINKING ATAXIA-TELANGIECTASIA WITH THE NIJMEGEN BREAKAGE SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF FRESNO,VALLEY CHILDRENS HOSP,DEPT CYTOGENET,FRESNO,CA 93703; UNIV CALIF FRESNO,VALLEY CHILDRENS HOSP,DEPT NEUROL,FRESNO,CA 93703; ERASMUS UNIV,CELL BIOL & GENET LAB,3000 DR ROTTERDAM,NETHERLANDS; UNIV CALIF SAN FRANCISCO,DEPT PEDIAT,SAN FRANCISCO,CA 94143; UNIV CALIF LOS ANGELES,DEPT PATHOL,LOS ANGELES,CA 90024	University of California System; University of California San Francisco; University of California San Francisco at Fresno; University of California System; University of California San Francisco; University of California San Francisco at Fresno; Erasmus University Rotterdam; University of California System; University of California San Francisco; University of California System; University of California Los Angeles	CURRY, CJR (corresponding author), UNIV CALIF FRESNO,VALLEY CHILDRENS HOSP,DEPT MED GENET,3151 N MILLBROOK,FRESNO,CA 93703, USA.							BYRNE E, 1984, J NEUROL SCI, V66, P307, DOI 10.1016/0022-510X(84)90019-4; CONLEY ME, 1986, BLOOD, V67, P1251; FIORILLI M, 1985, HUM GENET, V70, P274; GATTI RA, 1988, NATURE, V336, P577, DOI 10.1038/336577a0; JASPERS NGJ, 1988, AM J HUM GENET, V42, P66; JASPERS NGJ, 1982, P NATL ACAD SCI-BIOL, V79, P2641, DOI 10.1073/pnas.79.8.2641; JASPERS NGJ, IN PRESS CYTOGENET C; JASPERS NGJ, 1985, ATAXIA TELANGIECTASI, P147; KOJIS TL, IN PRESS HUM GENET; MARASCHIO P, 1986, CLIN GENET, V30, P353; SEEMANOVA E, 1985, AM J MED GENET, V20, P639, DOI 10.1002/ajmg.1320200410; SPERLING K, 1983, PROSPETTIVE PEDIAT, V49, P53; TAALMAN RDFM, 1983, MUTAT RES, V112, P23, DOI 10.1016/0167-8817(83)90021-4; TAYLOR AMR, 1987, J MED GENET, V24, P669, DOI 10.1136/jmg.24.11.669; TEEBI AS, 1987, AM J MED GENET, V26, P355, DOI 10.1002/ajmg.1320260214; WEEMAES CMR, 1981, ACTA PAEDIATR SCAND, V70, P557, DOI 10.1111/j.1651-2227.1981.tb05740.x; WEGNER RD, 1988, CLIN GENET, V33, P20	17	55	56	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1989	45	2					270	275						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AK380	2491181				2022-12-18	WOS:A1989AK38000009
J	PELLESTOR, F; SELE, B; JALBERT, H; JALBERT, P				PELLESTOR, F; SELE, B; JALBERT, H; JALBERT, P			DIRECT SEGREGATION ANALYSIS OF RECIPROCAL TRANSLOCATIONS - A STUDY OF 283 SPERM KARYOTYPES FROM 4 CARRIERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									GRENOBLE UNIV,SCH MED,CYTOGENET & REPROD BIOL LAB,F-38700 LA TRONCHE,FRANCE	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Universite de Franche-Comte								ARONSON MM, 1983, CYTOGENET CELL GENET, V36, P652, DOI 10.1159/000131990; AURIAS A, 1978, HUM GENET, V45, P259, DOI 10.1007/BF00278725; BALKAN W, 1983, HUM GENET, V63, P345, DOI 10.1007/BF00274760; BALKAN W, 1983, AM J MED GENET, V16, P169, DOI 10.1002/ajmg.1320160206; BOUE A, 1984, PRENATAL DIAG, V4, P45, DOI 10.1002/pd.1970040705; BRANDRIFF B, 1985, HUM GENET, V70, P18, DOI 10.1007/BF00389451; BRANDRIFF B, 1986, AM J HUM GENET, V38, P197; BURNS JP, 1986, AM J HUM GENET, V38, P954; DANIEL A, 1979, HUM GENET, V51, P171, DOI 10.1007/BF00287173; DANIEL A, 1986, PRENATAL DIAG, V6, P315, DOI 10.1002/pd.1970060502; DEARCE MA, 1986, AM J MED GENET, V24, P519, DOI 10.1002/ajmg.1320240315; EPSTEIN CJ, 1986, CONSEQUENCES CHROMOS, P65; FERGUSONSMITH MA, 1982, CYTOGENET CELL GENET, V32, P24, DOI 10.1159/000131684; FORD JH, 1982, CYTOGENET CELL GENET, V33, P327, DOI 10.1159/000131779; FRIEDMAN JM, 1982, AM J HUM GENET, V34, pA90; HAMERTON J, 1971, HUMAN CYTOGENETICS, V1, P247; ISELIUS L, 1983, HUM GENET, V64, P343, DOI 10.1007/BF00292366; JALBERT P, 1979, J MED GENET, V16, P467, DOI 10.1136/jmg.16.6.467; JALBERT P, 1980, HUM GENET, V55, P209, DOI 10.1007/BF00291769; Jalbert P, 1988, CYTOGENETICS MAMMALI, P267; Lejeune J, 1965, Ann Genet, V8, P9; MARTIN RH, 1984, CLIN GENET, V25, P357; MARTIN RH, 1988, CYTOGENET CELL GENET, V47, P48, DOI 10.1159/000132504; PELLESTOR F, 1987, HUM GENET, V76, P116, DOI 10.1007/BF00284905; PELLESTOR F, 1988, AM J HUM GENET, V42, P274; RUDAK E, 1978, NATURE, V274, P911, DOI 10.1038/274911a0; SELE B, 1985, ANN GENET-PARIS, V28, P81; TEMPLADO C, 1988, HUM REPROD, V3, P133, DOI 10.1093/oxfordjournals.humrep.a136662; TEMPLADO C, 1988, HUM GENET, V79, P24, DOI 10.1007/BF00291704	29	55	55	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1989	44	4					464	473						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	T8109	2818710				2022-12-18	WOS:A1989T810900005
J	GITSCHIER, J				GITSCHIER, J			MATERNAL DUPLICATION ASSOCIATED WITH GENE DELETION IN SPORADIC HEMOPHILIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco	GITSCHIER, J (corresponding author), UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,U-426,3RD & PARNASSUS AVE,SAN FRANCISCO,CA 94143, USA.							ANTONARAKIS SE, 1985, NEW ENGL J MED, V313, P842, DOI 10.1056/NEJM198510033131402; BAKKER E, 1987, NATURE, V329, P554, DOI 10.1038/329554a0; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; DARRAS BT, 1987, NATURE, V329, P556, DOI 10.1038/329556a0; EFSTRATIADIS A, 1980, CELL, V21, P653, DOI 10.1016/0092-8674(80)90429-8; FARABAUGH PJ, 1978, J MOL BIOL, V126, P847, DOI 10.1016/0022-2836(78)90023-2; GITSCHIER J, 1985, NATURE, V315, P427, DOI 10.1038/315427a0; GITSCHIER J, 1985, NATURE, V314, P738, DOI 10.1038/314738a0; GITSCHIER J, 1984, NATURE, V312, P326, DOI 10.1038/312326a0; GITSCHIER J, 1986, SCIENCE, V232, P1415, DOI 10.1126/science.3012775; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; KAZAZIAN HH, 1988, NATURE, V332, P164, DOI 10.1038/332164a0; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; LANMAN JT, 1987, AM J HUM GENET, V41, P138; OBERLE I, 1985, P NATL ACAD SCI USA, V82, P2824, DOI 10.1073/pnas.82.9.2824; PEAKE IR, 1986, LANCET, V1, P1335; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.bi.55.070186.003215; WION KL, 1986, NUCLEIC ACIDS RES, V14, P4535, DOI 10.1093/nar/14.11.4535; WOOD WI, 1984, NATURE, V312, P330, DOI 10.1038/312330a0; YOUSSOUFIAN H, 1987, P NATL ACAD SCI USA, V84, P3772, DOI 10.1073/pnas.84.11.3772; ZIMMERMAN TS, 1971, J CLIN INVEST, V50, P255, DOI 10.1172/JCI106481	23	55	55	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1988	43	3					274	279						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	P8841	2901224				2022-12-18	WOS:A1988P884100007
J	REILLY, DS; LEWIS, RA; LEDBETTER, DH; NUSSBAUM, RL				REILLY, DS; LEWIS, RA; LEDBETTER, DH; NUSSBAUM, RL			TIGHTLY LINKED FLANKING MARKERS FOR THE LOWE OCULOCEREBRORENAL SYNDROME, WITH APPLICATION TO CARRIER ASSESSMENT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CHILDRENS HOSP,DEPT PEDIAT,PHILADELPHIA,PA 19104; BAYLOR COLL MED,DEPT OPHTHALMOL,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT MED,HOUSTON,TX 77030; BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030	University of Pennsylvania; Childrens Hospital of Philadelphia; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	REILLY, DS (corresponding author), UNIV PENN,SCH MED,DEPT HUMAN GENET,HOWARD HUGHES MED INST,37TH & HAMILTON WALK,PHILADELPHIA,PA 19104, USA.			Reilly, Dorothy/0000-0002-6677-3132	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD023245] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD23245-01] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; BOGGS BA, 1984, SOMAT CELL MOLEC GEN, V10, P607, DOI 10.1007/BF01535226; Brown N, 1976, Birth Defects Orig Artic Ser, V12, P579; CAMERINO G, 1984, P NATL ACAD SCI-BIOL, V81, P498, DOI 10.1073/pnas.81.2.498; CIBIS GW, 1986, OPHTHALMOLOGY, V93, P1041; COHEN MM, 1972, AM J HUM GENET, V24, P583; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; DRAYNA D, 1984, P NATL ACAD SCI-BIOL, V81, P2836, DOI 10.1073/pnas.81.9.2836; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GRUNSTEIN M, 1975, P NATL ACAD SCI USA, V72, P3961, DOI 10.1073/pnas.72.10.3961; HODGSON SV, 1986, AM J MED GENET, V23, P837, DOI 10.1002/ajmg.1320230311; JACOBS PA, 1981, AM J HUM GENET, V33, P513; KAPUR S, 1987, AM J MED GENET, V26, P503, DOI 10.1002/ajmg.1320260230; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LESTER SC, 1982, SOMAT CELL GENET, V8, P265, DOI 10.1007/BF01538681; LITT M, 1985, P NATL ACAD SCI USA, V82, P6206, DOI 10.1073/pnas.82.18.6206; LOWE CU, 1952, AMA AM J DIS CHILD, V83, P164, DOI 10.1001/archpedi.1952.02040060030004; MACDERMOTT KD, 1986, CLIN GENET, V23, P167; McKusick V. A., 1986, MENDELIAN INHERITANC; MOSSMAN J, 1983, ARCH DIS CHILD, V58, P911, DOI 10.1136/adc.58.11.911; NUSSBAUM RL, 1983, P NATL ACAD SCI-BIOL, V80, P4035, DOI 10.1073/pnas.80.13.4035; OBERLE I, 1985, P NATL ACAD SCI USA, V82, P2824, DOI 10.1073/pnas.82.9.2824; POUSTKA A, 1984, P NATL ACAD SCI-BIOL, V81, P4129, DOI 10.1073/pnas.81.13.4129; SILVER DN, 1987, J CLIN INVEST, V79, P282, DOI 10.1172/JCI112795; SKARE JC, 1987, P NATL ACAD SCI USA, V84, P2015, DOI 10.1073/pnas.84.7.2015; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SZYBALSKA EH, 1962, P NATL ACAD SCI USA, V48, P2026, DOI 10.1073/pnas.48.12.2026; TRIPATHI RC, 1986, OPHTHALMOLOGY, V93, P1046; VERELLENDUMOULIN C, 1984, HUM GENET, V67, P115, DOI 10.1007/BF00270570; WILLARD HF, 1985, CYTOGENET CELL GENET, V40, P360, DOI 10.1159/000132180; WILSON JM, 1982, J CLIN INVEST, V69, P706, DOI 10.1172/JCI110499; ZATZ M, 1981, J MED GENET, V18, P442, DOI 10.1136/jmg.18.6.442	32	55	55	1	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1988	42	5					748	755						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	N1438	2895982				2022-12-18	WOS:A1988N143800011
J	RISCH, N; STEIN, Z; KLINE, J; WARBURTON, D				RISCH, N; STEIN, Z; KLINE, J; WARBURTON, D			THE RELATIONSHIP BETWEEN MATERNAL AGE AND CHROMOSOME SIZE IN AUTOSOMAL TRISOMY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510; COLUMBIA UNIV,NEW YORK STATE PSYCHIAT INST,NEW YORK,NY 10027; COLUMBIA UNIV,SERGIEVSKY CTR,NEW YORK,NY 10027; COLUMBIA UNIV,DEPT GENET & DEV,NEW YORK,NY 10027; COLUMBIA UNIV,DEPT PEDIAT,NEW YORK,NY 10027	Yale University; Columbia University; New York State Psychiatry Institute; Columbia University; Columbia University; Columbia University	RISCH, N (corresponding author), YALE UNIV,SCH MED,DEPT EPIDEMIOL & PUBL HLTH,60 COLL ST,POB 3333,NEW HAVEN,CT 06510, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K04HD000648] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-08838, HD-00648, HD-12207] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		HASSOLD T, 1984, AM J HUM GENET, V36, P1349; HASSOLD T, 1985, HUM GENET, V70, P11, DOI 10.1007/BF00389450; HASSOLD T, 1980, ANN HUM GENET, V44, P29, DOI 10.1111/j.1469-1809.1980.tb00943.x; HASSOLD T, 1984, ANN HUM GENET, V48, P129, DOI 10.1111/j.1469-1809.1984.tb01008.x; HOOK EB, 1981, OBSTET GYNECOL, V58, P282; HOOK EB, 1983, JAMA-J AM MED ASSOC, V249, P2034, DOI 10.1001/jama.249.15.2034; HULTEN M, 1974, HEREDITAS, V76, P55; KAPLAN EB, 1972, I STATISTICS MIMEO S, V823; LAMSON SH, 1980, AM J HUM GENET, V32, P743; Penrose L.S., 1966, DOWNS ANOMALY; SCHREINEMACHERS DM, 1982, HUM GENET, V61, P318; STEIN Z, 1986, LANCET; WARBURTON D, 1984, American Journal of Human Genetics, V36, p116S; WARBURTON D, 1980, HUMAN EMBRYONIC FETA, P261; [No title captured]	15	55	56	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1986	39	1					68	78						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	D9615	3752082				2022-12-18	WOS:A1986D961500006
J	HASSTEDT, SJ; ATKIN, CL; JUAN, ACS				HASSTEDT, SJ; ATKIN, CL; JUAN, ACS			GENETIC-HETEROGENEITY AMONG KINDREDS WITH ALPORT SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV UTAH,MED CTR,DEPT MED,SALT LAKE CITY,UT 84132; UNIV UTAH,MED CTR,DEPT BIOCHEM,SALT LAKE CITY,UT 84132	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	HASSTEDT, SJ (corresponding author), UNIV UTAH,MED CTR,DEPT HUMAN GENET,SALT LAKE CITY,UT 84132, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017463, R23HD017463] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-64] Funding Source: Medline; NIADDK NIH HHS [AM-26627] Funding Source: Medline; NICHD NIH HHS [HD-17463] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALPORT AC, 1927, BRIT MED J, V1, P504; ATKIN CL, 1986, STRAUSS WELTS DISEAS; CANNINGS C, 1978, ADV APPL PROBAB, V10, P26, DOI 10.2307/1426718; CHIU FJ, 1983, J BIOL CHEM, V258, P7200; CLARE NM, 1979, AM J CLIN PATHOL, V72, P111; CRAWFURD MD, 1968, Q J MED, V37, P563; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; EVANS SH, 1980, CLIN GENET, V17, P285; GLEESON MJ, 1984, J LARYNGOL OTOL, V98, P449, DOI 10.1017/S0022215100146894; GOVAN JAA, 1983, BRIT J OPHTHALMOL, V67, P493, DOI 10.1136/bjo.67.8.493; GRUNFELD JP, 1985, KIDNEY INT, V27, P83, DOI 10.1038/ki.1985.14; GUBLER M, 1981, AM J MED, V70, P493, DOI 10.1016/0002-9343(81)90571-4; Guthrie LG, 1902, LANCET, V1, P1243; HASSTEDT SJ, 1983, AM J HUM GENET, V35, P1241; HASSTEDT SJ, 1979, AM J HUM GENET, V31, pA135; Hasstedt SJ, 1981, 13 U UT DEP MED BIOP; HODGE SE, 1983, AM J HUM GENET, V35, P1139; LALOUEL JM, 1979, 14 U UT DEP MED BIOP; MENLOVE L, 1984, American Journal of Human Genetics, V36, p146S; MORTON NE, 1956, AM J HUM GENET, V8, P80; ONEILL WM, 1980, PATHOL RES PRACT, V168, P146, DOI 10.1016/S0344-0338(80)80214-7; ONEILL WM, 1978, ANN INTERN MED, V88, P176, DOI 10.7326/0003-4819-88-2-176; OTT J, 1983, ANN HUM GENET, V47, P311, DOI 10.1111/j.1469-1809.1983.tb01001.x; PERKOFF GT, 1951, ARCH INTERN MED, V88, P191, DOI 10.1001/archinte.1951.03810080059006; PERKOFF GT, 1958, ARCH INTERN MED, V102, P733, DOI 10.1001/archinte.1958.00260220049005; PERKOFF GT, 1963, DISEASES KIDNEY; RISCH N, 1982, ANN HUM GENET, V46, P153, DOI 10.1111/j.1469-1809.1982.tb00706.x; SCHNEIDER RG, 1963, NY STATE J MED  0915, P2644; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; SPEAR GS, 1984, CLIN NEPHROL, V21, P3; STEPHENS FE, 1951, AM J HUM GENET, V3, P303; THOMPSON EA, 1979, GENETIC ANAL COMMON, P363; TISHLER P V, 1974, Birth Defects Original Article Series, V10, P93; TISHLER PV, 1979, CLIN GENET, V16, P291; WILLIAMSON D, 1961, LANCET, V2, P1321	35	55	56	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1986	38	6					940	953						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	D3922	3728466				2022-12-18	WOS:A1986D392200016
J	JACKSONCOOK, CK; FLANNERY, DB; COREY, LA; NANCE, WE; BROWN, JA				JACKSONCOOK, CK; FLANNERY, DB; COREY, LA; NANCE, WE; BROWN, JA			NUCLEOLAR ORGANIZER REGION VARIANTS AS A RISK FACTOR FOR DOWN-SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PEDIAT,RICHMOND,VA 23298; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT OBSTET & GYNECOL,RICHMOND,VA 23298	Virginia Commonwealth University; Virginia Commonwealth University	JACKSONCOOK, CK (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT HUMAN GENET,RICHMOND,VA 23298, USA.		Flannery, David/O-6719-2019		NIGMS NIH HHS [GM-07492] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARCHIDIACONO N, 1977, HUM GENET, V37, P285, DOI 10.1007/BF00393610; BALICEK P, 1980, HUM GENET, V54, P343, DOI 10.1007/BF00291580; BERNSTEIN R, 1981, HUM GENET, V58, P135, DOI 10.1007/BF00278697; BLOOM SE, 1976, HUM GENET, V34, P199, DOI 10.1007/BF00278889; CRANDALL BF, 1973, CLIN GENET, V4, P517; DEKABAN A. S., 1963, CYTOGENETICS [BASEL], V2, P61, DOI 10.1159/000129768; DHADIAL R, 1972, J GENET HUM, V20, P297; DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478; EMBERGER JM, 1975, J GENET HUM, V23, P98; FERGUSON-SMITH M. A., 1964, CYTOGENETICS, V3, P124, DOI 10.1159/000129803; GIGLIANI F, 1972, HUMANGENETIK, V15, P191, DOI 10.1007/BF00295748; HAHNEMANN N, 1973, CLIN GENET, V4, P464; HANSSON A, 1978, CYTOGENET CELL GENET, V20, P194, DOI 10.1159/000130851; HAYATA I, 1977, HUM GENET, V36, P55, DOI 10.1007/BF00390436; HENDERSON AS, 1976, HUM GENET, V31, P113, DOI 10.1007/BF00270407; HOOK EB, 1981, J MED GENET, V18, P29, DOI 10.1136/jmg.18.1.29; JACKSONCOOK C, 1985, THESIS MED COLLEGE V; JACOBS PA, 1977, HUM HERED, V27, P59, DOI 10.1159/000152852; JACOBS PA, 1981, ANN HUM GENET, V45, P357, DOI 10.1111/j.1469-1809.1981.tb00349.x; JOTTERANDBELLOM, 1981, HUM GENET, V59, P185; JUBERG RC, 1983, AM J MED GENET, V16, P111, DOI 10.1002/ajmg.1320160117; LAU YF, 1979, HUM GENET, V46, P75, DOI 10.1007/BF00278904; MARKOVIC VD, 1978, HUM GENET, V41, P181, DOI 10.1007/BF00273100; MARTIN AO, 1979, HUM GENET, V48, P211, DOI 10.1007/BF00286906; MIKKELSEN M, 1980, ANN HUM GENET, V44, P17, DOI 10.1111/j.1469-1809.1980.tb00942.x; MIKKELSEN M, 1982, J MENT DEFIC RES, V26, P143; MILLER DA, 1977, AM J HUM GENET, V29, P490; MILLER DA, 1978, HUM GENET, V43, P289, DOI 10.1007/BF00278836; MIRRE C, 1980, P NATL ACAD SCI-BIOL, V77, P6017, DOI 10.1073/pnas.77.10.6017; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; MORTON CC, 1983, EXP CELL RES, V145, P405, DOI 10.1016/0014-4827(83)90019-8; SANDS VE, 1969, AM J HUM GENET, V21, P293; SCHMID M, 1983, HUM GENET, V64, P363, DOI 10.1007/BF00292368; SCHMID M, 1974, HUMANGENETIK, V23, P267, DOI 10.1007/BF00272510; SHAW MARGERY W., 1962, CYTOGENETICS, V1, P141, DOI 10.1159/000129726; SOFUNI T, 1980, HUM GENET, V55, P265, DOI 10.1007/BF00291776; THERKELSEN AJ, 1964, CYTOGENETICS, V3, P441, DOI 10.1159/000129832; WARBURTON D, 1976, CYTOGENET CELL GENET, V17, P221, DOI 10.1159/000130715; WERNER W, 1982, HUM GENET, V60, P202, DOI 10.1007/BF00569714; ZAKHAROV AF, 1982, HUM GENET, V60, P334, DOI 10.1007/BF00569214; ZANKL H, 1974, HUMANGENETIK, V23, P259, DOI 10.1007/BF00272509; 1972, CYTOGENETICS, V11, P313	42	55	56	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1985	37	6					1049	1061						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AXE36	2934977				2022-12-18	WOS:A1985AXE3600001
J	NUSSBAUM, RL; WALMSLEY, RM; LESKO, JG; AIRHART, SD; LEDBETTER, DH				NUSSBAUM, RL; WALMSLEY, RM; LESKO, JG; AIRHART, SD; LEDBETTER, DH			THYMIDYLATE SYNTHASE-DEFICIENT CHINESE-HAMSTER CELLS - A SELECTION SYSTEM FOR HUMAN-CHROMOSOME 18 AND EXPERIMENTAL SYSTEM FOR THE STUDY OF THYMIDYLATE SYNTHASE REGULATION AND FRAGILE-X EXPRESSION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV PENN,SCH MED,DEPT HUMAN GENET,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT PEDIAT,PHILADELPHIA,PA 19104; BAYLOR COLL MED,HOUSTON,TX 77030	University of Pennsylvania; University of Pennsylvania; Baylor College of Medicine	NUSSBAUM, RL (corresponding author), UNIV PENN,SCH MED,HOWARD HUGHES MED INST,PHILADELPHIA,PA 19104, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD020227] Funding Source: NIH RePORTER; NICHD NIH HHS [R0I-HD20227-02] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALHADEFF B, 1977, CYTOGENET CELL GENET, V19, P236, DOI 10.1159/000130814; AYUSAWA D, 1981, SOMAT CELL GENET, V7, P523, DOI 10.1007/BF01549656; AYUSAWA D, 1983, J BIOL CHEM, V258, P48; FRITSCH EF, 1980, CELL, V19, P959, DOI 10.1016/0092-8674(80)90087-2; FUSCOE JC, 1983, MOL CELL BIOL, V3, P1086, DOI 10.1128/MCB.3.6.1086; GEYER PK, 1984, J BIOL CHEM, V259, P7206; GLOVER TW, 1981, AM J HUM GENET, V33, P234; JOHNSON LF, 1978, J CELL PHYSIOL, V97, P397, DOI 10.1002/jcp.1040970314; LEDBETTER D H, 1984, American Journal of Human Genetics, V36, p203S; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANIATIS T, 1982, MOL CLONING LABORATO; MATTEI MG, 1981, HUM GENET, V59, P166, DOI 10.1007/BF00293069; NAVALGUND LG, 1980, J BIOL CHEM, V255, P7386; NUSSBAUM RL, 1983, HUM GENET, V64, P148, DOI 10.1007/BF00327113; NUSSBAUM RL, 1983, P NATL ACAD SCI-BIOL, V80, P4035, DOI 10.1073/pnas.80.13.4035; PATEL PI, 1984, SOMAT CELL MOLEC GEN, V10, P483, DOI 10.1007/BF01534853; REDDY GPV, 1982, BIOCHEM BIOPH RES CO, V109, P908, DOI 10.1016/0006-291X(82)92026-5; REDDY GPV, 1980, P NATL ACAD SCI-BIOL, V77, P3312; ROSSANA C, 1982, MOL CELL BIOL, V2, P1118, DOI 10.1128/MCB.2.9.1118; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SU TS, 1984, AM J HUM GENET, V36, P954; SUTHERLAND GR, 1977, SCIENCE, V197, P265, DOI 10.1126/science.877551; TAKEISHI K, 1984, J BIOCHEM, V95, P1477, DOI 10.1093/oxfordjournals.jbchem.a134755; TURNER G, 1983, ADV HUM GENET, V13, P83; TURNER G, 1980, J PEDIATR-US, V96, P837, DOI 10.1016/S0022-3476(80)80552-X; WALSH C, 1979, ENZYME REACTION MECH, P838; WICKREMASINGHE RG, 1982, EUR J BIOCHEM, V126, P589, DOI 10.1111/j.1432-1033.1982.tb06821.x; WICKREMASINGHE RG, 1983, BIOCHIM BIOPHYS ACTA, V740, P243, DOI 10.1016/0167-4781(83)90132-X	28	55	55	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1985	37	6					1192	1205						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AXE36	3002173				2022-12-18	WOS:A1985AXE3600014
J	INGLE, C; WILLIAMSON, R; DELACHAPELLE, A; HERVA, RR; HAAPALA, K; BATES, G; WILLARD, HF; PEARSON, P; DAVIES, KE				INGLE, C; WILLIAMSON, R; DELACHAPELLE, A; HERVA, RR; HAAPALA, K; BATES, G; WILLARD, HF; PEARSON, P; DAVIES, KE			MAPPING DNA-SEQUENCES IN A HUMAN X-CHROMOSOME DELETION WHICH EXTENDS ACROSS THE REGION OF THE DUCHENNE MUSCULAR-DYSTROPHY MUTATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV HELSINKI,DEPT MED GENET,SF-00170 HELSINKI 17,FINLAND; UNIV OULU,DEPT PATHOL,SF-90100 OULU 10,FINLAND; UNIV TORONTO,DEPT MED GENET,TORONTO M5S 1A1,ONTARIO,CANADA; LEIDEN STATE UNIV,DEPT HUMAN GENET,2312 AV LEIDEN,NETHERLANDS; UNIV LONDON,ST MARYS HOSP,SCH MED,DEPT BIOCHEM,LONDON W2 1PG,ENGLAND	University of Helsinki; University of Oulu; University of Toronto; Leiden University; Leiden University - Excl LUMC; Imperial College London; University of London			Bates, Gillian P/E-1146-2012	Bates, Gillian P/0000-0002-4041-6305				BENHAM FJ, 1984, EMBO J, V3, P2635, DOI 10.1002/j.1460-2075.1984.tb02186.x; CARRITT B, 1979, CYTOGENET CELL GENET, V23, P171, DOI 10.1159/000131323; DAVIES KE, 1983, NUCLEIC ACIDS RES, V11, P2303, DOI 10.1093/nar/11.8.2303; DRAYNA D, 1984, P NATL ACAD SCI-BIOL, V81, P2836, DOI 10.1073/pnas.81.9.2836; GOSS SJ, 1977, J CELL SCI, V25, P17; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; HARPER PS, 1983, J MED GENET, V20, P252, DOI 10.1136/jmg.20.4.252; HARTLEY DA, 1984, NUCLEIC ACIDS RES, V12, P5277, DOI 10.1093/nar/12.13.5277; HERVA R, 1979, AM J MED GENET, V3, P43, DOI 10.1002/ajmg.1320030110; KINGSTON HM, 1983, LANCET, V2, P1200; KUNKEL LM, 1982, NUCLEIC ACIDS RES, V10, P1557, DOI 10.1093/nar/10.5.1557; OBRIEN T, 1983, J MED GENET, V20, P249, DOI 10.1136/jmg.20.4.249; PEMBREY ME, 1984, ARCH DIS CHILD, V59, P208, DOI 10.1136/adc.59.3.208; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; WESTERVELD A, 1971, NATURE-NEW BIOL, V234, P20, DOI 10.1038/newbio234020a0; WIEACKER P, 1984, AM J HUM GENET, V36, P265; WILLARD HF, 1983, NUCLEIC ACIDS RES, V11, P2017, DOI 10.1093/nar/11.7.2017; WORTON RG, 1984, SCIENCE, V224, P1447, DOI 10.1126/science.6729462; YANG TP, 1982, P NATL ACAD SCI-BIOL, V79, P6593, DOI 10.1073/pnas.79.21.6593	19	55	55	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	3					451	462						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AKE07	2988331				2022-12-18	WOS:A1985AKE0700002
J	MULLIGAN, LM; PHILLIPS, MA; FORSTERGIBSON, CJ; BECKETT, J; PARTINGTON, MW; SIMPSON, NE; HOLDEN, JJA; WHITE, BN				MULLIGAN, LM; PHILLIPS, MA; FORSTERGIBSON, CJ; BECKETT, J; PARTINGTON, MW; SIMPSON, NE; HOLDEN, JJA; WHITE, BN			GENETIC-MAPPING OF DNA SEGMENTS RELATIVE TO THE LOCUS FOR THE FRAGILE-X SYNDROME AT XQ27.3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									QUEENS UNIV, DEPT PAEDIAT, DIV MED GENET, KINGSTON K7L 3N6, ONTARIO, CANADA	Queens University - Canada	MULLIGAN, LM (corresponding author), QUEENS UNIV, DEPT BIOL, KINGSTON K7L 3N6, ONTARIO, CANADA.							BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; CAMERINO G, 1983, NATURE, V306, P701, DOI 10.1038/306701a0; CAMERINO G, 1984, P NATL ACAD SCI-BIOL, V81, P498, DOI 10.1073/pnas.81.2.498; DEARCE MA, 1984, J MED GENET, V21, P84, DOI 10.1136/jmg.21.2.84; DRAYNA D, 1984, P NATL ACAD SCI-BIOL, V81, P2836, DOI 10.1073/pnas.81.9.2836; FILIPPI G, 1983, AM J MED GENET, V15, P113, DOI 10.1002/ajmg.1320150115; FORSTERGIBSON CJ, UNPUB RECOMBINATION; GIANNELLI F, 1984, LANCET, V1, P239; GIANNELLI F, 1983, NATURE, V303, P181, DOI 10.1038/303181a0; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; HAMERTON JL, 1984, CYTOGENET CELL GENET, V37, P486; HARPER K, 1984, LANCET, V2, P6; HARRISON CJ, 1983, J MED GENET, V20, P280, DOI 10.1136/jmg.20.4.280; HOLDEN JJA, 1984, AM J MED GENET, V17, P259, DOI 10.1002/ajmg.1320170118; KAN YW, 1980, NEW ENGL J MED, V302, P185, DOI 10.1056/NEJM198001243020401; KEATS B, 1983, HUM GENET, V64, P28, DOI 10.1007/BF00289474; MURRAY JM, 1982, NATURE, V300, P69, DOI 10.1038/300069a0; OTT J, 1974, AM J HUM GENET, V26, P588; PARTINGTON MW, 1984, AM J MED GENET, V17, P175, DOI 10.1002/ajmg.1320170111; PEAKE IR, 1984, LANCET, V1, P242; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; ROBINSON J, 1975, J VIROL, V15, P1065, DOI 10.1128/JVI.15.5.1065-1072.1975; SHERMAN SL, 1984, ANN HUM GENET, V48, P21, DOI 10.1111/j.1469-1809.1984.tb00830.x; SOUDEK D, 1984, AM J MED GENET, V17, P241, DOI 10.1002/ajmg.1320170115; SOUTHERN EM, 1982, CYTOGENET CELL GENET, V32, P52, DOI 10.1159/000131686; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SUTHERLAND GR, 1983, INT REV CYTOL, V81, P107, DOI 10.1016/S0074-7696(08)62336-0; WAIKAN Y, 1978, P NATL ACAD SCI USA, V75, P5631, DOI 10.1073/pnas.75.11.5631; 1984, CYTOGENET CELL GENET, V37, P210	29	55	55	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1985	37	3					463	472						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AKE07	2988332				2022-12-18	WOS:A1985AKE0700003
J	GOLDMAN, D; MERRIL, CR				GOLDMAN, D; MERRIL, CR			HUMAN-LYMPHOCYTE POLYMORPHISMS DETECTED BY QUANTITATIVE TWO-DIMENSIONAL ELECTROPHORESIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NIMH,GEN & COMPARAT BIOCHEM LAB,BETHESDA,MD 20205	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	GOLDMAN, D (corresponding author), NIMH,CLIN SCI LAB,BETHESDA,MD 20205, USA.		Goldman, David/F-9772-2010	Goldman, David/0000-0002-1724-5405				ANDERSON L, 1977, P NATL ACAD SCI USA, V74, P5421, DOI 10.1073/pnas.74.12.5421; BOSSINGER J, 1979, J BIOL CHEM, V254, P7986; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BROWN AJL, 1979, P NATL ACAD SCI USA, V76, P2381, DOI 10.1073/pnas.76.5.2381; BUCKNALL WE, 1975, JOHNS HOPKINS MED J, V137, P123; COHEN PTW, 1973, NATURE-NEW BIOL, V241, P229; COMINGS DE, 1979, NATURE, V277, P28, DOI 10.1038/277028a0; COMINGS DE, 1982, CLIN CHEM, V28, P813; COMINGS DE, 1982, CLIN CHEM, V28, P805; ELSTON RC, 1975, ANN HUM GENET, V38, P341, DOI 10.1111/j.1469-1809.1975.tb00619.x; GARRELS JI, 1979, J BIOL CHEM, V254, P7961; GOLDMAN D, 1982, CLIN CHEM, V28, P1021; HAMAGUCHI H, 1981, HUM GENET, V59, P215; HARRIS H, 1980, PRINCIPLES HUMAN BIO, P316; LUTIN WA, 1978, DEV BIOCHEM, V2, P93; MCCONKEY EH, 1979, P NATL ACAD SCI USA, V76, P6500, DOI 10.1073/pnas.76.12.6500; MERRIL CR, 1981, P NATL ACAD SCI-BIOL, V78, P6471, DOI 10.1073/pnas.78.10.6471; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; RACINE RR, 1980, NATURE, V283, P855, DOI 10.1038/283855a0; RENWICK JH, 1971, ANNU REV GENET, V5, P81, DOI 10.1146/annurev.ge.05.120171.000501; SMITH SC, 1980, GENETICS, V96, P967; STEINBERG RA, 1977, CELL, V10, P381, DOI 10.1016/0092-8674(77)90025-3; TAYLOR J, 1982, CLIN CHEM, V28, P861; VANDEKERCKHOVE J, 1978, J MOL BIOL, V126, P783, DOI 10.1016/0022-2836(78)90020-7; VANDEKERCKHOVE J, 1980, CELL, V22, P893, DOI 10.1016/0092-8674(80)90566-8; VOGEL F, 1979, PRINCIPLES BIOCH GEN, P550; WALTON KE, 1979, J BIOL CHEM, V254, P7951; WANNER LA, 1981, HUM GENET, V59, P215; WILLARD KE, 1981, CLIN CHEM, V27, P1327	29	55	58	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	5					827	837						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RK604	6577787				2022-12-18	WOS:A1983RK60400003
J	HODGE, SE				HODGE, SE			SOME EPISTATIC 2-LOCUS MODELS OF DISEASE .1. RELATIVE RISKS AND IDENTITY-BY-DESCENT DISTRIBUTIONS IN AFFECTED SIB PAIRS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											HODGE, SE (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,MENTAL RETARDAT POSTGRAD SCH,LOS ANGELES,CA 90024, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD004612] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-04612, HD-05615] Funding Source: Medline; NIMH NIH HHS [MH-33617] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALTER M, 1976, NEUROLOGY, V26, P31, DOI 10.1212/WNL.26.1.31; BARBOSA J, 1978, J CLIN INVEST, V62, P492, DOI 10.1172/JCI109151; BATCHELOR JR, 1978, BRIT MED BULL, V34, P279, DOI 10.1093/oxfordjournals.bmb.a071512; BENGTSSON B, UNPUBLISHED; CAMPBELL MA, 1971, ANN HUM GENET, V35, P225, DOI 10.1111/j.1469-1809.1956.tb01395.x; Christy M, 1979, Diabetes Care, V2, P209, DOI 10.2337/diacare.2.2.209; CUDWORTH AG, 1979, LANCET, V2, P389; CURIECOHEN M, 1977, TISSUE ANTIGENS, V9, P59; DARSEE JR, 1979, NEW ENGL J MED, V300, P877, DOI 10.1056/NEJM197904193001602; DAY NE, 1976, TISSUE ANTIGENS, V8, P109; DICK HM, 1978, BRIT MED BULL, V34, P271, DOI 10.1093/oxfordjournals.bmb.a071510; DRACHMAN DA, 1976, ARCH NEUROL-CHICAGO, V33, P406, DOI 10.1001/archneur.1976.00500060012004; EK J, 1978, SCAND J GASTROENTERO, V13, P229, DOI 10.3109/00365527809181753; ELDRIDGE R, 1978, ANN NEUROL, V3, P72, DOI 10.1002/ana.410030111; FAUCHET R, 1979, TISSUE ANTIGENS, V14, P10; FIENBERG SE, 1977, ANAL CROSS CLASSIFIE, P16; FISHMAN PM, 1978, AM J HUM GENET, V30, P308; GREENBERG DA, AM J MED GENET; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HENS L, 1978, TISSUE ANTIGENS, V11, P75, DOI 10.1111/j.1399-0039.1978.tb01230.x; HODGE SE, 1981, AM J HUM GENET, V33, P396; HODGE SE, 1980, ANN HUM GENET, V43, P399, DOI 10.1111/j.1469-1809.1980.tb01573.x; HODGE SE, 1980, TISSUE ANTIGENS, V15, P313; KIDD KK, 1977, HLA DISEASE, P72; KRAVITZ K, 1979, AM J HUM GENET, V31, P601; LI CC, 1954, BIOMETRICS, V10, P347, DOI 10.2307/3001590; MCDEVITT HO, 1974, LANCET, V1, P1269; MCMICHAEL AJ, 1978, BRIT J DERMATOL, V98, P287, DOI 10.1111/j.1365-2133.1978.tb06155.x; OLSSON JE, 1976, ARCH NEUROL-CHICAGO, V33, P808, DOI 10.1001/archneur.1976.00500120012002; PENA AS, 1978, GASTROENTEROLOGY, V75, P230; RACE RR, 1975, BLOOD GROUPS MAN, P20; ROTTER JI, 1978, DIABETES, V27, P599, DOI 10.2337/diabetes.27.5.599; RUBINSTEIN P, 1977, NEW ENGL J MED, V297, P1036, DOI 10.1056/NEJM197711102971905; SLATE DL, 1979, CELL, V16, P171, DOI 10.1016/0092-8674(79)90198-3; SMERALDI E, 1978, TISSUE ANTIGENS, V12, P270, DOI 10.1111/j.1399-0039.1978.tb01334.x; SPIELMAN RS, 1979, GENETIC ANAL COMMON, P567; STRICKBERGER MW, 1976, GENE INTERACTION LET, P202; SUAREZ B, 1979, DIABETES, V28, P527, DOI 10.2337/diabetes.28.6.527; SUAREZ BK, 1979, CLIN GENET, V15, P126; SVEJGAAR.A, 1974, TISSUE ANTIGENS, V4, P95; SVEJGAARD A, 1977, HLA DISEASE, P46; THOMSON G, 1980, ANN HUM GENET, V43, P383, DOI 10.1111/j.1469-1809.1980.tb01572.x; Thomson G, 1977, HLA DISEASE, P84; THOMSON G, 1977, MEASURING SELECTION, P545; TIWARI JL, 1980, AM J HUM GENET, V32, P103; UTERMANN G, 1979, CLIN GENET, V15, P37; VISSCHER BR, 1979, NEUROLOGY, V29, P1354, DOI 10.1212/WNL.29.10.1354; Wentworth EN, 1923, J AGRIC RES, V23, P0557; Wright S., 1963, P159	49	55	55	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	3					381	395						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LT725	6941695				2022-12-18	WOS:A1981LT72500006
J	KIMBERLING, WJ; FULBECK, T; DIXON, L; LUBS, HA				KIMBERLING, WJ; FULBECK, T; DIXON, L; LUBS, HA			LOCALIZATION OF SPHEROCYTOSIS TO CHROMOSOME-8 OR CHROMOSOME-12 AND REPORT OF A FAMILY WITH SPHEROCYTOSIS AND A RECIPROCAL TRANSLOCATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV COLORADO,MED CTR,DEPT PEDIAT,DENVER,CO 80220; UNIV COLORADO,MED CTR,DEPT BIOL,DENVER,CO 80220; UNIV COLORADO,MED CTR,DEPT BIOPHYS & GENET,DENVER,CO 80220	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver								BROWN B, 1973, HEMATOLOGY PRINCIPLE; CHAPMAN RG, 1969, BRIT J HAEMATOL, V16, P145, DOI 10.1111/j.1365-2141.1969.tb00386.x; CHAPMAN RG, 1968, J CLIN INVEST, V47, P2263, DOI 10.1172/JCI105911; HOPKINSON DA, 1969, BIOCHEMICAL METHODS, P337; JANDL JH, 1972, METABOLIC BASIS INHE, P1323; JONGSMA A P M, 1974, Birth Defects Original Article Series, V10, P106; KUCHERLAPATI RS, 1974, AM J HUM GENET, V26, pA51; LEWIS WHP, 1967, NATURE, V215, P351, DOI 10.1038/215351a0; LONG WK, 1967, SCIENCE, V155, P712, DOI 10.1126/science.155.3763.712; Lubs H A, 1973, Methods Cell Biol, V6, P345, DOI 10.1016/S0091-679X(08)60057-6; MACKENZIE W, IN PRESS; MORTON NE, 1956, AM J HUM GENET, V8, P80; MORTON NE, 1955, AM J HUM GENET, V7, P277; MORTON NE, 1962, AM J HUM GENET, V14, P170; PARKER WC, 1963, AM J HUM GENET, V15, P353; RACE RR, 1942, ANN EUGENIC, V11, P365; SPENCER N, 1968, ANN HUM GENET, V32, P9, DOI 10.1111/j.1469-1809.1968.tb00044.x; YOUNG LE, 1955, T ASSOC AM PHYSICIAN, V68, P141; 1973, BIRTH DEFECTS OAS	19	55	55	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1975	27	5					586	594						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AR239	1163534				2022-12-18	WOS:A1975AR23900002
J	GIBLETT, ER; ANDERSON, JE; CHEN, SH; TENG, YS; COHEN, F				GIBLETT, ER; ANDERSON, JE; CHEN, SH; TENG, YS; COHEN, F			URIDINE MONOPHOSPHATE KINASE - NEW GENETIC POLYMORPHISM WITH POSSIBLE CLINICAL IMPLICATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									KING CTY CENT BLOOD BANK,SEATTLE,WA 98104; UNIV WASHINGTON,SCH MED,DEPT PEDIAT,SEATTLE,WA 98195; CHILDRENS HOSP MICHIGAN,DETROIT,MI 48202; WAYNE STATE UNIV,DEPT PEDIAT,DETROIT,MI 48202	University of Washington; University of Washington Seattle; Children's Hospital of Michigan; Wayne State University								BEUTLER E, 1966, CLIN CHIM ACTA, V13, P369, DOI 10.1016/0009-8981(66)90217-8; Beutler E., 1971, RED CELL METABOLISM; BOIVIN P, 1971, PRESSE MED, V79, P215; CHEN SH, 1972, ANN HUM GENET, V35, P401; CHEN SH, 1971, AM J HUM GENET, V23, P87; FILDES RA, 1966, NATURE, V209, P261, DOI 10.1038/209261a0; GIBLETT ER, 1972, LANCET, V2, P1067; GREEN H, 1973, SCIENCE, V182, P836, DOI 10.1126/science.182.4114.836; HIRSCHHORN R, 1973, NATURE-NEW BIOL, V246, P200, DOI 10.1038/newbio246200a0; KELLY S, 1972, J MED GENET, V9, P129, DOI 10.1136/jmg.9.1.129; KNUDSEN BB, 1973, CLIN GENET, V4, P344; KOERNER JF, 1970, ANNU REV BIOCHEM, V39, P291, DOI 10.1146/annurev.bi.39.070170.001451; MODIANO G, 1970, AM J HUM GENET, V22, P292; MONN E, 1972, HUM HERED, V22, P18, DOI 10.1159/000152463; POLLARA B, 1973, PEDIATR RES, V7, pA362; SPENCER N, 1964, NATURE, V201, P299, DOI 10.1038/201299a0; SUGINO Y, 1966, J BIOL CHEM, V241, P961; SZEINBERG A, 1969, ACTA HAEMATOL-BASEL, V42, P111, DOI 10.1159/000208770; YOUNT J, 1974, J PEDIATR-US, V84, P173, DOI 10.1016/S0022-3476(74)80597-4	19	55	55	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1974	26	5					627	635						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	U0241	4138532				2022-12-18	WOS:A1974U024100010
J	TASHIAN, RE; BREWER, GJ; LEHMANN, H; DAVIES, DA; RUCKNAGEL, DL				TASHIAN, RE; BREWER, GJ; LEHMANN, H; DAVIES, DA; RUCKNAGEL, DL			FURTHER STUDIES ON XAVANTE INDIANS .V. GENETIC VARIABILITY IN SOME SERUM AND ERYTHROCYTE ENZYMES HEMOGLOBIN AND URINARY EXCRETION OF BETA-AMINOISOBUTYRIC ACID	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALLISON AC, 1959, NATURE, V183, P118, DOI 10.1038/183118a0; BLUMBERG BS, 1959, NATURE, V184, P1990, DOI 10.1038/1841990a0; BREWER GJ, 1964, AM J HUM GENET, V16, P472; CABANNES R., 1964, BULL SOC PATHOL EXOTIQUE, V57, P307; DAVIDSON RG, 1964, ANN HUM GENET, V28, P61, DOI 10.1111/j.1469-1809.1964.tb00460.x; DERN RJ, 1966, J LAB CLIN MED, V67, P255; DRABKIN DL, 1946, J BIOL CHEM, V164, P703; GARTLER SM, 1957, AM J HUM GENET, V9, P200; GARTLER SM, 1961, GENETICAL VARIATION, P62; GARTLER SM, 1961, CITED INDIRECTLY; GARTLER STANLEY M., 1959, ARCH BIOCHEM AND BIOPHYS, V80, P400, DOI 10.1016/0003-9861(59)90269-3; GIBLETT ER, 1965, AM J HUM GENET, V17, P425; GLOCK GE, 1953, BIOCHEM J, V55, P400, DOI 10.1042/bj0550400; HARRIS H, 1961, NATURE, V191, P496, DOI 10.1038/191496a0; HARRIS H, 1963, LANCET, V2, P218; HARRIS H, 1962, ANN HUM GENET, V26, P59, DOI 10.1111/j.1469-1809.1962.tb01310.x; HARRISON GA, 1961, GENETICAL VARIATI ED, P62; HOPKINSON DA, 1964, AM J HUM GENET, V16, P141; ISHIHARA I, 1952, IGAKU SEIBUT, V22, P1; KALOW W, 1957, CAN J BIOCHEM PHYS, V35, P339, DOI 10.1139/o57-041; KATTAMIS C, 1962, NATURE, V196, P599, DOI 10.1038/196599a0; KUNKEL HG, 1957, J CLIN INVEST, V36, P1615, DOI 10.1172/JCI103561; LISKER R, 1967, AM J HUM GENET, V19, P174; MATSUNAGA El, 1965, JAP J HUM GENET, V10, P1; MOTULSKY AG, 1966, AM J HUM GENET, V18, P514; NEEL JV, 1964, AM J HUM GENET, V16, P52; OMOTO K, 1965, NATURE, V205, P726, DOI 10.1038/205726a0; SALZANO FM, 1967, AM J HUM GENET, V19, P463; SCOTT EM, 1966, AM J HUM GENET, V18, P408; SHOWS TB, 1964, SCIENCE, V145, P1056, DOI 10.1126/science.145.3636.1056; SINGER K, 1951, BLOOD, V6, P413, DOI 10.1182/blood.V6.5.413.413; SMITHIES O, 1959, BIOCHEM J, V71, P585, DOI 10.1042/bj0710585; STANBURY JB, 1960, METABOLIC BASIS I ED, P792; SUTTON HE, 1960, METABOLIC BASIS INHE, P792; TASHIAN RE, 1965, AM J HUM GENET, V17, P257; VESELL ES, 1962, J GEN PHYSIOL, V45, P553, DOI 10.1085/jgp.45.3.553; ZINKHAM WH, 1959, J PEDIATR-US, V55, P319, DOI 10.1016/S0022-3476(59)80228-6	37	55	55	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1967	19	4					524	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	98570	4962437				2022-12-18	WOS:A19679857000005
J	YUNIS, JJ; HOOK, EB; MAYER, M				YUNIS, JJ; HOOK, EB; MAYER, M			IDENTIFICATION OF MONGOLISM CHROMOSOME BY DNA REPLICATION ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		GERMAN J, 1964, J CELL BIOL, V20, P37, DOI 10.1083/jcb.20.1.37; GILBERT CW, 1962, NATURE, V195, P869, DOI 10.1038/195869a0; LEJEUNE JEROME, 1964, PROGR MED GENET, V3, P144; OHNO S., 1962, CYTOGENETICS, V1, P42, DOI 10.1159/000129712; PATAU K, 1960, AM J HUM GENET, V12, P250; PATAU K, 1964, AMER SOC HUM GEN, P20; SCHMID W., 1963, CYTOGENETICS [BASEL], V2, P175, DOI 10.1159/000129778; YUNIS J, IN PRESS; YUNIS JJ, 1964, LANCET, V2, P935; YUNIS JJ, 1964, NEW ENGL J MED, V271, P1133, DOI 10.1056/NEJM196411262712203; YUNIS JJ, 1964, LANCET, V2, P286; YUNIS JJ, 1963, CHROMOSOMA, V14, P146, DOI 10.1007/BF00336756; 1960, ACTA GENET STAT MED, V4, P322; 1965, LANCET, V1, P465	14	55	55	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1965	17	3					191	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	65219	14295489				2022-12-18	WOS:A19656521900001
J	TUCHINDA, S; RUCKNAGEL, DL; BOONYAPRAKOB, U; BALANKURA, K; MINNICH, V; SUVATEE, V				TUCHINDA, S; RUCKNAGEL, DL; BOONYAPRAKOB, U; BALANKURA, K; MINNICH, V; SUVATEE, V			COEXISTENCE OF GENES FOR HEMOGLOBIN E + ALPHA THALASSEMIA IN THAIS WITH RESULTANT SUPPRESSION OF HEMOGLOBIN E SYNTHESIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		AGER JAM, 1958, BMJ-BRIT MED J, V1, P929, DOI 10.1136/bmj.1.5076.929; AKSOY M, 1957, LANCET, V1, P792; AKSOY M, 1957, BRIT MED J, V1, P734, DOI 10.1136/bmj.1.5021.734; ALLEN DW, 1958, J AM CHEM SOC, V80, P1628, DOI 10.1021/ja01540a030; ATWATER J, 1960, NEW ENGL J MED, V263, P1215, DOI 10.1056/NEJM196012152632402; BINGLE JP, 1958, BRIT MED J, V2, P1389, DOI 10.1136/bmj.2.5109.1389; BOYER SH, 1963, AM J HUM GENET, V15, P438; CHERNOFF AI, 1956, J LAB CLIN MED, V47, P455; CHERNOFF AI, 1961, BLOOD, V17, P54, DOI 10.1182/blood.V17.1.54.54; CHOREMIS C, 1959, BRIT MED J, V2, P348, DOI 10.1136/bmj.2.5148.348; COHEN F, 1959, BLOOD, V14, P816, DOI 10.1182/blood.V14.7.816.816; DETRAVERSE PM, 1960, 7 P C EUR SOC HAEM, V2, P1053; DITTMAN WA, 1960, BLOOD, V16, P975, DOI 10.1182/blood.V16.1.975.975; DORMANDY KM, 1961, BRIT MED J, V1, P1582, DOI 10.1136/bmj.1.5239.1582; FESSAS P, 1957, SCIENCE, V126, P1119, DOI 10.1126/science.126.3283.1119; GAMMACK DB, 1961, ACTA GENET STAT MED, V11, P1; GERALD PS, 1958, BLOOD, V13, P61, DOI 10.1182/blood.V13.1.61.61; GOUTTAS A, 1955, Sang, V26, P911; HEDENBERG F, 1958, Acta Paediatr, V47, P652, DOI 10.1111/j.1651-2227.1958.tb07681.x; HUEHNS ER, 1960, BRIT J HAEMATOL, V6, P388, DOI 10.1111/j.1365-2141.1960.tb06257.x; HUISMAN THJ, 1958, J LAB CLIN MED, V52, P312; HUNT JA, 1960, BIOCHIM BIOPHYS ACTA, V42, P409, DOI 10.1016/0006-3002(60)90818-0; HUNT JA, 1959, NATURE, V184, P870, DOI 10.1038/184872a0; INGRAM VM, 1958, BIOCHIM BIOPHYS ACTA, V28, P539, DOI 10.1016/0006-3002(58)90516-X; INGRAM VM, 1959, NATURE, V184, P1903, DOI 10.1038/1841903a0; INGRAM VM, 1963, AM J MED, V34, P674, DOI 10.1016/0002-9343(63)90106-2; ITANO HA, 1956, MEDICINE, V35, P121, DOI 10.1097/00005792-195605000-00002; ITANO HA, 1962, C HEMOGLOBIN, P316; JONES RT, 1959, J AM CHEM SOC, V81, P3161, DOI 10.1021/ja01521a080; KATZ AM, 1959, J BIOL CHEM, V234, P2897; KOLER RD, 1961, ANN HUM GENET, V25, P95, DOI 10.1111/j.1469-1809.1961.tb01503.x; KUNKEL HG, 1955, SCIENCE, V122, P288, DOI 10.1126/science.122.3163.288; KUNKEL HG, 1957, J CLIN INVEST, V36, P1615, DOI 10.1172/JCI103561; LIE-INJO LUAN ENG, 1961, JOUR TROP MED AND HYG, V64, P136; LIEINJO LE, 1962, BLOOD, V20, P581; LIEINJO LE, 1957, ACTA HAEMAT, V18, P156; MINNICH V, 1954, BLOOD, V9, P1; MINNICH V, 1962, BLOOD, V19, P137, DOI 10.1182/blood.V19.2.137.137; MINNICH V, 1956, 6 P C INT SOC HAEM, P743; MOTULSKY AG, 1956, NATURE, V178, P1055, DOI 10.1038/1781055b0; MOTULSKY AG, 1962, NATURE, V194, P607, DOI 10.1038/194607b0; NANAKORN S, 1956, J LAB CLIN MED, V47, P490; NANCE WE, 1963, SCIENCE, V141, P123, DOI 10.1126/science.141.3576.123; NEEL JV, 1961, BLOOD, V18, P769, DOI 10.1182/blood.V18.6.769.769; NEEL JV, 1958, NAS NRC CHNASNRCP 55, P253; PEARSON HA, 1962, J LAB CLIN MED, V59, P147; QUATTRIN N, 1961, MINERVA MED, V52, P3189; RAMOT B, 1959, BRIT MED J, V2, P1228, DOI 10.1136/bmj.2.5161.1228; RIGAS DA, 1956, J LAB CLIN MED, V47, P51; RUCKNAGEL DONALD L., 1961, PROGR MED GENET, V1, P158; SINGER K, 1951, BLOOD, V6, P413, DOI 10.1182/blood.V6.5.413.413; SINGER SJ, 1959, P NATL ACAD SCI USA, V45, P174, DOI 10.1073/pnas.45.2.174; SMITH EW, 1953, B JOHNS HOPKINS HOSP, V93, P94; SMITHIES O, 1959, BIOCHEM J, V71, P585, DOI 10.1042/bj0710585; SOBER HA, 1956, J AM CHEM SOC, V78, P756, DOI 10.1021/ja01585a017; STURGEON P, 1962, 8 P C INT SOC HEM, P1041; TUCHINDA S, 1959, PEDIATRICS, V24, P43; TUCHINDA S, 1962, 9 C INT SOC HEM; VELLA F, 1958, BMJ-BRIT MED J, V1, P752, DOI 10.1136/bmj.1.5073.752; WOLFF JA, 1958, BLOOD, V13, P492, DOI 10.1182/blood.V13.5.492.492; ZUELZER WW, 1956, PROG HEMATOL, V1, P91; ZUELZER WW, 1954, BLOOD, V9, P1047, DOI 10.1182/blood.V9.11.1047.1047	62	55	55	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1964	16	3					311	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2973A	14207548				2022-12-18	WOS:A19642973A00008
J	BROWN, KS; HANNA, BL; DAHLBERG, AA; STRANDSKOV, HH				BROWN, KS; HANNA, BL; DAHLBERG, AA; STRANDSKOV, HH			DISTRIBUTION OF BLOOD GROUP ALLELES AMONG INDIANS OF SOUTHWEST NORTH-AMERICA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Allen FW, 1937, J IMMUNOL, V32, P301; ALLEN FW, 1935, PRELIMINARY REPORT B; ALLEN FW, 1935, 2 U N MEX B        4, P2; ARTEAGA C, 1952, ANN EUGENIC, V16, P351; BIRDSELL JB, 1950, COLD SPRING HARBOR S, V15, P123; BOYD WC, 1954, AM J HUM GENET, V6, P303; BOYD WC, 1954, AM J HUM GENET, V6, P1; Boyd WC, 1949, AM J PHYS ANTHROP-NE, V7, P569, DOI 10.1002/ajpa.1330070411; Breazeale EL, 1941, J IMMUNOL, V40, P161; CHOWN B, 1952, COMMUNICATION; Chown B, 1955, AM J PHYS ANTHROP-NE, V13, P181, DOI 10.1002/ajpa.1330130202; Chown B, 1953, AM J PHYS ANTHROP-NE, V11, P369, DOI 10.1002/ajpa.1330110312; DUNN LC, 1957, SCI AM, V196, P118; GERSHOWITZ H, 1957, COMMUNICATION; HANNA BL, 1953, AM J HUM GENET, V5, P377; HANNA BL, UNPUBLISHED; HANNA BL, 1957, VA J SC, V8; IKIN EW, 1952, COMMUNICATION; KAUTI C, 1955, THESIS U CHICAGO; KELLY WH, 1953, 1ST U AR BUR ETHN RE; KRAUS BS, 1956, AM ANTHROPOL, V58, P1017, DOI 10.1525/aa.1956.58.6.02a00040; KROEBER AL, 1907, 4 U CAL AM ARCH ETHN; Lessa WA, 1953, AM J PHYS ANTHROP-NE, V11, P384; Matson GA, 1947, AM J PHYS ANTHROP-NE, V5, P357, DOI 10.1002/ajpa.1330050307; MATSON GA, 1941, P UTAH ACAD SCI ARTS, V18, P101; Mourant A., 1954, DISTRIBUTION HUMAN B; Neel JV, 1954, HUMAN HEREDITY; Nigg C, 1926, J IMMUNOL, V11, P319; Pantin AM, 1953, AM J PHYS ANTHROP-NE, V11, P91, DOI 10.1002/ajpa.1330110117; POWELL JW, 1891, 7TH BUR AM ETHN ANN, P39; Snyder LH, 1926, AM J PHYS ANTHROPOL, V9, P233, DOI 10.1002/ajpa.1330090216; Stevens WL, 1938, ANN EUGENIC, V8, P362, DOI 10.1111/j.1469-1809.1938.tb02188.x; Swadesh M., 1954, AM ANTHROPOL, V56, P361, DOI 10.1525/aa.1954.56.3.02a00060; THIEME FP, 1952, AM J HUM GENET, V4, P94; WIENER AS, 1945, J EXP MED, V81, P559, DOI 10.1084/jem.81.6.559; WRIGHT SEWALL, 1949, PROC AMER PHIL SOC, V93, P471	36	55	55	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1958	10	2					175	195						21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA219	13533395				2022-12-18	WOS:A1958WA21900006
J	Zhao, XY; Bhattacharyya, A				Zhao, Xinyu; Bhattacharyya, Anita			Human Models Are Needed for Studying Human Neurodevelopmental Disorders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							PLURIPOTENT STEM-CELLS; FRAGILE-X-SYNDROME; TS65DN MOUSE MODEL; HUMAN BRAIN-DEVELOPMENT; MEDIAL GANGLIONIC EMINENCE; OUTER SUBVENTRICULAR ZONE; IN-VITRO DIFFERENTIATION; DOWN-SYNDROME MODEL; FMR1 KNOCKOUT MICE; CORTICAL INTERNEURONS	The analysis of animal models of neurological disease has been instrumental in furthering our understanding of neurodevelopment and brain diseases. However, animal models are limited in revealing some of the most fundamental aspects of development, genetics, pathology, and disease mechanisms that are unique to humans. These shortcomings are exaggerated in disorders that affect the brain, where the most significant differences between humans and animal models exist, and could underscore failures in targeted therapeutic interventions in affected individuals. Human pluripotent stem cells have emerged as a much-needed model system for investigating human-specific biology and disease mechanisms. However, questions remain regarding whether these cell-culture-based models are sufficient or even necessary. In this review, we summarize human-specific features of neurodevelopment and the most common neurodevelopmental disorders, present discrepancies between animal models and human diseases, demonstrate how human stem cell models can provide meaningful information, and discuss the challenges that exist in our pursuit to understand distinctively human aspects of neurodevelopment and brain disease. This information argues for a more thoughtful approach to disease modeling through consideration of the valuable features and limitations of each model system, be they human or animal, to mimic disease characteristics.	[Zhao, Xinyu; Bhattacharyya, Anita] Univ Wisconsin Madison, Sch Med & Publ Hlth, Waisman Ctr, Madison, WI 53705 USA; [Zhao, Xinyu] Univ Wisconsin Madison, Sch Med & Publ Hlth, Dept Neurosci, Madison, WI 53705 USA; [Bhattacharyya, Anita] Univ Wisconsin Madison, Sch Med & Publ Hlth, Dept Cell & Regenerat Biol, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Zhao, XY; Bhattacharyya, A (corresponding author), Univ Wisconsin Madison, Sch Med & Publ Hlth, Waisman Ctr, Madison, WI 53705 USA.; Zhao, XY (corresponding author), Univ Wisconsin Madison, Sch Med & Publ Hlth, Dept Neurosci, Madison, WI 53705 USA.; Bhattacharyya, A (corresponding author), Univ Wisconsin Madison, Sch Med & Publ Hlth, Dept Cell & Regenerat Biol, Madison, WI 53705 USA.	xinyu.zhao@wisc.edu; bhattacharyy@waisman.wisc.edu		Bhattacharyya, Anita/0000-0002-0360-7145; Zhao, Xinyu/0000-0002-5128-4424	National Institutes of Health [R01MH078972, 1R01MH116582, R56MH113146, R21HD085288, R03HD083538, R21NS105339, U54HD090256]; University of Wisconsin-Madison; Wisconsin Alumni Research Foundation; Jenni and Kyle Professorship; John Merck Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD085288, R03HD083538, U54HD090256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078972, R01MH116582, R56MH113146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS105339] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin-Madison; Wisconsin Alumni Research Foundation; Jenni and Kyle Professorship; John Merck Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health (R01MH078972, 1R01MH116582, and R56MH113146 to X.Z.; R21HD085288 and R03HD083538 to A.B.; R21NS105339 to A.B. and X.Z.; and U54HD090256 to the Waisman Center), the University of Wisconsin-Madison and Wisconsin Alumni Research Foundation (to X.Z.), a Jenni and Kyle Professorship (to X.Z.), and the John Merck Fund (to X.Z. and A.B.).	Adorno M, 2013, NATURE, V501, P380, DOI 10.1038/nature12530; Al-Jaberi N, 2015, CEREB CORTEX, V25, P631, DOI 10.1093/cercor/bht254; Ananiev G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025255; Andersen RE, 2018, CELL TISSUE RES, V371, P55, DOI 10.1007/s00441-017-2711-z; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Anderson SA, 2002, CEREB CORTEX, V12, P702, DOI 10.1093/cercor/12.7.702; Anderson SA, 2001, DEVELOPMENT, V128, P353; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Antonarakis SE, 2001, CURR OPIN GENET DEV, V11, P241, DOI 10.1016/S0959-437X(00)00185-4; Arber C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00010; Armstrong LC, 2017, HUM MOL GENET, V26, P4629, DOI 10.1093/hmg/ddx345; Arshad A, 2016, CEREB CORTEX, V26, P2242, DOI 10.1093/cercor/bhv074; ASHLEY CT, 1993, NAT GENET, V4, P244, DOI 10.1038/ng0793-244; Auranen M, 2002, AM J HUM GENET, V71, P777, DOI 10.1086/342720; Bae BI, 2015, DEV CELL, V32, P423, DOI 10.1016/j.devcel.2015.01.035; Bagni C, 2012, J CLIN INVEST, V122, P4314, DOI 10.1172/JCI63141; Bahn S, 2002, LANCET, V359, P310, DOI 10.1016/S0140-6736(02)07497-4; Bakken TE, 2016, NATURE, V535, P367, DOI 10.1038/nature18637; Bakken TE, 2015, HUM MOL GENET, V24, P4327, DOI 10.1093/hmg/ddv166; BAKKER CE, 1994, CELL, V78, P23; Bardy C, 2016, MOL PSYCHIATR, V21, P1573, DOI 10.1038/mp.2016.158; Batista-Brito R, 2009, CURR TOP DEV BIOL, V87, P81, DOI 10.1016/S0070-2153(09)01203-4; Batzoglou S, 2000, GENOME RES, V10, P950, DOI 10.1101/gr.10.7.950; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; BECKER L, 1991, PROG CLIN BIOL RES, V373, P133; Becker W, 2014, CNS NEUROL DISORD-DR, V13, P26, DOI 10.2174/18715273113126660186; Belichenko NP, 2009, J NEUROSCI, V29, P5938, DOI 10.1523/JNEUROSCI.1547-09.2009; Belichenko PV, 2007, J COMP NEUROL, V504, P329, DOI 10.1002/cne.21433; Belichenko PV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134861; Bellmaine SF, 2017, ELIFE, V6, DOI 10.7554/eLife.24502; Ben-Yosef D, 2008, MOL CELL ENDOCRINOL, V282, P153, DOI 10.1016/j.mce.2007.11.010; Benda C.E., 1947, MONGOLISM CRETINISM; Berry-Kravis E, 2014, PEDIATR NEUROL, V50, P297, DOI 10.1016/j.pediatrneurol.2013.12.001; Berry-Kravis EM, 2018, NAT REV DRUG DISCOV, V17, P280, DOI 10.1038/nrd.2017.221; Bershteyn M, 2017, CELL STEM CELL, V20, P435, DOI 10.1016/j.stem.2016.12.007; Bhattacharyya A, 2003, GENES BRAIN BEHAV, V2, P179, DOI 10.1034/j.1601-183X.2003.00025.x; Bhattacharyya A, 2016, MOL CELL NEUROSCI, V73, P43, DOI 10.1016/j.mcn.2015.11.011; Bhattacharyya A, 2009, DEV NEUROSCI-BASEL, V31, P497, DOI 10.1159/000236899; Biancotti JC, 2010, STEM CELLS, V28, P1530, DOI 10.1002/stem.483; Birey F, 2017, NATURE, V545, P54, DOI 10.1038/nature22330; Birger Y, 2013, BLOOD, V122, P988, DOI 10.1182/blood-2012-10-460998; Boland MJ, 2017, BRAIN, V140, P582, DOI 10.1093/brain/aww357; Boldog E, 2018, NAT NEUROSCI, V21, P1185, DOI 10.1038/s41593-018-0205-2; Borrie SC, 2017, ANNU REV GENOM HUM G, V18, P115, DOI 10.1146/annurev-genom-091416-035332; Bosman A, 2015, STEM CELLS, V33, P1434, DOI 10.1002/stem.1961; Briggs JA, 2013, STEM CELLS, V31, P467, DOI 10.1002/stem.1297; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; BUSCIGLIO J, 1995, NATURE, V378, P776, DOI 10.1038/378776a0; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; Caldwell MA, 2001, NAT BIOTECHNOL, V19, P475, DOI 10.1038/88158; Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112; Carpenter MK, 1999, EXP NEUROL, V158, P265, DOI 10.1006/exnr.1999.7098; Carver EA, 1997, GENOME RES, V7, P1123, DOI 10.1101/gr.7.12.1123; Castro P, 2017, J NEUROL, V264, P804, DOI 10.1007/s00415-016-8308-8; Chakrabarti L, 2007, J NEUROSCI, V27, P11483, DOI 10.1523/JNEUROSCI.3406-07.2007; Chakrabarti L, 2010, NAT NEUROSCI, V13, P927, DOI 10.1038/nn.2600; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chapman R S, 2001, Downs Syndr Res Pract, V7, P1, DOI 10.3104/reviews.108; Charrier C, 2012, CELL, V149, P923, DOI 10.1016/j.cell.2012.03.034; Chen LS, 2003, HUM MOL GENET, V12, P3067, DOI 10.1093/hmg/ddg331; Chen YJ, 2016, CELL STEM CELL, V18, P817, DOI 10.1016/j.stem.2016.03.014; Cheung AYL, 2011, HUM MOL GENET, V20, P2103, DOI 10.1093/hmg/ddr093; Chou HH, 2002, P NATL ACAD SCI USA, V99, P11736, DOI 10.1073/pnas.182257399; Chu JH, 2015, NEUROPSYCHOPHARMACOL, V40, P16, DOI 10.1038/npp.2014.171; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Clowry G, 2010, J ANAT, V217, P276, DOI 10.1111/j.1469-7580.2010.01281.x; COLON EJ, 1972, NEUROPADIATRIE, V3, P362, DOI 10.1055/s-0028-1091775; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Contestabile A, 2007, HIPPOCAMPUS, V17, P665, DOI 10.1002/hipo.20308; Contractor A, 2015, NEURON, V87, P699, DOI 10.1016/j.neuron.2015.06.017; COYLE JT, 1988, TRENDS NEUROSCI, V11, P390, DOI 10.1016/0166-2236(88)90075-6; COYLE JT, 1986, BRAIN RES BULL, V16, P773, DOI 10.1016/0361-9230(86)90074-2; Cramer N, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/101542; Crawley JN, 2007, BRAIN PATHOL, V17, P448, DOI 10.1111/j.1750-3639.2007.00096.x; CROME L, 1967, PATHOLOGY MENTAL RET; Czepiel M, 2011, GLIA, V59, P882, DOI 10.1002/glia.21159; Dankwa S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11187; Darnell JC, 2005, GENES BRAIN BEHAV, V4, P341, DOI 10.1111/j.1601-183X.2005.00144.x; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Daunhauer LA, 2011, OCCUP THER HEALTH CA, V25, P7, DOI 10.3109/07380577.2010.535601; Davidoff LM, 1928, ARCH NEURO PSYCHIATR, V20, P1229, DOI 10.1001/archneurpsyc.1928.02210180080004; DAVIS WE, 1982, J MOTOR BEHAV, V14, P194; DAVIS WE, 1987, J MOTOR BEHAV, V19, P130, DOI 10.1080/00222895.1987.10735404; Davisson M T, 1993, Prog Clin Biol Res, V384, P117; DAVISSON MT, 1990, PROG CLIN BIOL RES, V360, P263; de la Torre-Ubieta L, 2018, CELL, V172, P289, DOI 10.1016/j.cell.2017.12.014; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Dehay C, 2015, NEURON, V85, P683, DOI 10.1016/j.neuron.2014.12.060; Dehay C, 2009, NEURON, V62, P455, DOI 10.1016/j.neuron.2009.05.006; Deidda G, 2015, NAT MED, V21, P318, DOI 10.1038/nm.3827; Delabar Jean-Maurice, 1993, European Journal of Human Genetics, V1, P114; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Di Lullo E, 2017, NAT REV NEUROSCI, V18, P573, DOI 10.1038/nrn.2017.107; Dierssen M, 2003, CEREB CORTEX, V13, P758, DOI 10.1093/cercor/13.7.758; Dierssen M, 2012, NAT REV NEUROSCI, V13, P844, DOI 10.1038/nrn3314; Doers ME, 2014, STEM CELLS DEV, V23, P1777, DOI 10.1089/scd.2014.0030; Duchon A, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00104; Dumevska B, 2016, STEM CELL RES, V16, P500, DOI 10.1016/j.scr.2016.02.003; Dumevska B, 2016, STEM CELL RES, V16, P401, DOI 10.1016/j.scr.2016.02.010; Dzaja D, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00103; Eiges R, 2007, CELL STEM CELL, V1, P568, DOI 10.1016/j.stem.2007.09.001; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Ellegood J, 2015, NEUROTHERAPEUTICS, V12, P521, DOI 10.1007/s13311-015-0360-z; Ellegood J, 2010, NEUROIMAGE, V53, P1023, DOI 10.1016/j.neuroimage.2010.03.038; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; EPSTEIN CJ, 1985, ANN NY ACAD SCI, V450, P157, DOI 10.1111/j.1749-6632.1985.tb21490.x; Ermak G, 2013, FREE RADICAL BIO MED, V62, P47, DOI 10.1016/j.freeradbiomed.2013.01.016; Esposito G, 2008, HUM MOL GENET, V17, P440, DOI 10.1093/hmg/ddm322; Espuny-Camacho I, 2013, NEURON, V77, P440, DOI 10.1016/j.neuron.2012.12.011; Ethridge LE, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0140-1; Fidler DJ, 2007, MENT RETARD DEV D R, V13, P262, DOI 10.1002/mrdd.20166; Fish JL, 2008, J CELL SCI, V121, P2783, DOI 10.1242/jcs.023465; Flames N, 2005, NEURON, V46, P377, DOI 10.1016/j.neuron.2005.04.020; Florio M, 2018, ELIFE, V7, DOI 10.7554/eLife.32332; Florio M, 2015, SCIENCE, V347, P1465, DOI 10.1126/science.aaa1975; Fougerousse F, 2000, HUM MOL GENET, V9, P165, DOI 10.1093/hmg/9.2.165; Franchini LF, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0428-9; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Fujita E, 2008, P NATL ACAD SCI USA, V105, P3117, DOI 10.1073/pnas.0712298105; Gardiner KJ, 2010, TRENDS PHARMACOL SCI, V31, P66, DOI 10.1016/j.tips.2009.10.010; Garner CC, 2012, ADV EXP MED BIOL, V970, P451, DOI 10.1007/978-3-7091-0932-8_20; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Gauducheau M, 2017, AUTISM RES, V10, P1067, DOI 10.1002/aur.1743; Gearhart J, 1998, SCIENCE, V282, P1061, DOI 10.1126/science.282.5391.1061; Gelman D.M., 2012, JASPERS BASIC MECH E; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Gittelman RM, 2015, GENOME RES, V25, P1245, DOI 10.1101/gr.192591.115; GOLDEN JA, 1994, J NEUROPATH EXP NEUR, V53, P513, DOI 10.1097/00005072-199409000-00011; Goodliffe JW, 2016, J NEUROSCI, V36, P2926, DOI 10.1523/JNEUROSCI.2513-15.2016; Greco CM, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-2; Grossman AW, 2006, BRAIN RES, V1084, P158, DOI 10.1016/j.brainres.2006.02.044; Groszer M, 2008, CURR BIOL, V18, P354, DOI 10.1016/j.cub.2008.01.060; Guedj F, 2016, SCI REP-UK, V6, DOI 10.1038/srep32353; Guidi S., 2018, BRAIN PATHOL; Guidi S, 2008, BRAIN PATHOL, V18, P180, DOI 10.1111/j.1750-3639.2007.00113.x; Guillaume DJ, 2006, J NEUROSCI RES, V84, P1165, DOI 10.1002/jnr.21022; Gupta M, 2016, MAMM GENOME, V27, P538, DOI 10.1007/s00335-016-9661-8; Haas MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078561; Hagerman RJ, 2005, CURR OPIN PSYCHIATR, V18, P490, DOI 10.1097/01.yco.0000179485.39520.b0; Hall JH, 2016, NEUROBIOL LEARN MEM, V130, P118, DOI 10.1016/j.nlm.2016.02.002; Hammerschmidt K, 2015, Genes Brain Behav, V14, P583, DOI 10.1111/gbb.12237; Hansen DV, 2013, NAT NEUROSCI, V16, P1576, DOI 10.1038/nn.3541; Hansen DV, 2011, NEURON, V70, P645, DOI 10.1016/j.neuron.2011.05.006; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Hargus G, 2010, P NATL ACAD SCI USA, V107, P15921, DOI 10.1073/pnas.1010209107; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Haydar TF, 1996, J NEUROSCI, V16, P6175; Head Elizabeth, 2012, Curr Gerontol Geriatr Res, V2012, P412536, DOI 10.1155/2012/412536; Heard TT, 2014, INT J DEV NEUROSCI, V38, P155, DOI 10.1016/j.ijdevneu.2014.07.002; Herault Y, 2017, DIS MODEL MECH, V10, P1165, DOI 10.1242/dmm.029728; Heulens I, 2013, EUR J HUM GENET, V21, P816, DOI 10.1038/ejhg.2012.265; Hibaoui Y, 2015, J CLIN MED, V4, P696, DOI 10.3390/jcm4040696; Hibaoui Y, 2014, EMBO MOL MED, V6, P259, DOI 10.1002/emmm.201302848; HINTON VJ, 1991, AM J MED GENET, V41, P289, DOI 10.1002/ajmg.1320410306; Hladnik A, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00050; Holtzman DM, 1996, P NATL ACAD SCI USA, V93, P13333, DOI 10.1073/pnas.93.23.13333; Hotta A, 2009, NAT METHODS, V6, P370, DOI [10.1038/NMETH.1325, 10.1038/nmeth.1325]; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Hu BY, 2009, NAT PROTOC, V4, P1614, DOI 10.1038/nprot.2009.186; Hu HY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2146; Huo HQ, 2018, STEM CELL REP, V10, P1251, DOI 10.1016/j.stemcr.2018.02.001; Hyde LA, 2001, BEHAV BRAIN RES, V118, P53, DOI 10.1016/S0166-4328(00)00313-2; Irwin SA, 2002, AM J MED GENET, V111, P140, DOI 10.1002/ajmg.10500; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Jakala P, 1997, J CLIN INVEST, V100, P331, DOI 10.1172/JCI119538; Jakovcevski I, 2011, CEREB CORTEX, V21, P1771, DOI 10.1093/cercor/bhq245; Jiang J, 2013, NATURE, V500, P296, DOI 10.1038/nature12394; Jobe EM, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00059; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Jones EG, 2009, CEREB CORTEX, V19, P1953, DOI 10.1093/cercor/bhp088; Julian LM, 2017, CANCER RES, V77, P5491, DOI 10.1158/0008-5472.CAN-17-0925; Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Kazdoba TM, 2016, GENES BRAIN BEHAV, V15, P7, DOI 10.1111/gbb.12256; Kazdoba TM, 2014, INTRACTABLE RARE DIS, V3, P118, DOI 10.5582/irdr.2014.01024; Kemp PJ, 2016, J PHYSIOL-LONDON, V594, P6583, DOI 10.1113/JP270655; Kempermann G, 2018, CELL STEM CELL, V23, P25, DOI 10.1016/j.stem.2018.04.004; Kennedy H, 2012, PROG BRAIN RES, V195, P341, DOI 10.1016/B978-0-444-53860-4.00016-7; Kepecs A, 2014, NATURE, V505, P318, DOI 10.1038/nature12983; Kessaris N, 2014, CURR OPIN NEUROBIOL, V26, P79, DOI 10.1016/j.conb.2013.12.012; KESSLAK JP, 1994, NEUROLOGY, V44, P1039, DOI 10.1212/WNL.44.6.1039; Kim KY, 2011, P NATL ACAD SCI USA, V108, P14169, DOI 10.1073/pnas.1018979108; Kim TG, 2014, STEM CELLS, V32, P1789, DOI 10.1002/stem.1704; Kirsammer G, 2008, BLOOD, V111, P767, DOI 10.1182/blood-2007-04-085670; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kleschevnikov AM, 2012, NEUROBIOL DIS, V45, P683, DOI 10.1016/j.nbd.2011.10.009; Kooy RF, 1999, EUR J HUM GENET, V7, P526, DOI 10.1038/sj.ejhg.5200348; Korecka JA, 2016, MOL CELL NEUROSCI, V73, P3, DOI [10.1016/j.mcn.2015.1/004, 10.1016/j.mcn.2015.12.004]; Korenberg J R, 1993, Prog Clin Biol Res, V384, P87; KORENBERG JR, 1990, AM J HUM GENET, V47, P236; Kosik KS, 2009, NAT REV NEUROSCI, V10, P754, DOI 10.1038/nrn2713; Krencik R, 2017, STEM CELL REP, V9, P1745, DOI 10.1016/j.stemcr.2017.10.026; Krencik R, 2011, NAT BIOTECHNOL, V29, P528, DOI 10.1038/nbt.1877; Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001; Kriegstein A, 2006, CEREB CORTEX, V16, pI1, DOI 10.1093/cercor/bhk041; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kwan KY, 2012, CELL, V149, P899, DOI 10.1016/j.cell.2012.02.060; Lai CSL, 2003, BRAIN, V126, P2455, DOI 10.1093/brain/awg247; Lai JKY, 2016, NEUROSCIENCE, V318, P12, DOI 10.1016/j.neuroscience.2016.01.021; Lam RS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169506; LaMonica BE, 2012, CURR OPIN NEUROBIOL, V22, P747, DOI 10.1016/j.conb.2012.03.006; Lana-Elola E, 2016, ELIFE, V5, DOI 10.7554/eLife.11614; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lapray D, 2012, NAT NEUROSCI, V15, P1265, DOI 10.1038/nn.3176; Latash ML, 2007, J INTELL DISABIL RES, V51, P962, DOI 10.1111/j.1365-2788.2007.01008.x; Lavdas AA, 1999, J NEUROSCI, V19, P7881; LEJEUNE J, 1959, ANN GENET-PARIS, V1, P41; Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779; Li HQ, 2016, GENETICS, V203, P763, DOI 10.1534/genetics.116.188045; Li M, 2017, STEM CELLS, V35, P158, DOI 10.1002/stem.2463; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Li XJ, 2008, STEM CELLS, V26, P886, DOI 10.1634/stemcells.2007-0620; Li XJ, 2006, METH MOL B, V331, P169; Li Y, 2015, J NEUROSCI, V35, P610, DOI 10.1523/JNEUROSCI.1003-14.2015; Li YQ, 2017, STEM CELL REP, V8, P883, DOI 10.1016/j.stemcr.2017.02.020; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Liu CH, 2011, DEV NEUROSCI-BASEL, V33, P404, DOI 10.1159/000329422; Liu SJ, 2017, SCIENCE, V355, DOI 10.1126/science.aah7111; Liu Y, 2013, NAT PROTOC, V8, P1670, DOI 10.1038/nprot.2013.106; Liu Y, 2013, NAT BIOTECHNOL, V31, P440, DOI 10.1038/nbt.2565; Lohith TG, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-15; Lokanga RA, 2013, HUM MUTAT, V34, P157, DOI 10.1002/humu.22177; Lott IT, 2012, PROG BRAIN RES, V197, P101, DOI 10.1016/B978-0-444-54299-1.00006-6; Lott IT, 2010, LANCET NEUROL, V9, P623, DOI 10.1016/S1474-4422(10)70112-5; Lozano R, 2014, INTRACTABLE RARE DIS, V3, P134, DOI 10.5582/irdr.2014.01022; Lu HE, 2013, EXP CELL RES, V319, P498, DOI 10.1016/j.yexcr.2012.09.017; Lu Jie, 2011, J Vis Exp, DOI 10.3791/2681; Lu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022126; Lu ZX, 2007, HUM MUTAT, V28, P978, DOI 10.1002/humu.20547; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Ma T, 2013, NAT NEUROSCI, V16, P1588, DOI 10.1038/nn.3536; MacDermot KD, 2005, AM J HUM GENET, V76, P1074, DOI 10.1086/430841; Mansour AA, 2018, NAT BIOTECHNOL, V36, P432, DOI 10.1038/nbt.4127; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Marin O, 2013, EUR J NEUROSCI, V38, P2019, DOI 10.1111/ejn.12225; Marin O, 2013, CELL STEM CELL, V12, P497, DOI 10.1016/j.stem.2013.04.017; MARINPAD.M, 1972, BRAIN RES, V44, P625, DOI 10.1016/0006-8993(72)90324-1; MARINPADILLA M, 1976, J COMP NEUROL, V167, P63, DOI 10.1002/cne.901670105; Maroof AM, 2013, CELL STEM CELL, V12, P559, DOI 10.1016/j.stem.2013.04.008; Marques AC, 2014, CURR OPIN GENET DEV, V27, P48, DOI 10.1016/j.gde.2014.03.009; Martin JZD, 2018, FREE RADICAL BIO MED, V114, P33, DOI 10.1016/j.freeradbiomed.2017.10.002; Martinez-Cue C, 2014, NEUROSCI BIOBEHAV R, V46, P218, DOI 10.1016/j.neubiorev.2013.12.008; Martinez-Cue C, 2013, J NEUROSCI, V33, P3953, DOI 10.1523/JNEUROSCI.1203-12.2013; Martins-Taylor K, 2014, HUM MOL GENET, V23, P2364, DOI 10.1093/hmg/ddt628; MCCORMICK MK, 1989, GENOMICS, V5, P325, DOI 10.1016/0888-7543(89)90065-7; Mientjes EJ, 2006, NEUROBIOL DIS, V21, P549, DOI 10.1016/j.nbd.2005.08.019; Mitchell C, 2018, SEMIN CELL DEV BIOL, V76, P23, DOI 10.1016/j.semcdb.2017.08.045; Molnar Z, 2012, PROG BRAIN RES, V195, P45, DOI 10.1016/B978-0-444-53860-4.00003-9; Morice E, 2008, LEARN MEMORY, V15, P492, DOI 10.1101/lm.969608; Muotri AR, 2005, P NATL ACAD SCI USA, V102, P18644, DOI 10.1073/pnas.0509315102; Murray A, 2015, STEM CELLS, V33, P2077, DOI 10.1002/stem.1968; Neale N, 2018, NEUROIMAGE-CLIN, V17, P263, DOI 10.1016/j.nicl.2017.10.022; Nicholas CR, 2013, CELL STEM CELL, V12, P573, DOI 10.1016/j.stem.2013.04.005; Noctor Stephen C, 2007, Novartis Found Symp, V288, P59; O'Doherty A, 2005, SCIENCE, V309, P2033, DOI 10.1126/science.1114535; Olmos-Serrano JL, 2016, NEURON, V89, P1208, DOI 10.1016/j.neuron.2016.01.042; ORourke NA, 1997, DEVELOPMENT, V124, P997; Otani T, 2016, CELL STEM CELL, V18, P467, DOI 10.1016/j.stem.2016.03.003; Paredes MF, 2016, SCIENCE, V354, DOI 10.1126/science.aaf7073; Park CY, 2015, CELL REP, V13, P234, DOI 10.1016/j.celrep.2015.08.084; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Parnavelas J G, 2000, Novartis Found Symp, V228, P129; Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]; Pasca SP, 2018, NATURE, V553, P437, DOI 10.1038/nature25032; Pastori C, 2014, HUM GENET, V133, P59, DOI 10.1007/s00439-013-1356-6; Patel A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10119; Pelleri MC, 2016, HUM MOL GENET, V25, P2525, DOI 10.1093/hmg/ddw116; Peschansky VJ, 2016, MOL CELL NEUROSCI, V74, P49, DOI 10.1016/j.mcn.2016.03.008; PETIT TL, 1984, EXP NEUROL, V83, P13, DOI 10.1016/0014-4886(84)90041-4; Pham MT, 2018, NEUROREPORT, V29, P588, DOI 10.1097/WNR.0000000000001014; Pickering Susan J, 2003, Reprod Biomed Online, V7, P353; Potier MC, 2014, CNS NEUROL DISORD-DR, V13, P8, DOI 10.2174/18715273113126660185; Prabhakar S, 2008, SCIENCE, V321, P1346, DOI 10.1126/science.1159974; Prabhakar S, 2006, SCIENCE, V314, P786, DOI 10.1126/science.1130738; Prasher VP, 2008, INT J GERIATR PSYCH, V23, P441, DOI 10.1002/gps.1883; Purpura D P, 1975, UCLA Forum Med Sci, P141; Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032; Qiu J, 2016, ELIFE, V5, DOI 10.7554/eLife.20337; Quadrato G, 2017, CURR OPIN CELL BIOL, V49, P47, DOI 10.1016/j.ceb.2017.11.010; Quadrato G, 2016, NAT MED, V22, P1220, DOI 10.1038/nm.4214; Radonjic NV, 2014, CELL REP, V9, P2139, DOI 10.1016/j.celrep.2014.11.026; RAHMANI Z, 1989, P NATL ACAD SCI USA, V86, P5958, DOI 10.1073/pnas.86.15.5958; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Reeves RH, 2001, TRENDS GENET, V17, P83, DOI 10.1016/S0168-9525(00)02172-7; REEVES RH, 1987, MOL BRAIN RES, V2, P215, DOI 10.1016/0169-328X(87)90028-3; Reinchisi G, 2012, CEREB CORTEX, V22, P2820, DOI 10.1093/cercor/bhr359; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Richtsmeier JT, 2002, AM J MED GENET, V107, P317, DOI 10.1002/ajmg.10175; Roper RJ, 2006, PLOS GENET, V2, P231, DOI 10.1371/journal.pgen.0020050; ROSS MH, 1984, NEUROLOGY, V34, P909, DOI 10.1212/WNL.34.7.909; Roubertoux PL, 2017, BEHAV GENET, V47, P305, DOI 10.1007/s10519-017-9835-5; RUDELLI RD, 1985, ACTA NEUROPATHOL, V67, P289, DOI 10.1007/BF00687814; Rueda N, 2005, NEUROSCI LETT, V380, P197, DOI 10.1016/j.neulet.2005.01.039; Rueda N, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/584071; Sabaratnam M, 2000, J INTELL DISABIL RES, V44, P81, DOI 10.1046/j.1365-2788.2000.00261.x; Sago H, 1998, P NATL ACAD SCI USA, V95, P6256, DOI 10.1073/pnas.95.11.6256; Sances S, 2016, NAT NEUROSCI, V19, P542, DOI 10.1038/nn.4273; SCHMIDTSIDOR B, 1990, CLIN NEUROPATHOL, V9, P181; Schupf N, 2010, NEUROLOGY, V75, P1639, DOI 10.1212/WNL.0b013e3181fb448b; Schupf N, 2007, ARCH NEUROL-CHICAGO, V64, P1007, DOI 10.1001/archneur.64.7.1007; Shaltouki A, 2013, STEM CELLS, V31, P941, DOI 10.1002/stem.1334; Sharp J, 2011, METHODS MOL BIOL, V767, P399, DOI 10.1007/978-1-61779-201-4_29; Sheridan SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026203; Shi YC, 2012, NAT PROTOC, V7, P1836, DOI 10.1038/nprot.2012.116; Shi YC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003771; Shu WG, 2007, DEVELOPMENT, V134, P1991, DOI 10.1242/dev.02846; Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Sidhu H, 2014, J NEUROSCI, V34, P9867, DOI 10.1523/JNEUROSCI.1162-14.2014; SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3; Silbereis JC, 2016, NEURON, V89, P248, DOI 10.1016/j.neuron.2015.12.008; Silverman W, 2007, MENT RETARD DEV D R, V13, P228, DOI 10.1002/mrdd.20156; Sinclair D, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0380-16.2017; Sloan SA, 2017, NEURON, V95, P779, DOI 10.1016/j.neuron.2017.07.035; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; Smith-Hicks CL, 2017, FRONT NEURAL CIRCUIT, V11, DOI 10.3389/fncir.2017.00006; Somel M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001214; Sousa AMM, 2017, CELL, V170, P226, DOI 10.1016/j.cell.2017.06.036; Stagni F, 2018, FREE RADICAL BIO MED, V114, P15, DOI 10.1016/j.freeradbiomed.2017.07.026; Starbuck JM, 2014, AM J MED GENET A, V164, P1981, DOI 10.1002/ajmg.a.36594; Steinbeck JA, 2015, NAT BIOTECHNOL, V33, P204, DOI 10.1038/nbt.3124; STONE I, 1967, ACTA GENET MED GEMEL, V16, P52, DOI 10.1017/S1120962300013287; Stringer M, 2017, MOL GENET GENOM MED, V5, P451, DOI 10.1002/mgg3.334; Sturgeon X, 2011, MAMM GENOME, V22, P261, DOI 10.1007/s00335-011-9321-y; Sun XJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095471, 10.1371/journal.pone.0114924]; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; SWEENEY JE, 1989, NEUROSCIENCE, V31, P413, DOI 10.1016/0306-4522(89)90384-9; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; TAKASHIMA S, 1994, J INTELL DISABIL RES, V38, P265; Telias M, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00121; Telias M, 2015, J NEUROSCI, V35, P15295, DOI 10.1523/JNEUROSCI.0317-15.2015; Telias M, 2013, DEV BIOL, V374, P32, DOI 10.1016/j.ydbio.2012.11.031; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tomaszewski B, 2018, J INTELL DISABIL RES, V62, P41, DOI 10.1111/jir.12450; Tyson JA, 2013, CELL CYCLE, V12, P3129, DOI 10.4161/cc.26351; Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005; Urraca N, 2018, MOL AUTISM, V9, DOI 10.1186/s13229-018-0191-y; van der Molen MJW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088451; Van der Molen MJW, 2013, BIOL PSYCHOL, V92, P216, DOI 10.1016/j.biopsycho.2012.11.013; Veeraragavan S, 2012, BEHAV BRAIN RES, V228, P1, DOI 10.1016/j.bbr.2011.11.018; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Verlinsky Y, 2005, REPROD BIOMED ONLINE, V10, P105, DOI 10.1016/S1472-6483(10)60810-3; Vernes SC, 2007, AM J HUM GENET, V81, P1232, DOI 10.1086/522238; Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998; Villar AJ, 2005, MAMM GENOME, V16, P79, DOI 10.1007/s00335-004-2428-7; Wang J, 2017, J NEURODEV DISORD, V9, DOI 10.1186/s11689-017-9191-z; Wang T, 2012, CURR OPIN GENET DEV, V22, P256, DOI 10.1016/j.gde.2012.02.002; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Weick JP, 2013, P NATL ACAD SCI USA, V110, P9962, DOI 10.1073/pnas.1216575110; Weick JP, 2011, P NATL ACAD SCI USA, V108, P20189, DOI 10.1073/pnas.1108487108; Weick JP, 2010, STEM CELLS, V28, P2008, DOI 10.1002/stem.514; Weitzdoerfer R, 2001, J NEURAL TRANSM-SUPP, P59; Whitney KN, 2013, EXP CLIN PSYCHOPHARM, V21, P345, DOI 10.1037/a0033965; WISNIEWSKI KE, 1984, NEW ENGL J MED, V311, P1187; WISNIEWSKI KE, 1990, AM J MED GENET, P274; Witton J, 2015, NAT NEUROSCI, V18, P1291, DOI 10.1038/nn.4072; Won HJ, 2016, NATURE, V538, P523, DOI 10.1038/nature19847; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Wu Q, 2014, ADV EXP MED BIOL, V800, P25, DOI [10.1007/978-94-007-7687-6_2, 10.1007/978-94-007-7687-6]; WU XW, 1994, P NATL ACAD SCI USA, V91, P742, DOI 10.1073/pnas.91.2.742; Xing Z, 2016, BRIT MED BULL, V120, P111, DOI 10.1093/bmb/ldw040; Yan YP, 2005, STEM CELLS, V23, P781, DOI 10.1634/stemcells.2004-0365; Yoon KJ, 2014, CELL STEM CELL, V15, P79, DOI 10.1016/j.stem.2014.05.003; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu T, 2010, HUM MOL GENET, V19, P2780, DOI 10.1093/hmg/ddq179; Yu XJ, 2011, J NEUROSCI, V31, P2413, DOI 10.1523/JNEUROSCI.5249-10.2011; Yuan F, 2015, SCI REP-UK, V5, DOI 10.1038/srep18550; Zampieri BL, 2014, PHYSIOL BEHAV, V128, P119, DOI 10.1016/j.physbeh.2014.02.020; Zeng HK, 2012, CELL, V149, P483, DOI 10.1016/j.cell.2012.02.052; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhang SC, 2006, BRAIN PATHOL, V16, P132, DOI 10.1111/j.1750-3639.2006.00008.x; Zhao XN, 2016, GENES-BASEL, V7, DOI 10.3390/genes7090070; Zis P, 2018, FREE RADICAL BIO MED, V114, P3, DOI 10.1016/j.freeradbiomed.2017.08.024	378	54	54	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 6	2018	103	6					829	857		10.1016/j.ajhg.2018.10.009	http://dx.doi.org/10.1016/j.ajhg.2018.10.009			29	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	HD4YX	30526865	Green Published, Bronze			2022-12-18	WOS:000452535600002
J	Nielsen, JB; Fritsche, LG; Zhou, W; Teslovich, TM; Holmen, OL; Gustafsson, S; Gabrielsen, ME; Schmidt, EM; Beaumont, R; Wolford, BN; Lin, MX; Brummett, CM; Preuss, MH; Refsgaard, L; Bottinger, EP; Graham, SE; Surakka, I; Chu, YH; Skogholt, AH; Dalen, H; Boyle, AP; Oral, H; Herron, TJ; Kitzman, J; Jalife, J; Svendsen, JH; Olesen, MS; Njolstad, I; Lochen, ML; Baras, A; Gottesman, O; Marcketta, A; O'Dushlaine, C; Ritchie, MD; Wilsgaard, T; Loos, RJF; Frayling, TM; Boehnke, M; Ingelsson, E; Carey, DJ; Dewey, FE; Kang, HM; Abecasis, GR; Hveem, K; Willer, CJ				Nielsen, Jonas B.; Fritsche, Lars G.; Zhou, Wei; Teslovich, Tanya M.; Holmen, Oddgeir L.; Gustafsson, Stefan; Gabrielsen, Maiken E.; Schmidt, Ellen M.; Beaumont, Robin; Wolford, Brooke N.; Lin, Maoxuan; Brummett, Chad M.; Preuss, Michael H.; Refsgaard, Lena; Bottinger, Erwin P.; Graham, Sarah E.; Surakka, Ida; Chu, Yunhan; Skogholt, Anne Heidi; Dalen, Havard; Boyle, Alan P.; Oral, Hakan; Herron, Todd J.; Kitzman, Jacob; Jalife, Jose; Svendsen, Jesper H.; Olesen, Morten S.; Njolstad, Inger; Lochen, Maja-Lisa; Baras, Aris; Gottesman, Omri; Marcketta, Anthony; O'Dushlaine, Colm; Ritchie, Marylyn D.; Wilsgaard, Tom; Loos, Ruth J. F.; Frayling, Timothy M.; Boehnke, Michael; Ingelsson, Erik; Carey, David J.; Dewey, Frederick E.; Kang, Hyun M.; Abecasis, Goncalo R.; Hveem, Kristian; Willer, Cristen J.			Genome-wide Study of Atrial Fibrillation Identifies Seven Risk Loci and Highlights Biological Pathways and Regulatory Elements Involved in Cardiac Development	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COHORT PROFILE; QRS DURATION; ASSOCIATION; VARIANTS; EFFICIENT; PROTEIN; PAX6; DIFFERENTIATION; EPIDEMIOLOGY; METAANALYSIS	Atrial fibrillation (AF) is a common cardiac arrhythmia and a major risk factor for stroke, heart failure, and premature death. The pathogenesis of AF remains poorly understood, which contributes to the current lack of highly effective treatments. To understand the genetic variation and biology underlying AF, we undertook a genome-wide association study (GWAS) of 6,337 AF individuals and 61,607 AF-free individuals from Norway, including replication in an additional 30,679 AF individuals and 278,895 AF-free individuals. Through genotyping and dense imputation mapping from whole-genome sequencing, we tested almost nine million genetic variants across the genome and identified seven risk loci, including two novel loci. One novel locus (lead single-nucleotide variant [SNV] rs12614435; p = 6.76 x 10(-18)) comprised intronic and several highly correlated missense variants situated in the I-, A-, and M-bands of titin, which is the largest protein in humans and responsible for the passive elasticity of heart and skeletal muscle. The other novel locus (lead SNV rs56202902; p = 1.54 x 10(-11)) covered a large, gene-dense chromosome 1 region that has previously been linked to cardiac conduction. Pathway and functional enrichment analyses suggested that many AF-associated genetic variants act through a mechanism of impaired muscle cell differentiation and tissue formation during fetal heart development.	[Nielsen, Jonas B.; Wolford, Brooke N.; Lin, Maoxuan; Graham, Sarah E.; Surakka, Ida; Oral, Hakan; Willer, Cristen J.] Univ Michigan, Div Cardiovasc Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Nielsen, Jonas B.; Zhou, Wei; Wolford, Brooke N.; Lin, Maoxuan; Boyle, Alan P.; Kitzman, Jacob; Willer, Cristen J.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Fritsche, Lars G.; Holmen, Oddgeir L.; Gabrielsen, Maiken E.; Chu, Yunhan; Skogholt, Anne Heidi; Hveem, Kristian] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, HUNT Res Ctr, N-7600 Levanger, Norway; [Fritsche, Lars G.; Zhou, Wei; Schmidt, Ellen M.; Boehnke, Michael; Kang, Hyun M.; Abecasis, Goncalo R.; Willer, Cristen J.] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Fritsche, Lars G.; Holmen, Oddgeir L.; Gabrielsen, Maiken E.; Chu, Yunhan; Skogholt, Anne Heidi; Boehnke, Michael; Abecasis, Goncalo R.; Hveem, Kristian; Willer, Cristen J.] Norwegian Univ Sci & Technol, Dept Publ Hlth, KG Jebsen Ctr Genet Epidemiol, N-7491 Trondheim, Norway; [Teslovich, Tanya M.; Baras, Aris; Gottesman, Omri; Marcketta, Anthony; O'Dushlaine, Colm; Dewey, Frederick E.] Regeneron Genet Ctr, Tarrytown, NY 10591 USA; [Holmen, Oddgeir L.; Dalen, Havard] St Olavs Univ Hosp, Dept Cardiol, N-7030 Trondheim, Norway; [Gustafsson, Stefan; Ingelsson, Erik] Uppsala Univ, Mol Epidemiol & Sci Life Lab, Dept Med Sci, S-75237 Uppsala, Sweden; [Beaumont, Robin; Frayling, Timothy M.] Royal Devon & Exeter NHS Fdn Trust, Exeter EX2 5WD, Devon, England; [Beaumont, Robin; Frayling, Timothy M.] Univ Exeter, Exeter EX2 5WD, Devon, England; [Brummett, Chad M.] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48109 USA; [Preuss, Michael H.; Bottinger, Erwin P.; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Preuss, Michael H.; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Genet Obes & Related Metab Traits Program, New York, NY 10029 USA; [Refsgaard, Lena; Svendsen, Jesper H.; Olesen, Morten S.] Univ Copenhagen, Rigshosp, Dept Cardiol, Lab Mol Cardiol, DK-2100 Copenhagen, Denmark; [Bottinger, Erwin P.] Icahn Sch Med Mt Sinai, Mindich Child Hlth Dev Inst, New York, NY 10029 USA; [Dalen, Havard; Hveem, Kristian] Nord Trondelag Hosp Trust, Levanger Hosp, Dept Med, N-7600 Levanger, Norway; [Dalen, Havard] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, N-7491 Trondheim, Norway; [Boyle, Alan P.; Willer, Cristen J.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Herron, Todd J.; Jalife, Jose] Univ Michigan, Ctr Arrhythmia Res, Dept Internal Med, Ann Arbor, MI 48109 USA; [Jalife, Jose] Fdn Ctr Nacl Invest Cardiovasc, Madrid 28029, Spain; [Svendsen, Jesper H.] Univ Copenhagen, Fac Hlth & Med Sci, DK-2200 Copenhagen, Denmark; [Olesen, Morten S.] Univ Copenhagen, Dept Biomed, DK-2200 Copenhagen, Denmark; [Njolstad, Inger; Lochen, Maja-Lisa; Wilsgaard, Tom] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Community Med, N-9019 Tromso, Norway; [Ritchie, Marylyn D.] Geisinger Hlth Syst, Danville, PA 17822 USA; [Ingelsson, Erik] Stanford Univ, Sch Med, Div Cardiovasc Med, Dept Med, Stanford, CA 94305 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Norwegian University of Science & Technology (NTNU); University of Michigan System; University of Michigan; Norwegian University of Science & Technology (NTNU); Regeneron; Norwegian University of Science & Technology (NTNU); Uppsala University; University of Exeter; University of Exeter; University of Michigan System; University of Michigan; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Rigshospitalet; University of Copenhagen; Icahn School of Medicine at Mount Sinai; Norwegian University of Science & Technology (NTNU); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Copenhagen; University of Copenhagen; UiT The Arctic University of Tromso; Geisinger Health System; Stanford University	Willer, CJ (corresponding author), Univ Michigan, Div Cardiovasc Med, Dept Internal Med, Ann Arbor, MI 48109 USA.; Willer, CJ (corresponding author), Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA.; Hveem, K (corresponding author), Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, HUNT Res Ctr, N-7600 Levanger, Norway.; Willer, CJ (corresponding author), Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA.; Hveem, K; Willer, CJ (corresponding author), Norwegian Univ Sci & Technol, Dept Publ Hlth, KG Jebsen Ctr Genet Epidemiol, N-7491 Trondheim, Norway.; Hveem, K (corresponding author), Nord Trondelag Hosp Trust, Levanger Hosp, Dept Med, N-7600 Levanger, Norway.; Willer, CJ (corresponding author), Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA.	kristian.hveem@ntnu.no; cristen@umich.edu	Hveem, Kristian/AFV-4683-2022; olesen, morten/AAC-5752-2021; Svendsen, Jesper Hastrup/G-8573-2017; Fritsche, Lars G/AAF-9387-2019; Loos, Ruth J F/Q-2862-2016; Wolford, Brooke/GQZ-2025-2022; Jalife, Jose/L-4833-2015; Njolstad, Inger/X-3784-2019; Loos, Ruth/GON-5877-2022; Boyle, Alan/I-1848-2014; Jalife, Jose/AAJ-9156-2021; Wolford, Brooke/Y-3162-2019; Jalife, Jose/A-8781-2019; Dalen, Havard/A-8087-2018	Svendsen, Jesper Hastrup/0000-0001-8466-8515; Fritsche, Lars G/0000-0002-2110-1690; Loos, Ruth J F/0000-0002-8532-5087; Jalife, Jose/0000-0003-0080-3500; Boyle, Alan/0000-0002-2081-1105; Jalife, Jose/0000-0003-0080-3500; Wolford, Brooke/0000-0003-3153-1552; Jalife, Jose/0000-0003-0080-3500; Dalen, Havard/0000-0003-1192-3663; Lochen, Maja-Lisa/0000-0002-8532-6573; Preuss, Michael/0000-0001-5266-8465; Refsgaard, Lena/0000-0002-6560-9357; Lin, Maoxuan/0000-0001-5191-1857; Olesen, Morten Salling/0000-0001-9477-5322; Brummett, Chad/0000-0003-0974-7242; Schmidt, Ellen/0000-0003-1198-7536; Kitzman, Jacob/0000-0002-6145-882X; Surakka, Ida/0000-0002-6669-5541; Beaumont, Robin/0000-0003-0750-8248	Danish Heart Foundation; Lundbeck Foundation; A.P Moller Foundation for the Advancement of Medical Science; Fondsborsvekselerer Henry Hansen og Hustru Karla Hansen Fodt Vestergaards Legat; National Institutes of Health (NIH) [HL109946, HL127564, HL130705]; Danish National Research Foundation; John and Birthe Meyer Foundation; Arvid Nilsson Foundation; Research Council of Rigshospitalet, Denmark; NIH [1R01DK106236-01A1, 1R01HL135313-01]; Knut och Alice Wallenberg Foundation [2013.0126]; Swedish Heart-Lung Foundation [20140422]; Goran Gustafsson Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130705, R01HL109946, R01HL127564, R01HL135313, R35HL135824] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG009293, T32HG000040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK106236, P30DK020572] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018522] Funding Source: NIH RePORTER	Danish Heart Foundation; Lundbeck Foundation(Lundbeckfonden); A.P Moller Foundation for the Advancement of Medical Science; Fondsborsvekselerer Henry Hansen og Hustru Karla Hansen Fodt Vestergaards Legat; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish National Research Foundation(Danmarks Grundforskningsfond); John and Birthe Meyer Foundation; Arvid Nilsson Foundation; Research Council of Rigshospitalet, Denmark; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Knut och Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Goran Gustafsson Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The Nord-Trondelag Health (HUNT) Study is a collaboration among the HUNT Research Centre (Faculty of Medicine, Norwegian University of Science and Technology), the Nord-Trondelag County Council, the Central Norway Health Authority, and the Norwegian Institute of Public Health. The HUNT-MI study, which comprises the genetic investigations of the HUNT Study, is a collaboration between investigators from the HUNT Study and the University of Michigan School of Public Health and the University of Michigan Medical School. The authors wish to thank all study participants who contributed to the scientific research. J.B.N. was supported by grants from the Danish Heart Foundation, the Lundbeck Foundation, the A.P Moller Foundation for the Advancement of Medical Science, and Fondsborsvekselerer Henry Hansen og Hustru Karla Hansen Fodt Vestergaards Legat. C.J.W. was supported by grants HL109946, HL127564, and HL130705 from the National Institutes of Health (NIH). J.H.S. and M.S.O. were supported by grants from the Danish National Research Foundation, the John and Birthe Meyer Foundation, the Arvid Nilsson Foundation, and the Research Council of Rigshospitalet, Denmark. E.I. was supported by the NIH (1R01DK106236-01A1 and 1R01HL135313-01), the Knut och Alice Wallenberg Foundation (2013.0126), the Swedish Heart-Lung Foundation (20140422), and the Goran Gustafsson Foundation. Finally, this research was conducted with the UK Biobank Resource under application number 13721.	Ammirabile G, 2012, CARDIOVASC RES, V93, P291, DOI 10.1093/cvr/cvr314; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Bode F, 2001, NATURE, V409, P35, DOI 10.1038/35051165; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Bult CJ, 2000, IEEE INTERNATIONAL SYMPOSIUM ON BIO-INFORMATICS AND BIOMEDICAL ENGINEERING, PROCEEDINGS, P29, DOI 10.1109/BIBE.2000.889586; Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771; Chinchilla A, 2011, CIRC-CARDIOVASC GENE, V4, P269, DOI 10.1161/CIRCGENETICS.110.958116; Christophersen IE, 2017, NAT GENET, V49, P946, DOI 10.1038/ng.3843; Christophersen IE, 2009, CIRC-ARRHYTHMIA ELEC, V2, P378, DOI 10.1161/CIRCEP.108.786665; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Colilla S, 2013, AM J CARDIOL, V112, P1142, DOI 10.1016/j.amjcard.2013.05.063; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; El-Chami MF, 2010, CLIN CARDIOL, V33, P132, DOI 10.1002/clc.20714; Ellinor PT, 2012, NAT GENET, V44, P670, DOI 10.1038/ng.2261; Faucourt M, 2001, DEV BIOL, V229, P287, DOI 10.1006/dbio.2000.9950; Fehrmann RSN, 2015, NAT GENET, V47, P115, DOI 10.1038/ng.3173; Finsterer J, 2008, INT J CARDIOL, V128, P304, DOI 10.1016/j.ijcard.2007.12.041; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; Fuchsberger C, 2015, BIOINFORMATICS, V31, P782, DOI 10.1093/bioinformatics/btu704; Gambetta K, 2008, AM J PHYSIOL-HEART C, V294, pH2268, DOI 10.1152/ajpheart.91494.2007; Gollob MH, 2006, NEW ENGL J MED, V354, P2677, DOI 10.1056/NEJMoa052800; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Granzier HL, 2004, CIRC RES, V94, P284, DOI 10.1161/01.RES.0000117769.88862.F8; GUAN KL, 1994, GENE DEV, V8, P2939, DOI 10.1101/gad.8.24.2939; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Gudbjartsson DF, 2015, NAT GENET, V47, P435, DOI 10.1038/ng.3247; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Hodgson-Zingman DM, 2008, NEW ENGL J MED, V359, P158, DOI 10.1056/NEJMoa0706300; Iotchkova V., 2016, BIORXIV; Iotchkova V, 2016, NAT GENET, V48, P1303, DOI 10.1038/ng.3668; Jacobsen BK, 2012, INT J EPIDEMIOL, V41, P961, DOI 10.1093/ije/dyr049; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kannel WB, 2009, CARDIOL CLIN, V27, P13, DOI 10.1016/j.ccl.2008.09.015; Kim MH, 2011, CIRC-CARDIOVASC QUAL, V4, P313, DOI 10.1161/CIRCOUTCOMES.110.958165; Krokstad S, 2013, INT J EPIDEMIOL, V42, P968, DOI 10.1093/ije/dys095; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Liu CY, 2002, DEVELOPMENT, V129, P5081; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Low SK, 2017, NAT GENET, V49, P953, DOI 10.1038/ng.3842; Lubitz SA, 2010, JAMA-J AM MED ASSOC, V304, P2263, DOI 10.1001/jama.2010.1690; Maron BJ, 2002, J AM COLL CARDIOL, V39, P301, DOI 10.1016/S0735-1097(01)01727-2; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; Okin PM, 2006, JAMA-J AM MED ASSOC, V296, P1242, DOI 10.1001/jama.296.10.1242; Olesen MS, 2014, EUR J HUM GENET, V22, P297, DOI 10.1038/ejhg.2013.139; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Schmidt EM, 2015, BIOINFORMATICS, V31, P2601, DOI 10.1093/bioinformatics/btv201; Schnabel RB, 2009, LANCET, V373, P739, DOI 10.1016/S0140-6736(09)60443-8; Sinner MF, 2014, CIRCULATION, V130, P1225, DOI 10.1161/CIRCULATIONAHA.114.009892; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; So HC, 2011, GENET EPIDEMIOL, V35, P310, DOI 10.1002/gepi.20579; Sotoodehnia N, 2010, NAT GENET, V42, P1068, DOI 10.1038/ng.716; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Tsai CT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10190; van der Harst P, 2016, J AM COLL CARDIOL, V68, P1435, DOI 10.1016/j.jacc.2016.07.729; van Spaendonck-Zwarts KY, 2013, EUR J HEART FAIL, V15, P628, DOI 10.1093/eurjhf/hft013; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wu LM, 2016, AM J CARDIOL, V118, P750, DOI 10.1016/j.amjcard.2016.06.003; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zaitlen N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003520	73	54	57	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 4	2018	102	1					103	115		10.1016/j.ajhg.2017.12.003	http://dx.doi.org/10.1016/j.ajhg.2017.12.003			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FR8DU	29290336	Bronze, Green Published			2022-12-18	WOS:000419305500008
J	Lelieveld, SH; Wiel, L; Venselaar, H; Pfundt, R; Vriend, G; Veltman, JA; Brunner, HG; Vissers, LELM; Gilissen, C				Lelieveld, Stefan H.; Wiel, Laurens; Venselaar, Hanka; Pfundt, Rolph; Vriend, Gerrit; Veltman, Joris A.; Brunner, Han G.; Vissers, Lisenka E. L. M.; Gilissen, Christian			Spatial Clustering of de Novo Missense Mutations Identifies Candidate Neurodevelopmental Disorder-Associated Genes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTELLECTUAL DISABILITY; PROTEIN; SUBUNITS; ANNOTATION; STABILITY; DOMINANT; SPECTRUM; RARE	Haploinsufficiency (HI) is the best characterized mechanism through which dominant mutations exert their effect and cause disease. Non-haploinsufficiency (NHI) mechanisms, such as gain-of-function and dominant-negative mechanisms, are often characterized by the spatial clustering of mutations, thereby affecting only particular regions or base pairs of a gene. Variants leading to haploinsufficency might occasionally cluster as well, for example in critical domains, but such clustering is on the whole less pronounced with mutations often spread throughout the gene. Here we exploit this property and develop a method to specifically identify genes with significant spatial clustering patterns of de novo mutations in large cohorts. We apply our method to a dataset of 4,061 de novo missense mutations from published exome studies of trios with intellectual disability and developmental disorders (ID/DD) and successfully identify 15 genes with clustering mutations, including 12 genes for which mutations are known to cause neurodevelopmental disorders. For 11 out of these 12, NHI mutation mechanisms have been reported. Additionally, we identify three candidate ID/DD-associated genes of which two have an established role in neuronal processes. We further observe a higher intolerance to normal genetic variation of the identified genes compared to known genes for which mutations lead to HI. Finally, 3D modeling of these mutations on their protein structures shows that 81% of the observed mutations are unlikely to affect the overall structural integrity and that they therefore most likely act through a mechanism other than HI.	[Lelieveld, Stefan H.; Wiel, Laurens] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Wiel, Laurens; Venselaar, Hanka; Vriend, Gerrit] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Ctr Mol & Biomol Informat, NL-6525 GA Nijmegen, Netherlands; [Pfundt, Rolph; Veltman, Joris A.; Brunner, Han G.; Vissers, Lisenka E. L. M.; Gilissen, Christian] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Vriend, Gerrit] Newcastle Univ, Int Ctr Life, Inst Genet Med, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Brunner, Han G.] Maastricht Univ, Med Ctr, Dept Clin Genet, NL-6202 AZ Maastricht, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Newcastle University - UK; Maastricht University	Gilissen, C (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands.	christian.gilissen@radboudumc.nl	Veltman, Joris A/F-5128-2010; Venselaar, Hanka/D-2009-2016; Vriend, G./H-8112-2014; van de Wiel, Laurens J.M./J-3943-2015; Gilissen, Christian/E-5246-2012; Pfundt, Rolph/L-4576-2015; Vissers, Lisenka ELM/A-2598-2015	Veltman, Joris A/0000-0002-3218-8250; Venselaar, Hanka/0000-0001-9824-6559; van de Wiel, Laurens J.M./0000-0003-3410-760X; Gilissen, Christian/0000-0003-1693-9699; Vissers, Lisenka ELM/0000-0001-6470-5497	Netherlands Organization for Scientific Research [916-14-043, 918-15-667]; European Research Council (ERC) [DENOVO 281964]; Radboud Institute for Molecular Life Sciences, Radboud university medical center [R0002793]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Research Council (ERC)(European Research Council (ERC)); Radboud Institute for Molecular Life Sciences, Radboud university medical center	This work was in part financially supported by grants from the Netherlands Organization for Scientific Research (916-14-043 to C.G. and 918-15-667 to J.A.V.), the European Research Council (ERC Starting grant DENOVO 281964 to J.A.V.) and from the Radboud Institute for Molecular Life Sciences, Radboud university medical center (R0002793 to G.V.). We thank Stephan Boersma for help with writing the software for analysis of cluster mutations.	Acuna-Hidalgo R, 2015, AM J HUM GENET, V97, P67, DOI 10.1016/j.ajhg.2015.05.008; Besenbacher S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006315; Choi KY, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.129; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021; Gallione C, 2010, AM J MED GENET A, V152A, P333, DOI 10.1002/ajmg.a.33206; Ge XY, 2016, NPJ GENOM MED, V1, DOI 10.1038/npjgenmed.2016.36; Ge XY, 2015, HUM MOL GENET, V24, P599, DOI 10.1093/hmg/ddu473; Geisheker MR, 2017, NAT NEUROSCI, V20, P1043, DOI 10.1038/nn.4589; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Goriely A, 2010, NAT REV GENET, V11, P589, DOI 10.1038/nrg2809-c1; Halvardson J, 2016, J MED GENET, V53, P697, DOI 10.1136/jmedgenet-2016-103814; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Johannesen K, 2016, NEUROLOGY, V87, P1140, DOI 10.1212/WNL.0000000000003087; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kamburov A, 2015, P NATL ACAD SCI USA, V112, pE5486, DOI 10.1073/pnas.1516373112; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krumm N, 2015, NAT GENET, V47, P582, DOI 10.1038/ng.3303; Kuroda Y, 2002, BIOCHEM BIOPH RES CO, V299, P328, DOI 10.1016/S0006-291X(02)02637-2; Le Goff C, 2012, NAT GENET, V44, P85, DOI 10.1038/ng.1016; LEE C, 1991, NATURE, V352, P448, DOI 10.1038/352448a0; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lelieveld SH, 2016, NAT NEUROSCI, V19, P1194, DOI 10.1038/nn.4352; Lemke JR, 2014, ANN NEUROL, V75, P147, DOI 10.1002/ana.24073; Mcrae JF, 2017, NATURE, V542, P433, DOI 10.1038/nature21062; Moller RS, 2017, NEUROLOGY, V88, P483, DOI 10.1212/WNL.0000000000003565; Ramirez OA, 2009, J BIOL CHEM, V284, P13077, DOI 10.1074/jbc.M900575200; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Robbins MJ, 2001, J NEUROSCI, V21, P8043, DOI 10.1523/JNEUROSCI.21-20-08043.2001; Schuurs-Hoeijmakers JHM, 2012, AM J HUM GENET, V91, P1122, DOI 10.1016/j.ajhg.2012.10.013; Srour M, 2016, HUM MUTAT, V37, P786, DOI 10.1002/humu.23004; Stehr H, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-54; Turner TN, 2017, NUCLEIC ACIDS RES, V45, pD804, DOI 10.1093/nar/gkw865; Turner TN, 2016, AM J HUM GENET, V98, P58, DOI 10.1016/j.ajhg.2015.11.023; Turner TN, 2015, HUM MOL GENET, V24, P5995, DOI 10.1093/hmg/ddv309; Venselaar H, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-352; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WILKIE AOM, 1994, J MED GENET, V31, P89, DOI 10.1136/jmg.31.2.89; Wuttke TV, 2007, NEUROLOGY, V69, P2045, DOI 10.1212/01.wnl.0000275523.95103.36; Yue P, 2005, J MOL BIOL, V353, P459, DOI 10.1016/j.jmb.2005.08.020	47	54	54	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 7	2017	101	3					478	484		10.1016/j.ajhg.2017.08.004	http://dx.doi.org/10.1016/j.ajhg.2017.08.004			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FG1CS	28867141	Green Published, Bronze			2022-12-18	WOS:000409530900014
J	Hannon, E; Weedon, M; Bray, N; O'Donovan, M; Mill, J				Hannon, Eilis; Weedon, Mike; Bray, Nicholas; O'Donovan, Michael; Mill, Jonathan			Pleiotropic Effects of Trait-Associated Genetic Variation on DNA Methylation: Utility for Refining GWAS Loci	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; 38 SUSCEPTIBILITY LOCI; ANALYSES IDENTIFY; BODY-MASS; SCHIZOPHRENIA; METAANALYSIS; RISK; ARCHITECTURE	Most genetic variants identified in genome-wide association studies (GWASs) of complex traits are thought to act by affecting gene regulation rather than directly altering the protein product. As a consequence, the actual genes involved in disease are not necessarily the most proximal to the associated variants. By integrating data from GWAS analyses with those from genetic studies of regulatory variation, it is possible to identify variants pleiotropically associated with both a complex trait and measures of gene regulation. In this study, we used summary-data-based Mendelian randomization (SMR), a method developed to identify variants pleiotropically associated with both complex traits and gene expression, to identify variants associated with complex traits and DNA methylation. We used large DNA methylation quantitative trait locus (mQTL) datasets generated from two different tissues (blood and fetal brain) to prioritize genes for >40 complex traits with robust GWAS data and found considerable overlap with the results of SMR analyses performed with expression QTL (eQTL) data. We identified multiple examples of variable DNA methylation associated with GWAS variants for a range of complex traits, demonstrating the utility of this approach for refining genetic association signals.	[Hannon, Eilis; Weedon, Mike; Mill, Jonathan] Univ Exeter, Med Sch, Exeter EX2 5DW, Devon, England; [Bray, Nicholas; O'Donovan, Michael] Cardiff Univ, Sch Med, MRC Ctr Neuropsychiat Genet & Genom, Cardiff CF24 4HQ, S Glam, Wales	University of Exeter; Cardiff University	Mill, J (corresponding author), Univ Exeter, Med Sch, Exeter EX2 5DW, Devon, England.	j.mill@exeter.ac.uk	Hannon, Eilis/T-1349-2019; Mill, Jonathan/B-5678-2014; O'Donovan, Michael C/P-7005-2018	Hannon, Eilis/0000-0001-6840-072X; Mill, Jonathan/0000-0003-1115-3224; O'Donovan, Michael C/0000-0001-7073-2379; Bray, Nicholas/0000-0002-4357-574X; Weedon, Michael/0000-0002-6174-6135	UK Medical Research Council [MR/K013807/1]; Medical Research Council [MR/L010305/1, MR/L010674/1, MR/K013807/1, MR/L010674/2] Funding Source: researchfish; MRC [MR/L010674/1, MR/K013807/1, MR/L010674/2] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a grant from the UK Medical Research Council (MR/K013807/1) to J.M.	Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Cousminer DL, 2014, HUM MOL GENET, V23, P4452, DOI 10.1093/hmg/ddu150; de Leon J, 2005, SCHIZOPHR RES, V76, P135, DOI 10.1016/j.schres.2005.02.010; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Gormley P, 2016, NAT GENET, V48, P856, DOI 10.1038/ng.3598; Hannon E, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1041-x; Hannon E, 2016, NAT NEUROSCI, V19, P48, DOI 10.1038/nn.4182; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Li M, 2016, NAT MED, V22, P649, DOI 10.1038/nm.4096; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McClave AK, 2010, AM J PUBLIC HEALTH, V100, P2464, DOI 10.2105/AJPH.2009.188136; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; van Rheenen W, 2016, NAT GENET, V48, P1043, DOI 10.1038/ng.3622; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538	25	54	54	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 1	2017	100	6					954	959		10.1016/j.ajhg.2017.04.013	http://dx.doi.org/10.1016/j.ajhg.2017.04.013			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EW7NL	28528868	hybrid, Green Published, Green Accepted			2022-12-18	WOS:000402700600010
J	Day, FR; Loh, PR; Scott, RA; Ong, KK; Perry, JRB				Day, Felix R.; Loh, Po-Ru; Scott, Robert A.; Ong, Ken K.; Perry, John R. B.			A Robust Example of Collider Bias in a Genetic Association Study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									[Day, Felix R.; Scott, Robert A.; Ong, Ken K.; Perry, John R. B.] Univ Cambridge, Inst Metab Sci, MRC, Epidemiol Unit, Box 285,Hills Rd, Cambridge CB2 0QQ, England; [Loh, Po-Ru] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Loh, Po-Ru] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA	University of Cambridge; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Perry, JRB (corresponding author), Univ Cambridge, Inst Metab Sci, MRC, Epidemiol Unit, Box 285,Hills Rd, Cambridge CB2 0QQ, England.	john.perry@mrc-epid.cam.ac.uk		Day, Felix/0000-0003-3789-7651	Medical Research Council [MC_QA137853, MC_U106179472, MC_UU_12015/1, MC_UU_12015/2] Funding Source: Medline; MRC [MC_UU_12015/1, MC_U106179472] Funding Source: UKRI; Medical Research Council [MC_qA137853] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Aschard H, 2015, AM J HUM GENET, V96, P329, DOI 10.1016/j.ajhg.2014.12.021; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Tu YK, 2005, AM J EPIDEMIOL, V161, P27, DOI 10.1093/aje/kwi002; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Yaghootkar H, 2015, DIABETES, V64, P2279, DOI 10.2337/db14-1456	6	54	54	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 4	2016	98	2					392	393		10.1016/j.ajhg.2015.12.019	http://dx.doi.org/10.1016/j.ajhg.2015.12.019			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DE3BR	26849114	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000370502300016
J	Johnston, JJ; Sanchez-Contreras, MY; Keppler-Noreuil, KM; Sapp, J; Crenshaw, M; Finch, NA; Cormier-Daire, V; Rademakers, R; Sybert, VP; Biesecker, LG				Johnston, Jennifer J.; Sanchez-Contreras, Monica Y.; Keppler-Noreuil, Kim M.; Sapp, Julie; Crenshaw, Molly; Finch, NiCole A.; Cormier-Daire, Valerie; Rademakers, Rosa; Sybert, Virginia P.; Biesecker, Leslie G.			A Point Mutation in PDGFRB Causes Autosomal-Dominant Penttinen Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BASAL GANGLIA CALCIFICATION; INFANTILE MYOFIBROMATOSIS; RECEPTOR	Penttinen syndrome is a distinctive disorder characterized by a prematurely aged appearance with lipoatrophy, epidermal and dermal atrophy along with hypertrophic lesions that resemble scars, thin hair, proptosis, underdeveloped cheekbones, and marked acro-osteolysis. All individuals have been simplex cases. Exome sequencing of an affected individual identified a de novo c.1994T>C p.Va1665Ala variant in PDGFRB, which encodes the platelet-derived growth factor receptor P. Three additional unrelated individuals with this condition were shown to have the identical variant in PDGFRB. Distinct mutations in PDGFRB have been shown to cause infantile myofibromatosis, idiopathic basal ganglia calcification, and an overgrowth disorder with dysmorphic facies and psychosis, none of which overlaps with the clinical findings in Penttinen syndrome. We evaluated the functional consequence of this causative variant on the PDGFRB signaling pathway by transfecting mutant and wild-type cDNA into HeLa cells, and transfection showed ligand-independent constitutive signaling through STAT3 and PLCy. Penttinen syndrome is a clinically distinct genetic condition caused by a PDGFRB gain-of-function mutation that is associated with a specific and unusual perturbation of receptor function.	[Johnston, Jennifer J.; Keppler-Noreuil, Kim M.; Sapp, Julie; Crenshaw, Molly; Biesecker, Leslie G.] NHGRI, Med Genom & Metab Genet Branch, NIH, Bethesda, MD 20892 USA; [Sanchez-Contreras, Monica Y.; Finch, NiCole A.; Rademakers, Rosa] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Cormier-Daire, Valerie] Univ Paris 05, Sorbonne Paris Cite, INSERM, Dept Genet,UMR1163, F-75006 Paris, France; [Cormier-Daire, Valerie] Hop Necker Enfants Malad, AP HP, Inst Imagine, F-75006 Paris, France; [Sybert, Virginia P.] Univ Washington, Sch Med, Div Med Genet, Seattle, WA 98195 USA; [Sybert, Virginia P.] Grp Hlth Cooperat Puget Sound, Dermatol, Seattle, WA 98112 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Mayo Clinic; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Washington; University of Washington Seattle; Group Health Cooperative	Biesecker, LG (corresponding author), NHGRI, Med Genom & Metab Genet Branch, NIH, Bethesda, MD 20892 USA.	lesb@mail.nih.gov	; cormier-daire, valerie/H-6520-2017	Sanchez-Contreras, Monica/0000-0002-3092-2781; Sapp, Julie/0000-0002-4003-258X; cormier-daire, valerie/0000-0002-2839-9856	Intramural Research Program of the National Human Genome Research Institute of the NIH; National Institute of Neurological Disorders and Stroke [P50 NS072187]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200328, ZIAHG200388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS072187] Funding Source: NIH RePORTER	Intramural Research Program of the National Human Genome Research Institute of the NIH; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Intramural Research Program of the National Human Genome Research Institute of the NIH and by the National Institute of Neurological Disorders and Stroke grant P50 NS072187. The authors are grateful to the individuals and their families for their support and cooperation in this work. We thank Dr. Brian Brooks and Dr. Thomas Darling for their involvement and help with individual 1, Dr. Judith Martin for her involvement and help with individual 4, Dr. Heather Brandling-Bennett for her involvement and help with individual 3, Dr. Raj Kapur for his help with interpretation of the biopsy of individual 3, Dr. Maila Penttinen for contact information for individual 1, and Dr. Yujun Han for the mutation-rate-prediction analysis. We thank Drs. Pamela Schwartzberg and Harold Varmus for advice and critical evaluation of the functional data. We thank Julia Fekecs for graphic-design support. The authors thank the Exome Aggregation Consortium and the groups that provided exome-variant data for comparison. L.G.B. is an uncompensated advisor to Illumina and receives royalties from Genentech.	Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Arts FA, 2015, J CELL MOL MED, V19, P239, DOI 10.1111/jcmm.12443; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Cheung YH, 2013, AM J HUM GENET, V92, P996, DOI 10.1016/j.ajhg.2013.04.026; Demoulin JB, 2014, CYTOKINE GROWTH F R, V25, P273, DOI 10.1016/j.cytogfr.2014.03.003; Hayashi T, 2015, PSYCHIAT CLIN NEUROS, V69, P77, DOI 10.1111/pcn.12238; Iwayama T, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-012-0304-0; KEATING MT, 1987, J BIOL CHEM, V262, P7932; Lim CP, 2006, ONCOGENE, V25, P5416, DOI 10.1038/sj.onc.1209531; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Martignetti JA, 2013, AM J HUM GENET, V92, P1001, DOI 10.1016/j.ajhg.2013.04.024; Nicolas G, 2013, BRAIN, V136, P3395, DOI 10.1093/brain/awt255; Penttinen M, 1997, AM J MED GENET, V69, P182, DOI 10.1002/(SICI)1096-8628(19970317)69:2<182::AID-AJMG13>3.3.CO;2-#; Sanchez-Contreras M, 2014, HUM MUTAT, V35, P964, DOI 10.1002/humu.22582; Takenouchi T, 2015, J PEDIATR-US, V166, P483, DOI 10.1016/j.jpeds.2014.10.015; Teer JK, 2012, BIOINFORMATICS, V28, P599, DOI 10.1093/bioinformatics/btr711; Teer JK, 2010, GENOME RES, V20, P1420, DOI 10.1101/gr.106716.110; Zufferey F, 2013, AM J MED GENET A, V161A, P1786, DOI 10.1002/ajmg.a.35984	18	54	56	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 3	2015	97	3					465	474		10.1016/j.ajhg.2015.07.009	http://dx.doi.org/10.1016/j.ajhg.2015.07.009			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CR1KW	26279204	Bronze, Green Published			2022-12-18	WOS:000361084700009
J	Murray, JE; van der Burg, M; IJspeert, H; Carroll, P; Wu, Q; Ochi, T; Leitch, A; Miller, ES; Kysela, B; Jawad, A; Bottani, A; Brancati, F; Cappa, M; Cormier-Daire, V; Deshpande, C; Faqeih, EA; Graham, GE; Ranza, E; Blundell, TL; Jackson, AP; Stewart, GS; Bicknell, LS				Murray, Jennie E.; van der Burg, Mirjam; IJspeert, Hanna; Carroll, Paula; Wu, Qian; Ochi, Takashi; Leitch, Andrea; Miller, Edward S.; Kysela, Boris; Jawad, Alireza; Bottani, Armand; Brancati, Francesco; Cappa, Marco; Cormier-Daire, Valerie; Deshpande, Charu; Faqeih, Eissa A.; Graham, Gail E.; Ranza, Emmanuelle; Blundell, Tom L.; Jackson, Andrew P.; Stewart, Grant S.; Bicknell, Louise S.			Mutations in the NHEJ Component XRCC4 Cause Primordial Dwarfism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA-LIGASE-IV; DOUBLE-STRAND BREAKS; SEVERE COMBINED IMMUNODEFICIENCY; ORIGIN RECOGNITION COMPLEX; GROWTH FAILURE; DEVELOPMENTAL DISORDER; REPAIR; PROTEINS; GENE; PATIENT	Non-homologous end joining (NHEJ) is a key cellular process ensuring genome integrity. Mutations in several components of the NHEJ pathway have been identified, often associated with severe combined immunodeficiency (SCID), consistent with the requirement for NHEJ during V(D)J recombination to ensure diversity of the adaptive immune system. In contrast, we have recently found that biallelic mutations in LIG4 are a common cause of microcephalic primordial dwarfism (MPD), a phenotype characterized by prenatal-onset extreme global growth failure. Here we provide definitive molecular genetic evidence supported by biochemical, cellular, and immunological data for mutations in XRCC4, encoding the obligate binding partner of LIG4, causing MPD. We report the identification of biallelic mutations in XRCC4 in five families. Biochemical and cellular studies demonstrate that these alterations substantially decrease XRCC4 protein levels leading to reduced cellular ligase IV activity. Consequently, NHEJ-dependent repair of ionizing-radiation-induced DNA double-strand breaks is compromised in XRCC4 cells. Similarly, immunoglobulin junctional diversification is impaired in cells. However, immunoglobulin levels are normal, and individuals lack overt signs of immunodeficiency. Additionally, in contrast to individuals with LIG4 mutations, pancytopenia leading to bone marrow failure has not been observed. Hence, alterations that alter different NHEJ proteins give rise to a phenotypic spectrum, from SCID to extreme growth failure, with deficiencies in certain key components of this repair pathway predominantly exhibiting growth deficits, reflecting differential developmental requirements for NHEJ proteins to support growth and immune maturation.	[Murray, Jennie E.; Carroll, Paula; Leitch, Andrea; Jackson, Andrew P.; Bicknell, Louise S.] Univ Edinburgh, Inst Genet & Mol Med, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [van der Burg, Mirjam; IJspeert, Hanna; Jawad, Alireza] Univ Med Ctr Rotterdam, Erasmus MC, Dept Immunol, NL-3015 Rotterdam, Netherlands; [Wu, Qian; Ochi, Takashi; Blundell, Tom L.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Miller, Edward S.; Stewart, Grant S.] Univ Birmingham, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England; [Kysela, Boris] Univ Birmingham, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England; [Bottani, Armand; Ranza, Emmanuelle] Univ Hosp Geneva, Dept Med Genet, CH-1205 Geneva, Switzerland; [Brancati, Francesco] Gabriele DAnnunzio Univ Chieti Pescara, Dept Med Oral & Biotechnol Sci, I-66100 Chieti, Italy; [Cappa, Marco] IRCCS Bambino Gesu Childrens Hosp, Endocrinol & Diabet Unit, I-00165 Rome, Italy; [Cormier-Daire, Valerie] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Dept Genet,INSERM,UMR 1163,Sorbonne Paris Cite,In, F-75015 Paris, France; [Deshpande, Charu] Guys & St Thomas NHS Fdn Trust, Guys Hosp, Dept Genet, London SE1 9RT, England; [Faqeih, Eissa A.] Childrens Specialist Hosp, King Fahad Med City, Riyadh 11525, Saudi Arabia; [Graham, Gail E.] Childrens Hosp Eastern Ontario, Dept Genet, Ottawa, ON K1H 8L1, Canada	University of Edinburgh; Erasmus University Rotterdam; Erasmus MC; University of Cambridge; University of Birmingham; University of Birmingham; University of Geneva; G d'Annunzio University of Chieti-Pescara; IRCCS Bambino Gesu; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Guy's & St Thomas' NHS Foundation Trust; University of Ottawa; Children's Hospital of Eastern Ontario	Jackson, AP (corresponding author), Univ Edinburgh, Inst Genet & Mol Med, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland.	andrew.jackson@igmm.ed.ac.uk; g.s.stewart@bham.ac.uk	IJspeert, Hanna/U-9479-2019; Brancati, Francesco/AAC-3778-2022; Bicknell, Louise/GLR-4215-2022; Bicknell, Louise/AAL-8003-2020; Jackson, Andrew P/D-3442-2009; cormier-daire, valerie/H-6520-2017	Brancati, Francesco/0000-0003-3624-2354; Bicknell, Louise/0000-0001-6899-9322; Jackson, Andrew P/0000-0002-8739-2646; CAPPA, MARCO/0000-0001-5647-7519; Stewart, Grant/0000-0002-0960-3241; Wu, Qian/0000-0002-6948-7043; cormier-daire, valerie/0000-0002-2839-9856; Ochi, Takashi/0000-0001-8546-6341	Medical Research Scotland; Newlife Foundation for Disabled Children; MRC [U127580972]; ERC [HumGensize 281847]; CR-UK Senior Fellowship [C17183/A13030]; Vidi grant of ZonMW [91712323]; MRC CiC; BWHRF [P/O 088314]; Wellcome Trust; Cancer Research UK [13030] Funding Source: researchfish; Medical Research Council [MC_PC_U127580972, G0900034] Funding Source: researchfish; MRC [MC_PC_U127580972, G0900034] Funding Source: UKRI	Medical Research Scotland; Newlife Foundation for Disabled Children; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ERC(European Research Council (ERC)European Commission); CR-UK Senior Fellowship; Vidi grant of ZonMW; MRC CiC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BWHRF; Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank the individuals and their families for their involvement and cooperation in this research; S. Brown and A. Gallagher and the MRC HGU sequencing core for technical support; M. McDonald and K. Mackenzie for helpful discussions; and Dr. Katherine Stott for her assistance with the CD experiment and data analysis. Ion Proton sequencing was performed by the Wellcome Trust Clinical Research Facility, Western General Hospital, Edinburgh. The authors acknowledge the Exome Aggregation Consortium and the groups therein for providing control exome variant data. A full list of contributing groups to ExAC can be found online (http://exac.broadinstitute.org/about). L.S.B. is funded by Medical Research Scotland. P.C. is funded by Newlife Foundation for Disabled Children. A.P.J. is funded by the MRC (U127580972) and ERC (HumGensize 281847). G.S.S. and A.P.J. are Lister Institute for Preventative Medicine Fellows. G.S.S. is funded by a CR-UK Senior Fellowship (C17183/A13030). M.v.d.B. and H.IJ. are supported by a Vidi grant of ZonMW (91712323). B.K. has been funded by MRC CiC and BWHRF (P/O 088314). T.O., Q.W., and T.L.B. are funded by Wellcome Trust.	Alamyar Eltaf, 2012, Methods Mol Biol, V882, P569, DOI 10.1007/978-1-61779-842-9_32; Ben-Omran TI, 2005, AM J MED GENET A, V137A, P283, DOI 10.1002/ajmg.a.30869; Bicknell LS, 2011, NAT GENET, V43, P356, DOI 10.1038/ng.775; Bicknell LS, 2011, NAT GENET, V43, P350, DOI 10.1038/ng.776; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Boubakour-Azzouz I, 2012, NUCLEIC ACIDS RES, V40, P8381, DOI 10.1093/nar/gks585; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Buck D, 2006, EUR J IMMUNOL, V36, P224, DOI 10.1002/eji.200535401; Chiruvella KK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012757; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cole TJ, 1998, STAT MED, V17, P407, DOI 10.1002/(SICI)1097-0258(19980228)17:4&lt;407::AID-SIM742&gt;3.0.CO;2-L; Critchlow SE, 1997, CURR BIOL, V7, P588, DOI 10.1016/S0960-9822(06)00258-2; de Miranda NFCC, 2013, J EXP MED, V210, P1729, DOI 10.1084/jem.20122842; Deriano L, 2013, ANNU REV GENET, V47, P433, DOI 10.1146/annurev-genet-110711-155540; Dutrannoy V, 2010, HUM MUTAT, V31, P1059, DOI 10.1002/humu.21315; Edery P, 2011, SCIENCE, V332, P240, DOI 10.1126/science.1202205; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Gruhn B, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-5; Guernsey DL, 2011, NAT GENET, V43, P360, DOI 10.1038/ng.777; He HL, 2011, SCIENCE, V332, P238, DOI 10.1126/science.1200587; Jspeert HI, 2013, HUM MUTAT, V34, P1611, DOI 10.1002/humu.22436; Klingseisen A, 2011, GENE DEV, V25, P2011, DOI 10.1101/gad.169037; KYSELA BP, 1993, INT J RADIAT BIOL, V64, P531, DOI 10.1080/09553009314551741; Lee GS, 2004, CELL, V117, P171, DOI 10.1016/S0092-8674(04)00301-0; Malu S, 2012, IMMUNOL RES, V54, P233, DOI 10.1007/s12026-012-8329-z; Martin CA, 2014, NAT GENET, V46, P1283, DOI 10.1038/ng.3122; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Murray JE, 2014, HUM MUTAT, V35, P76, DOI 10.1002/humu.22461; Neal JA, 2011, MUTAT RES-FUND MOL M, V711, P73, DOI 10.1016/j.mrfmmm.2011.02.010; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; O'Driscoll M, 2001, MOL CELL, V8, P1175, DOI 10.1016/S1097-2765(01)00408-7; Ogi T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002945; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Pires DEV, 2014, NUCLEIC ACIDS RES, V42, pW314, DOI 10.1093/nar/gku411; PLOWMAN PN, 1990, BRIT J RADIOL, V63, P624, DOI 10.1259/0007-1285-63-752-624; Qvist P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002310; R Core Team, 2013, R LANGUAGE ENV STAT; Rauch A., SCIENCE, V319, P816; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Riballo E, 1999, CURR BIOL, V9, P699, DOI 10.1016/S0960-9822(99)80311-X; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Shaheen R, 2014, GENOME RES, V24, P291, DOI 10.1101/gr.160572.113; Sibanda BL, 2001, NAT STRUCT BIOL, V8, P1015, DOI 10.1038/nsb725; Stewart DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098686; van der Burg M, 2006, J CLIN INVEST, V116, P137, DOI 10.1172/JCI26121; van der Burg M, 2009, J CLIN INVEST, V119, P91, DOI 10.1172/JCI37141; Van der Burg M, 2007, EUR J IMMUNOL, V37, P3522, DOI 10.1002/eji.200737624; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Wang Y, 2007, BIOCHEMISTRY-US, V46, P4962, DOI 10.1021/bi0621516; Willems M, 2010, J MED GENET, V47, P797, DOI 10.1136/jmg.2009.067298; Woodbine L, 2014, DNA REPAIR, V16, P84, DOI 10.1016/j.dnarep.2014.02.011; Woodbine L, 2013, J CLIN INVEST, V123, P2969, DOI 10.1172/JCI67349; Wu Q, 2011, BIOCHEM SOC T, V39, P1387, DOI 10.1042/BST0391387; Zha S, 2011, NATURE, V469, P250, DOI 10.1038/nature09604	59	54	57	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 5	2015	96	3					412	424		10.1016/j.ajhg.2015.01.013	http://dx.doi.org/10.1016/j.ajhg.2015.01.013			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CD0GD	25728776	Green Published, Bronze			2022-12-18	WOS:000350747800013
J	Popadin, K; Gutierrez-Arcelus, M; Dermitzakis, ET; Antonarakis, SE				Popadin, Konstantin; Gutierrez-Arcelus, Maria; Dermitzakis, Emmanouil T.; Antonarakis, Stylianos E.			Genetic and Epigenetic Regulation of Human lincRNA Gene Expression	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LONG NONCODING RNAS; HUMAN GENOME; NATURAL-SELECTION; DNA METHYLATION; EVOLUTIONARY RATE; CHROMATIN; ANNOTATION; DIFFERENTIATION; PLURIPOTENCY; POPULATION	Large intergenic noncoding RNAs (lincRNAs) are still poorly functionally characterized. We analyzed the genetic and epigenetic regulation of human lincRNA expression in the GenCord collection by using three cell types from 195 unrelated European individuals. We detected a considerable number of cis expression quantitative trait loci (cis-eQTLs) and demonstrated that the genetic regulation of lincRNA expression is independent of the regulation of neighboring protein-coding genes. lincRNAs have relatively more cis-eQTLs than do equally expressed protein-coding genes with the same exon number. lincRNA cis-eQTLs are located closer to transcription start sites (TSSs) and their effect sizes are higher than cis-eQTLs found for protein-coding genes, suggesting that lincRNA expression levels are less constrained than that of protein-coding genes. Additionally, lincRNA cis-eQTLs can influence the expression level of nearby protein-coding genes and thus could be considered as QTLs for enhancer activity. Enrichment of expressed lincRNA promoters in enhancer marks provides an additional argument for the involvement of lincRNAs in the regulation of transcription in cis. By investigating the epigenetic regulation of lincRNAs, we observed both positive and negative correlations between DNA methylation and gene expression (expression quantitative trait methylation [eQTMs]), as expected, and found that the landscapes of passive and active roles of DNA methylation in gene regulation are similar to protein-coding genes. However, lincRNA eQTMs are located closer to TSSs than are protein-coding gene eQTMs. These similarities and differences in genetic and epigenetic regulation between lincRNAs and protein-coding genes contribute to the elucidation of potential functions of lincRNAs.	[Popadin, Konstantin; Gutierrez-Arcelus, Maria; Dermitzakis, Emmanouil T.; Antonarakis, Stylianos E.] Univ Geneva, Dept Genet Med & Dev, Sch Med, CH-1211 Geneva, Switzerland; [Popadin, Konstantin; Gutierrez-Arcelus, Maria; Dermitzakis, Emmanouil T.; Antonarakis, Stylianos E.] Inst Genet & Genom Geneva iGE3, CH-1211 Geneva, Switzerland; [Popadin, Konstantin] Russian Acad Sci, Inst Informat Transmiss Problems, Kharkevich Inst, Moscow 127994, Russia; [Gutierrez-Arcelus, Maria; Dermitzakis, Emmanouil T.] Swiss Inst Bioinformat SIB, CH-1211 Geneva, Switzerland; [Dermitzakis, Emmanouil T.] King Abdulaziz Univ, Ctr Excellence Genom Med Res, Jeddah 21589, Saudi Arabia	University of Geneva; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Swiss Institute of Bioinformatics; King Abdulaziz University	Dermitzakis, ET (corresponding author), Univ Geneva, Dept Genet Med & Dev, Sch Med, 1 Rue Michel Servet, CH-1211 Geneva, Switzerland.	emmanouil.dermitzakis@unige.ch; stylianos.antonarakis@unige.ch	Antonarakis, Stylianos E/N-8866-2014; Popadin, Konstantin/L-7459-2017	Antonarakis, Stylianos E/0000-0001-8907-5823; 	SNF [144082]; ERC [249968, 260927 POPRNASEQ]; SNFRNA [31003A_130342]; Louis-Jeantet foundation; EMBO long-term fellowship program [ALTF 527-2010]; Novartis [3A15]	SNF; ERC(European Research Council (ERC)European Commission); SNFRNA; Louis-Jeantet foundation; EMBO long-term fellowship program; Novartis(Novartis)	We acknowledge X. Bonilla for editing the manuscript, F. Santoni and M. Garieri for discussion of statistical analyses, S. Nikolaev for discussion of potential roles of lincRNAs, and S. Lukowski for the help in the preparation of the manuscript. This study has been supported by SNF grant 144082 and ERC grant 249968 to S.E.A. and by SNFRNA grant 31003A_130342, ERC grant 260927 POPRNASEQ, and Louis-Jeantet foundation to E.T.D. K.P. was supported by EMBO long-term fellowship program ALTF 527-2010 and Novartis grant No 3A15. The computations were performed at the Vital-IT Center for high-performance computing of the SIB Swiss Institute of Bioinformatics.	Alba MM, 2005, MOL BIOL EVOL, V22, P598, DOI 10.1093/molbev/msi045; Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Clark MB, 2012, GENOME RES, V22, P885, DOI 10.1101/gr.131037.111; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dimas AS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000244; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Fay JC, 2008, HEREDITY, V100, P191, DOI 10.1038/sj.hdy.6801000; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Gilad Y, 2006, TRENDS GENET, V22, P456, DOI 10.1016/j.tig.2006.06.002; Gutierrez-Arcelus M, 2013, ELIFE, V2, DOI 10.7554/eLife.00523; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kudaravalli S, 2009, MOL BIOL EVOL, V26, P649, DOI 10.1093/molbev/msn289; Kulis M, 2012, NAT GENET, V44, P1236, DOI 10.1038/ng.2443; Kumar V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003201; Latos PA, 2012, SCIENCE, V338, P1469, DOI 10.1126/science.1228110; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Managadze D, 2011, GENOME BIOL EVOL, V3, P1390, DOI 10.1093/gbe/evr116; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Orom UA, 2011, CURR OPIN GENET DEV, V21, P194, DOI 10.1016/j.gde.2011.01.020; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Ponjavic J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000617; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Scutari M, 2010, J STAT SOFTW, V35, P1, DOI 10.18637/jss.v035.i03; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; van Eijk KR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-636; Vishnoi A, 2010, GENOME RES, V20, P1574, DOI 10.1101/gr.109595.110; Wolf YI, 2009, P NATL ACAD SCI USA, V106, P7273, DOI 10.1073/pnas.0901808106; Zhang DD, 2010, AM J HUM GENET, V86, P411, DOI 10.1016/j.ajhg.2010.02.005	47	54	56	1	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 5	2013	93	6					1015	1026		10.1016/j.ajhg.2013.10.022	http://dx.doi.org/10.1016/j.ajhg.2013.10.022			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	273FS	24268656	Green Published, Bronze			2022-12-18	WOS:000328521300002
J	Hirata, H; Nanda, I; van Riesen, A; McMichael, G; Hu, H; Hambrock, M; Papon, MA; Fischer, U; Marouillat, S; Ding, C; Alirol, S; Bienek, M; Preisler-Adams, S; Grimme, A; Seelow, D; Webster, R; Haan, E; MacLennan, A; Stenzel, W; Yap, TY; Gardner, A; Nguyen, LS; Shaw, M; Lebrun, N; Haas, SA; Kress, W; Haaf, T; Schellenberger, E; Chelly, J; Viot, G; Shaffer, LG; Rosenfeld, JA; Kramer, N; Falk, R; El-Khechen, D; Escobar, LF; Hennekam, R; Wieacker, P; Hubner, C; Ropers, HH; Gecz, J; Schuelke, M; Laumonnier, F; Kalscheuer, VM				Hirata, Hiromi; Nanda, Indrajit; van Riesen, Anne; McMichael, Gai; Hu, Hao; Hambrock, Melanie; Papon, Marie-Amelie; Fischer, Ute; Marouillat, Sylviane; Ding, Can; Alirol, Servane; Bienek, Melanie; Preisler-Adams, Sabine; Grimme, Astrid; Seelow, Dominik; Webster, Richard; Haan, Eric; MacLennan, Alastair; Stenzel, Werner; Yap, Tzu Ying; Gardner, Alison; Lam Son Nguyen; Shaw, Marie; Lebrun, Nicolas; Haas, Stefan A.; Kress, Wolfram; Haaf, Thomas; Schellenberger, Elke; Chelly, Jamel; Viot, Geraldine; Shaffer, Lisa G.; Rosenfeld, Jill A.; Kramer, Nancy; Falk, Rena; El-Khechen, Dima; Escobar, Luis F.; Hennekam, Raoul; Wieacker, Peter; Huebner, Christoph; Ropers, Hans-Hilger; Gecz, Jozef; Schuelke, Markus; Laumonnier, Frederic; Kalscheuer, Vera M.			ZC4H2 Mutations Are Associated with Arthrogryposis Multiplex Congenita and Intellectual Disability through Impairment of Central and Peripheral Synaptic Plasticity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPINAL MUSCULAR-ATROPHY; X-LINKED ARTHROGRYPOSIS; WIEACKER-WOLFF SYNDROME; ZINC-FINGER PROTEIN; DISTAL ARTHROGRYPOSIS; GENE; LINKAGE; DISEASE; MICRODELETION; MORPHOGENESIS	Arthrogryposis multiplex congenita (AMC) is caused by heterogeneous pathologies leading to multiple antenatal joint contractures through fetal akinesia. Understanding the pathophysiology of this disorder is important for clinical care of the affected individuals and genetic counseling of the families. We thus aimed to establish the genetic basis of an AMC subtype that is associated with multiple dysmorphic features and intellectual disability (ID). We used haplotype analysis, next-generation sequencing, array comparative genomic hybridization, and chromosome breakpoint mapping to identify the pathogenic mutations in families and simplex cases. Suspected disease variants were verified by cosegregation analysis. We identified disease-causing mutations in the zinc-finger gene ZC4H2 in four families affected by X-linked AMC plus ID and one family affected by cerebral palsy. Several heterozygous females were also affected, but to a lesser degree. Furthermore, we found two ZC4H2 deletions and one rearrangement in two female and one male unrelated simplex cases, respectively. In mouse primary hippocampal neurons, transiently produced ZC4H2 localized to the postsynaptic compartment of excitatory synapses, and the altered protein influenced dendritic spine density. In zebrafish, antisense-morpholino-mediated zc4h2 knockdown caused abnormal swimming and impaired alpha-motoneuron development. All missense mutations identified herein failed to rescue the swimming defect of zebrafish morphants. We conclude that ZC4H2 point mutations, rearrangements, and small deletions cause a clinically variable broad-spectrum neurodevelopmental disorder of the central and peripheral nervous systems in both familial and simplex cases of both sexes. Our results highlight the importance of ZC4H2 for genetic testing of individuals presenting with ID plus muscle weakness and minor or major forms of AMC.	[Hirata, Hiromi] Japan Sci & Technol Agcy, Frontier Res Ctr, Natl Inst Genet Precursory Res Embryon Sci & Tech, Mishima, Shizuoka 4118540, Japan; [Nanda, Indrajit; Kress, Wolfram; Haaf, Thomas] Univ Wurzburg, Inst Human Genet, Bioctr, D-97047 Wurzburg, Germany; [van Riesen, Anne; Ding, Can; Seelow, Dominik; Huebner, Christoph; Schuelke, Markus] Charite, Dept Neuropediat, D-13353 Berlin, Germany; [van Riesen, Anne; Ding, Can; Seelow, Dominik; Huebner, Christoph; Schuelke, Markus] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany; [McMichael, Gai; MacLennan, Alastair] Univ Adelaide, Robinson Inst, Adelaide, SA 5000, Australia; [Hu, Hao; Hambrock, Melanie; Fischer, Ute; Bienek, Melanie; Grimme, Astrid; Ropers, Hans-Hilger; Kalscheuer, Vera M.] Max Planck Inst Mol Genet, Dept Human Mol Genet, D-14195 Berlin, Germany; [Papon, Marie-Amelie; Marouillat, Sylviane; Alirol, Servane; Laumonnier, Frederic] Univ Tours, F-37032 Tours, France; [Papon, Marie-Amelie; Marouillat, Sylviane; Alirol, Servane; Laumonnier, Frederic] INSERM, U930, F-37032 Tours, France; [Preisler-Adams, Sabine; Wieacker, Peter] Univ Munster, Inst Human Genet, D-48149 Munster, Germany; [Webster, Richard] Childrens Hosp Westmead, Dept Neurol & Neurosurg, Sydney, NSW 2145, Australia; [Haan, Eric] SA Pathol, South Australian Clin Genet Serv, Adelaide, SA 5000, Australia; [Haan, Eric; Yap, Tzu Ying; Lam Son Nguyen; Shaw, Marie; Gecz, Jozef] Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA 5000, Australia; [Stenzel, Werner] Charite, Inst Neuropathol, D-13353 Berlin, Germany; [Gardner, Alison; Gecz, Jozef] SA Pathol, Neurogenet, Adelaide, SA 5000, Australia; [Lebrun, Nicolas; Chelly, Jamel] Univ Paris 05, F-75006 Paris, France; [Lebrun, Nicolas; Chelly, Jamel] Inst Cochin, CNRS, INSERM, UMR 8104,U1016, F-75014 Paris, France; [Haas, Stefan A.] Max Planck Inst Mol Genet, Dept Computat Biol, D-14195 Berlin, Germany; [Schellenberger, Elke] Kinderfachabt Missionsarztlichen Klin Wurzburg, Kinderklin Monchberg, D-97067 Wurzburg, Germany; [Viot, Geraldine] Cochin Hosp, AP HP, Dept Gynecol & Obstet, F-75014 Paris, France; [Shaffer, Lisa G.; Rosenfeld, Jill A.] PerkinElmer Inc, Signature Genom Labs, Spokane, WA 99207 USA; [Kramer, Nancy; Falk, Rena] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Falk, Rena] Cedars Sinai Med Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90048 USA; [El-Khechen, Dima; Escobar, Luis F.] Peyton Manning St Vincent Childrens Hosp, Med Genet & Neurodev Ctr, Indianapolis, IN 46260 USA; [Hennekam, Raoul] Univ Amsterdam, Acad Med Ctr, Dept Pediat & Clin Genet, NL-1105 AZ Amsterdam, Netherlands; [Laumonnier, Frederic] Ctr Hosp Reg Univ, Dept Med Genet, F-37044 Tours, France	Japan Science & Technology Agency (JST); University of Wurzburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Robinson Research Institute; University of Adelaide; Max Planck Society; Universite de Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Munster; University of Sydney; SA Pathology; University of Adelaide; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; SA Pathology; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Max Planck Society; University of Wurzburg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; CHU Tours	Kalscheuer, VM (corresponding author), Max Planck Inst Mol Genet, Dept Human Mol Genet, Ihnestr 73, D-14195 Berlin, Germany.	markus.schuelke@charite.de; kalscheu@molgen.mpg.de	Gecz, Jozef/X-3469-2019; Chelly, Jamel/J-7528-2015; Laumonnier, Frederic/N-1165-2016; Seelow, Dominik/HGB-3124-2022	Gecz, Jozef/0000-0002-7884-6861; Chelly, Jamel/0000-0002-0939-8719; Laumonnier, Frederic/0000-0003-2567-0708; Seelow, Dominik/0000-0002-9746-4412; Schuelke, Markus/0000-0003-2824-3891; Kalscheuer, Vera/0000-0001-6898-3259; Stenzel, Werner/0000-0002-1143-2103; Hirata, Hiromi/0000-0002-3769-7441; Haas, Stefan/0000-0003-3418-3688; Nguyen, Lam Son/0000-0002-0114-1222	German Ministry of Education and Research through the German Mental Retardation Network; Deutsche Forschungsgemeinschaft [SFB665 TP C4]; Einsteinstiftung Berlin [A-2011-63]; European Union [241995]; Australian National Health and Medical Research Council (NHMRC) [APP1019928, APP1008077]; Australian NHMRC Research Fellowship [APP508043]; Australian Cerebral Palsy Foundation; Adelaide Women's & Children's Hospital Research Foundation; Grants-in-Aid for Scientific Research [23700477] Funding Source: KAKEN	German Ministry of Education and Research through the German Mental Retardation Network; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Einsteinstiftung Berlin; European Union(European Commission); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian NHMRC Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Cerebral Palsy Foundation; Adelaide Women's & Children's Hospital Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank all family members and affected individuals for participating in this study, Susanne Freier and Susanne Lutzkendorf for excellent technical assistance, Cordula Nuener for help with fluorescence in situ hybridization, Karoline Gemeinhardt for initial RT-PCR experiments, and the Department of Microscopy (P.P.F.) of the University of Tours. J.A.R. is an employee of Signature Genomic Laboratories, a subsidiary of Perkin Elmer, Inc. This work was financed by a grant from the German Ministry of Education and Research through the German Mental Retardation Network; by the Deutsche Forschungsgemeinschaft (SFB665 TP C4); by the Einsteinstiftung Berlin (A-2011-63); by Project GENCODYS (241995), which is funded by the European Union Framework Program 7; by Australian National Health and Medical Research Council (NHMRC) grants APP1019928 and APP1008077; by Australian NHMRC Research Fellowship APP508043 (to J.G.); by the Australian Cerebral Palsy Foundation; and by the Adelaide Women's & Children's Hospital Research Foundation.	Ballif BC, 2008, CLIN GENET, V74, P469, DOI 10.1111/j.1399-0004.2008.01094.x; Bamshad M, 2009, J BONE JOINT SURG AM, V91A, P40, DOI 10.2106/JBJS.I.00281; BOYLAN KB, 1992, ANN NEUROL, V31, P337, DOI 10.1002/ana.410310318; Burglen L, 1996, J CLIN INVEST, V98, P1130, DOI 10.1172/JCI118895; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Dieterich K, 2013, HUM MOL GENET, V22, P1483, DOI 10.1093/hmg/dds514; Duker AL, 2010, EUR J HUM GENET, V18, P1196, DOI 10.1038/ejhg.2010.102; Germiller JA, 1998, J PEDIATR ORTHOPED, V18, P314; Gibson JH, 2005, BRAIN DEV-JPN, V27, P266, DOI 10.1016/j.braindev.2004.07.002; HALL JG, 1982, CLIN GENET, V21, P81; HENNEKAM RCM, 1991, EUR J PEDIATR, V150, P656, DOI 10.1007/BF02072628; Hoff JM, 2011, EUR J OBSTET GYN R B, V159, P347, DOI 10.1016/j.ejogrb.2011.09.027; Holman SK, 2013, CLIN GENET, V83, P251, DOI 10.1111/j.1399-0004.2012.01905.x; Hu Hao, 2009, Hugo J, V3, P41, DOI 10.1007/s11568-010-9137-y; Kloos DU, 1997, HUM GENET, V100, P426, DOI 10.1007/s004390050528; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lombard Z, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-30; Marvizon JCG, 2007, NEUROSCIENCE, V148, P250, DOI 10.1016/j.neuroscience.2007.05.036; McMillin MJ, 2013, AM J HUM GENET, V92, P150, DOI 10.1016/j.ajhg.2012.11.014; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; NAZIR MA, 1984, J REPROD MED, V29, P168; Ogino K, 2011, J BIOL CHEM, V286, P806, DOI 10.1074/jbc.M110.125500; Pasterkamp RJ, 2012, NAT REV NEUROSCI, V13, P605, DOI 10.1038/nrn3302; Pellegrino MW, 2011, DEVELOPMENT, V138, P4649, DOI 10.1242/dev.071951; Pellegrino MW, 2009, DEV BIOL, V336, P84, DOI 10.1016/j.ydbio.2009.09.036; Ramser J, 2008, AM J HUM GENET, V82, P188, DOI 10.1016/j.ajhg.2007.09.009; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Reimann J, 2009, NEUROLOGY, V73, P1806, DOI 10.1212/WNL.0b013e3181c34a65; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Seelow D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003874; Steinlein OK, 2007, LIFE SCI, V80, P2186, DOI 10.1016/j.lfs.2007.03.007; Tajsharghi H, 2013, ACTA NEUROPATHOL, V125, P3, DOI 10.1007/s00401-012-1024-2; Venselaar H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-548; WIEACKER P, 1987, AM J MED GENET, V28, P245, DOI 10.1002/ajmg.1320280137; WIEACKER P, 1985, AM J MED GENET, V20, P597, DOI 10.1002/ajmg.1320200405; Zanni G, 2012, P NATL ACAD SCI USA, V109, P14514, DOI 10.1073/pnas.1207488109	39	54	60	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 2	2013	92	5					681	695		10.1016/j.ajhg.2013.03.021	http://dx.doi.org/10.1016/j.ajhg.2013.03.021			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	139KY	23623388	Green Published, Bronze			2022-12-18	WOS:000318582800005
J	Liu, B; Yang, L; Huang, BF; Cheng, M; Wang, H; Li, YY; Huang, D; Zheng, J; Li, QC; Zhang, X; Ji, WD; Zhou, YF; Lu, J				Liu, Bin; Yang, Lei; Huang, Binfang; Cheng, Mei; Wang, Hui; Li, Yinyan; Huang, Dongsheng; Zheng, Jian; Li, Qingchu; Zhang, Xin; Ji, Weidong; Zhou, Yifeng; Lu, Jiachun			A Functional Copy-Number Variation in MAPKAPK2 Predicts Risk and Prognosis of Lung Cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EASTERN CHINESE; KINASE; ACTIVATION; EXPRESSION; GENE; MK2; PHOSPHORYLATION; PROGRESSION; SURVIVAL; SOUTHERN	Mitogen-activated protein kinase-activated protein kinase 2 (MAPKAPK2) may promote cancer development and progression by inducing tumorigenesis and drug resistance. To assess whether the copy-number variation g.CNV-30450 located in the MAPKAPK2 promoter has any effect on lung cancer risk or prognosis, we investigated the association between g.CNV-30450 and cancer risk in three independent case-control studies of 2,332 individuals with lung cancer and 2,457 controls and the effects of g.CNV-30450 on cancer prognosis in 1,137 individuals with lung cancer with survival data in southern and eastern Chinese populations. We found that those subjects who had four copies of g.CNV-30450 had an increased cancer risk (odds ratio = 1.94, 95% confidence interval [CI] = 1.61-2.35) and a worse prognosis for individuals with lung cancer (with a median survival time of only 9 months) (hazard ratio = 1.47, 95% Cl = 1.22-1.78) compared with those with two or three copies (with a median survival time of 14 months). Meanwhile, four copies of g.CNV-30450 significantly increased MAPKAPK2 expression, both in vitro and in vivo, compared with two or three copies. Our study establishes a robust association between the functional g.CNV-30450 in MAPKAPK2 and risk as well as prognosis of lung cancer, and it presents this functional copy-number variation as a potential biomarker for susceptibility to and prognosis for lung cancer.	[Liu, Bin; Yang, Lei; Huang, Binfang; Cheng, Mei; Wang, Hui; Li, Yinyan; Huang, Dongsheng; Li, Qingchu; Zhang, Xin; Ji, Weidong; Lu, Jiachun] Guangzhou Med Univ, State Key Lab Resp Dis, Inst Chem Carcinogenesis, Guangzhou 510182, Guangdong, Peoples R China; [Liu, Bin; Huang, Binfang] Guangzhou Med Univ, Guangzhou Hosp 12, Guangzhou 510620, Guangdong, Peoples R China; [Zheng, Jian; Zhou, Yifeng] Soochow Univ, Coll Med, Lab Canc Mol Genet, Suzhou 215123, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Guangzhou Medical University; Soochow University - China	Lu, J (corresponding author), Guangzhou Med Univ, State Key Lab Resp Dis, Inst Chem Carcinogenesis, 195 Dongfengxi Rd, Guangzhou 510182, Guangdong, Peoples R China.	jclu@gzhmc.edu.cn	Liu, Bin/AAP-2376-2020; ji, weidong/AAX-7397-2020	Liu, Bin/0000-0001-5785-2579; 	National Natural Scientific Foundation of China [30671813, 30872178, 81072366, 30972540]; Guangdong Provincial Scientific Research grants [8251018201000005, 2008B060600008]; Guangdong Provincial High Level Experts grant [2010-79]; Changjiang Scholars and Innovative Research Team in University [IRT0961]; Guangdong Natural Science Foundation [10351012003000000];  [30872142];  [81001278]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Scientific Research grants; Guangdong Provincial High Level Experts grant; Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); ; 	We thank Qingyi Wei (Department of Epidemiology, University of Texas MD Anderson Cancer Center) for careful scientific editing. This study was supported by the National Natural Scientific Foundation of China grants 30671813, 30872178, 81072366 (J.L.), and 30972540 (B.L.), and partly by 30872142 (W.J.) and 81001278 (Y.Z.); Guangdong Provincial Scientific Research grants 8251018201000005 (J.L.) and 2008B060600008 (B.L.); Guangdong Provincial High Level Experts grant 2010-79; Changjiang Scholars and Innovative Research Team in University grant IRT0961; and Guangdong Natural Science Foundation team grant 10351012003000000 (J.L.). We thank Zhanhong Xie, Wanmin Zeng, and Ling Liu for their assistance in recruiting the subjects and Fuman Qiu and Yehua Liu for their laboratory assistance.	Akaike H., 1973, 2 INT S INF THEOR, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Chakraborty S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-163; Chen JM, 2008, CYTOGENET GENOME RES, V123, P102, DOI 10.1159/000184697; Colobran R, 2010, CLIN EXP IMMUNOL, V162, P41, DOI 10.1111/j.1365-2249.2010.04224.x; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; Eckel-Passow JE, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-220; Gabeau-Lacet D, 2009, J NEUROPATH EXP NEUR, V68, P1155, DOI 10.1097/NEN.0b013e3181ba3952; Guo H, 2010, J CLIN ONCOL, V28, P1928, DOI 10.1200/JCO.2009.24.4954; Huang BF, 2012, INT J CANCER, V131, pE744, DOI 10.1002/ijc.27407; HUANG LM, 2012, CARCINOGENESIS, V33, P94, DOI DOI 10.1093/carcin/bgr228; Jackson RM, 2008, EXP LUNG RES, V34, P245, DOI 10.1080/01902140802022500; Jansen M, 2012, NEUROPATH APPL NEURO, V38, P213, DOI 10.1111/j.1365-2990.2011.01222.x; Kobayashi M, 2006, EMBO J, V25, P713, DOI 10.1038/sj.emboj.7600973; Li Y, 2003, J BIOL CHEM, V278, P13663, DOI 10.1074/jbc.M300862200; Lu JC, 2011, HUM MUTAT, V32, P1299, DOI 10.1002/humu.21574; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; Maruyama J, 2009, CURR MED CHEM, V16, P1229, DOI 10.2174/092986709787846613; Mayo P, 2010, CURR PROTOC HUM GENE, V67; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Pomerance M, 2006, J PATHOL, V209, P298, DOI 10.1002/path.1975; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Ronkina N, 2008, FRONT BIOSCI-LANDMRK, V13, P5511, DOI 10.2741/3095; Ronkina N, 2010, BIOCHEM PHARMACOL, V80, P1915, DOI 10.1016/j.bcp.2010.06.021; Seisenbacher G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002168; Shlien A, 2010, CURR OPIN ONCOL, V22, P55, DOI 10.1097/CCO.0b013e328333dca4; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Spitz MR, 2007, JNCI-J NATL CANCER I, V99, P715, DOI 10.1093/jnci/djk153; Stearman RS, 2005, AM J PATHOL, V167, P1763, DOI 10.1016/S0002-9440(10)61257-6; Tang J, 2008, ONCOGENE, V27, P6635, DOI 10.1038/onc.2008.262; ten Hove W, 2007, MOL IMMUNOL, V44, P2492, DOI 10.1016/j.molimm.2006.10.009; Wu R, 2007, J BIOL CHEM, V282, P21598, DOI 10.1074/jbc.M611316200; Yang L, 2012, CARCINOGENESIS, V33, P338, DOI 10.1093/carcin/bgr272	33	54	57	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG 10	2012	91	2					384	390		10.1016/j.ajhg.2012.07.003	http://dx.doi.org/10.1016/j.ajhg.2012.07.003			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	990CN	22883146	Green Published, Bronze			2022-12-18	WOS:000307608700019
J	Zhao, H; Xu, JF; Zhang, HB; Sun, JL; Sun, YP; Wang, Z; Liu, JY; Ding, Q; Lu, SM; Shi, R; You, L; Qin, YY; Zhao, XM; Lin, XL; Li, X; Feng, JJ; Wang, L; Trent, JM; Xu, CY; Gao, Y; Zhang, B; Gao, X; Hu, JM; Chen, H; Li, GY; Zhao, JZ; Zou, SH; Jiang, H; Hao, CF; Zhao, YR; Ma, JL; Zheng, SL; Chen, ZJ				Zhao, Han; Xu, Jianfeng; Zhang, Haobo; Sun, Jielin; Sun, Yingpu; Wang, Zhong; Liu, Jiayin; Ding, Qiang; Lu, Shaoming; Shi, Rong; You, Li; Qin, Yingying; Zhao, Xiaoming; Lin, Xiaoling; Li, Xiao; Feng, Junjie; Wang, Li; Trent, Jeffrey M.; Xu, Chengyan; Gao, Ying; Zhang, Bo; Gao, Xuan; Hu, Jingmei; Chen, Hong; Li, Guangyu; Zhao, Junzhao; Zou, Shuhua; Jiang, Hong; Hao, Cuifang; Zhao, Yueran; Ma, Jinglong; Zheng, S. Lilly; Chen, Zi-Jiang			A Genome-wide Association Study Reveals that Variants within the HLA Region Are Associated with Risk for Nonobstructive Azoospermia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEVERE OLIGOZOOSPERMIA; INFERTILE MEN; GENE; POLYMORPHISMS; VISUALIZATION; METAANALYSIS; DISSECTION; DISEASE; ONSET; MHC	A genome-wide association study of Han Chinese subjects was conducted to identify genetic susceptibility loci for nonobstructive azoospermia (NOA). In the discovery stage, 802 azoospermia cases and 1,863 controls were screened for genetic variants in the genome. Promising SNPs were subsequently confirmed in two independent sets of subjects: 818 azoospermia cases and 1,755 controls from northern China, and 606 azoospermia cases and 958 controls from central and southern China. We detected variants at human leukocyte antigen (HLA) regions that were independently associated with NOA (HLA-DRA, rs3129878, p(combine) = 3.70 x 10(-16), odds ratio [OR] = 1.37; C6orf10 and BTNL2, rs498422, p(combine) = 2.43 x 10(-12), OR = 1.42). These findings provide additional insight into the pathogenesis of NOA.	[Zhao, Han; Zhang, Haobo; Lu, Shaoming; You, Li; Qin, Yingying; Li, Xiao; Wang, Li; Xu, Chengyan; Gao, Xuan; Hu, Jingmei; Chen, Hong; Li, Guangyu; Zhao, Yueran; Ma, Jinglong; Chen, Zi-Jiang] Shandong Univ, Shandong Prov Hosp, Ctr Reprod Med, Jinan 250021, Shandong, Peoples R China; [Zhao, Han; Zhang, Haobo; You, Li; Qin, Yingying; Wang, Li; Gao, Xuan; Hu, Jingmei; Zhao, Yueran; Ma, Jinglong; Chen, Zi-Jiang] Shandong Univ, Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Jinan 250021, Shandong, Peoples R China; [Zhao, Han; Zhang, Haobo; You, Li; Qin, Yingying; Wang, Li; Gao, Xuan; Hu, Jingmei; Chen, Hong; Li, Guangyu; Zhao, Yueran; Ma, Jinglong; Chen, Zi-Jiang] Shandong Univ, Minist Educ, Key Lab Reprod Endocrinol, Jinan 250021, Shandong, Peoples R China; [Zhao, Han; Lu, Shaoming; You, Li; Qin, Yingying; Li, Xiao; Wang, Li; Xu, Chengyan; Chen, Hong; Li, Guangyu; Zhao, Yueran; Ma, Jinglong; Chen, Zi-Jiang] Shandong Univ, Shandong Prov Key Lab Reprod Med, Jinan 250021, Shandong, Peoples R China; [Xu, Jianfeng; Lin, Xiaoling] Fudan Univ, Sch Life Sci, Fudan VARI Ctr Genet Epidemiol, Shanghai 200433, Peoples R China; [Xu, Jianfeng; Ding, Qiang] Huashan Hosp, Fudan Inst Urol, Shanghai 200040, Peoples R China; [Xu, Jianfeng; Sun, Jielin; Wang, Zhong; Feng, Junjie; Zheng, S. Lilly] Wake Forest Univ, Bowman Gray Sch Med, Ctr Canc Genom, Winston Salem, NC 27157 USA; [Xu, Jianfeng; Trent, Jeffrey M.] Van Andel Res Inst, Grand Rapids, MI 49503 USA; [Sun, Yingpu] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China; [Liu, Jiayin] Nanjing Med Univ, Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R China; [Shi, Rong] Shanghai Jiao Tong Univ, Sch Publ Hlth, Shanghai 200025, Peoples R China; [Zhao, Xiaoming] Shanghai Jiao Tong Univ, Renji Hosp, Shanghai 200001, Peoples R China; [Gao, Ying] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Wuhan 430022, Hubei, Peoples R China; [Zhang, Bo] Maternal & Child Hlth Hosp Guangxi, Nanning 530003, Guangxi, Peoples R China; [Zhao, Junzhao] Wenzhou Med Coll, Affiliated Hosp 1, Wenzhou 325035, Zhejiang, Peoples R China; [Zou, Shuhua] Qingdao Women & Children Med Healthcare Ctr, Qingdao 266011, Shandong, Peoples R China; [Jiang, Hong] 105th Hosp Peoples Liberat Army, Hefei 230031, Anhui, Peoples R China; [Hao, Cuifang] Yantai Yuhuangding Hosp, Yantai 264000, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University; Shandong University; Shandong University; Fudan University; Fudan University; Wake Forest University; Wake Forest Baptist Medical Center; Van Andel Institute; Zhengzhou University; Nanjing Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Huazhong University of Science & Technology; Wenzhou Medical University	Chen, ZJ (corresponding author), Shandong Univ, Shandong Prov Hosp, Ctr Reprod Med, 324 Jingwu Rd, Jinan 250021, Shandong, Peoples R China.	chenzijiang@hotmail.com	Li, Yuan/GXV-1310-2022; Chen, Zi-Jiang/GOE-6119-2022; Yan, Junhao/AAH-8310-2019	Chen, Zi-Jiang/0000-0001-6637-6631; Zhang, Haobo/0000-0003-3821-9676	National Basic Research Program of China (973 Program) [2012CB944700]; National Natural Science Foundation of China [30973170, 81000238, 81000236]; National Key Technology Research and Development Program [2011BAI17B00]; Science Research Foundation Item of No-earnings Health Vocation [201002013]; Huashan Hospital	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Research and Development Program(National Key Technology R&D Program); Science Research Foundation Item of No-earnings Health Vocation; Huashan Hospital	We thank Di Wu, Changming Zhang, Yongzhi Cao, Gang Ma, Chongfu Zhong, Jiaolong Liu and Yanhong Xiao from Shandong University for sample collection and categorization; Qingzhi Hao and Pingshuai Jiang for data organization. This study was supported by grants from the National Basic Research Program of China (973 Program) (2012CB944700), the National Natural Science Foundation of China (30973170, 81000238, 81000236), the National Key Technology Research and Development Program (2011BAI17B00), the Science Research Foundation Item of No-earnings Health Vocation (201002013), and an intramural grant from Huashan Hospital. We thank all participants involved in this study. All authors critically reviewed the article and approved the final manuscript.	Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Aston KI, 2009, J ANDROL, V30, P711, DOI 10.2164/jandrol.109.007971; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chun-Lai T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021069; Chung SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001323; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Dohle GR, 2002, HUM REPROD, V17, P13, DOI 10.1093/humrep/17.1.13; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; JAROW JP, 1989, J UROLOGY, V142, P62, DOI 10.1016/S0022-5347(17)38662-7; Jin Y, 2011, J INVEST DERMATOL, V131, P1308, DOI 10.1038/jid.2011.12; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; MATSUMIYA K, 1994, INT J ANDROL, V17, P140, DOI 10.1111/j.1365-2605.1994.tb01233.x; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; Noble JA, 2011, CURR DIABETES REP, V11, P533, DOI 10.1007/s11892-011-0223-x; Nuti F, 2008, REPROD BIOMED ONLINE, V16, P504, DOI 10.1016/S1472-6483(10)60457-9; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reijo R, 1996, LANCET, V347, P1290, DOI 10.1016/S0140-6736(96)90938-1; Spiess AN, 2007, HUM REPROD, V22, P2936, DOI 10.1093/humrep/dem292; Tuttelmann F, 2007, REPROD BIOMED ONLINE, V15, P643, DOI 10.1016/s1472-6483(10)60531-7; Valentonyte R, 2005, NAT GENET, V37, P357, DOI 10.1038/ng1519; Van Assche E., 1996, HUM REPROD S4, V11, P25; VanAssche E, 1996, HUM REPROD, V11, P1, DOI 10.1093/humrep/11.suppl_4.1; WILLOTT GM, 1982, FORENSIC SCI INT, V20, P9, DOI 10.1016/0379-0738(82)90099-8; World Health Organization, 1999, WHO LAB MANUAL EXAMI, V4th; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015	29	54	57	1	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 4	2012	90	5					900	906		10.1016/j.ajhg.2012.04.001	http://dx.doi.org/10.1016/j.ajhg.2012.04.001			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	940QG	22541561	Bronze, Green Published			2022-12-18	WOS:000303907500015
J	Bhatia, G; Patterson, N; Pasaniuc, B; Zaitlen, N; Genovese, G; Pollack, S; Mallick, S; Myers, S; Tandon, A; Spencer, C; Palmer, CD; Adeyemo, AA; Akylbekova, EL; Cupples, LA; Divers, J; Fornage, M; Kao, WHL; Lange, L; Li, MY; Musani, S; Mychaleckyj, JC; Ogunniyi, A; Papanicolaou, G; Rotimi, CN; Rotter, JI; Ruczinski, I; Salako, B; Siscovick, DS; Tayo, BO; Yang, Q; McCarro, S; Sabeti, P; Lettre, G; De Jager, P; Hirschhorn, J; Zhu, XF; Cooper, R; Reich, D; Wilson, JG; Price, AL				Bhatia, Gaurav; Patterson, Nick; Pasaniuc, Bogdan; Zaitlen, Noah; Genovese, Giulio; Pollack, Samuela; Mallick, Swapan; Myers, Simon; Tandon, Arti; Spencer, Chris; Palmer, Cameron D.; Adeyemo, Adebowale A.; Akylbekova, Ermeg L.; Cupples, L. Adrienne; Divers, Jasmin; Fornage, Myriam; Kao, W. H. Linda; Lange, Leslie; Li, Mingyao; Musani, Solomon; Mychaleckyj, Josyf C.; Ogunniyi, Adesola; Papanicolaou, George; Rotimi, Charles N.; Rotter, Jerome I.; Ruczinski, Ingo; Salako, Babatunde; Siscovick, David S.; Tayo, Bamidele O.; Yang, Qiong; McCarro, Steve; Sabeti, Pardis; Lettre, Guillaume; De Jager, Phil; Hirschhorn, Joel; Zhu, Xiaofeng; Cooper, Richard; Reich, David; Wilson, James G.; Price, Alkes L.			Genome-wide Comparison of African-Ancestry Populations from CARe and Other Cohorts Reveals Signals of Natural Selection	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECENT POSITIVE SELECTION; GENETIC-VARIATION; ASSOCIATION ANALYSIS; HAPLOTYPE MAP; MALARIA; DIFFERENTIATION; SUSCEPTIBILITY; DISEASE; HLA; TUBERCULOSIS	The study of recent natural selection in human populations has important applications to human history and medicine. Positive natural selection drives the increase in beneficial alleles and plays a role in explaining diversity across human populations. By discovering traits subject to positive selection, we can better understand the population level response to environmental pressures including infectious disease. Our study examines unusual population differentiation between three large data sets to detect natural selection. The populations examined, African Americans, Nigerians, and Gambians, are genetically close to one another (F-ST < 0.01 for all pairs), allowing us to detect selection even with moderate changes in allele frequency. We also develop a tree-based method to pinpoint the population in which selection occurred, incorporating information across populations. Our genome-wide significant results corroborate loci previously reported to be under selection in Africans including HBB and CD36. At the HLA locus on chromosome 6, results suggest the existence of multiple, independent targets of population-specific selective pressure. In addition, we report a genome-wide significant (p = 1.36 x 10(-11)) signal of selection in the prostate stem cell antigen (PSCA) gene. The most significantly differentiated marker in our analysis, rs2920283, is highly differentiated in both Africa and East Asia and has prior genome-wide significant associations to bladder and gastric cancers.	[Bhatia, Gaurav] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Bhatia, Gaurav; Patterson, Nick; Pasaniuc, Bogdan; Zaitlen, Noah; Pollack, Samuela; Mallick, Swapan; Tandon, Arti; Palmer, Cameron D.; McCarro, Steve; De Jager, Phil; Hirschhorn, Joel; Reich, David; Price, Alkes L.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Pasaniuc, Bogdan; Zaitlen, Noah; Pollack, Samuela; Price, Alkes L.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Pasaniuc, Bogdan; Zaitlen, Noah; Pollack, Samuela; Price, Alkes L.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Genovese, Giulio] Beth Israel Deaconess Med Ctr, Dept Med, Div Nephrol, Boston, MA 02215 USA; [Genovese, Giulio] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Mallick, Swapan; Tandon, Arti; McCarro, Steve; Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Myers, Simon] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Spencer, Chris] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Palmer, Cameron D.; Hirschhorn, Joel] Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Palmer, Cameron D.; Hirschhorn, Joel] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Palmer, Cameron D.; Hirschhorn, Joel] Childrens Hosp, Program Genom, Boston, MA 02115 USA; [Adeyemo, Adebowale A.] NHGRI, NIH, Intramural Ctr Res Genom & Global Hlth, Bethesda, MD 20892 USA; [Akylbekova, Ermeg L.] Jackson State Univ, Jackson Heart Study, Jackson, MS 39213 USA; [Cupples, L. Adrienne; Yang, Qiong] Boston Univ, Sch Publ Hlth, Dept Biostat & Epidemiol, Boston, MA 02218 USA; [Divers, Jasmin] Wake Forest Univ, Div Publ Hlth Sci, Dept Biostat Sci, Winston Salem, NC 27157 USA; [Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Div Epidemiol, Houston, TX 77030 USA; [Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Inst Mol Med, Houston, TX 77030 USA; [Kao, W. H. Linda; Ruczinski, Ingo] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD 21205 USA; [Kao, W. H. Linda] Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA; [Lange, Leslie] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Li, Mingyao] Univ Penn, Philadelphia, PA 19104 USA; [Musani, Solomon; Wilson, James G.] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; [Mychaleckyj, Josyf C.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22902 USA; [Ogunniyi, Adesola; Salako, Babatunde] Univ Ibadan, Dept Med, Ibadan 5017, Nigeria; [Papanicolaou, George] NHLBI, Div Cardiovasc Sci, NIH, Bethesda, MD 20892 USA; [Rotimi, Charles N.] NHGRI, Ctr Res Genom & Global Hlth, Bethesda, MD 20892 USA; [Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Siscovick, David S.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Siscovick, David S.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Siscovick, David S.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Tayo, Bamidele O.; Cooper, Richard] Loyola Univ Chicago, Stritch Sch Med, Dept Prevent Med & Epidemiol, Maywood, IL 60153 USA; [Sabeti, Pardis] Harvard Univ, Cambridge, MA 02138 USA; [Lettre, Guillaume] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Lettre, Guillaume] Univ Montreal, Dept Med, Montreal, PQ H3T 3J7, Canada; [De Jager, Phil] Brigham & Womens Hosp, Ctr Neurol Dis, Div Mol Immunol, Boston, MA 02115 USA; [De Jager, Phil] Partners Ctr Personalized Genet Med, Boston, MA 02115 USA; [Zhu, Xiaofeng] Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA	Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Jackson State University; Boston University; Wake Forest University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Johns Hopkins University; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania; University of Mississippi; University of Mississippi Medical Center; University of Virginia; University of Ibadan; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Cedars Sinai Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Loyola University Chicago; Harvard University; Universite de Montreal; Universite de Montreal; Harvard University; Brigham & Women's Hospital; Case Western Reserve University	Bhatia, G (corresponding author), MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.	gbhatia@mit.edu; aprice@hsph.harvard.edu	Myers, Simon R/A-6792-2015; Sabeti, Pardis/GQH-8610-2022; Zhu, Xiaofeng/O-6874-2019; Rotter, Jerome/AAY-6598-2021; Pasaniuc, Bogdan/E-9310-2012; Yang, Qiong/G-5438-2014	Myers, Simon R/0000-0002-2585-9626; Adeyemo, Adebowale/0000-0002-3105-3231; Zhu, Xiaofeng/0000-0003-0037-411X; Cupples, L. Adrienne/0000-0003-0273-7965; Pasaniuc, Bogdan/0000-0002-0227-2056	NIH [R01 HG005224, RC1 GM091332, 5T32ES007142-27]; National Human Genome Research Institute (NHGRI) [T32 HG002295]; NIH/NHGRI [U01 HG004726-01]; NHLBI's CARe consortium [HHSN268200960009C]; Grand Challenges in Global Health Initiative; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004726, R03HG006170, ZIAHG200362, R01HG006399, T32HG002295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC1GM091332] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH/NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI's CARe consortium; Grand Challenges in Global Health Initiative; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH grants R01 HG005224 (B.P. S.P., A.L.P.), RC1 GM091332 (N.P., D.R., J.G.W.) and by grant T32 HG002295 from the National Human Genome Research Institute (NHGRI) (G.B.) and NIH fellowship 5T32ES007142-27 (N.Z.), and used data from NHLBI's CARe project. C.H., D.R., N.P., and A.T. were supported by NIH/NHGRI grant U01 HG004726-01. We acknowledge the contributions of the participants and investigators of NHLBI's CARe consortium (contract number HHSN268200960009C). Funding information for CARe and its parent cohorts can be found at http://public.nhlbi.nih.gov/GeneticsGenomics/home/care.aspx. This study makes use of data generated by MalariaGEN. A full list of the investigators who contributed to the generation of the data is available from www.MalariaGEN.net. Funding for this project was provided by the Foundation for the National Institutes of Health and the Wellcome Trust. The funding for this project comes through the Grand Challenges in Global Health Initiative.	Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Ayodo G, 2007, AM J HUM GENET, V81, P234, DOI 10.1086/519221; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campbell CD, 2011, AM J HUM GENET, V88, P317, DOI 10.1016/j.ajhg.2011.02.004; Cann HM, 2002, SCIENCE, V296, P261; Cao K, 2004, TISSUE ANTIGENS, V63, P293, DOI 10.1111/j.0001-2815.2004.00192.x; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Currat M, 2002, AM J HUM GENET, V70, P207, DOI 10.1086/338304; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Edwards M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000867; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fry AE, 2009, HUM MOL GENET, V18, P2683, DOI 10.1093/hmg/ddp192; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Hamblin MT, 2000, AM J HUM GENET, V66, P1669, DOI 10.1086/302879; Hancock AM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040032; HEDRICK PW, 1983, GENETICS, V104, P449; HEDRICK PW, 2011, HEREDITY IN PRESS; Hernandez RD, 2011, SCIENCE, V331, P920, DOI 10.1126/science.1198878; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Ko WY, 2011, AM J HUM GENET, V88, P741, DOI 10.1016/j.ajhg.2011.05.005; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Lettre G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001300; Lewinsohn DA, 2007, PLOS PATHOG, V3, P1240, DOI 10.1371/journal.ppat.0030127; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Mattiangeli V, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r74; McEvoy B, 2006, HUM MOL GENET, V15, pR176, DOI 10.1093/hmg/ddl217; McVicker G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000471; Medland SE, 2009, AM J HUM GENET, V85, P750, DOI 10.1016/j.ajhg.2009.10.009; Nicholson G, 2002, J ROY STAT SOC B, V64, P695, DOI 10.1111/1467-9868.00357; Nielsen R, 2007, NAT REV GENET, V8, P857, DOI 10.1038/nrg2187; Norton HL, 2007, MOL BIOL EVOL, V24, P710, DOI 10.1093/molbev/msl203; Novembre J, 2009, NAT REV GENET, V10, P745, DOI 10.1038/nrg2632; Pasaniuc B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001371; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000505; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000519; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sakamoto H, 2008, NAT GENET, V40, P730, DOI 10.1038/ng.152; Shriver Mark D, 2004, Hum Genomics, V1, P274; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Thye T, 2010, NAT GENET, V42, P739, DOI 10.1038/ng.639; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; WAINSCOAT JS, 1986, NATURE, V319, P491, DOI 10.1038/319491a0; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Wu XF, 2009, NAT GENET, V41, P991, DOI 10.1038/ng.421; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371	61	54	54	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 9	2011	89	3					368	381		10.1016/j.ajhg.2011.07.025	http://dx.doi.org/10.1016/j.ajhg.2011.07.025			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	820XQ	21907010	Green Published, Bronze			2022-12-18	WOS:000294939800002
J	Poulton, CJ; Schot, R; Kia, SK; Jones, M; Verheijen, FW; Venselaar, H; de Wit, MCY; de Graaff, E; Bertoli-Avella, AM; Mancini, GMS				Poulton, Cathryn J.; Schot, Rachel; Kia, Sima Kheradmand; Jones, Marta; Verheijen, Frans W.; Venselaar, Hanka; de Wit, Marie-Claire Y.; de Graaff, Esther; Bertoli-Avella, Aida M.; Mancini, Grazia M. S.			Microcephaly with Simplified Gyration, Epilepsy, and Infantile Diabetes Linked to Inappropriate Apoptosis of Neural Progenitors	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MUTATIONS; PROTEIN; COMPLEX; DEATH; SIZE; LIFE	We describe a syndrome of primary microcephaly with simplified gyral pattern in combination with severe infantile epileptic encephalopathy and early-onset permanent diabetes in two unrelated consanguineous families with at least three affected children. Linkage analysis revealed a region on chromosome 18 with a significant LOD score of 4.3. In this area, two homozygous nonconserved missense mutations in immediate early response 3 interacting protein 1 (IER3IP1) were found in patients from both families. IER3IP1,1 is highly expressed in the fetal brain cortex and fetal pancreas and is thought to be involved in endoplasmic reticulum stress response. We reported one of these families previously in a paper on Wolcott-Rallison syndrome (WRS). WRS is characterized by increased apoptotic cell death as part of an uncontrolled unfolded protein response. Increased apoptosis has been shown to be a cause of microcephaly in animal models. An autopsy specimen from one patient showed increased apoptosis in the cerebral cortex and pancreas beta cells, implicating premature cell death as the pathogenetic mechanism. Both patient fibroblasts and control fibroblasts treated with siRNA specific for IER3IP1 showed an increased susceptibility to apoptotic cell death under stress conditions in comparison to controls. This directly implicates IER3IP1 in the regulation of cell survival. Identification of IER3IP1 mutations sheds light on the mechanisms of brain development and on the pathogenesis of infantile epilepsy and early-onset permanent diabetes.	[Poulton, Cathryn J.; Schot, Rachel; Kia, Sima Kheradmand; Verheijen, Frans W.; Bertoli-Avella, Aida M.; Mancini, Grazia M. S.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [de Wit, Marie-Claire Y.] Erasmus MC, Dept Paediat Neurol, Rotterdam, Netherlands; [Jones, Marta] Childrens Hosp, Dept Pathol, Neuropathol Unit, La Plata, Buenos Aires, Argentina; [Venselaar, Hanka] Radboud Univ Nijmegen, Med Ctr, CMBI Nijmegen, NL-6500 HB Nijmegen, Netherlands; [de Graaff, Esther] Univ Utrecht, Fac Sci, Dept Cell Biol, NL-3508 TC Utrecht, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen; Utrecht University	Mancini, GMS (corresponding author), Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands.	g.mancini@erasmusmc.nl	de Wit, Marie-Claire/X-4168-2019; Venselaar, Hanka/D-2009-2016; de Graaff, Esther/D-3287-2011; Bertoli-Avella, Aida/AAW-2751-2020	Venselaar, Hanka/0000-0001-9824-6559; Bertoli-Avella, Aida/0000-0001-9544-1877	EMBO; International Pediatric Research Foundation; Leverhulme Trust	EMBO(European Molecular Biology Organization (EMBO)); International Pediatric Research Foundation; Leverhulme Trust(Leverhulme Trust)	C.J.P was supported by a short-term EMBO fellowship, the International Pediatric Research Foundation (Young Investigator Exchange Program 2009), and the Leverhulme Trust Abroad Studentships. We thank F.G. Grosveld, at the Department of Cell Biology and A. Kremer at the Department of Bioinformatics, ErasmusMC, for useful discussions and support.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arlt A, 2011, EUR J CELL BIOL, V90, P545, DOI 10.1016/j.ejcb.2010.10.002; Barkovich AJ, 2005, NEUROLOGY, V65, P1873, DOI 10.1212/01.wnl.0000183747.05269.2d; Basel-Vanagaite L, 2010, PEDIATR NEUROL, V43, P7, DOI 10.1016/j.pediatrneurol.2010.02.015; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Boztug K, 2009, NEW ENGL J MED, V360, P32, DOI 10.1056/NEJMoa0805051; Bromberg Y, 2008, BIOINFORMATICS, V24, P2397, DOI 10.1093/bioinformatics/btn435; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Darvish H, 2010, J MED GENET, V47, P823, DOI 10.1136/jmg.2009.076398; de Wit MCY, 2006, NEUROGENETICS, V7, P259, DOI 10.1007/s10048-006-0061-1; Decraene C, 2002, GENOME BIOL, V3; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Dunlavy DM, 2005, J COMPUT BIOL, V12, P1275, DOI 10.1089/cmb.2005.12.1275; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Guerrini R, 2008, TRENDS NEUROSCI, V31, P154, DOI 10.1016/j.tins.2007.12.004; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Haydar TF, 1999, CEREB CORTEX, V9, P621, DOI 10.1093/cercor/9.6.621; Heidtman M, 2005, MOL BIOL CELL, V16, P1673, DOI 10.1091/mbc.E04-10-0873; Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571; Kaindl AM, 2010, PROG NEUROBIOL, V90, P363, DOI 10.1016/j.pneurobio.2009.11.002; Kraft AD, 2009, NEUROTOXICOLOGY, V30, P785, DOI 10.1016/j.neuro.2009.07.001; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Merksamer PI, 2010, J CELL SCI, V123, P1003, DOI 10.1242/jcs.035832; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Rubio-Cabezas O, 2009, J CLIN ENDOCR METAB, V94, P4162, DOI 10.1210/jc.2009-1137; SANES DH, 2006, DEV NERVOUS SYSTEM, P173; Sanno H, 2010, J NEUROSCI, V30, P4221, DOI 10.1523/JNEUROSCI.3318-09.2010; Shen J, 2010, NAT GENET, V42, P245, DOI 10.1038/ng.526; Silver DL, 2010, NAT NEUROSCI, V13, P551, DOI 10.1038/nn.2527; Slingerland AS, 2009, DIABETOLOGIA, V52, P1683, DOI 10.1007/s00125-009-1416-6; Venselaar H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-548; Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809; Yiu WH, 2010, CELL BIOCHEM FUNCT, V28, P31, DOI 10.1002/cbf.1613; Yiu WH, 2004, GENE, V337, P37, DOI 10.1016/j.gene.2004.04.033; Yu TW, 2010, NAT GENET, V42, P1015, DOI 10.1038/ng.683; Zhang Y, 2002, P NATL ACAD SCI USA, V99, P878, DOI 10.1073/pnas.022326699	43	54	56	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 12	2011	89	2					265	276		10.1016/j.ajhg.2011.07.006	http://dx.doi.org/10.1016/j.ajhg.2011.07.006			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	810TA	21835305	Bronze, Green Published			2022-12-18	WOS:000294148800006
J	Jordan, DM; Kiezun, A; Baxter, SM; Agarwala, V; Green, RC; Murray, MF; Pugh, T; Lebo, MS; Rehm, HL; Funke, BH; Sunyaev, SR				Jordan, Daniel M.; Kiezun, Adam; Baxter, Samantha M.; Agarwala, Vineeta; Green, Robert C.; Murray, Michael F.; Pugh, Trevor; Lebo, Matthew S.; Rehm, Heidi L.; Funke, Birgit H.; Sunyaev, Shamil R.			Development and Validation of a Computational Method for Assessment of Missense Variants in Hypertrophic Cardiomyopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AMINO-ACID SUBSTITUTIONS; PROTEIN FUNCTION; MUTATIONS; MYOSIN; HAPLOINSUFFICIENCY; RECOMMENDATIONS; PREDICTION; EVOLUTION; DIAGNOSIS; FAMILIES	Assessing the significance of novel genetic variants revealed by DNA sequencing is a major challenge to the integration of genomic techniques with medical practice. Many variants remain difficult to classify by traditional genetic methods. Computational methods have been developed that could contribute to classifying these variants, but they have not been properly validated and are generally not considered mature enough to be used effectively in a clinical setting. We developed a computational method for predicting the effects of missense variants detected in patients with hypertrophic cardiomyopathy (HCM). We used a curated clinical data set of 74 missense variants in six genes associated with HCM to train and validate an automated predictor. The predictor is based on support vector regression and uses phylogenetic and structural features specific to genes involved in HCM. Ten-fold cross validation estimated our predictor's sensitivity at 94% (95% confidence interval: 83%-98%) and specificity at 89% (95% confidence interval: 72%-100%). This corresponds to an odds ratio of 10 for a prediction of pathogenic (95% confidence interval: 4.0 infinity), or an odds ratio of 9.9 for a prediction of benign (95% confidence interval: 4.6-21). Coverage (proportion of variants for which a prediction was made) was 57% (95% confidence interval: 49%-64%). This performance exceeds that of existing methods that are not specifically designed for HCM. The accuracy of this predictor provides support for the clinical use of automated predictions alongside family segregation and population frequency data in the interpretation of new missense variants and suggests future development of similar tools for other diseases.	[Baxter, Samantha M.; Agarwala, Vineeta; Pugh, Trevor; Lebo, Matthew S.; Rehm, Heidi L.; Funke, Birgit H.] Partners HealthCare Ctr Personalized Genet Med, Mol Med Lab, Cambridge, MA 02139 USA; [Jordan, Daniel M.; Kiezun, Adam; Murray, Michael F.; Sunyaev, Shamil R.] Brigham & Womens Hosp, Dept Med, Div Gen Med, Boston, MA 02115 USA; [Jordan, Daniel M.; Kiezun, Adam; Murray, Michael F.; Sunyaev, Shamil R.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Jordan, Daniel M.; Agarwala, Vineeta] Harvard Univ, Program Biophys, Cambridge, MA 02138 USA; [Green, Robert C.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Green, Robert C.] Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA; [Green, Robert C.; Pugh, Trevor; Lebo, Matthew S.] Harvard Univ, Sch Med, Genet Training Program, Boston, MA 02115 USA; [Funke, Birgit H.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Partners Healthcare System; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston University; Boston University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Funke, BH (corresponding author), Partners HealthCare Ctr Personalized Genet Med, Mol Med Lab, Cambridge, MA 02139 USA.	bfunke@partners.org; ssunyaev@rics.bwh.harvard.edu	Pugh, Trevor/Y-2535-2019; Jordan, Daniel/M-6842-2019	Pugh, Trevor/0000-0002-8073-5888; Jordan, Daniel/0000-0002-5318-8225; Rehm, Heidi L./0000-0002-6025-0015; Lebo, Matthew/0000-0002-9733-5207	National Institutes of Health [R01 GM078598, T32 GM008313]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, R01GM078598, T32GM008313] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grants from the National Institutes of Health (R01 GM078598, T32 GM008313). We would like to thank Steve DePalma, Dan Hermann, and Jon and Christine Seidman for their help with the CardioGenomics database and insights into HCM.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Andersen PS, 2004, EUR J HUM GENET, V12, P673, DOI 10.1038/sj.ejhg.5201190; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Dorfman R, 2010, CLIN GENET, V77, P464, DOI 10.1111/j.1399-0004.2009.01351.x; Goldgar DE, 2004, AM J HUM GENET, V75, P535, DOI 10.1086/424388; Himmel DM, 2002, P NATL ACAD SCI USA, V99, P12645, DOI 10.1073/pnas.202476799; Houdusse A, 1999, CELL, V97, P459, DOI 10.1016/S0092-8674(00)80756-4; Jordan DM, 2010, CURR OPIN STRUC BIOL, V20, P342, DOI 10.1016/j.sbi.2010.03.006; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lupas A, 1996, METHOD ENZYMOL, V266, P513; Marston S, 2009, CIRC RES, V105, P219, DOI 10.1161/CIRCRESAHA.109.202440; Martinez L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-306; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Plon SE, 2008, HUM MUTAT, V29, P1282, DOI 10.1002/humu.20880; Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Tavtigian SV, 2008, HUM MUTAT, V29, P1327, DOI 10.1002/humu.20892; Tchernitchko D, 2004, CLIN CHEM, V50, P1974, DOI 10.1373/clinchem.2004.036053; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thusberg J, 2009, HUM MUTAT, V30, P703, DOI 10.1002/humu.20938; Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102; Wang LB, 2010, ANN INTERN MED, V152, P513, DOI 10.7326/0003-4819-152-8-201004200-00008; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166; Yue P, 2006, J MOL BIOL, V356, P1263, DOI 10.1016/j.jmb.2005.12.025	29	54	58	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB 11	2011	88	2					183	192		10.1016/j.ajhg.2011.01.011	http://dx.doi.org/10.1016/j.ajhg.2011.01.011			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	725YZ	21310275	Green Published, Bronze			2022-12-18	WOS:000287684100006
J	Morange, PE; Bezemer, I; Saut, N; Bare, L; Burgos, G; Brocheton, J; Durand, H; Biron-Andreani, C; Schved, JF; Pernod, G; Galan, P; Drouet, L; Zelenika, D; Germain, M; Nicaud, V; Heath, S; Ninio, E; Delluc, A; Munzel, T; Zeller, T; Brand-Herrmann, SM; Alessi, MC; Tiret, L; Lathrop, M; Cambien, F; Blankenberg, S; Emmerich, J; Tregouet, DA; Rosendaal, FR				Morange, Pierre-Emmanuel; Bezemer, Irene; Saut, Noemie; Bare, Lance; Burgos, Gwenaelle; Brocheton, Jessy; Durand, Herve; Biron-Andreani, Christine; Schved, Jean-Francois; Pernod, Gilles; Galan, Pilar; Drouet, Ludovic; Zelenika, Diana; Germain, Marine; Nicaud, Viviane; Heath, Simon; Ninio, Ewa; Delluc, Aurelien; Muenzel, Thomas; Zeller, Tanja; Brand-Herrmann, Stefan-Martin; Alessi, Marie-Christine; Tiret, Laurence; Lathrop, Mark; Cambien, Francois; Blankenberg, Stefan; Emmerich, Joseph; Tregouet, David-Alexandre; Rosendaal, Frits R.			A Follow-Up Study of a Genome-wide Association Scan Identifies a Susceptibility Locus for Venous Thrombosis on Chromosome 6p24.1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKING INFLAMMATION; PROTEIN; RISK	To identify genetic susceptibility factors conferring increased risk of venous thrombosis (VT), we conducted a multistage study, following results of a previously published GWAS that failed to detect loci for developing VT. Using a collection of 5862 cases with VT and 7112 healthy controls, we identified the HIVEP1 locus on chromosome 6p24.1 as a susceptibility locus for VT. Indeed, the HIVEP1 rs169713C allele was associated with an increased risk for VT, with an odds ratio of 1.20 (95% confidence interval 1.13-1.27, p = 2.86 x 10(-9)). HIVEP1 codes for a protein that participates in the transcriptional regulation of inflammatory target genes by binding specific DNA sequences in their promoter and enhancer regions. The current results provide the identification of a locus involved in VT susceptibility that lies outside the traditional coagulation/fibrinolysis pathway.	[Morange, Pierre-Emmanuel; Saut, Noemie; Burgos, Gwenaelle; Alessi, Marie-Christine] Univ Mediterranee, INSERM, UMR S 626, F-13385 Marseille, France; [Bezemer, Irene; Rosendaal, Frits R.] Leiden Univ, Dept Thrombosis & Hemostasis, Dept Clin Epidemiol, Med Ctr, NL-2300 MC Leiden, Netherlands; [Bezemer, Irene; Rosendaal, Frits R.] Leiden Univ, Einthoven Lab Expt Vasc Med, Med Ctr, NL-2300 MC Leiden, Netherlands; [Bare, Lance] Celera, Alameda, CA 94502 USA; [Brocheton, Jessy; Durand, Herve; Drouet, Ludovic; Germain, Marine; Nicaud, Viviane; Ninio, Ewa; Tiret, Laurence; Cambien, Francois; Tregouet, David-Alexandre] INSERM, UMRS 937, F-75013 Paris, France; [Biron-Andreani, Christine; Schved, Jean-Francois] CHU Montpellier, Hematol Lab, F-34295 Montpellier, France; [Pernod, Gilles] CHU Grenoble, Serv Med Vasc, F-38043 Grenoble, France; [Galan, Pilar] INSERM, UMR S U872, F-75270 Paris, France; [Zelenika, Diana; Heath, Simon; Lathrop, Mark] Ctr Natl Genotypage, Commissariat Energie Atom, Inst Genom, F-91057 Evry, France; [Delluc, Aurelien] Univ Brest, EA3878, INSERM, IFR 148, F-29609 Brest, France; [Muenzel, Thomas; Zeller, Tanja; Blankenberg, Stefan] Johannes Gutenberg Univ Mainz, Med Klin & Poliklin, Univ Med, D-55131 Mainz, Germany; [Delluc, Aurelien] Brest Univ Hosp, Dept Internal Med & Chest Dis, F-29609 Brest, France; [Brocheton, Jessy; Durand, Herve; Drouet, Ludovic; Germain, Marine; Nicaud, Viviane; Ninio, Ewa; Tiret, Laurence; Cambien, Francois; Tregouet, David-Alexandre] Univ Paris 06, F-75013 Paris, France; [Galan, Pilar] Fac Med Rene Descartes, Dept Sante Publ & Informat Med, F-75270 Paris, France; [Brand-Herrmann, Stefan-Martin] Univ Munster, Leibniz Inst Arteriosclerosis Res, Dept Mol Genet Cardiovasc Dis, D-48149 Munster, Germany; [Emmerich, Joseph] Univ Paris 05, INSERM, U765, Med Vasc HTA,Hop Europeen Georges Pompidou, F-75908 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; Johannes Gutenberg University of Mainz; CHU Brest; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; University of Munster; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Morange, PE (corresponding author), Univ Mediterranee, INSERM, UMR S 626, F-13385 Marseille, France.	pierre.morange@ap-hm.fr	Heath, Simon C/J-4138-2012; Munzel, Thomas/A-2912-2014; Tregouet, David-Alexandre/E-3961-2016; Pilar, Galan/F-2908-2017; Cambien, Francois/AAP-9751-2020; DROUET, ludovic/GYR-3249-2022; Rosendaal, Frits/Q-3842-2017; Morange, Pierre/T-9070-2019; ALESSI, Marie-christine/AAK-3582-2020; Trégouët, David-Alexandre/P-9210-2019; Stefanadis, Christodoulos/ABH-2232-2020	Heath, Simon C/0000-0002-9550-0897; Munzel, Thomas/0000-0001-5503-4150; Pilar, Galan/0000-0003-1706-3107; Rosendaal, Frits/0000-0003-2558-7496; Morange, Pierre/0000-0002-9065-722X; ALESSI, Marie-christine/0000-0003-3927-5792; Trégouët, David-Alexandre/0000-0001-9084-7800; Schved, Jean-Francois/0000-0003-0332-3254; Zeller, Tanja/0000-0003-3379-2641; Durand, Herve/0000-0002-8167-4693; Stefanadis, Christodoulos/0000-0001-5974-6454; Germain, Marine/0000-0002-8489-8916	Fondation pour la Recherche Medicale; Program Hospitalier de Recherche Clinique; Fondation de France; Leducq Foundation; Program Hospitalier de la Recherche Clinique; Agence Nationale pour la Recherche [ANR-07-MRAR-021]; EU [FP6-2005-LIFE-SCIHEALTH-6, FP7-ICT-2007-2, 224635]; Virtual Pathological Heart of the Virtual Physiological Human (VPH2); government of Rheinland-Pfalz [AZ 961-386261/733]; Johnnes Guten-berg-University of Mainz; Boehringer Ingelheim; PHILIPS Medical Systems; Gutenberg Heart Study; Federal Ministry of Education and Research, Germany [A3 01GS0833]	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Program Hospitalier de Recherche Clinique; Fondation de France(Fondation de France); Leducq Foundation(Leducq Foundation); Program Hospitalier de la Recherche Clinique; Agence Nationale pour la Recherche(French National Research Agency (ANR)); EU(European Commission); Virtual Pathological Heart of the Virtual Physiological Human (VPH2); government of Rheinland-Pfalz; Johnnes Guten-berg-University of Mainz; Boehringer Ingelheim(Boehringer Ingelheim); PHILIPS Medical Systems; Gutenberg Heart Study; Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF))	All participants provided written informed consent, and the protocol was approved by the ethics committee of each participating institution. The FARIVE study was supported by grants from the Fondation pour la Recherche Medicale, the Program Hospitalier de Recherche Clinique, the Fondation de France, and the Leducq Foundation. The MARTHA study was supported by a grant from the Program Hospitalier de la Recherche Clinique. M.G. is supported by a grant funded by the Agence Nationale pour la Recherche (project ANR-07-MRAR-021). SM.B.-H. is supported by a grant from the EU-Project Network of Excellence, FP6-2005-LIFE-SCIHEALTH-6, Integrating Genomics, Clinical Research and Care in Hypertension, InGenious HyperCare proposal no. 037093 to Information and Communication Technologies (ICT), FP7-ICT-2007-2, project number 224635, Virtual Pathological Heart of the Virtual Physiological Human (VPH2). The Gutenberg Heart Study is funded through the government of Rheinland-Pfalz ("Stiftung Rheinland Pfalz fur Innovation," contract no. AZ 961-386261/733), the research programs "Wissen schafft Zukunft" and "Schwerpunkt Vaskulare Pravention" of the Johnnes Guten-berg-University of Mainz, and its contract with Boehringer Ingelheim and PHILIPS Medical Systems, including an unrestricted grant for the Gutenberg Heart Study. Specifically, the research reported in this article was supported by the National Genome Network "NGFNplus" (contract project no. A3 01GS0833) by the Federal Ministry of Education and Research, Germany.	Antoniades C, 2009, J AM COLL CARDIOL, V54, P669, DOI 10.1016/j.jacc.2009.03.076; BALDWIN AS, 1990, MOL CELL BIOL, V10, P1406, DOI 10.1128/MCB.10.4.1406; Blom JW, 2005, JAMA-J AM MED ASSOC, V293, P715, DOI 10.1001/jama.293.6.715; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Esmon CT, 2003, J THROMB HAEMOST, V1, P1343, DOI 10.1046/j.1538-7836.2003.00261.x; FAN CM, 1990, GENE DEV, V4, P29, DOI 10.1101/gad.4.1.29; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; MAJERUS PW, 1994, NATURE, V369, P14, DOI 10.1038/369014a0; Malaver E, 2009, J THROMB HAEMOST, V7, P1333, DOI 10.1111/j.1538-7836.2009.03492.x; Morange PE, 2010, BRIT J HAEMATOL, V148, P495, DOI 10.1111/j.1365-2141.2009.07975.x; Prandoni P, 2003, NEW ENGL J MED, V348, P1435, DOI 10.1056/NEJMoa022157; Ridker PM, 2008, J PERIODONTOL, V79, P1544, DOI 10.1902/jop.2008.080249; Simoncini S, 2009, CIRC RES, V104, P943, DOI 10.1161/CIRCRESAHA.108.183285; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Tregouet DA, 2009, BLOOD, V113, P5298, DOI 10.1182/blood-2008-11-190389	15	54	56	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 9	2010	86	4					592	595		10.1016/j.ajhg.2010.02.011	http://dx.doi.org/10.1016/j.ajhg.2010.02.011			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	583YP	20226436	Green Published, Bronze			2022-12-18	WOS:000276716800009
J	Huang, L; Wang, CL; Rosenberg, NA				Huang, Lucy; Wang, Chaolong; Rosenberg, Noah A.			The Relationship between Imputation Error and Statistical Power in Genetic Association Studies in Diverse Populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; WORLDWIDE HUMAN-POPULATIONS; HAPLOTYPE-PHASE INFERENCE; LINKAGE DISEQUILIBRIUM; GENOTYPE-IMPUTATION; SUSCEPTIBILITY LOCI; MISSING GENOTYPES; METAANALYSIS; ACCURACY; DISEASE	Genotype-imputation methods provide an essential technique for high-resolution genome-wide association (GWA) studies with millions of single-nucleotide polymorphisms. For optimal design and interpretation of imputation-based GWA studies, it is important to understand the connection between imputation error and power to detect associations at imputed markers. Here, using a 2 x 3 chi-square test, we describe a relationship between genotype-imputation error rates and the sample-size inflation required for achieving statistical power at an imputed marker equal to that obtained if genotypes at the marker were known with certainty. Surprisingly, typical imputation error rates (similar to 2%-6%) lead to a large increase in the required sample size (similar to 10%-60%), and in some African populations whose genotypes are particularly difficult to impute, the required sample-size increase is as high as similar to 30%-150%. In most populations, each 1% increase in imputation error leads to an increase of similar to 5%-13% in the sample size required for maintaining power. These results imply that in GWA sample-size calculations investigators will need to account for a potentially considerable loss of power from even low levels of imputation error and that development of additional genomic resources that decrease imputation error will translate into substantial reduction in the sample sizes needed for imputation-based detection of the variants that underlie complex human diseases.	[Huang, Lucy; Wang, Chaolong; Rosenberg, Noah A.] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Rosenberg, Noah A.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Rosenberg, Noah A.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Rosenberg, NA (corresponding author), Univ Michigan, Ctr Computat Med & Bioinformat, 2017 Palmer Commons,100 Washtenaw Ave, Ann Arbor, MI 48109 USA.	rnoah@umich.edu		Rosenberg, Noah/0000-0002-1829-8664; Wang, Chaolong/0000-0003-3945-1012	National Institutes of Health [R01 GM081441, R01 HL090564]; Burroughs Wellcome Fund; Alfred P. Sloan Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Alfred P. Sloan Research(Alfred P. Sloan Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Boehnke, Y. Li, and two reviewers for helpful comments. This work was supported by National Institutes of Health grants R01 GM081441 and R01 HL090564, by a Burroughs Wellcome Fund Career Award in the Biomedical Sciences, and by an Alfred P. Sloan Research Fellowship.	Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Becker T, 2009, HUM HERED, V68, P23, DOI 10.1159/000210446; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Browning SR, 2008, HUM GENET, V124, P439, DOI 10.1007/s00439-008-0568-7; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Cooper RS, 2008, HUM MOL GENET, V17, pR151, DOI 10.1093/hmg/ddn263; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Gordon D, 2002, HUM HERED, V54, P22, DOI 10.1159/000066696; Guan YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000279; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang L, 2009, AM J HUM GENET, V84, P235, DOI 10.1016/j.ajhg.2009.01.013; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kang SJ, 2004, GENET EPIDEMIOL, V26, P132, DOI 10.1002/gepi.10301; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Nicolae DL, 2006, GENET EPIDEMIOL, V30, P718, DOI 10.1002/gepi.20182; Nothnagel M, 2009, HUM GENET, V125, P163, DOI 10.1007/s00439-008-0606-5; Pei YF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003551; Pemberton TJ, 2008, ANN HUM GENET, V72, P535, DOI 10.1111/j.1469-1809.2008.00457.x; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Yu ZX, 2007, HUM GENET, V122, P495, DOI 10.1007/s00439-007-0427-y; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhao ZM, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-85	28	54	57	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 13	2009	85	5					692	698		10.1016/j.ajhg.2009.09.017	http://dx.doi.org/10.1016/j.ajhg.2009.09.017			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	521JH	19853241	Green Published, Bronze			2022-12-18	WOS:000271916500015
J	Rosser, ZH; Balaresque, P; Jobling, MA				Rosser, Zoe H.; Balaresque, Patricia; Jobling, Mark A.			Gene Conversion between the X Chromosome and the Male-Specific Region of the Y Chromosome at a Translocation Hotspot	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEIN-KINASE GENE; HOT-SPOTS; SEQUENCE; INTERCHANGE; INSTABILITY; MUTATION; TREE	Outside the pseudoautosomal regions, the mammalian sex chromosomes are thought to have been genetically isolated for up to 350 million years. However, in humans pathogenic XY translocations occur in XY-homologous (gametologous) regions, causing sex-reversal and infertility. Gene conversion might accompany recombination intermediates that resolve without translocation and persist in the population. We resequenced X and Y copies of a translocation hotspot adjacent to the PRKX and PRKY genes and found evidence of historical exchange between the male-specific region of the human Y and the X in patchy flanking gene-conversion tracts on both chromosomes. The rate of X-to-Y conversion (per base per generation) is four to five orders of magnitude more rapid than the rate of Y-chromosomal base-substitution mutation, and given assumptions about the recombination history of the X locus, tract lengths have an overall average length of -100 bp. Sequence exchange outside the pseudoautosomal regions could play a role in protecting the Y-linked copies of gametologous genes from degeneration.	[Rosser, Zoe H.; Balaresque, Patricia; Jobling, Mark A.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England	University of Leicester	Jobling, MA (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.	maj4@le.ac.uk	BALARESQUE, Patricia/G-3731-2010	BALARESQUE, Patricia/0000-0003-3516-5537; Jobling, Mark/0000-0002-8061-1308	Wellcome Trust [057559]	Wellcome Trust(Wellcome TrustEuropean Commission)	We thank Raymond Dalgleish for assistance and Celia May for helpful comments. Z.H.R. and P.B. were supported by the Wellcome Trust, and M.A.J. was supported by a Wellcome Trust Senior Fellowship in Basic Biomedical Science (grant no. 057559).	Adams SM, 2006, FORENSIC SCI INT, V159, P14, DOI 10.1016/j.forsciint.2005.06.003; BALLABIO A, 1989, ANN HUM GENET, V53, P9, DOI 10.1111/j.1469-1809.1989.tb01117.x; Bosch E, 2004, GENOME RES, V14, P835, DOI 10.1101/gr.2177404; Ellis N, 2002, GENOME RES, V12, P339; FERGUSON-SMITH M A, 1965, J Med Genet, V2, P142, DOI 10.1136/jmg.2.2.142; Garcia-Moreno J, 2000, MOL BIOL EVOL, V17, P1826, DOI 10.1093/oxfordjournals.molbev.a026283; Graves JAM, 2006, CELL, V124, P901, DOI 10.1016/j.cell.2006.02.024; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jobling MA, 1998, CURR BIOL, V8, P1391, DOI 10.1016/S0960-9822(98)00020-7; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; KLINK A, 1995, HUM MOL GENET, V4, P869, DOI 10.1093/hmg/4.5.869; LAHN BT, 1994, NAT GENET, V8, P243, DOI 10.1038/ng1194-243; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Ohno S., 1967, SEX CHROMOSOMES SEX; Repping S, 2006, NAT GENET, V38, P463, DOI 10.1038/ng1754; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; Schiebel K, 1997, HUM MOL GENET, V6, P1985, DOI 10.1093/hmg/6.11.1985; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Slattery JP, 2000, P NATL ACAD SCI USA, V97, P5307, DOI 10.1073/pnas.97.10.5307; WEIL D, 1994, NAT GENET, V7, P414, DOI 10.1038/ng0794-414; Wolf A, 2009, HUM MUTAT, V30, P239, DOI 10.1002/humu.20850	22	54	57	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 10	2009	85	1					130	134		10.1016/j.ajhg.2009.06.009	http://dx.doi.org/10.1016/j.ajhg.2009.06.009			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	470RO	19576564	Green Published, Bronze			2022-12-18	WOS:000267997600015
J	Schrauwen, I; Ealy, M; Huentelman, MJ; Thys, M; Homer, N; Vanderstraeten, K; Fransen, E; Corneveaux, JJ; Craig, DW; Claustres, M; Cremers, CWRJ; Dhooge, I; de Heyning, PV; Vincent, R; Offeciers, E; Smith, RJH; Van Camp, G				Schrauwen, Isabelle; Ealy, Megan; Huentelman, Matthew J.; Thys, Melissa; Homer, Nils; Vanderstraeten, Kathleen; Fransen, Erik; Corneveaux, Jason J.; Craig, David W.; Claustres, Mireille; Cremers, Cor W. R. J.; Dhooge, Ingeborg; de Heyning, Paul Van; Vincent, Robert; Offeciers, Erwin; Smith, Richard J. H.; Van Camp, Guy			A Genome-wide Analysis Identifies Genetic Variants in the RELN Gene Associated with Otosclerosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEARING-LOSS; EXTRACELLULAR-MATRIX; BRAIN-DEVELOPMENT; MOTOR PROTEIN; REELIN; LOCUS; MAPS; EXPRESSION; REPLICATION; SURVIVAL	Otosclerosis is a common form of progressive hearing loss, characterized by abnormal bone remodeling in the otic capsule. The etiology of the disease is largely unknown, and both environmental and genetic factors have been implicated. To identify genetic factors involved in otosclerosis, we used a case-control discovery group to complete a genome-wide association (GWA) study with 555,000 single-nucleotide polymorphisms (SNPs), utilizing pooled DNA samples. By individual genotyping of the top 250 SNPs in a stepwise strategy, we were able to identify two highly associated SNPs that replicated in two additional independent populations. We then genotyped 79 tagSNPs to fine map the two genomic regions defined by the associated SNPs. The region with the strongest association signal, P-combined 6.23 x 10(-10), is on chromosome 7q22.1 and spans intron 1 to intron 4 of reelin (RELN), a gene known for its role in neuronal migration. Evidence for allelic heterogeneity was found in this region. Consistent with the GWA data, expression of RELN was confirmed in the inner ear and in stapes footplate specimens. In conclusion, we provide evidence that implicates RELN in the pathogenesis of otosclerosis.	[Ealy, Megan; Smith, Richard J. H.] Univ Iowa, Dept Otolaryngol, Mol Otolaryngol Res Labs, Iowa City, IA 52242 USA; [Schrauwen, Isabelle; Thys, Melissa; Vanderstraeten, Kathleen; Fransen, Erik; Van Camp, Guy] Univ Antwerp, Dept Med Genet, B-2610 Antwerp, Belgium; [Huentelman, Matthew J.; Homer, Nils; Corneveaux, Jason J.; Craig, David W.] Translat Genom Res Inst TGen, Neurogen Div, Phoenix, AZ 85004 USA; [Homer, Nils] Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90095 USA; [Claustres, Mireille] IURC, Genet Mol Lab, CHU, F-34000 Montpellier, France; [Claustres, Mireille] Univ Montpellier 1, Fac Med, F-34000 Montpellier, France; [Cremers, Cor W. R. J.] Radboud Univ Nijmegen Med Ctr, Dept Otorhinolaryngol, Donders Ctr Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands; [Dhooge, Ingeborg] Ghent Univ Hosp, Dept Otorhinolaryngol, B-9000 Ghent, Belgium; [de Heyning, Paul Van] Univ Antwerp Hosp, Dept ORL, B-2650 Edegem, Belgium; [Vincent, Robert] Jean Causse Ear Clin, F-34440 Traverse De Bezierrs, Colombiers, France; [Offeciers, Erwin] St Augustinus Hosp Antwerp, Univ Dept Otolaryngol, B-2610 Antwerp, Belgium	University of Iowa; University of Antwerp; Translational Genomics Research Institute; University of California System; University of California Los Angeles; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; Radboud University Nijmegen; Ghent University; Ghent University Hospital; University of Antwerp	Smith, RJH (corresponding author), Univ Iowa, Dept Otolaryngol, Mol Otolaryngol Res Labs, 200 Hawkins Dr, Iowa City, IA 52242 USA.	richard-smith@uiowa.edu	Heyning, Paul H Vande/I-8278-2017; Van Camp, Guy/F-3386-2013; Schrauwen, Isabelle/H-5908-2019; Dhooge, Ingeborg/ABB-7221-2021; Craig, David Wesley/K-6961-2019; Fransen, Erik/C-4102-2015; Cremers, C.W.R.J./L-4254-2015	Heyning, Paul H Vande/0000-0002-8424-3717; Van Camp, Guy/0000-0001-5105-9000; Schrauwen, Isabelle/0000-0001-7310-6082; Dhooge, Ingeborg/0000-0002-5915-1079; Craig, David Wesley/0000-0003-2040-1955; Fransen, Erik/0000-0001-7785-4790; Smith, Richard/0000-0003-1201-6731	European Commission [LSHG-CT200S4-512063]; FWO [G.0138.07]; University of Antwerp; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008629] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); FWO(FWO); University of Antwerp; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank A.M. Goffinet for his helpful insights about the RELN pathway and Szabi Szelinger for technical assistance. I.S. is a fellow of the "Fonds voor Wetenschappelijk Onderzoek Vlaanderen" (FWO). M.T. is a fellow of the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen). This study was supported by grants from the European Commission (FP6 integrated project EuroHear LSHG-CT200S4-512063), the FWO (grant. G.0138.07), and the University of Antwerp (TOP grant).	Ali IBH, 2008, HUM GENET, V123, P267, DOI 10.1007/s00439-008-0470-3; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Brownstein Z, 2006, ARCH OTOLARYNGOL, V132, P416, DOI 10.1001/archotol.132.4.416; Chen W, 2007, CLIN GENET, V71, P406, DOI 10.1111/j.1399-0004.2007.00794.x; Chen W, 2002, J MED GENET, V39, P473, DOI 10.1136/jmg.39.7.473; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Clarke GM, 2007, AM J HUM GENET, V81, P995, DOI 10.1086/521952; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Dalton DS, 2003, GERONTOLOGIST, V43, P661, DOI 10.1093/geront/43.5.661; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; de Rouvroit CL, 1999, EXP NEUROL, V156, P214, DOI 10.1006/exnr.1998.7007; Declau F, 2001, OTOL NEUROTOL, V22, P596, DOI 10.1097/00129492-200109000-00006; FOWLER EP, 1966, ARCHIV OTOLARYNGOL, V83, P324; Guild S., 1944, ANN OTO RHINOL LARYN, V53, P246; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Ikeda Y, 1997, DEV DYNAM, V210, P157, DOI 10.1002/(SICI)1097-0177(199710)210:2<157::AID-AJA8>3.0.CO;2-F; Imauchi Y, 2008, OTOL NEUROTOL, V29, P295; Jamesdaniel S, 2008, J PROTEOME RES, V7, P3516, DOI 10.1021/pr8002479; Kathiresan S, 2004, EUR HEART J, V25, P1378, DOI 10.1016/j.ehj.2004.06.035; Liu XZ, 2003, HUM MOL GENET, V12, P1155, DOI 10.1093/hmg/ddg127; Macgregor S, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1060; Moskvina V, 2005, ANN HUM GENET, V69, P566, DOI 10.1111/j.1529-8817.2005.00175.x; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Nyholt DR, 2001, HUM GENET, V109, P564, DOI 10.1007/s00439-001-0611-4; Ohkubo N, 2007, J NEUROCHEM, V103, P820, DOI 10.1111/j.1471-4159.2007.04804.x; Pearson JV, 2007, AM J HUM GENET, V80, P126, DOI 10.1086/510686; Quattrocchi CC, 2002, J BIOL CHEM, V277, P303, DOI 10.1074/jbc.M106996200; RAMSAY HAW, 1994, AM J OTOL, V15, P536; ROBERTSON NG, 1994, GENOMICS, V23, P42, DOI 10.1006/geno.1994.1457; Schiffmann SN, 1997, EUR J NEUROSCI, V9, P1055, DOI 10.1111/j.1460-9568.1997.tb01456.x; Schrauwen I, 2008, J BONE MINER RES, V23, P507, DOI 10.1359/JBMR.071112; SCHUKNECHT HF, 1974, LARYNGOSCOPE, V84, P766, DOI 10.1288/00005537-197405000-00008; Thys M, 2007, HUM MOL GENET, V16, P2021, DOI 10.1093/hmg/ddm150; Thys M, 2007, EUR J HUM GENET, V15, P362, DOI 10.1038/sj.ejhg.5201761; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Tomek MS, 1998, HUM MOL GENET, V7, P285, DOI 10.1093/hmg/7.2.285; TOYNBEE J, 1861, MED CHIR T, V24, P190; Van Den Bogaert K, 2004, J MED GENET, V41, P450, DOI 10.1136/jmg.2004.018671; Van den Bogaert K, 2001, AM J HUM GENET, V68, P495, DOI 10.1086/318185; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; [No title captured]	43	54	55	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 13	2009	84	3					328	338		10.1016/j.ajhg.2009.01.023	http://dx.doi.org/10.1016/j.ajhg.2009.01.023			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	420QL	19230858	Green Published, Bronze			2022-12-18	WOS:000264304200004
J	Schorderet, DF; Nichini, O; Boisset, G; Polok, B; Tiab, L; Mayeur, H; Raji, B; de la Houssaye, G; Abitbol, MM; Munier, FL				Schorderet, Daniel F.; Nichini, Olivia; Boisset, Gaeelle; Polok, Bozena; Tiab, Leila; Mayeur, Helene; Raji, Bahija; de la Houssaye, Gauillaume; Abitbol, Marc M.; Munier, Francis L.			Mutation in the human homeobox gene NKX5-3 causes an oculo-auricular syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NERVOUS-SYSTEM; SENSORY ORGANS; NEURAL RETINA; INNER-EAR; EXPRESSION; FAMILY; MECHANISMS; EYE; HMX	Several dysmorphic syndromes affect the development of both the eye and the ear, but only a few are restricted to the eye and the external ear. We describe a developmental defect affecting the eye and the external ear in three members of a consanguineous family. This syndrome is characterized by ophthalmic anomalies (microcornea, microphthalmia, anterior-segment dysgenesis, cataract, coloboma of various parts of the eye, abnormalities of the retinal pigment epithelium, and rod-cone dystrophy) and a particular cleft ear lobule. Linkage analysis and mutation screening revealed in the first exon of the NKX5-3 gene a homozygous 26 nucleotide deletion, generating a truncating protein that lacked the complete homeodomain. Morpholino knockdown expression of the zebrafish nkx5-3 induced microphthalmia and disorganization of the developing retina, thus confirming that this gene represents an additional member implicated in axial patterning of the retina.	[Schorderet, Daniel F.; Nichini, Olivia; Boisset, Gaeelle; Polok, Bozena; Tiab, Leila] Inst Rech Ophtalmol, CH-1950 Sion, Switzerland; [Schorderet, Daniel F.; Nichini, Olivia; Boisset, Gaeelle; Munier, Francis L.] Univ Lausanne, Dept Ophthalmol, CH-1000 Lausanne, Switzerland; [Schorderet, Daniel F.] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland; [Mayeur, Helene; Raji, Bahija; de la Houssaye, Gauillaume; Abitbol, Marc M.] Fac Med, CERTO EA 2502 Minist Rech, F-75015 Paris, France; [Munier, Francis L.] Jules Gonin Eye Hosp, CH-1004 Lausanne, Switzerland	University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Schorderet, DF (corresponding author), Inst Rech Ophtalmol, CH-1950 Sion, Switzerland.	daniel.schorderet@irovision.ch						Adamska M, 2001, DEV GENES EVOL, V211, P338, DOI 10.1007/s004270100162; DEITCHER DL, 1994, J NEUROSCI, V14, P486; FRANCESCHETTI A, 1945, CONFIN NEUROL, V6, P255; Hever AM, 2006, CLIN GENET, V69, P459, DOI 10.1111/j.1399-0004.2006.00619.x; Huberman AD, 2005, NAT NEUROSCI, V8, P1013, DOI 10.1038/nn1505; Lupo G, 2006, NAT REV NEUROSCI, V7, P103, DOI 10.1038/nrn1843; Peters MA, 2002, CURR OPIN NEUROBIOL, V12, P43, DOI 10.1016/S0959-4388(02)00288-X; Picker A, 2005, DEVELOPMENT, V132, P4951, DOI 10.1242/dev.02071; Represa J, 2000, ACTA OTO-LARYNGOL, V120, P5; Schulte D, 2000, DEVELOPMENT, V127, P5033; STADLER HS, 1992, P NATL ACAD SCI USA, V89, P11579, DOI 10.1073/pnas.89.23.11579; STADLER HS, 1995, MAMM GENOME, V6, P383, DOI 10.1007/BF00355637; Takahashi H, 2003, DEVELOPMENT, V130, P5203, DOI 10.1242/dev.00724; Wang WD, 2005, EXP CELL RES, V306, P373, DOI 10.1016/j.yexcr.2005.03.016; Wang WD, 2001, DEVELOPMENT, V128, P5017; Wang WD, 2000, MECH DEVELOP, V99, P123, DOI 10.1016/S0925-4773(00)00488-3; Yoshiura K, 1998, GENOMICS, V50, P61, DOI 10.1006/geno.1998.5284	17	54	61	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2008	82	5					1178	1184		10.1016/j.ajhg.2008.03.007	http://dx.doi.org/10.1016/j.ajhg.2008.03.007			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	301VJ	18423520	Bronze, Green Published			2022-12-18	WOS:000255923600018
J	O'Driscoll, M; Dobyns, WB; van Hagen, JM; Jeggo, PA				O'Driscoll, Mark; Dobyns, William B.; van Hagen, Johanna M.; Jeggo, Penny A.			Cellular and clinical impact of haploinsufficiency for genes involved in ATR signaling	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							REPLICATION-FACTOR-C; DEPENDENT PHOSPHORYLATION EVENTS; DNA-DAMAGE-RESPONSE; STRAND BREAK REPAIR; S-PHASE CHECKPOINT; WILLIAMS-SYNDROME; SACCHAROMYCES-CEREVISIAE; INVERSUS SYNDROME; SECKEL-SYNDROME; DIEKER-SYNDROME	Ataxia telangiectasia and Rad3-related (ATR) protein, a kinase that regulates a DNA damage-response pathway, is mutated in ATR-Seckel syndrome (ATR-SS), a disorder characterized by severe microcephaly and growth delay. Impaired ATR signaling is also observed in cell lines from additional disorders characterized by microcephaly and growth delay, including non-ATR-SS, Nijmegen breakage syndrome, and MCPH1 (microcephaly, primary autosomal recessive, 1)-dependent primary microcephaly. Here, we examined ATR-pathway function in cell lines from three haploinsufficient contiguous gene-deletion disorders-a subset of blepharophimosis-ptosis-epicanthus inversus syndrome, Miller-Dieker lissencephaly syndrome, and Williams-Beuren syndrome-in which the deleted region encompasses ATR, RPA1, and RFC2, respectively. These three genes function in ATR signaling. Cell lines from these disorders displayed an impaired ATR-dependent DNA damage response. Thus, we describe ATR signaling as a pathway unusually sensitive to haploinsufficiency and identify three further human disorders displaying a defective ATR-dependent DNA damage response. The striking correlation of ATR-pathway dysfunction with the presence of microcephaly and growth delay strongly suggests a causal relationship.	Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9QG, E Sussex, England; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, NL-1081 HV Amsterdam, Netherlands	University of Sussex; University of Chicago; Vrije Universiteit Amsterdam	O'Driscoll, M (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9QG, E Sussex, England.	m.o-driscoll@sussex.ac.uk	Dobyns, William/AAI-2768-2020; Dobyns, William Brian/ABC-6525-2021	Dobyns, William/0000-0002-7681-2844; O'Driscoll, Mark/0000-0003-2765-316X	MRC [G0300428] Funding Source: UKRI; Medical Research Council [G0300428] Funding Source: Medline; Medical Research Council [G0300662B] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431; Alderton GK, 2004, HUM MOL GENET, V13, P3127, DOI 10.1093/hmg/ddh335; Amenta S, 2004, CANCER GENET CYTOGEN, V154, P86, DOI 10.1016/j.cancergencyto.2004.02.004; Bakhshi S, 2003, J PEDIAT HEMATOL ONC, V25, P248, DOI 10.1097/00043426-200303000-00013; Cardoso C, 2003, AM J HUM GENET, V72, P918, DOI 10.1086/374320; Cardoso C, 2002, HUM MUTAT, V19, P4, DOI 10.1002/humu.10028; CARR AM, 1995, CURR BIOL, V5, P1179, DOI 10.1016/S0960-9822(95)00234-X; Chen YH, 2004, DNA REPAIR, V3, P1025, DOI 10.1016/j.dnarep.2004.03.003; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Cox J, 2006, TRENDS MOL MED, V12, P358, DOI 10.1016/j.molmed.2006.06.006; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; De Baere E, 2001, HUM MOL GENET, V10, P1591, DOI 10.1093/hmg/10.15.1591; de Ru MH, 2005, AM J MED GENET A, V137A, P81, DOI 10.1002/ajmg.a.30786; Dierov J, 2004, CANCER CELL, V5, P275, DOI 10.1016/S1535-6108(04)00056-X; Ellison V, 2003, PLOS BIOL, V1, P231, DOI 10.1371/journal.pbio.0000033; Fang Y, 2004, EMBO J, V23, P3164, DOI 10.1038/sj.emboj.7600315; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Girard PM, 2002, ONCOGENE, V21, P4191, DOI 10.1038/sj.onc.1205596; Johnson A, 2006, J BIOL CHEM, V281, P35531, DOI 10.1074/jbc.M606090200; Kim HS, 2001, MOL CELL BIOL, V21, P3725, DOI 10.1128/MCB.21.11.3725-3737.2001; Leventer RJ, 2001, TRENDS NEUROSCI, V24, P489, DOI 10.1016/S0166-2236(00)01887-7; Lewis KA, 2005, CANCER RES, V65, P7091, DOI 10.1158/0008-5472.CAN-05-1019; Liu A, 2005, LAB INVEST, V85, P436, DOI 10.1038/labinvest.3700235; Liu QH, 2000, GENE DEV, V14, P1448; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Noskov VN, 1998, MOL CELL BIOL, V18, P4914, DOI 10.1128/MCB.18.8.4914; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; O'Driscoll M, 2003, CELL CYCLE, V2, P194, DOI 10.4161/cc.2.3.404; Page GP, 2003, AM J HUM GENET, V73, P711, DOI 10.1086/378900; Petermann E, 2006, CELL CYCLE, V5, P2203, DOI 10.4161/cc.5.19.3256; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rogers PB, 2000, RADIOTHER ONCOL, V57, P143, DOI 10.1016/S0167-8140(00)00249-8; SECKEL HPG, 1960, BIRD HEADED DWARDS S; SEMMEKROT BA, 1986, PEDIATR NEUROSCI, V12, P188, DOI 10.1159/000120245; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; Sheen VL, 2006, ANN NEUROL, V60, P137, DOI 10.1002/ana.20843; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; SHIZUYO U, 2006, ACTA PAEDIATR, V95, P113; Stiff T, 2005, EMBO J, V24, P199, DOI 10.1038/sj.emboj.7600504; Tassabehji M, 1997, HUM MOL GENET, V6, P1029, DOI 10.1093/hmg/6.7.1029; Tassabehji M, 2003, HUM MOL GENET, V12, pR229, DOI 10.1093/hmg/ddg299; Thornburg CD, 2005, J PEDIAT HEMATOL ONC, V27, P109, DOI 10.1097/01.mph.0000153444.43816.ea; Toyo-oka K, 2003, NAT GENET, V34, P274, DOI 10.1038/ng1169; Wang YX, 2005, NAT GENET, V37, P750, DOI 10.1038/ng1587; Wu YQ, 1998, AM J MED GENET, V78, P82, DOI 10.1002/(SICI)1096-8628(19980616)78:1<82::AID-AJMG17>3.0.CO;2-K; Yao NY, 2006, J BIOL CHEM, V281, P17528, DOI 10.1074/jbc.M601273200; Yingling J, 2003, AM J HUM GENET, V73, P475, DOI 10.1086/378096; Zachos G, 2003, EMBO J, V22, P713, DOI 10.1093/emboj/cdg060; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	53	54	55	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2007	81	1					77	86		10.1086/518696	http://dx.doi.org/10.1086/518696			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	175UO	17564965	Green Published, Bronze, Green Accepted			2022-12-18	WOS:000247039700007
J	Wijsman, EM; Rothstein, JH; Thompson, EA				Wijsman, Ellen M.; Rothstein, Joseph H.; Thompson, Elizabeth A.			Multipoint linkage analysis with many multiallelic or dense diallelic markers: Markov chain-Monte Carlo provides practical approaches for genome scans on general pedigrees	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; GENETIC-ANALYSIS; LOCUS; SCREEN; MAPS; SEGREGATION; LIKELIHOOD; TRAITS; FISHER; SCORES	Computations for genome scans need to adapt to the increasing use of dense diallelic markers as well as of full-chromosome multipoint linkage analysis with either diallelic or multiallelic markers. Whereas suitable exact-computation tools are available for use with small pedigrees, equivalent exact computation for larger pedigrees remains infeasible. Markov chain-Monte Carlo (MCMC)-based methods currently provide the only computationally practical option. To date, no systematic comparison of the performance of MCMC-based programs is available, nor have these programs been systematically evaluated for use with dense diallelic markers. Using simulated data, we evaluate the performance of two MCMC-based linkage-analysis programs-1m_markers from the MORGAN package and SimWalk2-under a variety of analysis conditions. Pedigrees consisted of 14, 52, or 98 individuals in 3, 5, or 6 generations, respectively, with increasing amounts of missing data in larger pedigrees. One hundred replicates of markers and trait data were simulated on a 100cM chromosome, with up to 10 multiallelic and up to 200 diallelic markers used simultaneously for computation of multipoint LOD scores. Exact computation was available for comparison in most situations, and comparison with a perfectly informative marker or interprogram comparison was available in the remaining situations. Our results confirm the accuracy of both programs in multipoint analysis with multiallelic markers on pedigrees of varied sizes and missing-data patterns, but there are some computational differences. In contrast, for large numbers of dense diallelic markers, only the 1m_markers program was able to provide accurate results within a computationally practical time. Thus, programs in the MORGAN package are the first available to provide a computationally practical option for accurate linkage analyses in genome scans with both large numbers of diallelic markers and large pedigrees.	Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Univ Washington, Dept Stat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Wijsman, EM (corresponding author), Univ Washington, Dept Med, Div Med Genet, Box 357720, Seattle, WA 98195 USA.	wijsman@u.washington.edu		Wijsman, Ellen/0000-0002-2725-6669	NHLBI NIH HHS [T32 HL007183, HL07183] Funding Source: Medline; NIA NIH HHS [P50 AG005136, AG05136] Funding Source: Medline; NICHD NIH HHS [HD34565] Funding Source: Medline; NIGMS NIH HHS [GM46255, R37 GM046255, R01 GM046255] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM046255, R01GM046255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005136] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Baird PN, 2005, HUM GENET, V117, P249, DOI 10.1007/s00439-005-1296-x; BOEHNKE M, 1994, AM J HUM GENET, V55, P379; Cader MZ, 2005, NEUROLOGY, V65, P156, DOI 10.1212/01.wnl.0000167186.05465.7c; de Andrade M, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S112; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Gagnon F, 2005, HUM GENET, V117, P494, DOI 10.1007/s00439-005-1338-4; Gao GM, 2004, GENETICS, V167, P2055, DOI 10.1534/genetics.103.021055; George AW, 2005, HUM HERED, V59, P98, DOI 10.1159/000085224; George AW, 2003, STAT SCI, V18, P515, DOI 10.1214/ss/1081443233; George AW, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S71; George AW, 2001, AM J HUM GENET, V69, P411; Heath SC, 1997, GENET EPIDEMIOL, V14, P1011, DOI 10.1002/(SICI)1098-2272(1997)14:6<1011::AID-GEPI75>3.3.CO;2-E; Heath SC, 1997, AM J HUM GENET, V61, P748, DOI 10.1086/515506; Hwu WL, 2005, J MED GENET, V42, P152, DOI 10.1136/jmg.2004.018564; Igo RP, 2006, AM J MED GENET B, V141B, P15, DOI 10.1002/ajmg.b.30245; KONG A, 1993, GENET EPIDEMIOL, V10, P483, DOI 10.1002/gepi.1370100626; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LANGE K, 1991, AM J HUM GENET, V49, P1320; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; Li J, 2005, J COMPUT BIOL, V12, P719, DOI 10.1089/cmb.2005.12.719; Matise TC, 2003, AM J HUM GENET, V73, P271, DOI 10.1086/377137; Matsuzaki H, 2004, GENOME RES, V14, P414, DOI 10.1101/gr.2014904; MORTON NE, 1955, AM J HUM GENET, V7, P277; Mukhopadhyay N, 2005, BIOINFORMATICS, V21, P2556, DOI 10.1093/bioinformatics/bti364; Murray SS, 2004, NAT METHODS, V1, P113, DOI 10.1038/NMETH712; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Orlacchio A, 2005, ANN NEUROL, V58, P423, DOI 10.1002/ana.20590; Qian DJ, 2002, AM J HUM GENET, V70, P1434, DOI 10.1086/340610; Schaid DJ, 2004, AM J HUM GENET, V75, P948, DOI 10.1086/425870; Service S, 2006, AM J MED GENET B, V141B, P367, DOI 10.1002/ajmg.b.30323; Sieh W, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S11; Sobel E, 2001, HUM HERED, V52, P121, DOI 10.1159/000053366; Sobel E, 1996, AM J HUM GENET, V58, P1323; Suarez BK, 2006, AM J HUM GENET, V78, P315, DOI 10.1086/500272; Thomas A, 2000, STAT COMPUT, V10, P259, DOI 10.1023/A:1008947712763; Thompson EA, 1996, ANN STAT, V24, P449; THOMPSON EA, 1994, STAT SCI, V9, P355, DOI 10.1214/ss/1177010381; THOMPSON EA, 1993, GENET EPIDEMIOL, V10, P677, DOI 10.1002/gepi.1370100658; Thompson EA, 2000, INT STAT REV, V68, P53, DOI 10.1111/j.1751-5823.2000.tb00387.x; THOMPSON EA, 1999, STAT MOL BIOL GENETI, P93; THOMPSON EA, 2003, HDB STAT GENETICS, P893; THOMPSON EA, 1999, IMS LECT NOTE MONOGR, V33, P95; Thompson EA, 2005, LECT NOTES SER INST, V7, P183; Webb EL, 2005, BIOINFORMATICS, V21, P3060, DOI 10.1093/bioinformatics/bti449; Wijsman EM, 1997, GENET EPIDEMIOL, V14, P719, DOI 10.1002/(SICI)1098-2272(1997)14:6<719::AID-GEPI28>3.0.CO;2-S; WIJSMAN EM, 1987, AM J HUM GENET, V41, P356; Wijsman EM, 2003, GENET EPIDEMIOL, V25, pS64, DOI 10.1002/gepi.10286; Wijsman EM, 2004, AM J HUM GENET, V75, P398, DOI 10.1086/423393; Wilcox MA, 2005, GENET EPIDEMIOL, V29, pS7, DOI 10.1002/gepi.20106; Yang XH, 2005, INT J CANCER, V116, P487, DOI 10.1002/ijc.21006	51	54	55	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2006	79	5					846	858		10.1086/508472	http://dx.doi.org/10.1086/508472			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	100KJ	17033961	Green Published, Bronze			2022-12-18	WOS:000241667400006
J	Anttila, V; Kallela, M; Oswell, G; Kaunisto, MA; Nyholt, DR; Hamalainen, E; Havanka, H; Ilmavirta, M; Terwilliger, J; Sobel, E; Peltonen, L; Kaprio, J; Farkkila, M; Wessman, M; Palotie, A				Anttila, V.; Kallela, M.; Oswell, G.; Kaunisto, M. A.; Nyholt, D. R.; Hamalainen, E.; Havanka, H.; Ilmavirta, M.; Terwilliger, J.; Sobel, E.; Peltonen, L.; Kaprio, J.; Farkkila, M.; Wessman, M.; Palotie, A.			Trait components provide tools to dissect the genetic susceptibility of migraine	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL HEMIPLEGIC MIGRAINE; GENOME-WIDE SCAN; SIGNIFICANT LINKAGE; COMBINED HYPERLIPIDEMIA; LATENT CLASS; LOD SCORES; AURA; LOCUS; PHENOTYPES; SCHIZOPHRENIA	The commonly used "end diagnosis" phenotype that is adopted in linkage and association studies of complex traits is likely to represent an oversimplified model of the genetic background of a disease. This is also likely to be the case for common types of migraine, for which no convincingly associated genetic variants have been reported. In headache disorders, most genetic studies have used end diagnoses of the International Headache Society ( IHS) classification as phenotypes. Here, we introduce an alternative strategy; we use trait components-individual clinical symptoms of migraine-to determine affection status in genomewide linkage analyses of migraine-affected families. We identified linkage between several traits and markers on chromosome 4q24 ( highest LOD score under locus heterogeneity [ HLOD] 4.52), a locus we previously reported to be linked to the end diagnosis migraine with aura. The pulsation trait identified a novel locus on 17p13 ( HLOD 4.65). Additionally, a trait combination phenotype ( IHS full criteria) revealed a locus on 18q12 ( HLOD 3.29), and the age at onset trait revealed a locus on 4q28 ( HLOD 2.99). Furthermore, suggestive or nearly suggestive evidence of linkage to four additional loci was observed with the traits phonophobia ( 10q22) and aggravation by physical exercise ( 12q21, 15q14, and Xp21), and, interestingly, these loci have been linked to migraine in previous studies. Our findings suggest that the use of symptom components of migraine instead of the end diagnosis provides a useful tool in stratifying the sample for genetic studies.	Finnish Genome Ctr, Helsinki, Finland; Biomedicum, Res Program Mol Med, Helsinki, Finland; Univ Helsinki, Dept Clin Chem, Helsinki, Finland; Univ Helsinki, Dept Med Genet, Helsinki, Finland; Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki, Finland; Natl Publ Hlth Inst, Dept Human Mol Genet, Helsinki, Finland; Natl Publ Hlth Inst, Dept Mental Hlth & Alcohol Res, Helsinki, Finland; Folkhalsan Res Ctr, Helsinki, Finland; Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA USA; Queensland Inst Med Res, Genet Epidemiol Lab, Brisbane, Qld 4006, Australia; Lansi Pohja Cent Hosp, Dept Neurol, Kemi, Finland; Cent Hosp Cent Finland, Dept Neurol, Jyvaskyla, Finland; Columbia Univ, Dept Psychiat, New York, NY USA; Columbia Univ, Columbia Genome Ctr, New York, NY USA; MIT, Broad Inst, Cambridge, MA USA; Harvard Univ, Cambridge, MA USA	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; Folkhalsan Research Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; QIMR Berghofer Medical Research Institute; Central Finland Central Hospital; Columbia University; Columbia University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Palotie, A (corresponding author), Finnish Genome Ctr, Haartmaninkatu 8, Helsinki, Finland.	aarno.palotie@helsinki.fi	Kaprio, Jaakko/A-1820-2008; Nyholt, Dale Robert/J-3174-2017	Kaprio, Jaakko/0000-0002-3716-2455; Nyholt, Dale Robert/0000-0001-7159-3040; Kaunisto, Mari/0000-0002-6946-9195; Palotie, Aarno/0000-0002-2527-5874; Sobel, Eric/0000-0002-1718-0031	NINDS NIH HHS [R01 NS037675] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alarcon M, 2002, AM J HUM GENET, V70, P60, DOI 10.1086/338241; Ashina M, 2000, NEUROLOGY, V55, P1335, DOI 10.1212/WNL.55.9.1335; Bjornsson A, 2003, AM J HUM GENET, V73, P986, DOI 10.1086/378417; BLAU J, 1995, CEPHALALGIA, V15, P186, DOI 10.1046/j.1468-2982.1995.015003186.x; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Bouzigon E, 2004, HUM MOL GENET, V13, P3103, DOI 10.1093/hmg/ddh340; Cader ZM, 2003, HUM MOL GENET, V12, P2511, DOI 10.1093/hmg/ddg252; Carlsson A, 2002, NEUROLOGY, V59, P1804, DOI 10.1212/01.WNL.0000036617.04943.96; Cheverud JM, 2001, HEREDITY, V87, P52, DOI 10.1046/j.1365-2540.2001.00901.x; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; Dichgans M, 2005, LANCET, V366, P371, DOI 10.1016/S0140-6736(05)66786-4; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Egan MF, 2003, METH MOLEC MED, V77, P163; Gervil M, 1999, ANN NEUROL, V46, P606, DOI 10.1002/1531-8249(199910)46:4<606::AID-ANA8>3.0.CO;2-O; Goring HHH, 2000, AM J HUM GENET, V66, P1298, DOI 10.1086/302846; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Hamet P, 2005, AM J HUM GENET, V76, P815, DOI 10.1086/430133; HONKASALO ML, 1995, HEADACHE, V35, P70, DOI 10.1111/j.1526-4610.1995.hed3502070.x; HOVATTA I, 1994, GENOMICS, V23, P707, DOI 10.1006/geno.1994.1563; Kallela M, 2001, EUR J NEUROL, V8, P61, DOI 10.1046/j.1468-1331.2001.00165.x; KIDD KK, 1984, CYTOGENET CELL GENET, V37, P510; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Laitinen T, 2001, NAT GENET, V28, P87, DOI 10.1038/88319; LARSSON B, 1995, HEADACHE, V35, P513, DOI 10.1111/j.1526-4610.1995.hed3509513.x; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Lea RA, 2005, NEUROGENETICS, V6, P67, DOI 10.1007/s10048-005-0215-6; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Nyholt DR, 2000, HUM GENET, V107, P18; Nyholt DR, 2005, AM J HUM GENET, V77, P500, DOI 10.1086/444510; Nyholt DR, 2004, GENET EPIDEMIOL, V26, P231, DOI 10.1002/gepi.10311; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; OTT J, 1983, ANN HUM GENET, V47, P311, DOI 10.1111/j.1469-1809.1983.tb01001.x; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Owen MJ, 2005, TRENDS GENET, V21, P518, DOI 10.1016/j.tig.2005.06.011; Pajukanta P, 1998, NAT GENET, V18, P369, DOI 10.1038/ng0498-369; Paunio T, 2004, HUM MOL GENET, V13, P1693, DOI 10.1093/hmg/ddh184; RINDSKOPF D, 1986, STAT MED, V5, P21, DOI 10.1002/sim.4780050105; RUSSELL MB, 1995, INT J EPIDEMIOL, V24, P612, DOI 10.1093/ije/24.3.612; Russell MB, 2002, HEADACHE, V42, P332, DOI 10.1046/j.1526-4610.2002.02102.x; Russell MB, 1996, CEPHALALGIA, V16, P305, DOI 10.1046/j.1468-2982.1996.1605305.x; Russo L, 2005, AM J HUM GENET, V76, P327, DOI 10.1086/427521; Shoulders CC, 2004, HUM MOL GENET, V13, pR149, DOI 10.1093/hmg/ddh069; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Sobel E, 1996, AM J HUM GENET, V58, P1323; Soragna D, 2003, AM J HUM GENET, V72, P161, DOI 10.1086/345298; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; Ulrich V, 1999, ANN NEUROL, V45, P242, DOI 10.1002/1531-8249(199902)45:2<242::AID-ANA15>3.0.CO;2-1; Wessman M, 2002, AM J HUM GENET, V70, P652, DOI 10.1086/339078	50	54	55	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2006	79	1					85	99		10.1086/504814	http://dx.doi.org/10.1086/504814			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	053YD	16773568	Green Published, Bronze			2022-12-18	WOS:000238341200009
J	Tartaglia, M; Cordeddu, V; Chang, H; Shaw, A; Kalidas, K; Crosby, A; Patton, MA; Sorcini, M; van der Burgt, I; Jeffery, S; Gelb, BD				Tartaglia, M; Cordeddu, V; Chang, H; Shaw, A; Kalidas, K; Crosby, A; Patton, MA; Sorcini, M; van der Burgt, I; Jeffery, S; Gelb, BD			Paternal germline origin and sex-ratio distortion in transmission of PTPN11 mutations in Noonan syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOTYPE-PHENOTYPE CORRELATION; PROTEIN-TYROSINE-PHOSPHATASE; GROWTH-FACTOR RECEPTOR-3; PARENTAL ORIGIN; TURNER-PHENOTYPE; FGFR2 MUTATIONS; APERT-SYNDROME; HUMAN SPERM; GENE; AGE	Germline mutations in PTPN11-the gene encoding the nonreceptor protein tyrosine phosphatase SHP-2-represent a major cause of Noonan syndrome (NS), a developmental disorder characterized by short stature and facial dysmorphism, as well as skeletal, hematologic, and congenital heart defects. Like many autosomal dominant disorders, a significant percentage of NS cases appear to arise from de novo mutations. Here, we investigated the parental origin of de novo PTPN11 lesions and explored the effect of paternal age in NS. By analyzing intronic portions that flank the exonic PTPN11 lesions in 49 sporadic NS cases, we traced the parental origin of mutations in 14 families. Our results showed that all mutations were inherited from the father, despite the fact that no substitution affected a CpG dinucleotide. We also report that advanced paternal age was observed among cohorts of sporadic NS cases with and without PTPN11 mutations and that a significant sex-ratio bias favoring transmission to males was present in subjects with sporadic NS caused by PTPN11 mutations, as well as in families inheriting the disorder.	Ist Super Sanita, Dipartimento Biol Cellulare & Neurosci, I-00161 Rome, Italy; Mt Sinai Sch Med, Dept Pediat, New York, NY USA; Mt Sinai Sch Med, Dept Human Genet, New York, NY USA; Tufts Univ New England Med Ctr, Div Clin Care Res, Hlth Inst, Boston, MA USA; Univ London St Georges Hosp, Sch Med, Div Med Genet, London SW17 0RE, England; Univ Hosp Maastricht, Dept Med Genet, Maastricht, Netherlands	Istituto Superiore di Sanita (ISS); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Tufts Medical Center; St Georges University London; Maastricht University; Maastricht University Medical Centre (MUMC)	Tartaglia, M (corresponding author), Ist Super Sanita, Dipartimento Biol Cellulare & Neurosci, Viale Regina Elena 299, I-00161 Rome, Italy.	mtartaglia@iss.it	Tartaglia, Marco/K-2955-2018; cordeddu, viviana/A-5612-2016; cordeddu, viviana/J-2272-2014; Crosby, Andrew H/E-2218-2015	Tartaglia, Marco/0000-0001-7736-9672; cordeddu, viviana/0000-0001-7159-7383; Crosby, Andrew H/0000-0003-3667-9054	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K24HD001294] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071207] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL071207, HL71207] Funding Source: Medline; NICHD NIH HHS [HD01294, K24 HD001294] Funding Source: Medline; Telethon [GGP04172] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Telethon(Fondazione Telethon)		ALLANSON JE, 1987, J MED GENET, V24, P9, DOI 10.1136/jmg.24.1.9; BELLUS GA, 1995, NAT GENET, V10, P357, DOI 10.1038/ng0795-357; Bohossian HB, 2000, NATURE, V406, P622, DOI 10.1038/35020557; CARLSON KM, 1994, AM J HUM GENET, V55, P1076; Digilio MC, 2002, AM J HUM GENET, V71, P389, DOI 10.1086/341528; Dryja TP, 1997, HUM GENET, V100, P446, DOI 10.1007/s004390050531; ELSAWI MM, 1994, J MED GENET, V31, P468, DOI 10.1136/jmg.31.6.468; Fragale A, 2004, HUM MUTAT, V23, P267, DOI 10.1002/humu.20005; Glaser RL, 2000, AM J HUM GENET, V66, P768, DOI 10.1086/302831; Glaser RL, 2003, AM J HUM GENET, V73, P939, DOI 10.1086/378419; GLASER RL, 2004, SCI AGING KNOWLEDGE, V3, P1; Goriely A, 2003, SCIENCE, V301, P643, DOI 10.1126/science.1085710; JADAYEL D, 1990, NATURE, V343, P558, DOI 10.1038/343558a0; JAMIESON CR, 1994, NAT GENET, V8, P357, DOI 10.1038/ng1294-357; Ketterling RP, 1999, HUM GENET, V105, P629, DOI 10.1007/s004390051155; Kluwe L, 2000, NEUROGENETICS, V3, P17, DOI 10.1007/s100480000088; Kondoh T, 2003, EUR J PEDIATR, V162, P548, DOI 10.1007/s00431-003-1227-6; Kosaki K, 2002, J CLIN ENDOCR METAB, V87, P3529, DOI 10.1210/jc.87.8.3529; Legius E, 2002, J MED GENET, V39, P571, DOI 10.1136/jmg.39.8.571; Loh ML, 2004, BLOOD, V103, P2325, DOI 10.1182/blood-2003-09-3287; Maheshwari M, 2002, HUM MUTAT, V20, P298, DOI 10.1002/humu.10129; Moloney DM, 1996, NAT GENET, V13, P48, DOI 10.1038/ng0596-48; Musante L, 2003, EUR J HUM GENET, V11, P201, DOI 10.1038/sj.ejhg.5200935; NAKAHORI Y, 1991, AM J MED GENET, V39, P472, DOI 10.1002/ajmg.1320390420; NOONAN JA, 1968, AM J DIS CHILD, V116, P373, DOI 10.1001/archpedi.1968.02100020377005; NORA JJ, 1974, AM J DIS CHILD, V127, P48, DOI 10.1001/archpedi.1974.02110200050007; PENROSE LS, 1955, LANCET, V2, P312; RICHARDS FM, 1995, HUM MOL GENET, V4, P2139, DOI 10.1093/hmg/4.11.2139; RISCH N, 1987, AM J HUM GENET, V41, P218; SAPIENZA C, 1994, AM J HUM GENET, V55, P1073; Schollen E, 2003, EUR J HUM GENET, V11, P85, DOI 10.1038/sj.ejhg.5200915; Schuffenecker I, 1997, AM J HUM GENET, V60, P233; Singh NP, 2003, FERTIL STERIL, V80, P1420, DOI 10.1016/j.fertnstert.2003.04.002; Splendore A, 2003, EUR J HUM GENET, V11, P718, DOI 10.1038/sj.ejhg.5201029; Tartaglia M, 2004, BLOOD, V104, P307, DOI 10.1182/blood-2003-11-3876; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tartaglia M, 2002, AM J HUM GENET, V70, P1555, DOI 10.1086/340847; Tiemann-Boege I, 2002, P NATL ACAD SCI USA, V99, P14952, DOI 10.1073/pnas.232568699; Trappe R, 2001, AM J HUM GENET, V68, P1093, DOI 10.1086/320109; Weinberg W., 1912, ARCH RASSEN U GESEL, V9, P710; Wilkin DJ, 1998, AM J HUM GENET, V63, P711, DOI 10.1086/302000; Zenker M, 2004, J PEDIATR-US, V144, P368, DOI 10.1016/j.jpeds.2003.11.032; ZHU XP, 1989, NATURE, V340, P312, DOI 10.1038/340312a0	44	54	58	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2004	75	3					492	497		10.1086/423493	http://dx.doi.org/10.1086/423493			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	845VA	15248152	Bronze, Green Published			2022-12-18	WOS:000223272200013
J	Shrimpton, AE; Levinsohn, EM; Yozawitz, JM; Packard, DS; Cady, RB; Middleton, FA; Persico, AM; Hootnick, DR				Shrimpton, AE; Levinsohn, EM; Yozawitz, JM; Packard, DS; Cady, RB; Middleton, FA; Persico, AM; Hootnick, DR			A HOX gene mutation in a family with isolated congenital vertical talus and Charcot-Marie-Tooth disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA; HOMEODOMAIN; RECOGNITION; PROTEINS	Congenital vertical talus (CVT), also known as "rocker-bottom foot" deformity, is a dislocation of the talonavicular joint, with rigid dorsal dislocation of the navicular over the neck of the talus. This condition is usually associated with multiple other congenital deformities and only rarely is an isolated deformity. The reported familial cases are consistent with an autosomal dominant mode of inheritance with incomplete penetrance. In contrast, Charcot-Marie-Tooth disease (CMT) is thought to be a completely distinct heterogeneous group of disorders, with foot abnormalities that typically develop a high-arched "claw foot" appearance later in life. In the present study, DNA was isolated from 36 members of a single upstate (northern) New York white family of Italian descent in which both CVT and CMT were segregating. Whole-genome linkage analysis with Affymetrix GeneChip Mapping 10K Array defined a 7-Mb critical region on chromosome 2q31, which led to candidate-gene sequencing of six HOX genes and detection of a single missense mutation, M319K (956T-->A), in the HOXD10 gene. In the study family, this mutation was fully penetrant and exhibited significant evidence of linkage (LOD 6.33; theta = 0), and it very likely accounts for both CVT and CMT in heterozygotes.	SUNY, Upstate Med Univ, Dept Clin Pathol, Syracuse, NY USA; SUNY, Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY USA; SUNY, Upstate Med Univ, Dept Pediat, Syracuse, NY USA; SUNY, Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY USA; SUNY, Upstate Med Univ, Dept Orthoped Surg, Syracuse, NY USA; Crouse Hosp, Dept Med Imaging, Syracuse, NY USA; Univ Campus Biomed, Lab Mol Psychiat & Neurogenet, Rome, Italy	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; SUNY Maritime College; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; SUNY Maritime College; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; SUNY Maritime College; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; SUNY Maritime College; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; SUNY Maritime College; University Campus Bio-Medico - Rome Italy	Shrimpton, AE (corresponding author), 750 E Adams St, Syracuse, NY 13210 USA.	shrimpta@upstate.edu	Persico, Antonio/AAB-9504-2022	Middleton, Frank/0000-0002-3107-7188; Persico, Antonio/0000-0001-8910-4479				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; ADES SE, 1994, BIOCHEMISTRY-US, V33, P9187, DOI 10.1021/bi00197a022; Dobbs Matthew B, 2002, Iowa Orthop J, V22, P25; Duboule D, 2002, NATURE, V418, P492, DOI 10.1038/418492a; EKKER SC, 1994, EMBO J, V13, P3551, DOI 10.1002/j.1460-2075.1994.tb06662.x; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; Goodman FR, 2002, AM J HUM GENET, V70, P547, DOI 10.1086/338921; Goodman FR, 2002, AM J MED GENET, V112, P256, DOI 10.1002/ajmg.10776; Goodman FR, 2001, CLIN GENET, V59, P1, DOI 10.1034/j.1399-0004.2001.590101.x; HAMANISHI C, 1984, J PEDIATR ORTHOPED, V4, P318, DOI 10.1097/01241398-198405000-00007; HANES SD, 1991, SCIENCE, V251, P426, DOI 10.1126/science.1671176; Innis Jeffrey W, 2002, Hum Mutat, V19, P573; Kennedy GC, 2003, NAT BIOTECHNOL, V21, P1233, DOI 10.1038/nbt869; Kmita M, 2002, NATURE, V420, P145, DOI 10.1038/nature01189; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Mortlock DP, 1997, NAT GENET, V15, P179, DOI 10.1038/ng0297-179; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; Nelson CE, 1996, DEVELOPMENT, V122, P1449; OGATA K, 1979, CLIN ORTHOP RELAT R, P128; Pareyson D, 1999, MUSCLE NERVE, V22, P1498, DOI 10.1002/(SICI)1097-4598(199911)22:11<1498::AID-MUS4>3.0.CO;2-9; ROBBINS H, 1991, DISORDERS FOOT ANKLE, P848; STERN HJ, 1989, CLIN GENET, V36, P427	22	54	55	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2004	75	1					92	96		10.1086/422015	http://dx.doi.org/10.1086/422015			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	829FG	15146389	Green Published, Bronze			2022-12-18	WOS:000222031300011
J	Lenski, C; Abidi, F; Meindl, A; Gibson, A; Platzer, M; Kooy, RF; Lubs, HA; Stevenson, RE; Ramser, J; Schwartz, CE				Lenski, C; Abidi, F; Meindl, A; Gibson, A; Platzer, M; Kooy, RF; Lubs, HA; Stevenson, RE; Ramser, J; Schwartz, CE			Novel truncating mutations in the polyglutamine tract binding protein 1 gene (PQBP1) cause Renpenning syndrome and X-linked mental retardation in another family with microcephaly	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							MARTIN-BELL		Univ Munich, Dept Med Genet, Munich, Germany; Greenwood Genet Ctr, JC Self Res Inst, Greenwood, SC 29646 USA; Royal Univ Hosp, Saskatoon, SK S7N 0W8, Canada; Inst Mol Biotechnol, Jena, Germany; Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium; Univ Miami, Sch Med, Mailman Ctr Child Dev, Miami, FL USA	University of Munich; Greenwood Genetic Center; University of Saskatchewan; University of Antwerp; University of Miami	Schwartz, CE (corresponding author), Univ Munich, Dept Med Genet, Munich, Germany.	schwartz@ggc.org	Kooy, Frank/F-5276-2014	Kooy, Frank/0000-0003-2024-0485	NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH057840] Funding Source: NIH RePORTER; NICHD NIH HHS [HD26208] Funding Source: Medline; NIMH NIH HHS [R24 MH057840, MH57840] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Allan W, 1944, AM J MENT DEF, V48, P325; ARCHIDIACONO N, 1987, Journal de Genetique Humaine, V35, P381; BICKERS DS, 1949, BRAIN, V72, P246, DOI 10.1093/brain/72.2.246; GERRARD JW, 1974, LANCET, V1, P1346, DOI 10.1016/S0140-6736(74)90714-4; HOWARDPEEBLES PN, 1979, AM J HUM GENET, V31, P214; JENNINGS M, 1980, AM J MED GENET, V7, P417, DOI 10.1002/ajmg.1320070404; Kalscheuer VM, 2003, NAT GENET, V35, P313, DOI 10.1038/ng1264; LOSOWSKY MS, 1961, J MENT DEFIC RES, V5, P60, DOI 10.1111/jir.1961.5.1.60; Martin JP, 1943, J NEUROL PSYCHIATRY, V6, P154, DOI 10.1136/jnnp.6.3-4.154; MCLARTY JW, 1980, J OCCUP ENVIRON MED, V22, P92, DOI 10.1097/00043764-198002000-00006; PROOPS R, 1981, J MED GENET, V18, P366, DOI 10.1136/jmg.18.5.366; RENPENNING H, 1962, CAN MED ASSOC J, V87, P954; RICHARDS BW, 1970, LANCET, V2, P520; STEELE MW, 1974, LANCET, V1, P752; Stevenson RE, 2000, AM J MED GENET, V97, P174, DOI 10.1002/1096-8628(200023)97:3<174::AID-AJMG1034>3.0.CO;2-4; Stevenson RE, 2003, AM J MED GENET A, V123A, P29, DOI 10.1002/ajmg.a.20492; Stevenson RE, 2002, CYTOGENET GENOME RES, V99, P265, DOI 10.1159/000071603; Stevenson RE, 1998, AM J HUM GENET, V62, P1092, DOI 10.1086/301835; Sudol M, 2001, FEBS LETT, V490, P190, DOI 10.1016/S0014-5793(01)02122-6; Waragai M, 1999, HUM MOL GENET, V8, P977, DOI 10.1093/hmg/8.6.977	20	54	55	0	5	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2004	74	4					777	780		10.1086/383205	http://dx.doi.org/10.1086/383205			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	804EA	15024694	Green Published, Bronze			2022-12-18	WOS:000220280800019
J	McGovern, DPB; van Heel, DA; Negoro, K; Ahmad, T; Jewell, DP				McGovern, DPB; van Heel, DA; Negoro, K; Ahmad, T; Jewell, DP			Further evidence of IBD5/CARD15 (NOD2) epistasis in the susceptibility to ulcerative colitis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							CROHNS-DISEASE; GENE; HAPLOTYPE; CARD15; LOCUS; IBD5; RISK; 5Q31		Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Oxford, Dept Gastroenterol, Oxford OX3 7BN, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford	McGovern, DPB (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.			van Heel, David/0000-0002-0637-2265				Armuzzi A, 2003, GUT, V52, P1133, DOI 10.1136/gut.52.8.1133; Bonen DK, 2003, GASTROENTEROLOGY, V124, P140, DOI 10.1053/gast.2003.50019; Giallourakis C, 2003, AM J HUM GENET, V73, P205, DOI 10.1086/376417; Mirza MM, 2003, AM J HUM GENET, V72, P1018, DOI 10.1086/373880; Negoro K, 2003, GUT, V52, P541, DOI 10.1136/gut.52.4.541; Rahman P, 2003, AM J HUM GENET, V73, P677, DOI 10.1086/378076; Sugimura K, 2003, AM J HUM GENET, V72, P509, DOI 10.1086/367848	7	54	55	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2003	73	6					1465	1466		10.1086/379745	http://dx.doi.org/10.1086/379745			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	756PW	14655097	Bronze, Green Published			2022-12-18	WOS:000187491100022
J	Feingold, E				Feingold, E			Regression-based quantitative-trait-locus mapping in the 21st century	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							HASEMAN-ELSTON; LINKAGE ANALYSIS; SIB-PAIR; POWER; QTL		Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Feingold, E (corresponding author), Univ Pittsburgh, Dept Human Genet, 130 DeSoto St A310, Pittsburgh, PA 15261 USA.	feingold@pitt.edu		Feingold, Eleanor/0000-0003-2898-6484	NHGRI NIH HHS [R01 HG002374, R01 HG 02374-01] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002374] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1994, AM J HUM GENET, V54, P535; Drigalenko E, 1998, AM J HUM GENET, V63, P1242; Elston RC, 2000, GENET EPIDEMIOL, V19, P1, DOI 10.1002/1098-2272(200007)19:1<1::AID-GEPI1>3.0.CO;2-E; Feingold E, 2001, THEOR POPUL BIOL, V60, P167, DOI 10.1006/tpbi.2001.1545; Forrest WF, 2001, HUM HERED, V52, P47, DOI 10.1159/000053353; GAINES RE, 1969, AM J HUM GENET, V21, P457; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Miller RG, 1986, ANOVA BASICS APPL ST; Palmer LJ, 2000, GENET EPIDEMIOL, V19, P456, DOI 10.1002/1098-2272(200012)19:4<456::AID-GEPI15>3.0.CO;2-N; Putter H, 2002, GENET EPIDEMIOL, V22, P345, DOI 10.1002/gepi.01104; Sham PC, 2002, AM J HUM GENET, V71, P238, DOI 10.1086/341560; Sham PC, 2001, AM J HUM GENET, V68, P1527, DOI 10.1086/320593; TANS HK, 2001, BIOSTATISTICS, V2, P147; Visscher PM, 2001, ANN HUM GENET, V65, P583, DOI [10.1046/j.1469-1809.2001.6560583.x, 10.1017/S0003480001008909]; Wang DL, 2001, AM J HUM GENET, V68, P1238, DOI 10.1086/320101; Wang K, 2002, AM J HUM GENET, V70, P412, DOI 10.1086/338659; Wright FA, 1997, AM J HUM GENET, V60, P740; Xu X, 2000, AM J HUM GENET, V67, P1025, DOI 10.1086/303081	20	54	55	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2002	71	2					217	222		10.1086/341964	http://dx.doi.org/10.1086/341964			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	575ZE	12154779	Green Published, Bronze			2022-12-18	WOS:000176977700001
J	Mayeux, R; Lee, JH; Romas, SN; Mayo, D; Santana, V; Williamson, J; Ciappa, A; Rondon, HZ; Estevez, P; Lantigua, R; Medrano, M; Torres, M; Stern, Y; Tycko, B; Knowles, JA				Mayeux, R; Lee, JH; Romas, SN; Mayo, D; Santana, V; Williamson, J; Ciappa, A; Rondon, HZ; Estevez, P; Lantigua, R; Medrano, M; Torres, M; Stern, Y; Tycko, B; Knowles, JA			Chromosome-12 mapping of late-onset Alzheimer disease among Caribbean Hispanics	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PARADIGM-BASED DIAGNOSIS; LINKAGE ANALYSIS; PROTEIN GENE; HETEROGENEOUS POPULATION; APOLIPOPROTEIN-E; POLYMORPHISM; ALPHA-2-MACROGLOBULIN; ASSOCIATION; DEMENTIA; LOCUS	Linkage to chromosome 12p for familial Alzheimer disease (AD) has been inconsistent. Using 35 markers near the centromere of chromosome 12, we investigated 79 Caribbean Hispanic families with AD. Two-point linkage analysis using affected sib pairs yielded LOD scores of 3.15 at D12S1623 and 1.43 at D12S1042. The LOD score at D12S1623 decreased to 1.62 in families with late-onset (age > 65 years) AD (LOAD), but the LOD score at D12S1042 was unchanged. Among families negative for the apolipoprotein E (APOE-epsilon4) allele, the LOD score for D12S1623 was lower (1.01), whereas that for D12S1042 increased to 1.73. Among families positive for the APOE-epsilon4 allele, none of the LOD scores reached 1. Multipoint affected-relative-pair analysis showed peaks at D12S1623 (nonparametric linkage [NPL] score 1.52; P = .028) and near D12S1042, at D12S1057 (NPL score 1.57; P = .027). NPL scores for both D12S1623 and D12S1057 increased in families affected with LOAD, but, in APOE-epsilon4-negative families, only scores for the region flanking D12S1623 remained elevated (NPL score 1.74; P = .013). This study of Caribbean Hispanics with familial AD extends and provides modest evidence of linkage to loci on chromosome 12p. Linkage varied by age at onset of AD and by the presence or absence of the APOE-epsilon4 allele.	Columbia Univ, Gertrude H Sergievsky Ctr, New York, NY 10032 USA; Columbia Univ, Taub Inst Alzheimers Dis & Aging Brain, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; Columbia Univ, Sch Publ Hlth, Div Epidemiol, New York, NY 10032 USA; Columbia Univ, Columbia Genome Ctr, New York, NY 10032 USA; Univ Tecnol Santiago, Santiago, Dominican Rep; Plaza Salud Hosp, Santo Domingo, Dominican Rep	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Mayeux, R (corresponding author), Columbia Univ, Gertrude H Sergievsky Ctr, 630 W 168th St, New York, NY 10032 USA.		medrano, martin/AAF-8221-2020; Lee, Joseph H/D-2441-2012; Mayeux, Richard/E-9788-2013	Lee, Joseph H/0000-0002-2000-4821; Mayeux, Richard/0000-0001-6519-9696; Stern, Yaakov/0000-0001-7542-3241	NATIONAL INSTITUTE ON AGING [RF1AG015473, R37AG015473, P50AG008702, P01AG007232, R01AG015473] Funding Source: NIH RePORTER; NIA NIH HHS [AG08702, AG15473, P01 AG007232, R37 AG015473, R01 AG015473, AG07232, P50 AG008702, RF1 AG015473] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baum L, 1998, NEUROSCI LETT, V256, P5, DOI 10.1016/S0304-3940(98)00734-4; Beffert U, 1999, NEUROSCI LETT, V259, P29, DOI 10.1016/S0304-3940(98)00888-X; Blacker D, 1998, NAT GENET, V19, P357, DOI 10.1038/1243; Clatworthy AE, 1997, ARCH NEUROL-CHICAGO, V54, P1289, DOI 10.1001/archneur.1997.00550220087019; Dodel RC, 2000, NEUROLOGY, V54, P438, DOI 10.1212/WNL.54.2.438; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Gibson AM, 2000, NEUROLOGY, V54, P433, DOI 10.1212/WNL.54.2.433; Goring HHH, 2000, AM J HUM GENET, V66, P1298, DOI 10.1086/302846; Goring HHH, 1997, EUR J HUM GENET, V5, P69, DOI 10.1159/000484736; Gurland BJ, 1999, INT J GERIATR PSYCH, V14, P481, DOI 10.1002/(SICI)1099-1166(199906)14:6<481::AID-GPS959>3.3.CO;2-X; HIXSON JE, 1990, J LIPID RES, V31, P545; Hollenbach E, 1998, NEUROLOGY, V50, P1905, DOI 10.1212/WNL.50.6.1905; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; KNAPP M, 1994, HUM HERED, V44, P44, DOI 10.1159/000154188; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Liao A, 1998, HUM MOL GENET, V7, P1953, DOI 10.1093/hmg/7.12.1953; MAESTRE G, 1995, ANN NEUROL, V37, P254, DOI 10.1002/ana.410370217; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; PericakVance MA, 1997, JAMA-J AM MED ASSOC, V278, P1237, DOI 10.1001/jama.278.15.1237; Perkins P, 1997, NEUROLOGY, V49, P44, DOI 10.1212/WNL.49.1.44; PITTMAN J, 1992, ARCH NEUROL-CHICAGO, V49, P461, DOI 10.1001/archneur.1992.00530290043010; RISCH N, 1992, HUM HERED, V42, P77, DOI 10.1159/000154047; Rogaeva E, 1998, JAMA-J AM MED ASSOC, V280, P614, DOI 10.1001/jama.280.7.614; Romas SN, 2000, NEUROSCI LETT, V279, P133, DOI 10.1016/S0304-3940(99)00972-6; Scott WK, 2000, AM J HUM GENET, V66, P922, DOI 10.1086/302828; Scott WK, 1999, JAMA-J AM MED ASSOC, V281, P513, DOI 10.1001/jama.281.6.513; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; STERN Y, 1992, ARCH NEUROL-CHICAGO, V49, P453, DOI 10.1001/archneur.1992.00530290035009; Tang MX, 2001, NEUROLOGY, V56, P49, DOI 10.1212/WNL.56.1.49; Wu WS, 1998, JAMA-J AM MED ASSOC, V280, P619, DOI 10.1001/jama.280.7.619; Zubenko GS, 1999, NEUROLOGY, V52, P725, DOI 10.1212/WNL.52.4.725	32	54	58	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2002	70	1					237	243		10.1086/324773	http://dx.doi.org/10.1086/324773			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	499LD	11715112	Green Published, Bronze			2022-12-18	WOS:000172571900021
J	Buiting, K; Barnicoat, A; Lich, C; Pembrey, M; Malcolm, S; Horsthemke, B				Buiting, K; Barnicoat, A; Lich, C; Pembrey, M; Malcolm, S; Horsthemke, B			Disruption of the bipartite imprinting center in a family with Angelman syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRADER-WILLI-SYNDROME; SNRPN GENE; REGION; HUMAN-CHROMOSOME-15; DELETIONS; 15Q11-Q13; MUTATION; DEFINE	Imprinting in 15q11-q13 is controlled by a bipartite imprinting center (IC), which maps to the SNURF-SNRPN locus. Deletions of the exon 1 region impair the establishment or maintenance of the paternal imprint and can cause Prader-Willi syndrome (PWS). Deletions of a region 35 kb upstream of exon 1 impair maternal imprinting and can cause Angelman syndrome (AS). So far, in all affected sibs with an imprinting defect, an inherited IC deletion was identified. We report on two sibs with AS who do not have an IC deletion but instead have a 1-1.5 Mb inversion separating the two IC elements. The inversion is transmitted silently through the male germline but impairs maternal imprinting after transmission through the female germline. Our findings suggest that the close proximity and/or the correct orientation of the two IC elements are/is necessary for the establishment of a maternal imprint.	Univ Klinikum Essen, Inst Human Genet, D-45122 Essen, Germany; Inst Child Hlth, Clin & Mol Genet Unit, London, England	University of Duisburg Essen; University of London; University College London	Buiting, K (corresponding author), Univ Klinikum Essen, Inst Human Genet, Hufelandstr 55, D-45122 Essen, Germany.							Buiting K, 2000, CLIN GENET, V58, P284, DOI 10.1034/j.1399-0004.2000.580406.x; Buiting K, 1998, AM J HUM GENET, V63, P170, DOI 10.1086/301935; Buiting K, 1999, HUM GENET, V105, P665, DOI 10.1007/s004390051160; Buiting K, 1998, CYTOGENET CELL GENET, V81, P247, DOI 10.1159/000015039; BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; Christian SL, 1999, HUM MOL GENET, V8, P1025, DOI 10.1093/hmg/8.6.1025; Dittrich B, 1996, NAT GENET, V14, P163, DOI 10.1038/ng1096-163; Farber C, 1999, HUM MOL GENET, V8, P337, DOI 10.1093/hmg/8.2.337; Gillessen-Kaesbach G, 1999, EUR J HUM GENET, V7, P638, DOI 10.1038/sj.ejhg.5200362; Ji YG, 1999, HUM MOL GENET, V8, P533, DOI 10.1093/hmg/8.3.533; Jong MTC, 1999, HUM MOL GENET, V8, P783, DOI 10.1093/hmg/8.5.783; Ohta T, 1999, AM J HUM GENET, V64, P397, DOI 10.1086/302233; Ohta T, 1999, AM J HUM GENET, V64, P385, DOI 10.1086/302232; Saitoh S, 1996, P NATL ACAD SCI USA, V93, P7811, DOI 10.1073/pnas.93.15.7811; Shemer R, 2000, NAT GENET, V26, P440, DOI 10.1038/82571; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52	16	54	54	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2001	68	5					1290	1294		10.1086/320120	http://dx.doi.org/10.1086/320120			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	423HZ	11283796	Green Published, Bronze			2022-12-18	WOS:000168171200023
J	Astuto, LM; Weston, MD; Carney, CA; Hoover, DM; Cremers, CWRJ; Wagenaar, M; Moller, C; Smith, RJH; Pieke-Dahl, S; Greenberg, J; Ramesar, R; Jacobson, SG; Ayuso, C; Heckenlively, JR; Tamayo, M; Gorin, MB; Reardon, W; Kimerling, WJ				Astuto, LM; Weston, MD; Carney, CA; Hoover, DM; Cremers, CWRJ; Wagenaar, M; Moller, C; Smith, RJH; Pieke-Dahl, S; Greenberg, J; Ramesar, R; Jacobson, SG; Ayuso, C; Heckenlively, JR; Tamayo, M; Gorin, MB; Reardon, W; Kimerling, WJ			Genetic heterogeneity of Usher syndrome: Analysis of 151 families with Usher type I	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MYOSIN VIIA GENE; LINKAGE ANALYSIS; CHROMOSOME 3Q; LOCALIZATION; MUTATIONS; MAPS; PREVALENCE; PIGMENTOSA; DEAFNESS; LOCUS	Usher syndrome type I is an autosomal recessive disorder marked by hearing loss, vestibular areflexia, and retinitis pigmentosa. Six Usher I genetic subtypes at loci USH1A-USH1F have been reported. The MYO7A gene is responsible for USH1B, the most common subtype. In our analysis, 151 families with Usher I were screened by linkage and mutation analysis. MYO7A mutations were identified in 64 families with Usher I. Of the remaining 87 families, who were negative for MYO7A mutations, 54 were informative for linkage analysis and were screened with the remaining USH1 loci markers. Results of linkage and heterogeneity analyses showed no evidence of Usher types Ia or Ie. However, one maximum LOD score was observed lying within the USH1D region. Two lesser peak LOD scores were observed outside and between the putative regions for USH1D and USH1F, on chromosome 10. A HOMOG chi (2)((1)) plot shows evidence of heterogeneity across the USH1D, USH1F, and intervening regions. These results provide conclusive evidence that the second-most-common subtype of Usher I is due to genes on chromosome 10, and they confirm the existence of one Usher I gene in the previously defined USH1D region, as well as providing evidence for a second, and possibly a third, gene in the 10p/q region.	Boys Town Natl Res Hosp, Ctr Hereditary Commun Disorders, Omaha, NE 68131 USA; Univ Nijmegen Hosp, Dept Otorhinolaryngol, NL-6500 HB Nijmegen, Netherlands; Sahlgrens Univ Hosp, Dept Audiol, S-41345 Gothenburg, Sweden; Univ Iowa, Dept Otolaryngol, Iowa City, IA USA; Univ Cape Town, Sch Med, Dept Human Genet, ZA-7925 Cape Town, South Africa; Scheie Eye Inst, Dept Ophthalmol, Philadelphia, PA USA; Fdn Jimenez Diaz, E-28040 Madrid, Spain; Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90024 USA; Univ Javeriana, Inst Genet Humana, Bogota, Colombia; Univ Pittsburgh, Dept Ophthalmol, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15260 USA; Univ London, Inst Child Hlth, London WC1E 7HU, England	Boys Town National Research Hospital; Radboud University Nijmegen; Sahlgrenska University Hospital; University of Iowa; University of Cape Town; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Pontificia Universidad Javeriana; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of London; University College London	Kimerling, WJ (corresponding author), Boys Town Natl Res Hosp, Ctr Hereditary Commun Disorders, 555 N 30th St, Omaha, NE 68131 USA.		Ramesar, Raj S/I-6941-2015; Cremers, C.W.R.J./L-4254-2015	Ramesar, Raj S/0000-0001-5688-1634; Tamayo, Martha Lucia/0000-0001-8297-3970; Jacobson, Samuel/0000-0003-2122-169X; Smith, Richard/0000-0003-1201-6731; Reardon, Willie/0000-0001-7329-9179; Ayuso, Carmen/0000-0002-9242-7065	NIDCD NIH HHS [P60 DC00982, R01 DC002842, R01 DC00677-07, P01 DC01813] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P01DC001813, R01DC000677, R01DC002842, P60DC000982] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BOUGHMAN JA, 1983, J CHRON DIS, V36, P595, DOI 10.1016/0021-9681(83)90147-9; Chaib H, 1997, HUM MOL GENET, V6, P27, DOI 10.1093/hmg/6.1.27; Espinos C, 1998, J MED GENET, V35, P391, DOI 10.1136/jmg.35.5.391; Gasparini P, 1998, J MED GENET, V35, P666, DOI 10.1136/jmg.35.8.666; GRONDAHL J, 1987, CLIN GENET, V31, P255; HALLGREN B, 1959, ACTA PSYCHIAT SCAND, V138, P1; Hmani M, 1999, EUR J HUM GENET, V7, P363, DOI 10.1038/sj.ejhg.5200307; KAPLAN J, 1992, GENOMICS, V14, P979, DOI 10.1016/S0888-7543(05)80120-X; Kimberling W J, 1995, J Am Acad Audiol, V6, P63; KIMBERLING WJ, 1992, GENOMICS, V14, P988, DOI 10.1016/S0888-7543(05)80121-1; KIMBERLING WJ, 1990, GENOMICS, V7, P245, DOI 10.1016/0888-7543(90)90546-7; LATHROP GM, 1985, AM J HUM GENET, V37, P482; Levy G, 1997, HUM MOL GENET, V6, P111, DOI 10.1093/hmg/6.1.111; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Liu XZ, 1998, AM J HUM GENET, V63, P909, DOI 10.1086/302026; Liu XZ, 1997, NAT GENET, V17, P268, DOI 10.1038/ng1197-268; NUUTILA A, 1970, J GENET HUM, V18, P57; Pieke-Dahl S, 2000, J MED GENET, V37, P256, DOI 10.1136/jmg.37.4.256; Rickard S, 2000, J MED GENET, V37, P623, DOI 10.1136/jmg.37.8.623; SANKILA EM, 1995, HUM MOL GENET, V4, P93, DOI 10.1093/hmg/4.1.93; SMITH RJH, 1992, GENOMICS, V14, P995, DOI 10.1016/S0888-7543(05)80122-3; SMITH RJH, 1994, AM J MED GENET, V50, P32, DOI 10.1002/ajmg.1320500107; VERNON M, 1969, J CHRON DIS, V22, P133, DOI 10.1016/0021-9681(69)90055-1; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Wayne S, 1996, HUM MOL GENET, V5, P1689, DOI 10.1093/hmg/5.10.1689; Wayne S, 1997, AM J HUM GENET, V61, pA300; Weston MD, 1996, AM J HUM GENET, V59, P1074	27	54	60	0	8	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2000	67	6					1569	1574		10.1086/316889	http://dx.doi.org/10.1086/316889			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	378WE	11060213	Green Published, Bronze			2022-12-18	WOS:000165607600021
J	Jiao, XD; Munier, FL; Iwata, F; Hayakawa, M; Kanai, A; Lee, J; Schorderet, DF; Chen, MS; Kaiser-Kupfer, M; Hejtmancik, JF				Jiao, XD; Munier, FL; Iwata, F; Hayakawa, M; Kanai, A; Lee, J; Schorderet, DF; Chen, MS; Kaiser-Kupfer, M; Hejtmancik, JF			Genetic linkage of Bietti crystallin corneoretinal dystrophy to chromosome 4q35	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								Bietti crystalline corneoretinal dystrophy (BCD) is an autosomal recessive retinal degeneration characterized by multiple glistening intraretinal dots scattered over the fundus, degeneration of the retina, and sclerosis of the choroidal vessels, ultimately resulting in progressive night blindness and constriction of the visual field. Although BCD has been associated with abnormalities in fatty-acid metabolism and absence of fatty-acid binding by two cytosolic proteins, the genetic basis of BCD is unknown. We report linkage of the BCD locus to D4S426 (maximum LOD score [Z(max)] 4.81; recombination fraction [theta] 0), D4S2688 (Z(max) = 3.97; theta = 0), and D4S2299 (Z(max) = 5.31; theta = 0), on chromosome 4q35-4qtel. Multipoint analysis confirmed linkage to the region telomeric of D4S1652 with a Z(max) of 5.3 located 4 cM telomeric of marker D4S2930.	NEI, OGCSB, NIH, Bethesda, MD 20892 USA; Juntendo Univ, Sch Med, Tokyo 113, Japan; Jules Gonin Eye Hosp, Oculogenet Unit, Lausanne, Switzerland; Div Med Genet, Lausanne, Switzerland; Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Juntendo University; National Taiwan University; National Taiwan University Hospital	Hejtmancik, JF (corresponding author), NEI, OGCSB, NIH, Bldg 10,Room 10B10,10 Ctr Dr,MSC 1860, Bethesda, MD 20892 USA.				NATIONAL EYE INSTITUTE [ZIAEY000272, Z01EY000272] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bietti G., 1937, KLIN MBL AUGENHEILK, V99, P737; HU DN, 1983, OPHTHALMIC PAED GEN, V2, P39, DOI 10.3109/13816818309007148; KAISERKUPFER MI, 1994, AM J OPHTHALMOL, V118, P569, DOI 10.1016/S0002-9394(14)76572-9; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Lee J, 1998, MOL GENET METAB, V65, P143, DOI 10.1006/mgme.1998.2723; LEE JG, IN PRESS INVEST OPHT; RICHARDS BW, 1991, OPHTHALMOLOGY, V98, P658; SMITH RJH, 1989, CYTOGENET CELL GENET, V50, P102, DOI 10.1159/000132733; WILSON DJ, 1989, ARCH OPHTHALMOL-CHIC, V107, P213, DOI 10.1001/archopht.1989.01070010219026	9	54	60	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2000	67	5					1309	1313						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	369WW	11001583				2022-12-18	WOS:000165091600027
J	Vaidya, B; Imrie, H; Perros, P; Young, ET; Kelly, WF; Carr, D; Large, DM; Toft, AD; Kendall-Taylor, P; Pearce, SHS				Vaidya, B; Imrie, H; Perros, P; Young, ET; Kelly, WF; Carr, D; Large, DM; Toft, AD; Kendall-Taylor, P; Pearce, SHS			Evidence for a new Graves disease susceptibility locus at chromosome 18q21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEPENDENT DIABETES-MELLITUS; AUTOIMMUNE THYROID-DISEASE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; LINKAGE ANALYSIS; CANDIDATE GENES; CTLA-4 GENE; TYPE-1; FAMILIES; GENOME; TRANSMISSION	Graves disease (GD) is a common autoimmune thyroid disorder that is inherited as a complex multigenic trait. By using a single microsatellite marker at each locus, we screened the type 1 diabetes loci IDDM4 IDDM5, IDDM6, IDDM8, and IDDM10 and the fucosyltransferase-2 locus for linkage in sib pairs with GD. This showed a two-point nonparametric linkage (NPL) score of 1.57 (P = .06) at the IDDM6 marker D18S41, but NPL scores were <1.0 at the other five loci. Thus, the investigation of the IDDM6 locus was extended by genotyping 11 microsatellite markers spanning 48 cM across chromosome 18q12-q22 in 81 sib pairs affected with autoimmune thyroid disease (AITD). Multipoint analysis, designating all AITD sib pairs as affected, showed a peak NPL score of 3.46 (P = .0003), at the marker D18S487. Designation of only GD cases as affected (74 sib pairs) showed a peak NPL score of 3.09 (P = .001). Linkage to this region has been demonstrated in type 1 diabetes (IDDM6), rheumatoid arthritis, and systemic lupus erythematosus, which suggests that this locus may have a role in several forms of autoimmunity.	Univ Newcastle Upon Tyne, Sch Clin Med Sci, Dept Endocrinol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Freeman Rd Hosp, Dept Med, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; Wansbeck Gen Hosp, Dept Med, Ashington, Northumbria, England; Middlesbrough Gen Hosp, Diabet Care Ctr, Middlesbrough TS5 5AZ, Cleveland, England; N Tees Gen Hosp, Dept Med, Stockton On Tees, England; Cumberland Infirm, Dept Med, Carlisle, England; Royal Infirm, Endocrine Unit, Edinburgh, Midlothian, Scotland	Newcastle University - UK; Newcastle Freeman Hospital; Newcastle University - UK; University Hospital of North Tees; Royal Infirmary of Edinburgh	Vaidya, B (corresponding author), Univ Newcastle Upon Tyne, Sch Med, Dept Med, 4th Floor Leech Bldg, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.		Pearce, Simon/AAB-3692-2019; Peng, Bo/A-6920-2009; Vaidya, Bijay/AAF-1947-2020	Pearce, Simon/0000-0001-8384-8063; Peng, Bo/0000-0001-8225-2284; Perros, Petros/0000-0001-7320-5574; Vaidya, Bijay/0000-0002-2223-0494				Barbesino G, 1998, J CLIN ENDOCR METAB, V83, P3290, DOI 10.1210/jc.83.9.3290; BLACKWELL CC, 1987, BRIT MED J, V295, P1024, DOI 10.1136/bmj.295.6605.1024; Brix TH, 1998, THYROID, V8, P727, DOI 10.1089/thy.1998.8.727; COLLIER A, 1988, BRIT MED J, V296, P1162, DOI 10.1136/bmj.296.6630.1162; Concannon P, 1998, NAT GENET, V19, P292, DOI 10.1038/985; Cornelis F, 1998, P NATL ACAD SCI USA, V95, P10746, DOI 10.1073/pnas.95.18.10746; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; Curtis D, 1997, ANN HUM GENET, V61, P319, DOI 10.1017/S000348009700626X; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; Davies JL, 1996, HUM MOL GENET, V5, P1071, DOI 10.1093/hmg/5.7.1071; Delepine M, 1997, AM J HUM GENET, V60, P174; HASHIMOTO L, 1994, NATURE, V371, P161, DOI 10.1038/371161a0; Heward JM, 1999, J CLIN ENDOCR METAB, V84, P2398, DOI 10.1210/jc.84.7.2398; Heward JM, 1998, J CLIN ENDOCR METAB, V83, P3394, DOI 10.1210/jc.83.10.3394; KELLY RJ, 1995, J BIOL CHEM, V270, P4640, DOI 10.1074/jbc.270.9.4640; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Luo DF, 1996, HUM MOL GENET, V5, P693, DOI 10.1093/hmg/5.5.693; Marron MP, 1997, HUM MOL GENET, V6, P1275, DOI 10.1093/hmg/6.8.1275; Mehrian R, 1998, ARTHRITIS RHEUM, V41, P596, DOI 10.1002/1529-0131(199804)41:4<596::AID-ART6>3.0.CO;2-2; Mein CA, 1998, NAT GENET, V19, P297, DOI 10.1038/991; Merriman T, 1997, HUM MOL GENET, V6, P1003, DOI 10.1093/hmg/6.7.1003; Merriman TR, 1998, HUM MOL GENET, V7, P517, DOI 10.1093/hmg/7.3.517; Nakagawa Y, 1998, AM J HUM GENET, V63, P547, DOI 10.1086/301974; Nistico L, 1996, HUM MOL GENET, V5, P1075, DOI 10.1093/hmg/5.7.1075; PAYAMI H, 1989, GENET EPIDEMIOL, V6, P137, DOI 10.1002/gepi.1370060126; Pearce SHS, 1999, AM J HUM GENET, V65, P1462, DOI 10.1086/302610; Reed P, 1997, HUM MOL GENET, V6, P1011, DOI 10.1093/hmg/6.7.1011; RISCH N, 1987, AM J HUM GENET, V40, P1; Shai R, 1999, HUM MOL GENET, V8, P639, DOI 10.1093/hmg/8.4.639; Tomer Y, 1998, J CLIN ENDOCR METAB, V83, P4321, DOI 10.1210/jc.83.12.4321; Tomer Y, 1998, AM J HUM GENET, V63, P1749, DOI 10.1086/302146; TOMER Y, 1999, AM J HUM GENET, V84, P4656; Vaidya B, 1999, HUM MOL GENET, V8, P1195, DOI 10.1093/hmg/8.7.1195	35	54	55	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2000	66	5					1710	1714		10.1086/302908	http://dx.doi.org/10.1086/302908			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QT	10762555	Green Published, Bronze			2022-12-18	WOS:000088373700027
J	Deng, HW; Chen, WM; Recker, RR				Deng, HW; Chen, WM; Recker, RR			QTL fine mapping by measuring and testing for Hardy-Weinberg and linkage disequilibrium at a series of linked marker loci in extreme samples of populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; TRANSMISSION/DISEQUILIBRIUM TEST; DIASTROPHIC DYSPLASIA; POSITIONAL CLONING; GENE; ASSOCIATION; DISEASE; ALLELES; RESOLUTION; FAMILIES	It has recently been demonstrated that fine-scale mapping of a susceptibility locus for a complex disease can be accomplished on the basis of deviations from Hardy-Wieinberg (HW) equilibrium at closely linked marker loci among affected individuals. We extend this theory to fine-scale localization of a quantitative-trait locus (QTL) from extreme individuals in populations, by means of HW and linkage-disequilibrium (LD) analyses. QTL mapping and/or linkage analyses can establish a large genomic region (similar to 30 chi) that contains a QTL. The QTL can be fine mapped by examination of the degree of deviation from HW and LD at a series of closely linked marker loci. The tests can be performed for samples of individuals belonging to either high or low percentiles of the phenotype distribution or for combined samples of these extreme individuals. The statistical properties (the power and the size) of the tests of this fine-mapping approach are investigated and are compared extensively, under various genetic models and parameters for the QTL and marker loci. On the basis of the results, a two-stage procedure that uses extreme samples and different tests (for HW and LD) is suggested for QTL fine mapping. This two-step procedure is economic and powerful and can accurately narrow a genomic region containing a QTL from similar to 30-1 cM, a range that renders physical mapping feasible for identification of the QTL. In addition, the relationship between parameterizations of complex diseases, by means of penetrance, and those of complex quantitative traits, by means of genotypic values, is outlined. This means that many statistical genetic methods developed for searching for susceptibility loci of complex diseases can be directly adopted and/or extended to QTL mapping for quantitative traits.	Creighton Univ, Osteoporosis Res Ctr, Omaha, NE 68131 USA; Creighton Univ, Dept Biomed Sci, Omaha, NE 68131 USA	Creighton University; Creighton University	Deng, HW (corresponding author), Creighton Univ, Osteoporosis Res Ctr, 601 N 30th St, Omaha, NE 68131 USA.		Chen, Wei-Min/A-8469-2009	Deng, Hong-Wen/0000-0002-0387-8818	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045349] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR45349] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Allison DB, 1997, AM J HUM GENET, V60, P676; BENGTSSON BO, 1981, TISSUE ANTIGENS, V18, P356, DOI 10.1111/j.1399-0039.1981.tb01404.x; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; BOEHNKE M, 1994, AM J HUM GENET, V55, P379; Boehnke M, 1998, AM J HUM GENET, V62, P950, DOI 10.1086/301787; Chagnon YC, 1998, OBES RES, V6, P76, DOI 10.1002/j.1550-8528.1998.tb00318.x; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Crow J.F., 1970, INTRO POPULATION GEN; CURTIS D, 1995, AM J HUM GENET, V56, P811; Deng HW, 1998, HUM GENET, V103, P576, DOI 10.1007/s004390050872; Devlin B, 1996, GENOMICS, V36, P1, DOI 10.1006/geno.1996.0419; Falconer D. S., 1989, Introduction to quantitative genetics.; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Fulker DW, 1999, AM J HUM GENET, V64, P259, DOI 10.1086/302193; GLASER B, 1995, HUM MOL GENET, V4, P879, DOI 10.1093/hmg/4.5.879; Hartl D. L., 1989, PRINCIPLES POPULATIO; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; Kaplan NL, 1997, AM J HUM GENET, V60, P691; Lazzeroni LC, 1998, HUM HERED, V48, P67, DOI 10.1159/000022784; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; LYNCH M, 1998, GENETICS DATA ANAL Q; Martin ER, 1997, AM J HUM GENET, V61, P439, DOI 10.1086/514860; MENG RC, 1966, J AM STAT ASSOC, V61, P965, DOI 10.2307/2283192; Nielsen DM, 1998, AM J HUM GENET, V63, P1531, DOI 10.1086/302114; Ott J., 1991, ANAL HUMAN GENETIC L; Rabinowitz D, 1997, HUM HERED, V47, P342, DOI 10.1159/000154433; Sham P, 1997, AM J HUM GENET, V61, P774; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; SHAM PC, 1995, ANN HUM GENET, V59, P97, DOI 10.1111/j.1469-1809.1995.tb01608.x; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; Tregouet DA, 1997, AM J HUM GENET, V61, P189, DOI 10.1086/513895; Weir B., 1996, GENETIC DATA ANAL; Xiong MI, 1997, GENETICS, V145, P1201; Xiong MM, 1999, AM J HUM GENET, V64, P629, DOI 10.1086/302231; XIONG MM, 1997, AM J HUM GENET, V60, P151	38	54	63	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2000	66	3					1027	1045		10.1086/302804	http://dx.doi.org/10.1086/302804			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QM	10712216	Green Published, Bronze			2022-12-18	WOS:000088373200024
J	Eisenbarth, I; Beyer, K; Krone, W; Assum, G				Eisenbarth, I; Beyer, K; Krone, W; Assum, G			Toward a survey of somatic mutation of the NF1 gene in benign neurofibromas of patients with neurofibromatosis type 1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							REPEAT POLYMORPHISMS; CELL-LINES; IDENTIFICATION; METHYLATION; DELETIONS; ALLELES; TUMORS; PCR	Neurofibromatosis type 1 (NF1), a common autosomal dominant disorder caused by mutations of the NF1 gene, is characterized by multiple neurofibromas, pigmentation anomalies, and a variety of other possible complications, including an increased risk of malignant neoplasias. Tumorigenesis in NF1 is believed to follow the two-hit hypothesis postulated for tumor-suppressor genes. Loss of heterozygosity (LOH) has been shown to occur in NF1-associated malignancies and in benign neurofibromas, but only few of the latter yielded a positive result. Here we describe a systematic approach of searching for somatic inactivation of the NF1: gene in neurofibromas. In the course of these studies, two new intragenic polymorphisms of the NF1 gene, a tetranucleotide repeat and a 21-bp duplication, could be identified. Three tumor-specific point mutations and two LOH events were detected among seven neurofibromas from four different NF1 patients. Our results suggest that small subtle mutations occur with similar frequency to that of LOH in benign neurofibromas and that somatic inactivation of the NF1 gene is a general event in these tumors. The spectrum of somatic mutations occurring in various tumors from individual NF1 patients may contribute to the understanding of variable expressivity of the NF1 phenotype.	Univ Ulm, Abt Humangenet, D-89081 Ulm, Germany	Ulm University	Eisenbarth, I (corresponding author), Univ Ulm, Abt Humangenet, Albert Einstein Allee 11, D-89081 Ulm, Germany.	ingrid.eisenbarth@medizin.uni-ulm.de						AINSWORTH PJ, 1991, AM J HUM GENET, V49, P1098; Anderson JC., 1992, J BUS-BUS MARK, V1, P3, DOI [DOI 10.1300/J033V01N01_02, 10.1300/J033v01n01_02]; Andrews JD, 1996, HUM MOL GENET, V5, P503, DOI 10.1093/hmg/5.4.503; [Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; Beroud C, 1996, NUCLEIC ACIDS RES, V24, P121, DOI 10.1093/nar/24.1.121; Cappione AJ, 1997, AM J HUM GENET, V60, P305; COLMAN SD, 1995, NAT GENET, V11, P90, DOI 10.1038/ng0995-90; Daschner K, 1997, BIOCHEM BIOPH RES CO, V234, P346, DOI 10.1006/bbrc.1997.6645; FAHSOLD R, 1999, MED GENETIK, V11, P190; HEIM RA, 1995, HUM MOL GENET, V4, P975, DOI 10.1093/hmg/4.6.975; HOFFMEYER S, 1994, HUM GENET, V93, P481; JOHNSON MR, 1993, P NATL ACAD SCI USA, V90, P5539, DOI 10.1073/pnas.90.12.5539; Kluwe L, 1999, GENE CHROMOSOME CANC, V24, P283, DOI 10.1002/(SICI)1098-2264(199903)24:3<283::AID-GCC15>3.0.CO;2-K; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; LAZARO C, 1993, HUM GENET, V92, P429, DOI 10.1007/BF01247353; LAZARO C, 1994, HUM GENET, V93, P351, DOI 10.1007/BF00212039; LAZARO C, 1993, HUM MOL GENET, V2, P725, DOI 10.1093/hmg/2.6.725; LEGIUS E, 1993, NAT GENET, V3, P122, DOI 10.1038/ng0293-122; Park VM, 1998, J MED GENET, V35, P813, DOI 10.1136/jmg.35.10.813; Purandare SM, 1996, AM J HUM GENET, V59, P159; Sawada S, 1996, NAT GENET, V14, P110, DOI 10.1038/ng0996-110; Serra E, 1997, AM J HUM GENET, V61, P512, DOI 10.1086/515504; SHANNON KM, 1994, NEW ENGL J MED, V330, P597, DOI 10.1056/NEJM199403033300903; Skuse GR, 1997, HUM MOL GENET, V6, P1707, DOI 10.1093/hmg/6.10.1707; Spirio LN, 1998, NAT GENET, V20, P385, DOI 10.1038/3865; STEPHENS K, 1998, AM J HUM GENET, V63, pA39; Upadhyaya M, 1997, HUM GENET, V99, P88; Upadhyaya MCDN, 1998, NEUROFIBROMATOSIS TY; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4640, DOI 10.1093/nar/18.15.4640-a; WOODCOCK DM, 1988, GENE, V74, P151, DOI 10.1016/0378-1119(88)90273-9; XU W, 1992, GENE CHROMOSOME CANC, V4, P337, DOI 10.1002/gcc.2870040411	31	54	57	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					393	401		10.1086/302747	http://dx.doi.org/10.1086/302747			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	10677298	Bronze, Green Published			2022-12-18	WOS:000088373100005
J	van den Oord, EJCG; Vermunt, JK				van den Oord, EJCG; Vermunt, JK			Testing for linkage disequilibrium, maternal effects, and imprinting with (ln)complete case-parent triads, by use of the computer program LEM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							ASSOCIATION		Univ Utrecht, Dept Child & Adolescent Psychol, NL-3508 TC Utrecht, Netherlands; Tilburg Univ, Dept Methodol, NL-5000 LE Tilburg, Netherlands	Utrecht University; Tilburg University	van den Oord, EJCG (corresponding author), Univ Utrecht, Dept Child & Adolescent Psychol, Heidelberglaan 1,Ctr Gebouw Zuid,Postbus 80140, NL-3508 TC Utrecht, Netherlands.		vermunt, jeroen k/K-3680-2012	vermunt, jeroen k/0000-0001-9053-9330				CURTIS D, 1995, AM J HUM GENET, V56, P811; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; SCHAID DJ, 1993, AM J HUM GENET, V53, P1114; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; THOMSON G, 1995, AM J HUM GENET, V57, P487; van den Oord EJCG, 1999, BEHAV GENET, V29, P245, DOI 10.1023/A:1021690206763; Vermunt J. K., 1997, ADV QUANTITATIVE TEC, V8; VERMUNT JK, 1997, LEM GEN PROGAM ANAL; Weinberg CR, 1999, AM J HUM GENET, V65, P229, DOI 10.1086/302466; Weinberg CR, 1999, AM J HUM GENET, V64, P1186, DOI 10.1086/302337	10	54	54	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2000	66	1					335	338		10.1086/302708	http://dx.doi.org/10.1086/302708			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279FK	10631165	Bronze, Green Published			2022-12-18	WOS:000085033600036
J	Capon, F; Semprini, S; Dallapiccola, B; Novelli, G				Capon, F; Semprini, S; Dallapiccola, B; Novelli, G			Evidence for interaction between psoriasis-susceptibility loci on chromosomes 6p21 and 1q21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							FAMILIAL PSORIASIS; COMPLEX DISORDER; LINKAGE; HLA; DISEQUILIBRIUM; MARKERS; DISEASE; REGION; GENE; 17Q		Univ Roma Tor Vergata, Cattedra Genet Umana, Dipartimento Biopatol & Diagnost Immagini, I-00133 Rome, Italy; CSS Mendel Inst, Rome, Italy	University of Rome Tor Vergata; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel	Novelli, G (corresponding author), Univ Roma Tor Vergata, Cattedra Genet Umana, Dipartimento Biopatol & Diagnost Immagini, Via Tor Vergata 135, I-00133 Rome, Italy.		Novelli, Giuseppe/A-5195-2013; Novelli, Giuseppe/T-8822-2019; Novelli, Giuseppe/GQB-3329-2022; Capon, Francesca/F-4763-2011; Dallapiccola, Bruno/K-8692-2016	Novelli, Giuseppe/0000-0002-7781-602X; Novelli, Giuseppe/0000-0002-7781-602X; Capon, Francesca/0000-0003-2432-5793; Dallapiccola, Bruno/0000-0002-5031-1013	Telethon [E.0557] Funding Source: Medline	Telethon(Fondazione Telethon)		BARNES RI, 1998, AM J HUM GENET S, V63, pA281; Bhalerao J, 1998, HUM MOL GENET, V7, P1537, DOI 10.1093/hmg/7.10.1537; Capon F, 1999, J INVEST DERMATOL, V112, P32, DOI 10.1046/j.1523-1747.1999.00471.x; Christophers E, 1993, DERMATOLOGY GEN MED, P489; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; ELDER JT, 1994, J INVEST DERMATOL, V103, pS150, DOI 10.1111/1523-1747.ep12399486; Enlund F, 1999, HUM HERED, V49, P2, DOI 10.1159/000022832; FARBER EM, 1974, DERMATOLOGICA, V148, P1, DOI 10.1159/000251595; HELLGREN I, 1967, PSORIASIS PREVALENCE; Jenisch S, 1998, AM J HUM GENET, V63, P191, DOI 10.1086/301899; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Leder RO, 1998, HUM HERED, V48, P198, DOI 10.1159/000022802; MACLEAN CJ, 1993, AM J HUM GENET, V53, P353; Marenholz I, 1996, GENOMICS, V37, P295, DOI 10.1006/geno.1996.0563; Matthews D, 1996, NAT GENET, V14, P231, DOI 10.1038/ng1096-231; Nair RP, 1997, HUM MOL GENET, V6, P1349, DOI 10.1093/hmg/6.8.1349; Nevitt GJ, 1996, BRIT J DERMATOL, V135, P533, DOI 10.1046/j.1365-2133.1996.d01-1035.x; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; TATARI Z, 1995, P NATL ACAD SCI USA, V92, P8803, DOI 10.1073/pnas.92.19.8803; TOMFOHRDE J, 1994, SCIENCE, V264, P1141, DOI 10.1126/science.8178173; Trembath RC, 1997, HUM MOL GENET, V6, P813, DOI 10.1093/hmg/6.5.813	21	54	56	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1999	65	6					1798	1800		10.1086/302653	http://dx.doi.org/10.1086/302653			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	266CF	10577939	Green Published, Bronze			2022-12-18	WOS:000084282500040
J	Stratton, JF; Thompson, D; Bobrow, L; Dalal, N; Gore, M; Bishop, DT; Scott, I; Evans, G; Daly, P; Easton, DF; Ponder, BAJ				Stratton, JF; Thompson, D; Bobrow, L; Dalal, N; Gore, M; Bishop, DT; Scott, I; Evans, G; Daly, P; Easton, DF; Ponder, BAJ			The genetic epidemiology of early-onset epithelial ovarian cancer: A population-based study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							STRAND CONFORMATION POLYMORPHISM; FAMILIAL BREAST-CANCER; LINE BRCA1 MUTATIONS; GERMLINE MUTATIONS; POINT MUTATIONS; HETERODUPLEX ANALYSIS; GEL-ELECTROPHORESIS; CHROMOSOME 13Q12-13; COLORECTAL-CANCER; RAPID DETECTION	We conducted a population-based study to determine the contribution of germline mutations in known candidate genes to ovarian cancer diagnosed at age <30 years. Women with epithelial ovarian cancer were identified through cancer registries. DNA samples were analyzed for mutations in BRCA1, the "ovarian cancer-cluster region" (nucleotides 3139-7069) of BRCA2, and the mismatch-repair genes hMSH2 and hMLH1. probable germline mutations in hMLH1 were identified in 2 (2%; 95% confidence interval 1%-8%) of 101 women with invasive ovarian cancer diagnosed at age <30 years. No germline mutations were identified in any of the other genes analyzed. There were no striking pedigrees suggestive of families with either breast/ovarian cancer or hereditary nonpolyposis colorectal cancer (HNPCC). There was a significantly increased incidence of all cancers in first-degree relatives of women with invasive disease (relative risk [RR] = 1.6, P=.01) but not in second-degree relatives or in relatives of women with borderline cases. First-degree relatives of women with invasive disease had increased risks of ovarian cancer (RR = 4.8, P=.03), myeloma (RR = 10, P=.01), and non-Hodgkin lymphoma (RR = 7, P =.004). Germline mutations in BRCA1, BRCA2, msh2, and mlh1 contribute to only a minority of cases of early-onset epithelial ovarian cancer. Our data suggest that early-onset ovarian cancer is not associated with a greatly increased risk of cancer in close relatives.	Univ Cambridge, Cambridge Inst Med Res, WellBeing Ovarian Canc Res Ctr, Cambridge, England; Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Dept Histopathol, Cambridge CB2 2QQ, England; Univ Cambridge, Cambridge Inst Med Res, Canc Res Campaign, Genet Epidemiol Unit,Strangeways Res Lab, Cambridge, England; Univ Cambridge, Cambridge Inst Med Res, Canc Res Campaign, Dept Oncol, Cambridge, England; Royal Marsden Hosp, Dept Clin Oncol, London SW3 6JJ, England; St James Univ Hosp, Imperial Canc Res Fund, Genet Epidemiol Unit, Leeds LS9 7TF, W Yorkshire, England; Derby City Gen Hosp, Dept Obstet & Gynaecol, Derby, England; St Marys Hosp, Reg Genet Serv, Manchester M13 0JH, Lancs, England; St James Hosp, Dept Haematol & Oncol, Dublin 8, Ireland	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; CRUK Cambridge Institute; University of Cambridge; CRUK Cambridge Institute; University of Cambridge; Royal Marsden NHS Foundation Trust; Saint James's University Hospital; University of Nottingham; University of Manchester; Trinity College Dublin	Ponder, BAJ (corresponding author), Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Dept Oncol, Box 139,Hills Rd, Cambridge CB2 2XY, England.	bajp@mole.bio.cam.ac.uk	Evans, D Gareth/AAB-4308-2022	Evans, D Gareth/0000-0002-8482-5784; Bishop, Tim/0000-0002-8752-8785				BORRESEN AL, 1995, HUM MOL GENET, V4, P2065, DOI 10.1093/hmg/4.11.2065; Brunet JS, 1997, NEW ENGL J MED, V336, P1256; COLEMAN M, 1989, 891006 IARC; CONDIE A, 1993, HUM MUTAT, V2, P58, DOI 10.1002/humu.1380020111; Easton DF, 1997, AM J HUM GENET, V61, P120, DOI 10.1086/513891; EASTON DF, 1995, AM J HUM GENET, V56, P265; EASTON DF, 1993, AM J HUM GENET, V52, P678; FitzGerald MG, 1996, NEW ENGL J MED, V334, P143, DOI 10.1056/NEJM199601183340302; FORD D, 1995, AM J HUM GENET, V57, P1457; FORD D, 1995, BRIT J CANCER, V72, P805, DOI 10.1038/bjc.1995.417; Foster KA, 1996, CANCER RES, V56, P3622; Friedman LS, 1997, AM J HUM GENET, V60, P313; Gayther SA, 1997, NAT GENET, V15, P103, DOI 10.1038/ng0197-103; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; Gayther SA, 1996, AM J HUM GENET, V58, P451; GLAVAC D, 1995, HUM MUTAT, V6, P281, DOI 10.1002/humu.1380060402; GLAVAC D, 1993, HUM MUTAT, V2, P404, DOI 10.1002/humu.1380020513; Hakansson S, 1997, AM J HUM GENET, V60, P1068; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Han HJ, 1996, JNCI-J NATL CANCER I, V88, P1317, DOI 10.1093/jnci/88.18.1317; HOGERVORST FBL, 1995, NAT GENET, V10, P208, DOI 10.1038/ng0695-208; Johannsson OT, 1998, J CLIN ONCOL, V16, P397, DOI 10.1200/JCO.1998.16.2.397; Johannsson OT, 1997, EUR J CANCER, V33, P362, DOI 10.1016/S0959-8049(96)00469-8; Krainer M, 1997, NEW ENGL J MED, V336, P1416, DOI 10.1056/NEJM199705153362003; Langston AA, 1996, NEW ENGL J MED, V334, P137, DOI 10.1056/NEJM199601183340301; Moslein G, 1996, HUM MOL GENET, V5, P1245, DOI 10.1093/hmg/5.9.1245; NAN HJ, 1995, HUM MOL GENET, V4, P237, DOI 10.1093/hmg/4.2.237; NAROD SA, 1995, AM J HUM GENET, V56, P254; NAROD SA, 1991, LANCET, V338, P82; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; ROSSETTI S, 1995, MOL CELL PROBE, V9, P195, DOI 10.1006/mcpr.1994.0028; Rubin SC, 1996, NEW ENGL J MED, V335, P1413, DOI 10.1056/NEJM199611073351901; SHEFFIELD VC, 1993, GENOMICS, V16, P325, DOI 10.1006/geno.1993.1193; Stratton JF, 1997, NEW ENGL J MED, V336, P1125, DOI 10.1056/NEJM199704173361602; Takahashi H, 1996, CANCER RES, V56, P2738; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Whittemore AS, 1997, AM J HUM GENET, V60, P496; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231	39	54	56	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1999	65	6					1725	1732		10.1086/302671	http://dx.doi.org/10.1086/302671			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	266CF	10577927	Green Published, Bronze			2022-12-18	WOS:000084282500028
J	Lanasa, MC; Hogge, WA; Kubik, C; Blancato, J; Hoffman, EP				Lanasa, MC; Hogge, WA; Kubik, C; Blancato, J; Hoffman, EP			Highly skewed X-chromosome inactivation is associated with idiopathic recurrent spontaneous abortion	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							PATTERNS; FEMALES; GENE; AGE		Univ Pittsburgh, Dept Mol Genet & Biochem, Pittsburgh, PA USA; Magee Womens Hosp, Dept Obstet Gynecol Reprod Sci & Human Genet, Pittsburgh, PA USA; Magee Womens Hosp, Dept Reprod Endocrinol, Pittsburgh, PA USA; Georgetown Univ, Med Ctr, Inst Mol & Human Genet, Washington, DC 20007 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Georgetown University	Lanasa, MC (corresponding author), Childrens Natl Med Ctr, Res Ctr Genet Med, 111 Michigan Ave NW, Washington, DC 20010 USA.			Hoffman, Eric/0000-0001-6470-5139	NICHD NIH HHS [R01 HD37148-01] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Belmont JW, 1996, AM J HUM GENET, V58, P1101; Busque L, 1996, BLOOD, V88, P59; Gale RE, 1997, BRIT J HAEMATOL, V98, P512, DOI 10.1046/j.1365-2141.1997.2573078.x; HATASAKA HH, 1994, CLIN OBSTET GYNECOL, V37, P625, DOI 10.1097/00003081-199409000-00016; MOTULSKY F, 1997, HUMAN GENETICS PROBL; Naumova AK, 1996, AM J HUM GENET, V58, P1111; PEGORARO E, 1994, AM J HUM GENET, V54, P989; Pegoraro E, 1997, AM J HUM GENET, V61, P160, DOI 10.1086/513901; Plenge RM, 1997, NAT GENET, V17, P353, DOI 10.1038/ng1197-353; Stephenson MD, 1996, FERTIL STERIL, V66, P24	10	54	57	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1999	65	1					252	254		10.1086/302441	http://dx.doi.org/10.1086/302441			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	212NZ	10364540	Green Published, Bronze			2022-12-18	WOS:000081224300032
J	Berg, T; Riise, HMF; Hansen, GN; Malm, D; Tranebjaerg, L; Tollersrud, OK; Nilssen, O				Berg, T; Riise, HMF; Hansen, GN; Malm, D; Tranebjaerg, L; Tollersrud, OK; Nilssen, O			Spectrum of mutations in alpha-mannosidosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FULL-LENGTH CDNA; GENOMIC STRUCTURE; EXPRESSION; CLONING; DISEASE; PURIFICATION; FIBROBLASTS; SIBLINGS; GENE	alpha-Mannosidosis is an autosomal recessive disorder caused by deficiency of lysosomal alpha-mannosidase (LAMAN). The resulting intracellular accumulation of mannose-containing oligosaccharides leads to mental retardation, hearing impairment, skeletal changes, and immunodeficiency. Recently, we reported the first alpha-mannosidosis-causing mutation affecting two Palestinian siblings. In the present study 21 novel mutations and four polymorphic amino acid positions were identified by the screening of 43 patients, from 39 families, mainly of European origin. Disease-causing mutations were identified in 72% of the alleles and included eight splicing, six missense, and three nonsense mutations, as well as two small insertions and two small deletions. In addition, Southern blot analysis indicated rearrangements in some alleles. Most mutations were private or occurred in two or three families, except for a missense mutation resulting in an R750W substitution. This mutation was found in 13 patients, from different European countries, and accounted for 21% of the disease alleles. Although there were clinical variations among the patients, no significant LAMAN activity could be detected in any of the fibroblast cultures. In addition, no correlation between the types of mutations and the clinical manifestations was evident.	Univ Tromso Hosp, Dept Med Genet, N-9037 Tromso, Norway; Univ Tromso Hosp, Dept Biochem Med, N-9037 Tromso, Norway; Univ Tromso Hosp, Dept Med, N-9037 Tromso, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University Hospital of North Norway	Nilssen, O (corresponding author), Univ Tromso Hosp, Dept Med Genet, N-9037 Tromso, Norway.							Antonarakis SE, 1998, HUM MUTAT, V11, P1; ARONSON NN, 1989, FASEB J, V3, P2615, DOI 10.1096/fasebj.3.14.2531691; AUTIO S, 1973, ACTA PAEDIATR SCAND, V62, P555, DOI 10.1111/j.1651-2227.1973.tb17065.x; AYLSWORTH AS, 1976, J PEDIATR-US, V88, P814, DOI 10.1016/S0022-3476(76)81120-1; BACH G, 1978, PEDIATR RES, V12, P1010, DOI 10.1203/00006450-197810000-00012; Beccari T, 1997, BIOCHEM J, V327, P45, DOI 10.1042/bj3270045; BENNET JK, 1995, AM J MED GENET, V55, P21, DOI 10.1002/ajmg.1320550108; Berg T, 1997, BIOCHEM J, V328, P863, DOI 10.1042/bj3280863; Berg T, 1997, RES VET SCI, V63, P279, DOI 10.1016/S0034-5288(97)90034-5; BURDITT LJ, 1980, BIOCHEM J, V189, P467, DOI 10.1042/bj1890467; BURDITT LJ, 1978, FEBS LETT, V91, P186, DOI 10.1016/0014-5793(78)81168-5; Chester MA, 1982, GENETIC ERRORS GLYCO, P89; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; FARRIAUX JP, 1975, NOUV PRESSE MED, V4, P1867; Gehler J, 1975, Birth Defects Orig Artic Ser, V11, P269; Gotoda Y, 1998, AM J HUM GENET, V63, P1015, DOI 10.1086/302048; Grard T, 1996, BIOCHEM J, V316, P787, DOI 10.1042/bj3160787; HOCKING JD, 1972, BIOCHEM J, V128, P69, DOI 10.1042/bj1280069; JACKSON IJ, 1991, NUCLEIC ACIDS RES, V19, P3795; JANSEN PHP, 1987, CLIN NEUROL NEUROSUR, V89, P185, DOI 10.1016/S0303-8467(87)80053-7; KANEDA Y, 1987, CHROMOSOMA, V95, P8, DOI 10.1007/BF00293835; Liao YF, 1996, J BIOL CHEM, V271, P28348, DOI 10.1074/jbc.271.45.28348; LOEB H, 1969, ACTA PAEDIATR SCAND, V58, P220, DOI 10.1111/j.1651-2227.1969.tb04710.x; MAINARDI PC, 1982, PEDIAT MED CHIR, V4, P203; Malm Dag, 1995, Tidsskrift for den Norske Laegeforening, V115, P594; MERSMANN G, 1977, FEBS LETT, V73, P123, DOI 10.1016/0014-5793(77)80030-6; MICHALSKI JC, 1996, GLYCOPROTEINS DIS, P55; Michelakakis H, 1992, Genet Couns, V3, P195; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MITCHELL ML, 1981, CLIN GENET, V20, P191; MOREMEN KW, 1991, J CELL BIOL, V115, P1521, DOI 10.1083/jcb.115.6.1521; NEBES VL, 1994, BIOCHEM BIOPH RES CO, V200, P239, DOI 10.1006/bbrc.1994.1440; Nilssen O, 1997, HUM MOL GENET, V6, P717, DOI 10.1093/hmg/6.5.717; NILSSEN O, 1993, HUM MOL GENET, V2, P484, DOI 10.1093/hmg/2.4.484; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.biochem.55.1.1119; PARK H, 1991, FEBS LETT, V288, P168, DOI 10.1016/0014-5793(91)81027-6; PATTON MA, 1982, CLIN GENET, V22, P284; POENARU L, 1980, AM J HUM GENET, V32, P354; POHLMANN R, 1983, BIOCHEM BIOPH RES CO, V115, P1083, DOI 10.1016/S0006-291X(83)80046-1; Riise HMF, 1997, GENOMICS, V42, P200, DOI 10.1006/geno.1997.4668; SPRANGER J, 1976, RADIOLOGY, V119, P401, DOI 10.1148/119.2.401; THOMAS GH, 1995, METABOLIC MOL BASES, V5, P2529; Tollersrud OK, 1997, EUR J BIOCHEM, V246, P410, DOI 10.1111/j.1432-1033.1997.00410.x; WARNER TG, 1984, CLIN GENET, V25, P248	44	54	56	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1999	64	1					77	88		10.1086/302183	http://dx.doi.org/10.1086/302183			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164RM	9915946	Green Published, Bronze			2022-12-18	WOS:000078477400012
J	Kelley, RI				Kelley, RI			RSH/Smith-Lemli-Opitz syndrome: Mutations and metabolic morphogenesis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							DEFECTIVE CHOLESTEROL-BIOSYNTHESIS; SONIC HEDGEHOG; AMNIOTIC-FLUID; GENE; PLASMA; LETHALITY; DIAGNOSIS		Johns Hopkins Univ, Sch Med, Kennedy Krieger Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA	Johns Hopkins University; Kennedy Krieger Institute; Johns Hopkins University	Kelley, RI (corresponding author), Johns Hopkins Univ, Sch Med, Kennedy Krieger Inst, 707 N Broadway, Baltimore, MD 21205 USA.							ABUELO DN, 1995, AM J MED GENET, V56, P281, DOI 10.1002/ajmg.1320560309; ALLEY TL, 1995, AM J HUM GENET, V56, P1411; ANDERSON AJ, 1998, IN PRESS AM J MED GE; BARBU V, 1984, P SOC EXP BIOL MED, V176, P54; BIALER MG, 1987, AM J MED GENET, V28, P723, DOI 10.1002/ajmg.1320280320; Bitgood MJ, 1996, CURR BIOL, V6, P298, DOI 10.1016/S0960-9822(02)00480-3; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Cunniff C, 1997, AM J MED GENET, V68, P263, DOI 10.1002/(SICI)1096-8628(19970131)68:3<263::AID-AJMG4>3.3.CO;2-5; CURRY C J R, 1987, American Journal of Medical Genetics, V26, P45, DOI 10.1002/ajmg.1320260110; DEHART DB, 1997, SAM J MED GENET, V68, P328; FARESE RV, 1995, P NATL ACAD SCI USA, V92, P1774, DOI 10.1073/pnas.92.5.1774; Fitzky BU, 1998, P NATL ACAD SCI USA, V95, P8181, DOI 10.1073/pnas.95.14.8181; FitzPatrick DR, 1998, AM J MED GENET, V75, P145, DOI 10.1002/(SICI)1096-8628(19980113)75:2<145::AID-AJMG5>3.0.CO;2-S; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; INGHAM PW, 1991, NATURE, V353, P184, DOI 10.1038/353184a0; IRONS M, 1993, LANCET, V341, P1414, DOI 10.1016/0140-6736(93)90983-N; Iwasaki M, 1997, MECH DEVELOP, V69, P197, DOI 10.1016/S0925-4773(97)00145-7; Kelley RI, 1996, AM J MED GENET, V66, P478, DOI 10.1002/(SICI)1096-8628(19961230)66:4<478::AID-AJMG22>3.0.CO;2-Q; KELLEY RI, 1995, CLIN CHIM ACTA, V236, P45, DOI 10.1016/0009-8981(95)06038-4; Lanoue L, 1997, AM J MED GENET, V73, P24; MCKEEVER PA, 1990, J MED GENET, V27, P465, DOI 10.1136/jmg.27.7.465; Miller JM, 1996, CLIN OBSTET GYNECOL, V39, P1; Moebius FF, 1998, P NATL ACAD SCI USA, V95, P1899, DOI 10.1073/pnas.95.4.1899; Moebius FF, 1997, TRENDS PHARMACOL SCI, V18, P67, DOI 10.1016/S0165-6147(96)01037-1; OPITZ JM, 1994, AM J MED GENET, V50, P326, DOI 10.1002/ajmg.1320500406; OPITZ JM, 1994, AM J MED GENET, V50, P344, DOI 10.1002/ajmg.1320500408; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Porter JA, 1996, CELL, V86, P21, DOI 10.1016/S0092-8674(00)80074-4; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; ROSSITER JP, 1995, AM J MED GENET, V56, P272, DOI 10.1002/ajmg.1320560307; ROUX C, 1980, J NUTR, V110, P2310, DOI 10.1093/jn/110.11.2310; ROUX C, 1966, CR SOC BIOL, V160, P1353; SMITH DW, 1964, J PEDIATR-US, V64, P210, DOI 10.1016/S0022-3476(64)80264-X; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; TINT GS, 1995, J PEDIATR-US, V127, P82, DOI 10.1016/S0022-3476(95)70261-X; TINT GS, 1994, NEW ENGL J MED, V330, P107, DOI 10.1056/NEJM199401133300205; Wassif CA, 1998, AM J HUM GENET, V63, P55, DOI 10.1086/301936; Waterham HR, 1998, AM J HUM GENET, V63, P329, DOI 10.1086/301982; Willnow TE, 1996, P NATL ACAD SCI USA, V93, P8460, DOI 10.1073/pnas.93.16.8460	41	54	58	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1998	63	2					322	326		10.1086/301987	http://dx.doi.org/10.1086/301987			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110CB	9683618	Green Published, Bronze			2022-12-18	WOS:000075360800006
J	Ruiz, A; Borrego, S; Marcos, I; Antinolo, G				Ruiz, A; Borrego, S; Marcos, I; Antinolo, G			A major locus for autosomal recessive retinitis pigmentosa on 6q, determined by homozygosity mapping of chromosomal regions that contain gamma-aminobutyric acid receptor clusters	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GABA(C) RECEPTORS; VERTEBRATE RETINA; MACULAR DYSTROPHY; ALPHA-SUBUNIT; HUMAN GENOME; GENE; MUTATIONS; MAP; PHOSPHODIESTERASE; IDENTIFICATION	Retinitis pigmentosa (RP) is the most common inherited retinal dystrophy, with extensive allelic and nonallelic genetic heterogeneity. autosomal recessive RP (arRP) is the most common form of RP worldwide, with at least nine loci known and accountable for similar to 10%-15% of all cases. Gamma-aminobutyric acid (GABA) is the major inhibitory transmitter in the CNS. Different GABA receptors are expressed in all retinal layers, and inhibition mediated by GABA receptors in the human retina could be related to RF. We have selected chromosomal regions containing genes that encode the different subunits of the GABA receptors, for homozygosity mapping in inbred families affected by arRP. We identify a new locus for arRP, on chromosome 6, between markers D6S257 and D6S1644. Our data suggest chat 10%-20% of Spanish families affected bg typical arRP could have linkage to this new locus. This region contains subunits GABRR1 and GABRR2 of the GABA-C receptor, which is the effector of lateral inhibition at the retina.	Hosp Univ Virgen Del Rocio, Unidad Genet Med & Diagnost Prenatal, Sevilla 41013, Spain		Antinolo, G (corresponding author), Hosp Univ Virgen Del Rocio, Unidad Genet Med & Diagnost Prenatal, Ave Manuel Siurot S-N, Sevilla 41013, Spain.		IBIS, GENETICA/P-3384-2015; IBIS, REPRODUCCION/P-3399-2015; Ruiz, Agustin/G-5677-2012; Borrego, Salud/M-6314-2015	Ruiz Laza, Agustin/0000-0003-2633-2495; Antinolo Gil, Guillermo/0000-0002-2113-074X				BORMANN J, 1995, TRENDS NEUROSCI, V18, P515, DOI 10.1016/0166-2236(95)98370-E; CUTTING GR, 1992, GENOMICS, V12, P801, DOI 10.1016/0888-7543(92)90312-G; CUTTING GR, 1991, P NATL ACAD SCI USA, V88, P2673, DOI 10.1073/pnas.88.7.2673; DELOREY TM, 1992, J BIOL CHEM, V267, P16747; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DRACAPOLI NH, 1994, CURRENT PROTOCOLS HU; DRYJA TP, 1995, P NATL ACAD SCI USA, V92, P10177, DOI 10.1073/pnas.92.22.10177; DRYJA TP, 1990, NATURE, V347, P614, DOI 10.1038/347614a0; DRYJA TP, 1995, HUM MOL GENET, V4, P1739, DOI 10.1093/hmg/4.suppl_1.1739; FARRALL M, 1993, NAT GENET, V5, P107, DOI 10.1038/ng1093-107; Fukai K, 1996, AM J HUM GENET, V59, P620; Gladwin A, 1997, HUM MOL GENET, V6, P123, DOI 10.1093/hmg/6.1.123; Gschwend M, 1996, AM J HUM GENET, V59, P377; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; HUANG SH, 1995, NAT GENET, V11, P468, DOI 10.1038/ng1295-468; Inglehearn CF, 1997, NAT GENET, V16, P15, DOI 10.1038/ng0597-15; JIMENEZSIERRA JM, 1989, INHERITED RETINAL DI; KELSELL RE, 1995, HUM MOL GENET, V4, P1653, DOI 10.1093/hmg/4.9.1653; KNOWLES JA, 1994, HUM MOL GENET, V3, P1401, DOI 10.1093/hmg/3.8.1401; KOLB H, 1974, J COMP NEUROL, V155, P1, DOI 10.1002/cne.901550102; KOLB H, 1994, INVEST OPHTH VIS SCI, V35, P2385; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; LISMAN J, 1995, NAT MED, V1, P1254, DOI 10.1038/nm1295-1254; Lukasiewicz PD, 1996, MOL NEUROBIOL, V12, P181, DOI 10.1007/BF02755587; MartinezMir A, 1997, GENOMICS, V40, P142, DOI 10.1006/geno.1996.4528; Maw MA, 1997, NAT GENET, V17, P198, DOI 10.1038/ng1097-198; MCLAUGHLIN ME, 1993, NAT GENET, V4, P130, DOI 10.1038/ng0693-130; Pastural E, 1997, NAT GENET, V16, P289, DOI 10.1038/ng0797-289; RAPAPORT DH, 1989, VISUAL NEUROSCI, V3, P21, DOI 10.1017/S0952523800012475; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; SIVILOTTI L, 1991, PROG NEUROBIOL, V36, P35, DOI 10.1016/0301-0082(91)90036-Z; SMALL KW, 1992, GENOMICS, V13, P681, DOI 10.1016/0888-7543(92)90141-E; STONE EM, 1994, ARCH OPHTHALMOL-CHIC, V112, P765, DOI 10.1001/archopht.1994.01090180063036; STRACHAN T, 1996, HUM MOL GENETICS; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; VANSOEST S, 1994, GENOMICS, V22, P499, DOI 10.1006/geno.1994.1422; WILCOX AS, 1992, P NATL ACAD SCI USA, V89, P5857, DOI 10.1073/pnas.89.13.5857	40	54	54	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1998	62	6					1452	1459		10.1086/301866	http://dx.doi.org/10.1086/301866			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZU224	9585594	Green Published, Bronze			2022-12-18	WOS:000074174700022
J	Gelb, BD; Willner, JP; Dunn, TM; Kardon, NB; Verloes, A; Poncin, J; Desnick, RJ				Gelb, BD; Willner, JP; Dunn, TM; Kardon, NB; Verloes, A; Poncin, J; Desnick, RJ			Paternal uniparental disomy for chromosome 1 revealed by molecular analysis of a patient with pycnodysostosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CATHEPSIN-K; CLONING; ISODISOMY; OSTEOCLASTOMAS; DEFICIENCY; DIAGNOSIS; LINKAGE; 1Q21; MAPS; GENE	Molecular analysis of a patient affected by the autosomal recessive skeletal dysplasia, pycnodysostosis (cathepsin K deficiency; MIM 265 800), revealed homozygosity for a novel missense mutation (A277V). Since the A277V mutation was carried by the patient's father but not by his mother, who had two normal cathepsin K alleles, paternal uniparental disomy was suspected. Karyotyping of the patient and of both parents was normal, and high-resolution cytogenetic analyses of chromosome 1, to which cathepsin K is mapped, revealed no abnormalities. Evaluation of polymorphic DNA markers spanning chromosome 1 demonstrated that the patient had inherited two paternal chromosome 1 homologues, whereas alleles for markers from other chromosomes were inherited in a Mendelian fashion. The patient was homoallelic for informative markers mapping near the chromosome 1 centromere, but he was heteroallelic for markers near both telomeres, establishing that the paternal uniparental disomy with partial isodisomy was caused by a meiosis II nondisjunction event. Phenotypically, the patient had normal birth height and weight, had normal psychomotor development at age 7 years, and had only the usual features of pycnodysostosis. This patient represents the first case of paternal uniparental disomy of chromosome 1 and provides conclusive evidence that paternally derived genes on human chromosome 1 are not imprinted.	CUNY Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; Walloon Univ Ctr Human Genet, Liege, Belgium	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Gelb, BD (corresponding author), CUNY Mt Sinai Sch Med, Dept Pediat, 1 Gustave L Levy Pl, New York, NY 10029 USA.	gelb@msvax.mssm.edu	VERLOES, Alain/E-7287-2014	VERLOES, Alain/0000-0003-4819-0264	NCRR NIH HHS [5 M01 RR00071] Funding Source: Medline; NIAMS NIH HHS [1 R29 AR44231] Funding Source: Medline; NIDDK NIH HHS [5 R37 DK34045] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR044231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK034045] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDREN L., 1962, ACTA CHIR SCAND, V124, P496; Benlian P, 1996, AM J HUM GENET, V59, P431; BROMME D, 1995, BIOL CHEM H-S, V376, P379, DOI 10.1515/bchm3.1995.376.6.379; CATTANACH BM, 1995, GENOMIC IMPRINTING C, P327; CHEVRET E, 1995, CYTOGENET CELL GENET, V71, P126, DOI 10.1159/000134090; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; EDELSON JG, 1992, CLIN ORTHOP RELAT R, P263; ENGEL E, 1980, AM J MED GENET, V6, P137, DOI 10.1002/ajmg.1320060207; Gelb BD, 1997, GENOMICS, V41, P258, DOI 10.1006/geno.1997.4631; GELB BD, 1995, NAT GENET, V10, P235, DOI 10.1038/ng0695-235; Gelb BD, 1996, SCIENCE, V273, P1236, DOI 10.1126/science.273.5279.1236; Hanna JS, 1997, AM J MED GENET, V68, P98, DOI 10.1002/(SICI)1096-8628(19970110)68:1<98::AID-AJMG20>3.3.CO;2-I; HOGGARD N, 1995, CHROMOSOME RES, V3, P137, DOI 10.1007/BF00710677; HOGLUND P, 1994, AM J HUM GENET, V55, P747; HULTEN MA, 1982, ANN HUM GENET, V46, P167, DOI 10.1111/j.1469-1809.1982.tb00707.x; INAOKA T, 1995, BIOCHEM BIOPH RES CO, V206, P89, DOI 10.1006/bbrc.1995.1013; Johnson MR, 1996, GENOME RES, V6, P1050, DOI 10.1101/gr.6.11.1050; LEDBETTER DH, 1995, HUM MOL GENET, V4, P1757, DOI 10.1093/hmg/4.suppl_1.1757; LI YP, 1995, J BONE MINER RES, V10, P1197; Marenholz I, 1996, GENOMICS, V37, P295, DOI 10.1006/geno.1996.0563; MAROTEAUX P, 1962, PRESSE MED, V70, P999; MORISSETTE J, 1995, CYTOGENET CELL GENET, V69, P59, DOI 10.1159/000133938; MUTIRANGURA A, 1993, HUM MOL GENET, V2, P143, DOI 10.1093/hmg/2.2.143; POLYMEROPOULOS MH, 1995, NAT GENET, V10, P238, DOI 10.1038/ng0695-238; Pulkkinen L, 1997, AM J HUM GENET, V61, P611, DOI 10.1086/515524; Rood JA, 1997, GENOMICS, V41, P169, DOI 10.1006/geno.1997.4614; Sambrook J., 1989, MOL CLONING; SEDANO HD, 1968, AM J DIS CHILD, V116, P70, DOI 10.1001/archpedi.1968.02100020072010; SHI GP, 1995, FEBS LETT, V357, P129, DOI 10.1016/0014-5793(94)01349-6; SPRIGGS EL, 1995, CYTOGENET CELL GENET, V71, P47, DOI 10.1159/000134060	30	54	56	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1998	62	4					848	854		10.1086/301795	http://dx.doi.org/10.1086/301795			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZM197	9529353	Bronze, Green Published			2022-12-18	WOS:000073514400016
J	Giltay, JC; Brunt, T; Beemer, FA; Wit, JM; van Amstel, HKP; Pearson, PL; Wijmenga, C				Giltay, JC; Brunt, T; Beemer, FA; Wit, JM; van Amstel, HKP; Pearson, PL; Wijmenga, C			Polymorphic detection of a parthenogenetic maternal and double paternal contribution to a 46,XX/46,XY hermaphrodite	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACTIVATED HUMAN OOCYTES; CHIMERISM; DNA	True hermaphroditism in humans usually is associated with a 46,XX karyotype or with mosaicism in which admixtures of cells with an XX and an XY karyotype are seen. However, the mechanisms that cause such mosaicisms are poorly understood. To date, with rare exceptions, analyses of hermaphrodites have been limited mostly to cytogenetic investigations. In this report, we describe a 5-year-old patient with true hermaphroditism and a 46,XX/46,XY karyotype (ratio 38:12) in lymphocytes, suggesting involvement of two fertilization events. Microsatellite DNA polymorphisms distributed throughout the genome were analyzed, to investigate the origin of the cell lines concerned. The results are consistent with double paternal and single maternal genetic contributions. Possible mechanisms that would explain these findings are discussed. The most likely mechanism involves a single haploid ovum dividing parthenogenetically into two haploid ova, followed by double fertilization and fusion of the two zygotes into a single individual, at the early embryonic stage.	Univ Utrecht, Dept Human Genet, Utrecht, Netherlands; Clin Genet Ctr, Utrecht, Netherlands; Wilhelmina Childrens Hosp, Utrecht, Netherlands	Utrecht University; Wilhelmina Kinderziekenhuis	Giltay, JC (corresponding author), POB 18009, NL-3501 CA Utrecht, Netherlands.	Giltay@pobox.ruu.nl	Wijmenga, Cisca/D-2173-2009; Wijmenga, Cisca/AAE-7719-2019; Brunt, Tibor/V-1264-2019	Wijmenga, Cisca/0000-0002-5635-1614; Brunt, Tibor/0000-0001-5337-9649				Bonthron DT, 1997, AM J HUM GENET, V61, pA147; EMERY AEH, 1996, PRINCIPLES PRACTICE; FITZGERALD PH, 1979, CLIN GENET, V15, P89; GREEN AJ, 1994, J MED GENET, V31, P816, DOI 10.1136/jmg.31.10.816; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MINOWADA S, 1982, HUM GENET, V60, P376, DOI 10.1007/BF00569224; NYBERG RH, 1992, CLIN GENET, V42, P257; PLACHOT M, 1992, HUM REPROD, V7, P89, DOI 10.1093/humrep/7.suppl_1.89; SCHOENLE E, 1983, HUM GENET, V64, P86, DOI 10.1007/BF00289485; STRAIN L, 1995, NAT GENET, V11, P164, DOI 10.1038/ng1095-164; TAYLOR AS, 1994, HUM REPROD, V9, P2389, DOI 10.1093/oxfordjournals.humrep.a138457; UEHARA S, 1995, FERTIL STERIL, V63, P189, DOI 10.1016/S0015-0282(16)57317-8; VANBLERKOM J, 1994, HUM REPROD, V9, P2381; VANNIEKERK WA, 1981, HUM GENET, V58, P117, DOI 10.1007/BF00284158; WIT JM, 1987, CLIN GENET, V31, P243	15	54	57	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1998	62	4					937	940		10.1086/301796	http://dx.doi.org/10.1086/301796			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZM197	9529354	Green Published, Bronze			2022-12-18	WOS:000073514400025
J	Schnur, RE; Gao, M; Wick, PA; Keller, M; Benke, PJ; Edwards, MJ; Grix, AW; Hockey, A; Jung, JH; Kidd, KK; Kistenmacher, M; Levin, AV; Lewis, RA; Musarella, MA; Nowakowski, RW; Orlow, SJ; Pagon, RS; Pillers, DAM; Punnett, HH; Quinn, GE; Tezcan, K; Wagstaff, J; Weleber, RG				Schnur, RE; Gao, M; Wick, PA; Keller, M; Benke, PJ; Edwards, MJ; Grix, AW; Hockey, A; Jung, JH; Kidd, KK; Kistenmacher, M; Levin, AV; Lewis, RA; Musarella, MA; Nowakowski, RW; Orlow, SJ; Pagon, RS; Pillers, DAM; Punnett, HH; Quinn, GE; Tezcan, K; Wagstaff, J; Weleber, RG			OA1 mutations and deletions in X-linked ocular albinism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE; LINKAGE; CHROMOSOME; SEQUENCE; CLONING; HOMOLOG; TYPE-1; FAMILY	X-linked ocular albinism (OA1), Nettleship-Falls type, is characterized by decreased ocular pigmentation, foveal hypoplasia, nystagmus, photodysphoria, and reduced visual acuity. Affected males usually demonstrate melanin macroglobules on skin biopsy. We now report results of deletion and mutation screening of the full-length OA1 gene in 29 unrelated North American and Australian X-linked ocular albinism (OA) probands, including five with additional, nonocular phenotypic abnormalities (Schnur et al. 1994). We detected 13 intragenic gene deletions, including 3 of exon 1, 2 of exon 2, 2 of exon 4, and 6 others, which span exons 2-8. Eight new missense mutations were identified, which cluster within exons 1, 2, 3, and 6 in conserved and/or putative transmembrane domains of the protein. There was also a splice acceptor-site mutation, a nonsense mutation, a single base deletion, and a previously reported 17-bp exon 1 deletion. All patients with nonocular phenotypic abnormalities had detectable mutations. In summary, 26 (similar to 90%) of 29 probands had detectable alterations of OA1, thus confirming that OA1 is the major locus for X-linked OA.	Univ Med & Dent New Jersey, Cooper Hosp, Childrens Reg Hosp, Camden, NJ 08103 USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; St Christophers Hosp Children, Philadelphia, PA 19133 USA; Univ Miami, Sch Med, Miami, FL USA; Newcastle Western Suburbs Hosp, Waratah, Australia; Univ Calif Davis, Davis, CA USA; King Edward Mem Hosp Women, Subiaco, WA 6008, Australia; London Hlth Sci Ctr, London, ON, Canada; Yale Univ, Sch Med, New Haven, CT USA; Hosp Sick Children, Toronto, ON M5G 1X8, Canada; Baylor Coll Med, Houston, TX 77030 USA; Univ Alabama, Birmingham, AL USA; NYU, Sch Med, New York, NY USA; Childrens Hosp & Med Ctr, Seattle, WA 98105 USA; Oregon Hlth Sci Univ, Portland, OR 97201 USA; Univ Connecticut, Ctr Hlth, Farmington, CT USA; Childrens Hosp, Boston, MA 02115 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Miami; University of California System; University of California Davis; King Edward Memorial Hospital; University of Western Australia; London Health Sciences Centre; Yale University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Baylor College of Medicine; University of Alabama System; University of Alabama Birmingham; New York University; Seattle Children's Hospital; Oregon Health & Science University; University of Connecticut; Harvard University; Boston Children's Hospital	Schnur, RE (corresponding author), Cooper Hosp Univ Med Ctr, Childrens Reg Hosp, Div Genet, 636-638 Benson St, Camden, NJ 08103 USA.		Edwards, Matthew/A-7560-2011; Edwards, Matthew/L-8698-2019	Edwards, Matthew/0000-0001-8437-8120; Edwards, Matthew/0000-0001-8437-8120; Orlow, Seth/0000-0003-2548-7380	NEI NIH HHS [EY10084] Funding Source: Medline; NICHD NIH HHS [HD28815] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD028815] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R29EY010084, R01EY010084] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; Bassi MT, 1996, GENOME RES, V6, P880, DOI 10.1101/gr.6.9.880; BASSI MT, 1995, NAT GENET, V10, P13, DOI 10.1038/ng0595-13; CHARLES SJ, 1992, EYE, V6, P75, DOI 10.1038/eye.1992.15; CREEL D, 1978, SCIENCE, V201, P931, DOI 10.1126/science.684419; FALLS HT, 1951, AM J OPHTHALMOL, V43, P41; GERSHONIBARUCH R, 1991, J AM ACAD DERMATOL, V24, P220, DOI 10.1016/0190-9622(91)70030-6; HOLBROOK KA, 1989, ANAT EMBRYOL, V180, P443, DOI 10.1007/BF00305119; JAEGER C, 1981, HUM GENET, V56, P299, DOI 10.1007/BF00274683; KIDD JR, 1985, AM J HUM GENET, V37, P161; LYON MF, 1962, AM J HUM GENET, V14, P135; NAKAGAWA H, 1984, J INVEST DERMATOL, V83, P134, DOI 10.1111/1523-1747.ep12263325; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; NETTLESHIP E, 1909, T OPHTHALMOLOGICAL S, V29, P57; Newton JM, 1996, GENOMICS, V37, P219, DOI 10.1006/geno.1996.0545; ODONNELL FE, 1980, CLIN GENET, V17, P403; ODONNELL FE, 1976, ARCH OPHTHALMOL-CHIC, V94, P1883, DOI 10.1001/archopht.1976.03910040593001; ODONNELL FE, 1978, ARCH OPHTHALMOL-CHIC, V96, P1189, DOI 10.1001/archopht.1978.03910060023005; ODONNELL FE, 1978, ARCH OPHTHALMOL-CHIC, V96, P1621, DOI 10.1001/archopht.1978.03910060255013; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PEARCE WG, 1972, J MED GENET, V9, P126, DOI 10.1136/jmg.9.1.126; REICHEL M, 1992, PEDIATR DERMATOL, V9, P103, DOI 10.1111/j.1525-1470.1992.tb01223.x; RUSSELLEGGITT I, 1990, BRIT J OPHTHALMOL, V74, P136, DOI 10.1136/bjo.74.3.136; SCHIAFFINO MV, 1995, HUM MOL GENET, V4, P2319, DOI 10.1093/hmg/4.12.2319; SCHNUR RE, 1990, GENOMICS, V8, P255, DOI 10.1016/0888-7543(90)90280-8; SCHNUR RE, 1993, GENOMICS, V15, P500, DOI 10.1006/geno.1993.1100; SCHNUR RE, 1989, AM J HUM GENET, V45, P706; SCHNUR RE, 1994, AM J HUM GENET, V55, P484; SCHNUR RE, 1991, GENOMICS, V9, P605, DOI 10.1016/0888-7543(91)90353-G	29	54	59	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1998	62	4					800	809		10.1086/301776	http://dx.doi.org/10.1086/301776			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZM197	9529334	Green Published, hybrid			2022-12-18	WOS:000073514400010
J	Brennan, TMH; Landau, D; Shalev, H; Lamb, F; Schutte, BC; Walder, RY; Mark, AL; Carmi, R; Sheffield, VC				Brennan, TMH; Landau, D; Shalev, H; Lamb, F; Schutte, BC; Walder, RY; Mark, AL; Carmi, R; Sheffield, VC			Linkage of infantile Bartter syndrome with sensorineural deafness to chromosome 1p	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NA+/H+ ANTIPORTER; DNA; LOCALIZATION; MUTATIONS; CHANNEL; VARIANT; CLONING; GENE	Bartter syndrome (BS) is a family of disorders manifested by hypokalemic hypochloremic metabolic alkalosis with normotensive hyperreninemic hyperaldosteronism. We evaluated a unique, inbred Bedouin kindred in which sensorineural deafness (SND) cosegregates with an infantile variant of the BS phenotype. Using a DNA-pooling strategy, we screened the human genome and successfully demonstrated linkage of this unique syndrome to chromosome 1p31. The genes for two kidney-specific chloride channels and a sodium/hydrogen antiporter, located near this region, were excluded as candidate genes. Although the search for the disease-causing gene in this family continues, this linkage further demonstrates the genetic heterogeneity of BS. In addition, the cosegregation of these phenotypes allows us to postulate that a single genetic alteration may be responsible for the SND and the BS phenotype. The identification and characterization of this gene would lead to a better understanding of the normal physiology of the kidney and the inner ear.	Univ Iowa, Dept Pediat, Div Med Genet, Iowa City, IA 52242 USA; Univ Iowa, Dept Med, Iowa City, IA 52242 USA; Ben Gurion Univ Negev, Howard Hughes Med Inst, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Dept Pediat, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Soroka Med Ctr, Genet Inst, IL-84105 Beer Sheva, Israel	University of Iowa; University of Iowa; Ben Gurion University; Ben Gurion University; Ben Gurion University; Soroka Medical Center	Sheffield, VC (corresponding author), Univ Iowa, Dept Pediat, Div Med Genet, Iowa City, IA 52242 USA.	val-sheffield@uiowa.edu		Brennan, Theresa/0000-0003-4587-8696; Sheffield, Val/0000-0002-6282-0835	NHGRI NIH HHS [HG00457] Funding Source: Medline; NHLBI NIH HHS [HL-55006] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL055006] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000457] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BARTTER FC, 1962, AM J MED, V33, P811, DOI 10.1016/0002-9343(62)90214-0; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Brandt S, 1995, FEBS LETT, V377, P15, DOI 10.1016/0014-5793(95)01298-2; CARMI R, 1995, HUM MOL GENET, V4, P9, DOI 10.1093/hmg/4.1.9; Chodynicki S, 1974, Otolaryngol Pol, V28, P5; CLIVE DM, 1995, AM J KIDNEY DIS, V25, P813, DOI 10.1016/0272-6386(95)90562-6; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; GRAHAM RM, 1986, HYPERTENSION, V8, P549, DOI 10.1161/01.HYP.8.6.549; Higaki J, 1992, Nihon Rinsho, V50, P3106; IKEDA K, 1989, HEARING RES, V39, P279, DOI 10.1016/0378-5955(89)90047-6; KIEFERLE S, 1994, P NATL ACAD SCI USA, V91, P6943, DOI 10.1073/pnas.91.15.6943; Kockerling A, 1996, J PEDIATR-US, V129, P519, DOI 10.1016/S0022-3476(96)70116-6; LANDAU D, 1995, AM J MED GENET, V59, P454, DOI 10.1002/ajmg.1320590411; LLOYDMOSTYN RH, 1971, LANCET, V2, P1156; MATTEI MG, 1988, CYTOGENET CELL GENET, V48, P6, DOI 10.1159/000132575; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; RODRIGUES PR, 1983, AM J MED GENET, V15, P79; SARDET C, 1989, CELL, V56, P271, DOI 10.1016/0092-8674(89)90901-X; SEIFTER JL, 1986, J CLIN INVEST, V78, P859, DOI 10.1172/JCI112671; SEYBERTH HJ, 1996, OXFORD TXB CLIN NEPH, P1085; SEYBERTH HW, 1985, J PEDIATR-US, V107, P694, DOI 10.1016/S0022-3476(85)80395-4; SHEFFIELD VC, 1993, GENOMICS, V16, P325, DOI 10.1006/geno.1993.1193; SHEFFIELD VC, 1994, HUM MOL GENET, V3, P331; Simon DB, 1996, NAT GENET, V14, P152, DOI 10.1038/ng1096-152; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Simon DB, 1996, NAT GENET, V13, P183, DOI 10.1038/ng0696-183; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; STEEL KP, 1994, TRENDS GENET, V10, P428, DOI 10.1016/0168-9525(94)90113-9; STEIN JH, 1985, KIDNEY INT, V28, P85, DOI 10.1038/ki.1985.123; TAKEUCHI Y, 1995, KIDNEY INT, V48, P1497, DOI 10.1038/ki.1995.439; VARGISH T, 1970, ANN INTERN MED, V72, P761, DOI 10.7326/0003-4819-72-5-761_1; YOSHIDA H, 1994, KIDNEY INT, V46, P1505, DOI 10.1038/ki.1994.431	33	54	57	0	4	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1998	62	2					355	361		10.1086/301708	http://dx.doi.org/10.1086/301708			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA927	9463315	Green Published, Bronze			2022-12-18	WOS:000072416000019
J	Scott, DA; Carmi, R; Elbedour, K; Yosefsberg, S; Stone, EM; Sheffield, VC				Scott, DA; Carmi, R; Elbedour, K; Yosefsberg, S; Stone, EM; Sheffield, VC			An autosomal recessive nonsyndromic-hearing-loss locus identified by DNA pooling using two inbred Bedouin kindreds	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NON-SYNDROMIC DEAFNESS; PERICENTROMERIC REGION; MAPS; FORM; GENE; MITOCHONDRIAL; POPULATION; LINKAGE; HOMOLOG	Autosomal recessive nonsyndromic hearing loss (ARNSHL) is the most common form of severe inherited childhood deafness. We present the linkage analysis of two inbred Bedouin kindreds from Israel that are affected with ARNSHL. A rapid genomewide screen for markers linked to the disease was performed by using pooled DNA samples. This screen revealed evidence for linkage with markers D9S922 and D9S301 on chromosome 9q. Genotyping of individuals from both kindreds confirmed linkage to chromosome 9q and a maximum combined LOD score of 26.2 (recombination fraction [theta] .025) with marker D9S927. The disease locus was mapped to a 1.6-cM region of chromosome 9q13-q21, between markers D9S15 and D9S927. The disease segregates with a common haplotype in the two kindreds, at markers D9S927, D9S175, and D9S284 in the linked interval, supporting the hypothesis that both kindreds inherited the deafness gene from a common ancestor. Although this nonsyndromic-hearing-loss (NSHL) locus maps to the same cytogenetic interval as DFNB7, it does not overlap the currently defined DFNB7 interval and may represent (1) a novel form of NSHL in close proximity to DFNB7 or (2) a relocalization of the DFNB7 interval to a region telomeric to its reported location. This study further demonstrates that DNA pooling is an effective means of quickly identifying regions of linkage in inbred families with heterogeneous autosomal recessive disorders.	UNIV IOWA,DEPT PEDIAT,DIV MED GENET,IOWA CITY,IA 52242; UNIV IOWA,DEPT OPHTHALMOL,IOWA CITY,IA 52242; BEN GURION UNIV NEGEV,GENET INST,IL-84105 BEER SHEVA,ISRAEL; BEN GURION UNIV NEGEV,FAC HLTH SCI,SOROKA MED CTR,IL-84105 BEER SHEVA,ISRAEL	University of Iowa; University of Iowa; Ben Gurion University; Ben Gurion University; Soroka Medical Center				Stone, Edwin M./0000-0003-3343-4414; Sheffield, Val/0000-0002-6282-0835	NHGRI NIH HHS [HG00457, P50HG00835] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG000835, R01HG000457] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BALDWIN CT, 1995, HUM MOL GENET, V4, P1637, DOI 10.1093/hmg/4.9.1637; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; BU XD, 1993, GENET EPIDEMIOL, V10, P3, DOI 10.1002/gepi.1370100102; CARMI R, 1995, HUM MOL GENET, V4, P9, DOI 10.1093/hmg/4.1.9; Chaib H, 1996, HUM MOL GENET, V5, P155, DOI 10.1093/hmg/5.1.155; CHAIB H, 1994, HUM MOL GENET, V3, P2219, DOI 10.1093/hmg/3.12.2219; FRIEDMAN TB, 1995, NAT GENET, V9, P86, DOI 10.1038/ng0195-86; FUKUSHIMA K, 1995, GENOME RES, V5, P305, DOI 10.1101/gr.5.3.305; FUKUSHIMA K, 1995, HUM MOL GENET, V4, P1643, DOI 10.1093/hmg/4.9.1643; GUILFORD P, 1994, HUM MOL GENET, V3, P989, DOI 10.1093/hmg/3.6.989; GUILFORD P, 1994, NAT GENET, V6, P24, DOI 10.1038/ng0194-24; JAIN PK, 1995, HUM MOL GENET, V4, P2391, DOI 10.1093/hmg/4.12.2391; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; MARAZITA ML, 1993, AM J MED GENET, V46, P486, DOI 10.1002/ajmg.1320460504; Moatti L, 1990, Ann Otolaryngol Chir Cervicofac, V107, P181; Nystuen A, 1996, HUM MOL GENET, V5, P525, DOI 10.1093/hmg/5.4.525; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; REARDON W, 1992, J MED GENET, V29, P521, DOI 10.1136/jmg.29.8.521; SCOTT DA, 1995, AM J HUM GENET, V57, P965; SHEFFIELD VC, 1995, CURR OPIN GENET DEV, V5, P335, DOI 10.1016/0959-437X(95)80048-4; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; SHEFFIELD VC, 1994, HUM MOL GENET, V3, P1331, DOI 10.1093/hmg/3.8.1331; Veske A, 1996, HUM MOL GENET, V5, P165, DOI 10.1093/hmg/5.1.165	23	54	56	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1996	59	2					385	391						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VM288	8755925				2022-12-18	WOS:A1996VM28800014
J	Sullivan, BA; Jenkins, LS; Karson, EM; LeanaCox, J; Schwartz, S				Sullivan, BA; Jenkins, LS; Karson, EM; LeanaCox, J; Schwartz, S			Evidence for structural heterogeneity from molecular cytogenetic analysis of dicentric Robertsonian translocations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN ACROCENTRIC CHROMOSOMES; SATELLITE-III DNA; FLUORESCENCE INSITU HYBRIDIZATION; IDENTIFICATION; SUBFAMILY; SEQUENCES; REGIONS; BREAKPOINTS	Most Robertsonian translocations are dicentric, suggesting that the location of chromosomal breaks leading to their formation occur in the acrocentric short arm. Previous cytogenetic and molecular cytogenetic studies have shown that few Robertsonian translocations retain ribosomal genes or beta-satellite DNA. Breakpoints in satellite III DNA, specifically between two chromosome 14-specific subfamilies, pTRS-47 and pTRS-63, have been indicated for most of the dicentric 14q21q and 13q14q translocations that have been studied. We have analyzed the structure of 36 dicentric translocations, using several repetitive DNA probes that localize to the acrocentric short arm. The majority of the translocations retained satellite III DNA, while others proved variable in structure. Of 10 14q21q translocations analyzed, satellite III DNA was undetected in 1; 6 retained one satellite III DNA subfamily, pTRS-47; and 3 appeared to contain two 14-specific satellite III DNA subfamilies, pTRS-47 and pTRS-63. In 10/11 translocations involving chromosome 15, the presence of satellite III DNA was observed. Our results show that various regions of the acrocentric short arm, and, particularly, satellite III DNA sequences, are involved in the formation of Robertsonian translocations.	CASE WESTERN RESERVE UNIV,DEPT GENET,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,CTR HUMAN GENET,CLEVELAND,OH 44106; UNIV HOSP CLEVELAND,CLEVELAND,OH 44106; UNIV MARYLAND,DIV HUMAN GENET,BALTIMORE,MD 21201; KAISER PERMANENTE MED GRP,SAN JOSE,CA; COLUMBIA WOMENS HOSP MED CTR,WASHINGTON,DC	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; University System of Maryland; University of Maryland Baltimore; Kaiser Permanente; Permanente Medical Groups			Sullivan, Beth A/Q-3456-2017	Sullivan, Beth A/0000-0001-5216-4603	NICHD NIH HHS [P01 HD32111] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD032111] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; BRASCH JM, 1979, CYTOGENET CELL GENET, V24, P122, DOI 10.1159/000131365; CHEUNG SW, 1990, CYTOGENET CELL GENET, V54, P97, DOI 10.1159/000132970; CHOO KH, 1990, GENOMICS, V7, P143, DOI 10.1016/0888-7543(90)90534-2; CHOO KH, 1988, NUCLEIC ACIDS RES, V16, P1273, DOI 10.1093/nar/16.4.1273; CHOO KH, 1990, NUCLEIC ACIDS RES, V18, P5641, DOI 10.1093/nar/18.19.5641; CHOO KHA, 1992, AM J HUM GENET, V50, P706; DANIEL A, 1976, J MED GENET, V13, P381, DOI 10.1136/jmg.13.5.381; EARLE E, 1992, AM J HUM GENET, V50, P717; FERGUSONSMITH MA, 1967, LANCET, V1, P1156; GOSDEN JR, 1981, AM J HUM GENET, V33, P243; GRAVHOLT CH, 1992, GENOMICS, V14, P924, DOI 10.1016/S0888-7543(05)80113-2; GUICHAOUA MR, 1986, CYTOGENET CELL GENET, V42, P191, DOI 10.1159/000132277; HAMERTON JL, 1975, CLIN GENET, V84, P63; HAN JY, 1994, AM J HUM GENET, V55, P960; HIGGINS MJ, 1985, CHROMOSOMA, V93, P77, DOI 10.1007/BF01259449; KALITSIS P, 1993, GENOMICS, V16, P104, DOI 10.1006/geno.1993.1147; MATTEI MG, 1979, HUM GENET, V54, P265; MIKKELSEN M, 1980, CYTOGENET CELL GENET, V26, P14, DOI 10.1159/000131416; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; NIEBUHR E, 1972, HUMANGENETIK, V16, P217, DOI 10.1007/BF00273467; Robertson WRB, 1916, J MORPHOL, V27, P179, DOI 10.1002/jmor.1050270202; SEABRIGH.M, 1971, LANCET, V2, P971; SULLIVAN BA, 1994, CHROMOSOMA, V103, P459; SULLIVAN BA, 1995, HUM MOL GENET, V4, P2189, DOI 10.1093/hmg/4.12.2189; THERMAN E, 1989, ANN HUM GENET, V53, P49, DOI 10.1111/j.1469-1809.1989.tb01121.x; THERMAN E, 1980, UMAN CHROMOSOMES STR; TROWELL HE, 1993, HUM MOL GENET, V2, P1639, DOI 10.1093/hmg/2.10.1639; WOLFF DJ, 1992, AM J HUM GENET, V50, P174	29	54	64	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1996	59	1					167	175						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL455	8659523				2022-12-18	WOS:A1996VL45500024
J	Ikeuchi, T; Igarashi, S; Takiyama, Y; Onodera, O; Oyake, M; Takano, H; Koide, R; Tanaka, H; Tsuji, S				Ikeuchi, T; Igarashi, S; Takiyama, Y; Onodera, O; Oyake, M; Takano, H; Koide, R; Tanaka, H; Tsuji, S			Non-Mendelian transmission in Dentatorubral-Pallidoluysian atrophy and Machado-Joseph disease: The mutant allele is preferentially transmitted in male meiosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MEIOTIC DRIVE; GENE	Autosomal dominant dentatorubral-pallidoluysian atrophy (DRPLA) and Machado-Joseph disease (MJD) are neurodegenerative disorders caused by CAG trinucleotide repeat expansions. An inverse correlation of age at onset with the length of the expanded CAG trinucleotide repeats has been demonstrated, and the intergenerational instability of the length of the CAG trinucleotide repeats, which is more prominent in paternal than in maternal transmissions, has been shown to underlie the basic mechanisms of anticipation in DRPLA and MJD. Our previous observations on DRPLA and MJD pedigrees, as well as a review of the literature, have suggested that the numbers of affected offspring exceed those of unaffected offspring, which is difficult to explain by the Mendelian principle of random segregation of alleles. In the present study, we analyzed the segregation patterns in 211 transmissions in 24 DRPLA pedigrees and 80 transmissions in 7 MJD pedigrees, with the diagnoses confirmed by molecular testing. Significant distortions in favor of transmission of the mutant alleles were found in male meiosis, where the mutant alleles were transmitted to 62% of all offspring in DRPLA (chi(2) = 7.69; P < .01) and 73% in MJD (chi(2) = 6.82; P < .01). The results were consistent with meiotic drive in DRPLA and MJD. Since more prominent meiotic instability of the length of the CAG trinucleotide repeats is observed in male meiosis than in female meiosis and meiotic drive is observed only in male meiosis, these results raise the possibility that a common molecular mechanism underlies the meiotic drive and the meiotic instability in male meiosis.	NIIGATA UNIV,BRAIN RES INST,DEPT NEUROL,NIIGATA 951,JAPAN; JICHI MED SCH,DEPT NEUROL,TOCHIGI,JAPAN	Niigata University; Jichi Medical University			Onodera, Osamu/K-7327-2013	Onodera, Osamu/0000-0003-3354-5472				CAREY N, 1994, NAT GENET, V6, P117, DOI 10.1038/ng0294-117; CAREY N, 1995, NAT GENET, V10, P133, DOI 10.1038/ng0695-133; EVANS K, 1994, NAT GENET, V6, P210, DOI 10.1038/ng0294-210; GENNARELLI M, 1994, J MED GENET, V31, P980, DOI 10.1136/jmg.31.12.980; HURST GDD, 1995, NAT GENET, V10, P132, DOI 10.1038/ng0695-132; IKEUCHI T, 1995, SEMIN CELL BIOL, V6, P37, DOI 10.1016/1043-4682(95)90013-6; IKEUCHI T, 1995, ANN NEUROL, V37, P769, DOI 10.1002/ana.410370610; JARVIK GP, 1994, AM J HUM GENET, V55, P710; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KOMURE O, 1995, NEUROLOGY, V45, P143, DOI 10.1212/WNL.45.1.143; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LYTTLE TW, 1993, TRENDS GENET, V9, P205, DOI 10.1016/0168-9525(93)90120-7; MARUYAMA H, 1995, HUM MOL GENET, V4, P807, DOI 10.1093/hmg/4.5.807; MUNIER F, 1992, HUM GENET, V89, P508, DOI 10.1007/BF00219175; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; NAITO H, 1982, NEUROLOGY, V32, P798, DOI 10.1212/WNL.32.8.798; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; RAJU NB, 1991, GENETICS, V129, P25; ROSENBERG RN, 1976, NEUROLOGY, V26, P703, DOI 10.1212/WNL.26.8.703; SILVER LM, 1993, TRENDS GENET, V9, P250, DOI 10.1016/0168-9525(93)90090-5; TAKIYAMA Y, 1995, HUM MOL GENET, V4, P1137, DOI 10.1093/hmg/4.7.1137; 1993, CELL, V72, P971	23	54	56	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1996	58	4					730	733						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UA380	8644735				2022-12-18	WOS:A1996UA38000009
J	WUYTS, W; RAMLAKHAN, S; VANHUL, W; HECHT, JT; VANDENOUWELAND, AMW; RASKIND, WH; HOFSTEDE, FC; REYNIERS, E; WELLS, DE; DEVRIES, B; CONRAD, EU; HILL, A; ZALATAYEV, D; WEISSENBACH, J; WAGNER, MJ; BAKKER, E; HALLEY, DJJ; WILLEMS, PJ				WUYTS, W; RAMLAKHAN, S; VANHUL, W; HECHT, JT; VANDENOUWELAND, AMW; RASKIND, WH; HOFSTEDE, FC; REYNIERS, E; WELLS, DE; DEVRIES, B; CONRAD, EU; HILL, A; ZALATAYEV, D; WEISSENBACH, J; WAGNER, MJ; BAKKER, E; HALLEY, DJJ; WILLEMS, PJ			REFINEMENT OF THE MULTIPLE EXOSTOSES LOCUS (EXT2) TO A 3-CM INTERVAL ON CHROMOSOME-11	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RHINO-PHALANGEAL SYNDROME; INTERSTITIAL DELETION; MENTAL-RETARDATION	Hereditary multiple exostoses (EXT) is an autosomal dominant skeletal disorder characterized by the formation of multiple exostoses on the long bones. EXT is genetically heterogeneous, with at least three loci involved: one (EXT1) in the Langer-Giedion region on 8q23-q24, a second (EXT2) in the pericentromeric region of chromosome 11, and a third (EXT3) on chromosome 19p. In this study, linkage analysis in seven extended EXT families, all linked to the EXT2 locus, refined the localization of the EXT2 gene to a 3-cM region flanked by D11S1355 and D11S13G1/D11S554. This implies that the EXT2 gene is located at the short arm of chromosome 11, in band 11p11-p12. The refined localization of EXT2 excludes a number of putative candidate genes located in the pericentromeric region of chromosome 11 and facilitates the process of isolating the EXT2 gene.	UNIV ANTWERP,DEPT MED GENET,B-2610 ANTWERP,BELGIUM; ERASMUS UNIV ROTTERDAM,DEPT CLIN GENET,ROTTERDAM,NETHERLANDS; UNIV ROTTERDAM HOSP,ROTTERDAM,NETHERLANDS; UNIV TEXAS,HLTH SCI CTR,DEPT PEDIAT,HOUSTON,TX; UNIV HOUSTON,DEPT BIOL,HOUSTON,TX; UNIV HOUSTON,INST MOLEC BIOL,HOUSTON,TX; UNIV WASHINGTON,DEPT MED,SEATTLE,WA; UNIV WASHINGTON,DEPT ORTHOPAED,SEATTLE,WA; LEIDEN UNIV,DEPT HUMAN GENET,LEIDEN,NETHERLANDS; RUSSIAN ACAD MED SCI,MED GENET RES CTR,MOSCOW,RUSSIA; GENETHON,EVRY,FRANCE	University of Antwerp; Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus MC; University of Texas System; University of Texas Health Science Center Houston; University of Houston System; University of Houston; University of Houston System; University of Houston; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Leiden University; Leiden University - Excl LUMC; Research Centre for Medical Genetics; Russian Academy of Medical Sciences			Zaletaev, Dmitri V/E-5331-2010; /AAD-2181-2020; Bakker, Egbert/D-3525-2009; wuyts, wim/B-6262-2017	Zaletaev, Dmitri V/0000-0002-9323-2673; Bakker, Egbert/0000-0002-2843-7357; wuyts, wim/0000-0002-4349-9038; Van Hul, Wim/0000-0002-5065-7858	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027981] Funding Source: NIH RePORTER; NICHD NIH HHS [HD27981] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ADAMS MD, 1992, NATURE, V355, P632, DOI 10.1038/355632a0; BUHLER EM, 1984, AM J MED GENET, V19, P113, DOI 10.1002/ajmg.1320190111; COOK A, 1993, AM J HUM GENET, V53, P71; COUILLIN P, 1994, GENOMICS, V21, P379, DOI 10.1006/geno.1994.1280; Eder H G, 1993, J Neurosurg Sci, V37, P53; GOLDBLATT J, 1986, CLIN GENET, V29, P434; GREWAL RP, 1992, GENOMICS, V13, P239, DOI 10.1016/0888-7543(92)90236-L; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HENNEKAM RCM, 1991, J MED GENET, V28, P262, DOI 10.1136/jmg.28.4.262; Jaffe HL, 1943, ARCH PATHOL, V36, P335; JAMES MR, 1994, NAT GENET, V8, P70, DOI 10.1038/ng0994-70; KNUDSON AG, 1976, NEW ENGL J MED, V45, P1120; LANGER LO, 1984, AM J MED GENET, V19, P81, DOI 10.1002/ajmg.1320190110; LEMERRER M, 1994, HUM MOL GENET, V3, P717, DOI 10.1093/hmg/3.5.717; POHLMANN R, 1988, EMBO J, V7, P2343, DOI 10.1002/j.1460-2075.1988.tb03078.x; Raskind W. H., 1994, American Journal of Human Genetics, V55, pA67; SCHMALE GA, 1994, J BONE JOINT SURG AM, V76A, P986, DOI 10.2106/00004623-199407000-00005; SHAFFER LG, 1993, AM J MED GENET, V45, P581, DOI 10.1002/ajmg.1320450512; SOLOMON L, 1961, J BONE JOINT SURG BR, V43, P700, DOI 10.1302/0301-620X.43B4.700; TOKINO T, 1991, AM J HUM GENET, V48, P258; VANCONG N, 1990, HUM GENET, V84, P542; WEN DY, 1989, NEUROSURGERY, V25, P472, DOI 10.1227/00006123-198909000-00028; WICKLUND CL, 1995, AM J MED GENET, V55, P43, DOI 10.1002/ajmg.1320550113; WU YQ, 1994, HUM MOL GENET, V3, P167	24	54	56	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1995	57	2					382	387						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RL771	7668264				2022-12-18	WOS:A1995RL77100021
J	SHIH, VE; FRINGER, JM; MANDELL, R; KRAUS, JP; BERRY, GT; HEIDENREICH, RA; KORSON, MS; LEVY, HL; RAMESH, V				SHIH, VE; FRINGER, JM; MANDELL, R; KRAUS, JP; BERRY, GT; HEIDENREICH, RA; KORSON, MS; LEVY, HL; RAMESH, V			A MISSENSE MUTATION (1278T) IN THE CYSTATHIONINE BETA-SYNTHASE GENE PREVALENT IN PYRIDOXINE-RESPONSIVE HOMOCYSTINURIA, AND ASSOCIATED WITH MILD CLINICAL PHENOTYPE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEFICIENCY; PATIENT	Cystathionine beta-synthase (CBS) deficiency is an autosomal recessive disorder characterized by homocystinuria and multisystem clinical disease. Patients responsive to pyridoxine usually have a milder clinical phenotype than do nonresponsive patients, and we studied the molecular pathology of this disorder in an attempt to understand the molecular basis of the clinical variation. We previously reported a T833C transition in exon 8 causing a substitution of threonine for isoleucine at codon 278 (I278T). By PCR amplification and sequencing of exon 8 from genomic DNA we have now detected the I278T mutation in 7 of 11 patients with in vivo pyridoxine responsiveness and in 0 of 27 pyridoxine-nonresponsive patients. Two pyridoxine-responsive patients are homezygous and five are heterozygous for I278T. We have now observed the I278T mutation in 41% (9 of 22) of the independent alleles in pyridoxine-responsive patients of varied ethnic backgrounds. In two of the compound heterozygotes we identified a novel mutation (G139R and E144K) in the other allele. The finding that the two patients who are homozygous for I278T have only ectopia lentis and mild bone demineralization suggests that this mutation is associated with both in vivo pyridoxine responsiveness and mild clinical disease. Compound heterozygous patients who have one copy of this missense mutation are likely to retain some degree of pyridoxine responsiveness.	MASSACHUSETTS GEN HOSP,AMINO ACID DISORDER LAB,CHILDRENS SERV,BOSTON,MA 02129; CHILDRENS HOSP,BOSTON,MA; UNIV COLORADO,SCH MED,DENVER,CO; CHILDRENS HOSP PHILADELPHIA,PHILADELPHIA,PA 19104; UNIV ARIZONA,TUCSON,AZ	Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Arizona	SHIH, VE (corresponding author), MASSACHUSETTS GEN HOSP,AMINO ACID DISORDER LAB,NEUROL SERV,BLDG 149,13TH ST,BOSTON,MA 02129, USA.			Berry, Gerard/0000-0001-5299-3313	NINDS NIH HHS [NS05096] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; GALLAGHER PM, IN PRESS HUM MUTAT; GAULL S, 1974, J PEDIATR, V84, P381; HU FL, 1993, HUM MOL GENET, V2, P1857, DOI 10.1093/hmg/2.11.1857; KERY V, 1994, J BIOL CHEM, V269, P25283; KOCH HG, 1994, 6TH INT C INB ERR ME; KOZICH V, 1993, HUM MOL GENET, V2, P815, DOI 10.1093/hmg/2.6.815; Kozich Viktor, 1992, Human Mutation, V1, P113, DOI 10.1002/humu.1380010206; KRAUS JP, 1994, J INHERIT METAB DIS, V17, P383, DOI 10.1007/BF00711354; LIPSON MH, 1980, J CLIN INVEST, V66, P188, DOI 10.1172/JCI109843; RAMESH V, 1986, DNA-J MOLEC CELL BIO, V5, P493, DOI 10.1089/dna.1.1986.5.493; Sebastio G., 1994, American Journal of Human Genetics, V55, pA241; Shih V. E., 1994, American Journal of Human Genetics, V55, pA242; UHLENDOR.BW, 1973, PEDIATR RES, V7, P645, DOI 10.1203/00006450-197307000-00008	14	54	56	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1995	57	1					34	39						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RE629	7611293				2022-12-18	WOS:A1995RE62900004
J	JOUET, M; MONCLA, A; PATERSON, J; MCKEOWN, C; FRYER, A; CARPENTER, N; HOLMBERG, E; WADELIUS, C; KENWRICK, S				JOUET, M; MONCLA, A; PATERSON, J; MCKEOWN, C; FRYER, A; CARPENTER, N; HOLMBERG, E; WADELIUS, C; KENWRICK, S			NEW DOMAINS OF NEURAL CELL-ADHESION MOLECULE L1 IMPLICATED IN X-LINKED HYDROCEPHALUS AND MASA SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IMMUNOGLOBULIN SUPERFAMILY; SPASTIC PARAPLEGIA; MENTAL-RETARDATION; NEURITE OUTGROWTH; MESSENGER-RNA; DNA PROBES; MUTATION; LINKAGE; MEMBER; L1CAM	The neural cell-adhesion molecule L1 is involved in intercellular recognition and neuronal migration in the CNS. Recently, we have shown that mutations in the gene encoding L1 are responsible for three related disorders; X-linked hydrocephalus, MASA (mental retardation, aphasia, shuffling gait, and adducted thumbs) syndrome, and spastic paraplegia type I (SPG1). These three disorders represent a clinical spectrum that varies not only between families but sometimes also within families. To date, 14 independent L1 mutations have been reported and shown to be disease causing. Here we report nine novel L1 mutations in X-linked hydrocephalus and MASA-syndrome families, including the first examples of mutations affecting the fibronectin type III domains of the molecule. They are discussed in relation both to phenotypes and to the insights that they provide into L1 function.	DUNCAN GUTHRIE INST MED GENET,GLASGOW,LANARK,SCOTLAND; HOP ENFANTS LA TIMONE,MARSEILLE,FRANCE; E BIRMINGHAM DIST GEN HOSP,CLIN GENET UNIT,BIRMINGHAM,W MIDLANDS,ENGLAND; UNIV LIVERPOOL,ROYAL LIVERPOOL HOSP,LIVERPOOL L69 3BX,MERSEYSIDE,ENGLAND; HA CHAPMAN INST MED GENET,TULSA,OK; UNIV HOSP NO SWEDEN,DEPT CLIN GENET,UMEA,SWEDEN; UNIV UPPSALA HOSP,DEPT CLIN GENET,UPPSALA,SWEDEN	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; Umea University; Uppsala University; Uppsala University Hospital	JOUET, M (corresponding author), UNIV CAMBRIDGE,ADDENBROOKES HOSP,DEPT MED,LEVEL 5,HILLS RD,CAMBRIDGE CB2 2QQ,ENGLAND.							APPEL F, 1993, J NEUROSCI, V13, P4764; BIANCHINE JW, 1974, CLIN GENET, V5, P298; BICKERS DS, 1949, BRAIN, V72, P246, DOI 10.1093/brain/72.2.246; BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; BURGOON MP, 1991, J CELL BIOL, V112, P1017, DOI 10.1083/jcb.112.5.1017; COUCKE P, 1994, HUM MOL GENET, V3, P671, DOI 10.1093/hmg/3.4.671; DAVIS JQ, 1991, J BIOL CHEM, V269, P27163; EDWARDS JH, 1961, ARCH DIS CHILD, V36, P481, DOI 10.1136/adc.36.189.481; FRANSEN E, 1994, HUM MOL GENET, V3, P2255, DOI 10.1093/hmg/3.12.2255; FRIEDLANDER DR, 1994, J CELL BIOL, V125, P669, DOI 10.1083/jcb.125.3.669; FRYNS JP, 1991, J MED GENET, V28, P429, DOI 10.1136/jmg.28.6.429-a; GAREIS FJ, 1984, AM J MED GENET, V17, P333, DOI 10.1002/ajmg.1320170126; Grumet M, 1991, Curr Opin Neurobiol, V1, P370, DOI 10.1016/0959-4388(91)90055-C; HALLIDAY J, 1986, J MED GENET, V23, P23, DOI 10.1136/jmg.23.1.23; HLAVIN ML, 1991, GENOMICS, V11, P416, DOI 10.1016/0888-7543(91)90150-D; JOUET M, 1993, J MED GENET, V30, P214, DOI 10.1136/jmg.30.3.214; JOUET M, 1994, NAT GENET, V7, P402, DOI 10.1038/ng0794-402; JOUET M, 1995, LANCET, V345, P161, DOI 10.1016/S0140-6736(95)90170-1; JOUET M, 1993, NAT GENET, V4, P331, DOI 10.1038/ng0893-331; JOUET M, IN PRESS MOL BRAIN R; KENWRICK S, 1986, HUM GENET, V73, P264, DOI 10.1007/BF00401241; KRAWCZAK M, 1992, HUM GENET, V90, P41; KUHN TB, 1991, J CELL BIOL, V115, P1113, DOI 10.1083/jcb.115.4.1113; KUPPUSWAMY MN, 1991, P NATL ACAD SCI USA, V88, P1143, DOI 10.1073/pnas.88.4.1143; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; MIURA M, 1991, FEBS LETT, V289, P91, DOI 10.1016/0014-5793(91)80915-P; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; REED R, 1989, GENE DEV, V3, P2113, DOI 10.1101/gad.3.12b.2113; Rosenthal A, 1992, DNA Seq, V3, P61, DOI 10.3109/10425179209039697; ROSENTHAL A, 1992, NAT GENET, V2, P107, DOI 10.1038/ng1092-107; Rutishauser U, 1989, CURR OPIN CELL BIOL, V1, P898, DOI 10.1016/0955-0674(89)90056-2; SCHRANDERSTUMPEL C, 1990, J MED GENET, V27, P688, DOI 10.1136/jmg.27.11.688; SONDEREGGER P, 1992, J CELL BIOL, V119, P1387, DOI 10.1083/jcb.119.6.1387; VANCAMP G, 1993, NAT GENET, V4, P421; VITS L, 1994, NAT GENET, V7, P408, DOI 10.1038/ng0794-408; WILLEMS PJ, 1987, AM J MED GENET, V27, P921, DOI 10.1002/ajmg.1320270419; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; WINTER RM, 1989, HUM GENET, V82, P367; YEATMAN GW, 1984, AM J MED GENET, V17, P339, DOI 10.1002/ajmg.1320170127	39	54	56	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1995	56	6					1304	1314						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA794	7762552				2022-12-18	WOS:A1995RA79400007
J	BALDWIN, CT; FARRER, LA; ADAIR, R; DHARMAVARAM, R; JIMENEZ, S; ANDERSON, L				BALDWIN, CT; FARRER, LA; ADAIR, R; DHARMAVARAM, R; JIMENEZ, S; ANDERSON, L			LINKAGE OF EARLY-ONSET OSTEOARTHRITIS AND CHONDROCALCINOSIS TO HUMAN-CHROMOSOME 8Q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							II GENE COL2A1; HEREDITARY CHONDROCALCINOSIS; SPONDYLOEPIPHYSEAL DYSPLASIA; ARTICULAR CHONDROCALCINOSIS; FAMILY; MUTATION; CHONDRODYSPLASIA; SUBSTITUTION; ASSOCIATION; PREVALENCE	Calcium pyrophosphate-deposition disease (CPDD), also called ''chondrocalcinosis'' or ''pseudogout,'' is a disorder characterized by the deposition of calcium-containing crystals in joint tissue, which leads to arthritis-like symptoms. The presence of these crystals in joint tissue is a common finding in the elderly, and, in this population, there is a poor correlation with joint pain. In contrast, early-onset CPDD has been described in several large families in which the disease progresses to severe degenerative osteoarthritis (OA). In these families, an autosomal dominant mode of inheritance is observed, with an age at onset between the 2d and 5th decades of life. In this report, we describe a large New England family with early-onset CPDD and severe degenerative OA. We found genetic linkage between the disease in this family and chromosome 8q, with a multipoint lod score of 4.06. These results suggest that a defective gene at this location causes the disease in this family.	BOSTON UNIV,SCH MED,DEPT PEDIAT,BOSTON,MA 02118; BOSTON UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02118; BOSTON UNIV,SCH MED,DEPT EPIDEMIOL & BIOSTAT,BOSTON,MA 02118; THOMAS JEFFERSON UNIV,DEPT MED,PHILADELPHIA,PA 19107; RHEUMATOL ASSOCIATES,PORTLAND,ME	Boston University; Boston University; Boston University; Jefferson University	BALDWIN, CT (corresponding author), BOSTON UNIV,SCH MED,CTR HUMAN GENET,80 E CONCORD ST,BOSTON,MA 02118, USA.		Farrer, Lindsay/AAS-1035-2020	Farrer, Lindsay/0000-0001-5533-4225; Baldwin, Clinton/0000-0002-3275-9463; Jimenez, Sergio/0000-0001-5213-1203	NIAMS NIH HHS [AR40152] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR040152] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AHMAD NN, 1991, P NATL ACAD SCI USA, V88, P6624, DOI 10.1073/pnas.88.15.6624; ALAKOKKO L, 1990, P NATL ACAD SCI USA, V87, P6565, DOI 10.1073/pnas.87.17.6565; BADLEY EM, 1994, J RHEUMATOL, V21, P505; BALSA A, 1990, ANN RHEUM DIS, V49, P531, DOI 10.1136/ard.49.7.531; BOGAERT R, 1992, J BIOL CHEM, V267, P22522; BOWCOCK AM, 1987, AM J HUM GENET, V41, P27; BRAVERMAN MS, 1985, COMPUT BIOMED RES, V18, P24, DOI 10.1016/0010-4809(85)90004-7; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; DOHERTY M, 1991, BRIT J RHEUMATOL, V30, P10; ESHEL G, 1990, ANN RHEUM DIS, V49, P528, DOI 10.1136/ard.49.7.528; FAM A G, 1992, Current Opinion in Rheumatology, V4, P574; FELSON DT, 1989, J RHEUMATOL, V16, P1241; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HAMZA M, 1992, CLIN EXP RHEUMATOL, V10, P43; LEDINGHAM J, 1992, ANN RHEUM DIS, V51, P1111, DOI 10.1136/ard.51.10.1111; LEE B, 1989, SCIENCE, V244, P978, DOI 10.1126/science.2543071; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; NACCACHE PH, 1993, ARTHRITIS RHEUM, V36, P117, DOI 10.1002/art.1780360119; OEHLMANN R, 1994, AM J HUM GENET, V54, P3; PATTRICK M, 1993, ANN RHEUM DIS, V52, P97, DOI 10.1136/ard.52.2.97; PUN YL, 1994, ARTHRITIS RHEUM, V37, P264, DOI 10.1002/art.1780370216; RICHARDSON BC, 1983, ARTHRITIS RHEUM, V26, P1387, DOI 10.1002/art.1780261112; Ryan L M, 1993, Curr Opin Rheumatol, V5, P517; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANMARTI R, 1993, ANN RHEUM DIS, V52, P418, DOI 10.1136/ard.52.6.418; TILLER GE, 1990, P NATL ACAD SCI USA, V87, P3889, DOI 10.1073/pnas.87.10.3889; VISSING H, 1989, J BIOL CHEM, V264, P18265; WARMAN ML, 1993, NAT GENET, V5, P79, DOI 10.1038/ng0993-79; WILLIAMS CJ, 1993, HUM GENET, V92, P499, DOI 10.1007/BF00216458	29	54	56	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1995	56	3					692	697						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QK918	7887424				2022-12-18	WOS:A1995QK91800019
J	WILDIN, RS; ANTUSH, MJ; BENNETT, RL; SCHOOF, JM; SCOTT, CR				WILDIN, RS; ANTUSH, MJ; BENNETT, RL; SCHOOF, JM; SCOTT, CR			HETEROGENEOUS AVPR2 GENE-MUTATIONS IN CONGENITAL NEPHROGENIC DIABETES-INSIPIDUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LUTEINIZING-HORMONE RECEPTOR; HUMAN ANTIDIURETIC-HORMONE; ADRENOCORTICOTROPIN RECEPTOR; GLUCOCORTICOID DEFICIENCY; RETINITIS-PIGMENTOSA; ALPHA-GALACTOSIDASE; PRECOCIOUS PUBERTY; POINT MUTATION; RHODOPSIN GENE; DIRECT REPEATS	Mutations in the AVPR2 gene encoding the receptor for arginine vasopressin in the kidney (V2 ADHR) have been reported in patients with congenital nephrogenic diabetes insipidus, a predominantly X-linked disorder of water homeostasis. We have used restriction-enzyme analysis and direct DNA sequencing of genomic PCR product to evaluate the AVPR2 gene in 11 unrelated affected males. Each patient has a different DNA sequence variation, and only one matches a previously reported mutation. Cosegregation of the variations with nephrogenic diabetes insipidus was demonstrated for two families, and a de novo mutation was documented in two additional cases. Carrier detection was accomplished in one family. All the variations predict frameshifts, truncations, or nonconservative amino acid substitutions in evolutionarily conserved positions in the V2 ADHR and related receptors. Of interest, a 28-bp deletion is found in one patient, while another, unrelated patient has a tandem duplication of the same 28-bp segment, suggesting that both resulted from the same unusual unequal crossing-over mechanism facilitated by 9-mer direct sequence repeats. Since the V2 ADHR is a member of the seven-transmembrane-domain, G-protein-coupled receptor superfamily, the loss-of-function mutations from this study and others provide important clues to the structure-function relationship of this and related receptors.	UNIV WASHINGTON, DEPT PEDIAT, DIV GEN PEDIAT, SEATTLE, WA 98195 USA	University of Washington; University of Washington Seattle					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD028834] Funding Source: NIH RePORTER; NICHD NIH HHS [NICHD HD28834] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BICHET DG, 1993, J CLIN INVEST, V92, P1262, DOI 10.1172/JCI116698; BIRNBAUMER M, 1992, NATURE, V357, P333, DOI 10.1038/357333a0; BRADLEY TB, 1967, SCIENCE, V157, P1581, DOI 10.1126/science.157.3796.1581; BRAUN EJ, 1989, AM J PHYSIOL, V256, pF639, DOI 10.1152/ajprenal.1989.256.4.F639; CARREEUSEBE D, 1992, HUM GENET, V90, P389; CLAPHAM DE, 1993, CELL, V75, P1237, DOI 10.1016/0092-8674(93)90609-T; CLARK AJL, 1993, LANCET, V341, P461, DOI 10.1016/0140-6736(93)90208-X; DEEB SS, 1992, AM J HUM GENET, V51, P687; DEMARCO L, 1993, AM J HUM GENET, V53, P423; DIEM K, INTRO STATISTICS STA, V2; DOHLMAN HG, 1987, BIOCHEMISTRY-US, V26, P2657, DOI 10.1021/bi00384a001; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; EFSTRATIADIS A, 1980, CELL, V21, P653, DOI 10.1016/0092-8674(80)90429-8; FUKUHARA Y, 1990, BIOCHEM BIOPH RES CO, V170, P296, DOI 10.1016/0006-291X(90)91273-U; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; HOLTZMAN EJ, 1993, HUM MOL GENET, V2, P1201, DOI 10.1093/hmg/2.8.1201; HOMMA S, 1991, AM J PHYSIOL, V261, pF345, DOI 10.1152/ajprenal.1991.261.2.F345; JANS DA, 1990, J BIOL CHEM, V265, P15379; KAMBOURIS M, 1988, AM J MED GENET, V29, P239, DOI 10.1002/ajmg.1320290138; KAWATA R, 1988, HEMOGLOBIN, V12, P311, DOI 10.3109/03630268808998032; KNOERS N, 1988, HUM GENET, V80, P31, DOI 10.1007/BF00451451; KOEBERL DD, 1990, AM J HUM GENET, V47, P202; KORNREICH R, 1990, J BIOL CHEM, V265, P9319; KOZAK CA, 1977, EXP CELL RES, V105, P109, DOI 10.1016/0014-4827(77)90156-2; KRAWCZAK M, 1991, HUM GENET, V86, P425; KREMER H, 1993, HUM MOL GENET, V2, P1779, DOI 10.1093/hmg/2.11.1779; KUHL DPA, 1993, CURR OPIN GENET DEV, V3, P404, DOI 10.1016/0959-437X(93)90112-3; LANGLEY JM, 1991, AM J MED GENET, V38, P90, DOI 10.1002/ajmg.1320380120; LOLAIT SJ, 1992, NATURE, V357, P336, DOI 10.1038/357336a0; MERENDINO JJ, 1993, NEW ENGL J MED, V328, P1538, DOI 10.1056/NEJM199305273282106; MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561; MOSES AM, 1988, J CLIN ENDOCR METAB, V66, P1259, DOI 10.1210/jcem-66-6-1259; NATHANS J, 1992, BIOCHEMISTRY-US, V31, P4923, DOI 10.1021/bi00136a001; PAN Y, 1992, NAT GENET, V2, P103, DOI 10.1038/ng1092-103; PANG Y, 1993, AM J HUM GENET, V53, P938; PARMA J, 1993, NATURE, V365, P649, DOI 10.1038/365649a0; POLLAK MR, 1993, CELL, V75, P1297, DOI 10.1016/0092-8674(93)90617-Y; REEVES WB, 1989, METABOLIC BASIS INHE, P1985; RICHARDS AJ, 1992, HUM GENET, V88, P325, DOI 10.1007/BF00197268; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209; ROSENSTRAUS M, 1975, P NATL ACAD SCI USA, V72, P493, DOI 10.1073/pnas.72.2.493; ROSENTHAL W, 1992, NATURE, V359, P233, DOI 10.1038/359233a0; ROSENTHAL W, 1993, J BIOL CHEM, V268, P13030; RUBNITZ J, 1984, MOL CELL BIOL, V4, P2253, DOI 10.1128/MCB.4.11.2253; Sambrook J., 1989, MOL CLONING LAB MANU; SAVARESE TM, 1992, BIOCHEM J, V283, P1; SEIBOLD A, 1992, AM J HUM GENET, V51, P1078; SHENKER A, 1993, NATURE, V365, P652, DOI 10.1038/365652a0; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; TANOUE A, 1991, J CLIN INVEST, V87, P1171, DOI 10.1172/JCI115115; TSIGOS C, 1993, J CLIN INVEST, V92, P2458, DOI 10.1172/JCI116853; VANDENOUWELAND AMW, 1992, NAT GENET, V2, P99, DOI 10.1038/ng1092-99; WAJCMAN H, 1992, HUM GENET, V89, P676, DOI 10.1007/BF00221961; WEATHERALL DJ, 1994, MOL BASIS BLOOD DISE; WESS J, 1993, LIFE SCI, V53, P1447, DOI 10.1016/0024-3205(93)90618-D	55	54	57	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1994	55	2					266	277						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NZ336	7913579				2022-12-18	WOS:A1994NZ33600006
J	FILON, D; ORON, V; KRICHEVSKI, S; SHAAG, A; SHAAG, Y; WARREN, TC; GOLDFARB, A; SHNEOR, Y; KOREN, A; AKER, M; ABRAMOV, A; RACHMILEWITZ, EA; RUND, D; KAZAZIAN, HH; OPPENHEIM, A				FILON, D; ORON, V; KRICHEVSKI, S; SHAAG, A; SHAAG, Y; WARREN, TC; GOLDFARB, A; SHNEOR, Y; KOREN, A; AKER, M; ABRAMOV, A; RACHMILEWITZ, EA; RUND, D; KAZAZIAN, HH; OPPENHEIM, A			DIVERSITY OF BETA-GLOBIN MUTATIONS IN ISRAELI ETHNIC-GROUPS REFLECTS RECENT HISTORIC EVENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							THALASSEMIA MUTATIONS; MOLECULAR-BASIS; PRENATAL-DIAGNOSIS; ASIAN INDIANS; GENE-CLUSTER; DNA; LINKAGE; ORIGIN; ARABS	We characterized nearly 500 beta-thalassemia genes from the Israeli population representing a variety of ethnic subgroups. We found 28 different mutations in the beta-globin gene, including three mutations (beta(5), beta(C), and beta(O-Arab)) causing hemoglobinopathies. Marked genetic heterogeneity was observed in both the Arab (20 mutations) and Jewish (17 mutations) populations. On the other hand, two ethnic isolates-Druze and Samaritans-had a single mutation each. Fifteen of the beta-thalassemia alleles are Mediterranean in type, 5 originated in Kurdistan, 2 are of Indian origin, and 2 sporadic alleles came from Europe. Only one mutant allele-nonsense codon 37-appears to be indigenous to Israel. While human habitation in Israel dates back to early prehistory, the present-day spectrum of beta-globin mutations can be largely explained by migration events that occurred in the past millennium.	HEBREW UNIV JERUSALEM,HADASSAH MED SCH,IL-91010 JERUSALEM,ISRAEL; SHAARE ZEDEK MEM HOSP,JERUSALEM,ISRAEL; JOHNS HOPKINS UNIV,SCH MED,BALTIMORE,MD; HAEMEK HOSP,AFULA,ISRAEL	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Johns Hopkins University; Emek Medical Center								ANGEL JL, 1966, SCIENCE, V153, P760, DOI 10.1126/science.153.3737.760; ANTONARAKIS SE, 1982, P NATL ACAD SCI-BIOL, V79, P137, DOI 10.1073/pnas.79.1.137; BASAK AN, 1992, HUM GENET, V89, P315, DOI 10.1007/BF00220549; BOEHM CD, 1986, BLOOD, V67, P1185; BOYO A, 1983, Bulletin of the World Health Organization, V61, P63; CHEHAB FF, 1987, BLOOD, V69, P1141; FAUSTINO P, 1992, HUM GENET, V89, P573; FREUNDLICH E, 1984, ISRAEL J MED SCI, V20, P1035; Goossens M, 1981, Methods Enzymol, V76, P805; Haldane J.B.S., 1949, HEREDITAS, V35, P267; HERSHKOVITZ I, 1991, AM J PHYS ANTHROPOL, V85, P7, DOI 10.1002/ajpa.1330850103; HOROWITZ A, 1966, BRIT J HAEMATOL, V12, P555, DOI 10.1111/j.1365-2141.1966.tb00138.x; HUSSEIN IR, 1993, HUM MUTAT, V2, P48, DOI 10.1002/humu.1380020109; KAZAZIAN HH, 1984, EMBO J, V3, P593, DOI 10.1002/j.1460-2075.1984.tb01853.x; LIEINJO LE, 1989, AM J HUM GENET, V45, P971; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; OPPENHEIM A, 1993, HUM MUTAT, V2, P155, DOI 10.1002/humu.1380020219; ORKIN SH, 1982, NATURE, V296, P627, DOI 10.1038/296627a0; RACHMILEWITZ EA, 1985, HUM GENET, V70, P119, DOI 10.1007/BF00273069; RUND D, 1991, P NATL ACAD SCI USA, V88, P310, DOI 10.1073/pnas.88.1.310; RUND D, 1990, HUM GENET, V85, P521; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; THEIN SL, 1988, BRIT J HAEMATOL, V70, P225, DOI 10.1111/j.1365-2141.1988.tb02468.x; Weatherall DJ, 1981, THALASSEMIA SYNDROME; WONG C, 1986, P NATL ACAD SCI USA, V83, P6529, DOI 10.1073/pnas.83.17.6529; WONG C, 1987, NATURE, V330, P384, DOI 10.1038/330384a0	26	54	54	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1994	54	5					836	843						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NH394	8178823				2022-12-18	WOS:A1994NH39400013
J	DEBOER, M; DEKLEIN, A; HOSSLE, JP; SEGER, R; CORBEEL, L; WEENING, RS; ROOS, D				DEBOER, M; DEKLEIN, A; HOSSLE, JP; SEGER, R; CORBEEL, L; WEENING, RS; ROOS, D			CYTOCHROME B558-NEGATIVE, AUTOSOMAL RECESSIVE CHRONIC GRANULOMATOUS-DISEASE - 2 NEW MUTATIONS IN THE CYTOCHROME B558 LIGHT CHAIN OF THE NADPH OXIDASE (P22-PHOX)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOMAL LOCATION; GENE; DEFICIENCIES; COMPONENTS; SYSTEM	Chronic granulomatous disease (CGD) is characterized by the failure of activated phagocytes to generate superoxide. Defects in at least four different genes lead to CGD. Patients with the X-linked form of CGD have mutations in the gene for the beta-subunit of cytochrome b558 (gp91-phox). Patients with a rare autosomal recessive form of CGD have mutations in the gene for the alpha-subunit of this cytochrome (p22-phox). Usually, this leads to the absence of cytochrome b558 in the phagocytes (A220 CGD). We studied the molecular defect in five European patients from three unrelated families with this type of CGD. P22-phox mRNA was reverse-transcribed, and the coding region was amplified by PCR in one fragment and sequenced. Three patients from one family, with parents that were first cousins, were homozygous for a single base substitution (G-297-->A) resulting in a nonconservative amino acid change (Arg-90-->Gln). This mutation was previously found in a compound heterozygote A220 CGD patient. Another patient, also from first-cousin parents, was homozygous for an A-309-->G mutation in the open reading frame that predicts a nonconservative amino acid replacement (His-94-->Arg). The fifth patient was also born from a first-cousin marriage and was shown to be homozygous for the absence of exon 4 from the cDNA. In this patient, a G-->A substitution was found at position 1 of intron 4 in the genomic DNA. Therefore, the absence of exon 4 in the cDNA of this patient is due to a splicing error. Two additional polymorphisms were also identified - one silent mutation in the open reading frame (G-508<-- -->A) and one A-640<-- -->G mutation in the 3' untranslated region of the p22-phox mRNA. This last mutation destroys a DraIII recognition site and is therefore potentially useful for RFLP analysis of CGD families.	NETHERLANDS RED CROSS, BLOOD TRANSFUS SERV, CENT LAB, AMSTERDAM, NETHERLANDS; UNIV AMSTERDAM, ACAD MED CTR, EMMA CHILDRENS HOSP, 1105 AZ AMSTERDAM, NETHERLANDS; UNIV AMSTERDAM, ACAD MED CTR, EXPTL & CLIN IMMUNOL LAB, 1105 AZ AMSTERDAM, NETHERLANDS; UNIV ZURICH, BOT & MICROBIOL, DIV HEMATOL IMMUNOL, CH-8006 ZURICH, SWITZERLAND; CATHOLIC UNIV LEUVEN, ACAD HOSP GASTHUISBERG, DEPT PEDIAT, B-3000 LOUVAIN, BELGIUM	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Zurich; KU Leuven								BOLSCHER BGJM, 1991, BLOOD, V77, P2482; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CLARK RA, 1989, NEW ENGL J MED, V321, P647, DOI 10.1056/NEJM198909073211005; CORBEEL L, 1978, ACTA PAEDIATR BELG, V31, P15; CURNUTTE JT, 1987, J BIOL CHEM, V262, P5563; DEBOER M, IN PRESS BLOOD; DINAUER MC, 1990, J CLIN INVEST, V86, P1729, DOI 10.1172/JCI114898; DINAUER MC, 1991, P NATL ACAD SCI USA, V88, P11231, DOI 10.1073/pnas.88.24.11231; DINAUER MC, 1987, NATURE, V327, P717, DOI 10.1038/327717a0; ORKIN SH, 1989, ANNU REV IMMUNOL, V7, P277; PARKOS CA, 1989, BLOOD, V73, P1416; PARKOS CA, 1988, P NATL ACAD SCI USA, V85, P3319, DOI 10.1073/pnas.85.10.3319; QUINN MT, 1991, CLIN RES, V39, pA353; ROOS D, IN PRESS MONONUCLEAR; ROYERPOKORA B, 1986, NATURE, V322, P32, DOI 10.1038/322032a0; Sambrook J., 1989, MOL CLONING LAB MANU; SCHAPIRO BL, 1991, NEW ENGL J MED, V325, P1786, DOI 10.1056/NEJM199112193252506; SEGAL AW, 1989, J CLIN INVEST, V83, P1785, DOI 10.1172/JCI114083; SMITH RM, 1991, BLOOD, V77, P673; TAUBER AI, 1983, MEDICINE, V62, P286, DOI 10.1097/00005792-198309000-00003; TEAHAN C, 1987, NATURE, V327, P720, DOI 10.1038/327720a0; VERHOEVEN AJ, 1989, BLOOD, V73, P1686; WEENING RS, 1985, J CLIN INVEST, V75, P915, DOI 10.1172/JCI111792	23	54	55	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1992	51	5					1127	1135						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JU840	1415254				2022-12-18	WOS:A1992JU84000023
J	PASSOSBUENO, MR; BAKKER, E; KNEPPERS, ALJ; TAKATA, RI; RAPAPORT, D; DENDUNNEN, JT; ZATZ, M; VANOMMEN, GJB				PASSOSBUENO, MR; BAKKER, E; KNEPPERS, ALJ; TAKATA, RI; RAPAPORT, D; DENDUNNEN, JT; ZATZ, M; VANOMMEN, GJB			DIFFERENT MOSAICISM FREQUENCIES FOR PROXIMAL AND DISTAL DUCHENNE MUSCULAR-DYSTROPHY (DMD) MUTATIONS INDICATE DIFFERENCE IN ETIOLOGY AND RECURRENCE RISK	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GERMINAL MOSAICISM; DELETIONS; GENE; CDNA; CLONING; ORIGIN	In about 65% of the cases of Duchenne muscular dystrophy (DMD) a partial gene deletion or duplication in the dystrophin gene can be detected. These mutations are clustered at two hot spots: 30% at the hot spot in the proximal part of the gene and about 70% at a more distal hot spot. Unexpectedly we observed a higher frequency of proximal gene rearrangements among proved "germ line" mosaic cases. Of the 24 mosaic cases we are aware of, 19 (79%) have a proximal mutation, while only 5 (21%) have a distal mutation. This finding indicates that the mutations at the two hot spots in the dystrophin gene differ in origin. Independent support for the different mosaicism frequency was found by comparing the mutation spectra observed in isolated cases of DMD and familial cases of DMD. In a large two-center study of 473 patients from Brazil and the Netherlands, we detected a significant difference in the deletion distribution of isolated (proximal:distal ratio 1:3) and familial cases (ratio 1:1). We conclude from these data that proximal deletions most likely occur early in embryonic development, causing them to have a higher chance of becoming familial, while distal deletions occur later and have a higher chance of causing only isolated cases. Finally, our findings have important consequences for the calculation of recurrence-risk estimates according to the site of the deletion: a "proximal" new mutant has an increased recurrence risk of approximately 30%, and a "distal" new mutant has a decreased recurrence risk of approximately 4%.	LEIDEN UNIV, SYLVIUS LAB, DEPT HUMAN GENET, WASSENAARSEWEG 72, 2333 AL LEIDEN, NETHERLANDS; UNIV SAO PAULO, INST BIOCIENCIAS, DEPT BIOL, CTR MIOPATIAS, SAO PAULO, BRAZIL	Leiden University; Leiden University - Excl LUMC; Universidade de Sao Paulo			Bakker, Egbert/D-3525-2009; dunnen, johan den/ABH-4228-2020; Passos-Bueno, Maria Rita/I-6796-2016; Zatz, Mayana/M-5338-2015	Bakker, Egbert/0000-0002-2843-7357; dunnen, johan den/0000-0002-6304-1710; Passos-Bueno, Maria Rita/0000-0002-9248-3008; Zatz, Mayana/0000-0003-3970-8025				BAKKER E, 1987, NATURE, V329, P554, DOI 10.1038/329554a0; BAKKER E, 1989, J MED GENET, V26, P553, DOI 10.1136/jmg.26.9.553; BARTLETT RJ, 1988, NEUROLOGY, V38, P1; BECH-HANSEN N T, 1987, American Journal of Human Genetics, V41, pA93; BEGGS AH, 1990, HUM GENET, V86, P45; BROCKERVRIENDS AHJT, 1990, HUM GENET, V85, P288; BYERS PH, 1988, AM J HUM GENET, V42, P237; CHAMBERLAIN JS, 1989, PCR PROTOCOLS GUIDE, P272; CHAMBERLAIN JS, IN PRESS JAMA; CLAUSTRES M, 1990, HUM GENET, V86, P241; DARRAS BT, 1987, NATURE, V329, P556, DOI 10.1038/329556a0; DENDUNNEN JT, 1989, AM J HUM GENET, V45, P835; EDWARDS JH, 1989, ANN HUM GENET, V53, P33, DOI 10.1111/j.1469-1809.1989.tb01120.x; EMERY AEH, 1988, OXFORD MONOGRAPHS ME; FORREST SM, 1987, NATURE, V329, P638, DOI 10.1038/329638a0; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; LANMAN JT, 1987, AM J HUM GENET, V41, P138; LEBO RV, 1990, AM J MED GENET, V37, P187, DOI 10.1002/ajmg.1320370206; LINDLOF M, 1990, THESIS U HELSINKI HE; MADDALENA A, 1987, American Journal of Human Genetics, V41, pA227; MALHOTRA SB, 1988, SCIENCE, V242, P755, DOI 10.1126/science.3055295; MONACO AP, 1987, HUM GENET, V75, P221, DOI 10.1007/BF00281063; PASSOSBUENO MR, 1990, J MED GENET, V27, P727, DOI 10.1136/jmg.27.11.727; PASSOSBUENO MR, 1990, J MED GENET, V27, P145, DOI 10.1136/jmg.27.3.145; VANESSEN AJ, 1992, HUM GENET, V88, P249, DOI 10.1007/BF00197255; WAPENAAR M C, 1988, Genomics, V2, P101, DOI 10.1016/0888-7543(88)90090-0; WOOD S, 1988, HUM GENET, V78, P282, DOI 10.1007/BF00291677	28	54	58	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1992	51	5					1150	1155						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JU840	1415256				2022-12-18	WOS:A1992JU84000025
J	HAYWARD, C; LIVINGSTONE, J; HOLLOWAY, S; LISTON, WA; BROCK, DJH				HAYWARD, C; LIVINGSTONE, J; HOLLOWAY, S; LISTON, WA; BROCK, DJH			AN EXCLUSION MAP FOR PREECLAMPSIA - ASSUMING AUTOSOMAL RECESSIVE INHERITANCE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; POLYMERASE CHAIN-REACTION; FRAGMENT LENGTH POLYMORPHISMS; HUMAN NUCLEATED CELLS; GENE LOCUS; EXTRACTING DNA; HLA-DR; PREECLAMPSIA; LINKAGE; SUSCEPTIBILITY	Pre-eclampsia is a common complication of the second half of pregnancy that is associated with substantial fetal and maternal morbidity. Although the genetic basis of the disorder is unclear, epidemiological studies suggest that it occurs predominantly in the first pregnancies of women who are homozygous for a relatively common susceptibility gene. Using this epidemiological model, we have begun to construct an exclusion map by using both candidate genes and random DNA markers on a panel of two-generation families in which pre-eclampsia was rigorously defined. No evidence was found for linkage to the HLA region or to several genes implicated in the pathogenesis of hypertension.	ROYAL INFIRM, SIMPSON MEM MATERN PAVIL, EDINBURGH EH3 9HB, MIDLOTHIAN, SCOTLAND	Royal Infirmary of Edinburgh	HAYWARD, C (corresponding author), UNIV EDINBURGH, WESTERN GEN HOSP, HUMAN GENET UNIT, EDINBURGH EH4 2XU, MIDLOTHIAN, SCOTLAND.		Hayward, Caroline/M-8818-2016	Hayward, Caroline/0000-0002-9405-9550	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AMSTELL HKP, 1990, NUCLEIC ACIDS RES, V18, P4957; ARNGRIMSSON R, 1990, BRIT J OBSTET GYNAEC, V97, P762, DOI 10.1111/j.1471-0528.1990.tb02569.x; ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; BELL JI, 1989, ADV HUM GENET, V18, P1; BLANTON SH, 1990, J MED GENET, V27, P73, DOI 10.1136/jmg.27.2.73; BOERWINKLE E, 1989, P NATL ACAD SCI USA, V86, P212, DOI 10.1073/pnas.86.1.212; CARLSON M, 1988, NUCLEIC ACIDS RES, V16, P378, DOI 10.1093/nar/16.1.378; CHAMBERLAIN S, 1988, NATURE, V334, P248, DOI 10.1038/334248a0; CHESLEY LC, 1986, BRIT J OBSTET GYNAEC, V93, P898, DOI 10.1111/j.1471-0528.1986.tb08006.x; CHESLEY LC, 1968, OBSTET GYNECOL, V32, P303; COOPER DW, 1979, J MED GENET, V16, P409, DOI 10.1136/jmg.16.6.409; COOPER DW, 1988, BRIT J OBSTET GYNAEC, V95, P644, DOI 10.1111/j.1471-0528.1988.tb06524.x; EDWARDS JH, 1987, J MED GENET, V24, P539, DOI 10.1136/jmg.24.9.539; Erlich H. A., 1990, PCR PROTOCOLS, P261; ESTIVILL X, 1987, NATURE, V326, P840, DOI 10.1038/326840a0; FOURNIE A, 1981, BRIT J OBSTET GYNAEC, V88, P250, DOI 10.1111/j.1471-0528.1981.tb00977.x; FROSSARD PM, 1986, NUCLEIC ACIDS RES, V14, P6778, DOI 10.1093/nar/14.16.6778; FUJIMOTO E, 1988, NUCLEIC ACIDS RES, V16, P9357, DOI 10.1093/nar/16.19.9357; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; HARLEY HG, 1988, GENOMICS, V3, P380, DOI 10.1016/0888-7543(88)90131-0; HAYWARD C, 1990, LANCET, V335, P1458, DOI 10.1016/0140-6736(90)91483-Q; HIGGS DR, 1986, P NATL ACAD SCI USA, V83, P5165, DOI 10.1073/pnas.83.14.5165; HOLLENBERG SM, 1985, NATURE, V318, P635, DOI 10.1038/318635a0; HORN GT, 1989, NUCLEIC ACIDS RES, V17, P2140, DOI 10.1093/nar/17.5.2140; KILPATRICK DC, 1989, LANCET, V2, P1063; KILPATRICK DC, 1990, TISSUE ANTIGENS, V35, P178, DOI 10.1111/j.1399-0039.1990.tb01776.x; KINZLER KW, 1991, SCIENCE, V251, P1366, DOI 10.1126/science.1848370; KRAPCHO K, 1988, NUCLEIC ACIDS RES, V16, P5221, DOI 10.1093/nar/16.11.5221; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEPPERT M, 1987, SCIENCE, V238, P1411, DOI 10.1126/science.3479843; LEWIS JG, 1990, GENOMICS, V8, P400, DOI 10.1016/0888-7543(90)90300-J; LIFTON RP, 1990, GENOMICS, V7, P131, DOI 10.1016/0888-7543(90)90530-8; LITT M, 1990, NUCLEIC ACIDS RES, V18, P4301, DOI 10.1093/nar/18.14.4301; MACGILLIVRAY I, 1958, J OBSTET GYNAECOL, V65, P536; Maniatis T, 1989, MOL CLONING; MASHARANI U, 1988, HUM GENET, V80, P308, DOI 10.1007/BF01790106; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MOORE MP, 1987, RECENT ADV OBST GYNE, V15, P3; MURRAY JC, 1984, P NATL ACAD SCI-BIOL, V81, P3486, DOI 10.1073/pnas.81.11.3486; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P4186, DOI 10.1093/nar/16.9.4186; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P9882, DOI 10.1093/nar/16.20.9882; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P9354, DOI 10.1093/nar/16.19.9354; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P4743, DOI 10.1093/nar/16.10.4743; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P3119, DOI 10.1093/nar/16.7.3119; NAKAMURA Y, 1988, GENOMICS, V3, P389, DOI 10.1016/0888-7543(88)90133-4; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P9364, DOI 10.1093/nar/16.19.9364; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P4191, DOI 10.1093/nar/16.9.4191; NAKAMURA Y, 1987, NUCLEIC ACIDS RES, V15, P10073, DOI 10.1093/nar/15.23.10073; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P1229, DOI 10.1093/nar/16.3.1229; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P778, DOI 10.1093/nar/16.2.778; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P6255, DOI 10.1093/nar/16.13.6255; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P5222, DOI 10.1093/nar/16.11.5222; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P10607; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; NEMER M, 1986, NUCLEIC ACIDS RES, V14, P8696, DOI 10.1093/nar/14.21.8696; REDMAN CWG, 1978, LANCET, V2, P397; REDMAN CWG, 1988, BMJ-BRIT MED J, V296, P1209, DOI 10.1136/bmj.296.6631.1209; SAFTLAS AF, 1990, AM J OBSTET GYNECOL, V163, P460, DOI 10.1016/0002-9378(90)91176-D; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SIDDIQUE T, 1991, NEW ENGL J MED, V324, P1381, DOI 10.1056/NEJM199105163242001; SIMON P, 1988, KIDNEY INT, V34, pS125; SKRAASTAD MI, 1987, CYTOGENET CELL GENET, V46, P693; SUTHERLAND A, 1981, BRIT J OBSTET GYNAEC, V88, P785, DOI 10.1111/j.1471-0528.1981.tb01304.x; THORP JM, 1990, OBSTET GYNECOL, V75, P163; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4639, DOI 10.1093/nar/18.15.4639-a; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4637, DOI 10.1093/nar/18.15.4637; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4636, DOI 10.1093/nar/18.15.4636-a; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4640, DOI 10.1093/nar/18.15.4640-a; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4038, DOI 10.1093/nar/18.13.4038; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4035, DOI 10.1093/nar/18.13.4035; WILTON AN, 1990, LANCET, V336, P653, DOI 10.1016/0140-6736(90)92149-C; WONG Z, 1987, ANN HUM GENET, V51, P269, DOI 10.1111/j.1469-1809.1987.tb01062.x; ZEMEL MB, 1990, NEW ENGL J MED, V323, P434, DOI 10.1056/NEJM199008163230702	75	54	56	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1992	50	4					749	757						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HL848	1550119				2022-12-18	WOS:A1992HL84800010
J	DONO, R; MONTUORI, N; ROCCHI, M; DEPONTIZILLI, L; CICCODICOLA, A; PERSICO, MG				DONO, R; MONTUORI, N; ROCCHI, M; DEPONTIZILLI, L; CICCODICOLA, A; PERSICO, MG			ISOLATION AND CHARACTERIZATION OF THE CRIPTO AUTOSOMAL GENE AND ITS X-LINKED RELATED SEQUENCE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EPIDERMAL GROWTH-FACTOR; LDL RECEPTOR; GLOBIN GENE; PROMOTER; HYBRIDIZATION; PROTEINS; ACID; RNA; EMBRYOGENESIS; RETROPOSON	We have previously reported on the identification of a cDNA clone encoding a novel human growth factor, named "CRIPTO," that is abundantly expressed in undifferentiated human NTERA-2 clone D1 (NT2/D1) and mouse (F9) teratocarcinoma cells. We now report the organization and nucleotide sequence of two related genomic sequences. One (CR-1) corresponds to the structural gene encoding the human CRIPTO protein expressed in the undifferentiated human teratocarcinoma cells, and the other (CR-3) corresponds-to a complete copy of the mRNA containing seven base substitutions in the coding region representing both silent and replacement substitutions. The 440 bp 5' to the CAP site of CR-1 are preserved in CR-3. CR-1 maps to chromosome 3, and CR-3 maps to Xq21-q22. Southern blot analysis reveals that multiple CRIPTO-related DNA sequences are present in the human as well as in the mouse genome.	CNR,INT INST GENET & BIOPHYS,VIA MARCONI 10,I-80125 NAPLES,ITALY; IST GIANNINA GASLINI,MOLEC BIOL LAB,I-16148 GENOA,ITALY; NIDDK,MOLEC BIOL LAB,BETHESDA,MD	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Genoa; IRCCS Istituto Giannina Gaslini; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)			DONO, ROSANNA/I-7821-2016; Montuori, Nunzia/J-8542-2013	Montuori, Nunzia/0000-0001-8697-986X; Ciccodicola, Alfredo/0000-0002-9924-1482				ANDREWS PW, 1984, LAB INVEST, V50, P147; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BENOIST C, 1981, NATURE, V290, P304, DOI 10.1038/290304a0; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BOER PH, 1987, MOL CELL BIOL, V7, P3107, DOI 10.1128/MCB.7.9.3107; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CICCODICOLA A, 1989, EMBO J, V8, P1987, DOI 10.1002/j.1460-2075.1989.tb03605.x; CLARK BD, 1986, NUCLEIC ACIDS RES, V14, P7897, DOI 10.1093/nar/14.20.7897; DAVIDSON RL, 1976, SOMAT CELL GENET, V2, P165, DOI 10.1007/BF01542629; DERYNCK R, 1984, CELL, V38, P287, DOI 10.1016/0092-8674(84)90550-6; DEVEL TF, 1987, ANN REV CELL BIOL, V3, P443; EVANS T, 1984, NUCLEIC ACIDS RES, V12, P8043, DOI 10.1093/nar/12.21.8043; GREENWALD I, 1985, CELL, V43, P583, DOI 10.1016/0092-8674(85)90230-2; GRUNSTEIN M, 1975, P NATL ACAD SCI USA, V72, P3961, DOI 10.1073/pnas.72.10.3961; HATTORI M, 1985, NUCLEIC ACIDS RES, V13, P7813, DOI 10.1093/nar/13.21.7813; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; KIDD S, 1986, MOL CELL BIOL, V6, P3094, DOI 10.1128/MCB.6.9.3094; Maniatis T., 1982, MOL CLONING; MARTIN SL, 1983, J MOL BIOL, V164, P513, DOI 10.1016/0022-2836(83)90048-7; MCCARREY JR, 1987, NATURE, V326, P501, DOI 10.1038/326501a0; MERCOLA M, 1988, DEVELOPMENT, V102, P451; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; PLOWMAN GD, 1990, MOL CELL BIOL, V10, P1969, DOI 10.1128/MCB.10.5.1969; POUTSKA A, 1984, P NATL ACAD SCI USA, V81, P4129; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; ROCCHI M, 1986, HUM GENET, V74, P30; SAVAGE CR, 1972, J BIOL CHEM, V247, P7612; SOARES MB, 1985, MOL CELL BIOL, V5, P2090, DOI 10.1128/MCB.5.8.2090; SPORN MB, 1988, NATURE, V332, P217, DOI 10.1038/332217a0; SUDHOF TC, 1985, SCIENCE, V228, P893, DOI 10.1126/science.3873704; SUDHOF TC, 1985, SCIENCE, V228, P815, DOI 10.1126/science.2988123; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.bi.55.070186.003215; WHITMAN M, 1989, ANNU REV CELL BIOL, V5, P93; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; YU YT, 1986, CELL, V45, P743, DOI 10.1016/0092-8674(86)90788-9	36	54	87	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1991	49	3					555	565						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GE367	1882841				2022-12-18	WOS:A1991GE36700008
J	PODUSLO, SE; DEAN, M; KOLCH, U; OBRIEN, SJ				PODUSLO, SE; DEAN, M; KOLCH, U; OBRIEN, SJ			DETECTING HIGH-RESOLUTION POLYMORPHISMS IN HUMAN CODING LOCI BY COMBINING PCR AND SINGLE-STRAND CONFORMATION POLYMORPHISM (SSCP) ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA POLYMORPHISMS; CYSTIC-FIBROSIS; SEQUENCE; MUTATIONS; MULTIPLE; ONCOGENE; KINASE; GENES	A strategy is described that allows the development of polymorphic genetic markers to be characterized in individual genes. Segments of the 3' untranslated regions are amplified, and polymorphisms are detected by digestion with frequently cutting enzymes and with the detection of single-stranded conformation polymorphisms. This allows these genes, or DNA segments, to be placed on the linkage maps of human chromosomes. Polymorphisms in two genes have been identified using this approach. A HaeIII polymorphism was detected in the KIT proto-oncogene, physically assigned to chromosome 4q11-12. This polymorphism is linked to other chromosome 4p markers and is in linkage disequilibrium with a HindIII polymorphism previously described at this locus. We have also identified in the insulin-like growth factor1 receptor gene (IGF1R) a 2-bp deletion that is present at a frequency of .25 in the Caucasian population. Pedigree analysis with this insertion/deletion polymorphism placed the IGF1R gene at the end of the current linkage map of chromosome 15q, consistent with the physical assignment of 15q2526. Thus, polymorphisms in specific genes can be used to relate the physical, genetic, and comparative maps of mammalian genomes and to simplify the testing of candidate genes for human diseases.	NCI,FREDERICK CANC RES & DEV CTR,INC DYNCORP,PROGRAM RESOURCES,BLDG 560,FREDERICK,MD 21702; NCI,FREDERICK CANC RES & DEV CTR,VIRAL CARCINOGENESIS LAB,FREDERICK,MD 21702	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick			Dean, Michael C/G-8172-2012; Dean, Michael/R-7501-2019; OBRIEN, STEPHEN/ABD-1346-2020	Dean, Michael C/0000-0003-2234-0631; OBRIEN, STEPHEN/0000-0001-7857-0757	NCI NIH HHS [N01-CO-74102] Funding Source: Medline; OFFICE OF THE DIRECTOR, NCI [N01CO074102] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSON SK, 1985, MOL CELL BIOL, V5, P1122, DOI 10.1128/MCB.5.5.1122; BERDAHL LD, 1988, NUCLEIC ACIDS RES, V16, P4760; BUETOW KH, 1991, AM J HUM GENET, V48, P911; COUSSENS L, 1986, SCIENCE, V233, P859, DOI 10.1126/science.3755548; DAUSSET J, 1990, GENOMICS, V6, P676; DEAN M, 1991, BIOTECHNIQUES, V10, P332; DEAN M, 1990, CELL, V61, P863, DOI 10.1016/0092-8674(90)90196-L; DEAN M, 1990, NUCLEIC ACIDS RES, V18, P345, DOI 10.1093/nar/18.2.345; DORSSERS L, 1987, GENE, V55, P115, DOI 10.1016/0378-1119(87)90254-X; EPSTEIN N, 1990, NUCLEIC ACIDS RES, V18, P4634, DOI 10.1093/nar/18.15.4634; FURUTANI Y, 1986, NUCLEIC ACIDS RES, V14, P7897; GERRARD BC, UNPUB INCREASED CONS; JACKSON RJ, 1990, CELL, V62, P15, DOI 10.1016/0092-8674(90)90235-7; KIDD KK, 1989, CYTOGENET CELL GENET, V51, P622, DOI 10.1159/000132810; KREITMAN M, 1986, P NATL ACAD SCI USA, V83, P3562, DOI 10.1073/pnas.83.10.3562; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; NAKAMURA Y, 1988, GENOMICS, V3, P342, DOI 10.1016/0888-7543(88)90125-5; OBRIEN SJ, 1990, CYTOGENET CELL GENET, V55, P406, DOI 10.1159/000133025; OLSON M, 1989, SCIENCE, V245, P1434, DOI 10.1126/science.2781285; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; STRAUB TD, 1990, AM J HUM GENET, V47, pA237; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; YARDEN Y, 1987, EMBO J, V6, P3341, DOI 10.1002/j.1460-2075.1987.tb02655.x; ZAKUTHOURI R, 1987, GENE, V54, P105, DOI 10.1016/0378-1119(87)90352-0	25	54	55	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1991	49	1					106	111						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FW511	1676559				2022-12-18	WOS:A1991FW51100013
J	BERATIS, NG; LABADIE, GU; HIRSCHHORN, K				BERATIS, NG; LABADIE, GU; HIRSCHHORN, K			GENETIC-HETEROGENEITY IN ACID ALPHA-GLUCOSIDASE DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CUNY MT SINAI SCH MED,DEPT PEDIAT,DIV MED GENET,NEW YORK,NY 10029	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	BERATIS, NG (corresponding author), NEW YORK STATE INST BASIC RES MENTAL RETARDAT,DEPT HUMAN GENET,STATEN ISL,NY 10314, USA.				NIADDK NIH HHS [AM-22198] Funding Source: Medline	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALPERT E, 1974, LANCET, V1, P626; ARNON R, 1967, BIOCHEMISTRY-US, V6, P3942, DOI 10.1021/bi00864a041; BERATIS NG, 1980, AM J HUM GENET, V32, P137; BERATIS NG, 1978, J CLIN INVEST, V62, P1264, DOI 10.1172/JCI109247; BERATIS NG, 1975, PEDIATR RES, V9, P475, DOI 10.1203/00006450-197505000-00003; BROWN BI, 1970, BIOCHEMISTRY-US, V9, P1423, DOI 10.1021/bi00808a017; BROWN BI, 1975, ACS S SERIES, V15, P223; de Barsy T, 1972, Eur J Biochem, V31, P156; HERS HG, 1963, BIOCHEM J, V86, P11, DOI 10.1042/bj0860011; KOSTER JF, 1977, BIOCHIM BIOPHYS ACTA, V482, P89, DOI 10.1016/0005-2744(77)90357-6; LAURELL CB, 1970, SCAND J CLIN LAB I S, V124, P21; LINDER D, 1975, NEW ENGL J MED, V292, P63, DOI 10.1056/NEJM197501092920202; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MEHLER M, 1977, NEUROLOGY, V27, P178, DOI 10.1212/WNL.27.2.178; MURRAY AK, 1978, ARCH BIOCHEM BIOPHYS, V185, P511, DOI 10.1016/0003-9861(78)90196-0; REUSER AJJ, 1978, AM J HUM GENET, V30, P132; SCHRAM AW, 1979, BIOCHIM BIOPHYS ACTA, V567, P370, DOI 10.1016/0005-2744(79)90123-2; SWALLOW DM, 1975, ANN HUM GENET, V38, P391, DOI 10.1111/j.1469-1809.1975.tb00629.x	18	54	54	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	1					21	33						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB703	6401921				2022-12-18	WOS:A1983QB70300002
J	FEATHERSTONE, T; TAYLOR, AMR; HARNDEN, DG				FEATHERSTONE, T; TAYLOR, AMR; HARNDEN, DG			STUDIES ON THE RADIOSENSITIVITY OF CELLS FROM PATIENTS WITH BASAL-CELL NEVUS SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV BIRMINGHAM,SCH MED,DEPT CANC STUDIES,BIRMINGHAM B15 2TJ,W MIDLANDS,ENGLAND	University of Birmingham								ARLETT CF, 1980, CANCER RES, V40, P926; ARLETT CF, 1980, PROGR ENV MUTAGENESI, P161; CLEAVER JE, 1968, NATURE, V218, P652, DOI 10.1038/218652a0; COX R, 1981, INT J RADIAT BIOL, V39, P357, DOI 10.1080/09553008114550461; CUNLIFFE PN, 1975, BRIT J RADIOL, V48, P374, DOI 10.1259/0007-1285-48-569-374; GORLIN R J, 1971, Birth Defects Original Article Series, V7, P140; HARNDEN DG, 1965, HUMAN CHROMOSOME MET, P57; HARNDEN DG, 1980, CARCINOGENESIS FUNDA, P235; HARNDEN DG, 1980, GENETIC ENV FACTORS, P231; INOUE T, 1977, BIOCHIM BIOPHYS ACTA, V479, P497, DOI 10.1016/0005-2787(77)90042-9; KRAEMER KH, 1977, DNA REPAIR PROCESS, P37; LEHMANN AR, 1981, J CANCER RES CLIN ON, V1, P117; MORTEN JEN, 1981, CANCER RES, V41, P3635; PARRINGTON JM, 1971, ANN HUM GENET, V35, P149, DOI 10.1111/j.1469-1809.1956.tb01387.x; PATERSON MC, 1976, NATURE, V260, P444, DOI 10.1038/260444a0; Strong L. C., 1977, GENETICS HUMAN CANCE, P401; TAYLOR AMR, 1976, NATURE, V260, P441, DOI 10.1038/260441a0; TAYLOR AMR, 1975, NATURE, V258, P427, DOI 10.1038/258427a0; TAYLOR AMR, 1978, MUTAT RES, V50, P407, DOI 10.1016/0027-5107(78)90045-3; WEICHSELBAUM RR, 1978, NATURE, V271, P261, DOI 10.1038/271261a0; WEICHSELBAUM RR, 1980, CANCER RES, V40, P920	21	54	54	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	1					58	66						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB703	6823972				2022-12-18	WOS:A1983QB70300006
J	KAZAZIAN, HH; ORKIN, SH; BOEHM, CD; SEXTON, JP; ANTONARAKIS, SE				KAZAZIAN, HH; ORKIN, SH; BOEHM, CD; SEXTON, JP; ANTONARAKIS, SE			BETA-THALASSEMIA DUE TO A DELETION OF THE NUCLEOTIDE WHICH IS SUBSTITUTED IN THE BETA-S-GLOBIN GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note									HARVARD UNIV,SCH MED,DEPT PEDIAT,BOSTON,MA 02115	Harvard University; Harvard Medical School	KAZAZIAN, HH (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205, USA.		Antonarakis, Stylianos/N-8866-2014	Antonarakis, Stylianos/0000-0001-8907-5823	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM013983] Funding Source: NIH RePORTER; NIADDK NIH HHS [AM-13983] Funding Source: Medline	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AROUS N, 1982, FEBS LETT, V147, P247, DOI 10.1016/0014-5793(82)81052-1; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BLATTNER FR, 1978, SCIENCE, V202, P1279, DOI 10.1126/science.725603; CHANG JC, 1982, NEW ENGL J MED, V307, P30, DOI 10.1056/NEJM198207013070105; CHANG JC, 1981, LANCET, V2, P1127; DEWENT LN, 1968, NATURE, V220, P788; EFSTRATIADIS A, 1980, CELL, V21, P653, DOI 10.1016/0092-8674(80)90429-8; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; MAROTTA CA, 1977, J BIOL CHEM, V252, P5019; Maxam A M, 1980, Methods Enzymol, V65, P499; NATHAN DG, 1974, HEMATOLOGY INFANCY C, P19; ORKIN SH, 1982, NATURE, V300, P768, DOI 10.1038/300768a0; ORKIN SH, 1982, NEW ENGL J MED, V307, P32, DOI 10.1056/NEJM198207013070106; ORKIN SH, 1981, J BIOL CHEM, V256, P9782; ORKIN SH, 1982, NATURE, V296, P627, DOI 10.1038/296627a0; SCOTT AF, 1979, P NATL ACAD SCI USA, V76, P4563, DOI 10.1073/pnas.76.9.4563; Southern E, 1979, Methods Enzymol, V68, P152; SPRITZ RA, 1981, P NATL ACAD SCI-BIOL, V78, P2455, DOI 10.1073/pnas.78.4.2455; Weatherall D.J., 1981, THALASSAEMIA SYNDROM, V3rd ed.; WEATHERALL DJ, 1982, CELL, V29, P7, DOI 10.1016/0092-8674(82)90084-8; WILSON JT, 1982, P NATL ACAD SCI-BIOL, V79, P3628, DOI 10.1073/pnas.79.11.3628	21	54	54	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	5					1028	1033						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RK604	6310991				2022-12-18	WOS:A1983RK60400022
J	TAYLOR, EF; MARTINDELEON, PA				TAYLOR, EF; MARTINDELEON, PA			FAMILIAL SILVER STAINING PATTERNS OF HUMAN NUCLEOLUS ORGANIZER REGIONS (NORS)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV DELAWARE,SCH LIFE & HLTH SCI,NEWARK,DE 19711	University of Delaware								BLOOM SE, 1976, HUM GENET, V34, P199, DOI 10.1007/BF00278889; CROCE CM, 1977, P NATL ACAD SCI USA, V74, P694, DOI 10.1073/pnas.74.2.694; EVANS HJ, 1974, CHROMOSOMA, V48, P405, DOI 10.1007/BF00290996; GOODPASTURE C, 1975, CHROMOSOMA, V53, P37, DOI 10.1007/BF00329389; HOWELL WM, 1975, EXPERIENTIA, V31, P260, DOI 10.1007/BF01990741; MARKOVIC VD, 1978, HUM GENET, V41, P181, DOI 10.1007/BF00273100; MCCRACKEN AA, 1978, HUM GENET, V45, P253, DOI 10.1007/BF00278724; MIKELSAAR AV, 1977, HUM GENET, V37, P73, DOI 10.1007/BF00293774; MIKELSAAR AV, 1977, HUM GENET, V38, P183, DOI 10.1007/BF00527401; MILLER DA, 1978, HUM GENET, V43, P289, DOI 10.1007/BF00278836; MILLER OJ, 1976, P NATL ACAD SCI USA, V73, P4531, DOI 10.1073/pnas.73.12.4531; PHILLIPS RB, 1977, CAN J GENET CYTOL, V19, P405, DOI 10.1139/g77-044; ROBINSON JA, 1976, ANN HUM GENET, V40, P113, DOI 10.1111/j.1469-1809.1976.tb00169.x; SCHWARZACHER HG, 1978, CYTOGENET CELL GENET, V20, P24, DOI 10.1159/000130837; TANTRAVAHI R, 1976, CHROMOSOMA, V56, P15, DOI 10.1007/BF00293725; VANDYKE DL, 1977, AM J HUM GENET, V29, P431; VARLEY JM, 1977, CHROMOSOMA, V61, P207, DOI 10.1007/BF00292805; WARBURTON D, 1979, CYTOGENET CELL GENET, V24, P168, DOI 10.1159/000131373; WARBURTON D, 1977, MAMM CHROM NEWSLETTE, V18, P182; 1975, BIRTH DEFECTS OAS  S, V11	20	54	58	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	1					67	76						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LA930	6162381				2022-12-18	WOS:A1981LA93000008
J	PEAKMAN, DC; MORETON, MF; CORN, BJ; ROBINSON, A				PEAKMAN, DC; MORETON, MF; CORN, BJ; ROBINSON, A			CHROMOSOMAL MOSAICISM IN AMNIOTIC-FLUID CELL-CULTURES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV COLORADO,MED CTR,DEPT BIOPHYS & GENET,DENVER,CO 80220	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	PEAKMAN, DC (corresponding author), NATL JEWISH HOSP & RES CTR,DENVER,CO 80206, USA.							ABBO G, 1970, LANCET, V1, P216; BLOOM AD, 1974, J PEDIATR-US, V84, P732, DOI 10.1016/S0022-3476(74)80021-1; COX DM, 1974, PEDIATR RES, V8, P679, DOI 10.1203/00006450-197406000-00009; CRANDALL BF, 1976, OBSTET GYNECOL, V48, P158; DORAN TA, 1974, AM J OBSTET GYNECOL, V118, P314, DOI 10.1016/S0002-9378(16)33785-1; GRAY C, 1971, J PEDIATR-US, V79, P119, DOI 10.1016/S0022-3476(71)80070-7; GREENSHER A, 1971, J PEDIATR-US, V79, P305, DOI 10.1016/S0022-3476(71)80121-X; HSU LYF, 1976, CLIN GENET, V10, P232; HSU LYF, 1973, J MED GENET, V10, P112, DOI 10.1136/jmg.10.2.112; KAJII T, 1971, LANCET, V2, P1037; KARDON NB, 1977, J PEDIATR-US, V90, P501, DOI 10.1016/S0022-3476(77)80745-2; KARDON NB, 1972, CLIN GENET, V3, P83; KATAYAMA KP, 1974, OBSTET GYNECOL, V44, P693; KOHN G, 1975, ISRAEL J MED SCI, V11, P476; LADDA R, 1977, J PEDIATR-US, V90, P841, DOI 10.1016/S0022-3476(77)81268-7; LAURENCE KM, 1976, BRIT MED BULL, V32, P9, DOI 10.1093/oxfordjournals.bmb.a071331; LEE JC, 1972, J AMER MED ASSOC, V219, P1211, DOI 10.1001/jama.1972.03190350047017; LEJEUNE J, 1968, CR ACAD SCI D NAT, V266, P24; MAGENIS RE, 1970, SCIENCE, V170, P85, DOI 10.1126/science.170.3953.85; MILUNSKY A, 1976, J PEDIATR-US, V88, P365, DOI 10.1016/S0022-3476(76)81035-9; NIERMEIJER MF, 1976, J MED GENET, V13, P182, DOI 10.1136/jmg.13.3.182; NOEL B, 1977, EXP CELL RES, V104, P423, DOI 10.1016/0014-4827(77)90107-0; NUZZO F, 1975, J GENET HUM, V23, P225; Peakman D C, 1975, Pediatr Res, V9, P516, DOI 10.1203/00006450-197505000-00011; PEAKMAN DC, 1977, J MED GENET, V14, P37, DOI 10.1136/jmg.14.1.37; ROBINSON A, 1967, AM J HUM GENET, V19, P112; Rudd N L, 1977, Birth Defects Orig Artic Ser, V13, P249; SACHS ES, 1975, J GENET HUM, V23, P233; SCHMID W, 1975, HUMANGENETIK, V30, P325, DOI 10.1007/BF00275145; SEABRIGH.M, 1971, LANCET, V2, P971; SUTHERLAND GR, 1975, CLIN GENET, V7, P400; WAHLSTROM J, 1978, HUM GENET, V41, P265, DOI 10.1007/BF00284760; WARBURTON D, AM J HUM GENET	33	54	56	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1979	31	2					149	155						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GZ386	453199				2022-12-18	WOS:A1979GZ38600006
J	FRIEDLAENDER, JS; SGARAMEL.LA; KIDD, KK; LAI, LYC; CLARK, P; WALSH, RJ				FRIEDLAENDER, JS; SGARAMEL.LA; KIDD, KK; LAI, LYC; CLARK, P; WALSH, RJ			BIOLOGICAL DIVERGENCES IN SOUTH-CENTRAL BOUGAINVILLE - ANALYSIS OF BLOOD POLYMORPHISM GENE FREQUENCIES AND ANTHROPOMETRIC MEASUREMENTS UTILIZING TREE MODELS, AND A COMPARISON OF THESE VARIABLES WITH LINGUISTIC, GEOGRAPHIC, AND MIGRATIONAL DISTANCES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Allen Jerry, 1963, LANGUAGES BOUGAINVIL; BODMER WF, 1968, GENETICS, V59, P565; BOOTH PB, 1967, ARCHAEOLOGY PHYS ANT, V2, P227; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; CAVALLISFORZA LL, 1959, 10 P INT C GEN MONTR, V1, P389; FITCH WM, 1969, AM J HUM GENET, V21, P384; FRIEDLAE.JS, 1970, NATURE, V228, P59, DOI 10.1038/228059a0; FRIEDLAENDER JS, 1969, THESIS HARVARD U; GILES E, 1966, ARCHAEOL PHYS ANTHRO, V1, P135; GOLSON J, 1968, PREHISTORIC CULTURE, P3; HARRISON GA, 1967, 3 P INT C HUM GEN CH, P351; HIERNAUX J, 1956, ANNALES MUSEE ROYAL, V3; HOWELLS WW, 1966, CURR ANTHROPOL, V7, P531, DOI 10.1086/200769; KARIKS J, 1957, OCEANIA, V28, P146, DOI 10.1002/j.1834-4461.1957.tb00735.x; KIDD KK, 1971, AM J HUM GENET, V23, P235; KIDD KK, 1969, GENETICS, V61, pS31; KIDD KK, 1969, THESIS U WISCONSIN; KIRK R. L., 1965, PROGR MED GENET, V4, P202; KIRK RL, 1969, ARCHAEOL PHYS ANTHRO, V4, P238; MORTON NE, 1968, AM J PHYS ANTHROPOL, V28, P191, DOI 10.1002/ajpa.1330280216; MORTON NE, 1962, DEPLACEMENTS HUMAINS, V1, P185; OLIVER DL, 1961, 6 ACT C INT SCIENC A, V1, P497; POLLITZER WS, 1958, AM J PHYS ANTHROPOL, V16, P213; Rao C.R., 1952, ADV STAT METHODS BIO; SANGHVI LD, 1953, AMERICAL J PHYSICAL, V11, P305; SMITH CAB, 1969, ANN HUM GENET, V32, P251, DOI 10.1111/j.1469-1809.1969.tb00074.x; SUTTER J, 1957, COLD SPRING HARB SYM, V22, P379, DOI 10.1101/SQB.1957.022.01.035; YASUDA N, 1967, 3RD P INT C HUM GEN, P249; ZONTA LA, 1966, ATTI ASSOC GENET IT, V11, P326	29	54	54	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1971	23	3					253	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	J3602	4996844				2022-12-18	WOS:A1971J360200002
J	SCHLEUTERMANN, DA; BIAS, WB; MURDOCH, JL; MCKUSICK, VA				SCHLEUTERMANN, DA; BIAS, WB; MURDOCH, JL; MCKUSICK, VA			LINKAGE OF LOCI FOR NAIL-PATELLA SYNDROME AND ADENYLATE KINASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BIAS WB, 1969, AM J HUM GENET, V21, P552; DUTHIE RB, 1963, J BONE JOINT SURG BR, V45, P259, DOI 10.1302/0301-620X.45B2.259; FILDES RA, 1966, NATURE, V209, P261, DOI 10.1038/209261a0; LEAHY MS, 1966, AM J DIS CHILD, V112, P237, DOI 10.1001/archpedi.1966.02090120105011; LEJEUNE J, 1965, CHROMOSOMES HUMAINES; LUCAS GL, 1966, J PEDIATR-US, V68, P273, DOI 10.1016/S0022-3476(66)80159-2; MORGAN BE, 1964, OBSTET GYNECOL, V24, P644; PAPADIMITRIOU D G, 1960, South Med J, V53, P186; RAPLEY S, 1968, ANN HUM GENET, V31, P237, DOI 10.1111/j.1469-1809.1968.tb00554.x; RENWICK JH, 1955, ANN HUM GENET, V19, P312, DOI 10.1111/j.1469-1809.1955.tb01356.x; RENWICK JH, 1956, ANN HUM GENET, V21, P159, DOI 10.1111/j.1469-1809.1971.tb00278.x; RENWICK JH, 1968, B EUR SOC HUM GENET, V2, P7; RENWICK JH, 1965, ANN HUM GENET, V28, P379, DOI 10.1111/j.1469-1809.1965.tb00493.x; RUBENSTEIN MM, 1964, AM J DIS CHILD, V107, P640, DOI 10.1001/archpedi.1964.02080060642016; SILVERMAN JD, 1967, ARCH INT MED CHICAGO, V120, P68	15	54	54	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1969	21	6					606	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	F0121	5365763				2022-12-18	WOS:A1969F012100009
J	PARKER, WC; BEARN, AG; CLEVE, H				PARKER, WC; BEARN, AG; CLEVE, H			DETERMINATION OF PHENOTYPES IN HUMAN GROUP-SPECIFIC COMPONENT (GC) SYSTEM BY STARCH GEL ELECTROPHORESIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		CLEVE H, 1963, AM J HUM GENET, V15, P368; CLEVE H, 1961, AM J HUM GENET, V13, P372; CLEVE HARTWIG, 1962, PROGR MED GENET, V2, P64; GIBLETT E. R., 1962, PROGR MED GENET, V2, P34; HIRSCHFELD J, 1959, ACTA PATHOL MIC SC, V46, P224; HIRSCHFELD J, 1962, PROG ALLERGY, V6, P1; HIRSCHFELD JAN, 1959, ACTA PATHOL ET MICROBIOL SCAND, V47, P160; NERSTROM B, 1963, ACTA PATHOL MIC SC, V58, P257; PARKER WC, 1962, SCIENCE, V137, P854, DOI 10.1126/science.137.3533.854; POULIK MD, 1957, NATURE, V180, P1477, DOI 10.1038/1801477a0; SCHEIDEGGER JJ, 1955, INT ARCH ALLER A IMM, V7, P103, DOI 10.1159/000228215; SCHULTZE HE, 1962, NATURWISSENSCHAFTEN, V49, P108, DOI 10.1007/BF00631985; SCHULZE HE, 1962, NATURWISSENSCHAFTEN, V49, P16, DOI 10.1007/BF00632837; SMITHIES O, 1957, NATURE, V180, P1482, DOI 10.1038/1801482a0; SMITHIES O, 1959, BIOCHEM J, V71, P585, DOI 10.1042/bj0710585; SMITHIES O, 1955, BIOCHEM J, V61, P629, DOI 10.1042/bj0610629; SMITHIES O, 1959, ADV PROTEIN CHEM, V14, P65, DOI 10.1016/S0065-3233(08)60609-9	17	54	54	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1963	15	4					353	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2968A	14097230				2022-12-18	WOS:A19632968A00012
J	HERNDON, CN; JENNINGS, RG				HERNDON, CN; JENNINGS, RG			A TWIN-FAMILY STUDY OF SUSCEPTIBILITY TO POLIOMYELITIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ADDAIR J, 1942, J HERED, V33, P306; AYCOCK WL, 1934, W VIRGINIA M J, V30, P481; AYCOCK WL, 1942, AM J MED SCI, V203, P452; BORGSTROM CA, 1939, Z MENSCHL VERERB, V23, P540; CZICKELI H, 1948, SCHWEIZ MED WSCHR, V78, P1092; STEVICK CP, 1945, POLIOMYELITIS N CARO; STEVICK CP, 1950, COMMUNICATION; Strandskov HH, 1945, AM J PHYS ANTHROP-NE, V3, P49, DOI 10.1002/ajpa.1330030117; STRANDSKOV HH, 1946, GENETICS, V31, P438; WEINBERG W, 1902, PFLUGERS ARCH GES PH, V88, P346; WIENER AS, 1946, BLOOD GROUPS TRANSFU	11	54	55	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1951	3	1					17	46						30	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XS392	13171372				2022-12-18	WOS:A1951XS39200002
J	Wells, HRR; Freidin, MB; Abidin, FNZ; Payton, A; Dawes, P; Munro, KJ; Morton, CC; Moore, DR; Dawson, SJ; Williams, FMK				Wells, Helena R. R.; Freidin, Maxim B.; Abidin, Fatin N. Zainul; Payton, Antony; Dawes, Piers; Munro, Kevin J.; Morton, Cynthia C.; Moore, David R.; Dawson, Sally J.; Williams, Frances M. K.			GWAS Identifies 44 Independent Associated Genomic Loci for Self-Reported Adult Hearing Difficulty in UK Biobank	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MIXED-MODEL ANALYSIS; WIDE ASSOCIATION; MESSENGER-RNA; AGE; MUTATIONS; PROTEIN; IMPAIRMENT; GENE; EYA4; HERITABILITY	Age-related hearing impairment (ARHI) is the most common sensory impairment in the aging population; a third of individuals are affected by disabling hearing loss by the age of 65. It causes social isolation and depression and has recently been identified as a risk factor for dementia. The genetic risk factors and underlying pathology of ARHI are largely unknown, meaning that targets for new therapies remain elusive, yet heritability estimates range between 35% and 55%. We performed genome-wide association studies (GWASs) for two self-reported hearing phenotypes, using more than 250,000 UK Biobank (UKBB) volunteers aged between 40 and 69 years. Forty-four independent genome-wide significant loci (p < 5E-08) were identified, considerably increasing the number of established trait loci. Thirty-four loci are novel associations with hearing loss of any form, and only one of the ten known hearing loci has a previously reported association with an ARHI-related trait. Gene sets from these loci are enriched in auditory processes such as synaptic activities, nervous system processes, inner ear morphology, and cognition, while genetic correlation analysis revealed strong positive correlations with multiple personality and psychological traits for the first time. Immunohistochemistry for protein localization in adult mouse cochlea implicate metabolic, sensory, and neuronal functions for NID2, CLRN2, and ARHGEF28. These results provide insight into the genetic landscape underlying ARHI, opening up novel therapeutic targets for further investigation. In a wider context, our study also highlights the viability of using self-report phenotypes for genetic discovery in very large samples when deep phenotyping is unavailable.	[Wells, Helena R. R.; Freidin, Maxim B.; Williams, Frances M. K.] Kings Coll London, Sch Life Course Sci, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Wells, Helena R. R.; Abidin, Fatin N. Zainul; Dawson, Sally J.] UCL, UCL Ear Inst, London WC1X 8EE, England; [Abidin, Fatin N. Zainul] UCL, Dept Med Phys & Biomed Engn, Ctr Med Image Comp, London WC1E 7JE, England; [Payton, Antony] Univ Manchester, Div Informat Imaging & Data Sci, Manchester M13 9PT, Lancs, England; [Dawes, Piers; Munro, Kevin J.; Morton, Cynthia C.; Moore, David R.] Univ Manchester, Manchester Ctr Audiol & Deafness, Manchester M13 9PL, Lancs, England; [Munro, Kevin J.; Morton, Cynthia C.] Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester M13 9WL, Lancs, England; [Morton, Cynthia C.] Harvard Med Sch, Brigham & Womens Hosp, Dept Obstet & Gynecol, Boston, MA 02115 USA; [Morton, Cynthia C.] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Moore, David R.] Univ Cincinnati, Coll Med, Dept Otolaryngol, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA	University of London; King's College London; University of London; University College London; University of London; University College London; University of Manchester; University of Manchester; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Williams, FMK (corresponding author), Kings Coll London, Sch Life Course Sci, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England.; Dawson, SJ (corresponding author), UCL, UCL Ear Inst, London WC1X 8EE, England.	sally.dawson@ucl.ac.uk; frances.williams@kcl.ac.uk	Freydin, Maxim/A-5603-2011; munro, kevin/A-2899-2015	Freydin, Maxim/0000-0002-1439-6259; Payton, Antony/0000-0003-0335-152X; Dawes, Piers/0000-0003-3180-9884; Dawson, Sally/0000-0002-4421-2043; Williams, Frances/0000-0002-2998-2744; Zainul Abidin, Fatin/0000-0001-7296-3752; munro, kevin/0000-0001-6543-9098	Action on Hearing Loss [11516]; NIHR UCLH BRC Deafness and Hearing Problems Theme; NIHR Manchester Biomedical Research Centre; Economic and Social Research Council; National Institute on Aging; Wellcome; MRC [MR/N01104X/1 2018-2020, ES/S008349/1]; Wellcome Trust; Medical Research Council; European Union; National Institute for Health Research (NIHR); Clinical Research Facility, and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; King's College London; ESRC; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC015052] Funding Source: NIH RePORTER; ESRC [ES/S008349/1] Funding Source: UKRI; MRC [G1001799, MR/N01104X/2, MR/N01104X/1] Funding Source: UKRI	Action on Hearing Loss; NIHR UCLH BRC Deafness and Hearing Problems Theme; NIHR Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Wellcome; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Clinical Research Facility, and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; King's College London(General Electric); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research was carried out using the UK Biobank Resource under application number 11516. H.R.R.W. is funded by a PhD Studentship Grant, S44, from Action on Hearing Loss. The study was also supported by funding from NIHR UCLH BRC Deafness and Hearing Problems Theme, a grant from MED_ EL, and the NIHR Manchester Biomedical Research Centre. The EnglishLongitudinal Study of Aging is jointly run by University College London, Institute for Fiscal Studies, University of Manchester, and National Centre for Social Research. Genetic analyses have been carried out by UCL Genomics and funded by the Economic and Social Research Council and the National Institute on Aging. Data governance was provided by the METADAC data access committee, funded by ESRC, Wellcome, and MRC (2015-2018: Grant Number MR/N01104X/1 2018-2020: Grant Number ES/S008349/1). TwinsUK is funded by the Wellcome Trust, Medical Research Council, European Union, the National Institute for Health Research (NIHR)-funded BioResource, Clinical Research Facility, and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London. We would like to thank all the participants of UK Biobank, English Longitudinal Study of Aging, and TwinsUK.	Adato A, 2002, EUR J HUM GENET, V10, P339, DOI 10.1038/sj.ejhg.5200831; Bedin E, 2009, INT J AUDIOL, V48, P465, DOI 10.1080/14992020902822039; Bogo R, 2015, J GERONTOL A-BIOL, V70, P647, DOI 10.1093/gerona/glu245; Bowl MR, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00595-4; Brewster KK, 2018, AM J GERIAT PSYCHIAT, V26, P788, DOI 10.1016/j.jagp.2018.04.003; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bycroft C., 2017, BIORXIV, DOI [DOI 10.1101/16629824, DOI 10.1101/166298]; Canete-Soler R, 2001, J BIOL CHEM, V276, P32046, DOI 10.1074/jbc.M104104200; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Dawes P, 2014, EAR HEARING, V35, pE44, DOI 10.1097/AUD.0000000000000010; de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219; Droppelmann CA, 2013, AMYOTROPH LAT SCL FR, V14, P444, DOI 10.3109/21678421.2012.758288; Fields RR, 2002, AM J HUM GENET, V71, P607, DOI 10.1086/342098; Fransen E, 2015, EUR J HUM GENET, V23, P110, DOI 10.1038/ejhg.2014.56; Friedman RA, 2009, HUM MOL GENET, V18, P785, DOI 10.1093/hmg/ddn402; Gates GA, 1999, ARCH OTOLARYNGOL, V125, P654, DOI 10.1001/archotol.125.6.654; Girotto G, 2011, J MED GENET, V48, P369, DOI 10.1136/jmg.2010.088310; Gurgel RK, 2014, OTOL NEUROTOL, V35, P775, DOI 10.1097/MAO.0000000000000313; Han JH, 2019, EPIDEMIOL PSYCH SCI, V28, P343, DOI 10.1017/S2045796018000045; Hoffmann TJ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006371; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huddle MG, 2017, JAMA OTOLARYNGOL, V143, P1040, DOI 10.1001/jamaoto.2017.1243; Jayakody DMP, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00125; Keidser G, 2015, INT J AUDIOL, V54, P653, DOI 10.3109/14992027.2015.1046503; Kiefer AK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003299; Kohfeldt E, 1998, J MOL BIOL, V282, P99, DOI 10.1006/jmbi.1998.2004; Kraft P, 2009, STAT SCI, V24, P561, DOI 10.1214/09-STS290; Lin FR, 2011, ARCH NEUROL-CHICAGO, V68, P214, DOI 10.1001/archneurol.2010.362; Liu Y, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav7803; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Luo HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077153; Makishima T, 2007, AM J MED GENET A, V143A, P1592, DOI 10.1002/ajmg.a.31793; Manji SSM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017607; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Moayyeri A, 2013, TWIN RES HUM GENET, V16, P144, DOI 10.1017/thg.2012.89; Moore DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107720; Newman DL, 2012, HEARING RES, V294, P125, DOI 10.1016/j.heares.2012.08.016; Noben-Trauth K, 2003, NAT GENET, V35, P21, DOI 10.1038/ng1226; Nolan LS, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.02.009; OHLEMILLER KK, 1995, NEUROREPORT, V6, P845, DOI 10.1097/00001756-199504190-00005; Pfister M, 2002, MOL MED, V8, P607, DOI 10.1007/BF03402171; Riazuddin S, 2006, AM J HUM GENET, V78, P137, DOI 10.1086/499164; Richardson GP, 2019, CSH PERSPECT MED, V9, DOI 10.1101/cshperspect.a033142; Rico B, 2004, NAT NEUROSCI, V7, P1059, DOI 10.1038/nn1317; Rutherford BR, 2018, AM J PSYCHIAT, V175, P215, DOI 10.1176/appi.ajp.2017.17040423; Sawyer CS, 2019, EAR HEARING, V40, P1061, DOI 10.1097/AUD.0000000000000695; Schonberger J, 2005, NAT GENET, V37, P418, DOI 10.1038/ng1527; Schultz JM, 2011, J MED GENET, V48, P767, DOI 10.1136/jmedgenet-2011-100262; Shahin H, 2006, AM J HUM GENET, V78, P144, DOI 10.1086/499495; Sheets L, 2011, DEVELOPMENT, V138, P1309, DOI 10.1242/dev.059451; Shi H, 2016, AM J HUM GENET, V99, P139, DOI 10.1016/j.ajhg.2016.05.013; Steptoe A, 2013, INT J EPIDEMIOL, V42, P1640, DOI 10.1093/ije/dys168; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Van Laer L, 2010, EUR J HUM GENET, V18, P685, DOI 10.1038/ejhg.2009.234; Visscher PM, 2017, AM J HUM GENET, V101, P5, DOI 10.1016/j.ajhg.2017.06.005; Volkening K, 2010, AMYOTROPH LATERAL SC, V11, P97, DOI 10.3109/17482960902995584; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Vuckovic D, 2015, HUM MOL GENET, V24, P5655, DOI 10.1093/hmg/ddv279; Watanabe K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01261-5; Wei JK, 2017, DEMENT GER COGN D EX, V7, P440, DOI 10.1159/000485178; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wolber LE, 2014, HUM MOL GENET, V23, P6407, DOI 10.1093/hmg/ddu346; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Zaitlen N, 2012, HUM GENET, V131, P1655, DOI 10.1007/s00439-012-1199-6; Zheng J, 2017, BIOINFORMATICS, V33, P272, DOI 10.1093/bioinformatics/btw613; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	68	53	55	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 3	2019	105	4					788	802		10.1016/j.ajhg.2019.09.008	http://dx.doi.org/10.1016/j.ajhg.2019.09.008			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC0EX	31564434	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000488953400009
J	Pehlivan, D; Bayram, Y; Gunes, N; Akdemir, ZC; Shukla, A; Bierhals, T; Tabakci, B; Sahin, Y; Gezdirici, A; Fatih, JM; Gulec, EY; Yesil, G; Punetha, J; Ocak, Z; Grochowski, CM; Karaca, E; Albayrak, HM; Radhakrishnan, P; Erdem, HB; Sahin, I; Yildirim, T; Bayhan, IA; Bursali, A; Elmas, M; Yuksel, Z; Ozdemir, O; Silan, F; Yildiz, O; Yesilbas, O; Isikay, S; Balta, B; Gu, S; Jhangiani, SN; Doddapaneni, H; Hu, JH; Muzny, DM; Boerwinkle, E; Gibbs, RA; Tsiakas, K; Hempel, M; Girisha, KM; Gul, D; Posey, JE; Elcioglu, NH; Tuysuz, B; Lupski, JR				Pehlivan, Davut; Bayram, Yavuz; Gunes, Nilay; Akdemir, Zeynep Coban; Shukla, Anju; Bierhals, Tatjana; Tabakci, Burcu; Sahin, Yavuz; Gezdirici, Alper; Fatih, Jawid M.; Gulec, Elif Yilmaz; Yesil, Gozde; Punetha, Jaya; Ocak, Zeynep; Grochowski, Christopher M.; Karaca, Ender; Albayrak, Hatice Mutlu; Radhakrishnan, Periyasamy; Erdem, Haktan Bagis; Sahin, Ibrahim; Yildirim, Timur; Bayhan, Ilhan A.; Bursali, Aysegul; Elmas, Muhsin; Yuksel, Zafer; Ozdemir, Ozturk; Silan, Fatma; Yildiz, Onur; Yesilbas, Osman; Isikay, Sedat; Balta, Burhan; Gu, Shen; Jhangiani, Shalini N.; Doddapaneni, Harsha; Hu, Jianhong; Muzny, Donna M.; Boerwinkle, Eric; Gibbs, Richard A.; Tsiakas, Konstantinos; Hempel, Maja; Girisha, Katta Mohan; Gul, Davut; Posey, Jennifer E.; Elcioglu, Nursel H.; Tuysuz, Beyhan; Lupski, James R.		Baylor-Hopkins Ctr Mendelian	The Genomics of Arthrogryposis, a Complex Trait: Candidate Genes and Further Evidence for Oligogenic Inheritance	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DE-NOVO; MULTIPLEX CONGENITA; SKELETAL-MUSCLE; MUTATIONS; PATIENT; FAT1; MECHANISMS; MYOPATHY; DELETION; DISEASE	Arthrogryposis is a clinical finding that is present either as a feature of a neuromuscular condition or as part of a systemic disease in over 400 Mendelian conditions. The underlying molecular etiology remains largely unknown because of genetic and phenotypic heterogeneity. We applied exome sequencing (ES) in a cohort of 89 families with the clinical sign of arthrogryposis. Additional molecular techniques including array comparative genomic hybridization (aCGH) and Droplet Digital PCR (ddPCR) were performed on individuals who were found to have pathogenic copy number variants (CNVs) and mosaicism, respectively. A molecular diagnosis was established in 65.2% (58/89) of families. Eleven out of 58 families (19.0%) showed evidence for potential involvement of pathogenic variation at more than one locus, probably driven by absence of heterozygosity (AOH) burden due to identity-by-descent (IBD). RYR3, MYOM2, ERGIC1, SPTBN4, and ABCA7 represent genes, identified in two or more families, for which mutations are probably causative for arthrogryposis. We also provide evidence for the involvement of CNVs in the etiology of arthrogryposis and for the idea that both mono-allelic and bi-allelic variants in the same gene cause either similar or distinct syndromes. We were able to identify the molecular etiology in nine out of 20 families who underwent reanalysis. In summary, our data from family-based ES further delineate the molecular etiology of arthrogryposis, yielded several candidate disease-associated genes, and provide evidence for mutational burden in a biological pathway or network. Our study also highlights the importance of reanalysis of individuals with unsolved diagnoses in conjunction with sequencing extended family members.	[Pehlivan, Davut; Bayram, Yavuz; Akdemir, Zeynep Coban; Fatih, Jawid M.; Punetha, Jaya; Grochowski, Christopher M.; Karaca, Ender; Gu, Shen; Gibbs, Richard A.; Posey, Jennifer E.; Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Pehlivan, Davut; Lupski, James R.] Baylor Coll Med, Dept Pediat, Sect Pediat Neurol & Dev Neurosci, Houston, TX 77030 USA; [Bayram, Yavuz] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Gunes, Nilay; Tuysuz, Beyhan] Istanbul Univ, Cerrahpasa Med Fac, Dept Pediat Genet, TR-34096 Istanbul, Turkey; [Shukla, Anju; Radhakrishnan, Periyasamy; Girisha, Katta Mohan] Manipal Acad Higher Educ, Kasturba Med Coll, Dept Med Genet, Manipal 576104, Karnataka, India; [Bierhals, Tatjana; Hempel, Maja] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, Martinistr 52, D-20246 Hamburg, Germany; [Tabakci, Burcu; Elcioglu, Nursel H.] Marmara Univ, Sch Med, Dept Pediat Genet, TR-34854 Istanbul, Turkey; [Sahin, Yavuz] Necip Fazil City Hosp, Dept Med Genet, TR-46050 Kahramanmaras, Turkey; [Gezdirici, Alper; Gulec, Elif Yilmaz; Ocak, Zeynep] Kanuni Sultan Suleyman Training & Res Hosp, Dept Med Genet, TR-34303 Istanbul, Turkey; [Yesil, Gozde] Bezmi Alem Vakif Univ, Fac Med, Dept Med Genet, TR-34093 Istanbul, Turkey; [Albayrak, Hatice Mutlu] Ondokuz Mayis Univ, Fac Med, Div Pediat Genet, Dept Pediat, TR-55270 Samsun, Turkey; [Erdem, Haktan Bagis] Univ Hlth Sci, Diskapi Yildirim Beyazit Training & Res Hosp, Dept Med Genet, TR-06110 Ankara, Turkey; [Sahin, Ibrahim] Univ Erzurum, Sch Med, Dept Med Genet, TR-25240 Erzurum, Turkey; [Yildirim, Timur; Bayhan, Ilhan A.; Bursali, Aysegul] Baltalimani Bone Dis Training & Res Hosp, Dept Orthoped & Traumatol, TR-34470 Istanbul, Turkey; [Elmas, Muhsin] Afyon Kocatepe Univ, Sch Med, Dept Med Genet, TR-03218 Afyon, Turkey; [Yuksel, Zafer] Mersin Women & Children Hosp, Med Genet Clin, TR-33330 Mersin, Turkey; [Ozdemir, Ozturk; Silan, Fatma; Yildiz, Onur] Onsekiz Mart Univ, Fac Med, Dept Med Genet, TR-17000 Canakkale, Turkey; [Yesilbas, Osman] Univ Hlth Sci, Van Training & Res Hosp, Dept Pediat, Div Crit Care Med, TR-65130 Van, Turkey; [Isikay, Sedat] Hasan Kalyoncu Univ, Sch Hlth Sci, Dept Physiotherapy & Rehabil, TR-27000 Gaziantep, Turkey; [Balta, Burhan] Kayseri Training & Res Hosp, Dept Med Genet, TR-38080 Kayseri, Turkey; [Jhangiani, Shalini N.; Doddapaneni, Harsha; Hu, Jianhong; Muzny, Donna M.; Boerwinkle, Eric; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Ctr Human Genet, Houston, TX 77030 USA; [Tsiakas, Konstantinos] Univ Med Ctr Hamburg Eppendorf, Dept Pediat, D-20246 Hamburg, Germany; [Gul, Davut] Gulhane Mil Med Acad, Dept Med Genet, TR-06010 Ankara, Turkey; [Elcioglu, Nursel H.] Eastern Mediterranean Univ, Sch Med, Mersin 10, Famagusta, Northern Cyprus, Turkey; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Icahn School of Medicine at Mount Sinai; Istanbul University; Istanbul University - Cerrahpasa; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; University of Hamburg; University Medical Center Hamburg-Eppendorf; Marmara University; Kahramanmaras Necip Fazil City Hospital; Istanbul Kanuni Sultan Suleyman Training & Research Hospital; Bezmialem Vakif University; Ondokuz Mayis University; Diskapi Yildirim Beyazit Training & Research Hospital; University of Health Sciences Turkey; Ataturk University; Baltalimani Bone Diseases Training & Research Hospital; Afyon Kocatepe University; Canakkale Onsekiz Mart University; University of Health Sciences Turkey; Van Training & Research Hospital; Hasan Kalyoncu University; Kayseri Training & Research Hospital; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Hamburg; University Medical Center Hamburg-Eppendorf; Gulhane Military Medical Academy; Eastern Mediterranean University; Baylor College of Medicine; Baylor College of Medicine	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Lupski, JR (corresponding author), Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.; Lupski, JR (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.; Lupski, JR (corresponding author), Texas Childrens Hosp, Houston, TX 77030 USA.	jlupski@bcm.edu	YESIL, GOZDE/ABE-1615-2020; Albayrak, Hatice Mutlu/A-3635-2017; Tüysüz, Beyhan/AAN-4858-2020; ışıkay, sedat/AAA-9993-2020; KM, Girisha/AAK-6867-2020; Sahin, Yavuz/E-9966-2013; Yildirim, Timur/B-1524-2018; Gezdirici, Alper/W-8459-2018; Grochowski, Christopher/AAZ-2462-2020; Gezdirici, Alper/AAG-5480-2019; sahin, ibrahim/AFY-3566-2022; Yüksel, Zafer/HHC-9711-2022; gunes, nilay/ABS-0969-2022; Gu, Shen/AAE-2641-2020; Yilmaz Gulec, Elif/X-2778-2018; Balta, Burhan/A-8009-2018; ocak, zeynep/AGU-7822-2022; Yeşilbaş, Osman/AAR-9176-2021; Yılmaz Gulec, Elif/GPS-8141-2022; Erdem, Haktan Bağış/AAL-8210-2020; sahin, ibrahim/AGE-3168-2022; Bayhan, Ilhan/L-5947-2018	YESIL, GOZDE/0000-0003-1964-6306; Albayrak, Hatice Mutlu/0000-0001-5624-3878; ışıkay, sedat/0000-0003-0103-9612; KM, Girisha/0000-0002-0139-8239; Sahin, Yavuz/0000-0002-7831-067X; Gezdirici, Alper/0000-0002-2432-9279; Grochowski, Christopher/0000-0002-3884-7720; Gezdirici, Alper/0000-0002-2432-9279; sahin, ibrahim/0000-0002-6050-816X; Yüksel, Zafer/0000-0002-2085-5773; gunes, nilay/0000-0002-7787-3630; Gu, Shen/0000-0003-3107-1218; Yilmaz Gulec, Elif/0000-0003-0872-3898; Balta, Burhan/0000-0003-2672-2493; ocak, zeynep/0000-0002-5954-5086; Yılmaz Gulec, Elif/0000-0003-0872-3898; Erdem, Haktan Bağış/0000-0002-4391-1387; Posey, Jennifer/0000-0003-4814-6765; Fatih, Jawid/0000-0002-3927-2711; doddapaneni, harshavardhan/0000-0002-2433-633X; Bayhan, Ilhan/0000-0001-8308-1309; , Radhakrishnan/0000-0002-7690-3201; YILDIRIM, Timur/0000-0003-0291-7632; Tuysuz, Beyhan/0000-0002-9620-5021; Punetha, Jaya/0000-0002-6774-4464	National Human Genome Research Institute (NHGRI) [UM1 HG006542]; National Heart, Lung, and Blood Institute (NHLBI) [UM1 HG006542]; NHGRI [K08 HG008986]; National Institutes of Health - Brain Disorders and Development Training Grant [T32 NS043124-17]; Clinical Research Training Scholarship in Neuromuscular Disease; Tubitak project, Turkey [217S675]; Indian Council of Medical Research, New Delhi, India [5/13/58/2015/NCD-III];  [R35 NS105078];  [512848]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006542, K08HG008986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS043124, R35NS105078] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health - Brain Disorders and Development Training Grant; Clinical Research Training Scholarship in Neuromuscular Disease; Tubitak project, Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR)); ; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by R35 NS105078 and MDA#512848 to J.R.L. and a jointly funded National Human Genome Research Institute (NHGRI) and National Heart, Lung, and Blood Institute (NHLBI) grant to the Baylor-Hopkins Center for Mendelian Genomics (UM1 HG006542). J.E.P. is supported by NHGRI K08 HG008986. D.P. is supported by the National Institutes of Health - Brain Disorders and Development Training Grant (T32 NS043124-17) and a Clinical Research Training Scholarship in Neuromuscular Disease partnered by the American Brain Foundation (ABF) and Muscle Study Group (MSG). This study is partly funded by Tubitak project number 217S675, Turkey to N.E. and B.T.. This study is partly funded by Indian Council of Medical Research, New Delhi, India with File no.: No. 5/13/58/2015/NCD-III to A.S.	Alazami AM, 2015, J MED GENET, V52, P400, DOI 10.1136/jmedgenet-2014-102964; Anazi S, 2017, HUM GENET, V136, P1419, DOI 10.1007/s00439-017-1843-2; Balci TB, 2017, CLIN GENET, V92, P281, DOI 10.1111/cge.12987; Balta B, 2017, AM J MED GENET A, V173, P2798, DOI 10.1002/ajmg.a.38386; Bayram Y, 2016, J CLIN INVEST, V126, P762, DOI 10.1172/JCI84457; Bertocchini F, 1997, EMBO J, V16, P6956, DOI 10.1093/emboj/16.23.6956; Bohm J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067527; Bower NI, 2010, PHYSIOL GENOMICS, V42A, P114, DOI 10.1152/physiolgenomics.00065.2010; Breuza L, 2004, J BIOL CHEM, V279, P47242, DOI 10.1074/jbc.M406644200; Carrascosa-Romero MC, 2013, AM J MED GENET A, V161, P2281, DOI 10.1002/ajmg.a.35862; Caruso N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003550; Carvalho CMB, 2016, NAT REV GENET, V17, P224, DOI 10.1038/nrg.2015.25; Casey WM, 2008, BIOMARKERS, V13, P364, DOI [10.1080/13547500801903545, 10.1080/13547500801903545 ]; Challis D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-8; Cheedipudi S, 2015, NUCLEIC ACIDS RES, V43, P6236, DOI 10.1093/nar/gkv567; Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887; Eldomery MK, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0412-6; Flix B, 2013, INT J BIOCHEM CELL B, V45, P1927, DOI 10.1016/j.biocel.2013.06.007; Gambin T, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0472-7; Gambin T, 2017, NUCLEIC ACIDS RES, V45, P1633, DOI 10.1093/nar/gkw1237; Gee HY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10822; Hall JG, 2016, MOL SYNDROMOL, V7, P101, DOI 10.1159/000446617; Hall JG, 2014, EUR J MED GENET, V57, P464, DOI 10.1016/j.ejmg.2014.03.008; Harel T, 2016, AM J HUM GENET, V99, P831, DOI 10.1016/j.ajhg.2016.08.007; Helsmoortel C, 2014, NAT GENET, V46, P380, DOI 10.1038/ng.2899; Hodgson B, 2018, CURR STEM CELL RES T, V13, P384, DOI 10.2174/1574888X11666170907113151; Hou R, 2009, J BIOL CHEM, V284, P6955, DOI 10.1074/jbc.M809333200; Hu YH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-357; Jeyakumar LH, 1998, J BIOL CHEM, V273, P16011, DOI 10.1074/jbc.273.26.16011; Karaca E, 2018, GENET MED, V20, P1528, DOI 10.1038/gim.2018.33; Karaca E, 2015, NEURON, V88, P499, DOI 10.1016/j.neuron.2015.09.048; Knierim E, 2017, HUM GENET, V136, P903, DOI 10.1007/s00439-017-1814-7; Lange S, 2009, J CELL SCI, V122, P2640, DOI 10.1242/jcs.046193; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lowry RB, 2010, BIRTH DEFECTS RES A, V88, P1057, DOI 10.1002/bdra.20738; Lukusa T, 2010, GENET COUNSEL, V21, P25; Lupski JR, 2011, CELL, V147, P32, DOI 10.1016/j.cell.2011.09.008; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; Malfatti Edoardo, 2015, J Neuromuscul Dis, V2, P219; Mariot V, 2015, ANN NEUROL, V78, P387, DOI 10.1002/ana.24446; Moeller MJ, 2004, EMBO J, V23, P3769, DOI 10.1038/sj.emboj.7600380; Monies D, 2017, GENET MED, V19, P1144, DOI 10.1038/gim.2017.22; Neto OA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110888; Nilipour Y, 2018, EUR J NEUROL, V25, P841, DOI 10.1111/ene.13607; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Park HJ, 2018, YONSEI MED J, V59, P337, DOI 10.3349/ymj.2018.59.2.337; Pehlivan D, 2012, GENET MED, V14, P313, DOI 10.1038/gim.2011.13; Posey JE, 2019, GENET MED, V21, P798, DOI 10.1038/s41436-018-0408-7; Posey JE, 2017, NEW ENGL J MED, V376, P21, DOI 10.1056/NEJMoa1516767; Posey JE, 2016, GENET MED, V18, P678, DOI 10.1038/gim.2015.142; Puppo F, 2015, HUM MUTAT, V36, P443, DOI 10.1002/humu.22760; Rainger J, 2014, AM J HUM GENET, V94, P915, DOI 10.1016/j.ajhg.2014.05.005; Reid JG, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-30; Reinstein E, 2018, CLIN GENET, V93, P160, DOI 10.1111/cge.13018; Shin K, 2017, ANIM SCI J, V88, P712, DOI 10.1111/asj.12687; Shin K, 2017, CELL BIOL INT, V41, P213, DOI 10.1002/cbin.10713; Skouloudaki K, 2009, P NATL ACAD SCI USA, V106, P8579, DOI 10.1073/pnas.0811691106; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Sobreira N, 2015, HUM MUTAT, V36, P425, DOI 10.1002/humu.22769; SPENCE JE, 1988, AM J HUM GENET, V42, P217; Szpiech Z. A, 2018, BIORXIV, DOI [10.1101/382721, DOI 10.1101/382721]; Tabet AC, 2010, AM J MED GENET A, V152A, P1781, DOI 10.1002/ajmg.a.33433; Tarailo-Graovac M, 2016, NEW ENGL J MED, V374, P2246, DOI 10.1056/NEJMoa1515792; Todd EJ, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0364-0; Tsai EA, 2015, HUM MUTAT, V36, P631, DOI 10.1002/humu.22786; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Warner LE, 1998, NAT GENET, V18, P382, DOI 10.1038/ng0498-382; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028; Yamamoto S, 2014, CELL, V159, P200, DOI 10.1016/j.cell.2014.09.002; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555	71	53	54	3	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 3	2019	105	1					132	150		10.1016/j.ajhg.2019.05.015	http://dx.doi.org/10.1016/j.ajhg.2019.05.015			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IG3RM	31230720	Green Published, Bronze			2022-12-18	WOS:000473723000011
J	De Brouwer, APM; Abou Jamra, R; Kortel, N; Soyris, C; Polla, DL; Safra, M; Zisso, A; Powell, CA; Rebelo-Guiomar, P; Dinges, N; Morin, V; Stock, M; Hussain, M; Shahzad, M; Riazuddin, S; Ahmed, ZM; Pfundt, R; Schwarz, F; de Boer, L; Reis, A; Grozeva, D; Raymond, FL; Riazuddin, S; Koolen, DA; Minczuk, M; Roignant, JY; van Bokhoven, H; Schwartz, S				De Brouwer, Arjan P. M.; Abou Jamra, Rami; Koertel, Nadine; Soyris, Clara; Polla, Daniel L.; Safra, Modi; Zisso, Avia; Powell, Christopher A.; Rebelo-Guiomar, Pedro; Dinges, Nadja; Morin, Violeta; Stock, Michael; Hussain, Mureed; Shahzad, Mohsin; Riazuddin, Saima; Ahmed, Zubair M.; Pfundt, Rolph; Schwarz, Franziska; de Boer, Lonneke; Reis, Andre; Grozeva, Detilina; Raymond, F. Lucy; Riazuddin, Sheikh; Koolen, David A.; Minczuk, Michal; Roignant, Jean-Yves; van Bokhoven, Hans; Schwartz, Schraga			Variants in PUS7 Cause Intellectual Disability with Speech Delay, Microcephaly, Short Stature, and Aggressive Behavior	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSFER-RNA; MITOCHONDRIAL MYOPATHY; CONSANGUINEOUS FAMILIES; SIDEROBLASTIC ANEMIA; MESSENGER-RNA; PSEUDOURIDINE; SYNTHASE; MUTATION; YEAST; STABILIZATION	We describe six persons from three families with three homozygous protein truncating variants in PUS7: c.89_90del (p.Thr30Lysfs*20), c.1348C>T (p.Arg450*), and a deletion of the penultimate exon 15. All these individuals have intellectual disability with speech delay, short stature, microcephaly, and aggressive behavior. PUS7 encodes the RNA-independent pseudouridylate synthase 7. Pseudouridylation is the most abundant post-transcriptional modification in RNA, which is primarily thought to stabilize secondary structures of RNA. We show that the disease-related variants lead to abolishment of PUS7 activity on both tRNA and mRNA substrates. Moreover, pus7 knockout in Drosophila melanogaster results in a number of behavioral defects, including increased activity, disorientation, and aggressiveness supporting that neurological defects are caused by PUS7 variants. Our findings demonstrate that RNA pseudouridylation by PUS7 is essential for proper neuronal development and function.	[De Brouwer, Arjan P. M.; Polla, Daniel L.; Hussain, Mureed; Pfundt, Rolph; Schwarz, Franziska; Koolen, David A.; van Bokhoven, Hans] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands; [Abou Jamra, Rami; Reis, Andre] Friedrich Alexander Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany; [Abou Jamra, Rami] Univ Med Ctr Leipzig, Inst Human Genet, D-04109 Leipzig, Germany; [Koertel, Nadine; Dinges, Nadja; Morin, Violeta; Stock, Michael; Roignant, Jean-Yves] IMB, Lab RNA Epigenet, D-55128 Mainz, Germany; [Soyris, Clara; Safra, Modi; Zisso, Avia; Schwartz, Schraga] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Polla, Daniel L.] Minist Educ Brazil, CAPES Fdn, BR-70040020 Brasilia, DF, Brazil; [Powell, Christopher A.; Rebelo-Guiomar, Pedro; Minczuk, Michal] Univ Cambridge, MRC Mitochondrial Biol Unit, Cambridge CB2 0XY, England; [Hussain, Mureed; Riazuddin, Sheikh] Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore 53700, Pakistan; [Hussain, Mureed; Riazuddin, Saima; Ahmed, Zubair M.] Univ Maryland, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Baltimore, MD 21201 USA; [Shahzad, Mohsin; Riazuddin, Sheikh] Shaheed Zulfiqar Ali Bhutto Med Univ, Ctr Genet Dis, Pakistan Inst Med Sci, Islamabad 44000, Pakistan; [de Boer, Lonneke] Radboud Univ Nijmegen, Radboud Ctr Mitochondrial Med, Dept Paediat, Med Ctr, NL-6525 GA Nijmegen, Netherlands; [Grozeva, Detilina; Raymond, F. Lucy] Univ Cambridge, Dept Med Genet, Cambridge CB2 0QQ, England; [Riazuddin, Sheikh] Univ Hlth Sci, Allama Iqbal Med Coll, Lahore 54600, Pakistan	Radboud University Nijmegen; University of Erlangen Nuremberg; Leipzig University; Institute of Molecular Biology (IMB); Weizmann Institute of Science; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); University of Cambridge; National Center of Excellence in Molecular Biology - Pakistan; University of Punjab; University System of Maryland; University of Maryland Baltimore; Pakistan Institute of Medical Sciences; Radboud University Nijmegen; University of Cambridge; University of Health Science - Pakistan	De Brouwer, APM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands.; Schwartz, S (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	arjan.debrouwer@radboudumc.nl; schwartz@weizmann.ac.il	Bokhoven, J.H.L.M. van van/H-8015-2014; Koolen, D.A./L-4448-2015; Polla, Daniel L./B-3887-2015; Rebelo-Guiomar, Pedro/AAT-3575-2021; Reis, André/D-2309-2009; de Brouwer, Arjan PM/P-5949-2015; Abou Jamra, Rami/AAC-8192-2019; , WaNgtJ/AAR-7045-2020; Minczuk, Michal/G-1638-2014	Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Polla, Daniel L./0000-0002-5552-3488; Rebelo-Guiomar, Pedro/0000-0002-5060-7519; Reis, André/0000-0002-6301-6363; Abou Jamra, Rami/0000-0002-1542-1399; Shahzad, Mohsin/0000-0003-1537-3195; Grozeva, Detelina/0000-0003-3239-8415; Minczuk, Michal/0000-0001-8242-1420; Roignant, Jean-Yves/0000-0003-1395-2150; Hussain, Mureed/0000-0002-5985-6546; Reis, AlessanRSS/0000-0001-8486-7469	NIHR Biomedical Research Centre, UK; Israel Science Foundation [543165]; European Research Council (ERC) under the European Union [714023]; Abramson Family Center for Young Scientists; David and Fela Shapell Family Foundation INCPM Fund for Preclinical Studies; Berlin Family Foundation New Scientist Fund; DFG (Deutsche Forschungsgemeinschaft) [AB393/2-2, RO4681/9-1]; CAPES Fellowship [99999.013311/2013-01]; EU [241995]; Higher Education Commission in Pakistan; Medical Research Council, UK [MC_UU_00015/4]; Action Medical Research; Estate of David Turner; DIP [RO4681/6-1]; University of Maryland; MRC [MC_UU_00015/4] Funding Source: UKRI	NIHR Biomedical Research Centre, UK(National Institute for Health Research (NIHR)); Israel Science Foundation(Israel Science Foundation); European Research Council (ERC) under the European Union(European Research Council (ERC)); Abramson Family Center for Young Scientists; David and Fela Shapell Family Foundation INCPM Fund for Preclinical Studies; Berlin Family Foundation New Scientist Fund; DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); CAPES Fellowship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); EU(European Commission); Higher Education Commission in Pakistan(Higher Education Commission of Pakistan); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Action Medical Research; Estate of David Turner; DIP; University of Maryland; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are very grateful to the families for their participation. We would like to thank Saskia van de Velde-Visser (Radboudumc, Nijmegen, the Netherlands) for technical assistance culturing the cell lines. We would like to thank Farah Radwan (Institute of Human Genetics, Erlangen, Germany) for technical assistance with genetic analysis of family 2. In addition, we thank the group of Prof. Roland Strauss, in particular Teuta Wille, for assistance with performing the Buridan paradigm experiments. This work was supported by the Action Medical Research and NIHR Biomedical Research Centre, UK (to F.L.R.), the Israel Science Foundation (543165) and the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement no. 714023), The Abramson Family Center for Young Scientists, the David and Fela Shapell Family Foundation INCPM Fund for Preclinical Studies, the Estate of David Turner, and the Berlin Family Foundation New Scientist Fund (to S.S.), by the DFG (Deutsche Forschungsgemeinschaft) AB393/2-2 (to R.A.J. and A.R.) and RO4681/9-1 (to J.-Y.R.), by the DIP RO4681/6-1 (to J.-Y.R.), by CAPES Fellowship 99999.013311/2013-01 (to D.L.P.), by the EU FP7 Large-Scale Integrating Project Genetic and Epigenetic Networks in Cognitive Dysfunction (241995) (to H.v.B. and Sheikh Riazzudin), and by Higher Education Commission in Pakistan, the University of Maryland, and the Medical Research Council, UK (MC_UU_00015/4) (to C.A.P., P.R.-G., and M.M.). The funders had no role in design, conduct, analysis, and reporting of this study.	Abou Jamra R, 2011, EUR J HUM GENET, V19, P1161, DOI 10.1038/ejhg.2011.98; ARNEZ JG, 1994, BIOCHEMISTRY-US, V33, P7560, DOI 10.1021/bi00190a008; Behm-Ansmant I, 2003, RNA, V9, P1371, DOI 10.1261/rna.5520403; Berardinelli A., 2009, BMJ CASE REP, V2009, P2009; BRANLANT C, 1981, NUCLEIC ACIDS RES, V9, P4303, DOI 10.1093/nar/9.17.4303; Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530; Cao M, 2016, NEUROGENETICS, V17, P65, DOI 10.1007/s10048-015-0465-x; Carlile TM, 2014, NATURE, V515, P143, DOI 10.1038/nature13802; Casas KA, 2004, AM J MED GENET A, V125A, P201, DOI 10.1002/ajmg.a.20368; Charette M, 2000, IUBMB LIFE, V49, P341; Chen JG, 2000, BIOCHEMISTRY-US, V39, P12723, DOI 10.1021/bi001109m; Davis DR, 1995, NUCLEIC ACIDS RES, V23, P5020, DOI 10.1093/nar/23.24.5020; GROSJEAN H, 1995, BIOCHIMIE, V77, P139, DOI 10.1016/0300-9084(96)88117-X; Guzzi N, 2018, CELL, V173, P1204, DOI 10.1016/j.cell.2018.03.008; Hu YH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-357; Leppik M, 2007, FEBS J, V274, P5759, DOI 10.1111/j.1742-4658.2007.06101.x; Li XY, 2015, NAT CHEM BIOL, V11, P592, DOI [10.1038/NCHEMBIO.1836, 10.1038/nchembio.1836]; Lovejoy AF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110799; Metodiev MD, 2015, EUR J HUM GENET, V23, P880, DOI 10.1038/ejhg.2014.192; Motorin Y, 1998, RNA, V4, P856, DOI 10.1017/S1355838298980396; Newby MI, 2002, P NATL ACAD SCI USA, V99, P12697, DOI 10.1073/pnas.202477199; Newby MI, 2001, RNA, V7, P833, DOI 10.1017/S1355838201002308; Riazuddin S, 2017, MOL PSYCHIATR, V22, P1604, DOI 10.1038/mp.2016.109; Riecken LB, 2015, HUM MUTAT, V36, P270, DOI 10.1002/humu.22737; Safra M, 2017, GENOME RES, V27, P393, DOI 10.1101/gr.207613.116; Schattner P, 2006, RNA, V12, P15, DOI 10.1261/rna.2210406; Schwartz S, 2014, CELL, V159, P148, DOI 10.1016/j.cell.2014.08.028; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; Shaheen R, 2016, HUM GENET, V135, P707, DOI 10.1007/s00439-016-1665-7; Spenkuch F, 2014, RNA BIOL, V11, P1540, DOI 10.4161/15476286.2014.992278; SPRINZL M, 1982, NUCLEIC ACIDS RES, V10, pR57; STRAUSS R, 1992, J NEUROGENET, V8, P125, DOI 10.3109/01677069209083444; Sumita M, 2005, RNA, V11, P1420, DOI 10.1261/rna.2320605; Trannoy S, 2015, JOVE-J VIS EXP, DOI 10.3791/53395; Yu AT, 2011, PROTEIN CELL, V2, P712, DOI 10.1007/s13238-011-1087-1; Zebarjadian Y, 1999, MOL CELL BIOL, V19, P7461; Zeharia A, 2005, J CHILD NEUROL, V20, P449, DOI 10.1177/08830738050200051301; Zhao XL, 2002, RNA, V8, P1515, DOI 10.1017/S1355838202022537	38	53	55	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 6	2018	103	6					1045	1052		10.1016/j.ajhg.2018.10.026	http://dx.doi.org/10.1016/j.ajhg.2018.10.026			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HD4YX	30526862	Green Published, Bronze			2022-12-18	WOS:000452535600018
J	Bauer, CK; Calligari, P; Radio, FC; Caputo, V; Dentici, ML; Falah, N; High, F; Pantaleoni, F; Barresi, S; Ciolfi, A; Pizzi, S; Bruselles, A; Person, R; Richards, S; Cho, MT; Sepulveda, DJC; Pro, S; Battini, R; Zampino, G; Digilio, MC; Bocchinfuso, G; Dallapiccola, B; Stella, L; Tartaglia, M				Bauer, Christiane K.; Calligari, Paolo; Radio, Francesca Clementina; Caputo, Viviana; Dentici, Maria Lisa; Falah, Nadia; High, Frances; Pantaleoni, Francesca; Barresi, Sabina; Ciolfi, Andrea; Pizzi, Simone; Bruselles, Alessandro; Person, Richard; Richards, Sarah; Cho, Megan T.; Sepulveda, Daniela J. Claps; Pro, Stefano; Battini, Roberta; Zampino, Giuseppe; Digilio, Maria Cristina; Bocchinfuso, Gianfranco; Dallapiccola, Bruno; Stella, Lorenzo; Tartaglia, Marco			Mutations in KCNK4 that Affect Gating Cause a Recognizable Neurodevelopmental Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTELLECTUAL DISABILITY; POTASSIUM CHANNELS; MISSENSE MUTATIONS; K+ CHANNELS; TRAAK; K-2P; VARIANTS; MECHANOSENSITIVITY; ACTIVATION; PHYSIOLOGY	Aberrant activation or inhibition of potassium (K+) currents across the plasma membrane of cells has been causally linked to altered neurotransmission, cardiac arrhythmias, endocrine dysfunction, and (more rarely) perturbed developmental processes. The K+ channel subfamily K member 4 (KCNK4), also known as TRAAK (TWIK-related arachidonic acid-stimulated K+ channel), belongs to the mechano-gated ion channels of the TRAAK/TREK subfamily of two-pore-domain (K2P) K+ channels. While K2P channels are well known to contribute to the resting membrane potential and cellular excitability, their involvement in pathophysiological processes remains largely uncharacterized. We report that de novo missense mutations in KCNK4 cause a recognizable syndrome with a distinctive facial gestalt, for which we propose the acronym FHEIG (facial dysmorphism, hypertrichosis, epilepsy, intellectual disability/developmental delay, and gingival overgrowth). Patch-clamp analyses documented a significant gain of function of the identified KCNK4 channel mutants basally and impaired sensitivity to mechanical stimulation and arachidonic acid. Co-expression experiments indicated a dominant behavior of the disease-causing mutations. Molecular dynamics simulations consistently indicated that mutations favor sealing of the lateral intramembrane fenestration that has been proposed to negatively control K+ flow by allowing lipid access to the central cavity of the channel. Overall, our findings illustrate the pleiotropic effect of dysregulated KCNK4 function and provide support to the hypothesis of a gating mechanism based on the lateral fenestrations of K2P channels.	[Bauer, Christiane K.] Univ Med Ctr Hamburg Eppendorf, Ctr Expt Med, Inst Cellular & Integrat Physiol, D-20246 Hamburg, Germany; [Calligari, Paolo; Bocchinfuso, Gianfranco; Stella, Lorenzo] Univ Roma Tor Vergata, Dept Chem Sci & Technol, I-00133 Rome, Italy; [Radio, Francesca Clementina; Dentici, Maria Lisa; Pantaleoni, Francesca; Barresi, Sabina; Ciolfi, Andrea; Pizzi, Simone; Sepulveda, Daniela J. Claps; Pro, Stefano; Digilio, Maria Cristina; Dallapiccola, Bruno; Tartaglia, Marco] Osped Pediat Bambino Gesu, IRCCS, Genet & Rare Dis Res Div, I-00146 Rome, Italy; [Caputo, Viviana] Sapienza Univ Rome, Dept Expt Med, I-00161 Rome, Italy; [Falah, Nadia] Nemours Childrens Hosp, Div Clin Genet, Orlando, FL 32827 USA; [High, Frances] Massachusetts Gen Hosp, Mass Gen Hosp Children, Med Genet, Boston, MA 02114 USA; [Bruselles, Alessandro] Ist Super Sanita, Dept Oncol & Mol Med, I-00161 Rome, Italy; [Person, Richard; Richards, Sarah; Cho, Megan T.] GeneDX, Gaithersburg, MD 20877 USA; [Battini, Roberta] IRCCS Stella Maris, Dept Dev Neurosci, I-56128 Calambrone, Italy; [Zampino, Giuseppe] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli, IRCCS, Ctr Rare Dis & Congenital Defects, I-00168 Rome, Italy	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Rome Tor Vergata; IRCCS Bambino Gesu; Sapienza University Rome; Harvard University; Massachusetts General Hospital; Istituto Superiore di Sanita (ISS); IRCCS Fondazione Stella Maris; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Bauer, CK (corresponding author), Univ Med Ctr Hamburg Eppendorf, Ctr Expt Med, Inst Cellular & Integrat Physiol, D-20246 Hamburg, Germany.; Tartaglia, M (corresponding author), Osped Pediat Bambino Gesu, IRCCS, Genet & Rare Dis Res Div, I-00146 Rome, Italy.	cbauer@uke.uni-hamburg.de; marco.tartaglia@opbg.net	Radio, Francesca Clementina/I-9417-2014; Calligari, Paolo/AAC-5705-2020; Bruselles, Alessandro/M-7908-2017; Bocchinfuso, Gianfranco/E-9014-2011; Bruselles, Alessandro/M-6012-2019; Stella, Lorenzo/A-7996-2010; battini, roberta/P-9095-2017; Zampino, Giuseppe/AAC-2152-2019; Digilio, Maria Cristina/AAI-2434-2019; Dentici, Maria Lisa/AAC-7654-2022; Ciolfi, Andrea/J-4954-2018; Pizzi, Simone/AAI-1767-2019; Tartaglia, Marco/K-2955-2018; Dallapiccola, Bruno/K-8692-2016	Radio, Francesca Clementina/0000-0003-1993-8018; Bruselles, Alessandro/0000-0002-1556-4998; Bocchinfuso, Gianfranco/0000-0002-5556-7691; Bruselles, Alessandro/0000-0002-1556-4998; Stella, Lorenzo/0000-0002-5489-7381; battini, roberta/0000-0002-7889-1355; Dentici, Maria Lisa/0000-0002-9505-5906; Ciolfi, Andrea/0000-0002-6191-0978; Tartaglia, Marco/0000-0001-7736-9672; Pro, Stefano/0000-0002-6486-5201; Bauer, Christiane K./0000-0002-2078-3503; Dallapiccola, Bruno/0000-0002-5031-1013	Fondazione Bambino Gesu; Italian Ministry of Health; PRACE (Partnership for Advanced Computing in Europe) [2017174118]	Fondazione Bambino Gesu; Italian Ministry of Health(Ministry of Health, Italy); PRACE (Partnership for Advanced Computing in Europe)	The authors wish to thank the participating families; Thomas Baukrowitz (Institute of Physiology, Kiel University, Kiel) for providing the KCNK4 cDNA; Fanny Kortum, Frederike L. Harms, and Inka Jantke (Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg) for generating KCNK4 expression constructs; and Serenella Venanzi (Istituto Superiore di Sanita, Rome) and Annett Hasse (Institute of Cellular and Integrative Physiology, University Medical Center Hamburg-Eppendorf, Hamburg) for technical support. This work was supported, in part, by Fondazione Bambino Gesu (Vite Coraggiose to B.D. and M.T.) and the Italian Ministry of Health (Ricerca Corrente 2017 and 2018 to M.L.D., M.C.D., A.C., and M.T.). G.B. acknowledges PRACE (Partnership for Advanced Computing in Europe, grant 2017174118), and M.T. and G.B. acknowledge CINECA for the computational resources.	Aryal P, 2017, STRUCTURE, V25, P708, DOI 10.1016/j.str.2017.03.006; Bobone S, 2013, J PEPT SCI, V19, P758, DOI 10.1002/psc.2574; Bockenhauer D, 2009, NEW ENGL J MED, V360, P1960, DOI 10.1056/NEJMoa0810276; Brohawn SG, 2015, ANN NY ACAD SCI, V1352, P20, DOI 10.1111/nyas.12874; Brohawn SG, 2014, NATURE, V516, P126, DOI 10.1038/nature14013; Brohawn SG, 2013, P NATL ACAD SCI USA, V110, P2129, DOI 10.1073/pnas.1218950110; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; Chiamvimonvat N, 2017, J PHYSIOL-LONDON, V595, P2229, DOI 10.1113/JP272883; Cooper PE, 2014, HUM MUTAT, V35, P809, DOI 10.1002/humu.22555; Feliciangeli S, 2015, J PHYSIOL-LONDON, V593, P2587, DOI 10.1113/jphysiol.2014.287268; Fink M, 1998, EMBO J, V17, P3297, DOI 10.1093/emboj/17.12.3297; Flex E, 2016, AM J HUM GENET, V99, P962, DOI 10.1016/j.ajhg.2016.08.003; Harakalova M, 2012, NAT GENET, V44, P793, DOI 10.1038/ng.2324; Heurteaux C, 2004, EMBO J, V23, P2684, DOI 10.1038/sj.emboj.7600234; Hille B., 2001, ION CHANNELS EXCITAB; Niemeyer MI, 2016, MOL PHARMACOL, V90, P309, DOI 10.1124/mol.116.103895; Jagadeesh KA, 2016, NAT GENET, V48, P1581, DOI 10.1038/ng.3703; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kortum F, 2015, NAT GENET, V47, P661, DOI 10.1038/ng.3282; Laigle C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053266; Lehman A, 2017, AM J HUM GENET, V101, P65, DOI 10.1016/j.ajhg.2017.05.016; Li Q, 2017, AM J HUM GENET, V100, P267, DOI 10.1016/j.ajhg.2017.01.004; Lolicato M, 2014, NEURON, V84, P1198, DOI 10.1016/j.neuron.2014.11.017; Masetti M, 2016, J CHEM THEORY COMPUT, V12, P5681, DOI 10.1021/acs.jctc.6b00972; McClenaghan C, 2016, J GEN PHYSIOL, V147, P497, DOI 10.1085/jgp.201611601; Mirkovic K, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00060; Niceta M, 2015, AM J HUM GENET, V96, P816, DOI 10.1016/j.ajhg.2015.03.001; Noel J, 2009, EMBO J, V28, P1308, DOI 10.1038/emboj.2009.57; Renigunta V, 2015, PFLUG ARCH EUR J PHY, V467, P867, DOI 10.1007/s00424-015-1703-7; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Sabbadini M, 2009, J MOL BIOL, V385, P1331, DOI 10.1016/j.jmb.2008.11.048; Schewe M., 2016, MOL PHARM, V90, P309; Schewe M, 2016, CELL, V164, P937, DOI 10.1016/j.cell.2016.02.002; Schmidt D, 2012, P NATL ACAD SCI USA, V109, P10352, DOI 10.1073/pnas.1204700109; Sepulveda FV, 2015, PHYSIOL REV, V95, P179, DOI 10.1152/physrev.00016.2014; Sferra A, 2016, AM J HUM GENET, V99, P974, DOI 10.1016/j.ajhg.2016.08.006; Shieh CC, 2000, PHARMACOL REV, V52, P557; Simons C, 2015, NAT GENET, V47, P73, DOI 10.1038/ng.3153; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Tanaka AJ, 2015, AM J HUM GENET, V97, P457, DOI 10.1016/j.ajhg.2015.07.014; Tian CA, 2014, CHEM BIOL DRUG DES, V83, P1, DOI 10.1111/cbdd.12237; Tommiska J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01429-z; Urrego D, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0094	44	53	54	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 4	2018	103	4					621	630		10.1016/j.ajhg.2018.09.001	http://dx.doi.org/10.1016/j.ajhg.2018.09.001			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GV7MS	30290154	Green Submitted, Bronze, Green Published			2022-12-18	WOS:000446312200014
J	Kherraf, ZE; Amiri-Yekta, A; Dacheux, D; Karaouzene, T; Coutton, C; Christou-Kent, M; Martinez, G; Landrein, N; Le Tanno, P; Ben Mustapha, SF; Halouani, L; Marrakchi, O; Makni, M; Latrous, H; Kharouf, M; Pernet-Gallay, K; Gourabi, H; Robinson, DR; Crouzy, S; Blum, M; Thierry-Mieg, N; Toure, A; Zouari, R; Arnoult, C; Bonhivers, M; Ray, PF				Kherraf, Zine-Eddine; Amiri-Yekta, Amir; Dacheux, Denis; Karaouzene, Thomas; Coutton, Charles; Christou-Kent, Marie; Martinez, Guillaume; Landrein, Nicolas; Le Tanno, Pauline; Ben Mustapha, Selima Fourati; Halouani, Lazhar; Marrakchi, Ouafi; Makni, Mounir; Latrous, Habib; Kharouf, Mahmoud; Pernet-Gallay, Karin; Gourabi, Hamid; Robinson, Derrick R.; Crouzy, Serge; Blum, Michael; Thierry-Mieg, Nicolas; Toure, Aminata; Zouari, Raoudha; Arnoult, Christophe; Bonhivers, Melanie; Ray, Pierre F.			A Homozygous Ancestral SVA-Insertion-Mediated Deletion in WDR66 Induces Multiple Morphological Abnormalities of the Sperm Flagellum and Male Infertility	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COPY-NUMBER VARIATION; STRUCTURAL VARIATION; GENE; PROTEINS; MUTATIONS; DATABASE; SYSTEM; DYNEIN; MODEL	Multiple morphological abnormalities of the sperm flagellum (MMAF) is a severe form of male infertility defined by the presence of a mosaic of anomalies, including short, bent, curled, thick, or absent flagella, resulting from a severe disorganization of the axoneme and of the peri-axonemal structures. Mutations in DNAH1, CFAP43, and CFAP44, three genes encoding axoneme-related proteins, have been described to account for approximately 30% of the MMAF cases reported so far. Here, we searched for pathological copy-number variants in whole-exome sequencing data from a cohort of 78 MMAF-affected subjects to identify additional genes associated with MMAF. In 7 of 78 affected individuals, we identified a homozygous deletion that removes the two penultimate exons of WDR66 (also named CFAP251), a gene coding for an axonemal protein preferentially localized in the testis and described to localize to the calmodulinand spoke-associated complex at the base of radial spoke 3. Sequence analysis of the breakpoint region revealed in all deleted subjects the presence of a single chimeric SVA (SINE-VNTR-Alu) at the breakpoint site, suggesting that the initial deletion event was potentially mediated by an SVA insertion-recombination mechanism. Study of Trypanosoma WDR66's ortholog (TbWDR66) highlighted high sequence and structural analogy with the human protein and confirmed axonemal localization of the protein. Reproduction of the human deletion in TbWDR66 impaired flagellar movement, thus confirming WDR66 as a gene associated with the MMAF phenotype and highlighting the importance of the WDR66 C-terminal region.	[Kherraf, Zine-Eddine; Amiri-Yekta, Amir; Karaouzene, Thomas; Coutton, Charles; Christou-Kent, Marie; Martinez, Guillaume; Le Tanno, Pauline; Arnoult, Christophe; Ray, Pierre F.] Univ Grenoble Alpes, CNRS UMR 5309, INSERM U1209, Genet Epigenet & Therapies Infertil,Inst Adv Bios, F-38000 Grenoble, France; [Kherraf, Zine-Eddine; Amiri-Yekta, Amir; Ray, Pierre F.] Ctr Hosp Univ Grenoble, UM GI DPI, F-38000 Grenoble, France; [Amiri-Yekta, Amir; Gourabi, Hamid] Acad Ctr Educ Culture & Res, Royan Inst Reprod Biomed, Dept Genet, Reprod Biomed Res Ctr, POB 16635-148, Tehran, Iran; [Dacheux, Denis; Landrein, Nicolas; Robinson, Derrick R.; Bonhivers, Melanie] Univ Bordeaux, CNRS UMR 5234, Microbiol Fondamentale & Pathogenicite, Bordeaux, France; [Dacheux, Denis] Inst Polytech Bordeaux, CNRS UMR 5234, Microbiol Fondamentale & Pathogenicite, Bordeaux, France; [Coutton, Charles; Martinez, Guillaume] Ctr Hosp Univ Grenoble, UM Genet Chromos, F-38000 Grenoble, France; [Ben Mustapha, Selima Fourati; Halouani, Lazhar; Marrakchi, Ouafi; Makni, Mounir; Latrous, Habib; Kharouf, Mahmoud; Zouari, Raoudha] Polyclin Jasmins, Ctr Aide Med Procreat, Ctr Urbain Nord, Tunis 1003, Tunisia; [Pernet-Gallay, Karin] Grenoble Neurosci Inst, INSERM 1216, F-38000 Grenoble, France; [Blum, Michael; Thierry-Mieg, Nicolas] Univ Grenoble Alpes, CNRS, TIMC IMAG, F-38000 Grenoble, France; [Crouzy, Serge] Univ Grenoble Alpes, Inst Rech Technol & Sci Vivant, Lab Chim & Biol Met, CEA iRTSV LCBM GMCT,CNRS UMR 5249, F-38054 Grenoble 9, France; [Toure, Aminata] Inst Cochin, INSERM U1016, F-75014 Paris, France; [Toure, Aminata] CNRS UMR 8104, F-75014 Paris, France; [Toure, Aminata] Univ Paris 05, Sorbonne Paris Cite, Fac Med, F-75014 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Academic Center for Education, Culture & Research (ACECR); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Ray, PF (corresponding author), Univ Grenoble Alpes, CNRS UMR 5309, INSERM U1209, Genet Epigenet & Therapies Infertil,Inst Adv Bios, F-38000 Grenoble, France.; Ray, PF (corresponding author), Ctr Hosp Univ Grenoble, UM GI DPI, F-38000 Grenoble, France.	pray@chu-grenoble.fr	KHERRAF, Zine-Eddine/F-1585-2019; TOURE, Aminata/B-3236-2018; Dacheux, Denis/AGF-5359-2022; Thierry-Mieg, Nicolas/M-6007-2014; Bonhivers, Melanie/Z-5889-2019; Amiri-Yekta, Amir/AAF-1062-2020; Ray, Pierre F/D-7315-2019; Christou-Kent, Marie/AAA-4584-2021; COUTTON, Charles/G-2859-2014; ARNOULT, christophe/E-8312-2013; Martinez, Guillaume/O-3959-2018	KHERRAF, Zine-Eddine/0000-0003-0351-6689; TOURE, Aminata/0000-0001-5629-849X; Thierry-Mieg, Nicolas/0000-0002-7667-2853; Bonhivers, Melanie/0000-0001-9179-8473; Ray, Pierre F/0000-0003-1544-7449; Christou-Kent, Marie/0000-0002-6008-7350; LANDREIN, Nicolas/0000-0001-8875-4242; ARNOULT, christophe/0000-0002-3753-5901; FOURATI BEN MUSTAPHA, Selima/0000-0002-0107-6440; Martinez, Guillaume/0000-0002-7572-9096; Coutton, Charles/0000-0002-8873-8098; DACHEUX, Denis/0000-0002-9956-4839; PERNET GALLAY, Karin/0000-0003-3468-3316; Amiri-Yekta, Amir/0000-0002-8099-7984	Agence Nationale de la Recherche (ANR) through the "MAS-Flagella'' project [DS0401-2014, ANR-14-CE15-0002]; Direction Generale de l'Offre de Soins through Programme de Recherche Translationnelle en Sante; Fondation Maladies Rares through "Whole genome sequencing of individuals with Flagellar Growth Defects (FGD)'' of Sequencage a Haut Debit program; ANR LabEx through the ParaFrap grant [ANR-11-LABX-0024]; ANR [ANR-10-INBS-04]	Agence Nationale de la Recherche (ANR) through the "MAS-Flagella'' project(French National Research Agency (ANR)); Direction Generale de l'Offre de Soins through Programme de Recherche Translationnelle en Sante; Fondation Maladies Rares through "Whole genome sequencing of individuals with Flagellar Growth Defects (FGD)'' of Sequencage a Haut Debit program; ANR LabEx through the ParaFrap grant(French National Research Agency (ANR)); ANR(French National Research Agency (ANR))	We thank the affected and control individuals for their participation. This work was mainly supported by the Agence Nationale de la Recherche (ANR; programme DS0401-2014, project ANR-14-CE15-0002) through the "MAS-Flagella'' project, the Direction Generale de l'Offre de Soins through the 2014 Programme de Recherche Translationnelle en Sante (to P.F.R., M.B., A.T., C.A., and N.T.M.), the Fondation Maladies Rares through "Whole genome sequencing of individuals with Flagellar Growth Defects (FGD)'' of the 2012 Sequencage a Haut Debit program (to P.F.R.), and ANR LabEx through the ParaFrap grant (ANR-11-LABX-0024 to D.R.R.; http://www.labex-parafrap.fr/fr). Stimulated emission depletion microscopy was performed at the Bordeaux Imaging Centre, a service unit of the CNRS-INSERM and Bordeaux University and a member of France-BioImaging, supported by the ANR (ANR-10-INBS-04). The help of Patrice Mascalchi is acknowledged. Some of the electron microscopy was performed at the Bordeaux Imaging Centre. We thank Nicolas Biteau (Bordeaux University) for the rabbit anti-PFR2 antibody, Sam Dean (Oxford University) for the pPOTv7 plasmid, Keith Gull (Oxford University) for the anti-tubulin (TAT1) antibody, and Philippe Bastin (Institut Pasteur, Paris) for the anti-TY1 antibody. We also thank the Grenoble Institut des Neurosciences electron microscopy platform and Anne Bertrand as well as the Institut pour l'Avancee des Biosciences microscopy platform, Alexei Grichine, and Jacques Mazzega for their technical help.	Almal SH, 2012, J HUM GENET, V57, P6, DOI 10.1038/jhg.2011.108; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Ben Khelifa M, 2014, AM J HUM GENET, V94, P95, DOI 10.1016/j.ajhg.2013.11.017; Bragin E, 2014, NUCLEIC ACIDS RES, V42, pD993, DOI 10.1093/nar/gkt937; Brett M, 2017, J HUM GENET, V62, P711, DOI 10.1038/jhg.2017.32; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; BRUN R, 1979, ACTA TROP, V36, P289; Burkard GS, 2011, MOL BIOCHEM PARASIT, V175, P91, DOI 10.1016/j.molbiopara.2010.09.002; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Coutton C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02792-7; Coutton C, 2015, HUM REPROD UPDATE, V21, P455, DOI 10.1093/humupd/dmv020; Dean S, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.140197; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Hancks DC, 2016, MOBILE DNA-UK, V7, DOI 10.1186/s13100-016-0065-9; Heuser T, 2012, MOL BIOL CELL, V23, P3143, DOI 10.1091/mbc.E12-05-0357; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Ishikawa T, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028076; Jan SZ, 2017, DEVELOPMENT, V144, P3659, DOI 10.1242/dev.152413; Jensen-Seaman MI, 2004, GENOME RES, V14, P528, DOI 10.1101/gr.1970304; Jungwirth A, 2012, EUR UROL, V62, P324, DOI 10.1016/j.eururo.2012.04.048; Labuda M, 1996, AM J HUM GENET, V59, P633; LaCount DJ, 2002, J BIOL CHEM, V277, P17580, DOI 10.1074/jbc.M200873200; Lee J, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/807270; Legoix P, 2000, GENOMICS, V65, P62, DOI 10.1006/geno.2000.6139; Lindemann CB, 2016, CYTOSKELETON, V73, P652, DOI 10.1002/cm.21338; Lores P, 2018, HUM MOL GENET, V27, P1196, DOI 10.1093/hmg/ddy034; Ma DX, 2017, AM J MED GENET A, V173, P2605, DOI 10.1002/ajmg.a.38350; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Nakamura Y, 2015, INT J HEMATOL, V102, P134, DOI 10.1007/s12185-015-1765-5; Neto FTL, 2016, SEMIN CELL DEV BIOL, V59, P10, DOI 10.1016/j.semcdb.2016.04.009; Oberholzer M, 2009, METHOD CELL BIOL, V93, P21, DOI 10.1016/S0091-679X(08)93002-8; Plagnol V, 2012, BIOINFORMATICS, V28, P2747, DOI 10.1093/bioinformatics/bts526; Qiu FJ, 2012, HUM MUTAT, V33, pE2375, DOI 10.1002/humu.22163; Raiz J, 2012, NUCLEIC ACIDS RES, V40, P1666, DOI 10.1093/nar/gkr863; Ray PF, 2017, CLIN GENET, V91, P217, DOI 10.1111/cge.12905; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; Schweingruber C, 2013, BBA-GENE REGUL MECH, V1829, P612, DOI 10.1016/j.bbagrm.2013.02.005; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sha YW, 2019, REPROD SCI, V26, P26, DOI 10.1177/1933719117749756; Sha YW, 2017, GENE, V633, P48, DOI 10.1016/j.gene.2017.08.033; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Slatkin M, 2000, ANNU REV GENOM HUM G, V1, P225, DOI 10.1146/annurev.genom.1.1.225; Subota I, 2014, MOL CELL PROTEOMICS, V13, P1769, DOI 10.1074/mcp.M113.033357; Takasu M, 2007, TISSUE ANTIGENS, V70, P144, DOI 10.1111/j.1399-0039.2007.00870.x; Tang SY, 2017, AM J HUM GENET, V100, P854, DOI 10.1016/j.ajhg.2017.04.012; Tsuchida N, 2018, CLIN GENET, V93, P577, DOI 10.1111/cge.13144; Urbanska P, 2015, MOL BIOL CELL, V26, P1463, DOI 10.1091/mbc.E14-11-1545; Vincensini L, 2011, BIOL CELL, V103, P109, DOI 10.1042/BC20100104; Vogt J, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r80; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Xiong H, 2009, AM J MED GENET A, V149A, P2403, DOI 10.1002/ajmg.a.33057	53	53	58	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 6	2018	103	3					400	412		10.1016/j.ajhg.2018.07.014	http://dx.doi.org/10.1016/j.ajhg.2018.07.014			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GS6PJ	30122540	Bronze, Green Published			2022-12-18	WOS:000443819500009
J	Chen, XF; Zhu, DL; Yang, M; Hu, WX; Duan, YY; Lu, BJ; Rong, Y; Dong, SS; Hao, RH; Chen, JB; Chen, YX; Yao, S; Thynn, HN; Guo, Y; Yang, TL				Chen, Xiao-Feng; Zhu, Dong-Li; Yang, Man; Hu, Wei-Xin; Duan, Yuan-Yuan; Lu, Bing-Jie; Rong, Yu; Dong, Shan-Shan; Hao, Ruo-Han; Chen, Jia-Bin; Chen, Yi-Xiao; Yao, Shi; Thynn, Hlaing Nwe; Guo, Yan; Yang, Tie-Lin			An Osteoporosis Risk SNP at 1p36.12 Acts as an Allele-Specific Enhancer to Modulate LINC00339 Expression via Long-Range Loop Formation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BONE-MINERAL DENSITY; GENOME-WIDE ASSOCIATION; CHROMATIN INTERACTIONS; GENE-EXPRESSION; NONCODING RNAS; HUMAN-CELLS; COMPLEX TRAITS; LOCI; TRANSCRIPTION; DISEASE	Genome-wide association studies (GWASs) have reproducibly associated variants within intergenic regions of 1p36.12 locus with osteoporosis, but the functional roles underlying these noncoding variants are unknown. Through an integrative functional genomic and epigenomic analyses, we prioritized rs6426749 as a potential causal SNP for osteoporosis at 1p36.12. Dual-luciferase assay and CRISPR/ Cas9 experiments demonstrate that rs6426749 acts as a distal allele-specific enhancer regulating expression of a lncRNA (LINC00339) (similar to 360 kb) via long-range chromatin loop formation and that this loop is mediated by CTCF occupied near rs6426749 and LINC00339 promoter region. Specifically, rs6426749-G allele can bind transcription factor TFAP2A, which efficiently elevates the enhancer activity and increases LINC00339 expression. Downregulation of LINC00339 significantly increases the expression of CDC42 in osteoblast cells, which is a pivotal regulator involved in bone metabolism. Our study provides mechanistic insight into how a noncoding SNP affects osteoporosis by long-range interaction, a finding that could indicate promising therapeutic targets for osteoporosis.	[Chen, Xiao-Feng; Zhu, Dong-Li; Yang, Man; Hu, Wei-Xin; Duan, Yuan-Yuan; Lu, Bing-Jie; Rong, Yu; Dong, Shan-Shan; Hao, Ruo-Han; Chen, Jia-Bin; Chen, Yi-Xiao; Yao, Shi; Thynn, Hlaing Nwe; Guo, Yan; Yang, Tie-Lin] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Minist Educ, Key Lab Biomed Informat Engn, Xian 710049, Shaanxi, Peoples R China; [Chen, Xiao-Feng; Zhu, Dong-Li] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Inst Mol Genet, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Guo, Y; Yang, TL (corresponding author), Xi An Jiao Tong Univ, Sch Life Sci & Technol, Minist Educ, Key Lab Biomed Informat Engn, Xian 710049, Shaanxi, Peoples R China.	guoyan253@mail.xjtu.edu.cn; yangtielin@mail.xjtu.edu.cn	Yao, Shi/GON-6117-2022; Chen, Xiao-Feng/AAN-8808-2020; Yang, Tie-Lin/G-8365-2014	Chen, Xiao-Feng/0000-0002-5886-6427; Yang, Tie-Lin/0000-0001-7062-3025; Hu, Weixin/0000-0002-7572-5482; Yao, Shi/0000-0002-4574-8106	National Natural Science Foundation of China [31771399, 81573241, 31471188, 31701095]; China Postdoctoral Science Foundation [2016M602797]; Natural Science Basic Research Program Shaanxi Province [2016JQ3026]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Basic Research Program Shaanxi Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (31771399, 81573241, 31471188, 31701095), China Postdoctoral Science Foundation (2016M602797), Natural Science Basic Research Program Shaanxi Province (2016JQ3026), and the Fundamental Research Funds for the Central Universities. We thank the GTEx Consortium. We obtained GTEx data through dbGaP authorized access at https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=login with the accession number of phs000424.v6.p1. We would also like to thank the School of Life Science and Technology at Xi'an Jiaotong University for the sharing platform of laboratory apparatus.	Aizawa R, 2012, MECH DEVELOP, V129, P38, DOI 10.1016/j.mod.2012.02.002; Albertsen HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058257; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Battle A, 2014, GENOME RES, V24, P14, DOI 10.1101/gr.155192.113; Blake JA, 2017, NUCLEIC ACIDS RES, V45, pD723, DOI 10.1093/nar/gkw1040; Bogachek MV, 2014, CANCER CELL, V25, P748, DOI 10.1016/j.ccr.2014.04.008; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Chun S, 2017, NAT GENET, V49, P600, DOI 10.1038/ng.3795; Corradin O, 2016, NAT GENET, V48, P1313, DOI 10.1038/ng.3674; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Greenblatt MB, 2013, ANNU REV CELL DEV BI, V29, P63, DOI 10.1146/annurev-cellbio-101512-122347; Guo HY, 2016, NAT GENET, V48, P1142, DOI 10.1038/ng.3637; Gupta RM, 2017, CELL, V170, P522, DOI 10.1016/j.cell.2017.06.049; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hon CC, 2017, NATURE, V543, P199, DOI 10.1038/nature21374; Hsu YH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000977; Hwang JY, 2013, J MED GENET, V50, P212, DOI 10.1136/jmedgenet-2012-101156; Ito Y, 2010, J CLIN INVEST, V120, P1981, DOI 10.1172/JCI39650; Javierre BM, 2016, CELL, V167, P1369, DOI 10.1016/j.cell.2016.09.037; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; Kanis JA, 1997, OSTEOPOROSIS INT, V7, P390, DOI 10.1007/BF01623782; Kemp JP, 2017, NAT GENET, V49, P1468, DOI 10.1038/ng.3949; Kemp JP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004423; Kuchenbaecker KB, 2015, NAT GENET, V47, P164, DOI 10.1038/ng.3185; Kulakovskiy IV, 2016, NUCLEIC ACIDS RES, V44, pD116, DOI 10.1093/nar/gkv1249; Kwan T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000608; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Liu NQ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14418; Liu Yong-Jun, 2014, J Bone Metab, V21, P99, DOI 10.11005/jbm.2014.21.2.99; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Ma WX, 2015, NAT METHODS, V12, P71, DOI [10.1038/nmeth.3205, 10.1038/NMETH.3205]; Majumder P, 2008, J EXP MED, V205, P785, DOI 10.1084/jem.20071843; Majumder P, 2010, MOL CELL BIOL, V30, P4211, DOI 10.1128/MCB.00327-10; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Mifsud B, 2015, NAT GENET, V47, P598, DOI 10.1038/ng.3286; MITCHELL PJ, 1987, CELL, V50, P847, DOI 10.1016/0092-8674(87)90512-5; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Oldridge DA, 2015, NATURE, V528, P418, DOI 10.1038/nature15540; Pachkov M, 2013, NUCLEIC ACIDS RES, V41, pD214, DOI 10.1093/nar/gks1145; Peacock M, 2002, ENDOCR REV, V23, P303, DOI 10.1210/er.23.3.303; Powell JE, 2016, HUM MOL GENET, V25, P5046, DOI 10.1093/hmg/ddw320; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Richards JB, 2012, NAT REV GENET, V13, P576, DOI 10.1038/nrg3228; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Styrkarsdottir U, 2009, NAT GENET, V41, P15, DOI 10.1038/ng.284; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Tang RQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19877; Tang ZH, 2015, CELL, V163, P1611, DOI 10.1016/j.cell.2015.11.024; Teng L, 2015, BIOINFORMATICS, V31, P2560, DOI 10.1093/bioinformatics/btv158; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Ward LD, 2016, NUCLEIC ACIDS RES, V44, pD877, DOI 10.1093/nar/gkv1340; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; WILLIAMS T, 1991, GENE DEV, V5, P670, DOI 10.1101/gad.5.4.670; Wuerfel C, 2012, BONE, V50, pS43, DOI 10.1016/j.bone.2012.02.113; Xiang JF, 2014, CELL RES, V24, P513, DOI 10.1038/cr.2014.35; Yang TL, 2012, OSTEOPOROSIS INT, V23, P781, DOI 10.1007/s00198-011-1626-x; Yang TL, 2015, J BONE MINER RES, V30, P2119, DOI 10.1002/jbmr.2558; Yavorska OO, 2017, INT J EPIDEMIOL, V46, P1734, DOI 10.1093/ije/dyx034; Yu B, 2014, NAT MED, V20, P1009, DOI 10.1038/nm.3586; Zhang L, 2014, HUM MOL GENET, V23, P1923, DOI 10.1093/hmg/ddt575; Zheng HF, 2015, NATURE, V526, P112, DOI 10.1038/nature14878; Zhu DL, 2017, HUM MUTAT, V38, P725, DOI 10.1002/humu.23216; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538; Zuin J, 2014, P NATL ACAD SCI USA, V111, P996, DOI 10.1073/pnas.1317788111	77	53	55	4	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 3	2018	102	5					776	793		10.1016/j.ajhg.2018.03.001	http://dx.doi.org/10.1016/j.ajhg.2018.03.001			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GG1IH	29706346	Green Published, Bronze			2022-12-18	WOS:000432440100005
J	Shriner, D; Rotimi, CN				Shriner, Daniel; Rotimi, Charles N.			Whole-Genome-Sequence-Based Haplotypes Reveal Single Origin of the Sickle Allele during the Holocene Wet Phase	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BETA-GLOBIN GENE; MOLECULAR ANALYSIS; CELL MUTATION; CLUSTER HAPLOTYPES; VARIANT GENE; AFRICA; POPULATIONS; EVOLUTION; ANEMIA; REGION	Five classical designations of sickle haplotypes are made on the basis of the presence or absence of restriction sites and are named after the ethno-linguistic groups or geographic regions from which the individuals with sickle cell anemia originated. Each haplotype is thought to represent an independent occurrence of the sickle mutation rs334 (c.20A>T [p.Glu7Val] in HBB). We investigated the origins of the sickle mutation by using whole-genome-sequence data. We identified 156 carriers from the 1000 Genomes Project, the African Genome Variation Project, and Qatar. We classified haplotypes by using 27 polymorphisms in linkage disequilibrium with rs334. Network analysis revealed a common haplotype that differed from the ancestral haplotype only by the derived sickle mutation at rs334 and correlated collectively with the Central African Republic (CAR), Cameroon, and Arabian/Indian haplotypes. Other haplotypes were derived from this haplotype and fell into two clusters, one composed of Senegal haplotypes and the other composed of Benin and Senegal haplotypes. The near-exclusive presence of the original sickle haplotype in the CAR, Kenya, Uganda, and South Africa is consistent with this haplotype predating the Bantu expansions. Modeling of balancing selection indicated that the heterozygote advantage was 15.2%, an equilibrium frequency of 12.0% was reached after 87 generations, and the selective environment predated the mutation. The posterior distribution of the ancestral recombination graph yielded a sickle mutation age of 259 generations, corresponding to 7,300 years ago during the Holocene Wet Phase. These results clarify the origin of the sickle allele and improve and simplify the classification of sickle haplotypes.	[Shriner, Daniel; Rotimi, Charles N.] NHGRI, Ctr Res Genom & Global Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Rotimi, CN (corresponding author), NHGRI, Ctr Res Genom & Global Hlth, Bethesda, MD 20892 USA.	rotimic@mail.nih.gov		Shriner, Daniel/0000-0003-1928-5520	Intramural Research Program of the Center for Research on Genomics and Global Health (CRGGH); National Human Genome Research Institute; National Institute of Diabetes and Digestive and Kidney Diseases; Center for Information Technology; Office of the Director at the National Institutes of Health [1ZIAHG200362]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200362] Funding Source: NIH RePORTER	Intramural Research Program of the Center for Research on Genomics and Global Health (CRGGH); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Center for Information Technology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); Office of the Director at the National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We acknowledge the assistance of Neil Hanchard with the restriction site data. The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official view of the National Institutes of Health. This research was supported by the Intramural Research Program of the Center for Research on Genomics and Global Health (CRGGH). The CRGGH is supported by the National Human Genome Research Institute, the National Institute of Diabetes and Digestive and Kidney Diseases, the Center for Information Technology, and the Office of the Director at the National Institutes of Health (1ZIAHG200362).	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; ANTONARAKIS SE, 1984, P NATL ACAD SCI-BIOL, V81, P853, DOI 10.1073/pnas.81.3.853; Arrow K. J., 2004, SAVING LIVES BUYING, P125; Baker JL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01837-7; Bergsma W, 2013, J KOREAN STAT SOC, V42, P323, DOI 10.1016/j.jkss.2012.10.002; Bhagat S, 2013, J CLIN DIAGN RES, V7, P269, DOI 10.7860/JCDR/2013/4381.2744; Bitoungui VJN, 2015, OMICS, V19, P171, DOI 10.1089/omi.2014.0134; Carter R, 2002, CLIN MICROBIOL REV, V15, P564, DOI 10.1128/CMR.15.4.564-594.2002; Castaneda IS, 2009, P NATL ACAD SCI USA, V106, P20159, DOI 10.1073/pnas.0905771106; CHEBLOUNE Y, 1988, P NATL ACAD SCI USA, V85, P4431, DOI 10.1073/pnas.85.12.4431; Currat M, 2002, AM J HUM GENET, V70, P207, DOI 10.1086/338304; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Ehret C, 2001, INT J AFR HIST STUD, V34, P5, DOI 10.2307/3097285; Elderdery AY, 2012, INT J LAB HEMATOL, V34, P262, DOI 10.1111/j.1751-553X.2011.01388.x; Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188; FLINT J, 1993, HUM GENET, V91, P91; GELPI AP, 1973, ANN INTERN MED, V79, P258, DOI 10.7326/0003-4819-79-2-258; Gurdasani D, 2015, NATURE, V517, P327, DOI 10.1038/nature13997; Hanchard N, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-52; Holloway K, 2006, HUM MOL GENET, V15, P1099, DOI 10.1093/hmg/ddl025; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jostins L, 2014, ARXIV14077988; KAN YW, 1978, LANCET, V2, P910; KONOTEYAFI, 1974, ARCH INTERN MED, V133, P611, DOI DOI 10.1001/ARCHINTE.1974.00320160105009; KULOZIK AE, 1986, AM J HUM GENET, V39, P239; KURNIT DM, 1979, LANCET, V1, P104; LAPOUMEROULIE C, 1992, HUM GENET, V89, P333; Lehmann H, 1954, EUGEN REV, V46, P101; LIVINGSTONE F B, 1989, American Journal of Human Biology, V1, P289, DOI 10.1002/ajhb.1310010309; MAAT GJR, 1993, INT J OSTEOARCHAEOL, V3, P77, DOI DOI 10.1002/OA.1390030204; Mallick S, 2016, NATURE, V538, P201, DOI 10.1038/nature18964; Marin A, 1999, Boll Soc Ital Biol Sper, V75, P27; MEARS JG, 1981, J CLIN INVEST, V68, P606, DOI 10.1172/JCI110294; Moorjani P, 2016, P NATL ACAD SCI USA, V113, P5652, DOI 10.1073/pnas.1514696113; PAGNIER J, 1984, P NATL ACAD SCI-BIOL, V81, P1771, DOI 10.1073/pnas.81.6.1771; Papadakis MN, 1999, HUM GENET, V104, P117, DOI 10.1007/s004390050923; Piel FB, 2017, NEW ENGL J MED, V376, P1561, DOI 10.1056/NEJMra1510865; Piel FB, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1104; R Foundation for Statistical Computing, 2021, R LANG ENV STAT COMP; Rasmussen MD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004342; Rodriguez-Flores JL, 2016, GENOME RES, V26, P151, DOI 10.1101/gr.191478.115; Sallares R, 2004, MED HIST, V48, P311, DOI 10.1017/S0025727300007651; Shaikho EM, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4013-y; SOLOMON E, 1979, LANCET, V1, P923; SRINIVAS R, 1988, AM J HEMATOL, V29, P60, DOI 10.1002/ajh.2830290117; STINE OC, 1992, J MOL EVOL, V34, P336; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Trombetta B, 2015, GENOME BIOL EVOL, V7, P1940, DOI 10.1093/gbe/evv118; Vianello D, 2013, HUM MUTAT, V34, P1189, DOI 10.1002/humu.22356; WAIKAN Y, 1978, P NATL ACAD SCI USA, V75, P5631, DOI 10.1073/pnas.75.11.5631; WAINSCOAT JS, 1987, ACTA HAEMATOL-BASEL, V78, P154, DOI 10.1159/000205867; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917	54	53	54	2	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 5	2018	102	4					547	556		10.1016/j.ajhg.2018.02.003	http://dx.doi.org/10.1016/j.ajhg.2018.02.003			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GB8QQ	29526279	Green Published, hybrid, Green Submitted			2022-12-18	WOS:000429340800004
J	Crawford, JE; Amaru, R; Song, JY; Julian, CG; Racimo, F; Cheng, JY; Guo, XQ; Yao, J; Ambale-Venkatesh, B; Lima, JA; Rotter, JI; Stehlik, J; Moore, LG; Prchal, JT; Nielsen, R				Crawford, Jacob E.; Amaru, Ricardo; Song, Jihyun; Julian, Colleen G.; Racimo, Fernando; Cheng, Jade Yu; Guo, Xiuqing; Yao, Jie; Ambale-Venkatesh, Bharath; Lima, Joao A.; Rotter, Jerome I.; Stehlik, Josef; Moore, Lorna G.; Prchal, Josef T.; Nielsen, Rasmus			Natural Selection on Genes Related to Cardiovascular Health in High-Altitude Adapted Andeans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENERATION SEQUENCING DATA; LOW HEMOGLOBIN CONCENTRATION; CHRONIC MOUNTAIN-SICKNESS; NITRIC-OXIDE; PULMONARY-HYPERTENSION; POSITIVE SELECTION; HUMAN ADAPTATION; GENOME SEQUENCE; BLOOD-VISCOSITY; HYPOXIA	The increase in red blood cell mass (polycythemia) due to the reduced oxygen availability (hypoxia) of residence at high altitude or other conditions is generally thought to be beneficial in terms of increasing tissue oxygen supply. However, the extreme polycythemia and accompanying increased mortality due to heart failure in chronic mountain sickness most likely reduces fitness. Tibetan highlanders have adapted to high altitude, possibly in part via the selection of genetic variants associated with reduced polycythemic response to hypoxia. In contrast, high-altitude-adapted Quechua-and Aymara-speaking inhabitants of the Andean Altiplano are not protected from high-altitude polycythemia in the same way, yet they exhibit other adaptive features for which the genetic underpinnings remain obscure. Here, we used whole-genome sequencing to scan high-altitude Andeans for signals of selection. The genes showing the strongest evidence of selection-including BRINP3, NOS2, and TBX5-are associated with cardiovascular development and function but are not in the response-to-hypoxia pathway. Using association mapping, we demonstrated that the haplotypes under selection are associated with phenotypic variations related to cardiovascular health. We hypothesize that selection in response to hypoxia in Andeans could have vascular effects and could serve to mitigate the deleterious effects of polycythemia rather than reduce polycythemia itself.	[Crawford, Jacob E.; Racimo, Fernando; Cheng, Jade Yu; Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94702 USA; [Amaru, Ricardo] San Andres Univ, Med Sch, Cell Biol Unit, La Paz, Bolivia; [Song, Jihyun; Stehlik, Josef; Prchal, Josef T.] Univ Utah, Dept Med, Hlth Ctr, Salt Lake City, UT 84123 USA; [Song, Jihyun; Stehlik, Josef; Prchal, Josef T.] Vet AffairsMed Ctr, Salt Lake City, UT 84123 USA; [Julian, Colleen G.] Univ Colorado Denver, Dept Med, Anschutz Med Campus, Aurora, CO 80045 USA; [Racimo, Fernando; Cheng, Jade Yu] Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum Denmark, Oster Voldgade 5-7, DK-1350 Copenhagen, Denmark; [Guo, Xiuqing; Yao, Jie; Rotter, Jerome I.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, 1124 West Carson St, Torrance, CA 90502 USA; [Ambale-Venkatesh, Bharath; Lima, Joao A.] Johns Hopkins Univ, Dept Cardiol, 600 North Wolfe St, Baltimore, MD 21205 USA; [Moore, Lorna G.] Univ Colorado Denver, Dept Obstet & Gynecol, Anschutz Med Campus, Aurora, CO 80045 USA; [Nielsen, Rasmus] Univ Copenhagen, Museum Nat Hist, Oster Voldgade 5-7, DK-1350 Copenhagen, Denmark; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94702 USA; [Crawford, Jacob E.] Verily Life Sci, San Francisco, CA 94080 USA	University of California System; University of California Berkeley; Universidad Mayor de San Andres; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Copenhagen; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Johns Hopkins University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Copenhagen; University of California System; University of California Berkeley	Nielsen, R (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94702 USA.; Prchal, JT (corresponding author), Univ Utah, Dept Med, Hlth Ctr, Salt Lake City, UT 84123 USA.; Prchal, JT (corresponding author), Vet AffairsMed Ctr, Salt Lake City, UT 84123 USA.; Nielsen, R (corresponding author), Univ Copenhagen, Museum Nat Hist, Oster Voldgade 5-7, DK-1350 Copenhagen, Denmark.; Nielsen, R (corresponding author), Univ Calif Berkeley, Dept Stat, Berkeley, CA 94702 USA.	josef.prchal@hsc.utah.edu; rasmus_nielsen@berkeley.edu	Rotter, Jerome/AAY-6598-2021; Nielsen, Rasmus/D-4405-2009; Ambale Venkatesh, Bharath/F-4941-2016	Nielsen, Rasmus/0000-0003-0513-6591; Crawford, Jacob/0000-0002-6745-9145; Racimo, Fernando/0000-0002-5025-2607; Stehlik, Josef/0000-0002-7362-0513; Ambale Venkatesh, Bharath/0000-0002-2330-2373	NIH [HLBI 079647, TW 001188, HHSN2682015000031, N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169]; National Center for Research Resources [UL1-TR-000040, UL1-TR-001079, UL1-RR-025005]; NHLBI [N02-HL-6-4278]; National Center for Advancing Translational Sciences; Clinical and Translational Science Institute [UL1TR000124]; National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center [DK063491]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD088590] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R21TW010797] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124, UL1TR000040, UL1TR001079, UL1TR001881] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R44HL095169, R43HL095167, R43HL095169, R43HL095161, R43HL095160, R13HL095166, R01HL095163, R21HL095165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Clinical and Translational Science Institute; National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	For the Colorado cohort, we thank the Instituto Boliviano de Biologia de Altura investigators and the local physicians and other health-care personnel who helped with the study, the many subjects who generously participated, and grant support from the NIH (HLBI 079647 and TW 001188). The Multi-Ethnic Study of Atherosclerosis (MESA) is supported by NIH contracts HHSN2682015000031, N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, and N01-HC-95169 and by grants UL1-TR-000040, UL1-TR-001079, and UL1-RR-025005 from the National Center for Research Resources. Funding for MESA SHARe genotyping was provided by NHLBI contract N02-HL-6-4278. The provision of genotyping data was supported in part by the National Center for Advancing Translational Sciences, the Clinical and Translational Science Institute (grant UL1TR000124), and the National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center (grant DK063491 to the Southern California Diabetes Endocrinology Research Center). We also thank two anonymous reviewers for their comments, which helped to improve the manuscript.	Alkorta-Aranburu G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003110; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Appiah D, 2016, THROMB RES, V143, P50, DOI 10.1016/j.thromres.2016.04.023; Beall CM, 2006, INTEGR COMP BIOL, V46, P18, DOI 10.1093/icb/icj004; Beall CM, 2002, P NATL ACAD SCI USA, V99, P17215, DOI 10.1073/pnas.252649199; BEALL CM, 1990, AM J HUM BIOL, V2, P639, DOI 10.1002/ajhb.1310020607; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116; Bigham AW, 2014, PHYSIOL GENOMICS, V46, P687, DOI 10.1152/physiolgenomics.00063.2014; Bigham AW, 2013, AM J HUM BIOL, V25, P190, DOI 10.1002/ajhb.22358; Bigham Abigail W., 2009, Human Genomics, V4, P79; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boogerd CJ, 2016, DEV CELL, V36, P242, DOI 10.1016/j.devcel.2016.01.015; Bryc K, 2010, P NATL ACAD SCI USA, V107, P8954, DOI 10.1073/pnas.0914618107; Cheng JY, 2017, BIOINFORMATICS, V33, P2148, DOI 10.1093/bioinformatics/btx098; Cline JL, 2013, BIOL RES NURS, V15, P160, DOI 10.1177/1099800411424487; Cole AM, 2014, HIGH ALT MED BIOL, V15, P497, DOI 10.1089/ham.2014.1036; Connelly JJ, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-33; Crawford JE, 2013, MOL ECOL, V22, P6131, DOI 10.1111/mec.12562; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Durand EY, 2011, MOL BIOL EVOL, V28, P2239, DOI 10.1093/molbev/msr048; Erslev A J, 1989, Transfus Med Rev, V3, P237, DOI 10.1016/S0887-7963(89)70084-5; Erzurum SC, 2007, P NATL ACAD SCI USA, V104, P17593, DOI 10.1073/pnas.0707462104; Favaro E, 2012, CELL METAB, V16, P751, DOI 10.1016/j.cmet.2012.10.017; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fumagalli M, 2014, BIOINFORMATICS, V30, P1486, DOI 10.1093/bioinformatics/btu041; Gonzales GF, 2009, AM J PHYSIOL-REG I, V297, pR1477, DOI 10.1152/ajpregu.00275.2009; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; GROVES BM, 1993, J APPL PHYSIOL, V74, P312, DOI 10.1152/jappl.1993.74.1.312; GUYTON AC, 1961, CIRC RES, V9, P157, DOI 10.1161/01.RES.9.1.157; Heath D, 1989, HIGH ALTITUDE MED PA, P102; Holm H, 2010, NAT GENET, V42, P117, DOI 10.1038/ng.511; Homburger JR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005602; Huerta-Sanchez E, 2014, NATURE, V512, P194, DOI 10.1038/nature13408; Huerta-Sanchez E, 2013, MOL BIOL EVOL, V30, P1877, DOI 10.1093/molbev/mst089; Hultgren H.N, 1997, HIGH ALTITUDE MED, P87; Javadi M, 2012, J BIOL CHEM, V287, P26223, DOI 10.1074/jbc.M112.382721; Jensen TE, 2012, J PHYSIOL-LONDON, V590, P1069, DOI 10.1113/jphysiol.2011.224972; Jung F, 2000, CIRC RES, V86, P319, DOI 10.1161/01.RES.86.3.319; Kawano H, 2004, MOL BRAIN RES, V125, P60, DOI 10.1016/j.molbrainres.2004.04.001; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4; Larson MG, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S5; Leon-Velarde F, 2005, HIGH ALT MED BIOL, V6, P147, DOI 10.1089/ham.2005.6.147; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lorenzo FR, 2014, NAT GENET, V46, P951, DOI 10.1038/ng.3067; LOWE GDO, 1993, CIRCULATION, V87, P1915, DOI 10.1161/01.CIR.87.6.1915; Lu XF, 2015, HUM MOL GENET, V24, P865, DOI 10.1093/hmg/ddu478; Marnetto D, 2017, METHODS ECOL EVOL, V8, P1389, DOI 10.1111/2041-210X.12747; Martin SH, 2015, MOL BIOL EVOL, V32, P244, DOI 10.1093/molbev/msu269; MATSUDA T, 1976, THROMB RES, V8, P25, DOI 10.1016/0049-3848(76)90044-X; Maul H, 2003, CURR PHARM DESIGN, V9, P359, DOI 10.2174/1381612033391784; Mendez FL, 2012, AM J HUM GENET, V91, P265, DOI 10.1016/j.ajhg.2012.06.015; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; MONCADA S, 1991, EUR J CLIN INVEST, V21, P361, DOI 10.1111/j.1365-2362.1991.tb01383.x; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; Moore LG, 1998, YEARB PHYS ANTHROPOL, V41, P25; MURRAY JF, 1963, J CLIN INVEST, V42, P1150, DOI 10.1172/JCI104800; Newman JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7863; Nienaber-Rousseau C, 2015, BLOOD COAGUL FIBRIN, V26, P389, DOI 10.1097/MBC.0000000000000256; Niermeyer S, 2015, PULM CIRC, V5, P48, DOI 10.1086/679719; Okumiya K, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009728; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Pescador N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009644; Prchal JT, 2015, WILLIAMS HEMATOLOGY, P503; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Racimo F, 2017, MOL BIOL EVOL, V34, P509, DOI 10.1093/molbev/msw283; Racimo F, 2017, MOL BIOL EVOL, V34, P296, DOI 10.1093/molbev/msw216; Racimo F, 2015, NAT REV GENET, V16, P359, DOI 10.1038/nrg3936; Santos JL, 2001, NUTRITION, V17, P305, DOI 10.1016/S0899-9007(00)00551-7; Sato J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107236; Scheinfeldt LB, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r1; Seguin-Orlando A, 2014, SCIENCE, V346, P1113, DOI 10.1126/science.aaa0114; Semenza GL, 2014, ANNU REV PATHOL-MECH, V9, P47, DOI 10.1146/annurev-pathol-012513-104720; SIME F, 1963, AM J CARDIOL, V11, P143, DOI 10.1016/0002-9149(63)90054-7; Simonson TS, 2015, J PHYSIOL-LONDON, V593, P3207, DOI 10.1113/JP270518; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Sinner MF, 2014, CIRCULATION, V130, P1225, DOI 10.1161/CIRCULATIONAHA.114.009892; Skotte L, 2013, GENETICS, V195, P693, DOI 10.1534/genetics.113.154138; Stec JJ, 2000, CIRCULATION, V102, P1634, DOI 10.1161/01.CIR.102.14.1634; Thompson L, 2009, PEDIATR RES, V65, P188, DOI 10.1203/PDR.0b013e31818d6ad0; Vasan RS, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S2; Wang S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000037; Wang Y, 2002, ANN NY ACAD SCI, V962, P423, DOI 10.1111/j.1749-6632.2002.tb04086.x; WINSLOW RM, 1989, J APPL PHYSIOL, V66, P1561, DOI 10.1152/jappl.1989.66.4.1561; Woolcott OO, 2015, ENDOCR REV, V36, P149, DOI 10.1210/er.2014-1063; Woolcott OO, 2014, OBESITY, V22, P2080, DOI 10.1002/oby.20800; Wu TY, 2005, J APPL PHYSIOL, V98, P598, DOI 10.1152/japplphysiol.01034.2002; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zhou D, 2013, AM J HUM GENET, V93, P452, DOI 10.1016/j.ajhg.2013.07.011	91	53	54	3	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 2	2017	101	5					752	767		10.1016/j.ajhg.2017.09.023	http://dx.doi.org/10.1016/j.ajhg.2017.09.023			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FL5DL	29100088	Green Published, Bronze			2022-12-18	WOS:000414251600008
J	Gallagher, MD; Posavi, M; Huang, P; Unger, TL; Berlyand, Y; Gruenewald, AL; Chesi, A; Manduchi, E; Wells, AD; Grant, SFA; Blobel, GA; Brown, CD; Chen-Plotkin, AS				Gallagher, Michael D.; Posavi, Marijan; Huang, Peng; Unger, Travis L.; Berlyand, Yosef; Gruenewald, Analise L.; Chesi, Alessandra; Manduchi, Elisabetta; Wells, Andrew D.; Grant, Struan F. A.; Blobel, Gerd A.; Brown, Christopher D.; Chen-Plotkin, Alice S.			A Dementia-Associated Risk Variant near TMEM106B Alters Chromatin Architecture and Gene Expression	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; GENOME-WIDE ASSOCIATION; HUMAN CELL-TYPES; CHROMOSOME CONFORMATION; PROTEIN-LEVELS; IN-VIVO; DISEASE; COMMON; ANNOTATION; ENHANCERS	Neurodegenerative diseases pose an extraordinary threat to the world's aging population, yet no disease-modifying therapies are available. Although genome-wide association studies (GWASs) have identified hundreds of risk loci for neurodegeneration, the mechanisms by which these loci influence disease risk are largely unknown. Here, we investigated the association between common genetic variants at the 7p21 locus and risk of the neurodegenerative disease frontotemporal lobar degeneration. We showed that variants associated with disease risk correlate with increased expression of the 7p21 gene TMEM106B and no other genes; co-localization analyses implicated a common causal variant underlying both association with disease and association with TMEM106B expression in lymphoblastoid cell lines and human brain. Furthermore, increases in the amount of TMEM106B resulted in increases in abnormal lysosomal phenotypes and cell toxicity in both immortalized cell lines and neurons. We then combined fine-mapping, bioinformatics, and bench-based approaches to functionally characterize all candidate causal variants at this locus. This approach identified a noncoding variant, rs1990620, that differentially recruits CTCF in lymphoblastoid cell lines and human brain to influence CTCF-mediated long-range chromatin- looping interactions between multiple cis-regulatory elements, including the TMEM106B promoter. Our findings thus provide an in-depth analysis of the 7p21 locus linked by GWASs to frontotemporal lobar degeneration, nominating a causal variant and causal mechanism for allele-specific expression and disease association at this locus. Finally, we show that genetic variants associated with risk of neurodegenerative diseases beyond frontotemporal lobar degeneration are enriched in CTCF-binding sites found in brain-relevant tissues, implicating CTCF-mediated gene regulation in risk of neurodegeneration more generally.	[Gallagher, Michael D.; Posavi, Marijan; Unger, Travis L.; Berlyand, Yosef; Gruenewald, Analise L.; Chen-Plotkin, Alice S.] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Huang, Peng; Grant, Struan F. A.; Blobel, Gerd A.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Huang, Peng; Chesi, Alessandra; Manduchi, Elisabetta; Wells, Andrew D.; Grant, Struan F. A.; Blobel, Gerd A.] Childrens Hosp Philadelphia, Ctr Spatial & Funct Genom, Philadelphia, PA 19104 USA; [Chesi, Alessandra; Manduchi, Elisabetta; Grant, Struan F. A.] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Manduchi, Elisabetta; Brown, Christopher D.] Univ Penn, Inst Biomed Informat, Philadelphia, PA 19104 USA; [Wells, Andrew D.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Grant, Struan F. A.; Brown, Christopher D.] Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Chen-Plotkin, AS (corresponding author), Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA.	chenplot@pennmedicine.upenn.edu	Chesi, Alessandra/AAT-8248-2020; Sander-Effron, Samuel/AAX-2231-2020; Resource Center, NINDS Human Genetics/AGF-2474-2022; Manduchi, Elisabetta/AAU-1939-2021; Gallagher, Michael Dane/G-7113-2015; Huang, Peng/AGV-1517-2022; Chesi, Alessandra/N-7693-2017	Manduchi, Elisabetta/0000-0002-4110-3714; Gallagher, Michael Dane/0000-0002-2109-1293; Chesi, Alessandra/0000-0002-0954-7446; Grant, Struan/0000-0003-2025-5302; Brown, Christopher/0000-0002-3785-5008; Berlyand, Yosef/0000-0003-2313-8507	NIH [RO1 NS082265, UO1 HL129998, RO1 MH101822, F31 NS090892]; Burroughs Wellcome Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL129998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082265, F31NS090892] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank Dr. Jonathan Schug of the University of Pennsylvania for conceptual and technical expertise in highthroughput sequencing experiments and Nathaniel D. Berkowitz for computational assistance. Funding sources for this work include the NIH (RO1 NS082265, UO1 HL129998, RO1 MH101822, and F31 NS090892) and the Burroughs Wellcome Fund.	Abraham G, 2015, CURR OPIN GENET DEV, V33, P10, DOI 10.1016/j.gde.2015.06.005; Adrianto I, 2011, NAT GENET, V43, P253, DOI 10.1038/ng.766; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Arnold M, 2015, BIOINFORMATICS, V31, P1334, DOI 10.1093/bioinformatics/btu779; Bang J, 2015, LANCET, V386, P1672, DOI 10.1016/S0140-6736(15)00461-4; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Brady OA, 2013, HUM MOL GENET, V22, P685, DOI 10.1093/hmg/dds475; Brown CD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003649; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Busch JI, 2016, HUM MOL GENET, V25, P2681, DOI 10.1093/hmg/ddw127; Cairns J, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0992-2; CHEN SD, 2012, TRANSL NEURODEGENER, V1; Chen-Plotkin AS, 2012, J NEUROSCI, V32, P11213, DOI 10.1523/JNEUROSCI.0521-12.2012; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Cruchaga C, 2011, ARCH NEUROL-CHICAGO, V68, P581, DOI 10.1001/archneurol.2010.350; Davies JOJ, 2016, NAT METHODS, V13, P74, DOI [10.1038/NMETH.3664, 10.1038/nmeth.3664]; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dunning AM, 2016, NAT GENET, V48, P374, DOI 10.1038/ng.3521; Dunning AM, 2000, AM J HUM GENET, V67, P1544, DOI 10.1086/316906; Durand NC, 2016, CELL SYST, V3, P99, DOI 10.1016/j.cels.2015.07.012; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Finch N, 2011, NEUROLOGY, V76, P467, DOI 10.1212/WNL.0b013e31820a0e3b; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Fraldi A, 2016, ANNU REV NEUROSCI, V39, P277, DOI 10.1146/annurev-neuro-070815-014031; Fu JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002431; Gallagher MD, 2014, ACTA NEUROPATHOL, V127, P407, DOI 10.1007/s00401-013-1239-x; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Guo Y, 2015, CELL, V162, P900, DOI 10.1016/j.cell.2015.07.038; Hakim O, 2012, CELL, V148, P1068, DOI 10.1016/j.cell.2012.02.019; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; Hernandez I, 2015, J ALZHEIMERS DIS, V43, P325, DOI 10.3233/JAD-132432; Hinrichs AS, 2016, BIOINFORMATICS, V32, P1430, DOI 10.1093/bioinformatics/btv766; Huang QL, 2014, NAT GENET, V46, P126, DOI 10.1038/ng.2862; Hughes JR, 2014, NAT GENET, V46, P205, DOI 10.1038/ng.2871; Jun MH, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0177-z; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Lang CM, 2012, J BIOL CHEM, V287, P19355, DOI 10.1074/jbc.M112.365098; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liang LM, 2013, GENOME RES, V23, P716, DOI 10.1101/gr.142521.112; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Maurano MT, 2015, NAT GENET, V47, P1393, DOI 10.1038/ng.3432; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Merkenschlager M, 2016, ANNU REV GENOM HUM G, V17, P17, DOI 10.1146/annurev-genom-083115-022339; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Nicholson AM, 2013, J NEUROCHEM, V126, P781, DOI 10.1111/jnc.12329; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Peters JE, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005908; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Ramanan Vijay K, 2013, Am J Neurodegener Dis, V2, P145; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rhinn H, 2017, CELL SYST, V4, P404, DOI 10.1016/j.cels.2017.02.009; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Schmidt EM, 2015, BIOINFORMATICS, V31, P2601, DOI 10.1093/bioinformatics/btv201; Seelaar H, 2011, J NEUROL NEUROSUR PS, V82, P476, DOI 10.1136/jnnp.2010.212225; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Soldner F, 2016, NATURE, V533, P95, DOI 10.1038/nature17939; Spisak S, 2015, NAT MED, V21, P1357, DOI 10.1038/nm.3975; Stagi M, 2014, MOL CELL NEUROSCI, V61, P226, DOI 10.1016/j.mcn.2014.07.006; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Tang ZH, 2015, CELL, V163, P1611, DOI 10.1016/j.cell.2015.11.024; Tewhey R, 2016, CELL, V165, P1519, DOI 10.1016/j.cell.2016.04.027; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; van Blitterswijk M, 2014, ACTA NEUROPATHOL, V127, P397, DOI 10.1007/s00401-013-1240-4; Van Deerlin VM, 2010, NAT GENET, V42, P234, DOI 10.1038/ng.536; van der Zee J, 2011, BRAIN, V134, P808, DOI 10.1093/brain/awr007; Vass R, 2011, ACTA NEUROPATHOL, V121, P373, DOI 10.1007/s00401-010-0782-y; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; White CC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002287; Williams RL, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku156; Won HJ, 2016, NATURE, V538, P523, DOI 10.1038/nature19847; Yu L, 2015, NEUROLOGY, V84, P927, DOI 10.1212/WNL.0000000000001313; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zhou Xin, 2012, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1010s40; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538	98	53	53	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 2	2017	101	5					643	663		10.1016/j.ajhg.2017.09.004	http://dx.doi.org/10.1016/j.ajhg.2017.09.004			21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FL5DL	29056226	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000414251600001
J	Ko, YA; Yi, HG; Qiu, CX; Huang, SZ; Park, J; Ledo, N; Kottgen, A; Li, HZ; Rader, DJ; Pack, MA; Brown, CD; Susztak, K				Ko, Yi-An; Yi, Huiguang; Qiu, Chengxiang; Huang, Shizheng; Park, Jihwan; Ledo, Nora; Koettgen, Anna; Li, Hongzhe; Rader, Daniel J.; Pack, Michael A.; Brown, Christopher D.; Susztak, Katalin			Genetic-Variation-Driven Gene-Expression Changes Highlight Genes with Important Functions for Kidney Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; IGA NEPHROPATHY; SUSCEPTIBILITY LOCI; STATISTICAL COLOCALIZATION; FIBROSIS DEVELOPMENT; RISK VARIANTS; HAN CHINESE; IDENTIFICATION; HYPERTENSION; METAANALYSIS	Chronic kidney disease (CKD) is a complex gene-environmental disease affecting close to 10% of the US population. Genome-wide association studies (GWASs) have identified sequence variants, localized to non-coding genomic regions, associated with kidney function. Despite these robust observations, the mechanism by which variants lead to CKD remains a critical unanswered question. Expression quantitative trait loci (eQTL) analysis is a method to identify genetic variation associated with gene expression changes in specific tissue types. We hypothesized that an integrative analysis combining CKD GWAS and kidney eQTL results can identify candidate genes for CKD. We performed eQTL analysis by correlating genotype with RNA-seq-based gene expression levels in 96 human kidney samples. Applying stringent statistical criteria, we detected 1,886 genes whose expression differs with the sequence variants. Using direct overlap and Bayesian methods, we identified new potential target genes for CKD. With respect to one of the target genes, lysosomal beta A mannosidase (MANBA), we observed that genetic variants associated with MANBA expression in the kidney showed statistically significant colocalization with variants identified in CKD GWASs, indicating that MANBA is a potential target gene for CKD. The expression of MANBA was significantly lower in kidneys of subjects with risk alleles. Suppressing manba expression in zebrafish resulted in renal tubule defects and pericardial edema, phenotypes typically induced by kidney dysfunction. Our analysis shows that gene-expression changes driven by genetic variation in the kidney can highlight potential new target genes for CKD development.	[Ko, Yi-An; Yi, Huiguang; Qiu, Chengxiang; Huang, Shizheng; Park, Jihwan; Ledo, Nora; Susztak, Katalin] Univ Penn, Perelman Sch Med, Dept Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA; [Koettgen, Anna] Univ Freiburg, Fac Med, Med Ctr, Inst Genet Epidemiol, D-79106 Freiburg, Germany; [Li, Hongzhe] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Rader, Daniel J.; Brown, Christopher D.; Susztak, Katalin] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Pack, Michael A.] Univ Penn, Perelman Sch Med, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Freiburg; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Susztak, K (corresponding author), Univ Penn, Perelman Sch Med, Dept Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA.; Susztak, K (corresponding author), Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA.	ksusztak@mail.med.upenn.edu	Ledó, Nóra/O-2296-2015; Qiu, Chengxiang/X-5040-2019; Susztak, Katalin/ABE-7474-2021	Ledó, Nóra/0000-0002-2439-9218; Qiu, Chengxiang/0000-0002-6346-8669; Susztak, Katalin/0000-0002-1005-3726; Brown, Christopher/0000-0002-3785-5008; Yi, Huiguang/0000-0002-9676-7438; Huang, Shizheng/0000-0002-9240-1578	US NIH [DP3 DK108220, R01 DK087635, DK076077, DK108220]; German Research Foundation [CRC 1140, KO 3598/3-1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087635, DP3DK108220, R01DK076077] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Work in the Susztak lab is supported by the US NIH DP3 DK108220, R01 DK087635, DK076077, and DK108220. The work of A.K. was funded by the German Research Foundation (CRC 1140 and KO 3598/3-1). The Susztak lab received research support from Boehringer Ingelheim, Biogen, Merck, GSK, Regeneron, Lilly, Celgene, and ONO Pharma for projects that are not related to this work.	Aguet F., 2016, BIORXIV; Alroy J, 2002, J AM SOC NEPHROL, V13, pS134, DOI 10.1097/01.ASN.0000016684.07368.75; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Astor BC, 2011, KIDNEY INT, V79, P1331, DOI 10.1038/ki.2010.550; Birn H, 2006, KIDNEY INT, V69, P440, DOI 10.1038/sj.ki.5000141; Boger CA, 2011, J AM SOC NEPHROL, V22, P555, DOI 10.1681/ASN.2010060598; Bonner C, 2015, NAT MED, V21, P512, DOI 10.1038/nm.3828; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chasman DI, 2012, HUM MOL GENET, V21, P5329, DOI 10.1093/hmg/dds369; Craciun FL, 2016, J AM SOC NEPHROL, V27, P1702, DOI 10.1681/ASN.2015020225; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Eckardt KU, 2013, LANCET, V382, P158, DOI 10.1016/S0140-6736(13)60439-0; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Feehally J, 2010, J AM SOC NEPHROL, V21, P1791, DOI 10.1681/ASN.2010010076; Fortune MD, 2015, NAT GENET, V47, P839, DOI 10.1038/ng.3330; Gbadegesin RA, 2015, J AM SOC NEPHROL, V26, P1701, DOI 10.1681/ASN.2014030247; Genovese G, 2010, KIDNEY INT, V78, P698, DOI 10.1038/ki.2010.251; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gharavi AG, 2011, NAT GENET, V43, P321, DOI 10.1038/ng.787; Guo H, 2015, HUM MOL GENET, V24, P3305, DOI 10.1093/hmg/ddv077; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Howard MF, 2014, AM J HUM GENET, V94, P278, DOI 10.1016/j.ajhg.2013.12.012; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kang HM, 2015, NAT MED, V21, P37, DOI 10.1038/nm.3762; Kiryluk K, 2014, NAT GENET, V46, P1187, DOI 10.1038/ng.3118; Kiryluk K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002765; Ko YA, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r108; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Kovesdy CP, 2010, NEPHROL DIAL TRANSPL, V25, P3003, DOI 10.1093/ndt/gfq144; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Lee JW, 2015, J AM SOC NEPHROL, V26, P2669, DOI 10.1681/ASN.2014111067; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Li M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8270; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Okada Y, 2012, NAT GENET, V44, P904, DOI 10.1038/ng.2352; Ongen H, 2016, BIOINFORMATICS, V32, P1479, DOI 10.1093/bioinformatics/btv722; Palmer ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029202; Pattaro C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10023; Pattaro C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002584; Rhee CM, 2015, NAT REV NEPHROL, V11, DOI 10.1038/nrneph.2015.25; Rossignol P, 2015, LANCET, V386, P1588, DOI 10.1016/S0140-6736(15)00418-3; Sandholm N, 2013, J AM SOC NEPHROL, V24, P1537, DOI 10.1681/ASN.2012111122; Sandholm N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002921; Seiler C, 2011, GENE EXPR PATTERNS, V11, P118, DOI 10.1016/j.gep.2010.10.002; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Stanescu HC, 2011, NEW ENGL J MED, V364, P616, DOI 10.1056/NEJMoa1009742; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Sud M, 2016, NEPHROL DIAL TRANSPL, V31, P1122, DOI 10.1093/ndt/gfv389; Surendran K, 2014, PEDIATR NEPHROL, V29, P2253, DOI 10.1007/s00467-013-2652-z; Thompson S, 2015, J AM SOC NEPHROL, V26, P2504, DOI 10.1681/ASN.2014070714; Trudu M, 2013, NAT MED, V19, P1655, DOI 10.1038/nm.3384; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wallace C, 2012, HUM MOL GENET, V21, P2815, DOI 10.1093/hmg/dds098; Wang J, 2013, NUCLEIC ACIDS RES, V41, pD171, DOI 10.1093/nar/gks1221; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Wang JB, 2016, AM J HUM GENET, V98, P697, DOI 10.1016/j.ajhg.2016.02.020; Wang YT, 2013, J BIOL CHEM, V288, P25490, DOI 10.1074/jbc.M113.492611; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Yu XQ, 2012, NAT GENET, V44, P178, DOI 10.1038/ng.1047; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606; Zhu M, 2006, HUM MOL GENET, V15, P493, DOI 10.1093/hmg/ddi465	66	53	53	3	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 1	2017	100	6					940	953		10.1016/j.ajhg.2017.05.004	http://dx.doi.org/10.1016/j.ajhg.2017.05.004			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EW7NL	28575649	Bronze, Green Published			2022-12-18	WOS:000402700600009
J	Panagiotou, ES; Soriano, CS; Poulter, JA; Lord, EC; Dzulova, D; Kondo, H; Hiyoshi, A; Chung, BHY; Chu, YWY; Lai, CHY; Tafoya, ME; Karjosukarso, D; Collin, RWJ; Topping, J; Downey, LM; Ali, M; Inglehearn, CF; Toomes, C				Panagiotou, Evangelia S.; Soriano, Carla Sanjurjo; Poulter, James A.; Lord, Emma C.; Dzulova, Denisa; Kondo, Hiroyuki; Hiyoshi, Atsushi; Chung, Brian Hon-Yin; Chu, Yoyo Wing-Yiu; Lai, Connie H. Y.; Tafoya, Mark E.; Karjosukarso, Dyah; Collin, Rob W. J.; Topping, Joanne; Downey, Louise M.; Ali, Manir; Inglehearn, Chris F.; Toomes, Carmel			Defects in the Cell Signaling Mediator beta-Catenin Cause the Retinal Vascular Condition FEVR	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL EXUDATIVE VITREORETINOPATHY; DNA-SEQUENCING DATA; INTELLECTUAL DISABILITY; FUNCTION MUTATIONS; NORRIE-DISEASE; ANGIOGENESIS; FRIZZLED-4; SPECTRUM; GENE; LRP5	Familial exudative vitreoretinopathy (FEVR) is an inherited blinding disorder characterized by the abnormal development of the retinal vasculature. The majority of mutations identified in FEVR are found within four genes that encode the receptor complex (FZD4, LRP5, and TSPAN12) and ligand (NDP) of a molecular pathway that controls angiogenesis, the Norrin-beta-catenin signaling pathway. However, half of all FEVR-affected case subjects do not harbor mutations in these genes, indicating that further mutated genes remain to be identified. Here we report the identification of mutations in CTNNB1, the gene encoding b-catenin, as a cause of FEVR. We describe heterozygous mutations (c.2142_2157dup [p.His720*] and c.2128C>T [p.Arg710Cys]) in two dominant FEVR-affected families and a de novo mutation (c.1434_1435insC [p.Glu479Argfs*18]) in a simplex case subject. Previous studies have reported heterozygous de novo CTNNB1 mutations as a cause of syndromic intellectual disability (ID) and autism spectrum disorder, and somatic mutations are linked to many cancers. However, in this study we show that Mendelian inherited CTNNB1 mutations can cause non-syndromic FEVR and that FEVR can be a part of the syndromic ID phenotype, further establishing the role that b-catenin signaling plays in the development of the retinal vasculature.	[Panagiotou, Evangelia S.; Soriano, Carla Sanjurjo; Poulter, James A.; Lord, Emma C.; Dzulova, Denisa; Topping, Joanne; Downey, Louise M.; Ali, Manir; Inglehearn, Chris F.; Toomes, Carmel] Univ Leeds, Leeds Inst Mol Med, Sect Ophthalmol & Neurosci, Leeds LS9 7TF, W Yorkshire, England; [Kondo, Hiroyuki; Hiyoshi, Atsushi] Fukuoka Univ, Dept Ophthalmol, Fukuoka 8140180, Japan; [Kondo, Hiroyuki] Univ Occupat & Environm Hlth, Dept Ophthalmol, Kitakyushu, Fukuoka 8078555, Japan; [Chung, Brian Hon-Yin; Chu, Yoyo Wing-Yiu] Univ Hong Kong, Queen Mary Hosp, Ctr Genom Sci, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [Lai, Connie H. Y.] Univ Hong Kong, Queen Mary Hosp, Dept Ophthalmol, Hong Kong, Hong Kong, Peoples R China; [Tafoya, Mark E.] Pacific Retina Care, Waikele, HI 96797 USA; [Karjosukarso, Dyah] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, NL-6525 GA Nijmegen, Netherlands; [Karjosukarso, Dyah] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Med Ctr, NL-6525 GA Nijmegen, Netherlands; [Downey, Louise M.] Hull Royal Infirm, Dept Ophthalmol, Kingston Upon Hull HU3 2JZ, N Humberside, England	University of Leeds; Fukuoka University; University of Occupational & Environmental Health - Japan; University of Hong Kong; University of Hong Kong; Radboud University Nijmegen; Radboud University Nijmegen; University of Hull	Toomes, C (corresponding author), Univ Leeds, Leeds Inst Mol Med, Sect Ophthalmol & Neurosci, Leeds LS9 7TF, W Yorkshire, England.	c.toomes@leeds.ac.uk	Poulter, James A/A-8190-2013; Inglehearn, Chris/GYD-9783-2022; Ali, Manir/ABE-5251-2020; Karjosukarso, Dyah Winiarty/A-9523-2016	Poulter, James A/0000-0003-2048-5693; Ali, Manir/0000-0003-3204-3788; Karjosukarso, Dyah Winiarty/0000-0002-0881-9905; Lai, Connie/0000-0002-8951-6788; Dzulova, Denisa/0000-0002-5388-0190; Toomes, Carmel/0000-0001-8373-9545	European Union [317472]; Fight For Sight [1493/1494, GR586]; RP Fighting Blindness [GR586]; UK Inherited Retinal Disease Consortium	European Union(European Commission); Fight For Sight; RP Fighting Blindness; UK Inherited Retinal Disease Consortium	We thank the FEVR-affected families for their participation in this study and Professor Jeremy Nathans (John Hopkins University School of Medicine) for kindly providing the STF cells. This project has received funding from the European Union's Seventh Framework Programme for research, technological development, and demonstration under grant agreement no. 317472 (EyeTN), Fight For Sight (grants 1493/1494 and GR586), and RP Fighting Blindness (grant GR586). We acknowledge the support of the UK Inherited Retinal Disease Consortium.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Azmitia EC, 2016, J AUTISM DEV DISORD, V46, P1307, DOI 10.1007/s10803-015-2672-6; Benson W E, 1995, Trans Am Ophthalmol Soc, V93, P473; CHEN ZY, 1993, NAT GENET, V5, P180, DOI 10.1038/ng1093-180; Clevers H, 2009, CELL, V139, P227, DOI 10.1016/j.cell.2009.09.027; Collin RWJ, 2013, P NATL ACAD SCI USA, V110, P9856, DOI 10.1073/pnas.1220864110; Costa G, 2016, NAT CELL BIOL, V18, P1292, DOI 10.1038/ncb3443; Cox RT, 1999, GENETICS, V153, P319; CRISWICK VG, 1969, AM J OPHTHALMOL, V68, P578, DOI 10.1016/0002-9394(69)91237-9; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; De Silva TM, 2016, CELL MOL NEUROBIOL, V36, P241, DOI 10.1007/s10571-015-0308-1; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dixon MW, 2016, OPHTHALMIC GENET, V37, P468, DOI 10.3109/13816810.2015.1120318; Downey LM, 2001, AM J HUM GENET, V68, P778, DOI 10.1086/318790; Dubruc E, 2014, AM J MED GENET A, V164, P1571, DOI 10.1002/ajmg.a.36484; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Jiao XD, 2004, AM J HUM GENET, V75, P878, DOI 10.1086/425080; Kervestin S, 2012, NAT REV MOL CELL BIO, V13, P700, DOI 10.1038/nrm3454; Khan K, 2012, HUM MOL GENET, V21, P776, DOI 10.1093/hmg/ddr509; Kharbanda M, 2017, EUR J MED GENET, V60, P130, DOI 10.1016/j.ejmg.2016.11.008; Kuechler A, 2015, HUM GENET, V134, P97, DOI 10.1007/s00439-014-1498-1; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Mbom BC, 2013, BIOESSAYS, V35, P804, DOI 10.1002/bies.201300045; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Newton SS, 2013, CELL MOL LIFE SCI, V70, P1739, DOI 10.1007/s00018-013-1281-9; Nikopoulos K, 2010, AM J HUM GENET, V86, P240, DOI 10.1016/j.ajhg.2009.12.016; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; Pimentel-Coelho PM, 2012, EUR J NEUROSCI, V35, P1917, DOI 10.1111/j.1460-9568.2012.08126.x; Plagnol V, 2012, BIOINFORMATICS, V28, P2747, DOI 10.1093/bioinformatics/bts526; Poulter JA, 2012, INVEST OPHTH VIS SCI, V53, P2873, DOI 10.1167/iovs.11-8629; Poulter JA, 2010, AM J HUM GENET, V86, P248, DOI 10.1016/j.ajhg.2010.01.012; Qin M, 2008, HUM GENET, V122, P615, DOI 10.1007/s00439-007-0438-8; Rehm HL, 2002, J NEUROSCI, V22, P4286, DOI 10.1523/JNEUROSCI.22-11-04286.2002; Robitaille J, 2002, NAT GENET, V32, P326, DOI 10.1038/ng957; Robitaille JM, 2014, JAMA OPHTHALMOL, V132, P1393, DOI 10.1001/jamaophthalmol.2014.2814; Salvo J, 2015, INVEST OPHTH VIS SCI, V56, P1937, DOI 10.1167/iovs.14-16065; Stamos JL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007898; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Toomes C, 2004, AM J HUM GENET, V74, P721, DOI 10.1086/383202; Toomes C, 2004, INVEST OPHTH VIS SCI, V45, P2083, DOI 10.1167/iovs.03-1044; Tucci V, 2014, J CLIN INVEST, V124, P1468, DOI 10.1172/JCI70372; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang YS, 2001, J NEUROSCI, V21, P4761, DOI 10.1523/JNEUROSCI.21-13-04761.2001; Wu J. F., 2016, J SENSORS, V2016, P1, DOI DOI 10.1371/J0URNAL.P0NE.0146261; Xing Y, 2008, STRUCTURE, V16, P478, DOI 10.1016/j.str.2007.12.021; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Ye X, 2010, TRENDS MOL MED, V16, P417, DOI 10.1016/j.molmed.2010.07.003; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047; Zhou YL, 2014, J CLIN INVEST, V124, P3825, DOI 10.1172/JCI76431	53	53	58	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 1	2017	100	6					960	968		10.1016/j.ajhg.2017.05.001	http://dx.doi.org/10.1016/j.ajhg.2017.05.001			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EW7NL	28575650	Green Published, Green Accepted, Bronze			2022-12-18	WOS:000402700600011
J	Li, HD; Bielas, SL; Zaki, MS; Ismail, S; Farfara, D; Um, K; Rosti, RO; Scott, EC; Tu, S; Chi, NC; Gabriel, S; Erson-Omay, EZ; Ercan-Sencicek, AG; Yasuno, K; Caglayan, AO; Kaymakcalan, H; Ekici, B; Bilguvar, K; Gunel, M; Gleeson, JG				Li, Hongda; Bielas, Stephanie L.; Zaki, Maha S.; Ismail, Samira; Farfara, Dorit; Um, Kyongmi; Rosti, Rasim O.; Scott, Eric C.; Tu, Shu; Chi, Neil C.; Gabriel, Stacey; Erson-Omay, Emine Z.; Ercan-Sencicek, A. Gulhan; Yasuno, Katsuhito; Caglayan, Ahmet Okay; Kaymakcalan, Hande; Ekici, Baris; Bilguvar, Kaya; Gunel, Murat; Gleeson, Joseph G.			Biallelic Mutations in Citron Kinase Link Mitotic Cytokinesis to Human Primary Microcephaly	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEIN-KINASES; NEURAL PROGENITORS; RHO; CELLS; ASPM; MECHANISM; PHOSPHORYLATION; NEUROGENESIS; ORGANIZATION; ACTIVATION	Cell division terminates with cytokinesis and cellular separation. Autosomal-recessive primary microcephaly (PMCPH) is a neurodevelopmental disorder characterized by a reduction in brain and head size at birth in addition to non-progressive intellectual disability. MCPH is genetically heterogeneous, and 16 loci are known to be associated with loss-of-function mutations predominantly affecting centrosomal-associated proteins, but the multiple roles of centrosomes in cellular function has left questions about etiology. Here, we identified three families affected by homozygous missense mutations in CIT, encoding citron rho-interacting kinase (CIT), which has established roles in cytokinesis. All mutations caused substitution of conserved amino acid residues in the kinase domain and impaired kinase activity. Neural progenitors that were differentiated from induced pluripotent stem cells (iPSCs) derived from individuals with these mutations exhibited abnormal cytokinesis with delayed mitosis, multipolar spindles, and increased apoptosis, rescued by CRISPR/Cas9 genome editing. Our results highlight the importance of cytokinesis in the pathology of primary microcephaly.	[Li, Hongda; Bielas, Stephanie L.; Farfara, Dorit; Um, Kyongmi; Rosti, Rasim O.; Scott, Eric C.; Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Rady Childrens Inst Genom Med, San Diego, CA 92093 USA; [Li, Hongda; Bielas, Stephanie L.; Farfara, Dorit; Um, Kyongmi; Rosti, Rasim O.; Scott, Eric C.; Gleeson, Joseph G.] Rockefeller Univ, Lab Pediat Brain Dis, New York, NY 10065 USA; [Bielas, Stephanie L.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; [Zaki, Maha S.; Ismail, Samira] Natl Res Ctr, Dept Clin Genet, Human Genet & Genome Res Div, Cairo 12311, Egypt; [Tu, Shu; Chi, Neil C.] Univ Calif San Diego, Dept Med, Div Cardiol, San Diego, CA 92093 USA; [Gabriel, Stacey] Broad Inst MIT & Harvard, Cambridge, MA 02141 USA; [Erson-Omay, Emine Z.; Ercan-Sencicek, A. Gulhan; Yasuno, Katsuhito; Bilguvar, Kaya; Gunel, Murat] Yale Univ, Dept Neurosurg, Yale Program Neurogenet, New Haven, CT 06510 USA; [Erson-Omay, Emine Z.; Ercan-Sencicek, A. Gulhan; Yasuno, Katsuhito; Bilguvar, Kaya; Gunel, Murat] Yale Univ, Dept Neurobiol, New Haven, CT 06510 USA; [Erson-Omay, Emine Z.; Ercan-Sencicek, A. Gulhan; Yasuno, Katsuhito; Bilguvar, Kaya; Gunel, Murat] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Caglayan, Ahmet Okay] Istanbul Bilim Univ, Sch Med, Dept Med Genet, TR-34394 Istanbul, Turkey; [Kaymakcalan, Hande; Ekici, Baris] Istanbul Bilim Univ, Dept Pediat, TR-34394 Istanbul, Turkey	Howard Hughes Medical Institute; University of California System; University of California San Diego; Rockefeller University; University of Michigan System; University of Michigan; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); University of California System; University of California San Diego; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Yale University; Yale University; Yale University; Demiroglu Bilim University; Demiroglu Bilim University	Gleeson, JG (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Rady Childrens Inst Genom Med, San Diego, CA 92093 USA.; Gleeson, JG (corresponding author), Rockefeller Univ, Lab Pediat Brain Dis, New York, NY 10065 USA.; Gunel, M (corresponding author), Yale Univ, Dept Neurosurg, Yale Program Neurogenet, New Haven, CT 06510 USA.; Gunel, M (corresponding author), Yale Univ, Dept Neurobiol, New Haven, CT 06510 USA.; Gunel, M (corresponding author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA.	murat.gunel@yale.edu; jogleeson@ucsd.edu	Li, Hongda/F-3034-2017; Kaymakcalan, Hande/AAO-4208-2021; Zaki, Maha S/B-9361-2013; Caglayan, Ahmet O/D-1066-2012; Kaymakcalan, Hande/AFP-2191-2022; Yasuno, Katsuhito/E-1960-2012	Li, Hongda/0000-0001-6754-5150; Kaymakcalan, Hande/0000-0001-7736-7634; Caglayan, Ahmet O/0000-0002-2332-322X; Yasuno, Katsuhito/0000-0002-3606-532X; Zaki, Maha/0000-0001-7840-0002; Bielas, Stephanie/0000-0003-0567-5632	NIH [R01NS041537, R01NS048453, R01NS052455, P01HD070494]; Howard Hughes Medical Institute; New York Stem Cell Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070494] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863, KL2TR001862] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006504, U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041537, R01NS052455, R01NS048453, P30NS047101] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); New York Stem Cell Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Joseph LoTurco and Ferdinando Di Cunto for communicating unpublished results and Susan Taylor for providing suggestions on the project. We thank the subjects and their families for their contributions to this study. This work was supported by the NIH (R01NS041537, R01NS048453, R01NS052455, and P01HD070494 to N.C.), the Howard Hughes Medical Institute (J.G.G.), and the Druckenmiller Fellowship from the New York Stem Cell Foundation (to H.L). We thank the Broad Institute (U54HG003067 to E. Lander) and the Yale Center for Mendelian Disorders (U54HG006504 to R. Lifton) for sequencing support.	Adachi Y, 2011, AM J NEURORADIOL, V32, P1123, DOI 10.3174/ajnr.A2440; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Camera P, 2003, NAT CELL BIOL, V5, P1071, DOI 10.1038/ncb1064; CARRERA AC, 1993, P NATL ACAD SCI USA, V90, P442, DOI 10.1073/pnas.90.2.442; Desir J, 2008, AM J MED GENET A, V146A, P1439, DOI 10.1002/ajmg.a.32312; Di Cunto F, 2000, NEURON, V28, P115, DOI 10.1016/S0896-6273(00)00090-8; Di Cunto F, 1998, J BIOL CHEM, V273, P29706, DOI 10.1074/jbc.273.45.29706; Dixon-Salazar TJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003544; Eda M, 2001, J CELL SCI, V114, P3273; Faheem M, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S1-S4; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Gai M, 2011, MOL BIOL CELL, V22, P3768, DOI 10.1091/mbc.E10-12-0952; Green RA, 2012, ANNU REV CELL DEV BI, V28, P29, DOI 10.1146/annurev-cellbio-101011-155718; Gruneberg U, 2006, J CELL BIOL, V172, P363, DOI 10.1083/jcb.200511061; Harding BN, 2016, AM J HUM GENET, V99, P511, DOI 10.1016/j.ajhg.2016.07.003; Hauge C, 2007, EMBO J, V26, P2251, DOI 10.1038/sj.emboj.7601682; Higgins J, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-85; Hu WF, 2014, NEURON, V84, P1240, DOI 10.1016/j.neuron.2014.12.017; Insolera R, 2014, NAT NEUROSCI, V17, P1528, DOI 10.1038/nn.3831; Jacobs M, 2006, J BIOL CHEM, V281, P260, DOI 10.1074/jbc.M508847200; Kaindl AM, 2010, PROG NEUROBIOL, V90, P363, DOI 10.1016/j.pneurobio.2009.11.002; Kaltschmidt JA, 2000, NAT CELL BIOL, V2, P7, DOI 10.1038/71323; Kodani A, 2015, ELIFE, V4, DOI 10.7554/eLife.07519; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Madaule P, 1995, FEBS LETT, V377, P243, DOI 10.1016/0014-5793(95)01351-2; Madaule P, 1998, NATURE, V394, P491, DOI 10.1038/28873; Marjanovic M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8676; McIntyre RE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003022; Neitzel H, 2002, AM J HUM GENET, V70, P1015, DOI 10.1086/339518; Novarino G, 2012, SCIENCE, V338, P394, DOI 10.1126/science.1224631; Novorol C, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130065; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Paramasivam M, 2007, CELL CYCLE, V6, P1605, DOI 10.4161/cc.6.13.4356; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pilaz LJ, 2016, NEURON, V89, P83, DOI 10.1016/j.neuron.2015.12.007; Sgro F, 2016, CELL DEATH DIFFER, V23, P801, DOI 10.1038/cdd.2015.142; Tong CK, 2014, P NATL ACAD SCI USA, V111, P12438, DOI 10.1073/pnas.1321425111; Watanabe S, 2013, J CELL SCI, V126, P1773, DOI 10.1242/jcs.116608; Waters AM, 2015, J MED GENET, V52, P147, DOI 10.1136/jmedgenet-2014-102691; Woods CG, 2014, CURR BIOL, V24, pR1109, DOI 10.1016/j.cub.2014.09.063	40	53	53	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 4	2016	99	2					501	510		10.1016/j.ajhg.2016.07.004	http://dx.doi.org/10.1016/j.ajhg.2016.07.004			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT6TO	27453578	Bronze, Green Published			2022-12-18	WOS:000381617200022
J	Okada, Y; Suzuki, A; Ikari, K; Terao, C; Kochi, Y; Ohmura, K; Higasa, K; Akiyama, M; Ashikawa, K; Kanai, M; Hirata, J; Suita, N; Teo, YY; Xu, HJ; Bae, SC; Takahashi, A; Momozawa, Y; Matsuda, K; Momohara, S; Taniguchi, A; Yamada, R; Mimori, T; Kubo, M; Brown, MA; Raychaudhuri, S; Matsuda, F; Yamanaka, H; Kamatani, Y; Yamamoto, K				Okada, Yukinori; Suzuki, Akari; Ikari, Katsunori; Terao, Chikashi; Kochi, Yuta; Ohmura, Koichiro; Higasa, Koichiro; Akiyama, Masato; Ashikawa, Kyota; Kanai, Masahiro; Hirata, Jun; Suita, Naomasa; Teo, Yik-Ying; Xu, Huji; Bae, Sang-Cheol; Takahashi, Atsushi; Momozawa, Yukihide; Matsuda, Koichi; Momohara, Shigeki; Taniguchi, Atsuo; Yamada, Ryo; Mimori, Tsuneyo; Kubo, Michiaki; Brown, Matthew A.; Raychaudhuri, Soumya; Matsuda, Fumihiko; Yamanaka, Hisashi; Kamatani, Yoichiro; Yamamoto, Kazuhiko			Contribution of a Non-classical HLA Gene, HLA-DOA, to the Risk of Rheumatoid Arthritis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; SHARED EPITOPE; JAPANESE PATIENTS; HLA-DRB1 ALLELES; ANTIBODY-LEVELS; ASSOCIATION; DISEASE; CLASSIFICATION; SUSCEPTIBILITY; IDENTIFICATION	Despite the progress in human leukocyte antigen (HLA) causal variant mapping, independent localization of major histocompatibility complex (MHC) risk from classical HLA genes is challenging. Here, we conducted a large-scale MHC fine-mapping analysis of rheumatoid arthritis (RA) in a Japanese population (6,244 RA cases and 23,731 controls) population by using HLA imputation, followed by a multi-ethnic validation study including east Asian and European populations (n=7,097 and 23,149, respectively). Our study identified an independent risk of a synonymous mutation at HLA-DOA, a non-classical HLA gene, on anti-citrullinated protein autoantibody (ACPA)-positive RA risk (p=1.4 x 10(-) 9), which demonstrated a cis-expression quantitative trait loci (cis-eQTL) effect on HLA-DOA expression. Trans-ethnic comparison revealed different linkage disequilibrium (LD) patterns in HLA-DOA and HLA-DRB1, explaining the observed HLA-DOA variant risk heterogeneity among ethnicities, which was most evident in the Japanese population. Although previous HLA fine-mapping studies have identified amino acid polymorphisms of the classical HLA genes as driving genetic susceptibility to disease, our study additionally identifies the dosage contribution of a non-classical HLA gene to disease etiology. Our study contributes to the understanding of HLA immunology in human diseases and suggests the value of incorporating additional ancestry in MHC fine-mapping.	[Okada, Yukinori; Kanai, Masahiro; Hirata, Jun; Suita, Naomasa] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Human Genet & Dis Div, Tokyo 1130034, Japan; [Okada, Yukinori; Akiyama, Masato; Kanai, Masahiro; Takahashi, Atsushi; Kamatani, Yoichiro] RIKEN Ctr Integrat Med Sci, Lab Stat Anal, Yokohama, Kanagawa 2300045, Japan; [Okada, Yukinori] Osaka Univ, Grad Sch Med, Dept Stat Genet, Osaka 5650871, Japan; [Suzuki, Akari] RIKEN Ctr Integrat Med Sci, Lab Autoimmune Dis, Yokohama, Kanagawa 2300045, Japan; [Ikari, Katsunori; Momohara, Shigeki; Taniguchi, Atsuo; Yamanaka, Hisashi] Tokyo Womens Med Univ, Inst Rheumatol, Tokyo 1620054, Japan; [Ikari, Katsunori; Kochi, Yuta] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol CREST, Tokyo 1620054, Japan; [Terao, Chikashi; Raychaudhuri, Soumya] Harvard Univ, Sch Med, Div Rheumatol Immunol & Allergy Brigham & Women, Boston, MA 02115 USA; [Terao, Chikashi; Raychaudhuri, Soumya] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Terao, Chikashi] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Terao, Chikashi] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto 6068507, Japan; [Terao, Chikashi] Kyoto Univ, Ctr Promot Interdisciplinary Educ & Res, Kyoto 6068501, Japan; [Ohmura, Koichiro; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto 6068507, Japan; [Ashikawa, Kyota; Momozawa, Yukihide; Kubo, Michiaki] RIKEN Ctr Integrat Med Sci, Lab Genotyping Dev, Yokohama, Kanagawa 2300045, Japan; [Hirata, Jun] Pharmaceut Discovery Res Labs, Hino, Tokyo 1918512, Japan; [Suita, Naomasa] Tsukuba Res Inst, Adv Med Res Labs, Tsukuba, Ibaraki 3004247, Japan; [Teo, Yik-Ying] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117549, Singapore; [Xu, Huji] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Rheumatol & Immunol, Shanghai 200433, Peoples R China; [Bae, Sang-Cheol] Hanyang Univ Hosp Rheumat Dis, Dept Rheumatol, Seoul 04763, South Korea; [Matsuda, Koichi] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo 1088639, Japan; [Brown, Matthew A.] Univ Queensland, Diamantina Inst, Translat Res Inst, Princess Alexandra Hosp Brisbane, Brisbane, Qld 4072, Australia; [Raychaudhuri, Soumya] Partners Ctr Personalized Genet Med, Boston, MA 02115 USA; [Raychaudhuri, Soumya] Univ Manchester, Fac Med & Human Sci, Manchester M13 9PL, Lancs, England; [Yamamoto, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo 1130033, Japan	Tokyo Medical & Dental University (TMDU); RIKEN; Osaka University; RIKEN; Tokyo Women's Medical University; Japan Science & Technology Agency (JST); Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Kyoto University; Kyoto University; Kyoto University; RIKEN; Novartis; National University of Singapore; Naval Medical University; Hanyang University; Hanyang University Hospital; University of Tokyo; University of Queensland; University of Manchester; University of Tokyo	Okada, Y (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Human Genet & Dis Div, Tokyo 1130034, Japan.; Okada, Y (corresponding author), RIKEN Ctr Integrat Med Sci, Lab Stat Anal, Yokohama, Kanagawa 2300045, Japan.; Okada, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Stat Genet, Osaka 5650871, Japan.	yokada@sg.med.osaka-u.ac.jp	Xu, Huji/AAB-2902-2021; Kanai, Masahiro/AAD-6726-2021; Yamamoto, Kazuhiko/N-5096-2015; Suzuki, Akari/N-5389-2015; Akiyama, Masato/AHC-2589-2022; Brown, Matthew A/E-5749-2010; Kochi, Yuta/P-4487-2018; Matsuda, Koichi/D-4597-2011	Xu, Huji/0000-0002-8588-118X; Kanai, Masahiro/0000-0001-5165-4408; Brown, Matthew A/0000-0003-0538-8211; Matsuda, Koichi/0000-0001-7292-2686; Yamada, Ryo/0000-0002-1587-630X; Bae, Sang-Cheol/0000-0003-4658-1093; Raychaudhuri, Soumya/0000-0002-1901-8265	Japan Society for the Promotion of Science KAKENHI [15H05670, 15H05907, 15H05911, 15K14429, 16H03269, 16K15738]; Japan Science and Technology Agency; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takeda Science Foundation; Gout Research Foundation; Tokyo Biochemical Research Foundation; Japan Rheumatism Foundation; Ministry for Health and Welfare, Republic of Korea [HI13C2124]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Japan Agency for Medical Research and Development (AMED); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [UH2AR067677, R01AR063759] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takeda Science Foundation(Takeda Science Foundation (TSF)); Gout Research Foundation; Tokyo Biochemical Research Foundation; Japan Rheumatism Foundation(Japan Rheumatism Foundation); Ministry for Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Y.O. was supported by the Japan Society for the Promotion of Science KAKENHI grant numbers 15H05670, 15H05907, 15H05911, 15K14429, 16H03269, and 16K15738, the Japan Science and Technology Agency, Mochida Memorial Foundation for Medical and Pharmaceutical Research, Takeda Science Foundation, Gout Research Foundation, the Tokyo Biochemical Research Foundation, and the Japan Rheumatism Foundation. S.-C.B. was supported by the Korea Healthcare Technology R&D Project, Ministry for Health and Welfare, Republic of Korea (HI13C2124). This research was also partially supported by the Tailor-Made Medical Treatment program (the BioBank Japan Project) of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) and the Japan Agency for Medical Research and Development (AMED). J.H. is an employee of Teijin Pharma. N.S. is an employee of Ono Pharmaceutical.	Anderson RP, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-188; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Cortes A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8146; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Gu YP, 2013, J IMMUNOL, V190, P126, DOI 10.4049/jimmunol.1200993; Guce AI, 2013, NAT STRUCT MOL BIOL, V20, P90, DOI 10.1038/nsmb.2460; Han B, 2014, AM J HUM GENET, V94, P522, DOI 10.1016/j.ajhg.2014.02.013; Hosomichi K, 2015, J HUM GENET, V60, P665, DOI 10.1038/jhg.2015.102; Inaguma Y, 2016, BRIT J HAEMATOL, V172, P131, DOI 10.1111/bjh.13464; Jia XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064683; Jiang L, 2014, ARTHRITIS RHEUMATOL, V66, P1121, DOI 10.1002/art.38353; Kochi Y, 2004, ARTHRITIS RHEUM, V50, P63, DOI 10.1002/art.11366; Lenz TL, 2015, NAT GENET, V47, P1085, DOI 10.1038/ng.3379; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; Mitsunaga S, 2013, J HUM GENET, V58, P210, DOI 10.1038/jhg.2013.2; Moon SM, 2005, TISSUE ANTIGENS, V66, P242, DOI 10.1111/j.1399-0039.2005.00446.x; Narahara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100924; Neogi T, 2010, ARTHRITIS RHEUM-US, V62, P2582, DOI 10.1002/art.27580; Okada Y, 2015, NAT GENET, V47, P798, DOI 10.1038/ng.3310; Okada Y, 2014, HUM MOL GENET, V23, P6916, DOI 10.1093/hmg/ddu387; Okada Y, 2014, AM J HUM GENET, V95, P162, DOI 10.1016/j.ajhg.2014.07.002; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Okada Y, 2010, ANN RHEUM DIS, V69, P1569, DOI 10.1136/ard.2009.118018; Okada Y, 2009, ARTHRITIS RHEUM-US, V60, P3582, DOI 10.1002/art.24939; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Pillai NE, 2014, HUM MOL GENET, V23, P4443, DOI 10.1093/hmg/ddu149; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Shimane K, 2013, RHEUMATOLOGY, V52, P1172, DOI 10.1093/rheumatology/kes427; Terao C., 2016, MOD RHEUMATOL, V4, P1; Terao C, 2015, ARTHRITIS RHEUMATOL, V67, P2038, DOI 10.1002/art.39133; Terao C, 2012, ANN RHEUM DIS, V71, P1095, DOI 10.1136/annrheumdis-2011-200907; Terao C, 2011, ANN RHEUM DIS, V70, P2134, DOI 10.1136/annrheumdis-2011-200353; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Yamamoto K, 2015, P JPN ACAD B-PHYS, V91, P410, DOI 10.2183/pjab.91.410; Yi W, 2010, J CLIN INVEST, V120, P1324, DOI 10.1172/JCI40220	37	53	53	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 4	2016	99	2					366	374		10.1016/j.ajhg.2016.06.019	http://dx.doi.org/10.1016/j.ajhg.2016.06.019			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT6TO	27486778	Bronze, Green Published			2022-12-18	WOS:000381617200008
J	Wallmeier, J; Shiratori, H; Dougherty, GW; Edelbusch, C; Hjeij, R; Loges, NT; Menchen, T; Olbrich, H; Pennekamp, P; Raidt, J; Werner, C; Minegishi, K; Shinohara, K; Asai, Y; Takaoka, K; Lee, C; Griese, M; Memari, Y; Durbin, R; Kolb-Kokocinski, A; Sauer, S; Wallingford, JB; Hamada, H; Omran, H				Wallmeier, Julia; Shiratori, Hidetaka; Dougherty, Gerard W.; Edelbusch, Christine; Hjeij, Rim; Loges, Niki T.; Menchen, Tabea; Olbrich, Heike; Pennekamp, Petra; Raidt, Johanna; Werner, Claudius; Minegishi, Katsura; Shinohara, Kyosuke; Asai, Yasuko; Takaoka, Katsuyoshi; Lee, Chanjae; Griese, Matthias; Memari, Yasin; Durbin, Richard; Kolb-Kokocinski, Anja; Sauer, Sascha; Wallingford, John B.; Hamada, Hiroshi; Omran, Heymut			TTC25 Deficiency Results in Defects of the Outer Dynein Arm Docking Machinery and Primary Ciliary Dyskinesia with Left-Right Body Asymmetry Randomization	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEIN; MUTATIONS; CILIOGENESIS; COMPLEX; CCDC151	Multiprotein complexes referred to as outer dynein arms (ODAs) develop the main mechanical force to generate the ciliary and flagellar beat. ODA defects are the most common cause of primary ciliary dyskinesia (PCD), a congenital disorder of ciliary beating, characterized by recurrent infections of the upper and lower airways, as well as by progressive lung failure and randomization of left-right body asymmetry. Using a whole-exome sequencing approach, we identified recessive loss-of-function mutations within TTC25 in three individuals from two unrelated families affected by PCD. Mice generated by CRISPR/Cas9 technology and carrying a deletion of exons 2 and 3 in Ttc25 presented with laterality defects. Consistently, we observed immotile nodal cilia and missing leftward flow via particle image velocimetry. Furthermore, transmission electron microscopy (TEM) analysis in TTC25-deficient mice revealed an absence of ODAs. Consistent with our findings in mice, we were able to show loss of the ciliary ODAs in humans via TEM and immunofluorescence (IF) analyses. Additionally, IF analyses revealed an absence of the ODA docking complex (ODA-DC), along with its known components CCDC114, CCDC151, and ARMC4. Co-immunoprecipitation revealed interaction between the ODA-DC component CCDC114 and TTC25. Thus, here we report TTC25 as a new member of the ODA-DC machinery in humans and mice.	[Wallmeier, Julia; Dougherty, Gerard W.; Edelbusch, Christine; Hjeij, Rim; Loges, Niki T.; Menchen, Tabea; Olbrich, Heike; Pennekamp, Petra; Raidt, Johanna; Werner, Claudius; Omran, Heymut] Univ Hosp Muenster, Dept Pediat, D-48149 Munster, Germany; [Shiratori, Hidetaka; Minegishi, Katsura; Shinohara, Kyosuke; Asai, Yasuko; Takaoka, Katsuyoshi; Hamada, Hiroshi] Osaka Univ, Grad Sch Frontier Biosci, Dev Genet Grp, Suita, Osaka 5650871, Japan; [Lee, Chanjae; Wallingford, John B.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Griese, Matthias] Hauner Childrens Hosp, Dept Pediat Pulmonol, D-80337 Munich, Germany; [Griese, Matthias] Univ Munich, German Ctr Lung Res DZL, D-80337 Munich, Germany; [Memari, Yasin; Durbin, Richard; Kolb-Kokocinski, Anja; Sauer, Sascha] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Sauer, Sascha] Max Delbruck Ctr Mol Med, Berlin Inst Med Syst Biol, Robert Rossle Str 10, D-13125 Berlin, Germany; [Sauer, Sascha] Max Delbruck Ctr Mol Med, Berlin Inst Hlth Genom Platforms, Lab Funct Genom Nutrigen & Syst Biol, Robert Rossle Str 10, D-13125 Berlin, Germany; [Sauer, Sascha] Max Planck Inst Mol Genet, Otto Warburg Lab, Ihnestr 63-73, D-14195 Berlin, Germany	University of Munster; Osaka University; University of Texas System; University of Texas Austin; University of Munich; University of Munich; Wellcome Trust Sanger Institute; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Berlin Institute of Health; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Max Planck Society	Omran, H (corresponding author), Univ Hosp Muenster, Dept Pediat, D-48149 Munster, Germany.	heymut.omran@ukmuenster.de	Durbin, Richard/AAE-7178-2019; Noethe-Menchen, Tabea/AAW-1667-2021; Shinohara, Kyosuke/I-1470-2016; Hamada, Hiroshi/N-6374-2015; Shinohara, Kyosuke/AAU-2471-2020	Durbin, Richard/0000-0002-9130-1006; Noethe-Menchen, Tabea/0000-0002-0571-6767; Hamada, Hiroshi/0000-0002-7196-5948; Shinohara, Kyosuke/0000-0002-6350-1684; Wallmeier, Julia/0000-0002-3958-9065; Memari, Yasin/0000-0002-1747-542X; Raidt, Johanna/0000-0002-1571-2647; Omran, Heymut/0000-0003-0282-6765; Hjeij, Rim/0000-0003-1464-7289	Deutsche Forschungsgemeinschaft [Om6/4, Om6/7, Om6/8, OL450/1]; European Commission [262055]; Interdisziplinaeres Zentrum fur Klinische Forschung Muenster [Om2/009/12, Om2/015/16]; BESTCILIA [305404]; Schroeder Stiftung; Kindness for Kids; Innovative Medizinische Forschung [WA 1 2 14 18, LO 1 2 15 17]; CREST, Japan Science and Technology Agency [13417760]; Japan Society for the Promotion of Science [24113004]; US National Heart, Lung, and Blood Institute [HL117164]; Wellcome Trust [WT098051]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117164] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); Interdisziplinaeres Zentrum fur Klinische Forschung Muenster; BESTCILIA; Schroeder Stiftung; Kindness for Kids; Innovative Medizinische Forschung; CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); US National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the affected individuals and their families for participating in this study. We thank C. Westermann from the Pathology Department of the University of Muenster for electron microscopy assistance. We thank M. Herting, S. Helms, B. Lechtape, L. Overkamp, A. Robbers, and F.-J. Seesing for their technical assistance. Furthermore, we thank Y. Ikawa for maintaining the mutant mouse and Y. Uegaki and H. Nishimura for the help in generating and maintaining the mutant mouse. We also thank K. Okamoto (University of Tokyo) for providing the PIV analysis software. This work was funded by the Deutsche Forschungsgemeinschaft (Om6/4, Om6/7, and Om6/8 to H. Omran and OL450/1 to H. Olbrich). Furthermore, this study was supported by the European Commission (FP7/2007-2013, under grant agreement number 262055 [ESGI], as a Transnational Access project of the European Sequencing and Genotyping Infrastructure), the Interdisziplinaeres Zentrum fur Klinische Forschung Muenster (Om2/009/12 and Om2/015/16 to H. Omran), BESTCILIA (under grant agreement number 305404), the Schroeder Stiftung (H. Omran), Kindness for Kids (H. Omran), and the Innovative Medizinische Forschung (WA 1 2 14 18 to J.W. and LO 1 2 15 17 to N.T.L.), as well as by CREST, Japan Science and Technology Agency (project no. 13417760), and the Japan Society for the Promotion of Science (project no. 24113004) to H.H. C.L. and J.B.W. were supported by funding from the US National Heart, Lung, and Blood Institute (HL117164). R.D. and A.K-K. were supported by Wellcome Trust grant WT098051.	AFZELIUS B A, 1976, Science (Washington D C), V193, P317; Chung MI, 2012, DEV BIOL, V363, P155, DOI 10.1016/j.ydbio.2011.12.029; Collins SA, 2014, EUR RESPIR J, V44, P1589, DOI 10.1183/09031936.00088614; Fliegauf M, 2005, AM J RESP CRIT CARE, V171, P1343, DOI 10.1164/rccm.200411-1583OC; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Fowkes ME, 1998, MOL BIOL CELL, V9, P2337, DOI 10.1091/mbc.9.9.2337; Frommer A, 2015, AM J RESP CELL MOL, V53, P563, DOI 10.1165/rcmb.2014-0483OC; Hayes JM, 2007, DEV BIOL, V312, P115, DOI 10.1016/j.ydbio.2007.09.031; Hjeij R, 2014, AM J HUM GENET, V95, P257, DOI 10.1016/j.ajhg.2014.08.005; Hou YQ, 2007, J CELL BIOL, V176, P653, DOI 10.1083/jcb.200608041; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Ibanez-Tallon I, 2002, HUM MOL GENET, V11, P715, DOI 10.1093/hmg/11.6.715; Jerber J, 2014, HUM MOL GENET, V23, P563, DOI 10.1093/hmg/ddt445; Loges NT, 2009, AM J HUM GENET, V85, P883, DOI 10.1016/j.ajhg.2009.10.018; Ogawa K, 2006, BIOCHEM BIOPH RES CO, V343, P385, DOI 10.1016/j.bbrc.2006.02.157; Olbrich H, 2015, AM J HUM GENET, V97, P546, DOI 10.1016/j.ajhg.2015.08.012; Olbrich H, 2012, AM J HUM GENET, V91, P672, DOI 10.1016/j.ajhg.2012.08.016; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Pennekamp Petra, 2015, Cilia, V4, P1, DOI 10.1186/s13630-014-0010-9; Raidt J, 2014, EUR RESPIR J, V44, P1579, DOI 10.1183/09031936.00052014; Rashid S, 2006, MOL REPROD DEV, V73, P784, DOI 10.1002/mrd.20475; TAKADA S, 1994, J CELL BIOL, V126, P737, DOI 10.1083/jcb.126.3.737; Tarkar A, 2013, NAT GENET, V45, P995, DOI 10.1038/ng.2707; Xu YA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124378; Zeytuni N, 2012, STRUCTURE, V20, P397, DOI 10.1016/j.str.2012.01.006	25	53	57	3	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 4	2016	99	2					460	469		10.1016/j.ajhg.2016.06.014	http://dx.doi.org/10.1016/j.ajhg.2016.06.014			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT6TO	27486780	Bronze, Green Published			2022-12-18	WOS:000381617200018
J	Bennett, JT; Tan, TY; Alcantara, D; Tetrault, M; Timms, AE; Jensen, D; Collins, S; Nowaczyk, MJM; Lindhurst, MJ; Christensen, KM; Braddock, SR; Brandling-Bennett, H; Hennekam, RCM; Chung, B; Lehman, A; Su, J; Ng, S; Amor, DJ; Majewski, J; Biesecker, LG; Boycott, KM; Dobyns, WB; O'Driscoll, M; Moog, U; McDonell, LM				Bennett, James T.; Tan, Tiong Yang; Alcantara, Diana; Tetrault, Martine; Timms, Andrew E.; Jensen, Dana; Collins, Sarah; Nowaczyk, Malgorzata J. M.; Lindhurst, Marjorie J.; Christensen, Katherine M.; Braddock, Stephen R.; Brandling-Bennett, Heather; Hennekam, Raoul C. M.; Chung, Brian; Lehman, Anna; Su, John; Ng, SuYuen; Amor, David J.; Majewski, Jacek; Biesecker, Les G.; Boycott, Kym M.; Dobyns, William B.; O'Driscoll, Mark; Moog, Ute; McDonell, Laura M.		Univ Washington Ctr Mendelian Geno; Care4Rare Canada Consortium	Mosaic Activating Mutations in FGFR1 Cause Encephalocraniocutaneous Lipomatosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GROWTH-FACTOR RECEPTOR-3; OCULOECTODERMAL SYNDROME; GENE; SEQUENCE; CANCER; ASTROCYTOMA; REVEALS; PATIENT	Encephalocraniocutaneous lipomatosis (ECCL) is a sporadic condition characterized by ocular, cutaneous, and central nervous system anomalies. Key clinical features include a well-demarcated hairless fatty nevus on the scalp, benign ocular tumors, and central nervous system lipomas. Seizures, spasticity, and intellectual disability can be present, although affected individuals without seizures and with normal intellect have also been reported. Given the patchy and asymmetric nature of the malformations, ECCL has been hypothesized to be due to a post-zygotic, mosaic mutation. Despite phenotypic overlap with several other disorders associated with mutations in the RAS-MAPK and PI3K-AKT pathways, the molecular etiology of ECCL remains unknown. Using exome sequencing of DNA from multiple affected tissues from five unrelated individuals with ECCL, we identified two mosaic mutations, c.1638C>A (p.Asn546Lys) and c.1966A>G (plys656G1u) within the tyrosine kinase domain of FGFR1, in two affected individuals each. These two residues are the most commonly mutated residues in FGFR1 in human cancers and are associated primarily with CNS tumors. Targeted resequencing of FGFR1 in multiple tissues from an independent cohort of individuals with ECCL identified one additional individual with a c.1638C>A (p.Asn546Lys) mutation in FGFR1. Functional studies of ECCL fibroblast cell lines show increased levels of phosphorylated FGFRs and phosphorylated FRS2, a direct substrate of FGFR1, as well as constitutive activation of RAS-MAPK signaling. In addition to identifying the molecular etiology of ECCL, our results support the emerging overlap between mosaic developmental disorders and tumorigenesis.	[Bennett, James T.; Dobyns, William B.] Univ Washington, Dept Pediat Genet, Seattle, WA 98195 USA; [Bennett, James T.; Jensen, Dana; Collins, Sarah; Dobyns, William B.] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA 98101 USA; [Tan, Tiong Yang; Amor, David J.] Univ Melbourne, Dept Paediat, Murdoch Childrens Res Inst, Victorian Clin Genet Serv, Melbourne, Vic 3052, Australia; [Alcantara, Diana; O'Driscoll, Mark] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; [Tetrault, Martine; Majewski, Jacek] McGill Univ, Dept Human Genet, Montreal, PQ H3A 0G4, Canada; [Timms, Andrew E.] Seattle Childrens Res Inst, Ctr Dev Biol & Regenerat Med, Seattle, WA 98101 USA; [Nowaczyk, Malgorzata J. M.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8S 4J9, Canada; [Lindhurst, Marjorie J.; Biesecker, Les G.] NHGRI, NIH, Bethesda, MD 20892 USA; [Christensen, Katherine M.; Braddock, Stephen R.] Cardinal Glennon Childrens Med Ctr, Dept Pediat, St Louis, MO 63104 USA; [Brandling-Bennett, Heather] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Brandling-Bennett, Heather] Univ Washington, Dept Med Dermatol, Seattle, WA 98195 USA; [Hennekam, Raoul C. M.] Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands; [Chung, Brian] Univ Hong Kong, Queen Mary Hosp, Dept Paediat & Adolescent Med, 21 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China; [Lehman, Anna] Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada; [Su, John; Ng, SuYuen] Monash Univ, Eastern Hlth, Dept Dermatol, Box Hill, Vic 3128, Australia; [Boycott, Kym M.; McDonell, Laura M.] Univ Ottawa, Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 5B2, Canada; [Dobyns, William B.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Moog, Ute] Heidelberg Univ, Inst Human Genet, D-69120 Heidelberg, Germany	University of Washington; University of Washington Seattle; Seattle Children's Hospital; Murdoch Children's Research Institute; University of Melbourne; University of Sussex; McGill University; Seattle Children's Hospital; McMaster University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Amsterdam; Academic Medical Center Amsterdam; University of Hong Kong; University of British Columbia; Monash University; University of Ottawa; Children's Hospital of Eastern Ontario; University of Washington; University of Washington Seattle; Ruprecht Karls University Heidelberg	O'Driscoll, M (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England.; Moog, U (corresponding author), Heidelberg Univ, Inst Human Genet, D-69120 Heidelberg, Germany.	m.o-driscoll@sussex.ac.uk; ute.moog@med.uni-heidelberg.de	Braddock, Stephen/AAL-1667-2021; Lehman, Anna/R-6706-2017; Dobyns, William/AAI-2768-2020; Dobyns, William Brian/ABC-6525-2021; Su, John C/E-6040-2017; Biesecker, Leslie/AAG-2526-2021; Su, John/AAH-9042-2019; Lindhurst, Marjorie/AHD-3412-2022; Amor, David J/A-6478-2018; Tan, Tiong Yang/AAV-6563-2020	Lehman, Anna/0000-0003-0636-123X; Dobyns, William/0000-0002-7681-2844; Su, John C/0000-0002-4021-5423; Su, John/0000-0002-4021-5423; Amor, David J/0000-0001-7191-8511; Tan, Tiong Yang/0000-0001-8455-7778; Alcantara, Diana/0000-0003-3185-1548; Bennett, James/0000-0003-2843-5594; O'Driscoll, Mark/0000-0003-2765-316X; Blue, Elizabeth/0000-0002-0633-0305	Care4Rare Canada Consortium - Genome Canada; Canadian Institutes of Health Research; Ontario Genomics Institute; Ontario Research Fund; Genome Quebec; Children's Hospital of Eastern Ontario Foundation; National Institute of Neurological Disorders and Stroke (NINDS) [1R01NS092772]; National Human Genome Research Institute of the National Institutes of Health; National Human Genome Research Institute; National Heart, Lung and Blood Institute [U54HG006493]; Reseau de Medecine Genique Appliquee; CIHR; Consortium National de Formation en Sante; Australian National Health and Medical Research Council Postdoctoral Overseas Training Scholarship [607431]; Cancer Research UK; Cancer Research UK [15394] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083091] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130996] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200388, U54HG006493, ZIAHG200328, UM1HG006493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS092772] Funding Source: NIH RePORTER	Care4Rare Canada Consortium - Genome Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Genomics Institute; Ontario Research Fund; Genome Quebec; Children's Hospital of Eastern Ontario Foundation; National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Human Genome Research Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Reseau de Medecine Genique Appliquee; CIHR(Canadian Institutes of Health Research (CIHR)); Consortium National de Formation en Sante; Australian National Health and Medical Research Council Postdoctoral Overseas Training Scholarship(National Health and Medical Research Council (NHMRC) of Australia); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the individuals and families who participated in this study. Research reported in this publication was supported by the Care4Rare Canada Consortium (Enhanced Care for Rare Genetic Diseases in Canada) funded by Genome Canada, the Canadian Institutes of Health Research, the Ontario Genomics Institute, Ontario Research Fund, Genome Quebec, and Children's Hospital of Eastern Ontario Foundation; and by the National Institute of Neurological Disorders and Stroke (NINDS) under award numbers 1R01NS092772 (W.B.D.) and the National Human Genome Research Institute of the National Institutes of Health. Some sequencing in this study was provided by the University of Washington Center for Mendelian Genomics (UW-CMG) and was funded by the National Human Genome Research Institute and the National Heart, Lung and Blood Institute grant U54HG006493 to Drs. Debbie Nickerson, Jay Shendure, and Michael Bamshad. M.J.L. and L.G.B. are supported by the Intramural Research Program of the National Human Genome Research Institute. We also acknowledge the contributions of the high-throughput sequencing platform of the McGill University and Genome Quebec Innovation Centre, Montreal, Canada. M.T. received a post-doctoral fellowship from the Reseau de Medecine Genique Appliquee. L.M.M. is supported by a scholarship from the (CIHR) and Consortium National de Formation en Sante. T.Y.T. was supported by an Australian National Health and Medical Research Council Postdoctoral Overseas Training Scholarship (#607431). D.A. and M.O'D. are supported by Cancer Research UK. None of the authors have any conflicts of interest to declare.	Ardinger HH, 2007, AM J MED GENET A, V143A, P2959, DOI 10.1002/ajmg.a.31969; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Bellacosa A, 2013, AM J MED GENET A, V161, P2788, DOI 10.1002/ajmg.a.36267; Bellus GA, 1996, NAT GENET, V14, P174, DOI 10.1038/ng1096-174; Berk DR, 2007, ARCH DERMATOL, V143, P1153, DOI 10.1001/archderm.143.9.1153; Bieser S, 2015, AM J MED GENET A, V167, P878, DOI 10.1002/ajmg.a.37017; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Brassesco MS, 2010, J NEURO-ONCOL, V96, P437, DOI 10.1007/s11060-009-9978-1; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dode C, 2003, NAT GENET, V33, P463, DOI 10.1038/ng1122; Dombrowski C, 2013, STEM CELLS, V31, P2724, DOI 10.1002/stem.1514; Dorey K, 2010, DEVELOPMENT, V137, P3731, DOI 10.1242/dev.037689; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Gotoh N, 2008, CANCER SCI, V99, P1319, DOI 10.1111/j.1349-7006.2008.00840.x; Hafner C, 2007, J INVEST DERMATOL, V127, P1572, DOI 10.1038/sj.jid.5700772; HALL JG, 1988, AM J HUM GENET, V43, P355; Hamm H, 1999, AM J MED GENET, V85, P342, DOI 10.1002/(SICI)1096-8628(19990806)85:4<342::AID-AJMG6>3.0.CO;2-8; HAPPLE R, 1986, HUM GENET, V72, P280, DOI 10.1007/BF00291899; HAPPLE R, 1993, ARCH DERMATOL, V129, P1460, DOI 10.1001/archderm.129.11.1460; Hart KC, 2000, ONCOGENE, V19, P3309, DOI 10.1038/sj.onc.1203650; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Hiatt JB, 2013, GENOME RES, V23, P843, DOI 10.1101/gr.147686.112; Hunter AGW, 2006, AM J MED GENET A, V140A, P709, DOI 10.1002/ajmg.a.31149; JABS EW, 1994, NAT GENET, V8, P275, DOI 10.1038/ng1194-275; Jones DTW, 2013, NAT GENET, V45, P927, DOI 10.1038/ng.2682; Kan S, 2002, AM J HUM GENET, V70, P472, DOI 10.1086/338758; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kocak O., 2015, CHILD NERV SYST, P1; Kupsik M, 2013, PEDIATR DERMATOL, V30, P491, DOI 10.1111/j.1525-1470.2012.01837.x; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lew ED, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000021; McDonell LM, 2015, HUM MOL GENET, V24, pR60, DOI 10.1093/hmg/ddv254; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Moog U, 2009, J MED GENET, V46, P721, DOI 10.1136/jmg.2009.066068; Moog U, 2007, AM J MED GENET A, V143A, P2963, DOI 10.1002/ajmg.a.32074; Moog U, 2007, AM J MED GENET A, V143A, P2973, DOI 10.1002/ajmg.a.31957; Muenke M, 1997, AM J HUM GENET, V60, P555; MUENKE M, 1994, NAT GENET, V8, P269, DOI 10.1038/ng1194-269; Nowaczyk MJM, 2000, AM J MED GENET, V91, P261, DOI 10.1002/(SICI)1096-8628(20000410)91:4<261::AID-AJMG4>3.3.CO;2-J; Peacock JD, 2015, AM J MED GENET A, V167, P1429, DOI 10.1002/ajmg.a.37048; Phi JH, 2010, NEUROSURGERY, V67, P1156, DOI 10.1227/NEU.0b013e3181edb24c; PRINOS P, 1995, HUM MOL GENET, V4, P2097, DOI 10.1093/hmg/4.11.2097; Rand V, 2005, P NATL ACAD SCI USA, V102, P14344, DOI 10.1073/pnas.0507200102; REARDON W, 1994, NAT GENET, V8, P98, DOI 10.1038/ng0994-98; Rohmann E, 2006, NAT GENET, V38, P414, DOI 10.1038/ng1757; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; Simonis N, 2013, J MED GENET, V50, P585, DOI 10.1136/jmedgenet-2013-101603; Sohl CD, 2015, ACS CHEM BIOL, V10, P1319, DOI 10.1021/acschembio.5b00014; Soria JC, 2014, ANN ONCOL, V25, P2244, DOI 10.1093/annonc/mdu390; TAVORMINA PL, 1995, NAT GENET, V9, P321, DOI 10.1038/ng0395-321; Valera ET, 2012, CHILD NERV SYST, V28, P19, DOI 10.1007/s00381-011-1601-z; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Widberg CH, 2009, AM J PHYSIOL-ENDOC M, V296, pE121, DOI 10.1152/ajpendo.90602.2008; Wilcox WR, 1998, AM J MED GENET, V78, P274, DOI 10.1002/(SICI)1096-8628(19980707)78:3<274::AID-AJMG14>3.0.CO;2-C; Wilkie AOM, 2006, AM J MED GENET A, V140A, P2631, DOI 10.1002/ajmg.a.31366; Wilkie AOM, 2005, CYTOKINE GROWTH F R, V16, P187, DOI 10.1016/j.cytogfr.2005.03.001; WILKIE AOM, 1995, NAT GENET, V9, P165, DOI 10.1038/ng0295-165	60	53	56	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 3	2016	98	3					579	587		10.1016/j.ajhg.2016.02.006	http://dx.doi.org/10.1016/j.ajhg.2016.02.006			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DG9DN	26942290	Bronze, Green Published			2022-12-18	WOS:000372383100020
J	Lalani, SR; Liu, PF; Rosenfeld, JA; Watkin, LB; Chiang, T; Leduc, MS; Zhu, WM; Ding, Y; Pan, SJ; Vetrini, F; Miyake, CY; Shinawi, M; Gambin, T; Eldomery, MK; Akdemir, ZHC; Emrick, L; Wilnai, Y; Schelley, S; Koenig, MK; Memon, N; Farach, LS; Coe, BP; Azamian, M; Hernandez, P; Zapata, G; Jhangiani, SN; Muzny, DM; Lotze, T; Clark, G; Wilfong, A; Northrup, H; Adesina, A; Bacino, CA; Scaglia, F; Bonnen, PE; Crosson, J; Duis, J; Maegawa, GHB; Coman, D; Inwood, A; McGill, J; Boerwinkle, E; Graham, B; Beaudet, A; Eng, CM; Hanchard, NA; Xia, F; Orange, JS; Gibbs, RA; Lupski, JR; Yang, YP				Lalani, Seema R.; Liu, Pengfei; Rosenfeld, Jill A.; Watkin, Levi B.; Chiang, Theodore; Leduc, Magalie S.; Zhu, Wenmiao; Ding, Yan; Pan, Shujuan; Vetrini, Francesco; Miyake, Christina Y.; Shinawi, Marwan; Gambin, Tomasz; Eldomery, Mohammad K.; Akdemir, Zeynep Hande Coban; Emrick, Lisa; Wilnai, Yael; Schelley, Susan; Koenig, Mary Kay; Memon, Nada; Farach, Laura S.; Coe, Bradley P.; Azamian, Mahshid; Hernandez, Patricia; Zapata, Gladys; Jhangiani, Shalini N.; Muzny, Donna M.; Lotze, Timothy; Clark, Gary; Wilfong, Angus; Northrup, Hope; Adesina, Adekunle; Bacino, Carlos A.; Scaglia, Fernando; Bonnen, Penelope E.; Crosson, Jane; Duis, Jessica; Maegawa, Gustavo H. B.; Coman, David; Inwood, Anita; McGill, Jim; Boerwinkle, Eric; Graham, Brett; Beaudet, Art; Eng, Christine M.; Hanchard, Neil A.; Xia, Fan; Orange, Jordan S.; Gibbs, Richard A.; Lupski, James R.; Yang, Yaping			Recurrent Muscle Weakness with Rhabdomyolysis, Metabolic Crises, and Cardiac Arrhythmia Due to Bi-allelic TANGO2 Mutations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COPY-NUMBER VARIATION; DEHYDROGENASE-DEFICIENCY; DEVELOPMENTAL DELAY; GOLGI-APPARATUS; MYOGLOBINURIA; GENOMICS; DISEASE; DISORDERS	The underlying genetic etiology of rhabdomyolysis remains elusive in a significant fraction of individuals presenting with recurrent metabolic crises and muscle weakness. Using exome sequencing, we identified bi-allelic mutations in TANGO2 encoding transport and Golgi organization 2 homolog (Drosophila) in 12 subjects with episodic rhabdomyolysis, hypoglycemia, hyperammonemia, and susceptibility to life-threatening cardiac tachyarrhythmias. A recurrent homozygous c. 460G> A (p. Gly154Arg) mutation was found in four unrelated individuals of Hispanic/Latino origin, and a homozygous -34 kb deletion affecting exons 3-9 was observed in two families of European ancestry. One individual of mixed Hispanic/European descent was found to be compound heterozygous for c. 460G> A (p. Gly154Arg) and the deletion of exons 3-9. Additionally, a homozygous exons 4-6 deletion was identified in a consanguineous Middle Eastern Arab family. No homozygotes have been reported for these changes in control databases. Fibroblasts derived from a subject with the recurrent c. 460G> A (p. Gly154Arg) mutation showed evidence of increased endoplasmic reticulum stress and a reduction in Golgi volume density in comparison to control. Our results show that the c. 460G> A (p. Gly154Arg) mutation and the exons 3-9 heterozygous deletion in TANGO2 are recurrent pathogenic alleles present in the Latino/Hispanic and European populations, respectively, causing considerable morbidity in the homozygotes in these populations.	[Lalani, Seema R.; Liu, Pengfei; Rosenfeld, Jill A.; Leduc, Magalie S.; Pan, Shujuan; Gambin, Tomasz; Eldomery, Mohammad K.; Akdemir, Zeynep Hande Coban; Azamian, Mahshid; Hernandez, Patricia; Zapata, Gladys; Jhangiani, Shalini N.; Muzny, Donna M.; Bacino, Carlos A.; Scaglia, Fernando; Bonnen, Penelope E.; Graham, Brett; Beaudet, Art; Eng, Christine M.; Hanchard, Neil A.; Xia, Fan; Gibbs, Richard A.; Lupski, James R.; Yang, Yaping] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Liu, Pengfei; Leduc, Magalie S.; Zhu, Wenmiao; Vetrini, Francesco; Eng, Christine M.; Xia, Fan; Yang, Yaping] Baylor Miraca Genet Labs, Houston, TX 77030 USA; [Watkin, Levi B.; Lotze, Timothy; Clark, Gary; Wilfong, Angus; Hanchard, Neil A.; Orange, Jordan S.; Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Watkin, Levi B.; Orange, Jordan S.] Texas Childrens Hosp, Ctr Human Immunobiol, Houston, TX 77030 USA; [Chiang, Theodore; Ding, Yan; Jhangiani, Shalini N.; Muzny, Donna M.; Boerwinkle, Eric; Gibbs, Richard A.; Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Miyake, Christina Y.] Texas Childrens Hosp, Dept Pediat Cardiol, Houston, TX 77030 USA; [Shinawi, Marwan] Washington Univ, Sch Med, Div Genet & Genom Med, St Louis, MO 63110 USA; [Emrick, Lisa; Lotze, Timothy; Clark, Gary; Wilfong, Angus] Baylor Coll Med, Div Neurol & Dev Neurosci, Houston, TX 77030 USA; [Wilnai, Yael; Schelley, Susan] Stanford Sch Med, Div Med Genet, Stanford, CA 94304 USA; [Koenig, Mary Kay] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Div Child & Adolescent Neurol, Houston, TX 77030 USA; [Memon, Nada] DCH Reg Med Ctr, Div Cardiol, Tuscaloosa, AL 35401 USA; [Farach, Laura S.; Northrup, Hope] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Div Med Genet, Houston, TX 77030 USA; [Coe, Bradley P.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Adesina, Adekunle] Texas Childrens Hosp, Dept Pathol, Houston, TX 77030 USA; [Crosson, Jane] Johns Hopkins Univ, Sch Med, Div Pediat Cardiol, Baltimore, MD 21205 USA; [Duis, Jessica; Maegawa, Gustavo H. B.] Johns Hopkins Univ, Sch Med, Mckusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Duis, Jessica; Maegawa, Gustavo H. B.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Maegawa, Gustavo H. B.] Univ Florida, Dept Pediat, Div Genet & Metab, Gainesville, FL 32610 USA; [Coman, David; Inwood, Anita; McGill, Jim] Lady Cilento Childrens Hosp, Dept Metab Med, South Brisbane, Qld 4101, Australia; [Boerwinkle, Eric] Univ Houston, Hlth Sci Ctr, Sch Publ Hlth, Ctr Human Genet, Houston, TX 77030 USA; [Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Washington University (WUSTL); Baylor College of Medicine; Stanford University; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Washington; University of Washington Seattle; Baylor College of Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; State University System of Florida; University of Florida; University of Houston System; University of Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Baylor College of Medicine	Lalani, SR; Yang, YP (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Yang, YP (corresponding author), Baylor Miraca Genet Labs, Houston, TX 77030 USA.	seemal@bcm.edu; yapingy@bcm.edu	Leduc, Magalie/R-9884-2019; Graham, Brett/R-8685-2018; Hanchard, Neil/AAY-9075-2021; Lalani, Seema/AAI-5090-2020; Coe, Bradley/A-2878-2009; Gambin, Tomasz/HDN-5840-2022; Liu, Pengfei/U-9743-2019; Coman, David/F-5145-2013	Graham, Brett/0000-0001-8451-8154; Hanchard, Neil/0000-0003-1925-2665; Gambin, Tomasz/0000-0002-0941-4571; Liu, Pengfei/0000-0002-4177-709X; Coe, Bradley/0000-0001-8471-4016; orange, jordan/0000-0001-7117-7725; shinawi, Marwan/0000-0003-1329-4100; Coman, David/0000-0001-6303-6471; Maegawa, Gustavo/0000-0001-6933-4138; Azamian, Mahshid/0000-0002-8543-8284; Watkin, Levi/0000-0003-0404-4548	US National Human Genome Research Institute (NHGRI)/National Heart Lung and Blood Institute (NHLBI) [U54HG006542]; Regeneron Pharmaceuticals; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083726] Funding Source: NIH RePORTER	US National Human Genome Research Institute (NHGRI)/National Heart Lung and Blood Institute (NHLBI); Regeneron Pharmaceuticals(Regeneron); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the families for their participation and collaboration. The study was supported in part by the US National Human Genome Research Institute (NHGRI)/National Heart Lung and Blood Institute (NHLBI) Grant No. U54HG006542 to the Baylor-Hopkins Center for Mendelian Genomics. J.R.L. is a paid consultant for Regeneron Pharmaceuticals, holds stock ownership in 23andMe and Lasergen, Inc., and is a co-inventor on United States and European patents related to molecular diagnostics. The Department of Molecular and Human Genetics at Baylor College of Medicine derives revenue from molecular genetic testing offered at the Baylor Miraca Genetics Laboratories.	Abreu AP, 2013, NEW ENGL J MED, V368, P2467, DOI 10.1056/NEJMoa1302160; Bagley WH, 2007, INTERN EMERG MED, V2, P210, DOI 10.1007/s11739-007-0060-8; Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377; Bonnet D, 1999, CIRCULATION, V100, P2248, DOI 10.1161/01.CIR.100.22.2248; Cervellin G, 2010, CLIN CHEM LAB MED, V48, P749, DOI 10.1515/CCLM.2010.151; Choong K, 2001, PEDIATR DEVEL PATHOL, V4, P573, DOI 10.1007/s10024001-0101-7; Coe BP, 2014, NAT GENET, V46, P1063, DOI 10.1038/ng.3092; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; D'Arcangelo JG, 2013, BBA-MOL CELL RES, V1833, P2464, DOI 10.1016/j.bbamcr.2013.02.003; de Meijer AR, 2003, INTENS CARE MED, V29, P1121, DOI 10.1007/s00134-003-1800-5; Dlamini N, 2013, NEUROMUSCULAR DISORD, V23, P540, DOI 10.1016/j.nmd.2013.03.008; Fan J, 2008, INT J DEV NEUROSCI, V26, P523, DOI 10.1016/j.ijdevneu.2008.05.006; Fromer M, 2012, AM J HUM GENET, V91, P597, DOI 10.1016/j.ajhg.2012.08.005; GONATAS NK, 1992, AM J PATHOL, V140, P731; Kurki MI, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004134; Lupski JR, 2011, CELL, V147, P32, DOI 10.1016/j.cell.2011.09.008; Olpin SE, 2015, J CLIN PATHOL, V68, P410, DOI 10.1136/jclinpath-2014-202808; Pichler K, 2015, MUSCLE NERVE, V52, P437, DOI 10.1002/mus.24749; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Roe CR, 2008, NEUROLOGY, V71, P260, DOI 10.1212/01.wnl.0000318283.42961.e9; Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025; Scalco RS, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0264-3; Shaikh TH, 2009, GENOME RES, V19, P1682, DOI 10.1101/gr.083501.108; Slater MS, 1998, J AM COLL SURGEONS, V186, P693, DOI 10.1016/S1072-7515(98)00089-1; Straussberg R, 1997, PEDIATRICS, V99, P894, DOI 10.1542/peds.99.6.894; Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184; TONIN P, 1990, ANN NEUROL, V27, P181, DOI 10.1002/ana.410270214; Tyni T, 1999, ACTA PAEDIATR, V88, P237, DOI 10.1080/08035259950169954; Watkin LB, 2015, NAT GENET, V47, P654, DOI 10.1038/ng.3279; Wiszniewski W, 2013, AM J HUM GENET, V93, P197, DOI 10.1016/j.ajhg.2013.05.027; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Zeharia A, 2008, AM J HUM GENET, V83, P489, DOI 10.1016/j.ajhg.2008.09.002	33	53	56	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 4	2016	98	2					347	357		10.1016/j.ajhg.2015.12.008	http://dx.doi.org/10.1016/j.ajhg.2015.12.008			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DE3BR	26805781	Green Published, Bronze			2022-12-18	WOS:000370502300011
J	de Pagter, MS; van Roosmalen, MJ; Baas, AF; Renkens, I; Duran, KJ; van Binsbergen, E; Tavakoli-Yaraki, M; Hochstenbach, R; van der Veken, LT; Cuppen, E; Kloosterman, WP				de Pagter, Mirjam S.; van Roosmalen, Markus J.; Baas, Annette F.; Renkens, Ivo; Duran, Karen J.; van Binsbergen, Ellen; Tavakoli-Yaraki, Masoumeh; Hochstenbach, Ron; van der Veken, Lars T.; Cuppen, Edwin; Kloosterman, Wigard P.			Chromothripsis in Healthy Individuals Affects Multiple Protein-Coding Genes and Can Result in Severe Congenital Abnormalities in Offspring	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX CHROMOSOME REARRANGEMENTS	Chromothripsis represents an extreme class of complex chromosome rearrangements ( CCRs) with major effects on chromosomal architecture. Although recent studies have associated chromothripsis with congenital abnormalities, the incidence and pathogenic effects of this phenomenon require further investigation. Here, we analyzed the genomes of three families in which chromothripsis rearrangements were transmitted from a mother to her child. The chromothripsis in the mothers resulted in completely balanced rearrangements involving 8-23 breakpoint junctions across three to five chromosomes. Two mothers did not show any phenotypic abnormalities, although 3-13 protein-coding genes were affected by breakpoints. Unbalanced but stable transmission of a subset of the derivative chromosomes caused apparently de novo complex copy-number changes in two children. This resulted in gene-dosage changes, which are probably responsible for the severe congenital phenotypes of these two children. In contrast, the third child, who has a severe congenital disease, harbored all three chromothripsis chromosomes from his healthy mother, but one of the chromosomes acquired de novo rearrangements leading to copy-number changes. These results show that the human genome can tolerate extreme reshuffling of chromosomal architecture, including breakage of multiple protein-coding genes, without noticeable phenotypic effects. The presence of chromothripsis in healthy individuals affects reproduction and is expected to substantially increase the risk of miscarriages, abortions, and severe congenital disease.	[de Pagter, Mirjam S.; van Roosmalen, Markus J.; Baas, Annette F.; Renkens, Ivo; Duran, Karen J.; van Binsbergen, Ellen; Tavakoli-Yaraki, Masoumeh; Hochstenbach, Ron; van der Veken, Lars T.; Cuppen, Edwin; Kloosterman, Wigard P.] Univ Med Ctr Utrecht, Ctr Mol Med, Dept Med Genet, NL-3584 CG Utrecht, Netherlands; [Cuppen, Edwin] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Cuppen, Edwin] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Kloosterman, WP (corresponding author), Univ Med Ctr Utrecht, Ctr Mol Med, Dept Med Genet, NL-3584 CG Utrecht, Netherlands.	w.kloosterman@umcutrecht.nl	Cuppen, Edwin/H-2389-2016; Tavakoli-Yaraki, Masoumeh/O-9058-2018; Cuppen, Edwin/F-5696-2011	Cuppen, Edwin/0000-0002-0400-9542; Cuppen, Edwin/0000-0002-0400-9542	Child Health priority program at the University Medical Center Utrecht	Child Health priority program at the University Medical Center Utrecht	We are grateful to the families for participating in this study. This research was supported by the Child Health priority program at the University Medical Center Utrecht. We thank M.E.M. Swinkels and E.F. Ippel for counseling family 2 and family 3, respectively. We would like to thank M. Poot for providing access to SNP array data for family 2.	BATISTA DAS, 1994, AM J MED GENET, V53, P255, DOI 10.1002/ajmg.1320530311; Brisset S, 2002, AM J MED GENET, V113, P339, DOI 10.1002/ajmg.b.10740; Chiang C, 2012, NAT GENET, V44, P390, DOI 10.1038/ng.2202; de Pater JM, 2002, CLIN GENET, V62, P482, DOI 10.1034/j.1399-0004.2002.620611.x; Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021; GORSKI JL, 1988, AM J MED GENET, V29, P247, DOI 10.1002/ajmg.1320290202; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Kloosterman WP, 2013, CURR OPIN CELL BIOL, V25, P341, DOI 10.1016/j.ceb.2013.02.008; Kloosterman WP, 2012, CELL REP, V1, P648, DOI 10.1016/j.celrep.2012.05.009; Kloosterman WP, 2011, HUM MOL GENET, V20, P1916, DOI 10.1093/hmg/ddr073; Korbel JO, 2013, CELL, V152, P1226, DOI 10.1016/j.cell.2013.02.023; Laus AC, 2012, AM J MED GENET A, V158A, P821, DOI 10.1002/ajmg.a.32988; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Macera M.J., 2014, PRENAT DIAGN; Madan K, 2012, AM J MED GENET A, V158A, P947, DOI 10.1002/ajmg.a.35220; Nazaryan L, 2014, EUR J HUM GENET, V22, P338, DOI 10.1038/ejhg.2013.147; Pellestor F, 2011, HUM REPROD UPDATE, V17, P476, DOI 10.1093/humupd/dmr010; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; van Binsbergen E, 2012, AM J MED GENET A, V158A, P2888, DOI 10.1002/ajmg.a.35580; Zhang CZ, 2013, GENE DEV, V27, P2513, DOI 10.1101/gad.229559.113	20	53	53	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 2	2015	96	4					651	656		10.1016/j.ajhg.2015.02.005	http://dx.doi.org/10.1016/j.ajhg.2015.02.005			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CF0DJ	25799107	Green Published, Bronze			2022-12-18	WOS:000352212600012
J	Kim, BY; Lohmueller, KE				Kim, Bernard Y.; Lohmueller, Kirk E.			Selection and Reduced Population Size Cannot Explain Higher Amounts of Neandertal Ancestry in East Asian than in European Human Populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME SEQUENCE; GENETIC-VARIATION; EVOLUTION; HAPLOTYPE	It has been hypothesized that the greater proportion of Neandertal ancestry in East Asians than in Europeans is due to the fact that purifying selection is less effective at removing weakly deleterious Neandertal alleles from East Asian populations. Using simulations of a broad range of models of selection and demography, we have shown that this hypothesis cannot account for the higher proportion of Neandertal ancestry in East Asians than in Europeans. Instead, more complex demographic scenarios, most likely involving multiple pulses of Neandertal admixture, are required to explain the data.	[Kim, Bernard Y.; Lohmueller, Kirk E.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Lohmueller, Kirk E.] Univ Calif Los Angeles, Interdept Program Bioinformat, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Lohmueller, KE (corresponding author), Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA.	klohmueller@ucla.edu			Searle Scholars Fellowship	Searle Scholars Fellowship	We thank Emilia Huerta-Sanchez, Bogdan Pasaniuc, Joshua M. Akey, Sriram Sankararaman, and members of the K.E.L. and Pasaniuc labs for helpful discussions and/or comments on the manuscript. K.E.L. is supported by a Searle Scholars Fellowship.	Akashi H, 2012, GENETICS, V192, P15, DOI 10.1534/genetics.112.140178; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Charlesworth B., 2010, ELEMENTS EVOLUTIONAR; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Currat M, 2011, P NATL ACAD SCI USA, V108, P15129, DOI 10.1073/pnas.1107450108; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; KIMURA M., 1964, J. appl. Prob., V1, P177, DOI 10.2307/3211856; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; NAGYLAKI T, 1980, J MATH BIOL, V9, P101, DOI 10.1007/BF00275916; OHTA T, 1992, ANNU REV ECOL SYST, V23, P263, DOI 10.1146/annurev.es.23.110192.001403; OHTA T, 1972, J MOL EVOL, V1, P305, DOI 10.1007/BF01653959; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Sankararaman S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002947; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Vernot B, 2015, AM J HUM GENET, V96, P448, DOI 10.1016/j.ajhg.2015.01.006; Vernot B, 2014, SCIENCE, V343, P1017, DOI 10.1126/science.1245938; Voight BF, 2005, P NATL ACAD SCI USA, V102, P18508, DOI 10.1073/pnas.0507325102; Wall JD, 2013, GENETICS, V194, P199, DOI 10.1534/genetics.112.148213; Wang SG, 2013, GENOME BIOL EVOL, V5, P2075, DOI 10.1093/gbe/evt160; Yang MA, 2012, MOL BIOL EVOL, V29, P2987, DOI 10.1093/molbev/mss117	26	53	53	1	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 5	2015	96	3					454	461		10.1016/j.ajhg.2014.12.029	http://dx.doi.org/10.1016/j.ajhg.2014.12.029			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CD0GD	25683122	Green Published, Bronze			2022-12-18	WOS:000350747800018
J	Dudbridge, F; Fletcher, O				Dudbridge, Frank; Fletcher, Olivia			Gene-Environment Dependence Creates Spurious Gene-Environment Interaction	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SAMPLE-SIZE REQUIREMENTS; ASSOCIATION; CANCER; MISCLASSIFICATION; MENARCHE; MODELS; CYP3A; BIAS; AGE	Gene-environment interactions have the potential to shed light on biological processes leading to disease and to improve the accuracy of epidemiological risk models. However, relatively few such interactions have yet been confirmed. In part this is because genetic markers such as tag SNPs are usually studied, rather than the causal variants themselves. Previous work has shown that this leads to substantial loss of power and increased sample size when gene and environment are independent. However, dependence between gene and environment can arise in several ways including mediation, pleiotropy, and confounding, and several examples of gene-environment interaction under gene-environment dependence have recently been published. Here we show that under gene-environment dependence, a statistical interaction can be present between a marker and environment even if there is no interaction between the causal variant and the environment. We give simple conditions under which there is no marker-environment interaction and note that they do not hold in general when there is gene-environment dependence. Furthermore, the gene-environment dependence applies to the causal variant and cannot be assessed from marker data. Gene-gene interactions are susceptible to the same problem if two causal variants are in linkage disequilibrium. In addition to existing concerns about mechanistic interpretations, we suggest further caution in reporting interactions for genetic markers.	[Dudbridge, Frank] Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England; [Fletcher, Olivia] Breakthrough Breast Canc Res Ctr, Inst Canc Res, London SW7 3RP, England; [Fletcher, Olivia] Inst Canc Res, Div Breast Canc Res, London SW7 3RP, England	University of London; London School of Hygiene & Tropical Medicine; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Dudbridge, F (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England.	frank.dudbridge@lshtm.ac.uk		Fletcher, Olivia/0000-0001-9387-7116	MRC [G1000718, K006215]; Breakthough Breast Cancer; NHS; Cancer Research UK [C1287/A10118, C1287/A12014]; European Community [223175 (HEALTH-F2-2009-223175)]; Medical Research Council [G1000718, MR/K006215/1] Funding Source: researchfish; MRC [MR/K006215/1] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Breakthough Breast Cancer; NHS; Cancer Research UK(Cancer Research UK); European Community(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We acknowledge support from the MRC (G1000718 and K006215), Breakthough Breast Cancer, and NHS funding to the NIHR Biomedical Research Centre. We thank the Breast Cancer Association Consortium (BCAC) for access to the data published in Johnson et al.<SUP>15</SUP> BCAC is funded by Cancer Research UK (C1287/A10118, C1287/A12014) and by the European Community's Seventh Framework Programme under grant agreement number 223175 (HEALTH-F2-2009-223175) (COGS).	Anderson CA, 2008, J CLIN ENDOCR METAB, V93, P3965, DOI 10.1210/jc.2007-2568; Clayton DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000540; Dai JY, 2012, BIOMETRIKA, V99, P929, DOI 10.1093/biomet/ass044; Dempfle A, 2008, EUR J HUM GENET, V16, P1164, DOI 10.1038/ejhg.2008.106; Garcia-Closas M, 1998, AM J EPIDEMIOL, V147, P426; Garcia-Closas M, 1999, CANCER EPIDEM BIOMAR, V8, P1043; Gauderman WJ, 2013, GENET EPIDEMIOL, V37, P603, DOI 10.1002/gepi.21748; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Goldman D, 2005, NAT REV GENET, V6, P521, DOI 10.1038/nrg1635; Greenwood Darren C, 2006, BMC Med Res Methodol, V6, P21, DOI 10.1186/1471-2288-6-21; Hein R, 2008, GENET EPIDEMIOL, V32, P235, DOI 10.1002/gepi.20298; Hemani G, 2014, NATURE, V508, P249, DOI 10.1038/nature13005; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Johnson N, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3662; Johnson N, 2012, JNCI-J NATL CANCER I, V104, P657, DOI 10.1093/jnci/djs156; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Mukherjee B, 2008, BIOMETRICS, V64, P685, DOI 10.1111/j.1541-0420.2007.00953.x; Murad H, 2007, STAT MED, V26, P4293, DOI 10.1002/sim.2849; Nickels S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003284; PIEGORSCH WW, 1994, STAT MED, V13, P153, DOI 10.1002/sim.4780130206; Rehm J, 2010, ADDICTION, V105, P817, DOI 10.1111/j.1360-0443.2010.02899.x; Saccone NL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001053; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Spitz Margaret R, 2008, J Natl Cancer Inst, V100, P1552, DOI 10.1093/jnci/djn363; Taylor AE, 2011, J OBES, V2011, DOI 10.1155/2011/307542; THOMPSON WD, 1991, J CLIN EPIDEMIOL, V44, P221, DOI 10.1016/0895-4356(91)90033-6; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Wason JMS, 2012, AM J HUM GENET, V90, P760, DOI 10.1016/j.ajhg.2012.03.007; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wray NR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000579	30	53	53	2	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 4	2014	95	3					301	307		10.1016/j.ajhg.2014.07.014	http://dx.doi.org/10.1016/j.ajhg.2014.07.014			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AO5RX	25152454	hybrid, Green Published			2022-12-18	WOS:000341404100006
J	Ayub, Q; Moutsianas, L; Chen, Y; Panoutsopoulou, K; Colonna, V; Pagani, L; Prokopenko, I; Ritchie, GRS; Tyler-Smith, C; McCarthy, MI; Zeggini, E; Xue, YL				Ayub, Qasim; Moutsianas, Loukas; Chen, Yuan; Panoutsopoulou, Kalliope; Colonna, Vincenza; Pagani, Luca; Prokopenko, Inga; Ritchie, Graham R. S.; Tyler-Smith, Chris; McCarthy, Mark I.; Zeggini, Eleftheria; Xue, Yali			Revisiting the Thrifty Gene Hypothesis via 65 Loci Associated with Susceptibility to Type 2 Diabetes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POSITIVE SELECTION; HUMAN GENOME; EUROPEAN POPULATIONS; VARIANTS; MELLITUS; GENOTYPE; SEQUENCE; HISTORY; DISEASE; IMPACT	We have investigated the evidence for positive selection in samples of African, European, and East Asian ancestry at 65 loci associated with susceptibility to type 2 diabetes (T2D) previously identified through genome-wide association studies. Selection early in human evolutionary history is predicted to lead to ancestral risk alleles shared between populations, whereas late selection would result in population-specific signals at derived risk alleles. By using a wide variety of tests based on the site frequency spectrum, haplotype structure, and population differentiation, we found no global signal of enrichment for positive selection when we considered all T2D risk loci collectively. However, in a locus-by-locus analysis, we found nominal evidence for positive selection at 14 of the loci. Selection favored the protective and risk alleles in similar proportions, rather than the risk alleles specifically as predicted by the thrifty gene hypothesis, and may not be related to influence on diabetes. Overall, we conclude that past positive selection has not been a powerful influence driving the prevalence of T2D risk alleles.	[Ayub, Qasim; Chen, Yuan; Panoutsopoulou, Kalliope; Colonna, Vincenza; Pagani, Luca; Ritchie, Graham R. S.; Tyler-Smith, Chris; Zeggini, Eleftheria; Xue, Yali] Wellcome Trust Sanger Inst, Hinxton CB10 1HH, England; [Moutsianas, Loukas; Prokopenko, Inga; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Colonna, Vincenza] Natl Res Council CNR, Inst Genet & Biophys, I-80125 Naples, Italy; [Ritchie, Graham R. S.] European Bioinformat Inst, Hinxton CB10 1SH, England; [McCarthy, Mark I.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [McCarthy, Mark I.] Churchill Hosp, Oxford NIHR Biomed Res Ctr, Oxford OX3 7LJ, England	Wellcome Trust Sanger Institute; University of Oxford; Wellcome Centre for Human Genetics; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); European Molecular Biology Laboratory (EMBL); University of Oxford; University of Oxford	Xue, YL (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1HH, England.	ylx@sanger.ac.uk	Prokopenko, Inga/H-3241-2014; Pagani, Luca/G-8511-2017; Prokopenko, Inga/AAU-9895-2020; McCarthy, Mark/M-3763-2015; Colonna, Vincenza/H-2021-2014	Prokopenko, Inga/0000-0003-1624-7457; Pagani, Luca/0000-0002-6639-524X; Ayub, Qasim/0000-0003-3291-0917; Panoutsopoulou, Kalliope/0000-0002-5460-8025; Zeggini, Eleftheria/0000-0003-4238-659X; McCarthy, Mark/0000-0002-4393-0510; Colonna, Vincenza/0000-0002-3966-0474; Moutsianas, Loukas/0000-0001-5453-345X	Wellcome Trust [098051, 098381, WT090367MA]; Framework 7: ENGAGE [HEALTH-F4-2007- 201413]; National Institute for Health Research [NF-SI-0611-10099] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Framework 7: ENGAGE; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by The Wellcome Trust (grant 098051 to Q.A., Y.C., K.P., V.C., L.P., G.R.S.R., C.T.-S., E.Z., and Y.X.; grants 098381 and WT090367MA to M.I.M.) and by Framework 7: ENGAGE (HEALTH-F4-2007- 201413 to M.I.M.).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Ayub Q, 2013, AM J HUM GENET, V92, P696, DOI 10.1016/j.ajhg.2013.03.019; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Chen R, 2012, PLOS GENET, V8, P100, DOI 10.1371/journal.pgen.1002621; Corona E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003447; Diamond J, 2003, NATURE, V423, P599, DOI 10.1038/423599a; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Fay JC, 2000, GENETICS, V155, P1405; FISHER RA, 1954, STAT METHODS RES WOR, P356; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; Jia HM, 2013, VALUE HEALTH, V16, P140, DOI 10.1016/j.jval.2012.08.2208; JOBLING M, 2004, HUMAN EVOLUTIONARY G, P15253; Klimentidis YC, 2011, HUM GENET, V129, P407, DOI 10.1007/s00439-010-0935-z; La Vignera S, 2012, J ANDROL, V33, P145, DOI 10.2164/jandrol.111.013193; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Livshits A, 2009, WOMENS HEALTH, V5, P701, DOI 10.2217/WHE.09.47; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Neel JV, 1999, NUTR REV, V57, pS2, DOI 10.1111/j.1753-4887.1999.tb01782.x; NEEL JV, 1962, AM J HUM GENET, V14, P353; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Paten B, 2008, GENOME RES, V18, P1814, DOI 10.1101/gr.076554.108; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Segurel L, 2013, EUR J HUM GENET, V21, P1146, DOI 10.1038/ejhg.2012.295; Shu XO, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001127; Southam L, 2009, DIABETOLOGIA, V52, P1846, DOI 10.1007/s00125-009-1419-3; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; TAJIMA F, 1989, GENETICS, V123, P585; Tsai FJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000847; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whitworth KW, 2011, DIABETOLOGIA, V54, P516, DOI 10.1007/s00125-010-2003-6; WHO, 2011, GLOB STAT REP NONC D; World Health Organization, 2009, GLOB HLTH RISKS MORT; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207	46	53	55	0	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 6	2014	94	2					176	185		10.1016/j.ajhg.2013.12.010	http://dx.doi.org/10.1016/j.ajhg.2013.12.010			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AA9NF	24412096	Green Published, Bronze			2022-12-18	WOS:000331419500002
J	Epstein, MP; Duncan, R; Jiang, YX; Conneely, KN; Allen, AS; Satten, GA				Epstein, Michael P.; Duncan, Richard; Jiang, Yunxuan; Conneely, Karen N.; Allen, Andrew S.; Satten, Glen A.			A Permutation Procedure to Correct for Confounders in Case-Control Studies, Including Tests of Rare Variation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WHOLE-GENOME ASSOCIATION; POPULATION STRATIFICATION; GENETIC-ASSOCIATION; DISEASE VARIANTS; COMMON DISEASES; SEQUENCE DATA; STRATEGIES; DISORDERS; MAP	Many case-control tests of rare variation are implemented in statistical frameworks that make correction for confounders like population stratification difficult. Simple permutation of disease status is unacceptable for resolving this issue because the replicate data sets do not have the same confounding as the original data set. These limitations make it difficult to apply rare-variant tests to samples in which confounding most likely exists, e.g., samples collected from admixed populations. To enable the use of such rare-variant methods in structured samples, as well as to facilitate permutation tests for any situation in which case-control tests require adjustment for confounding covariates, we propose to establish the significance of a rare-variant test via a modified permutation procedure. Our procedure uses Fisher's noncentral hypergeometric distribution to generate permuted data sets with the same structure present in the actual data set such that inference is valid in the presence of confounding factors. We use simulated sequence data based on coalescent models to show that our permutation strategy corrects for confounding due to population stratification that, if ignored, would otherwise inflate the size of a rare-variant test. We further illustrate the approach by using sequence data from the Dallas Heart Study of energy metabolism traits. Researchers can implement our permutation approach by using the R package BiasedUrn.	[Epstein, Michael P.; Duncan, Richard; Conneely, Karen N.] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA; [Jiang, Yunxuan] Emory Univ, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA; [Allen, Andrew S.] Duke Univ, Dept Biostat & Bioinformat, Durham, NC 27710 USA; [Satten, Glen A.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA	Emory University; Emory University; Duke University; Centers for Disease Control & Prevention - USA	Epstein, MP (corresponding author), Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA.	mpepste@emory.edu		Satten, Glen/0000-0001-7275-5371	National Institutes of Health [HG003618, MH084680]; National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Any opinions expressed in this paper are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention. This work was supported by National Institutes of Health grants HG003618 (to M.P.E and R.D.) and MH084680 (to A.S.A). We thank Jonathan Cohen for providing us with sequence data from the Dallas Heart Study. We thank Michael Boehnke and three anonymous reviewers for their valuable comments that improved this article. We thank Cheryl Strauss for assistance with technical editing of the article. Funding support for "Genome-Wide Association Study of Schizophrenia" was provided by the National Institutes of Health, and the genotyping of samples was a courtesy of the Genetic Association Information Network. The data set used for the analyses described in this manuscript was obtained from the database of Genotype and Phenotype (dbGaP) found at http://www.ncbi.nlm.nih.gov/gap through dbGaP accession number phs000021.v2.p1. Samples and associated phenotype data for "Genome-Wide Association Study of Schizophrenia" were provided by Pablo V. Gejman, MD.	Allen A, 2010, GENET EPIDEMIOL, V34, P383, DOI 10.1002/gepi.20487; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Chen HS, 2003, ANN HUM GENET, V67, P250, DOI 10.1046/j.1469-1809.2003.00036.x; Davison AC, 1997, BOOTSTRAP METHODS TH; EFRON B, 1985, BIOMETRIKA, V72, P45, DOI 10.2307/2336334; Efron B., 1993, INTRO BOOTSTRAP; Epstein MP, 2007, AM J HUM GENET, V80, P921, DOI 10.1086/516842; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fog A., 2011, BIASEDURN BIASED URN; Fog A, 2008, COMMUN STAT-SIMUL C, V37, P241, DOI 10.1080/03610910701790236; Han F, 2010, HUM HERED, V70, P42, DOI 10.1159/000288704; HARKNESS WL, 1965, ANN MATH STAT, V36, P938, DOI 10.1214/aoms/1177700066; Hoffmann TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013584; Ionita-Laza I, 2012, AM J HUM GENET, V90, P1002, DOI 10.1016/j.ajhg.2012.04.010; Ionita-Laza I, 2011, AM J HUM GENET, V89, P701, DOI 10.1016/j.ajhg.2011.11.003; Ionita-Laza I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001289; Kimmel G, 2007, AM J HUM GENET, V81, P895, DOI 10.1086/521372; Kinnamon DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030238; Lee AB, 2010, GENET EPIDEMIOL, V34, P51, DOI 10.1002/gepi.20434; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li Y, 2010, AM J HUM GENET, V87, P728, DOI 10.1016/j.ajhg.2010.10.014; Lin DY, 2011, AM J HUM GENET, V89, P354, DOI [10.1016/j.ajhg.2011.07.015, 10.1016/j.ajhg.2011.07.015.]; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Manolio TA, 2007, NAT GENET, V39, P1045, DOI 10.1038/ng2127; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000519; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Sul JH, 2011, GENETICS, V188, P181, DOI 10.1534/genetics.110.125070; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; Wu CQ, 2011, ANN HUM GENET, V75, P418, DOI 10.1111/j.1469-1809.2010.00639.x; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zawistowski M, 2010, AM J HUM GENET, V87, P604, DOI 10.1016/j.ajhg.2010.10.012; ZELTERMAN D, 1988, J AM STAT ASSOC, V83, P179, DOI 10.2307/2288939	41	53	53	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG 10	2012	91	2					215	223		10.1016/j.ajhg.2012.06.004	http://dx.doi.org/10.1016/j.ajhg.2012.06.004			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	990CN	22818855	Bronze, Green Published			2022-12-18	WOS:000307608700001
J	Mervis, CB; Dida, J; Lam, E; Crawford-Zelli, NA; Young, EJ; Henderson, DR; Onay, T; Morris, CA; Woodruff-Borden, J; Yeomans, J; Osborne, LR				Mervis, Carolyn B.; Dida, Joana; Lam, Emily; Crawford-Zelli, Nicole A.; Young, Edwin J.; Henderson, Danielle R.; Onay, Tuncer; Morris, Colleen A.; Woodruff-Borden, Janet; Yeomans, John; Osborne, Lucy R.			Duplication of GTF2I Results in Separation Anxiety in Mice and Humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ULTRASONIC VOCALIZATIONS; INTERVIEW SCHEDULE; TFII-I; CHILDREN; EXPRESSION; DISORDERS; REARRANGEMENTS; ADOLESCENTS; PREVALENCE; ACTIVATION	Duplication (dup7q11.23) and deletion (Williams syndrome) of chromosomal region 7q11.23 cause neurodevelopmental disorders with contrasting anxiety phenotypes. We found that 30% of 4- to 12-year-olds with dup7q11.23 but fewer than 5% of children with WS or in the general population met diagnostic criteria for a separation-anxiety disorder. To address the role of one commonly duplicated or deleted gene in separation anxiety, we compared mice that had varying numbers of Gtf2i copies. Relative to mouse pups with one or two Gtf2i copies, pups with additional Gtf2i copies showed significantly increased maternal separation-induced anxiety as measured by ultrasonic vocalizations. This study links the copy number of a single gene from 7q11.23 to separation anxiety in both mice and humans, highlighting the utility of mouse models in dissecting specific gene functions for genomic disorders that span many genes. This study also offers insight into molecular separation-anxiety pathways that might enable the development of targeted therapeutics.	[Dida, Joana; Lam, Emily; Young, Edwin J.; Osborne, Lucy R.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Mervis, Carolyn B.; Crawford-Zelli, Nicole A.; Henderson, Danielle R.; Woodruff-Borden, Janet] Univ Louisville, Dept Psychol & Brain Sci, Louisville, KY 40292 USA; [Dida, Joana; Yeomans, John] Univ Toronto, Ctr Biol Timing & Cognit, Dept Psychol, Toronto, ON M5S 3G3, Canada; [Onay, Tuncer] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Morris, Colleen A.] Univ Nevada, Sch Med, Dept Pediat, Las Vegas, NV 89102 USA; [Osborne, Lucy R.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; [Osborne, Lucy R.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Louisville; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Toronto; University of Toronto	Osborne, LR (corresponding author), Univ Toronto, Inst Med Sci, 100 Coll St, Toronto, ON M5S 1A8, Canada.	lucy.osborne@utoronto.ca		Onay, Tuncer/0000-0001-8891-2300; Young, Ted (Edwin)/0000-0003-4882-6752	Canadian Institutes of Health Research [MOP77720]; National Institute of Neurological Disorders and Stroke [R01 NS35102]; National Institute of Child Health and Development [R37 HD29957]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD029957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035102] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the children and their parents for their enthusiastic participation in our research, Elaine Tam for her assistance in maintaining the mouse colony, Lap-Chee Tsui for supporting the generation of the Gtf2i<SUP>+/3'UTRloxP</SUP> mice, and Doris J. Kistler for statistical consultation. This work was funded by a grant from the Canadian Institutes of Health Research (MOP77720) to L.R.O. and by grants from the National Institute of Neurological Disorders and Stroke (R01 NS35102) and the National Institute of Child Health and Development (R37 HD29957) to C.B.M.	Bayes M, 2003, AM J HUM GENET, V73, P131, DOI 10.1086/376565; Beesdo K, 2009, PSYCHIAT CLIN N AM, V32, P483, DOI 10.1016/j.psc.2009.06.002; Caraveo G, 2006, SCIENCE, V314, P122, DOI 10.1126/science.1127815; Cheriyath V, 2002, J BIOL CHEM, V277, P22798, DOI 10.1074/jbc.M202956200; Connolly SD, 2011, CURR PSYCHIAT REP, V13, P99, DOI 10.1007/s11920-010-0173-z; Enkhmandakh B, 2004, GENE EXPR PATTERNS, V4, P25, DOI 10.1016/S1567-133X(03)00155-8; Fijalkowska Iwona, 2010, BMC Res Notes, V3, P203, DOI 10.1186/1756-0500-3-203; Fish EW, 2004, J PHARMACOL EXP THER, V308, P474, DOI 10.1124/jpet.103.058206; Hasegawa S, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-6; Hobart H.H., 2010, AM J MED GENET C, V154C, P220; Hodgson RA, 2008, PHARMACOL BIOCHEM BE, V88, P341, DOI 10.1016/j.pbb.2007.09.005; Kennedy J. C., 2006, JEFFERSON J PSYCHIAT, V20, P22, DOI DOI 10.29046/JJP.020.1.003; Leyfer O, 2009, J NEURODEV DISORD, V1, P4, DOI 10.1007/s11689-009-9003-1; Leyfer OT, 2006, AM J MED GENET B, V141B, P615, DOI 10.1002/ajmg.b.30344; Maldonado R, 1999, P NATL ACAD SCI USA, V96, P14094, DOI 10.1073/pnas.96.24.14094; Mervis CB, 2010, AM J MED GENET C, V154C, P229, DOI 10.1002/ajmg.c.30263; Nibuya M, 1996, J NEUROSCI, V16, P2365; Osborne Lucy R., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S146239940700035X; Perez-Cadahia B, 2011, BIOCHEM CELL BIOL, V89, P61, DOI 10.1139/O10-138; Proulx E, 2010, J NEURODEV DISORD, V2, P99, DOI 10.1007/s11689-010-9044-5; Roy AL, 2001, GENE, V274, P1, DOI 10.1016/S0378-1119(01)00625-4; Scattoni ML, 2009, NEUROSCI BIOBEHAV R, V33, P508, DOI 10.1016/j.neubiorev.2008.08.003; Shaffer D, 1996, J AM ACAD CHILD PSY, V35, P865, DOI 10.1097/00004583-199607000-00012; Shum FWF, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-22; Silverman WK, 2001, J AM ACAD CHILD PSY, V40, P937, DOI 10.1097/00004583-200108000-00016; Silverman WK, 1996, ANXIETY DISORDERS IN; Smoller JW, 2008, AM J MED GENET C, V148C, P118, DOI 10.1002/ajmg.c.30174; Somerville MJ, 2005, NEW ENGL J MED, V353, P1694, DOI 10.1056/NEJMoa051962; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Valverde O, 2004, NEUROPSYCHOPHARMACOL, V29, P1122, DOI 10.1038/sj.npp.1300416; Velleman Shelley L, 2011, Perspect Lang Learn Educ, V18, P108; Vidal F, 1998, MOL REPROD DEV, V51, P274, DOI 10.1002/(SICI)1098-2795(199811)51:3&lt;274::AID-MRD6&gt;3.0.CO;2-M; Woodruff-Borden J, 2010, AM J MED GENET C, V154C, P277, DOI 10.1002/ajmg.c.30259; Young EJ, 2008, GENES BRAIN BEHAV, V7, P224, DOI 10.1111/j.1601-183X.2007.00343.x; Zheng BH, 1999, NUCLEIC ACIDS RES, V27, P2354, DOI 10.1093/nar/27.11.2354	35	53	55	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 8	2012	90	6					1064	1070		10.1016/j.ajhg.2012.04.012	http://dx.doi.org/10.1016/j.ajhg.2012.04.012			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	958TC	22578324	Green Published, Bronze			2022-12-18	WOS:000305262600010
J	Depienne, C; Bouteiller, D; Meneret, A; Billot, S; Groppa, S; Klebe, S; Charbonnier-Beaupel, F; Corvol, JC; Saraiva, JP; Brueggemann, N; Bhatia, K; Cincotta, M; Brochard, V; Flamand-Roze, C; Carpentier, W; Meunier, S; Marie, Y; Gaussen, M; Stevanin, G; Wehrle, R; Vidailhet, M; Klein, C; Dusart, I; Brice, A; Roze, E				Depienne, Christel; Bouteiller, Delphine; Meneret, Aurelie; Billot, Segolene; Groppa, Sergiu; Klebe, Stephan; Charbonnier-Beaupel, Fanny; Corvol, Jean-Christophe; Saraiva, Jean-Paul; Brueggemann, Norbert; Bhatia, Kailash; Cincotta, Massimo; Brochard, Vanessa; Flamand-Roze, Constance; Carpentier, Wassila; Meunier, Sabine; Marie, Yannick; Gaussen, Marion; Stevanin, Giovanni; Wehrle, Rosine; Vidailhet, Marie; Klein, Christine; Dusart, Isabelle; Brice, Alexis; Roze, Emmanuel			RAD51 Haploinsufficiency Causes Congenital Mirror Movements in Humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC-HETEROGENEITY; CORTICAL DEVELOPMENT; DCC MUTATION; RECOMBINATION; IDENTIFICATION; CANCER; EXPRESSION; DISORDERS; MICE	Congenital mirror movements (CMM) are characterized by involuntary movements of one side of the body that mirror intentional movements on the opposite side. CMM reflect dysfunctions and structural abnormalities of the motor network and are mainly inherited in an autosomal-dominant fashion. Recently, heterozygous mutations in UCC, the gene encoding the receptor for netrin 1 and involved in the guidance of developing axons toward the midline, have been identified but CMM are genetically heterogeneous. By combining genome-wide linkage analysis and exome sequencing, we identified heterozygous mutations introducing premature termination codons in RAD51 in two families with CMM. RAD51 mRNA was significantly downregulated in individuals with CMM resulting from the degradation of the mutated mRNA by nonsense-mediated decay. RAD51 was specifically present in the developing mouse cortex and, more particularly, in a subpopulation of corticospinal axons at the pyramidal decussation. The identification of mutations in RAD51 known for its key role in the repair of DNA double-strand breaks through homologous recombination, in individuals with CMM reveals a totally unexpected role of RAD51 in neurodevelopment. These findings open a new field of investigation for researchers attempting to unravel the molecular pathways underlying bimanual motor control in humans.	[Depienne, Christel; Bouteiller, Delphine; Meneret, Aurelie; Klebe, Stephan; Charbonnier-Beaupel, Fanny; Corvol, Jean-Christophe; Meunier, Sabine; Marie, Yannick; Gaussen, Marion; Stevanin, Giovanni; Vidailhet, Marie; Brice, Alexis; Roze, Emmanuel] Hop La Pitie Salpetriere, INSERM, U975, CRICM, F-75013 Paris, France; [Depienne, Christel; Bouteiller, Delphine; Klebe, Stephan; Charbonnier-Beaupel, Fanny; Corvol, Jean-Christophe; Gaussen, Marion; Stevanin, Giovanni; Vidailhet, Marie; Brice, Alexis] Hop La Pitie Salpetriere, CNRS 7225, CRICM, F-75013 Paris, France; [Depienne, Christel; Klebe, Stephan; Stevanin, Giovanni; Brice, Alexis] Hop La Pitie Salpetriere, AP HP, Dept Genet & Cytogenet, Ctr Genet Mol & Chromosom, F-75013 Paris, France; [Depienne, Christel; Bouteiller, Delphine; Klebe, Stephan; Charbonnier-Beaupel, Fanny; Corvol, Jean-Christophe; Marie, Yannick; Gaussen, Marion; Stevanin, Giovanni; Vidailhet, Marie; Brice, Alexis; Roze, Emmanuel] Univ Paris 06, UMR S 975, F-75013 Paris, France; [Depienne, Christel; Bouteiller, Delphine; Marie, Yannick] Hop La Pitie Salpetriere, PFGS Platform, ICM, F-75013 Paris, France; [Meneret, Aurelie; Vidailhet, Marie; Roze, Emmanuel] Hop La Pitie Salpetriere, AP HP, Dept Neurol, F-75013 Paris, France; [Billot, Segolene] Hop Avicenne, AP HP, Serv Neurol, F-93000 Bobigny, France; [Groppa, Sergiu; Klebe, Stephan] Univ Hosp Schleswig Holstein, Dept Neurol, D-24105 Kiel, Germany; [Klebe, Stephan; Corvol, Jean-Christophe; Brochard, Vanessa] AP HP, Ctr Invest Clin 9503, INSERM, F-75013 Paris, France; [Saraiva, Jean-Paul] Integragen SA, F-91000 Evry, France; [Brueggemann, Norbert; Klein, Christine] Univ Lubeck, Dept Neurol, Sect Clin & Mol Neurogenet, D-23538 Lubeck, Germany; [Bhatia, Kailash] UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England; [Cincotta, Massimo] Osped San Giovanni Dio, Azienda Sanit Firenze, Unita Operat Neurol, I-50124 Florence, Italy; [Flamand-Roze, Constance] Hop Bicetre, AP HP, Serv Neurol, F-94275 Paris, France; [Carpentier, Wassila] Hop La Pitie Salpetriere, Platform P3S, F-75013 Paris, France; [Stevanin, Giovanni] Ecole Prat Hautes Etud, F-75007 Paris, France; [Dusart, Isabelle] CNRS, UMR 7102, F-75005 Paris, France; [Wehrle, Rosine; Dusart, Isabelle] Univ Paris 06, UMR 7102, F-75005 Paris, France; [Roze, Emmanuel] INSERM, UMRS 952, F-75013 Paris, France; [Roze, Emmanuel] CNRS, UMR 7224, F-75005 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; University of Kiel; Schleswig Holstein University Hospital; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Lubeck; University of London; University College London; Azienda Sanitaria di Firenze; Presidio Ospedaliero San Giovanni di Dio; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Brice, A (corresponding author), Hop La Pitie Salpetriere, INSERM, U975, CRICM, F-75013 Paris, France.	alexis.brice@upmc.fr	brice, alexis/AAE-8275-2019; Brice, Alexis/A-2170-2009; meunier, sabine/G-7622-2014; Groppa, Sergiu/G-4606-2014; Groppa, Sergiu/A-5711-2019; Cincotta, Massimo/AAA-7532-2019; Depienne, Christel/AAL-3835-2021; Klebe, Stephan/AAD-2082-2022; Corvol, Jean-Christophe/F-2124-2017; Stevanin, Giovanni/E-5038-2016; Klein, Christine/AGK-8003-2022	brice, alexis/0000-0002-0941-3990; meunier, sabine/0000-0002-6167-4602; Groppa, Sergiu/0000-0002-2551-5655; Cincotta, Massimo/0000-0001-5223-646X; Depienne, Christel/0000-0002-7212-9554; Corvol, Jean-Christophe/0000-0001-7325-0199; Stevanin, Giovanni/0000-0001-9368-8657; Bhatia, Kailash/0000-0001-8185-286X; Meneret, Aurelie/0000-0002-7623-1142; Dusart, Isabelle/0000-0002-3211-4323; Klein, Christine/0000-0003-2102-3431	INSERM; IPSEN; Hermann and Lilly Schilling Foundation; Ente Cassa di Risparmio di Firenze	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); IPSEN(Ipsen); Hermann and Lilly Schilling Foundation; Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze)	We thank the families for their participation, the DNA and cell bank for DNA extraction and cell culture, Khadija Tahiri for RNA preparation, and Agnes Rastetter for technical support in western blot analysis. This work was supported by INSERM, by Djilalli Mehri, and by an unrestricted research grant from IPSEN. C.K. was supported by the Hermann and Lilly Schilling Foundation. M.C.'s unit was supported by Ente Cassa di Risparmio di Firenze.	Ajioka I, 2006, EUR J NEUROSCI, V23, P296, DOI 10.1111/j.1460-9568.2005.04544.x; Bonnet C, 2010, MOVEMENT DISORD, V25, P1317, DOI 10.1002/mds.22944; Carreira A, 2009, CELL, V136, P1032, DOI 10.1016/j.cell.2009.02.019; Deans B, 2000, EMBO J, V19, P6675, DOI 10.1093/emboj/19.24.6675; Depienne C, 2011, NEUROLOGY, V76, P260, DOI 10.1212/WNL.0b013e318207b1e0; Djarmati-Westenberger A, 2011, NEUROLOGY, V77, P1580, DOI 10.1212/WNL.0b013e318230b140; Francis F, 2006, EUR J NEUROSCI, V23, P877, DOI 10.1111/j.1460-9568.2006.04649.x; Gallea C, 2011, J NEUROL, V258, P1911, DOI 10.1007/s00415-011-6107-9; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Kato M, 2000, J HUM GENET, V45, P133, DOI 10.1007/s100380050199; Klein HL, 2008, DNA REPAIR, V7, P686, DOI 10.1016/j.dnarep.2007.12.008; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Lim DS, 1996, MOL CELL BIOL, V16, P7133; Orre LM, 2006, BIOCHEM BIOPH RES CO, V341, P334, DOI 10.1016/j.bbrc.2005.12.185; Park JY, 2008, NUCLEIC ACIDS RES, V36, P3226, DOI 10.1093/nar/gkn171; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; Sage JM, 2010, J BIOL CHEM, V285, P18984, DOI 10.1074/jbc.M109.099846; Shu TZ, 2000, J COMP NEUROL, V416, P201, DOI 10.1002/(SICI)1096-9861(20000110)416:2<201::AID-CNE6>3.0.CO;2-Z; Slupianek A, 2001, MOL CELL, V8, P795, DOI 10.1016/S1097-2765(01)00357-4; Srour M, 2010, SCIENCE, V328, P592, DOI 10.1126/science.1186463; Thacker J, 2005, CANCER LETT, V219, P125, DOI 10.1016/j.canlet.2004.08.018; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127	23	53	55	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB 10	2012	90	2					301	307		10.1016/j.ajhg.2011.12.002	http://dx.doi.org/10.1016/j.ajhg.2011.12.002			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	898KV	22305526	Green Published, Bronze			2022-12-18	WOS:000300742200011
J	Doi, H; Yoshida, K; Yasuda, T; Fukuda, M; Fukuda, Y; Morita, H; Ikeda, S; Kato, R; Tsurusaki, Y; Miyake, N; Saitsu, H; Sakai, H; Miyatake, S; Shiina, M; Nukina, N; Koyano, S; Tsuji, S; Kuroiwa, Y; Matsumoto, N				Doi, Hiroshi; Yoshida, Kunihiro; Yasuda, Takao; Fukuda, Mitsunori; Fukuda, Yoko; Morita, Hiroshi; Ikeda, Shu-ichi; Kato, Rumiko; Tsurusaki, Yoshinori; Miyake, Noriko; Saitsu, Hirotomo; Sakai, Haruya; Miyatake, Satoko; Shiina, Masaaki; Nukina, Nobuyuki; Koyano, Shigeru; Tsuji, Shoji; Kuroiwa, Yoshiyuki; Matsumoto, Naomichi			Exome Sequencing Reveals a Homozygous SYT14 Mutation in Adult-Onset, Autosomal-Recessive Spinocerebellar Ataxia with Psychomotor Retardation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CEREBELLAR ATAXIAS; ENDOPLASMIC-RETICULUM; SYNAPTOTAGMIN FAMILY; C2 DOMAINS; EXOCYTOSIS	Autosomal-recessive cerebellar ataxias (ARCAs) are clinically and genetically heterogeneous disorders associated with diverse neurological and nonneurological features that occur before the age of 20. Currently, mutations in more than 20 genes have been identified, but approximately half of the ARCA patients remain genetically unresolved. In this report, we describe a Japanese family in which two siblings have slow progression of a type of ARCA with psychomotor retardation. Using whole-exome sequencing combined with homozygosity mapping, we identified a homozygous missense mutation in SYT14, encoding synaptotagmin XIV (SYT14). Expression analysis of the mRNA of SYT14 by a Taq Man assay confirmed that SYT14 mRNA was highly expressed in human fetal and adult brain tissue as well as in the mouse brain (especially in the cerebellum). In an in vitro overexpression system, the mutant SYT14 showed intracellular localization different from that of the wild-type. An immunohistochemical analysis clearly showed that SYT14 is specifically localized to Purkinje cells of the cerebellum in humans and mice. Synaptotagmins are associated with exocytosis of secretory vesicles (including synaptic vesicles), indicating that the alteration of the membrane-trafficking machinery by the SYT14 mutation may represent a distinct pathomechanism associated with human neurodegenerative disorders.	[Doi, Hiroshi; Tsurusaki, Yoshinori; Miyake, Noriko; Saitsu, Hirotomo; Sakai, Haruya; Miyatake, Satoko; Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Doi, Hiroshi; Koyano, Shigeru; Kuroiwa, Yoshiyuki] Yokohama City Univ, Grad Sch Med, Dept Clin Neurol & Stroke Med, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Yoshida, Kunihiro] Shinshu Univ, Sch Med, Dept Brain Dis Reseach, Div Neurogenet, Nagano 3908621, Japan; [Yasuda, Takao; Fukuda, Mitsunori] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Lab Membrane Trafficking Mech,Aoba Ku, Sendai, Miyagi 9808578, Japan; [Fukuda, Yoko; Tsuji, Shoji] Univ Tokyo, Grad Sch Med, Dept Neurol, Bunkyo Ku, Tokyo 1138655, Japan; [Morita, Hiroshi; Ikeda, Shu-ichi] Shinshu Univ, Sch Med, Dept Med Neurol & Rheumatol, Nagano 3908621, Japan; [Kato, Rumiko] Natl Higashi Saitama Hosp, Dept Pediat, Hasuda 3490196, Japan; [Shiina, Masaaki] Yokohama City Univ, Grad Sch Med, Dept Biochem, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Nukina, Nobuyuki] RIKEN, Brain Sci Inst, Lab Struct Neuropathol, Wako, Saitama 3510198, Japan	Yokohama City University; Yokohama City University; Shinshu University; Tohoku University; University of Tokyo; Shinshu University; Yokohama City University; RIKEN	Matsumoto, N (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Human Genet, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	naomat@yokohama-cu.ac.jp	Saitsu, Hirotomo/AAM-7131-2021; Fukuda, MItsunori/I-1511-2015; Nukina, Nobuyuki/GPP-6265-2022; Morita, Hiroshi/AFO-0038-2022	Fukuda, MItsunori/0000-0002-8620-5853; Morita, Hiroshi/0000-0003-3224-2058; Tsurusaki, Yoshinori/0000-0002-7240-6355; Saitsu, Hirotomo/0000-0003-0723-0960	Ministry of Health, Labour, and Welfare; Japan Science and Technology Agency; Japan Society for the Promotion of Science; Kimi Imai Memorial Foundation for Research of Incurable Neuromuscular Diseases; Grants-in-Aid for Scientific Research [20591021, 22790823] Funding Source: KAKEN	Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kimi Imai Memorial Foundation for Research of Incurable Neuromuscular Diseases; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We would like to thank the patients and their family for their participation in this study. We are indebted to Syu-ichi Hirai (Department of Molecular Biology, Yokohama City University) for providing useful technical information about subcellular fractionation and to Keiko Yamaoka (Kanagawa Rehabilitation Center) for providing brain tissue from the control subject. This work was supported by research grants from the Ministry of Health, Labour, and Welfare (H.S., N. Miyake, and N. Matsumoto), the Japan Science and Technology Agency (N. Matsumoto), a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (N. Matsumoto), a Grant-in-Aid for Young Scientist from the Japan Society for the Promotion of Science (H.D., N. Miyake, and H.S.) and a grant-in-aid from The Kimi Imai Memorial Foundation for Research of Incurable Neuromuscular Diseases (H.D.).	Adolfsen B, 2004, J CELL BIOL, V166, P249, DOI 10.1083/jcb.200312054; Anheim M, 2010, NEUROGENETICS, V11, P1, DOI 10.1007/s10048-009-0196-y; Bahlo M, 2009, BIOINFORMATICS, V25, P1961, DOI 10.1093/bioinformatics/btp313; Bai JH, 2004, TRENDS BIOCHEM SCI, V29, P143, DOI 10.1016/j.tibs.2004.01.008; Becker J, 2011, AM J HUM GENET, V88, P362, DOI 10.1016/j.ajhg.2011.01.015; Bhalla A, 2008, J BIOL CHEM, V283, P21799, DOI 10.1074/jbc.M709628200; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Colgan SM, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399410001742; Doi H, 2004, FEBS LETT, V571, P171, DOI 10.1016/j.febslet.2004.06.077; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Embirucu EK, 2009, ARQ NEURO-PSIQUIAT, V67, P1143, DOI 10.1590/S0004-282X2009000600036; Fogel BL, 2007, LANCET NEUROL, V6, P245, DOI 10.1016/S1474-4422(07)70054-6; Fukuda M, 1996, J BIOL CHEM, V271, P8430, DOI 10.1074/jbc.271.14.8430; Fukuda M, 2003, J BIOCHEM, V133, P641, DOI 10.1093/jb/mvg082; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; Glavan G, 2009, ANAT REC, V292, P1849, DOI 10.1002/ar.21026; Gros-Louis F, 2007, NAT GENET, V39, P80, DOI 10.1038/ng1927; Gudbjartsson DF, 2005, NAT GENET, V37, P1015, DOI 10.1038/ng1005-1015; Jana NR, 2000, HUM MOL GENET, V9, P2009, DOI 10.1093/hmg/9.13.2009; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Manto M, 2009, CURR OPIN NEUROL, V22, P419, DOI 10.1097/WCO.0b013e32832b9897; McCue HV, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004085; Michelsen U, 2009, METHOD ENZYMOL, V463, P305, DOI 10.1016/S0076-6879(09)63019-6; Oyama F, 2006, J NEUROCHEM, V98, P518, DOI 10.1111/j.1471-4159.2006.03893.x; Palau F, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-47; Quintero-Rivera F, 2007, AM J MED GENET A, V143A, P558, DOI 10.1002/ajmg.a.31618; Rickman C, 2004, BIOCHEM J, V378, P681, DOI 10.1042/BJ20031407; Schmitz-Hubsch T, 2006, NEUROLOGY, V66, P1717, DOI 10.1212/01.wnl.0000219042.60538.92; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; Tsurusaki Y, 2011, J MED GENET, V48, P606, DOI 10.1136/jmg.2010.083535; Vermeer S, 2010, AM J HUM GENET, V87, P813, DOI 10.1016/j.ajhg.2010.10.015; Zhang G, 2011, NEURON, V69, P523, DOI 10.1016/j.neuron.2010.12.036	32	53	58	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG 12	2011	89	2					320	327		10.1016/j.ajhg.2011.07.012	http://dx.doi.org/10.1016/j.ajhg.2011.07.012			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	810TA	21835308	Green Published, Bronze			2022-12-18	WOS:000294148800013
J	Israeli, S; Khamaysi, Z; Fuchs-Telem, D; Nousbeck, J; Bergman, R; Sarig, O; Sprecher, E				Israeli, Shirli; Khamaysi, Ziyad; Fuchs-Telem, Dana; Nousbeck, Janna; Bergman, Reuven; Sarig, Ofer; Sprecher, Eli			A Mutation in LIPN, Encoding Epidermal Lipase N, Causes a Late-Onset Form of Autosomal-Recessive Congenital Ichthyosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRIGLYCERIDE	Autosomal-recessive congenital ichthyoses represent a large and heterogeneous group of disorders of epidermal cornification. Recent data suggest that most of these disorders might result from defective lipid transport and metabolism. In the present study, we describe a late-onset form of recessive ichthyosis in a large consanguineous pedigree. By using a combination of homozygosity mapping and positional candidate-gene screening, we identified a 2 bp deletion in LIPN that segregated with the disease phenotype throughout the family. LIPN encodes one of six acid lipases known to be involved in triglyceride metabolism in mammals. LIPN was found to be exclusively expressed in the epidermis and to be strongly induced during keratinocyte differentiation.	[Israeli, Shirli; Fuchs-Telem, Dana; Nousbeck, Janna; Sarig, Ofer; Sprecher, Eli] Tel Aviv Sourasky Med Ctr, Dept Dermatol, IL-64239 Tel Aviv, Israel; [Israeli, Shirli; Fuchs-Telem, Dana; Sprecher, Eli] Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-69978 Ramat Aviv, Israel; [Khamaysi, Ziyad; Bergman, Reuven] Rambam Med Ctr, Dept Dermatol, IL-31096 Haifa, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Rambam Health Care Campus; Technion Israel Institute of Technology	Sprecher, E (corresponding author), Tel Aviv Sourasky Med Ctr, Dept Dermatol, IL-64239 Tel Aviv, Israel.	elisp@tasmc.health.gov.il			Israel General Trustee Fund	Israel General Trustee Fund	We would like to acknowledge the participation of the family in this study. This study was supported in part by grants from the Israel General Trustee Fund.	Akiyama M, 2008, EXP DERMATOL, V17, P373, DOI 10.1111/j.1600-0625.2007.00691.x; Akiyama M, 2010, HUM MUTAT, V31, P1090, DOI 10.1002/humu.21326; ASSMANN G, 1973, J BIOL CHEM, V248, P7184; BODMER MW, 1987, BIOCHIM BIOPHYS ACTA, V909, P237, DOI 10.1016/0167-4781(87)90083-2; Brown JM, 2007, J LIPID RES, V48, P2295, DOI 10.1194/jlr.M700279-JLR200; Bruno C, 2008, BIOCHEM BIOPH RES CO, V369, P1125, DOI 10.1016/j.bbrc.2008.03.010; Elias PM, 2008, J LIPID RES, V49, P697, DOI 10.1194/jlr.R800002-JLR200; Elias PM, 2004, J INVEST DERMATOL, V122, P314, DOI 10.1046/j.1523-1747.2003.22258.x; Fischer J, 2009, J INVEST DERMATOL, V129, P1319, DOI 10.1038/jid.2009.57; Fishelson M., 2002, BIOINFORMATICS, V18, pS189, DOI [10.1093/bioinformatics/18.suppl_1.S189, DOI 10.1093/BIOINFORMATICS/18.SUPPL_1.S189]; Fuchs-Telem D, 2011, BRIT J DERMATOL, V164, P610, DOI 10.1111/j.1365-2133.2010.10133.x; Furstenberger G, 2007, PROSTAG OTH LIPID M, V82, P128, DOI 10.1016/j.prostaglandins.2006.05.006; Hatsell SJ, 2003, BRIT J DERMATOL, V149, P174, DOI 10.1046/j.1365-2133.2003.05386.x; HOEG JM, 1984, AM J HUM GENET, V36, P1190; Holmes RS, 2010, COMP BIOCHEM PHYS D, V5, P217, DOI 10.1016/j.cbd.2010.05.004; Hovnanian A, 2005, J CLIN INVEST, V115, P1708, DOI 10.1172/JCI25736; Klar J, 2009, AM J HUM GENET, V85, P248, DOI 10.1016/j.ajhg.2009.06.021; Lugassy J, 2008, ARCH DERMATOL RES, V300, P81, DOI 10.1007/s00403-007-0815-0; Mizrachi-Koren M, 2005, J INVEST DERMATOL, V125, P456, DOI 10.1111/j.0022-202X.2005.23777.x; Mizrachi-Koren M, 2006, J AM ACAD DERMATOL, V55, P393, DOI 10.1016/j.jaad.2006.02.020; Montero-Moran G, 2010, J LIPID RES, V51, P709, DOI 10.1194/jlr.M001917; Oji V, 2010, J AM ACAD DERMATOL, V63, P607, DOI 10.1016/j.jaad.2009.11.020; Pilgram GSK, 2001, J INVEST DERMATOL, V117, P710, DOI 10.1046/j.0022-202x.2001.01455.x; Radner FPW, 2010, J BIOL CHEM, V285, P7300, DOI 10.1074/jbc.M109.081877; Schmuth Matthias, 2007, Adv Dermatol, V23, P231, DOI 10.1016/j.yadr.2007.07.011; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Styperek AR, 2010, PEDIATR DERMATOL, V27, P325, DOI 10.1111/j.1525-1470.2010.01160.x; Toulza E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r107; Vahlquist A, 2010, ACTA DERM-VENEREOL, V90, P454, DOI 10.2340/00015555-0937; Wu WM, 2011, J DERMATOL SCI, V61, P62, DOI 10.1016/j.jdermsci.2010.10.011	30	53	55	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 8	2011	88	4					482	487		10.1016/j.ajhg.2011.02.011	http://dx.doi.org/10.1016/j.ajhg.2011.02.011			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	752BY	21439540	Green Published, Bronze			2022-12-18	WOS:000289664300008
J	McEvoy, BP; Lind, JM; Wang, ET; Moyzis, RK; Visscher, PM; Pellekaan, SMV; Wilton, AN				McEvoy, Brian P.; Lind, Joanne M.; Wang, Eric T.; Moyzis, Robert K.; Visscher, Peter M.; Pellekaan, Sheila M. van Holst; Wilton, Alan N.			Whole-Genome Genetic Diversity in a Sample of Australians with Deep Aboriginal Ancestry	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							Y-CHROMOSOME; DIABETIC-NEPHROPATHY; WIDE ASSOCIATION; NEW-GUINEA; POPULATION; SELECTION; MTDNA; POLYMORPHISMS; SETTLEMENT; EVOLUTION	Australia was probably settled soon after modern humans left Africa, but details of this ancient migration are not well understood. Debate centers on whether the Pleistocene Sahul continent (composed of New Guinea, Australia, and Tasmania) was first settled by a single wave followed by regional divergence into Aboriginal Australian and New Guinean populations (common origin) or whether different parts of the continent were initially populated independently. Australia has been the subject of relatively few DNA studies even though understanding regional variation in genomic structure and diversity will be important if disease-association mapping methods are to be successfully evaluated and applied across populations. We report on a genome-wide investigation of Australian Aboriginal SNP diversity in a sample of participants from the Riverine region. The phylogenetic relationship of these Aboriginal Australians to a range of other global populations demonstrates a deep common origin with Papuan New Guineans and Melanesians, with little evidence of substantial later migration until the very recent arrival of European colonists. The study provides valuable and robust insights into an early and important phase of human colonization of the globe. A broader survey of Australia, including diverse geographic sample populations, will be required to fully appreciate the continent's unique population history and consequent genetic heritage, as well as the importance of both to the understanding of health issues.	[McEvoy, Brian P.; Visscher, Peter M.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Lind, Joanne M.] Univ Western Sydney, Unit Mol Physiol, Sch Med, Campbelltown, NSW 2560, Australia; [Wang, Eric T.] Veracyte, Dept Res & Dev, San Francisco, CA 94080 USA; [Moyzis, Robert K.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Moyzis, Robert K.] Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA 92697 USA; [Pellekaan, Sheila M. van Holst; Wilton, Alan N.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Pellekaan, Sheila M. van Holst; Wilton, Alan N.] Univ New S Wales, Ramaciotti Ctr Gene Funct Anal, Sydney, NSW 2052, Australia	QIMR Berghofer Medical Research Institute; Western Sydney University; University of California System; University of California Irvine; University of California System; University of California Irvine; University of New South Wales Sydney; University of New South Wales Sydney	McEvoy, BP (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4006, Australia.	brian.mcevoy@qimr.edu.au; s.vanholst@unsw.edu.au	Wilton, Alan N/C-2430-2011; Visscher, Peter/ABB-6151-2020	Visscher, Peter/0000-0002-2143-8760	Australian National Health and Research Council (NHMRC) [389892, 613601]; Australian Research Council [DP0770096]	Australian National Health and Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	The participants in this study are from the main language groups of Barkindji (Paakintji) and Ngiyambaa and from several associated language groups now living in the communities of Wilcannia, Menindee, and Dareton in the Darling River region of western New South Wales, Australia. Their friendship and participation over many years is greatly appreciated. We thank Nick Martin for his role in facilitating and initiating this study and the staff at the Ramaciotti Centre for Gene Function Analysis, University of New South Wales, Sydney, who carried out the genotyping. Experiment costs were provided by the researchers. B.P.M. and P.M.V. are supported by grants from the Australian National Health and Research Council (NHMRC; grants 389892 and 613601) and the Australian Research Council (grant DP0770096). J.M.L. is supported by an NHMRC Peter Doherty Australian Biomedical Fellowship.	Balme J, 2009, QUATERN INT, V202, P59, DOI 10.1016/j.quaint.2008.10.002; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; Ewens KG, 2005, DIABETES, V54, P3305, DOI 10.2337/diabetes.54.11.3305; Falush D, 2003, GENETICS, V164, P1567; Friedlaender J, 2005, MOL BIOL EVOL, V22, P1506, DOI 10.1093/molbev/msi142; GROUBE L, 1986, NATURE, V324, P453, DOI 10.1038/324453a0; Hudjashov G, 2007, P NATL ACAD SCI USA, V104, P8726, DOI 10.1073/pnas.0702928104; Huoponen K, 2001, HUM IMMUNOL, V62, P954, DOI 10.1016/S0198-8859(01)00294-4; Ingman M, 2003, GENOME RES, V13, P1600, DOI 10.1101/gr.686603; Iyengar SK, 2007, DIABETES, V56, P1577, DOI 10.2337/db06-1154; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Kayser M, 2001, AM J HUM GENET, V68, P173, DOI 10.1086/316949; Kayser M, 2008, AM J HUM GENET, V82, P194, DOI 10.1016/j.ajhg.2007.09.010; Kayser M, 2006, MOL BIOL EVOL, V23, P2234, DOI 10.1093/molbev/msl093; Kayser M, 2010, CURR BIOL, V20, pR194, DOI 10.1016/j.cub.2009.12.004; Kimura R, 2008, MOL BIOL EVOL, V25, P1750, DOI 10.1093/molbev/msn128; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McDonough CW, 2009, HUM GENET, V126, P805, DOI 10.1007/s00439-009-0732-8; Moodley Y, 2009, SCIENCE, V323, P527, DOI 10.1126/science.1166083; Mulvaney D. J., 1999, PREHISTORY AUSTR; Need AC, 2009, TRENDS GENET, V25, P489, DOI 10.1016/j.tig.2009.09.012; O'Connell JF, 2004, J ARCHAEOL SCI, V31, P835, DOI 10.1016/j.jas.2003.11.005; Oppenheimer S, 2009, QUATERN INT, V202, P2, DOI 10.1016/j.quaint.2008.05.015; Pellekaan SMV, 1998, AM J HUM GENET, V62, P435, DOI 10.1086/301710; PELLEKAAN SV, 2006, FARMING; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Quintana-Murci L, 2010, AM J HUM GENET, V86, P611, DOI 10.1016/j.ajhg.2010.02.014; Redd AJ, 1999, AM J HUM GENET, V65, P808, DOI 10.1086/302533; Redd AJ, 2002, CURR BIOL, V12, P673, DOI 10.1016/S0960-9822(02)00789-3; RobertsThomson JM, 1996, AM J HUM GENET, V58, P1017; Rosenberg NA, 2010, NAT REV GENET, V11, P356, DOI 10.1038/nrg2760; Savolainen P, 2004, P NATL ACAD SCI USA, V101, P12387, DOI 10.1073/pnas.0401814101; Seldin MF, 2007, CURR OPIN GENET DEV, V17, P177, DOI 10.1016/j.gde.2007.03.002; Stoneking M, 1997, GENOME RES, V7, P1061, DOI 10.1101/gr.7.11.1061; Sturm RA, 2008, AM J HUM GENET, V82, P424, DOI 10.1016/j.ajhg.2007.11.005; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; THOMAS N, 2008, OVERVIEW AUSTR INDIG; TSINTSOF AS, 1990, AM J HUM GENET, V46, P138; van Holst Pellekaan S., 2000, J AUST ABORIGINAL ST, P65; Pellekaan SMV, 2006, AM J PHYS ANTHROPOL, V131, P282, DOI 10.1002/ajpa.20426	49	53	54	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 13	2010	87	2					297	305		10.1016/j.ajhg.2010.07.008	http://dx.doi.org/10.1016/j.ajhg.2010.07.008			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641EG	20691402	Bronze, Green Published			2022-12-18	WOS:000281107000015
J	Nishimura, DY; Baye, LM; Perveen, R; Searby, CC; Avila-Fernandez, A; Pereiro, I; Ayuso, C; Valverde, D; Bishop, PN; Manson, FDC; Urquhart, J; Stone, EM; Slusarski, DC; Black, GCM; Sheffield, VC				Nishimura, Darryl Y.; Baye, Lisa M.; Perveen, Rahat; Searby, Charles C.; Avila-Fernandez, Almudena; Pereiro, Ines; Ayuso, Carmen; Valverde, Diana; Bishop, Paul N.; Manson, Forbes D. C.; Urquhart, Jill; Stone, Edwin M.; Slusarski, Diane C.; Black, Graeme C. M.; Sheffield, Val C.			Discovery and Functional Analysis of a Retinitis Pigmentosa Gene, C2ORF71	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EXPRESSION ANALYSIS; PROTEIN LIPIDATION; HOMEOBOX GENE; DANIO-RERIO; PALMITOYLATION; ZEBRAFISH; IDENTIFICATION; MYRISTOYLATION; TRAFFICKING; RESOURCE	Retinitis pigmentosa is a genetically heterogeneous group of inherited ocular disorders characterized by progressive photoreceptor cell loss, night blindness, constriction of the visual field, and progressive visual disability. Homozygosity mapping and gene expression studies identified a 2 exon gene, C2ORF71. The encoded protein has no homologs and is highly expressed in the eye, where it is specifically expressed in photoreceptor cells. Two mutations were found in C2ORF71 in human RP patients: A nonsense mutation (p.W253X) in the first exon is likely to be a null allele; the second, a missense mutation (p.1201F) within a highly conserved region of the protein, leads to proteosomal degradation. Bioinformatic and functional studies identified and validated sites of lipid modification within the first three amino acids of the C2ORF71 protein. Using morpholino oligonucleotides to knockdown c2orf71 expression in zebrafish results in visual defects, confirming that C2ORF71 plays an important role in the development of normal vision. Finally, localization of C2ORF71 to primary cilia in cultured cells suggests that the protein is likely to localize to the connecting cilium or outer segment of photoreceptor cells.	[Perveen, Rahat; Manson, Forbes D. C.; Urquhart, Jill; Black, Graeme C. M.] Univ Manchester, Manchester Acad Heath Sci Ctr, Cent Manchester Univ Hosp NHS Fdn Trust, Manchester, Lancs, England; [Nishimura, Darryl Y.; Searby, Charles C.; Sheffield, Val C.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Nishimura, Darryl Y.; Searby, Charles C.; Stone, Edwin M.; Sheffield, Val C.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Baye, Lisa M.; Slusarski, Diane C.] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Stone, Edwin M.] Univ Iowa, Dept Ophthalmol, Iowa City, IA 52242 USA; [Bishop, Paul N.; Manson, Forbes D. C.; Black, Graeme C. M.] Univ Manchester, Manchester Acad Heath Sci Ctr, Cent Manchester Univ Hosp NHS Fdn Trust, Acad Unit Ophthalmol,Royal Eye Hosp, Manchester, Lancs, England; [Avila-Fernandez, Almudena; Ayuso, Carmen] Fdn Jimenez Diaz, Dept Med Genet, CIBERER, E-28040 Madrid, Spain; [Pereiro, Ines; Valverde, Diana] Univ Vigo, Dept Biochem, Vigo 36310, Spain	University of Manchester; University of Iowa; Howard Hughes Medical Institute; University of Iowa; University of Iowa; Manchester Royal Eye Hospital; University of Manchester; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidade de Vigo	Black, GCM (corresponding author), Univ Manchester, Manchester Acad Heath Sci Ctr, Cent Manchester Univ Hosp NHS Fdn Trust, Manchester, Lancs, England.	gblack@man.ac.uk	Diana, Valverde/I-2409-2012; Urquhart, Jill/G-2282-2015; Valverde, Diana/Y-1101-2019; Manson, Forbes/G-2222-2015; Black, Graeme/K-7374-2015	Diana, Valverde/0000-0002-7024-1657; Urquhart, Jill/0000-0002-5788-5511; Valverde, Diana/0000-0002-7024-1657; Manson, Forbes/0000-0002-8342-660X; Stone, Edwin M./0000-0003-3343-4414; Black, Graeme/0000-0001-8727-6592; Bishop, Paul/0000-0001-7937-7932; Slusarski, Diane/0000-0003-3793-8636; Searby, Charles/0000-0002-8108-8782; Ayuso, Carmen/0000-0002-9242-7065; Sheffield, Val/0000-0002-6282-0835	Iowa Cardiovascular Center; Foundation Fighting Blindness; National Institutes of Health [REY110298, REY017168, R01CA112369]; Fight for Sight; Manchester Academic Health Sciences Centre (MAHSC); NIHR Manchester Biomedical Research Centre; NATIONAL CANCER INSTITUTE [R01CA112369] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY017168] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007121] Funding Source: NIH RePORTER	Iowa Cardiovascular Center; Foundation Fighting Blindness(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fight for Sight; Manchester Academic Health Sciences Centre (MAHSC); NIHR Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We acknowledge the families who provided DNA samples and their consent for inclusion in these studies. The following individuals provided technical support: Gun-Hee Kim, Svetha Swaminathan, Pamela Pretorius, and John Beck. We also acknowledge the following sources of funding: Iowa Cardiovascular Center Institutional Research Fellowship (L.M.B.), Foundation Fighting Blindness (EMS. and V.C.S.), the National Institutes of Health grants REY110298 (V.C.S.), REY017168 (V.C.S.), R01CA112369 (D.C.S.), Fight for Sight (GB. and F.M.), the Manchester Academic Health Sciences Centre (MAHSC), and NIHR Manchester Biomedical Research Centre. V.C.S. and E.M.S. are investigators of the Howard Hughes Medical Institute.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Blackshaw S, 2001, CELL, V107, P579, DOI 10.1016/S0092-8674(01)00574-8; Bologna G, 2004, PROTEOMICS, V4, P1626, DOI 10.1002/pmic.200300783; BRANCHEK T, 1984, J COMP NEUROL, V224, P116, DOI 10.1002/cne.902240110; CASEY PJ, 1995, SCIENCE, V268, P221, DOI 10.1126/science.7716512; Chakrabandhu K, 2007, EMBO J, V26, P209, DOI 10.1038/sj.emboj.7601456; Chapple JP, 2002, INVEST OPHTH VIS SCI, V43, P2015; Chowers I, 2003, INVEST OPHTH VIS SCI, V44, P3732, DOI 10.1167/iovs.02-1080; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; Demos C, 2008, MOL VIS, V14, P1639; Draper JM, 2007, J LIPID RES, V48, P1873, DOI 10.1194/jlr.M700179-JLR200; Easter SS, 1996, DEV BIOL, V180, P646; Feig C, 2007, EMBO J, V26, P221, DOI 10.1038/sj.emboj.7601460; Geisert EE, 2009, MOL VIS, V15, P1730; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; Horton P, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P147; Hu M, 1999, DEV BIOL, V207, P309, DOI 10.1006/dbio.1998.9031; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kurayoshi M, 2007, BIOCHEM J, V402, P515, DOI 10.1042/BJ20061476; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Liu YH, 2001, INVEST OPHTH VIS SCI, V42, P481; Martinez A, 2008, PROTEOMICS, V8, P2809, DOI 10.1002/pmic.200701191; Maurer-Stroh S, 2002, J MOL BIOL, V317, P541, DOI 10.1006/jmbi.2002.5426; Nadolski MJ, 2007, FEBS J, V274, P5202, DOI 10.1111/j.1742-4658.2007.06056.x; Nishimura DY, 2005, AM J HUM GENET, V77, P1021, DOI 10.1086/498323; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; Resh MD, 2006, METHODS, V40, P191, DOI 10.1016/j.ymeth.2006.04.013; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Schmitt EA, 1999, J COMP NEUROL, V404, P515; Shen YC, 2004, DEV BIOL, V269, P237, DOI 10.1016/j.ydbio.2004.01.037; Swiderski RE, 2007, INVEST OPHTH VIS SCI, V48, P3329, DOI 10.1167/iovs.06-1477; Westerfield M, 1995, ZEBRAFISH BOOK	32	53	55	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 14	2010	86	5					686	695		10.1016/j.ajhg.2010.03.005	http://dx.doi.org/10.1016/j.ajhg.2010.03.005			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	601GC	20398886	Bronze, Green Published			2022-12-18	WOS:000278045300005
J	Kloeckener-Gruissem, B; Vandekerckhove, K; Nurnberg, G; Neidhardt, J; Zeitz, C; Nuernberg, P; Schipper, I; Berger, W				Kloeckener-Gruissem, Barbara; Vandekerckhove, Kristof; Nuernberg, Gudrun; Neidhardt, John; Zeitz, Christina; Nuernberg, Peter; Schipper, Isaak; Berger, Wolfgang			Mutation of solute carrier SLC16A12 associates with a syndrome combining juvenile cataract with microcornea and renal glucosuria	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOSOMAL-DOMINANT CATARACTS; MONOCARBOXYLATE TRANSPORTERS; CONGENITAL CATARACT; GENE; IDENTIFICATION; KIDNEY; FAMILY; CELLS; PITX3; LENS	Unobstructed vision requires a particular refractive index of the lens, a measure based on the organization of the structural proteins within the differentiated lens cells. To ensure an intact lens structure, homeostasis within the lens cells is indispensable. Alterations of the lens structure result in opacity and lead to cataract. Renal glucosuria is defined by elevated glucose level in the urine without hyperglycemia and without evidence of morphological renal anomalies. In a Swiss family with autosomal dominant juvenile cataract, microcornea, and renal glucosuria, we have identified a nonsense mutation in a member of the carboxylic acid transporter family SLC16. The underlying gene defect in SLC16A12 resides within a 3 cM region on chromosome 10q23.13 defined by linkage mapping of this phenotype. We found tissue-specific variability of SLC16A12 transcript levels in control samples, with high expression in the eye and kidney, the two organs affected by this syndrome. This report demonstrates biological relevance of this solute carrier. We hypothesize that SLC16A12 is important for lens and kidney homeostasis and discuss its potential role in age-related cataract.	[Kloeckener-Gruissem, Barbara; Neidhardt, John; Zeitz, Christina; Berger, Wolfgang] Univ Zurich, Inst Med Genet, Div Med Mol Genet & Gene Diagnost, CH-8603 Schwerzenbach, Switzerland; [Kloeckener-Gruissem, Barbara] ETH, Dept Biol, CH-8092 Zurich, Switzerland; [Vandekerckhove, Kristof; Schipper, Isaak] Kanton Hosp Luzern, Eye Clin, CH-6000 Luzern, Switzerland; [Nuernberg, Peter] Univ Cologne, Inst Genet, DE-50674 Cologne, Germany; [Nuernberg, Gudrun; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, DE-50674 Cologne, Germany; [Nuernberg, Gudrun] RZPD Deutsch Ressourcenzentrum Genomforsch GmbH, DE-14509 Berlin, Germany	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Lucerne Cantonal Hospital; University of Cologne; University of Cologne	Kloeckener-Gruissem, B (corresponding author), Univ Zurich, Inst Med Genet, Div Med Mol Genet & Gene Diagnost, CH-8603 Schwerzenbach, Switzerland.	kloeckener@medgen.unizh.ch	Vandekerckhove, Kristof/M-9012-2019; Zeitz, Christina/F-2757-2017; Neidhardt, John/J-4310-2017; Vandekerckhove, Kristof/ABH-3798-2020	Vandekerckhove, Kristof/0000-0002-1481-0878; Zeitz, Christina/0000-0002-3510-1712; Neidhardt, John/0000-0002-9205-8394				AUGUSTEYN RC, 2007, MOL VIS, V13, P352; Burdon KP, 2006, MOL VIS, V12, P367; Deora AA, 2005, P NATL ACAD SCI USA, V102, P16245, DOI 10.1073/pnas.0504419102; Francis PJ, 2000, J MED GENET, V37, P481, DOI 10.1136/jmg.37.7.481; Futter CE, 2005, INVEST OPHTH VIS SCI, V46, P3256, DOI 10.1167/iovs.05-0086; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Hammond CJ, 2000, NEW ENGL J MED, V342, P1786, DOI 10.1056/NEJM200006153422404; Hammond CJ, 2001, INVEST OPHTH VIS SCI, V42, P601; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Jamieson RV, 2007, HUM MUTAT, V28, P968, DOI 10.1002/humu.20545; Lorenz B, 2007, OPHTHALMOLOGE, V104, P559, DOI 10.1007/s00347-007-1557-2; Neidhardt J, 2007, HUM MUTAT, V28, P797, DOI 10.1002/humu.20521; Philp NJ, 2003, INVEST OPHTH VIS SCI, V44, P1716, DOI 10.1167/iovs.02-0287; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Santer R, 2003, J AM SOC NEPHROL, V14, P2873, DOI 10.1097/01.ASN.0000092790.89332.D2; Semina EV, 1998, NAT GENET, V19, P167, DOI 10.1038/527; Shiels A, 2007, AM J HUM GENET, V81, P596, DOI 10.1086/519980; Shiels A, 2007, ARCH OPHTHALMOL-CHIC, V125, P165, DOI 10.1001/archopht.125.2.165; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; Vandekerckhove K, 2007, KLIN MONATSBL AUGENH, V224, P344, DOI 10.1055/s-2007-962943; Wallner EI, 2001, RENAL FAILURE, V23, P301, DOI 10.1081/JDI-100104714	23	53	56	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2008	82	3					772	779		10.1016/j.ajhg.2007.12.013	http://dx.doi.org/10.1016/j.ajhg.2007.12.013			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	275JN	18304496	Green Published, Bronze			2022-12-18	WOS:000254067800022
J	Sass, JO; Mohr, V; Olbrich, H; Engelke, U; Horvath, J; Fliegauf, M; Loges, NT; Schweitzer-Krantz, S; Moebus, R; Weiler, P; Kispert, A; Superti-Furga, A; Wevers, RA; Omran, H				Sass, JO; Mohr, V; Olbrich, H; Engelke, U; Horvath, J; Fliegauf, M; Loges, NT; Schweitzer-Krantz, S; Moebus, R; Weiler, P; Kispert, A; Superti-Furga, A; Wevers, RA; Omran, H			Mutations in ACY1, the gene encoding aminoacylase 1, cause a novel inborn error of metabolism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CANAVAN-DISEASE; LOCALIZATION; PROTEINS; ACYLASE; CLONING	N-terminal acetylation of proteins is a widespread and highly conserved process. Aminoacylase 1 (ACY1; EC 3.5.14) is the most abundant of the aminoacylases, a class of enzymes involved in hydrolysis of N-acetylated proteins. Here, we present four children with genetic deficiency of ACY1. They were identified through organic acid analyses using gas chromatography - mass spectrometry, revealing increased urinary excretion of several N-acetylated amino acids, including the derivatives of methionine, glutamic acid, alanine, leucine, glycine, valine, and isoleucine. Nuclear magnetic resonance spectroscopy analysis of urine samples detected a distinct pattern of N-acetylated metabolites, consistent with ACY1 dysfunction. Functional analyses of patients' lymphoblasts demonstrated ACY1 deficiency. lMutation analysis uncovered recessive loss-of-function or missense ACY1 mutations in all four individuals affected. We conclude that ACY1 mutations in these children led to functional ACY1 deficiency and excretion of N-acetylated amino acids. Questions remain, however, as to the clinical significance of ACY1 deficiency. The ACY1-deficient individuals were ascertained through urine metabolic screening because of unspecific psychomotor delay (one subject), psychomotor delay with atrophy of the vermis and syringomyelia (one subject), marked muscular hypotonia (one subject), and follow-up for early treated biotinidase deficiency and normal clinical findings (one subject). Because ACY1 is evolutionarily conserved in fish, frog, mouse, and human and is expressed in the central nervous system (CNS) in human, a role in CNS function or development is conceivable but has yet to be demonstrated. Thus, at this point, we cannot state whether ACY1 deficiency has pathogenic significance with pleiotropic clinical expression or is simply a biochemical variant. Awareness of this new genetic entity may help both in delineating its clinical significance and in avoiding erroneous diagnoses.	Univ Freiburg, Childrens Hosp, Dept Gen Pediat & Adolescent Med, D-79106 Freiburg, Germany; Univ Freiburg, Childrens Hosp, Dept Pediat Neurol & Muscle Dis, D-79106 Freiburg, Germany; Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands; Pediat Practice, Bad Homburg, Germany; Evangel Krankenhaus, Dusseldorf, Germany; Childrens Hosp, Dortmund, Germany; Inst Mol Biol, Hannover, Germany; Sch Med, Hannover, Germany	University of Freiburg; University of Freiburg; Radboud University Nijmegen	Sass, JO (corresponding author), Univ Freiburg, Childrens Hosp, Dept Gen Pediat & Adolescent Med, Mathildenstr 1, D-79106 Freiburg, Germany.	Sass@kikLi.ukL.uni-freiburg.de	Engelke, U.F.H./L-4293-2015; Wevers, Ron A./H-8116-2014; superti-furga, andrea/E-9162-2015	Wevers, Ron A./0000-0003-2278-9746; superti-furga, andrea/0000-0002-3543-7531; Omran, Heymut/0000-0003-0282-6765				Anders M W, 1994, Adv Pharmacol, V27, P431, DOI 10.1016/S1054-3589(08)61042-X; Baslow MH, 1997, J MOL NEUROSCI, V9, P109, DOI 10.1007/BF02736855; BIRNBAUM SM, 1952, J BIOL CHEM, V194, P455; Canavan MM, 1931, ARCH NEURO PSYCHIATR, V25, P299, DOI 10.1001/archneurpsyc.1931.02230020085005; COOK RM, 1993, J BIOL CHEM, V268, P17010; Engelke UFH, 2004, CLIN CHEM, V50, P58, DOI 10.1373/clinchem.2003.020214; Giardina T, 1997, BIOCHIMIE, V79, P265, DOI 10.1016/S0300-9084(97)83514-6; Gordon N, 2001, Eur J Paediatr Neurol, V5, P65, DOI 10.1053/ejpn.2001.0467; KAUL R, 1993, NAT GENET, V5, P118, DOI 10.1038/ng1093-118; LEHNERT W, 1994, EUR J PEDIATR, V153, P9; Lindner H, 2000, BIOCHIMIE, V82, P129, DOI 10.1016/S0300-9084(00)00191-7; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MILLER HI, 1990, HUM GENE THER, V1, P3, DOI 10.1089/hum.1990.1.1-3; NAYLOR SL, 1979, SOMAT CELL GENET, V5, P11, DOI 10.1007/BF01538782; NAYLOR SL, 1982, AM J HUM GENET, V34, P235; Perrier J, 2005, BIOCHIMIE, V87, P673, DOI 10.1016/j.biochi.2005.04.002; Polevoda B, 2000, J BIOL CHEM, V275, P36479, DOI 10.1074/jbc.R000023200; Schmiedeberg O., 1881, ARCH EXP PATHOL PH, V14, P379; SMORODINZEW IA, 1922, HOPPESEYLERS Z PHYSL, V124, P123	19	53	62	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2006	78	3					401	409		10.1086/500563	http://dx.doi.org/10.1086/500563			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032AY	16465618	Bronze, Green Published			2022-12-18	WOS:000236747500008
J	Openo, KK; Schulz, JM; Vargas, CA; Orton, CS; Epstein, MP; Schnur, RE; Scaglia, F; Berry, GT; Gottesman, GS; Ficicioglu, C; Slonim, AE; Schroer, RJ; Yu, CL; Rangel, VE; Keenan, J; Lamance, K; Fridovich-Keil, JL				Openo, KK; Schulz, JM; Vargas, CA; Orton, CS; Epstein, MP; Schnur, RE; Scaglia, F; Berry, GT; Gottesman, GS; Ficicioglu, C; Slonim, AE; Schroer, RJ; Yu, CL; Rangel, VE; Keenan, J; Lamance, K; Fridovich-Keil, JL			Epimerase-deficiency galactosemia is not a binary condition	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DIPHOSPHATE GALACTOSE-4-EPIMERASE DEFICIENCY; LOW-DENSITY-LIPOPROTEIN; RED-BLOOD-CELLS; HUMAN UDP-GALACTOSE-4-EPIMERASE; GALACTOKINASE DEFICIENCY; 4-EPIMERASE DEFICIENCY; TUMOR CELLS; EXPRESSION; IDENTIFICATION; 4'-EPIMERASE	Epimerase-deficiency galactosemia results from the impairment of UDP-galactose 4'-epimerase ( GALE), the third enzyme in the Leloir pathway of galactose metabolism. Originally identified as a clinically benign "peripheral" condition with enzyme impairment restricted to circulating blood cells, GALE deficiency was later demonstrated also to exist in a rare but clinically severe "generalized" form, with enzyme impairment affecting a range of tissues. Isolated cases of clinically and/or biochemically intermediate cases of epimerase deficiency have also been reported. We report here studies of 10 patients who, in the neonatal period, received the diagnosis of hemolysate epimerase deficiency. We have characterized these patients with regard to three parameters: ( 1) GALE activity in transformed lymphoblasts, representing a "nonperipheral" tissue, ( 2) metabolic sensitivity of those lymphoblasts to galactose challenge in culture, and ( 3) evidence of normal versus abnormal galactose metabolism in the patients themselves. Our results demonstrate two important points. First, whereas some of the patients studied exhibited near-normal levels of GALE activity in lymphoblasts, consistent with a diagnosis of peripheral epimerase deficiency, many did not. We detected a spectrum of GALE activity levels ranging from 15%-64% of control levels, demonstrating that epimerase deficiency is not a binary condition; it is a continuum disorder. Second, lymphoblasts demonstrating the most severe reduction in GALE activity also demonstrated abnormal metabolite levels in the presence of external galactose and, in some cases, also in the absence of galactose. These abnormalities included elevated galactose-1P, elevated UDP-galactose, and deficient UDP-glucose. Moreover, some of the patients themselves also demonstrated metabolic abnormalities, both on and off galactose- restricted diet. Long-term follow-up studies of these and other patients will be required to elucidate the clinical significance of these biochemical abnormalities and the potential impact of dietary intervention on outcome.	Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; Emory Univ, Grad Program Nutr Hlth Sci, Atlanta, GA 30322 USA; Emory Coll, Atlanta, GA USA; Cooper Univ Hosp, Dept Pediat, Div Genet, Robert Wood Johnson Med Sch, Camden, NJ USA; Texas Childrens Hosp, Dept Mol & Human Gnet, Houston, TX 77030 USA; Baylor Coll Med, Houston, TX 77030 USA; Childrens Hosp Philadelphia, Div Metab, Philadelphia, PA 19104 USA; Jefferson Med Coll, Philadelphia, PA USA; SSM Cardinal Glennon Childrens Hosp, St Louis, MO USA; Columbia Univ, Sch Med, New York, NY 10027 USA; Greenwood Genet Ctr, Greenwood, SC 29646 USA	Emory University; Emory University; Cooper University Hospital; Rutgers State University New Brunswick; Rutgers State University Medical Center; Baylor College of Medicine; Baylor College of Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Jefferson University; Columbia University; Greenwood Genetic Center	Fridovich-Keil, JL (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Room 325-2,Whitehead Bldg,615 Michael St, Atlanta, GA 30322 USA.	jfridov@emory.edu	Ficicioglu, Can/AAQ-8002-2020	Ficicioglu, Can/0000-0002-8331-9804; Berry, Gerard/0000-0001-5299-3313				Alano A, 1998, J INHERIT METAB DIS, V21, P341, DOI 10.1023/A:1005342306080; ALANO A, 1997, J INVEST MED, V45, P191; Davis LG, 1994, BASIC METHODS MOL BI; ENDRES W, 1990, J INHERIT METAB DIS, V13, P509, DOI 10.1007/BF01799508; Ficicioglu C, 2005, MOL GENET METAB, V84, P152, DOI 10.1016/j.ymgme.2004.11.001; GITZELMANN R, 1972, HELV PAEDIATR ACTA, V27, P125; GITZELMANN R, 1977, HELV PAEDIATR ACTA, V31, P441; GITZELMANN R, 1973, HELV PAEDIATR ACTA, V28, P497; GITZELMANN R, 1967, PEDIATR RES, V1, P14, DOI 10.1203/00006450-196701000-00002; GOPPERT, 1917, KLIN WOCHENSCHR, V54, P473; Holton J. B., 2000, METABOLIC MOL BASES, P1553; HOLTON JB, 1981, ARCH DIS CHILD, V56, P885, DOI 10.1136/adc.56.11.885; Hotelling H, 1936, ANN MATH STAT, V7, P29, DOI 10.1214/aoms/1177732543; KALCKAR HM, 1965, SCIENCE, V150, P305, DOI 10.1126/science.150.3694.305; KINGSLEY DM, 1986, CELL, V44, P749, DOI 10.1016/0092-8674(86)90841-X; KINGSLEY DM, 1986, NEW ENGL J MED, V314, P1257; Kolmogoroff A, 1941, ANN MATH STAT, V12, P461, DOI 10.1214/aoms/1177731684; KRIEGER M, 1981, J MOL BIOL, V150, P167, DOI 10.1016/0022-2836(81)90447-2; KRIEGER M, 1989, METHOD CELL BIOL, V32, P57; KRUSKAL WH, 1952, ANN MATH STAT, V23, P525, DOI 10.1214/aoms/1177729332; Levy H.L., 1980, INHERITED DISORDERS, P133, DOI [10.1007/978-94-009-9215-3_8, DOI 10.1007/978-94-009-9215-3_8]; Maceratesi P, 1998, MOL GENET METAB, V63, P26, DOI 10.1006/mgme.1997.2645; MAYES JS, 1968, BIOCHEM GENET, V2, P219, DOI 10.1007/BF01474761; MITCHELL B, 1975, P NATL ACAD SCI USA, V72, P5026, DOI 10.1073/pnas.72.12.5026; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; PILLER F, 1983, J BIOL CHEM, V258, P774; Quimby BB, 1997, AM J HUM GENET, V61, P590, DOI 10.1086/515517; ROBINSON EA, 1963, BIOCHEM BIOPH RES CO, V13, P313, DOI 10.1016/0006-291X(63)90491-1; ROBINSON EA, 1966, J BIOL CHEM, V241, P2737; Ross KL, 2004, MOL GENET METAB, V83, P103, DOI 10.1016/j.ymgme.2004.07.005; SARDHARWALLA IB, 1988, J INHERIT METAB DIS, V11, P249, DOI 10.1007/BF01804249; SCHULPIS KH, 1993, J INHERIT METAB DIS, V16, P903, DOI 10.1007/BF00714292; Schulz JM, 2005, J BIOL CHEM, V280, P13493, DOI 10.1074/jbc.M414045200; Schulz JM, 2004, J BIOL CHEM, V279, P32796, DOI 10.1074/jbc.M405005200; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; SHIN Y, 1991, TECHNIQUES DIAGNOSTI, P280; Shin YS, 2000, J INHERIT METAB DIS, V23, P383, DOI 10.1023/A:1005699719068; Smits HP, 1998, ANAL BIOCHEM, V261, P36, DOI 10.1006/abio.1998.2714; WAGGONER DD, 1990, J INHERIT METAB DIS, V13, P802, DOI 10.1007/BF01800204; Walter JH, 1999, ARCH DIS CHILD, V80, P374, DOI 10.1136/adc.80.4.374; Wasilenko J, 2005, MOL GENET METAB, V84, P32, DOI 10.1016/j.ymgme.2004.09.003; Wehrli SL, 2001, NMR BIOMED, V14, P192, DOI 10.1002/nbm.694; Wohlers TM, 2000, J INHERIT METAB DIS, V23, P713, DOI 10.1023/A:1005682913784; Wohlers TM, 1999, AM J HUM GENET, V64, P462, DOI 10.1086/302263; Yager CT, 2003, MOL GENET METAB, V80, P283, DOI 10.1016/j.ymgme.2003.08.021	45	53	58	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2006	78	1					89	102		10.1086/498985	http://dx.doi.org/10.1086/498985			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	993CN	16385452	Green Published, Bronze			2022-12-18	WOS:000233930400009
J	Sellick, GS; Webb, EL; Allinson, R; Matutes, E; Dyer, MJS; Jonsson, V; Langerak, AW; Mauro, FR; Fuller, S; Wiley, J; Lyttelton, M; Callea, V; Yuille, M; Catovsky, D; Houlston, RS				Sellick, GS; Webb, EL; Allinson, R; Matutes, E; Dyer, MJS; Jonsson, V; Langerak, AW; Mauro, FR; Fuller, S; Wiley, J; Lyttelton, M; Callea, V; Yuille, M; Catovsky, D; Houlston, RS			A high-density SNP genomewide linkage scan for chronic lymphocytic leukemia-susceptibility loci	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; DISEQUILIBRIUM MEASURES; ATAXIA-TELANGIECTASIA; FAMILIES; DISEASE; MICROSATELLITES; PREDISPOSITION; GUIDELINES; CANCERS; MEMBERS	Chronic lymphocytic leukemia (CLL) and other B-cell lymphoproliferative disorders (LPDs) show clear evidence of familial aggregation, but the inherited basis is largely unknown. To identify a susceptibility gene for CLL, we conducted a genomewidelinkage analysis of 115 pedigrees, using a high-density single-nucleotide polymorphism (SNP) array containing 11,560 markers. Multipoint linkage analyses were undertaken using both nonparametric (model-free) and parametric (model-based) methods. Our results confirm that the presence of high linkage disequilibrium (LD) between SNP markers can lead to inflated nonparametric linkage (NPL) and LOD scores. After the removal of high-LD SNPs, we obtained a maximum NPL of 3.14 (P=.0008) on chromosome 11p11. The same genomic position also yielded the highest multipoint heterogeneity LOD (HLOD) score under both dominant ( HLOD 1.95) and recessive (HLOD 2.78) models. In addition, four other chromosomal positions (5q22-23, 6p22, 10q25, and 14q32) displayed HLOD scores > 1.15 (which corresponds to a nominal P value <. 01). None of the regions coincided with areas of common chromosomal abnormalities frequently observed for CLL. These findings strengthen the argument for an inherited predisposition to CLL and related B-cell LPDs.	Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; Inst Canc Res, Sect Haemato Oncol, Sutton SM2 5NG, Surrey, England; Univ Leicester, Med Res Council, Toxicol Unit, Leicester, Leics, England; Univ Oslo, Aker Univ Hosp, Dept Haematol, Oslo, Norway; Unit Rotterdam, Med Ctr, Erasmus Sch Ctr, Dept Immunol, Rotterdam, Netherlands; Univ Roma La Sapienza, Dipartimento Biotecnol Cellulari & Ematol, Div Hematol, Rome, Italy; Univ Sydney, Dept Med, Nepean Hosp, Penrith, Australia; Gen Hosp Kettering, Kettering, Northants, England; Azienda Osped Bianchi Melacrino Morelli, Dept Haematol, Reggio Di Calabria, Italy; Rosalind Franklin Ctr Genom Res, Wellcome Trust Genome Campus, Hinxton, England	University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Leicester; University of Oslo; Erasmus University Rotterdam; Sapienza University Rome; Nepean Hospital; University of Sydney; Wellcome Trust Sanger Institute	Houlston, RS (corresponding author), Inst Canc Res, Sect Canc Genet, 15 Cotswold Rd, Sutton SM2 5NG, Surrey, England.	Richard.Houlston@icr.ac.uk	Fuller, Stephen/W-6646-2019; Dyer, Martin/F-2691-2014	Fuller, Stephen/0000-0003-4637-7391; Dyer, Martin/0000-0002-5033-2236; Wiley, James/0000-0001-9421-4154; Webb, Emily/0000-0002-4019-7456; Houlston, Richard/0000-0002-5268-0242; Mauro, Francesca Romana/0000-0003-2425-9474; Yuille, Martin/0000-0002-4992-5405				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Bevan S, 1999, LEUKEMIA, V13, P1497, DOI 10.1038/sj.leu.2401531; CARTWRIGHT RA, 1987, BRIT J CANCER, V56, P79, DOI 10.1038/bjc.1987.158; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Evans DM, 2004, AM J HUM GENET, V75, P687, DOI 10.1086/424696; FARAWAY JJ, 1993, GENET EPIDEMIOL, V10, P75, DOI 10.1002/gepi.1370100108; Goldin LR, 2004, BLOOD, V104, P1850, DOI 10.1182/blood-2004-01-0341; Goldin LR, 2003, BRIT J HAEMATOL, V121, P866, DOI 10.1046/j.1365-2141.2003.04372.x; Gozzetti Alessandro, 2004, Hematology, V9, P383, DOI 10.1080/10245330400010661; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; GUNZ FW, 1975, SCAND J HAEMATOL, V15, P117; HEDRICK PW, 1987, GENETICS, V117, P331; Houlston RS, 2003, LEUKEMIA RES, V27, P871, DOI 10.1016/S0145-2126(03)00023-7; Huang QQ, 2004, AM J HUM GENET, V75, P1106, DOI 10.1086/426000; John S, 2004, AM J HUM GENET, V75, P54, DOI 10.1086/422195; Karnolsky I N, 2000, Folia Med (Plovdiv), V42, P5; KLITZ W, 1994, AM J HUM GENET, V54, P497; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LINET MS, 1989, AM J EPIDEMIOL, V130, P655, DOI 10.1093/oxfordjournals.aje.a115387; Machulla HKG, 2001, INT J CANCER, V92, P203, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1167>3.0.CO;2-A; Matsuzaki H, 2004, GENOME RES, V14, P414, DOI 10.1101/gr.2014904; MULLERHERMELINK HK, 2001, WHO CLASSIFICATION T, P127; POTTERN LM, 1991, LEUKEMIA RES, V15, P305, DOI 10.1016/0145-2126(91)90005-E; RADOVANOVIC Z, 1994, EUR J EPIDEMIOL, V10, P211, DOI 10.1007/BF01730372; Rawstron AC, 2002, BLOOD, V100, P635, DOI 10.1182/blood.V100.2.635; Rawstron AC, 2002, BLOOD, V100, P2289, DOI 10.1182/blood-2002-03-0892; Ries LAG, 2003, SEER CANC STAT REV 1; Schaid DJ, 2004, AM J HUM GENET, V75, P948, DOI 10.1086/425870; SCHWEITZER M, 1973, SCAND J HAEMATOL, V11, P97; SELLICK G, 2004, EFFECTIVE MANAGEMENT, P3; Sellick GS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh163; Stankovic T, 1999, LANCET, V353, P26, DOI 10.1016/S0140-6736(98)10117-4; SWIFT M, 1987, NEW ENGL J MED, V316, P1289, DOI 10.1056/NEJM198705213162101; Webb EL, 2005, BIOINFORMATICS, V21, P3060, DOI 10.1093/bioinformatics/bti449; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Yuille MR, 2002, BLOOD, V100, P603, DOI 10.1182/blood.V100.2.603	37	53	55	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2005	77	3					420	429		10.1086/444472	http://dx.doi.org/10.1086/444472			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	956QE	16080117	Bronze, Green Published			2022-12-18	WOS:000231314100008
J	Oliveira, SA; Li, YJ; Noureddine, MA; Zuchner, S; Qin, XJ; Pericak-Vance, MA; Vance, JM				Oliveira, SA; Li, YJ; Noureddine, MA; Zuchner, S; Qin, XJ; Pericak-Vance, MA; Vance, JM			Identification of risk and age-at-onset genes on chromosome 1p in Parkinson disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILY-BASED TESTS; LINKAGE DISEQUILIBRIUM; ALZHEIMER-DISEASE; ASSOCIATION; MUTATIONS; EXPRESSION; PEDIGREES; DEMENTIA; SUBUNITS; LOCUS	We previously reported a linkage region on chromosome 1p (LOD = 3.41) for genes controlling age at onset (AAO) in Parkinson disease (PD). This region overlaps with the previously reported PARK10 locus. To identify the gene( s) associated with AAO and risk of PD in this region, we first applied a genomic convergence approach that combined gene expression and linkage data. No significant results were found. Second, we performed association mapping across a 19.2-Mb region centered under the AAO linkage peak. An iterative association mapping approach was done by initially genotyping single-nucleotide polymorphisms at an average distance of 100 kb apart and then by increasing the density of markers as needed. Using the overall data set of 267 multiplex families, we identified six associated genes in the region, but further screening of a subset of 83 families linked to the chromosome 1 locus identified only two genes significantly associated with AAO in PD: the g subunit of the translation initiation factor EIF2B gene (EIF2B3), which was more significant in the linked subset and the ubiquitin-specific protease 24 gene (USP24). Unexpectedly, the human immunodeficiency virus enhancer-binding protein 3 gene (HIVEP3) was found to be associated with risk for susceptibility to PD. We used several criteria to define significant results in the presence of multiple testing, including criteria derived from a novel cluster approach. The known or putative functions of these genes fit well with the current suspected pathogenic mechanisms of PD and thus show great potential as candidates for the PARK10 locus.	Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA	Duke University; Duke University	Vance, JM (corresponding author), Duke Univ, Med Ctr, Dept Med, 595 LaSalle St,Box 3445, Durham, NC 27710 USA.	jeff.vance@duke.edu	Oliveira, Sofia/F-3386-2010	Li, Yi-Ju/0000-0001-6996-4834; Vance, Jeffery/0000-0003-3815-8199; Oliveira, Sofia A/0000-0001-7919-4191	NINDS NIH HHS [P50-NS-039764, P50 NS039764, R01 NS311560-10] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS039764] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Allen Carl E, 2002, BMC Immunol, V3, P10, DOI 10.1186/1471-2172-3-10; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Antic D, 1997, AM J HUM GENET, V61, P273, DOI 10.1086/514866; Blomqvist MEL, 2004, NEUROGENETICS, V5, P115, DOI 10.1007/s10048-004-0173-4; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; DeStefano AL, 2002, AM J HUM GENET, V70, P1089, DOI 10.1086/339814; Goetz CG, 2003, MOVEMENT DISORD, V18, P738, DOI 10.1002/mds.10473; Hauser MA, 2005, ARCH NEUROL-CHICAGO, V62, P917, DOI 10.1001/archneur.62.6.917; Hauser MA, 2003, HUM MOL GENET, V12, P671, DOI 10.1093/hmg/ddg070; Haynes C., 1995, American Journal of Human Genetics, V57, pA193; Hicks AA, 2002, ANN NEUROL, V52, P549, DOI 10.1002/ana.10324; Horvath S, 2004, GENET EPIDEMIOL, V26, P61, DOI 10.1002/gepi.10295; Hubble JP, 1999, NEUROLOGY, V52, pA13; Inamura N, 2003, NEUROSCI LETT, V346, P117, DOI 10.1016/S0304-3940(03)00592-5; Karamohamed S, 2003, NEUROLOGY, V61, P1557, DOI 10.1212/01.WNL.0000095966.99430.F4; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kolsch H, 2004, NEUROLOGY, V63, P2255, DOI 10.1212/01.WNL.0000147294.29309.47; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Laliberte RE, 2003, J BIOL CHEM, V278, P16567, DOI 10.1074/jbc.M211596200; Leroy E, 1998, HUM GENET, V103, P424, DOI 10.1007/s004390050845; Li YJ, 2004, NEUROLOGY, V62, P2005, DOI 10.1212/01.WNL.0000128089.53030.AC; Li YJ, 2002, AM J HUM GENET, V70, P985, DOI 10.1086/339815; Li YJ, 2003, HUM MOL GENET, V12, P3259, DOI 10.1093/hmg/ddg357; Lopez OL, 1999, NEUROPSY NEUROPSY BE, V12, P184; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Martin ER, 2003, GENET EPIDEMIOL, V25, P203, DOI 10.1002/gepi.10258; Monks SA, 2000, AM J HUM GENET, V66, P576, DOI 10.1086/302745; NOUREDDINE MA, 2005, GENOMIC CONVERGENCE; Oukka M, 2002, MOL CELL, V9, P121, DOI 10.1016/S1097-2765(01)00434-8; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Scott WK, 2001, JAMA-J AM MED ASSOC, V286, P2239, DOI 10.1001/jama.286.18.2239; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; van der Knaap MS, 2002, ANN NEUROL, V51, P264, DOI 10.1002/ana.10112; ZAYKIN D, 1995, GENETICA, V96, P169, DOI 10.1007/BF01441162	37	53	58	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2005	77	2					252	264		10.1086/432588	http://dx.doi.org/10.1086/432588			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	943WW	15986317	Green Published, Bronze			2022-12-18	WOS:000230387200007
J	Fingerlin, TE; Boehnke, M; Abecasis, GR				Fingerlin, TE; Boehnke, M; Abecasis, GR			Increasing the power and efficiency of disease-marker case-control association studies through use of allele-sharing information	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE-DISEQUILIBRIUM; NONPARAMETRIC LINKAGE; BREAST-CANCER; GENETIC-VARIATION; TESTS; STATISTICS; PEDIGREES; FAMILIES; DESIGNS; BLOCKS	Case-control disease-marker association studies are often used in the search for variants that predispose to complex diseases. One approach to increasing the power of these studies is to enrich the case sample for individuals likely to be affected because of genetic factors. In this article, we compare three case-selection strategies that use allele-sharing information with the standard strategy that selects a single individual from each family at random. In affected sibship samples, we show that, by carefully selecting sibships and/or individuals on the basis of allele sharing, we can increase the frequency of disease-associated alleles in the case sample. When these cases are compared with unrelated controls, the difference in the frequency of the disease-associated allele is therefore also increased. We find that, by choosing the affected sib who shows the most evidence for pairwise allele sharing with the other affected sibs in families, the test statistic is increased by >20%, on average, for additive models with modest genotype relative risks. In addition, we find that the per-genotype information associated with the allele sharing - based strategies is increased compared with that associated with random selection of a sib for genotyping. Even though we select sibs on the basis of a nonparametric statistic, the additional gain for selection based on the unknown underlying mode of inheritance is minimal. We show that these properties hold even when the power to detect linkage to a region in the entire sample is negligible. This approach can be extended to more-general pedigree structures and quantitative traits.	Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Fingerlin, TE (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Prevent Med & Biometr, Box B119,4200 E 9th Ave, Denver, CO 80262 USA.	Tasha.Fingerlin@uchsc.edu	Abecasis, Goncalo R/B-7840-2010	Abecasis, Goncalo/0000-0003-1509-1825	Intramural NIH HHS [Z01 HG000040] Funding Source: Medline; NHGRI NIH HHS [HG02651, R01 HG000376, HG00376, R01 HG002651, T32 HG000040] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000040, R01HG002651, R01HG000376, Z01HG000040, R29HG000376] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Abecasis GR, 2001, AM J HUM GENET, V68, P191, DOI 10.1086/316944; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2000, EUR J HUM GENET, V8, P545, DOI 10.1038/sj.ejhg.5200494; ARNHEIM N, 1985, P NATL ACAD SCI USA, V82, P6970, DOI 10.1073/pnas.82.20.6970; Barcellos LF, 1997, AM J HUM GENET, V61, P734, DOI 10.1086/515512; Boehnke M, 1998, AM J HUM GENET, V62, P950, DOI 10.1086/301787; Camp NJ, 2001, GENET EPIDEMIOL, V21, pS461, DOI 10.1002/gepi.2001.21.s1.s461; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Carlson CS, 2003, NAT GENET, V33, P518, DOI 10.1038/ng1128; Davis CC, 2001, GENET EPIDEMIOL, V21, pS123, DOI 10.1002/gepi.2001.21.s1.s123; Dawson E, 2002, NATURE, V418, P544, DOI 10.1038/nature00864; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; GO RCP, 1983, J NATL CANCER I, V71, P455; GOLDSTEIN AM, 1987, JNCI-J NATL CANCER I, V78, P911; Haldane JBS, 1919, J GENET, V8, P299; HALL JM, 1992, AM J HUM GENET, V50, P1235; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Li C, 2001, AM J HUM GENET, V69, P408; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; McPeek MS, 1999, GENET EPIDEMIOL, V16, P225, DOI 10.1002/(SICI)1098-2272(1999)16:3<225::AID-GEPI1>3.0.CO;2-#; Mohlke KL, 2002, P NATL ACAD SCI USA, V99, P16928, DOI 10.1073/pnas.262661399; OLIPHANT A, 2002, BIOTECHNIQUES S, V56, P60; Olivier M, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf052; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Risch N, 1998, GENOME RES, V8, P1273, DOI 10.1101/gr.8.12.1273; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sengul H, 2001, AM J HUM GENET, V69, P179, DOI 10.1086/321264; Sham PC, 2002, AM J HUM GENET, V71, P238, DOI 10.1086/341560; Slager SL, 2001, AM J HUM GENET, V68, P1457, DOI 10.1086/320608; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; Syvanen AC, 2001, NAT REV GENET, V2, P930, DOI 10.1038/35103535; Valle T, 1998, DIABETES CARE, V21, P949, DOI 10.2337/diacare.21.6.949; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Wolford JK, 2000, HUM GENET, V107, P483, DOI 10.1007/s004390000396	38	53	55	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2004	74	3					432	443		10.1086/381652	http://dx.doi.org/10.1086/381652			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	801TP	14752704	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000220118500010
J	Janssens, ACJW; Pardo, MC; Steyerberg, EW; van Duijn, CM				Janssens, ACJW; Pardo, MC; Steyerberg, EW; van Duijn, CM			Revisiting the clinical validity of multiplex genetic testing in complex diseases	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Ctr Clin Decis Sci, NL-3000 DR Rotterdam, Netherlands; Univ Med Ctr Rotterdam, Erasmus MC, Dept Epidemiol & Biostat, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Janssens, ACJW (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Ctr Clin Decis Sci, POB 1738, NL-3000 DR Rotterdam, Netherlands.	a.janssens@erasmusmc.nl	janssens, cecile c/L-1075-2015; Steyerberg, Ewout/C-1509-2018	Van Duijn, Cornelia/0000-0002-2374-9204; Janssens, A Cecile/0000-0002-6153-4976; Steyerberg, Ewout/0000-0002-7787-0122				Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Holtzman NA, 2000, NEW ENGL J MED, V343, P141, DOI 10.1056/NEJM200007133430213; THOMPSON ML, 1989, STAT MED, V8, P1277, DOI 10.1002/sim.4780081011; Vineis P, 2001, LANCET, V357, P709, DOI 10.1016/S0140-6736(00)04136-2; Yang QH, 2003, AM J HUM GENET, V72, P636, DOI 10.1086/367923	6	53	55	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2004	74	3					585	588		10.1086/382052	http://dx.doi.org/10.1086/382052			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	801TP	14973786	Bronze, Green Published			2022-12-18	WOS:000220118500027
J	Bandyopadhyay, R; Heller, A; Knox-DuBois, C; McCaskill, C; Berend, SA; Page, SL; Shaffer, LG				Bandyopadhyay, R; Heller, A; Knox-DuBois, C; McCaskill, C; Berend, SA; Page, SL; Shaffer, LG			Parental origin and timing of de novo robertsonian translocation formation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							X-AUTOSOME TRANSLOCATION; DOUBLE-STRAND BREAKS; ACROCENTRIC CHROMOSOMES; MUSCULAR-DYSTROPHY; MOLECULAR ANALYSIS; DNA-REPLICATION; RECOMBINATION; REPAIR; IDENTIFICATION; REARRANGEMENTS	Robertsonian translocations (ROBs) are the most common chromosomal rearrangements in humans. ROBs are whole-arm rearrangements between the acrocentric chromosomes 13-15, 21, and 22. ROBs can be classified into two groups depending on their frequency of occurrence, common (rob(13q14q) and rob( 14q21q)), and rare (all remaining possible nonhomologous combinations). Herein, we have studied 29 case subjects of common and rare de novo ROBs to determine their parental origins and timing of formation. We compared these case subjects to 35 published case subjects of common ROBs and found that most common ROBs apparently have the same breakpoints and arise mainly during oogenesis (50/54). These probably form through a common mechanism and have been termed "class 1." Collectively, rare ROBs also occur mostly during oogenesis (7/10) but probably arise through a more "random" mechanism or a variety of mechanisms and have been termed "class 2." Thus, we demonstrate that although both classes of ROBs occur predominantly during meiosis, the common, class 1 ROBs occur primarily during oogenesis and likely form through a mechanism distinct from that forming class 2 ROBs.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Inst Human Genet & Anthropol, Jena, Germany; Genzyme Genet, Santa Fe, NM USA; Stowers Inst Med Res, Kansas City, MO USA	Baylor College of Medicine; Sanofi-Aventis; Genzyme Corporation; Stowers Institute for Medical Research	Shaffer, LG (corresponding author), Washington State Univ, Sch Mol Biosci, Hlth Res & Educ Ctr, 310 N Riverpoint Blvd, Spokane, WA 99202 USA.		Page, Scott L/B-4984-2009					Akgun E, 1997, MOL CELL BIOL, V17, P5559, DOI 10.1128/MCB.17.9.5559; Bandyopadhyay R, 2001, CHROMOSOME RES, V9, P223, DOI 10.1023/A:1016648404388; Bandyopadhyay R, 2001, CHROMOSOME RES, V9, P235, DOI 10.1023/A:1016652621226; BODRUG SE, 1987, SCIENCE, V237, P1620, DOI 10.1126/science.3629260; BODRUG SE, 1991, EMBO J, V10, P3931, DOI 10.1002/j.1460-2075.1991.tb04963.x; Borde V, 2000, SCIENCE, V290, P806, DOI 10.1126/science.290.5492.806; BYSKOV AG, 1982, REPROD MAMMALS, V6, P1; Cohen PE, 2001, BIOESSAYS, V23, P996, DOI 10.1002/bies.1145; Constantinou A, 2001, CELL, V104, P259, DOI 10.1016/S0092-8674(01)00210-0; Davis L, 2001, GENETICS, V157, P1179; EARLE E, 1992, AM J HUM GENET, V50, P717; GIACALONE JP, 1992, AM J HUM GENET, V50, P725; HAMERTON JL, 1975, CLIN GENET, V8, P223; HAN JY, 1994, AM J HUM GENET, V55, P960; JACKSON SP, 1995, TRENDS BIOCHEM SCI, V20, P412, DOI 10.1016/S0968-0004(00)89090-8; JACOBS PA, 1981, AM J HUM GENET, V33, P44; KALITSIS P, 1993, GENOMICS, V16, P104, DOI 10.1006/geno.1993.1147; Knight SJL, 2000, AM J HUM GENET, V67, P320, DOI 10.1086/302998; Murakami H, 2001, NAT GENET, V28, P290, DOI 10.1038/90142; Page SL, 1997, NAT GENET, V15, P231, DOI 10.1038/ng0397-231; Page SL, 1996, HUM MOL GENET, V5, P1279, DOI 10.1093/hmg/5.9.1279; Richardson C, 1998, GENE DEV, V12, P3831, DOI 10.1101/gad.12.24.3831; ROBINSON WP, 1994, AM J HUM GENET, V54, P290; Roth D., 1988, GENETIC RECOMBINATIO, P621; Sargent RG, 1997, MOL CELL BIOL, V17, P267, DOI 10.1128/MCB.17.1.267; SHAFFER LG, 1992, AM J MED GENET, V43, P957, DOI 10.1002/ajmg.1320430611; Shaffer LG, 2000, ANNU REV GENET, V34, P297, DOI 10.1146/annurev.genet.34.1.297; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Sullivan BA, 1996, AM J HUM GENET, V59, P167; THERMAN E, 1989, ANN HUM GENET, V53, P49, DOI 10.1111/j.1469-1809.1989.tb01121.x; VOGEL F, 1997, HUMAN GENETICS PROBL, P396; WAHLS WP, 1990, CELL, V60, P95, DOI 10.1016/0092-8674(90)90719-U	32	53	54	1	7	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2002	71	6					1456	1462		10.1086/344662	http://dx.doi.org/10.1086/344662			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621KD	12424707	Green Published, Bronze			2022-12-18	WOS:000179586800020
J	Xu, JF; Bleecker, ER; Jongepier, H; Howard, TD; Koppelman, GH; Postman, DS; Meyers, DA				Xu, JF; Bleecker, ER; Jongepier, H; Howard, TD; Koppelman, GH; Postman, DS; Meyers, DA			Major recessive gene(s) with considerable residual polygenic effect regulating adult height: Confirmation of genomewide scan results for chromosomes 6, 9, and 12	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BODY-MASS INDEX; LINKAGE ANALYSIS; STATURE; WEIGHT; TRENDS; ASTHMA	Segregation and linkage analyses were performed for adult height in a population of 200 Dutch families, each of which was ascertained through a proband with asthma. The best-fit model from the segregation analysis was a major recessive gene with a significant residual polygenic background. Models without a polygenic component were rejected. A genomewide scan was performed, and it confirmed previous linkage results for chromosomes 6q25 (LOD = 3.06, D6S2436), 9p1 (LOD = 2.09, D9S301), and 12q1 (LOD = 1.86, D12S375). Our results provide evidence that a combination of segregation and linkage approaches is valuable in understanding genetic determination of common complex traits.	Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genom, Winston Salem, NC 27157 USA; Univ Groningen Hosp, Dept Pulmonol, Groningen, Netherlands	Wake Forest University; Wake Forest Baptist Medical Center; University of Groningen	Xu, JF (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genom, Med Ctr Blvd, Winston Salem, NC 27157 USA.		Koppelman, Gerard/AAG-9187-2020	Koppelman, Gerard/0000-0001-8567-3252	NCRR NIH HHS [P41 RR003655, 1-P41-RR03655] Funding Source: Medline; NHLBI NIH HHS [R01-HL48341, R01 HL048341, R01 HL066393, R01-HL66393] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048341, R01HL066393] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akaike H, 1974, IEEE T AUTOMAT CONTR, V19, P719; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Altmuller J, 2001, AM J HUM GENET, V69, P936, DOI 10.1086/324069; BONNEY GE, 1986, BIOMETRICS, V42, P611, DOI 10.2307/2531211; CARMICHAEL CM, 1995, J GERONTOL A-BIOL, V50, pB237, DOI 10.1093/gerona/50A.4.B237; HASSTEDT SJ, 1989, GENET EPIDEMIOL, V6, P319, DOI 10.1002/gepi.1370060203; Hirschhorn JN, 2001, AM J HUM GENET, V69, P106, DOI 10.1086/321287; Pearson K., 1903, BIOMETRIKA, V2, P357; Perola M, 2001, AM J HUM GENET, V69, P117, DOI 10.1086/321286; PHILLIPS K, 1990, ACTA GENET MED GEMEL, V39, P143, DOI 10.1017/S0001566000005389; POSTMA DS, 1995, NEW ENGL J MED, V333, P894, DOI 10.1056/NEJM199510053331402; Preece MA, 1996, HORM RES, V45, P56, DOI 10.1159/000184849; PROVINCE MA, 1985, AM J HUM GENET, V37, P178; Silventoinen K, 2000, AM J PUBLIC HEALTH, V90, P627, DOI 10.2105/AJPH.90.4.627; Villard E, 1996, AM J HUM GENET, V58, P1268; Wiltshire S, 2002, AM J HUM GENET, V70, P543, DOI 10.1086/338760; Xu JF, 2000, AM J HUM GENET, V67, P1163, DOI 10.1086/321190	17	53	53	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2002	71	3					646	650		10.1086/342216	http://dx.doi.org/10.1086/342216			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	584VN	12119602	Green Published, Bronze			2022-12-18	WOS:000177489600019
J	Anikster, Y; Huizing, M; Anderson, PD; Fitzpatrick, DL; Klar, A; Gross-Kieselstein, E; Berkun, Y; Shazberg, G; Gahl, WA; Hurvitz, H				Anikster, Y; Huizing, M; Anderson, PD; Fitzpatrick, DL; Klar, A; Gross-Kieselstein, E; Berkun, Y; Shazberg, G; Gahl, WA; Hurvitz, H			Evidence that Griscelli syndrome with neurological involvement is caused by mutations in RAB27A, not MYO5A	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHEDIAK-HIGASHI-SYNDROME; MYOSIN-VA GENE; MELANOSOME TRANSPORT; VESICLE TRANSPORT; PALESTINIAN ARABS; ELEJALDE-SYNDROME; PARTIAL ALBINISM; PROTEINS; IDENTIFICATION; CLONING	Griscelli syndrome (GS), a rare autosomal recessive disorder, is characterized by partial albinism, along with immunologic abnormalities or severe neurological impairment or both. Mutations in one of two different genes on chromosome 15q can cause the different subtypes of GS. Most patients with GS display the hemophagocytic syndrome and have mutations in RAB27A, which codes for a small GTPase. Two patients with neurological involvement have mutations in MYO5A, which codes for an actin-based molecular motor. The RAB27A and MYO5A gene products interact with each other and function in vesicle trafficking. We report the molecular basis of GS in a Muslim Arab kindred whose members have extremely variable neurological involvement, along with the hemophagocytic syndrome and immunologic abnormalities. The patients have normal MYO5A genes but exhibit a homozygous 67.5-kb deletion that eliminates RAB27A mRNA and immunocytofluorescence-detectable protein. We also describe the molecular organization of RAB27A and a multiplex polymerase chain reaction assay for the founder deletion in this kindred. Finally, we propose that all patients with GS have RAB27A mutations and immunologic abnormalities that sometimes result in secondary neurological involvement. The two patients described elsewhere who have MYO5A mutations and neurological complications but no immunologic defects may not have GS but instead may have Elejalde syndrome, a condition characterized by mild hypopigmentation and severe, primary neurological abnormalities.	NICHHD, Heritable Disorders Branch, NIH, Bethesda, MD 20892 USA; Bikur Cholim Gen Hosp, Dept Pediat, Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91010 Jerusalem, Israel	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Hebrew University of Jerusalem	Huizing, M (corresponding author), NICHD, NIH, 10 Ctr Dr,MSC 1830,Bldg 10,Rom 9S-241, Bethesda, MD 20892 USA.	mhuizing@mail.nih.gov	Huizing, Marjan/AAR-8860-2020; Berkun, Yackov/A-1694-2009	Berkun, Yackov/0000-0001-9823-4750	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000131] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000215, Z01HG000215] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Barbosa MDFS, 1996, NATURE, V382, P262, DOI 10.1038/382262a0; Chen D, 1997, BIOCHEM MOL MED, V60, P27, DOI 10.1006/bmme.1996.2559; Duran-McKinster C, 1999, ARCH DERMATOL, V135, P182, DOI 10.1001/archderm.135.2.182; ELEJALDE BR, 1979, AM J MED GENET, V3, P65, DOI 10.1002/ajmg.1320030112; GOGUS S, 1995, PEDIATR PATHOL LAB M, V15, P309; GRISCELLI C, 1978, AM J MED, V65, P691, DOI 10.1016/0002-9343(78)90858-6; Huang JD, 1998, GENETICS, V148, P1963; Hume AN, 2002, TRAFFIC, V3, P193, DOI 10.1034/j.1600-0854.2002.030305.x; Hume AN, 2001, J CELL BIOL, V152, P795, DOI 10.1083/jcb.152.4.795; HURVITZ H, 1993, EUR J PEDIATR, V152, P402, DOI 10.1007/BF01955897; Introne W, 1999, MOL GENET METAB, V68, P283, DOI 10.1006/mgme.1999.2927; KINSELLA BT, 1992, J BIOL CHEM, V267, P3940; Kjeldsen L, 1998, J LEUKOCYTE BIOL, V64, P72, DOI 10.1002/jlb.64.1.72; KLEIN C, 1994, J PEDIATR-US, V125, P886, DOI 10.1016/S0022-3476(05)82003-7; Lambert J, 2000, J INVEST DERMATOL, V114, P731, DOI 10.1046/j.1523-1747.2000.00933.x; Lambert J, 1998, BIOCHEM BIOPH RES CO, V252, P329, DOI 10.1006/bbrc.1998.9644; Matesic LE, 2001, P NATL ACAD SCI USA, V98, P10238, DOI 10.1073/pnas.181336698; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; MOORE KJ, 1988, GENETICS, V119, P933; Nagle DL, 1996, NAT GENET, V14, P307, DOI 10.1038/ng1196-307; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; Pastural E, 2000, GENOMICS, V63, P299, DOI 10.1006/geno.1999.6081; Pastural E, 1997, NAT GENET, V16, P289, DOI 10.1038/ng0797-289; Perou CM, 1996, NAT GENET, V13, P303, DOI 10.1038/ng0796-303; Perou CM, 1997, J BIOL CHEM, V272, P29790, DOI 10.1074/jbc.272.47.29790; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Provance DW, 2002, TRAFFIC, V3, P124, DOI 10.1034/j.1600-0854.2002.030205.x; RENDU F, 1983, AM J PATHOL, V111, P307; Sanal O, 2000, J NEUROL, V247, P570, DOI 10.1007/s004150070162; Stinchcombe JC, 2001, J CELL BIOL, V152, P825, DOI 10.1083/jcb.152.4.825; Swank RT, 1998, PIGM CELL RES, V11, P60, DOI 10.1111/j.1600-0749.1998.tb00713.x; Tolmachova T, 1999, GENE, V239, P109, DOI 10.1016/S0378-1119(99)00371-6; Ward DM, 2000, TRAFFIC, V1, P816; Westbroek W, 2001, PIGM CELL RES, V14, P320, DOI 10.1034/j.1600-0749.2001.140503.x; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797; Wu XF, 2001, J CELL SCI, V114, P1091; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Zlotogora J, 1997, J MED GENET, V34, P765, DOI 10.1136/jmg.34.9.765; Zlotogora J, 2000, AM J MED GENET, V92, P343, DOI 10.1002/1096-8628(20000619)92:5<343::AID-AJMG9>3.0.CO;2-I	41	53	55	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2002	71	2					407	414		10.1086/341606	http://dx.doi.org/10.1086/341606			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	575ZE	12058346	Green Published, Bronze			2022-12-18	WOS:000176977700019
J	Kallijarvi, J; Avela, K; Lipsanen-Nyman, M; Ulmanen, I; Lehesjoki, AE				Kallijarvi, J; Avela, K; Lipsanen-Nyman, M; Ulmanen, I; Lehesjoki, AE			The TRIM37 gene encodes a peroxisomal RING-B-box-coiled-coil protein: Classification of mulibrey nanism as a new peroxisomal disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BIOGENESIS DISORDERS; FINGER PROTEIN; MUTATIONS; DOMAINS; ELEGANS; RNA	Mulibrey nanism is a rare growth disorder of prenatal onset caused by mutations in the TRIM37 gene, which encodes a RING-B-box-coiled-coil protein. The pathogenetic mechanisms of mulibrey nanism are unknown. We have used transiently transfected cells and antibodies raised against the predicted TRIM37 protein to characterize the TRIM37 gene product and to determine its intracellular localization. We show that the human TRIM37 cDNA encodes a peroxisomal protein with an apparent molecular weight of 130 kD. Peroxisomal localization is compromised in mutant protein representing the major Finnish TRIM37 mutation but is retained in the protein representing the minor Finnish mutation. Colocalization of endogenous TRIM37 with peroxisomal markers was observed by double immunofluorescence staining in HepG2 and human intestinal smooth muscle cell lines. In human tissue sections, TRIM37 shows a granular cytoplasmic pattern. Endogenous TRIM37 is not imported into peroxisomes in peroxin 1 (PEX1(-/-)) and peroxin 5 (PEX5(-/-)) mutant fibroblasts but is imported normally in peroxin 7 (PEX7(-/-)) deficient fibroblasts, giving further evidence for a peroxisomal localization of TRIM37. Fibroblasts derived from patients with mulibrey nanism lack C-terminal TRIM37 immunoreactivity but stain normally for both peroxisomal matrix and membrane markers, suggesting apparently normal peroxisome biogenesis in patient fibroblasts. Taken together, this molecular evidence unequivocally indicates that TRIM37 is located in the peroxisomes, and Mulibrey nanism thus can be classified as a new peroxisomal disorder.	Univ Helsinki, Biomedicum Helsinki, Folkhalsan Inst Genet, FIN-00014 Helsinki, Finland; Univ Helsinki, Biomedicum Helsinki, Haartman Inst, Dept Med Genet, FIN-00014 Helsinki, Finland; Univ Helsinki, Biomedicum Helsinki, Natl Publ Hlth Inst, Dept Mol Med, FIN-00014 Helsinki, Finland; Univ Helsinki, Hosp Children & Adolescents, FIN-00014 Helsinki, Finland; Univ Helsinki, Cent Hosp, Helsinki, Finland	University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Lehesjoki, AE (corresponding author), Univ Helsinki, Biomedicum Helsinki, Folkhalsan Inst Genet, POB 63 Haartmaninkatu 8, FIN-00014 Helsinki, Finland.		Kallijarvi, Jukka/AAV-5091-2021	Kallijarvi, Jukka/0000-0003-3773-7025				Aravind L, 1999, TRENDS BIOCHEM SCI, V24, P47, DOI 10.1016/S0968-0004(98)01341-3; Avela K, 2000, NAT GENET, V25, P298, DOI 10.1038/77053; Baumeister B, 1996, OHIO ST U M, V4, P3; Borden KLB, 2000, J MOL BIOL, V295, P1103, DOI 10.1006/jmbi.1999.3429; Borden KLB, 1996, CURR OPIN STRUC BIOL, V6, P395, DOI 10.1016/S0959-440X(96)80060-1; Cainarca S, 1999, HUM MOL GENET, V8, P1387, DOI 10.1093/hmg/8.8.1387; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; Eitzen GA, 1997, J CELL BIOL, V137, P1265, DOI 10.1083/jcb.137.6.1265; El-Husseini AE, 1999, J BIOL CHEM, V274, P19771, DOI 10.1074/jbc.274.28.19771; ERDMANN R, 1995, J CELL BIOL, V128, P509, DOI 10.1083/jcb.128.4.509; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; GRAHAM JM, 1997, SUBCELLULAR FRACTION, P143; Hsieh J, 1999, GENE DEV, V13, P2958, DOI 10.1101/gad.13.22.2958; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAPUNZINA P, 1995, AM J MED GENET, V55, P349, DOI 10.1002/ajmg.1320550320; LEDOUARIN B, 1995, EMBO J, V14, P2020, DOI 10.1002/j.1460-2075.1995.tb07194.x; Lehesjoki AE, 2001, MECH DEVELOP, V108, P221, DOI 10.1016/S0925-4773(01)00491-9; LIPSANENNYMAN M, 1986, THESIS U HELSINKI HE; Moser HW, 2000, FRONT BIOSCI, V5, pD298, DOI 10.2741/Moser; Nagase T, 1998, DNA Res, V5, P355, DOI 10.1093/dnares/5.6.355; Okumoto K, 2000, J BIOL CHEM, V275, P25700, DOI 10.1074/jbc.M003303200; Okumoto K, 1998, HUM MOL GENET, V7, P1399, DOI 10.1093/hmg/7.9.1399; Peng HZ, 2000, J MOL BIOL, V295, P1139, DOI 10.1006/jmbi.1999.3402; PERHEENTUPA J, 1973, LANCET, V2, P351, DOI 10.1016/S0140-6736(73)93193-0; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Sacksteder KA, 2000, ANNU REV GENET, V34, P623, DOI 10.1146/annurev.genet.34.1.623; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; SCHUTGENS RBH, 1994, J INHERIT METAB DIS, V17, P626, DOI 10.1007/BF00711603; Seemanova E, 1999, AM J MED GENET, V85, P76, DOI 10.1002/(SICI)1096-8628(19990702)85:1<76::AID-AJMG12>3.0.CO;2-Z; SHIMOZAWA N, 1992, SCIENCE, V255, P1132, DOI 10.1126/science.1546315; SIMILA S, 1980, CLIN GENET, V17, P29; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; SLAWECKI ML, 1995, J CELL SCI, V108, P1817; Spencer JA, 2000, J CELL BIOL, V150, P771, DOI 10.1083/jcb.150.4.771; TAKAHASHI M, 1988, MOL CELL BIOL, V8, P1853, DOI 10.1128/MCB.8.4.1853; Titorenko VI, 2001, NAT REV MOL CELL BIO, V2, P357, DOI 10.1038/35073063; Wajant H, 2001, CELL SIGNAL, V13, P389, DOI 10.1016/S0898-6568(01)00160-7; Yang XD, 2001, EUR J CELL BIOL, V80, P126, DOI 10.1078/0171-9335-00144; Zapata JM, 2001, J BIOL CHEM, V276, P24242, DOI 10.1074/jbc.M100354200	42	53	55	1	9	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2002	70	5					1215	1228		10.1086/340256	http://dx.doi.org/10.1086/340256			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	541XT	11938494	Green Published, Bronze			2022-12-18	WOS:000175012400011
J	Raas-Rothschild, A; Wanders, RJA; Mooijer, PAW; Gootjes, J; Waterham, HR; Gutman, A; Suzuki, Y; Shimozawa, N; Kondo, N; Eshel, G; Espeel, M; Roels, F; Korman, SH				Raas-Rothschild, A; Wanders, RJA; Mooijer, PAW; Gootjes, J; Waterham, HR; Gutman, A; Suzuki, Y; Shimozawa, N; Kondo, N; Eshel, G; Espeel, M; Roels, F; Korman, SH			A PEX6-defective peroxisomal biogenesis disorder with severe phenotype in an infant, versus mild phenotype resembling Usher syndrome in the affected parents	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN SKIN FIBROBLASTS; LIVER; COMPLEMENTATION; MOSAICISM; DISEASE; DIAGNOSIS; OXIDATION; PROTEINS; CELLS; PEX6	Sensorineural deafness and retinitis pigmentosa (RP) are the hallmarks of Usher syndrome (USH) but are also prominent features in peroxisomal biogenesis defects (PBDs); both are autosomal recessively inherited. The firstborn son of unrelated parents, who both had sensorineural deafness and RP diagnosed as USH, presented with sensorineural deafness, RP, dysmorphism, developmental delay, hepatomegaly, and hypsarrhythmia and died at age 17 mo. The infant was shown to have a PBD, on the basis of elevated plasma levels of very-long- and branched-chain fatty acids (VLCFAs and BCFAs), deficiency of multiple peroxisomal functions in fibroblasts, and complete absence of peroxisomes in fibroblasts and liver. Surprisingly, both parents had elevated plasma levels of VLCFAs and BCFAs. Fibroblast studies confirmed that both parents had a PBD. The parents' milder phenotypes correlated with relatively mild peroxisomal biochemical dysfunction and with catalase immunofluorescence microscopy demonstrating mosaicism and temperature sensitivity in fibroblasts. The infant and both of his parents belonged to complementation group C. PEX6 gene sequencing revealed mutations on both alleles, in the infant and in his parents. This unique family is the first report of a PBD with which the parents are themselves affected individuals rather than asymptomatic carriers. Because of considerable overlap between USH and milder PBD phenotypes, individuals suspected to have USH should be screened for peroxisomal dysfunction.	Hadassah Univ Hosp, Dept Clin Biochem, IL-91120 Jerusalem, Israel; Hadassah Univ Hosp, Dept Human Genet, IL-91120 Jerusalem, Israel; Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, NL-1105 AZ Amsterdam, Netherlands; Gifu Univ, Sch Med, Dept Pediat, Gifu 500, Japan; Assaf Harofeh Med Ctr, Pediat Intens Care Unit, IL-70300 Zerifin, Israel; State Univ Ghent, Dept Human Anat Embryol & Histol, B-9000 Ghent, Belgium	Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Gifu University; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Ghent University	Korman, SH (corresponding author), Hadassah Univ Hosp, Dept Clin Biochem, POB 12000, IL-91120 Jerusalem, Israel.			Shimozawa, Nobuyuki/0000-0003-3040-5458				Bader PI, 2000, AM J MED GENET, V90, P110, DOI 10.1002/(SICI)1096-8628(20000117)90:2<110::AID-AJMG4>3.0.CO;2-#; Baumgartner MR, 1998, ANN NEUROL, V44, P720, DOI 10.1002/ana.410440505; Collins CS, 2000, MOL CELL BIOL, V20, P7516, DOI 10.1128/MCB.20.20.7516-7526.2000; Espeel M, 1995, J INHERIT METAB DIS, V18, P135, DOI 10.1007/BF00711436; ESPEEL M, 1995, HEPATOLOGY, V22, P497, DOI 10.1016/0270-9139(95)90571-5; ESPEEL M, 1995, EUR J CELL BIOL, V67, P319; FUKUDA S, 1996, AM J HUM GENET, V59, P12010; Giros M, 1996, ANN NY ACAD SCI, V804, P747, DOI 10.1111/j.1749-6632.1996.tb18689.x; Gootjes J., 2001, Journal of Inherited Metabolic Disease, V24, P90; Gould SJ, 2000, TRENDS GENET, V16, P340, DOI 10.1016/S0168-9525(00)02056-4; IJLST L, 1994, BBA-LIPID LIPID MET, V1215, P347, DOI 10.1016/0005-2760(94)90064-7; Imamura A, 2000, PEDIATR RES, V48, P541, DOI 10.1203/00006450-200010000-00020; Imamura A, 1998, AM J HUM GENET, V62, P1539, DOI 10.1086/301881; Korman SH, 2000, J INHERIT METAB DIS, V23, P425, DOI 10.1023/A:1005624523611; Matsumoto N, 2001, J HUM GENET, V46, P273, DOI 10.1007/s100380170078; MOSER AB, 1995, J PEDIATR-US, V127, P13, DOI 10.1016/S0022-3476(95)70250-4; Moser AB, 1999, ANN NEUROL, V45, P100, DOI 10.1002/1531-8249(199901)45:1<100::AID-ART16>3.0.CO;2-U; Moser HW, 1999, MOL GENET METAB, V68, P316, DOI 10.1006/mgme.1999.2926; Petit C, 2001, ANNU REV GENOM HUM G, V2, P271, DOI 10.1146/annurev.genom.2.1.271; Pineda M, 1999, J CHILD NEUROL, V14, P434, DOI 10.1177/088307389901400705; ROELS F, 1995, J INHERIT METAB D S1, V18, P1; SCHRAKAMP G, 1988, J LIPID RES, V29, P325; Suzuki Y, 2001, J INHERIT METAB DIS, V24, P151, DOI 10.1023/A:1010310816743; Wanders RJA, 1999, NEUROCHEM RES, V24, P565, DOI 10.1023/A:1022592014988; Wanders RJA, 1995, J INHERIT METAB DIS, V18, P113, DOI 10.1007/BF00711434; WANDERS RJA, 1989, J INHERIT METAB DIS, V12, P301, DOI 10.1007/BF03335405; Wanders RJA, 1995, J INHERIT METAB DIS, V18, P90, DOI 10.1007/BF00711432; WANDERS RJA, 1993, BIOCHIM BIOPHYS ACTA, V1167, P345, DOI 10.1016/0005-2760(93)90239-6; Wanders RJA, 1995, J INHERIT METAB DIS, V18, P101, DOI 10.1007/BF00711433; WELEBER RG, 1984, ARCH OPHTHALMOL-CHIC, V102, P1317; Yahraus T, 1996, EMBO J, V15, P2914, DOI 10.1002/j.1460-2075.1996.tb00654.x; YAJIMA S, 1992, HUM GENET, V88, P491, DOI 10.1007/BF00219334; Zhang ZY, 1999, HUM MUTAT, V13, P487, DOI 10.1002/(SICI)1098-1004(1999)13:6<487::AID-HUMU9>3.0.CO;2-T	33	53	53	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2002	70	4					1062	1068		10.1086/339766	http://dx.doi.org/10.1086/339766			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	528PL	11873320	Green Published, Bronze			2022-12-18	WOS:000174252100028
J	Zhang, SL; Pakstis, AJ; Kidd, KK; Zhao, HY				Zhang, SL; Pakstis, AJ; Kidd, KK; Zhao, HY			Comparisons of two methods for haplotype reconstruction and haplotype frequency estimation from population data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							LOCUS		Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA	Yale University; Yale University	Zhao, HY (corresponding author), Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, 60 Coll St, New Haven, CT 06520 USA.				NIAAA NIH HHS [AA09379, R01 AA009379] Funding Source: Medline; NICHD NIH HHS [HD36834] Funding Source: Medline; NIGMS NIH HHS [GM57672, P01 GM057672, R01 GM059507, GM59507] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059507, P01GM057672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA009379] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; LONG JC, 1995, AM J HUM GENET, V56, P799; Osier MV, 2001, NUCLEIC ACIDS RES, V29, P317, DOI 10.1093/nar/29.1.317; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tishkoff SA, 2000, AM J HUM GENET, V67, P518, DOI 10.1086/303000; XIE X, 1993, AM J HUM GENET, V53, P1107	7	53	55	1	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2001	69	4					906	912		10.1086/323622	http://dx.doi.org/10.1086/323622			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	472WP	11536083	Green Published, Bronze			2022-12-18	WOS:000171008200027
J	Krawczak, M; Cooper, DN; Schmidtke, J				Krawczak, M; Cooper, DN; Schmidtke, J			Estimating the efficacy and efficiency of cascade genetic screening	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYSTIC-FIBROSIS; COLORECTAL-CANCER; HEMOCHROMATOSIS; POPULATION; BEHAVIOR	Screening for genetic variants that predispose individuals or their offspring to disease may be performed at the general population level or may instead be targeted at the relatives of previously identified carriers. The latter strategy has come to be known as "cascade genetic screening." Since the carrier risk of close relatives of known carriers is generally higher than the population risk, cascade screening is more efficient than population screening, in the sense that fewer individuals have to be genotyped per detected carrier. The efficacy of cascade screening, as measured by the overall proportion of carriers detected in a given population, is, however, lower than that of population-wide screening, and the respective inclusion rates vary according to the population frequency and mode of inheritance of the predisposing variants. For dominant mutations, we have developed equations that allow the inclusion rates of cascade screening to be calculated in an iterative fashion, depending upon screening depth and penetrance. For recessive mutations, we derived only equations for the screening of siblings and the children of patients. Owing to their mathematical complexity, it was necessary to study more extended screening strategies by simulation. Cascade screening turned out to result in low inclusion rates (<1%) when aimed at the identification of heterozygous carriers of rare recessive variants. Considerably higher rates are achievable, however, when screening is performed to detect covert homozygotes for frequent recessive mutations with reduced penetrance. This situation is exemplified by hereditary hemochromatosis, for which up to 40% of at-risk individuals may be identifiable through screening of first-to third-degree relatives of overt carriers (i.e., patients); the efficiency of this screening strategy was found to be <similar to>50 times higher than that of population-wide screening. For dominant mutations, inclusion rates of cascade screening were estimated to be higher than for recessive variants. Thus, some 80% of all carriers of the factor V Leiden mutation would be detected if screening were to be targeted specifically at first-to third-degree relatives of patients with venous thrombosis. The relative cost efficiency of cascade as compared with population-wide screening (i.e., the overall savings in the extra managerial cost of the condition) is also likely to be higher for dominant than for recessive mutations. This notwithstanding, once screening has become cost-effective at the population level, it can be expected that cascade screening would only transiently represent an economically viable option.	Cardiff Univ, Inst Med Genet, Cardiff CF14 4XN, S Glam, Wales; Cardiff Univ, Dept Psychol Med, Cardiff CF14 4XN, S Glam, Wales; Hannover Med Sch, Inst Humangenet, Hannover, Germany	Cardiff University; Cardiff University; Hannover Medical School	Krawczak, M (corresponding author), Cardiff Univ, Inst Med Genet, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	krawczak@cardiff.ac.uk	Krawczak, Michael/A-8964-2010; Cooper, David N/H-4384-2011	Krawczak, Michael/0000-0003-2603-1502; Cooper, David N/0000-0002-8943-8484				Allen K, 1999, J MED ETHICS, V25, P209, DOI 10.1136/jme.25.2.209; ARVEUX P, 1992, PREV MED, V21, P574, DOI 10.1016/0091-7435(92)90065-P; Beutler E, 2001, DRUG METAB DISPOS, V29, P495; Beutler E, 2001, METABOLIC MOL BASES, P3127; BOWLING A, 1989, FAM PRACT, V6, P224, DOI 10.1093/fampra/6.3.224; Bradley L A, 1996, J Med Screen, V3, P178; Bradley L A, 1996, J Med Screen, V3, P171; COOPER DN, 1997, VENOUS THROMBOSIS GE; Creinin MD, 1999, FERTIL STERIL, V72, P646, DOI 10.1016/S0015-0282(99)00318-0; DARR A, 1988, J MED GENET, V25, P186, DOI 10.1136/jmg.25.3.186; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Girodon-Boulandet E, 2000, HUM MUTAT, V15, P135, DOI 10.1002/(SICI)1098-1004(200002)15:2<135::AID-HUMU2>3.0.CO;2-H; Grann VR, 1999, J CLIN ONCOL, V17, P494, DOI 10.1200/JCO.1999.17.2.494; Holloway S, 1994, J Med Screen, V1, P159; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; MARTEAU T, 1994, BRIT MED J, V308, P1468, DOI 10.1136/bmj.308.6942.1468; Olynyk JK, 1999, NEW ENGL J MED, V341, P718, DOI 10.1056/NEJM199909023411002; Robson KJH, 1997, GUT, V41, P841; Schmidtke J, 1998, Community Genet, V1, P53, DOI 10.1159/000016136; SCHOFFSKI O, 2000, COMMUNITY GENET, V3, P2; Scotet V, 2000, LANCET, V356, P789, DOI 10.1016/S0140-6736(00)02652-0; SCRIVER CR, 2001, METABOLIC MOL BASES, P1667; SUPER M, 1994, BRIT MED J, V308, P1462, DOI 10.1136/bmj.308.6942.1462; SUPER M, 1994, BRIT MED J, V308, P877; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; WELLER DP, 1995, AUST J PUBLIC HEALTH, V19, P19; Wildhagen MF, 1998, BRIT MED BULL, V54, P857; Wildhagen MF, 1999, J MED SCREEN, V6, P70, DOI 10.1136/jms.6.2.70	28	53	53	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2001	69	2					361	370		10.1086/321973	http://dx.doi.org/10.1086/321973			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XN	11431707	Bronze, Green Published			2022-12-18	WOS:000170108200011
J	Vesprini, D; Nam, RK; Trachtenberg, J; Jewett, MAS; Tavtigian, SV; Emami, M; Ho, M; Toi, A; Narod, SA				Vesprini, D; Nam, RK; Trachtenberg, J; Jewett, MAS; Tavtigian, SV; Emami, M; Ho, M; Toi, A; Narod, SA			HPC2 variants and screen-detected prostate cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ANDROGEN RECEPTOR GENE; SUSCEPTIBILITY LOCUS; ASSOCIATION; REPEAT	Two studies have reported significant associations between susceptibility to prostate cancer and two common missense variants of the HPC2/ELAC2 gene, with estimated relative risks in the range of two- to threefold. We investigated whether these polymorphisms could be informative in the prediction of the presence of prostate cancer in men undergoing prostatic biopsy for the evaluation of an elevated serum-PSA level (greater than or equal to4.0 ng/ml). We genotyped 944 men who underwent a prostate biopsy at our institution, as well as a control population of 922 healthy, unselected women from the same population. The prevalence of the HPC2 Ala541Thr allele was similar in men with prostate cancer (6.3%), men with other prostatic conditions (6.8%), and healthy women (6.3%) (P=.83). We conclude that HPC2 genotyping is unlikely to be a useful adjunct to PSA in the prediction of the presence of biopsy-detected prostate cancer in asymptomatic men.	Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada; Univ Toronto, Univ Hlth Network, Princess Margaret Hosp, Dept Med Imaging, Toronto, ON, Canada; Myriad Genet Inc, Salt Lake City, UT USA	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Myriad Genetics, Inc	Narod, SA (corresponding author), 790 Bay St,7th Floor, Toronto, ON M5G 1N8, Canada.	steven.narod@swchsc.on.ca	Narod, Steven A/AAA-6112-2022					Berry R, 2000, AM J HUM GENET, V67, P82, DOI 10.1086/302994; Berthon P, 1998, AM J HUM GENET, V62, P1416, DOI 10.1086/301879; Fleshner NE, 1997, J UROLOGY, V158, P505, DOI 10.1016/S0022-5347(01)64518-X; Gibbs M, 1999, AM J HUM GENET, V64, P776, DOI 10.1086/302287; Giovannucci E, 1997, P NATL ACAD SCI USA, V94, P3320, DOI 10.1073/pnas.94.7.3320; Ingles SA, 1997, J NATL CANCER I, V89, P166, DOI 10.1093/jnci/89.2.166; Jaffe JM, 2000, CANCER RES, V60, P1626; Makridakis NM, 1999, LANCET, V354, P975, DOI 10.1016/S0140-6736(98)11282-5; Nam RK, 2001, UROLOGY, V57, P199, DOI 10.1016/S0090-4295(00)00928-6; Narod S, 1999, BBA-REV CANCER, V1423, pF1, DOI 10.1016/S0304-419X(98)00030-4; NAROD SA, 1995, NAT MED, V1, P99, DOI 10.1038/nm0295-99; Rebbeck TR, 2000, AM J HUM GENET, V67, P1014, DOI 10.1086/303096; Rebbeck TR, 1998, J NATL CANCER I, V90, P1225, DOI 10.1093/jnci/90.16.1225; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; Stanford JL, 1997, CANCER RES, V57, P1194; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; Xu JF, 1998, NAT GENET, V20, P175, DOI 10.1038/2477	17	53	56	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2001	68	4					912	917		10.1086/319502	http://dx.doi.org/10.1086/319502			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	414KQ	11254449	Bronze, Green Published			2022-12-18	WOS:000167666000013
J	Seyda, A; Newbold, RF; Hudson, TJ; Verner, A; MacKay, N; Winter, S; Feigenbaum, A; Malaney, S; Gonzalez-Halphen, D; Cuthbert, AP; Robinson, BH				Seyda, A; Newbold, RF; Hudson, TJ; Verner, A; MacKay, N; Winter, S; Feigenbaum, A; Malaney, S; Gonzalez-Halphen, D; Cuthbert, AP; Robinson, BH			A novel syndrome affecting multiple mitochondrial functions, located by microcell-mediated transfer to chromosome 2p14-2p13	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYTOCHROME BC(1) COMPLEX; CONGENITAL LACTIC-ACIDOSIS; RESPIRATORY-CHAIN DEFECTS; SKIN FIBROBLAST-CULTURES; OXIDASE DEFICIENCY; I DEFICIENCY; C-REDUCTASE; DEHYDROGENASE; DISEASE; MECHANISMS	We have studied cultured skin fibroblasts from three siblings and one unrelated individual, all of whom had fatal mitochondrial disease manifesting soon after birth. After incubation with 1 mM glucose, these four cell strains exhibited lactate/pyruvate ratios that were six times greater than those of controls. On further analysis, enzymatic activities of the pyruvate dehydrogenase complex, the 2-oxoglutarate dehydrogenase complex, NADH cytochrome c reductase, succinate dehydrogenase, and succinate cytochrome c reductase were severely deficient. In two of the siblings the enzymatic activity of cytochrome oxidase was mildly decreased (by similar to 50%). Metabolite analysis performed on urine samples taken from these patients revealed high levels of glycine, leucine, valine, and isoleucine, indicating abnormalities of both the glycine-cleavage system and branched-chain alpha -ketoacid dehydrogenase. In contrast, the activities of fibroblast pyruvate carboxylase, mitochondrial aconitase, and citrate synthase were normal. Immunoblot analysis of selected complex III subunits (core 1, cyt c(1), and iron-sulfur protein) and of the pyruvate dehydrogenase complex subunits revealed no visible changes in the levels of all examined proteins, decreasing the possibility that an import and/or assembly factor is involved. To elucidate the underlying molecular defect, analysis of microcell-mediated chromosome-fusion was performed between the present study's fibroblasts (recipients) and a panel of A9 mouse: human hybrids (donors) developed by Cuthbert et al. (1995). Complementation was observed between the recipient cells from both families and the mouse: human hybrid clone carrying human chromosome 2. These results indicate that the underlying defect in our patients is under the control of a nuclear gene, the locus of which is on chromosome 2. A 5-cM interval has been identified as potentially containing the critical region for the unknown gene. This interval maps to region 2p14-2p13.	Hosp Sick Children, Res Inst, Metab Dis Programme, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Div Clin Genet, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Biochem, Toronto, ON, Canada; Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada; Brunel Univ, Dept Biol & Biochem, Uxbridge UB8 3PH, Middx, England; Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada; Valley Childrens Hosp, Fresno, CA USA; St Vincents Hosp, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia; Univ Nacl Autonoma Mexico, Dept Bioenerget, Mexico City 04510, DF, Mexico; Guys Hosp, Guys Kings & St Thomas Sch Med, Div Med & Mol Genet, London SE1 9RT, England	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Brunel University; McGill University; Garvan Institute of Medical Research; St Vincents Hospital Sydney; Universidad Nacional Autonoma de Mexico; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Robinson, BH (corresponding author), Hosp Sick Children, Res Inst, Metab Dis Programme, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	bhr@sickkids.on.ca	Gonzalez-Halphen, Diego/C-2664-2013	Gonzalez-Halphen, Diego/0000-0003-0654-655X; Hudson, Thomas/0000-0002-1376-4849				BODNAR AG, 1995, BIOCHEM J, V305, P817, DOI 10.1042/bj3050817; Boitier E, 1998, J NEUROL SCI, V156, P41, DOI 10.1016/S0022-510X(98)00006-9; Brasseur G, 1997, EUR J BIOCHEM, V246, P103, DOI 10.1111/j.1432-1033.1997.t01-1-00103.x; BROWN GK, 1988, EUR J PEDIATR, V147, P10, DOI 10.1007/BF00442603; BROWN MD, 1994, J BIOENERG BIOMEMBR, V26, P273, DOI 10.1007/BF00763099; COMPTON T, 1993, J VIROL, V67, P3644, DOI 10.1128/JVI.67.6.3644-3648.1993; Craig EE, 1997, AM J PHYSIOL-HEART C, V272, pH2983, DOI 10.1152/ajpheart.1997.272.6.H2983; CUTHBERT AP, 1995, CYTOGENET CELL GENET, V71, P68, DOI 10.1159/000134066; Darley-Usmar V. M., 1987, MITOCHONDRIA PRACTIC; DiMauro S, 1988, Adv Neurol, V48, P93; EKONG J, 1982, THESIS U TORONTO TOR; FOURNIER REK, 1981, P NATL ACAD SCI-BIOL, V78, P6349, DOI 10.1073/pnas.78.10.6349; Grossman LI, 1996, BIOESSAYS, V18, P983, DOI 10.1002/bies.950181208; HALL RE, 1993, J CLIN INVEST, V92, P2660, DOI 10.1172/JCI116882; Hatefi Y, 1978, Methods Enzymol, V53, P21; HOPPEL CL, 1987, J CLIN INVEST, V80, P71, DOI 10.1172/JCI113066; HYLAND K, 1983, CLIN CHIM ACTA, V133, P177, DOI 10.1016/0009-8981(83)90403-5; Jin H, 1999, GENOMICS, V61, P259, DOI 10.1006/geno.1999.5966; Jin H, 1996, NAT GENET, V14, P177, DOI 10.1038/ng1096-177; Kapazoglou A, 2000, EUR J BIOCHEM, V267, P352, DOI 10.1046/j.1432-1327.2000.01006.x; KENNAWAY N G, 1988, Journal of Bioenergetics and Biomembranes, V20, P325, DOI 10.1007/BF00769636; Koehler CM, 1999, P NATL ACAD SCI USA, V96, P2141, DOI 10.1073/pnas.96.5.2141; LEACH RJ, 1989, GENOMICS, V5, P167, DOI 10.1016/0888-7543(89)90043-8; Lombes A, 1996, J INHERIT METAB DIS, V19, P286, DOI 10.1007/BF01799256; LOMBES A, 1989, ANN NEUROL, V26, P20, DOI 10.1002/ana.410260104; Moraes CT, 1999, MOL BIOL CELL, V10, P3345, DOI 10.1091/mbc.10.10.3345; MOREADITH RW, 1984, J CLIN INVEST, V74, P685, DOI 10.1172/JCI111484; Morten KJ, 1998, NEUROLOGY, V51, P1324, DOI 10.1212/WNL.51.5.1324; Newbold Robert F., 1996, P53; Petruzzella V, 1998, GENOMICS, V54, P494, DOI 10.1006/geno.1998.5580; Pitkanen S, 1996, BIOCHEM MOL MED, V59, P134, DOI 10.1006/bmme.1996.0078; Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798; RACKER E, 1950, BIOCHIM BIOPHYS ACTA, V4, P211, DOI 10.1016/0006-3002(50)90026-6; Raha S, 2000, FREE RADICAL BIO MED, V29, P170, DOI 10.1016/S0891-5849(00)00338-5; Robinson B.H., 1995, METABOLIC MOL BASES, P1479; ROBINSON BH, 1990, PEDIATR RES, V28, P549, DOI 10.1203/00006450-199011000-00027; ROBINSON BH, 1987, J PEDIATR-US, V110, P216, DOI 10.1016/S0022-3476(87)80157-9; ROBINSON BH, 1985, AM J HUM GENET, V37, P938; Robinson JB., 1987, MITOCHONDRIA PRACTIC, P153, DOI DOI 10.1016/J.BBRC.2005.02.135; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; SHEU KFR, 1981, J CLIN INVEST, V67, P1463, DOI 10.1172/JCI110176; Soriano GM, 1999, J BIOENERG BIOMEMBR, V31, P201, DOI 10.1023/A:1005463527752; Valnot I, 1999, HUM GENET, V104, P460, DOI 10.1007/s004390050988; van Dijl JM, 1998, P NATL ACAD SCI USA, V95, P10584, DOI 10.1073/pnas.95.18.10584; VAZQUEZACEVEDO M, 1993, J BIOENERG BIOMEMBR, V25, P401, DOI 10.1007/BF00762466; YU L, 1982, J BIOL CHEM, V257, P2016; ZEVIANI M, 1989, NEUROL CLIN, V7, P123, DOI 10.1016/S0733-8619(18)30832-6	47	53	58	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2001	68	2					386	396		10.1086/318196	http://dx.doi.org/10.1086/318196			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	394LD	11156534	Green Published, Bronze			2022-12-18	WOS:000166524800009
J	Berend, SA; Horwitz, J; McCaskill, C; Shaffer, LG				Berend, SA; Horwitz, J; McCaskill, C; Shaffer, LG			Identification of uniparental disomy following prenatal detection of Robertsonian translocations and isochromosomes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MECHANISMS; DIAGNOSIS; HUMANS	Rearrangements of the acrocentric chromosomes (Robertsonian translocations and isochromosomes) are associated with an increased risk, of aneuploidy. Given this, and the large number of reported cases of uniparental disomy (UPD) associated with an acrocentric rearrangement, carriers are presumed to be at risk for UPD. However, an accurate risk estimate for UPD associated with these rearrangements is lacking. A total of 174 prenatally identified acrocentric rearrangements, including both Robertsonian translocations and isochromosomes, were studied prospectively to identify UPD for the chromosomes involved in the rearrangements. The overall goal of the study was to provide an estimate of the risk of UPD associated with nonhomologous Robertsonian translocations and homologous acrocentric rearrangements. Of the 168 nonhomologous Robertsonian translocations studied, one showed UPD for chromosome 13, providing a risk estimate of 0.6%. Four of the six homologous acrocentric rearrangements showed UPD, providing a risk estimate of 66%. These cases have also allowed delineation of the mechanisms involved in producing UPD unique to Robertsonian translocations. Given the relatively high risk for UPD in prenatally identified Robertsonian translocations and isochromosomes, UPD testing should be considered, especially for cases involving the acrocentric chromosomes 14 and 15, in which UPD is associated with adverse clinical outcomes.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Genzyme Genet, Santa Fe, NM USA	Baylor College of Medicine; Sanofi-Aventis; Genzyme Corporation	Shaffer, LG (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Pl,Room 15E, Houston, TX 77030 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056845] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM56845-03] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berend SA, 1999, AM J MED GENET, V82, P275, DOI 10.1002/(SICI)1096-8628(19990129)82:3<275::AID-AJMG15>3.0.CO;2-2; CASSIDY SB, 1992, AM J HUM GENET, V51, P701; Cheung SW, 1997, AM J MED GENET, V72, P47, DOI 10.1002/(SICI)1096-8628(19971003)72:1<47::AID-AJMG10>3.0.CO;2-U; ENGEL E, 1980, AM J MED GENET, V6, P137, DOI 10.1002/ajmg.1320060207; HAMERTON JL, 1975, CLIN GENET, V8, P223; HAN JY, 1994, AM J HUM GENET, V55, P960; HARRIS DJ, 1979, AM J MED GENET, V3, P175, DOI 10.1002/ajmg.1320030208; HOOK EB, 1977, AM J HUM GENET, V29, P94; Klein J, 1999, AM J HUM GENET, V65, pA179; Koehler KE, 1996, HUM MOL GENET, V5, P1495, DOI 10.1093/hmg/5.Supplement_1.1495; Kotzot D, 1999, AM J MED GENET, V82, P265, DOI 10.1002/(SICI)1096-8628(19990129)82:3<265::AID-AJMG14>3.3.CO;2-Y; LAI EC, 1983, AM J HUM GENET, V35, P385; LEDBETTER DH, 1995, HUM MOL GENET, V4, P1757, DOI 10.1093/hmg/4.suppl_1.1757; MARES A, 1991, GENOMICS, V11, P215, DOI 10.1016/0888-7543(91)90122-U; NERI G, 1983, AM J MED GENET, V16, P535, DOI 10.1002/ajmg.1320160412; Page SL, 1996, HUM MOL GENET, V5, P1279, DOI 10.1093/hmg/5.9.1279; Robinson WP, 1996, AM J MED GENET, V61, P158, DOI 10.1002/(SICI)1096-8628(19960111)61:2<158::AID-AJMG11>3.0.CO;2-T; Robinson WP, 1996, PRENATAL DIAG, V16, P837, DOI 10.1002/(SICI)1097-0223(199609)16:9<837::AID-PD956>3.0.CO;2-7; SHAFFER LG, 1993, AM J MED GENET, V47, P383, DOI 10.1002/ajmg.1320470317; SHAFFER LG, 1993, AM J MED GENET, V47, P1218, DOI 10.1002/ajmg.1320470818; Shaffer LG, 1998, AM J MED GENET, V79, P366, DOI 10.1002/(SICI)1096-8628(19981012)79:5<366::AID-AJMG7>3.3.CO;2-L; SHAFFER LG, 1994, AM J HUM GENET, V55, P968; SPENCE JE, 1988, AM J HUM GENET, V42, P217; Sullivan BA, 1996, AM J HUM GENET, V59, P167; THERMAN E, 1989, ANN HUM GENET, V53, P49, DOI 10.1111/j.1469-1809.1989.tb01121.x	25	53	59	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2000	66	6					1787	1793		10.1086/302916	http://dx.doi.org/10.1086/302916			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QU	10775524	Bronze, Green Published			2022-12-18	WOS:000088373800007
J	Reid, E; Dearlove, AM; Osborn, O; Rogers, MT; Rubinsztein, DC				Reid, E; Dearlove, AM; Osborn, O; Rogers, MT; Rubinsztein, DC			A locus for autosomal dominant "pure" hereditary spastic paraplegia maps to chromosome 19q13	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC-HETEROGENEITY; LINKAGE ANALYSIS; PHENOTYPE; FAMILIES; 14Q; 2P; 8Q	Genetic loci for autosomal dominant pure hereditary spastic paraplegia (ADPHSP) hare been mapped to chromosomes 2p, 8q, 12q, 14q, and 15q. We undertook a genomewide linkage screen of a large family with ADPHSP, for which linkage at all previously identified ADPHSP loci was excluded. Analysis of markers on chromosome 19q gave a peak pairwise LOD score of 3.72 at D19S420, allowing assignment of a novel ADPHSP locus ( which we have termed "SPG12") to this region. Haplotype construction and analysis of recombination events narrowed the SPG12 locus to a 16.1-cM region between markers D19S868 and D19S902.	Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 2XY, England; MRC, Human Genome Mapping Project Resource Ctr, Cambridge, England; Univ Wales Coll Cardiff, Inst Med Genet, Cardiff CF1 3NS, S Glam, Wales	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cardiff University	Rubinsztein, DC (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Level 4,Wellcome MRC Bldg,Hills Rd, Cambridge CB2 2XY, England.	dcr1000@cus.cam.ac.uk	Reid, Evan/F-3250-2010; osborn, olivia/R-1460-2018; Rubinsztein, David C/C-3472-2011	Reid, Evan/0000-0003-1623-7304; osborn, olivia/0000-0003-0516-7937; 				BARTON D E, 1987, Genomics, V1, P107, DOI 10.1016/0888-7543(87)90002-4; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Durr A, 1996, BRAIN, V119, P1487, DOI 10.1093/brain/119.5.1487; FINK JK, 1995, AM J HUM GENET, V56, P188; Fink JK, 1996, NEUROLOGY, V46, P1507, DOI 10.1212/WNL.46.6.1507; GISPERT S, 1995, AM J HUM GENET, V56, P183; HARDING A, 1984, HEREDITARY ATAXIAS R; HARDING AE, 1981, J NEUROL NEUROSUR PS, V44, P871, DOI 10.1136/jnnp.44.10.871; HAZAN J, 1993, NAT GENET, V5, P163, DOI 10.1038/ng1093-163; HAZAN J, 1994, HUM MOL GENET, V3, P1569, DOI 10.1093/hmg/3.9.1569; Hedera P, 1999, NEUROLOGY, V53, P44, DOI 10.1212/WNL.53.1.44; Hedera P, 1999, AM J HUM GENET, V64, P563, DOI 10.1086/302258; HENTATI A, 1994, HUM MOL GENET, V3, P1867, DOI 10.1093/hmg/3.10.1867; Huang SZ, 1997, HUM GENET, V100, P620, DOI 10.1007/s004390050563; Kobayashi H, 1996, J NEUROL SCI, V137, P131, DOI 10.1016/0022-510X(95)00349-7; LATHROP GM, 1985, AM J HUM GENET, V37, P482; Nielsen JE, 1998, J NEUROL NEUROSUR PS, V64, P61, DOI 10.1136/jnnp.64.1.61; Paternotte C, 1998, GENOME RES, V8, P1216, DOI 10.1101/gr.8.11.1216; Reid E, 1999, J MED GENET, V36, P797, DOI 10.1136/jmg.36.10.797; Reid E, 1999, BRAIN, V122, P1741, DOI 10.1093/brain/122.9.1741; Reid E, 1999, J NEUROL, V246, P995, DOI 10.1007/s004150050503; Reid E, 1999, NEUROLOGY, V53, P1844, DOI 10.1212/WNL.53.8.1844; Reid E, 1999, AM J HUM GENET, V65, P757, DOI 10.1086/302555; Rocco PS, 1999, AM J HUM GENET, V65, pA442; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Watanabe TK, 1996, CYTOGENET CELL GENET, V72, P208, DOI 10.1159/000134191	27	53	54	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					728	732		10.1086/302783	http://dx.doi.org/10.1086/302783			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	10677333	Bronze, Green Published			2022-12-18	WOS:000088373100040
J	Jung, M; Poepping, I; Perrot, A; Ellmer, AE; Wienker, TF; Dietz, R; Reis, A; Osterziel, KJ				Jung, M; Poepping, I; Perrot, A; Ellmer, AE; Wienker, TF; Dietz, R; Reis, A; Osterziel, KJ			Investigation of a family with autosomal dominant dilated cardiomyopathy defines a novel locus on chromosome 2q14-q22	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							X-LINKED GENE; HEART-FAILURE; MUSCULAR-DYSTROPHY; NEMALINE MYOPATHY; LINKAGE ANALYSIS; DISEASE; EPIDEMIOLOGY; FREQUENCY; MUTATION; MUSCLE	Dilated cardiomyopathy (DCM) is a leading cause of heart failure and the most frequent indication for heart transplantation in young patients. Probably >25% of DCM cases are of familial etiology. We report here genetic localization in a three-generation German family with 12 affected individuals with autosomal dominant familial DCM characterized by ventricular dilatation, impaired systolic function, and conduction disease. After exclusion of known DCM loci, we performed a whole-genome screen and detected linkage of DCM to chromosome 2q14-q22. Investigation of only affected individuals defines a 24-cM interval between markers D2S2224 and D2S2324; when unaffected individuals are also included, the critical region decreases to 11 cM between markers D2S2224 and D2S112, with a peak LOD score of 3.73 at recombination fraction 0 at D2S2339. The identification of an additional locus for familial autosomal dominant DCM underlines the genetic heterogeneity and may assist in the elucidation of the causes of this disease.	Humboldt Univ, Charite Franz Volhard Klin, D-13122 Berlin, Germany; Max Delbruck Centrum, Mikrosatellitenzentrum, Berlin, Germany; Humboldt Univ, Inst Humangenet, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Humboldt University of Berlin	Osterziel, KJ (corresponding author), Humboldt Univ, Charite Franz Volhard Klin, Wiltbergstr 50, D-13122 Berlin, Germany.		Reis, André/D-2309-2009	Reis, André/0000-0002-6301-6363; Perrot, Andreas/0000-0002-8800-342X				Arber S, 1997, CELL, V88, P393, DOI 10.1016/S0092-8674(00)81878-4; ARTS WF, 1978, ARCH NEUROL-CHICAGO, V35, P72, DOI 10.1001/archneur.1978.00500260010002; BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; BERKO BA, 1987, NEW ENGL J MED, V316, P1186, DOI 10.1056/NEJM198705073161904; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; Bowles KR, 1996, J CLIN INVEST, V98, P1355, DOI 10.1172/JCI118922; CODD MB, 1989, CIRCULATION, V80, P564, DOI 10.1161/01.CIR.80.3.564; DAdamo P, 1997, AM J HUM GENET, V61, P862, DOI 10.1086/514886; DEC GW, 1994, NEW ENGL J MED, V331, P1564, DOI 10.1056/NEJM199412083312307; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DURAND JB, 1995, CIRCULATION, V92, P3387, DOI 10.1161/01.CIR.92.12.3387; Goebel HH, 1998, NEUROMUSCULAR DISORD, V8, P162, DOI 10.1016/S0960-8966(98)00022-4; Greelish JP, 1999, NAT MED, V5, P439, DOI 10.1038/7439; Grunig E, 1998, J AM COLL CARDIOL, V31, P186, DOI 10.1016/S0735-1097(97)00434-8; HENRY WL, 1980, CIRCULATION, V62, P1054, DOI 10.1161/01.CIR.62.5.1054; HILDEBRANDT F, 1993, COMPUT BIOMED RES, V26, P592, DOI 10.1006/cbmr.1993.1042; HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107; KASS S, 1994, NAT GENET, V7, P546, DOI 10.1038/ng0894-546; KEELING PJ, 1995, BRIT HEART J, V73, P417; KRAJINOVIC M, 1995, AM J HUM GENET, V57, P846; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Messina DN, 1997, AM J HUM GENET, V61, P909, DOI 10.1086/514896; Mestroni L, 1999, EUR HEART J, V20, P93, DOI 10.1053/euhj.1998.1145; Mestroni L, 1997, CURR OPIN CARDIOL, V12, P303, DOI 10.1097/00001573-199705000-00012; MICHELS VV, 1992, NEW ENGL J MED, V326, P77, DOI 10.1056/NEJM199201093260201; Milasin J, 1996, HUM MOL GENET, V5, P73, DOI 10.1093/hmg/5.1.73; MUNTONI F, 1993, NEW ENGL J MED, V329, P921, DOI 10.1056/NEJM199309233291304; NEUSTEIN HB, 1979, PEDIATRICS, V64, P24; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Olson TM, 1996, J CLIN INVEST, V97, P528, DOI 10.1172/JCI118445; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; Pelin K, 1999, P NATL ACAD SCI USA, V96, P2305, DOI 10.1073/pnas.96.5.2305; Rakar S, 1997, EUR HEART J, V18, P117; Sakamoto A, 1997, P NATL ACAD SCI USA, V94, P13873, DOI 10.1073/pnas.94.25.13873; SANDLER H, 1968, AM HEART J, V75, P325, DOI 10.1016/0002-8703(68)90089-6; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Siu BL, 1999, CIRCULATION, V99, P1022, DOI 10.1161/01.CIR.99.8.1022; TOWBIN JA, 1993, CIRCULATION, V87, P1854, DOI 10.1161/01.CIR.87.6.1854; WALLGRENPETTERSSON C, 1988, J NEUROL SCI, V83, P243, DOI 10.1016/0022-510X(88)90072-X; WALLGRENPETTERSSON C, 1995, NEUROMUSCULAR DISORD, V5, P441, DOI 10.1016/0960-8966(95)00022-F; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; WHITFIELD AG, 1961, Q J MED, V3, P119	42	53	56	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1999	65	4					1068	1077		10.1086/302580	http://dx.doi.org/10.1086/302580			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	241XW	10486326	Green Published, Bronze			2022-12-18	WOS:000082910000016
J	Lossi, AM; Millan, JM; Villard, L; Orellana, C; Cardoso, C; Prieto, F; Fontes, M; Martinez, F				Lossi, AM; Millan, JM; Villard, L; Orellana, C; Cardoso, C; Prieto, F; Fontes, M; Martinez, F			Mutation of the XNP/ATR-X gene in a family with severe mental retardation, spastic paraplegia and skewed pattern of X inactivation: Demonstration that the mutation is involved in the inactivation bias	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							ALPHA-THALASSEMIA; ATR-X; PROTEIN; CHROMOSOME; CARRIERS		Fac Med Timone, INSERM U491, Marseille, France; Univ Valencia, Hosp La Fe, Unidad Genet, Valencia, Spain	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Hospital Universitari i Politecnic La Fe; University of Valencia	Fontes, M (corresponding author), Fac Med Timone, INSERM U491, Marseille, France.		Cardoso, Carlos/H-4520-2016; Orellana, Carmen/B-1925-2009; Martinez, Francisco/A-2543-2009; Villard, Laurent/E-3941-2016; Cardoso, Carlos/M-2767-2019	Cardoso, Carlos/0000-0003-1914-9553; Orellana, Carmen/0000-0003-4271-5859; Martinez, Francisco/0000-0002-0589-2584; Villard, Laurent/0000-0001-6657-5008; Cardoso, Carlos/0000-0003-1914-9553				ABIDI F, IN PRESS AM J MED GE; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Cardoso C, 1998, HUM MOL GENET, V7, P679, DOI 10.1093/hmg/7.4.679; GECZ J, 1994, HUM MOL GENET, V3, P39, DOI 10.1093/hmg/3.1.39; GIBBONS RJ, 1995, AM J MED GENET, V55, P288, DOI 10.1002/ajmg.1320550309; GIBBONS RJ, 1995, CELL, V80, P837, DOI 10.1016/0092-8674(95)90287-2; Martinez F, 1998, J MED GENET, V35, P284, DOI 10.1136/jmg.35.4.284; Orstavik KH, 1998, AM J HUM GENET, V63, P1457, DOI 10.1086/302095; PEROGARO E, 1997, AM J HUM GENET, V61, P160; Plenge RM, 1999, AM J HUM GENET, V64, P759, DOI 10.1086/302286; Villard L, 1997, GENOMICS, V43, P149, DOI 10.1006/geno.1997.4793; Villard L, 1996, AM J HUM GENET, V58, P499; Villard L, 1996, EUR J HUM GENET, V4, P316; Villard L, 1996, NAT GENET, V12, P359, DOI 10.1038/ng0496-359	14	53	54	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1999	65	2					558	562		10.1086/302499	http://dx.doi.org/10.1086/302499			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	223JA	10417298	Green Published, Bronze			2022-12-18	WOS:000081836900031
J	Goldstein, DB; Reich, DE; Bradman, N; Usher, S; Seligsohn, U; Peretz, H				Goldstein, DB; Reich, DE; Bradman, N; Usher, S; Seligsohn, U; Peretz, H			Age estimates of two common mutations causing factor XI deficiency: Recent genetic drift is not necessary for elevated disease incidence among Ashkenazi Jews	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ORIGIN	The type II and type III mutations at the FXI locus, which cause coagulation factor XI deficiency, have high frequencies in Jewish populations. The type III mutation is largely restricted to Ashkenazi Jews, but the type II mutation is observed at high frequency in both Ashkenazi and Iraqi Jews, suggesting the possibility that the mutation appeared before the separation of these communities. Here we report estimates of the ages of the type II and type III mutations, based on the observed distribution of allelic variants at a flanking microsatellite marker (D4S171). The results are consistent with a recent origin for the type III mutation but suggest that the type II mutation appeared >120 generations ago. This finding demonstrates that the high frequency of the type II mutation among Jews is independent of the demographic upheavals among Ashkenazi Jews in the 16th and 17th centuries.	Univ London Univ Coll, Galton Lab, Dept Biol, London NW1 2HE, England; Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Sourasky Med Ctr, Dept Clin Biochem, Tel Aviv, Israel; Chaim Sheba Med Ctr, Dept Haematol, Inst Thrombosis & Hemostasis, IL-52621 Tel Hashomer, Israel	University of London; University College London; University of Oxford; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Chaim Sheba Medical Center	Goldstein, DB (corresponding author), Univ London Univ Coll, Galton Lab, Dept Biol, Wolfson House,4 Stephenson Way, London NW1 2HE, England.		Goldstein, David/AAY-8125-2020; Peng, Bo/A-6920-2009	Peng, Bo/0000-0001-8225-2284				BOLTONMAGGS PHB, 1992, 24 C INT SOC HEM LON; Goldstein DB, 1997, J HERED, V88, P335, DOI 10.1093/oxfordjournals.jhered.a023114; GOODMAN RM, 1978, GENETIC DISORDERS JE; Peretz H, 1997, BLOOD, V90, P2654, DOI 10.1182/blood.V90.7.2654.2654_2654_2659; REICH D, IN PRESS MICROSATELL; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; SAITO H, 1985, J LAB CLIN MED, V106, P718; SELIGSOHN U, 1978, BLOOD, V51, P1223; SHPILBERG O, 1995, BLOOD, V85, P429, DOI 10.1182/blood.V85.2.429.bloodjournal852429; Slatkin M, 1997, AM J HUM GENET, V60, P447; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; Thomas MG, 1998, NATURE, V394, P138, DOI 10.1038/28083; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123	13	53	53	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1999	64	4					1071	1075		10.1086/302313	http://dx.doi.org/10.1086/302313			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184UV	10090892	Bronze, Green Published			2022-12-18	WOS:000079632900018
J	Kerrison, JB; Vagefi, MR; Barmada, MM; Maumenee, LH				Kerrison, JB; Vagefi, MR; Barmada, MM; Maumenee, LH			Congenital motor nystagmus linked to Xq26-q27	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; CEREBELLAR DEGENERATION; GENETIC-MAP; HUMANS	Congenital motor nystagmus (CMN) is a hereditary disorder characterized by bilateral ocular oscillations that begin in the first 6 mo of life. It must be distinguished from those genetic disorders-such as ocular albinism (OA), congenital stationary night blindness (CSNB), and blue-cone monochromatism (BCM)-in which nystagmus accompanies a clinically apparent defect in the visual sensory system. Although CMN is presumed to arise from a neurological abnormality of fixation, it is not known whether the molecular defect is located in the eye or in the brain. It may be inherited in an autosomal dominant, autosomal recessive, or X-linked pattern. Three families with CMN inherited in an X-linked, irregularly dominant pattern were investigated with linkage and candidate gene analysis. The penetrance among obligate female carriers was 54%. Evaluation of markers in the region of the genes for X-linked OA, CSNB, and BCM revealed no evidence of linkage, supporting the hypothesis that CMN represents a distinct entity. The gene was mapped to chromosome Xq26-q27 with the following markers: GATA172D05 (LOD score 3.164; recombination fraction [theta] = 0.156), DXS1047 (LOD score 10.296; theta = 0), DXS1192 (LOD score 8.174; theta = 0.027), DXS1232 (LOD score 6.015; theta = 0.036), DXS984 (LOD score 6.695; theta = 0), and GATA31E08 (LOD score 4.940; theta = 0.083). Assessment of haplotypes and multipoint linkage analysis, which gave a maximum LOD score of 10.790 with the 1-LOD-unit support interval spanning similar to 7 cM, place the gene in a region between GATA172D05 and DXS1192. Evaluation of candidate genes CDR1 and SOX3 did not reveal mutations in affected male subjects.	Wilmer Eye Inst, Johns Hopkins Ctr Hereditary Eye Dis, Baltimore, MD USA; Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA	Johns Hopkins University; Johns Hopkins Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Maumenee, LH (corresponding author), Wilmer Eye Inst, Johns Hopkins Ctr Hereditary Eye Dis, Maumenee 517,600 N Wolfe St, Baltimore, MD USA.			Barmada, M Michael/0000-0002-3604-6460				Allen Mary, 1942, JOUR HEREDITY, V33, P454; CHEN YT, 1990, P NATL ACAD SCI USA, V87, P3077, DOI 10.1073/pnas.87.8.3077; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DELLOSSO LF, 1993, NEUROLOGY, V43, P1741, DOI 10.1212/WNL.43.9.1741; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DICHGANS J, 1964, ACTA GENET STAT MED, V14, P240; DROPCHO EJ, 1987, P NATL ACAD SCI USA, V84, P4552, DOI 10.1073/pnas.84.13.4552; Gedeon AK, 1996, AM J MED GENET, V64, P63, DOI 10.1002/(SICI)1096-8628(19960712)64:1<63::AID-AJMG9>3.0.CO;2-S; Kerrison JB, 1996, GENOMICS, V33, P523, DOI 10.1006/geno.1996.0229; Kerrison JB, 1998, AM J OPHTHALMOL, V125, P64, DOI 10.1016/S0002-9394(99)80236-0; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1986, GENET EPIDEMIOL, V3, P39, DOI 10.1002/gepi.1370030105; Mumm S, 1997, AM J MED GENET, V72, P376, DOI 10.1002/(SICI)1096-8628(19971031)72:3<376::AID-AJMG27>3.3.CO;2-N; NETTLESHIP E, 1911, T OPHTHAL SOC UK, V31, P159; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Patton S, 1993, J Nurs Care Qual, V7, P15; PEARCE WG, 1972, J MED GENET, V9, P126, DOI 10.1136/jmg.9.1.126; PETERSON K, 1992, NEUROLOGY, V42, P1931, DOI 10.1212/wnl.42.10.1931; Rosenblum S F, 1987, Metab Pediatr Syst Ophthalmol (1985), V10, P103; RUTTUM MS, 1992, OPHTHALMOLOGY, V99, P747; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SINISCALCO M, 1991, AM J MED GENET, V38, P257; STAYTE M, 1993, BRIT J OPHTHALMOL, V77, P228, DOI 10.1136/bjo.77.4.228; STEVANOVIC M, 1993, HUM MOL GENET, V3, P2013; WAARDENBURG PJ, 1963, GENET OPHTHALMOL, V2, P1036	27	53	60	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1999	64	2					600	607		10.1086/302244	http://dx.doi.org/10.1086/302244			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	169HA	9973299	Green Published, Bronze			2022-12-18	WOS:000078740600031
J	Guioli, S; Schmitt, K; Critcher, R; Bouzyk, M; Spurr, NK; Ogata, T; Hoo, JJ; Pinsky, L; Gimelli, G; Pasztor, L; Goodfellow, PN				Guioli, S; Schmitt, K; Critcher, R; Bouzyk, M; Spurr, NK; Ogata, T; Hoo, JJ; Pinsky, L; Gimelli, G; Pasztor, L; Goodfellow, PN			Molecular analysis of 9p deletions associated with XY sex reversal: Refining the localization of a sex-determining gene to the tip of the chromosome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							CAMPOMELIC DYSPLASIA; MONOSOMY; SOX9; MAP		Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; Imperial Canc Res Fund, Clare Hall Labs, S Mimms EN6 3LD, Herts, England; Keio Univ, Sch Med, Dept Paediat, Tokyo, Japan; SUNY Hlth Sci Ctr, Dept Pediat, Syracuse, NY 13210 USA; Sir Mortimer B Davis Jewish Hosp, Dept Med, Montreal, PQ H3T 1E2, Canada; Ist Giannina Gaslini, I-16148 Genoa, Italy; Childrens Mercy Hosp, Cytogenet Lab, Kansas City, MO 64108 USA	University of Cambridge; Keio University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; McGill University; University of Genoa; IRCCS Istituto Giannina Gaslini; Children's Mercy Hospital	Guioli, S (corresponding author), Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England.			Ogata, Tsutomu/0000-0001-7178-9991; Guioli, Silvana/0000-0002-4920-7745				BARDONI B, 1994, NAT GENET, V7, P497, DOI 10.1038/ng0894-497; Begleiter M. L., 1995, American Journal of Human Genetics, V57, pA107; BENNETT CP, 1993, J MED GENET, V30, P518, DOI 10.1136/jmg.30.6.518; Bouzyk M, 1996, GENOMICS, V34, P187, DOI 10.1006/geno.1996.0264; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FORD CE, 1959, LANCET, V1, P711; HOO J J, 1989, American Journal of Human Genetics, V45, pA78; HURET JL, 1988, J MED GENET, V25, P741, DOI 10.1136/jmg.25.11.741; JACOBS PA, 1959, NATURE, V183, P302, DOI 10.1038/183302a0; Jost A., 1973, Recent Progress Hormone Res, V29, P1; KWOK C, 1995, AM J HUM GENET, V57, P1028; McDonald MT, 1997, AM J MED GENET, V73, P321; Meyer J, 1997, HUM MOL GENET, V6, P91, DOI 10.1093/hmg/6.1.91; Ogata T, 1997, J MED GENET, V34, P331, DOI 10.1136/jmg.34.4.331; Raymond CS, 1998, NATURE, V391, P691, DOI 10.1038/35618; Schafer AJ, 1996, BIOESSAYS, V18, P955, DOI 10.1002/bies.950181205; Veitia R, 1997, GENOMICS, V41, P271, DOI 10.1006/geno.1997.4648	17	53	57	0	5	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1998	63	3					905	908		10.1086/302017	http://dx.doi.org/10.1086/302017			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	119VN	9718347	Bronze, Green Published			2022-12-18	WOS:000075919000033
J	Abel, L; Muller-Myhsok, B				Abel, L; Muller-Myhsok, B			Robustness and power of the maximum-likelihood-binomial and maximum-likelihood-scope methods, in multipoint linkage analysis of affected-sibship data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETICALLY COMPLEX TRAITS; SIB-PAIR ANALYSIS; STRATEGIES; GENES	The maximum-likelihood-binomial (MLB) method, based on the binomial distribution of parental marker alleles among affected offspring, recently was shown to provide promising results by two-point linkage analysis of affected-sibship data. In this article, we extend the MLB method to multipoint linkage analysis, using the general framework of hidden Markov models. Furthermore, we perform a large simulation study to investigate the robustness and power of the MLB method, compared with those of the maximum-likelihood-score (MLS) method as implemented in MAPMARKER/SIBS, in the multipoint analysis of different affected sibship samples. Analyses of multiple-affected sibships by means of the MLS were conducted by consideration of all possible sib pairs, with (weighted MLS [MLSw]) or without (unweighted MLS [MLSu]) application of a classic weighting procedure. In simulations under the null hypothesis,the MLB provided very consistent type I errors regardless of the type of family sample (sib pairs or multiple-affected sibships), as did the MLS for samples with sib pairs only When samples included multiple-affected sibships, the MLSu led to inflation of low type I errors, whereas the MLSw yielded very conservative tests. Power comparisons showed that the MLB generally was more powerful than the MLS, except in recessive models with allele frequencies <.3. Missing parental marker data did not strongly influence type I error and power results in these multipoint analyses. The MLB approach, which in a natural way accounts for multiple-affected sibships and which provides a simple likelihood-ratio test for linkage, is an interesting alternative for multipoint analysis of sibships.	Hop La Pitie Salpetriere, INSERM, U436, F-75013 Paris, France; Bernhard Nocht Inst Trop Med, Dept Mol Med, Hamburg, Germany	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Bernhard Nocht Institut fur Tropenmedizin	Abel, L (corresponding author), Hop La Pitie Salpetriere, INSERM, U436, 91 Bd Hop, F-75013 Paris, France.	abel@biomath.jussieu.fr	Abel, Laurent/H-8888-2017; Müller-Myhsok, Bertram/A-3289-2013	Abel, Laurent/0000-0001-7016-6493; 				Abel L, 1998, GENET EPIDEMIOL, V15, P371, DOI 10.1002/(SICI)1098-2272(1998)15:4<371::AID-GEPI4>3.0.CO;2-5; ALCAIS A, 1997, 47 ANN M AM SOC HUM; BADNER J A, 1984, Genetic Epidemiology, V1, P329, DOI 10.1002/gepi.1370010405; Daly MJ, 1996, NAT GENET, V14, P131, DOI 10.1038/ng1096-131; Hanis CL, 1996, NAT GENET, V13, P161, DOI 10.1038/ng0696-161; HOLMANS P, 1993, AM J HUM GENET, V52, P362; KNAPP M, 1994, HUM HERED, V44, P44, DOI 10.1159/000154188; Kong A, 1997, NAT GENET, V17, P148, DOI 10.1038/ng1097-148; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; MAJUMDER PP, 1987, GENET EPIDEMIOL, V4, P277, DOI 10.1002/gepi.1370040406; Meunier F, 1997, GENET EPIDEMIOL, V14, P1107, DOI 10.1002/(SICI)1098-2272(1997)14:6<1107::AID-GEPI91>3.0.CO;2-K; RISCH N, 1990, AM J HUM GENET, V46, P242; RISCH N, 1990, AM J HUM GENET, V46, P222; Speer MC, 1995, GENET EPIDEMIOL, V12, P561, DOI 10.1002/gepi.1370120606; SUAREZ BK, 1984, AM J MED GENET, V18, P135, DOI 10.1002/ajmg.1320180117	17	53	53	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1998	63	2					638	647		10.1086/301958	http://dx.doi.org/10.1086/301958			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110CB	9683590	Green Published, Bronze			2022-12-18	WOS:000075360800039
J	Chen, XN; Knauf, JA; Gonsky, R; Wang, M; Lai, EH; Chissoe, S; Fagin, JA; Korenberg, JR				Chen, XN; Knauf, JA; Gonsky, R; Wang, M; Lai, EH; Chissoe, S; Fagin, JA; Korenberg, JR			From amplification to gene in thyroid cancer: A high-resolution mapped bacterial-artificial-chromosome resource for cancer chromosome aberrations guides gene discovery after comparative genome hybridization	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IN-SITU HYBRIDIZATION; HUMAN BREAST-CANCER; KINASE C FAMILY; PROTEIN-KINASE; PROSTATE-CANCER; COPY NUMBER; MOLECULAR-GENETICS; HUMAN SARCOMAS; DNA-SEQUENCES; SOLID TUMORS	Chromosome rearrangements associated with neoplasms provide a rich resource for definition of the pathways of tumorigenesis. The power of comparative genome hybridization (CGH) to identify novel genes depends on the existence of suitable markers, which are lacking throughout most of the genome. We now report a general approach that translates CGH data into higher-resolution genomic-clone data that are then used to define the genes located in aneuploid regions. We used CGH to study 33 thyroid-tumor DNAs and two tumor-cell-line DNAs. The results revealed amplifications of chromosome band 2p21, with less-intense amplification on 2p13, 19q13.1, and 1p36 and with least-intense amplification on 1p34, 1q42, 5q31, 5q33-34, 9q32-34, and 14q32. To define the 2p21 region amplified, a dense array of 373 FISH-mapped chromosome 2 bacterial artificial chromosomes (BACs) was constructed, and 87 of these were hybridized to a tumor-cell line. Four BACs carried genomic DNA that was amplified in these cells. The maximum amplified region was narrowed to 3-6 Mb by multicolor FISH with the flanking BACs, and the minimum amplicon size was defined by a contig of 420 kb. Sequence analysis of the amplified BAC 1D9 revealed a fragment of the gene, encoding protein kinase C epsilon (PKC epsilon), that was then shown to be amplified and rearranged in tumor cells. In summary, CGH combined with a dense mapped resource of BACs;and large-scale sequencing has led directly to the definition of PKC epsilon as a previously unmapped candidate gene involved in thyroid tumorigenesis.	Univ Calif Los Angeles, Sch Med, Cedars Sinai Res Inst, Dept Med,Div Endocrinol, Los Angeles, CA USA; Univ Calif Los Angeles, Sch Med, Cedars Sinai Res Inst, Ahmanson Dept Pediat,Div Genet, Los Angeles, CA USA; Univ Cincinnati, Div Endocrinol Metab, Cincinnati, OH USA; Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA; Washington Univ, Sch Med, St Louis, MO USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University System of Ohio; University of Cincinnati; University of North Carolina; University of North Carolina Chapel Hill; Washington University (WUSTL)	Korenberg, JR (corresponding author), Univ Calif Los Angeles, Cedars Sinai Med Ctr, 110 George Burns Rd,Suite 2069, Los Angeles, CA 90048 USA.			Knauf, Jeffrey/0000-0003-4456-8792	NATIONAL CANCER INSTITUTE [R29CA050706, R01CA050706, R01CA072597] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050025] Funding Source: NIH RePORTER; NCI NIH HHS [CA72597, CA50706] Funding Source: Medline; NHLBI NIH HHS [R01 HL50025] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BASTA P, 1992, BIOCHIM BIOPHYS ACTA, V1132, P154, DOI 10.1016/0167-4781(92)90006-L; Bentz M, 1996, BLOOD, V88, P1437, DOI 10.1182/blood.V88.4.1437.bloodjournal8841437; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; Bockmuhl U, 1996, LARYNGO RHINO OTOL, V75, P408, DOI 10.1055/s-2007-997605; Boerman RH, 1996, J NEUROPATH EXP NEUR, V55, P973, DOI 10.1097/00005072-199609000-00004; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; CHEN XN, 1996, 46 ANN M AM SOC HUM; Cher ML, 1996, CANCER RES, V56, P3091; CHEUNG VG, 1996, 4L ANN M AM SOC HUM; Chissoe SL, 1997, NUCLEIC ACIDS RES, V25, P2960, DOI 10.1093/nar/25.15.2960; DAVIS LG, 1986, BASIC METHODS MOL BI, P133; DEAR S, 1991, NUCLEIC ACIDS RES, V19, P3907, DOI 10.1093/nar/19.14.3907; DENKO NC, 1994, P NATL ACAD SCI USA, V91, P5124, DOI 10.1073/pnas.91.11.5124; FAGIN JA, 1994, ANNU REV MED, V45, P45; FAGIN JA, 1993, J CLIN INVEST, V91, P179, DOI 10.1172/JCI116168; FINNEY RE, 1993, SCIENCE, V260, P1524, DOI 10.1126/science.8502998; FORUS A, 1995, GENE CHROMOSOME CANC, V14, P15, DOI 10.1002/gcc.2870140104; FULTON LL, 1994, BIOTECHNIQUES, V17, P298; Ghazvini S, 1996, CANCER GENET CYTOGEN, V90, P95, DOI 10.1016/S0165-4608(96)00076-3; GORDON KB, 1994, CANCER RES, V54, P4764; GUAN XY, 1994, NAT GENET, V8, P155, DOI 10.1038/ng1094-155; HOULDSWORTH J, 1994, AM J PATHOL, V145, P1253; Houldsworth J, 1996, BLOOD, V87, P25; IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84; IWABUCHI H, 1995, CANCER RES, V55, P6172; JOOS S, 1995, GENE CHROMOSOME CANC, V14, P267, DOI 10.1002/gcc.2870140405; JOSSART GH, 1995, SURGERY, V118, P1018, DOI 10.1016/S0039-6060(05)80108-4; Jossart GH, 1996, CYTOGENET CELL GENET, V75, P254, DOI 10.1159/000134495; KALLIONIEMI A, 1994, P NATL ACAD SCI USA, V91, P2156, DOI 10.1073/pnas.91.6.2156; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; KALLIONIEMI OP, 1994, GENE CHROMOSOME CANC, V10, P231, DOI 10.1002/gcc.2870100403; Kallioniemi OP, 1997, NAT GENET, V15, P5, DOI 10.1038/ng0197-5; Koivisto P, 1997, CANCER RES, V57, P314; KORENBERG JR, 1995, CYTOGENET CELL GENET, V69, P196, DOI 10.1159/000133962; KURANAMI M, 1995, J SURG RES, V58, P233, DOI 10.1006/jsre.1995.1036; Lehmann L, 1997, CANCER GENET CYTOGEN, V96, P30, DOI 10.1016/S0165-4608(96)00279-8; LEMOINE NR, 1989, ONCOGENE, V4, P159; MARDIS ER, 1994, NUCLEIC ACIDS RES, V22, P2173, DOI 10.1093/nar/22.11.2173; Matsumura K, 1995, Kokubyo Gakkai Zasshi, V62, P513; MITELMAN F, 1994, CA-CANCER J CLIN, V44, P133, DOI 10.3322/canjclin.44.3.133; NAMBA H, 1990, MOL ENDOCRINOL, V4, P1474, DOI 10.1210/mend-4-10-1474; OHNO S, 1988, CELL, V53, P731, DOI 10.1016/0092-8674(88)90091-8; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; ONO Y, 1987, FEBS LETT, V226, P125, DOI 10.1016/0014-5793(87)80564-1; RIED T, 1995, CANCER RES, V55, P5415; Ried T, 1996, GENE CHROMOSOME CANC, V15, P234, DOI 10.1002/(SICI)1098-2264(199604)15:4<234::AID-GCC5>3.0.CO;2-2; SCHAAP D, 1989, FEBS LETT, V243, P351, DOI 10.1016/0014-5793(89)80160-7; SCHIMKE RT, 1988, J BIOL CHEM, V263, P5989; Schrock E, 1996, GENE CHROMOSOME CANC, V15, P199, DOI 10.1002/(SICI)1098-2264(199604)15:4<199::AID-GCC1>3.0.CO;2-X; Schutz BR, 1996, GENE CHROMOSOME CANC, V16, P196; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SUAREZ HG, 1990, ONCOGENE, V5, P565; Szymanska J, 1996, GENE CHROMOSOME CANC, V15, P89, DOI 10.1002/(SICI)1098-2264(199602)15:2<89::AID-GCC2>3.0.CO;2-#; TANIWAKI M, 1995, BLOOD, V86, P1481, DOI 10.1182/blood.V86.4.1481.bloodjournal8641481; TANNER MM, 1994, CANCER RES, V54, P4257; Tanner MM, 1996, CANCER RES, V56, P3441; VISAKORPI T, 1995, CANCER RES, V55, P342; VOORTER C, 1995, AM J PATHOL, V146, P1341; WANG M, 1994, GENOMICS, V24, P527, DOI 10.1006/geno.1994.1662; Wilson RK, 1997, GENOME ANAL, V1, P397; ZEKI K, 1994, J CLIN ENDOCR METAB, V79, P1317, DOI 10.1210/jc.79.5.1317	64	53	53	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1998	63	2					625	637		10.1086/301973	http://dx.doi.org/10.1086/301973			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110CB	9683604	Green Published, Bronze			2022-12-18	WOS:000075360800038
J	Nakagawa, Y; Kawaguchi, Y; Twells, RCJ; Muxworthy, C; Hunter, KMD; Wilson, A; Merriman, ME; Cox, RD; Merriman, T; Cucca, F; McKinney, PA; Shield, JPH; Tuomilehto, J; Tuomilehto-Wolf, E; Nistico, L; Buzzetti, R; Pozzilli, P; Joner, G; Thorsby, E; Undlien, DE; Pociot, F; Nerup, J; Ronningen, KS; Bain, SC; Todd, JA				Nakagawa, Y; Kawaguchi, Y; Twells, RCJ; Muxworthy, C; Hunter, KMD; Wilson, A; Merriman, ME; Cox, RD; Merriman, T; Cucca, F; McKinney, PA; Shield, JPH; Tuomilehto, J; Tuomilehto-Wolf, E; Nistico, L; Buzzetti, R; Pozzilli, P; Joner, G; Thorsby, E; Undlien, DE; Pociot, F; Nerup, J; Ronningen, KS; Bain, SC; Todd, JA		San-Raffaele Family Study; Barts-Oxford Family Study Grp	Fine mapping of the diabetes-susceptibility locus, IDDM4, on chromosome 11q13	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; INSULIN GENE; MELLITUS; NATIONWIDE; REGION; MICE	Genomewide linkage studies of type 1 diabetes (or insulin-dependent diabetes mellitus [IDDM]) indicate that several unlinked susceptibility loci can explain the clustering of the disease in families. One such locus has been mapped to chromosome 11q13 (IDDM4). In the present report we have analyzed 707 affected sib pairs, obtaining a peak multipoint maximum LOD score (MLS) of 2.7 (lambda(s) = 1.09) with linkage (MLS greater than or equal to 0.7) extending over a 15-cM region. The problem is, therefore, to fine map the locus to permit structural analysis of positional candidate genes. In a two-stage approach, we first scanned the 15-cM linked region for increased or decreased transmission, from heterozygous parents to affected siblings in 340 families, of the three most common alleles of each of 12 microsatellite loci. One of the 36 alleles showed decreased transmission (50% expected, 45.1% observed [P = .02, corrected P = .72]) ar marker D11S1917. Analysis of an additional 1,702 families provided further support for negative transmission (48%) of D11S1917 allele 3 to affected offspring and positive transmission (55%) to unaffected siblings (test of heterogeneity P = 3 x 10(-4), corrected P = .01]). A second polymorphic marker, H0570polyA, was isolated from a cosmid clone containing D11S1917, and genotyping of 2,042 families revealed strong linkage disequilibrium between the two markers (15 kb apart), with a specific haplotype, D11S1317*03-H0570polyA*02, showing decreased transmission (46.4%) to affected offspring and increased transmission (56.6%) to unaffected siblings (test of heterogeneity P = 1.5 x 10(-6), corrected P = 4.3 x 10-4). These results not only provide sufficient justification for analysis of the gene content of the D11S1917 region for positional candidates but also show that, in the mapping of genes for common multifactorial diseases, analysis of both affected and unaffected siblings is of value and that both predisposing and nonpredisposing alleles should be anticipated.	Univ Oxford, Nuffield Dept Surg, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Leeds, Res Sch Med, Paediat Epidemiol Grp, Leeds, W Yorkshire, England; Univ Bristol, Royal Hosp Sick Children, Inst Child Hlth, Bristol BS8 1TH, Avon, England; Univ Bristol, S Meads Hosp, Med Sch Unit, Dept Diabet & Metab, Bristol BS8 1TH, Avon, England; Natl Publ Hlth Inst, Diabet & Genet Epidemiol Unit, Helsinki, Finland; Clin Nutr & Metab Dis, Bucharest, Romania; CNR, Ist Biol Cellulare, I-00016 Monterotondo, Italy; Univ Rome La Sapienza, Ist Clin Med 2, Rome, Italy; Libero Ist Univ Campus Biomed, Rome, Italy; Univ Milan, Ist Sci San Raffaele, Milan, Italy; Aker Univ Hosp, Aker Diabet Res Ctr, Oslo, Norway; Natl Hosp, Inst Transplantat Immunol, Oslo, Norway; Natl Inst Publ Hlth, Dept Populat Hlth Sci, Oslo, Norway; Steno Diabet Ctr, DK-2820 Gentofte, Denmark; Univ Birmingham, Birmingham Heartlands Hosp, Dept Med, Birmingham, W Midlands, England	University of Oxford; Wellcome Centre for Human Genetics; University of Leeds; Bristol Royal Hospital For Children; University of Bristol; University of Bristol; Finland National Institute for Health & Welfare; Consiglio Nazionale delle Ricerche (CNR); Sapienza University Rome; University Campus Bio-Medico - Rome Italy; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Oslo; University of Oslo; National Hospital Norway; Steno Diabetes Center; Heart of England NHS Foundation Trust; University of Birmingham	Todd, JA (corresponding author), Univ Oxford, Nuffield Dept Surg, Wellcome Trust Ctr Human Genet, Windmill Rd, Oxford OX3 7BN, England.		Pozzilli, Paolo/A-5235-2010; Todd, John A/A-3542-2010; Buzzetti, Raffaella/K-3090-2016; Shield, Julian PH/D-6297-2014; Nisticò, Lorenza/N-7470-2017; Nisticò, Lorenza/AAD-1662-2021	Todd, John A/0000-0003-2740-8148; Buzzetti, Raffaella/0000-0003-1490-6041; Shield, Julian PH/0000-0003-2601-7575; Nisticò, Lorenza/0000-0003-1805-6240; Nisticò, Lorenza/0000-0003-1805-6240; Cox, Roger/0000-0001-7170-5014; Merriman, Tony/0000-0003-0844-8726; Wilson, Amanda/0000-0001-5681-9611; CUCCA, Francesco/0000-0002-7414-1995; Pociot, Flemming/0000-0003-3274-5448	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037957] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 37957] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission)		BAIN SC, 1990, AUTOIMMUNITY, V7, P83, DOI 10.3109/08916939008993380; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; COPEMAN JB, 1995, NAT GENET, V9, P80, DOI 10.1038/ng0195-80; Courseaux A, 1997, GENOMICS, V40, P13, DOI 10.1006/geno.1996.4527; CUCCA F, 1996, HLA MHC GENES MOL FU, P383; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; FIELD LL, 1994, NAT GENET, V8, P189, DOI 10.1038/ng1094-189; Gardner SG, 1997, BRIT MED J, V315, P713, DOI 10.1136/bmj.315.7110.713; HASHIMOTO L, 1994, NATURE, V371, P161, DOI 10.1038/371161a0; HEY PJ, IN PRESS GENE; HOLMANS P, 1993, AM J HUM GENET, V52, P362; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LERNMARK A, 1990, AM J HUM GENET, V47, P1028; Luo DF, 1996, HUM MOL GENET, V5, P693, DOI 10.1093/hmg/5.5.693; Martin ER, 1997, AM J HUM GENET, V61, P439, DOI 10.1086/514860; Merriman T, 1997, HUM MOL GENET, V6, P1003, DOI 10.1093/hmg/6.7.1003; Merriman TR, 1998, HUM MOL GENET, V7, P517, DOI 10.1093/hmg/7.3.517; Nistico L, 1996, HUM MOL GENET, V5, P1075, DOI 10.1093/hmg/5.7.1075; NIZETIC D, 1994, MAMM GENOME, V5, P801, DOI 10.1007/BF00292017; POCIOT F, 1993, DIABETOLOGIA, V36, P870, DOI 10.1007/BF00400364; Podolin PL, 1998, MAMM GENOME, V9, P283, DOI 10.1007/s003359900749; Podolin PL, 1997, J IMMUNOL, V159, P1835; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857; She JX, 1996, IMMUNOL TODAY, V17, P323, DOI 10.1016/0167-5699(96)10014-1; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Thorsby E, 1996, J PEDIATR ENDOCR MET, V9, P75; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; TODD JA, 1991, NATURE, V351, P542, DOI 10.1038/351542a0; TUOMILEHTO J, 1992, DIABETOLOGIA, V35, P70, DOI 10.1007/BF00400854; Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289; WADSWORTH E, 1995, BRIT MED J, V310, P700, DOI 10.1136/bmj.310.6981.700; WICKER LS, 1994, J EXP MED, V180, P1705, DOI 10.1084/jem.180.5.1705	35	53	60	0	6	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1998	63	2					547	556		10.1086/301974	http://dx.doi.org/10.1086/301974			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110CB	9683605	Green Published, Bronze			2022-12-18	WOS:000075360800031
J	Cappione, AJ; French, BL; Skuse, GR				Cappione, AJ; French, BL; Skuse, GR			A potential role for NF1 mRNA editing in the pathogenesis of NF1 tumors	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEUROFIBROMATOSIS TYPE-1 GENE; MESSENGER-RNA; VONRECKLINGHAUSEN NEUROFIBROMATOSIS; EXPRESSION; RAT; MUTATION; MUSCLE; GAP	Neurofibromatosis type I (NF1) is a common disorder that predisposes to neoplasia in tissues derived from the embryonic neural crest. The NF1 gene encodes a tumor suppressor that most likely acts through the interaction of its GTPase-activating protein (GAP) -related domain (GRD) with the product of the ras protooncogene. We have previously identified a site in the NF1 mRNA, within the first half of the NF1 GRD, which undergoes base-modification editing. Editing at that site changes a C to a U, thereby introducing an in-frame stop codon, NF1 RNA editing has been detected in all cell types studied, to date. In order to investigate the role played by editing in NF1 tumorigenesis, we analyzed RNA from 19 NF1 and 4 non-NF1 tumors. We observed varying levels of NF1 mRNA editing in different tumors, with a higher range of editing levels in more malignant tumors (e.g., neurofibrosarcomas) compared to benign tumors (cutaneous neurofibromas). Plexiform neurofibromas have an intermediate range of levels of NF1 mRNA editing. We also compared tumor and nontumor tissues from several NF1 individuals, to determine the extent of variability present in the constitutional levels of NF1 mRNA editing and to determine whether higher levels are present in tumors. The constitutional levels of NF1 mRNA editing varied slightly but were consistent with the levels observed in non-NF1 individuals. In every case, there was a greater level of NF1 mRNA editing in the tumor than in the nontumor tissue from the same patient. These results suggest that inappropriately high levels of NF1 mRNA editing does play a role in NF1 tumorigenesis and that editing may result in the functional equivalent of biallelic inactivation of the NF1 tumor suppressor.	UNIV ROCHESTER, SCH MED & DENT, DEPT MED, DIV GENET, ROCHESTER, MI USA; UNIV ROCHESTER, SCH MED & DENT, DEPT RADIAT ONCOL, ROCHESTER, MI USA; UNIV ROCHESTER, SCH MED & DENT, CTR CANC, ROCHESTER, MI USA	University of Rochester; University of Rochester; University of Rochester					NCI NIH HHS [CA55173] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA055173, R01CA055173] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; BAUM CL, 1990, J BIOL CHEM, V265, P19263; BOLLAG G, 1993, EMBO J, V12, P1923, DOI 10.1002/j.1460-2075.1993.tb05841.x; BUCHBERG AM, 1990, NATURE, V347, P291, DOI 10.1038/347291a0; COLMAN SD, 1995, NAT GENET, V11, P90, DOI 10.1038/ng0995-90; EASTON DF, 1993, AM J HUM GENET, V53, P305; GREEVE J, 1993, J LIPID RES, V34, P1367; GUTMANN DH, 1993, HUM MOL GENET, V2, P989; GUTMANN DH, 1995, DEV DYNAM, V202, P302, DOI 10.1002/aja.1002020309; Hope D G, 1981, Adv Neurol, V29, P33; HUSON SM, 1989, J MED GENET, V26, P704, DOI 10.1136/jmg.26.11.704; INUI Y, 1994, J LIPID RES, V35, P1477; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KYRITSIS AP, 1992, INT J ONCOL, V1, P149; LI Y, 1995, GENOMICS, V25, P9, DOI 10.1016/0888-7543(95)80104-T; METHENY LJ, 1995, J NEUROPATH EXP NEUR, V54, P753, DOI 10.1097/00005072-199511000-00001; NISHI T, 1991, ONCOGENE, V6, P1555; RICCARDI VM, 1986, NEUROFIBROMATOSIS PH, P214; SHARMA PM, 1994, GENE DEV, V8, P720, DOI 10.1101/gad.8.6.720; Skuse GR, 1996, NUCLEIC ACIDS RES, V24, P478, DOI 10.1093/nar/24.3.478; SKUSE GR, 1991, AM J HUM GENET, V49, P600; SKUSE GR, 1989, GENE CHROMOSOME CANC, V1, P36, DOI 10.1002/gcc.2870010107; UCHIDA T, 1992, BIOCHEM BIOPH RES CO, V187, P332, DOI 10.1016/S0006-291X(05)81497-4; XU GF, 1990, CELL, V62, P599, DOI 10.1016/0092-8674(90)90024-9	24	53	60	2	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1997	60	2					305	312						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WE931	9012403				2022-12-18	WOS:A1997WE93100009
J	Toda, T; Miyake, M; Kobayashi, K; Mizuno, K; Saito, K; Osawa, M; Nakamura, Y; Kanazawa, I; Nakagome, Y; Tokunaga, K; Nakahori, Y				Toda, T; Miyake, M; Kobayashi, K; Mizuno, K; Saito, K; Osawa, M; Nakamura, Y; Kanazawa, I; Nakagome, Y; Tokunaga, K; Nakahori, Y			Linkage-disequilibrium mapping narrows the fukuyama-type congenital muscular dystrophy (FCMD) candidate region to <100 kb	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DIASTROPHIC DYSPLASIA; GENE; LOCALIZATION; MAP	Fukuyama-type congenital muscular dystrophy (FCMD), the second most common form of muscular dystrophy in Japan, is an autosomal recessive severe muscular dystrophy associated with brain anomalies. After our initial mapping of the FCMD locus to chromosome 9q31-33, we have further defined the locus within a similar to 5-cM region between D9S127 and D9S2111 and have found linkage disequilibrium between FCMD and D9S306 in this candidate region on 9q31. The high prevalence of FCMD among the Japanese, who are a relatively isolated population, provides an opportunity to utilize linkage-disequilibrium mapping. We developed three new microsatellites, near D9S306, from the FCMD YAC contig, determined their positions on YACs, and performed linkage-disequilibrium mapping with these markers and other newly published loci. The maximum value of p(excess), which represents the strength of linkage disequilibrium, was obtained at D9S2107; and this value showed a relatively steady rise and fall across the region that is likely to contain FCMD. Distances between FCMD and each marker were presumed to be similar to 1 Mb, similar to 350 kb, similar to 140 kb, similar to 20 kb, similar to 280 kb, similar to 450 kb, and similar to 740 kb for D9S306, A107XF9, D9S2105, D9S2107, D9S172, D9S299, and D9S2109, respectively. Haplotype analysis using the three closest markers D9S2105, D9S2107, and D9S172 indicated that most FCMD-bearing chromosomes are derived from a single ancestral founder and suggested that these markers can be used for the diagnosis of sporadic FCMD. Thus, the FCMD gene is most likely to lie within a region of <100 kb containing D9S2107.	UNIV TOKYO, DEPT NEUROL, TOKYO 113, JAPAN; UNIV TOKYO, INST MED SCI, MOL MED LAB, TOKYO 113, JAPAN; TOKYO WOMENS MED COLL, DEPT PEDIAT, TOKYO 162, JAPAN	University of Tokyo; University of Tokyo; Tokyo Women's Medical University	Toda, T (corresponding author), UNIV TOKYO, GRAD SCH INT HLTH, DEPT HUMAN GENET, BUNKYO KU, 7-3-1 HONGO, TOKYO 113, JAPAN.		Kobayashi, Kazuhiro/AAH-8638-2021	Kobayashi, Kazuhiro/0000-0001-7801-147X; Saito, Kayoko/0000-0003-2632-0873				BICKMORE WA, 1992, METHOD ENZYMOL, V216, P224; FOWLER M, 1973, CLIN STUDIES MYOLO 2, P192; FUKUYAMA Y, 1981, BRAIN DEV-JPN, V3, P1; FUKUYAMA Y, 1984, BRAIN DEV-JPN, V6, P373, DOI 10.1016/S0387-7604(84)80113-8; Fukuyama Y, 1960, PAEDIAT U TOKYO, V4, P5; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HOLMQUIST GP, 1992, AM J HUM GENET, V51, P17; IIZUKA M, 1993, GENET ANAL-BIOMOL E, V10, P2, DOI 10.1016/1050-3862(93)90017-D; JORDE LB, 1995, AM J HUM GENET, V56, P11; KESTILA M, 1994, AM J HUM GENET, V54, P757; KONDO E, IN PRESS AM J MED GE; KRIJGSMAN JB, 1980, NEUROPADIATRIE, V11, P108, DOI 10.1055/s-2008-1071382; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; LERNER TJ, 1995, CELL, V82, P949, DOI 10.1016/0092-8674(95)90274-0; Luria SE, 1943, GENETICS, V28, P491; Mckusick V.A., 1994, MENDELIAN INHERITANC; MITCHISON HM, 1995, AM J HUM GENET, V56, P654; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; Nakano I, 1996, ACTA NEUROPATHOL, V91, P313, DOI 10.1007/s004010050431; PETERS ACB, 1984, BRAIN DEV-JPN, V6, P406, DOI 10.1016/S0387-7604(84)80117-5; SULISALO T, 1994, AM J HUM GENET, V55, P937; TODA T, 1993, NAT GENET, V5, P283, DOI 10.1038/ng1193-283; TODA T, 1995, ANN NEUROL, V37, P99, DOI 10.1002/ana.410370118; TODA T, 1994, AM J HUM GENET, V55, P946; Toda T, 1995, JPN J HUM GENET, V40, P333, DOI 10.1007/BF01900600; TODA T, 1995, AM J HUM GENET, V40, P333; VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9; WEBER JL, 1993, GENOME DATA BASE GDB; Yamamoto T, 1996, NEUROPATHOLOGY, V16, P184, DOI 10.1111/j.1440-1789.1996.tb00180.x	32	53	54	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1996	59	6					1313	1320						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV315	8940277				2022-12-18	WOS:A1996VV31500018
J	Amati, P; Gasparini, P; Zlotogora, J; Zelante, L; Chomel, JC; Kitzis, A; Kaplan, J; Bonneau, D				Amati, P; Gasparini, P; Zlotogora, J; Zelante, L; Chomel, JC; Kitzis, A; Kaplan, J; Bonneau, D			A gene for premature ovarian failure associated with eyelid malformation maps to chromosome 3q22-q23	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							EPICANTHUS INVERSUS SYNDROME; BLEPHAROPHIMOSIS; PTOSIS		IRCCS OSPED,SERV GENET MED,SAN GIOVANNI ROTO,ITALY; HEBREW UNIV JERUSALEM,HADASSAH MED SCH,MED CTR,DEPT HUMAN GENET,IL-91010 JERUSALEM,ISRAEL; HOP NECKER ENFANTS MALAD,INSERM U393,SERV GENET,PARIS,FRANCE; HOP NECKER ENFANTS MALAD,INSERM U393,UNITE RECH HANDICAPS GENET ENFANT,PARIS,FRANCE; CHU POITIERS,LAB GENET CELLULAIRE & MOLEC,F-86021 POITIERS,FRANCE	Hebrew University of Jerusalem; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Poitiers; Universite de Poitiers	Amati, P (corresponding author), CHU POITIERS,UNITE GENET MED,BP 577,F-86021 POITIERS,FRANCE.		Bonneau, Dominique/K-6110-2015; Chomel, Jean-Claude/AAE-9039-2021; Gasparini, Paolo/B-6173-2014	Chomel, Jean Claude/0000-0001-9227-1104				AITTOMAKI K, 1994, AM J HUM GENET, V54, P844; AMATI P, 1995, HUM GENET, V96, P213, DOI 10.1007/BF00207381; JONES CA, 1984, BRIT J OPHTHALMOL, V68, P533, DOI 10.1136/bjo.68.8.533; LAWSON CT, 1995, HUM MOL GENET, V4, P963, DOI 10.1093/hmg/4.5.963; McKusick V.A., 1992, MENDELIAN INHERITANC; NICOLINO M, 1995, J PEDIATR ENDOCR MET, V8, P127; OLEY C, 1988, J MED GENET, V25, P47, DOI 10.1136/jmg.25.1.47; SMALL KW, 1995, HUM MOL GENET, V4, P443, DOI 10.1093/hmg/4.3.443; SMITH A, 1989, J MED GENET, V26, P434, DOI 10.1136/jmg.26.7.434; TOWNES PL, 1978, ARCH OPHTHALMOL-CHIC, V97, P1664; VASSALLI A, 1994, GENE DEV, V8, P414, DOI 10.1101/gad.8.4.414; ZLOTOGORA J, 1983, AM J HUM GENET, V35, P1020	12	53	58	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1996	58	5					1089	1092						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UH192	8651270				2022-12-18	WOS:A1996UH19200022
J	ITOH, T; FUJIWARA, Y; ONO, T; YAMAIZUMI, M				ITOH, T; FUJIWARA, Y; ONO, T; YAMAIZUMI, M			UVS SYNDROME, A NEW GENERAL CATEGORY OF PHOTOSENSITIVE DISORDER WITH DEFECTIVE-DNA REPAIR, IS DISTINCT FROM XERODERMA-PIGMENTOSUM VARIANT AND RODENT COMPLEMENTATION GROUP-1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COCKAYNE-SYNDROME; EXCISION-REPAIR; ULTRAVIOLET-LIGHT; SUN SENSITIVITY; GROUP-A; TRICHOTHIODYSTROPHY; CELLS; DEFICIENCY; ABNORMALITIES; HETEROGENEITY	Previously, we reported two DNA repair-defective siblings who did not belong to any complementation group of xeroderma pigmentosum (XP) or Cockayne syndrome (CS). By surveying other photosensitive patients whose fibroblasts showed similar biochemical phenotypes, we found another nonconsanguineous Japanese patient belonging to the same complementation group as our previous cases. Postreplication repair of the cells derived from these patients was normal, indicating that they cannot be classified as XP variant. Neither transfection nor microinjection of the cells with the human DNA repair gene ERCC1, which is known not to correct any complementation groups of XP or CS, failed to correct the defect of these cells, indicating that they do not belong to the rodent complementation group 1. However, the defect in recovery of RNA synthesis (RRS) after UV irradiation was restored by microinjection of HeLa cell extract. Although clinical manifestations of these patients-such as acute sunburn, dryness, freckling, pigmentation anomalies on sun-exposed skin, and teleangiectasia without neurological abnormalities or tumors-are similar to a mild XP phenotype, cellular characteristics such as UV sensitivity and defective RRS after UV irradiation with normal unscheduled DNA synthesis (UDS) are reminiscent of CS. On the basis of these results, we propose that these patients be included under a general category designated ''UV-sensitive'' (UVs) syndrome.	KUMAMOTO UNIV,SCH MED,INST MOLEC EMBRYOL & GENET,KUMAMOTO 862,JAPAN; KUMAMOTO UNIV,SCH MED,DEPT DERMATOL,KUMAMOTO 862,JAPAN; KOBE UNIV,SCH MED,DEPT RADIAT BIOPHYS & GENET,KOBE,JAPAN	Kumamoto University; Kumamoto University; Kobe University								BIGGERSTAFF M, 1993, EMBO J, V12, P3685, DOI 10.1002/j.1460-2075.1993.tb06043.x; BROUGHTON BC, 1990, MUTAT RES, V235, P33, DOI 10.1016/0921-8777(90)90020-6; CLEAVER JE, 1993, ARCH DERMATOL, V129, P348, DOI 10.1001/archderm.129.3.348; CLEAVER JE, 1992, DNA REPAIR MECHANISM, P56; Cleaver JE, 1989, METABOLIC BASIS INHE, V6th, P2949; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; FLEJTER WL, 1992, P NATL ACAD SCI USA, V89, P261, DOI 10.1073/pnas.89.1.261; FUJIWARA Y, 1981, J INVEST DERMATOL, V77, P256, DOI 10.1111/1523-1747.ep12482447; GREENHAW GA, 1992, AM J HUM GENET, V50, P677; ITOH T, 1994, MUTAT RES, V314, P233, DOI 10.1016/0921-8777(94)90068-X; KAUFMANN WK, 1981, J MOL BIOL, V149, P171, DOI 10.1016/0022-2836(81)90297-7; KENNEDY RM, 1980, NEUROLOGY, V30, P1268, DOI 10.1212/WNL.30.12.1268; KRAEMER KH, 1987, ARCH DERMATOL, V123, P241, DOI 10.1001/archderm.123.2.241; LEHMANN AR, 1988, CANCER RES, V48, P6090; LEHMANN AR, 1981, DNA REPAIR LABORATOR, V1, P471; MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217; MIYAUCHI H, 1994, J AM ACAD DERMATOL, V30, P329, DOI 10.1016/S0190-9622(94)70034-6; ODONOVAN A, 1993, NATURE, V363, P185, DOI 10.1038/363185a0; ROBBINS JH, 1991, HUM GENET, V88, P242; ROBBINS JH, 1974, ANN INTERN MED, V80, P221, DOI 10.7326/0003-4819-80-2-221; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; SCHAEFFER L, 1994, EMBO J, V13, P2388, DOI 10.1002/j.1460-2075.1994.tb06522.x; SCHERLY D, 1993, NATURE, V363, P182, DOI 10.1038/363182a0; SCOTT RJ, 1993, J AM ACAD DERMATOL, V29, P883, DOI 10.1016/0190-9622(93)70263-S; SHIOMI T, 1982, SOMAT CELL GENET, V8, P329, DOI 10.1007/BF01538891; STEFANINI M, 1986, HUM GENET, V74, P107, DOI 10.1007/BF00282072; STEFANINI M, 1992, MUTAT RES, V273, P119, DOI 10.1016/0921-8777(92)90073-C; STEFANINI M, 1993, CARCINOGENESIS, V14, P1101, DOI 10.1093/carcin/14.6.1101; STEFANINI M, 1993, AM J HUM GENET, V53, P817; THOMPSON LH, 1988, SOMAT CELL MOLEC GEN, V14, P605, DOI 10.1007/BF01535314; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; VANDUIN M, 1989, MUTAT RES, V217, P83, DOI 10.1016/0921-8777(89)90059-1; VENEMA J, 1990, P NATL ACAD SCI USA, V87, P4707, DOI 10.1073/pnas.87.12.4707; VERMEULEN W, 1993, AM J HUM GENET, V53, P185; WEEDA G, 1990, CELL, V62, P777, DOI 10.1016/0092-8674(90)90122-U; WESTERVELD A, 1984, NATURE, V310, P425, DOI 10.1038/310425a0; WOOD RD, 1982, MUTAT RES, V95, P505, DOI 10.1016/0027-5107(82)90281-0; YAMAIZUMI M, 1986, P NATL ACAD SCI USA, V83, P1476, DOI 10.1073/pnas.83.5.1476	38	53	53	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1995	56	6					1267	1276						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA794	7539208				2022-12-18	WOS:A1995RA79400003
J	BLEYL, S; NELSON, L; ODELBERG, SJ; RUTTENBERG, HD; OTTERUD, B; LEPPERT, M; WARD, K				BLEYL, S; NELSON, L; ODELBERG, SJ; RUTTENBERG, HD; OTTERUD, B; LEPPERT, M; WARD, K			A GENE FOR FAMILIAL TOTAL ANOMALOUS PULMONARY VENOUS RETURN MAPS TO CHROMOSOME 4P13-Q12	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CELL GROWTH-FACTOR; REPEAT POLYMORPHISM; MISSENSE MUTATION; TYROSINE KINASE; MOLECULAR-BASIS; CONNECTION; RECEPTOR; IDENTIFICATION; MALFORMATIONS; CHILDREN	Total anomalous pulmonary venous return (TAPVR) is a cyanotic congenital heart defect that, without surgical correction, has a high mortality rate in the first year of life. It usually occurs without a family history and has a low recurrence risk. However, we recently reported a large Utah-Idaho family in which TAPVR segregates as an autosomal dominant trait with decreased penetrance. Linkage mapping with highly polymorphic microsatellite markers localizes the disease locus in this pedigree to the centromeric region of chromosome 4 (maximum lod = 6.51 at theta = .00). Apparent genetic anticipation in the pedigree prompted a search for expanded trinucleotide repeats by using repeat expansion detection. We have found no evidence for a trinucleotide repeat expansion that segregates with TAPVR. A vascular endothelial growth-factor receptor that is thought to have a role in vasculogenesis maps near the pericentric region of chromosome 4 and is a candidate gene for both familial and sporadic cases of TAPVR.	UNIV UTAH, SCH MED, DEPT OBSTET & GYNECOL, SALT LAKE CITY, UT 84132 USA; UNIV UTAH, SCH MED, DEPT HUMAN GENET, SALT LAKE CITY, UT 84132 USA; UNIV UTAH, SCH MED, ECCLES PROGRAM HUMAN MOLEC BIOL & GENET, SALT LAKE CITY, UT USA; UNIV UTAH, DEPT PEDIAT, DIV PEDIAT CARDIOL, SALT LAKE CITY, UT USA; PRIMARY CHILDRENS MED CTR, SALT LAKE CITY, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah								BARON P, 1982, AM HEART J, V104, P1107, DOI 10.1016/0002-8703(82)90450-1; BLEYL S, 1994, AM J MED GENET, V52, P462, DOI 10.1002/ajmg.1320520412; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; CLARKE CP, 1973, AUST NZ J MED, V3, P629; CORREAVILLASENOR A, 1991, TERATOLOGY, V44, P415, DOI 10.1002/tera.1420440408; CURRAN ME, 1993, CELL, V73, P159, DOI 10.1016/0092-8674(93)90168-P; DEAN M, 1991, AM J HUM GENET, V49, P621; DELISLE G, 1976, AM HEART J, V91, P99, DOI 10.1016/S0002-8703(76)80440-1; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; GATHMAN GE, 1970, CIRCULATION, V42, P143, DOI 10.1161/01.CIR.42.1.143; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; GLEASON MM, 1989, AM HEART J, V118, P1338, DOI 10.1016/0002-8703(89)90029-X; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HOFFMAN JIE, 1990, PEDIATR CLIN N AM, V37, P25; HOLT M, 1960, BRIT HEART J, V22, P236; KAUFMAN R L, 1972, Birth Defects Original Article Series, V8, P88; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Maniatis T., 1982, MOL CLONING; MATISE TC, 1993, GENET EPIDEMIOL, V10, P401, DOI 10.1002/gepi.1370100612; MATTHEWS W, 1991, P NATL ACAD SCI USA, V88, P9026, DOI 10.1073/pnas.88.20.9026; MCDERMID HE, 1986, SCIENCE, V232, P646, DOI 10.1126/science.3961499; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; MILNER S, 1977, ARCH DIS CHILD, V52, P984, DOI 10.1136/adc.52.12.984; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; PAZ JE, 1971, J MED GENET, V8, P312, DOI 10.1136/jmg.8.3.312; QUINN TP, 1993, P NATL ACAD SCI USA, V90, P7533, DOI 10.1073/pnas.90.16.7533; RAISHER BD, 1991, AM J MED GENET, V40, P105, DOI 10.1002/ajmg.1320400122; RAMER JC, 1990, AM J MED GENET, V37, P392, DOI 10.1002/ajmg.1320370320; ROSE V, 1975, BRIT HEART J, V37, P840; SCHACHENMANN G, 1965, LANCET, V2, P290; SCHALLING M, 1993, NAT GENET, V4, P135, DOI 10.1038/ng0693-135; SOLYMAR L, 1987, ACTA PAEDIATR SCAND, V76, P124, DOI 10.1111/j.1651-2227.1987.tb10427.x; SPRITZ RA, 1994, GENOMICS, V22, P431, DOI 10.1006/geno.1994.1405; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; TERMAN BI, 1991, ONCOGENE, V6, P1677; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; VINH LT, 1968, ARCH FR PEDIATR, V25, P1141; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4636, DOI 10.1093/nar/18.15.4636-a	39	53	55	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1995	56	2					408	415						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QF423	7847375				2022-12-18	WOS:A1995QF42300008
J	LEITERSDORF, E; SAFADI, R; MEINER, V; RESHEF, A; BJORKHEM, I; FRIEDLANDER, Y; MORKOS, S; BERGINER, VM				LEITERSDORF, E; SAFADI, R; MEINER, V; RESHEF, A; BJORKHEM, I; FRIEDLANDER, Y; MORKOS, S; BERGINER, VM			CEREBROTENDINOUS XANTHOMATOSIS IN THE ISRAELI DRUZE - MOLECULAR-GENETICS AND PHENOTYPIC CHARACTERISTICS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHENODEOXYCHOLIC ACID; STEROL 27-HYDROXYLASE; COMPLEX SEGREGATION; BILE-ACIDS; DNA; POLYMERASE; MUTATIONS; PLASMA	Cerebrotendinous xanthomatosis (CTX) is an autosomal recessive lipid-storage disease caused by mutations in the sterol 27 hydroxylase gene (CYP27). Clinically, a multitude of neurological, skeletal, and vascular manifestations are usually present. Premature atherosclerosis has been reported in CTX and may be related to the metabolic derangement caused by the deficiency of the enzyme. A CYP27 nonsense mutation created by the deletion of cytosine(376) has been identified in four Israeli Druze CTX patients residing in the same village. Molecular screening for this mutation in families of two probands revealed a total of 10 homozygotes and 28 heterozygotes whose clinical and biochemical characteristics are described. Overall, except for tendon xanthomas, most of the clinical manifestations progress with age. The CYP27 mutation was associated with modest differences in the levels of plasma total cholesterol (TC) and LDL cholesterol (LDL-C). The distribution of plasma concentrations of TC and LDL-C in the CTX families was consistent with a polygenic model. A similar model that includes also the effects of the CYP27 genotypes was not better supported by the data. It may be concluded that, in CTX, the presence of a CYP27 mutation does not significantly affect the plasma concentrations of lipids and lipoproteins. Therefore, the reported increased prevalence of atherosclerosis in this disease must be related to other factors.	HEBREW UNIV JERUSALEM,HADASSAH SCH PUBL HLTH,FAC MED,DEPT SOCIAL MED,JERUSALEM,ISRAEL; HUDDINGE UNIV HOSP,KAROLINSKA INST,DEPT CLIN CHEM,S-14186 HUDDINGE,SWEDEN; KUPAT HOLIM KLALIT,YARKA,ISRAEL; BEN GURION UNIV NEGEV,FAC HLTH SCI,SOROKA MED CTR,DEPT NEUROL,BEER SHEVA,ISRAEL	Hebrew University of Jerusalem; Karolinska Institutet; Ben Gurion University; Soroka Medical Center	LEITERSDORF, E (corresponding author), HADASSAH UNIV HOSP,DIV MED,CTR RES PREVENT & TREATMENT ATHEROSCLEROSIS,IL-91120 JERUSALEM,ISRAEL.			Bjorkhem, Ingemar/0000-0001-6087-9190; Bjorkhem, Ingemar/0000-0002-0575-9425				BALLANTYNE CM, 1987, METABOLISM, V36, P270, DOI 10.1016/0026-0495(87)90187-9; BEIL U, 1982, METABOLISM, V31, P438, DOI 10.1016/0026-0495(82)90231-1; Ben Dror G, 1988, Harefuah, V115, P224; BERGINER VM, 1984, NEW ENGL J MED, V311, P1649, DOI 10.1056/NEJM198412273112601; BERGINER VM, 1993, MOL GENETIC BASIS NE, P295; BJORKHEM I, IN PRESS P NATL ACAD; BJORKHEM I, 1989, METABOLIC BASIS INHE, P1283; CALI JJ, 1991, J BIOL CHEM, V266, P7774; CALI JJ, 1991, J BIOL CHEM, V266, P779; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; FUJIYAMA J, 1991, CLIN CHIM ACTA, V200, P1, DOI 10.1016/0009-8981(91)90328-A; GOETZ PW, 1986, NEW ENCY BRITANNICA, V4; Hasstedt SJ, 1981, 13 U UT DEP MED BIOP; HUIJGHEBAERT SW, 1989, J LIPID RES, V30, P1673; KIBE A, 1980, J LIPID RES, V21, P594; KURIYAMA M, 1991, J NEUROL SCI, V102, P225, DOI 10.1016/0022-510X(91)90073-G; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; LALOUEL JM, 1979, 14 U UT DEP MED BIOP; LEITERSDORF E, 1993, J CLIN INVEST, V91, P2488, DOI 10.1172/JCI116484; MCMASTER GK, 1977, P NATL ACAD SCI USA, V74, P4835, DOI 10.1073/pnas.74.11.4835; MEINER V, 1994, HUM MOL GENET, V3, P193, DOI 10.1093/hmg/3.1.193; MEINER V, 1994, NEUROLOGY, V44, P288, DOI 10.1212/WNL.44.2.288; MORTON NE, 1974, AM J HUM GENET, V26, P489; NEVO S, 1988, AM J PHYS ANTHROPOL, V77, P183, DOI 10.1002/ajpa.1330770206; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; RESHEF A, 1994, J LIPID RES, V35, P478; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEYAMA Y, 1976, J BIOCHEM-TOKYO, V80, P223, DOI 10.1093/oxfordjournals.jbchem.a131268; SHORE V, 1981, J CLIN INVEST, V68, P1295, DOI 10.1172/JCI110376; TINT GS, 1989, J LIPID RES, V30, P633; ZLOTOGORA J, 1985, AM J MED GENET, V21, P765, DOI 10.1002/ajmg.1320210420	34	53	54	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1994	55	5					907	915						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB682	7977352				2022-12-18	WOS:A1994QB68200009
J	ROBERTS, DJ; TABIN, C				ROBERTS, DJ; TABIN, C			THE GENETICS OF HUMAN LIMB DEVELOPMENT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							APICAL ECTODERMAL RIDGE; HOMEOBOX GENES; HOMEOTIC TRANSFORMATIONS; BUD CELLS; MOUSE; EXPRESSION; FGF-4; MAPS; CRANIOSYNOSTOSIS; SPECIFICATION		HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA	Harvard University; Harvard Medical School	ROBERTS, DJ (corresponding author), BRIGHAM & WOMENS HOSP,DEPT PATHOL,DIV WOMENS & PERINATAL PATHOL,75 FRANCIS ST,BOSTON,MA 02115, USA.				NICHD NIH HHS [HD01060] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K11HD001060] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDERSON R, 1993, DEVELOPMENT, V117, P1421; BLAUTH W, 1990, CLIN ORTHOPAEDICS, V258, P41; BOLLES RG, IN PRESS AM J MED GE; BONCINELLI E, 1988, HUM REPROD, V3, P880, DOI 10.1093/oxfordjournals.humrep.a136802; BRAVERMAN N, 1993, AM J HUM GENET, V53, P410; BRUETON L, 1988, AM J MED GENET, V31, P799, DOI 10.1002/ajmg.1320310412; BRUETON LA, 1992, J MED GENET, V29, P681, DOI 10.1136/jmg.29.10.681; BURKE AC, 1985, J MORPHOL, V186, P119, DOI 10.1002/jmor.1051860111; COELHO CND, 1992, DIFFERENTIATION, V49, P85, DOI 10.1111/j.1432-0436.1992.tb00772.x; COELHO CND, 1991, DEVELOPMENT, V113, P1487; COELHO CND, 1992, DEVELOPMENT, V115, P629; DAVIDSON DR, 1991, NATURE, V352, P429, DOI 10.1038/352429a0; DOLLE P, 1993, CELL, V75, P431, DOI 10.1016/0092-8674(93)90378-4; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; FRANCIS PH, 1994, DEVELOPMENT, V120, P209; HAQUE MFU, 1993, HUM GENET, V91, P17; HEUTINK P, 1994, NAT GENET, V6, P287, DOI 10.1038/ng0394-287; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; INGHAM PW, 1994, CURR BIOL, V4, P1; IVENS A, 1990, HUM GENET, V84, P473; JABS EW, 1993, CELL, V75, P443, DOI 10.1016/0092-8674(93)90379-5; KORNBERG T, 1981, P NATL ACAD SCI-BIOL, V78, P1095, DOI 10.1073/pnas.78.2.1095; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; LYONS KM, 1990, DEVELOPMENT, V109, P833; MARTIN GR, 1990, GENOMICS, V6, P302, DOI 10.1016/0888-7543(90)90570-K; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; MORGAN BA, 1993, CURR OPIN GENET DEV, V3, P668, DOI 10.1016/0959-437X(93)90105-X; MORGAN BA, 1992, NATURE, V358, P236, DOI 10.1038/358236a0; NISWANDER L, 1993, CELL, V75, P579, DOI 10.1016/0092-8674(93)90391-3; NISWANDER L, 1993, NATURE, V361, P68, DOI 10.1038/361068a0; ORRURTREGER A, 1991, DEVELOPMENT, V113, P1419; PALMER SE, 1994, AM J HUM GENET, V55; PETERS KG, 1992, DEVELOPMENT, V114, P233; RAO VVNG, 1992, HUM GENET, V90, P299; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; ROBERT B, 1989, EMBO J, V8, P91, DOI 10.1002/j.1460-2075.1989.tb03352.x; RUPPERT JM, 1990, MOL CELL BIOL, V10, P5408, DOI 10.1128/MCB.10.10.5408; SAUNDERS JOHN WARREN, 1957, J MORPH, V101, P57, DOI 10.1002/jmor.1051010104; SAUNDERS JW, 1948, J EXP ZOOL, V108, P363, DOI 10.1002/jez.1401080304; SAUNDERS JW, 1968, EPITHELIAL MESENCHYM; SAVAGE MP, 1993, DEV DYNAM, V198, P159, DOI 10.1002/aja.1001980302; SCHERER SW, 1994, AM J HUM GENET, V55; SMALL KM, 1993, GENE DEV, V7, P2318, DOI 10.1101/gad.7.12a.2318; SMITH JC, 1994, CELL, V76, P193, DOI 10.1016/0092-8674(94)90325-5; SOLURSH M, 1988, J EXP ZOOL, V248, P147, DOI 10.1002/jez.1402480204; SUMMERBELL D, 1974, J EMBRYOL EXP MORPH, V32, P651; SUZUKI HR, 1992, DEV BIOL, V150, P219, DOI 10.1016/0012-1606(92)90020-H; TABAS JA, 1993, CLIN ORTHOP RELAT R, V293, P310; TABIN CJ, 1992, DEVELOPMENT, V116, P289; TICKLE C, 1975, NATURE, V254, P199, DOI 10.1038/254199a0; TSUKUROV O, 1994, NAT GENET, V6, P282, DOI 10.1038/ng0394-282; VOGEL A, 1993, DEVELOPMENT, V119, P199; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; WATSON AG, 1986, CLIN ORTHOP RELAT R, V202, P294; YOSHIDA MC, 1988, P NATL ACAD SCI USA, V85, P4861, DOI 10.1073/pnas.85.13.4861	55	53	53	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1994	55	1					1	6						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NW461	7912883				2022-12-18	WOS:A1994NW46100001
J	ISBRANDT, D; ARLT, G; BROOKS, DA; HOPWOOD, JJ; VONFIGURA, K; PETERS, C				ISBRANDT, D; ARLT, G; BROOKS, DA; HOPWOOD, JJ; VONFIGURA, K; PETERS, C			MUCOPOLYSACCHARIDOSIS-VI (MAROTEAUX-LAMY SYNDROME) - 6 UNIQUE ARYLSULFATASE-B GENE ALLELES CAUSING VARIABLE DISEASE PHENOTYPES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CDNA; N-ACETYLGALACTOSAMINE-4-SULFATASE; EXPRESSION; DEFICIENCY; SULFATASE; CLONING; CELLS; ACID	Mucopolysaccharidosis type VI, or Maroteaux-Lamy syndrome, is a lysosomal storage disorder caused by a deficiency of the enzyme arylsulfatase B (ASB), also known as N-acetylgalactosamine-4-sulfatase. Multiple clinical phenotypes of this autosomal recessively inherited disease have been described. Recent isolation and characterization of the human ASB gene facilitated the analysis of molecular defects underlying the different phenotypes. Conditions for PCR amplification of the entire open reading frame from genomic DNA and for subsequent direct automated DNA sequencing of the resulting DNA fragments were established. Besides two polymorphisms described elsewhere that cause methionine-for-valine substitutions in the arylsulfatase B gene, six new mutations in six patients were detected: four point mutations resulting in amino acid substitutions, a l-bp deletion, and a 1-bp insertion. The point mutations were two G-to-A and two T-to-C transitions. The Gto-A transitions cause an arginine-for-glycine substitution at residue 144 in a homoallelic patient with a severe disease phenotype and a tyrosine-for-cysteine substitution at residue 521 in a potentially heteroallelic patient with the severe form of the disease. The T-to-C transitions cause an arginine-for-cysteine substitution at amino acid residue 192 in a homoallelic patient with mild symptoms and a proline-for-leucine substitution at amino acid 321 in a homoallelic patient with the intermediate form. The insertion between nucleotides T1284 and G1285 resulted in a loss of the 100 C-terminal amino acids of the wild-type protein and in the deletion of nucleotide C1577 in a 33-amino-acid C-terminal extension of the ASB polypeptide. Both mutations were detected in homoallelic patients with the severe form of the disease. Expression of mutant cDNAs encoding the four amino acid substitutions and the deletion resulted in severe reduction of both ASB protein levels and arylsulfatase enzyme activity in comparison with a wild-type control. The six mutations described in the present study were unique among 25 unrelated mucopolysaccharidosis VI patients, suggesting a broad molecular heterogeneity of the Maroteaux-Lamy syndrome.	UNIV GOTTINGEN,D-37073 GOTTINGEN,GERMANY; ADELAIDE MED CTR WOMEN & CHILDREN,DEPT CHEM PATHOL,LYSOSOMAL DIS RES UNIT,ADELAIDE,SA,AUSTRALIA	University of Gottingen; Womens & Childrens Hospital Australia			Brooks, Doug A/K-6714-2012	Isbrandt, Dirk/0000-0002-4720-1016; Brooks, Doug/0000-0001-9098-3626				ALLEN E, 1968, BIOCHIM BIOPHYS ACTA, V168, P243, DOI 10.1016/0005-2795(68)90147-5; ARLT G, IN PRESS J BIOL CHEM; ARTELT P, 1988, GENE, V68, P213, DOI 10.1016/0378-1119(88)90023-6; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; JIN WD, 1991, NUCLEIC ACIDS RES, V19, P4305, DOI 10.1093/nar/19.15.4305-a; JIN WD, 1992, AM J HUM GENET, V50, P795; LITJENS T, 1991, BIOCHEM INT, V24, P209; Litjens Tom, 1992, Human Mutation, V1, P397, DOI 10.1002/humu.1380010509; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LYONS K, 1989, P NATL ACAD SCI USA, V86, P4554, DOI 10.1073/pnas.86.12.4554; MATALON R, 1974, BIOCHEM BIOPH RES CO, V61, P1450, DOI 10.1016/S0006-291X(74)80446-8; MODARESSI S, 1993, BIOL CHEM H-S, V374, P327, DOI 10.1515/bchm3.1993.374.1-6.327; NAKAMAYE KL, 1986, NUCLEIC ACIDS RES, V14, P9679, DOI 10.1093/nar/14.24.9679; Neufeld EF, 1989, METABOLIC BASIS INHE, P1565; OBRIEN JF, 1974, BIOCHEM BIOPH RES CO, V60, P1170, DOI 10.1016/0006-291X(74)90435-5; PETERS C, 1990, J BIOL CHEM, V265, P3374; SCHUCHMAN EH, 1990, GENOMICS, V6, P149, DOI 10.1016/0888-7543(90)90460-C; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; Strauss W. M., 1990, CURRENT PROTOCOLS MO; STRECKEL F, 1983, J BIOL CHEM, V258, P14322; VANBIERVLIET JPGM, 1977, ARCH FR PEDIATR, V34, P362; VONFIGURA K, 1983, P NATL ACAD SCI-BIOL, V80, P6066; WICKER G, 1991, J BIOL CHEM, V266, P21386; WIGLER M, 1977, CELL, V11, P223, DOI 10.1016/0092-8674(77)90333-6; WILSON PJ, 1990, P NATL ACAD SCI USA, V87, P8531, DOI 10.1073/pnas.87.21.8531	25	53	56	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1994	54	3					454	463						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ158	8116615				2022-12-18	WOS:A1994MZ15800008
J	BLOUIN, JL; AVRAMOPOULOS, D; PANGALOS, C; ANTONARAKIS, SE				BLOUIN, JL; AVRAMOPOULOS, D; PANGALOS, C; ANTONARAKIS, SE			NORMAL PHENOTYPE WITH PATERNAL UNIPARENTAL ISODISOMY FOR CHROMOSOME-21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRADER-WILLI SYNDROME; NORMAL DAUGHTER; HUMAN GENOME; DISOMY; TRANSLOCATION; MOUSE; TRANSMISSION; HETERODISOMY; ASSOCIATION; MECHANISM	Uniparental disomy (UPD) involving several different chromosomes has been described in several cases of human pathologies. In order to investigate whether UPD for chromosome 21 is associated with abnormal phenotypes, we analyzed DNA polymorphisms in DNA from a family with de novo Robertsonian translocation t(21q;21q). The proband was a healthy male with 45 dup(21q) who was ascertained through his trisomy 21 offspring. No phenotypic abnormalities were noted in the physical exam, and his past medical history was unremarkable. We obtained genotypes for the proband and his parents' leukocyte DNAs f rom 17 highly informative short sequence repeat polymorphisms that map in the pericentromeric region and along the entire length of 21q. The order of the markers has been previously determined through the linkage and physical maps of this chromosome. For the nine informative markers there was no maternal allele contribution to the genotype of the proband; in addition, there was always reduction to homozygosity of a paternal allele. These data indicated that there was paternal uniparental isodisomy for chromosome 21 (pUPiD21). We conclude that pUPiD21 is not associated with abnormal phenotypes and that there are probably no imprinted genes on chromosome 21.	JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,CMSC 1003,BALTIMORE,MD 21287; DIAGNOST GENET CTR,ATHENS,GREECE; UNIV GENEVA,SCH MED,INST MED GENET,CH-1211 GENEVA 4,SWITZERLAND	Johns Hopkins University; University of Geneva			Antonarakis, Stylianos E/N-8866-2014; Avramopoulos, Dimitrios/J-4392-2012	Antonarakis, Stylianos E/0000-0001-8907-5823; 	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD024605] Funding Source: NIH RePORTER; NICHD NIH HHS [HD24605] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANTONARAKIS SE, 1993, AM J HUM GENET, V52, P1145; ANTONARAKIS SE, 1992, GENOMICS, V14, P1126, DOI 10.1016/S0888-7543(05)80148-X; BELDJORD C, 1992, BLOOD, V80, P287; BENNETT P, 1992, LANCET, V340, P1284, DOI 10.1016/0140-6736(92)92980-T; BERGER CN, 1989, GENET RES, V54, P227, DOI 10.1017/S001667230002869X; CREAUGOLDBERG N, 1987, HUM GENET, V76, P396, DOI 10.1007/BF00272452; DRISCOLL DJ, 1992, GENOMICS, V13, P917, DOI 10.1016/0888-7543(92)90001-9; DWORNICZAK B, 1992, LANCET, V340, P1285; ECONOMOU EP, 1990, P NATL ACAD SCI USA, V87, P2951, DOI 10.1073/pnas.87.8.2951; ENGEL E, 1991, AM J MED GENET, V40, P432, DOI 10.1002/ajmg.1320400411; ENGEL E, 1980, AM J MED GENET, V6, P132; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; Henry I., 1993, European Journal of Human Genetics, V1, P19; HENRY I, 1991, NATURE, V351, P665, DOI 10.1038/351665a0; KALOUSEK DK, 1993, AM J HUM GENET, V52, P8; KIRKELS VGHJ, 1980, CLIN GENET, V18, P456; MALCOLM S, 1991, LANCET, V337, P694, DOI 10.1016/0140-6736(91)90278-W; MCINNIS MG, 1993, GENOMICS, V16, P562, DOI 10.1006/geno.1993.1231; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; OBRIEN SJ, 1993, NAT GENET, V3, P103, DOI 10.1038/ng0293-103; PALMER CG, 1980, CLIN GENET, V17, P418; PENTAO L, 1992, AM J HUM GENET, V50, P690; PETERSEN MB, 1991, AM J HUM GENET, V48, P65; PETERSEN MB, 1992, GENOMICS, V13, P269, DOI 10.1016/0888-7543(92)90242-K; REEVES RH, 1992, MAMM GENOME, V3, pS233, DOI 10.1007/BF00648434; ROBINSON WP, 1991, AM J HUM GENET, V49, P1219; SEARLE AG, 1989, ANN HUM GENET, V53, P89, DOI 10.1111/j.1469-1809.1989.tb01777.x; SILVER LM, 1992, GENOME, V3, pS241; SPENCE JE, 1988, AM J HUM GENET, V42, P217; SPOTILA LD, 1992, AM J HUM GENET, V51, P1396; TAYLOR BA, 1992, MAMM GENOME, V3, pS153, DOI 10.1007/BF00648428; TEMPLE IK, 1991, J MED GENET, V28, P511, DOI 10.1136/jmg.28.8.511; VOSS R, 1989, AM J HUM GENET, V45, P373; WANG JCC, 1991, AM J HUM GENET, V48, P1069; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WELCH TR, 1990, J CLIN INVEST, V86, P675, DOI 10.1172/JCI114760	36	53	54	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1993	53	5					1074	1078						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MC333	8213833				2022-12-18	WOS:A1993MC33300011
J	REBBECK, TR; DIETZ, FR; MURRAY, JC; BUETOW, KH				REBBECK, TR; DIETZ, FR; MURRAY, JC; BUETOW, KH			A SINGLE-GENE EXPLANATION FOR THE PROBABILITY OF HAVING IDIOPATHIC TALIPES EQUINOVARUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CLEFT-LIP; CLUB FOOT; PALATE; MODELS	It has been hypothesized that the pathogenesis of idiopathic talipes equinovarus (ITEV, or clubfoot) is explained by genetic regulation of development and growth. The objective of the present study was to determine whether a single Mendelian gene explains the probability of having ITEV in a sample of 143 Caucasian pedigrees from Iowa. These pedigrees were ascertained through probands with ITEV. Complex segregation analyses were undertaken using a regressive logistic model. The results of these analyses strongly rejected the hypotheses that the probability of having ITEV in these pedigrees was explained by a non-Mendelian pattern of transmission with residual sibling correlation, a nontransmitted (environmental) factor with residual sibling correlation, or residual sibling correlation alone. These results were consistent with the hypothesis that the probability of having ITEV was explained by the Mendelian segregation of a single gene with two alleles plus the effects of some unmeasured factor(s) shared among siblings. The segregation of alleles at this single Mendelian gene indicated that the disease allele A was incompletely dominant to the nondisease allele B. The disease allele A, associated with ITEV affection, was estimated to occur in the population of inference with a frequency of .007. After adjusting for sex-specific population incidences of ITEV, the conditional probability (penetrance) of ITEV affection given the AA, AB, and BB genotypes was computed to be 1.0, .039, and .0006, respectively. Individual pedigrees in this sample that most strongly supported the single Mendelian gene hypothesis were identified. These pedigrees are candidates for genetic linkage analyses or DNA association studies.	UNIV IOWA HOSP & CLIN,DEPT PEDIAT,DIV MED GENET,IOWA CITY,IA 52242; UNIV IOWA HOSP & CLIN,DEPT ORTHOPAED SURG,IOWA CITY,IA 52242	University of Iowa; University of Iowa	REBBECK, TR (corresponding author), FOX CHASE CANC CTR,DIV POPULAT SCI,7701 BURHOLME AVE,PHILADELPHIA,PA 19111, USA.		Rebbeck, Timothy/GLU-8348-2022	Rebbeck, Timothy/0000-0002-4799-1900	NCRR NIH HHS [RR03655] Funding Source: Medline; NHGRI NIH HHS [HG00206, HG00355] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG000206, R01HG000355] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ARDINGER HH, 1989, AM J HUM GENET, V45, P348; BONNEY GE, 1986, BIOMETRICS, V42, P611, DOI 10.2307/2531211; CANNINGS C, 1978, ADV APPL PROBAB, V10, P26, DOI 10.2307/1426718; CARTER CO, 1965, PROGR MED GENETICS, V4; CARTLIDGE I, 1984, J MED GENET, V21, P290, DOI 10.1136/jmg.21.4.290; CHUNG CS, 1969, HUM HERED, V19, P321, DOI 10.1159/000152236; CZEIZEL A, 1981, J MED GENET, V19, P99; DIETZ FR, 1983, J PEDIATR ORTHOPED, V3, P311, DOI 10.1097/01241398-198307000-00008; DIETZ FR, 1986, IOWA ORTHOPED J, V5, P53; Falconer D.S., 1986, INTRO QUANTITATIVE G; FRANCOMANO C A, 1987, Genomics, V1, P293, DOI 10.1016/0888-7543(87)90027-9; HANDELSMAN JE, 1981, J PEDIATR ORTHOPED, V1, P23, DOI 10.1097/01241398-198101010-00004; HASTBACKA J, 1990, P NATL ACAD SCI USA, V87, P8056, DOI 10.1073/pnas.87.20.8056; HECHT JT, 1991, AM J HUM GENET, V49, P674; HOLLAND PWH, 1991, GENE, V98, P253, DOI 10.1016/0378-1119(91)90182-B; ISAACS H, 1977, J BONE JOINT SURG BR, V59, P465, DOI 10.1302/0301-620X.59B4.925057; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; Kite J, 1964, CLUBFOOT; LAAVEG SJ, 1980, J BONE JOINT SURG AM, V62, P23, DOI 10.2106/00004623-198062010-00004; MORRELL R, 1992, HUM MOL GENET, V1, P243; PALMER RM, 1964, J BONE JOINT SURG AM, V46, P542, DOI 10.2106/00004623-196446030-00008; PALMER RM, 1974, P AM ORTH FOOT SOC, V5, P99; SORANT AJM, 1989, SAGE STATISTICAL ANA; TABIN CJ, 1991, CELL, V66, P199, DOI 10.1016/0092-8674(91)90612-3; THOMPSON JS, 1980, GNETICS MED; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; WANG JH, 1988, AM J HUM GENET, V42, P772; WHITTEMORE AS, 1981, J AM STAT ASSOC, V76, P27, DOI 10.2307/2287036; WRIGHT CUE, 1989, TRENDS BIOCHEM SCI, V14, P55; WYNNEDAVIES R, 1982, J MED GENET, V19, P321, DOI 10.1136/jmg.19.5.321; YAMAMOTO H, 1979, JPN J HUM GENET, V24, P37, DOI 10.1007/BF01890110; YANG HY, 1987, GENET EPIDEMIOL, V4, P299, DOI 10.1002/gepi.1370040408; 1991, POSSUM VERSION 3 0	34	53	56	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1993	53	5					1051	1063						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MC333	8213831				2022-12-18	WOS:A1993MC33300009
J	ZIELENSKI, J; FUJIWARA, TM; MARKIEWICZ, D; PARADIS, AJ; ANACLETO, AI; RICHARDS, B; SCHWARTZ, RH; KLINGER, KW; TSUI, LC; MORGAN, K				ZIELENSKI, J; FUJIWARA, TM; MARKIEWICZ, D; PARADIS, AJ; ANACLETO, AI; RICHARDS, B; SCHWARTZ, RH; KLINGER, KW; TSUI, LC; MORGAN, K			IDENTIFICATION OF THE M1101K MUTATION IN THE CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) GENE AND COMPLETE DETECTION OF CYSTIC-FIBROSIS MUTATIONS IN THE HUTTERITE POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA; POLYMORPHISM; CLONING; HAPLOTYPES; POLYMERASE; FAMILIES; BRETHREN; SEQUENCE	The Hutterite population is a genetic isolate with an increased incidence of cystic fibrosis (CF). Previously we identified three CF haplotypes defined by polymorphisms flanking the CF transmembrane conductance regulator (CFTR) gene. DELTAF508 was present on one of the haplotypes in only 35% of CF chromosomes. We hypothesized that the other two CF haplotypes, one of which was the most common and the other of which is rare, each harbored different non-DELTAF508 mutations. Single-strand conformation polymorphism analysis detected a missense mutation, M1101K, in both chromosomes of a Hutterite patient carrying the two non-DELTAF508 haplotypes. M1101K appears to have originated on an uncommon CFTR allele and to be infrequent outside the Hutterite population. The presence of M1101K on two haplotypes is likely the result of a CFTR intragenic recombination which occurred since the founding, 10-12 generations ago, of the Hutterite population. The crossover was located between exons 14a and 17b, an interval of approximately 15 kbp. DELTAF508 and M1101K accounted for all of the CF mutations in patients from 16 CF families representing the three subdivisions of the Hutterite population.	MCGILL UNIV,DEPT EPIDEMIOL & BIOSTAT,MONTREAL H3A 2T5,QUEBEC,CANADA; MCGILL UNIV,DEPT MED,MONTREAL H3A 2T5,QUEBEC,CANADA; MCGILL UNIV,DEPT PEDIAT,MONTREAL H3A 2T5,QUEBEC,CANADA; MCGILL UNIV,CTR HUMAN GENET,MONTREAL H3A 2T5,QUEBEC,CANADA; INTEGRATED GENET INC,FRAMINGHAM,MA; UNIV ROCHESTER,DEPT PEDIAT,ROCHESTER,NY 14627; HOSP SICK CHILDREN,RES INST,DEPT GENET,TORONTO M5G 1X8,ONTARIO,CANADA; UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO M5S 1A1,ONTARIO,CANADA	McGill University; McGill University; McGill University; McGill University; University of Rochester; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto			Tsui, Lap-chee/A-1081-2010					ABELIOVICH D, 1992, AM J HUM GENET, V51, P951; CHEBAB FF, 1991, AM J HUM GENET, V48, P223; CHILLON M, 1991, NUCLEIC ACIDS RES, V19, P6343, DOI 10.1093/nar/19.22.6343; CUPPENS H, 1992, MOL CELL PROBE, V6, P33, DOI 10.1016/0890-8508(92)90069-A; CUTTING GR, 1992, AM J HUM GENET, V50, P1185; Cystic Fibrosis Genetic Anal Consortium, 1990, AM J HUM GENET, V47, P354; DIAMOND G, 1991, J BIOL CHEM, V266, P22761; DORK T, 1991, NUCLEIC ACIDS RES, V19, P2517, DOI 10.1093/nar/19.9.2517-a; DORK T, 1992, HUM GENET, V88, P417, DOI 10.1007/BF00215676; FANEN P, 1992, GENOMICS, V13, P770, DOI 10.1016/0888-7543(92)90152-I; FEREC C, 1992, NAT GENET, V1, P188, DOI 10.1038/ng0692-188; FUJIWARA TM, 1989, AM J HUM GENET, V44, P327; GASPARINI P, 1991, HUM GENET, V86, P625; HOSTETLER JA, 1985, AM J MED GENET, V22, P453, DOI 10.1002/ajmg.1320220303; KEREM BS, 1990, P NATL ACAD SCI USA, V87, P8447, DOI 10.1073/pnas.87.21.8447; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KLINGER K, 1990, AM J HUM GENET, V46, P983; KLINGER KW, 1991, ADV EXP MED BIOL, V290, P39; LIECHTIGALLATI S, 1991, PEDIATR RES, V30, P304, DOI 10.1203/00006450-199110000-00003; MILLER SR, 1992, AM J PUBLIC HEALTH, V82, P236, DOI 10.2105/AJPH.82.2.236; MORRAL N, 1991, GENOMICS, V10, P692, DOI 10.1016/0888-7543(91)90454-M; NUNES V, 1991, HUM GENET, V87, P737; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS J, 1990, AM J HUM GENET, V46, P395; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; ROZEN R, 1992, AM J MED GENET, V42, P360, DOI 10.1002/ajmg.1320420322; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SHOSHANI T, 1992, AM J HUM GENET, V50, P222; SHRIMPTON AE, 1991, J MED GENET, V28, P317, DOI 10.1136/jmg.28.5.317; TATA F, 1991, GENOMICS, V10, P301, DOI 10.1016/0888-7543(91)90312-3; THOMPSON EA, 1989, ANN HUM GENET, V53, P357, DOI 10.1111/j.1469-1809.1989.tb01804.x; TSUI LC, 1992, TRENDS GENET, V8, P392, DOI 10.1016/0168-9525(92)90301-J; YORIFUJI T, 1991, GENOMICS, V10, P547, DOI 10.1016/0888-7543(91)90434-G; ZIELENSKI J, 1991, GENOMICS, V10, P229, DOI 10.1016/0888-7543(91)90504-8; ZIELENSKI J, 1991, GENOMICS, V10, P214, DOI 10.1016/0888-7543(91)90503-7; ZIELENSKI J, 1991, AM J HUM GENET, V49, P1256; 1990, HUM GENET, V85, P436	38	53	54	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1993	52	3					609	615						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KR720	7680525				2022-12-18	WOS:A1993KR72000018
J	WIJMENGA, C; SANDKUIJL, LA; MOERER, P; VANDERBOORN, N; BODRUG, SE; RAY, PN; BROUWER, OF; MURRAY, JC; VANOMMEN, GJB; PADBERG, GW; FRANTS, RR				WIJMENGA, C; SANDKUIJL, LA; MOERER, P; VANDERBOORN, N; BODRUG, SE; RAY, PN; BROUWER, OF; MURRAY, JC; VANOMMEN, GJB; PADBERG, GW; FRANTS, RR			GENETIC-LINKAGE MAP OF FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY AND 5 POLYMORPHIC LOCI ON CHROMOSOME 4Q35-QTER	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FACTOR-XI GENE; LONG ARM; HUNTINGTONS-DISEASE; DNA MARKER; REGION	A genetic map of five polymorphic markers in the area of the facioscapulohumeral muscular dystrophy (FSHD) gene on chromosome 4q35-qter has been constructed. With these five markers, a number of recombinants have been identified that allow ordering of the marker and the disease loci. The most likely locus order and the relative position of the FSHD gene supported by the recombinants is centromere-D4S171-F11-D4S187-D4S163-D4S139-FSHD-telomere. However, at least one recombination event appears to be inconsistent with this order and suggests a location of FSHD proximal to D4S139.	LEIDEN UNIV,SYLVIUS LAB,MGC DEPT HUMAN GENET,MGC,WASSENAARSWEG 72,2333 AL LEIDEN,NETHERLANDS; LEIDEN UNIV,DEPT NEUROL,2333 AL LEIDEN,NETHERLANDS; UNIV ROTTERDAM,DIJKZIGT HOSP,DEPT CLIN GENET,ROTTERDAM,NETHERLANDS; HOSP SICK CHILDREN,TORONTO M5G 1X8,ONTARIO,CANADA; UNIV IOWA HOSP & CLIN,DEPT PEDIAT,IOWA CITY,IA 52242	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Iowa			Padberg, G.W.A.M./H-8079-2014; Wijmenga, Cisca/D-2173-2009; Wijmenga, Cisca/AAE-7719-2019	Wijmenga, Cisca/0000-0002-5635-1614				ALTHERR MR, 1991, NUCLEIC ACIDS RES, V19, P1168, DOI 10.1093/nar/19.5.1168; BODRUG SE, 1990, J MED GENET, V27, P426, DOI 10.1136/jmg.27.7.426; BUTLER MG, 1990, NUCLEIC ACIDS RES, V18, P5327, DOI 10.1093/nar/18.17.5327-a; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; KATO A, 1989, CYTOGENET CELL GENET, V52, P77, DOI 10.1159/000132844; LATHROP GM, 1988, AM J HUM GENET, V42, P498; LUNT PW, 1989, J MED GENET, V26, P535, DOI 10.1136/jmg.26.8.535; MACDONALD ME, 1989, NEURON, V3, P183, DOI 10.1016/0896-6273(89)90031-7; MILLS KA, 1992, AM J HUM GENET, V51, P432; MILNER ECB, 1989, NUCLEIC ACIDS RES, V17, P4002, DOI 10.1093/nar/17.10.4002; NEUWEILER J, 1990, NUCLEIC ACIDS RES, V18, P691, DOI 10.1093/nar/18.3.691; Padberg GW, 1982, THESIS LEIDEN U LEID; SARFARAZI M, 1992, AM J HUM GENET, V51, P396; SNELL RG, 1989, CYTOGENET CELL GENET, V51, P1083; UPADHYAYA M, 1990, LANCET, V336, P1320, DOI 10.1016/0140-6736(90)93005-A; UPADHYAYA M, 1991, J MED GENET, V28, P665, DOI 10.1136/jmg.28.10.665; WIJMENGA C, 1990, J NEUROL SCI, V95, P225, DOI 10.1016/0022-510X(90)90245-I; Wijmenga C, 1990, LANCET, V336, P651, DOI 10.1016/0140-6736(90)92148-B; WIJMENGA C, 1991, GENOMICS, V9, P570, DOI 10.1016/0888-7543(91)90348-I; [No title captured]	20	53	54	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1992	51	2					411	415						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JF776	1642239				2022-12-18	WOS:A1992JF77600022
J	VANDENHURK, JAJM; VANDEPOL, TJR; MOLLOY, CM; BRUNSMANN, F; RUTHER, K; ZRENNER, E; PINCKERS, AJLG; PAWLOWITZKI, IH; BLEEKERWAGEMAKERS, EM; WIERINGA, B; ROPERS, HH; CREMERS, FPM				VANDENHURK, JAJM; VANDEPOL, TJR; MOLLOY, CM; BRUNSMANN, F; RUTHER, K; ZRENNER, E; PINCKERS, AJLG; PAWLOWITZKI, IH; BLEEKERWAGEMAKERS, EM; WIERINGA, B; ROPERS, HH; CREMERS, FPM			DETECTION AND CHARACTERIZATION OF POINT MUTATIONS IN THE CHOROIDEREMIA CANDIDATE GENE BY PCR-SSCP ANALYSIS AND DIRECT DNA SEQUENCING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							X-CHROMOSOME; CLONING; DELETIONS; LOCUS; POLYMERASE; XQ21	By making use of positional cloning strategies we recently isolated a candidate gene for choroideremia (CHM), which is transcribed in retina, choroid, and/or retinal pigment epithelium. The gene contains an open reading frame that is structurally altered in 10 CHM patients with sizable deletions and in a female patient with a balanced translocation involving the Xq21 band. Employing PCR-SSCP analysis and direct DNA sequencing we have now detected and characterized different point mutations in five patients with CHM. Each of these mutations introduces a termination codon into the open reading frame of the CHM candidate gene, thereby predicting a distinct truncated protein product. Together these findings provide convincing evidence for the candidate gene being identical with the choroideremia gene.	UNIV MUNSTER,INST HUMAN GENET,W-4400 MUNSTER,GERMANY; UNIV TUBINGEN,AUGENKLIN,W-7400 TUBINGEN 1,GERMANY; UNIV HOSP NIJMEGEN,DEPT OPHTHALMOL,NIJMEGEN,NETHERLANDS; IOI,DEPT OPHTHALMOL,AMSTERDAM,NETHERLANDS; UNIV HOSP NIJMEGEN,DEPT CELL BIOL & HISTOL,NIJMEGEN,NETHERLANDS	University of Munster; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Radboud University Nijmegen; Radboud University Nijmegen	VANDENHURK, JAJM (corresponding author), UNIV HOSP NIJMEGEN,DEPT HUMAN GENET,POB 9101,6500 HB NIJMEGEN,NETHERLANDS.		Wieringa, Berend/A-5346-2011; Cremers, Frans/A-5625-2014	Wieringa, Berend/0000-0001-9192-8020; Cremers, Frans/0000-0002-4954-5592				ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; CREMERS FPM, 1990, HUM GENET, V86, P61, DOI 10.1007/BF00205174; CREMERS FPM, 1989, P NATL ACAD SCI USA, V86, P7510, DOI 10.1073/pnas.86.19.7510; CREMERS FPM, 1990, NATURE, V347, P674, DOI 10.1038/347674a0; CREMERS FPM, 1989, GENOMICS, V4, P41, DOI 10.1016/0888-7543(89)90312-1; CREMERS FPM, 1990, AM J HUM GENET, V47, P622; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FODOR E, 1991, NATURE, V351, P614, DOI 10.1038/351614b0; Goedbloed J., 1942, OPHTHALMOLOGICA, V104, P308; HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3; Heckenlively J. R., 1988, RETINITIS PIGMENTOSA; MATSUI Y, 1990, MOL CELL BIOL, V10, P4116, DOI 10.1128/MCB.10.8.4116; MERRY DE, 1989, AM J HUM GENET, V45, P530; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; SCHWARTZ M, 1988, HUM GENET, V78, P156, DOI 10.1007/BF00278188; STOKER AW, 1990, NUCLEIC ACIDS RES, V18, P4290, DOI 10.1093/nar/18.14.4290; TANABE T, 1985, NATURE, V315, P242, DOI 10.1038/315242a0; VANDEPOL TJR, 1990, NUCLEIC ACIDS RES, V18, P725, DOI 10.1093/nar/18.4.725; WAARDENBURG PJ, 1942, ACTA OPHTHALMOL, V20, P235; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445	21	53	54	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1992	50	6					1195	1202						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HY654	1598901				2022-12-18	WOS:A1992HY65400006
J	HODGE, SE; GREENBERG, DA				HODGE, SE; GREENBERG, DA			SENSITIVITY OF LOD SCORES TO CHANGES IN DIAGNOSTIC STATUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MELANOMA DYSPLASTIC NEVUS; LINKAGE; SCHIZOPHRENIA; CHROMOSOME-5; DISORDERS; MARKERS; LOCUS; GENE	This paper investigates effects on lod scores when one individual in a data set changes diagnostic or recombinant status. First we examine the situation in which a single offspring in a nuclear family changes status. The nuclear-family situation, in addition to being of interest in its own right, also has general theoretical importance, since nuclear families are "transparent"; that is, one can track genetic events more precisely in nuclear families than in complex pedigrees. We demonstrate that in nuclear families log10 [(1 - theta) / theta] gives an upper limit on the impact that a single offspring's change in status can have on the lod score at that recombination fraction (theta). These limits hold for a fully penetrant dominant condition and fully informative marker, in either phase-known or phase-unknown matings. Moreover, log10 [(1 - theta) / theta] (where theta denotes the value of theta at which Z(max) occurs) gives an upper limit on the impact of a single offspring's status change on the maximum lod score (Z(max)). In extended pedigrees, in contrast to nuclear families, no comparable limit can be set on the impact of a single individual on the lod score. Complex pedigrees are subject to both stabilizing and destabilizing influences, and these are described. Finally, we describe a "sensitivity analysis," in which, after all linkage analysis is completed, every informative individual in the data set is changed, one at a time, to see the effect which each separate change has on the lod scores. The procedure includes identifying "critical individuals," i.e., those who would have the greatest impact on the lod scores, should their diagnostic status in fact change. To illustrate use of the sensitivity analysis, we apply it to the large bipolar pedigree reported by Egeland et al. and Kelsoe et al. We show that the changes in lod scores observed there, on the order of 1.1-1.2 per person, are not unusual. We recommend that investigators include a sensitivity analysis as a standard part of reporting the results of a linkage analysis.	COLUMBIA UNIV COLL PHYS & SURG,DEPT PSYCHIAT,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,DEPT BIOSTAT,NEW YORK,NY 10032; CUNY MT SINAI SCH MED,DEPT PSYCHIAT,NEW YORK,NY 10029; CUNY MT SINAI SCH MED,DEPT BIOMATH,NEW YORK,NY 10029	Columbia University; Columbia University; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	HODGE, SE (corresponding author), NEW YORK STATE PSYCHIAT INST & HOSP,BOX 14,722 W 168TH ST,NEW YORK,NY 10032, USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R55DK031813, R01DK031775, R01DK031813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027941] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-31775, DK-31813] Funding Source: Medline; NINDS NIH HHS [NS-27941] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BALE SJ, 1989, NEW ENGL J MED, V320, P1367, DOI 10.1056/NEJM198905253202102; CANNONALBRIGHT LA, 1990, AM J HUM GENET, V46, P912; EGELAND JA, 1987, NATURE, V325, P783, DOI 10.1038/325783a0; Egeland Janice A., 1990, Psychiatric Genetics, V1, P5; HODGE SE, 1990, AM J HUM GENET S, V47, pA183; KELSOE JR, 1989, NATURE, V342, P238, DOI 10.1038/342238a0; KENNEDY JL, 1988, NATURE, V336, P167, DOI 10.1038/336167a0; KIDD KK, 1984, CYTOGENET CELL GENET, V37, P150; Ott J., 1991, ANAL HUMAN GENETIC L; RISCH N, 1990, GENET EPIDEMIOL, V7, P3, DOI 10.1002/gepi.1370070103; SHERRINGTON R, 1988, NATURE, V336, P164, DOI 10.1038/336164a0; SKOLNICK M H, 1984, Genetic Epidemiology, V1, P363, DOI 10.1002/gepi.1370010408; Stuart A., 1991, KENDALLS ADV THEORY, V2; WEEKS DE, 1990, GENET EPIDEMIOL, V7, P237, DOI 10.1002/gepi.1370070402; XIE X, 1990, AM J HUM GENET, V47, pA205	15	53	54	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1992	50	5					1053	1066						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HR473	1570835				2022-12-18	WOS:A1992HR47300022
J	ASHTON, LJ; BROOKS, DA; MCCOURT, PAG; MULLER, VJ; CLEMENTS, PR; HOPWOOD, JJ				ASHTON, LJ; BROOKS, DA; MCCOURT, PAG; MULLER, VJ; CLEMENTS, PR; HOPWOOD, JJ			IMMUNOQUANTIFICATION AND ENZYME-KINETICS OF ALPHA-L-IDURONIDASE IN CULTURED FIBROBLASTS FROM NORMAL CONTROLS AND MUCOPOLYSACCHARIDOSIS TYPE-I PATIENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								Alpha-L-Iduronidase activity is deficient in mucopolysaccharidosis type I (MPS I; Hurler syndrome, Scheie syndrome) patients and results in the disruption of the sequential degradation of the glycosaminoglycans dermatan sulfate and heparan sulfate. A monoclonal antibody-based immunoquantification assay has been developed for alpha-L-iduronidase, which enables the detection of at least 16 pg alpha-L-iduronidase protein. Cultured human skin fibroblasts from 12 normal controls contained 17-54 ng alpha-L-iduronidase protein/mg extracted cell protein. Fibroblasts from 23 MPS I patients were assayed for alpha-L-iduronidase protein content. Fibroblast extracts from one MPS I patient contained at least six times the level of alpha-L-iduronidase protein for normal controls-but contained no associated enzyme activity-and is proposed to represent a mutation affecting the active site of the enzyme. Fibroblast extracts from 11 MPS I patients contained 0.05-2.03 ng alpha-L-iduronidase protein/mg extracted cell protein, whereas immunodetectable protein could not be detected in the other 11 patients. Four fibroblast extracts with no immunodetectable alpha-L-iduronidase protein had residual alpha-L-iduronidase activity, suggesting that the mutant alpha-L-iduronidase in cultured cells from these MPS I patients has been modified to mask or remove the epitopes detected by two monoclonal antibodies used in the quantification assay. Both the absence of immunoreactivity in a mild MPS I patient and high protein level in a severe MPS I patient present limiatations to the use of immunoquantification analysis as a sole measure of patient phenotype. Enzyme kinetic analysis of alpha-L-iduronidase from MPS I fibroblasts revealed a number of patients with either abnormal substrate binding or catalytic activity. A combination of techniques, including immunochemical analysis and biochemical parameters, have been evaluated as predictors of the severity of clinical phenotype in MPS I patients. A high level of genetic heterogeneity in MPS I patients is suggested from the data presented.	ADELAIDE CHILDRENS HOSP INC,DEPT CHEM PATHOL,LYSOSOMAL DIS RES UNIT,72 KING WILLIAM RD,ADELAIDE,SA 5006,AUSTRALIA				McCourt, Peter/B-3043-2009; Brooks, Doug A/K-6714-2012	McCourt, Peter/0000-0001-5072-4590; Brooks, Doug/0000-0001-9098-3626				AVILA JL, 1973, CLIN CHIM ACTA, V47, P335, DOI 10.1016/0009-8981(73)90265-9; CLEMENTS PR, 1989, BIOCHEM J, V259, P199, DOI 10.1042/bj2590199; CLEMENTS PR, 1985, EUR J BIOCHEM, V152, P21, DOI 10.1111/j.1432-1033.1985.tb09158.x; CONZELMANN E, 1983, DEV NEUROSCI, V6, P58; HOPWOOD JJ, 1990, MOL BIOL MED, V7, P381; HOPWOOD JJ, 1982, CLIN SCI, V62, P193, DOI 10.1042/cs0620193; HOPWOOD JJ, 1979, CLIN SCI, V57, P265, DOI 10.1042/cs0570265; LEABACK DH, 1961, BIOCHEM J, V78, P151, DOI 10.1042/bj0780151; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATALON R, 1983, J INHERIT METAB DIS, V6, P133, DOI 10.1007/BF01810363; MCKUSICK VA, 1983, METABOLIC BASIS INHE, P751; MULLER VJ, 1984, CLIN GENET, V26, P414; Neufeld EF, 1989, METABOLIC BASIS INHE, P1565; SCHUCHMAN EH, 1988, J CLIN INVEST, V81, P98, DOI 10.1172/JCI113317; TAYLOR JA, 1991, BIOCHEM J, V274, P263, DOI 10.1042/bj2740263; ULLRICH K, 1981, J INHERIT METAB DIS, V4, P171, DOI 10.1007/BF02263645	16	53	58	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1992	50	4					787	794						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HL848	1550122				2022-12-18	WOS:A1992HL84800014
J	HYER, RN; JULIER, C; BUCKLEY, JD; TRUCCO, M; ROTTER, J; SPIELMAN, R; BARNETT, A; BAIN, S; BOITARD, C; DESCHAMPS, I; TODD, JA; BELL, JI; LATHROP, GM				HYER, RN; JULIER, C; BUCKLEY, JD; TRUCCO, M; ROTTER, J; SPIELMAN, R; BARNETT, A; BAIN, S; BOITARD, C; DESCHAMPS, I; TODD, JA; BELL, JI; LATHROP, GM			HIGH-RESOLUTION LINKAGE MAPPING FOR SUSCEPTIBILITY GENES IN HUMAN POLYGENIC DISEASE - INSULIN-DEPENDENT DIABETES-MELLITUS AND CHROMOSOME-11Q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NOD MOUSE; HLA; DNA; HETEROGENEITY; POLYMORPHISM; INHERITANCE; COMPLEX; FAMILY; MAPS	Insulin-dependent diabetes mellitus (IDDM) has a complex pattern of genetic inheritance. In addition to genes mapping to the major histocompatibility complex (MHC), several lines of evidence point to the existence of other genetic susceptibility factors. Recent studies of the nonobese diabetic mouse (NOD) model of IDDM have suggested the presence, on mouse chromosome 9, of a susceptibility gene linked to the locus encoding the T-cell antigen, Thy-1. A region on human chromosome 11q is syntenic to this region on mouse chromosome 9. We have used a set of polymorphic DNA markers from chromosome 11q to investigate this region for linkage to a susceptibility gene in 81 multiplex diabetic pedigrees. The data were investigated by maximization of lod scores over genetic models and by multiple-locus affected-sib-pair analysis. We were able to exclude the presence of a susceptibility gene (location scores < -2) throughout >90% of the chromosome 11q homology region, under the assumption that the susceptibility factor would cause >50% of affected sib pairs to share two alleles identical by descent. Theoretical estimates of the power to map susceptibility genes with a high-resolution map of linked markers in a candidate region were made, using HLA as a model locus. This result illustrates the feasibility that IDDM linkage studies using mapped sets of polymorphic DNA markers have, both for other areas of the genome in IDDM and for other polygenic diseases. The analytic approaches introduced here will be useful for affected-sib-pair studies of other complex phenotypes.	UNIV OXFORD,INST MOLEC MED,OXFORD OX3 9DU,ENGLAND; UNIV OXFORD,NUFFIELD DEPT SURG,OXFORD OX3 9DU,ENGLAND; UNIV SO CALIF,DEPT PREVENT MED,LOS ANGELES,CA 90089; INSERM,U25,CTR ETUDE POLYMORPHISM HUMAINE,F-75005 PARIS,FRANCE; INSERM,U25,HOP NECKER,F-75005 PARIS,FRANCE; UNIV CALIF LOS ANGELES,SCH MED,DEPT PEDIAT,LOS ANGELES,CA 90024; UNIV PENN,SCH MED,DEPT HUMAN GENET,PHILADELPHIA,PA 19104; UNIV BIRMINGHAM,SCH MED,BIRMINGHAM B15 2TT,W MIDLANDS,ENGLAND; UNIV PITTSBURGH,SCH MED,SCH MED,DEPT PEDIAT,DIV ENDOCRINOL,PITTSBURGH,PA 15261	University of Oxford; University of Oxford; University of Southern California; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Pennsylvania; University of Birmingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh			JULIER, Cécile/M-9824-2017; Todd, John A/A-3542-2010	JULIER, Cécile/0000-0002-1538-0240; Todd, John A/0000-0003-2740-8148; BOITARD, Christian/0000-0003-3985-9405				BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; BISHOP DT, 1990, AM J HUM GENET, V46, P254; BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; COX NJ, 1988, AM J HUM GENET, V42, P167; DAY NE, 1976, TISSUE ANTIGENS, V8, P109; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GOLDIN L, 1988, GENET EPIDEMIOL, V5, P32; HATTORI M, 1986, SCIENCE, V231, P733, DOI 10.1126/science.3003909; JACKSON RA, 1984, J EXP MED, V159, P1629, DOI 10.1084/jem.159.6.1629; JULIER C, 1990, GENOMICS, V7, P335, DOI 10.1016/0888-7543(90)90167-S; LANGE K, 1986, AM J HUM GENET, V39, P148; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1986, GENET EPIDEMIOL, V3, P39, DOI 10.1002/gepi.1370030105; LATHROP GM, 1985, HDB STATISTICS, V8; LLEWELLYN DH, 1987, NUCLEIC ACIDS RES, V15, P1349, DOI 10.1093/nar/15.3.1349; Maslen CL, 1988, GENOMICS, V2, P66, DOI 10.1016/0888-7543(88)90110-3; NADEAU JH, 1989, TRENDS GENET, V5, P82, DOI 10.1016/0168-9525(89)90031-0; NAKAMURA Y, 1988, AM J HUM GENET, V43, P638; NERUP J, 1974, LANCET, V2, P864; OTT J, 1983, ANN HUM GENET, V47, P311, DOI 10.1111/j.1469-1809.1983.tb01001.x; PAYAMI H, 1985, ANN HUM GENET, V49, P303, DOI 10.1111/j.1469-1809.1985.tb01706.x; PROCHAZKA M, 1987, SCIENCE, V237, P286, DOI 10.1126/science.2885918; REED KC, 1985, NUCLEIC ACIDS RES, V13, P7207, DOI 10.1093/nar/13.20.7207; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P242; RISCH N, 1987, AM J HUM GENET, V40, P1; RISCH N, 1989, GENET EPIDEMIOL, V6, P143, DOI 10.1002/gepi.1370060127; ROTTER JI, 1984, CLIN GENET, V26, P529; Sambrook J., 1989, MOL CLONING LAB MANU; SHEEHY MJ, 1989, J CLIN INVEST, V83, P830, DOI 10.1172/JCI113965; SMITH CAB, 1963, ANN HUM GENET, V38, P451; SUAREZ BK, 1978, ANN HUM GENET, V42, P87, DOI 10.1111/j.1469-1809.1978.tb00933.x; SVEJGAARD A, 1980, HISTOCOMPATIBILITY T, P638; THOMSON G, 1988, AM J HUM GENET, V43, P799; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; WICKER LS, 1987, J EXP MED, V165, P1639, DOI 10.1084/jem.165.6.1639	38	53	53	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1991	48	2					243	257						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EV744	1990836				2022-12-18	WOS:A1991EV74400009
J	CUTTING, GR; ANTONARAKIS, SE; BUETOW, KH; KASCH, LM; ROSENSTEIN, BJ; KAZAZIAN, HH				CUTTING, GR; ANTONARAKIS, SE; BUETOW, KH; KASCH, LM; ROSENSTEIN, BJ; KAZAZIAN, HH			ANALYSIS OF DNA POLYMORPHISM HAPLOTYPES LINKED TO THE CYSTIC-FIBROSIS LOCUS IN NORTH-AMERICAN BLACK AND CAUCASIAN FAMILIES SUPPORTS THE EXISTENCE OF MULTIPLE MUTATIONS OF THE CYSTIC-FIBROSIS GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,CYST FIBROSIS CLIN,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,PEDIAT GENET UNIT,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University			Antonarakis, Stylianos/N-8866-2014	Antonarakis, Stylianos/0000-0001-8907-5823				ANTONARAKIS SE, 1982, P NATL ACAD SCI-BIOL, V79, P6608, DOI 10.1073/pnas.79.21.6608; ANTONARAKIS SE, 1984, P NATL ACAD SCI-BIOL, V81, P853, DOI 10.1073/pnas.81.3.853; ANTONARAKIS SE, 1985, NEW ENGL J MED, V313, P842, DOI 10.1056/NEJM198510033131402; BEAUDET A, 1986, AM J HUM GENET, V39, P681; BEAUDET AL, 1988, NEW ENGL J MED, V318, P50; Bishop YM., 2007, DISCRETE MULTIVARIAT; BROWN WRA, 1986, NATURE, V322, P477, DOI 10.1038/322477a0; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; CHAKRAVARTI A, 1983, AM J HUM GENET, V36, P177; CONNEALLY PM, 1973, TEX REP BIOL MED, V31, P639; CONTE WJ, 1984, AM J HUM GENET, V36, P152; DEAN M, 1987, J PEDIATR-US, V111, P490, DOI 10.1016/S0022-3476(87)80106-3; EDWARDS JH, 1977, ARCH DIS CHILD, V52, P343, DOI 10.1136/adc.52.5.343; ESTIVILL X, 1987, Genomics, V1, P257, DOI 10.1016/0888-7543(87)90052-8; ESTIVILL X, 1988, AM J HUM GENET, V43, P23; ESTIVILL X, 1987, NATURE, V326, P840, DOI 10.1038/326840a0; FLEISS JL, 1973, STATISTICAL METHODS; GROVE S S, 1959, S Afr J Lab Clin Med, V5, P113; HOLLANDER DH, 1982, MED HYPOTHESES, V8, P191, DOI 10.1016/0306-9877(82)90102-5; KAPLAN GC, 1987, PEDIATR PULMONOL S, V1, P108; KAZAZIAN HH, 1988, BLOOD, V72, P1107; KNOWLTON RG, 1985, NATURE, V318, P380, DOI 10.1038/318380a0; KULCZYCKI LL, 1974, AM J DIS CHILD, V127, P64, DOI 10.1001/archpedi.1974.02110200066009; LATHROP GM, 1988, AM J HUM GENET, V42, P38; Levin S E, 1967, S Afr Med J, V41, P482; MACDOUGALL LG, 1962, LANCET, V1, P409; MORNET E, 1988, LANCET, V1, P376; PAGNIER J, 1984, P NATL ACAD SCI-BIOL, V81, P1771, DOI 10.1073/pnas.81.6.1771; REED TE, 1969, SCIENCE, V165, P762, DOI 10.1126/science.165.3895.762; REITNAUER PJ, 1982, DIABETES, V31, P532, DOI 10.2337/diabetes.31.6.532; SCAMBLER PJ, 1985, LANCET, V2, P1241; SCAMBLER PJ, 1986, NUCLEIC ACIDS RES, V14, P1951, DOI 10.1093/nar/14.5.1951; SENECAL J., 1954, Bull. Mod. de l'Afrique Occidentale Francaise., V11, P95; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPENCE JE, 1986, AM J HUM GENET, V39, P729; STERN RC, 1976, J PEDIATR-US, V89, P412, DOI 10.1016/S0022-3476(76)80538-0; TSUI LC, 1986, AM J HUM GENET, V39, P720; TSUI LC, 1985, SCIENCE, V230, P1054, DOI 10.1126/science.2997931; WAINWRIGHT BJ, 1985, NATURE, V318, P384, DOI 10.1038/318384a0; WHITE R, 1985, NATURE, V318, P382, DOI 10.1038/318382a0	40	53	56	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1989	44	3					307	318						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	T3535	2563631				2022-12-18	WOS:A1989T353500002
J	ROTWEIN, P; YOKOYAMA, S; DIDIER, DK; CHIRGWIN, JM				ROTWEIN, P; YOKOYAMA, S; DIDIER, DK; CHIRGWIN, JM			GENETIC-ANALYSIS OF THE HYPERVARIABLE REGION FLANKING THE HUMAN INSULIN GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									WASHINGTON UNIV,SCH MED,DEPT PSYCHIAT,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT ANAT,ST LOUIS,MO 63110	Washington University (WUSTL); Washington University (WUSTL)	ROTWEIN, P (corresponding author), WASHINGTON UNIV,SCH MED,DEPT INTERNAL MED,660 S EUCLID AVE,ST LOUIS,MO 63110, USA.		Rotwein, Peter/R-5783-2019	Rotwein, Peter/0000-0002-9505-1817				ANDREONE T, 1985, DIABETES, V34, P108, DOI 10.2337/diabetes.34.2.108; BELL GI, 1982, NATURE, V295, P31, DOI 10.1038/295031a0; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BELL JI, 1983, BRIT MED J, V286, P590, DOI 10.1136/bmj.286.6365.590; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; CAPON DJ, 1983, NATURE, V302, P33, DOI 10.1038/302033a0; EDLUND T, 1985, SCIENCE, V230, P912, DOI 10.1126/science.3904002; ELBEIN S, 1985, DIABETES, V34, P433, DOI 10.2337/diabetes.34.5.433; HARPER ME, 1981, P NATL ACAD SCI-BIOL, V78, P4458, DOI 10.1073/pnas.78.7.4458; HELMS C, 1985, DNA-J MOLEC CELL BIO, V4, P39, DOI 10.1089/dna.1985.4.39; HILL AVS, 1985, CELL, V42, P809, DOI 10.1016/0092-8674(85)90277-6; HITMAN GA, 1984, CLIN SCI, V66, P383, DOI 10.1042/cs0660383; HONG GF, 1982, J MOL BIOL, V158, P539, DOI 10.1016/0022-2836(82)90213-3; JOWETT NI, 1984, BRIT MED J, V288, P96, DOI 10.1136/bmj.288.6411.96; LARSON R, 1983, DNA-J MOLEC CELL BIO, V2, P31, DOI 10.1089/dna.1.1983.2.31; LEBO RV, 1983, P NATL ACAD SCI-BIOL, V80, P4808, DOI 10.1073/pnas.80.15.4808; MANDRUPPOULSEN T, 1984, LANCET, V1, P250; MANIATIS T, 1982, MOL CLONING LABORATO, P282; MIGONE N, 1983, P NATL ACAD SCI-BIOL, V80, P467, DOI 10.1073/pnas.80.2.467; NEI M, 1982, EVOL BIOL, V14, P1; Nei M., 1975, MOL POPULATION GENET; NORRANDER J, 1983, GENE, V26, P101, DOI 10.1016/0378-1119(83)90040-9; OWERBACH D, 1982, LANCET, V1, P880; OWERBACH D, 1982, LANCET, V2, P1291; OWERBACH D, 1981, DIABETES, V30, P267, DOI 10.2337/diabetes.30.3.267; OWERBACH D, 1982, DIABETES, V31, P275, DOI 10.2337/diabetes.31.3.275; OWERBACH D, 1980, NATURE, V286, P82, DOI 10.1038/286082a0; OWERBACH D, 1984, GENE, V32, P475, DOI 10.1016/0378-1119(84)90021-0; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; ROTWEIN P, 1981, SCIENCE, V213, P1117, DOI 10.1126/science.6267694; ROTWEIN PS, 1983, NEW ENGL J MED, V308, P65, DOI 10.1056/NEJM198301133080202; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; ULLRICH A, 1982, NUCLEIC ACIDS RES, V10, P2225, DOI 10.1093/nar/10.7.2225; WAHL GM, 1979, P NATL ACAD SCI USA, V76, P3683, DOI 10.1073/pnas.76.8.3683; WALKER MD, 1983, NATURE, V306, P557, DOI 10.1038/306557a0; Woo S L, 1979, Methods Enzymol, V68, P389; WYMAN AR, 1980, P NATL ACAD SCI-BIOL, V77, P6754, DOI 10.1073/pnas.77.11.6754	39	53	53	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1986	39	3					291	299						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	E3644	2876625				2022-12-18	WOS:A1986E364400001
J	ROBINSON, BH; MCKAY, N; GOODYER, P; LANCASTER, G				ROBINSON, BH; MCKAY, N; GOODYER, P; LANCASTER, G			DEFECTIVE INTRAMITOCHONDRIAL NADH OXIDATION IN SKIN FIBROBLASTS FROM AN INFANT WITH FATAL NEONATAL LACTIC-ACIDEMIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HOSP SICK CHILDREN,RES INST,TORONTO M5G 1X8,ONTARIO,CANADA; MONTREAL CHILDRENS HOSP,MONTREAL H3H 1P3,QUEBEC,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McGill University	ROBINSON, BH (corresponding author), UNIV TORONTO,DEPT PEDIAT & BIOCHEM,TORONTO M5S 1A1,ONTARIO,CANADA.							ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ATKIN BM, 1979, PEDIATR RES, V13, P38, DOI 10.1203/00006450-197901000-00009; BALLARD FJ, 1967, BIOCHEM J, V104, P866, DOI 10.1042/bj1040866; BLASS JP, 1983, METABOLIC BASIS INHE, P193; CLARK JB, 1983, BIOCHEM SOC T, V11, P626, DOI 10.1042/bst0110626; DIMAURO S, 1980, NEUROLOGY, V30, P795, DOI 10.1212/WNL.30.8.795; GOODYER PR, 1981, PEDIATR RES, V15, P562, DOI 10.1203/00006450-198104001-00741; HEIMANPATTERSON TD, 1982, NEUROLOGY, V32, P898, DOI 10.1212/WNL.32.8.898; HERON C, 1979, BIOCHEM J, V181, P435, DOI 10.1042/bj1810435; HYLAND K, 1983, CLIN CHIM ACTA, V133, P177, DOI 10.1016/0009-8981(83)90403-5; KUZELA S, 1981, FEBS LETT, V135, P89, DOI 10.1016/0014-5793(81)80950-7; MCKAY ND, 1983, BIOCHIM BIOPHYS ACTA, V762, P198, DOI 10.1016/0167-4889(83)90071-X; MIYABAYASHI S, 1983, J INHERIT METAB DIS, V6, P121, DOI 10.1007/BF01800742; MOREADITH RW, 1984, J CLIN INVEST, V74, P685, DOI 10.1172/JCI111484; MORGANHUGHES JA, 1977, BRAIN, V100, P617, DOI 10.1093/brain/100.4.617; MORGANHUGHES JA, 1979, J NEUROL SCI, V43, P27, DOI 10.1016/0022-510X(79)90071-6; ROBINSON BH, 1983, BIOCHEM SOC T, V11, P623, DOI 10.1042/bst0110623; ROBINSON BH, 1984, J INHERIT METAB DIS, V7, P69, DOI 10.1007/BF03047378; ROBINSON BH, 1980, PEDIATR RES, V14, P956, DOI 10.1203/00006450-198008000-00013; ROBINSON BH, 1983, EUR J PEDIATR, V140, P98, DOI 10.1007/BF00441651; ROBINSON BH, 1984, AM J HUM GENET, V36, P283; ROSAMOND J, 1982, BIOCHEM J, V202, P1; SHEU KFR, 1981, J CLIN INVEST, V67, P1463, DOI 10.1172/JCI110176; SPIRO AJ, 1970, ARCH NEUROL-CHICAGO, V23, P103, DOI 10.1001/archneur.1970.00480260009002; VANBIERVLIET JPGM, 1977, PEDIATR RES, V11, P1088, DOI 10.1203/00006450-197711100-00005; WILLEMS JL, 1977, PEDIATRICS, V60, P850; WILLIAMSON JR, 1969, METHOD ENZYMOL, V13, P435; ZURENDONK PF, 1979, BIOCH BIOPHYS ACTA, V333, P393	28	53	54	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	5					938	946						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ASD55	4050791				2022-12-18	WOS:A1985ASD5500011
J	MOHANDAS, T; SPARKES, RS; SHAPIRO, LJ				MOHANDAS, T; SPARKES, RS; SHAPIRO, LJ			GENETIC-EVIDENCE FOR THE INACTIVATION OF A HUMAN AUTOSOMAL LOCUS ATTACHED TO AN INACTIVE X-CHROMOSOME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note									UNIV CALIF LOS ANGELES, LOS ANGELES CTY HARBOR MED CTR, DEPT MED, DIV MED GENET, TORRANCE, CA 90509 USA; UNIV CALIF LOS ANGELES, LOS ANGELES CTY HARBOR MED CTR, DEPT PSYCHIAT, DIV MED GENET, TORRANCE, CA 90509 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	MOHANDAS, T (corresponding author), UNIV CALIF LOS ANGELES, LOS ANGELES CTY HARBOR MED CTR, DEPT PEDIAT, DIV MED GENET, TORRANCE, CA 90509 USA.				NICHD NIH HHS [HD-12178, HD-05616, HD-04612] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD004612] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD012178] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BEUTLER E, 1969, BIOCHEM GENET, V3, P189, DOI 10.1007/BF00520353; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; CHEN S, 1975, CYTOGENET CELL GENET, V14, P269, DOI 10.1159/000130360; COUTURIER J, 1979, HUM GENET, V49, P319, DOI 10.1007/BF00569351; CROSS HE, 1977, AM J OPHTHALMOL, V84, P548, DOI 10.1016/0002-9394(77)90450-0; DISTECHE CM, 1979, P NATL ACAD SCI USA, V76, P5234, DOI 10.1073/pnas.76.10.5234; EICHER EM, 1970, ADV GENET, V15, P175, DOI 10.1016/S0065-2660(08)60074-7; Harris, 1976, HDB ENZYME ELECTROPH; HOPKINSON DA, 1973, ANN HUM GENET, V37, P119, DOI 10.1111/j.1469-1809.1973.tb01820.x; JOHNSON GG, 1979, SCIENCE, V203, P174, DOI 10.1126/science.569362; LITTLEFIELD JW, 1964, SCIENCE, V145, P709, DOI 10.1126/science.145.3633.709; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; MOHANDAS T, 1977, P NATL ACAD SCI USA, V74, P5628, DOI 10.1073/pnas.74.12.5628; MOHANDAS T, 1981, SCIENCE, V211, P393, DOI 10.1126/science.6164095; MOHANDAS T, 1979, P NATL ACAD SCI USA, V76, P5779, DOI 10.1073/pnas.76.11.5779; NICHOLS WW, 1980, AM J OPHTHALMOL, V89, P621, DOI 10.1016/0002-9394(80)90276-7; RATTAZZI MC, 1972, NATURE, V237, P393, DOI 10.1038/237393a0; RAY M, 1972, NATURE, V237, P396, DOI 10.1038/237396a0; SPARKES RS, 1979, SCIENCE, V203, P1027, DOI 10.1126/science.424728; SPARKES RS, 1969, J LAB CLIN MED, V73, P531; SPARKES RS, 1980, SCIENCE, V208, P1042, DOI 10.1126/science.7375916; SUMMITT RL, 1978, BIRTH DEFECTS ORIG A, V14, P175; SZYBALSKA EH, 1962, P NATL ACAD SCI USA, V48, P2026, DOI 10.1073/pnas.48.12.2026; VANHEYNINGEN V, 1975, ANN HUM GENET, V38, P295; WILSON MG, 1977, CLIN GENET, V12, P1	25	53	54	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1982	34	5					811	817						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PH242	7124733				2022-12-18	WOS:A1982PH24200011
J	VOGEL, F				VOGEL, F			PROBABLE SEX DIFFERENCE IN SOME MUTATION-RATES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material									UNIV HEIDELBERG,INST HUMAN GENET,D-6900 HEIDELBERG 1,FED REP GER	Ruprecht Karls University Heidelberg								ANDREASSEN M, 1943, HAEMOFILI DANMARK; BARRAI I, 1968, AM J HUM GENET, V20, P175; BECKER PE, 1972, HUMANGENETIK, V17, P1, DOI 10.1007/BF01789595; BECKER PE, 1964, HUMANGENETIK, V3, P411; BIGGS R, 1976, LANCET, V2, P431; BITTER K, 1964, Z MENSCHL VERERBUNGS, V37, P251; CHEESEMAN EA, 1958, ANN HUM GENET, V22, P235, DOI 10.1111/j.1469-1809.1958.tb01418.x; DEUTSCH E., 1962, WIENER KLIN WOCHENSCHR, V74, P793; DIDISHEIM P, 1958, ARCH INTERN MED, V101, P347, DOI 10.1001/archinte.1958.00260140179027; DRAKE JW, 1969, MOLECULAR BASIS MUTA; FONIO A, 1961, GERINNUNGSFAKTOREN H; FONIO A, 1954, 10 SCHW AK MED WISS; FRANCKE U, 1977, AM J HUM GENET, V29, P307; FRANCKE V, 1976, AM J HUM GENET, V28, P123; GEORGES A, 1968, POPULATION, V23, P1055, DOI 10.2307/1528644; HALDANE JBS, 1947, ANN EUGENIC, V13, P262; HALDANE JBS, 1956, ANN HUM GENET, V20, P344; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; Haldane JBS, 1939, J GENET, V38, P193, DOI 10.1007/BF02982171; HERRMANN J, 1966, HUMANGENETIK, V3, P1, DOI 10.1007/BF00273014; IKKALA E, 1960, HAEMOPHILIA STUDY IT; KOSOWER D, 1962, AM J HUM GENET, V14, P159; Lehmann H, 1974, MANS HAEMOGLOBINS; MORTON NE, 1977, AM J HUM GENET, V29, P304; MORTON NE, 1956, P NATL ACAD SCI USA, V42, P855, DOI 10.1073/pnas.42.11.855; MORTON NE, 1959, AM J HUM GENET, V11, P360; NILSSON IM, 1959, ACTA MED SCAND, V165, P357; RATNOFF OD, IN PRESS; REITH W, 1970, THESIS MUNSTER; SEARLE AG, 1972, HUMANGENETIK, V16, P33, DOI 10.1007/BF00393982; SJOELIN KE, 1960, HAEMOPHILIC DISEASES; STEVENSON AC, 1953, ANN EUGENIC, V18, P50; STEVENSON AC, 1958, ANN HUM GENET, V22, P231, DOI 10.1111/j.1469-1809.1958.tb01417.x; VOGEL F, 1965, HUMANGENETIK, V1, P253, DOI 10.1007/BF00395656; VOGEL F, 1975, ADV HUM GENET, V5, P223; VOGEL F, 1955, BLUT, V1, P91; VOGEL F, 1956, Z MENSCHL VERERB KON, V34, P389; WALTON JN, 1955, ANN HUM GENET, V20, P1, DOI 10.1111/j.1469-1809.1955.tb01274.x	38	53	53	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1977	29	3					312	318						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DG794	868880				2022-12-18	WOS:A1977DG79400014
J	CHILDS, B; GORDIS, L; KABACK, MM; KAZAZIAN, HH				CHILDS, B; GORDIS, L; KABACK, MM; KAZAZIAN, HH			TAY-SACHS SCREENING - SOCIAL AND PSYCHOLOGICAL IMPACT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT EPIDEMIOL,BALTIMORE,MD 21205; HARBOR GEN HOSP,DEPT PEDIAT,TORRANCE,CA 90509	Johns Hopkins University; Johns Hopkins University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center								BECK E, 1974, NEW ENGL J MED, V291, P1166, DOI 10.1056/NEJM197411282912206; CHILDS B, 1976, AM J HUM GENET, V28, P537; KUHR MI, 1975, N ENGL J MED, V292, P271; ROSENSTOCK IM, 1975, GENETIC SCREENING ST; 1975, GENETIC SCREENING PR	5	53	53	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1976	28	6					550	558						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	CQ152	1032905				2022-12-18	WOS:A1976CQ15200002
J	CHING, GHS; CHUNG, CS				CHING, GHS; CHUNG, CS			GENETIC STUDY OF CLEFT-LIP AND PALATE IN HAWAII - INTERRACIAL CROSSES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV HAWAII,DEPT GENET,1960 EW RD,HONOLULU,HI 96822; UNIV HAWAII,DEPT PUBL HLTH,1960 EW RD,HONOLULU,HI 96822	University of Hawaii System; University of Hawaii System								BARDHAN A, 1967, ACTA GENET MED GEMEL, V16, P101, DOI 10.1017/S1120962300013317; CARTER C. O., 1965, PROGR MED GENET, V4, P59; CHUNG CS, 1968, AM J HUM GENET, V20, P44; CHUNG CS, 1974, AM J HUM GENET, V26, P177; DRAPER NR, 1966, APPLIED REGRESSION A; EDWARDS JH, 1969, BRIT MED BULL, V25, P58, DOI 10.1093/oxfordjournals.bmb.a070672; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; Fogh-Andersen, 1942, INHERITANCE HARELIP; FRASER FC, 1963, 2 P INT C HUM GEN, V3, P1852; FRASER GR, 1961, ARCH DIS CHILD, V36, P420, DOI 10.1136/adc.36.188.420; GREENE JC, 1964, J AM DENT ASSOC, V68, P387, DOI 10.14219/jada.archive.1964.0079; GRUNEBERG H, 1952, J GENET, V51, P95, DOI 10.1007/BF02986708; Hay S, 1967, Cleft Palate J, V4, P205; Kobayasi Y., 1958, JPN J HUM GENET, V3, P73; Krantz HC, 1947, J SPEECH DISORD, V12, P267, DOI 10.1044/jshd.1203.267; LECK I, 1972, TERATOLOGY, V5, P303, DOI 10.1002/tera.1420050305; MESKIN LH, 1967, J DENT RES, V46, P1456, DOI 10.1177/00220345670460065001; MI MP, 1967, 3 P INT C HUM GEN, P489; MORTON NE, 1971, AM J HUM GENET, V23, P602; MORTON NE, 1967, GENETICS INTERRACIAL; NEEL JV, 1958, AM J HUM GENET, V10, P398; PERRY TB, 1972, TERATOLOGY, V6, P241, DOI 10.1002/tera.1420060218; SMITH C, 1970, ANN HUM GENET, V34, P85, DOI 10.1111/j.1469-1809.1970.tb00223.x; SMITH C, 1971, AM J HUM GENET, V23, P578; WOOLF CM, 1963, AM J HUM GENET, V15, P389	25	53	54	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1974	26	2					162	176						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	S7582	4823025				2022-12-18	WOS:A1974S758200005
J	RARY, JM; BENDER, MA; KELLY, TE				RARY, JM; BENDER, MA; KELLY, TE			CYTOGENETIC STUDIES OF ATAXIA TELANGIECTASIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract									JOHNS HOPKINS UNIV,SCH MED,BALTIMORE,MD 21218	Johns Hopkins University									0	53	53	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1974	26	6					A70	A70						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V0911					2022-12-18	WOS:A1974V091100203
J	WOOD, S; NADLER, HL				WOOD, S; NADLER, HL			FABRYS-DISEASE - ABSENCE OF AN ALPHA-GALACTOSIDASE ISOENZYME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BRADY RO, 1967, NEW ENGL J MED, V276, P1163, DOI 10.1056/NEJM196705252762101; BRADY RO, 1971, SCIENCE, V172, P174, DOI 10.1126/science.172.3979.174; DESNICK RJ, 1971, NEW ENGL J MED, V284, P739, DOI 10.1056/NEJM197104082841401; GOLDSTON.A, 1971, FEBS LETT, V13, P68, DOI 10.1016/0014-5793(71)80667-1; HAKOMORI SI, 1971, J BIOL CHEM, V246, P2271; HANDA S, 1971, J BIOCHEM-TOKYO, V69, P625; KINT J A, 1970, Science (Washington D C), V167, P1268, DOI 10.1126/science.167.3922.1268; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAPES CA, 1970, SCIENCE, V169, P987, DOI 10.1126/science.169.3949.987; MATALON R, 1969, SCIENCE, V164, P1522, DOI 10.1126/science.164.3887.1522; NADLER HL, 1967, NATURE, V213, P1261, DOI 10.1038/2131261a0; OKADA S, 1969, SCIENCE, V165, P698, DOI 10.1126/science.165.3894.698; PORTER MT, 1969, P NATL ACAD SCI USA, V62, P887, DOI 10.1073/pnas.62.3.887; ROMEO G, 1970, SCIENCE, V170, P180, DOI 10.1126/science.170.3954.180; SWEELEY CC, 1963, J BIOL CHEM, V238, P3148; SWEELEY CHARLES C., 1966, P618	16	53	55	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1972	24	3					250	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M6948	5028965				2022-12-18	WOS:A1972M694800002
J	MORTON, NE; YEE, S; LEW, R				MORTON, NE; YEE, S; LEW, R			COMPLEX SEGREGATION ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BARRAI I, 1965, AM J HUM GENET, V17, P221; EDWARDS JH, 1967, 3RD P INT C HUM GEN, P483; ELANDTJOHNSON RC, 1970, AM J HUM GENET, V22, P129; ELSTON RC, IN PRESS; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; GINI C, 1911, STUDI EC GIURIDICI U, V3, P5; GRUNEBERG H, 1952, J GENET, V51, P95, DOI 10.1007/BF02986708; Hastings C., 1955, APPROXIMATIONS DIGIT, DOI 10.1515/9781400875597; HUSSELS I, IN PRESS; JACKSON JB, IN PRESS; LI CC, 1963, POPULATION GENETICS; MORTON N E, 1970, Clinical Genetics, V1, P81; MORTON NE, 1956, P NATL ACAD SCI USA, V42, P855, DOI 10.1073/pnas.42.11.855; MORTON NE, 1967, AM J HUM GENET, V19, P23; MORTON NE, 1969, COMPUTER APPLICATION, P129; SKELLAM JG, 1948, J ROY STAT SOC B, V10, P257; SMITH C, 1970, ANN HUM GENET, V34, P45	17	53	53	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1971	23	6					602	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	L2014	5132068				2022-12-18	WOS:A1971L201400007
J	LASKER, GW				LASKER, GW			OCCURRENCE OF IDENTICAL (ISONYMOUS) SURNAMES IN VARIOUS RELATIONSHIPS IN PEDIGREES - A PRELIMINARY ANALYSIS OF RELATION OF SURNAME COMBINATIONS TO INBREEDING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		CROW JF, 1965, EUGEN QUART, V12, P199, DOI 10.1080/19485565.1965.9987630; CROW JF, 1967, 3 P INT C HUM GEN ED, P249; LASKER GW, 1964, HUM BIOL, V36, P327; LASKER GW, 1965, HOMENAJE J COMAS 65, V2, P189; MORTON NE, 1963, 1 ENTR MON SCIENC HU, P185; SHAW RICHARD F., 1960, JOUR HEREDITY, V51, P221; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x; YASUDA N, 1967, 3RD P INT C HUM GEN, P249	8	53	53	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1968	20	3					250	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	B8693	5657360				2022-12-18	WOS:A1968B869300005
J	KATO, H; SCHULL, WJ; NEEL, JV				KATO, H; SCHULL, WJ; NEEL, JV			A COHORT-TYPE STUDY OF SURVIVAL IN CHILDREN OF PARENTS EXPOSED TO ATOMIC BOMBINGS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ARAKAWA ET, 1960, NEW ENGL J MED, V263, P488, DOI 10.1056/NEJM196009082631005; CHAPMAN AB, 1964, GENETICS, V50, P1029; COX DF, 1962, GENETICS, V47, P785; COX DF, 1964, GENETICS, V50, P1025; COX DW, 1964, AM J HUM GENET, V16, P214; CROW JF, 1955, AMER J ROENTGENOL RA, V73, P467; EISENHART C, TECHNIQUES STATISTIC; FISHER RA, 1938, STATISTICAL TABLES B; FROLEN H, 1965, MUTAT RES, V2, P287, DOI 10.1016/0027-5107(65)90039-4; JABLON S, 1963, 0163 ABCC TECHN REP; KAPLAN I I, 1957, Can Med Assoc J, V76, P43; KOHN HI, 1960, GENETICS, V45, P771; MACHT SH, 1955, AMER J ROENTGENOL RA, V73, P442; MCGREGOR JF, 1960, RADIAT RES, V12, P61, DOI 10.2307/3570823; MULLER HJ, 1950, AM J HUM GENET, V2, P111; NARUGE T, 1956, PRACTICE KOSEKI THEO; Neel JV, 1954, HUMAN HEREDITY; NEEL JV, 1963, CHANGING PERSPECTIVE; NEEL JV, 1956, 461 NAT AC SCIEN NAT; NEWCOMBE HB, 1965, AM J HUM GENET, V17, P163; NEWCOMBE HB, 1964, ANN HUM GENET, V27, P367; OHKURA K, 1960, JPN J HUM GENET, V5, P61; RITCHIE R H, 1959, Health Phys, V1, P390, DOI 10.1097/00004032-195810000-00004; RODERICK TH, 1964, GENETICS, V50, P1213; RUSSELL W L, 1959, Prog Nucl Energy 6 Biol Sci, V2, P179; RUSSELL WL, 1959, P NATL ACAD SCI USA, V45, P18, DOI 10.1073/pnas.45.1.18; RUSSELL WL, 1965, P NATL ACAD SCI USA, V54, P1552, DOI 10.1073/pnas.54.6.1552; RUSSELL WL, 1958, SCIENCE, V128, P1546, DOI 10.1126/science.128.3338.1546; RUSSELL WL, 1955, P INT C PEACEFUL USE, V2, P382; SCHULL WJ, 1959, AM J PUBLIC HEALTH N, V49, P1621, DOI 10.2105/AJPH.49.12.1621; SCHULL WJ, 1966, AM J HUM GENET, V18, P328; Schull WJ, 1965, EFFECTS INBREEDING J; SUGAHARA T, 1964, GENETICS, V50, P1143; TANAKA K, 1958, JPN J HUM GENET, V3, P135; TSUNODA R, 1956, KOSEKI NO SHIHYOINDE, V3, P2; YANASE T, 1962, USE VITAL HLTH STATI, P119; YERUSHALMY J., 1938, AMER JOUR HYG, V28, P244; 1958, GENERAL ASSEMBLY OFF; 1956, BIOLOGICAL EFFECTS A	39	53	53	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1966	18	4					339	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	81309	17948513				2022-12-18	WOS:A19668130900003
J	BERRY, H; SUTHERLAND, B; GUEST, GM				BERRY, H; SUTHERLAND, B; GUEST, GM			PHENYLALANINE TOLERANCE TESTS ON RELATIVES OF PHENYLKETONURIC CHILDREN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ARMSTRONG MD, 1955, J BIOL CHEM, V213, P797; ARMSTRONG MD, 1955, J BIOL CHEM, V213, P805; BERRY HK, 1957, P SOC EXP BIOL MED, V95, P71, DOI 10.3181/00379727-95-23124; BERRY HK, 1951, 5109 U TEX PUBL, P150; BERRY JP, 1952, NATURE, V169, P202, DOI 10.1038/169202a0; BOSCOTT RJ, 1953, SCAND J CLIN LAB INV, V5, P380, DOI 10.3109/00365515309094216; CAWTE J. E., 1954, MED JOUR AUSTRALIA, V2, P15; DALGLIESH CE, 1955, ARCH BIOCHEM BIOPHYS, V58, P214, DOI 10.1016/0003-9861(55)90108-9; DALGLIESH CE, 1954, BIOCHEM J, V58, pR45; DALGLIESH CE, 1955, ADV PROTEIN CHEM, V10, P52; Fisher R. A., 1950, STATISTICAL METHODS; FOLLING A., 1934, Nordisk medicinsk Tidsskrift, V8, P1054; HSIA DYY, 1956, NATURE, V178, P1239, DOI 10.1038/1781239a0; JERVIS GA, 1947, J BIOL CHEM, V169, P615; Jervis GA, 1939, J MENT SCI, V85, P719, DOI 10.1192/bjp.85.357.719; Penrose LS, 1935, LANCET, V2, P192; WOOLF LI, 1951, BIOCHEM J, V49, pR9	17	53	53	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1957	9	4					310	316						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA217	13497999				2022-12-18	WOS:A1957WA21700005
J	STECHER, RM; HERSH, AH; SOLOMON, WM; WOLPAW, R				STECHER, RM; HERSH, AH; SOLOMON, WM; WOLPAW, R			THE GENETICS OF RHEUMATOID ARTHRITIS - ANALYSIS OF 224 FAMILIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BARTER RW, 1952, ANN RHEUM DIS, V11, P39, DOI 10.1136/ard.11.1.39; Bell Julia, 1935, TREASURY HUMAN INH 2, VIV; BERGLUND S, 1940, NORD MED, V8, P2272; Child G, 1935, GENETICS, V20, P0127; DAVIDSON LSP, 1952, RHEUMATIC DISEASES; DUNN LC, 1940, HARVEY LECT, V35, P135; Edstrom G, 1941, ACTA MED SCAND, V108, P398; GORDON M, 1951, GROWTH S, V10, P153; HANGARTER W, 1939, ERBBILD RHEUMATISCHE; HESTON W. E., 1951, GROWTH, V15, P23; Hogben Lancelot, 1933, NATURE NURTURE; HOLSTI O., 1938, ACTA MED SCAND SUPPL, V89, P128; LEWISFANING E, 1950, ANN RHEUMATIC DIS S, V9; LITTLE CC, 1947, GENETICS MED MAN, pCH3; Osborn D, 1916, J HERED, V7, P347, DOI 10.1093/oxfordjournals.jhered.a110746; Pemberton Roland, COMMUNICATION; Penrose LS, 1938, CLIN GENETIC STUDY 1; SHORT CL, 1952, RHEUMATIC DISEASES; Snyder LH, 1946, PRINCIPLES HEREDITY, V3; Stecher RM, 1944, J CLIN INVEST, V23, P699, DOI 10.1172/JCI101540; WHITTINGHILL M, 1951, J E MITCHELL SCI SOC, V67, P185; Wright S, 1934, GENETICS, V19, P0537; Wright S, 1934, GENETICS, V19, P0471; ZELLNER E, 1930, WIEN ARCH INN MED, V19, P477	24	53	54	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1953	5	2					118	138						21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XW630	13065260				2022-12-18	WOS:A1953XW63000002
J	Tankard, RM; Bennett, ME; Degorski, P; Delatycki, MB; Lockhart, PJ; Bahlo, M				Tankard, Rick M.; Bennett, Mark E.; Degorski, Peter; Delatycki, Martin B.; Lockhart, Paul J.; Bahlo, Melanie			Detecting Expansions of Tandem Repeats in Cohorts Sequenced with Short-Read Sequencing Data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA-REPAIR; DIAGNOSIS; BIAS	Repeat expansions cause more than 30 inherited disorders, predominantly neurogenetic. These can present with overlapping clinical phenotypes, making molecular diagnosis challenging. Single-gene or small-panel PCR-based methods can help to identify the precise genetic cause, but they can be slow and costly and often yield no result. Researchers are increasingly performing genomic analysis via whole-exome and whole-genome sequencing (WES and WGS) to diagnose genetic disorders. However, until recently, analysis protocols could not identify repeat expansions in these datasets. We developed exSTRa (expanded short tandem repeat algorithm), a method that uses either WES or WGS to identify repeat expansions. Performance of exSTRa was assessed in a simulation study. In addition, four retrospective cohorts of individuals with eleven different known repeat-expansion disorders were analyzed with exSTRa. We assessed results by comparing the findings to known disease status. Performance was also compared to three other analysis methods (ExpansionHunter, STRetch, and TREDPARSE), which were developed specifically for WGS data. Expansions in the assessed STR loci were successfully identified in WES and WGS datasets by all four methods with high specificity and sensitivity. Overall, exSTRa demonstrated more robust and superior performance for WES data than did the other three methods. We demonstrate that exSTRa can be effectively utilized as a screening tool for detecting repeat expansions in WES and WGS data, although the best performance would be produced by consensus calling, wherein at least two out of the four currently available screening methods call an expansion.	[Tankard, Rick M.; Bennett, Mark E.; Degorski, Peter; Bahlo, Melanie] Walter & Eliza Hall Inst Med Res, Populat Hlth & Immun Div, Parkville, Vic 3052, Australia; [Tankard, Rick M.; Bennett, Mark E.; Degorski, Peter; Bahlo, Melanie] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia; [Tankard, Rick M.] Murdoch Univ, Math & Stat, Murdoch, WA 6150, Australia; [Bennett, Mark E.] Univ Melbourne, Epilepsy Res Ctr, Dept Med, Austin Hlth, Heidelberg, Vic 3084, Australia; [Delatycki, Martin B.; Lockhart, Paul J.] Royal Childrens Hosp, Bruce Lefroy Ctr Genet Hlth Res, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Delatycki, Martin B.; Lockhart, Paul J.] Victorian Clin Genet Serv, Parkville, Vic 3052, Australia; [Delatycki, Martin B.; Lockhart, Paul J.] Univ Melbourne, Dept Paediat, Parkville, Vic 3058, Australia	Walter & Eliza Hall Institute; University of Melbourne; Murdoch University; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne	Bahlo, M (corresponding author), Walter & Eliza Hall Inst Med Res, Populat Hlth & Immun Div, Parkville, Vic 3052, Australia.; Bahlo, M (corresponding author), Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia.	bahlo@wehi.edu.au	Lockhart, Paul J/E-7753-2011	Lockhart, Paul J/0000-0003-2531-8413; Tankard, Rick M/0000-0002-8847-9401; Bennett, Mark/0000-0002-3561-6804; Bahlo, Melanie/0000-0001-5132-0774	Australian Postgraduate Award; Edith Moffat fund; Australian National Health and Medical Research Council (NHMRC) Career Development Award Level 2 [GNT1032364]; NHMRC [GNT1054618]; NHMRC Senior Research Fellowship [GNT1102971]; Victorian Government's Operational Infrastructure Support Program; NHMRC Independent Research Institute Infrastructure Support Scheme (IRIISS)	Australian Postgraduate Award(Australian Government); Edith Moffat fund; Australian National Health and Medical Research Council (NHMRC) Career Development Award Level 2(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program; NHMRC Independent Research Institute Infrastructure Support Scheme (IRIISS)(National Health and Medical Research Council (NHMRC) of Australia)	We would like to thank Egor Dolzhenko and Michael Eberle (Illumina), who produced the STR specification files for Expansion-Hunter and who facilitated access to the dataset EGA00001003562 from the European Genome-Phenome Archive. We thank Leslie Burnett, Ben Lundie, Katie Ayres, and Andrew Sinclair for granting access to control datasets. We also thank Kate Pope and Greta Gillies for assistance with recruitment and sample preparation. R.M.T. was supported by an Australian Postgraduate Award and funding from the Edith Moffat fund. P.J.L. was supported by the Australian National Health and Medical Research Council (NHMRC) Career Development Award Level 2 (GNT1032364). M.B. was supported by an NHMRC Program Grant (GNT1054618) and an NHMRC Senior Research Fellowship (GNT1102971). This work was supported by the Victorian Government's Operational Infrastructure Support Program and the NHMRC Independent Research Institute Infrastructure Support Scheme (IRIISS).	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Ashley EA, 2015, JAMA-J AM MED ASSOC, V313, P2119, DOI 10.1001/jama.2015.3595; Bahlo Melanie, 2018, F1000Res, V7, DOI 10.12688/f1000research.13980.1; Benjamini Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks001; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bettencourt C, 2016, ANN NEUROL, V79, P983, DOI 10.1002/ana.24656; Dashnow H, 2018, DETECTING TANDEM REP, V19, P121, DOI DOI 10.1186/; Dolzhenko E, 2017, GENOME RES, V27, P1895, DOI 10.1101/gr.225672.117; Gymrek M, 2012, GENOME RES, V22, P1154, DOI 10.1101/gr.135780.111; Hagerman R, 2013, LANCET NEUROL, V12, P786, DOI 10.1016/S1474-4422(13)70125-X; Hagerman RJ, 2015, CURR OPIN PSYCHIATR, V28, P107, DOI 10.1097/YCO.0000000000000131; Hannan AJ, 2018, NAT REV GENET, V19, P286, DOI 10.1038/nrg.2017.115; Highnam G, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks981; Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708; Hunter J, 2014, AM J MED GENET A, V164, P1648, DOI 10.1002/ajmg.a.36511; Ishiura H, 2018, NAT GENET, V50, P581, DOI 10.1038/s41588-018-0067-2; Jones L, 2017, LANCET NEUROL, V16, P88, DOI 10.1016/S1474-4422(16)30350-7; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee JM, 2015, CELL, V162, P516, DOI 10.1016/j.cell.2015.07.003; Ligsay A, 2016, INTRACTABLE RARE DIS, V5, P158, DOI 10.5582/irdr.2016.01045; Cao MD, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1313; Mousavi N, 2018, BIORXIV, DOI [10.1101/361162, DOI 10.1101/361162]; Nemeth AH, 2013, BRAIN, V136, P3106, DOI 10.1093/brain/awt236; Pedersen BS, 2017, AM J HUM GENET, V100, P406, DOI 10.1016/j.ajhg.2017.01.017; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rehm HL, 2017, NAT REV GENET, V18, P259, DOI 10.1038/nrg.2016.162; Schulz JB, 2009, NAT REV NEUROL, V5, P222, DOI 10.1038/nrneurol.2009.26; Seixas AI, 2017, AM J HUM GENET, V101, P87, DOI 10.1016/j.ajhg.2017.06.007; Seltzer MM, 2012, AM J MED GENET B, V159B, P589, DOI 10.1002/ajmg.b.32065; Tae H, 2014, BIOINFORMATICS, V30, P652, DOI 10.1093/bioinformatics/btt595; Tang HB, 2017, AM J HUM GENET, V101, P700, DOI 10.1016/j.ajhg.2017.09.013; Tassone F, 2014, JAMA NEUROL, V71, P355, DOI 10.1001/jamaneurol.2013.4808; Willems T, 2017, NAT METHODS, V14, P590, DOI [10.1038/NMETH.4267, 10.1038/nmeth.4267]	33	52	53	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 6	2018	103	6					858	873		10.1016/j.ajhg.2018.10.015	http://dx.doi.org/10.1016/j.ajhg.2018.10.015			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HD4YX	30503517	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000452535600003
J	Zhu, FX; Liu, C; Wang, FS; Yang, XY; Zhang, JJ; Wu, H; Zhang, ZG; He, XJ; Zhang, Z; Zhou, P; Wei, ZL; Shang, YL; Wang, L; Zhang, RD; Ouyang, YC; Sun, QY; Cao, YX; Li, W				Zhu, Fuxi; Liu, Chao; Wang, Fengsong; Yang, Xiaoyu; Zhang, Jingjing; Wu, Huan; Zhang, Zhiguo; He, Xiaojin; Zhang, Zhou; Zhou, Ping; Wei, Zhaolian; Shang, Yongliang; Wang, Lina; Zhang, Ruidan; Ouyang, Ying-Chun; Sun, Qing-Yuan; Cao, Yunxia; Li, Wei			Mutations in PMFBP1 Cause Acephalic Spermatozoa Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEAD-TO-TAIL; CONNECTING-PIECE; GENETIC-ASPECTS; MALE-FERTILITY; SPERM DEFECT; 2 BROTHERS; MOUSE; SPERMATOGENESIS; FERTILIZATION; ODF1/HSPB10	Acephalic spermatozoa syndrome is a severe teratozoospermia that leads to male infertility. Our previous work showed that biallelic SUN5 mutations are responsible for acephalic spermatozoa syndrome in about half of affected individuals, while pathogenic mechanisms in the other individuals remain to be elucidated. Here, we identified a homozygous nonsense mutation in the testis-specific gene PMFBP1 using whole-exome sequencing in a consanguineous family with two infertile brothers with acephalic spermatozoa syndrome. Sanger sequencing of PMFBP1 in ten additional infertile men with acephalic spermatozoa syndrome and without SUN5 mutations revealed two homozygous variants and one compound heterozygous variant. The disruption of Pmfbp1 in male mice led to infertility due to the production of acephalic spermatozoa and the disruption of PMFBP1's cooperation with SUN5 and SPATA6, which plays a role in connecting sperm head to the tail. PMFBP1 mutation-associated male infertility could be successfully overcome by intracytoplasmic sperm injection (ICSI) in both mouse and human. Thus, mutations in PMFBP1 are an important cause of infertility in men with acephalic spermatozoa syndrome.	[Zhu, Fuxi; Zhang, Jingjing; Wu, Huan; Zhang, Zhiguo; He, Xiaojin; Zhang, Zhou; Zhou, Ping; Wei, Zhaolian; Cao, Yunxia] Anhui Med Univ, Affiliated Hosp 1, Reprod Med Ctr, Dept Obstet & Gynecol, Hefei 230022, Anhui, Peoples R China; [Liu, Chao; Shang, Yongliang; Wang, Lina; Zhang, Ruidan; Ouyang, Ying-Chun; Sun, Qing-Yuan; Li, Wei] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China; [Zhu, Fuxi; Zhang, Jingjing; Wu, Huan; Zhang, Zhiguo; He, Xiaojin; Zhang, Zhou; Zhou, Ping; Wei, Zhaolian; Cao, Yunxia] Anhui Med Univ, Anhui Prov Key Lab Reprod Hlth & Genet, Hefei 230022, Anhui, Peoples R China; [Liu, Chao; Shang, Yongliang; Wang, Lina; Zhang, Ruidan; Ouyang, Ying-Chun; Sun, Qing-Yuan; Li, Wei] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China; [Wang, Fengsong] Anhui Med Univ, Sch Life Sci, Hefei 230022, Anhui, Peoples R China; [Yang, Xiaoyu] Nanjing Med Univ, Affiliated Hosp 1, Clin Ctr Reprod Med, State Key Lab Reprod Med, Nanjing 210029, Jiangsu, Peoples R China; [Zhang, Zhiguo; He, Xiaojin; Zhou, Ping; Wei, Zhaolian; Cao, Yunxia] Anhui Prov Engn Technol Res Ctr Biopreservat & Ar, Hefei 230022, Anhui, Peoples R China	Anhui Medical University; Chinese Academy of Sciences; Institute of Zoology, CAS; Anhui Medical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Anhui Medical University; Nanjing Medical University	Cao, YX (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Reprod Med Ctr, Dept Obstet & Gynecol, Hefei 230022, Anhui, Peoples R China.; Li, W (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.; Cao, YX (corresponding author), Anhui Med Univ, Anhui Prov Key Lab Reprod Hlth & Genet, Hefei 230022, Anhui, Peoples R China.; Li, W (corresponding author), Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China.; Cao, YX (corresponding author), Anhui Prov Engn Technol Res Ctr Biopreservat & Ar, Hefei 230022, Anhui, Peoples R China.	caoyunxia6@126.com; leways@ioz.ac.cn	杨, 玉/W-7221-2019; Wu, Huan/AAL-7095-2021		National key R&D program of China [2016YFA0500901]; National Natural Science Foundation of China [81401251, 81572283, 31771501]; Scientific Research Foundation of the Institute for Translational Medicine of Anhui Province [SRFITMAP 2017zhyx29]	National key R&D program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation of the Institute for Translational Medicine of Anhui Province	We thank Tracey Baas for critical reading of the manuscript and Dr. Wei Yan for kindly gifting the SPATA6 antibody. This work was supported by the National key R&D program of China (grant no. 2016YFA0500901), the National Natural Science Foundation of China (81401251, 81572283, 31771501), and Scientific Research Foundation of the Institute for Translational Medicine of Anhui Province (SRFITMAP 2017zhyx29).	BACCETTI B, 1989, GAMETE RES, V23, P181, DOI 10.1002/mrd.1120230205; Chemes HE, 1999, HUM REPROD, V14, P1811, DOI 10.1093/humrep/14.7.1811; CHEMES HE, 1987, FERTIL STERIL, V47, P310; De Braekeleer M, 2015, J ASSIST REPROD GEN, V32, P615, DOI 10.1007/s10815-015-0433-2; Elkhatib RA, 2017, HUM MOL GENET, V26, P3167, DOI 10.1093/hmg/ddx200; Fang JZ, 2018, HUM REPROD, V33, P372, DOI 10.1093/humrep/dex382; Gardner DK, 1999, TOWARDS REPRODUCTIVE CERTAINTY, P378; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Inhorn MC, 2015, HUM REPROD UPDATE, V21, P411, DOI 10.1093/humupd/dmv016; IRONS MJ, 1983, J ULTRA MOL STRUCT R, V82, P27, DOI 10.1016/S0022-5320(83)90094-1; Kierszenbaum AL, 2011, DEV DYNAM, V240, P723, DOI 10.1002/dvdy.22563; Li L, 2017, ONCOTARGET, V8, P19914, DOI 10.18632/oncotarget.15251; Liska F, 2009, BIOL REPROD, V81, P1196, DOI 10.1095/biolreprod.109.078980; Manandhar G, 2000, HUM REPROD, V15, P256, DOI 10.1093/humrep/15.2.256; Mendoza-Lujambio I, 2002, HUM MOL GENET, V11, P1647, DOI 10.1093/hmg/11.14.1647; Netzel-Arnett S, 2009, BIOL REPROD, V81, P921, DOI 10.1095/biolreprod.109.076273; Ohuchi J, 2001, MOL REPROD DEV, V59, P350, DOI 10.1002/mrd.1041; Pasek RC, 2016, DEV BIOL, V412, P208, DOI 10.1016/j.ydbio.2016.01.042; PEROTTI ME, 1981, J REPROD FERTIL, V63, P543; Perrin A, 2013, ANDROLOGIA, V45, P1, DOI 10.1111/j.1439-0272.2012.01308.x; Porcu G, 2003, HUM REPROD, V18, P562, DOI 10.1093/humrep/deg121; Ray PF, 2017, CLIN GENET, V91, P217, DOI 10.1111/cge.12905; Schatten H, 2009, MOL HUM REPROD, V15, P531, DOI 10.1093/molehr/gap049; Sha YW, 2018, CLIN GENET, V93, P776, DOI 10.1111/cge.13140; Shang YL, 2018, J BIOL CHEM, V293, P2395, DOI 10.1074/jbc.RA117.000861; Shang YL, 2017, ELIFE, V6, DOI [10.7554/eLife.28199.001, 10.7554/eLife.28199]; Tokuhiro K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000712; Wang HN, 2014, CELL RES, V24, P852, DOI 10.1038/cr.2014.70; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yang KF, 2014, REPRODUCTION, V148, P499, DOI 10.1530/REP-14-0370; Yang KF, 2012, MOL CELL BIOL, V32, P216, DOI 10.1128/MCB.06158-11; Yuan SQ, 2015, P NATL ACAD SCI USA, V112, pE430, DOI 10.1073/pnas.1424648112; Zhu FX, 2016, AM J HUM GENET, V99, P942, DOI 10.1016/j.ajhg.2016.08.004	33	52	59	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 2	2018	103	2					188	199		10.1016/j.ajhg.2018.06.010	http://dx.doi.org/10.1016/j.ajhg.2018.06.010			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GP1GR	30032984	Green Published, Bronze			2022-12-18	WOS:000440563700002
